FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Hermann, G
   Coudray, N
   Buessler, JL
   Caujolle-Bert, D
   Remigy, HW
   Urban, JP
AF Hermann, Gilles
   Coudray, Nicolas
   Buessler, Jean-Luc
   Caujolle-Bert, Daniel
   Remigy, Herve-William
   Urban, Jean-Philippe
TI ANIMATED-TEM: a toolbox for electron microscope automation based on
   image analysis
SO MACHINE VISION AND APPLICATIONS
LA English
DT Article
DE Automated image acquisition; Transmission electron microscope; Target
   selection; Specimen characterization; Fully automated electron
   microscope
ID DATA-ACQUISITION; TOMOGRAPHY; SYSTEM; RECONSTRUCTION; PARTICLES;
   LEGINON; ICE
AB To automate electron microscopy tasks, the main challenge is to integrate image interpretation. This article presents a first achievement in the domain of electron microscopy. ANalysis of IMages for Automatic Targeting and Extraction of Data in Transmission Electron Microscopy (ANIMATED-TEM) is a software toolbox composed of a set of image analysis algorithms and an examination scenario. Combined with microscope software, it runs all the microscope tasks and manages the exploration strategy of the carbon-coated grids on which the sample of interest (viruses, proteins, bi-dimensional crystal of membrane proteins, etc.) has been deposited. ANIMATED-TEM realizes the automatic examination of biological samples, working at several magnifications without human intervention. Online image analysis of micrographs is an essential part both to extract characteristic data and to manage automation, as interesting regions need to be identified to trigger new acquisitions at higher magnifications. This toolbox has been developed to perform high-throughput screening of 2D-crystallization experiments. It is operational on a microscope equipped with an automatic grid loading system, allowing the continuous and automatic analysis of up to 96 samples. Intensive testing over a period of several months confirms that ANIMATED-TEM achieves full automation with an efficient target selection and in a suitable computational time.
C1 [Hermann, Gilles; Coudray, Nicolas; Buessler, Jean-Luc; Urban, Jean-Philippe] Univ Haute Alsace, MIPS Lab, Mulhouse, France.
   [Caujolle-Bert, Daniel; Remigy, Herve-William] Univ Basel, Biozentrum, C CINA, ME Mueller Inst Struct Biol, Basel, Switzerland.
   [Remigy, Herve-William] FEI Electron Opt BV, Eindhoven, Netherlands.
RP Urban, JP (corresponding author), Univ Haute Alsace, MIPS Lab, Mulhouse, France.
EM Jean-Philippe.Urban@uha.fr
RI Coudray, Nicolas/O-5935-2015
OI Coudray, Nicolas/0000-0002-6050-2219
FU EUEuropean Union (EU) [HT3DEM, LSHG-CT-2005-018811]
FX This work was supported by the EU 6th framework (HT3DEM,
   LSHG-CT-2005-018811). Francoise Erne-Brand is warmly acknowledged for
   sample preparations and data acquisitions.
CR Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074
   Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020
   Cheng A, 2007, J STRUCT BIOL, V160, P324, DOI 10.1016/j.jsb.2007.09.012
   Coudray N, 2007, LECT NOTES COMPUT SC, V4633, P1005
   Coudray N, 2011, J STRUCT BIOL, V173, P365, DOI 10.1016/j.jsb.2010.09.019
   Coudray N, 2010, PATTERN RECOGN LETT, V31, P1010, DOI 10.1016/j.patrec.2009.12.025
   DIERKSEN K, 1995, BIOPHYS J, V68, P1416, DOI 10.1016/S0006-3495(95)80314-0
   FAN GY, 1993, ULTRAMICROSCOPY, V52, P499, DOI 10.1016/0304-3991(93)90066-7
   Fung JC, 1996, J STRUCT BIOL, V116, P181, DOI 10.1006/jsbi.1996.0029
   Hermann G., 2011, ISRN SIGNAL PROCESSI, V2011, P10
   Hermann G., 2010, 2010 INT C BIOINF CO
   Hu MH, 2010, J STRUCT BIOL, V171, P102, DOI 10.1016/j.jsb.2010.02.018
   Karathanou A., 2009, DIGITAL IMAGING SENS
   Karathanou A, 2010, ADV EXP MED BIOL, V680, P327, DOI 10.1007/978-1-4419-5913-3_37
   Kisseberth N, 1997, J STRUCT BIOL, V120, P309, DOI 10.1006/jsbi.1997.3918
   KOSTER AJ, 1992, ULTRAMICROSCOPY, V46, P207, DOI 10.1016/0304-3991(92)90016-D
   Kylberg G, 2009, LECT NOTES COMPUT SC, V5575, P169, DOI 10.1007/978-3-642-02230-2_18
   Lefman J, 2007, J STRUCT BIOL, V158, P318, DOI 10.1016/j.jsb.2006.11.007
   Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4
   Nicholson WV, 2001, J STRUCT BIOL, V133, P90, DOI 10.1006/jsbi.2001.4348
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9
   Potter CS, 2004, J STRUCT BIOL, V146, P431, DOI 10.1016/j.jsb.2004.02.002
   Shi J, 2008, J STRUCT BIOL, V164, P166, DOI 10.1016/j.jsb.2008.05.011
   Stagg SM, 2006, J STRUCT BIOL, V155, P470, DOI 10.1016/j.jsb.2006.04.005
   Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010
   Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019
   Zhang JJ, 2009, J STRUCT BIOL, V165, P1, DOI 10.1016/j.jsb.2008.09.006
   Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005
NR 31
TC 2
Z9 2
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-8092
EI 1432-1769
J9 MACH VISION APPL
JI Mach. Vis. Appl.
PD JUL
PY 2012
VL 23
IS 4
SI SI
BP 691
EP 711
DI 10.1007/s00138-011-0357-5
PG 21
WC Computer Science, Artificial Intelligence; Computer Science,
   Cybernetics; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA 958EY
UT WOS:000305220500007
DA 2021-01-25
ER

PT J
AU Papadopoulos, DK
   Skouloudaki, K
   Adachi, Y
   Samakovlis, C
   Gehring, WJ
AF Papadopoulos, Dimitrios K.
   Skouloudaki, Kassiani
   Adachi, Yoshitsugu
   Samakovlis, Christos
   Gehring, Walter J.
TI Dimer formation via the homeodomain is required for function and
   specificity of Sex combs reduced in Drosophila
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Sex combs reduced; Homeodomain dimerization; Antennapedia; ELEKEF motif;
   Transcriptional specificity; Homeotic function
ID SALIVARY-GLAND DETERMINATION; ANTENNAPEDIA HOMEODOMAIN; DNA-BINDING;
   GENE-EXPRESSION; HOX SPECIFICITY; IN-VIVO; PROTEIN; COMPLEX; CELLS;
   EXTRADENTICLE
AB Hox transcription factors specify body segments along the anteroposterior axis of the embryo. Despite conservation of the homeodomain (HD), different Hox paralogs instruct remarkably different developmental fates. We have unexpectedly found that the Drosophila Sex combs reduced (Scr) protein dimerizes in vivo via the homeodomain, whereas its closest relative, Antennapedia (Antp), does not. Dimerization requires the conserved residue 19 in the ELEKEF motif of the HD and is facilitated by DNA binding. To study Scr dimerization in vivo, we generate a giant transcriptional puff in live salivary gland cells, consisting of a controllable multiple Scr-binding site of the fork head enhancer, and visualize Scr dimer formation upon specific DNA binding. Scr dimerization is required not only for transcriptional activation of the fork head gene but also for Scr homeotic function in the fly (formation of ectopic salivary glands, posterior transformations in the embryo and antenna-to-tarsus transformations). Finally, we attempt to attribute the differential behavior in dimer formation observed between Antp and Scr to diverse amino acid regions between the two proteins that account for dimerization in Scr versus non-dimerization in Antp. By constructing hybrid Antp proteins, we find that the C terminus and linker region between the YPWM motif and the HD of Scr are independently sufficient to confer dimer formation in Antp, whereas the long N terminus of the protein and the HD are largely dispensable. Our results indicate that Scr functions as a homodimer to increase its transcriptional specificity and suggest that the formation of HD homo- or heterodimers might underlie the functional distinction between very similar HD proteins in vivo. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Papadopoulos, Dimitrios K.; Skouloudaki, Kassiani; Adachi, Yoshitsugu; Samakovlis, Christos; Gehring, Walter J.] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
OI Papadopoulos, Dimitrios/0000-0003-0914-3051
FU Kanton of Basel-Stadt; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [PBBSP-138700]; European Network of Excellence
   "Cells into Organs"; European Molecular Biology OrganizationEuropean
   Molecular Biology Organization (EMBO) [ASTF 499-2010]; Federation of
   European Biochemical Societies; Wenner-Gren stipendium fran Wenner-Gren
   Stiftelserna; Kanton of Basel-Landschaft
FX This work was supported by the Kantons of Basel-Stadt and
   Basel-Landschaft, a grant from the Swiss National Science Foundation and
   the European Network of Excellence "Cells into Organs". D.K.P. has been
   also supported by a European Molecular Biology Organization short term
   fellowship (ASTF 499-2010), a long term fellowship from the Swiss
   National Science Foundation (PBBSP-138700) and a long term fellowship
   from the Federation of European Biochemical Societies. KS. was supported
   by a Wenner-Gren stipendium fran Wenner-Gren Stiftelserna.
CR AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093
   Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10
   Berry M, 2000, EMBO J, V19, P2946, DOI 10.1093/emboj/19.12.2946
   BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661
   Birrane G, 2009, BIOCHEMISTRY-US, V48, P1148, DOI 10.1021/bi802052y
   Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252
   Duncan D, 2010, DEV BIOL, V347, P82, DOI 10.1016/j.ydbio.2010.08.012
   FURUKUBOTOKUNAGA K, 1993, P NATL ACAD SCI USA, V90, P6360, DOI 10.1073/pnas.90.13.6360
   Gehring WJ, 2009, CURR TOP DEV BIOL, V88, P35, DOI 10.1016/S0070-2153(09)88002-2
   GIBSON G, 1988, DEVELOPMENT, V102, P657
   Grieder NC, 2000, DEVELOPMENT, V127, P4253
   Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3
   Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024
   Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200
   Lelli KM, 2011, P NATL ACAD SCI USA, V108, P21122, DOI 10.1073/pnas.1114118109
   Lopes FJP, 2005, J THEOR BIOL, V235, P185, DOI 10.1016/j.jtbi.2005.01.002
   Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4
   Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3
   MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x
   PANZER S, 1992, DEVELOPMENT, V114, P49
   Papadopoulos D.K., 2011, P NATL ACAD SCI US
   Papadopoulos DK, 2010, P NATL ACAD SCI USA, V107, P4087, DOI 10.1073/pnas.0914595107
   Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833
   Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802
   Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105
   QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8
   QIAN YQ, 1992, P NATL ACAD SCI USA, V89, P10738, DOI 10.1073/pnas.89.22.10738
   Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704
   Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645
   Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053
   SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435
   STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585
   Vukojevic V, 2010, P NATL ACAD SCI USA, V107, P4093, DOI 10.1073/pnas.0914612107
   Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105
   Zhang HL, 2009, STEM CELLS, V27, P2884, DOI 10.1002/stem.203
   Zhou B, 2001, DEV BIOL, V237, P54, DOI 10.1006/dbio.2001.0367
NR 36
TC 17
Z9 17
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD JUL 1
PY 2012
VL 367
IS 1
BP 78
EP 89
DI 10.1016/j.ydbio.2012.04.021
PG 12
WC Developmental Biology
SC Developmental Biology
GA 957LA
UT WOS:000305163300007
PM 22564794
OA Bronze
DA 2021-01-25
ER

PT J
AU Barrera, B
   Otero, JA
   Egido, E
   Prieto, JG
   Seelig, A
   Alvarez, AI
   Merino, G
AF Barrera, Borja
   Otero, Jon A.
   Egido, Estefania
   Prieto, Julio G.
   Seelig, Anna
   Alvarez, Ana I.
   Merino, Gracia
TI The Anthelmintic Triclabendazole and Its Metabolites Inhibit the
   Membrane Transporter ABCG2/BCRP
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN; MILK SECRETION; DRUG
   INTERACTIONS; IN-VITRO; BCRP/ABCG2; PHARMACOKINETICS; NITROFURANTOIN;
   CELLS; SHEEP
AB ABCG2/BCRP is an ATP-binding cassette transporter that extrudes compounds from cells in the intestine, liver, kidney, and other organs, such as the mammary gland, affecting pharmacokinetics and milk secretion of antibiotics, anticancer drugs, and other compounds and mediating drug-drug interactions. In addition, ABCG2 expression in cancer cells may directly cause resistance by active efflux of anticancer drugs. The development of ABCG2 modulators is critical in order to improve drug pharmacokinetic properties, reduce milk secretion of xenotoxins, and/or increase the effective intracellular concentrations of substrates. Our purpose was to determine whether the anthelmintic triclabendazole (TCBZ) and its main plasma metabolites triclabendazole sulfoxide (TCBZSO) and triclabendazole sulfone (TCBZSO(2)) inhibit ABCG2 activity. ATPase assays using human ABCG2-enriched membranes demonstrated a clear ABCG2 inhibition exerted by these compounds. Mitoxantrone accumulation assays using murine Abcg2- and human ABCG2-transduced MDCK-II cells confirmed that TCBZSO and TCBZSO(2) are ABCG2 inhibitors, reaching inhibitory potencies between 40 and 55% for a concentration range from 5 to 25 mu M. Transepithelial transport assays of ABCG2 substrates in the presence of both TCBZ metabolites at 15 mu M showed very efficient inhibition of the Abcg2/ABCG2-mediated transport of the antibacterial agents nitrofurantoin and danofloxacin. TCBZSO administration also inhibited nitrofurantoin Abcg2-mediated secretion into milk by more than 2-fold and increased plasma levels of the sulfonamide sulfasalazine by more than 1.5-fold in mice. These results support the potential role of TCBZSO and TCBZSO(2) as ABCG2 inhibitors to participate in drug interactions and modulate ABCG2-mediated pharmacokinetic processes.
C1 [Barrera, Borja; Otero, Jon A.; Egido, Estefania; Prieto, Julio G.; Alvarez, Ana I.; Merino, Gracia] Univ Leon, Fac Vet, Dept Ciencias Biomed Fisiol, E-24071 Leon, Spain.
   [Barrera, Borja; Otero, Jon A.; Egido, Estefania; Alvarez, Ana I.; Merino, Gracia] Univ Leon, Inst Desarrollo Ganadero & Sanidad Anim INDEGSAL, E-24071 Leon, Spain.
   [Prieto, Julio G.] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain.
   [Egido, Estefania; Seelig, Anna] Univ Basel, Biozentrum, Basel, Switzerland.
RP Merino, G (corresponding author), Univ Leon, Fac Vet, Dept Ciencias Biomed Fisiol, Campus Vegazana, E-24071 Leon, Spain.
EM gmerp@unileon.es
RI Barrera, Borja/M-7348-2015; Merino, Gracia/H-8811-2015; /I-1716-2015;
   Alvarez, Ana I/H-5669-2015
OI Barrera, Borja/0000-0001-9412-6103; Merino, Gracia/0000-0002-7620-3475;
   Alvarez, Ana I/0000-0001-9206-9539; Prieto Fernandez, Julio
   Gabriel/0000-0002-6194-4967
FU Ramon y Cajal grant from the Ministry of Science and Technology;
   European Regional Development Fund (Spain)European Union (EU);
   predoctoral grant (FPU) from the Ministry of Education (Spain); 
   [AGL2009-11730]
FX This work was supported by the research project grant AGL2009-11730 and
   the Ramon y Cajal grant (to G.M.) from the Ministry of Science and
   Technology and the European Regional Development Fund (Spain) and by a
   predoctoral grant (FPU) (to B.B.) from the Ministry of Education
   (Spain).
CR Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Breedveld P, 2005, CANCER RES, V65, P2577, DOI 10.1158/0008-5472.CAN-04-2416
   Breedveld P, 2004, CANCER RES, V64, P5804, DOI 10.1158/0008-5472.CAN-03-4062
   Dupuy J, 2010, CHEM-BIOL INTERACT, V186, P280, DOI 10.1016/j.cbi.2010.05.013
   El-Tantawy WH, 2007, PHARM WORLD SCI, V29, P190, DOI 10.1007/s11096-006-9069-8
   Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377
   Fairweather I, 2009, J HELMINTHOL, V83, P139, DOI 10.1017/S0022149X09321173
   Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028
   Glavinas Hristos, 2007, Drug Metab Dispos, V35, P1533, DOI 10.1124/dmd.106.014605
   HENNESSY DR, 1987, J VET PHARMACOL THER, V10, P64, DOI 10.1111/j.1365-2885.1987.tb00078.x
   Jonker JW, 2000, JNCI-J NATL CANCER I, V92, P1651, DOI 10.1093/jnci/92.20.1651
   Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186
   Kita T, 2001, BIOL PHARM BULL, V24, P1176, DOI 10.1248/bpb.24.1176
   Kruijtzer CMF, 2002, J CLIN ONCOL, V20, P2943, DOI 10.1200/JCO.2002.12.116
   Lifschitz A, 2009, VET J, V182, P261, DOI 10.1016/j.tvjl.2008.06.001
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6
   Marchetti S, 2007, ONCOLOGIST, V12, P927, DOI 10.1634/theoncologist.12-8-927
   Merino G, 2006, DRUG METAB DISPOS, V34, P690, DOI 10.1124/dmd.105.008219
   Merino G, 2005, MOL PHARMACOL, V67, P1758, DOI 10.1124/mol.104.010439
   Merino G, 2005, DRUG METAB DISPOS, V33, P614, DOI 10.1124/dmd.104.003319
   Merino G, 2010, PHARM RES-DORDR, V27, P2098, DOI 10.1007/s11095-010-0208-5
   Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003
   Pavek P, 2005, J PHARMACOL EXP THER, V312, P144, DOI 10.1124/jpet.104.073916
   Perez M, 2009, J VET PHARMACOL THER, V32, P498, DOI 10.1111/j.1365-2885.2008.01050.x
   Perez M, 2009, CHEM-BIOL INTERACT, V180, P106, DOI 10.1016/j.cbi.2009.02.009
   Real R, 2011, J VET PHARMACOL THER, V34, P313, DOI 10.1111/j.1365-2885.2010.01241.x
   Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y
   Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540
   Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984
   Tang SC, 2012, INT J CANCER, V130, P223, DOI 10.1002/ijc.26000
   van Herwaarden AE, 2006, TRENDS PHARMACOL SCI, V27, P10, DOI 10.1016/j.tips.2005.11.007
   van Herwaarden AE, 2006, CARCINOGENESIS, V27, P123, DOI 10.1093/carcin/bgi176
   Wang L, 2008, DRUG METAB DISPOS, V36, P2591, DOI 10.1124/dmd.108.021980
   Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474
   Zaher H, 2006, MOL PHARMACEUT, V3, P55, DOI 10.1021/mp050113v
   Zhou L, 2008, MOL PHARMACOL, V73, P949, DOI 10.1124/mol.107.041616
NR 36
TC 15
Z9 16
U1 1
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUL
PY 2012
VL 56
IS 7
BP 3535
EP 3543
DI 10.1128/AAC.06345-11
PG 9
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 964DD
UT WOS:000305673000009
PM 22508302
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Bertseva, E
   Grebenkov, D
   Schmidhauser, P
   Gribkova, S
   Jeney, S
   Forro, L
AF Bertseva, E.
   Grebenkov, D.
   Schmidhauser, P.
   Gribkova, S.
   Jeney, S.
   Forro, L.
TI Optical trapping microrheology in cultured human cells
SO EUROPEAN PHYSICAL JOURNAL E
LA English
DT Article
ID F-ACTIN; SLOW DYNAMICS; TRACKING; MECHANICS; VISCOELASTICITY
AB We present the microrheological study of the two close human epithelial cell lines: non-cancerous HCV29 and cancerous T24. The optical tweezers tracking was applied to extract the several seconds long trajectories of endogenous lipid granules at time step of 1 mu s. They were analyzed using a recently proposed equation for mean square displacement (MSD) in the case of subdiffusion influenced by an optical trap. This equation leads to an explicit form for viscoelastic moduli. The moduli of the two cell lines were found to be the same within the experimental accuracy for frequencies 10(2)-10(5) Hz. For both cell lines subdiffusion was observed with the exponent close to 3/4, the value predicted by the theory of semiflexible polymers. For times longer than 0.1 s the MSD of cancerous cells exceeds the MSD of non-cancerous cells for all values of the trapping force. Such behavior can be interpreted as a signature of the active processes and prevents the extraction of the low-frequency viscoelastic moduli for the living cells by passive microrheology.
C1 [Bertseva, E.; Schmidhauser, P.; Jeney, S.; Forro, L.] EPFL, Lab Phys Complex Matter, Stn 3, CH-1015 Lausanne Vd, Switzerland.
   [Grebenkov, D.; Gribkova, S.] Ecole Polytech, Phys Mat Condensee Lab, CNRS, F-91128 Palaiseau, France.
   [Grebenkov, D.] Independent Univ Moscow, Lab Poncelet, UMI 2615, CNRS, Moscow 119002, Russia.
   [Jeney, S.] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Basel, Switzerland.
RP Bertseva, E (corresponding author), EPFL, Lab Phys Complex Matter, Stn 3, CH-1015 Lausanne Vd, Switzerland.
EM elena.bertseva@epfl.ch
OI Bertseva, Elena/0000-0002-2760-9735
FU National Swiss Fond MHV subsidy [PMPDP2_134178/1]
FX The authors thank Dr. Manlio Tassieri for the Matlab code and useful
   comments, Dr. Malgorzata Lekka for providing the cell lines, and Dr.
   Janusz Lekki for the technical support in the instrumental part. Elena
   Bertseva thanks for support the National Swiss Fond MHV subsidy
   PMPDP2_134178/1. We also thank Dr. Andrzej Kulik and Chiara Gabella for
   useful discussions.
CR Arcizet D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248103
   Bertseva E, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285709
   Bruno L, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011912
   Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404
   Caspi A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011916
   Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1
   Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685
   Desposito MA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021111
   Desposito MA, 2011, PHYSICA A, V390, P1026, DOI 10.1016/j.physa.2010.11.040
   Evans RML, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.012501
   Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102
   Gisler T, 1999, PHYS REV LETT, V82, P1606, DOI 10.1103/PhysRevLett.82.1606
   Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007
   Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241
   Grebenkov DS, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061117
   Guzman C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020713
   Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054
   Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103
   Hough LA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031802
   Jeney S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/25/255102
   Jeney S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240604
   Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103
   Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002
   Kimura Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.041005
   Kubo R., 1985, STAT PHYS, V2
   Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101
   Lee H, 2010, ACTA BIOMATER, V6, P1207, DOI 10.1016/j.actbio.2009.10.044
   Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213
   Lekka M, 2001, BBA-MOL CELL RES, V1540, P127, DOI 10.1016/S0167-4889(01)00125-2
   Li YX, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3257253
   Lin YC, 2011, SOFT MATTER, V7, P902, DOI 10.1039/c0sm00478b
   Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094
   Mason TG, 1997, J OPT SOC AM A, V14, P139, DOI 10.1364/JOSAA.14.000139
   Mizuno D, 2008, MACROMOLECULES, V41, P7194, DOI 10.1021/ma801218z
   Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404
   Mofrad MRK, 2009, ANNU REV FLUID MECH, V41, P433, DOI 10.1146/annurev.fluid.010908.165236
   Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u
   Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844
   Raucher D, 2008, METHOD CELL BIOL, V89, P451, DOI 10.1016/S0091-679X(08)00617-1
   Rohrbach A, 2004, REV SCI INSTRUM, V75, P2197, DOI 10.1063/1.1753097
   Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373
   Suresh S, 2007, ACTA MATER, V55, P3989, DOI 10.1016/j.actamat.2007.04.022
   Tolic-Norrelykke IM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.078102
   Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8
   Van Citters KM, 2006, BIOPHYS J, V91, P3946, DOI 10.1529/biophysj.106.091264
   Wei MT, 2008, OPT EXPRESS, V16, P8594, DOI 10.1364/OE.16.008594
   Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724
   Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7
   Yao A, 2009, LAB CHIP, V9, P2568, DOI 10.1039/b907992k
NR 49
TC 35
Z9 36
U1 0
U2 39
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1292-8941
EI 1292-895X
J9 EUR PHYS J E
JI Eur. Phys. J. E
PD JUL
PY 2012
VL 35
IS 7
AR 63
DI 10.1140/epje/i2012-12063-4
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 985QE
UT WOS:000307282100010
PM 22821510
DA 2021-01-25
ER

PT J
AU Olofsson, PS
   Rosas-Ballina, M
   Levine, YA
   Tracey, KJ
AF Olofsson, Peder S.
   Rosas-Ballina, Mauricio
   Levine, Yaakov A.
   Tracey, Kevin J.
TI Rethinking inflammation: neural circuits in the regulation of immunity
SO IMMUNOLOGICAL REVIEWS
LA English
DT Review
DE inflammation; neuroimmunology; spleen; vagus nerve
ID CHOLINERGIC ANTIINFLAMMATORY PATHWAY; NICOTINIC ACETYLCHOLINE-RECEPTOR;
   TO-BRAIN COMMUNICATION; ENTERIC NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR;
   NORADRENERGIC SYMPATHETIC INNERVATION; ACETYLTRANSFERASE MESSENGER-RNA;
   PRIMARY AFFERENT NEURONS; DORSAL MOTOR NUCLEUS; KAPPA-B ACTIVATION
AB Neural reflex circuits regulate cytokine release to prevent potentially damaging inflammation and maintain homeostasis. In the inflammatory reflex, sensory input elicited by infection or injury travels through the afferent vagus nerve to integrative regions in the brainstem, and efferent nerves carry outbound signals that terminate in the spleen and other tissues. Neurotransmitters from peripheral autonomic nerves subsequently promote acetylcholine-release from a subset of CD4+ T cells that relay the neural signal to other immune cells, e.g. through activation of a7 nicotinic acetylcholine receptors on macrophages. Here, we review recent progress in the understanding of the inflammatory reflex and discuss potential therapeutic implications of current findings in this evolving field.
C1 [Olofsson, Peder S.; Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA.
   [Rosas-Ballina, Mauricio] Univ Basel, Biozentrum, Basel, Switzerland.
   [Levine, Yaakov A.] Setpoint Med Corp, Valencia, CA USA.
RP Tracey, KJ (corresponding author), Feinstein Inst Med Res, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA.
EM kjtracey@nshs.edu
RI Levine, Yaakov/AAA-2578-2020
OI Tracey, Kevin J/0000-0003-1884-6314; Levine, Yaakov/0000-0002-3313-6858
FU National Institute of General Medical Sciences, NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS); Wenner
   Foundation in Stockholm; Gren Foundation in Stockholm; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM057226, R01GM057226,
   R01GM057226, R01GM057226, R01GM057226, R01GM057226, R01GM057226,
   R01GM057226, R01GM057226, R01GM057226, R01GM057226, R01GM057226,
   R01GM057226, R01GM057226, R01GM057226, R01GM057226] Funding Source: NIH
   RePORTER
FX We thank Valentin A Pavlov and Eugene Golanov for critically reading the
   manuscript. This work was supported in part by grants from National
   Institute of General Medical Sciences, NIH, to K.J.T. and from the
   Wenner-Gren Foundations in Stockholm to P.S.O. K.J.T. is consultant to
   and Y.A.L. is an employee of SetPoint Medical, Inc. M. R. B and P.S.O.
   have no conflicts of interest to declare.
CR Akinci SB, 2005, WORLD J SURG, V29, P1483, DOI 10.1007/s00268-005-0073-2
   Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82
   ANTONICA A, 1994, J AUTONOM NERV SYST, V48, P187, DOI 10.1016/0165-1838(94)90047-7
   Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018
   Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022
   Aydemir M, 2010, LUPUS, V19, P255, DOI 10.1177/0961203309351540
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Balemba OB, 1999, J ANAT, V195, P1, DOI 10.1046/j.1469-7580.1999.19510001.x
   Balemba OB, 1998, J ANAT, V192, P257, DOI 10.1046/j.1469-7580.1998.19220257.x
   Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373
   Bautista LE, 2003, J HUM HYPERTENS, V17, P223, DOI 10.1038/sj.jhh.1001537
   BELLINGER DL, 1987, J NEUROSCI RES, V18, P55, DOI 10.1002/jnr.490180110
   Benfante R, 2011, J NEUROIMMUNOL, V230, P74, DOI 10.1016/j.jneuroim.2010.09.008
   BENISHIN CG, 1983, J NEUROCHEM, V41, P1030, DOI 10.1111/j.1471-4159.1983.tb09047.x
   Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643
   Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714
   Berthoud HR, 1996, MICROSC RES TECHNIQ, V35, P80, DOI 10.1002/(SICI)1097-0029(19960901)35:1<80::AID-JEMT7>3.0.CO;2-W
   BERTHOUD HR, 1993, J AUTONOM NERV SYST, V42, P153, DOI 10.1016/0165-1838(93)90046-W
   Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0
   Berthoud HR, 2001, ANAT REC, V262, P29, DOI 10.1002/1097-0185(20010101)262:1<29::AID-AR1008>3.0.CO;2-B
   Boettger MK, 2008, ARTHRITIS RHEUM-US, V58, P2368, DOI 10.1002/art.23608
   Boland C, 2011, INFLAMMATION, V34, P29, DOI 10.1007/s10753-010-9204-5
   Borovikova LV, 2000, NATURE, V405, P458
   Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2
   Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108
   Bregeon F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022386
   Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361
   Bruchfeld A, 2010, J INTERN MED, V268, P94, DOI 10.1111/j.1365-2796.2010.02226.x
   Cailotto C, 2012, NEUROGASTROENT MOTIL, V24, P191, DOI 10.1111/j.1365-2982.2011.01824.x
   Chatterjee PK, 2009, AM J PHYSIOL-CELL PH, V297, pC1294, DOI 10.1152/ajpcell.00160.2009
   Chiocchetti R, 2008, CELL TISSUE RES, V332, P185, DOI 10.1007/s00441-008-0583-y
   Cooper MD, 2010, NAT REV IMMUNOL, V10, P2, DOI 10.1038/nri2686
   Costantini TW, 2010, J TRAUMA, V68, P1349, DOI 10.1097/TA.0b013e3181dccea0
   COUPLAND RE, 1989, J ANAT, V163, P173
   Czura CJ, 2010, SHOCK, V33, P608, DOI 10.1097/SHK.0b013e3181cc0183
   Dale HH, 1929, J PHYSIOL-LONDON, V68, P97, DOI 10.1113/jphysiol.1929.sp002598
   de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229
   de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067
   Defaweux V, 2005, MICROSC RES TECHNIQ, V66, P1, DOI 10.1002/jemt.20135
   Dobransky T, 2000, BIOCHEM J, V349, P141, DOI 10.1042/0264-6021:3490141
   dos Santos CC, 2011, AM J RESP CRIT CARE, V183, P471, DOI 10.1164/rccm.201002-0314OC
   Ek M, 1998, J NEUROSCI, V18, P9471
   Elenkov IJ, 2000, PHARMACOL REV, V52, P595
   Fairchild KD, 2011, AM J PHYSIOL-REG I, V300, pR330, DOI 10.1152/ajpregu.00487.2010
   Feher A, 2009, DEMENT GERIATR COGN, V28, P56, DOI 10.1159/000230036
   FELTEN SY, 1987, J NEUROSCI RES, V18, P37, DOI 10.1002/jnr.490180108
   Fernandez R, 2011, RESP PHYSIOL NEUROBI, V175, P336, DOI 10.1016/j.resp.2010.12.014
   Flomen RH, 2006, AM J MED GENET B, V141B, P571, DOI 10.1002/ajmg.b.30306
   Fogel-Petrovic M, 2004, IMMUNOL CELL BIOL, V82, P47, DOI 10.1111/j.1440-1711.2004.01213.x
   Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710
   Freedman R, 2008, AM J PSYCHIAT, V165, P1040, DOI 10.1176/appi.ajp.2008.07071135
   Fujii T, 1998, J NEUROIMMUNOL, V82, P101, DOI 10.1016/S0165-5728(97)00195-1
   Fujii T, 2003, LIFE SCI, V72, P2131, DOI 10.1016/S0024-3205(03)00073-0
   Fujii T, 2001, JPN J PHARMACOL, V85, P11, DOI 10.1254/jjp.85.11
   Fujii T, 2008, J PHARMACOL SCI, V106, P186, DOI 10.1254/jphs.FM0070109
   Fujii T, 2012, J NEUROIMMUNOL, V244, P16, DOI 10.1016/j.jneuroim.2011.12.022
   Fujii T, 2009, J NEUROSCI RES, V87, P3024, DOI 10.1002/jnr.22117
   FURCHGOTT RF, 1984, ANNU REV PHARMACOL, V24, P175, DOI 10.1146/annurev.pa.24.040184.001135
   Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363
   Gaykema RPA, 1998, NEUROIMMUNOMODULAT, V5, P234, DOI 10.1159/000026343
   Ghia JE, 2011, INFLAMM BOWEL DIS, V17, P1474, DOI 10.1002/ibd.21531
   GOEHLER LE, 1995, NEUROSCI LETT, V185, P163, DOI 10.1016/0304-3940(95)11251-Q
   Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8
   Goehler LE, 1998, BRAIN RES, V804, P306, DOI 10.1016/S0006-8993(98)00685-4
   Goldstein RS, 2007, MOL MED, V13, P210, DOI 10.2119/2006-00108.Goldstein
   Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED
   Hayakawa T, 2006, J COMP NEUROL, V498, P352, DOI 10.1002/cne.21069
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Hofer S, 2008, CRIT CARE MED, V36, P404, DOI 10.1097/01.CCM.0B013E31816208B3
   Hosoi T, 2005, AUTON NEUROSCI-BASIC, V120, P104, DOI 10.1016/j.autneu.2004.11.012
   Huston JM, 2008, J IMMUNOL, V181, P3535, DOI 10.4049/jimmunol.181.5.3535
   Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA
   Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362
   Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684
   Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710
   Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016
   Kawashima K, 2004, FRONT BIOSCI-LANDMRK, V9, P2063, DOI 10.2741/1390
   Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036
   Kees MG, 2003, J NEUROIMMUNOL, V145, P77, DOI 10.1016/j.jneuroim.2003.09.011
   KENGAKU M, 1993, MOL BRAIN RES, V18, P71, DOI 10.1016/0169-328X(93)90174-N
   KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U
   Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028
   Kox M, 2011, BRIT J ANAESTH, V107, P559, DOI 10.1093/bja/aer202
   Kox M, 2011, SHOCK, V36, P5, DOI 10.1097/SHK.0b013e3182168d56
   KRAMMER HJ, 1993, CELL TISSUE RES, V272, P267, DOI 10.1007/BF00302732
   Kreier F, 2002, J CLIN INVEST, V110, P1243, DOI 10.1172/JCI200215736
   Krzyzaniak M, 2011, J TRAUMA, V70, P1168, DOI 10.1097/TA.0b013e318216f754
   Kulkarni-Narla A, 1999, CELL TISSUE RES, V298, P275, DOI 10.1007/s004419900096
   La Rovere MT, 1998, LANCET, V351, P478
   Lee ST, 2010, BRAIN RES, V1309, P164, DOI 10.1016/j.brainres.2009.10.076
   Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568
   Li DJ, 2011, HYPERTENSION, V57, P298, DOI 10.1161/HYPERTENSIONAHA.110.160077
   Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200
   Lips KS, 2006, J MOL NEUROSCI, V30, P15, DOI 10.1385/JMN:30:1:15
   Lubbers T, 2010, ANN SURG, V252, P376, DOI 10.1097/SLA.0b013e3181dae411
   Luyer MD, 2005, J EXP MED, V202, P1023, DOI 10.1084/jem.20042397
   Maier SF, 1998, PSYCHOL REV, V105, P83, DOI 10.1037/0033-295X.105.1.83
   Mallet J, 1998, J PHYSIOL-PARIS, V92, P145, DOI 10.1016/S0928-4257(98)80153-8
   Marsland AL, 2007, PSYCHOSOM MED, V69, P709, DOI 10.1097/PSY.0b013e3181576118
   Mawe GM, 1998, NEWS PHYSIOL SCI, V13, P84
   Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007
   Michel V, 2006, EXP BIOL MED, V231, P490
   Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095
   Mina-Osorio P, 2012, MOL MED, V18, P618, DOI 10.2119/molmed.2012.00027
   Mioni C, 2005, CRIT CARE MED, V33, P2621, DOI 10.1097/01.CCM.0000186762.05301.13
   Misawa H, 1997, MOL BRAIN RES, V44, P323, DOI 10.1016/S0169-328X(96)00231-8
   MISAWA H, 1992, J BIOL CHEM, V267, P20392
   MISAWA H, 1994, J NEUROCHEM, V62, P465
   Nefti W, 2009, AM J PHYSIOL-REG I, V296, pR1681, DOI 10.1152/ajpregu.90733.2008
   NIIJIMA A, 1995, BRAIN RES BULL, V38, P319, DOI 10.1016/0361-9230(95)00103-L
   Niijima A, 1996, J AUTONOM NERV SYST, V61, P287, DOI 10.1016/S0165-1838(96)00098-7
   NIIJIMA A, 1991, J AUTONOM NERV SYST, V36, P183, DOI 10.1016/0165-1838(91)90042-2
   O'Mahony C, 2009, AM J PHYSIOL-REG I, V297, pR1118, DOI 10.1152/ajpregu.90904.2008
   Ogawa H, 2003, LIFE SCI, V72, P2127, DOI 10.1016/S0024-3205(03)00072-9
   Oke SL, 2008, J LEUKOCYTE BIOL, V83, P512, DOI 10.1189/jlb.0607363
   Okuda T, 2003, NEUROCHEM RES, V28, P483, DOI 10.1023/A:1022809003997
   Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405
   ORTEGAVILLALOBOS M, 1990, BRAIN RES BULL, V25, P365, DOI 10.1016/0361-9230(90)90221-K
   Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish
   Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103
   Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177
   Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96
   Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011
   Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097
   Peter C, 2010, SHOCK, V33, P405, DOI 10.1097/SHK.0b013e3181b77e82
   Pruitt BA, 2011, J TRAUMA, V70, P1175
   Rinner I, 1998, J NEUROIMMUNOL, V81, P31, DOI 10.1016/S0165-5728(97)00155-0
   Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402
   Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105
   Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985
   Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463
   Schmidt H, 2005, CRIT CARE MED, V33, P1994, DOI 10.1097/01.CCM.0000178181.91250.99
   Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760
   Severance EG, 2008, GENES BRAIN BEHAV, V7, P37, DOI 10.1111/j.1601-183X.2007.00323.x
   Sha D, 2004, NEUROCHEM RES, V29, P199, DOI 10.1023/B:NERE.0000010449.05927.f9
   Sharma P, 2009, DIGEST DIS SCI, V54, P853, DOI 10.1007/s10620-008-0424-6
   SMOLEN AJ, 1988, J ELECTRON MICR TECH, V10, P187, DOI 10.1002/jemt.1060100205
   Song XM, 2008, SHOCK, V30, P468, DOI 10.1097/SHK.0b013e31816d5e49
   Song XM, 2010, BURNS, V36, P75, DOI 10.1016/j.burns.2009.02.002
   Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411
   Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102
   Tayebati SK, 2002, J NEUROIMMUNOL, V132, P147, DOI 10.1016/S0165-5728(02)00325-9
   TAYO EK, 1988, NEUROSCI LETT, V90, P1, DOI 10.1016/0304-3940(88)90776-8
   The FO, 2011, BRIT J PHARMACOL, V163, P1007, DOI 10.1111/j.1476-5381.2011.01296.x
   The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022
   Todman D, 2008, EUR NEUROL, V60, P162, DOI 10.1159/000145336
   Tooyama I, 2000, J CHEM NEUROANAT, V17, P217, DOI 10.1016/S0891-0618(99)00043-5
   Tracey KJ, 2012, CELL, V148, P392, DOI 10.1016/j.cell.2012.01.025
   Tracey KJ, 2011, SCIENCE, V332, P673, DOI 10.1126/science.1206353
   Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566
   Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321
   van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007
   van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P114, DOI 10.1002/art.24177
   Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022
   Vida G, 2011, FASEB J, V25, P4476, DOI 10.1096/fj.11-191007
   Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722
   Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7
   Vulchanova L, 2007, J NEUROIMMUNOL, V185, P64, DOI 10.1016/j.jneuroim.2007.01.014
   Walter GC, 2009, J NEUROSCI METH, V178, P1, DOI 10.1016/j.jneumeth.2008.11.003
   Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339
   WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R
   WATKINS LR, 1995, LIFE SCI, V57, P1011, DOI 10.1016/0024-3205(95)02047-M
   Watkins LR, 1999, P NATL ACAD SCI USA, V96, P7710, DOI 10.1073/pnas.96.14.7710
   Wilund KR, 2009, BIOCHEM BIOPH RES CO, V390, P148, DOI 10.1016/j.bbrc.2009.09.088
   Wolf SE, 2010, J TRAUMA, V68, P1354
   Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301
   Woodman Isabel, 2011, Nat Rev Immunol, V11, P720, DOI 10.1038/nri3091
   Xiong J, 2012, INFLAMMATION, V35, P1357, DOI 10.1007/s10753-012-9449-2
   Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94
NR 169
TC 213
Z9 223
U1 2
U2 68
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0105-2896
EI 1600-065X
J9 IMMUNOL REV
JI Immunol. Rev.
PD JUL
PY 2012
VL 248
SI SI
BP 188
EP 204
DI 10.1111/j.1600-065X.2012.01138.x
PG 17
WC Immunology
SC Immunology
GA 962UP
UT WOS:000305571800013
PM 22725962
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Zhuravleva, E
   Gut, H
   Hynx, D
   Marcellin, D
   Bleck, CKE
   Genoud, C
   Cron, P
   Keusch, JJ
   Dummler, B
   Esposti, MD
   Hemmings, BA
AF Zhuravleva, Elena
   Gut, Heinz
   Hynx, Debby
   Marcellin, David
   Bleck, Christopher K. E.
   Genoud, Christel
   Cron, Peter
   Keusch, Jeremy J.
   Dummler, Bettina
   Esposti, Mauro Degli
   Hemmings, Brian A.
TI Acyl Coenzyme A Thioesterase Them5/Acot15 Is Involved in Cardiolipin
   Remodeling and Fatty Liver Development
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID MITOCHONDRIAL DYSFUNCTION; COA THIOESTERASE; BARTH-SYNDROME; PROTEIN;
   ALCAT1; SUPERFAMILY; DIVERGENCE; BACTERIAL; TAFAZZIN; STRESS
AB Acyl coenzyme A (acyl-CoA) thioesterases hydrolyze thioester bonds in acyl-CoA metabolites. The majority of mammalian thioesterases are alpha/beta-hydrolases and have been studied extensively. A second class of Hotdog-fold enzymes has been less well described. Here, we present a structural and functional analysis of a new mammalian mitochondrial thioesterase, Them5. Them5 and its paralog, Them4, adopt the classical Hotdog-fold structure and form homodimers in crystals. In vitro, Them5 shows strong thioesterase activity with long-chain acyl-CoAs. Loss of Them5 specifically alters the remodeling process of the mitochondrial phospholipid cardiolipin. Thein5(-/-) mice show deregulation of lipid metabolism and the development of fatty liver, exacerbated by a high-fat diet. Consequently, mitochondrial morphology is affected, and functions such as respiration and beta-oxidation are impaired. The novel mitochondrial acyl-CoA thioesterase Them5 has a critical and specific role in the cardiolipin remodeling process, connecting it to the development of fatty liver and related conditions.
C1 [Zhuravleva, Elena; Gut, Heinz; Hynx, Debby; Genoud, Christel; Cron, Peter; Keusch, Jeremy J.; Dummler, Bettina; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
   [Marcellin, David] Novartis Inst BioMed Res, Basel, Switzerland.
   [Bleck, Christopher K. E.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, Focal Area Struct Biol & Biophys, Basel, Switzerland.
   [Esposti, Mauro Degli] Univ Manchester, Fac Life Sci, Manchester, Lancs, England.
   [Esposti, Mauro Degli] Italian Inst Technol, Genoa, Italy.
RP Hemmings, BA (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
EM elena.zhuravleva@fmi.ch; brian.hemmings@fmi.ch
OI Bleck, Christopher/0000-0003-1029-3444
FU Swiss Bridge fellowship
FX E.Z. was supported by a Swiss Bridge fellowship. Work in Manchester was
   undertaken with the FLS Biomolecular Analysis Facility. The Friedrich
   Miescher Institute for Biomedical Research is part of the Novartis
   Research Foundation.
CR Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088
   Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047
   Brocker Chad, 2010, Hum Genomics, V4, P411
   Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z
   Cao JS, 2009, AM J PHYSIOL-ENDOC M, V296, pE647, DOI 10.1152/ajpendo.90761.2008
   Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200
   Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006
   Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003
   Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177
   Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Esposti MD, 2003, CELL DEATH DIFFER, V10, P1300, DOI 10.1038/sj.cdd.4401306
   Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104
   Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0
   Kang HW, 2012, FASEB J, V26, P2209, DOI 10.1096/fj.11-202853
   Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001
   Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003
   McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617
   Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166
   Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Parcellier A, 2009, CELL SIGNAL, V21, P639, DOI 10.1016/j.cellsig.2009.01.016
   Pidugu LS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-37
   Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023
   Rijken PJ, 2009, J BIOL CHEM, V284, P27609, DOI 10.1074/jbc.M109.016311
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200
   Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022
   Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365
   vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101
   Xiao JY, 2011, P NATL ACAD SCI USA, V108, P11860, DOI 10.1073/pnas.1109290108
   Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007
   Zhao H, 2009, BIOCHEMISTRY-US, V48, P5507, DOI 10.1021/bi900710w
   Zhuang ZH, 2008, BIOCHEMISTRY-US, V47, P2789, DOI 10.1021/bi702334h
NR 37
TC 32
Z9 38
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD JUL
PY 2012
VL 32
IS 14
BP 2685
EP 2697
DI 10.1128/MCB.00312-12
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 972AR
UT WOS:000306249400005
PM 22586271
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Tippmann, SC
   Ivanek, R
   Gaidatzis, D
   Scholer, A
   Hoerner, L
   van Nimwegen, E
   Stadler, PF
   Stadler, MB
   Schubeler, D
AF Tippmann, Sylvia C.
   Ivanek, Robert
   Gaidatzis, Dimos
   Schoeler, Anne
   Hoerner, Leslie
   van Nimwegen, Erik
   Stadler, Peter F.
   Stadler, Michael B.
   Schuebeler, Dirk
TI Chromatin measurements reveal contributions of synthesis and decay to
   steady-state mRNA levels
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE chromatin; histone modifications; microRNA; RNA decay; transcriptional
   regulation
ID HUMAN HOUSEKEEPING GENES; NOVO DNA METHYLATION; HISTONE H3;
   TRANSCRIPTIONAL ELONGATION; H4K16 ACETYLATION; H3K36 METHYLATION;
   CHIP-SEQ; EXPRESSION; SET2; MOUSE
AB Messenger RNA levels in eukaryotes are controlled by multiple consecutive regulatory processes, which can be classified into two layers: primary transcriptional regulation at the chromosomal level and secondary, co- and post-transcriptional regulation of the mRNA. To identify the individual contribution of these layers to steady-state RNA levels requires separate quantification. Using mouse as a model organism, we show that chromatin features are sufficient to model RNA levels but with different sensitivities in dividing versus postmitotic cells. In both cases, chromatin-derived transcription rates explain over 80% of the observed variance in measured RNA levels. Further inclusion of measurements of mRNA half-life and microRNA expression data enabled the identification of a low quantitative contribution of RNA decay by either microRNA or general differential turnover to final mRNA levels. Together, this establishes a chromatin-based quantitative model for the contribution of transcriptional and post-transcriptional processes to steady-state levels of messenger RNA. Molecular Systems Biology 8: 593; published online 17 July 2012; doi:10.1038/msb.2012.23 Subject Categories: chromatin & transcription; RNA
C1 [Tippmann, Sylvia C.; Ivanek, Robert; Gaidatzis, Dimos; Schoeler, Anne; Hoerner, Leslie; Stadler, Michael B.; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland.
   [Tippmann, Sylvia C.; Gaidatzis, Dimos; Schoeler, Anne; van Nimwegen, Erik; Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland.
   [Stadler, Peter F.] Univ Vienna, Dept Theoret Chem, Vienna, Austria.
   [Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany.
   [Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany.
   [Stadler, Peter F.] Max Planck Inst Math Sci, Leipzig, Germany.
   [Stadler, Peter F.] Fraunhofer Inst Zelltherapie & Immunol IZI, Leipzig, Germany.
   [Stadler, Peter F.] Univ Copenhagen, Ctr Non Coding RNA Technol & Hlth, Frederiksberg C, Denmark.
   [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA.
RP Stadler, MB (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
EM michael.stadler@fmi.ch; dirk@fmi.ch
RI Ivanek, Robert/A-8852-2008; Stadler, Peter F. F/L-7857-2015
OI Stadler, Peter F. F/0000-0002-5016-5191; van Nimwegen,
   Erik/0000-0001-6338-1312; Ivanek, Robert/0000-0002-8403-056X
FU Boehringer Ingelheim FoundationBoehringer Ingelheim; Novartis Research
   Foundation; European UnionEuropean Union (EU) [FP7-HEALTH-2010-257082,
   LSHG-CT-2006-037415]; European Research CouncilEuropean Research Council
   (ERC) [ERC-204264]; Swiss initiative in Systems Biology (SystemsX.ch)
FX We thank members of the Schubeler laboratory for feedback on the
   manuscript. Illumina sequencing was carried out at the Quantitative
   Genomics Facility of the Department of Biosystems Science and
   Engineering (D-BSSE). SCT is supported by a predoctoral fellowship of
   the Boehringer Ingelheim Foundation. Research in the laboratory of DS is
   supported by the Novartis Research Foundation, by the European Union
   (NoE 'EpiGeneSys' FP7-HEALTH-2010-257082, LSHG-CT-2006-037415), the
   European Research Council (ERC-204264) and the Swiss initiative in
   Systems Biology (SystemsX.ch).
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308
   Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009
   Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640
   Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926
   Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825
   Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733
   Buratowski S, 2010, COLD SH Q B, V75, P95, DOI 10.1101/sqb.2010.75.036
   Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777
   Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017
   Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108
   Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909
   Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967
   Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9
   Enright AJ, 2004, GENOME BIOL, V5
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566
   Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961
   Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021
   Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107
   Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025
   Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005
   Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3
   Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003
   Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200
   Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200
   Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090
   Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008
   Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176
   Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511
   Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007
   Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005
   Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905
   Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102
   Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909
   Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106
   Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026
   Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861
   Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591
   Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030
   She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269
   Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391
   Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023
   Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200
   Team RDC, 2011, R LANG ENV STAT COMP
   Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036
   Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06
   van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267
   Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006
   Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274
   Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990
   Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705
   Wyrick JJ, 1999, NATURE, V402, P418
   Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503
   Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416
   Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200
   Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172
NR 74
TC 30
Z9 30
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD JUL
PY 2012
VL 8
AR 593
DI 10.1038/msb.2012.23
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 984FF
UT WOS:000307174800001
PM 22806141
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Spang, A
AF Spang, Anne
TI The DSL1 Complex: The Smallest but Not the Least CATCHR
SO TRAFFIC
LA English
DT Review
DE CATCHR; DSL complex; dynein; endoplasmic reticulum; mitosis; nuclear
   function; Rab GTPases; syntaxin 18 complex; tethers; vesicle fusion
ID ENDOPLASMIC RETICULUM RETRIEVAL; VESICLE TETHERING COMPLEXES;
   SACCHAROMYCES-CEREVISIAE; SNARE COMPLEX; RAD50-INTERACTING PROTEIN;
   CHECKPOINT CONTROL; PICHIA-PASTORIS; MEMBRANE-FUSION; COPII VESICLES; ER
   RETRIEVAL
AB The DSL1 complex is a conserved tethering complex at the endoplasmic reticulum that recognizes Golgi-derived COPI vesicles and hands them over to the fusion machinery. The DSL1 complex is the simplest tethering complex of the complexes associated with tethering containing helical rods (CATCHR) family. CATCHR tethering complexes play a role at compartments along the exocytic and endocytic pathways. In this review, different functions of the DSL1 complex are discussed, some open questions with the seemingly straightforward picture are pointed out and alternative functions of the DSL1 complex members are mentioned.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel
FX The work on retrograde transport from the Golgi to the ER in the Spang
   lab is supported by the Swiss National Science Foundation and the
   University of Basel. I acknowledge the help of Faustin Kamena with some
   experiments on the crystal-like structure in tip20 mutants. I would like
   to thank Hans Dieter Schmitt for helpful comments and the permission to
   use his unpublished data.
CR Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200
   Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200
   Arai S, 2008, CURR BIOL, V18, P987, DOI 10.1016/j.cub.2008.06.028
   BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4
   Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097
   Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852
   Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985
   Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6
   Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527
   CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5
   Civril F, 2010, STRUCTURE, V18, P616, DOI 10.1016/j.str.2010.02.014
   Cosson P, 1997, EUR J CELL BIOL, V73, P93
   Cosson P, 1996, EMBO J, V15, P1792, DOI 10.1002/j.1460-2075.1996.tb00528.x
   Diefenbacher M, 2011, J BIOL CHEM, V286, P25027, DOI 10.1074/jbc.M110.215657
   Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905
   Frigerio G, 1998, YEAST, V14, P633, DOI 10.1002/(SICI)1097-0061(199805)14:7<633::AID-YEA267>3.0.CO;2-3
   Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498
   Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049
   Kamena F, 2008, J CELL SCI, V121, P1293, DOI 10.1242/jcs.016998
   Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003
   Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938
   Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136
   Kong LJ, 2006, MOL CELL, V22, P63, DOI 10.1016/j.molcel.2006.02.016
   Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29
   Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056
   Levi SK, 2010, TRAFFIC, V11, P1168, DOI 10.1111/j.1600-0854.2010.01089.x
   Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969
   Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9
   Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327
   Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142
   Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013
   Morsomme P, 2002, DEV CELL, V2, P307, DOI 10.1016/S1534-5807(02)00133-8
   Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965
   Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054
   Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783
   Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002
   Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69
   SCHMID SL, 1985, J BIOL CHEM, V260, P57
   Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001
   Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108
   Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199
   Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003
   SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x
   Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030
   Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548
   Vallee RB, 2006, CELL CYCLE, V5, P2447, DOI 10.4161/cc.5.21.3395
   van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748
   VanRheenen SM, 2001, TRAFFIC, V2, P212, DOI 10.1034/j.1600-0854.2001.020307.x
   Varma D, 2006, J CELL BIOL, V172, P655, DOI 10.1083/jcb.200510120
   Whyte JRC, 2002, J CELL SCI, V115, P2627
   Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6
   Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225
   Xiao J, 2001, J BIOL CHEM, V276, P6105, DOI 10.1074/jbc.M008893200
   Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327
   Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012
   Zong M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029995
NR 56
TC 22
Z9 24
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-9219
J9 TRAFFIC
JI Traffic
PD JUL
PY 2012
VL 13
IS 7
BP 908
EP 913
DI 10.1111/j.1600-0854.2012.01362.x
PG 6
WC Cell Biology
SC Cell Biology
GA 966CA
UT WOS:000305813500003
PM 22486903
OA Bronze
DA 2021-01-25
ER

PT J
AU Wang, SH
   Orabi, EA
   Baday, S
   Berneche, S
   Lamoureux, G
AF Wang, Shihao
   Orabi, Esam A.
   Baday, Sefer
   Berneche, Simon
   Lamoureux, Guillaume
TI Ammonium Transporters Achieve Charge Transfer by Fragmenting Their
   Substrate
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; PROTON-TRANSFER REACTIONS; POLARIZABLE
   FORCE-FIELD; HYDROGEN-ATOM TRANSFER; CHANNEL PROTEIN AMTB;
   ESCHERICHIA-COLI; FREE-ENERGY; POTENTIAL FUNCTIONS;
   SACCHAROMYCES-CEREVISIAE; DEPROTONATION MECHANISM
AB Proteins of the Amt/MEP family facilitate ammonium transport across the membranes of plants, fungi, and bacteria and are essential for growth in nitrogen-poor environments. Some are known to facilitate the diffusion of the neutral NH3, while others, notably in plants, transport the positively charged NH4+. On the basis of the structural data for AmtB from Escherichia coli, we illustrate the mechanism by which proteins from the Amt family can sustain electrogenic transport. Free energy calculations show that NH4+ is stable in the ArritB pore, reaching a binding site from which it can spontaneously transfer a proton to a pore-lining histidine residue (His168). The substrate diffuses down the pore in the form of NH3, while the excess proton is cotransported through a highly conserved hydrogen-bonded His168-His318 pair. This constitutes a novel permeation mechanism that confers to the histidine dyad an essential mechanistic role that was so far unknown.
C1 [Baday, Sefer; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Wang, Shihao; Orabi, Esam A.; Lamoureux, Guillaume] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H4B 1R6, Canada.
   [Wang, Shihao; Orabi, Esam A.; Lamoureux, Guillaume] Concordia Univ, Ctr Res Mol Modeling CERMM, Montreal, PQ H4B 1R6, Canada.
   [Baday, Sefer; Berneche, Simon] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Berneche, S (corresponding author), Univ Basel, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM simon.berneche@unibas.ch; guillaume.lamoureux@concordia.ca
RI Lamoureux, Guillaume/K-4038-2013; baday, sefer/ABA-9111-2020; Berneche,
   Simon/L-6389-2013
OI baday, sefer/0000-0002-2913-6687; Berneche, Simon/0000-0002-6274-4094;
   Orabi, Esam/0000-0002-5338-9203
FU FQRNT Nouveaux chercheurs grantFQRNT; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [118928]; PROTEO
   scholarship; GEPROM scholarship
FX We thank Arnaud Javelle for discussions and critical reading of the
   manuscript. This work has been supported by an FQRNT Nouveaux chercheurs
   grant to G.L., by a grant from the Swiss National Science Foundation to
   S.B. (SNF-Professorship #118928), and by a PROTEO scholarship and a
   GEPROM scholarship to E.A.O. Computational resources were provided by
   Calcul Quebec and by the Swiss National Supercomputing Centre (CSCS).
CR Ahn KH, 2003, ORG LETT, V5, P1419, DOI 10.1021/ol034041m
   Akgun U, 2011, P NATL ACAD SCI USA, V108, P3970, DOI 10.1073/pnas.1007240108
   Alhambra C, 2001, CHEM PHYS LETT, V347, P512, DOI 10.1016/S0009-2614(01)00921-6
   Alhambra C, 2000, J AM CHEM SOC, V122, P8197, DOI 10.1021/ja001476l
   Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200
   BENNAIM A, 1984, J CHEM PHYS, V81, P2016, DOI 10.1063/1.447824
   Berezhkovskii A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.064503
   Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200
   Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Cao Z, 2007, ANGEW CHEM INT EDIT, V46, P6811, DOI 10.1002/anie.200701348
   Chen HN, 2007, BIOPHYS J, V92, P46, DOI 10.1529/biophysj.106.091934
   Chipot C, 1996, J AM CHEM SOC, V118, P2998, DOI 10.1021/ja950302e
   Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104
   Cui Q, 2003, J PHYS CHEM B, V107, P1071, DOI 10.1021/jp021931v
   Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978
   Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861
   Elsasser B, 2010, PHYS CHEM CHEM PHYS, V12, P11081, DOI 10.1039/c001097a
   FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480
   Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104
   Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c
   GAO JL, 1993, J PHYS CHEM-US, V97, P9241, DOI 10.1021/j100138a028
   Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104
   Hall JA, 2011, P NATL ACAD SCI USA, V108, P13270, DOI 10.1073/pnas.1108451108
   Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132
   Henin J, 2010, J CHEM THEORY COMPUT, V6, P35, DOI 10.1021/ct9004432
   Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535
   Hunter EPL, 1998, J PHYS CHEM REF DATA, V27, P413, DOI 10.1063/1.556018
   Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n
   Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200
   Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105
   Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200
   Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952
   KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004
   Laino T, 2005, J CHEM THEORY COMPUT, V1, P1176, DOI 10.1021/ct050123f
   Lamoureux G, 2006, J PHYS CHEM B, V110, P3308, DOI 10.1021/jp056043p
   Lamoureux G, 2006, CHEM PHYS LETT, V418, P245, DOI 10.1016/j.cplett.2005.10.135
   Lamoureux G, 2003, J CHEM PHYS, V119, P5185, DOI 10.1063/1.1598191
   Lamoureux G, 2010, TRANSFUS CLIN BIOL, V17, P168, DOI 10.1016/j.tracli.2010.06.004
   Lamoureux G, 2007, BIOPHYS J, V92, pL82, DOI 10.1529/biophysj.106.102756
   Lee YS, 2004, J AM CHEM SOC, V126, P2225, DOI 10.1021/ja036115v
   Liang CW, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3522770
   Limbach HH, 2004, Z PHYS CHEM, V218, P17, DOI 10.1524/zpch.218.1.17.25386
   Lin YC, 2009, J PHYS CHEM B, V113, P4922, DOI 10.1021/jp810651m
   Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549
   Lopes PEM, 2009, THEOR CHEM ACC, V124, P11, DOI 10.1007/s00214-009-0617-x
   Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012
   Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200
   Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Manca C, 2005, INT REV PHYS CHEM, V24, P457, DOI 10.1080/01442350500390912
   MARCUS Y, 1991, J CHEM SOC FARADAY T, V87, P2995, DOI 10.1039/ft9918702995
   MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x
   Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8
   Marini AM, 2000, NAT GENET, V26, P341
   Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282
   Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5
   Martin-Garcia F, 2012, BIOPHYS J, V102, P152, DOI 10.1016/j.bpj.2011.11.4005
   Mujika JI, 2012, ORG BIOMOL CHEM, V10, P1207, DOI 10.1039/c1ob06444d
   NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x
   Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714
   Nygaard TP, 2010, J PHYS CHEM B, V114, P11859, DOI 10.1021/jp102338h
   Orabi EA, 2012, J CHEM THEORY COMPUT, V8, P182, DOI 10.1021/ct200569x
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Riccardi D, 2006, J AM CHEM SOC, V128, P16302, DOI 10.1021/ja065451j
   Robertson WH, 2003, SCIENCE, V299, P1367, DOI 10.1126/science.1080695
   Roux B, 2002, BIOPHYS J, V82, P1681, DOI 10.1016/S0006-3495(02)75520-3
   Sa RJ, 2006, J PHYS CHEM B, V110, P5094, DOI 10.1021/jp051692m
   Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398
   Smedarchina Z, 2003, J AM CHEM SOC, V125, P243, DOI 10.1021/ja0210594
   Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030
   Soupene E, 2002, J BACTERIOL, V184, P3396, DOI 10.1128/JB.184.12.3396-3400.2002
   STRAATSMA TP, 1992, ANNU REV PHYS CHEM, V43, P407
   Tanner C, 2006, J PHYS CHEM A, V110, P1758, DOI 10.1021/jp056151b
   Yang HY, 2007, BIOPHYS J, V92, P877, DOI 10.1529/biophysj.106.090191
   Yu HB, 2010, J CHEM THEORY COMPUT, V6, P774, DOI 10.1021/ct900576a
   Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
NR 79
TC 52
Z9 52
U1 0
U2 38
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUN 27
PY 2012
VL 134
IS 25
BP 10419
EP 10427
DI 10.1021/ja300129x
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 964SJ
UT WOS:000305716700026
PM 22631217
DA 2021-01-25
ER

PT J
AU Arber, S
AF Arber, Silvia
TI Motor Circuits in Action: Specification, Connectivity, and Function
SO NEURON
LA English
DT Review
ID DEVELOPING CEREBRAL-CORTEX; ZEBRAFISH SPINAL-CORD; ETS GENE PEA3;
   LOCOMOTOR-ACTIVITY; REGULATORY NETWORK; TRANSCRIPTIONAL CODES;
   SPINOCEREBELLAR TRACT; EXTENSOR MOTONEURONS; NEURONAL DIVERSITY;
   HINDLIMB MUSCLES
AB Mammalian motor behavior is enabled by a hierarchy of interleaved circuit modules constructed by interneurons in the spinal cord, sensory feedback loops, and bilateral communication with supraspinal centers. Neuronal subpopulations are specified through a process of precisely timed neurogenesis, acquisition of transcriptional programs, and migration to spatially confined domains. Developmental and genetic programs instruct stereotyped and highly specific connectivity patterns, binding functionally distinct neuronal subpopulations into motor circuit modules at all hierarchical levels. Recent work demonstrates that spatial organization of motor circuits relates to precise connectivity patterns and that these patterns frequently correlate with specific behavioral functions of motor output. This Review highlights key examples of how developmental specification dictates organization of motor circuit connectivity and thereby controls movement.
C1 [Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X
FU ERCEuropean Research Council (ERC); Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Kanton Basel-Stadt;
   EUEuropean Union (EU); Novartis Research Foundation
FX The broad coverage of topics in this review required a citation strategy
   mainly focusing on original recent literature described in more detail
   here. I would like to apologize to authors of the many additional
   important original studies for citing Review articles instead. I am
   grateful to Rui Costa and Ole Kiehn for discussions and comments on the
   manuscript and to Ole Kiehn for pointing out the term
   "pseudocommissural" to me. S.A. was supported by an ERC Advanced Grant,
   the Swiss National Science Foundation, the Kanton Basel-Stadt, EU
   Framework Program 7, and the Novartis Research Foundation.
CR Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038
   Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012
   Alstermark B, 2007, ACTA PHYSIOL, V189, P123, DOI 10.1111/j.1748-1716.2006.01655.x
   Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711
   Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200
   Angel MJ, 2005, J PHYSIOL-LONDON, V563, P597, DOI 10.1113/jphysiol.2004.076034
   Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036
   ARSHAVSKY YI, 1978, BRAIN RES, V151, P493, DOI 10.1016/0006-8993(78)91082-X
   Batista MF, 2008, DEV BIOL, V322, P263, DOI 10.1016/j.ydbio.2008.07.015
   Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036
   Bello SM, 2012, J NEUROSCI, V32, P490, DOI 10.1523/JNEUROSCI.4382-11.2012
   Benito-Gonzalez A, 2012, J NEUROSCI, V32, P1156, DOI 10.1523/JNEUROSCI.3630-12.2012
   Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028
   BROWN AG, 1981, ORG SPINAL CORD
   Burke RE, 1996, J COMP NEUROL, V372, P465
   Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007
   Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105
   CONWAY BA, 1987, EXP BRAIN RES, V68, P643
   Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009
   Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019
   Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009
   Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768
   Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868
   Demireva EY, 2011, CELL, V147, P641, DOI 10.1016/j.cell.2011.09.037
   di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002
   Ding JB, 2012, NAT NEUROSCI, V15, P215, DOI 10.1038/nn.3003
   ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794
   Edgley SA, 2001, J PHYSIOL-LONDON, V533, P51, DOI 10.1111/j.1469-7793.2001.0051b.x
   Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008
   Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717
   Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x
   Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641
   Gezelius H, 2006, J PHYSIOL-PARIS, V100, P297, DOI 10.1016/j.jphysparis.2007.05.001
   Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167
   Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545
   Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608
   Granmo M, 2008, J NEUROSCI, V28, P5494, DOI 10.1523/JNEUROSCI.0651-08.2008
   Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004
   Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hantman AW, 2010, NAT NEUROSCI, V13, P1233, DOI 10.1038/nn.2637
   Henny P, 2012, NAT NEUROSCI, V15, P613, DOI 10.1038/nn.3048
   Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027
   Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2
   Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022
   Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x
   Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263
   Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745
   Joshi K, 2009, NEURON, V61, P839, DOI 10.1016/j.neuron.2009.02.011
   Jovanovic K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011743
   Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7
   Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004
   Kimura Y, 2008, DEVELOPMENT, V135, P3001, DOI 10.1242/dev.024802
   Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381
   Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159
   Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005
   KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3
   Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641
   Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026
   Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1
   Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021
   Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547
   Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797
   McCrea DA, 1998, ANN NY ACAD SCI, V860, P216, DOI 10.1111/j.1749-6632.1998.tb09051.x
   MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082
   McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588
   McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009
   McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225
   Mears SC, 1997, J NEUROSCI, V17, P3128
   Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706
   Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030
   NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1
   Orlovsky G. N., 1999, NEURONAL CONTROL LOC
   OSCARSSON O, 1965, PHYSIOL REV, V45, P495
   Panayi H, 2010, J NEUROSCI, V30, P12274, DOI 10.1523/JNEUROSCI.2402-10.2010
   Pearson KG, 1998, ANN NY ACAD SCI, V860, P203, DOI 10.1111/j.1749-6632.1998.tb09050.x
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719
   Pettersson LG, 2007, ACTA PHYSIOL, V189, P141, DOI 10.1111/j.1748-1716.2006.01650.x
   Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005
   Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103
   Renshaw B, 1941, J NEUROPHYSIOL, V4, P167
   Restrepo CE, 2011, EUR J NEUROSCI, V34, P1102, DOI 10.1111/j.1460-9568.2011.07838.x
   ROMANES G. J., 1964, PROGR BRAIN RES, V11, P93
   Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005
   Satou C, 2012, J NEUROSCI, V32, P1771, DOI 10.1523/JNEUROSCI.5500-11.2012
   Schouenborg J, 2008, BRAIN RES REV, V57, P111, DOI 10.1016/j.brainresrev.2007.08.007
   SCOTT SA, 1992, SENSORY NEURONS DIVE
   Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916
   SMITH CL, 1988, BRAIN BEHAV EVOLUT, V31, P227, DOI 10.1159/000116591
   SMITH JC, 1988, FASEB J, V2, P2283
   Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627
   Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134
   Stepien AE, 2008, NEURON, V60, P1, DOI 10.1016/j.neuron.2008.09.030
   Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019
   Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012
   Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011
   Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947
   Tripodi M, 2012, CURR OPIN NEUROBIOL, V22, P615, DOI 10.1016/j.conb.2012.02.011
   Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538
   Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006
   WALMSLEY B, 1991, PROG NEUROBIOL, V36, P391, DOI 10.1016/0301-0082(91)90017-U
   Wang Z, 2008, J NEUROPHYSIOL, V100, P185, DOI 10.1152/jn.90354.2008
   Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038
   Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033
   Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010
   WINDHORST U, 1990, PROG NEUROBIOL, V35, P135, DOI 10.1016/0301-0082(90)90020-H
   Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017
   Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027
NR 115
TC 162
Z9 165
U1 0
U2 48
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD JUN 21
PY 2012
VL 74
IS 6
BP 975
EP 989
DI 10.1016/j.neuron.2012.05.011
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA 963YA
UT WOS:000305659700005
PM 22726829
OA Bronze
DA 2021-01-25
ER

PT J
AU Ashrafi, S
   Lalancette-Hebert, M
   Friese, A
   Sigrist, M
   Arber, S
   Shneider, NA
   Kaltschmidt, JA
AF Ashrafi, Soha
   Lalancette-Hebert, Melanie
   Friese, Andreas
   Sigrist, Markus
   Arber, Silvia
   Shneider, Neil A.
   Kaltschmidt, Julia A.
TI Wnt7A Identifies Embryonic gamma-Motor Neurons and Reveals Early
   Postnatal Dependence of gamma-Motor Neurons on a Muscle Spindle-Derived
   Signal
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID TRANSCRIPTION FACTOR EGR3; ENTERIC NERVOUS-SYSTEM; ETS GENE PEA3; MICE
   LACKING; SPINAL-CORD; EXPRESSION; SUBTYPES; INNERVATION; CELLS; RET
AB Motor pools comprise a heterogeneous population of motor neurons that innervate distinct intramuscular targets. While the organization of motor neurons into motor pools has been well described, the time course and mechanism of motor pool diversification into functionally distinct classes remains unclear. gamma-Motor neurons (gamma-MNs) and alpha-motor neurons (alpha-MNs) differ in size, molecular identity, synaptic input and peripheral target. While alpha-MNs innervate extrafusal skeletal muscle fibers to mediate muscle contraction, gamma-MNs innervate intrafusal fibers of the muscle spindle, and regulate sensitivity of the muscle spindle in response to stretch. In this study, we find that the secreted signaling molecule Wnt7a is selectively expressed in gamma-MNs in the mouse spinal cord by embryonic day 17.5 and continues to molecularly distinguish gamma-from alpha-MNs into the third postnatal week. Our data demonstrate that Wnt7a is the earliest known gamma-MN marker, supporting a model of developmental divergence between alpha- and gamma-MNs at embryonic stages. Furthermore, using Wnt7a expression as an early marker of gamma-MN identity, we demonstrate a previously unknown dependence of gamma-MNs on a muscle spindle-derived, GDNF-independent signal during the first postnatal week.
C1 [Ashrafi, Soha; Kaltschmidt, Julia A.] Weill Cornell Med Coll, Neurosci Program, New York, NY 10065 USA.
   [Ashrafi, Soha; Kaltschmidt, Julia A.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.
   [Lalancette-Hebert, Melanie; Shneider, Neil A.] Columbia Univ, Dept Neurol, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA.
   [Friese, Andreas; Sigrist, Markus; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Friese, Andreas; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Kaltschmidt, Julia A.] Weill Cornell Med Coll, Cell & Dev Biol Program, New York, NY 10065 USA.
RP Kaltschmidt, JA (corresponding author), Life Technol, Frankfurter Str 129b, D-64293 Darmstadt, Germany.
EM kaltschj@mskcc.org
RI Shneider, Neil/ABF-5751-2020
OI Shneider, Neil/0000-0002-3223-7366; Arber, Silvia/0000-0002-6261-250X
FU European Research CouncilEuropean Research Council (ERC); Swiss National
   Science FoundationSwiss National Science Foundation (SNSF); Kanton
   Basel-Stadt, European Union (EU); Novartis Research Foundation; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21 NS072573]; Motor
   Neuron Center at Columbia University; Memorial Sloan-Kettering;
   Whitehall Foundation; Louis V. Gerstner, Jr. Young Investigators Award;
   NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [R21NS072573,
   R21NS072573] Funding Source: NIH RePORTER
FX A.F., M.S., and S. Arber were supported by a European Research Council
   Advanced Grant, the Swiss National Science Foundation, the Kanton
   Basel-Stadt, European Union (EU) Framework Program 7, and the Novartis
   Research Foundation. M.L-H. and N.A.S. were supported by grants from the
   National Institutes of Health (R21 NS072573) and the Motor Neuron Center
   at Columbia University; J.A.K. was funded by Memorial Sloan-Kettering
   start-up funds, a Whitehall Foundation Research Grant, and a Louis V.
   Gerstner, Jr. Young Investigators Award. We are grateful to Zaiqi Wu and
   Frank Costantini for providing Ret mutant mice. We also thank Susan
   Morton and Thomas Jessell for providing unpublished rabbit anti-ChAT and
   guinea pig anti-Islet1 antibodies, and Dritan Agalliu and Jan Kitajewski
   for providing Wnt7a antisense probe. We thank Thomas Jessell and Peter
   van Roessel for comments on the manuscript.
CR Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026
   Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   BURKE RE, 1977, J NEUROPHYSIOL, V40, P667
   Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348
   Enjin A, 2010, J COMP NEUROL, V518, P2284, DOI 10.1002/cne.22332
   Enomoto H, 2004, NEURON, V44, P623, DOI 10.1016/j.neuron.2004.10.032
   Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3
   Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106
   Gould TW, 2008, J NEUROSCI, V28, P2131, DOI 10.1523/JNEUROSCI.5185-07.2008
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722
   KUFFLER SW, 1951, J NEUROPHYSIOL, V14, P29
   Lamballe F, 2011, J NEUROSCI, V31, P11144, DOI 10.1523/JNEUROSCI.2198-11.2011
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003
   PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0
   Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013
   ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209
   Sabharwal P, 2011, NEURON, V71, P1058, DOI 10.1016/j.neuron.2011.07.028
   SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0
   Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42
   Tourtellotte WG, 1998, NAT GENET, V20, P87
   Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
NR 30
TC 18
Z9 18
U1 0
U2 5
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUN 20
PY 2012
VL 32
IS 25
BP 8725
EP 8731
DI 10.1523/JNEUROSCI.1160-12.2012
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 964FD
UT WOS:000305678500031
PM 22723712
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Camargo, DCR
   Link, NM
   Dames, SA
AF Camargo, Diana C. Rodriguez
   Link, Nina M.
   Dames, Sonja A.
TI The FKBP-Rapamycin Binding Domain of Human TOR Undergoes Strong
   Conformational Changes in the Presence of Membrane Mimetics with and
   without the Regulator Phosphatidic Acid
SO BIOCHEMISTRY
LA English
DT Article
ID CELL-GROWTH CONTROL; MAMMALIAN TARGET; STRUCTURAL BASIS; CANCER-THERAPY;
   HEAT REPEATS; FATC DOMAIN; MTOR; PROTEIN; LOCALIZATION; COMPLEX
AB The Ser/Thr kinase target of rapamycin (TOR) is a central controller of cellular growth and metabolism. Misregulation of TOR signaling is involved in metabolic and neurological disorders and tumor formation. TOR can be inhibited by association of a complex of rapamycin and FKBP12 to the FKBP12-rapamycin binding (FRB) domain. This domain was further proposed to interact with phosphatidic acid (PA), a lipid second messenger present in cellular membranes. Because mammalian TOR has been localized at various cellular membranes and in the nucleus, the output of TOR signaling may depend on its localization, which is expected to be influenced by the interaction with complex partners and regulators in response to cellular signals. Here, we present a detailed characterization of the interaction of the FRB domain with PA and how it is influenced by the surrounding membrane environment. On the basis of nuclear magnetic resonance- and circular dichroism-monitored binding studies using different neutral and negatively charged lipids as well as different membrane mimetics (micelles, bicelles, and liposomes), the FRB domain may function as a conditional peripheral membrane protein. However, the data for the isolated domain just indicate an increased affinity for negatively charged lipids and membrane patches but no specific preference for PA or PA-enriched regions. The membrane-mimetic environment induces strong conformational changes that largely maintain the alpha-helical secondary structure content but presumably disperse the helices in the lipidic environment. Consistent with overlapping binding surfaces for different lipids and the FKBP12-rapamycin complex, binding of the inhibitor complex protects the FRB domain from interactions with membrane mimetics at lower lipid concentrations.
C1 [Camargo, Diana C. Rodriguez; Dames, Sonja A.] Tech Univ Munich, Dept Chem, Biomol NMR Spect, Munich, Germany.
   [Link, Nina M.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.
EM sonja.dames@tum.de
OI Dames, Sonja/0000-0001-7495-6943
FU German Research Foundation (DFG)German Research Foundation (DFG)
   [DA1195/3-1]; Novartis foundation (Basel, Switzerland)Novartis; Freie
   Akademische Gesellschaft Basel (Basel, Switzerland)
FX This work was supported from the German Research Foundation (DFG Grant
   DA1195/3-1) to SAD. N.L.M. was supported by a stipend from the Novartis
   foundation (Basel, Switzerland) and funding from the Freie Akademische
   Gesellschaft Basel (Basel, Switzerland).
CR Ahn HC, 2006, J AM CHEM SOC, V128, P4398, DOI 10.1021/ja057773d
   ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115
   Araki K, 2011, CURR OPIN CELL BIOL, V23, P707, DOI 10.1016/j.ceb.2011.08.006
   Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379
   Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y
   Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001
   Bhat V, 2012, J MOL BIOL, V416, P57, DOI 10.1016/j.jmb.2011.12.015
   Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362
   Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220
   Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239
   Choo AY, 2006, CANCER CELL, V9, P77, DOI 10.1016/j.ccr.2006.01.021
   Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885
   Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200
   Dames SA, 2008, PROTEIN EXPRES PURIF, V59, P31, DOI 10.1016/j.pep.2008.01.014
   Dames SA, 2011, J BIOL CHEM, V286, P36907, DOI 10.1074/jbc.M111.225052
   Dames SA, 2010, J BIOL CHEM, V285, P7766, DOI 10.1074/jbc.M109.058404
   Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003
   De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884
   Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200
   Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015
   Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Ha SH, 2006, CELL SIGNAL, V18, P2283, DOI 10.1016/j.cellsig.2006.05.021
   Hauser H, 2000, BBA-BIOMEMBRANES, V1508, P164, DOI 10.1016/S0304-4157(00)00008-3
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Kam Y, 2004, FASEB J, V18, P311, DOI 10.1096/fj.03-0731com
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KORADI R, 1996, J MOL GRAPHICS, V14, P29
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v
   McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002
   Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012
   Odagaki Y, 1997, J AM CHEM SOC, V119, P10253, DOI 10.1021/ja972098w
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x
   Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t
   STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031
   Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105
   Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x
   TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9
   Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005
   Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08
   Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693
   Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Weschayanwiwat P, 2005, J SURFACTANTS DETERG, V8, P65, DOI 10.1007/s11743-005-0332-8
   Withers DJ, 1997, BIOCHEM BIOPH RES CO, V241, P704, DOI 10.1006/bbrc.1997.7878
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xian WJ, 2002, J MOL BIOL, V322, P755, DOI 10.1016/S0022-2836(02)00841-0
   Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631
   Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006
   Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026
   Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109
   Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200
   Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
NR 69
TC 18
Z9 18
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUN 19
PY 2012
VL 51
IS 24
BP 4909
EP 4921
DI 10.1021/bi3002133
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 959NZ
UT WOS:000305320800014
PM 22620485
DA 2021-01-25
ER

PT J
AU Mata, R
   Hau, R
   Papassotiropoulos, A
   Hertwig, R
AF Mata, Rui
   Hau, Robin
   Papassotiropoulos, Andreas
   Hertwig, Ralph
TI DAT1 Polymorphism Is Associated with Risk Taking in the Balloon Analogue
   Risk Task (BART)
SO PLOS ONE
LA English
DT Article
ID DOPAMINE TRANSPORTER GENE; VARIABLE NUMBER; PERSONALITY-TRAIT; VNTR
   POLYMORPHISM; IMAGING GENETICS; AVAILABILITY; IMPULSIVITY; PROPENSITY;
   GENOTYPE; BRAIN
AB Twin-studies suggest that a significant portion of individual differences in the propensity to take risks resides in people's genetic make-up and there is evidence that variability in dopaminergic systems relates to individual differences in risky choice. We examined the link between risk taking in a risk taking task (the Balloon Analogue Risk Task, BART) and a variable number tandem repeat (VNTR) polymorphism in the 3'UTR of the dopamine transporter gene (SLC6A3/DAT1). Behavior in BART is known to be associated with activity in striatal reward-processing regions, and DAT1 is assumed to modulate striatal dopamine levels. We find that carriers of DAT1 alleles, which presumably result in lower striatal dopamine availability, showed more risk taking, relative to carriers of the alleles associated with higher striatal dopamine availability. Our analyses suggest that the mechanism underlying this association is diminished sensitivity to rewards among those who take more risks. Overall, our results support the notion that a behavioral genetic approach can be helpful in uncovering the basis of individual differences in risk taking.
C1 [Mata, Rui; Hau, Robin; Hertwig, Ralph] Univ Basel, Dept Psychol, Ctr Cognit & Decis Sci, Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Div Mol Neurosci, Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Univ Psychiat Clin, Div Mol Neurosci, Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, Basel, Switzerland.
   [Hertwig, Ralph] Max Planck Inst Human Dev, Berlin, Germany.
RP Mata, R (corresponding author), Univ Basel, Dept Psychol, Ctr Cognit & Decis Sci, Basel, Switzerland.
EM rui.mata@unibas.ch
RI Hertwig, Ralph/B-3468-2015; Mata, Rui/K-8138-2015
OI Hertwig, Ralph/0000-0002-9908-9556; Mata, Rui/0000-0002-1679-906X;
   Papassotiropoulos, Andreas/0000-0002-2210-9651
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [100014-126558]; Swiss National Science Foundation SinergiaSwiss
   National Science Foundation (SNSF) [CRSIK0_122691, CRSI33_130080];
   European UnionEuropean Union (EU) [HEALTH-F4-2009-242257]; National
   Center for Competence in Research synapsy
FX This work was funded by a grant from the Swiss National Science
   Foundation to Ralph Hertwig (100014-126558), the Swiss National Science
   Foundation Sinergia grants (CRSIK0_122691, CRSI33_130080), the 7th
   framework programme of the European Union (ADAMS project,
   HEALTH-F4-2009-242257), and the National Center for Competence in
   Research synapsy (www.nccr-synapsy.ch). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anokhin AP, 2009, TWIN RES HUM GENET, V12, P366, DOI 10.1375/twin.12.4.366
   Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005
   Bedard AC, 2010, NEUROIMAGE, V53, P935, DOI 10.1016/j.neuroimage.2009.12.041
   Bishara AJ, 2009, J BEHAV DECIS MAKING, V22, P435, DOI 10.1002/bdm.641
   Bornovalova MA, 2005, EXP CLIN PSYCHOPHARM, V13, P311, DOI 10.1037/1064-1297.13.4.311
   Bornovalova MA, 2009, PHARMACOL BIOCHEM BE, V93, P258, DOI 10.1016/j.pbb.2008.10.023
   Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778
   BYERLEY W, 1993, HUM MOL GENET, V2, P335, DOI 10.1093/hmg/2.3.335
   Cesarini D, 2011, MANAGEMENT SCI
   Cesarini D, 2010, J FINANC, V65, P1725, DOI 10.1111/j.1540-6261.2010.01592.x
   Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809
   Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106
   Durston S, 2010, NEUROIMAGE, V53, P832, DOI 10.1016/j.neuroimage.2010.02.071
   Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78
   Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007
   Fein G, 2008, DRUG ALCOHOL DEPEN, V92, P141, DOI 10.1016/j.drugalcdep.2007.07.017
   Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086
   Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96
   Fuke S., 2001, Pharmacogenomics Journal, V1, P152
   Guo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009352
   Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02
   Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8
   Jaber M, 1997, MOVEMENT DISORD, V12, P629, DOI 10.1002/mds.870120502
   Jacobsen LK, 2000, AM J PSYCHIAT, V157, P1700, DOI 10.1176/appi.ajp.157.10.1700
   Jentsch JD, 2010, NEUROPSYCHOPHARMACOL, V35, P1797, DOI 10.1038/npp.2010.47
   Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583
   Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362
   Lejuez CW, 2005, NICOTINE TOB RES, V7, P71, DOI 10.1080/14622200412331328484
   Lejuez CW, 2004, ADDICT BEHAV, V29, P1643, DOI 10.1016/j.addbeh.2004.02.035
   Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26
   Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75
   Lighthall N. R., 2011, SOCIAL COGNITIVE AFF, DOI 10.1093/scan/nsr026
   Lynch DR, 2003, MOVEMENT DISORD, V18, P804, DOI 10.1002/mds.10430
   Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P553, DOI 10.1016/S0893-133X(00)00216-5
   Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x
   Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948
   Mitchell RJ, 2000, HUM BIOL, V72, P295
   Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010
   Nikolova YS, 2011, NEUROPSYCHOPHARMACOL, V36, P1940, DOI 10.1038/npp.2011.82
   Pleskac TJ, 2008, EXP CLIN PSYCHOPHARM, V16, P555, DOI 10.1037/a0014245
   Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046
   Rao HY, 2010, MOVEMENT DISORD, V25, P1660, DOI 10.1002/mds.23147
   Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020
   Riba J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002479
   Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002
   Simon JR, 2011, BEHAV BRAIN RES, V216, P452, DOI 10.1016/j.bbr.2010.08.043
   Simonson I, 2011, J CONSUM RES, V37, P951, DOI 10.1086/657022
   Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550
   Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010
   Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239
   van Dyck CH, 2005, J NUCL MED, V46, P745
   VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7
   VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55
   Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104
   Zhong SF, 2012, NEUROIMAGE, V59, P540, DOI 10.1016/j.neuroimage.2011.07.031
   Zhong SF, 2009, TWIN RES HUM GENET, V12, P103, DOI 10.1375/twin.12.1.103
   Zyphur MJ, 2009, J BEHAV DECIS MAKING, V22, P367, DOI 10.1002/bdm.643
NR 58
TC 37
Z9 37
U1 0
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 18
PY 2012
VL 7
IS 6
AR e39135
DI 10.1371/journal.pone.0039135
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 962XO
UT WOS:000305583300100
PM 22723947
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Johansen, JP
   Wolff, SBE
   Luthi, A
   LeDoux, JE
AF Johansen, Joshua P.
   Wolff, Steffen B. E.
   Luethi, Andreas
   LeDoux, Joseph E.
TI Controlling the Elements: An Optogenetic Approach to Understanding the
   Neural Circuits of Fear
SO BIOLOGICAL PSYCHIATRY
LA English
DT Article
DE Electrophysiology; fear conditioning; learning and memory; neural
   circuits; neural plasticity; optogenetics
ID UNCONDITIONED STIMULUS PATHWAYS; MEDIAL GENICULATE-NUCLEUS; LATERAL
   AMYGDALA NEURONS; LONG-TERM POTENTIATION; RAT AUDITORY THALAMUS;
   CONDITIONED FEAR; RESPONSE PROPERTIES; MILLISECOND-TIMESCALE; OPTICAL
   TECHNOLOGIES; SYNAPTIC PLASTICITY
AB Neural circuits underlie our ability to interact in the world and to learn adaptively from experience. Understanding neural circuits and how circuit structure gives rise to neural firing patterns or computations is fundamental to our understanding of human experience and behavior. Fear conditioning is a powerful model system in which to study neural circuits and information processing and relate them to learning and behavior. Until recently, technological limitations have made it difficult to study the causal role of specific circuit elements during fear conditioning. However, newly developed optogenetic tools allow researchers to manipulate individual circuit components such as anatomically or molecularly defined cell populations, with high temporal precision. Applying these tools to the study of fear conditioning to control specific neural subpopulations in the fear circuit will facilitate a causal analysis of the role of these circuit elements in fear learning and memory. By combining this approach with in vivo electrophysiological recordings in awake, behaving animals, it will also be possible to determine the functional contribution of specific cell populations to neural processing in the fear circuit. As a result, the application of optogenetics to fear conditioning could shed light on how specific circuit elements contribute to neural coding and to fear learning and memory. Furthermore, this approach may reveal general rules for how circuit structure and neural coding within circuits gives rise to sensory experience and behavior.
C1 [Johansen, Joshua P.] RIKEN Brain Sci Inst, Lab Neural Circuitry Memory, Wako, Saitama 3510198, Japan.
   [Johansen, Joshua P.; LeDoux, Joseph E.] NYU, Ctr Neural Sci, New York, NY 10003 USA.
   [Wolff, Steffen B. E.; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
   [Wolff, Steffen B. E.; Luethi, Andreas] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [LeDoux, Joseph E.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY USA.
RP Johansen, JP (corresponding author), RIKEN Brain Sci Inst, Lab Neural Circuitry Memory, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM johaono@yahoo.com
RI Johansen, Joshua/N-8010-2015
OI Johansen, Joshua/0000-0003-4240-1550
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [F32-MH082505,
   R01-MH046516]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); European CommissionEuropean CommissionEuropean
   Commission Joint Research Centre [HEALTH-F2-2009-241498]; Novartis
   Research Foundation; Schering Foundation; NATIONAL INSTITUTE OF MENTAL
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01MH046516, R01MH046516, R01MH046516, R01MH046516, R01MH046516,
   R01MH046516, R01MH046516, F32MH082505, R01MH046516, R01MH046516,
   R01MH046516, R01MH046516, R01MH046516, R01MH046516, R01MH046516,
   R01MH046516, R01MH046516, R01MH046516, R01MH046516, R01MH046516,
   R01MH046516, R01MH046516, F32MH082505, F32MH082505, R01MH046516,
   R01MH046516, R01MH046516, R01MH046516] Funding Source: NIH RePORTER
FX This work was supported by National Institutes of Health Grant Nos.
   F32-MH082505 to JPJ and R01-MH046516 to JEL. AL is supported by grants
   from the Swiss National Science Foundation, the European Commission
   (Eurospin Project, Contract HEALTH-F2-2009-241498), and the Novartis
   Research Foundation. SBEW is supported by a grant from the Schering
   Foundation. We thank Linnaea Ostroff and Tamas Madarasz for valuable
   comments on the article.
CR Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005
   Antunes R, 2010, J NEUROSCI, V30, P9782, DOI 10.1523/JNEUROSCI.1037-10.2010
   APPLEGATE CD, 1982, BRAIN RES, V238, P457, DOI 10.1016/0006-8993(82)90123-8
   Armony JL, 1998, J NEUROSCI, V18, P2592
   Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004
   Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x
   BORDI F, 1993, BEHAV NEUROSCI, V107, P757, DOI 10.1037/0735-7044.107.5.757
   BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414
   BORDI F, 1992, J NEUROSCI, V12, P2493
   BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415
   Boyden Edward S, 2011, F1000 Biol Rep, V3, P11, DOI 10.3410/B3-11
   Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525
   Brunzell DH, 2001, BEHAV NEUROSCI, V115, P365, DOI 10.1037//0735-7044.115.2.365
   CAMPEAU S, 1995, J NEUROSCI, V15, P2312
   Carlen M, 2011, MOL PSYCHIAT
   CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406
   Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x
   Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652
   Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559
   Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97
   Cousens G, 1998, BEHAV NEUROSCI, V112, P1092, DOI 10.1037/0735-7044.112.5.1092
   Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025
   DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033
   Day HEW, 1999, J COMP NEUROL, V413, P113
   Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006
   Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749
   Duvarci S, 2011, J NEUROSCI, V31, P289, DOI 10.1523/JNEUROSCI.4985-10.2011
   Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213
   Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817
   Furtak SC, 2007, J NEUROSCI, V27, P12277, DOI 10.1523/JNEUROSCI.1653-07.2007
   Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037
   Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299
   Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011
   Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553
   Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002
   Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x
   HITCHCOCK JM, 1991, BEHAV NEUROSCI, V105, P826, DOI 10.1037/0735-7044.105.6.826
   Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636
   Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019
   Johansen J, 2010, SOC NEUR ABSTR, V914, P15
   Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009
   Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594
   Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107
   KAPP BS, 1979, PHYSIOL BEHAV, V23, P1109, DOI 10.1016/0031-9384(79)90304-4
   Kholodar-Smith DB, 2008, BEHAV NEUROSCI, V122, P1178, DOI 10.1037/a0012902
   Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005
   Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010
   Kravitz AV, 2011, CURR OPIN NEUROBIOL, V21, P433, DOI 10.1016/j.conb.2011.02.010
   Lanuza E, 2008, NEUROSCIENCE, V155, P959, DOI 10.1016/j.neuroscience.2008.06.028
   Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034
   LeDoux J., 1996, EMOTIONAL BRAIN
   LEDOUX JE, 1984, J NEUROSCI, V4, P683
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099
   Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002
   Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535
   MAREN S, 1991, BRAIN RES, V549, P311, DOI 10.1016/0006-8993(91)90473-9
   Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001
   Martin EI, 2010, BIOL PSYCHIAT, V67, P1212, DOI 10.1016/j.biopsych.2010.01.026
   McNally GP, 2011, TRENDS NEUROSCI, V34, P283, DOI 10.1016/j.tins.2011.03.005
   Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520
   Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008
   Morozov A, 2011, J NEUROSCI, V31, P339, DOI 10.1523/JNEUROSCI.5537-10.2011
   Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100
   NISHIJO H, 1988, J NEUROSCI, V8, P3556
   Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009
   Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004
   PASCOE JP, 1985, BEHAV BRAIN RES, V16, P117, DOI 10.1016/0166-4328(85)90087-7
   Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891
   Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709
   Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9
   Poremba A, 2001, J NEUROSCI, V21, P270, DOI 10.1523/JNEUROSCI.21-01-00270.2001
   Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X
   QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6
   Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038
   Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512
   Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944
   Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601
   ROMANSKI LM, 1992, J NEUROSCI, V12, P4501
   ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444
   Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x
   Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020
   Shi CJ, 1999, J NEUROSCI, V19, P420
   Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399
   Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991
   Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005
   Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194
   Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010
   Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6
   Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010
   Tully K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-15
   Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820
   Walker DL, 2005, LEARN MEMORY, V12, P120, DOI 10.1101/lm.87105
   Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807
   Weinberger NM, 2011, HEARING RES, V274, P61, DOI 10.1016/j.heares.2010.03.093
   Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004
   Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711
   Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192
   Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744
   Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988
NR 100
TC 62
Z9 64
U1 0
U2 41
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD JUN 15
PY 2012
VL 71
IS 12
BP 1053
EP 1060
DI 10.1016/j.biopsych.2011.10.023
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 947YT
UT WOS:000304471300006
PM 22169096
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Pulliainen, AT
   Pieles, K
   Brand, CS
   Hauert, B
   Bohm, A
   Quebatte, M
   Wepf, A
   Gstaiger, M
   Aebersold, R
   Dessauer, CW
   Dehio, C
AF Pulliainen, Arto T.
   Pieles, Kathrin
   Brand, Cameron S.
   Hauert, Barbara
   Boehm, Alex
   Quebatte, Maxime
   Wepf, Alexander
   Gstaiger, Matthias
   Aebersold, Ruedi
   Dessauer, Carmen W.
   Dehio, Christoph
TI Bacterial effector binds host cell adenylyl cyclase to potentiate G
   alpha s-dependent cAMP production
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE bacterial infection; apoptosis; tumorigenesis; type IV secretion
ID BARTONELLA-HENSELAE; PROTEIN; MECHANISM; SYSTEM; TOXIN;
   PHOSPHODIESTERASE; CONSTRUCTION; INHIBITION; ACTIVATION; DOMAINS
AB Subversion of host organism cAMP signaling is an efficient and widespread mechanism of microbial pathogenesis. Bartonella effector protein A (BepA) of vasculotumorigenic Bartonella henselae protects the infected human endothelial cells against apoptotic stimuli by elevation of cellular cAMP levels by an as yet unknown mechanism. Here, adenylyl cyclase (AC) and the alpha-subunit of the AC-stimulating G protein (G alpha s) were identified as potential cellular target proteins for BepA by gel-free proteomics. Results of the proteomics screen were evaluated for physical and functional interaction by: (i) a heterologous in vivo coexpression system, where human AC activity was reconstituted under the regulation of G alpha s and BepA in Escherichia coli; (ii) in vitro AC assays with membrane-anchored full-length human AC and recombinant BepA and G alpha s; (iii) surface plasmon resonance experiments; and (iv) an in vivo fluorescence bimolecular complementation-analysis. The data demonstrate that BepA directly binds host cell AC to potentiate the G alpha s-dependent cAMP production. As opposed to the known microbial mechanisms, such as ADP ribosylation of G protein alpha-subunits by cholera and pertussis toxins, the fundamentally different BepA-mediated elevation of host cell cAMP concentration appears subtle and is dependent on the stimulus of a G protein-coupled receptor-released G alpha s. We propose that this mechanism contributes to the persistence of Bartonella henselae in the chronically infected vascular endothelium.
C1 [Pulliainen, Arto T.; Pieles, Kathrin; Hauert, Barbara; Boehm, Alex; Quebatte, Maxime; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Brand, Cameron S.; Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.
   [Wepf, Alexander; Gstaiger, Matthias; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM Christoph.Dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019; Dessauer,
   Carmen/N-6933-2018
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Dessauer, Carmen/0000-0003-1210-4280;
   Pulliainen, Arto Tapio/0000-0002-9361-8963; Quebatte,
   Maxime/0000-0002-3733-1511
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100-061777]; SystemsX.ch Swiss Initiative for Systems Biology
   [51RT 0_126008]; National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [GM060419]; Academy of FinlandAcademy of Finland [119880]; Emil Aaltonen
   Foundation; Turku University Foundation; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM060419, R01GM060419,
   R01GM060419, R01GM060419, R01GM060419, R01GM060419, R01GM060419,
   R01GM060419, R01GM060419, R01GM060419, R01GM060419, R01GM060419,
   R01GM060419, R01GM060419, R01GM060419, R01GM060419, R01GM060419,
   R01GM060419, R01GM060419, R01GM060419] Funding Source: NIH RePORTER
FX We thank Paul Jeno, Timo Glatter, and Erik Ahrne for mass
   spectrometry-based detection of covalent amino acid modifications. This
   work was supported by Grant 3100-061777 from the Swiss National Science
   Foundation (to C.D.); Grant 51RT 0_126008 (InfectX) in the frame of the
   SystemsX.ch Swiss Initiative for Systems Biology (to C.D.); Grant
   GM060419 from the National Institutes of Health (to C.W.D.); and Grant
   119880 from the Academy of Finland (to A.T.P.); A.T.P. also received
   financial support from the Emil Aaltonen Foundation and the Turku
   University Foundation.
CR Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123
   Ahuja N, 2004, CRIT REV MICROBIOL, V30, P187, DOI 10.1080/10408410490468795
   CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669
   Dessauer CW, 2002, J BIOL CHEM, V277, P28823, DOI 10.1074/jbc.M203962200
   Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]
   HOSONO K, 1985, J BIOL CHEM, V260, P1252
   KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129
   Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106
   Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x
   Ribet D, 2010, CELL, V143, P694, DOI 10.1016/j.cell.2010.11.019
   Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277
   SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1
   Sunahara RK, 1997, J BIOL CHEM, V272, P22265, DOI 10.1074/jbc.272.35.22265
   TANG WJ, 1995, SCIENCE, V268, P1769, DOI 10.1126/science.7792604
   Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907
   Yan SZ, 2002, METHOD ENZYMOL, V345, P231
   Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103
NR 23
TC 26
Z9 26
U1 0
U2 11
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 12
PY 2012
VL 109
IS 24
BP 9581
EP 9586
DI 10.1073/pnas.1117651109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 962AL
UT WOS:000305511300075
PM 22635269
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Ochoa-Espinosa, A
   Baer, MM
   Affolter, M
AF Ochoa-Espinosa, Amanda
   Baer, Magdalena M.
   Affolter, Markus
TI Tubulogenesis: Src42A Goes to Great Lengths in Tube Elongation
SO CURRENT BIOLOGY
LA English
DT Editorial Material
ID DROSOPHILA TRACHEAL SYSTEM; MORPHOGENESIS; JUNCTIONS; SIZE
C1 [Ochoa-Espinosa, Amanda; Baer, Magdalena M.; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ochoa-Espinosa, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM Markus.Affolter@unibas.ch
OI Baer, Magdalena/0000-0003-3315-0921; Affolter,
   Markus/0000-0002-5171-0016; Ochoa-Espinosa, Amanda/0000-0003-1943-790X
CR Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013
   Beitel GJ, 2000, DEVELOPMENT, V127, P3271
   Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062
   Chung S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000746
   Dell K. M., 2004, PEDIAT NEPHROLOGY, V5, P675
   Forster D, 2012, NAT CELL BIOL, V14, P526, DOI 10.1038/ncb2456
   Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200
   Maruyama R, 2012, DEV DYNAM, V241, P119, DOI 10.1002/dvdy.22775
   Marx M, 2001, EXP MOL PATHOL, V70, P201, DOI 10.1006/exmp.2001.2358
   Nelson K.S., 2012, NAT CELL BIOL
   Sadler T. W., 1985, LANGMANS MED EMBRYOL
   Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016
   Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982
   Sweeney WE, 2008, J AM SOC NEPHROL, V19, P1331, DOI 10.1681/ASN.2007060665
   Takahashi F, 1996, GENE DEV, V10, P1645, DOI 10.1101/gad.10.13.1645
   Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850
   Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513
   Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008
NR 20
TC 2
Z9 2
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD JUN 5
PY 2012
VL 22
IS 11
BP R446
EP R449
DI 10.1016/j.cub.2012.04.033
PG 4
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 955QB
UT WOS:000305034900010
PM 22677286
OA Bronze
DA 2021-01-25
ER

PT J
AU Graziussi, DF
   Suga, H
   Schmid, V
   Gehring, WJ
AF Graziussi, Daria Federica
   Suga, Hiroshi
   Schmid, Volker
   Gehring, Walter Jakob
TI The "Eyes absent" (eya) Gene in the Eye-Bearing Hydrozoan Jellyfish
   Cladonema radiatum: Conservation of the Retinal Determination Network
SO JOURNAL OF EXPERIMENTAL ZOOLOGY PART B-MOLECULAR AND DEVELOPMENTAL
   EVOLUTION
LA English
DT Article
ID DROSOPHILA EYE; ECTOPIC EYES; EYELESS GENE; SINE-OCULIS; CELL FATE;
   REGENERATION; EVOLUTION; SPECIFICATION; EXPRESSION; DIFFERENTIATION
AB Eyes absent (Eya) is a member of the Retinal Determination Gene Network (RDGN), a set of genes responsible for eye specification in Drosophila. Eya is a dual function protein, working as a transcription factor in the nucleus and as a tyrosine phosphatase in the cytoplasm. It had been shown that Pax and Six family genes, main components of the RDGN, are present in the hydrozoan Cladonema radiatum and that they are expressed in the eye. However, nothing had been known about the Eya family in hydrozoan jellyfish. Here we report the presence of an Eya homologue (CrEya) in Cladonema. Real-time PCR analysis and in situ hybridization showed that CrEya is expressed in the eye. Furthermore, the comprehensive survey of eukaryote genomes revealed that the acquisition of the N-terminal transactivation domain, including the EYA Domain 2 and its adjacent sequence shared by all eumetazoans, happened early in evolution, before the separation of Cnidaria and Bilateria. Our results uncover the evolution of the two domains and show a conservation of the expression pattern of the Eya gene between Cnidaria and Bilateria, which, together with previous data, supports the hypothesis of the monophyletic origin of metazoans eyes. We additionally show that CrEya is also expressed in the oocytes, where two other members of the RDGN, CrPaxB, and Six4/5-Cr, are known to be expressed. These data suggest that several members of the RDGN have begun to be localized also into the different context of egg development early in the course of metazoan evolution. J. Exp. Zool. (Mol. Dev. Evol.) 318:257267, 2012. (c) 2012 Wiley Periodicals, Inc.
C1 [Graziussi, Daria Federica; Suga, Hiroshi; Schmid, Volker; Gehring, Walter Jakob] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
CR Bai JW, 2002, DEVELOPMENT, V129, P5377, DOI 10.1242/dev.00115
   BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7
   Bonini NM, 1997, DEVELOPMENT, V124, P4819
   Boyle M, 1997, DEVELOPMENT, V124, P971
   Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z
   Bui QT, 2000, GENETICS, V155, P709
   Carroll SB, 2001, PRIMACY REGULATORY E, P173
   Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4
   Hazelett DJ, 1998, DEVELOPMENT, V125, P3741
   Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231
   JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134
   Jenic J, 2007, ANNU REV BIOCHEM, V76, P513, DOI 10.1146/annurev.biochem.76.052705.164916
   Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083
   MARDON G, 1994, DEVELOPMENT, V120, P3473
   Muller P, 2003, DEV BIOL, V255, P216, DOI 10.1016/S0012-1606(02)00091-X
   Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Pineda D, 2000, P NATL ACAD SCI USA, V97, P4525, DOI 10.1073/pnas.97.9.4525
   Pineda D, 2002, DEVELOPMENT, V129, P1423
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   Rajakumar V, 2007, DEV BIOL, V301, P240, DOI 10.1016/j.ydbio.2006.08.068
   Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093
   Reber-Muller S, 2006, INT J DEV BIOL, V50, P377, DOI 10.1387/ijdb.052085sr
   Seimiya M, 2000, DEVELOPMENT, V127, P1879
   SERIKAKU MA, 1994, GENETICS, V138, P1137
   Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003
   Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539
   Spring J, 2000, DEV BIOL, V228, P363, DOI 10.1006/dbio.2000.9956
   STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585
   Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458
   Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018
   Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059
   Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107
   Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097
   von Salvini-Plawen L., 1977, Evolutionary Biology (New York), V10, P207
   WEBER C, 1978, REV SUISSE ZOOL, V85, P762, DOI 10.5962/bhl.part.82265
   WEBER C, 1981, J MORPHOL, V167, P313, DOI 10.1002/jmor.1051670306
   Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005
   Yanze N, 2001, DEV BIOL, V236, P89, DOI 10.1006/dbio.2001.0299
   Zimmerman JE, 1997, GENOME RES, V7, P128, DOI 10.1101/gr.7.2.128
NR 44
TC 16
Z9 17
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-5007
EI 1552-5015
J9 J EXP ZOOL PART B
JI J. Exp. Zool. Part B
PD JUN
PY 2012
VL 318B
IS 4
BP 257
EP 267
DI 10.1002/jez.b.22442
PG 11
WC Evolutionary Biology; Developmental Biology; Zoology
SC Evolutionary Biology; Developmental Biology; Zoology
GA 976UI
UT WOS:000306610700004
PM 22821862
DA 2021-01-25
ER

PT J
AU Punga, AR
   Ruegg, MA
AF Punga, Anna Rostedt
   Ruegg, Markus A.
TI Signaling and aging at the neuromuscular synapse: lessons learnt from
   neuromuscular diseases
SO CURRENT OPINION IN PHARMACOLOGY
LA English
DT Article
ID CONGENITAL MYASTHENIC SYNDROME; JUNCTION IN-VIVO; SKELETAL-MUSCLES; MUSK
   ANTIBODY; RECEPTOR DENSITY; AGRIN; MUTATIONS; GRAVIS; MICE; FORM
AB The neuromuscular junction (NMJ) is a specialized synapse between motor neurons and skeletal muscle with a complex signaling network that assures highly reliable neuromuscular transmission. Diseases of the NMJ cause skeletal muscle fatigue and include inherited and acquired disorders that affect presynaptic, intrasynaptic or postsynaptic components. Moreover, fragmentation of the NMJ contributes to sarcopenia, the loss of muscle mass during aging. Studies from recent years indicate that the formation and stabilization of NMJs differs between various muscles and that this difference affects their response under pathological conditions. This review summarizes the most important mechanisms involved in the development, maintenance and dysfunction of the NMJ and it discusses their significance in myasthenic disorders and aging and as targets for possible future treatment of NMJ dysfunction.
C1 [Ruegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Punga, Anna Rostedt] Univ Uppsala Hosp, Dept Clin Neurophysiol, Inst Neurosci, S-75185 Uppsala, Sweden.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Punga, Anna/0000-0002-2178-9413
FU Cantons of Basel-Stadt and Baselland; Swiss Foundation for Research on
   Muscle Disease; FP7 project [242210 'FIGHT-MG']
FX We acknowledge support from the Cantons of Basel-Stadt and Baselland,
   the Swiss Foundation for Research on Muscle Disease and the FP7 project
   number 242210 'FIGHT-MG'.
CR Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503
   Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Bezakova G, 2001, P NATL ACAD SCI USA, V98, P9924, DOI 10.1073/pnas.171539698
   Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005
   Butikofer L, 2011, FASEB J, V25, P4378, DOI 10.1096/fj.11-191262
   Chen FJ, 2011, NAT NEUROSCI, V14, P570, DOI 10.1038/nn.2792
   Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333
   Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371
   Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101
   Escher P, 2005, SCIENCE, V308, P1920, DOI 10.1126/science.1108258
   Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223
   Farrugia ME, 2006, BRAIN, V129, P1481, DOI 10.1093/brain/awl095
   GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   Guergueltcheva V, 2012, J NEUROL, V259, P838, DOI 10.1007/s00415-011-6262-z
   Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312
   Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520
   Huze C, 2009, AM J HUM GENET, V85, P155, DOI 10.1016/j.ajhg.2009.06.015
   Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654
   Kawakami Y, 2011, NEUROLOGY, V77, P1819, DOI 10.1212/WNL.0b013e318237f660
   Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002
   Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026
   Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006
   Lashley D, 2010, NEUROLOGY, V74, P1517, DOI 10.1212/WNL.0b013e3181dd43bf
   Li Y, 2011, J NEUROSCI, V31, P14910, DOI 10.1523/JNEUROSCI.3590-11.2011
   Li Y, 2011, J NEUROSCI, V31, P13191, DOI 10.1523/JNEUROSCI.2953-11.2011
   Liewluck T, 2011, MUSCLE NERVE, V44, P789, DOI 10.1002/mus.22176
   Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105
   Maselli RA, 2009, J MED GENET, V46, P203, DOI 10.1136/jmg.2008.063693
   Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102
   Mittaud P, 2001, J BIOL CHEM, V276, P14505, DOI 10.1074/jbc.M007024200
   Mori S, 2012, AM J PATHOL, V180, P798, DOI 10.1016/j.ajpath.2011.10.031
   MOTOMURA M, 1995, J NEUROL NEUROSUR PS, V58, P85, DOI 10.1136/jnnp.58.1.85
   Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017
   Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142
   Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0
   Punga AR, 2011, EUR J NEUROSCI, V33, P890, DOI 10.1111/j.1460-9568.2010.07569.x
   Punga AR, 2006, MUSCLE NERVE, V34, P111, DOI 10.1002/mus.20515
   Punga AR, 2011, EXP NEUROL, V230, P207, DOI 10.1016/j.expneurol.2011.04.018
   Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716
   Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537
   Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1
   Schmidt N, 2011, J CELL BIOL, V195, P1171, DOI 10.1083/jcb.201107083
   Senderek J, 2011, AM J HUM GENET, V88, P162, DOI 10.1016/j.ajhg.2011.01.008
   Slater Clarke R, 2008, Handb Clin Neurol, V91, P27, DOI 10.1016/S0072-9752(07)01502-3
   Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107
   Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006
NR 48
TC 44
Z9 45
U1 2
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4892
EI 1471-4973
J9 CURR OPIN PHARMACOL
JI Curr. Opin. Pharmacol.
PD JUN
PY 2012
VL 12
IS 3
BP 340
EP 346
DI 10.1016/j.coph.2012.02.002
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 970VO
UT WOS:000306160600017
PM 22365504
DA 2021-01-25
ER

PT J
AU Bergmiller, T
   Ackermann, M
   Silander, OK
AF Bergmiller, Tobias
   Ackermann, Martin
   Silander, Olin K.
TI Patterns of Evolutionary Conservation of Essential Genes Correlate with
   Their Compensability
SO PLOS GENETICS
LA English
DT Article
ID ESCHERICHIA-COLI GENE; CELL-DIVISION GENE; EXTRACYTOPLASMIC STRESS;
   MULTICOPY SUPPRESSORS; COMPLETE SET; MUTANTS; IDENTIFICATION;
   EXPRESSION; SEQUENCE; LIBRARY
AB Essential genes code for fundamental cellular functions required for the viability of an organism. For this reason, essential genes are often highly conserved across organisms. However, this is not always the case: orthologues of genes that are essential in one organism are sometimes not essential in other organisms or are absent from their genomes. This suggests that, in the course of evolution, essential genes can be rendered nonessential. How can a gene become non-essential? Here we used genetic manipulation to deplete the products of 26 different essential genes in Escherichia coli. This depletion results in a lethal phenotype, which could often be rescued by the overexpression of a non-homologous, non-essential gene, most likely through replacement of the essential function. We also show that, in a smaller number of cases, the essential genes can be fully deleted from the genome, suggesting that complete functional replacement is possible. Finally, we show that essential genes whose function can be replaced in the laboratory are more likely to be non-essential or not present in other taxa. These results are consistent with the notion that patterns of evolutionary conservation of essential genes are influenced by their compensability-that is, by how easily they can be functionally replaced, for example through increased expression of other genes.
C1 [Bergmiller, Tobias; Ackermann, Martin; Silander, Olin K.] ETH, Dept Environm Syst Sci, Zurich, Switzerland.
   [Bergmiller, Tobias; Ackermann, Martin; Silander, Olin K.] Eawag, Dept Environm Microbiol, Dubendorf, Switzerland.
   [Silander, Olin K.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Bergmiller, T (corresponding author), IST Austria, Klosterneuburg, Austria.
EM tobias.bergmiller@ist.ac.at; olinsilander@gmail.com
RI Ackermann, Martin/V-4554-2017
OI Ackermann, Martin/0000-0003-0087-4819; Silander,
   Olin/0000-0003-4105-8316; Bergmiller, Tobias/0000-0001-5396-4346
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Swiss National FoundationSwiss National Science Foundation
   (SNSF)
FX TB, MA, and OKS were supported by a grant from the Swiss National
   Science Foundation to MA. In addition, OKS was supported by an Ambizione
   fellowship from the Swiss National Foundation. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902
   Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050
   Barbosa JARG, 2000, J MOL BIOL, V303, P405, DOI 10.1006/jmbi.2000.4138
   Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996
   BEGG KJ, 1995, J BACTERIOL, V177, P6211, DOI 10.1128/jb.177.21.6211-6222.1995
   Bergmiller T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-118
   Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453
   BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2
   Cairrao F, 2001, MOL MICROBIOL, V39, P1550, DOI 10.1046/j.1365-2958.2001.02342.x
   Campbell TL, 2008, J BACTERIOL, V190, P2537, DOI 10.1128/JB.01744-07
   Campbell TL, 2007, J BACTERIOL, V189, P3318, DOI 10.1128/JB.00131-06
   Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763
   CASHEL M, 1996, ESCHERICHIA COLI SAL
   Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291
   CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A
   Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58
   CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172
   Costa CS, 2003, FEMS MICROBIOL LETT, V222, P25, DOI 10.1016/S0378-1097(03)00221-0
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10
   DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x
   Douchin V, 2006, J BIOL CHEM, V281, P12253, DOI 10.1074/jbc.M600819200
   Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Firth AE, 2005, BIOINFORMATICS, V21, P3314, DOI 10.1093/bioinformatics/bti516
   French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x
   Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104
   Gaudu P, 2000, J BACTERIOL, V182, P1788, DOI 10.1128/JB.182.7.1788-1793.2000
   Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100
   Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003
   Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103
   Guarino E, 2007, J BACTERIOL, V189, P3496, DOI 10.1128/JB.01632-06
   Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09
   Hashimoto C, 2011, J BACTERIOL, V193, P6075, DOI 10.1128/JB.05733-11
   Joerger AC, 2003, P NATL ACAD SCI USA, V100, P5694, DOI 10.1073/pnas.0531477100
   Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702
   Kalamorz F, 2007, MOL MICROBIOL, V65, P1518, DOI 10.1111/j.1365-2958.2007.05888.x
   Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174
   Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012
   Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100
   Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751
   KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5
   Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109
   McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x
   Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998
   Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630
   Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902
   Peist R, 1997, J BACTERIOL, V179, P7679, DOI 10.1128/jb.179.24.7679-7686.1997
   R Development Core Team, 2007, R LANG ENV STAT COMP
   RAETZ CRH, 1979, J BACTERIOL, V139, P544, DOI 10.1128/JB.139.2.544-551.1979
   RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y
   Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Roux A, 2005, J BACTERIOL, V187, P1001, DOI 10.1128/JB.187.3.1001-1013.2005
   Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63
   Serres Margrethe Hauge, 2000, Microbial and Comparative Genomics, V5, P205, DOI 10.1089/omi.1.2000.5.205
   Silander Olin K, 2009, BMC Res Notes, V2, P2, DOI 10.1186/1756-0500-2-2
   SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5
   Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343
   Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164
   TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995
   van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]
   Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x
   Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103
   XIAO H, 1991, J BIOL CHEM, V266, P5980
   YAMANAKA K, 1994, MOL GEN GENET, V243, P9, DOI 10.1007/BF00283870
   Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597
NR 70
TC 38
Z9 38
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD JUN
PY 2012
VL 8
IS 6
AR e1002803
DI 10.1371/journal.pgen.1002803
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA 968EW
UT WOS:000305961000055
PM 22761596
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Malone, JG
   Jaeger, T
   Manfredi, P
   Dotsch, A
   Blanka, A
   Bos, R
   Cornelis, GR
   Haussler, S
   Jenal, U
AF Malone, Jacob G.
   Jaeger, Tina
   Manfredi, Pablo
   Doetsch, Andreas
   Blanka, Andrea
   Bos, Raphael
   Cornelis, Guy R.
   Haeussler, Susanne
   Jenal, Urs
TI The YfiBNR Signal Transduction Mechanism Reveals Novel Targets for the
   Evolution of Persistent Pseudomonas aeruginosa in Cystic Fibrosis
   Airways
SO PLOS PATHOGENS
LA English
DT Article
ID SMALL-COLONY VARIANTS; GRAM-NEGATIVE BACTERIA; TOL-PAL COMPLEX;
   ESCHERICHIA-COLI; RECOMBINATION SYSTEM; MUTATIONAL ANALYSIS; RESPONSE
   REGULATOR; TWITCHING MOTILITY; BIOFILM FORMATION; LIPOPROTEIN PAL
AB The genetic adaptation of pathogens in host tissue plays a key role in the establishment of chronic infections. While whole genome sequencing has opened up the analysis of genetic changes occurring during long-term infections, the identification and characterization of adaptive traits is often obscured by a lack of knowledge of the underlying molecular processes. Our research addresses the role of Pseudomonas aeruginosa small colony variant (SCV) morphotypes in long-term infections. In the lungs of cystic fibrosis patients, the appearance of SCVs correlates with a prolonged persistence of infection and poor lung function. Formation of P. aeruginosa SCVs is linked to increased levels of the second messenger c-di-GMP. Our previous work identified the YfiBNR system as a key regulator of the SCV phenotype. The effector of this tripartite signaling module is the membrane bound diguanylate cyclase YfiN. Through a combination of genetic and biochemical analyses we first outline the mechanistic principles of YfiN regulation in detail. In particular, we identify a number of activating mutations in all three components of the Yfi regulatory system. YfiBNR is shown to function via tightly controlled competition between allosteric binding sites on the three Yfi proteins; a novel regulatory mechanism that is apparently widespread among periplasmic signaling systems in bacteria. We then show that during long-term lung infections of CF patients, activating mutations invade the population, driving SCV formation in vivo. The identification of mutational "scars'' in the yfi genes of clinical isolates suggests that Yfi activity is both under positive and negative selection in vivo and that continuous adaptation of the c-di-GMP network contributes to the in vivo fitness of P. aeruginosa during chronic lung infections. These experiments uncover an important new principle of in vivo persistence, and identify the c-di-GMP network as a valid target for novel anti-infectives directed against chronic infections.
C1 [Malone, Jacob G.; Jaeger, Tina; Manfredi, Pablo; Bos, Raphael; Cornelis, Guy R.; Jenal, Urs] Univ Basel, Biozentrum, Basel, Switzerland.
   [Malone, Jacob G.] Univ E Anglia, John Innes Ctr, Norwich NR4 7TJ, Norfolk, England.
   [Doetsch, Andreas; Haeussler, Susanne] Helmholtz Ctr Infect Res, Braunschweig, Germany.
   [Blanka, Andrea] Ctr Clin & Expt Infect Res, Twincore, Hannover, Germany.
RP Malone, JG (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM urs.jenal@unibas.ch
RI Dotsch, Andreas/AAL-6015-2020; Dotsch, Andreas/H-1383-2013; Haussler,
   Susanne/I-2605-2014
OI Dotsch, Andreas/0000-0001-9086-2584; Dotsch,
   Andreas/0000-0001-9086-2584; Haussler, Susanne/0000-0001-6141-9102;
   Malone, Jacob/0000-0003-1959-6820
FU SNF [31-108186, 31003A_130469]; Mukoviszidose e.V [S07/05];
   Bundesministerium fur Bildung und Forschung (BMBF)Federal Ministry of
   Education & Research (BMBF) [01FP09104A]; ERCEuropean Research Council
   (ERC) [RESISTOME 1500092]; International Research Training Group [1273];
   German Research Foundation (DFG)German Research Foundation (DFG)
FX This work was supported by SNF research grants 31-108186 and
   31003A_130469 to UJ (SNF, http://www.snf.ch/E/Pages/default.aspx), the
   Mukoviszidose e.V (S07/05, http://muko.info/), the Bundesministerium fur
   Bildung und Forschung (01FP09104A, BMBF, http://www.bmbf.de/) and an ERC
   starter grant (http://erc.europa.eu/) and an ERC starter grant to SH
   (RESISTOME 1500092). AB was supported by the International Research
   Training Group 1273 funded by the German Research Foundation (DFG,
   http://www.dfg.de/index.jsp). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alm RA, 1996, J BACTERIOL, V178, P46, DOI 10.1128/jb.178.1.46-53.1996
   Ames P, 2008, J BACTERIOL, V190, P6676, DOI 10.1128/JB.00750-08
   An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10
   BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4
   Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504
   Bianconi I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001270
   Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224
   Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x
   BURKE V, 1991, PATHOLOGY, V23, P145, DOI 10.3109/00313029109060814
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Chang C, 2010, J BACTERIOL, V192, P1156, DOI 10.1128/JB.01508-09
   Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765
   CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   COLLINS LA, 1992, J BACTERIOL, V174, P3667, DOI 10.1128/JB.174.11.3667-3675.1992
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l
   D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002
   De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067
   Diab F, 2006, MICROBIOL-SGM, V152, P1395, DOI 10.1099/mic.0.28652-0
   Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x
   Giddens SR, 2007, P NATL ACAD SCI USA, V104, P18247, DOI 10.1073/pnas.0706739104
   Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154
   Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x
   Godlewska R, 2009, FEMS MICROBIOL LETT, V298, P1, DOI 10.1111/j.1574-6968.2009.01659.x
   Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996
   Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863
   HANCOCK REW, 1978, J BACTERIOL, V136, P381, DOI 10.1128/JB.136.1.381-390.1978
   Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0
   Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644
   Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0
   Haussler S, 2004, ENVIRON MICROBIOL, V6, P546, DOI 10.1111/j.1462-2920.2004.00618.x
   Haussler S, 2003, EUR J CLIN MICROBIOL, V22, P249, DOI 10.1007/s10096-003-0901-y
   Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102
   Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9
   Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003
   Huse HK, 2010, MBIO, V1, DOI 10.1128/mBio.00199-10
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x
   Key J, 2005, BIOCHEMISTRY-US, V44, P4627, DOI 10.1021/bi047942r
   Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005
   Klebensberger J, 2006, ARCH MICROBIOL, V185, P417, DOI 10.1007/s00203-006-0111-y
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   Kresse AU, 2003, MOL MICROBIOL, V47, P145, DOI 10.1046/j.1365-2958.2003.03261.x
   Kuchma SL, 2005, J BACTERIOL, V187, P1441, DOI 10.1128/JB.187.4.1441-1454.2005
   Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156
   Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x
   Lim A, 1997, MICROBIOL-SGM, V143, P1709, DOI 10.1099/00221287-143-5-1709
   Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0
   Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804
   Manson MD, 2008, J BACTERIOL, V190, P6544, DOI 10.1128/JB.00943-08
   McDonald MJ, 2009, GENETICS, V183, P1041, DOI 10.1534/genetics.109.107110
   Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x
   Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00
   Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10
   Miller J., 1972, EXPT MOL GENETICS, P352
   Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011
   MORGAN AF, 1979, J BACTERIOL, V139, P137, DOI 10.1128/JB.139.1.137-140.1979
   Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x
   Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824
   Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588
   Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587
   Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106
   Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251
   Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200
   Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215
   Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i
   Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008
   Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x
   Razeto A, 2004, J MOL BIOL, V336, P319, DOI 10.1016/j.jmb.2003.12.057
   Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200
   Reinhardt A, 2007, ANTIMICROB AGENTS CH, V51, P1341, DOI 10.1128/AAC.01278-06
   Rosenfeld M, 2001, J PEDIATR-US, V139, P359, DOI 10.1067/mpd.2001.117288
   Sevvana M, 2008, J MOL BIOL, V377, P512, DOI 10.1016/j.jmb.2008.01.024
   Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103
   SNEATH PHA, 1962, NATURE, V193, P855, DOI 10.1038/193855a0
   Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020
   Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001
   Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09
   Stover CK, 2000, NATURE, V406, P959
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483
   Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198
   Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406
   VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Wilksch JJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002204
   Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10
   Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597
   Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x
NR 98
TC 60
Z9 60
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUN
PY 2012
VL 8
IS 6
AR e1002760
DI 10.1371/journal.ppat.1002760
PG 19
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 968ND
UT WOS:000305987800030
PM 22719254
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Burkard, ME
   Santamaria, A
   Jallepalli, PV
AF Burkard, Mark E.
   Santamaria, Anna
   Jallepalli, Prasad V.
TI Enabling and Disabling Polo-like Kinase 1 Inhibition through Chemical
   Genetics
SO ACS CHEMICAL BIOLOGY
LA English
DT Article
ID CANCER-CELLS; PLK1; REVEALS; ROLES
AB Polo-like kinase 1 (Plk1) is a core regulator of cell division and an emerging target for cancer therapy. Pharmacologic inhibitors of Plk1 exist but affect other kinases, complicating their in vivo validation. To address this, we examined effects of two structurally unrelated Plk1 inhibitors (BI-2536 and TAL) against isogenic human cell lines that solely express wildtype (wt) or analogue-sensitive (as) Plk1 alleles. Unexpectedly, Pik1(as) cells displayed profound biochemical and functional resistance to both inhibitors. Cells that co-express Plk1(wt) and Plk1(as) exhibit loss-of-function phenotypes only when both kinase alleles are inhibited. Resistance to BI-2536 is linked to an intragenic suppressor mutation (C67V) that restores an otherwise invariant valine to the kinase active site. Structural modeling demonstrates that this mutation not only enables Plk1(as) to function in vivo but also occludes BI-2536 from the ATP-binding pocket. Our results reveal the molecular basis of Plk inhibitor selectivity and a potential mechanism for tumor cell resistance.
C1 [Burkard, Mark E.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA.
   [Burkard, Mark E.] Univ Wisconsin, Dept Med, Hematol & Med Oncol Div, Madison, WI 53706 USA.
   [Santamaria, Anna] Univ Basel, Biozentrum, Basel, Switzerland.
   [Jallepalli, Prasad V.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.
RP Burkard, ME (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA.
EM mburkard@wisc.edu; jallepap@mskcc.org
OI Burkard, Mark/0000-0002-4215-7722
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM094972, GM097245];
   Flight Attendant Medical Research Institute; National Center for
   Research Resources of the NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [1UL1RR025011]; NATIONAL CANCER
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748,
   P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748] Funding
   Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR000427, UL1TR000427, UL1TR000427,
   UL1TR000427, UL1TR000427, UL1TR000427] Funding Source: NIH RePORTER;
   NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [UL1RR025011, UL1RR025011,
   UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011,
   UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011,
   UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011,
   UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011,
   UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011,
   UL1RR025011, UL1RR025011, UL1RR025011, UL1RR025011] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM094972, R01GM097245, R01GM097245, R01GM094972, R01GM097245,
   R01GM094972, R01GM097245, R01GM094972, R01GM094972, R01GM094972,
   R01GM097245, R01GM094972, R01GM094972, R01GM094972, R01GM094972] Funding
   Source: NIH RePORTER
FX This study was supported by grants from the National Institutes of
   Health (GM094972 to P.V.J. and GM097245 to M.E.B.) and the Flight
   Attendant Medical Research Institute (to M.E.B.). M.E.B. is supported by
   the National Center for Research Resources of the NIH through Grant
   1UL1RR025011. We thank E. A. Nigg for supporting this work, Bayern
   Schering Pharma for providing TAL, and O. Ouerfelli and the MSKCC
   organic synthesis core facility for preparing BI-2536.
CR Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017
   Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104
   Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111
   Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x
   Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701
   Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046
   Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006
   Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006
   Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547
   Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445
   Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517
   Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049
   Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106
NR 15
TC 21
Z9 21
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1554-8929
J9 ACS CHEM BIOL
JI ACS Chem. Biol.
PD JUN
PY 2012
VL 7
IS 6
BP 978
EP 981
DI 10.1021/cb200551p
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 958AE
UT WOS:000305207400005
PM 22422077
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Liu, QS
   Ren, T
   Fresques, T
   Oppliger, W
   Niles, BJ
   Hur, W
   Sabatini, DM
   Hall, MN
   Powers, T
   Gray, NS
AF Liu, Qingsong
   Ren, Tao
   Fresques, Tara
   Oppliger, Wolfgang
   Niles, Brad J.
   Hur, Wooyoung
   Sabatini, David M.
   Hall, Michael N.
   Powers, Ted
   Gray, Nathanael S.
TI Selective ATP-Competitive Inhibitors of TOR Suppress
   Rapamycin-Insensitive Function of TORC2 in Saccharomyces cerevisiae
SO ACS CHEMICAL BIOLOGY
LA English
DT Article
ID MAMMALIAN TARGET; KINASE INHIBITOR; YEAST; DISCOVERY; GROWTH; POTENT;
   MTOR
AB The target of rapamycin (TOR) is a critical regulator of growth, survival, and energy metabolism. The allosteric TORC1 inhibitor rapamycin has been used extensively to elucidate the TOR related signal pathway but is limited by its inability to inhibit TORC2. We used an unbiased cell proliferation assay of a kinase inhibitor library to discover QL-IX-55 as a potent inhibitor of S. cerevisiae growth. The functional target of QL-IX-55 is the ATP-binding site of TOR2 as evidenced by the discovery of resistant alleles of TOR2 through rational design and unbiased selection strategies. QL-IX-55 is capable of potently inhibiting both TOR complex 1 and 2 (TORC1 and TORC2) as demonstrated by biochemical IP kinase assays (IC50 < 50 nM) and cellular assays for inhibition of substrate YPK1 phosphorylation. In contrast to rapamycin, QL-IX-55 is capable of inhibiting TORC2-dependent transcription, which suggests that this compound will be a powerful probe to dissect the Tor2/TORC2-related signaling pathway in yeast.
C1 [Liu, Qingsong; Hur, Wooyoung; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.
   [Liu, Qingsong; Hur, Wooyoung; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
   [Fresques, Tara; Niles, Brad J.; Powers, Ted] Univ Calif Davis, Coll Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
   [Oppliger, Wolfgang; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.
   [Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.
   [Sabatini, David M.] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA.
RP Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.
EM Nathanael_Gray@dfci.harvard.edu
OI /0000-0002-1446-7256; liu, qing song/0000-0002-7829-2547
FU NERCE [U54 A1057159]; NIH LINCS [HG006097]; NIHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01GM86387]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Human Genome Research Institute (NHGRI) [U54HG006097,
   U54HG006097, U54HG006097, U54HG006097, U54HG006097, U54HG006097,
   U54HG006097, U54HG006097, U54HG006097, U54HG006097, U54HG006097,
   U54HG006097, U54HG006097, U54HG006097] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM086387,
   R01GM086387, R01GM086387, R01GM086387, R01GM086387] Funding Source: NIH
   RePORTER
FX We thank K. Struhl (Harvard Medical School) for providing yeast plasmids
   and medium and H. H. Wong (Harvard Medical School) for productive
   discussion. We thank T. Kapoor for suggesting we perform an unbiased
   kinase library screen for antifungals. We are also acknowledge a NERCE
   Grant (U54 A1057159) for partial financial support to R.T., a NIH LINCS
   Grant (HG006097) for the support of Q.L., and a NIH Grant (R01GM86387)
   to T.P.
CR Arendrup MC, 2009, CLIN MICROBIOL INFEC, V15, P613, DOI 10.1111/j.1469-0691.2009.02909.x
   Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274
   Chen J, 2012, ACS CHEM BIOL, V7, P715, DOI 10.1021/cb200452r
   Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751
   Diner P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020012
   Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038
   GABER RF, 1989, MOL CELL BIOL, V9, P3447, DOI 10.1128/MCB.9.8.3447
   Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964
   Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Maggon K, 2011, TYROSINE KINASE INHI, P49
   Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200
   Nawrocki A, 2001, PROTEOMICS, V1, P1022, DOI 10.1002/1615-9861(200108)1:8<1022::AID-PROT1022>3.0.CO;2-7
   Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187
   Sussman A, 2004, EUKARYOT CELL, V3, P932, DOI 10.1128/EC.3.4.932-943.2004
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299
NR 23
TC 8
Z9 8
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1554-8929
J9 ACS CHEM BIOL
JI ACS Chem. Biol.
PD JUN
PY 2012
VL 7
IS 6
BP 982
EP 987
DI 10.1021/cb300058v
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 958AE
UT WOS:000305207400006
PM 22496512
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Martin, G
   Gruber, AR
   Keller, W
   Zavolan, M
AF Martin, Georges
   Gruber, Andreas R.
   Keller, Walter
   Zavolan, Mihaela
TI Genome-wide Analysis of Pre-mRNA 3 ' End Processing Reveals a Decisive
   Role of Human Cleavage Factor I in the Regulation of 3 ' UTR Length
SO CELL REPORTS
LA English
DT Article
ID POLYADENYLATION SPECIFICITY FACTOR; DISTINCT SEQUENCE MOTIFS; MICRORNA
   TARGET SITES; 25 KDA SUBUNIT; ALTERNATIVE POLYADENYLATION; UNTRANSLATED
   REGIONS; 68-KDA SUBUNIT; PROTEIN; POLY(A); CLIP
AB Through alternative polyadenylation, human mRNAs acquire longer or shorter 3' untranslated regions, the latter typically associated with higher transcript stability and increased protein production. To understand the dynamics of polyadenylation site usage, we performed transcriptome-wide mapping of both binding sites of 3' end processing factors CPSF-160, CPSF-100, CPSF-73, CPSF-30, Fip1, CstF-64, CstF-64 tau, CF I(m)25, CF I(m)59, and CF I(m)68 and 3' end processing sites in HEK293 cells. We found that although binding sites of these factors generally cluster around the poly(A) sites most frequently used in cleavage, CstF-64/CstF-64 tau and CFIm proteins have much higher positional specificity compared to CPSF components. Knockdown of CF I(m)68 induced a systematic use of proximal polyadenylation sites, indicating that changes in relative abundance of a single 3' end processing factor can modulate the length of 3' untranslated regions across the transcriptome and suggesting a mechanism behind the previously observed increase in tumor cell invasiveness upon CF I(m)68 knockdown.
C1 [Martin, Georges; Gruber, Andreas R.; Keller, Walter; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Keller, W (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM walter.keller@unibas.ch; mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Gruber, Andreas/0000-0003-1219-4239; Zavolan,
   Mihaela/0000-0002-8832-2041
FU University of Basel; Louis-Jeantet Foundation for Medicine; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [31003A_133145]
FX We acknowledge the excellent technical assistance of Beatrice
   Dimitriades and the constructive comments from members of the Zavolan
   group, particularly Shivendra Kishore, on the manuscript. We also thank
   Christian Beisel, Ina Nissen, and Manuel Kohler from the DBSSE of the
   ETH for the support to accomplish the Illumina sequencing. The work was
   supported by the University of Basel, the Louis-Jeantet Foundation for
   Medicine and the Swiss National Science Foundation (grant 31003A_133145
   to W.K.).
CR Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001
   Beyer K, 1997, J BIOL CHEM, V272, P26769, DOI 10.1074/jbc.272.42.26769
   Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2
   Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259
   Cardinale S, 2007, MOL BIOL CELL, V18, P1282, DOI 10.1091/mbc.E06-09-0846
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Coseno M, 2008, NUCLEIC ACIDS RES, V36, P3474, DOI 10.1093/nar/gkn079
   Dass B, 2007, P NATL ACAD SCI USA, V104, P20374, DOI 10.1073/pnas.0707589104
   de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895
   Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200
   Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017
   GILMARTIN GM, 1995, GENE DEV, V9, P72, DOI 10.1101/gad.9.1.72
   Goke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002304
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616
   JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183
   Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106
   Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479
   Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070
   KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x
   Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940
   Kim S, 2010, GENES CELLS, V15, P1003, DOI 10.1111/j.1365-2443.2010.01436.x
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Kubo T, 2006, NUCLEIC ACIDS RES, V34, P6264, DOI 10.1093/nar/gkl794
   Li H, 2011, CELL RES, V21, P1039, DOI 10.1038/cr.2011.67
   Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488
   Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3
   Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363
   Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244
   Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807
   Martin G, 2010, RNA, V16, P1646, DOI 10.1261/rna.2164210
   Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044
   Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095
   Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016
   Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331
   Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176
   Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443
   MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672
   Nag A, 2007, NAT STRUCT MOL BIOL, V14, P662, DOI 10.1038/nsmb1253
   Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002
   Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411
   Ruegsegger U, 1996, J BIOL CHEM, V271, P6107
   Ruepp MD, 2009, MOL BIOL CELL, V20, P5211, DOI 10.1091/mbc.E09-05-0389
   Ryan K, 2007, RNA BIOL, V4, P26, DOI 10.4161/rna.4.1.4365
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583
   Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711
   Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028
   Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042
   Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0
   Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018
   Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605
   WICKENS M, 1990, TRENDS BIOCHEM SCI, V15, P277, DOI 10.1016/0968-0004(90)90054-F
   Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021
   Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907
   Yu K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000129
   ZARKOWER D, 1987, EMBO J, V6, P4185, DOI 10.1002/j.1460-2075.1987.tb02765.x
   Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055
NR 60
TC 195
Z9 198
U1 1
U2 31
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN
PY 2012
VL 1
IS 6
BP 753
EP 763
DI 10.1016/j.celrep.2012.05.003
PG 11
WC Cell Biology
SC Cell Biology
GA 019BY
UT WOS:000309713100018
PM 22813749
OA DOAJ Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Pesole, G
   Allen, JF
   Lane, N
   Martin, W
   Rand, DM
   Schatz, G
   Saccone, C
AF Pesole, Graziano
   Allen, John F.
   Lane, Nick
   Martin, William
   Rand, David M.
   Schatz, Gottfried
   Saccone, Cecilia
TI The neglected genome
SO EMBO REPORTS
LA English
DT Editorial Material
ID GENE-EXPRESSION; ORGANELLES; DISEASE; DNA; MITOCHONDRIA; AUTOPHAGY
C1 [Pesole, Graziano; Saccone, Cecilia] CNR, Ist Biomembrane & Bioenerget, Bari, Italy.
   [Pesole, Graziano; Saccone, Cecilia] Univ Bari, Dipartimento Biosci Biotecnol & Sci Farmacol, I-70121 Bari, Italy.
   [Allen, John F.] Univ London, Sch Biol & Chem Sci, London WC1E 7HU, England.
   [Lane, Nick] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England.
   [Martin, William] Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany.
   [Rand, David M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
   [Schatz, Gottfried] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Pesole, G (corresponding author), CNR, Ist Biomembrane & Bioenerget, Bari, Italy.
RI Pesole, Graziano/E-9051-2014; Allen, John/K-6309-2019; Pesole,
   Graziano/C-1408-2009; Pesole, Graziano/K-5283-2019; Martin,
   William/O-5446-2015; Martin, William F./AAB-8761-2019
OI Pesole, Graziano/0000-0003-3663-0859; Allen, John/0000-0002-0950-0429;
   Pesole, Graziano/0000-0003-3663-0859; Martin,
   William/0000-0003-1478-6449; Martin, William F./0000-0003-1478-6449;
   Lane, Nick/0000-0002-5433-3973
CR Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727
   de Paula WBM, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P105, DOI 10.1007/978-3-642-22380-8_5
   GRIVELL LA, 1995, CRIT REV BIOCHEM MOL, V30, P121, DOI 10.3109/10409239509085141
   Horner DS, 2003, PHILOS T ROY SOC B, V358, P37
   Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157
   Lane N, 2011, SCIENCE, V334, P184, DOI 10.1126/science.1214012
   Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486
   Lutz KA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-54
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
   Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348
NR 17
TC 27
Z9 28
U1 0
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD JUN
PY 2012
VL 13
IS 6
BP 473
EP 474
DI 10.1038/embor.2012.57
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 956DG
UT WOS:000305069400003
PM 22555611
OA Green Published
DA 2021-01-25
ER

PT J
AU Yu, TY
   Raschle, T
   Hiller, S
   Wagner, G
AF Yu, Tsyr-Yan
   Raschle, Thomas
   Hiller, Sebastian
   Wagner, Gerhard
TI Solution NMR spectroscopic characterization of human VDAC-2 in detergent
   micelles and lipid bilayer nanodiscs
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE VDAC; Mitochondrion; NMR spectroscopy; Micelle; Nanodisc; Membrane
   protein
ID DEPENDENT ANION CHANNEL; CYTOCHROME-C; TRANSMEMBRANE DOMAIN; CELL-DEATH;
   MEMBRANE; APOPTOSIS; PROTEINS; DYNAMICS; INSIGHTS; REVEALS
AB Three isoforms of the human voltage-dependent anion channel (VDAC), located in the outer mitochondrial membrane, are crucial regulators of mitochondrial function. Numerous studies have been carried out to elucidate biochemical properties, as well as the three-dimensional structure of VDAC-1. However, functional and structural studies of VDAC-2 and VDAC-3 at atomic resolution are still scarce. VDAC-2 is highly similar to VDAC-1 in amino acid sequence, but has substantially different biochemical functions and expression profiles. Here, we report the reconstitution of functional VDAC-2 in lauryldimethylamine-oxide (LDAO) detergent micelles and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) lipid bilayer nanodiscs. We find that VDAC-2 is properly folded in both membrane-mimicking systems and that structural and functional characterization by solution NMR spectroscopy is feasible. This article is part of a Special Issue entitled: VDAC structure, function, and regulation of mitochondrial metabolism. (C) 2011 Elsevier BM. All rights reserved.
C1 [Yu, Tsyr-Yan; Raschle, Thomas; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
   [Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.
EM gerhard_wagner@hms.harvard.edu
RI Yu, Tsyr-Yan/O-3303-2013; sinica, iams/F-4084-2012; Hiller,
   Sebastian/B-3573-2008
OI Yu, Tsyr-Yan/0000-0001-7051-4769; Hiller, Sebastian/0000-0002-6709-4684
FU National Science Council in TaiwanMinistry of Science and Technology,
   Taiwan [NSC98-2917-I-564-157]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [GM075879,
   GM047467, S10 RR026417, EB002026]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); ERCEuropean Research
   Council (ERC) [MOMP 281764]; Taplin Fund for Discovery; NATIONAL CENTER
   FOR RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [S10RR015742, S10RR026417] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND
   BIOENGINEERINGUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Biomedical Imaging & Bioengineering (NIBIB) [P41EB002026,
   P41EB002026, P41EB002026, P41EB002026, P41EB002026, P41EB002026,
   P41EB002026, P41EB002026, P41EB002026, P41EB002026, P41EB002026,
   P41EB002026, P41EB002026, P41EB002026, P41EB002026, P41EB002026,
   P41EB002026, P41EB002026, P41EB002026] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, R01GM075879, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, R01GM075879,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P41GM066360,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P41GM066360, P01GM047467, P01GM047467, P41GM066360, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, R01GM075879, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, R01GM075879, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P41GM066360, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, R01GM075879, P01GM047467, R01GM075879,
   P01GM047467, P01GM047467, P01GM047467, P41GM066360, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, R01GM075879, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   R01GM075879, P01GM047467, P01GM047467, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467, R01GM075879, P01GM047467, P01GM047467,
   P01GM047467, P01GM047467] Funding Source: NIH RePORTER
FX T.-Y. Yu was supported in part by National Science Council in Taiwan
   (NSC98-2917-I-564-157). This research was supported by NIH (grants
   GM075879 and GM047467) and the Swiss National Science Foundation. S.
   Hiller was supported by ERC grant MOMP 281764. Purchase and maintenance
   of the instruments used for these studies were supported by NIH grants
   S10 RR026417 and EB002026, and the Taplin Fund for Discovery.
CR Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214
   Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247
   Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105
   Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995
   Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574
   Fernandez C, 2003, FEBS LETT, V555, P144, DOI 10.1016/S0014-5793(03)01155-4
   Granville DJ, 2003, CURR MED CHEM, V10, P1527, DOI 10.2174/0929867033457214
   Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302
   Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005
   Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013
   Hinsch KD, 2004, J BIOL CHEM, V279, P15281, DOI 10.1074/jbc.M313433200
   Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499
   Kusano H, 2000, ONCOGENE, V19, P4807, DOI 10.1038/sj.onc.1203868
   Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014
   Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104
   Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057
   Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h
   Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102
   Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200
   Raschle T, 2009, J AM CHEM SOC, V131, P17777, DOI 10.1021/ja907918r
   Renault M, 2009, J MOL BIOL, V385, P117, DOI 10.1016/j.jmb.2008.10.021
   Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966
   SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662
   Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531
   Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959
   Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237
   Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002
   Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105
   Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540
   Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859
   Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31
   Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028
   ZIZI M, 1994, J BIOL CHEM, V269, P1614
NR 33
TC 40
Z9 41
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD JUN
PY 2012
VL 1818
IS 6
SI SI
BP 1562
EP 1569
DI 10.1016/j.bbamem.2011.11.012
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 933KI
UT WOS:000303359900015
PM 22119777
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU de Quervain, DJF
   Kolassa, IT
   Ackermann, S
   Aerni, A
   Boesiger, P
   Demougin, P
   Elbert, T
   Ertl, V
   Gschwind, L
   Hadziselimovic, N
   Hanser, E
   Heck, A
   Hieber, P
   Huynh, KD
   Klarhofer, M
   Luechinger, R
   Rasch, B
   Scheffler, K
   Spalek, K
   Stippich, C
   Vogler, C
   Vukojevic, V
   Stetak, A
   Papassotiropoulos, A
AF de Quervain, Dominique J. -F.
   Kolassa, Iris-Tatjana
   Ackermann, Sandra
   Aerni, Amanda
   Boesiger, Peter
   Demougin, Philippe
   Elbert, Thomas
   Ertl, Verena
   Gschwind, Leo
   Hadziselimovic, Nils
   Hanser, Edveena
   Heck, Angela
   Hieber, Petra
   Huynh, Kim-Dung
   Klarhoefer, Markus
   Luechinger, Roger
   Rasch, Bjoern
   Scheffler, Klaus
   Spalek, Klara
   Stippich, Christoph
   Vogler, Christian
   Vukojevic, Vanja
   Stetak, Attila
   Papassotiropoulos, Andreas
TI PKC alpha is genetically linked to memory capacity in healthy subjects
   and to risk for posttraumatic stress disorder in genocide survivors
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE emotion; trauma; single nucleotide polymorphism
ID CHILDHOOD SEXUAL-ABUSE; PROTEIN-KINASE-C; EMOTIONAL INFORMATION;
   AMYGDALA; CONSOLIDATION; ASSOCIATION; MECHANISMS; TRAUMA; WOMEN; FMRI
AB Strong memory of a traumatic event is thought to contribute to the development and symptoms of posttraumatic stress disorder (PTSD). Therefore, a genetic predisposition to build strong memories could lead to increased risk for PTSD after a traumatic event. Here we show that genetic variability of the gene encoding PKC alpha (PRKCA) was associated with memory capacity-including aversive memory-in nontraumatized subjects of European descent. This finding was replicated in an independent sample of nontraumatized subjects, who additionally underwent functional magnetic resonance imaging (fMRI). fMRI analysis revealed PRKCA genotype-dependent brain activation differences during successful encoding of aversive information. Further, the identified genetic variant was also related to traumatic memory and to the risk for PTSD in heavily traumatized survivors of the Rwandan genocide. Our results indicate a role for PKCa in memory and suggest a genetic link between memory and the risk for PTSD.
C1 [de Quervain, Dominique J. -F.; Aerni, Amanda; Gschwind, Leo; Rasch, Bjoern; Spalek, Klara] Univ Basel, Div Cognit Neurosci, Dept Psychol, CH-4055 Basel, Switzerland.
   [Ackermann, Sandra; Demougin, Philippe; Gschwind, Leo; Hadziselimovic, Nils; Hanser, Edveena; Heck, Angela; Hieber, Petra; Huynh, Kim-Dung; Rasch, Bjoern; Vogler, Christian; Vukojevic, Vanja; Stetak, Attila; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Dept Psychol, CH-4055 Basel, Switzerland.
   [de Quervain, Dominique J. -F.; Heck, Angela; Vogler, Christian; Papassotiropoulos, Andreas] Univ Basel, Psychiat Univ Clin, CH-4012 Basel, Switzerland.
   [Kolassa, Iris-Tatjana] Univ Ulm, Inst Psychol & Educ, D-89069 Ulm, Germany.
   [Boesiger, Peter; Luechinger, Roger] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland.
   [Boesiger, Peter; Luechinger, Roger] ETH, CH-8092 Zurich, Switzerland.
   [Demougin, Philippe; Hadziselimovic, Nils; Hanser, Edveena; Huynh, Kim-Dung; Vukojevic, Vanja; Stetak, Attila; Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland.
   [Elbert, Thomas; Ertl, Verena] Univ Konstanz, D-78457 Constance, Germany.
   [Klarhoefer, Markus] Univ Basel, Univ Basel Hosp, Div Radiol Phys, CH-4031 Basel, Switzerland.
   [Rasch, Bjoern] Univ Zurich, Div Biopsychol, Dept Psychol, CH-8050 Zurich, Switzerland.
   [Scheffler, Klaus] Max Planck Inst Biol Cybernet, Magnet Resonance Ctr Dept, D-72012 Tubingen, Germany.
   [Scheffler, Klaus] Univ Tubingen, Dept Neuroimaging & Magnet Resonance Phys, D-72076 Tubingen, Germany.
   [Stippich, Christoph] Univ Basel Hosp, Dept Diagnost & Intervent Neuroradiol, CH-4031 Basel, Switzerland.
RP de Quervain, DJF (corresponding author), Univ Basel, Div Cognit Neurosci, Dept Psychol, CH-4055 Basel, Switzerland.
EM dominique.dequervain@unibas.ch; andreas.papas@unibas.ch
RI Rasch, Bjorn/A-3119-2015; Kolassa, Iris Tatjana/Y-3032-2018; Luechinger,
   Roger/AAD-5192-2019; Elbert, Thomas/C-8556-2009
OI Rasch, Bjorn/0000-0001-7607-3415; Luechinger, Roger/0000-0002-7365-0421;
   Elbert, Thomas/0000-0003-1332-4939; Vogler,
   Christian/0000-0003-3922-109X; Papassotiropoulos,
   Andreas/0000-0002-2210-9651
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [CRSIK0_122691, CRSI33_130080]; European Union [Alzheimer's
   Disease, Alcoholism, Memory, Schizophrenia (ADAMS)]
   [health-F4-2009-242257]; National Center for Competence in Research
   SYNAPSY; German Research Foundation" (Deutsche
   Forschungsgemeinschaft)German Research Foundation (DFG)
FX This work was funded by Swiss National Science Foundation Sinergia
   Grants CRSIK0_122691 and CRSI33_130080 (to D.J.-F.d.Q. and A.P.), by the
   Seventh Framework Programme of the European Union [Alzheimer's Disease,
   Alcoholism, Memory, Schizophrenia (ADAMS) Project,
   health-F4-2009-242257], by the National Center for Competence in
   Research SYNAPSY, and by the German Research Foundation" (Deutsche
   Forschungsgemeinschaft; grants to I.-T.K. and T.E.).
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Bremner JD, 1999, AM J PSYCHIAT, V156, P1787
   Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7
   Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113
   Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102
   Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x
   Dong C, 2009, NEUROSCIENCE, V163, P811, DOI 10.1016/j.neuroscience.2009.06.069
   Elbert T, 2002, NATURE, V419, P883, DOI 10.1038/419883a
   Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445
   GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G
   Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032
   Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu
   Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009
   Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8
   Lang P.J., 1999, A4 U FLOR CTR RES PS
   Liao GY, 2001, MOL PHARMACOL, V59, P960
   Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1
   McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7
   McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248
   McGaugh JL, 2003, MAKING LASTING MEMOR
   Michael T, 2005, EMOTION, V5, P103, DOI 10.1037/1528-3542.5.1.103
   Moradi AR, 2000, J ANXIETY DISORD, V14, P521, DOI 10.1016/S0887-6185(00)00037-2
   Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030
   Neuner F, 2008, J CONSULT CLIN PSYCH, V76, P686, DOI 10.1037/0022-006X.76.4.686
   Neuner F, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-34
   ONYUT LP, 2004, INTERVENTION, V2, P90
   Paunovic N, 2002, J ANXIETY DISORD, V16, P675, DOI 10.1016/S0887-6185(02)00136-6
   Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025
   PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S
   Ranganath C, 2010, HIPPOCAMPUS, V20, P1263, DOI 10.1002/hipo.20852
   Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014
   Thomaes K., 2011, SOC COGN AFFECT NEUR
   Todd RM, 2011, NEUROPSYCHOLOGIA, V49, P734, DOI 10.1016/j.neuropsychologia.2010.11.010
   Weeber EJ, 2000, J NEUROSCI, V20, P5906, DOI 10.1523/JNEUROSCI.20-16-05906.2000
NR 38
TC 39
Z9 39
U1 1
U2 18
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 29
PY 2012
VL 109
IS 22
BP 8746
EP 8751
DI 10.1073/pnas.1200857109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 953PD
UT WOS:000304881700077
PM 22586106
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Stoeber, M
   Stoeck, IK
   Hanni, C
   Bleck, CKE
   Balistreri, G
   Helenius, A
AF Stoeber, Miriam
   Stoeck, Ina Karen
   Haenni, Christine
   Bleck, Christopher Karl Ernst
   Balistreri, Giuseppe
   Helenius, Ari
TI Oligomers of the ATPase EHD2 confine caveolae to the plasma membrane
   through association with actin
SO EMBO JOURNAL
LA English
DT Article
DE actin cytoskeleton; ATPase; caveolae; EHD2; endocytosis
ID MEDIATED ENDOCYTOSIS; LIPID RAFTS; DOMAINS; CYTOSKELETON; TRAFFICKING;
   PROTEINS; DYNAMIN; INTERNALIZATION; TRANSPORT; CAVIN
AB Caveolae are specialized domains present in the plasma membrane (PM) of most mammalian cell types. They function in signalling, membrane regulation, and endocytosis. We found that the Eps- 15 homology domain-containing protein 2 (EHD2, an ATPase) associated with the static population of PM caveolae. Recruitment to the PM involved ATP binding, interaction with anionic lipids, and oligomerization into large complexes (60-75S) via interaction of the EH domains with intrinsic NPF/KPF motifs. Hydrolysis of ATP was essential for binding of EHD2 complexes to caveolae. EHD2 was found to undergo dynamic exchange at caveolae, a process that depended on a functional ATPase cycle. Depletion of EHD2 by siRNA or expression of a dominant-negative mutant dramatically increased the fraction of mobile caveolar vesicles coming from the PM. Overexpression of EHD2, in turn, caused confinement of cholera toxin B in caveolae. The confining role of EHD2 relied on its capacity to link caveolae to actin filaments. Thus, EHD2 likely plays a key role in adjusting the balance between PM functions of stationary caveolae and the role of caveolae as vesicular carriers. The EMBO Journal (2012) 31, 2350-2364. doi: 10.1038/emboj.2012.98; Published online 13 April 2012
C1 [Stoeber, Miriam; Stoeck, Ina Karen; Haenni, Christine; Balistreri, Giuseppe; Helenius, Ari] ETH, Inst Biochem, CH-8093 Zurich, Switzerland.
   [Bleck, Christopher Karl Ernst] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
RP Helenius, A (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.
EM ari.helenius@bc.biol.ethz.ch
OI Bleck, Christopher/0000-0003-1029-3444; Balistreri,
   Giuseppe/0000-0002-3585-559X
FU ETH ZurichETH Zurich; European Research Council (ERC)European Research
   Council (ERC); SNF; Boehringer Ingelheim FondsBoehringer Ingelheim
FX We are grateful to Arnold Hayer for experimental advice throughout the
   project and critical reading of the manuscript. We thank Nikolaus
   Schmitz for help with the PyMOL software, Manju George for EHD1-4
   constructs, the Light Microscopy Centre of ETH Zurich and members of the
   Helenius laboratory for support, especially Florian Schmidt and Jason
   Mercer for comments on the manuscript. We thank Prof. H Stahlberg for
   supporting CB with working space and EM equipment. Funding was provided
   by ETH Zurich, the European Research Council (ERC), and the SNF Sinergia
   Projects. MS was supported by a Boehringer Ingelheim Fonds PhD
   fellowship.
CR Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647
   Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053
   Benjamin S, 2011, BIOCHEM J, V439, P433, DOI 10.1042/BJ20111010
   Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006
   Botos E, 2008, J CELL MOL MED, V12, P1632, DOI 10.1111/j.1582-4934.2007.00167.x
   Boucrot E, 2011, J CELL SCI, V124, P1965, DOI 10.1242/jcs.076570
   Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x
   Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173
   Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688
   Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104
   FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655
   George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3
   Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200
   Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005
   Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887
   Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319
   Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086
   Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x
   Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85
   Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042
   Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011
   Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078
   Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002
   Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9
   Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200
   Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007
   McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46
   Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787
   Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117
   Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804
   Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003
   Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101
   PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199
   PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861
   Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122
   Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866
   Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003
   Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784
   Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571
   Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x
   Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557
   Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x
   ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z
   SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407
   SCHLIWA M, 1981, P NATL ACAD SCI-BIOL, V78, P1037, DOI 10.1073/pnas.78.2.1037
   Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803
   Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x
   Singh RD, 2010, TRAFFIC, V11, P348, DOI 10.1111/j.1600-0854.2009.01022.x
   Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031
   Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325
   Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x
   Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997
   Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103
   Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317
   TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551
   van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9
   Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n
NR 57
TC 93
Z9 93
U1 1
U2 20
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD MAY 16
PY 2012
VL 31
IS 10
BP 2350
EP 2364
DI 10.1038/emboj.2012.98
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 945AN
UT WOS:000304245300014
PM 22505029
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Berkemeier, C
   Hall, M
   Hollander, G
AF Berkemeier, Caroline
   Hall, Mike
   Hollander, Georg
TI The Role of the mTOR pathway for the development and function of the
   mouse thymic epithelium
SO SWISS MEDICAL WEEKLY
LA English
DT Meeting Abstract
C1 [Berkemeier, Caroline; Hollander, Georg] Univ Kinderspital Beider Basel, Basel, Switzerland.
   [Hall, Mike] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
EI 1424-3997
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD MAY 12
PY 2012
VL 142
SU 192
MA P 116
BP 38S
EP 38S
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA VG6CH
UT WOS:000447690100151
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Jeyaprakash, AA
   Santamaria, A
   Jayachandran, U
   Chan, YW
   Benda, C
   Nigg, EA
   Conti, E
AF Jeyaprakash, A. Arockia
   Santamaria, Anna
   Jayachandran, Uma
   Chan, Ying Wai
   Benda, Christian
   Nigg, Erich A.
   Conti, Elena
TI Structural and Functional Organization of the Ska Complex, a Key
   Component of the Kinetochore-Microtubule Interface
SO MOLECULAR CELL
LA English
DT Article
ID DAM1 COMPLEX; NDC80 COMPLEX; RING COMPLEX; DEPOLYMERIZATION;
   ARCHITECTURE; ATTACHMENT; SPINDLE; NETWORK; POINT
AB The Ska complex is an essential mitotic component required for accurate cell division in human cells. It is composed of three subunits that function together to establish stable kinetochore-microtubule interactions in concert with the Ndc80 network. We show that the structure of the Ska core complex is a W-shaped dimer of coiled coils, formed by intertwined interactions between Ska1, Ska2, and Ska3. The C-terminal domains of Skal and Ska3 protrude at each end of the homodimer, bind microtubules in vitro when connected to the central core, and are essential in vivo. Mutations disrupting the central coiled coil or the dimerization interface result in chromosome congression failure followed by cell death. The Ska complex is thus endowed with bipartite and cooperative tubulin-binding properties at the ends of a 350 angstrom-long molecule. We discuss how this symmetric architecture might complement and stabilize the Ndc80-microtubule attachments with analogies to the yeast Dam1/DASH complex.
C1 [Jeyaprakash, A. Arockia; Jayachandran, Uma; Benda, Christian; Conti, Elena] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany.
   [Jeyaprakash, A. Arockia] Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.
   [Santamaria, Anna; Chan, Ying Wai; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Chan, Ying Wai] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.
RP Conti, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.
EM conti@biochem.mpg.de
RI Arulanandam, Arockia Jeyaprakash/Y-5885-2019; Chan, Ying Wai/P-7347-2019
OI Arulanandam, Arockia Jeyaprakash/0000-0002-1889-8635; Chan, Ying
   Wai/0000-0002-6196-7675; nigg, erich/0000-0003-4835-5719; Benda,
   Christian/0000-0001-5551-1332
FU Max Planck GesellschaftMax Planck Society; Deutsche
   Forschungsgemeinschaft (DFG)German Research Foundation (DFG); Center for
   Integrated Protein Science Munich (CIPSM); Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Swiss Cancer League
   [KFS 02657-08-2010];  [Sonderforschungsbereich SFB646]
FX We would like to thank C. Basquin for the SLS experiments and J.
   Basquin, K. Valer-Saldana, and S. Pleyer in the MPI Biochemistry
   Crystallization Facility. We also thank R. Zenke for help with the light
   microscopes and O. Mihalache for the electron microscopes. We thank the
   staff of the PXII beamline at the Swiss Light Source for assistance
   during data collection. We also thank E. Lorentzen, F. Bonneau, S.
   Chakrabarti, and A. Murachelli for critical reading of the manuscript.
   This study was supported by the Max Planck Gesellschaft, the
   Sonderforschungsbereich SFB646, the Gottfried Wilhelm Leibniz Program of
   the Deutsche Forschungsgemeinschaft (DFG), and the Center for Integrated
   Protein Science Munich (CIPSM) to E.C. E.A.N., Y.W.C., and A.S.
   acknowledge support from the Swiss National Science Foundation and the
   Swiss Cancer League (KFS 02657-08-2010).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Buttrick GJ, 2011, CHROMOSOME RES, V19, P393, DOI 10.1007/s10577-011-9185-8
   Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310
   Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039
   Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X
   Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020
   Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238
   Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005
   Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017
   DeLuca JG, 2012, CURR OPIN CELL BIOL, V24, P48, DOI 10.1016/j.ceb.2011.11.003
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96
   Gao Q, 2010, P NATL ACAD SCI USA, V107, P13330, DOI 10.1073/pnas.1004887107
   Gascoigne KE, 2011, CURR OPIN CELL BIOL, V23, P102, DOI 10.1016/j.ceb.2010.07.007
   Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702
   Guimaraes GJ, 2009, EMBO J, V28, P1375, DOI 10.1038/emboj.2009.124
   Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426
   Hardwick Kevin G, 2010, F1000 Biol Rep, V2, P55, DOI 10.3410/B2-55
   Ikeuchi A, 2010, BIOTECHNOL PROGR, V26, P945, DOI 10.1002/btpr.403
   Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010
   Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021
   Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104
   Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790
   Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050
   Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896
   Nogales E, 2009, J CELL SCI, V122, P3831, DOI 10.1242/jcs.004689
   Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047
   Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045
   Raaijmakers JA, 2009, J CELL SCI, V122, P2436, DOI 10.1242/jcs.051912
   Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173
   Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200
   Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765
   Theis M, 2009, EMBO J, V28, P1453, DOI 10.1038/emboj.2009.114
   Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142
   Tooley JG, 2011, MOL BIOL CELL, V22, P1217, DOI 10.1091/mbc.E10-07-0626
   Wang HW, 2007, NAT STRUCT MOL BIOL, V14, P721, DOI 10.1038/nsmb1274
   Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186
   Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011
   Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409
   Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170
NR 42
TC 90
Z9 95
U1 0
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD MAY 11
PY 2012
VL 46
IS 3
BP 274
EP 286
DI 10.1016/j.molcel.2012.03.005
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 942SZ
UT WOS:000304071100006
PM 22483620
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Willer, Y
   Muller, B
   Bumann, D
AF Willer, Yvonne
   Mueller, Beatrice
   Bumann, Dirk
TI Intestinal Inflammation Responds to Microbial Tissue Load Independent of
   Pathogen/Non-Pathogen Discrimination
SO PLOS ONE
LA English
DT Article
ID TOLL-LIKE RECEPTORS; ESCHERICHIA-COLI NISSLE-1917; ORAL SALMONELLA
   INFECTION; INNATE IMMUNE-SYSTEM; DENDRITIC CELLS; ULCERATIVE-COLITIS;
   LYMPHOID-TISSUE; MUCOSAL DEFENSE; PEYERS-PATCHES; COMMENSAL
AB The intestinal immune system mounts inflammatory responses to pathogens but tolerates harmless commensal microbiota. Various mechanisms for pathogen/non-pathogen discrimination have been proposed but their general relevance for inflammation control is unclear. Here, we compared intestinal responses to pathogenic Salmonella and non-pathogenic E. coli. Both microbes entered intestinal Peyer's patches and, surprisingly, induced qualitatively and quantitatively similar initial inflammatory responses revealing a striking discrimination failure. Diverging inflammatory responses only occurred when Salmonella subsequently proliferated and induced escalating neutrophil infiltration, while harmless E. coli was rapidly cleared from the tissue and inflammation resolved. Transient intestinal inflammation induced by harmless E. coli tolerized against subsequent exposure thereby preventing chronic inflammation during repeated exposure. These data revealed a striking failure of the intestinal immune system to discriminate pathogens from harmless microbes based on distinct molecular signatures. Instead, appropriate intestinal responses to gut microbiota might be ensured by immediate inflammatory responses to any rise in microbial tissue loads, and desensitization after bacterial clearance.
C1 [Willer, Yvonne; Bumann, Dirk] Hannover Med Sch, Jr Grp Mucosal Infect, D-3000 Hannover, Germany.
   [Bumann, Dirk] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany.
   [Mueller, Beatrice; Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland.
RP Willer, Y (corresponding author), Hannover Med Sch, Jr Grp Mucosal Infect, D-3000 Hannover, Germany.
EM Dirk.Bumann@unibas.ch
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 621
   A9]
FX This work was in part supported by Deutsche Forschungsgemeinschaft (SFB
   621 A9). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. No
   additional external funding was received for this study.
CR Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675
   Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282
   Cheminay U, 2004, INFECT IMMUN, V72, P468, DOI 10.1128/IAI.72.1.468-477.2004
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Fukushima K, 1999, J GASTROENTEROL, V34, P54, DOI 10.1007/s005350050216
   Grabig A, 2006, INFECT IMMUN, V74, P4075, DOI 10.1128/IAI.01449-05
   Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   Hopkins SA, 2000, CELL MICROBIOL, V2, P59
   Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301
   Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747
   Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625
   Ogawa H, 2000, AM J PHYSIOL-GASTR L, V279, pG492
   Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526
   Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007
   Rakoff-Nahoum S, 2006, CURR TOP MICROBIOL, V308, P1
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0
   Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373
   Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095
   Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789
   Rydstrom A, 2009, EUR J IMMUNOL, V39, P3019, DOI 10.1002/eji.200939483
   Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015
   Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77
   Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420
   Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377
   Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003
   Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749
   Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007
   Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202
   Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463
NR 31
TC 4
Z9 6
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2012
VL 7
IS 5
AR e35992
DI 10.1371/journal.pone.0035992
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TC
UT WOS:000305335000020
PM 22586458
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Hagiwara, A
   Cornu, M
   Cybulski, N
   Polak, P
   Betz, C
   Trapani, F
   Terracciano, L
   Heim, MH
   Ruegg, MA
   Hall, MN
AF Hagiwara, Asami
   Cornu, Marion
   Cybulski, Nadine
   Polak, Pazit
   Betz, Charles
   Trapani, Francesca
   Terracciano, Luigi
   Heim, Markus H.
   Rueegg, Markus A.
   Hall, Michael N.
TI Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt,
   Glucokinase, and SREBP1c
SO CELL METABOLISM
LA English
DT Article
ID ELEMENT-BINDING PROTEIN-1C; LIPID-METABOLISM; TRANSCRIPTION FACTORS;
   INSULIN-RESISTANCE; GENE-EXPRESSION; PHOSPHOINOSITIDE 3-KINASE; MOTIF
   PHOSPHORYLATION; DIABETIC-NEPHROPATHY; GLUCOSE-UTILIZATION; CELL-GROWTH
AB Mammalian target of rapamycin complex 2 (mTORC2) phosphorylates and activates AGC kinase family members, including Akt, SGK1, and PKC, in response to insulin/IGF1. The liver is a key organ in insulin-mediated regulation of metabolism. To assess the role of hepatic mTORC2, we generated liver-specific rictor knockout (LiRiKO) mice. Fed LiRikO mice displayed loss of Akt Ser473 phosphorylation and reduced glucokinase and SREBP1c activity in the liver, leading to constitutive gluconeogenesis, and impaired glycolysis and lipogenesis, suggesting that the mTORC2-deficient liver is unable to sense satiety. These liver-specific defects resulted in systemic hyperglycemia, hyperinsulinemia, and hypolipidemia. Expression of constitutively active Akt2 in mTORC2-deficient hepatocytes restored both glucose flux and lipogenesis, whereas glucokinase overexpression rescued glucose flux but not lipogenesis. Thus, mTORC2 regulates hepatic glucose and lipid metabolism via insulin-induced Akt signaling to control whole-body metabolic homeostasis. These findings have implications for emerging drug therapies that target mTORC2.
C1 [Hagiwara, Asami; Cornu, Marion; Cybulski, Nadine; Polak, Pazit; Betz, Charles; Rueegg, Markus A.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Trapani, Francesca; Terracciano, Luigi] Univ Basel Hosp, Inst Pathol, CH-4003 Basel, Switzerland.
   [Heim, Markus H.] Univ Basel Hosp, Dept Biomed, CH-4003 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
RI Betz, Charles/B-7444-2008; Heim, Markus/A-7526-2008; Ruegg,
   Markus/X-7256-2019
OI Betz, Charles/0000-0002-9837-6916; Heim, Markus/0000-0002-7523-4894;
   Ruegg, Markus/0000-0002-4974-9384
FU Ajinomoto Co., Inc.; Misrock Foundation; SFD-ALFEDIAM; Louis Jeantet
   Foundation; Canton of Basel; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF)
FX We thank Andrea Loeschmann for expert technical support; Christoph
   Handschin (University of Basel, Switzerland) for use of the EchoMRI-100
   qNMR and cobas c; and Brian A. Hemmings (FMI, Switzerland), Wataru Ogawa
   (Kobe University, Japan), and Bernard Thorens (University of Lausanne,
   Switzerland) for reagents. We acknowledge support from Ajinomoto Co.,
   Inc. (A.H.), the SFD-ALFEDIAM (M.C.), the Misrock Foundation (C.B.), the
   Louis Jeantet Foundation (M.N.H.), the Canton of Basel, and the Swiss
   National Science Foundation.
CR Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106
   Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003
   Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008
   Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200
   Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735
   Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120
   Ferre T, 1996, FASEB J, V10, P1213
   Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931
   Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200
   Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119
   Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075
   Kim KH, 2004, J BIOL CHEM, V279, P51999, DOI 10.1074/jbc.M405522200
   Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742
   Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004
   Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107
   Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Markman B, 2010, ONCOTARGET, V1, P530, DOI 10.18632/oncotarget.188
   Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411
   Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Polak P, 2006, DEV CELL, V11, P433, DOI 10.1016/j.devcel.2006.09.005
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200
   Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100
   Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010
   Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005
   Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008
   Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
   Yang RJ, 2002, J BIOL CHEM, V277, P1514, DOI 10.1074/jbc.M107001200
   Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002
   Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914
   Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Zhang YJ, 2011, DRUG DISCOV TODAY, V16, P325, DOI 10.1016/j.drudis.2011.02.008
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
NR 73
TC 307
Z9 314
U1 2
U2 49
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD MAY 2
PY 2012
VL 15
IS 5
BP 725
EP 738
DI 10.1016/j.cmet.2012.03.015
PG 14
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 937WL
UT WOS:000303694100020
PM 22521878
OA Bronze
DA 2021-01-25
ER

PT J
AU Zschiedrich, S
   Godel, M
   Hartleben, B
   Eulenbruch, K
   Munder, S
   Herbach, N
   Rastaldi, MP
   Cohen, CD
   Hall, MN
   Ruegg, MA
   Walz, G
   Huber, TB
AF Zschiedrich, Stefan
   Goedel, Markus
   Hartleben, Bjoern
   Eulenbruch, Kristina
   Munder, Stefan
   Herbach, Nadja
   Rastaldi, Maria-Pia
   Cohen, Clemens D.
   Hall, Michael N.
   Rueegg, Markus A.
   Walz, Gerd
   Huber, Tobias B.
TI MTORC1 CONTRIBUTES TO THE PATHOGENESIS OF FSGS
SO NEPHROLOGY DIALYSIS TRANSPLANTATION
LA English
DT Meeting Abstract
CT 49th Congress of the
   European-Renal-Association/European-Dialysis-and-Transplant-Association
   (ERA-EDTA)
CY MAY 24-27, 2012
CL Paris, FRANCE
SP European Renal Assoc (ERA), European Dialysis & Transplant Assoc (EDTA)
C1 [Zschiedrich, Stefan; Goedel, Markus; Hartleben, Bjoern; Eulenbruch, Kristina; Munder, Stefan; Walz, Gerd; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, Freiburg, Germany.
   [Herbach, Nadja] Univ Munich, Inst Vet Pathol, Munich, Germany.
   [Rastaldi, Maria-Pia] Renal Res Lab, Milan, Italy.
   [Cohen, Clemens D.] Univ Hosp, Div Renal, Geneva, Switzerland.
   [Cohen, Clemens D.] Univ Hosp, Inst Physiol, Geneva, Switzerland.
   [Cohen, Clemens D.] Univ Zurich, CH-8006 Zurich, Switzerland.
   [Hall, Michael N.; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RI Zschiedrich, Stefan/ABE-9871-2020; Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0931-0509
J9 NEPHROL DIAL TRANSPL
JI Nephrol. Dial. Transplant.
PD MAY
PY 2012
VL 27
SU 2
BP 32
EP 32
PG 1
WC Transplantation; Urology & Nephrology
SC Transplantation; Urology & Nephrology
GA 042TU
UT WOS:000311494700069
DA 2021-01-25
ER

PT J
AU Ittig, S
   Lindner, B
   Stenta, M
   Manfredi, P
   Zdorovenko, E
   Knirel, YA
   dal Peraro, M
   Cornelis, GR
   Zahringer, U
AF Ittig, Simon
   Lindner, Buko
   Stenta, Marco
   Manfredi, Pablo
   Zdorovenko, Evelina
   Knirel, Yuriy A.
   dal Peraro, Matteo
   Cornelis, Guy R.
   Zaehringer, Ulrich
TI The Lipopolysaccharide from Capnocytophaga canimorsus Reveals an
   Unexpected Role of the Core-Oligosaccharide in MD-2 Binding
SO PLOS PATHOGENS
LA English
DT Article
ID FREE-ENERGY DECOMPOSITION; RECEPTOR 4 RESPONSES; GAUSSIAN-BASIS SETS;
   LIPID-A COMPONENT; PORPHYROMONAS-GINGIVALIS; MOLECULAR-DYNAMICS;
   ESCHERICHIA-COLI; STRUCTURAL-CHARACTERIZATION; ENDOTOXIN ANTAGONIST;
   HELICOBACTER-PYLORI
AB Capnocytophaga canimorsus is a usual member of dog's mouths flora that causes rare but dramatic human infections after dog bites. We determined the structure of C. canimorsus lipid A. The main features are that it is penta-acylated and composed of a "hybrid backbone'' lacking the 4' phosphate and having a 1 phosphoethanolamine (P-Etn) at 2-amino-2-deoxy-D-glucose (GlcN). C. canimorsus LPS was 100 fold less endotoxic than Escherichia coli LPS. Surprisingly, C. canimorsus lipid A was 20,000 fold less endotoxic than the C. canimorsus lipid A-core. This represents the first example in which the core-oligosaccharide dramatically increases endotoxicity of a low endotoxic lipid A. The binding to human myeloid differentiation factor 2 (MD-2) was dramatically increased upon presence of the LPS core on the lipid A, explaining the difference in endotoxicity. Interaction of MD-2, cluster of differentiation antigen 14 (CD14) or LPS-binding protein (LBP) with the negative charge in the 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) of the core might be needed to form the MD-2 - lipid A complex in case the 4' phosphate is not present.
C1 [Ittig, Simon; Manfredi, Pablo; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Lindner, Buko; Zaehringer, Ulrich] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, Borstel, Germany.
   [Stenta, Marco; dal Peraro, Matteo] EPF Lausanne, Swiss Fed Inst Technol, Sch Life Sci, Lab Biomol Modeling,Inst Bioengn, Lausanne, Switzerland.
   [Zdorovenko, Evelina; Knirel, Yuriy A.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia.
RP Ittig, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM uzaehr@fz-borstel.de
RI Lindner, Buko/G-9731-2014; Knirel, Yuriy A/E-2058-2014
OI Zdorovenko, Evelina/0000-0001-8625-2169
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-128659, 200021_135450]; Werner-Siemens Foundation
FX This work was supported by the Swiss National Science Foundation (grant
   3100A0-128659 to GRC, grant 200021_135450 to MdP). SI was supported by
   the Werner-Siemens Foundation. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m
   Altoe P, 2007, THEOR CHEM ACC, V118, P219, DOI 10.1007/s00214-007-0275-9
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Blanche P, 1998, J INFECTION, V36, P134, DOI 10.1016/S0163-4453(98)93918-4
   BOBO RA, 1976, AM J CLIN PATHOL, V65, P564
   BRENNER DJ, 1989, J CLIN MICROBIOL, V27, P231, DOI 10.1128/JCM.27.2.231-235.1989
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   CICCOTTI G, 1986, COMPUT PHYS REP, V4, P345
   Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x
   Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10
   Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x
   Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454
   DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153
   Frisch M. J., 2009, GAUSSIAN09
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Ingram BO, 2010, BBA-MOL CELL BIOL L, V1801, P593, DOI 10.1016/j.bbalip.2010.02.001
   Janda JM, 2006, EMERG INFECT DIS, V12, P340, DOI 10.3201/eid1202.050783
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kato H, 1998, J BACTERIOL, V180, P3891, DOI 10.1128/JB.180.15.3891-3899.1998
   Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002
   KIRKLAND TN, 1993, J BIOL CHEM, V268, P24818
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721
   Kumada H, 2008, ORAL MICROBIOL IMMUN, V23, P60, DOI 10.1111/j.1399-302X.2007.00392.x
   LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697
   LOWRY OH, 1954, J BIOL CHEM, V207, P1
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082
   MAITRA SK, 1978, P NATL ACAD SCI USA, V75, P3993, DOI 10.1073/pnas.75.8.3993
   Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164
   Manfredi P, 2011, J BACTERIOL, V193, P5558, DOI 10.1128/JB.05853-11
   Manfredi P, 2011, MOL MICROBIOL, V81, P1050, DOI 10.1111/j.1365-2958.2011.07750.x
   Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131
   Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668
   Meyer S, 2008, IMMUNOBIOLOGY, V213, P805, DOI 10.1016/j.imbio.2008.07.019
   Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068
   MORAN AP, 1991, EUR J BIOCHEM, V198, P459, DOI 10.1111/j.1432-1033.1991.tb16036.x
   Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81
   Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111
   Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830
   Pers C, 1996, CLIN INFECT DIS, V23, P71, DOI 10.1093/clinids/23.1.71
   Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27
   Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803
   Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200
   RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021
   Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414
   Renzi F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002118
   Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200
   RIETSCHEL ET, 1994, FASEB J, V8, P217
   ROSENFELDER G, 1974, EUR J BIOCHEM, V44, P411, DOI 10.1111/j.1432-1033.1974.tb03499.x
   Rucker R, 2010, PROTEINS, V78, P671, DOI 10.1002/prot.22596
   Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651
   SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096
   Schlegel HB, 2003, J COMPUT CHEM, V24, P1514, DOI 10.1002/jcc.10231
   Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777
   Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243
   Shin H, 2009, INFECT IMMUN, V77, P2262, DOI 10.1128/IAI.01324-08
   Showalter SA, 2007, J CHEM THEORY COMPUT, V3, P961, DOI 10.1021/ct7000045
   St Swierzko A, 2000, J MED MICROBIOL, V49, P127, DOI 10.1099/0022-1317-49-2-127
   Stead CM, 2010, MOL MICROBIOL, V78, P837, DOI 10.1111/j.1365-2958.2010.07304.x
   Sweet CR, 2004, J BIOL CHEM, V279, P25400, DOI 10.1074/jbc.M400596200
   Tessier MB, 2008, MOL SIMULAT, V34, P349, DOI 10.1080/08927020701710890
   Tran AX, 2006, J BACTERIOL, V188, P4531, DOI 10.1128/JB.00146-06
   ULEVITCH RJ, 1993, ADV IMMUNOL, V53, P267, DOI 10.1016/S0065-2776(08)60502-7
   Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1
   Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200
   Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104
   Wang XY, 2006, J BIOL CHEM, V281, P9321, DOI 10.1074/jbc.M600435200
   Weigend F, 1998, CHEM PHYS LETT, V294, P143, DOI 10.1016/S0009-2614(98)00862-8
   WEINTRAUB A, 1989, EUR J BIOCHEM, V183, P425, DOI 10.1111/j.1432-1033.1989.tb14945.x
   WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83
   WESTWELL AJ, 1989, BRIT MED J, V298, P116, DOI 10.1136/bmj.298.6666.116-c
   WOLLENWEBER HW, 1990, J MICROBIOL METH, V11, P195, DOI 10.1016/0167-7012(90)90056-C
   WOODS RJ, 1995, J PHYS CHEM-US, V99, P3832, DOI 10.1021/j100011a061
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   Yoshimura A, 2002, INFECT IMMUN, V70, P218, DOI 10.1128/IAI.70.1.218-225.2002
   Zahringer U, 2001, J ENDOTOXIN RES, V7, P133, DOI 10.1177/09680519010070020801
   Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93
   Zhao JS, 2010, MOL MICROBIOL, V78, P820, DOI 10.1111/j.1365-2958.2010.07305.x
   Zimmer SM, 2007, GLYCOBIOLOGY, V17, P847, DOI 10.1093/glycob/cwm057
   Zoete V, 2010, J MOL RECOGNIT, V23, P142, DOI 10.1002/jmr.1005
NR 82
TC 26
Z9 26
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2012
VL 8
IS 5
AR e1002667
DI 10.1371/journal.ppat.1002667
PG 18
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 959OS
UT WOS:000305322900006
PM 22570611
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Werlen, G
   Chou, PC
   Oh, W
   Wu, CC
   Ruegg, M
   Hall, M
   Jacinto, E
AF Werlen, Guy
   Chou, Po-Chien
   Oh, Won
   Wu, Chang-Chih
   Ruegg, Markus
   Hall, Michael
   Jacinto, Estela
TI mTORC2 controls T-cell receptor processing and surface expression during
   thymocyte development
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 99th Annual Meeting of the American-Association-of-Immunologists
CY MAY 04-08, 2012
CL Boston, MA
SP Amer Assoc Immunol
C1 [Werlen, Guy; Chou, Po-Chien] Rutgers State Univ, Piscataway, NJ USA.
   [Chou, Po-Chien; Oh, Won; Wu, Chang-Chih; Jacinto, Estela] UMDNJ Robert Wood Johnson Med Sch, Piscataway, NJ USA.
   [Ruegg, Markus; Hall, Michael] Univ Basel, Biozentrum, Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2012
VL 188
PG 1
WC Immunology
SC Immunology
GA 950OX
UT WOS:000304659701135
DA 2021-01-25
ER

PT J
AU Kudryashev, M
   Stahlberg, H
   Castano-Diez, D
AF Kudryashev, Mikhail
   Stahlberg, Henning
   Castano-Diez, Daniel
TI Assessing the benefits of focal pair cryo-electron tomography
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Cryo electron tomography; Image processing; CTF correction
ID FIDUCIAL-LESS ALIGNMENT; ELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE;
   TILT-SERIES; IN-SITU; SINGLE PARTICLES; FLAGELLAR MOTOR; PHASE PLATES;
   RECONSTRUCTION; MICROSCOPY
AB Cryo electron tomography provides nanometer-scale information on biological matter preserved in a close-to native state. The resolution of tomograms and structures resolved by sub-tomogram averaging is typically limited by the contrast transfer function of the electron microscope, which is especially critical for thick samples. Here, we report a method to increase the attainable resolution by recording tomographic 'focal pairs', which are pairs of tilt series of the same object acquired in complementary defocus conditions. Low defocus imaging provides high resolution at low contrast, while high defocus imaging yields high contrast at the price of limited resolution. Quantitative assessment of the quality of lipid bilayer reconstructions in the resulting tomograms demonstrates stable resolution preservation beyond 3 nm for cells thicker than 500 nm. Further, in computational simulations on synthetic datasets we show the applicability of the method to sub-tomogram averaging, demonstrating its potential for achieving higher resolution. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Kudryashev, Mikhail; Stahlberg, Henning; Castano-Diez, Daniel] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland.
RP Stahlberg, H (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, WRO 1058,Mattenstr 26, CH-4058 Basel, Switzerland.
EM Henning.Stahlberg@unibas.ch; Daniel.Castano@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Kudryashev,
   Misha/0000-0003-3550-6274; Castano-Diez, daniel/0000-0002-0197-163X
FU CINA from SystemX.ch; Swiss Initiative for Systems Biology; Swiss
   National Sciene Foundation NCCRs Nano, TransCure, and Structural Biology
FX We thank the groups of Guy Cornelis and Urs Jenal for providing bacteria
   used for imaging, Bill Anderson, Kenneth Goldie, and Radosav Pantelic
   for help with microscopy, discussions and comments on the manuscript,
   and Ilya Yakovlev, Fernando Amat for discussions and comments on the
   manuscript. The work was supported by the CINA grant from SystemX.ch,
   the Swiss Initiative for Systems Biology, and by the Swiss National
   Sciene Foundation NCCRs Nano, TransCure, and Structural Biology.
CR Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994
   Al-Amoudi A, 2011, P NATL ACAD SCI USA, V108, P6480, DOI 10.1073/pnas.1019469108
   Amat F, 2010, METHOD ENZYMOL, V482, P343, DOI 10.1016/S0076-6879(10)82014-2
   Amat F, 2010, J STRUCT BIOL, V171, P332, DOI 10.1016/j.jsb.2010.05.013
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]
   Brandt F, 2010, MOL CELL, V39, P560, DOI 10.1016/j.molcel.2010.08.003
   Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106
   Castano-Diez D, 2007, J STRUCT BIOL, V159, P413, DOI 10.1016/j.jsb.2007.04.014
   Castano-Diez D, 2010, J STRUCT BIOL, V170, P117, DOI 10.1016/j.jsb.2010.01.014
   Chen S, 2011, EMBO J, DOI 10.1038
   CROWTHER RA, 1971, J THEOR BIOL, V32, P199, DOI 10.1016/0022-5193(71)90147-0
   de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215
   Faruqi AR, 2011, Q REV BIOPHYS, V44, P357, DOI 10.1017/S0033583511000035
   Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004
   Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102
   Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299
   Frank J, 2009, Q REV BIOPHYS, V42, P139, DOI 10.1017/S0033583509990059
   Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X
   Grigorieff N, 2000, ACTA CRYSTALLOGR D, V56, P1270, DOI 10.1107/S0907444900009549
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Kudryashev M, 2009, J STRUCT BIOL
   Leis A., 2008, TRENDS BIOCH SCI
   Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159
   Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09
   Ludtke SJ, 2003, J STRUCT BIOL, V144, P73, DOI 10.1016/j.jsb.2003.10.012
   Murata K, 2010, STRUCTURE, V18, P903, DOI 10.1016/j.str.2010.06.006
   Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015
   Nagayama K, 2008, PHILOS T R SOC B, V363, P2153, DOI 10.1098/rstb.2008.2268
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Ortiz JO, 2010, J CELL BIOL, V190, P613, DOI 10.1083/jcb.201005007
   Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095
   Philippsen A, 2007, ULTRAMICROSCOPY, V107, P202, DOI 10.1016/j.ultramic.2006.07.010
   Radermacher M., 1987, J PHYS SCI, V146, P113
   Rigort A, 2010, J STRUCT BIOL, V172, P169, DOI 10.1016/j.jsb.2010.02.011
   Sorzano COS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-124
   THON F, 1971, J ELECTRON MICROSC, V20, P215
   Trepout S, 2010, BBA-BIOMEMBRANES, V1798, P1953, DOI 10.1016/j.bbamem.2010.06.019
   Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044
   WADE RH, 1992, ULTRAMICROSCOPY, V46, P145, DOI 10.1016/0304-3991(92)90011-8
   Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007
   Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014
   Xiong QR, 2009, J STRUCT BIOL, V168, P378, DOI 10.1016/j.jsb.2009.08.016
   Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083
   Zanetti G, 2009, J STRUCT BIOL, V168, P305, DOI 10.1016/j.jsb.2009.08.002
NR 46
TC 7
Z9 7
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAY
PY 2012
VL 178
IS 2
SI SI
BP 88
EP 97
DI 10.1016/j.jsb.2011.10.004
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 945PB
UT WOS:000304287400004
PM 22056466
DA 2021-01-25
ER

PT J
AU Bruning, M
   Barsukov, I
   Franke, B
   Barbieri, S
   Volk, M
   Leopoldseder, S
   Ucurum, Z
   Mayans, O
AF Bruning, Marc
   Barsukov, Igor
   Franke, Barbara
   Barbieri, Sonia
   Volk, Martin
   Leopoldseder, Sonja
   Ucurum, Zoehre
   Mayans, Olga
TI The intracellular Ig fold: a robust protein scaffold for the engineering
   of molecular recognition
SO PROTEIN ENGINEERING DESIGN & SELECTION
LA English
DT Article
DE differential scanning fluorimetry; infrared spectroscopy; intracellular
   Ig domain; NMR spectroscopy; protein scaffold engineering for peptide
   display
ID IMMUNOGLOBULIN-LIKE MODULES; ANTIBODY FRAGMENTS; TITIN; DOMAIN;
   ELASTICITY; STABILITY; BINDING; CONSERVATION; SPECTROSCOPY; MECHANISM
AB Protein scaffolds that support molecular recognition have multiple applications in biotechnology. Thus, protein frames with robust structural cores but adaptable surface loops are in continued demand. Recently, notable progress has been made in the characterization of Ig domains of intracellular originin particular, modular components of the titin myofilament. These Ig belong to the I(intermediate)-type, are remarkably stable, highly soluble and undemanding to produce in the cytoplasm of Escherichia coli. Using the Z1 domain from titin as representative, we show that the I-Ig fold tolerates the drastic diversification of its CD loop, constituting an effective peptide display system. We examine the stability of CD-loop-grafted Z1-peptide chimeras using differential scanning fluorimetry, Fourier transform infrared spectroscopy and nuclear magnetic resonance and demonstrate that the introduction of bioreactive affinity binders in this position does not compromise the structural integrity of the domain. Further, the binding efficiency of the exogenous peptide sequences in Z1 is analyzed using pull-down assays and isothermal titration calorimetry. We show that an internally grafted, affinity FLAG tag is functional within the context of the fold, interacting with the anti-FLAG M2 antibody in solution and in affinity gel. Together, these data reveal the potential of the intracellular Ig scaffold for targeted functionalization.
C1 [Bruning, Marc; Barsukov, Igor; Franke, Barbara; Barbieri, Sonia; Mayans, Olga] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.
   [Bruning, Marc; Barbieri, Sonia; Leopoldseder, Sonja; Ucurum, Zoehre] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   [Volk, Martin] Univ Liverpool, Dept Chem, Surface Sci Res Ctr, Liverpool L69 7ZD, Merseyside, England.
RP Mayans, O (corresponding author), Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England.
EM Olga.Mayans@liv.ac.uk
RI Volk, Martin/J-2912-2012
OI Mayans, Olga/0000-0001-6876-8532
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [3100A0-112595]; BBSRCBiotechnology and Biological Sciences Research
   Council (BBSRC)
FX This work was supported by the Swiss National Foundation
   (3100A0-112595). B.F. was funded by a BBSRC studentship.
CR Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Bruning M, 2010, NANO LETT, V10, P4533, DOI 10.1021/nl1024886
   Bucher RM, 2010, J MOL BIOL, V401, P843, DOI 10.1016/j.jmb.2010.06.011
   Chami M, 2011, J BIOSCI BIOENG, V112, P178, DOI 10.1016/j.jbiosc.2011.04.014
   Charles PT, 2004, BIOSENS BIOELECTRON, V20, P753, DOI 10.1016/j.bios.2004.04.007
   Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008
   Chi YH, 2001, BIOCHEMISTRY-US, V40, P7746, DOI 10.1021/bi002364+
   Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028
   Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9
   Edlich C, 2003, J BIOMOL NMR, V27, P283, DOI 10.1023/A:1025493410292
   Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627
   Goll CM, 1998, STRUCTURE, V6, P1291, DOI 10.1016/S0969-2126(98)00129-4
   Gronwall C, 2009, J BIOTECHNOL, V140, P254, DOI 10.1016/j.jbiotec.2009.01.014
   Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563
   Hamill SJ, 2000, J MOL BIOL, V295, P641, DOI 10.1006/jmbi.1999.3360
   Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142
   Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6
   Ioerger TR, 1999, MOL IMMUNOL, V36, P373, DOI 10.1016/S0161-5890(99)00032-2
   Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Lo A. S. -Y., 2008, V181, P343
   Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002
   Marino M, 2005, J MUSCLE RES CELL M, V26, P355, DOI 10.1007/s10974-005-9017-6
   Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009
   Mayans O, 2001, STRUCTURE, V9, P331, DOI 10.1016/S0969-2126(01)00591-3
   Mrosek M, 2007, FASEB J, V21, P1383, DOI 10.1096/fj.06-7644com
   Mueller S, 2007, J MOL BIOL, V371, P469, DOI 10.1016/j.jmb.2007.05.055
   Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331
   Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321
   Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072
   Pernigo S, 2010, P NATL ACAD SCI USA, V107, P2908, DOI 10.1073/pnas.0913736107
   PFUHL M, 1995, STRUCTURE, V3, P391, DOI 10.1016/S0969-2126(01)00170-8
   Politou AS, 1995, BIOPHYS J, V69, P2601, DOI 10.1016/S0006-3495(95)80131-1
   Steinmeyer DE, 2008, DRUG DISCOV TODAY, V13, P613, DOI 10.1016/j.drudis.2008.04.005
   Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   Wright CF, 2004, PROTEIN ENG DES SEL, V17, P443, DOI 10.1093/protein/gzh052
   Wurch T, 2008, CURR PHARM BIOTECHNO, V9, P502, DOI 10.2174/138920108786786385
   Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343
NR 41
TC 6
Z9 6
U1 0
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1741-0126
EI 1741-0134
J9 PROTEIN ENG DES SEL
JI Protein Eng. Des. Sel.
PD MAY
PY 2012
VL 25
IS 5
BP 205
EP 212
DI 10.1093/protein/gzs007
PG 8
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 933DX
UT WOS:000303341000001
PM 22355150
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Dehio, C
   Berry, C
   Bartenschlager, R
AF Dehio, Christoph
   Berry, Colin
   Bartenschlager, Ralf
TI Persistent intracellular pathogens
SO FEMS MICROBIOLOGY REVIEWS
LA English
DT Editorial Material
C1 [Dehio, Christoph] Univ Basel, Res Area Infect Biol Biozentrum, CH-4056 Basel, Switzerland.
   [Berry, Colin] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AT, S Glam, Wales.
   [Bartenschlager, Ralf] Univ Heidelberg, Dept Infect Dis Mol Virol, D-69120 Heidelberg, Germany.
RP Dehio, C (corresponding author), Univ Basel, Res Area Infect Biol Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch; berry@cf.ac.uk;
   ralf.bartenschlager@med.uni-heidelberg.de
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016;
   Bartenschlager, Ralf/L-2582-2015
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Bartenschlager, Ralf/0000-0001-5601-9307;
   Berry, Colin/0000-0002-9943-548X; Plummer, Beverley/0000-0002-6559-7237
NR 0
TC 4
Z9 4
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0168-6445
J9 FEMS MICROBIOL REV
JI Fems Microbiol. Rev.
PD MAY
PY 2012
VL 36
IS 3
SI SI
BP 513
EP 513
DI 10.1111/j.1574-6976.2012.00336.x
PG 1
WC Microbiology
SC Microbiology
GA 918HR
UT WOS:000302240500001
PM 22404271
OA Bronze, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Nikolaev, Y
   Pervushin, K
AF Nikolaev, Yaroslav
   Pervushin, Konstantin
TI Structural basis of RNA binding by leucine zipper GCN4
SO PROTEIN SCIENCE
LA English
DT Article
DE leucine zipper; GCN4; bZIP; coiled coil; ribonuclease; NMR; protein-RNA
   interaction
ID MOONLIGHTING PROTEINS; CIRCULAR-DICHROISM; GENE-EXPRESSION; ACTIVE-SITE;
   DNA; RIBONUCLEASES; SPECTROSCOPY; EQUILIBRIUM; HYDROLYSIS; EUKARYOTES
AB Recently, we showed that leucine zipper (LZ) motifs of basic leucine zipper (bZIP) transcription factors GCN4 and c-Jun are capable of catalyzing degradation of RNA (Nikolaev et al., PLoS ONE 2010; 5:e10765). This observation is intriguing given the tight regulation of RNA turnover control and the antiquity of bZIP transcription factors. To support further mechanistic studies, herein, we elucidated RNA binding interface of the GCN4 leucine zipper motif from yeast. Solution NMR experiments showed that the LZ-RNA interaction interface is located in the first two heptads of LZ moiety, and that only the dimeric (coiled coil) LZ conformation is capable of binding RNA. Site-directed mutagenesis of the LZ-GCN4 RNA binding interface showed that substrate binding is facilitated by lysine and arginine side chains, and that at least one nucleophilic residue is located in proximity to the RNA phosphate backbone. Further studies in the context of full-length bZIP factors are envisaged to address the biological relevance of LZ RNase activity.
C1 [Pervushin, Konstantin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
   [Nikolaev, Yaroslav; Pervushin, Konstantin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pervushin, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
EM yaroslav@trosy.com; kpervushin@ntu.edu.sg
RI Pervushin, Konstantin/AAJ-6580-2020; Nikolaev, Yaroslav/I-1976-2013
OI Pervushin, Konstantin/0000-0002-6393-4340; Nikolaev,
   Yaroslav/0000-0002-1479-7474
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-118381]
FX Grant sponsor: Swiss National Science Foundation; Grant number:
   3100A0-118381.
CR BARBIER B, 1992, J AM CHEM SOC, V114, P3511, DOI 10.1021/ja00035a053
   Bluthgen N, 2010, MOL BIOSYST, V6, P1277, DOI 10.1039/c002598d
   Camacho CJ, 2000, BIOPHYS J, V78, P1094, DOI 10.1016/S0006-3495(00)76668-9
   Cranz S, 2004, BIOCHEMISTRY-US, V43, P718, DOI 10.1021/bi0355793
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022
   FINDLAY D, 1961, NATURE, V190, P781, DOI 10.1038/190781a0
   Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037
   Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8
   Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n
   Keller R, 2004, COMPUTER AIDED RESON
   Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387
   Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p
   Koroleva LS, 2007, PROTEIN PEPTIDE LETT, V14, P151, DOI 10.2174/092986607779816177
   Leman LJ, 2007, J AM CHEM SOC, V129, P2959, DOI 10.1021/ja068052x
   Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005
   Meisner WK, 2004, P NATL ACAD SCI USA, V101, P13478, DOI 10.1073/pnas.0404057101
   Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991
   Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030
   Nikolaev Y, NAT P IN PRESS
   Nikolaev Y, 2007, J AM CHEM SOC, V129, P6461, DOI 10.1021/ja0685295
   Nikolaev Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010765
   Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798
   Schwalbe M, 2010, PROTEINS, V78, P2433, DOI 10.1002/prot.22752
   Scott WG, 1999, CURR OPIN CHEM BIOL, V3, P705, DOI 10.1016/S1367-5931(99)00029-0
   Seldeen KL, 2008, ARCH BIOCHEM BIOPHYS, V480, P75, DOI 10.1016/j.abb.2008.10.010
   Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885
   Sorrentino S, 1998, CELL MOL LIFE SCI, V54, P785, DOI 10.1007/s000180050207
   Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104
   Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011
   Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005
   Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011
   WOODY RW, 1995, METHOD ENZYMOL, V246, P34
   YOSHINARI K, 1991, J AM CHEM SOC, V113, P5899, DOI 10.1021/ja00015a075
   ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042
NR 35
TC 3
Z9 3
U1 0
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD MAY
PY 2012
VL 21
IS 5
BP 667
EP 676
DI 10.1002/pro.2051
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 923LK
UT WOS:000302620600007
PM 22374868
OA Green Published
DA 2021-01-25
ER

PT J
AU Pulliainen, AT
   Dehio, C
AF Pulliainen, Arto T.
   Dehio, Christoph
TI Persistence of Bartonella spp. stealth pathogens: from subclinical
   infections to vasoproliferative tumor formation
SO FEMS MICROBIOLOGY REVIEWS
LA English
DT Review
DE Bartonella; bacteremia; immunity; zoonosis; angiogenesis; cancer
ID OUTER-MEMBRANE PROTEINS; ENDOTHELIAL GROWTH-FACTOR; IV SECRETION SYSTEM;
   VINSONII SUBSP BERKHOFFII; CAT-SCRATCH DISEASE; CELLS IN-VITRO;
   NF-KAPPA-B; CULTURE-NEGATIVE ENDOCARDITIS; TRENCH FEVER RICKETTSIA;
   HENSELAE SP-NOV
AB Bartonella spp. are facultative intracellular bacteria that typically cause a long-lasting intraerythrocytic bacteremia in their mammalian reservoir hosts, thereby favoring transmission by blood-sucking arthropods. In most cases, natural reservoir host infections are subclinical and the relapsing intraerythrocytic bacteremia may last weeks, months, or even years. In this review, we will follow the infection cycle of Bartonella spp. in a reservoir host, which typically starts with an intradermal inoculation of bacteria that are superficially scratched into the skin from arthropod feces and terminates with the pathogen exit by the blood-sucking arthropod. The current knowledge of bacterial countermeasures against mammalian immune response will be presented for each critical step of the pathogenesis. The prevailing models of the still-enigmatic primary niche and the anatomical location where bacteria reside, persist, and are periodically seeded into the bloodstream to cause the typical relapsing Bartonella spp. bacteremia will also be critically discussed. The review will end up with a discussion of the ability of Bartonella spp., namely Bartonella henselae, Bartonella quintana, and Bartonella bacilliformis, to induce tumor-like vascular deformations in humans having compromised immune response such as in patients with AIDS.
C1 [Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Pulliainen, Arto T.] Univ Turku, Inst Biomed, Turku, Finland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Pulliainen, Arto
   Tapio/0000-0002-9361-8963
FU Academy of FinlandAcademy of Finland [119880]; Emil Aaltonen Foundation;
   Turku University Foundation; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [31003A-132979]; SystemsX.ch, the
   Swiss Initiative for Systems Biology [51RT-0-126008]
FX We thank Alexander Harms for critical reading of the manuscript. Dr Arto
   Tapio Pulliainen is indebted to the Academy of Finland (grant 119880),
   Emil Aaltonen Foundation, and Turku University Foundation for financial
   support. Prof Christoph Dehio acknowledges financial support from the
   Swiss National Science Foundation (grant 31003A-132979) and from
   SystemsX.ch, the Swiss Initiative for Systems Biology (grant
   51RT-0-126008).
CR Abbott RC, 1997, COMP IMMUNOL MICROB, V20, P41, DOI 10.1016/S0147-9571(96)00025-2
   Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848
   Agan BK, 2002, CLIN LAB MED, V22, P937, DOI 10.1016/S0272-2712(02)00017-3
   Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200
   Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081
   Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102
   ANDERSON B, 1995, J CLIN MICROBIOL, V33, P2358, DOI 10.1128/JCM.33.9.2358-2365.1995
   Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X
   Angelakis E, 2008, EMERG INFECT DIS, V14, P1951, DOI 10.3201/eid1412.080757
   Avidor B, 2004, J CLIN MICROBIOL, V42, P3462, DOI 10.1128/JCM.42.8.3462-3468.2004
   Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002
   Bai Y, 2011, VET MICROBIOL, V148, P329, DOI 10.1016/j.vetmic.2010.09.022
   Bai Y, 2011, APPL ENVIRON MICROB, V77, P1728, DOI 10.1128/AEM.02203-10
   Bai Y, 2010, VET MICROBIOL, V146, P314, DOI 10.1016/j.vetmic.2010.05.017
   Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100
   BATTERMAN HJ, 1995, INFECT IMMUN, V63, P4553, DOI 10.1128/IAI.63.11.4553-4556.1995
   Battisti JM, 2007, INFECT IMMUN, V75, P4373, DOI 10.1128/IAI.00497-07
   Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06
   Battisti JM, 1999, APPL ENVIRON MICROB, V65, P3441
   Bayliss CD, 2009, FEMS MICROBIOL REV, V33, P504, DOI 10.1111/j.1574-6976.2009.00162.x
   BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986
   Berglund EC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-152
   Bermond D, 2002, INT J SYST EVOL MICR, V52, P383, DOI 10.1099/00207713-52-2-383
   Bermond D, 2000, INT J SYST EVOL MICR, V50, P1973, DOI 10.1099/00207713-50-6-1973
   Berrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020204
   Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07
   Billeter SA, 2011, APPL ENVIRON MICROB, V77, P7850, DOI 10.1128/AEM.06012-11
   Billeter SA, 2009, EXP APPL ACAROL, V49, P193, DOI 10.1007/s10493-009-9255-1
   BIRTLES RJ, 1995, INT J SYST BACTERIOL, V45, P1, DOI 10.1099/00207713-45-1-1
   Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06
   Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011
   Boulouis HJ, 2001, INFECT IMMUN, V69, P5313, DOI 10.1128/IAI.69.9.5313-5317.2001
   Bowers TJ, 1998, GENE, V206, P49, DOI 10.1016/S0378-1119(97)00580-5
   Bown KJ, 2004, EMERG INFECT DIS, V10, P684, DOI 10.3201/eid1004.030455
   BREITSCHWERDT EB, 1995, J CLIN MICROBIOL, V33, P154, DOI 10.1128/JCM.33.1.154-160.1995
   Breitschwerdt EB, 2007, J CLIN MICROBIOL, V45, P270, DOI 10.1128/JCM.01451-06
   Breitschwerdt EB, 2009, J CLIN MICROBIOL, V47, P1957, DOI 10.1128/JCM.00069-09
   Brouqui P, 1996, RES MICROBIOL, V147, P719, DOI 10.1016/S0923-2508(97)85119-4
   Buckles EL, 2000, MICROB PATHOGENESIS, V29, P165, DOI 10.1006/mpat.2000.0381
   Burgess AWO, 1998, MICROB PATHOGENESIS, V25, P157, DOI 10.1006/mpat.1998.0223
   Burgess AWO, 2000, MICROB PATHOGENESIS, V29, P73, DOI 10.1006/mpat.2000.0366
   Carroll JA, 2000, INFECT IMMUN, V68, P6750, DOI 10.1128/IAI.68.12.6750-6757.2000
   Cartwright JL, 1999, BIOCHEM BIOPH RES CO, V256, P474, DOI 10.1006/bbrc.1999.0354
   Cerimele F, 2003, AM J PATHOL, V163, P1321, DOI 10.1016/S0002-9440(10)63491-8
   Chang CC, 2000, J CLIN MICROBIOL, V38, P4193, DOI 10.1128/JCM.38.11.4193-4200.2000
   Chang CC, 2011, VET MICROBIOL, V149, P147, DOI 10.1016/j.vetmic.2010.09.033
   Chenoweth MR, 2004, APPL ENVIRON MICROB, V70, P656, DOI 10.1128/AEM.70.2.656-663.2004
   Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009010
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011
   Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630
   Chung CY, 2004, EMERG INFECT DIS, V10, P1311
   Clifton DR, 1998, P NATL ACAD SCI USA, V95, P4646, DOI 10.1073/pnas.95.8.4646
   COCKERELL CJ, 1990, ARCH DERMATOL, V126, P787, DOI 10.1001/archderm.126.6.787
   Coleman SA, 2003, MICROB PATHOGENESIS, V34, P179, DOI 10.1016/S0882-4010(03)00005-6
   Coleman SA, 2001, INFECT IMMUN, V69, P4373, DOI 10.1128/IAI.69.7.4373-4381.2001
   CONLEY T, 1994, J LAB CLIN MED, V124, P521
   Conyers GB, 1999, J BIOL CHEM, V274, P1203, DOI 10.1074/jbc.274.3.1203
   Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124
   Dabo SM, 2006, MICROB PATHOGENESIS, V41, P10, DOI 10.1016/j.micpath.2006.04.003
   Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006
   DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993
   Dang TA, 1999, MOL MICROBIOL, V32, P1239, DOI 10.1046/j.1365-2958.1999.01436.x
   De Palma M, 2011, CLIN CANCER RES, V17, P5226, DOI 10.1158/1078-0432.CCR-10-0171
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, J CLIN MICROBIOL, V42, P5320, DOI 10.1128/JCM.42.11.5320-5323.2004
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2001, INT J SYST EVOL MICR, V51, P1557, DOI 10.1099/00207713-51-4-1557
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Derrick SC, 2001, BLOOD CELL MOL DIS, V27, P1013, DOI 10.1006/bcmd.2001.0475
   Droz S, 1999, J CLIN MICROBIOL, V37, P1117, DOI 10.1128/JCM.37.4.1117-1122.1999
   Eberhardt C, 2009, PROTEOMICS, V9, P1967, DOI 10.1002/pmic.200700670
   Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010
   Ellis BA, 1999, J INFECT DIS, V180, P220, DOI 10.1086/314824
   Engbaek K, 2004, APMIS, V112, P336, DOI 10.1111/j.1600-0463.2004.apm1120603.x
   Engel P, 2009, GENOME DYNAM, V6, P158, DOI 10.1159/000235769
   Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296
   ENGLISH CK, 1988, JAMA-J AM MED ASSOC, V259, P1347, DOI 10.1001/jama.259.9.1347
   Fenollar F, 2005, J CLIN MICROBIOL, V43, P945, DOI 10.1128/JCM.43.2.945-947.2005
   Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402
   Foil L, 1998, J MED ENTOMOL, V35, P625, DOI 10.1093/jmedent/35.5.625
   Foucault C, 2002, CLIN INFECT DIS, V35, P684, DOI 10.1086/342065
   Fournier PE, 2001, INFECT IMMUN, V69, P1876, DOI 10.1128/IAI.69.3.1876-1879.2001
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   FUMAROLA D, 1994, IMMUNOPHARM IMMUNOT, V16, P449, DOI 10.3109/08923979409007104
   Gabriel MW, 2009, VECTOR-BORNE ZOONOT, V9, P597, DOI 10.1089/vbz.2008.0134
   GARCIA FU, 1990, AM J PATHOL, V136, P1125
   GARCIA FU, 1992, J INFECT DIS, V165, P1138, DOI 10.1093/infdis/165.6.1138
   Gaudry M, 1997, BLOOD, V90, P4153, DOI 10.1182/blood.V90.10.4153
   George JG, 2006, SCAND J INFECT DIS, V38, P127, DOI 10.1080/00365540500372929
   Gilmore RD, 2005, INFECT IMMUN, V73, P3128, DOI 10.1128/IAI.73.5.3128-3136.2005
   Gunn MD, 1998, NATURE, V391, P799
   Guptill L, 1997, J INFECT DIS, V176, P206, DOI 10.1086/514026
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   Heller R, 1997, J CLIN MICROBIOL, V35, P1327, DOI 10.1128/JCM.35.6.1327-1331.1997
   Heller R, 1999, INT J SYST BACTERIOL, V49, P283, DOI 10.1099/00207713-49-1-283
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200
   Hendrix LR, 2000, FEMS MICROBIOL LETT, V182, P119, DOI 10.1111/j.1574-6968.2000.tb08884.x
   Henn JB, 2009, EMERG INFECT DIS, V15, P1984, DOI 10.3201/eid1512.081692
   Higgins JA, 1996, J MED ENTOMOL, V33, P490, DOI 10.1093/jmedent/33.3.490
   HILL EM, 1992, INFECT IMMUN, V60, P4051, DOI 10.1128/IAI.60.10.4051-4058.1992
   HOLLINGDALE MR, 1980, J INFECT DIS, V141, P672, DOI 10.1093/infdis/141.5.672
   Holmes NE, 2011, J MED MICROBIOL, V60, P142, DOI 10.1099/jmm.0.015867-0
   HUANG KY, 1967, J BACTERIOL, V93, P853, DOI 10.1128/JB.93.3.853-859.1967
   Huang RT, 2011, EMERG INFECT DIS, V17, P1707, DOI 10.3201/eid1709.110133
   Inoue K, 2009, EMERG INFECT DIS, V15, P526, DOI 10.3201/eid1504.081223
   Iwaki-Egawa S, 1997, FEMS MICROBIOL LETT, V157, P207, DOI 10.1111/j.1574-6968.1997.tb12775.x
   Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796
   JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x
   Kabeya H, 2002, VET MICROBIOL, V89, P211, DOI 10.1016/S0378-1135(02)00175-X
   Kaiser PO, 2008, CELL MICROBIOL, V10, P2223, DOI 10.1111/j.1462-5822.2008.01201.x
   Kaiser PO, 2011, INT J MED MICROBIOL, V301, P7, DOI 10.1016/j.ijmm.2010.06.004
   Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007
   Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x
   Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7
   Kempf VAJ, 2005, CELL MICROBIOL, V7, P91, DOI 10.1111/j.1462-5822.2004.00440.x
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kerkhoff FT, 1999, J CLIN MICROBIOL, V37, P4034, DOI 10.1128/JCM.37.12.4034-4038.1999
   Kernif T, 2010, EMERG INFECT DIS, V16, P2013, DOI 10.3201/eid1612.100696
   Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x
   Kirby JE, 2004, INFECT IMMUN, V72, P7315, DOI 10.1128/IAI.72.12.7315-7317.2004
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Klotz SA, 2011, AM FAM PHYSICIAN, V83, P152
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   Kolb-Maurer A, 2002, BLOOD, V100, P3703, DOI 10.1182/blood-2002-03-0898
   KORDICK DL, 1995, J CLIN MICROBIOL, V33, P1655, DOI 10.1128/JCM.33.6.1655-1656.1995
   Kordick DL, 1997, J CLIN MICROBIOL, V35, P1813, DOI 10.1128/JCM.35.7.1813-1818.1997
   KOSTIANOVSKY M, 1994, ULTRASTRUCT PATHOL, V18, P349, DOI 10.3109/01913129409023203
   Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10
   Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699
   Kunz S, 2008, AM J PATHOL, V172, P1005, DOI 10.2353/ajpath.2008.070591
   Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998
   Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x
   Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0
   Leo JC, 2011, ADV EXP MED BIOL, V715, P1, DOI 10.1007/978-94-007-0940-9_1
   Li DM, 2007, J WILDLIFE DIS, V43, P609, DOI 10.7589/0090-3558-43.4.609
   Lin JW, 2008, J MED MICROBIOL, V57, P1496, DOI 10.1099/jmm.0.2008/004671-0
   Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005
   Litwin CM, 2005, INFECT IMMUN, V73, P4205, DOI 10.1128/IAI.73.7.4205-4213.2005
   Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360
   MacKichan JK, 2008, INFECT IMMUN, V76, P788, DOI 10.1128/IAI.01174-07
   Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315
   Maeno N, 2002, SCAND J IMMUNOL, V55, P366, DOI 10.1046/j.1365-3083.2002.01065.x
   Maggi RG, 2005, J MOL MICROB BIOTECH, V9, P44, DOI 10.1159/000088145
   Maggi RG, 2005, J CLIN MICROBIOL, V43, P2651, DOI 10.1128/JCM.43.6.2651-2655.2005
   Maguina C, 2009, CLIN DERMATOL, V27, P271, DOI 10.1016/j.clindermatol.2008.10.006
   Maillard R, 2004, INT J SYST EVOL MICR, V54, P215, DOI 10.1099/ijs.0.02770-0
   Mandle T, 2005, BLOOD, V106, P1215, DOI 10.1182/blood-2004-12-4670
   Marie JL, 2006, AM J TROP MED HYG, V74, P436, DOI 10.4269/ajtmh.2006.74.436
   Marignac G, 2010, COMP IMMUNOL MICROB, V33, P95, DOI 10.1016/j.cimid.2008.07.011
   Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2
   Mascarelli PE, 2011, J CLIN MICROBIOL, V49, P4006, DOI 10.1128/JCM.05527-11
   McCord AM, 2005, INFECT IMMUN, V73, P5735, DOI 10.1128/IAI.73.9.5735-5742.2005
   McCord AM, 2007, DNA CELL BIOL, V26, P657, DOI 10.1089/dna.2007.0592
   McCord AM, 2006, INFECT IMMUN, V74, P5185, DOI 10.1128/IAI.00622-06
   Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018
   MERNAUGH G, 1992, INFECT IMMUN, V60, P937, DOI 10.1128/IAI.60.3.937-943.1992
   Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017
   Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068
   MINNICK MF, 1994, INFECT IMMUN, V62, P2644, DOI 10.1128/IAI.62.6.2644-2648.1994
   Minnick MF, 2003, INFECT IMMUN, V71, P6933, DOI 10.1128/IAI.71.12.6933-6942.2003
   Minnick MF, 2003, INFECT IMMUN, V71, P814, DOI 10.1128/IAI.71.2.814-821.2003
   MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995
   Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x
   Muller NF, 2011, INFECT IMMUN, V79, P2544, DOI 10.1128/IAI.01309-10
   Musso T, 2001, INFECT IMMUN, V69, P5974, DOI 10.1128/IAI.69.10.5974-5980.2001
   MYERS SA, 1992, J PEDIATR-US, V121, P574, DOI 10.1016/S0022-3476(05)81148-5
   MYERS WF, 1978, INFECT IMMUN, V22, P288, DOI 10.1128/IAI.22.1.288-289.1978
   Neumeister B, 1998, INFECT IMMUN, V66, P4151
   Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252
   O'Halloran HS, 1998, RETINA-J RET VIT DIS, V18, P276, DOI 10.1097/00006982-199803000-00015
   O'Reilly KL, 1999, INFECT IMMUN, V67, P3066
   Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497
   Ohad DG, 2010, VET MICROBIOL, V141, P182, DOI 10.1016/j.vetmic.2009.08.005
   Ott T, 2005, CURR BIOL, V15, P531, DOI 10.1016/j.cub.2005.01.042
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x
   Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581
   Palmari J, 1996, ANAL CELL PATHOL, V11, P13
   Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273
   Pappalardo BL, 2001, VET IMMUNOL IMMUNOP, V83, P125, DOI 10.1016/S0165-2427(01)00372-5
   Pappalardo BL, 2000, VET IMMUNOL IMMUNOP, V75, P43, DOI 10.1016/S0165-2427(00)00182-3
   Parrow NL, 2009, INFECT IMMUN, V77, P307, DOI 10.1128/IAI.01194-08
   Perez C, 2011, J VET INTERN MED, V25, P805, DOI 10.1111/j.1939-1676.2011.0736.x
   Popa C, 2007, INFECT IMMUN, V75, P4831, DOI 10.1128/IAI.00237-07
   Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018
   Pulliainen AT, 2005, MOL MICROBIOL, V57, P1086, DOI 10.1111/j.1365-2958.2005.04756.x
   Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200
   Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   Raoult D, 2006, J CLIN MICROBIOL, V44, P278, DOI 10.1128/JCM.44.1.278-279.2006
   Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x
   Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1
   Reeves WK, 2007, J VECTOR ECOL, V32, P118, DOI 10.3376/1081-1710(2007)32[118:AOBWTF]2.0.CO;2
   Regnery RL, 1996, AM J VET RES, V57, P1714
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   Reis C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001186
   Relman DA, 1999, J INFECT DIS, V180, P1386, DOI 10.1086/314975
   Resto-Ruiz SI, 2000, INFECT IMMUN, V68, P5970, DOI 10.1128/IAI.68.10.5970-5978.2000
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Rhomberg TA, 2004, PROTEOMICS, V4, P3021, DOI 10.1002/pmic.200400933
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Riess T, 2008, APPL ENVIRON MICROB, V74, P5224, DOI 10.1128/AEM.00621-08
   Riess T, 2007, INFECT IMMUN, V75, P35, DOI 10.1128/IAI.00963-06
   RODRIGUEZBARRADAS MC, 1995, INFECT IMMUN, V63, P2367, DOI 10.1128/IAI.63.6.2367-2370.1995
   Rolain JM, 2003, ANN NY ACAD SCI, V990, P236, DOI 10.1111/j.1749-6632.2003.tb07370.x
   Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278
   Rolain JM, 2003, ANTIMICROB AGENTS CH, V47, P614, DOI 10.1128/AAC.47.2.614-619.2003
   Rolain JM, 2002, LANCET, V360, P226, DOI 10.1016/S0140-6736(02)09462-X
   Roux V, 2000, J CLIN MICROBIOL, V38, P1698, DOI 10.1128/JCM.38.4.1698-1700.2000
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Safdar A, 2002, CLIN INFECT DIS, V35, P1577, DOI 10.1086/344793
   Sagulenko E, 2001, J BACTERIOL, V183, P5813, DOI 10.1128/JB.183.20.5813-5825.2001
   Salvatore P, 2008, P NATL ACAD SCI USA, V105, P9427, DOI 10.1073/pnas.0803602105
   Sander A, 2000, J CLIN MICROBIOL, V38, P2943, DOI 10.1128/JCM.38.8.2943-2948.2000
   Sander A, 2000, FEMS MICROBIOL LETT, V189, P55, DOI 10.1111/j.1574-6968.2000.tb09205.x
   Schaefer JD, 2011, VET MICROBIOL, V154, P135, DOI 10.1016/j.vetmic.2011.06.031
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Scheidegger F, 2011, CELL MICROBIOL, V13, P419, DOI 10.1111/j.1462-5822.2010.01545.x
   SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schmiederer M, 2001, INFECT IMMUN, V69, P6495, DOI 10.1128/IAI.69.10.6495-6502.2001
   Schroder G, 2011, P NATL ACAD SCI USA, V108, P14643, DOI 10.1073/pnas.1019074108
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Schulte B, 2006, INFECT IMMUN, V74, P5003, DOI 10.1128/IAI.00663-06
   Schultz MG, 2010, EMERG INFECT DIS, V16, P1026, DOI 10.3201/eid1606.091937
   SCHWARTZMAN WA, 1993, J CLIN MICROBIOL, V31, P1882, DOI 10.1128/JCM.31.7.1882-1885.1993
   Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Shamaei-Tousi A, 2004, J BACTERIOL, V186, P4796, DOI 10.1128/JB.186.14.4796-4801.2004
   Silva-Herzog E, 2008, CELL MICROBIOL, V10, P2151, DOI 10.1111/j.1462-5822.2008.01192.x
   Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011
   Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005
   STOLER MH, 1983, AM J CLIN PATHOL, V80, P714, DOI 10.1093/ajcp/80.5.714
   Sweger D, 2000, CLIN DIAGN LAB IMMUN, V7, P251, DOI 10.1128/CDLI.7.2.251-257.2000
   TAPPERO JW, 1993, ANN INTERN MED, V118, P363, DOI 10.7326/0003-4819-118-5-199303010-00007
   Tappero JW, 1997, NEW ENGL J MED, V337, P1888, DOI 10.1056/NEJM199712253372605
   Telfer S, 2007, PARASITOLOGY, V134, P413, DOI 10.1017/S0031182006001624
   Truttmann MC, 2011, J CELL SCI, V124, P3591, DOI 10.1242/jcs.084459
   Truttmann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025106
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   Tsai YL, 2011, VECTOR-BORNE ZOONOT, V11, P1023, DOI 10.1089/vbz.2010.0085
   Tsai YL, 2010, AM J TROP MED HYG, V83, P917, DOI 10.4269/ajtmh.2010.10-0083
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   van der Flier M, 2000, INFECT IMMUN, V68, P4792, DOI 10.1128/IAI.68.8.4792-4794.2000
   van der Flier M, 2001, J INFECT DIS, V183, P149, DOI 10.1086/317643
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Vayssier-Taussat M, 2009, ANN NY ACAD SCI, V1166, P127, DOI 10.1111/j.1749-6632.2009.04531.x
   Verma A, 2000, INFECT IMMUN, V68, P5960, DOI 10.1128/IAI.68.10.5960-5969.2000
   Verma A, 2002, CELL MICROBIOL, V4, P557, DOI 10.1046/j.1462-5822.2002.00217.x
   Verma A, 2001, CELL MICROBIOL, V3, P169, DOI 10.1046/j.1462-5822.2001.00104.x
   Vermi W, 2006, BLOOD, V107, P454, DOI 10.1182/blood-2005-04-1342
   Vitale G, 2009, J CLIN MICROBIOL, V47, P862, DOI 10.1128/JCM.01012-08
   WALKER TS, 1981, INFECT IMMUN, V31, P480, DOI 10.1128/IAI.31.1.480-486.1981
   Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843
   WEISS E, 1978, INFECT IMMUN, V19, P1013, DOI 10.1128/IAI.19.3.1013-1020.1978
   Welch DF, 1999, J CLIN MICROBIOL, V37, P2598, DOI 10.1128/JCM.37.8.2598-2601.1999
   WELCH DF, 1992, J CLIN MICROBIOL, V30, P275, DOI 10.1128/JCM.30.2.275-280.1992
   Williams-Bouyer NM, 1999, FEMS MICROBIOL LETT, V171, P191, DOI 10.1111/j.1574-6968.1999.tb13432.x
   WONG MT, 1995, J CLIN MICROBIOL, V33, P742, DOI 10.1128/JCM.33.3.742-744.1995
   WONG MT, 1995, CLIN INFECT DIS, V21, P352, DOI 10.1093/clinids/21.2.352
   Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008
   Yamada Y, 2011, DIAGN MICR INFEC DIS, V70, P395, DOI 10.1016/j.diagmicrobio.2011.03.011
   Yamamoto Y, 2000, J BACTERIOL, V182, P3740, DOI 10.1128/JB.182.13.3740-3747.2000
   Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382
   Ying B, 2002, AM J TROP MED HYG, V66, P622, DOI 10.4269/ajtmh.2002.66.622
   Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200
   ZBINDEN R, 1995, CLIN DIAGN LAB IMMUN, V2, P693, DOI 10.1128/CDLI.2.6.693-695.1995
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
   Zimmermann R, 2003, J BACTERIOL, V185, P1739, DOI 10.1128/JB.185.5.1739-1744.2003
NR 276
TC 61
Z9 61
U1 1
U2 21
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0168-6445
EI 1574-6976
J9 FEMS MICROBIOL REV
JI Fems Microbiol. Rev.
PD MAY
PY 2012
VL 36
IS 3
SI SI
BP 563
EP 599
DI 10.1111/j.1574-6976.2012.00324.x
PG 37
WC Microbiology
SC Microbiology
GA 918HR
UT WOS:000302240500004
PM 22229763
OA Bronze
DA 2021-01-25
ER

PT J
AU Castano-Diez, D
   Kudryashev, M
   Arheit, M
   Stahlberg, H
AF Castano-Diez, Daniel
   Kudryashev, Mikhail
   Arheit, Marcel
   Stahlberg, Henning
TI Dynamo: A flexible, user-friendly development tool for subtomogram
   averaging of cryo-EM data in high-performance computing environments
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Subtomogram averaging; Single Particle Tomography; High-performance
   computing; CPU computing; Classification
ID CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; ELECTRON
   CRYOTOMOGRAPHY; 3D RECONSTRUCTION; CLASSIFICATION; VISUALIZATION;
   ALGORITHMS; SYSTEM; CELLS; MAPS
AB Dynamo is a new software package for subtomogram averaging of cryo Electron Tomography (cryo-ET) data with three main goals: first, Dynamo allows user-transparent adaptation to a variety of high-performance computing platforms such as CPUs or CPU clusters. Second, Dynamo implements user-friendliness through GUI interfaces and scripting resources. Third, Dynamo offers user-flexibility through a plugin API. Besides the alignment and averaging procedures, Dynamo includes native tools for visualization and analysis of results and data, as well as support for third party visualization software, such as Chimera UCSF or EMAN2. As a demonstration of these functionalities, we studied bacterial flagellar motors and showed automatically detected classes with absent and present C-rings.
   Subtomogram averaging is a common task in current cryo-ET pipelines, which requires extensive computational resources and follows a well-established workflow. However, due to the data diversity, many existing packages offer slight variations of the same algorithm to improve results. One of the main purposes behind Dynamo is to provide explicit tools to allow the user the insertion of custom designed procedures - or plugins - to replace or complement the native algorithms in the different steps of the processing pipeline for subtomogram averaging without the burden of handling parallelization. Custom scripts that implement new approaches devised by the user are integrated into the Dynamo data management system, so that they can be controlled by the GUI or the scripting capacities.
   Dynamo executables do not require licenses for third party commercial software. Sources, executables and documentation are freely distributed on http://www.dynamo-em.org. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Castano-Diez, Daniel; Kudryashev, Mikhail; Arheit, Marcel; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, CH-4058 Basel, Switzerland.
RP Castano-Diez, D (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, Mattenstr 26, CH-4058 Basel, Switzerland.
EM daniel.castano@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Castano-Diez,
   daniel/0000-0002-0197-163X; Kudryashev, Misha/0000-0003-3550-6274
FU Swiss initiative for Systems Biology (SystemsX.ch); Swiss National
   Supercomputing Centre (CSCS) [274-2011]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [205321_126490]; NCCR
   TransCure; NCCR Nano; NCCR Structural BiologySwiss National Science
   Foundation (SNSF)
FX This work was in part supported by the Swiss initiative for Systems
   Biology (SystemsX.ch, grant CINA), the Swiss National Supercomputing
   Centre (CSCS, grant under project ID 274-2011), the Swiss National
   Science Foundation (Grant 205321_126490), the NCCR TransCure, the NCCR
   Nano, and the NCCR Structural Biology.
CR Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994
   Amat F, 2010, J STRUCT BIOL, V171, P332, DOI 10.1016/j.jsb.2010.05.013
   Bartesaghi A, 2008, J STRUCT BIOL, V162, P436, DOI 10.1016/j.jsb.2008.02.008
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016
   Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106
   Butenhof DR, 1997, PROGRAMMING POSIX TH
   Castano-Diez D, 2008, J STRUCT BIOL, V164, P153, DOI 10.1016/j.jsb.2008.07.006
   Castano-Diez D, 2010, J STRUCT BIOL, V170, P117, DOI 10.1016/j.jsb.2010.01.014
   Chandra R, 2001, PARALLEL PROGRAMMING
   Diez DC, 2007, J STRUCT BIOL, V157, P288, DOI 10.1016/j.jsb.2006.08.010
   Fernandez JJ, 2008, J STRUCT BIOL, V164, P1, DOI 10.1016/j.jsb.2008.07.005
   Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004
   Forster F, 2008, J STRUCT BIOL, V161, P276, DOI 10.1016/j.jsb.2007.07.006
   Forster F, 2007, METHOD CELL BIOL, V79, P741, DOI 10.1016/S0091-679X(06)79029-X
   Frank J., 2006, ELECT TOMOGRAPHY MET
   Gipson BR, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011916
   Heumann JM, 2011, J STRUCT BIOL, V175, P288, DOI 10.1016/j.jsb.2011.05.011
   Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002
   Huiskonen JT, 2010, J VIROL, V84, P4889, DOI 10.1128/JVI.00057-10
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Kudryashev M, 2012, J STRUCT BIOL, V178, P88, DOI 10.1016/j.jsb.2011.10.004
   Kudryashev M, 2010, J STRUCT BIOL, V169, P54, DOI 10.1016/j.jsb.2009.08.008
   Kudryashev M, 2009, MOL MICROBIOL, V71, P1415, DOI 10.1111/j.1365-2958.2009.06613.x
   Lebart L., 1984, MULTIVARIATE DESCRIP
   Li XM, 2010, J STRUCT BIOL, V172, P407, DOI 10.1016/j.jsb.2010.06.010
   Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Ortiz JO, 2010, J CELL BIOL, V190, P613, DOI 10.1083/jcb.201005007
   Pacheco PS, 1997, PARALLEL PROGRAMMING
   Palenstijn WJ, 2011, J STRUCT BIOL, V176, P250, DOI 10.1016/j.jsb.2011.07.017
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Rath BK, 2003, J STRUCT BIOL, V144, P95, DOI 10.1016/j.jsb.2003.09.029
   Renken C, 2009, J STRUCT BIOL, V165, P53, DOI 10.1016/j.jsb.2008.09.011
   Roseman AM, 2003, ULTRAMICROSCOPY, V94, P225, DOI 10.1016/S0304-3991(02)00333-9
   Scheres SHW, 2009, STRUCTURE, V17, P1563, DOI 10.1016/j.str.2009.10.009
   Schmeisser M, 2009, ACTA CRYSTALLOGR D, V65, P659, DOI 10.1107/S0907444909011433
   Schmid MF, 2008, J STRUCT BIOL, V161, P243, DOI 10.1016/j.jsb.2007.09.018
   Schmid MF, 2011, ADV PROTEIN CHEM STR, V82, P37, DOI 10.1016/B978-0-12-386507-6.00002-6
   Stolken M, 2011, J STRUCT BIOL, V173, P77, DOI 10.1016/j.jsb.2010.08.005
   Tagare HD, 2010, J STRUCT BIOL, V171, P256, DOI 10.1016/j.jsb.2010.06.004
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967
   Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014
   Winkler H, 2009, J STRUCT BIOL, V165, P64, DOI 10.1016/j.jsb.2008.10.004
   Xiong QR, 2009, J STRUCT BIOL, V168, P378, DOI 10.1016/j.jsb.2009.08.016
   Xu ML, 2011, INT J BIOMED IMAGING, V2011, DOI 10.1155/2011/843924
   Xu W, 2010, J STRUCT BIOL, V171, P142, DOI 10.1016/j.jsb.2010.03.018
   Zhang XK, 2010, J STRUCT BIOL, V172, P400, DOI 10.1016/j.jsb.2010.05.006
   Zheng SQ, 2011, ULTRAMICROSCOPY, V111, P1137, DOI 10.1016/j.ultramic.2011.03.015
NR 53
TC 126
Z9 127
U1 0
U2 21
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAY
PY 2012
VL 178
IS 2
SI SI
BP 139
EP 151
DI 10.1016/j.jsb.2011.12.017
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 945PB
UT WOS:000304287400009
PM 22245546
DA 2021-01-25
ER

PT J
AU Picollo, A
   Xu, YY
   Johner, N
   Berneche, S
   Accardi, A
AF Picollo, Alessandra
   Xu, Yanyan
   Johner, Niklaus
   Berneche, Simon
   Accardi, Alessio
TI Synergistic substrate binding determines the stoichiometry of transport
   of a prokaryotic H+/Cl- exchanger
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID CL-/H+ ANTIPORTER; CHLORIDE CHANNEL; PING-PONG; ALTERNATING ACCESS;
   CRYSTAL-STRUCTURE; MOLECULAR-BASIS; HOMOLOG; SELECTIVITY; MECHANISM;
   KINETICS
AB Active exchangers dissipate the gradient of one substrate to accumulate nutrients, export xenobiotics and maintain cellular homeostasis. Mechanistic studies have suggested that two fundamental properties are shared by all exchangers: substrate binding is antagonistic, and coupling is maintained by preventing shuttling of the empty transporter. The CLC H+/Cl- exchangers control the homeostasis of cellular compartments in most living organisms, but their transport mechanism remains unclear. We show that substrate binding to CLC-ec1 is synergistic rather than antagonistic: chloride binding induces protonation of a crucial glutamate. The simultaneous binding of H+ and Cl- gives rise to a fully loaded state that is incompatible with conventional transport mechanisms. Mutations in the Cl- transport pathway identically alter the stoichiometries of H+/Cl- exchange and binding. We propose that the thermodynamics of synergistic substrate binding, rather than the kinetics of conformational changes and ion binding, determine the stoichiometry of transport.
C1 [Picollo, Alessandra; Accardi, Alessio] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA.
   [Xu, Yanyan; Johner, Niklaus; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, Biozentrum, Basel, Switzerland.
   [Johner, Niklaus; Accardi, Alessio] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA.
   [Accardi, Alessio] Weill Cornell Med Coll, Dept Biochem, New York, NY USA.
RP Accardi, A (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA.
EM simon.berneche@unibas.ch; ala2022@med.cornell.edu
RI Berneche, Simon/L-6389-2013; Picollo, Alessandra/G-1709-2014; Picollo,
   Alessandra/O-1696-2016
OI Berneche, Simon/0000-0002-6274-4094; Picollo,
   Alessandra/0000-0003-2980-7951; Accardi, Alessio/0000-0002-6584-0102;
   Johner, Niklaus/0000-0003-2257-7508
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1R01GM085232]; Swiss
   National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [118928]; China Scholarship CouncilChina Scholarship Council;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM085232,
   R01GM085232, R01GM085232, R01GM085232, R01GM085232, R01GM085232] Funding
   Source: NIH RePORTER
FX The authors thank C. Miller (Brandeis University) for the gift of
   <SUP>36</SUP>Cl<SUP>-</SUP> and D. Posson, D. Basilio, M. Malvezzi, C.
   Nimigean and H. Weinstein for helpful discussions and comments on the
   manuscript. This work was supported by grants from the National
   Institutes of Health (1R01GM085232 to A. A.) and by a grant from the
   Swiss National Science Foundation (SNF-Professorship #118928 to S. B.).
   Y.X. is supported by the China Scholarship Council. Part of the
   simulations were performed using the facilities of the Swiss National
   Supercomputing Centre (CSCS).
CR Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196
   Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417
   Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935
   Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314
   Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081
   Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022
   Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104
   Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824
   Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1
   Beauge L, 2009, CELL PHYSIOL BIOCHEM, V23, P37, DOI 10.1159/000204078
   Boiteux C, 2011, STRUCTURE, V19, P70, DOI 10.1016/j.str.2010.10.008
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Chen MF, 2003, J GEN PHYSIOL, V122, P133, DOI 10.1085/jgp.200308844
   Contreras-Jurado C, 2005, FRONT BIOSCI-LANDMRK, V10, P1693, DOI 10.2741/1653
   De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013
   Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a
   Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708
   Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201
   Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023
   Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230
   Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.3.CO;2-F
   Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907
   Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000
   JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0
   JENKS WP, 1969, CATALYSIS CHEM ENZYM
   JENNINGS ML, 1989, ANNU REV BIOPHYS BIO, V18, P397, DOI 10.1146/annurev.bb.18.060189.002145
   Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945
   Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5
   Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035
   Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466
   Lobet S, 2006, EMBO J, V25, P24, DOI 10.1038/sj.emboj.7600909
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713
   Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007
   Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002
   MILANICK MA, 1992, COMP BIOCHEM PHYS A, V102, P619, DOI 10.1016/0300-9629(92)90714-2
   Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419
   Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006
   Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070
   Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418
   Petrosian SA, 2000, PROTEIN SCI, V9, P387
   Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720
   Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704
   Pohorille A, 2010, J PHYS CHEM B, V114, P10235, DOI 10.1021/jp102971x
   Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008
   RESTREPO D, 1992, J GEN PHYSIOL, V100, P825, DOI 10.1085/jgp.100.5.825
   RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338
   Scheel O, 2005, NATURE, V436, P424, DOI 10.1038/nature0386O
   SEKLER I, 1995, J BIOL CHEM, V270, P28751, DOI 10.1074/jbc.270.48.28751
   Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088
   Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303
   Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177
   Souaille M, 2001, COMPUT PHYS COMMUN, V135, P40, DOI 10.1016/S0010-4655(00)00215-0
   THOMSON JA, 2004, BIOCALORIMETRY, V2, pCH2
   Velazquez-Campoy A, 2000, PROTEIN SCI, V9, P1801, DOI 10.1110/ps.9.9.1801
   Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756
   Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978
   Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018
   Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200
   Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284
NR 60
TC 48
Z9 49
U1 0
U2 14
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD MAY
PY 2012
VL 19
IS 5
BP 525
EP U87
DI 10.1038/nsmb.2277
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 936SV
UT WOS:000303611200011
PM 22484316
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Conde-Alvarez, R
   Arce-Gorvel, V
   Iriarte, M
   Mancek-Keber, M
   Barquero-Calvo, E
   Palacios-Chaves, L
   Chacon-Diaz, C
   Chaves-Olarte, E
   Martirosyan, A
   von Bargen, K
   Grillo, MJ
   Jerala, R
   Brandenburg, K
   Llobet, E
   Bengoechea, JA
   Moreno, E
   Moriyon, I
   Gorvel, JP
AF Conde-Alvarez, Raquel
   Arce-Gorvel, Vilma
   Iriarte, Maite
   Mancek-Keber, Mateja
   Barquero-Calvo, Elias
   Palacios-Chaves, Leyre
   Chacon-Diaz, Carlos
   Chaves-Olarte, Esteban
   Martirosyan, Anna
   von Bargen, Kristine
   Grillo, Maria-Jesus
   Jerala, Roman
   Brandenburg, Klaus
   Llobet, Enrique
   Bengoechea, Jose A.
   Moreno, Edgardo
   Moriyon, Ignacio
   Gorvel, Jean-Pierre
TI The Lipopolysaccharide Core of Brucella abortus Acts as a Shield Against
   Innate Immunity Recognition
SO PLOS PATHOGENS
LA English
DT Article
ID DENDRITIC CELL MATURATION; POLYSACCHARIDE SYNTHESIS; CATIONIC PEPTIDES;
   O-POLYSACCHARIDE; ROUGH VACCINES; CUTTING EDGE; LIPID-A; GENE;
   VIRULENCE; MUTANTS
AB Innate immunity recognizes bacterial molecules bearing pathogen-associated molecular patterns to launch inflammatory responses leading to the activation of adaptive immunity. However, the lipopolysaccharide (LPS) of the gram-negative bacterium Brucella lacks a marked pathogen-associated molecular pattern, and it has been postulated that this delays the development of immunity, creating a gap that is critical for the bacterium to reach the intracellular replicative niche. We found that a B. abortus mutant in the wadC gene displayed a disrupted LPS core while keeping both the LPS O-polysaccharide and lipid A. In mice, the wadC mutant induced proinflammatory responses and was attenuated. In addition, it was sensitive to killing by non-immune serum and bactericidal peptides and did not multiply in dendritic cells being targeted to lysosomal compartments. In contrast to wild type B. abortus, the wadC mutant induced dendritic cell maturation and secretion of pro-inflammatory cytokines. All these properties were reproduced by the wadC mutant purified LPS in a TLR4-dependent manner. Moreover, the core-mutated LPS displayed an increased binding to MD-2, the TLR4 co-receptor leading to subsequent increase in intracellular signaling. Here we show that Brucella escapes recognition in early stages of infection by expressing a shield against recognition by innate immunity in its LPS core and identify a novel virulence mechanism in intracellular pathogenic gram-negative bacteria. These results also encourage for an improvement in the generation of novel bacterial vaccines.
C1 [Conde-Alvarez, Raquel; Iriarte, Maite; Palacios-Chaves, Leyre; Moriyon, Ignacio] Univ Navarra, Inst Trop Hlth, E-31080 Pamplona, Spain.
   [Conde-Alvarez, Raquel; Iriarte, Maite; Palacios-Chaves, Leyre; Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain.
   [Conde-Alvarez, Raquel] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Arce-Gorvel, Vilma; Martirosyan, Anna; von Bargen, Kristine; Gorvel, Jean-Pierre] Aix Marseille Univ, UM2 Marseille France,UMR7280, CIML, INSERM,CNRS,Marseille France U1104, Marseille, France.
   [Mancek-Keber, Mateja; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.
   [Barquero-Calvo, Elias; Chaves-Olarte, Esteban; Moreno, Edgardo] Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Tropicales, Heredia, Costa Rica.
   [Chacon-Diaz, Carlos; Chaves-Olarte, Esteban] Univ Costa Rica, Ctr Invest Enfermedades Tropicales, San Jose, Costa Rica.
   [Grillo, Maria-Jesus] Inst Agrobiotecnol CSIC UPNA Gobierno Navarra, Pamplona, Spain.
   [Brandenburg, Klaus] Forschungzentrum Borstel, Borstel, Germany.
   [Llobet, Enrique; Bengoechea, Jose A.] Fdn Invest Sanitaria Illes Balears CSIC, Lab Microbial Patogenesis, Bunyola, Spain.
   [Moreno, Edgardo] Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica.
RP Conde-Alvarez, R (corresponding author), Univ Navarra, Inst Trop Hlth, E-31080 Pamplona, Spain.
EM gorvel@ciml.univ-mrs.fr
RI IRIARTE, MAITE/L-9460-2014; Conde-Alvarez, Raquel/K-5854-2014; Moriyon,
   Ignacio/N-4764-2016; Gorvel, Jean-Pierre/O-1332-2018; Grillo,
   Maria-Jesus/F-9621-2011; Jerala, Roman/H-9850-2015
OI IRIARTE, MAITE/0000-0002-6726-8920; Conde-Alvarez,
   Raquel/0000-0003-0046-3577; Moriyon, Ignacio/0000-0002-4288-0195;
   Gorvel, Jean-Pierre/0000-0002-2829-9804; Grillo,
   Maria-Jesus/0000-0002-1819-0186; Arce-Gorvel, Vilma/0000-0003-0090-837X;
   Jerala, Roman/0000-0002-6337-5251; Bengoechea, Jose/0000-0002-9677-8751
FU Spanish Ministerio de Ciencia y TecnologiaSpanish Government
   [AGL2008-04514-C03-01, SAF2009-07885, AGL2010-20247]; EUEuropean Union
   (EU) [221948]; FIDA; Universidad Nacional de Costa Rica; FS-Conare
   UNA/UCR IFEG29 Costa Rica; NeTropica [P00059, F00013-02]; MICIT/CONICIT
   IFDG12; Fundacion CRUSA-CSIC [2008CR0006, 2010CR0005]; Centre National
   de la Recherche Scientifique, Institut National de la Sante et de la
   Recherche MedicaleInstitut National de la Sante et de la Recherche
   Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS);
   ANRFrench National Research Agency (ANR) [2010BLAN1308]; Ministerio de
   Ciencia y Tecnologia of Spain, Gobierno de Navarra; Ministry of
   Education in France; Friends of the University of Navarra
FX This work was funded by grants from the Spanish Ministerio de Ciencia y
   Tecnologia (AGL2008-04514-C03-01 to I.M.; SAF2009-07885 to J.A.B and
   AGL2010-20247 to MJG), EU Grant agreement No 221948, FIDA, Universidad
   Nacional de Costa Rica; FS-Conare UNA/UCR IFEG29 Costa Rica; NeTropica
   P00059 and F00013-02; MICIT/CONICIT IFDG12; Fundacion CRUSA-CSIC
   2008CR0006 and 2010CR0005; Centre National de la Recherche Scientifique,
   Institut National de la Sante et de la Recherche Medicale. Cooperation
   between University of Navarra, PIET and CSIC has been favoured by the
   Collaboration Agreement reference 2010020113. Research and fellowship
   support for KVB from ANR 2010BLAN1308 BruTir, fellowship support for
   R.C.-A. and L. P.-C. from the Ministerio de Ciencia y Tecnologia of
   Spain, Gobierno de Navarra and Friends of the University of Navarra and
   for A. M. from the Ministry of Education in France are gratefully
   acknowledged. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Allen CA, 1998, INFECT IMMUN, V66, P1008, DOI 10.1128/IAI.66.3.1008-1016.1998
   Alton G., 1988, TECHNIQUES BRUCELLOS
   Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631
   Barquero-Calvo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005893
   Billard E, 2007, INFECT IMMUN, V75, P5916, DOI 10.1128/IAI.00931-07
   Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07
   Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792
   BOWDEN RA, 1995, INFECT IMMUN, V63, P3945, DOI 10.1128/IAI.63.10.3945-3952.1995
   Brandenburg K, 1997, BBA-BIOMEMBRANES, V1329, P183, DOI 10.1016/S0005-2736(97)00109-0
   Brandenburg K, 2005, BIOPHYS J, V88, P1845, DOI 10.1529/biophysj.104.047944
   DECHASTELLIER C, 1993, INFECT IMMUN, V61, P3775, DOI 10.1128/IAI.61.9.3775-3784.1993
   Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x
   DETEJADA GM, 1995, INFECT IMMUN, V63, P3054
   DIAZAPARICIO E, 1993, J CLIN MICROBIOL, V31, P3136
   Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204
   Eisenschenk FC, 1999, VET MICROBIOL, V68, P235, DOI 10.1016/S0378-1135(99)00075-9
   El Hamidi A, 2005, J LIPID RES, V46, P1773, DOI 10.1194/jlr.D500014-JLR200
   Freer E, 1996, J BACTERIOL, V178, P5867, DOI 10.1128/jb.178.20.5867-5876.1996
   GARINBASTUJI B, 1990, J CLIN MICROBIOL, V28, P2169, DOI 10.1128/JCM.28.10.2169-2174.1990
   Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229
   Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760
   Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6
   Gradisar H, 2007, J LEUKOCYTE BIOL, V82, P968, DOI 10.1189/jlb.1206727
   Hallez R, 2007, APPL ENVIRON MICROB, V73, P1375, DOI 10.1128/AEM.01873-06
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618
   Hoshino K, 1999, J IMMUNOL, V162, P3749
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Iriarte M., 2004, Brucella: molecular and cellular biology, P159
   Kadrmas JL, 1998, J BIOL CHEM, V273, P26432, DOI 10.1074/jbc.273.41.26432
   Lapaque N, 2006, CELL MICROBIOL, V8, P401, DOI 10.1111/j.1462-5822.2005.00629.x
   Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003
   LEONG D, 1970, Infection and Immunity, V1, P174
   Mancek-Keber M, 2006, FASEB J, V20, P1836, DOI 10.1096/fj.06-5862com
   Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x
   Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003
   Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037
   Moriyon I., 2003, INTRACELLULAR PATHOG, P204
   Palacios-Chaves L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016030
   Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830
   Perez-Gutierrez C, 2010, INFECT IMMUN, V78, P2768, DOI 10.1128/IAI.01417-09
   Petrovska L, 2004, CELL MICROBIOL, V6, P1071, DOI 10.1111/j.1462-5822.2004.00419.x
   Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5
   Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021
   Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x
   Svensson M, 2000, INFECT IMMUN, V68, P6311, DOI 10.1128/IAI.68.11.6311-6320.2000
   TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X
   Ugalde JE, 2000, INFECT IMMUN, V68, P5716, DOI 10.1128/IAI.68.10.5716-5723.2000
   Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000
NR 49
TC 73
Z9 78
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2012
VL 8
IS 5
AR e1002675
DI 10.1371/journal.ppat.1002675
PG 14
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 959OS
UT WOS:000305322900011
PM 22589715
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Appenzeller-Herzog, C
   Hall, MN
AF Appenzeller-Herzog, Christian
   Hall, Michael N.
TI Bidirectional crosstalk between endoplasmic reticulum stress and mTOR
   signaling
SO TRENDS IN CELL BIOLOGY
LA English
DT Review
DE mTORC1; mTORC2; endoplasmic reticulum stress; unfolded protein response;
   anabolism; apoptosis
ID UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; ER STRESS; TUBEROUS SCLEROSIS;
   DIABETIC-NEPHROPATHY; INSULIN-RESISTANCE; MAMMALIAN TARGET;
   DOWN-REGULATION; UP-REGULATION; RAG GTPASES
AB Many cellular processes including apoptosis, autophagy, translation, energy metabolism, and inflammation are controlled by the mammalian target of rapamycin (mTOR) kinase and the endoplasmic reticulum (ER) stress pathway, also known as the unfolded protein response (UPR). Although both of these signaling nodes have attracted wide attention in fundamental cell biology and drug discovery, crosstalk between the two pathways has emerged only very recently. mTOR complex 1 (mTORC1) operates both upstream and downstream of ER stress signals, which can either enhance or antagonize the anabolic output of mTORC1. Upon prolonged ER stress, mTORC1 contributes to apoptotic signaling by suppressing the survival kinase Akt through feedback inhibition. Likewise, chronic ER stress obstructs activation of Akt by mTOR complex 2. This review surveys our knowledge of mTOR-ER stress intersections and highlights potential therapeutic implications.
C1 [Appenzeller-Herzog, Christian] Univ Basel, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland.
   [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Appenzeller-Herzog, C (corresponding author), Univ Basel, Dept Pharmaceut Sci, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christian.appenzeller@unibas.ch; m.hall@unibas.ch
RI Appenzeller-Herzog, Christian/A-2894-2014
OI Appenzeller-Herzog, Christian/0000-0001-7430-294X
FU Canton of Basel; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); August Collin-Fonds; Louis-Jeantet Foundation
FX We thank Don Benjamin for critical review of the manuscript. Funding by
   the Canton of Basel, the Swiss National Science Foundation (C.A.H. and
   M.N.H.), the August Collin-Fonds (C.A.H.), and the Louis-Jeantet
   Foundation (M.N.H.) is gratefully acknowledged.
CR Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105
   Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202
   Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034
   Cao Y, 2006, J BIOL CHEM, V281, P40242, DOI 10.1074/jbc.M608116200
   Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731
   Chin KT, 2011, FASEB J, V25, P2583, DOI 10.1096/fj.11-184622
   Christis C, 2010, J CELL SCI, V123, P787, DOI 10.1242/jcs.041111
   Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323
   Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062
   Dan HC, 2008, J IMMUNOL, V180, P7582, DOI 10.4049/jimmunol.180.11.7582
   Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308
   Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003
   Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993
   DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608
   Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009
   Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09
   Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87
   Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817
   Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257
   DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09
   Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968
   Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774
   Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002
   Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Hotokezaka Y, 2009, CELL DEATH DIFFER, V16, P1505, DOI 10.1038/cdd.2009.90
   Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200
   Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021
   Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055
   Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771
   Ishigaki S, 2010, CELL DEATH DIFFER, V17, P774, DOI 10.1038/cdd.2009.175
   Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135
   Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760
   Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007
   Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82
   Karassek S, 2010, J BIOL CHEM, V285, P33979, DOI 10.1074/jbc.M109.095968
   Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755
   Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042
   LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9
   Leibowitz G, 2010, DIABETES OBES METAB, V12, P66, DOI 10.1111/j.1463-1326.2010.01280.x
   Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492
   Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031
   Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3
   Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003
   May D, 2005, ONCOGENE, V24, P1011, DOI 10.1038/sj.onc.1208325
   Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504
   Moore CE, 2011, MOL ENDOCRINOL, V25, P315, DOI 10.1210/me.2010-0309
   Morishima N, 2011, J BIOL CHEM, V286, P35227, DOI 10.1074/jbc.M111.233502
   Mounir Z, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001630
   Mujtaba T, 2011, DISCOV MED, V12, P471
   Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596
   Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]
   Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Pfaffenbach KT, 2010, J NUTR, V140, P879, DOI 10.3945/jn.109.119883
   Pineau L, 2010, FEMS YEAST RES, V10, P1035, DOI 10.1111/j.1567-1364.2010.00674.x
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Polak P, 2006, DEV CELL, V11, P433, DOI 10.1016/j.devcel.2006.09.005
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400
   Ramming T, 2012, ANTIOXID REDOX SIGN, V16, P1109, DOI 10.1089/ars.2011.4475
   Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI [10.1089/ars.2009.2625, 10.1089/ARS.2009.2625]
   Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105
   Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074
   Stockwell SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028568
   Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184
   Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766
   Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337
   Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4
   Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017
   Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
   Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 89
TC 198
Z9 206
U1 3
U2 45
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0962-8924
EI 1879-3088
J9 TRENDS CELL BIOL
JI Trends Cell Biol.
PD MAY
PY 2012
VL 22
IS 5
BP 274
EP 282
DI 10.1016/j.tcb.2012.02.006
PG 9
WC Cell Biology
SC Cell Biology
GA 945SD
UT WOS:000304295400007
PM 22444729
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Erb, M
   Hoffmann-Enger, B
   Deppe, H
   Soeberdt, M
   Haefeli, RH
   Rummey, C
   Feurer, A
   Gueven, N
AF Erb, Michael
   Hoffmann-Enger, Barbara
   Deppe, Holger
   Soeberdt, Michael
   Haefeli, Roman H.
   Rummey, Christian
   Feurer, Achim
   Gueven, Nuri
TI Features of Idebenone and Related Short-Chain Quinones that Rescue ATP
   Levels under Conditions of Impaired Mitochondrial Complex I
SO PLOS ONE
LA English
DT Article
ID BRAIN MITOCHONDRIA; LIPID-PEROXIDATION; NAD(P)H-QUINONE
   OXIDOREDUCTASE-1; COENZYME-Q; INHIBITION; METABOLISM; MECHANISMS;
   REDUCTION; CHEMISTRY; SUBSTRATE
AB Short-chain quinones have been investigated as therapeutic molecules due to their ability to modulate cellular redox reactions, mitochondrial electron transfer and oxidative stress, which are pathologically altered in many mitochondrial and neuromuscular disorders. Recently, we and others described that certain short-chain quinones are able to bypass a deficiency in complex I by shuttling electrons directly from the cytoplasm to complex III of the mitochondrial respiratory chain to produce ATP. Although this energy rescue activity is highly interesting for the therapy of disorders associated with complex I dysfunction, no structure-activity-relationship has been reported for short-chain quinones so far. Using a panel of 70 quinones, we observed that the capacity for this cellular energy rescue as well as their effect on lipid peroxidation was influenced more by the physicochemical properties (in particular logD) of the whole molecule than the quinone moiety itself. Thus, the observed correlations allow us to explain the differential biological activities and therapeutic potential of short-chain quinones for the therapy of disorders associated with mitochondrial complex I dysfunction and/or oxidative stress.
C1 [Erb, Michael; Hoffmann-Enger, Barbara; Deppe, Holger; Soeberdt, Michael; Haefeli, Roman H.; Rummey, Christian; Feurer, Achim; Gueven, Nuri] Santhera Pharmaceut, Liestal, Switzerland.
   [Haefeli, Roman H.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Erb, M (corresponding author), Santhera Pharmaceut, Liestal, Switzerland.
EM nuri.gueven@santhera.com
RI Soeberdt, Michael/AAP-8617-2020
OI Soeberdt, Michael/0000-0003-2594-9901; Guven, Nuri/0000-0003-3782-767X;
   Rummey, Christian/0000-0003-4911-911X
CR Adikesavan AK, 2007, CANCER RES, V67, P7966, DOI 10.1158/0008-5472.CAN-06-4480
   Becker C, 2010, EXPERT OPIN DRUG MET, V6, P1437, DOI 10.1517/17425255.2010.530656
   Boutin JA, 2005, CHEM-BIOL INTERACT, V151, P213, DOI 10.1016/j.cbi.2005.01.002
   Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180
   Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270
   Colucci MA, 2008, ORG BIOMOL CHEM, V6, P637, DOI 10.1039/b715270a
   Courdier-Fruh I, 2006, MUSCLE NERVE, V33, P753, DOI 10.1002/mus.20549
   Dragan M, 2006, BRAIN RES, V1078, P9, DOI 10.1016/j.brainres.2006.01.068
   Ernster L., 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1
   Esposti MD, 1996, ARCH BIOCHEM BIOPHYS, V330, P395, DOI 10.1006/abbi.1996.0267
   FATO R, 2008, BIOCHIM BIOPHYS ACTA, V1787, P384
   Feurer A, 2012, Patent No. [WO/2012/022468, 2012022468]
   Feurer A, 2012, Patent No. [WO/2012/ 022467, 2012022467]
   Genova MW, 2003, EXP BIOL MED, V228, P506, DOI 10.1177/15353702-0322805-14
   Giorgio V, 2011, BIOCHIM BIOPHYS ACTA, V1817, P363
   Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963
   Haginoya K, 2009, J NEUROL SCI, V278, P112, DOI 10.1016/j.jns.2008.11.008
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055
   King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Long DJ, 2000, CHEM-BIOL INTERACT, V129, P99, DOI 10.1016/S0009-2797(00)00200-3
   MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U
   Mordente A, 1998, CHEM RES TOXICOL, V11, P54, DOI 10.1021/tx970136j
   Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015
   OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7
   Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Rauchova H, 2008, J BIOENERG BIOMEMBR, V40, P85, DOI 10.1007/s10863-008-9134-1
   Rauchova H, 2006, BIOCHEM BIOPH RES CO, V339, P362, DOI 10.1016/j.bbrc.2005.11.035
   Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X
   SUGIYAMA Y, 1985, J PHARMACOBIO-DYNAM, V8, P1006
   SUNO M, 1984, BIOCHEM BIOPH RES CO, V125, P1046, DOI 10.1016/0006-291X(84)91389-5
   SUNO M, 1989, ARCH GERONTOL GERIAT, V8, P291, DOI 10.1016/0167-4943(89)90010-1
   TSURUO Y, 1994, JPN J PHARMACOL, V65, P285, DOI 10.1254/jjp.65.285
NR 35
TC 47
Z9 47
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2012
VL 7
IS 4
AR e36153
DI 10.1371/journal.pone.0036153
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TJ
UT WOS:000305336000140
PM 22558363
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Kebbel, F
   Kurz, M
   Grutter, MG
   Stahlberg, H
AF Kebbel, Fabian
   Kurz, Mareike
   Gruetter, Markus G.
   Stahlberg, Henning
TI Projection Structure of the Secondary Citrate/Sodium Symporter CitS at 6
   angstrom Resolution by Electron Crystallography
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE secondary transporter; 2-hydroxycarboxylate transporter (2-HCT); CitS;
   electron crystallography; cryo-electron microscopy
ID 2-HYDROXYCARBOXYLATE TRANSPORTER FAMILY; X-RAY-STRUCTURE;
   KLEBSIELLA-PNEUMONIAE; CRYSTAL-STRUCTURE; MEMBRANE TOPOLOGY;
   ESCHERICHIA-COLI; CLASSIFICATION-SYSTEM; BACTERIAL HOMOLOG; CHLORIDE
   CHANNEL; REENTRANT LOOPS
AB CitS from Klebsiella pneumoniae acts as a secondary symporter of citrate and sodium ions across the inner membrane of the host. The protein is the best characterized member of the 2-hydroxycarboxylate transporter family, while no experimental structural information at sub-nanometer resolution is available on this class of membrane proteins. Here, we applied electron crystallography to two-dimensional crystals of CitS. Carbon-film-adsorbed tubular two-dimensional crystals were studied by cryo-electron microscopy, producing the 6-angstrom-resolution projection structure of the membrane-embedded protein. In the p22(1)2(1)-symmetrized projection map, the predicted dimeric structure is clearly visible. Each monomeric unit can tentatively be interpreted as being composed of 11 transmembrane alpha-helices. In projection, CitS shows a high degree of structural similarity to NhaP1, the Na+/H+ antiporter of Methanococcus jannaschii. We discuss possible locations for the dimer interface and models for the helical arrangements and domain organizations of the symporter based on existing models. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Kurz, Mareike; Gruetter, Markus G.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.
   [Kebbel, Fabian; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland.
RP Grutter, MG (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM Gruetter@bioc.unizh.ch; Henning.Stahlberg@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX We thank Mohamed Chami for support for cryo-EM. We also thank Werner
   Kuhlbrandt for permission to reproduce the NhaP1 map in Fig. 3d. This
   work was was supported by the Swiss National Science Foundation in the
   framework of the National Center of Competence in Research, Structural
   Biology, and in the Swiss Initiative for Systems Biology (SystemsX.ch).
CR Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196
   Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002
   Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010
   Bandell M, 1997, J BIOL CHEM, V272, P18140, DOI 10.1074/jbc.272.29.18140
   Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257
   Busch W, 2004, MOL BIOTECHNOL, V27, P253, DOI 10.1385/MB:27:3:253
   Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406
   Dobrowolski A, 2010, BIOCHEMISTRY-US, V49, P4509, DOI 10.1021/bi100336s
   Dobrowolski A, 2009, BIOCHEMISTRY-US, V48, P7448, DOI 10.1021/bi9004914
   Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a
   Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406
   Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201
   Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014
   Gipson B, 2008, MICROSC MICROANAL, V14, P1290
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321
   Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450
   Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619
   Huber T, 2007, J STRUCT BIOL, V159, P206, DOI 10.1016/j.jsb.2007.01.013
   Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692
   Kastner CN, 2000, ARCH MICROBIOL, V174, P67, DOI 10.1007/s002030000175
   Kastner CN, 2003, BIOPHYS J, V84, P1651
   Korkhov VM, 2009, ACTA CRYSTALLOGR D, V65, P186, DOI 10.1107/S0907444908036640
   Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143
   Krupnik T, 2011, MOL MEMBR BIOL, V28, P243, DOI 10.3109/09687688.2011.581252
   Lolkema JS, 2005, FEBS J, V272, P2334, DOI 10.1111/j.1742-4658.2005.04665.x
   LOLKEMA JS, 1994, EUR J BIOCHEM, V220, P469, DOI 10.1111/j.1432-1033.1994.tb18645.x
   Lolkema JS, 2003, J MOL BIOL, V327, P901, DOI 10.1016/S0022-2836(03)00214-6
   Lolkema JS, 1998, MOL MEMBR BIOL, V15, P33, DOI 10.3109/09687689809027516
   Lolkema JS, 2006, J MOL MICROB BIOTECH, V11, P318, DOI 10.1159/000095634
   Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885
   Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631
   Moscicka KB, 2009, BIOCHEMISTRY-US, V48, P6618, DOI 10.1021/bi900838d
   Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050
   Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309
   Paulsen IT, 1998, J MOL BIOL, V277, P573, DOI 10.1006/jmbi.1998.1609
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102
   Pos KM, 1996, BIOCHEMISTRY-US, V35, P1018, DOI 10.1021/bi951609t
   Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819
   Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000
   Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310
   Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088
   Sobczak I, 2005, BIOCHEMISTRY-US, V44, P5461, DOI 10.1021/bi047759y
   Sobczak I, 2004, J BIOL CHEM, V279, P31113, DOI 10.1074/jbc.M404283200
   Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005
   Tate CG, 2006, CURR OPIN STRUC BIOL, V16, P457, DOI 10.1016/j.sbi.2006.06.005
   ter Horst R, 2012, BBA-BIOMEMBRANES, V1818, P72, DOI 10.1016/j.bbamem.2011.09.021
   Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611
   VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445
   van Geest M, 2000, BBA-BIOMEMBRANES, V1466, P328, DOI 10.1016/S0005-2736(00)00185-1
   Vinothkumar KR, 2005, EMBO J, V24, P2720, DOI 10.1038/sj.emboj.7600727
   Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]
   Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978
   Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018
   Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629
NR 60
TC 4
Z9 4
U1 0
U2 7
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 20
PY 2012
VL 418
IS 1-2
BP 117
EP 126
DI 10.1016/j.jmb.2012.02.016
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 926KX
UT WOS:000302831000011
PM 22349493
OA Other Gold
DA 2021-01-25
ER

PT J
AU Tiwari, VK
   Burger, L
   Nikoletopoulou, V
   Deogracias, R
   Thakurela, S
   Wirbelauer, C
   Kaut, J
   Terranova, R
   Hoerner, L
   Mielke, C
   Boege, F
   Murr, R
   Peters, AHFM
   Barde, YA
   Schubeler, D
AF Tiwari, Vijay K.
   Burger, Lukas
   Nikoletopoulou, Vassiliki
   Deogracias, Ruben
   Thakurela, Sudhir
   Wirbelauer, Christiane
   Kaut, Johannes
   Terranova, Remi
   Hoerner, Leslie
   Mielke, Christian
   Boege, Fritz
   Murr, Rabih
   Peters, Antoine H. F. M.
   Barde, Yves-Alain
   Schuebeler, Dirk
TI Target genes of Topoisomerase II beta regulate neuronal survival and are
   defined by their chromatin state
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE epigenetic regulation; neurogenesis; gene expression; genomewide assays
ID EMBRYONIC STEM-CELLS; HISTONE H3; DNA TOPOISOMERASES; ALPHA;
   METHYLATION; EXPRESSION; LYSINE-4; PURIFICATION; REPLICATION;
   PLURIPOTENT
AB Topoisomerases are essential for DNA replication in dividing cells, but their genomic targets and function in postmitotic cells remain poorly understood. Here we show that a switch in the expression from Topoisomerases II alpha (Top2 alpha) to II beta(Top2 beta) occurs during neuronal differentiation in vitro and in vivo. Genome-scale location analysis in stem cell-derived postmitotic neurons reveals Top2 beta binding to chromosomal sites that are methylated at lysine 4 of histone H3, a feature of regulatory regions. Indeed Top2 beta-bound sites are preferentially promoters and become targets during the transition from neuronal progenitors to neurons, at a time when cells exit the cell cycle. Absence of Top2 beta protein or its activity leads to changes in transcription and chromatin accessibility at many target genes. Top2 beta deficiency does not impair stem cell properties and early steps of neuronal differentiation but causes premature death of postmitotic neurons. This neuronal degeneration is caused by up-regulation of Ngfr p75, a gene bound and repressed by Top2 beta. These findings suggest a chromatin-based targeting of Top2 beta to regulatory regions in the genome to govern the transcriptional program associated with neuronal differentiation and longevity.
C1 [Tiwari, Vijay K.; Burger, Lukas; Wirbelauer, Christiane; Kaut, Johannes; Terranova, Remi; Hoerner, Leslie; Murr, Rabih; Peters, Antoine H. F. M.; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Nikoletopoulou, Vassiliki; Deogracias, Ruben; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schuebeler, Dirk] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland.
   [Mielke, Christian; Boege, Fritz] Univ Dusseldorf, Inst Clin Chem & Lab Diagnost, Fac Med, D-40225 Dusseldorf, Germany.
   [Tiwari, Vijay K.; Thakurela, Sudhir] Inst Mol Biol, D-55128 Mainz, Germany.
RP Tiwari, VK (corresponding author), Inst Mol Biol, D-55128 Mainz, Germany.
EM v.tiwari@imb-mainz.de; dirk@fmi.ch
RI Boege, Fritz/H-3261-2019; Peters, Antoine/ABA-6283-2020; Deogracias,
   Ruben/I-5751-2015
OI Deogracias, Ruben/0000-0002-9279-7867; Murr, Rabih/0000-0002-3346-6590;
   Barde, Yves/0000-0002-7627-461X; Thakurela, Sudhir/0000-0003-1285-8680;
   Nikoletopoulou, Vassiliki/0000-0003-3646-992X
FU Marie Curie International Incoming FellowshipEuropean Union (EU);
   European Molecular Biology Organization long-term postdoctoral
   fellowship; European UnionEuropean Union (EU) [EuTRACC,
   LSHG-CT-2004-503433, LSHG-CT-2006-037415]; Swiss National
   FoundationSwiss National Science Foundation (SNSF); Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 728-A1];
   Novartis Research Foundation; European Research CouncilEuropean Research
   Council (ERC) [ERC-204264]; Swiss Initiative for Systems Biology
FX We thank Frederic Zilbermann for technical assistance, Dr. Ken Tsutsui
   (Okayama University) for providing Top2 beta (3B6) antibodies, Yi Lisa
   Lyu (University of Medicine and Dentistry of New Jersey-Robert Wood
   Johnson Medical School) for providing Top2 beta<SUP>+/-</SUP> mice, and
   Tim Roloff, Patrick Kopp, and Jean-Francois Spetz from facilities of the
   Friedrich Miescher Institute. We thank Christian Beisel and Ina Nissen
   from the Laboratory of Quantitative Genomics at the Department of
   Biosystems Science and Engineering, Swiss Federal Institute of
   TechnologyZurich for Illumina sequencing. We also thank members of the
   D. S. laboratory for critical comments about the manuscript. V.K.T. was
   supported by a Marie Curie International Incoming Fellowship and a
   European Molecular Biology Organization long-term postdoctoral
   fellowship. Research in the laboratory of Y.-A.B. is supported by
   European Union Grant EuTRACC and a Sinergia project from the Swiss
   National Foundation. Work in the laboratory of C.M. and F.B. was
   supported by Deutsche Forschungsgemeinschaft Grant SFB 728-A1. Research
   in the laboratory of D.S. is supported by the Novartis Research
   Foundation, European Union Grants LSHG-CT-2004-503433 and
   LSHG-CT-2006-037415, European Research Council Grant ERC-204264, the
   Swiss Initiative for Systems Biology (Project Cell Plasticity), and,
   together with Y.-A.B., by a Sinergia project from the Swiss National
   Foundation.
CR Akimitsu N, 2003, GENES CELLS, V8, P393, DOI 10.1046/j.1365-2443.2003.00643.x
   AUSTIN CA, 1993, BIOCHIM BIOPHYS ACTA, V1172, P283, DOI 10.1016/0167-4781(93)90215-Y
   Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q
   Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009
   Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017
   Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147
   Bryja V, 2006, STEM CELLS, V24, P844, DOI 10.1634/stemcells.2005-0444
   Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732
   Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369
   Chan DW, 2009, PROTEOMICS, V9, P2343, DOI 10.1002/pmic.200800600
   Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357
   Cuvier O, 2003, J CELL BIOL, V160, P645, DOI 10.1083/jcb.200209023
   Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131
   DRAKE FH, 1987, J BIOL CHEM, V262, P16739
   EARNSHAW WC, 1985, J CELL BIOL, V100, P1716, DOI 10.1083/jcb.100.5.1716
   Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017
   Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009
   Frade JM, 2000, TRENDS NEUROSCI, V23, P591, DOI 10.1016/S0166-2236(00)01704-5
   Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506
   Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003
   Goswami PC, 1996, MOL CELL BIOL, V16, P1500
   Grue P, 1998, J BIOL CHEM, V273, P33660, DOI 10.1074/jbc.273.50.33660
   Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162
   Isaacs RJ, 1996, J BIOL CHEM, V271, P16741, DOI 10.1074/jbc.271.28.16741
   Jensen AD, 1996, EUR J BIOCHEM, V236, P389, DOI 10.1111/j.1432-1033.1996.00389.x
   Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196
   KHELIFA T, 1994, MOL PHARMACOL, V46, P323
   Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005
   LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200
   Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012
   Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090
   Linka RM, 2007, NUCLEIC ACIDS RES, V35, P3810, DOI 10.1093/nar/gkm102
   Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06
   Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100
   Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752
   Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684
   Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008
   Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919
   Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007
   Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100
   Niimi A, 2001, CHROMOSOMA, V110, P102, DOI 10.1007/s004120100140
   Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011
   Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608
   Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004
   Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987
   Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420
   Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897
   Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242
   Razin SV, 1996, CRIT REV EUKAR GENE, V6, P247, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.70
   ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781
   Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994
   Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103
   Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200
   Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206
   Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046
   Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200
   Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M
   Turley H, 1997, BRIT J CANCER, V75, P1340, DOI 10.1038/bjc.1997.227
   Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010
   Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020
   Villman K, 2002, MODERN PATHOL, V15, P486, DOI 10.1038/modpathol.3880552
   von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730
   Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831
   WATANABE M, 1994, NEUROSCI RES, V19, P51, DOI 10.1016/0168-0102(94)90007-8
   Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990
   WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209
   Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036
   Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815
   Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131
NR 71
TC 81
Z9 81
U1 0
U2 20
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 17
PY 2012
VL 109
IS 16
BP E934
EP E943
DI 10.1073/pnas.1119798109
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 931UZ
UT WOS:000303246100005
PM 22474351
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Van den Bergh, R
   Morin, S
   Sass, HJ
   Grzesiek, S
   Vekemans, M
   Florence, E
   Huyen, TTT
   Imiru, RG
   Heyndrickx, L
   Vanham, G
   De Baetselier, P
   Raes, G
AF Van den Bergh, Rafael
   Morin, Sebastien
   Sass, Hans Juergen
   Grzesiek, Stephan
   Vekemans, Marc
   Florence, Eric
   Huyen Thanh Thi Tran
   Imiru, Rosina Gabriel
   Heyndrickx, Leo
   Vanham, Guido
   De Baetselier, Patrick
   Raes, Geert
TI Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV
   through the Adipocytokine Visfatin/NAMPT
SO PLOS ONE
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; EVOLUTIONARY DYNAMICS; BIOSENSOR
   TECHNOLOGY; REPLICATIVE FITNESS; CORECEPTOR SWITCH; TYPE-1 INFECTION;
   IN-VITRO; MACROPHAGES; TRANSMISSION
AB Background: The immune system exerts a diversifying selection pressure on HIV through cellular, humoral and innate mechanisms. This pressure drives viral evolution throughout infection. A better understanding of the natural immune pressure on the virus during infection is warranted, given the clinical interest in eliciting and sustaining an immune response to HIV which can help to control the infection. We undertook to evaluate the potential of the novel HIV-induced, monocyte-derived factor visfatin to modulate viral infection, as part of the innate immune pressure on viral populations.
   Results: We show that visfatin is capable of selectively inhibiting infection by R5 HIV strains in macrophages and resting PBMC in vitro, while at the same time remaining indifferent to or even favouring infection by X4 strains. Furthermore, visfatin exerts a direct effect on the relative fitness of R5 versus X4 infections in a viral competition setup. Direct interaction of visfatin with the CCR5 receptor is proposed as a putative mechanism for this differential effect. Possible in vivo relevance of visfatin induction is illustrated by its association with the dominance of CXCR4-using HIV in the plasma.
   Conclusions: As an innate factor produced by monocytes, visfatin is capable of inhibiting infections by R5 but not X4 strains, reflecting a potential selective pressure against R5 viruses.
C1 [Van den Bergh, Rafael; Huyen Thanh Thi Tran; Imiru, Rosina Gabriel; De Baetselier, Patrick; Raes, Geert] VIB, Dept Mol & Cellular Interact, Brussels, Belgium.
   [Van den Bergh, Rafael; Huyen Thanh Thi Tran; Imiru, Rosina Gabriel; De Baetselier, Patrick; Raes, Geert] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium.
   [Morin, Sebastien; Sass, Hans Juergen; Grzesiek, Stephan] Univ Basel, Div Struct Biol, Biozentrum, Basel, Switzerland.
   [Vekemans, Marc; Florence, Eric] Inst Trop Med, Dept Clin Sci, HIV STD Unit, B-2000 Antwerp, Belgium.
   [Imiru, Rosina Gabriel; Heyndrickx, Leo; Vanham, Guido] Inst Trop Med, Dept Microbiol, HIV Virol Unit, B-2000 Antwerp, Belgium.
   [Vanham, Guido] Vrije Univ Brussel, Fac Med & Pharm, Brussels, Belgium.
   [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Biomed & Vet Sci, B-2020 Antwerp, Belgium.
RP Van den Bergh, R (corresponding author), VIB, Dept Mol & Cellular Interact, Brussels, Belgium.
EM rvdbergh@vub.ac.be
RI Raes, Geert M/H-5185-2013; De Baetselier, Patrick/D-3866-2014
OI Raes, Geert M/0000-0002-9065-1549; Van den Bergh,
   Rafael/0000-0001-6277-8713; Grzesiek, Stephan/0000-0003-1998-4225;
   Florence, Eric/0000-0002-7004-9120; Morin, Sebastien/0000-0003-4426-326X
FU Institute for the Promotion of Innovation through Science and Technology
   in Flanders (IWT-Vlaanderen)Institute for the Promotion of Innovation by
   Science and Technology in Flanders (IWT) [IWT SB474]; European Molecular
   Biology Organization (EMBO)European Molecular Biology Organization
   (EMBO)
FX This work was supported in part by a grant of the Institute for the
   Promotion of Innovation through Science and Technology in Flanders
   (IWT-Vlaanderen) to RVdB (IWT SB474). The European Molecular Biology
   Organization (EMBO) is acknowledged for a postdoctoral fellowship to SM.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245
   Arien KK, 2006, VIROLOGY, V347, P65, DOI 10.1016/j.virol.2005.11.045
   Beirnaert E, 1998, J VIROL METHODS, V73, P65, DOI 10.1016/S0166-0934(98)00044-5
   Bewick S, 2011, B MATH BIOL
   Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047
   CROWE S, 1987, AIDS RES HUM RETROV, V3, P135, DOI 10.1089/aid.1987.3.135
   Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z
   Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45
   GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59
   Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171
   Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004
   Jones G, 2006, NEUROBIOL DIS, V21, P1, DOI 10.1016/j.nbd.2005.07.018
   Jones KL, 2010, J BIOL CHEM, V285, P18603, DOI 10.1074/jbc.M109.090126
   Kamp C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-274
   Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746
   Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935
   Korner A, 2007, J CLIN ENDOCR METAB, V92, P4783, DOI 10.1210/jc.2007-1304
   Lemey P, 2006, AIDS REV, V8, P125
   McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271
   Moncunill G, 2008, AIDS, V22, P23, DOI 10.1097/QAD.0b013e3282f303e6
   Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488
   Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660
   Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567
   Moschen AR, 2010, CURR PHARM DESIGN, V16, P1913, DOI 10.2174/138161210791208947
   Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017
   Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021
   Nisius L, 2008, PROTEIN EXPRES PURIF, V61, P155, DOI 10.1016/j.pep.2008.06.001
   Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058
   Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005
   Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100
   Sguanci L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S5
   SMITH SD, 1984, CANCER RES, V44, P5657
   Sonoli SS, 2011, EUR REV MED PHARMACO, V15, P9
   Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53
   Van Herrewege Y, 2002, AIDS RES HUM RETROV, V18, P1091, DOI 10.1089/088922202320567833
   Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042
   Vyakarnam A, 2001, AIDS, V15, P1613, DOI 10.1097/00002030-200109070-00003
   Wahl SM, 1997, J LEUKOCYTE BIOL, V62, P67
   Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004
   Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470
   WEISS A, 1984, J IMMUNOL, V133, P123
   WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089
NR 44
TC 14
Z9 14
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 6
PY 2012
VL 7
IS 4
AR e35074
DI 10.1371/journal.pone.0035074
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 955JA
UT WOS:000305012700073
PM 22493731
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Blattler, SM
   Cunningham, JT
   Verdeguer, F
   Chim, H
   Haas, W
   Liu, HF
   Romanino, K
   Ruegg, MA
   Gygi, SP
   Shi, Y
   Puigserver, P
AF Blaettler, Sharon M.
   Cunningham, John T.
   Verdeguer, Francisco
   Chim, Helen
   Haas, Wilhelm
   Liu, Huifei
   Romanino, Klaas
   Rueegg, Markus A.
   Gygi, Steven P.
   Shi, Yang
   Puigserver, Pere
TI Yin Yang 1 Deficiency in Skeletal Muscle Protects against
   Rapamycin-Induced Diabetic-like Symptoms through Activation of
   Insulin/IGF Signaling
SO CELL METABOLISM
LA English
DT Article
ID LIPID-METABOLISM; MICE LACKING; CELL-GROWTH; LIFE-SPAN; MTOR; COMPLEX;
   CANCER; DOWNSTREAM; MELLITUS; PATHWAY
AB Rapamycin and its derivatives are mTOR inhibitors used in tissue transplantation and cancer therapy. A percentage of patients treated with these inhibitors develop diabetic-like symptoms, but the molecular mechanisms are unknown. We show here that chronic rapamycin treatment in mice led to insulin resistance with suppression of insulin/IGF signaling and genes associated within this pathway, such as Igf1-2, Irs1-2, and Akt1-3. Importantly, skeletal muscle-specific YY1 knockout mice were protected from rapamycin-induced diabetic-like symptoms. This protection was caused by hyperactivation of insulin/IGF signaling with increased gene expression in this cascade that, in contrast to wild-type mice, was not suppressed by rapamycin. Mechanistically, rapamycin induced YY1 dephosphorylation and recruitment to promoters of insulin/IGF genes, which promoted interaction with the polycomb protein-2 corepressor. This was associated with H3K27 trimethylation leading to decreased gene expression and insulin signaling. These results have implications for rapamycin action in human diseases and biological processes such as longevity.
C1 [Blaettler, Sharon M.; Cunningham, John T.; Verdeguer, Francisco; Chim, Helen; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.
   [Blaettler, Sharon M.; Cunningham, John T.; Verdeguer, Francisco; Chim, Helen; Haas, Wilhelm; Liu, Huifei; Gygi, Steven P.; Shi, Yang; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA.
   [Romanino, Klaas; Rueegg, Markus A.] Univ Basel, Biozentrum, Dept Neurobiol, CH-4056 Basel, Switzerland.
RP Puigserver, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.
EM pere_puigserver@dfci.harvard.edu
RI Verdeguer, Francisco/O-5486-2016; Ruegg, Markus/X-7256-2019
OI Verdeguer, Francisco/0000-0002-5798-1503; Ruegg,
   Markus/0000-0002-4974-9384; Cunningham, John/0000-0001-6490-4533
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); NIH/NIDDKUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [RO1 DK081418];
   Muscular Dystrophy AssociationMuscular Dystrophy Association
   [MDA202237]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R01DK081418, R01DK081418,
   R01DK081418, R01DK081418, R01DK081418, R01DK081418, R01DK081418,
   R01DK081418, R01DK081418, R01DK081418, R01DK081418, R01DK081418] Funding
   Source: NIH RePORTER
FX We would like to thank members of the Puigserver lab for advice and
   fruitful discussions, Christine Chin for technical assistance, Benjamin
   Szlyk for assistance in the creation of the figures, Eric Olson for the
   myogenin CRE mice, Markus Schubert for the IRS2-driven luciferase
   construct, Nathanael Gray for Torin 2, and Owen McGuinness for
   interpretation of the clamp experiments. These studies were supported by
   a postdoctoral fellowship from the Swiss National Science Foundation
   (S.M.B.) and by the NIH/NIDDK RO1 DK081418 grant and Muscular Dystrophy
   Association MDA202237 (P.P.).
CR Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006
   Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010
   Bodziak KA, 2009, TRANSPL INT, V22, P519, DOI 10.1111/j.1432-2277.2008.00800.x
   Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016
   Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314
   Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728
   Cole EH, 2008, CLIN J AM SOC NEPHRO, V3, P814, DOI 10.2215/CJN.04681107
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Cuthbertson DJ, 2007, DIABETES, V56, P2078, DOI 10.2337/db06-1716
   Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532
   Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400
   Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802
   Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922
   Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885
   Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169
   Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202
   Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902
   Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007
   Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102
   Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v
   Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10
   Mauvoisin D, 2007, J CELL COMMUN SIGNAL, V1, P113, DOI 10.1007/s12079-007-0011-1
   McAlister VC, 2002, THER DRUG MONIT, V24, P346, DOI 10.1097/00007691-200206000-00004
   Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766
   Monaco AP, 2009, TRANSPLANTATION, V87, P157, DOI 10.1097/TP.0b013e318193886e
   Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074
   Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002
   Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902
   Plas DR, 2009, CURR OPIN CELL BIOL, V21, P230, DOI 10.1016/j.ceb.2008.12.013
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Roland M, 2008, TRANSPL INT, V21, P523, DOI 10.1111/j.1432-2277.2008.00640.x
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   Sampson JR, 2009, BIOCHEM SOC T, V37, P259, DOI 10.1042/BST0370259
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006
   Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5
   Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026
   Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103
   Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017
NR 57
TC 68
Z9 70
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD APR 4
PY 2012
VL 15
IS 4
BP 505
EP 517
DI 10.1016/j.cmet.2012.03.008
PG 13
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 922CC
UT WOS:000302523400012
PM 22482732
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Braissant, O
   Bindschedler, S
   Daniels, AU
   Verrecchia, EP
   Cailleau, G
AF Braissant, Olivier
   Bindschedler, Saskia
   Daniels, Alma U.
   Verrecchia, Eric P.
   Cailleau, Guillaume
TI MICROBIOLOGICAL ACTIVITIES IN MOONMILK MONITORED USING ISOTHERMAL
   MICROCALORIMETRY (CAVE OF VERS CHEZ LE BRANDT, NEUCHATEL, SWITZERLAND)
SO JOURNAL OF CAVE AND KARST STUDIES
LA English
DT Article
ID NEEDLE-FIBER CALCITE; MICROBIAL ACTIVITY; ALTAMIRA CAVE; EXOPOLYMERIC
   SUBSTANCES; SOIL BACTERIA; HUMIC ACIDS; ORIGIN; COMMUNITIES; FOREST;
   GEOMICROBIOLOGY
AB Studies of the influence of microbial communities on calcium carbonate deposits mostly rely on classical or molecular microbiology, isotopic analyses, and microscopy. Using these techniques, it is difficult to infer microbial activities in such deposits. In this context, we used isothermal microcalorimetry, a sensitive and non-destructive tool, to measure microbial activities associated with moonmilk ex-situ. Upon the addition of diluted LB medium and other carbon sources to fresh moonmilk samples, we estimated the number of colony forming units per gram of moonmilk to be 4.8 x 10(5) +/- 0.2 x 10(5). This number was close to the classical plate counts, but one cannot assume that all active cells producing metabolic heat were culturable. Using a similar approach, we estimated the overall growth rate and generation time of the microbial community associated with the moonmilk upon addition of various carbon sources. The range of apparent growth rates of the chemoheterotrophic microbial community observed was between 0.025 and 0.067 h(-1) and generation times were between 10 and 27 hours. The highest growth rates were observed for citrate and diluted LB medium, while the highest carbon-source consumption rates were observed for low molecular weight organic acids (oxalate and acetate) and glycerol. Considering the rapid degradation of organic acids, glucose, and other carbon sources observed in the moonmilk, it is obvious that upon addition of nutrients during snow melting or rainfall these communities can have high overall activities comparable to those observed in some soils. Such communities can influence the physico-chemical conditions and participate directly or indirectly to the formation of moonmilk.
C1 [Braissant, Olivier; Daniels, Alma U.] Univ Basel, Biozentrum Pharmazentrum, Lab Biomech & Biocalorimetry, CH-4056 Basel, Switzerland.
   [Bindschedler, Saskia; Verrecchia, Eric P.; Cailleau, Guillaume] Univ Lausanne, Inst Geol & Paleontol, Quartier UNIL Dorigny, CH-1015 Lausanne, Switzerland.
RP Braissant, O (corresponding author), Univ Basel, Biozentrum Pharmazentrum, Lab Biomech & Biocalorimetry, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM olivier.braissant@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995
   Badis A, 2009, AFR J MICROBIOL RES, V3, P997
   BARROS N, 1995, THERMOCHIM ACTA, V249, P161, DOI 10.1016/0040-6031(95)90686-X
   Barros N, 1999, THERMOCHIM ACTA, V328, P99, DOI 10.1016/S0040-6031(98)00629-7
   Barton HA, 2007, J CAVE KARST STUD, V69, P163
   Bindschedler S, 2010, GEOL SOC SPEC PUBL, V336, P225, DOI 10.1144/SP336.11
   BOQUET E, 1973, NATURE, V246, P527, DOI 10.1038/246527a0
   Borsato A, 2000, J SEDIMENT RES, V70, P1171, DOI 10.1306/032300701171
   Braissant O, 2007, GEOBIOLOGY, V5, P401, DOI 10.1111/j.1472-4669.2007.00117.x
   Braissant O, 2002, NATURWISSENSCHAFTEN, V89, P366, DOI 10.1007/s00114-002-0340-0
   Braissant O, 2009, FEMS MICROBIOL ECOL, V67, P293, DOI 10.1111/j.1574-6941.2008.00614.x
   Braissant O, 2004, GEOBIOLOGY, V2, P59, DOI 10.1111/j.1472-4677.2004.00019.x
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Bull A. T., 2004, MICROBIAL DIVERSITY
   Cailleau G, 2009, SEDIMENTOLOGY, V56, P1858, DOI 10.1111/j.1365-3091.2009.01060.x
   Cailleau G, 2009, J CRYST GROWTH, V311, P2490, DOI 10.1016/j.jcrysgro.2009.02.029
   CALLOT G, 1985, AGRONOMIE, V5, P209, DOI 10.1051/agro:19850303
   Canaveras JC, 2006, NATURWISSENSCHAFTEN, V93, P27, DOI 10.1007/s00114-005-0052-3
   Colwell R. R., 2000, NONCULTURABLE MICROO
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Cuezva S, 2009, INT J SPELEOL, V38, P83
   Curry MD, 2009, INT J SPELEOL, V38, P111, DOI 10.5038/1827-806X.38.2.3
   DARI K, 1995, FEMS MICROBIOL ECOL, V16, P115, DOI 10.1111/j.1574-6941.1995.tb00275.x
   Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005
   Engel A.S., 2008, KARST WATERS I SPECI, V13, P37
   Fujii K, 2010, PLANT SOIL, V334, P475, DOI 10.1007/s11104-010-0398-y
   Gaskell EE, 2010, ANTON LEEUW INT J G, V97, P211, DOI 10.1007/s10482-009-9402-z
   Gigon R., 1976, INVENTAIRE SPELEOLOG, V1
   GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201
   Higuera-Guisset J, 2005, THERMOCHIM ACTA, V427, P187, DOI 10.1016/j.tca.2004.09.010
   Holt JG, 1994, BERGEYS MANUAL DETER
   JAMES AM, 1987, THERMAL ENERGETIC ST
   Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002
   Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107
   Kawai M, 1999, J APPL MICROBIOL, V86, P496, DOI 10.1046/j.1365-2672.1999.00689.x
   KIMURA T, 1985, J GEN MICROBIOL, V131, P3083
   Konhauser K, 2007, INTRO GEOMICROBIOLOG
   Lacelle D, 2010, SEDIMENTOLOGY, V57, P1147, DOI 10.1111/j.1365-3091.2009.01134.x
   Laiz Leonila, 2000, International Microbiology, V3, P25
   Muchova M, 2009, WATER SCI TECHNOL, V60, P965, DOI 10.2166/wst.2009.443
   Mulec J, 2002, ACTA CARSOLOGICA, V31, P177
   Mulec J, 2008, ACTA CARSOLOGICA, V37, P153, DOI 10.3986/ac.v37i1.167
   Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750
   Parinkina O.M., 1973, B ECOLOGICAL RES COM, V17, P303
   Pasic L, 2010, FEMS MICROBIOL ECOL, V71, P50, DOI 10.1111/j.1574-6941.2009.00789.x
   Perrin J., 2003, THESIS NEUCHATEL U N
   PHILLIPS SE, 1987, AUST J SOIL RES, V25, P405, DOI 10.1071/SR9870405
   PHILLIPS SE, 1987, AUST J SOIL RES, V25, P429, DOI 10.1071/SR9870429
   PIRT SJ, 1987, J FERMENT BIOENG, V65, P173, DOI 10.1016/0385-6380(87)90161-0
   Portillo MC, 2008, J APPL MICROBIOL, V104, P681, DOI 10.1111/j.1365-2672.2007.03594.x
   Portillo MC, 2011, MICROB ECOL, V61, P182, DOI 10.1007/s00248-010-9731-5
   Qian F, 2007, J APPL MICROBIOL, V102, P1362, DOI 10.1111/j.1365-2672.2006.03215.x
   Rohwerder T, 2003, ACTA BIOTECHNOL, V23, P101, DOI 10.1002/abio.200390000
   Rong XM, 2007, PEDOSPHERE, V17, P137, DOI 10.1016/S1002-0160(07)60019-8
   Sahin N, 2004, NATURWISSENSCHAFTEN, V91, P498, DOI 10.1007/s00114-004-0562-4
   Sahin N, 2003, RES MICROBIOL, V154, P399, DOI 10.1016/S0923-2508(03)00112-8
   Segawa T, 2011, POLAR SCI, V5, P41, DOI 10.1016/j.polar.2010.12.002
   SHAW WV, 1976, J GEN MICROBIOL, V94, P159, DOI 10.1099/00221287-94-1-159
   Stomeo F, 2008, INT BIODETER BIODEGR, V62, P483, DOI 10.1016/j.ibiod.2007.12.011
   Tan H, 2009, LETT APPL MICROBIOL, V49, P248, DOI 10.1111/j.1472-765X.2009.02649.x
   van Hees PAW, 2002, SOIL BIOL BIOCHEM, V34, P1261, DOI 10.1016/S0038-0717(02)00068-8
   Wadso I, 2002, THERMOCHIM ACTA, V394, P305, DOI 10.1016/S0040-6031(02)00263-0
   Wadso I, 2009, J THERM ANAL CALORIM, V95, P843, DOI 10.1007/s10973-008-9467-3
NR 63
TC 13
Z9 14
U1 0
U2 21
PU NATL SPELEOLOGICAL SOC
PI HUNTSVILLE
PA 2813 CAVE AVE, HUNTSVILLE, AL 35810-4431 USA
SN 1090-6924
EI 2331-3714
J9 J CAVE KARST STUD
JI J. Cave Karst Stud.
PD APR
PY 2012
VL 74
IS 1
BP 116
EP 126
DI 10.4311/2011JCKS0213
PG 11
WC Geosciences, Multidisciplinary
SC Geology
GA 980GH
UT WOS:000306881100011
OA Bronze
DA 2021-01-25
ER

PT J
AU Leschner, S
   Deyneko, IV
   Lienenklaus, S
   Wolf, K
   Bloecker, H
   Bumann, D
   Loessner, H
   Weiss, S
AF Leschner, Sara
   Deyneko, Igor V.
   Lienenklaus, Stefan
   Wolf, Kathrin
   Bloecker, Helmut
   Bumann, Dirk
   Loessner, Holger
   Weiss, Siegfried
TI Identification of tumor-specific Salmonella Typhimurium promoters and
   their regulatory logic
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID ENTERICA SEROVAR TYPHIMURIUM; METASTATIC MELANOMA; TARGETED SALMONELLA;
   GENE-EXPRESSION; PHASE-I; CANCER; THERAPY
AB Conventional cancer therapies are often limited in effectiveness and exhibit strong side effects. Therefore, alternative therapeutic strategies are demanded. The employment of tumor-colonizing bacteria that exert anticancer effects is such a novel approach that attracts increasing attention. For instance, Salmonella enterica serovar Typhimurium has been used in many animal tumor models as well as in first clinical studies. These bacteria exhibit inherent tumoricidal effects. In addition, they can be used to deliver therapeutic agents. However, bacterial expression has to be restricted to the tumor to prevent toxic substances from harming healthy tissue. Therefore, we screened an S. Typhimurium promoter-trap library to identify promoters that exclusively drive gene expression in the cancerous tissue. Twelve elements could be detected that show reporter gene expression in tumors but not in spleen and liver. In addition, a DNA motif was identified that appears to be necessary for tumor specificity. Now, such tumor-specific promoters can be used to safely express therapeutic proteins by tumor-colonizing S. Typhimurium directly in the neoplasia.
C1 [Leschner, Sara; Deyneko, Igor V.; Lienenklaus, Stefan; Wolf, Kathrin; Bloecker, Helmut; Loessner, Holger; Weiss, Siegfried] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.
   [Bumann, Dirk] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Loessner, Holger] Paul Ehrlich Inst, Vet Dept, D-63225 Langen, Germany.
RP Leschner, S (corresponding author), Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany.
EM sara.leschner@helmholtz-hzi.de
RI Deyneko, Igor/K-7872-2019
OI Lienenklaus, Stefan/0000-0003-4790-3445
FU Federal Ministry of Education and Research (BMBF)Federal Ministry of
   Education & Research (BMBF); Deutsche Krebshilfe, the German Research
   Council (DFG); Helmholtz Gemeinschaft via HIRSIB; Hannover Biomedical
   Research School (HBRS); Helmholtz Centre for Infection Research
FX Federal Ministry of Education and Research (BMBF) (in part); Deutsche
   Krebshilfe, the German Research Council (DFG); Helmholtz Gemeinschaft
   via HIRSIB; Hannover Biomedical Research School (HBRS). Funding for open
   access charge: Helmholtz Centre for Infection Research.
CR Allen CA, 2008, ADV EXP MED BIOL, V635, P93, DOI 10.1007/978-0-387-09550-9_8
   Arrach N, 2008, CANCER RES, V68, P4827, DOI 10.1158/0008-5472.CAN-08-0552
   Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28
   Barbe S, 2006, J APPL MICROBIOL, V101, P571, DOI 10.1111/j.1365-2672.2006.02886.x
   Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x
   Bumann D, 2007, NAT PROTOC, V2, P770, DOI 10.1038/nprot.2007.78
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Crull K, 2011, CELL MICROBIOL, V13, P1223, DOI 10.1111/j.1462-5822.2011.01612.x
   Dolgin E, 2011, NAT MED, V17, P273, DOI 10.1038/nm0311-273
   Forbes NS, 2003, CANCER RES, V63, P5188
   Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24
   Heimann DM, 2003, J IMMUNOTHER, V26, P179, DOI 10.1097/00002371-200303000-00011
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143
   Leschner S, 2010, J MOL MED, V88, P763, DOI 10.1007/s00109-010-0636-z
   Leschner S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006692
   Liu F, 2010, CELL CYCLE, V9, P4518, DOI 10.4161/cc.9.22.13744
   Loessner H, 2007, CELL MICROBIOL, V9, P1529, DOI 10.1111/j.1462-5822.2007.00890.x
   Pawelek JM, 1997, CANCER RES, V57, P4537
   Thamm DH, 2005, CLIN CANCER RES, V11, P4827, DOI 10.1158/1078-0432.CCR-04-2510
   Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.2002.20.1.142
   Trebichavsky I, 2010, NUTR REV, V68, P459, DOI 10.1111/j.1753-4887.2010.00305.x
   Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984
   Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c
   Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102
   Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104
   Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716
NR 27
TC 27
Z9 30
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR
PY 2012
VL 40
IS 7
BP 2984
EP 2994
DI 10.1093/nar/gkr1041
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 930TQ
UT WOS:000303164400022
PM 22140114
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Grad, S
   Loparic, M
   Peter, R
   Stolz, M
   Aebi, U
   Alini, M
AF Grad, S.
   Loparic, M.
   Peter, R.
   Stolz, M.
   Aebi, U.
   Alini, M.
TI Sliding motion modulates stiffness and friction coefficient at the
   surface of tissue engineered cartilage
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE Articular cartilage; Functional tissue engineering; Atomic force
   microscopy; Stiffness; Friction; Lubricin
ID ATOMIC-FORCE MICROSCOPY; BOVINE ARTICULAR-CARTILAGE; SUPERFICIAL ZONE
   PROTEIN; GENE-EXPRESSION; POLYURETHANE SCAFFOLDS; FUNCTIONAL-PROPERTIES;
   ELASTIC-MODULUS; SYNOVIAL-FLUID; CHONDROCYTES; INDENTATION
AB Objective: Functional cartilage tissue engineering aims to generate grafts with a functional surface, similar to that of authentic cartilage. Bioreactors that stimulate cell-scaffold constructs by simulating natural joint movements hold great potential to generate cartilage with adequate surface properties. In this study two methods based on atomic force microscopy (AFM) were applied to obtain information about the quality of engineered graft surfaces. For better understanding of the molecule function relationships, AFM was complemented with immunohistochemistry.
   Methods: Bovine chondrocytes were seeded into polyurethane scaffolds and subjected to dynamic compression, applied by a ceramic ball, for 1 h daily [loading group 1 (LG1)]. In loading group 2 (LG2), the ball additionally oscillated over the scaffold, generating sliding surface motion. After 3 weeks, the surfaces of the engineered constructs were analyzed by friction force and indentation-type AFM (IT-AFM).
   Results were complemented and compared to immunohistochemical analyses. Results: The loading type significantly influenced the mechanical and histological outcomes. Constructs of LG2 exhibited lowest friction coefficient and highest micro- and nanostiffness. Collagen type II and aggrecan staining were readily observed in all constructs and appeared to reach deeper areas in loaded (LG1, LG2) compared to unloaded scaffolds. Lubricin was specifically detected at the top surface of LG2.
   Conclusions: This study proposes a quantitative AFM-based functional analysis at the micrometer- and nanometer scale to evaluate'the quality of cartilage surfaces. Mechanical testing (load-bearing) combined with friction analysis (gliding) can provide important information. Notably, sliding-type biomechanical stimuli may favor (re-)generation and maintenance of functional articular surfaces and support the development of mechanically competent engineered cartilage. (C) 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 [Grad, S.; Peter, R.; Alini, M.] AO Res Inst Davos, CH-7270 Davos, Switzerland.
   [Loparic, M.; Aebi, U.] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4003 Basel, Switzerland.
   [Stolz, M.] Univ Southampton, Sch Engn Sci, NCATS, Southampton SO9 5NH, Hants, England.
RP Grad, S (corresponding author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM sibylle.grad@aofoundation.org
RI Alini, Mauro/AAG-7961-2020
OI Stolz, Martin/0000-0002-0732-0811
CR Basalo IM, 2006, J BIOMECH ENG-T ASME, V128, P131, DOI 10.1115/1.2133764
   Bastiaansen-Jenniskens YM, 2008, OSTEOARTHR CARTILAGE, V16, P359, DOI 10.1016/j.joca.2007.07.003
   Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025
   Bian LM, 2010, TISSUE ENG PT A, V16, P1781, DOI [10.1089/ten.tea.2009.0482, 10.1089/ten.TEA.2009.0482]
   Blain EJ, 2007, FRONT BIOSCI-LANDMRK, V12, P507, DOI 10.2741/2078
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465
   Chan SMT, 2010, OSTEOARTHR CARTILAGE, V18, P956, DOI 10.1016/j.joca.2010.03.012
   Coles JM, 2008, J BIOMECH, V41, P541, DOI 10.1016/j.jbiomech.2007.10.013
   Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436
   Desrochers J, 2010, J BIOMECH, V43, P3091, DOI 10.1016/j.jbiomech.2010.08.009
   Elders MJ, 2000, J RHEUMATOL, V27, P6
   Eyre DR, 2004, CLIN ORTHOP RELAT R, pS118, DOI 10.1097/01.blo.0000144855.48640.b9
   Flannery CR, 1999, BIOCHEM BIOPH RES CO, V254, P535, DOI 10.1006/bbrc.1998.0104
   Fratzl P., 2008, COLLAGEN STRUCTURE M
   Gorna K, 2006, J BIOMED MATER RES A, V79A, P128, DOI 10.1002/jbm.a.30708
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   Grad S, 2005, TISSUE ENG, V11, P249, DOI 10.1089/ten.2005.11.249
   Grad S, 2006, BIORHEOLOGY, V43, P259
   Grad S, 2006, TISSUE ENG, V12, P3171, DOI 10.1089/ten.2006.12.3171
   Green CP, 2004, REV SCI INSTRUM, V75, P1988, DOI 10.1063/1.1753100
   Greene GW, 2011, P NATL ACAD SCI USA, V108, P5255, DOI 10.1073/pnas.1101002108
   Hedlund H, 1999, J BIOL CHEM, V274, P5777, DOI 10.1074/jbc.274.9.5777
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   Hunter CJ, 2004, OSTEOARTHR CARTILAGE, V12, P117, DOI 10.1016/j.joca.2003.08.009
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814
   Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791
   Imer R, 2009, ARCH HISTOL CYTOL, V72, P251, DOI 10.1679/aohc.72.251
   Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104
   Jay GD, 2001, J ORTHOPAED RES, V19, P677, DOI 10.1016/S0736-0266(00)00040-1
   Jay GD, 2007, ARTHRITIS RHEUM-US, V56, P3662, DOI 10.1002/art.22974
   Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325
   Katta J, 2008, P I MECH ENG H, V222, P1, DOI 10.1243/09544119JEIM325
   Kelly TAN, 2008, ANN BIOMED ENG, V36, P769, DOI 10.1007/s10439-008-9476-1
   Kisiday JD, 2004, J BIOMECH, V37, P595, DOI 10.1016/j.jbiomech.2003.10.005
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P430, DOI 10.1115/1.2720924
   Liu WH, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2745733
   Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013
   McFarland R, GUIDANCE IND PREPARA
   Milz S, 2007, J ANAT, V211, P1, DOI 10.1111/j.1469-7580.2007.00742.x
   Milz S, 2006, J ANAT, V208, P671, DOI 10.1111/j.1469-7580.2006.00552.x
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Park S, 2009, P I MECH ENG H, V223, P339, DOI 10.1243/09544119JEIM516
   Plodinec M, 2011, J STRUCT BIOL, V174, P476, DOI 10.1016/j.jsb.2011.03.011
   Preiss-Bloom O, 2009, ARTIF ORGANS, V33, P318, DOI 10.1111/j.1525-1594.2009.00723.x
   Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613
   Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446
   Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   Stoddart MJ, 2009, REGEN MED, V4, P81, DOI 10.2217/17460751.4.1.81
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]
   Strobel S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2942
   Tischer T, 2002, J HISTOCHEM CYTOCHEM, V50, P955, DOI 10.1177/002215540205000709
   Wachsmuth L, 2006, HISTOL HISTOPATHOL, V21, P477, DOI 10.14670/HH-21.477
   Wimmer MA, 2004, TISSUE ENG, V10, P1436, DOI 10.1089/ten.2004.10.1436
NR 58
TC 33
Z9 34
U1 2
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
EI 1522-9653
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD APR
PY 2012
VL 20
IS 4
BP 288
EP 295
DI 10.1016/j.joca.2011.12.010
PG 8
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 926LU
UT WOS:000302833300007
PM 22285735
OA Bronze
DA 2021-01-25
ER

PT J
AU Barbato, A
   Benkert, P
   Schwede, T
   Tramontano, A
   Kosinski, J
AF Barbato, Alessandro
   Benkert, Pascal
   Schwede, Torsten
   Tramontano, Anna
   Kosinski, Jan
TI Improving your target-template alignment with MODalign
SO BIOINFORMATICS
LA English
DT Article
ID PROTEIN SECONDARY STRUCTURE
AB MODalign is an interactive web-based tool aimed at helping protein structure modelers to inspect and manually modify the alignment between the sequences of a target protein and of its template(s). It interactively computes, displays and, upon modification of the target-template alignment, updates the multiple sequence alignments of the two protein families, their conservation score, secondary structure and solvent accessibility values, and local quality scores of the implied three-dimensional model(s). Although it has been designed to simplify the target-template alignment step in modeling, it is suitable for all cases where a sequence alignment needs to be inspected in the context of other biological information.
C1 [Barbato, Alessandro; Tramontano, Anna; Kosinski, Jan] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy.
   [Benkert, Pascal; Schwede, Torsten] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Benkert, Pascal; Schwede, Torsten] SIB Swiss Inst Bioinformat, Basel, Switzerland.
   [Tramontano, Anna] Univ Roma La Sapienza, Ctr Life Nano Sci Sapienza, Ist Italiano Tecnol, I-00185 Rome, Italy.
RP Kosinski, J (corresponding author), Univ Roma La Sapienza, Dept Phys, Ple A Moro 5, I-00185 Rome, Italy.
EM jan.kosinski@uniroma1.it
RI Schwede, Torsten/A-4650-2008; Kosinski, Jan/V-8540-2019; Tramontano,
   anna/D-5378-2009; Benkert, Pascal/C-3895-2009; Kosinski, Jan/G-9971-2012
OI Schwede, Torsten/0000-0003-2715-335X; Kosinski, Jan/0000-0002-3641-0322;
   Tramontano, anna/0000-0002-5610-3338; 
FU King Abdullah University of Science and Technology (KAUST)King Abdullah
   University of Science & Technology [KUK-I1-012-43]; Fondazione
   RomaFondazione Roma; Italian Ministry of HealthMinistry of Health, Italy
   [onc_ord 25/07]; FIRB PROTEOMICA; European Molecular Biology
   Organization (EMBO)European Molecular Biology Organization (EMBO)
FX KAUST Award No. KUK-I1-012-43 made by King Abdullah University of
   Science and Technology (KAUST), Fondazione Roma, the Italian Ministry of
   Health, Contract No. onc_ord 25/07, FIRB PROTEOMICA, and European
   Molecular Biology Organization (EMBO) long-term fellowship to J.K.
CR Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396
   Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171
   Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
NR 9
TC 9
Z9 10
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
J9 BIOINFORMATICS
JI Bioinformatics
PD APR 1
PY 2012
VL 28
IS 7
BP 1038
EP 1039
DI 10.1093/bioinformatics/bts070
PG 2
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 919CR
UT WOS:000302298900023
PM 22308148
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Petters, T
   Zhang, X
   Nesper, J
   Treuner-Lange, A
   Gomez-Santos, N
   Hoppert, M
   Jenal, U
   Sogaard-Andersen, L
AF Petters, Tobias
   Zhang, Xin
   Nesper, Jutta
   Treuner-Lange, Anke
   Gomez-Santos, Nuria
   Hoppert, Michael
   Jenal, Urs
   Sogaard-Andersen, Lotte
TI The orphan histidine protein kinase SgmT is a c-di-GMP receptor and
   regulates composition of the extracellular matrix together with the
   orphan DNA binding response regulator DigR in Myxococcus xanthus
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID 2-COMPONENT SIGNAL-TRANSDUCTION; BACTERIAL-CELL CYCLE; IV PILUS;
   MULTISTEP PHOSPHORELAY; ESCHERICHIA-COLI; GLIDING MOTILITY;
   PSEUDOMONAS-AERUGINOSA; CHEMOTAXIS HOMOLOGS; SOCIAL MOTILITY; O-ANTIGEN
AB In Myxococcus xanthus the extracellular matrix is essential for type IV pili-dependent motility and starvation-induced fruiting body formation. Proteins of two-component systems including the orphan DNA binding response regulator DigR are essential in regulating the composition of the extracellular matrix. We identify the orphan hybrid histidine kinase SgmT as the partner kinase of DigR. In addition to kinase and receiver domains, SgmT consists of an N-terminal GAF domain and a C-terminal GGDEF domain. The GAF domain is the primary sensor domain. The GGDEF domain binds the second messenger bis-(3'-5')-cyclic-dimeric-GMP (c-di-GMP) and functions as a c-di-GMP receptor to spatially sequester SgmT. We identify the DigR binding site in the promoter of the fibA gene, which encodes an abundant extracellular matrix metalloprotease. Whole-genome expression profiling experiments in combination with the identified DigR binding site allowed the identification of the DigR regulon and suggests that SgmT/DigR regulates the expression of genes for secreted proteins and enzymes involved in secondary metabolite synthesis. We suggest that SgmT/DigR regulates extracellular matrix composition and that SgmT activity is regulated by two sensor domains with ligand binding to the GAF domain resulting in SgmT activation and c-di-GMP binding to the GGDEF domain resulting in spatial sequestration of SgmT.
C1 [Petters, Tobias; Zhang, Xin; Treuner-Lange, Anke; Gomez-Santos, Nuria; Sogaard-Andersen, Lotte] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.
   [Nesper, Jutta; Jenal, Urs] Univ Basel, Biozentrum, CH-4054 Basel, Switzerland.
   [Hoppert, Michael] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany.
RP Sogaard-Andersen, L (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.
EM sogaard@staff.uni-marburg.de
OI Sogaard-Andersen, Lotte/0000-0002-0674-0013; Gomez Santos,
   Nuria/0000-0002-1161-250X
FU Max Planck SocietyMax Planck SocietyFoundation CELLEX
FX We thank Kai Thormann for plasmids, Anna Konovalova for many helpful
   discussions and Stuart Huntley for help with bioinformatics analyses.
   This work was supported by The Max Planck Society.
CR Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018
   Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0
   Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1
   Babu MM, 2003, TRENDS GENET, V19, P75, DOI 10.1016/S0168-9525(02)00039-2
   Begley M, 2009, APPL ENVIRON MICROB, V75, P5451, DOI 10.1128/AEM.00730-09
   BEHMLANDER RM, 1994, J BACTERIOL, V176, P6304, DOI 10.1128/jb.176.20.6304-6311.1994
   BEHMLANDER RM, 1994, J BACTERIOL, V176, P6295, DOI 10.1128/jb.176.20.6295-6303.1994
   Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321
   Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Bowden MG, 1998, MOL MICROBIOL, V30, P275, DOI 10.1046/j.1365-2958.1998.01060.x
   Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220
   Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076
   Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09
   Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187
   Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885
   Curtis PD, 2007, J BACTERIOL, V189, P7634, DOI 10.1128/JB.01007-07
   Dahl JL, 1997, J BIOL CHEM, V272, P1910, DOI 10.1074/jbc.272.3.1910
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131
   Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999
   Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214
   Gronewold TMA, 2001, MOL MICROBIOL, V40, P744, DOI 10.1046/j.1365-2958.2001.02428.x
   Guo DC, 1996, J BACTERIOL, V178, P1631, DOI 10.1128/jb.178.6.1631-1639.1996
   Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   HODGKIN J, 1977, P NATL ACAD SCI USA, V74, P2938, DOI 10.1073/pnas.74.7.2938
   HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004
   Hsu JL, 2008, J BIOL CHEM, V283, P9933, DOI 10.1074/jbc.M708836200
   Huntley S, 2011, MOL BIOL EVOL, V28, P1083, DOI 10.1093/molbev/msq292
   Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098
   KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952
   Kearns DB, 2002, J BACTERIOL, V184, P1678, DOI 10.1128/JB.184.6.1678-1684.2002
   Konovalova A, 2010, FEMS MICROBIOL REV, V34, P89, DOI 10.1111/j.1574-6976.2009.00194.x
   Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050
   Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548
   Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x
   Leonardy S, 2008, MOL BIOSYST, V4, P1009, DOI 10.1039/b806640j
   Li YN, 2003, P NATL ACAD SCI USA, V100, P5443, DOI 10.1073/pnas.0836639100
   Lobedanz S, 2003, GENE DEV, V17, P2151, DOI 10.1101/gad.274203
   LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718
   Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299
   Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0
   Meiser P, 2006, P NATL ACAD SCI USA, V103, P19128, DOI 10.1073/pnas.0606039103
   Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105
   Mignot T, 2007, SCIENCE, V315, P853, DOI 10.1126/science.1137223
   Muller FD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-264
   Nan BY, 2011, P NATL ACAD SCI USA, V108, P2498, DOI 10.1073/pnas.1018556108
   Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106
   Overgaard M, 2006, J BACTERIOL, V188, P4384, DOI 10.1128/JB.00189-06
   Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Rasmussen AA, 2006, MOL MICROBIOL, V60, P525, DOI 10.1111/j.1365-2958.2006.05118.x
   Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Scott KA, 2010, MOL MICROBIOL, V76, P318, DOI 10.1111/j.1365-2958.2010.07095.x
   SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378
   Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334
   Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698
   SogaardAndersen L, 1996, GENE DEV, V10, P740, DOI 10.1101/gad.10.6.740
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519
   Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3
   Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108
   Takeda S, 2001, MOL MICROBIOL, V40, P440, DOI 10.1046/j.1365-2958.2001.02393.x
   Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x
   Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007
   Tucker NP, 2008, J BIOL CHEM, V283, P908, DOI 10.1074/jbc.M705850200
   Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   van Hijum SAFT, 2009, MICROBIOL MOL BIOL R, V73, P481, DOI 10.1128/MMBR.00037-08
   Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Wegener-Feldbrugge S, 2009, J BACTERIOL, V191, P1765, DOI 10.1128/JB.01405-08
   Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2
   Whitworth DE, 2008, MICROBIOL-SGM, V154, P360, DOI 10.1099/mic.0.2007/013672-0
   Wilksch JJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002204
   Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997
   Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200
   Yang ZM, 2000, J BACTERIOL, V182, P5793, DOI 10.1128/JB.182.20.5793-5798.2000
   Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x
   Youderian P, 2006, GENETICS, V172, P1397, DOI 10.1534/genetics.105.050542
NR 92
TC 34
Z9 36
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD APR
PY 2012
VL 84
IS 1
BP 147
EP 165
DI 10.1111/j.1365-2958.2012.08015.x
PG 19
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 915HA
UT WOS:000302013500012
PM 22394314
OA Green Published
DA 2021-01-25
ER

PT J
AU Arnold, AS
   Christe, M
   Handschin, C
AF Arnold, Anne-Sophie
   Christe, Martine
   Handschin, Christoph
TI A Functional Motor Unit in the Culture Dish: Co-culture of Spinal Cord
   Explants and Muscle Cells
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Neuroscience; Issue 62; Human primary muscle cells; embryonic spinal
   cord explants; neurites; innervation; contraction; cell culture
AB Human primary muscle cells cultured aneurally in monolayer rarely contract spontaneously because, in the absence of a nerve component, cell differentiation is limited and motor neuron stimulation is missing1. These limitations hamper the in vitro study of many neuromuscular diseases in cultured muscle cells. Importantly, the experimental constraints of monolayered, cultured muscle cells can be overcome by functional innervation of myofibers with spinal cord explants in co-cultures.
   Here, we show the different steps required to achieve an efficient, proper innervation of human primary muscle cells, leading to complete differentiation and fiber contraction according to the method developed by Askanas(2). To do so, muscle cells are co-cultured with spinal cord explants of rat embryos at ED 13.5, with the dorsal root ganglia still attached to the spinal cord slices. After a few days, the muscle fibers start to contract and eventually become cross-striated through innervation by functional neurites projecting from the spinal cord explants that connecting to the muscle cells. This structure can be maintained for many months, simply by regular exchange of the culture medium.
   The applications of this invaluable tool are numerous, as it represents a functional model for multidisciplinary analyses of human muscle development and innervation. In fact, a complete de novo neuromuscular junction installation occurs in a culture dish, allowing an easy measurement of many parameters at each step, in a fundamental and physiological context.
   Just to cite a few examples, genomic and/or proteomic studies can be performed directly on the co-cultures. Furthermore, pre- and post-synaptic effects can be specifically and separately assessed at the neuromuscular junction, because both components come from different species, rat and human, respectively. The nerve-muscle co-culture can also be performed with human muscle cells isolated from patients suffering from muscle or neuromuscular diseases(3), and thus can be used as a screening tool for candidate drugs. Finally, no special equipment but a regular BSL2 facility is needed to reproduce a functional motor unit in a culture dish. This method thus is valuable for both the muscle as well as the neuromuscular research communities for physiological and mechanistic studies of neuromuscular function, in a normal and disease context.
C1 [Arnold, Anne-Sophie; Christe, Martine; Handschin, Christoph] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Arnold, AS (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM A.Arnold@unibas.ch; Christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF); Swiss Initiative in Systems Biology (SystemsX.ch); Muscular
   Dystrophy Association USA (MDA)Muscular Dystrophy Association;
   Association Francaise contre les Myopathies (AFM)Association Francaise
   contre les Myopathies; United Mitochondrial Disease Foundation (UMDF);
   Gebert-Ruf Foundation Rare Diseases Programme (GRF); Swiss Society for
   Research of the Muscle Diseases (SSEM/FSRMM); Swiss Life
   "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung";
   Roche Research Foundation; University of Basel
FX Our work is supported by the Swiss National Science Foundation (SNF),
   the Swiss Initiative in Systems Biology (SystemsX.ch), the Muscular
   Dystrophy Association USA (MDA), the Association Francaise contre les
   Myopathies (AFM), the United Mitochondrial Disease Foundation (UMDF),
   the Gebert-Ruf Foundation Rare Diseases Programme (GRF), the Swiss
   Society for Research of the Muscle Diseases (SSEM/FSRMM), the Swiss Life
   "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung", the
   Roche Research Foundation and the University of Basel.
CR ASKANAS V, 1975, NEUROLOGY, V25, P58, DOI 10.1212/WNL.25.1.58
   Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015
   BRAUN S, 1995, LANCET, V345, P694, DOI 10.1016/S0140-6736(95)90869-2
   DELAPORTE C, 1986, BIOL CELL, V57, P17, DOI 10.1111/j.1768-322X.1986.tb00460.x
   Dorchies OM, 2001, NEUROMUSCULAR DISORD, V11, P736, DOI 10.1016/S0960-8966(01)00221-8
   Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X
   Guettier-Sigrist S, 2000, EXP CELL RES, V259, P204, DOI 10.1006/excr.2000.4968
   Hsieh-Li HM, 2000, NAT GENET, V24, P66
   KOBAYASHI T, 1987, J NEUROSCI, V7, P3131
   LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3
   McFerrin J, 1998, NEUROREPORT, V9, P3201, DOI 10.1097/00001756-199810050-00013
   Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333
   Schnabel J, 2008, NATURE, V454, P682, DOI 10.1038/454682a
   Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920
   Sleigh JN, 2011, DIS MODEL MECH, V4, P457, DOI 10.1242/dmm.007245
NR 15
TC 11
Z9 11
U1 0
U2 3
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD APR
PY 2012
IS 62
AR e3616
DI 10.3791/3616
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36PG
UT WOS:000209222900019
PM 22525799
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Aceto, N
   Sausgruber, N
   Brinkhaus, H
   Gaidatzis, D
   Martiny-Baron, G
   Mazzarol, G
   Confalonieri, S
   Quarto, M
   Hu, G
   Balwierz, PJ
   Pachkov, M
   Elledge, SJ
   van Nimwegen, E
   Stadler, MB
   Bentires-Alj, M
AF Aceto, Nicola
   Sausgruber, Nina
   Brinkhaus, Heike
   Gaidatzis, Dimos
   Martiny-Baron, Georg
   Mazzarol, Giovanni
   Confalonieri, Stefano
   Quarto, Micaela
   Hu, Guang
   Balwierz, Piotr J.
   Pachkov, Mikhail
   Elledge, Stephen J.
   van Nimwegen, Erik
   Stadler, Michael B.
   Bentires-Alj, Mohamed
TI Tyrosine phosphatase SHP2 promotes breast cancer progression and
   maintains tumor-initiating cells via activation of key transcription
   factors and a positive feedback signaling loop
SO NATURE MEDICINE
LA English
DT Article
ID IN-VITRO PROPAGATION; STEM-CELL; MYELOID-LEUKEMIA; DUCTAL CARCINOMA;
   NOONAN-SYNDROME; PROTEIN; GENE; DIFFERENTIATION; METASTASIS; MUTATIONS
AB New cancer therapies are likely to arise from an in-depth understanding of the signaling networks influencing tumor initiation, progression and metastasis. We show a fundamental role for Src-homology 2 domain-containing phosphatase 2 (SHP2) in these processes in human epidermal growth factor receptor 2 (HER2)-positive and triple-negative breast cancers. Knockdown of SHP2 eradicated breast tumor-initiating cells in xenograft models, and SHP2 depletion also prevented invasion in three-dimensional cultures and in a transductal invasion assay in vivo. Notably, SHP2 knockdown in established breast tumors blocked their growth and reduced metastasis. Mechanistically, SHP2 activated stemness-associated transcription factors, including v-myc myelocytomatosis viral oncogene homolog (c-Myc) and zinc finger E-box binding homeobox 1 (ZEB1), which resulted in the repression of let-7 microRNA and the expression of a set of 'SHP2 signature' genes. We found these genes to be simultaneously activated in a large subset of human primary breast tumors that are associated with invasive behavior and poor prognosis. These results provide new insights into the signaling cascades influencing tumor-initiating cells as well as a rationale for targeting SHP2 in breast cancer.
C1 [Aceto, Nicola; Sausgruber, Nina; Brinkhaus, Heike; Gaidatzis, Dimos; Stadler, Michael B.; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland.
   [Martiny-Baron, Georg] Novartis Inst Biomed Res, Basel, Switzerland.
   [Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela] Fdn Ist FIRC Oncol Mol IFOM, Milan, Italy.
   [Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela] IEO, Milan, Italy.
   [Hu, Guang; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet,Med Sch, Boston, MA 02115 USA.
   [Hu, Guang; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Dept Genet, Div Genet,Med Sch, Boston, MA 02115 USA.
   [Balwierz, Piotr J.; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland.
   [Balwierz, Piotr J.; Pachkov, Mikhail; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland.
RP Bentires-Alj, M (corresponding author), Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland.
EM bentires@fmi.ch
RI Confalonieri, Stefano/AAQ-6786-2020; Hu, Guang/B-2909-2012; Hu,
   Guang/E-7474-2016; Balwierz, Piotr J/AAG-4187-2020; Mohamed,
   Bentires-Alj/F-4484-2015; Aceto, Nicola/O-2484-2014
OI Confalonieri, Stefano/0000-0001-6886-9851; Hu,
   Guang/0000-0002-8754-1541; Hu, Guang/0000-0003-0437-4723; Balwierz,
   Piotr J/0000-0002-1548-4605; Mohamed, Bentires-Alj/0000-0001-6344-1127;
   Aceto, Nicola/0000-0001-9579-6918; van Nimwegen,
   Erik/0000-0001-6338-1312
FU Novartis Research Foundation; European Research Council (ERC)European
   Research Council (ERC) [243211-PTPsBDC]; Swiss Cancer League; Krebsliga
   Beider Basel; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Environmental Health
   Sciences (NIEHS) [ZIAES102745, ZIAES102745, ZIAES102745, ZIAES102745,
   ZIAES102745, ZIAES102745, ZIAES102745, ZIAES102745, ZIAES102745] Funding
   Source: NIH RePORTER
FX We thank N. Hynes (FMI) and G. Christofori (University of Basel) for
   helpful comments on the manuscript, S. Gasser, W. Filipowicz, H.
   Grosshans, J. Krol (FMI) and R.B. Clarke (Manchester University) for
   helpful discussions, W. Xian (in the lab of J. Brugge, Harvard Medical
   School) and D. Medina (Baylor College of Medicine) for help with the
   intraductal protocol, T. Westbrook (Baylor College of Medicine) for
   providing the dox-inducible lentiviral vector, C. Kuperwasser (Tufts
   University) for providing the SUM159 and SUM1315 cells, V. Reddy (GNF)
   for providing the primary breast tumor, and A. Terrier (Novartis
   Institutes for Biomedical Research) for excellent technical assistance,
   as well as additional members of the Bentires-Alj lab for advice and
   discussions and various colleagues for reagents. We also thank the
   International Genomics Consortium and expO (http://www.intgen.org/expo/)
   for offering free access to clinically annotated tumor data. Research in
   the lab of M.B.-A. is supported by the Novartis Research Foundation, the
   European Research Council (ERC starting grant 243211-PTPsBDC), the Swiss
   Cancer League and the Krebsliga Beider Basel.
CR Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100
   Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358
   Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341
   Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923
   Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x
   Bocanegra M, 2010, ONCOGENE, V29, P774, DOI 10.1038/onc.2009.364
   Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021
   Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y
   Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106
   Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741
   Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
   Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2
   Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277
   Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x
   Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803
   Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140
   Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982
   Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014
   Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1
   Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147
   Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028
   Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014
   Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000
   Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5
   Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007
   Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622
   Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837
   Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325
   Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005
   Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626
   Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018
   Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837
   Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007
   Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610
   Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372
   Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000
   Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212
   Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772
   Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156
   Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267
   Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509
   Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040
   Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350
   Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087
   Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1
   Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998
   Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045
   Zhan Y, 2009, EXP CELL RES, V315, P2343, DOI 10.1016/j.yexcr.2009.05.001
   Zhou X, 2008, HISTOPATHOLOGY, V53, P389, DOI 10.1111/j.1365-2559.2008.03103.x
NR 51
TC 161
Z9 171
U1 0
U2 37
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
J9 NAT MED
JI Nat. Med.
PD APR
PY 2012
VL 18
IS 4
BP 529
EP 537
DI 10.1038/nm.2645
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 923KI
UT WOS:000302617800029
PM 22388088
DA 2021-01-25
ER

PT J
AU Hardwick, SW
   Gubbey, T
   Hug, I
   Jenal, U
   Luisi, BF
AF Hardwick, Steven W.
   Gubbey, Tobias
   Hug, Isabelle
   Jenal, Urs
   Luisi, Ben F.
TI Crystal structure of Caulobacter crescentus polynucleotide phosphorylase
   reveals a mechanism of RNA substrate channelling and RNA degradosome
   assembly
SO OPEN BIOLOGY
LA English
DT Article
DE polynucleotide phosphorylase; RNA degradosome; Caulobacter crescentus;
   RNA-protein interactions; molecular ratchet; conformational asymmetry
ID ESCHERICHIA-COLI; RIBOSOMAL-RNA; MESSENGER-RNA; PNPASE; DOMAIN;
   POLYMERIZATION; PHOSPHOROLYSIS; DEGRADATION; REFINEMENT; EXPRESSION
AB Polynucleotide phosphorylase (PNPase) is an exoribonuclease that cleaves single-stranded RNA substrates with 3'-5' directionality and processive behaviour. Its ring-like, trimeric architecture creates a central channel where phosphorolytic active sites reside. One face of the ring is decorated with RNA-binding K-homology (KH) and S1 domains, but exactly how these domains help to direct the 3' end of single-stranded RNA substrates towards the active sites is an unsolved puzzle. Insight into this process is provided by our crystal structures of RNA-bound and apo Caulobacter crescentus PNPase. In the RNA-free form, the S1 domains adopt a 'splayed' conformation that may facilitate capture of RNA substrates. In the RNA-bound structure, the three KH domains collectively close upon the RNA and direct the 3' end towards a constricted aperture at the entrance of the central channel. The KH domains make non-equivalent interactions with the RNA, and there is a marked asymmetry within the catalytic core of the enzyme. On the basis of these data, we propose that structural non-equivalence, induced upon RNA binding, helps to channel substrate to the active sites through mechanical ratcheting. Structural and biochemical analyses also reveal the basis for PNPase association with RNase E in the multi-enzyme RNA degradosome assembly of the alpha-proteobacteria.
C1 [Hardwick, Steven W.; Gubbey, Tobias; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.
   [Hug, Isabelle; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Luisi, BF (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.
EM bfl20@mole.bio.cam.ac.uk
OI Hardwick, Steven/0000-0001-9246-1864; Hug, Isabelle/0000-0002-4524-9569
FU Wellcome TrustWellcome Trust
FX The authors are supported by the Wellcome Trust. We thank the staff of
   Diamond Light Source for use of facilities and help with data
   collection. We thank Martyn Symmons for stimulating discussions and
   Zbyszek Pietras for preparing the molecular graphics movies. We thank A.
   J. Carpousis, Kenny McDowall, Martyn Symmons, Martin Moncrieffe and
   Kiyoshi Nagai for critical reading of the manuscript.
CR Andrade JM, 2008, RNA, V14, P543, DOI 10.1261/rna.683308
   Awano N, 2008, J BACTERIOL, V190, P5924, DOI 10.1128/JB.00500-08
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427
   Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9
   Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100
   Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099
   De Lay N, 2011, RNA, V17, P1172, DOI 10.1261/rna.2531211
   Del Favero M, 2008, J BIOL CHEM, V283, P27355, DOI 10.1074/jbc.C800113200
   Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Fernandez-Ramirez F, 2010, BIOCHIMIE, V92, P445, DOI 10.1016/j.biochi.2010.01.004
   Garcia-Mena J, 1999, MOL MICROBIOL, V33, P235, DOI 10.1046/j.1365-2958.1999.01451.x
   Gatewood ML, 2010, J BACTERIOL, V192, P4275, DOI 10.1128/JB.00367-10
   GODEFROY T, 1970, EUR J BIOCHEM, V14, P222, DOI 10.1111/j.1432-1033.1970.tb00281.x
   GODEFROY T, 1970, EUR J BIOCHEM, V12, P236, DOI 10.1111/j.1432-1033.1970.tb00843.x
   Hardwick SW, 2011, NUCLEIC ACIDS RES, V39, P1449, DOI 10.1093/nar/gkq928
   Hartung S, 2010, NUCLEIC ACIDS RES, V38, P5166, DOI 10.1093/nar/gkq238
   Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I
   Leszczyniecka M, 2002, P NATL ACAD SCI USA, V99, P16636, DOI 10.1073/pnas.252643699
   Lin CL, 2012, NUCLEIC ACIDS RES, V40, P4146, DOI 10.1093/nar/gkr1281
   Marchive C, 2009, PLANT PHYSIOL, V151, P905, DOI 10.1104/pp.109.145144
   McAdams HH, 2009, FEBS LETT, V583, P3984, DOI 10.1016/j.febslet.2009.09.030
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mohanty BK, 2000, MOL MICROBIOL, V36, P982, DOI 10.1046/j.1365-2958.2000.01921.x
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Ng CL, 2010, ACTA CRYSTALLOGR D, V66, P522, DOI 10.1107/S0907444910002908
   Nurmohamed S, 2011, J BIOL CHEM, V286, P14315, DOI 10.1074/jbc.M110.200741
   Nurmohamed S, 2009, J MOL BIOL, V389, P17, DOI 10.1016/j.jmb.2009.03.051
   Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1
   Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762
   Shi ZH, 2008, RNA, V14, P2361, DOI 10.1261/rna.1244308
   Siculella L, 2010, MOL MICROBIOL, V77, P716, DOI 10.1111/j.1365-2958.2010.07240.x
   Slomovic S, 2008, RNA, V14, P310, DOI 10.1261/rna.697308
   Stickney LM, 2005, J BACTERIOL, V187, P7214, DOI 10.1128/JB.187.21.7214-7221.2005
   Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5
   Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9
   Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x
   Viegas SC, 2007, NUCLEIC ACIDS RES, V35, P7651, DOI 10.1093/nar/gkm916
   Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605
   Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035
   Wurtmann EJ, 2010, P NATL ACAD SCI USA, V107, P4022, DOI 10.1073/pnas.1000307107
   Yang J, 2008, J BACTERIOL, V190, P3774, DOI 10.1128/JB.00147-08
   Ygberg SE, 2006, INFECT IMMUN, V74, P1243, DOI 10.1128/IAI.74.2.1243-1254.2006
NR 45
TC 33
Z9 33
U1 0
U2 9
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2046-2441
J9 OPEN BIOL
JI Open Biol
PD APR
PY 2012
VL 2
AR 120028
DI 10.1098/rsob.120028
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 983IE
UT WOS:000307112200002
PM 22724061
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Maguire, C
   Sieben, JM
   Erzer, F
   Goepfert, B
   Frank, M
   Ferber, G
   Jehn, M
   Schmidt-Trucksass, A
   de Bie, RA
AF Maguire, Clare
   Sieben, Judith M.
   Erzer, Florian
   Goepfert, Beat
   Frank, Matthias
   Ferber, Georg
   Jehn, Melissa
   Schmidt-Trucksaess, Arno
   de Bie, Robert A.
TI How to improve walking, balance and social participation following
   stroke: a comparison of the long term effects of two walking aids-canes
   and an orthosis TheraTogs-on the recovery of gait following acute
   stroke. A study protocol for a multi-centre, single blind, randomised
   control trial
SO BMC NEUROLOGY
LA English
DT Article
ID INDUCED MOVEMENT THERAPY; MOTOR RECOVERY; IMPACT SCALE; GO TEST;
   REHABILITATION; RELIABILITY; MECHANISMS; PEOPLE; PLASTICITY; VALIDITY
AB Background: Annually, some 9000 people in Switzerland suffer a first time stroke. Of these 60% are left with moderate to severe walking disability. Evidence shows that rehabilitation techniques which emphasise activity of the hemiplegic side increase ipsilesional cortical plasticity and improve functional outcomes. Canes are commonly used in gait rehabilitation although they significantly reduce hemiplegic muscle activity. We have shown that an orthosis "TheraTogs" (a corset with elasticated strapping) significantly increases hemiplegic muscle activity during gait. The aim of the present study is to investigate the long term effects on the recovery of gait, balance and social participation of gait rehabilitation with TheraTogs compared to gait rehabilitation with a cane following first time acute stroke.
   Methods/Design: Multi-centre, single blind, randomised trial with 120 patients after first stroke. When subjects have reached Functional Ambulation Category 3 they will be randomly allocated into TheraTogs or cane group. TheraTogs will be applied to support hip extensor and abductor musculature according to a standardised procedure. Cane walking held at the level of the radial styloid of the sound wrist. Subjects will walk throughout the day with only the assigned walking aid. Standard therapy treatments and usual care will remain unchanged and documented. The intervention will continue for five weeks or until patients have reached Functional Ambulation category 5. Outcome measures will be assessed the day before begin of intervention, the day after completion, 3 months, 6 months and 2 years. Primary outcome: Timed "up and go" test, secondary outcomes: peak surface EMG of gluteus maximus and gluteus medius, activation patterns of hemiplegic leg musculature, temporospatial gait parameters, hemiplegic hip kinematics in the frontal and sagittal planes, dynamic balance, daily activity measured by accelerometry, Stroke Impact Scale. Significance levels will be 5% with 95% CI's. Intention To Treat analyses will be performed. Descriptive statistics will be presented.
   Discussion: This study could have significant implications for the clinical practice of gait rehabilitation after stroke, particularly the effect and appropriate use of walking aids.
   The results could be important for the development of clinical guidelines and for the socio-economic costs of post-stroke care
C1 [Maguire, Clare] Bildungszentrum Gesundheit Basel Stadt, CH-4142 Basel, Switzerland.
   [Maguire, Clare] Bern Univ Appl Sci, CH-4142 Basel, Switzerland.
   [Sieben, Judith M.] Maastricht Univ, Dept Anat & Embryol, Caphri Res Sch, NL-6200 MD Maastricht, Netherlands.
   [Erzer, Florian] Rehab Basel, CH-4012 Basel, Switzerland.
   [Goepfert, Beat] Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
   [Frank, Matthias] Felix Platter Hosp, Geriatr Competence Ctr, CH-4055 Basel, Switzerland.
   [Ferber, Georg] Stat Georg Ferber GmbH, CH-4125 Riehen, Switzerland.
   [Jehn, Melissa; Schmidt-Trucksaess, Arno] Univ Basel, Dept Sports Med, Inst Exercise & Hlth Sci, CH-4052 Basel, Switzerland.
   [de Bie, Robert A.] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands.
RP Maguire, C (corresponding author), Bildungszentrum Gesundheit Basel Stadt, Binningerstr 2, CH-4142 Basel, Switzerland.
EM clare.maguire@bzgbs.ch
RI Schmidt-Trucksass, Arno/I-7673-2015
OI Schmidt-Trucksass, Arno/0000-0002-4662-3911
FU Physiotherapy Science Trust (PTW Stiftung) of Switzerland
FX We would like to thank the Physiotherapy Science Trust (PTW Stiftung) of
   Switzerland for the awarding of 25,000 CHF Prize to support this
   project. No further external funding has been provided.
CR Ajemian S, 2004, ARCH PHYS MED REHAB, V85, P1966, DOI 10.1016/j.apmr.2004.04.037
   Allum JHJ, 2005, CURR OPIN NEUROL, V18, P15, DOI 10.1097/00019052-200502000-00005
   Allum JHJ, 2002, GAIT POSTURE, V16, P264, DOI 10.1016/S0966-6362(02)00011-5
   Andersson AG, 2006, J REHABIL MED, V38, P186, DOI 10.1080/16501970500478023
   Asplund K, 1997, BMJ-BRIT MED J, V314, P1151
   Bischoff-Ferrari HA, 2006, OSTEOPOROSIS INT, V17, P656, DOI 10.1007/s00198-005-0030-9
   Buurke JH, 2005, GAIT POSTURE, V22, P164, DOI 10.1016/j.gaitpost.2004.09.003
   Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091
   Cheeran B, 2009, NEUROREHAB NEURAL RE, V23, P97, DOI 10.1177/1545968308326636
   Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131
   Enzinger C, 2008, STROKE, V39, P1507, DOI 10.1161/STROKEAHA.107.501999
   Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0
   Fenter PC, 2003, BRIT J SPORT MED, V37, P331, DOI 10.1136/bjsm.37.4.331
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Geschwindner HM, 2007, SWISS MED WKLY, V137, P205
   Hakkennes S, 2005, AUST J PHYSIOTHER, V51, P221, DOI 10.1016/S0004-9514(05)70003-9
   Hamzat TK, 2008, EUR J PHYS REHAB MED, V44, P121
   Hermens HJ, 1999, EUROPEAN RECOMMENDAT
   Heung THM, 2009, J REHABIL MED, V41, P719, DOI 10.2340/16501977-0411
   HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35
   Huang VS, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-5
   Indredavik B, 2008, STROKE, V39, P414, DOI 10.1161/STROKEAHA.107.489294
   Jehn M, 2009, J CARD FAIL, V15, P334, DOI 10.1016/j.cardfail.2008.11.011
   Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223
   Kautz SA, 2005, NEUROREHAB NEURAL RE, V19, P250, DOI 10.1177/1545968305279279
   Kim CM, 2004, GAIT POSTURE, V20, P140, DOI 10.1016/j.gaitpost.2003.07.002
   Kollen B, 2005, STROKE, V36, P2676, DOI 10.1161/01.STR.0000190839.29234.50
   Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281
   Lai SM, 2003, STROKE, V34, P488, DOI 10.1161/01.STR.0000054162.94998.C0
   Langhorne P, 2001, STROKE, V32, P268, DOI 10.1161/01.STR.32.1.268
   Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4
   Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017
   Maguire C, 2010, CLIN REHABIL, V24, P37, DOI 10.1177/0269215509342335
   Maki BE, 2007, J NEURAL TRANSM, V114, P1279, DOI 10.1007/s00702-007-0764-y
   Mochizuki G, 2009, NEUROSCI LETT, V451, P40, DOI 10.1016/j.neulet.2008.12.020
   Neumann DA, 1999, PHYS THER, V79, P1163, DOI 10.1093/ptj/79.12.1163
   Neumann DA, 1999, PHYS THER, V79, P1175, DOI 10.1093/ptj/79.12.1175
   Neumann DA, 1998, PHYS THER, V78, P490, DOI 10.1093/ptj/78.5.490
   Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011
   Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004
   Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2
   Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070
   Nudo RJ, 1996, J NEUROSCI, V16, P785
   OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014
   Richards LG, 2008, NEUROPSYCHOLOGIA, V46, P3, DOI 10.1016/j.neuropsychologia.2007.08.013
   Rossini P M, 2007, Eura Medicophys, V43, P241
   Rossini PM, 2000, BRAIN RES REV, V33, P131, DOI 10.1016/S0169-328X(00)00090-5
   Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588
   van de Port IGL, 2006, STROKE, V37, P167, DOI 10.1161/01.STR.0000195180.69904.f2
   Walker C, 2000, PHYS THER, V80, P886, DOI 10.1093/ptj/80.9.886
   Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844
   Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095
   Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4
NR 53
TC 11
Z9 13
U1 0
U2 22
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD MAR 30
PY 2012
VL 12
AR 18
DI 10.1186/1471-2377-12-18
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA 937OQ
UT WOS:000303668200001
PM 22462692
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Sun, L
   Edelmann, FT
   Kaiser, CJO
   Papsdorf, K
   Gaiser, AM
   Richter, K
AF Sun, Li
   Edelmann, Franziska T.
   Kaiser, Christoph J. O.
   Papsdorf, Katharina
   Gaiser, Andreas M.
   Richter, Klaus
TI The Lid Domain of Caenorhabditis elegans Hsc70 Influences ATP Turnover,
   Cofactor Binding and Protein Folding Activity
SO PLOS ONE
LA English
DT Article
ID MOLECULAR CHAPERONE DNAK; ESCHERICHIA-COLI DNAJ; HEAT-SHOCK PROTEINS;
   INDUCED CONFORMATIONAL-CHANGES; NUCLEOTIDE EXCHANGE FACTOR; HSP70
   MULTIGENE FAMILY; SUBSTRATE-BINDING; ALLOSTERIC REGULATION; INTERDOMAIN
   LINKER; CRYSTAL-STRUCTURE
AB Hsc70 is a conserved ATP-dependent molecular chaperone, which utilizes the energy of ATP hydrolysis to alter the folding state of its client proteins. In contrast to the Hsc70 systems of bacteria, yeast and humans, the Hsc70 system of C. elegans (CeHsc70) has not been studied to date. We find that CeHsc70 is characterized by a high ATP turnover rate and limited by post-hydrolysis nucleotide exchange. This rate-limiting step is defined by the helical lid domain at the C-terminus. A certain truncation in this domain (CeHsc70-D545) reduces the turnover rate and renders the hydrolysis step rate-limiting. The helical lid domain also affects cofactor affinities as the lidless mutant CeHsc70-D512 binds more strongly to DNJ-13, forming large protein complexes in the presence of ATP. Despite preserving the ability to hydrolyze ATP and interact with its cofactors DNJ-13 and BAG-1, the truncation of the helical lid domain leads to the loss of all protein folding activity, highlighting the requirement of this domain for the functionality of the nematode's Hsc70 protein.
C1 Tech Univ Munich, CIPSM, D-8046 Garching, Germany.
   Tech Univ Munich, Dept Chem, D-8046 Garching, Germany.
RP Sun, L (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM klaus.richter@ch.tum.de
RI Kaiser, Christoph JO/C-5609-2013; Richter, Klaus/A-2673-2010
OI Kaiser, Christoph JO/0000-0002-8481-6845; Richter,
   Klaus/0000-0002-8952-9642; Edelmann, Franziska/0000-0002-4391-1432
FU Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG)
   [RI1873/1-1]
FX This study was funded by a grant of the Deutsche Forschungsgemeinschaft
   to KR (DFG-grant RI1873/1-1). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033
   Aponte RA, 2010, J MOL BIOL, V399, P154, DOI 10.1016/j.jmb.2010.03.060
   Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200
   Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106
   Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871
   Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985
   Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588
   BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903
   Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200
   Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200
   Chesnokova LS, 2003, BIOCHEMISTRY-US, V42, P9028, DOI 10.1021/bi0346493
   CRAIG EA, 1984, CELL, V38, P841, DOI 10.1016/0092-8674(84)90279-4
   CRAIG EA, 1989, MOL CELL BIOL, V9, P3000, DOI 10.1128/MCB.9.7.3000
   Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481
   Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005
   Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200
   FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x
   Gaiser AM, 2009, J MOL BIOL
   Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485
   Gaiser AM, 2010, J BIOL CHEM, V285, P40921, DOI 10.1074/jbc.M110.131086
   Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229
   Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200
   Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108
   GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902
   Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2
   Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8
   Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431
   Hayes DB, 2010, MACROMOL BIOSCI, V10, P731, DOI 10.1002/mabi.201000075
   HESCHL MFP, 1990, COMP BIOCHEM PHYS B, V96, P633, DOI 10.1016/0305-0491(90)90206-9
   Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209
   Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022
   Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028
   JORDAN R, 1995, J BIOL CHEM, V270, P4563, DOI 10.1074/jbc.270.9.4563
   Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278
   Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941
   Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236
   Knarr G, 2002, J MOL BIOL, V318, P611, DOI 10.1016/S0022-2836(02)00166-3
   Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452
   LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874
   Lopez-Buesa P, 1998, P NATL ACAD SCI USA, V95, P15253, DOI 10.1073/pnas.95.26.15253
   Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970
   Mayer MP, 2000, NAT STRUCT BIOL, V7, P586
   Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6
   Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844
   MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284
   Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617
   Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776
   MORSHAUSER RC, 1995, BIOCHEMISTRY-US, V34, P6261, DOI 10.1021/bi00019a001
   Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321
   Nollen EAA, 2001, J BIOL CHEM, V276, P4677, DOI 10.1074/jbc.M009745200
   Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101
   Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l
   PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719
   Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072
   Popp S, 2005, J MOL BIOL, V347, P1039, DOI 10.1016/j.jmb.2005.02.026
   Popp SL, 2009, FEBS LETT, V583, P573, DOI 10.1016/j.febslet.2008.12.062
   Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200
   Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016
   Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036
   Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006
   SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x
   Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2
   Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200
   Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v
   Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200
   Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268
   STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y
   Strub A, 2003, J MOL BIOL, V334, P1087, DOI 10.1016/j.jmb.2003.10.023
   Stuart JK, 1998, J BIOL CHEM, V273, P22506, DOI 10.1074/jbc.273.35.22506
   Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415
   Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534
   Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223
   Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020
   Symersky J, 2004, ACTA CRYSTALLOGR D, V60, P1606, DOI [10.1107/S0907444904017603, 10.1107/S0907444904017605]
   SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345
   Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887
   Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200
   Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200
   Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200
   WALL D, 1994, J BIOL CHEM, V269, P5446
   Wang H, 1998, BIOCHEMISTRY-US, V37, P7929, DOI 10.1021/bi9800855
   WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307
   WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19300, DOI 10.1074/jbc.270.33.19300
   Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200
   Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157
   WELCH WJ, 1982, J BIOL CHEM, V257, P4949
   WIECH H, 1993, J BIOL CHEM, V268, P7414
   Wittung-Stafshede P, 2003, BIOCHEMISTRY-US, V42, P4937, DOI 10.1021/bi027333o
   Worrall LJ, 2007, BIOCHEM BIOPH RES CO, V357, P105, DOI 10.1016/j.bbrc.2007.03.107
   Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/O09-175, 10.1139/o09-175]
   Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492
   Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606
NR 92
TC 13
Z9 16
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 29
PY 2012
VL 7
IS 3
AR e33980
DI 10.1371/journal.pone.0033980
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 948SR
UT WOS:000304523400046
PM 22479492
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Li-Blatter, XC
   Beck, A
   Seelig, A
AF Li-Blatter, Xiaochun
   Beck, Andreas
   Seelig, Anna
TI P-Glycoprotein-ATPase Modulation: The Molecular Mechanisms
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID BRAIN-BARRIER PERMEATION; LIPID-MEMBRANES; MULTIDRUG TRANSPORTER;
   BINDING; DETERGENTS; BILAYERS; DRUGS; THERMODYNAMICS; INTERFACE;
   PRESSURE
AB P-glycoprotein-ATPase is an efflux transporter of broad specificity that counteracts passive allocrit influx. Understanding the rate of allocrit transport therefore matters. Generally, the rates of allocrit transport and ATP hydrolysis decrease exponentially with increasing allocrit affinity to the transporter. Here we report unexpectedly strong down-modulation of the P-glycoprotein-ATPase by certain detergents. To elucidate the underlying mechanism, we chose 34 electrically neutral and cationic detergents with different hydrophobic and hydrophilic characteristics. Measurement of the P-glycoprotein-ATPase activity as a function of concentration showed that seven detergents activated the ATPase as expected, whereas 27 closely related detergents reduced it significantly. Assessment of the free energy of detergent partitioning into the lipid membrane and the free energy of detergent binding from the membrane to the transporter revealed that the ratio, q, of the two free energies of binding determined the rate of ATP hydrolysis. Neutral (cationic) detergents with a ratio of q = 2.7 +/- 0.2 (q > 3) followed the aforementioned exponential dependence. Small deviations from the optimal ratio strongly reduced the rates of ATP hydrolysis and flopping, respectively, whereas larger deviations led to an absence of interaction with the transporter. P-glycoprotein-ATPase inhibition due to membrane disordering by detergents could be fully excluded using H-2-NMR-spectroscopy. Similar principles apply to modulating drugs.
C1 [Li-Blatter, Xiaochun; Beck, Andreas; Seelig, Anna] Univ Basel, Biozentrum, Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM anna.seelig@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-129701]
FX This work was supported by the Swiss National Science Foundation (Grant
   No. 31003A-129701).
CR Aanismaa P, 2008, BIOCHEMISTRY-US, V47, P10197, DOI 10.1021/bi800209h
   Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Akhtar N, 2011, EXPERT OPIN THER PAT, V21, P561, DOI 10.1517/13543776.2011.561784
   Al-Shawi MK, 2005, J BIOENERG BIOMEMBR, V37, P489, DOI 10.1007/s10863-005-9497-5
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361
   Beck A, 2010, J PHYS CHEM B, V114, P15862, DOI 10.1021/jp107088d
   BESCHIASCHVILI G, 1992, BIOCHEMISTRY-US, V31, P10044, DOI 10.1021/bi00156a026
   Blatter XL, 2010, BIOPHYS J, V99, P3589, DOI 10.1016/j.bpj.2010.10.033
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5
   DOIGE CA, 1993, BIOCHIM BIOPHYS ACTA, V1146, P65, DOI 10.1016/0005-2736(93)90339-2
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   FROMHERZ P, 1975, REV SCI INSTRUM, V46, P1380, DOI 10.1063/1.1134025
   Gannon MK, 2009, J MED CHEM, V52, P3328, DOI 10.1021/jm900253g
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 2008, Q REV BIOPHYS, V41, P205, DOI 10.1017/S0033583508004721
   HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A
   Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Meier M, 2006, BIOPHYS J, V91, P2943, DOI 10.1529/biophysj.106.089581
   Meier M, 2010, BIOPHYS J, V98, P1529, DOI 10.1016/j.bpj.2009.12.4286
   Nervi P, 2010, BBA-BIOMEMBRANES, V1798, P515, DOI 10.1016/j.bbamem.2009.11.022
   Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200
   Orlowski S, 1998, Cancer Biochem Biophys, V16, P85
   Sauna ZE, 2004, BIOCHEMISTRY-US, V43, P2262, DOI 10.1021/bi035965k
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   Seelig A., 2009, DRUG BIOAVAILABILITY, V40, P497
   SEELIG A, 2003, DRUG BIOAVAILABILITY, P461
   Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y
   Seelig A, 2006, EXPERT OPIN DRUG MET, V2, P733, DOI 10.1517/17425255.2.5.733
   SEELIG J, 1980, Q REV BIOPHYS, V13, P19, DOI 10.1017/S0033583500000305
   SEELIG J, 1991, BIOCHEMISTRY-US, V30, P9354, DOI 10.1021/bi00102a031
   Wenk MR, 1997, BIOPHYS J, V73, P2565, DOI 10.1016/S0006-3495(97)78285-7
   Wenk MR, 1997, BIOPHYS J, V72, P1719, DOI 10.1016/S0006-3495(97)78818-0
   Zolnerciks JK, 2011, ESSAYS BIOCHEM, V50, P43, DOI [10.1042/BSE0500043, 10.1042/bse0500043]
NR 39
TC 31
Z9 33
U1 0
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD MAR 21
PY 2012
VL 102
IS 6
BP 1383
EP 1393
DI 10.1016/j.bpj.2012.02.018
PG 11
WC Biophysics
SC Biophysics
GA 913WF
UT WOS:000301907400017
PM 22455921
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Vukojevic, V
   Gschwind, L
   Vogler, C
   Demougin, P
   de Quervain, DJF
   Papassotiropoulos, A
   Stetak, A
AF Vukojevic, Vanja
   Gschwind, Leo
   Vogler, Christian
   Demougin, Philippe
   de Quervain, Dominique J-F
   Papassotiropoulos, Andreas
   Stetak, Attila
TI A role for alpha-adducin (ADD-1) in nematode and human memory
SO EMBO JOURNAL
LA English
DT Article
DE actin cytoskeleton; adducin; C. elegans; episodic memory; glutamate
ID LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; SPECTRIN-ACTIN
   COMPLEXES; MARCKS-RELATED DOMAIN; CAENORHABDITIS-ELEGANS; DENDRITIC
   SPINES; C-ELEGANS; GLUTAMATE-RECEPTOR; BETA-ADDUCIN; SYNAPTIC PLASTICITY
AB Identifying molecular mechanisms that underlie learning and memory is one of the major challenges in neuroscience. Taken the advantages of the nematode Caenorhabditis elegans, we investigated alpha-adducin (add-1) in aversive olfactory associative learning and memory. Loss of add-1 function selectively impaired short- and long-term memory without causing acquisition, sensory, or motor deficits. We showed that alpha-adducin is required for consolidation of synaptic plasticity, for sustained synaptic increase of AMPA-type glutamate receptor (GLR-1) content and altered GLR-1 turnover dynamics. ADD-1, in a splice-form- and tissue-specific manner, controlled the storage of memories presumably through actin-capping activity. In support of the C. elegans results, genetic variability of the human ADD1 gene was significantly associated with episodic memory performance in healthy young subjects. Finally, human ADD1 expression in nematodes restored loss of C. elegans add-1 gene function. Taken together, our findings support a role for alpha-adducin in memory from nematodes to humans. Studying the molecular and genetic underpinnings of memory across distinct species may be helpful in the development of novel strategies to treat memory-related diseases.
C1 [Vukojevic, Vanja; Demougin, Philippe; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Life Sci Training Facil, Dept Biozentrum, CH-4056 Basel, Switzerland.
   [Vukojevic, Vanja; Gschwind, Leo; Vogler, Christian; Demougin, Philippe; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Div Mol Neurosci, Dept Psychol, CH-4056 Basel, Switzerland.
   [Gschwind, Leo; de Quervain, Dominique J-F] Univ Basel, Div Cognit Neurosci, Dept Psychol, CH-4056 Basel, Switzerland.
   [Vogler, Christian; de Quervain, Dominique J-F; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Univ Psychiat Clin, CH-4056 Basel, Switzerland.
RP Papassotiropoulos, A (corresponding author), Univ Basel, Life Sci Training Facil, Dept Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM andreas.papas@unibas.ch; a.stetak@unibas.ch
OI Vogler, Christian/0000-0003-3922-109X; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; de Quervain, Dominique/0000-0001-7131-2464;
   Vukojevic, Vanja/0000-0001-5303-9492
FU Swiss National Science Foundation (SNSF) SinergiaSwiss National Science
   Foundation (SNSF) [CRSIKO_122691, CRSI33_130080]; European Union (ADAMS
   [242257, FP7-HEALTH-2009]; Werner Siemens Foundation; Biozentrum
FX We thank Anne Spang and Jean Pieters for generously sharing methods,
   reagents, and instruments. We also like to thank the National
   Bioresource Project, Japan and the Caenorhabditis Genetic Center
   (supported by NIH-NCRR) for providing nematode strains. This work was
   supported in part by the Swiss National Science Foundation (SNSF)
   Sinergia Grants CRSIKO_122691 and CRSI33_130080 (DQ and AP). This work
   was also part of the National Centre of Competence in Research (NCCR)
   Synapsy and of the 7th framework program of the European Union (ADAMS,
   project number 242257, FP7-HEALTH-2009) (DQ and AP). VV was supported by
   the Werner Siemens Foundation PhD grant and Opportunities for Excellence
   PhD Program of the Biozentrum.
CR BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H
   Bednarek E, 2011, NEURON, V69, P1132, DOI 10.1016/j.neuron.2011.02.034
   BENNETT V, 1988, J BIOL CHEM, V263, P5860
   BRENNER S, 1974, GENETICS, V77, P71
   Cassata G, 2000, GENESIS, V27, P141, DOI 10.1002/1526-968X(200008)27:4<141::AID-GENE20>3.0.CO;2-K
   CHALFIE M, 1985, J NEUROSCI, V5, P956
   Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007
   Citterio L, 2003, BIOCHEM BIOPH RES CO, V309, P359, DOI 10.1016/j.bbrc.2003.08.011
   COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4
   COWAN AE, 1985, CELL, V41, P923, DOI 10.1016/S0092-8674(85)80073-8
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H
   Earnshaw BA, 2006, J NEUROSCI, V26, P12362, DOI 10.1523/JNEUROSCI.3601-06.2006
   FLANAGAN MD, 1980, J BIOL CHEM, V255, P835
   Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026
   Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347
   GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0
   GOLDSTEIN B, 1995, DEVELOPMENT, V121, P1227
   Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025
   HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0
   Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013
   HUGHES CA, 1995, J BIOL CHEM, V270, P18990, DOI 10.1074/jbc.270.32.18990
   Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372
   Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542
   Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797
   Kuhara A, 2006, J NEUROSCI, V26, P9355, DOI 10.1523/JNEUROSCI.0517-06.2006
   Kuhlman PA, 1996, J BIOL CHEM, V271, P7986, DOI 10.1074/jbc.271.14.7986
   Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101
   Lang P., 2008, A8 U FLOR
   Li W, 1996, LEARN MEMORY, V2, P320, DOI 10.1101/lm.2.6.320
   Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329
   Lisman J, 2006, SCI STKE, V2006, pre11, DOI DOI 10.1126/STKE.3562006RE11
   MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4
   Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485
   Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157
   Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731
   Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617
   Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754
   Mehren JE, 2004, J NEUROSCI, V24, P10584, DOI 10.1523/JNEUROSCI.3560-04.2004
   MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x
   MISCHE SM, 1987, J CELL BIOL, V105, P2837, DOI 10.1083/jcb.105.6.2837
   Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111
   Mori I, 2007, CURR OPIN NEUROBIOL, V17, P712, DOI 10.1016/j.conb.2007.11.010
   Morrison GE, 2001, BEHAV NEUROSCI, V115, P640, DOI 10.1037//0735-7044.115.3.640
   Morrison GE, 1997, BEHAV NEUROSCI, V111, P564, DOI 10.1037/0735-7044.111.3.564
   NAKAZAWA H, 1995, NEUROSCIENCE, V69, P585, DOI 10.1016/0306-4522(95)00293-R
   Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699
   Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311
   Phair RD, 2004, METHOD ENZYMOL, V375, P393
   Pielage J, 2011, NEURON, V69, P1114, DOI 10.1016/j.neuron.2011.02.007
   Porro F, 2010, GENES BRAIN BEHAV, V9, P84, DOI 10.1111/j.1601-183X.2009.00537.x
   Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005
   Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305
   Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1
   Rose JK, 2003, J NEUROSCI, V23, P9595
   Saeki S, 2001, J EXP BIOL, V204, P1757
   Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X
   SEGAL DS, 1971, SCIENCE, V172, P82, DOI 10.1126/science.172.3978.82
   Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010
   SQUIRE LR, 1970, NATURE, V225, P649, DOI 10.1038/225649a0
   Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019
   Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463
   Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024
   Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686
NR 64
TC 25
Z9 27
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD MAR 21
PY 2012
VL 31
IS 6
BP 1453
EP 1466
DI 10.1038/emboj.2012.14
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 916VP
UT WOS:000302131600011
PM 22307086
OA Green Published
DA 2021-01-25
ER

PT J
AU Dieni, S
   Matsumoto, T
   Dekkers, M
   Rauskolb, S
   Ionescu, MS
   Deogracias, R
   Gundelfinger, ED
   Kojima, M
   Nestel, S
   Frotscher, M
   Barde, YA
AF Dieni, Sandra
   Matsumoto, Tomoya
   Dekkers, Martijn
   Rauskolb, Stefanie
   Ionescu, Mihai S.
   Deogracias, Ruben
   Gundelfinger, Eckart D.
   Kojima, Masami
   Nestel, Sigrun
   Frotscher, Michael
   Barde, Yves-Alain
TI BDNF and its pro-peptide are stored in presynaptic dense core vesicles
   in brain neurons
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID FACTOR MESSENGER-RNA; ACTIVITY-DEPENDENT SECRETION; LONG-TERM
   POTENTIATION; NEUROTROPHIC FACTOR; MOSSY FIBER; SYNAPTIC PLASTICITY;
   ULTRASTRUCTURAL-LOCALIZATION; DENDRITIC TRAFFICKING; STRUCTURAL
   PLASTICITY; VAL66MET POLYMORPHISM
AB Although brain-derived neurotrophic factor (BDNF) regulates numerous and complex biological processes including memory retention, its extremely low levels in the mature central nervous system have greatly complicated attempts to reliably localize it. Using rigorous specificity controls, we found that antibodies reacting either with BDNF or its pro-peptide both stained large dense core vesicles in excitatory presynaptic terminals of the adult mouse hippocampus. Both moieties were similar to 10-fold more abundant than pro-BDNF. The lack of postsynaptic localization was confirmed in Bassoon mutants, a seizure-prone mouse line exhibiting markedly elevated levels of BDNF. These findings challenge previous conclusions based on work with cultured neurons, which suggested activity-dependent dendritic synthesis and release of BDNF. They instead provide an ultrastructural basis for an anterograde mode of action of BDNF, contrasting with the long-established retrograde model derived from experiments with nerve growth factor in the peripheral nervous system.
C1 [Matsumoto, Tomoya; Dekkers, Martijn; Rauskolb, Stefanie; Ionescu, Mihai S.; Deogracias, Ruben; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Dieni, Sandra; Nestel, Sigrun; Frotscher, Michael] Univ Freiburg, Dept Neuroanat, Inst Anat & Cell Biol, D-79104 Freiburg, Germany.
   [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany.
   [Kojima, Masami] Natl Inst Adv Ind Sci & Technol, Biointerface Res Grp, Hlth Res Inst, Ikeda, Osaka 5638577, Japan.
   [Kojima, Masami] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Deogracias, Ruben/I-5751-2015
OI Deogracias, Ruben/0000-0002-9279-7867; Barde, Yves/0000-0002-7627-461X
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [31003A_ 124902/1]; German Research FoundationGerman Research Foundation
   (DFG) [SFB 780, A4]; Alexander von Humboldt FoundationAlexander von
   Humboldt Foundation; Grants-in-Aid for Scientific ResearchMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [22500305] Funding Source: KAKEN
FX This work was supported by the Swiss National Foundation (31003A_
   124902/1), the German Research Foundation (SFB 780, project A4), and a
   Postdoctoral Research Fellowship (to S. Dieni) from the Alexander von
   Humboldt Foundation. M. Frotscher is a Senior Research Professor of the
   Hertie Foundation.
CR Adachi N, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-42
   Agassandian K, 2006, BRAIN RES, V1076, P78, DOI 10.1016/j.brainres.2006.01.009
   Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885
   Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6
   Amaral D, 2006, HIPPOCAMPUS BOOK, P37, DOI DOI 10.1093/ACPROF:OSO/9780195100273.001.0001
   An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045
   Angenstein F, 2007, CEREB CORTEX, V17, P28, DOI 10.1093/cercer/bhj121
   Avwenagha O, 2006, NEUROSCIENCE, V140, P913, DOI 10.1016/j.neuroscience.2006.02.056
   Baj G, 2011, P NATL ACAD SCI USA, V108, P16813, DOI 10.1073/pnas.1014168108
   Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004
   Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137
   Bischofberger J, 2006, PFLUG ARCH EUR J PHY, V453, P361, DOI 10.1007/s00424-006-0093-2
   Brigadski T, 2005, J NEUROSCI, V25, P7601, DOI 10.1523/JNEUROSCI.1776-05.2005
   BURGIN KE, 1990, J NEUROSCI, V10, P1788
   Calabrese F, 2007, NEUROPSYCHOPHARMACOL, V32, P2351, DOI 10.1038/sj.npp.1301360
   Cathomas F, 2010, INT J NEUROPSYCHOPH, V13, P975, DOI 10.1017/S1461145710000519
   Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027
   Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005
   CHENG PY, 1995, J NEUROSCI, V15, P5976
   Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106
   Conner JM, 1997, J NEUROSCI, V17, P2295
   Danzer SC, 2004, J NEUROSCI, V24, P11346, DOI 10.1523/JNEUROSCI.3846-04.2004
   Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315
   Diez M, 2003, EUR J NEUROSCI, V18, P3218, DOI 10.1111/j.1460-9568.2003.02994.x
   DUGICHDJORDJEVIC MM, 1995, EUR J NEUROSCI, V7, P1831, DOI 10.1111/j.1460-9568.1995.tb00703.x
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0
   Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432
   Frotscher M, 2000, CEREB CORTEX, V10, P946, DOI 10.1093/cercor/10.10.946
   Galimberti I, 2006, NEURON, V50, P749, DOI 10.1016/j.neuron.2006.04.026
   Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016
   GALL C, 1986, EXP BRAIN RES, V62, P431
   Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017
   Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550
   Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887
   Haubensak W, 1998, J CELL SCI, V111, P1483
   Heyden A, 2011, CELL TISSUE RES, V346, P11, DOI 10.1007/s00441-011-1233-3
   HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x
   ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q
   Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034
   JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8
   KAREY KP, 1989, ANAL BIOCHEM, V178, P255, DOI 10.1016/0003-2697(89)90634-9
   Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032
   Kerr AM, 2008, NEURON, V57, P5, DOI 10.1016/j.neuron.2007.12.015
   Kojima M, 2001, J NEUROSCI RES, V64, P1, DOI 10.1002/jnr.1080
   Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x
   KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856
   Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27
   Lang SB, 2007, J NEUROSCI, V27, P1097, DOI 10.1523/JNEUROSCI.3590-06.2007
   Lavebratt C, 2006, NEUROBIOL DIS, V24, P374, DOI 10.1016/j.nbd.2006.07.018
   LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0
   Li Y, 2010, J NEUROPHYSIOL, V103, P2846, DOI 10.1152/jn.01140.2009
   LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734
   Louhivuori V, 2011, NEUROBIOL DIS, V41, P469, DOI 10.1016/j.nbd.2010.10.018
   Luo XG, 2001, NEUROSCI RES, V39, P377, DOI 10.1016/S0168-0102(00)00238-8
   LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6
   Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009
   Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038
   Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525
   Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9
   Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786
   Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336
   Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3
   Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295
   Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010
   Rekart JL, 2007, LEARN MEMORY, V14, P416, DOI 10.1101/lm.516507
   Salio C, 2007, DEV NEUROBIOL, V67, P326, DOI 10.1002/dneu.20358
   Scharfman HE, 2002, J COMP NEUROL, V454, P424, DOI 10.1002/cne.10449
   SchmidtKastner R, 1996, NEUROSCIENCE, V74, P161, DOI 10.1016/0306-4522(96)00093-0
   Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864
   Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7
   Tongiorgi E, 2004, J NEUROSCI, V24, P6842, DOI 10.1523/JNEUROSCI.5471-03.2004
   Tongiorgi E, 1997, J NEUROSCI, V17, P9492
   Vezzani A, 1999, NEUROSCIENCE, V90, P1445, DOI 10.1016/S0306-4522(98)00553-3
   WETMORE C, 1991, P NATL ACAD SCI USA, V88, P9843, DOI 10.1073/pnas.88.21.9843
   Wu YC, 2011, J NEUROCHEM, V116, P1112, DOI 10.1111/j.1471-4159.2010.07166.x
   Wu YJ, 2004, J NEUROSCI RES, V75, P825, DOI 10.1002/jnr.20048
   Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6
   Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244
   ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x
   Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9
   Zhao S., 2012, J COMP NEUR IN PRESS
   Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x
   Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009
NR 84
TC 173
Z9 173
U1 0
U2 21
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD MAR 19
PY 2012
VL 196
IS 6
BP 775
EP 788
DI 10.1083/jcb.201201038
PG 14
WC Cell Biology
SC Cell Biology
GA 913NO
UT WOS:000301884900011
PM 22412021
OA Green Accepted, Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Huang, JR
   Gabel, F
   Jensen, MR
   Grzesiek, S
   Blackledge, M
AF Huang, Jie-rong
   Gabel, Frank
   Jensen, Malene Ringkjobing
   Grzesiek, Stephan
   Blackledge, Martin
TI Sequence-Specific Mapping of the Interaction between Urea and Unfolded
   Ubiquitin from Ensemble Analysis of NMR and Small Angle Scattering Data
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID RESIDUAL DIPOLAR COUPLINGS; INTRINSICALLY DISORDERED PROTEINS;
   MOLECULAR-DYNAMICS SIMULATIONS; PARTIALLY FOLDED PROTEINS; FORCE-FIELDS;
   DENATURED UBIQUITIN; X-RAY; HYDRATION DYNAMICS; HYDROGEN-BONDS;
   BETA-HAIRPIN
AB The molecular details of how urea interacts with, and eventually denatures proteins, remain largely unknown. In this study we have used extensive experimental NMR data, in combination with statistical coil ensemble modeling and small-angle scattering, to analyze the conformational behavior of the protein ubiquitin in the presence of urea. In order to develop an atomic resolution understanding of the denatured state, conformational ensembles of full-atom descriptions of unfolded proteins, including side chain conformations derived from rotamer libraries, are combined with random sampling of explicit urea molecules in interaction with the protein. Using this description of the conformational equilibrium, we demonstrate that the direct-binding model of urea to the protein backbone is compatible with available experimental data. We find that, in the presence of 8 M urea, between 30 and 40% of the backbone peptide groups bind a urea molecule, independently reproducing results from a model-free analysis of small-angle neutron and X-ray scattering data. Crucially, this analysis also provides sequence specific details of the interaction between urea and the protein backbone. The pattern of urea-binding along the amino-acid sequence reveals a higher level of binding in the central part of the protein, a trend which resembles independent results derived from chemical shift mapping of the urea protein interaction. Together these results substantiate the direct-binding model and provide a framework for studying the physical basis of interactions between proteins and solvent molecules.
C1 [Huang, Jie-rong; Gabel, Frank; Jensen, Malene Ringkjobing; Blackledge, Martin] CEA, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France.
   [Huang, Jie-rong; Gabel, Frank; Jensen, Malene Ringkjobing; Blackledge, Martin] CNRS, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France.
   [Huang, Jie-rong; Gabel, Frank; Jensen, Malene Ringkjobing; Blackledge, Martin] UJF Grenoble 1, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France.
   [Grzesiek, Stephan] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Blackledge, M (corresponding author), CEA, Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble, France.
EM martin.blackledge@ibs.fr
RI Huang, Jie-rong/O-3661-2019; Huang, Jie-rong/B-4222-2009
OI Huang, Jie-rong/0000-0003-3674-2228; Grzesiek,
   Stephan/0000-0003-1998-4225; Gabel, Frank/0000-0003-3446-2601; Jensen,
   Malene R./0000-0003-0419-2196
FU Agence National de Recherche from TAUSTRUCT - ANR MALZFrench National
   Research Agency (ANR); Proteindisorder - ANR JCJCFrench National
   Research Agency (ANR); National Science Council of TaiwanMinistry of
   Science and Technology, Taiwan [NSC98-2917-I-564-155]; SNF [31-132857]
FX We would like to acknowledge the Agence National de Recherche for
   financial support from TAUSTRUCT - ANR MALZ 2010 (to M.B.),
   Proteindisorder - ANR JCJC 2010 (M.R.J.), National Science Council of
   Taiwan NSC98-2917-I-564-155 (to J.-r.H.), and SNF grant 31-132857 to
   S.G. We would like to acknowledge the ESRF for SAXS beam-time on ID14-3
   in the framework of an IBS Block Allocation Group and Dr. Adam Round
   (local contact).
CR Almarza J, 2009, BIOCHEMISTRY-US, V48, P7608, DOI 10.1021/bi9007116
   Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Bernado P, 2009, BIOPHYS J, V97, P2839, DOI 10.1016/j.bpj.2009.08.044
   Berteotti A, 2011, J AM CHEM SOC, V133, P17200, DOI 10.1021/ja202849a
   Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696
   Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t
   Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154
   Caflisch A, 1999, STRUCT FOLD DES, V7, P477, DOI 10.1016/S0969-2126(99)80064-1
   Canchi DR, 2010, J AM CHEM SOC, V132, P2338, DOI 10.1021/ja909348c
   Cantor C.R., 2012, BIOPHYSICAL CHEM
   Chen X, 2007, J AM CHEM SOC, V129, P15104, DOI 10.1021/ja075034m
   Das A, 2009, J PHYS CHEM B, V113, P12816, DOI 10.1021/jp906350s
   Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s
   Eberini I, 2011, J MOL GRAPH MODEL, V30, P24, DOI 10.1016/j.jmgm.2011.06.004
   Esteban-Martin S, 2010, J AM CHEM SOC, V132, P4626, DOI 10.1021/ja906995x
   Eyal E, 2004, J COMPUT CHEM, V25, P712, DOI 10.1002/jcc.10420
   Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002
   Fitzkee NC, 2005, PROTEINS, V58, P852, DOI 10.1002/prot.20394
   Gabel F, 2009, J AM CHEM SOC, V131, P8769, DOI 10.1021/ja9013248
   Gong H, 2008, P NATL ACAD SCI USA, V105, P3321, DOI 10.1073/pnas.0712240105
   Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164
   Halle B, 2004, PHILOS T R SOC B, V359, P1207, DOI 10.1098/rstb.2004.1499
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   Hua L, 2008, P NATL ACAD SCI USA, V105, P16928, DOI 10.1073/pnas.0808427105
   Huang JR, 2010, J AM CHEM SOC, V132, P694, DOI 10.1021/ja907974m
   Jensen MR, 2008, J AM CHEM SOC, V130, P8055, DOI 10.1021/ja801332d
   Jensen MR, 2010, J AM CHEM SOC, V132, P1270, DOI 10.1021/ja909973n
   Jensen MR, 2009, STRUCTURE, V17, P1169, DOI 10.1016/j.str.2009.08.001
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   Klimov DK, 2004, P NATL ACAD SCI USA, V101, P14760, DOI 10.1073/pnas.0404570101
   Kokubo H, 2011, J AM CHEM SOC, V133, P1849, DOI 10.1021/ja1078128
   Latypov RF, 2009, BIOCHEMISTRY-US, V48, P10934, DOI 10.1021/bi901570k
   LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8
   Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898
   Lim WK, 2009, P NATL ACAD SCI USA, V106, P2595, DOI 10.1073/pnas.0812588106
   Lindorff-Larsen K, 2004, J AM CHEM SOC, V126, P3291, DOI 10.1021/ja039250g
   Lipsitz RS, 2002, J AM CHEM SOC, V124, P10621, DOI 10.1021/ja020676p
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   Markwick PRL, 2009, J AM CHEM SOC, V131, P16968, DOI 10.1021/ja907476w
   Meier S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2838167
   Meier S, 2007, J AM CHEM SOC, V129, P9799, DOI 10.1021/ja0724339
   Meier S, 2007, J AM CHEM SOC, V129, P754, DOI 10.1021/ja067522k
   Moltke S, 1999, J BIOMOL NMR, V15, P77, DOI 10.1023/A:1008309630377
   Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107
   Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159
   Nodet G, 2009, J AM CHEM SOC, V131, P17908, DOI 10.1021/ja9069024
   Nucci NV, 2011, J AM CHEM SOC, V133, P12326, DOI 10.1021/ja202033k
   O'Brien EP, 2007, J AM CHEM SOC, V129, P7346, DOI 10.1021/ja069232+
   Otting G, 1997, PROG NUCL MAG RES SP, V31, P259, DOI 10.1016/S0079-6565(97)00012-5
   OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083
   Porter LL, 2011, P NATL ACAD SCI USA, V108, P109, DOI 10.1073/pnas.1014674107
   PRYOR AW, 1970, ACTA CRYSTALL A-CRYS, VA 26, P543, DOI 10.1107/S0567739470001390
   Salmon L, 2010, J AM CHEM SOC, V132, P8407, DOI 10.1021/ja101645g
   SCHELLMAN JA, 1987, BIOPOLYMERS, V26, P549, DOI 10.1002/bip.360260408
   SCHELLMAN JOHN A., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P223
   Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001
   Sevcsik E, 2011, J AM CHEM SOC, V133, P7152, DOI 10.1021/ja2009554
   Shukla A, 2008, P NATL ACAD SCI USA, V105, P5075, DOI 10.1073/pnas.0711928105
   Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041
   Stumpe MC, 2007, J AM CHEM SOC, V129, P16126, DOI 10.1021/ja076216j
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   TANFORD C, 1964, J AM CHEM SOC, V86, P2050, DOI 10.1021/ja01064a028
   Tobi D, 2003, BIOPOLYMERS, V68, P359, DOI 10.1002/bip.10290
   Vajpai N, 2010, J AM CHEM SOC, V132, P3196, DOI 10.1021/ja910331t
   van Lune F, 2002, J BIOMOL NMR, V23, P169, DOI 10.1023/A:1019877830921
   Vitalis A, 2009, J COMPUT CHEM, V30, P673, DOI 10.1002/jcc.21005
   Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224
   Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105
   Went HM, 2005, PROTEIN ENG DES SEL, V18, P229, DOI 10.1093/protein/gzi025
   Xue Y, 2011, J AM CHEM SOC, V133, P14614, DOI 10.1021/ja201605c
   Zangi R, 2009, J AM CHEM SOC, V131, P1535, DOI 10.1021/ja807887g
   Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908
NR 75
TC 34
Z9 35
U1 1
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAR 7
PY 2012
VL 134
IS 9
BP 4429
EP 4436
DI 10.1021/ja2118688
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 909GL
UT WOS:000301550800083
PM 22309138
DA 2021-01-25
ER

PT J
AU Chan, YW
   Jeyaprakash, AA
   Nigg, EA
   Santamaria, A
AF Chan, Ying Wai
   Jeyaprakash, A. Arockia
   Nigg, Erich A.
   Santamaria, Anna
TI Aurora B controls kinetochore-microtubule attachments by inhibiting Ska
   complex-KMN network interaction
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID SMALL-MOLECULE INHIBITOR; SPINDLE CHECKPOINT; PHOSPHOPROTEOME ANALYSIS;
   OUTER KINETOCHORE; PROTEIN; KINASE; ANAPHASE; PHOSPHORYLATION;
   ORIENTATION; SEPARATION
AB The KMN network (named according to the acronym for KNL1, Mis12, and Ndc80) and the more recently identified Ska complex (Ska1-3) have been shown to mediate kinetochore (KT) microtubule (MT) attachments. How these two complexes cooperate to achieve stable end-on attachments remains unknown. In this paper, we show that Aurora B negatively regulates the localization of the Ska complex to KTs and that recruitment of the Ska complex to KTs depends on the KMN network. We identified interactions between members of the KMN and Ska complexes and demonstrated that these interactions are regulated by Aurora B. Aurora B directly phosphorylated Ska1 and Ska3 in vitro, and expression of phosphomimetic mutants of Ska1 and Ska3 impaired Ska KT recruitment and formation of stable KT-MT fibers (K-fibers), disrupting mitotic progression. We propose that Aurora B phosphorylation antagonizes the interaction between the Ska complex and the KMN network, thereby controlling Ska recruitment to KTs and stabilization of KT-MT attachments.
C1 [Jeyaprakash, A. Arockia] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Jeyaprakash, A. Arockia] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany.
RP Santamaria, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM anna.santamaria@unibas.ch
RI Chan, Ying Wai/P-7347-2019; Arulanandam, Arockia Jeyaprakash/Y-5885-2019
OI Chan, Ying Wai/0000-0002-6196-7675; Arulanandam, Arockia
   Jeyaprakash/0000-0002-1889-8635; nigg, erich/0000-0003-4835-5719
FU Max Planck GesellschaftMax Planck Society; University of Basel and the
   Swiss Cancer League [KFS 02657-08-2010]
FX We thank N.S. Gray, X. Yao, M. Yanagido, S.M. Lens, A. Musacchio, and
   I.M. Cheeseman for reagents, H.H. Sillje, A. Honisch, and A. Wehner for
   initial yeast two-hybrid screens, and T. Glotter for help with the mass
   spectrometry analysis. We also thank T.N. Goitanos and L.L. Fava for
   critical reading of the manuscript and all members of our laboratory for
   insightful discussion. A. Arockia Jeyaprokosh thanks E. Conti for
   support and the Max Planck Gesellschaft for funding.; This work was
   supported by the University of Basel and the Swiss Cancer League (KFS
   02657-08-2010 to A. Santamaria and E.A. Nigg). All authors declare no
   conflict of interest.
CR Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5
   Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167
   Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039
   Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020
   Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032
   Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017
   DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047
   Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091
   Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96
   Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810
   Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012
   Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426
   Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2
   Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975
   Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096
   Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345
   Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021
   Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102
   Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055
   Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006
   Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000
   Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790
   Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007
   Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103
   Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187
   Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047
   Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475
   Raaijmakers JA, 2009, J CELL SCI, V122, P2436, DOI 10.1242/jcs.051912
   Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761
   Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70
   Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036
   Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173
   Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517
   Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457
   Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129
   Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
   Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896
   Theis M, 2009, EMBO J, V28, P1453, DOI 10.1038/emboj.2009.114
   Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142
   Wang EX, 2011, J CELL BIOL, V194, P538, DOI 10.1083/jcb.201103044
   Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034
   Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011
   Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200
NR 46
TC 93
Z9 95
U1 0
U2 14
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD MAR 5
PY 2012
VL 196
IS 5
BP 563
EP 571
DI 10.1083/jcb.201109001
PG 9
WC Cell Biology
SC Cell Biology
GA 906CS
UT WOS:000301323100004
PM 22371557
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Agemark, M
   Kowal, J
   Kukulski, W
   Norden, K
   Gustavsson, N
   Johanson, U
   Engel, A
   Kjellbom, P
AF Agemark, Maria
   Kowal, Julia
   Kukulski, Wanda
   Norden, Kristina
   Gustavsson, Niklas
   Johanson, Urban
   Engel, Andreas
   Kjellbom, Per
TI Reconstitution of water channel function and 2D-crystallization of human
   aquaporin 8
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE Heterologous expression; AQP8; Aquaporin; 2D crystallization
ID CRYSTAL-STRUCTURE; ANGSTROM STRUCTURE; STRUCTURAL BASIS; PROTEIN;
   MEMBRANE; EXPRESSION; PERMEATION; CRYSTALLIZATION; FACILITATE; DIFFUSION
AB Among the thirteen human aquaporins (AQP0-12), the primary structure of AQP8 is unique. By sequence alignment it is evident that mammalian AQP8s form a separate subfamily distinct from the other mammalian aquaporins. The constriction region of the pore determining the solute specificity deviates in AQP8 making it permeable to both ammonia and H2O2 in addition to water. To better understand the selectivity and gating mechanism of aquaporins, high-resolution structures are necessary. So far, the structure of three human aquaporins (HsAQP1, H5AQP4, and HsAQP5) have been solved at atomic resolution. For mammalian aquaporins in general, high-resolution structures are only available for those belonging to the water-specific subfamily (including HsAQP1, HsAQP4 and H5AQP5). Thus, it is of interest to solve structures of other aquaporin subfamily members with different solute specificities. To achieve this the aquaporins need to be overexpressed heterologously and purified. Here we use the methylotrophic yeast Pichia pastoris as a host for the overexpression. A wide screen of different detergents and detergent lipid combinations resulted in the solubilization of functional human AQP8 protein and in well-ordered 2D crystals. It also became evident that removal of amino acids constituting affinity tags was crucial to achieve highly ordered 2D crystals diffracting to 3 angstrom. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Kowal, Julia; Kukulski, Wanda; Engel, Andreas] Univ Basel, Ctr Cellular Imaging & Nano Analyt, Biozentrum, CH-4002 Basel, Switzerland.
   [Agemark, Maria; Norden, Kristina; Gustavsson, Niklas; Johanson, Urban; Kjellbom, Per] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden.
RP Engel, A (corresponding author), Univ Basel, Ctr Cellular Imaging & Nano Analyt, Biozentrum, Mattenstr 26, CH-4002 Basel, Switzerland.
EM ahe13@case.edu; per.kjellbom@biochemistry.lu.se
RI Johanson, Urban/D-4344-2015; Kukulski, Wanda/H-1766-2013; Gustavsson,
   Niklas/D-5712-2011
OI Johanson, Urban/0000-0001-8862-128X; Kowal, Julia/0000-0003-4694-1896
FU Swedish Research Council (VR)Swedish Research Council; Research Council
   FormasSwedish Research Council Formas; Research School in Pharmaceutical
   Sciences (FLAK); Research School in Molecular Protein Science; Royal
   Physiographical SocietyRoyal Society of London; Bokelunds Traveling
   Grant; Swiss National FoundationSwiss National Science Foundation (SNSF)
   [3100A0-108299/2]; National Center of Competence in Structural Biology;
   Marie Curie FellowshipEuropean Union (EU) [MSCF-CT-2005-029458]
FX We thank Adine Karlsson for technical assistance, Nora Eifler for making
   the class average of the single particles and for help with the
   stopped-flow measurements and Maria Ekerot for help with the expression
   system. This work was supported by the Swedish Research Council (VR),
   the Research Council Formas, the Research School in Pharmaceutical
   Sciences (FLAK), the Research School in Molecular Protein Science, the
   Royal Physiographical Society and the Bokelunds Traveling Grant, the
   Swiss National Foundation (grant 3100A0-108299/2 to AE), the National
   Center of Competence in Structural Biology, and a Marie Curie Fellowship
   to JK in the program EMBNTrain (MSCF-CT-2005-029458).
CR BEARDEN JC, 1978, BIOCHIM BIOPHYS ACTA, V533, P525, DOI 10.1016/0005-2795(78)90398-7
   Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200
   Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26
   Calamita G, 2005, J BIOL CHEM, V280, P17149, DOI 10.1074/jbc.C400595200
   Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45
   de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003
   Ferri D, 2003, HEPATOLOGY, V38, P947, DOI 10.1053/jhep.2003.50397
   Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130
   Fotiadis D, 2001, J BIOL CHEM, V276, P1707, DOI 10.1074/jbc.M009383200
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7
   Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001
   Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101
   Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796
   Hedfalk K, 2008, PROTEIN EXPRES PURIF, V59, P69, DOI 10.1016/j.pep.2008.01.004
   Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2
   HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731
   Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081
   Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106
   Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1
   Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105
   Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782
   Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Jiang JS, 2006, J BIOL CHEM, V281, P454, DOI 10.1074/jbc.M508926200
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6
   King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469
   KISTLER J, 1994, J CELL BIOL, V126, P1047, DOI 10.1083/jcb.126.4.1047
   Koyama N, 1998, GENOMICS, V54, P169, DOI 10.1006/geno.1998.5552
   Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee JK, 2005, P NATL ACAD SCI USA, V102, P18932, DOI 10.1073/pnas.0509469102
   Liu K, 2006, BIOL CELL, V98, P153, DOI 10.1042/BC20050026
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Newby ZER, 2008, NAT STRUCT MOL BIOL, V15, P619, DOI 10.1038/nsmb.1431
   Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   PRESTON GM, 1993, J BIOL CHEM, V268, P17
   Saparov S.M., 2007, J BIOL CHEM
   Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   Schenk AD, 2005, J MOL BIOL, V350, P278, DOI 10.1016/j.jmb.2005.04.030
   SEELIG J, 1987, BIOCHEMISTRY-US, V26, P7535, DOI 10.1021/bi00398a001
   Soria LR, 2010, BIOCHEM BIOPH RES CO, V393, P217, DOI 10.1016/j.bbrc.2010.01.104
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Swofford DL, 2000, PAUP PHYLOGENETIC AN
   Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316
   Verkman A. S., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000690
   Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008
   Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101
   Yang BX, 2006, J BIOL CHEM, V281, P16202, DOI 10.1074/jbc.M601864200
   Yang BX, 2005, AM J PHYSIOL-CELL PH, V288, pC1161, DOI 10.1152/ajpcell.00564.2004
   Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134
NR 66
TC 13
Z9 13
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 1879-2642
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD MAR
PY 2012
VL 1818
IS 3
BP 839
EP 850
DI 10.1016/j.bbamem.2011.12.006
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 903XI
UT WOS:000301155600054
PM 22192778
OA Bronze
DA 2021-01-25
ER

PT J
AU Meyer, UA
AF Meyer, U. A.
TI Personalized Medicine: A Personal View
SO CLINICAL PHARMACOLOGY & THERAPEUTICS
LA English
DT Editorial Material
AB Personalized medicine is a strategy to prevent, diagnose, and treat disease so as to achieve an optimal result for the individual. The sequencing of the human genome and other technological advances have revealed the extent of genetic diversity and the relative contribution of genetic and nongenetic factors to human health, disease, and drug response. The challenge is to translate this knowledge into tangible benefits for the patient.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM urs-a.meyer@unibas.ch
CR [Anonymous], 2010, Nature, V467, P1026, DOI 10.1038/4671026a
   [Anonymous], 2011, NATURE, V473, P253
   Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375
   Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7
   Greely HT, 2011, NATURE, V469, P289, DOI 10.1038/469289a
   Meyer UA, 2004, NAT REV GENET, V5, P669, DOI 10.1038/nrg1428
   Mullard A, 2011, NAT REV DRUG DISCOV, V10, P82, DOI 10.1038/nrd3370
NR 7
TC 17
Z9 18
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0009-9236
J9 CLIN PHARMACOL THER
JI Clin. Pharmacol. Ther.
PD MAR
PY 2012
VL 91
IS 3
BP 373
EP 375
DI 10.1038/clpt.2011.238
PG 3
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 895VG
UT WOS:000300524200010
PM 22343810
DA 2021-01-25
ER

PT J
AU Giri, J
   Tang, JM
   Wirth, C
   Peneff, CM
   Eisenberg, B
AF Giri, Janhavi
   Tang, John M.
   Wirth, Christophe
   Peneff, Caroline M.
   Eisenberg, Bob
TI Single-channel measurements of an N-acetylneuraminic acid-inducible
   outer membrane channel in Escherichia coli
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Article
DE NanC; Single channel; E. coli outer; membrane protein; Sialic acid;
   N-acetylneuraminic acid
ID STEADY-STATE PROPERTIES; CRYSTAL-STRUCTURE; PATCH-CLAMP; JUNCTION
   POTENTIALS; BACTERIAL; PROTEIN; PORIN; TRANSPORT; SELECTIVITY;
   PERMEATION
AB NanC is an Escherichia coli outer membrane protein involved in sialic acid (Neu5Ac, i.e., N-acetylneuraminic acid) uptake. Expression of the NanC gene is induced and controlled by Neu5Ac. The transport mechanism of Neu5Ac is not known. The structure of NanC was recently solved (PDB code: 2WJQ) and includes a unique arrangement of positively charged (basic) side chains consistent with a role in acidic sugar transport. However, initial functional measurements of NanC failed to find its role in the transport of sialic acids, perhaps because of the ionic conditions used in the experiments. We show here that the ionic conditions generally preferred for measuring the function of outer-membrane porins are not appropriate for NanC. Single channels of NanC at pH 7.0 have: (1) conductance 100 pS to 800 pS in 100 mM KCl to 3 M KCl), (2) anion over cation selectivity (V (reversal) = +16 mV in 250 mM KCl || 1 M KCl), and (3) two forms of voltage-dependent gating (channel closures above +/- 200 mV). Single-channel conductance decreases by 50% when HEPES concentration is increased from 100 mu M to 100 mM in 250 mM KCl at pH 7.4, consistent with the two HEPES binding sites observed in the crystal structure. Studying alternative buffers, we find that phosphate interferes with the channel conductance. Single-channel conductance decreases by 19% when phosphate concentration is increased from 0 mM to 5 mM in 250 mM KCl at pH 8.0. Surprisingly, TRIS in the baths reacts with Ag|AgCl electrodes, producing artifacts even when the electrodes are on the far side of agar-KCl bridges. A suitable baseline solution for NanC is 250 mM KCl adjusted to pH 7.0 without buffer.
C1 [Giri, Janhavi; Tang, John M.; Eisenberg, Bob] Rush Univ, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA.
   [Giri, Janhavi] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
   [Wirth, Christophe; Peneff, Caroline M.] Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
RP Eisenberg, B (corresponding author), Rush Univ, Dept Mol Biophys & Physiol, 1750 W Harrison St, Chicago, IL 60612 USA.
EM beisenbe@rush.edu
RI Eisenberg, Robert/P-6070-2019; Eisenberg, Robert S/G-8716-2018
OI Eisenberg, Robert S/0000-0002-4860-5434; Wirth,
   Christophe/0000-0001-8864-6508; Tang, John/0000-0003-0104-8324
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GM076013]; NATIONAL INSTITUTE OF
   GENERAL MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM076013, R01GM076013,
   R01GM076013, R01GM076013, R01GM076013] Funding Source: NIH RePORTER
FX We thank Tilman Schirmer for sharing with us his experience and insight
   on porins and proteins. We are grateful for continual discussions with
   Tilman, Dirk Gillespie, Dezso Boda, and Jim Fonseca. Dr Guy Condemine
   was most generous in providing materials and welcoming us to this field
   of research. Funding was provided by NIH grant GM076013.
CR Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1
   AMMAN D, 1986, ION SELECTIVE MICROE
   Bard A. J., 2000, ELECTROCHEMICAL METH
   BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526
   BARRY PH, 1989, METHOD ENZYMOL, V171, P678
   BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0
   BARRY PH, 1970, J MEMBRANE BIOL, V3, P93, DOI [10.1007/BF01868022, 10.1007/BF01868023]
   Barry PH, 1996, JPCALC WINDOWS JPCAL
   Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002
   Bayley H, 2005, NANOBIOTECHNOLOGY
   BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137
   Benz R., 2004, BACTERIAL EUKARYOTIC
   Boulton AA, 1995, PATCH CLAMP APPL PRO
   Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5
   Chazalviel J.-N., 1999, COULOMB SCREENING MO
   Colquhoun D., 1983, SINGLE CHANNEL RECOR
   COMB DG, 1960, J BIOL CHEM, V235, P2529
   Condemine G, 2005, J BACTERIOL, V187, P1959, DOI 10.1128/JB.187.6.1959-1965.2005
   CONTI F, 1965, BIOPHYS J, V5, P511, DOI 10.1016/S0006-3495(65)86732-7
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   Delcour AH, 1997, FEMS MICROBIOL LETT, V151, P115, DOI 10.1016/S0378-1097(97)00166-3
   Delcour AH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1055, DOI 10.2741/1132
   EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364
   EISENMAN G, 1967, SCIENCE, V155, P965, DOI 10.1126/science.155.3765.965
   GARAVITO RM, 1980, J CELL BIOL, V86, P327, DOI 10.1083/jcb.86.1.327
   HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997
   HANRAHAN JW, 1990, J MEMBRANE BIOL, V116, P65, DOI 10.1007/BF01871673
   Helfferich F., 1962, ION EXCHANGE
   KARREMAN G, 1962, B MATH BIOPHYS, V24, P413, DOI 10.1007/BF02477998
   Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007
   Miedema H, 2004, BIOPHYS J, V87, P3137, DOI 10.1529/biophysj.104.041384
   Miedema H, 2007, NANO LETT, V7, P2886, DOI 10.1021/nl0716808
   Miller C., 1986, ION CHANNEL RECONSTI
   Molleman A., 2003, PATCH CLAMPING INTRO
   Morf W.J., 1981, PRINCIPLES ION SELEC
   MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0
   NAKAE T, 1976, BIOCHEM BIOPH RES CO, V71, P877, DOI 10.1016/0006-291X(76)90913-X
   NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0
   NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   Sakmann B., 1995, SINGLE CHANNEL RECOR
   Sattelle DB, 1993, BIOL TECHNIQUES SERI
   Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946
   SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948
   Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2
   Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0
   TEORELL T, 1953, PROG BIOPHYS BIOP CH, V3, P305, DOI 10.1016/S0096-4174(18)30049-0
   Tien HT, 2003, MEMBRANE SCI TECHNOL, V7
   Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004
   Vrouenraets M, 2006, BIOPHYS J, V90, P1202, DOI 10.1529/biophysj.105.072298
   WALKER JL, 1966, ANN NY ACAD SCI, V137, P777, DOI 10.1111/j.1749-6632.1966.tb50199.x
   WANDERSMAN C, 1982, J BACTERIOL, V151, P15, DOI 10.1128/JB.151.1.15-21.1982
   Wirth C, 2009, J MOL BIOL, V394, P718, DOI 10.1016/j.jmb.2009.09.054
   YAMAMOTO D, 1987, PROC R SOC SER B-BIO, V230, P93, DOI 10.1098/rspb.1987.0011
NR 54
TC 7
Z9 7
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD MAR
PY 2012
VL 41
IS 3
BP 259
EP 271
DI 10.1007/s00249-011-0781-5
PG 13
WC Biophysics
SC Biophysics
GA 895LB
UT WOS:000300496600001
PM 22246445
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Tritten, L
   Braissant, O
   Keiser, J
AF Tritten, Lucienne
   Braissant, Olivier
   Keiser, Jennifer
TI Comparison of novel and existing tools for studying drug sensitivity
   against the hookworm Ancylostoma ceylanicum in vitro
SO PARASITOLOGY
LA English
DT Article
DE hookworm; Ancylostoma ceylanicum; in vitro assays; motility assay;
   feeding inhibition assay; acid phosphatase; Alamar Blue (R); MTT;
   xCELLigence System; calorimetry
ID NEMATODE CAENORHABDITIS-ELEGANS; NEGLECTED TROPICAL DISEASES; 3RD-STAGE
   INFECTIVE LARVAE; ACID-PHOSPHATASE-ACTIVITY; RAPID COLORIMETRIC ASSAY;
   HELMINTH INFECTIONS; ANTHELMINTIC SENSITIVITY; INTERMEDIARY METABOLISM;
   DAUER LARVA; RESISTANCE
AB The motility assay is the current gold standard for evaluating drug effects on hookworm larvae and adults, however, among other drawbacks the assay is time consuming, and prone to individual subjectivity. We evaluated six alternative in vitro assays, namely the feeding inhibition assay, the colourimetric AlamarBlue (R), MTT formazan and acid phosphatase activity assays, as well as isothermal calorimetry and the xCELLigence System using Ancylostoma ceylanicum third-stage larvae, stimulated third-stage larvae and adults. The performances of the assays were compared to the motility assay using three standard drugs: albendazole, levamisole and ivermectin (100-1 mu g/ml). None of the assays investigated offered an advantage over the motility assay, because they were all inapplicable to third-stage larvae, which were presumably metabolically and physically too inactive. Among all assays tested the xCELLigence System performed best on adult worms as the test was accurate, simple, required a minimal number of worms and offered the possibility for conducting a medium-throughput screening.
C1 [Tritten, Lucienne; Keiser, Jennifer] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
   [Braissant, Olivier] Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum Pharmazentrum, CH-4003 Basel, Switzerland.
RP Keiser, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
EM jennifer.keiser@unibas.ch
RI Tritten, Lucienne/A-8945-2018; Braissant, Olivier/AAO-2371-2020;
   Braissant, Olivier/H-2284-2012
OI Tritten, Lucienne/0000-0001-6341-2561; Braissant,
   Olivier/0000-0003-0659-755X; Braissant, Olivier/0000-0003-0659-755X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PPOOA-114941]
FX J. Keiser is grateful to the Swiss National Science Foundation (project
   no. PPOOA-114941) for financial support. We thank Dr Cornelia Hertel for
   giving us access to the xCELLigence System, and Frederique Chammartin
   for statistical support.
CR [Anonymous], 2011, WHO MOD LIST ESS MED
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1
   Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006
   CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8
   Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7
   Demeler J, 2010, VET PARASITOL, V170, P61, DOI 10.1016/j.vetpar.2010.01.032
   Geerts S, 2001, TROP MED INT HEALTH, V6, P915, DOI 10.1046/j.1365-3156.2001.00774.x
   GILL JH, 1991, INT J PARASITOL, V21, P771, DOI 10.1016/0020-7519(91)90144-V
   Harhay MO, 2010, EXPERT REV ANTI-INFE, V8, P219, DOI [10.1586/eri.09.119, 10.1586/ERI.09.119]
   HAWDON JM, 1990, J PARASITOL, V76, P394, DOI 10.2307/3282673
   HAWDON JM, 1992, EXP PARASITOL, V75, P40, DOI 10.1016/0014-4894(92)90120-Y
   Hotez P, 2008, ANN NY ACAD SCI, V1136, P38, DOI 10.1196/annals.1425.000
   Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261
   Hotez PJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000718
   James CE, 2007, PARASITOL RES, V101, P975, DOI 10.1007/s00436-007-0572-1
   Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001
   Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6
   Kirchhofer C, 2011, ACTA TROP, V118, P56, DOI 10.1016/j.actatropica.2011.02.003
   Kopp SR, 2008, VET PARASITOL, V152, P284, DOI 10.1016/j.vetpar.2007.12.020
   Kotze AC, 2004, AM J TROP MED HYG, V71, P608, DOI 10.4269/ajtmh.2004.71.608
   LEJAMBRE LF, 1976, VET PARASITOL, V2, P385, DOI 10.1016/0304-4017(76)90067-4
   MAKI J, 1980, PARASITOLOGY, V80, P23, DOI 10.1017/S0031182000000482
   Manneck T, 2011, J CLIN MICROBIOL, V49, P1217, DOI 10.1128/JCM.02382-10
   Martin RJ, 1997, VET J, V154, P11, DOI 10.1016/S1090-0233(05)80005-X
   Martinez-Grueiro MM, 2002, PARASITOL RES, V88, P946, DOI 10.1007/s00436-002-0678-4
   MISRA A, 1981, J HELMINTHOL, V55, P273, DOI 10.1017/S0022149X00027875
   Moser JM, 2005, MOL BIOCHEM PARASIT, V143, P39, DOI 10.1016/j.molbiopara.2005.04.012
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   ORIORDAN VB, 1989, COMP BIOCHEM PHYS B, V92, P233, DOI 10.1016/0305-0491(89)90271-X
   ORIORDAN VB, 1990, COMP BIOCHEM PHYS B, V95, P125, DOI 10.1016/0305-0491(90)90258-U
   Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X
   RICHARDS JC, 1995, INT J PARASITOL, V25, P1185, DOI 10.1016/0020-7519(95)00036-2
   Satou T, 2001, VET PARASITOL, V99, P311, DOI 10.1016/S0304-4017(01)00472-1
   Silbereisen A, 2011, J MICROBIOL METH, V87, P169, DOI 10.1016/j.mimet.2011.08.009
   Smith RA, 2009, PARASITOL RES, V105, P1339, DOI 10.1007/s00436-009-1560-4
   Smout MJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000885
   Taylor MA, 2002, VET PARASITOL, V103, P183, DOI 10.1016/S0304-4017(01)00604-5
   Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010
   Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s
NR 42
TC 18
Z9 18
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
J9 PARASITOLOGY
JI Parasitology
PD MAR
PY 2012
VL 139
IS 3
BP 348
EP 357
DI 10.1017/S0031182011001934
PG 10
WC Parasitology
SC Parasitology
GA 891ZC
UT WOS:000300254600009
PM 22333187
DA 2021-01-25
ER

PT J
AU Arquint, C
   Sonnen, KF
   Stierhof, YD
   Nigg, EA
AF Arquint, Christian
   Sonnen, Katharina F.
   Stierhof, York-Dieter
   Nigg, Erich A.
TI Cell-cycle-regulated expression of STIL controls centriole number in
   human cells
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE APC/C; Centrosome; Centriole duplication; Centriole number; Daughter
   centriole; STIL
ID CENTROSOME DUPLICATION; PRIMARY CILIUM; SIL GENE; VERTEBRATE
   DEVELOPMENT; PROCENTRIOLE FORMATION; PHYLOGENETIC ANALYSIS; 9-FOLD
   SYMMETRY; POLO KINASE; C-ELEGANS; PROTEIN
AB Control of centriole number is crucial for genome stability and ciliogenesis. Here, we characterize the role of human STIL, a protein that displays distant sequence similarity to the centriole duplication factors Ana2 in Drosophila and SAS-5 in Caenorhabditis elegans. Using RNA interference, we show that STIL is required for centriole duplication in human cells. Conversely, overexpression of STIL triggers the near-simultaneous formation of multiple daughter centrioles surrounding each mother, which is highly reminiscent of the phenotype produced by overexpression of the polo-like kinase PLK4 or the spindle assembly abnormal protein 6 homolog (SAS-6). We further show, by fluorescence and immunoelectron microscopy, that STIL is recruited to nascent daughter centrioles at the onset of centriole duplication and degraded, in an APC/CCdc20-Cdh1-dependent manner, upon passage through mitosis. We did not detect a stable complex between STIL and SAS-6, but the two proteins resemble each other with regard to both localization and cell cycle control of expression. Thus, STIL cooperates with SAS-6 and PLK4 in the control of centriole number and represents a key centriole duplication factor in human cells.
C1 [Arquint, Christian; Sonnen, Katharina F.; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Stierhof, York-Dieter] Univ Tubingen, Ctr Plant Mol Biol, Electron Microscopy Unit, D-72076 Tubingen, Germany.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erich.nigg@unibas.ch
RI Sonnen, Katharina F/R-7747-2018
OI Sonnen, Katharina F/0000-0002-2902-9419; nigg, erich/0000-0003-4835-5719
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_132428/1]; Werner Siemens Foundation (Zug, Switzerland);
   Boehringer-Ingelheim FondsBoehringer Ingelheim; International Max Planck
   Research School for Molecular and Cellular Life Sciences (Martinsried,
   Germany)
FX This work was supported by the Swiss National Science Foundation [grant
   number 31003A_132428/1]. C.A. was funded by a PhD fellowship from the
   Werner Siemens Foundation (Zug, Switzerland). K.F.S. was supported by a
   PhD fellowship from the Boehringer-Ingelheim Fonds and the International
   Max Planck Research School for Molecular and Cellular Life Sciences
   (Martinsried, Germany).
CR Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   APLAN PD, 1991, MOL CELL BIOL, V11, P5462, DOI 10.1128/MCB.11.11.5462
   Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010
   Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042
   Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180
   Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004
   Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3
   Campaner S, 2005, MOL CELL BIOL, V25, P6660, DOI 10.1128/MCB.25.15.6660-6672.2005
   Castiel A, 2011, J CELL SCI, V124, P532, DOI 10.1242/jcs.079731
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167
   Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7
   Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439
   Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037
   Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418
   Duensing A, 2007, ONCOGENE, V26, P6280, DOI 10.1038/sj.onc.1210456
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Erez A, 2004, ONCOGENE, V23, P5371, DOI 10.1038/sj.onc.1207685
   Erez A, 2008, INT J CANCER, V123, P1721, DOI 10.1002/ijc.23665
   Erez A, 2007, CANCER RES, V67, P4022, DOI 10.1158/0008-5472.CAN-07-0064
   EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610
   Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470
   Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774
   Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896
   Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181
   Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429
   Izraeli S, 1997, CELL GROWTH DIFFER, V8, P1171
   Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017
   Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220
   Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100
   Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054
   Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046
   Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036
   Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318
   Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988
   Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07
   Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049
   Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016
   Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016
   Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004
   Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004
   Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985
   Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015
   Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008
   van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325
   Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0
   Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001
NR 61
TC 108
Z9 109
U1 0
U2 18
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD MAR 1
PY 2012
VL 125
IS 5
BP 1342
EP 1352
DI 10.1242/jcs.099887
PG 11
WC Cell Biology
SC Cell Biology
GA 928PI
UT WOS:000302994800025
PM 22349698
OA Bronze
DA 2021-01-25
ER

PT J
AU Ludwig, C
   Claassen, M
   Schmidt, A
   Aebersold, R
AF Ludwig, Christina
   Claassen, Manfred
   Schmidt, Alexander
   Aebersold, Ruedi
TI Estimation of Absolute Protein Quantities of Unlabeled Samples by
   Selected Reaction Monitoring Mass Spectrometry
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID QUANTITATIVE PROTEOMICS; QUANTIFICATION; PEPTIDES; EXPRESSION; ASSAYS;
   STOICHIOMETRY; PREDICTION
AB For many research questions in modern molecular and systems biology, information about absolute protein quantities is imperative. This information includes, for example, kinetic modeling of processes, protein turnover determinations, stoichiometric investigations of protein complexes, or quantitative comparisons of different proteins within one sample or across samples. To date, the vast majority of proteomic studies are limited to providing relative quantitative comparisons of protein levels between limited numbers of samples. Here we describe and demonstrate the utility of a targeting MS technique for the estimation of absolute protein abundance in unlabeled and nonfractionated cell lysates. The method is based on selected reaction monitoring (SRM) mass spectrometry and the "best flyer" hypothesis, which assumes that the specific MS signal intensity of the most intense tryptic peptides per protein is approximately constant throughout a whole proteome. SRM-targeted best flyer peptides were selected for each protein from the peptide precursor ion signal intensities from directed MS data. The most intense transitions per peptide were selected from full MS/MS scans of crude synthetic analogs. We used Monte Carlo cross-validation to systematically investigate the accuracy of the technique as a function of the number of measured best flyer peptides and the number of SRM transitions per peptide. We found that a linear model based on the two most intense transitions of the three best flying peptides per proteins (TopPep3/TopTra2) generated optimal results with a cross-correlated mean fold error of 1.8 and a squared Pearson coefficient R-2 of 0.88. Applying the optimized model to lysates of the microbe Leptospira interrogans, we detected significant protein abundance changes of 39 target proteins upon antibiotic treatment, which correlate well with literature values. The described method is generally applicable and exploits the inherent performance advantages of SRM, such as high sensitivity, selectivity, reproducibility, and dynamic range, and estimates absolute protein concentrations of selected proteins at minimized costs. Molecular & Cellular Proteomics 11: 10.1074/mcp.M111.013987, 1-16, 2012.
C1 [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland.
   [Ludwig, Christina] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Claassen, Manfred] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.
   [Schmidt, Alexander] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland.
RP Aebersold, R (corresponding author), Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland.
EM aebersold@imsb.biol.ethz.ch
OI Claassen, Manfred/0000-0002-4583-9083
FU European UnionEuropean Union (EU) [HEALTH-F4_2008-201648]; European
   Union via ERC Proteomics v3.0 [233226]
FX The work was supported in part by SystemsX.ch (YeastX project), the
   Swiss initiative for systems biology, European Union 7th Framework
   project PROSPECTS (Proteomics Specification in Space and Time) Grant
   HEALTH-F4_2008-201648, and the European Union via ERC Proteomics v3.0
   Grant 233226 (to R. A.). The costs of publication of this article were
   defrayed in part by the payment of page charges. This article must
   therefore be hereby marked " advertisement" in accordance with 18 U. S.
   C. Section 1734 solely to indicate this fact.
CR Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546
   Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6
   Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017
   Brun V, 2007, MOL CELL PROTEOMICS, V6, P2139, DOI 10.1074/mcp.M700163-MCP200
   Cima I., 2011, P NATL ACAD SCI US
   de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341
   DESIDERIO DM, 1983, BIOMED MASS SPECTROM, V10, P471, DOI 10.1002/bms.1200100806
   Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56
   Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375
   Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661
   Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123
   Farrah T., 2012, PASSEL PEPTIDEATLAS
   Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353
   Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0
   Fusaro VA, 2009, NAT BIOTECHNOL, V27, P190, DOI 10.1038/nbt.1524
   Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100
   Grossmann J., 2010, J PROTEOMICS
   Han Bomie, 2008, Briefings in Functional Genomics & Proteomics, V7, P340, DOI 10.1093/bfgp/eln032
   Holstein CA, 2011, J PROTEOME RES, V10, P231, DOI 10.1021/pr1004289
   Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200
   Kito K, 2008, CURR GENOMICS, V9, P263, DOI 10.2174/138920208784533647
   Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848
   Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330
   Lam H, 2008, NAT METHODS, V5, P873, DOI 10.1038/NMETH.1254
   Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61
   Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270
   MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303
   Mirzaei H, 2008, MOL CELL PROTEOMICS, V7, P813, DOI 10.1074/mcp.M700495-MCP200
   Nanavati D, 2008, MOL CELL PROTEOMICS, V7, P442, DOI 10.1074/mcp.M700345-MCP200
   Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475
   Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n
   Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031
   Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   Prakash A, 2009, J PROTEOME RES, V8, P2733, DOI 10.1021/pr801028b
   Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Rivers J, 2007, MOL CELL PROTEOMICS, V6, P1416, DOI 10.1074/mcp.M600456-MCP200
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Schmidt C, 2010, ANAL CHEM, V82, P2784, DOI 10.1021/ac902710k
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Uhlen M, 2008, BIOTECHNIQUES, V44, P649, DOI 10.2144/000112803
   Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]
   Zhang H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005678
NR 51
TC 86
Z9 86
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD MAR
PY 2012
VL 11
IS 3
SI SI
AR M111.013987
DI 10.1074/mcp.M111.013987
PG 16
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 905TG
UT WOS:000301296900005
PM 22101334
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Baranek, C
   Dittrich, M
   Parthasarathy, S
   Bonnon, CG
   Britanova, O
   Lanshakov, D
   Boukhtouche, F
   Sommer, JE
   Colmenares, C
   Tarabykin, V
   Atanasoski, S
AF Baranek, Constanze
   Dittrich, Manuela
   Parthasarathy, Srinivas
   Bonnon, Carine Gaiser
   Britanova, Olga
   Lanshakov, Dmitriy
   Boukhtouche, Fatiha
   Sommer, Julia E.
   Colmenares, Clemencia
   Tarabykin, Victor
   Atanasoski, Suzana
TI Protooncogene Ski cooperates with the chromatin-remodeling factor Satb2
   in specifying callosal neurons
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE cortical development; cell fate; transcriptional regulation
ID DEVELOPING CEREBRAL-CORTEX; SPECIFICATION; DETERMINANT; IDENTITY;
   ELEMENTS
AB First insights into the molecular programs orchestrating the progression from neural stem cells to cortical projection neurons are emerging. Loss of the transcriptional regulator Ski has been linked to the human 1p36 deletion syndrome, which includes central nervous system defects. Here, we report critical roles for Ski in the maintenance of the neural stem cell pool and the specification of callosal neurons. Ski-deficient callosal neurons lose their identity and ectopically express the transcription factor Ctip2. The misspecified callosal neurons largely fail to form the corpus callosum and instead redirect their axons toward subcortical targets. We identify the chromatin-remodeling factor Satb2 as a partner of Ski, and show that both proteins are required for transcriptional repression of Ctip2 in callosal neurons. We propose a model in which Satb2 recruits Ski to the Ctip2 locus, and Ski attracts histone deacetylases, thereby enabling the formation of a functional nucleosome remodeling and deacetylase repressor complex. Our findings establish a central role for Ski-Satb2 interactions in regulating transcriptional mechanisms of callosal neuron specification.
C1 [Baranek, Constanze; Dittrich, Manuela; Bonnon, Carine Gaiser; Atanasoski, Suzana] Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland.
   [Parthasarathy, Srinivas; Britanova, Olga; Lanshakov, Dmitriy; Tarabykin, Victor] Charite, Inst Cell Biol & Neurobiol, D-10117 Berlin, Germany.
   [Bonnon, Carine Gaiser; Atanasoski, Suzana] Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany.
   [Boukhtouche, Fatiha; Sommer, Julia E.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Colmenares, Clemencia] Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA.
RP Atanasoski, S (corresponding author), Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland.
EM suzana.atanasoski@unibas.ch
RI Lanshakov, Dmitriy A/M-7975-2016; Tarabykin, Victor/F-9467-2014
OI Lanshakov, Dmitriy A/0000-0002-8482-1302; 
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Novartis FoundationNovartis; Swiss Life; Botnar Foundation;
   Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG)
   [TA 303/3]; Boehringer Ingelheim FondsBoehringer Ingelheim;  [SFB 665]
FX We thank J. Kapfhammer for help with Dil labeling experiments; D. Leone
   and K. Srinivasan for primer sequences to generate in situ hybridization
   probes; C. Stolt for discussions; and R. Zeller and N. Mantei for
   valuable comments on the manuscript. Support for this work was provided
   by the Swiss National Science Foundation, the Novartis Foundation, Swiss
   Life, and the Botnar Foundation (S. A.). V. T. was supported by SFB 665,
   the Deutsche Forschungsgemeinschaft (DFG) Heisenberg Programme, and DFG
   Grant TA 303/3. Boehringer Ingelheim Fonds provided a PhD fellowship (S.
   P.) and a predoctoral fellowship (J.E.S.).
CR Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012
   Atanasoski S, 2004, NEURON, V43, P499, DOI 10.1016/j.neuron.2004.08.001
   Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029
   Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874
   Bonnon C, 2012, CELL TISSUE RES, V347, P51, DOI 10.1007/s00441-011-1180-z
   Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x
   Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028
   Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012
   Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002
   Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006
   LYONS GE, 1994, DEV DYNAM, V201, P354, DOI 10.1002/aja.1002010407
   Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151
   Shu TZ, 2003, DEVELOPMENT, V130, P2929, DOI 10.1242/dev.00514
   Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947
NR 14
TC 44
Z9 47
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 28
PY 2012
VL 109
IS 9
BP 3546
EP 3551
DI 10.1073/pnas.1108718109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 899PL
UT WOS:000300828200070
PM 22334647
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Fairley, JA
   Mitchell, LE
   Berg, T
   Kenneth, NS
   von Schubert, C
   Sillje, HHW
   Medema, RH
   Nigg, EA
   White, RJ
AF Fairley, Jennifer A.
   Mitchell, Louise E.
   Berg, Tracy
   Kenneth, Niall S.
   von Schubert, Conrad
   Sillje, Herman H. W.
   Medema, Rene H.
   Nigg, Erich A.
   White, Robert J.
TI Direct Regulation of tRNA and 5S rRNA Gene Transcription by Polo-like
   Kinase 1
SO MOLECULAR CELL
LA English
DT Article
ID POLYMERASE-III TRANSCRIPTION; CELL-CYCLE REGULATION; IN-VITRO; MITOTIC
   REPRESSION; PLK1-DEPENDENT PHOSPHORYLATION; PROTEIN; PLK1; CHROMATIN;
   LOCALIZATION; CYTOKINESIS
AB Polo-like kinase Plk1 controls numerous aspects of cell-cycle progression. We show that it associates with tRNA and 5S rRNA genes and regulates their transcription by RNA polymerase Ill (pol Ill) through direct binding and phosphorylation of transcription factor Brit During interphase, Plk1 promotes tRNA and 5S rRNA expression by phosphorylating Plk1 directly on serine 450. However, this stimulatory modification is overridden at mitosis, when elevated Plk1 activity causes Bill phosphorylation on threonine 270 (T270), which prevents pol III recruitment. Thus, although Plk1 enhances net tRNA and 5S rRNA production, consistent with its proliferation-stimulating function, it also suppresses untimely transcription when cells divide. Genomic instability is apparent in cells with BM T270 mutated to alanine to resist Plk1 -directed inactivation, suggesting that chromosome segregation is vulnerable to inappropriate pol III activity.
C1 [Fairley, Jennifer A.; Mitchell, Louise E.; Berg, Tracy; White, Robert J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland.
   [Fairley, Jennifer A.; Mitchell, Louise E.; Kenneth, Niall S.; White, Robert J.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.
   [von Schubert, Conrad; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Sillje, Herman H. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands.
   [Medema, Rene H.] Univ Med Ctr, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands.
RP White, RJ (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.
EM r.white@beatson.gla.ac.uk
OI nigg, erich/0000-0003-4835-5719; Medema, Rene/0000-0002-6754-0381;
   KENNETH, NIALL/0000-0001-8528-1021
FU Cancer Research UKCancer Research UK; Biotechnology and Biological
   Sciences Research CouncilBiotechnology and Biological Sciences Research
   Council (BBSRC); Max Planck SocietyMax Planck SocietyFoundation CELLEX
FX We thank Henrik Daub for sharing information from his proteomic screen,
   Anja Hanisch for recombinant Plk1, Louise Johnson for the GST-Plk1
   construct, and Frank Kozielski for structural analysis, and also Walter
   Kolch, David Gillespie, and Mike Olson for helpful discussions. This
   work was funded by grants to R.J.W. from Cancer Research UK and the
   Biotechnology and Biological Sciences Research Council. H.H.W.S. and
   E.A.N. are supported by the Max Planck Society.
CR Akoulitchev S, 1998, GENE DEV, V12, P3541, DOI 10.1101/gad.12.22.3541
   Almonacid M, 2011, CURR BIOL, V21, P473, DOI 10.1016/j.cub.2011.02.003
   Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401
   Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104
   Cairns CA, 1998, EMBO J, V17, P3112, DOI 10.1093/emboj/17.11.3112
   Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182
   Clemente-Blanco A, 2009, NATURE, V458, P219, DOI 10.1038/nature07652
   Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339
   Fairley JA, 2003, EMBO J, V22, P5841, DOI 10.1093/emboj/cdg544
   Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8
   French SL, 2008, MOL CELL BIOL, V28, P4576, DOI 10.1128/MCB.00127-08
   Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767
   GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617
   Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327
   Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1
   GOTTESFELD JM, 1994, SCIENCE, V263, P81, DOI 10.1126/science.8272869
   GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x
   HARTL P, 1993, J CELL BIOL, V120, P613, DOI 10.1083/jcb.120.3.613
   Hu P, 2004, MOL CELL, V16, P81, DOI 10.1016/j.molcel.2004.09.008
   ITTMANN M, 1987, MOL CELL BIOL, V7, P3386, DOI 10.1128/MCB.7.10.3386
   Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200
   Kassavetis GA, 1998, MOL CELL BIOL, V18, P5587, DOI 10.1128/MCB.18.9.5587
   KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x
   Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200
   Li HC, 2010, EMBO J, V29, P2953, DOI 10.1038/emboj.2010.174
   LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O
   Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08
   Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185
   Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035
   Offer T, 2004, FASEB J, V18, P485, DOI 10.1096/fj.04-2729fje
   Oppermann FS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.012351
   Papadopoulou K, 2008, J CELL SCI, V121, P38, DOI 10.1242/jcs.019489
   Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014
   Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201
   Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100
   Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457
   Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902
   Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425
   Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037
   Sutcliffe JE, 1999, MOL CELL BIOL, V19, P4255
   Sutcliffe JE, 2000, MOL CELL BIOL, V20, P9192, DOI 10.1128/MCB.20.24.9192-9202.2000
   Tsvetkov L, 2005, J BIOL CHEM, V280, P11943, DOI 10.1074/jbc.M413514200
   Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089
   van de Weerdt BCM, 2005, MOL CELL BIOL, V25, P2031, DOI 10.1128/MCB.25.5.2031-2044.2005
   van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015
   WHITE RJ, 1995, MOL CELL BIOL, V15, P6653
   WHITE RJ, 1995, MOL CELL BIOL, V15, P1983
NR 47
TC 20
Z9 20
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD FEB 24
PY 2012
VL 45
IS 4
BP 541
EP 552
DI 10.1016/j.molcel.2011.11.030
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 898PH
UT WOS:000300753800013
PM 22281053
OA Bronze
DA 2021-01-25
ER

PT J
AU Arnold, P
   Erb, I
   Pachkov, M
   Molina, N
   van Nimwegen, E
AF Arnold, Phil
   Erb, Ionas
   Pachkov, Mikhail
   Molina, Nacho
   van Nimwegen, Erik
TI MotEvo: integrated Bayesian probabilistic methods for inferring
   regulatory sites and motifs on multiple alignments of DNA sequences
SO BIOINFORMATICS
LA English
DT Article
ID FACTOR-BINDING-SITES; TRANSCRIPTION; IDENTIFICATION; PHYLOSCAN; ELEMENTS
AB Motivation: Probabilistic approaches for inferring transcription factor binding sites (TFBSs) and regulatory motifs from DNA sequences have been developed for over two decades. Previous work has shown that prediction accuracy can be significantly improved by incorporating features such as the competition of multiple transcription factors (TFs) for binding to nearby sites, the tendency of TFBSs for co-regulated TFs to cluster and form cis-regulatory modules and explicit evolutionary modeling of conservation of TFBSs across orthologous sequences. However, currently available tools only incorporate some of these features, and significant methodological hurdles hampered their synthesis into a single consistent probabilistic framework.
   Results: We present MotEvo, a integrated suite of Bayesian probabilistic methods for the prediction of TFBSs and inference of regulatory motifs from multiple alignments of phylogenetically related DNA sequences, which incorporates all features just mentioned. In addition, MotEvo incorporates a novel model for detecting unknown functional elements that are under evolutionary constraint, and a new robust model for treating gain and loss of TFBSs along a phylogeny. Rigorous benchmarking tests on ChIP-seq datasets show that MotEvo's novel features significantly improve the accuracy of TFBS prediction, motif inference and enhancer prediction.
C1 [Arnold, Phil; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Erb, Ionas] Ctr Genom Regulat CRG, Bioinformat & Genom Program, Barcelona, Spain.
   [Erb, Ionas] Pompeu Fabra Univ UPF, Barcelona, Spain.
   [Molina, Nacho] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
RI Molina, Nacho/F-2244-2010
OI Molina, Nacho/0000-0003-0233-3055; Erb, Ionas/0000-0002-2331-9714; van
   Nimwegen, Erik/0000-0001-6338-1312
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-118318]; SystemsX.ch through the CellPlasticity project
FX The work presented here was supported by Swiss National Science
   Foundation grant (31003A-118318) and by SystemsX.ch through the
   CellPlasticity project.
CR Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352
   Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28
   Bulyk ML, 2004, GENOME BIOL, V5
   Carmack CS, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-1
   Chen K, 2010, GENOME BIOL EVOL, V2, P697, DOI 10.1093/gbe/evq054
   Davidson EH, 2001, GENOMIC REGULATORY S
   Durbin R., 1998, BIOL SEQUENCE ANAL
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878
   Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995
   Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198
   Hawkins J, 2009, BIOINFORMATICS, V25, pI339, DOI 10.1093/bioinformatics/btp201
   Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112
   Ivan A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r22
   Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488
   Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139
   McBride Kevin M, 2003, Sci STKE, V2003, pRE13
   Molina N, 2008, GENOME RES, V18, P148, DOI 10.1101/gr.6759507
   Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Palumbo MJ, 2010, NUCLEIC ACIDS RES, V38, pW268, DOI 10.1093/nar/gkq330
   Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30
   Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170
   Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246
   van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4
   Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115
   Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109
   Wilczynski B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.35
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 37
TC 37
Z9 38
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD FEB 15
PY 2012
VL 28
IS 4
BP 487
EP 494
DI 10.1093/bioinformatics/btr695
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 895IT
UT WOS:000300490500006
PM 22334039
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Zehender, F
   Ziegler, A
   Schonfeld, HJ
   Seelig, J
AF Zehender, F.
   Ziegler, A.
   Schoenfeld, H. -J.
   Seelig, J.
TI Thermodynamics of Protein Self-Association and Unfolding. The Case of
   Apolipoprotein A-I
SO BIOCHEMISTRY
LA English
DT Article
ID HIGH-DENSITY-LIPOPROTEIN; HELIX-COIL TRANSITION; BETA-SHEET TRANSITION;
   CIRCULAR-DICHROISM; MEMBRANE ENVIRONMENT; CRYSTAL-STRUCTURE; ENTHALPY
   CHANGE; ALPHA-HELIX; MODEL; DENATURATION
AB Protein self-association and protein unfolding are two temperature-dependent processes whose understanding is of utmost importance for the development of biological pharmaceuticals because protein association may stabilize or destabilize protein structure and function. Here we present new theoretical and experimental methods for analyzing the thermodynamics of self-association and unfolding. We used isothermal dilution calorimetry and analytical ultracentrifugation to measure protein self-association and introduced binding partition functions to analyze the cooperative association equilibria. In a second type of experiment, we monitored thermal protein unfolding with differential scanning calorimetry and circular dichroism spectroscopy and used the Zimm-Bragg theory to analyze the unfolding process. For alpha-helical proteins, the cooperative Zimm-Bragg theory appears to be a powerful alternative to the classical two-state model. As a model protein, we chose highly purified human recombinant apolipoprotein A-I. Self-association of Apo A-I showed a maximum at 21 degrees C with an association constant K-a of 5.6 X 10(5) M-1, a cooperativity parameter sigma of 0.003, and a maximal association number n of 8. The association enthalpy was linearly dependent on temperature and changed from endothermic at low temperatures to exothermic above 21 degrees C with a molar heat capacity Delta C-p degrees of -2.76 kJ mol(-1) K-1. Above 45 degrees C, the association could no longer be measured because of the onset of unfolding. Unfolding occurred between 45 and 65 degrees C and was reversible and independent of protein concentration up to 160 mu M. The midpoint of unfolding (T-0) as measured by DSC was 52-53 degrees C; the enthalpy of unfolding (Delta H-N(U)) was 420 kJ/mol. The molar heat capacity (Delta C-U(N)p) increased by 5.0 +/- 0.5 kJ mol(-1) K-1 upon unfolding corresponding to a loss of 80-85 helical segments, which was confirmed by circular dichroism spectroscopy. Unfolding was highly cooperative with a nucleation parameter sigma of 4.4 X 10(-5).
C1 [Zehender, F.; Ziegler, A.; Seelig, J.] Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   [Schoenfeld, H. -J.] F Hoffman La Roche Ltd, Pharmaceut Res, CH-4070 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-129701]
FX Supported by Swiss National Science Foundation Grant 31003A-129701.
CR Acharya P, 2002, BBA-MOL CELL BIOL L, V1584, P9, DOI 10.1016/S1388-1981(02)00263-9
   Arnulphi C, 2004, BIOCHEMISTRY-US, V43, P12258, DOI 10.1021/bi036118k
   Beck A, 2010, J PHYS CHEM B, V114, P15862, DOI 10.1021/jp107088d
   Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291
   Brouillette CG, 2005, BIOCHEMISTRY-US, V44, P16413, DOI 10.1021/bi051018v
   Carra JH, 1996, BIOPHYS J, V71, P1994, DOI 10.1016/S0006-3495(96)79397-9
   Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106
   CHOU PY, 1971, BIOPOLYMERS, V10, P657, DOI 10.1002/bip.360100406
   Davidson N., 1962, STATISTICAL MECHANIC, P385
   FORMISANO S, 1978, J BIOL CHEM, V253, P354
   Frank PG, 2000, J LIPID RES, V41, P853
   Gursky O, 1998, BIOCHEMISTRY-US, V37, P1283, DOI 10.1021/bi971801q
   Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200
   Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485
   Kasimova MR, 1998, J MOL BIOL, V277, P409, DOI 10.1006/jmbi.1997.1613
   Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422
   Meier M, 2008, J AM CHEM SOC, V130, P1017, DOI 10.1021/ja077231r
   Meier M, 2007, J MOL BIOL, V369, P277, DOI 10.1016/j.jmb.2007.02.082
   MURPHY KP, 1991, J MOL BIOL, V222, P699, DOI 10.1016/0022-2836(91)90506-2
   NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3
   Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004
   PRIVALOV PL, 1989, PURE APPL CHEM, V61, P1097, DOI 10.1351/pac198961061097
   Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355
   RIALDI G, 1966, J AM CHEM SOC, V88, P5719, DOI 10.1021/ja00976a007
   Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200
   Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200
   SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304
   SCHOLTZ JM, 1991, P NATL ACAD SCI USA, V88, P2854, DOI 10.1073/pnas.88.7.2854
   Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002
   Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105
   Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+
   Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404
   Suurkuusk M, 1999, EUR J BIOCHEM, V265, P346, DOI 10.1046/j.1432-1327.1999.00739.x
   SWANEY JB, 1983, J BIOL CHEM, V258, P1254
   SWANEY JB, 1978, J BIOL CHEM, V253, P7069
   THOMPSON KS, 1993, BIOCHEMISTRY-US, V32, P5491, DOI 10.1021/bi00072a001
   VITELLO LB, 1976, J BIOL CHEM, V251, P1131
   Wyman J., 1990, BINDING LINKAGE FUNC
   ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390
NR 41
TC 16
Z9 16
U1 0
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 14
PY 2012
VL 51
IS 6
BP 1269
EP 1280
DI 10.1021/bi2013799
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 890GK
UT WOS:000300132900021
PM 22320308
DA 2021-01-25
ER

PT J
AU Egger, A
   Samardzija, M
   Sothilingam, V
   Tanimoto, N
   Lange, C
   Salatino, S
   Fang, L
   Garcia-Garrido, M
   Beck, S
   Okoniewski, MJ
   Neutzner, A
   Seeliger, MW
   Grimm, C
   Handschin, C
AF Egger, Anna
   Samardzija, Marijana
   Sothilingam, Vithiyanjali
   Tanimoto, Naoyuki
   Lange, Christina
   Salatino, Silvia
   Fang, Lei
   Garcia-Garrido, Marina
   Beck, Susanne
   Okoniewski, Michal J.
   Neutzner, Albert
   Seeliger, Mathias W.
   Grimm, Christian
   Handschin, Christoph
TI PGC-1 alpha Determines Light Damage Susceptibility of the Murine Retina
SO PLOS ONE
LA English
DT Article
ID SKELETAL-MUSCLE; ENERGY-METABOLISM; PGC-1 COACTIVATORS; PHOTORECEPTORS;
   EXPRESSION; EXERCISE; PGC1-ALPHA; MECHANISMS; PIGMENTOSA; APOPTOSIS
AB The peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) proteins are key regulators of cellular bioenergetics and are accordingly expressed in tissues with a high energetic demand. For example, PGC-1 alpha and PGC-1 beta control organ function of brown adipose tissue, heart, brain, liver and skeletal muscle. Surprisingly, despite their prominent role in the control of mitochondrial biogenesis and oxidative metabolism, expression and function of the PGC-1 coactivators in the retina, an organ with one of the highest energy demands per tissue weight, are completely unknown. Moreover, the molecular mechanisms that coordinate energy production with repair processes in the damaged retina remain enigmatic. In the present study, we thus investigated the expression and function of the PGC-1 coactivators in the healthy and the damaged retina. We show that PGC-1 alpha and PGC-1 beta are found at high levels in different structures of the mouse retina, most prominently in the photoreceptors. Furthermore, PGC-1 alpha knockout mice suffer from a striking deterioration in retinal morphology and function upon detrimental light exposure. Gene expression studies revealed dysregulation of all major pathways involved in retinal damage and apoptosis, repair and renewal in the PGC-1 alpha knockouts. The light-induced increase in apoptosis in vivo in the absence of PGC-1 alpha was substantiated in vitro, where overexpression of PGC-1 alpha evoked strong anti-apoptotic effects. Finally, we found that retinal levels of PGC-1 expression are reduced in different mouse models for retinitis pigmentosa. We demonstrate that PGC-1 alpha is a central coordinator of energy production and, importantly, all of the major processes involved in retinal damage and subsequent repair. Together with the observed dysregulation of PGC-1 alpha and PGC-1 beta in retinitis pigmentosa mouse models, these findings thus imply that PGC-1 alpha might be an attractive target for therapeutic approaches aimed at retinal degeneration diseases.
C1 [Egger, Anna; Salatino, Silvia; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
   [Samardzija, Marijana; Lange, Christina; Grimm, Christian] Univ Zurich, Dept Ophthalmol, Lab Retinal Cell Biol, Schlieren, Switzerland.
   [Sothilingam, Vithiyanjali; Tanimoto, Naoyuki; Beck, Susanne; Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Div Expt Ophthalmol, Tubingen, Germany.
   [Neutzner, Albert] Univ Basel Hosp, Dept Med, Univ Eye Clin, CH-4031 Basel, Switzerland.
   [Okoniewski, Michal J.] Funct Genom Ctr UNI ETH Zurich, Zurich, Switzerland.
RP Egger, A (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Samardzija, Marijana/B-9245-2008; Handschin, Christoph/E-6886-2015;
   Neutzner, Albert/ABC-4368-2020
OI Samardzija, Marijana/0000-0003-0991-4653; Handschin,
   Christoph/0000-0003-0603-1097; Neutzner, Albert/0000-0001-9254-5558;
   Grimm, Christian/0000-0001-9318-4352; Salatino,
   Silvia/0000-0003-1286-3076
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); SwissLife "Jubilaumsstiftung fur Volksgesundheit und
   medizinische Forschung"; Roche Research Foundation; United Mitochondrial
   Disease Foundation (UMDF); University of Basel
FX This project was funded by the Swiss National Science Foundation, the
   SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische
   Forschung", the Roche Research Foundation, the United Mitochondrial
   Disease Foundation (UMDF) and the University of Basel. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009
   AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020
   D'Errico I, 2011, P NATL ACAD SCI USA, V108, P6603, DOI 10.1073/pnas.1016354108
   Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427
   Ershov AV, 2000, J NEUROSCI RES, V60, P328, DOI 10.1002/(SICI)1097-4547(20000501)60:3<328::AID-JNR7>3.0.CO;2-5
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507
   Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Handschin C, 2011, CELL METAB, V13, P351, DOI 10.1016/j.cmet.2011.03.008
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Herzlich Alexandra A, 2009, Open Biol J, V2, P141
   Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008
   Kim HJ, 2011, ACTA BIOCH BIOPH SIN, V43, P589, DOI 10.1093/abbs/gmr053
   Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774
   NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499
   Nathans J, 1987, ANNU REV NEUROSCI, V10, P2897
   Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029
   Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Sahel J, 2010, DEV OPHTHALMOL, V47, P160, DOI 10.1159/000320079
   Samardzija M, 2006, INVEST OPHTH VIS SCI, V47, P5181, DOI 10.1167/iovs.06-0556
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409
   Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002
   Won JC, 2010, ARTERIOSCL THROM VAS, V30, P290, DOI 10.1161/ATVBAHA.109.198721
   Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Yu L, 2010, NEUROSCIENCE, V169, P23, DOI 10.1016/j.neuroscience.2010.04.063
   Zheng Z, 2010, DIABETES, V59, P2315, DOI 10.2337/db10-0638
NR 41
TC 32
Z9 33
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 13
PY 2012
VL 7
IS 2
AR e31272
DI 10.1371/journal.pone.0031272
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 925BB
UT WOS:000302733900036
PM 22348062
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Engel, P
   Goepfert, A
   Stanger, FV
   Harms, A
   Schmidt, A
   Schirmer, T
   Dehio, C
AF Engel, Philipp
   Goepfert, Arnaud
   Stanger, Frederic V.
   Harms, Alexander
   Schmidt, Alexander
   Schirmer, Tilman
   Dehio, Christoph
TI Adenylylation control by intra- or intermolecular active-site
   obstruction in Fic proteins
SO NATURE
LA English
DT Article
ID BARTONELLA-HENSELAE; AMPYLATION; FILAMENTATION; BINDING; GTPASES; DOC;
   AMP
AB Fic proteins that are defined by the ubiquitous FIC (filamentation induced by cyclic AMP) domain are known to catalyse adenylylation (also called AMPylation); that is, the transfer of AMP onto a target protein. In mammalian cells, adenylylation of small GTPases through Fic proteins injected by pathogenic bacteria can cause collapse of the actin cytoskeleton and cell death(1,2). It is unknown how this potentially deleterious adenylylation activity is regulated in the widespread Fic proteins that are found in all domains of life and that are thought to have critical roles in intrinsic signalling processes. Here we show that FIC-domain-mediated adenylylation is controlled by a conserved mechanism of ATP-binding-site obstruction that involves an inhibitory alpha-helix (alpha(inh)) with a conserved (S/T)XXXE(G/N) motif, and that in this mechanism the invariable glutamate competes with ATP gamma-phosphate binding. Consistent with this, FIC-domain-mediated growth arrest of bacteria by the VbhT toxin of Bartonella schoen-buchensis is intermolecularly repressed by the VbhA antitoxin through tight binding of its alpha(inh) to the FIC domain of VbhT, as shown by structure and function analysis. Furthermore, structural comparisons with other bacterial Fic proteins, such as Fic of Neisseria meningitidis and of Shewanella oneidensis, show that alpha(inh) frequently constitutes an amino-terminal or carboxy-terminal extension to the FIC domain, respectively, partially obstructing the ATP binding site in an intramolecular manner. After mutation of the inhibitory motif in various Fic proteins, including the human homologue FICD (also known as HYPE), adenylylation activity is considerably boosted, consistent with the anticipated relief of inhibition. Structural homology modelling of all annotated Fic proteins indicates that inhibition by alpha(inh) is universal and conserved through evolution, as the inhibitory motif is present in similar to 90% of all putatively adenylylation-active FIC domains, including examples from all domains of life and from viruses. Future studies should reveal how intrinsic or extrinsic factors modulate adenylylation activity by weakening the interaction of alpha(inh) with the FIC active site.
C1 [Goepfert, Arnaud; Stanger, Frederic V.; Schirmer, Tilman; Dehio, Christoph] Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, CH-4056 Basel, Switzerland.
   [Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, CH-4056 Basel, Switzerland.
EM Tilman.Schirmer@unibas.ch; Christoph.Dehio@unibas.ch
RI Harms, Alexander/J-5710-2019; Dehio, Christoph/AAD-5572-2019; Engel,
   Philipp/N-1788-2015; Dehio, Christoph/R-8277-2016
OI Harms, Alexander/0000-0003-2106-1286; Dehio,
   Christoph/0000-0001-7288-1052; Engel, Philipp/0000-0002-4678-6200;
   Dehio, Christoph/0000-0001-7288-1052; Stanger,
   Frederic/0000-0002-9847-5084
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100-061777, 3100-138414]; SystemsX.ch Swiss Initiative for
   Systems Biology [51RT 0_126008 (InfectX)]
FX We thank T. Glatter for mass spectrometry analysis of samples at the
   Core Proteomics facility. We thank the staff of beamline X06SA of the
   Swiss Light Source for assistance with data acquisition. We are grateful
   to G. Pluschke for providing the genomic DNA of Neisseria meningitidis,
   the ASU Biodesign Institute for providing the plasmid enclosing the
   Shewanella oneidensis Fic protein and S. Mattoo and J. Dixon for
   providing the pET-GSTX plasmids enclosing HYPE and HYPE(H295A). We also
   thank D. Bumann and A. Boehm for providing plasmid pC10E and E. coli
   strain AB472, respectively. This work was supported by grants
   3100-061777 and 3100-138414 from the Swiss National Science Foundation
   (to C. D. and T. S., respectively), and grant 51RT 0_126008 (InfectX) in
   the frame of the SystemsX.ch Swiss Initiative for Systems Biology (to
   C.D.).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2001, INT J SYST EVOL MICR, V51, P1557, DOI 10.1099/00207713-51-4-1557
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296
   Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135
   Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818
   Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107
   Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884
   Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   SELF AJ, 1995, METHOD ENZYMOL, V256, P3
   Smith Susan J M, 2002, Methods Mol Biol, V189, P13
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   UTSUMI R, 1982, J BACTERIOL, V151, P807, DOI 10.1128/JB.151.2.807-812.1982
   Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008
   Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867
   Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382
   Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110
NR 32
TC 87
Z9 95
U1 2
U2 37
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD FEB 2
PY 2012
VL 482
IS 7383
BP 107
EP U138
DI 10.1038/nature10729
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 884RN
UT WOS:000299726000045
PM 22266942
DA 2021-01-25
ER

PT J
AU Schmidt, FI
   Bleck, CKE
   Mercer, J
AF Schmidt, Florian Ingo
   Bleck, Christopher Karl Ernst
   Mercer, Jason
TI Poxvirus host cell entry
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID VACCINIA-VIRUS ENTRY; INTRACELLULAR MATURE VIRION; MEMBRANE-PROTEIN;
   ESSENTIAL COMPONENT; APOPTOTIC MIMICRY; A27L PROTEIN; ENTER CELLS;
   IN-VITRO; FUSION; ENVELOPE
AB Poxviruses are characterized by their large size, complex composition, and cytoplasmic life cycle. They produce two types of infectious particles: mature virions (MVs) and extracellular virions (EVs). Both MVs and EVs of vaccinia virus, the model poxvirus, take advantage of host cell endocytosis for internalization: they activate macropinocytosis - the most suitable form of endocytosis for large particles. Although largely dependent on the same cellular machinery, MV and EV entry differs with regard to the mechanisms used to trigger macropinocytosis and to undergo fusion. While EVs have to shed an additional membrane to expose the fusion complex, MV fusion requires the inactivation of fusion inhibitory proteins absent in EVs. This review highlights recent advances in the understanding of poxvirus MV and EV cell entry.
C1 [Schmidt, Florian Ingo; Mercer, Jason] ETH, Inst Biochem, CH-8093 Zurich, Switzerland.
   [Bleck, Christopher Karl Ernst] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, CH-4058 Basel, Switzerland.
RP Mercer, J (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.
EM jason.mercer@bc.biol.ethz.ch
RI Schmidt, Florian Ingo/J-1672-2019
OI Schmidt, Florian Ingo/0000-0002-9979-9769; Bleck,
   Christopher/0000-0003-1029-3444
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [Ambizione PZ00P3_131988, Sinergia CRSII3_125110/1]
FX We thank Ari Helenius for support and advice (F.I.S. and J.M.) and
   Henning Stahlberg for supporting C.K.E.B. with working space and EM
   equipment. We are grateful to Samuel Kilcher for critical reading of the
   manuscript. This work was in part funded by grants from the Swiss
   National Foundation (Ambizione PZ00P3_131988 and Sinergia
   CRSII3_125110/1).
CR Bengali Z, 2009, VIROLOGY, V389, P132, DOI 10.1016/j.virol.2009.04.012
   Bisht H, 2008, J VIROL, V82, P8687, DOI 10.1128/JVI.00852-08
   Brown E, 2006, J VIROL, V80, P9455, DOI 10.1128/JVI.01149-06
   Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0
   CHANG A, 1976, J GEN VIROL, V32, P275, DOI 10.1099/0022-1317-32-2-275
   Chang SJ, 2010, J VIROL, V84, P8422, DOI 10.1128/JVI.00599-10
   Charles-Whitbeck J, 2009, VIROLOGY, V385, P383, DOI 10.1016/j.virol.2008.12.029
   Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06
   Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998
   DALES S, 1963, J CELL BIOL, V18, P51, DOI 10.1083/jcb.18.1.51
   Damon I, 2007, FIELDS VIROLOGY, P2947
   DEVAUCHELLE G, 1971, J ULTRA MOL STRUCT R, V37, P301, DOI 10.1016/S0022-5320(71)80126-0
   Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173
   Earley AK, 2008, J VIROL, V82, P2161, DOI 10.1128/JVI.01971-07
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   Foo CH, 2009, VIROLOGY, V385, P368, DOI [10.1016/j.virol.2008.12.029, 10.1016/j.virol.2008.12.019]
   Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009
   GRANADOS RR, 1973, VIROLOGY, V52, P305, DOI 10.1016/0042-6822(73)90422-4
   Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080
   Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999
   Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998
   Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08
   Ichihashi Y, 1996, VIROLOGY, V217, P478, DOI 10.1006/viro.1996.0142
   Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009
   Izmailyan RA, 2006, J VIROL, V80, P8402, DOI 10.1128/JVI.00624-06
   Laliberte JP, 2009, P NATL ACAD SCI USA, V106, P17517, DOI 10.1073/pnas.0909376106
   Lantto J, 2011, J VIROL, V85, P1820, DOI 10.1128/JVI.02127-10
   Law M, 2006, P NATL ACAD SCI USA, V103, P5989, DOI 10.1073/pnas.0601025103
   Law M, 2001, VIROLOGY, V280, P132, DOI 10.1006/viro.2000.0750
   Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000
   Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497
   Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107
   Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510
   Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012
   Moss B, 2007, FIELDS VIROLOGY, P2906
   Nichols RJ, 2008, J VIROL, V82, P10247, DOI 10.1128/JVI.01035-08
   Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x
   Ojeda S, 2006, J VIROL, V80, P51, DOI 10.1128/JVI.80.1.51-61.2006
   Ojeda S, 2006, J VIROL, V80, P9822, DOI 10.1128/JVI.00987-06
   Orynbayeva Z, 2007, J VIROL, V81, P1140, DOI 10.1128/JVI.01345-06
   Perdiguero B, 2008, J VIROL, V82, P2150, DOI 10.1128/JVI.01969-07
   Perino J, 2011, ANTIVIR RES, V89, P89, DOI 10.1016/j.antiviral.2010.11.009
   Roberts KL, 2009, J GEN VIROL, V90, P1582, DOI 10.1099/vir.0.009092-0
   Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866
   Satheshkumar PS, 2009, J VIROL, V83, P12822, DOI 10.1128/JVI.01744-09
   Schmidt FI, 2011, EMBO J, V30, P3647, DOI 10.1038/emboj.2011.245
   Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102
   Senkevich TG, 2005, J VIROL, V79, P4744, DOI 10.1128/JVI.79.8.4744-4754.2005
   Senkevich TG, 2004, J VIROL, V78, P2357, DOI 10.1128/JVI.78.5.2357-2366.2004
   Senkevich TG, 2004, J VIROL, V78, P2348, DOI 10.1128/JVI.78.5.2348-2356.2004
   Shedlock DJ, 2010, VIROLOGY, V401, P228, DOI 10.1016/j.virol.2010.02.029
   Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037
   Townsley AC, 2005, J VIROL, V79, P10988, DOI 10.1128/JVI.79.17.10988-10998.2005
   Townsley AC, 2005, J VIROL, V79, P9458, DOI 10.1128/JVI.79.15.9458-9469.2005
   Townsley AC, 2007, J VIROL, V81, P8613, DOI 10.1128/JVI.00606-07
   Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06
   Turner PC, 2006, VIROLOGY, V347, P88, DOI 10.1016/j.virol.2005.11.012
   Turner PC, 2008, VIROLOGY, V380, P226, DOI 10.1016/j.virol.2008.07.020
   Ulaeto D, 1996, J VIROL, V70, P3372, DOI 10.1128/JVI.70.6.3372-3377.1996
   Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003
   Vanderplasschen A, 1997, J VIROL, V71, P4032, DOI 10.1128/JVI.71.5.4032-4041.1997
   Vanderplasschen A, 1998, J GEN VIROL, V79, P877, DOI 10.1099/0022-1317-79-4-877
   Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544
   Vermeer PD, 2007, J VIROL, V81, P9891, DOI 10.1128/JVI.00601-07
   Villa NY, 2010, VIROLOGY, V401, P266, DOI 10.1016/j.virol.2010.02.027
   Wagenaar TR, 2009, J VIROL, V83, P1546, DOI 10.1128/JVI.01684-08
   Wolfe CL, 2011, J VIROL
NR 70
TC 44
Z9 45
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD FEB
PY 2012
VL 2
IS 1
BP 20
EP 27
DI 10.1016/j.coviro.2011.11.007
PG 8
WC Virology
SC Virology
GA 051FW
UT WOS:000312112600004
PM 22440962
DA 2021-01-25
ER

PT J
AU Stolting, MNL
   Handschin, C
   Becskei, A
   Sulser, T
   Eberli, D
AF Stoelting, M. N. L.
   Handschin, C.
   Becskei, A.
   Sulser, T.
   Eberli, D.
TI Noninvasive electromagnetic stimulation for stress urinary incontinence
   improves regeneration of skeletal muscle, increases nerve ingrowth and
   acetylcholine receptor clustering
SO EUROPEAN UROLOGY SUPPLEMENTS
LA English
DT Meeting Abstract
C1 [Stoelting, M. N. L.; Sulser, T.; Eberli, D.] Univ Zurich Hosp, Dept Urol, CH-8091 Zurich, Switzerland.
   [Handschin, C.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Becskei, A.] Univ Zurich, Inst Mol Biol, Zurich, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-9056
J9 EUR UROL SUPPL
JI Eur. Urol. Suppl.
PD FEB
PY 2012
VL 11
IS 1
BP E1064
EP U221
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA 928RP
UT WOS:000303001302111
DA 2021-01-25
ER

PT J
AU Stolting, MNL
   Handschin, C
   Becskei, A
   Sulser, T
   Eberli, D
AF Stoelting, M. N. L.
   Handschin, C.
   Becskei, A.
   Sulser, T.
   Eberli, D.
TI In vivo electromagnetic stimulation supports muscle regeneration after
   stem cell injection by boosting muscular metabolism and stimulating
   nerve ingrowth
SO EUROPEAN UROLOGY SUPPLEMENTS
LA English
DT Meeting Abstract
C1 [Stoelting, M. N. L.; Sulser, T.; Eberli, D.] Univ Zurich Hosp, Dept Urol, CH-8091 Zurich, Switzerland.
   [Handschin, C.] Univ Basel, Biozentrum, Dept Focal Area Growth & Dev, Basel, Switzerland.
   [Becskei, A.] Univ Zurich, Inst Mol Biol, Zurich, Switzerland.
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-9056
J9 EUR UROL SUPPL
JI Eur. Urol. Suppl.
PD FEB
PY 2012
VL 11
IS 1
BP E1063
EP U219
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA 928RP
UT WOS:000303001302110
DA 2021-01-25
ER

PT J
AU Hsu, C
   Scherrer, S
   Buetti-Dinh, A
   Ratna, P
   Pizzolato, J
   Jaquet, V
   Becskei, A
AF Hsu, Chieh
   Scherrer, Simone
   Buetti-Dinh, Antoine
   Ratna, Prasuna
   Pizzolato, Julia
   Jaquet, Vincent
   Becskei, Attila
TI Stochastic signalling rewires the interaction map of a multiple feedback
   network during yeast evolution
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; POSITIVE FEEDBACK;
   KLUYVEROMYCES-LACTIS; SEQUENCE DIVERGENCE; GLUCOSE REPRESSION; CELLULAR
   MEMORY; LOOPS; GALACTOSE; BINDING
AB During evolution, genetic networks are rewired through strengthening or weakening their interactions to develop new regulatory schemes. In the galactose network, the GAL1/GAL3 paralogues and the GAL2 gene enhance their own expression mediated by the Gal4p transcriptional activator. The wiring strength in these feedback loops is set by the number of Gal4p binding sites. Here we show using synthetic circuits that multiplying the binding sites increases the expression of a gene under the direct control of an activator, but this enhancement is not fed back in the circuit. The feedback loops are rather activated by genes that have frequent stochastic bursts and fast RNA decay rates. In this way, rapid adaptation to galactose can be triggered even by weakly expressed genes. Our results indicate that nonlinear stochastic transcriptional responses enable feedback loops to function autonomously, or contrary to what is dictated by the strength of interactions enclosing the circuit.
C1 [Hsu, Chieh; Jaquet, Vincent; Becskei, Attila] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Scherrer, Simone; Buetti-Dinh, Antoine; Ratna, Prasuna; Pizzolato, Julia] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
RP Becskei, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM attila.becskei@unibas.ch
RI Scherrer, Simone/F-3663-2019
OI Scherrer, Simone/0000-0001-9548-8798; Hsu, Chieh/0000-0002-4780-1222;
   Jaquet, Vincent/0000-0003-2229-2406; Becskei,
   Attila/0000-0002-9462-0934; Buetti-Dinh, Antoine/0000-0002-6469-0296
FU Swiss National FoundationSwiss National Science Foundation (SNSF); UZH
   Stiftung fur Wissenschaftliche Forschung; UZH-URPP
FX We thank Faramand Firouzeh for the technical help, Reine Byun for the
   GAL4 expression plasmid, and Andreas Wagner and Aurelio de los Reyes V.
   for reading the manuscript. This work was supported by grants from the
   Swiss National Foundation, the UZH Stiftung fur Wissenschaftliche
   Forschung and the UZH-URPP. C. H. is a Long-Term Fellow of the Human
   Frontier Science Program.
CR Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524
   Acar M, 2010, SCIENCE, V329, P1656, DOI 10.1126/science.1190544
   Anders A, 2006, J BIOL CHEM, V281, P29337, DOI 10.1074/jbc.M604271200
   Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616
   Becskei A, 2004, NAT CELL BIOL, V6, P451, DOI 10.1038/ncb1124
   Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211
   Bhat PJ, 2008, GALACTOSE REGULON YE
   Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003
   Cheng Z, 2008, FEBS LETT, V582, P3776, DOI 10.1016/j.febslet.2008.10.005
   Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482
   Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603
   Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104
   CZYZ M, 1993, NUCLEIC ACIDS RES, V21, P4378, DOI 10.1093/nar/21.18.4378
   GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3
   Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607
   Hawkins KM, 2006, J BIOL CHEM, V281, P13485, DOI 10.1074/jbc.M512317200
   Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151
   Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4
   Horak J, 2005, BIOCHEM BIOPH RES CO, V335, P1185, DOI 10.1016/j.bbrc.2005.08.008
   Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016
   JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834
   Justman QA, 2009, SCIENCE, V324, P509, DOI 10.1126/science.1169498
   Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004
   Kelemen JZ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000332
   Kielbasa SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003210
   Kundu S, 2010, MOL CELL BIOL, V30, P2330, DOI 10.1128/MCB.01675-09
   Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841
   Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002
   Platt A, 2000, P NATL ACAD SCI USA, V97, P3154, DOI 10.1073/pnas.97.7.3154
   Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309
   Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869
   Ratna P, 2009, J MOL BIOL, V387, P826, DOI 10.1016/j.jmb.2009.02.025
   Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105
   SIERKSTRA LN, 1992, YEAST, V8, P1077, DOI 10.1002/yea.320081210
   Sun L, 2010, NATURE, V467, P163, DOI 10.1038/467163a
   Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817
   Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218
   Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340
   Tirosh I, 2008, TRENDS GENET, V24, P109, DOI 10.1016/j.tig.2007.12.004
   To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962
   Venkataram S, 2010, GENOME BIOL EVOL, V2, P851, DOI 10.1093/gbe/evq066
   Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044
NR 42
TC 30
Z9 30
U1 1
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB
PY 2012
VL 3
AR 682
DI 10.1038/ncomms1687
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 915XE
UT WOS:000302060100023
PM 22353713
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Schrimpf, SP
   von Mering, C
   Bendixen, E
   Heazlewood, JL
   Bumann, D
   Omenn, G
   Hengartner, MO
AF Schrimpf, Sabine P.
   von Mering, Christian
   Bendixen, Emoke
   Heazlewood, Joshua L.
   Bumann, Dirk
   Omenn, Gil
   Hengartner, Michael O.
TI The initiative on Model Organism Proteomes (iMOP) Session September 6,
   2011, Geneva, Switzerland
SO PROTEOMICS
LA English
DT Article
DE Arabidopsis thaliana organelles; Farm animals; Host-pathogen
   interactions; Quantitative proteomics
ID ARABIDOPSIS
AB iMOP the Initiative on Model Organism Proteomes was accepted as a new HUPO initiative at the Ninth HUPO meeting in Sydney in 2010. A goal of iMOP is to integrate research groups working on a great diversity of species into a model organism community. At the Tenth HUPO meeting in Geneva this variety was reflected in the iMOP session on Tuesday September 6, 2011. The presentations covered the quantitative proteome database PaxDb, proteomics projects studying farm animals, Arabidopsis thaliana, as well as hostpathogen interactions.
C1 [Schrimpf, Sabine P.; von Mering, Christian; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.
   [von Mering, Christian] Univ Zurich, Swiss Inst Bioinformat, Zurich, Switzerland.
   [Bendixen, Emoke] Aarhus Univ, Fac Agr Sci, Dept Anim Hlth & Biosci, Tjele, Denmark.
   [Heazlewood, Joshua L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA.
   [Heazlewood, Joshua L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.
   [Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland.
   [Omenn, Gil] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.
RP Schrimpf, SP (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.
RI Heazlewood, Joshua L/A-2554-2008; von Mering, Christian/B-3300-2008;
   Hengartner, Michael/E-6235-2011
OI Heazlewood, Joshua L/0000-0002-2080-3826; von Mering,
   Christian/0000-0001-7734-9102; Hengartner, Michael/0000-0002-7584-596X;
   Omenn, Gilbert S./0000-0002-8976-6074
CR Danielsen M, 2010, PROTEOMICS, V10, P2240, DOI 10.1002/pmic.200900771
   Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353
   Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863
   Joshi HJ, 2011, PLANT PHYSIOL, V155, P259, DOI 10.1104/pp.110.168195
   Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327
   Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993
   Nesse RM, 2010, P NATL ACAD SCI USA, V107, P1800, DOI 10.1073/pnas.0906224106
   Omenn GS, 2010, P NATL ACAD SCI USA, V107, P1702, DOI 10.1073/pnas.0906198106
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973
   Weiss M, 2010, PROTEOMICS, V10, P1297, DOI 10.1002/pmic.200900414
NR 11
TC 2
Z9 2
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD FEB
PY 2012
VL 12
IS 3
BP 346
EP 350
DI 10.1002/pmic.201290015
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 883HB
UT WOS:000299623700003
PM 22290801
DA 2021-01-25
ER

PT J
AU Marchand, CH
   Salmeron, C
   Raad, RB
   Meniche, X
   Chami, M
   Masi, M
   Blanot, D
   Daffe, M
   Tropis, M
   Huc, E
   Le Marechal, P
   Decottignies, P
   Bayan, N
AF Marchand, Christophe H.
   Salmeron, Christophe
   Raad, Roland Bou
   Meniche, Xavier
   Chami, Mohamed
   Masi, Muriel
   Blanot, Didier
   Daffe, Mamadou
   Tropis, Marielle
   Huc, Emilie
   Le Marechal, Pierre
   Decottignies, Paulette
   Bayan, Nicolas
TI Biochemical Disclosure of the Mycolate Outer Membrane of Corynebacterium
   glutamicum
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID PROTEIN IDENTIFICATION DATA; CELL-WALL; MYCOBACTERIUM-TUBERCULOSIS;
   HYDROPHOBIC DOMAIN; FORMING ACTIVITY; SIGNAL PEPTIDES; ERP PROTEIN;
   GENE; CHANNEL; ENVELOPE
AB Corynebacterineae is a specific suborder of Gram-positive bacteria that includes Mycobacterium tuberculosis and Corynebacterium glutamicum. The cell wall of these bacteria is composed of a heteropolymer of peptidoglycan (PG) linked to arabinogalactan (AG), which in turn is covalently associated with an atypical outer membrane, here called mycomembrane (M). The latter structure has been visualized by cryo-electron microscopy of vitreous sections, but its biochemical composition is still poorly defined, thereby hampering the elucidation of its physiological function. In this report, we show for the first time that the mycomembrane-linked heteropolymer of PG and AG (M-AG-PG) of C. glutamicum can be physically separated from the inner membrane on a flotation density gradient. Analysis of purified M-AG-PG showed that the lipids that composed the mycomembrane consisted almost exclusively of mycolic acid derivatives, with only a tiny amount, if any, of phospholipids and lipomannans, which were found with the characteristic lipoarabinomannans in the plasma membrane. Proteins associated with or inserted in the mycomembrane were extracted from M-AG-PG with lauryl-dimethylamine-oxide (LDAO), loaded on an SDS-PAGE gel, and analyzed by tandem mass spectrometry or by Western blotting. Sixty-eight different proteins were identified, 19 of which were also found in mycomembrane fragments released by the terminal-arabinosyl-transferase-defective Delta AftB strain. Almost all of them are predicted to contain a signal sequence and to adopt the characteristic beta-barrel structure of Gram-negative outer membrane proteins. These presumed mycomembrane proteins include the already-known pore-forming proteins (PorA and PorB), 5 mycoloyltransferases (cMytA, cMytB, cMytC, cMytD, and cMytF), several lipoproteins, and unknown proteins typified by a putative C-terminal hydrophobic anchor.
C1 [Salmeron, Christophe; Raad, Roland Bou; Meniche, Xavier; Masi, Muriel; Bayan, Nicolas] Univ Paris 11, Equipe Microbiol Mol & Cellulaire, IBBMC, Orsay, France.
   [Marchand, Christophe H.; Le Marechal, Pierre; Decottignies, Paulette] Univ Paris 11, Equipe Chim Prot, IBBMC, Orsay, France.
   [Blanot, Didier] Univ Paris 11, Equipe Enveloppes Bacteriennes & Antibiot, IBBMC, Orsay, France.
   [Marchand, Christophe H.; Salmeron, Christophe; Raad, Roland Bou; Meniche, Xavier; Masi, Muriel; Blanot, Didier; Le Marechal, Pierre; Decottignies, Paulette; Bayan, Nicolas] CNRS, UMR 8619, F-91405 Orsay, France.
   [Meniche, Xavier; Daffe, Mamadou; Tropis, Marielle; Huc, Emilie] Univ Toulouse 3, Inst Pharmacol & Biol Struct, Dept Mecanismes Mol Infect Mycobacteriennes, CNRS,UMR 5089, F-31062 Toulouse, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, C CINA Ctr Imaging & NanoAnalyt, Basel, Switzerland.
RP Bayan, N (corresponding author), Univ Paris 11, Equipe Microbiol Mol & Cellulaire, IBBMC, Orsay, France.
EM paulette.decottignies@u-psud.fr; nicolas.bayan@u-psud.fr
RI Claustre, Emilie Huc/M-6693-2016; Masi, Muriel/N-6758-2018; Bayan,
   Nicolas/AAI-5034-2020; MARCHAND, Christophe H/B-5854-2008
OI Claustre, Emilie Huc/0000-0002-8856-207X; Masi,
   Muriel/0000-0002-1444-7511; MARCHAND, Christophe H/0000-0002-0729-3841;
   Bayan, Nicolas/0000-0001-7760-0811
FU Agence Nationale pour la RechercheFrench National Research Agency (ANR)
   [ANR-07-BLAN-0363]; CNRSCentre National de la Recherche Scientifique
   (CNRS); University of Paris-Sud XI; C-CINA, Biozentrum, University of
   Basel, Basel, Switzerland
FX We are very grateful to Elodie Point and Christelle Lemy for their
   excellent technical assistance. We thank Celine Boursier and Florence
   Poirier (IFR141, Chatenay-Malabry, France) for providing access to their
   mass spectrometer. Roland Benz and Chris Huygens are kindly acknowledged
   for their generous gift of the PorA deletion strain, the anti-PorA
   polyclonal antibodies, and the anti-FbpA monoclonal antibodies,
   respectively. We are also very grateful to Andreas Engel and Henning
   Stahlberg (C-CINA, Biozentrum, University of Basel, Basel, Switzerland),
   Celia de Sousa, and Christine Houssin for constructive discussions and
   support.; This work was funded by Agence Nationale pour la Recherche
   grant ANR-07-BLAN-0363, the CNRS, and the University of Paris-Sud XI.
CR AGGERBECK LP, 1986, METHOD ENZYMOL, V128, P457
   Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006
   Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417
   Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108
   Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09
   Bayan N, 2003, J BIOTECHNOL, V104, P55, DOI 10.1016/S0168-1656(03)00163-9
   Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028
   Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   BONAMY C, 1990, FEMS MICROBIOL LETT, V66, P263, DOI 10.1016/0378-1097(90)90294-Z
   Bradshaw RA, 2006, MOL CELL PROTEOMICS, V5, P787, DOI 10.1074/mcp.E600005-MCP200
   BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333
   Buddelmeijer N, 2010, BIOCHEMISTRY-US, V49, P341, DOI 10.1021/bi9020346
   Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200
   Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x
   Costa-Riu N, 2003, J BACTERIOL, V185, P4779, DOI 10.1128/JB.185.16.4779-4786.2003
   Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131
   Draper P, 1997, BIOCHEM J, V327, P519, DOI 10.1042/bj3270519
   Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530
   Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114
   Ferrandez Y, 2008, MOL MICROBIOL, V69, P1349, DOI 10.1111/j.1365-2958.2008.06366.x
   Hartmann M, 2004, ARCH MICROBIOL, V182, P299, DOI 10.1007/s00203-004-0713-1
   Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105
   Huc E, 2010, J BIOL CHEM, V285, P21908, DOI 10.1074/jbc.C110.133033
   Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1
   JOLIFF G, 1992, MOL MICROBIOL, V6, P2349, DOI 10.1111/j.1365-2958.1992.tb01410.x
   Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8
   Kocincova D, 2004, INFECT IMMUN, V72, P2379, DOI 10.1128/IAI.72.4.2379-2382.2004
   Kocincova D, 2004, FEMS MICROBIOL LETT, V231, P191, DOI 10.1016/S0378-1097(03)00964-9
   Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lichtinger T, 1998, BIOCHEMISTRY-US, V37, P15024, DOI 10.1021/bi980961e
   Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mah N, 2010, MICROBIOL-SGM, V156, P2506, DOI 10.1099/mic.0.040089-0
   Mahne M, 2006, FEMS MICROBIOL LETT, V259, P226, DOI 10.1111/j.1574-6968.2006.00269.x
   Meniche X, 2008, MICROBIOL-SGM, V154, P2315, DOI 10.1099/mic.0.2008/016378-0
   Minnikin D.E., 1982, BIOL MYCOBACTERIA, P95
   Molle V, 2006, MOL MICROBIOL, V61, P826, DOI 10.1111/j.1365-2958.2006.05277.x
   Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4
   Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x
   NIEDERWEIS M, 1995, J BACTERIOL, V177, P5716, DOI 10.1128/jb.177.19.5716-5718.1995
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996
   Pajon R, 2006, TUBERCULOSIS, V86, P290, DOI 10.1016/j.tube.2006.01.005
   PEYRET JL, 1993, MOL MICROBIOL, V9, P97, DOI 10.1111/j.1365-2958.1993.tb01672.x
   Pitarque S, 2008, TUBERCULOSIS, V88, P560, DOI 10.1016/j.tube.2008.04.002
   Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101
   Preger V, 2009, PLANT PHYSIOL, V150, P606, DOI 10.1104/pp.109.139170
   Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365
   PUGSLEY AP, 1990, MOL MICROBIOL, V4, P59, DOI 10.1111/j.1365-2958.1990.tb02015.x
   Raad RB, 2010, J BACTERIOL, V192, P2691, DOI 10.1128/JB.00009-10
   RASTOGI N, 1991, RES MICROBIOL, V142, P464, DOI 10.1016/0923-2508(91)90121-P
   Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016
   Salim K, 1997, APPL ENVIRON MICROB, V63, P4392, DOI 10.1128/AEM.63.11.4392-4400.1997
   Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004
   Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08
   Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x
   Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x
   Sutcliffe IC, 1995, ARCH ORAL BIOL, V40, P1119, DOI 10.1016/0003-9969(95)00086-0
   SWEELEY CC, 1963, J LIPID RES, V4, P402
   Teriete P, 2010, BIOCHEMISTRY-US, V49, P2768, DOI 10.1021/bi100158s
   Tokuda H, 2004, BIOCHIM BIOPHYS ACTA, V1694, pIN1
   Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200
   Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07
NR 65
TC 42
Z9 45
U1 0
U2 21
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD FEB
PY 2012
VL 194
IS 3
BP 587
EP 597
DI 10.1128/JB.06138-11
PG 11
WC Microbiology
SC Microbiology
GA 879DF
UT WOS:000299309200006
PM 22123248
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Cardon, CM
   Beck, T
   Hall, MN
   Rutter, J
AF Cardon, Caleb M.
   Beck, Thomas
   Hall, Michael N.
   Rutter, Jared
TI PAS Kinase Promotes Cell Survival and Growth Through Activation of Rho1
SO SCIENCE SIGNALING
LA English
DT Article
ID GTP-BINDING PROTEIN; EXCHANGE FACTOR ROM2; SACCHAROMYCES-CEREVISIAE;
   ACTIN CYTOSKELETON; WALL INTEGRITY; YEAST; TOR2; TARGET; SSD1; GENE
AB In Saccharomyces cerevisiae, phosphorylation of Ugp1 by either of the yeast PASK family protein kinases (yPASK), Psk1 or Psk2, directs this metabolic enzyme to deliver glucose to the periphery for synthesis of the cell wall. However, we isolated PSK1 and PSK2 in a high-copy suppressor screen of a temperature-sensitive mutant of target of rapamycin 2 (TOR2). Posttranslational activation of yPASK, either by cell integrity stress or by growth on nonfermentative carbon sources, also suppressed the growth defect resulting from tor2 mutation. Although suppression of the tor2 mutant growth phenotype by activation of the kinase activity of yPASK required phosphorylation of the metabolic enzyme Ugp1 on serine 11, this resulted in the formation of a complex that induced Rho1 activation, rather than required the glucose partitioning function of Ugp1. In addition to phosphorylated Ugp1, this complex contained Rom2, a Rho1 guanine nucleotide exchange factor, and Ssd1, an mRNA-binding protein. Activation of yPASK-dependent Ugp1 phosphorylation, therefore, enables two processes that are required for cell growth and stress resistance: synthesis of the cell wall through partitioning glucose to the periphery and the formation of the signaling complex with Rom2 and Ssd1 to promote Rho1-dependent polarized cell growth. This complex may integrate metabolic and signaling responses required for cell growth and survival in suboptimal conditions.
C1 [Cardon, Caleb M.; Beck, Thomas; Rutter, Jared] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.
   [Beck, Thomas; Hall, Michael N.] Univ Basel, Biozentrum, Dept Biochem, CH-4046 Basel, Switzerland.
RP Rutter, J (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.
EM rutter@biochem.utah.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T32-GM07464, RO1DK071962]; NATIONAL
   INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Diabetes & Digestive & Kidney Diseases
   (NIDDK) [R01DK071962, R01DK071962, R01DK071962, R01DK071962,
   R01DK071962, R01DK071962, R01DK071962, R01DK071962] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [T32GM007464, T32GM007464, T32GM007464, T32GM007464, T32GM007464,
   T32GM007464, T32GM007464, T32GM007464, T32GM007464, T32GM007464,
   T32GM007464, T32GM007464, T32GM007464, T32GM007464, T32GM007464,
   T32GM007464, T32GM007464, T32GM007464, T32GM007464, T32GM007464,
   T32GM007464, T32GM007464, T32GM007464, T32GM007464, T32GM007464,
   T32GM007464, T32GM007464, T32GM007464, T32GM007464, T32GM007464,
   T32GM007464, T32GM007464, T32GM007464, T32GM007464] Funding Source: NIH
   RePORTER
FX We thank E. L. Weiss and D. J. Stillman for plasmids, strains, and
   critical reading of the manuscript. We are grateful to J. H. Grose for
   reagents and helpful discussions. We thank the Rutter lab for helpful
   discussions and J. Jaimez and A. Quint for technical support. Funding:
   C. M. C. was supported as a predoctoral trainee by NIH Genetics Training
   Grant T32-GM07464. This work was supported by NIH grant RO1DK071962 (J.
   R.). Author contributions: C. M. C. performed all of the experiments. C.
   M. C. and J. R. designed the experiments and wrote the paper. T. B. and
   M.N.H. provided unpublished data that contributed to the initiation of
   this project. Competing interests: J. R. is a consultant and Scientific
   Advisory Board member of BioEnergenix, LLC.
CR Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616
   Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235
   Chen CY, 1998, MICROBIOL-UK, V144, P2941, DOI 10.1099/00221287-144-11-2941
   DARAN JM, 1995, EUR J BIOCHEM, V233, P520, DOI 10.1111/j.1432-1033.1995.520_2.x
   Grose JH, 2007, EMBO J, V26, P4824, DOI 10.1038/sj.emboj.7601914
   Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104
   Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   Helliwell SB, 1998, GENETICS, V148, P99
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   Jansen JM, 2009, CURR BIOL, V19, P2114, DOI 10.1016/j.cub.2009.10.071
   Kaeberlein M, 2004, GENETICS, V166, P1661, DOI 10.1534/genetics.166.4.1661
   Kaeberlein M, 2002, GENETICS, V160, P83
   Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193
   Kikani CK, 2010, J BIOL CHEM, V285, P41034, DOI 10.1074/jbc.M110.157594
   Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200
   Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x
   Kono K, 2008, MOL BIOL CELL, V19, P1763, DOI 10.1091/mbc.E07-09-0950
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Kurischko C, 2011, J CELL BIOL, V192, P583, DOI 10.1083/jcb.201011061
   Li LH, 2009, MOL BIOL CELL, V20, P3851, DOI 10.1091/mbc.E09-04-0347
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Luukkonen BGM, 1999, NUCLEIC ACIDS RES, V27, P3455, DOI 10.1093/nar/27.17.3455
   Masuda CA, 2001, J BIOL CHEM, V276, P37794
   Mir SS, 2009, MOL CELL BIOL, V29, P187, DOI 10.1128/MCB.02271-07
   Moriya H, 1999, YEAST, V15, P481, DOI 10.1002/(SICI)1097-0061(199904)15:6<481::AID-YEA391>3.0.CO;2-M
   NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x
   Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x
   Pende M, 2000, NATURE, V408, P994
   Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279
   Rutter J, 2002, CELL, V111, P17, DOI 10.1016/S0092-8674(02)00974-1
   Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002
   Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026
   Smith TL, 2007, MOL CELL, V26, P491, DOI 10.1016/j.molcel.2007.03.025
   Tsuchiya E, 1996, GENE, V176, P35, DOI 10.1016/0378-1119(96)00204-1
   UESONO Y, 1994, GENE, V143, P135
   Uesono Y, 1997, J BIOL CHEM, V272, P16103, DOI 10.1074/jbc.272.26.16103
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
   YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 45
TC 8
Z9 9
U1 1
U2 12
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD JAN 31
PY 2012
VL 5
IS 209
AR ra9
DI 10.1126/scisignal.2002435
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 891MZ
UT WOS:000300222600002
PM 22296835
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Zehender, F
   Ziegler, A
   Schoenfeld, HJ
   Seelig, J
AF Zehender, Fabian
   Ziegler, Andre
   Schoenfeld, Hans-Joachim
   Seelig, Joachim
TI Thermodynamics of Protein Self-Association and Unfolding. The Case of
   Apolipoprotein A-I
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the Biophysical-Society
CY FEB 25-29, 2012
CL San Diego, CA
SP Biophys Soc
C1 [Zehender, Fabian; Ziegler, Andre; Seelig, Joachim] Univ Basel, Biozentrum, Basel, Switzerland.
   [Schoenfeld, Hans-Joachim] F Hoffmann La Roche Ltd, Basel, Switzerland.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN 31
PY 2012
VL 102
IS 3
SU 1
BP 57A
EP 57A
DI 10.1016/j.bpj.2011.11.339
PG 1
WC Biophysics
SC Biophysics
GA 179ZF
UT WOS:000321561200286
OA Bronze
DA 2021-01-25
ER

PT J
AU Morin, S
   Nisius, L
   Wiktor, M
   Kebbel, F
   Stahlberg, H
   Sass, HJ
   Grzesiek, S
AF Morin, Sebastien
   Nisius, Lydia
   Wiktor, Maciej
   Kebbel, Fabian
   Stahlberg, Henning
   Sass, Hans Juergen
   Grzesiek, Stephan
TI Interactions of CCR5, the Main HIV Coreceptor, with Rantes and Other
   Ligands
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the Biophysical-Society
CY FEB 25-29, 2012
CL San Diego, CA
SP Biophys Soc
C1 [Morin, Sebastien; Nisius, Lydia; Wiktor, Maciej; Kebbel, Fabian; Stahlberg, Henning; Sass, Hans Juergen; Grzesiek, Stephan] Univ Basel, Biozentrum, Basel, Switzerland.
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Grzesiek,
   Stephan/0000-0003-1998-4225
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN 31
PY 2012
VL 102
IS 3
SU 1
BP 239A
EP 240A
DI 10.1016/j.bpj.2011.11.1319
PG 2
WC Biophysics
SC Biophysics
GA 179ZF
UT WOS:000321561201511
DA 2021-01-25
ER

PT J
AU Casuso, I
   Duneau, JP
   Chami, M
   Paul-Gilloteaux, P
   Husain, M
   Khao, J
   Stahlberg, H
   Sturgis, J
   Scheuring, S
AF Casuso, Ignacio
   Duneau, Jean-Pierre
   Chami, Mohamed
   Paul-Gilloteaux, Perrine
   Husain, Mohamed
   Khao, Jonathan
   Stahlberg, Henning
   Sturgis, James
   Scheuring, Simon
TI Complete Lateral and Angular Diffusion and Protein-Protein Interaction
   Description of a Membrane Protein
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the Biophysical-Society
CY FEB 25-29, 2012
CL San Diego, CA
SP Biophys Soc
C1 [Casuso, Ignacio; Husain, Mohamed; Scheuring, Simon] Inst Curie, INSERM, Paris, France.
   [Duneau, Jean-Pierre; Khao, Jonathan; Sturgis, James] Univ Aix Marseille, Marseille, France.
   [Chami, Mohamed; Stahlberg, Henning] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
   [Paul-Gilloteaux, Perrine] Inst Curie, Paris, France.
RI Scheuring, Simon/L-9843-2018; Stahlberg, Henning/H-1868-2011;
   Paul-Gilloteaux, Perrine/L-8287-2018
OI Scheuring, Simon/0000-0003-3534-069X; Stahlberg,
   Henning/0000-0002-1185-4592; Paul-Gilloteaux,
   Perrine/0000-0002-4822-165X
NR 0
TC 0
Z9 0
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN 31
PY 2012
VL 102
IS 3
SU 1
BP 413A
EP 414A
DI 10.1016/j.bpj.2011.11.2261
PG 2
WC Biophysics
SC Biophysics
GA 179ZF
UT WOS:000321561202680
OA Bronze
DA 2021-01-25
ER

PT J
AU Heer, F
   Berneche, S
AF Heer, Florian
   Berneche, Simon
TI Ion Permeation in the MthK Potassium Channel
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the Biophysical-Society
CY FEB 25-29, 2012
CL San Diego, CA
SP Biophys Soc
C1 [Heer, Florian; Berneche, Simon] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN 31
PY 2012
VL 102
IS 3
SU 1
BP 677A
EP 677A
DI 10.1016/j.bpj.2011.11.3681
PG 1
WC Biophysics
SC Biophysics
GA 179ZF
UT WOS:000321561204596
OA Bronze
DA 2021-01-25
ER

PT J
AU Borer, AS
   Wassmann, P
   Schmidt, M
   Hoffman, DR
   Zhou, JJ
   Wright, C
   Schirmer, T
   Markovic-Housley, Z
AF Borer, Aline S.
   Wassmann, Paul
   Schmidt, Margit
   Hoffman, Donald R.
   Zhou, Jing-Jiang
   Wright, Christine
   Schirmer, Tilman
   Markovic-Housley, Zora
TI Crystal Structure of Sol i 2: A Major Allergen from Fire Ant Venom
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE major fire ant allergen; Sol i 2; crystal structure; hydrophobic cavity;
   odorant binding protein and pheromone binding protein LUSH
ID SOLENOPSIS-GEMINATA HYMENOPTERA; BINDING-PROTEIN LUSH; X-RAY; INVICTA;
   PHEROMONE; EPITOPE; MODEL; IDENTIFICATION; HYALURONIDASE; RECOGNITION
AB Sol i 2 is a potent allergen from the venom of red imported fire ant, which contains allergens Sol i 1, Sol i 2, Sol i 3, and Sol i 4 that are known to be powerful triggers of anaphylaxis. Sol i 2 causes IgE antibody production in about one-third of individuals stung by fire ants. Baculovirus recombinant dimeric Sol i 2 was crystallized as a native and selenomethionyl-derivatized protein, and its structure has been determined by single-wavelength anomalous dispersion at 2.6 angstrom resolution. The overall fold of each subunit consists of five helices that enclose a central hydrophobic cavity. The structure is stabilized by three intramolecular disulfide bridges and one intermolecular disulfide bridge. The nearest structural homologue is the sequence-unrelated odorant binding protein and pheromone binding protein LUSH of the fruit fly Drosophila, which may suggest a similar biological function. To test this hypothesis, we measured the reversible binding of various pheromones, plant odorants, and other ligands to Sol i 2 by the changes in N-phenyl-1-naphthylamine fluorescence emission upon binding of ligands that compete with N-phenyl-1-naphthylamine. The highest binding affinity was observed for hydrophobic ligands such as aphid alarm pheromone (E)-beta-farnesene, analogs of ant alarm pheromones, and plant volatiles decane, undecane, and beta-caryophyllene. Conceivably, Sol i 2 may play a role in capturing and/or transporting small hydrophobic ligands such as pheromones, odors, fatty acids, or short-living hydrophobic primers. Molecular surface analysis, in combination with sequence alignment, can explain the serological cross-reactivity observed between some ant species. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Borer, Aline S.; Wassmann, Paul; Schirmer, Tilman; Markovic-Housley, Zora] Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   [Schmidt, Margit] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.
   [Hoffman, Donald R.] E Carolina Univ, Brody Sch Med, Dept Pathol & Lab Med, Greenville, NC 27834 USA.
   [Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England.
   [Wright, Christine] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.
RP Markovic-Housley, Z (corresponding author), Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
EM zora.housley@unibas.ch
OI Wassmann, Paul/0000-0001-7391-1065
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-116804]; North Carolina Biotechnology Center; Biotechnology
   and Biological Science Research Council of United Kingdom
FX We would like to thank the staff at synchrotron beamline PX of the Swiss
   Light Source. This study was supported by Swiss National Science
   Foundation grant 31-116804 (to Z.M.-H.), the North Carolina
   Biotechnology Center (D.R.H.), and Rothamsted Research grant-aided
   support from the Biotechnology and Biological Science Research Council
   of United Kingdom. We are also indebted to the Institute of Structural
   Biology and Drug Discovery, Virginia Commonwealth University (Richmond,
   VA), for the use of their excellent modeling facilities.
CR ABRAHAM DJ, 1994, J COMPUT AID MOL DES, V8, P41, DOI 10.1007/BF00124348
   Ader L, 2010, BIOCHEMISTRY-US, V49, P6136, DOI 10.1021/bi100540k
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BILLEN JPJ, 1987, NATURWISSENSCHAFTEN, V74, P340, DOI 10.1007/BF00367931
   Chan SL, 2006, J IMMUNOL, V176, P4852, DOI 10.4049/jimmunol.176.8.4852
   Chen L, 2009, TOXICON, V53, P479, DOI 10.1016/j.toxicon.2009.01.016
   Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Freeman TM, 1997, ANN ALLERG ASTHMA IM, V78, P369, DOI 10.1016/S1081-1206(10)63198-5
   Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040
   GHOSE AK, 1993, J COMPUT CHEM, V14, P1050, DOI 10.1002/jcc.540140907
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160
   Hoffman DR, 2005, J ALLERGY CLIN IMMUN, V115, P611, DOI 10.1016/j.jaci.2004.11.020
   HOFFMAN DR, 1995, ALLERGY, V50, P535, DOI 10.1111/j.1398-9995.1995.tb01196.x
   Hoffman DR, 1997, J ALLERGY CLIN IMMUN, V100, P679, DOI 10.1016/S0091-6749(97)70173-8
   HOFFMAN DR, 1988, J ALLERGY CLIN IMMUN, V82, P818, DOI 10.1016/0091-6749(88)90084-X
   HOFFMAN DR, 1990, J ALLERGY CLIN IMMUN, V85, P988, DOI 10.1016/0091-6749(90)90042-3
   HOFFMAN DR, 1991, ANN ALLERGY, V66, P29
   HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V91, P71, DOI 10.1016/0091-6749(93)90298-T
   HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7
   Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KELLOGG GE, 1992, MED CHEM RES, V1, P444
   Khan SA, 1999, ANN SAUDI MED, V19, P462, DOI 10.5144/0256-4947.1999.462
   Knight David, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P808
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960
   Lai LC, 2009, ENVIRON ENTOMOL, V38, P879, DOI 10.1603/022.038.0342
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046
   LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P
   Leslie A. G. W., 1992, 26 SERC DAR LAB
   MACCONNELL JG, 1974, ANN ENTOMOL SOC AM, V67, P134, DOI 10.1093/aesa/67.1.134
   Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6
   MENG EC, 1994, J COMPUT AID MOL DES, V8, P299, DOI 10.1007/BF00126747
   MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6
   Padavattan S, 2008, J MOL BIOL, V383, P178, DOI 10.1016/j.jmb.2008.08.023
   Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036
   Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018
   Partridge ME, 2008, ANN ALLERG ASTHMA IM, V100, P54, DOI 10.1016/S1081-1206(10)60405-X
   Schmidt M, 2003, ALLERGY, V58, P342, DOI 10.1034/j.1398-9995.2003.00085.x
   SCHMIDT M, 1993, FEBS LETT, V319, P138, DOI 10.1016/0014-5793(93)80053-W
   Schmidt M, 1996, J ALLERGY CLIN IMMUN, V98, P82, DOI 10.1016/S0091-6749(96)70229-4
   SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956
   TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6016
   Thode AB, 2008, J MOL BIOL, V376, P1360, DOI 10.1016/j.jmb.2007.12.063
   Vander Meer R. K., 1984, FIRE ANT RECRUITMENT
   VANDERMEER RK, 1988, J CHEM ECOL, V14, P825, DOI 10.1007/BF01018776
   VANDERMEER RK, 1980, ANN ENTOMOL SOC AM, V73, P609
   VANDERMEER RK, 1983, FLA ENTOMOL, V66, P139, DOI 10.2307/3494560
   WILSON EO, 1959, SCIENCE, V129, P643, DOI 10.1126/science.129.3349.643
   Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736
   Wright CS, 1996, PROTEIN SCI, V5, P1466, DOI 10.1002/pro.5560050803
   Wu Bi-qiu, 2008, Yingyong Shengtai Xuebao, V19, P151
   Zhou JJ, 2004, FEBS LETT, V558, P23, DOI 10.1016/S0014-5793(03)01521-7
NR 62
TC 22
Z9 23
U1 0
U2 13
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 27
PY 2012
VL 415
IS 4
BP 635
EP 648
DI 10.1016/j.jmb.2011.10.009
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 895CW
UT WOS:000300474800002
PM 22100449
DA 2021-01-25
ER

PT J
AU Jiang, YR
   Reichert, H
AF Jiang, Yanrui
   Reichert, Heinrich
TI Programmed cell death in type II neuroblast lineages is required for
   central complex development in the Drosophila brain
SO NEURAL DEVELOPMENT
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; POSTEMBRYONIC DEVELOPMENT;
   PROGENITOR CELLS; MOSAIC ANALYSIS; GENETIC-CONTROL; MODEL SYSTEM;
   PROLIFERATION; APOPTOSIS; MECHANISMS
AB Background: The number of neurons generated by neural stem cells is dependent upon the regulation of cell proliferation and by programmed cell death. Recently, novel neural stem cells that amplify neural proliferation through intermediate neural progenitors, called type II neuroblasts, have been discovered, which are active during brain development in Drosophila. We investigated programmed cell death in the dorsomedial (DM) amplifying type II lineages that contribute neurons to the development of the central complex in Drosophila, using clonal mosaic analysis with a repressible cell marker (MARCM) and lineage-tracing techniques.
   Results: A significant number of the adult-specific neurons generated in these DM lineages were eliminated by programmed cell death. Programmed cell death occurred during both larval and pupal stages. During larval development, approximately one-quarter of the neuronal (but not glial) cells in the lineages were eliminated by apoptosis before the formation of synaptic connectivity during pupal stages. Lineage-tracing experiments documented the extensive contribution of intermediate neural progenitor-containing DM lineages to all of the major modular substructures of the adult central complex. Moreover, blockage of apoptotic cell death specifically in these lineages led to prominent innervation defects of DM-derived neural progeny in the major neuropile substructures of the adult central complex.
   Conclusions: Our findings indicate that significant neural overproliferation occurs normally in type II DM lineage development, and that elimination of excess neurons in these lineages through programmed cell death is required for the formation of correct neuropile innervation in the developing central complex. Thus, amplification of neuronal proliferation through intermediate progenitors and reduction of neuronal number through programmed cell death operate in concert in type II neural stem-cell lineages during brain development.
C1 [Jiang, Yanrui; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Jiang, YR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM yanrui.jiang@unibas.ch
FU SNSF-NFP63 'Stem cells and regenerative medicine' [406340128006/1];
   SNSFSwiss National Science Foundation (SNSF) [31003A12488/1]
FX We thank Jan Pielage for nc82 antibodies; the Developmental Studies
   Hybridoma Bank and the Bloomington Drosophila Stock Center for
   antibodies and fly stocks, Bruno Bello, Gudrun Victorin, and other
   members of the Reichert lab for discussions and assistance, and Susanne
   Flister for excellent technical help. This work was supported by
   SNSF-NFP63 'Stem cells and regenerative medicine' grant 406340128006/1
   and SNSF grant 31003A12488/1 to HR.
CR ABRAMS JM, 1993, DEVELOPMENT, V117, P29
   Awad TA, 1997, DEV BIOL, V187, P283, DOI 10.1006/dbio.1997.8587
   Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Boyan G, 2010, J MORPHOL, V271, P949, DOI 10.1002/jmor.10847
   Boyan GS, 2011, TRENDS NEUROSCI, V34, P247, DOI 10.1016/j.tins.2011.02.002
   Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9
   Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   HAY BA, 1994, DEVELOPMENT, V120, P2121
   HOFBAUER A, 1991, THESIS U WURZBURG WU
   Izergina N, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-44
   Karcavich R, 2005, J COMP NEUROL, V481, P240, DOI 10.1002/cne.20371
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010
   Kumar A, 2009, DEVELOPMENT, V136, P3433, DOI 10.1242/dev.037226
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699
   Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014
   Lundell MJ, 2003, DEVELOPMENT, V130, P4109, DOI 10.1242/dev.00593
   Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P6093, DOI 10.1242/dev.01521
   Miyata T, 2010, CURR OPIN NEUROBIOL, V20, P22, DOI 10.1016/j.conb.2010.01.001
   Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809
   Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639
   Pereanu W, 2011, J COMP NEUROL, V519, P661, DOI 10.1002/cne.22542
   Peterson C, 2002, DEVELOPMENT, V129, P1467
   Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105
   Rein K, 1999, CURR BIOL, V9, P93, DOI 10.1016/S0960-9822(99)80021-9
   Rogulja-Ortmann A, 2008, DEVELOPMENT, V135, P3435, DOI 10.1242/dev.023986
   Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Spindler SR, 2010, DEV GENES EVOL, V220, P1, DOI 10.1007/s00427-010-0323-7
   Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   Viktorin G, 2011, DEV BIOL, V356, P553, DOI 10.1016/j.ydbio.2011.06.013
   Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008
   Weng M, 2011, CURR OPIN NEUROBIOL, V21, P36, DOI 10.1016/j.conb.2010.09.005
   Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007
   WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319
   Williams JLD, 2008, ARTHROPOD STRUCT DEV, V37, P129, DOI 10.1016/j.asd.2007.05.005
NR 48
TC 28
Z9 28
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1749-8104
J9 NEURAL DEV
JI Neural Dev.
PD JAN 18
PY 2012
VL 7
AR 3
DI 10.1186/1749-8104-7-3
PG 14
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 918CW
UT WOS:000302227900001
PM 22257485
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Gentner, M
   Allan, MG
   Zaehringer, F
   Schirmer, T
   Grzesiek, S
AF Gentner, Martin
   Allan, Martin G.
   Zaehringer, Franziska
   Schirmer, Tilman
   Grzesiek, Stephan
TI Oligomer Formation of the Bacterial Second Messenger c-di-GMP: Reaction
   Rates and Equilibrium Constants Indicate a Monomeric State at
   Physiological Concentrations
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID CYCLIC DIGUANYLIC ACID; STRUCTURAL BASIS; NMR; POLYMORPHISM; RESOLUTION;
   MECHANISM; MOLECULE; FORMS
AB Cyclic diguanosine-monophosphate (c-di-GMP) is a bacterial signaling molecule that triggers a switch from motile to sessile bacterial lifestyles. This mechanism is of considerable pharmaceutical interest, since it is related to bacterial virulence, biofilm formation, and persistence of infection. Previously, c-di-GMP has been reported to display a rich polymorphism of various oligomeric forms at millimolar concentrations, which differ in base stacking and G-quartet interactions Here, we have analyzed the equilibrium and exchange kinetics between these various forms by NMR spectroscopy. We find that the association of the monomer into a dimeric form is in fast exchange (<milliseconds) with an equilibrium constant of about 1 mM. At concentrations above 100 mu M, higher oligomers are formed in the presence of cations. These are presumably tetramers and octamers, with octamers dominating above about 0.5 mM. Thus, at the low micromolar concentrations of the cellular environment and in the absence of additional compounds that stabilize oligomers, c-di-GMP should be predominantly monomeric. This finding has important implications for the understanding of c-di-GMP recognition by protein receptors. In contrast to the monomer/dimer exchange, formation and dissociation of higher oligomers occurs on a time scale of several hours to days. The time course can be described quantitatively by a simple kinetic model where tetramers are intermediates of octamer formation. The extremely slow oligomer dissociation may generate severe artifacts in biological experiments when c-di-GMP is diluted from concentrated stock solution. We present a simple method to quantify c-di-GMP monomers and oligomers from UV spectra and a procedure to dissolve the unwanted oligomers by an annealing step.
C1 [Gentner, Martin; Allan, Martin G.; Zaehringer, Franziska; Schirmer, Tilman; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch; stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
FU SNF [31-132857, 31-105587]
FX We thank U. Jenal, D. Haussinger, H.-J. Sass, and D. Samoray for helpful
   discussions. This work was supported by SNF grants 31-132857 to S.G. and
   31-105587 to T.S.
CR Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966
   Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918
   BLOMMERS MJJ, 1988, BIOCHEMISTRY-US, V27, P8361, DOI 10.1021/bi00422a011
   BOCK RM, 1956, ARCH BIOCHEM BIOPHYS, V62, P253, DOI 10.1016/0003-9861(56)90123-0
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   DANILOV VI, 1974, FEBS LETT, V47, P155, DOI 10.1016/0014-5793(74)80448-5
   De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067
   EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235
   Gilbert DE, 1999, CURR OPIN STRUC BIOL, V9, P305, DOI 10.1016/S0959-440X(99)80041-4
   GUAN Y, 1993, J BIOMOL STRUCT DYN, V11, P253, DOI 10.1080/07391102.1993.10508725
   Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047
   Ida R, 2008, J AM CHEM SOC, V130, P3590, DOI 10.1021/ja709975z
   Ida R, 2007, CHEM COMMUN, P795, DOI 10.1039/b613105k
   Kim D., 2010, 2 MESSENGER CYCLIC D, P76
   Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007
   Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185
   Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517
   LIAW YC, 1990, FEBS LETT, V264, P223, DOI 10.1016/0014-5793(90)80253-F
   Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200
   MOOREN MMW, 1994, NUCLEIC ACIDS RES, V22, P2658, DOI 10.1093/nar/22.13.2658
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Nakayama S, 2011, CHEM COMMUN, V47, P4766, DOI 10.1039/c0cc05432a
   Nakayama S, 2011, J AM CHEM SOC, V133, P4856, DOI 10.1021/ja1091062
   Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010
   Phillips K, 1997, J MOL BIOL, V273, P171, DOI 10.1006/jmbi.1997.1292
   Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Simm R, 2009, ANAL BIOCHEM, V386, P53, DOI 10.1016/j.ab.2008.12.013
   Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108
   Wang JX, 2011, J AM CHEM SOC, V133, P9320, DOI 10.1021/ja1112029
   Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t
   Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x
   Zhang LX, 2011, CHEMPHYSCHEM, V12, P295, DOI 10.1002/cphc.201000692
   Zhang ZY, 2006, J AM CHEM SOC, V128, P7015, DOI 10.1021/ja0613714
   Zhang ZY, 2004, J AM CHEM SOC, V126, P16700, DOI 10.1021/ja0449832
   Zhao JW, 2009, NUCLEOS NUCLEOT NUCL, V28, P352, DOI 10.1080/15257770903044523
NR 38
TC 34
Z9 35
U1 0
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
EI 1520-5126
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JAN 18
PY 2012
VL 134
IS 2
BP 1019
EP 1029
DI 10.1021/ja207742q
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 903AC
UT WOS:000301084300058
PM 22142443
DA 2021-01-25
ER

PT J
AU Wang, SS
   Meyer, H
   Ochoa-Espinosa, A
   Buchwald, U
   Onel, S
   Altenhein, B
   Heinisch, JJ
   Affolter, M
   Paululat, A
AF Wang, Shuoshuo
   Meyer, Heiko
   Ochoa-Espinosa, Amanda
   Buchwald, Ulf
   Oenel, Susanne
   Altenhein, Benjamin
   Heinisch, Juergen J.
   Affolter, Markus
   Paululat, Achim
TI GBF1 (Gartenzwerg)-dependent secretion is required for Drosophila
   tubulogenesis
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE ADP-ribosylation factor (Arf); COPI; Extracellular matrix (ECM); Guanine
   nucleotide exchange factor (GEF); Intracellular trafficking; Lipid
   homeostasis; Secretory pathway; Tubulogenesis
ID NUCLEOTIDE EXCHANGE FACTORS; OF-FUNCTION SCREEN; ADP-RIBOSYLATION;
   PROTEIN SECRETION; FACTORS GEA1P; CIS-GOLGI; TUBE MORPHOGENESIS; ARF;
   BINDING; GENES
AB Here we report on the generation and in vivo analysis of a series of loss-of-function mutants for the Drosophila ArfGEF, Gartenzwerg. The Drosophila gene gartenzwerg (garz) encodes the orthologue of mammalian GBF1. garz is expressed ubiquitously in embryos with substantially higher abundance in cells forming diverse tubular structures such as salivary glands, trachea, proventriculus or hindgut. In the absence of functional Garz protein, the integrity of the Golgi complex is impaired. As a result, both vesicle transport of cargo proteins and directed apical membrane delivery are severely disrupted. Dysfunction of the Arf1-COPI machinery caused by a loss of Garz leads to perturbations in establishing a polarized epithelial architecture of tubular organs. Furthermore, insufficient apical transport of proteins and other membrane components causes incomplete luminal diameter expansion and deficiencies in extracellular matrix assembly. The fact that homologues of Garz are present in every annotated metazoan genome indicates that secretion processes mediated by the GBF-type ArfGEFs play a universal role in animal development.
C1 [Wang, Shuoshuo; Meyer, Heiko; Buchwald, Ulf; Heinisch, Juergen J.; Paululat, Achim] Univ Osnabruck, Dept Biol, D-49069 Osnabruck, Germany.
   [Ochoa-Espinosa, Amanda; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Oenel, Susanne] Univ Marburg, Fachbereich Biol, D-35043 Marburg, Germany.
   [Altenhein, Benjamin] Johannes Gutenberg Univ Mainz, Inst Genet, D-55099 Mainz, Germany.
RP Paululat, A (corresponding author), Univ Osnabruck, Dept Biol, Barbarastr 11, D-49069 Osnabruck, Germany.
EM paululat@biologie.uni-osnabrueck.de
RI Heinisch, Juergen J./G-3801-2017; Wang, Shuoshuo/J-6649-2014
OI Wang, Shuoshuo/0000-0002-8216-6164; Ochoa-Espinosa,
   Amanda/0000-0003-1943-790X; Harten, Heiko/0000-0002-3304-4523; Affolter,
   Markus/0000-0002-5171-0016
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB
   431, SFB 944]; SystemsX.ch; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Kantons of Basel-Stadt and
   Basel-Land
FX This work was supported by the Deutsche Forschungsgemeinschaft within
   the framework of the SFB 431 and SFB 944 to A.P. and to J.J.H. A.O. and
   M.A. were supported by SystemsX.ch within the framework of the WingX
   RID, the Swiss National Science Foundation and the Kantons of
   Basel-Stadt and Basel-Land.
CR Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525
   Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498
   Albrecht S, 2006, MECH DEVELOP, V123, P372, DOI 10.1016/j.mod.2006.03.005
   Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016
   Alexandre Cyrille, 2008, V420, P197, DOI 10.1007/978-1-59745-583-1_11
   Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024
   Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003
   Baer MM, 2009, CURR TOP DEV BIOL, V89, P137, DOI 10.1016/S0070-2153(09)89006-6
   Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377
   Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611
   Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427
   Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292
   Benhra N, 2011, CURR BIOL, V21, P87, DOI 10.1016/j.cub.2010.12.010
   Boal F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009898
   Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619
   Bonifacino JS, 2003, CELL, V112, P141, DOI 10.1016/S0092-8674(03)00038-2
   Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523
   Chantalat S, 2003, MOL BIOL CELL, V14, P2357, DOI 10.1091/mbc.E02-10-0693
   Chung S, 2008, J CELL SCI, V121, P3501, DOI 10.1242/jcs.037887
   Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71
   de Wit MCY, 2009, NEUROGENETICS, V10, P333, DOI 10.1007/s10048-009-0192-2
   Duan H, 2001, DEVELOPMENT, V128, P4489
   Forster D, 2010, CURR BIOL, V20, P62, DOI 10.1016/j.cub.2009.11.062
   Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547
   Fucini RV, 2000, J BIOL CHEM, V275, P18824, DOI 10.1074/jbc.M000024200
   Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5
   Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926
   Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209
   Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607
   Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241
   Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928
   Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768
   Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106
   Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235
   Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423
   KAHN RA, 1986, J BIOL CHEM, V261, P7906
   Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980
   Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x
   KIEHART DP, 1990, CELL, V60, P347, DOI 10.1016/0092-8674(90)90583-Z
   Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5
   LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   Lehmacher C, 2009, ARTHROPOD STRUCT DEV, V38, P111, DOI 10.1016/j.asd.2008.09.002
   Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072
   Maybeck V, 2009, GENETICS, V181, P543, DOI 10.1534/genetics.108.094052
   Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x
   Meyer H, 2009, J EXP BIOL, V212, P3673, DOI 10.1242/jeb.034272
   Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20
   Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715
   Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599
   Norum M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010802
   Peyroche A, 2001, METHOD ENZYMOL, V329, P290
   Peyroche A, 2001, J CELL SCI, V114, P2241
   Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200
   Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967
   Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418
   Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658
   Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144
   Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016
   Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276
   Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130
   Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018
   Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035
   Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003
   Strilic B, 2010, CELL MOL LIFE SCI, V67, P3209, DOI 10.1007/s00018-010-0400-0
   Swanson LE, 2009, GENETICS, V181, P1281, DOI 10.1534/genetics.108.099531
   Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x
   Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769
   Szul Tomasz, 2011, Cell Logist, V1, P69
   Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023
   TEPASS U, 1994, DEVELOPMENT, V120, P579
   TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L
   Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008
   Vef O, 2006, DEV GENES EVOL, V216, P105, DOI 10.1007/s00427-005-0036-5
   Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045
   Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128
   Zakrzewska E, 2003, GENETICS, V165, P985
   Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420
NR 80
TC 20
Z9 20
U1 0
U2 8
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JAN 15
PY 2012
VL 125
IS 2
BP 461
EP 472
DI 10.1242/jcs.092551
PG 12
WC Cell Biology
SC Cell Biology
GA 909GM
UT WOS:000301551000020
PM 22302994
OA Bronze
DA 2021-01-25
ER

PT J
AU Robitaille, AM
   Hall, MN
AF Robitaille, Aaron M.
   Hall, Michael N.
TI Ramping Up Mitosis: An AMPK alpha 2-Regulated Signaling Network Promotes
   Mitotic Progression
SO MOLECULAR CELL
LA English
DT Editorial Material
ID ACTIVATED PROTEIN-KINASE; ENERGY SENSOR; PHOSPHORYLATION; CYTOKINESIS
AB In the December 23rd issue of Molecular Cell, Banko et al. (2011) describe a chemical genetic screen that identified 28 novel AMPK alpha 2 direct substrates. A subset of these substrates comprise a signaling network by which AMPK, seemingly independent of cellular energy status, promotes mitotic progression.
C1 [Robitaille, Aaron M.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
OI Robitaille, Aaron Mark/0000-0003-2774-2066
CR Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005
   Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/NCHEMBIO.610, 10.1038/nchembio.610]
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111
   Komatsu S, 2000, J BIOL CHEM, V275, P34512, DOI 10.1074/jbc.M003019200
   Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828
   Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053
   Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003
   Vazquez-Martin A, 2009, CELL CYCLE, V8, P2385, DOI 10.4161/cc.8.15.9082
   Winder WW, 2000, J APPL PHYSIOL, V88, P2219
NR 10
TC 5
Z9 5
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1097-2765
J9 MOL CELL
JI Mol. Cell
PD JAN 13
PY 2012
VL 45
IS 1
BP 8
EP 9
DI 10.1016/j.molcel.2011.12.018
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 879AE
UT WOS:000299301300004
PM 22244327
DA 2021-01-25
ER

PT J
AU Singh, P
   Cabernard, C
AF Singh, Priyanka
   Cabernard, Clemens
TI Neurogenesis: Premature Mitotic Entry Lets Cleavage Planes Take Off!
SO CURRENT BIOLOGY
LA English
DT Editorial Material
ID SPINDLE ORIENTATION; DROSOPHILA NEUROBLASTS; CENTROSOMES; CENTRIOLES;
   CHECKPOINT; DIVISION; PROTEIN; PATHWAY; CELLS; CYCLE
C1 [Singh, Priyanka; Cabernard, Clemens] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Singh, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM priyanka.singh@unibas.ch; clemens.cabernard@unibas.ch
RI singh, priyanka/N-1372-2018
OI singh, priyanka/0000-0003-0841-1544; Singh, Priyanka/0000-0002-5928-6280
CR Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025
   Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009
   Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103
   Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342
   Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165
   Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021
   Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140
   Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Wang C, 2011, DEV CELL, V21, P520, DOI 10.1016/j.devcel.2011.08.002
   Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200
   Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128
NR 14
TC 0
Z9 0
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD JAN 10
PY 2012
VL 22
IS 1
BP R25
EP R28
DI 10.1016/j.cub.2011.11.015
PG 4
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 876YR
UT WOS:000299144200013
PM 22240477
DA 2021-01-25
ER

PT S
AU Engstler, M
   Heddergott, N
   Kruger, T
   Stellamanns, E
   Uppaluri, S
   Pfohl, T
AF Engstler, Markus
   Heddergott, Niko
   Krueger, Tim
   Stellamanns, Eric
   Uppaluri, Sravanti
   Pfohl, Thomas
BE Tropea, C
   Bleckmann, H
TI African Trypanosomes as Model System for Functional Analyses of
   Microbial Motility
SO NATURE-INSPIRED FLUID MECHANICS: RESULTS OF THE DFG PRIORITY PROGRAMME
   1207 NATURE-INSPIRED FLUID MECHANICS 2006-2012
SE Notes on Numerical Fluid Mechanics and Multidisciplinary Design
LA English
DT Article; Book Chapter
ID SLEEPING SICKNESS; CELL BIOLOGY; SURFACE; CILIA; BRUCEI;
   DIFFERENTIATION; FLAGELLAR; TRAFFICKING; MEMBRANES
C1 [Engstler, Markus; Heddergott, Niko; Krueger, Tim] Univ Wurzburg, Dept Cell & Dev Biol, Biozentrum, D-97070 Wurzburg, Germany.
   [Stellamanns, Eric; Uppaluri, Sravanti; Pfohl, Thomas] Max Planck Inst Dynam & Self Org, Gottingen, Germany.
   [Pfohl, Thomas] Univ Basel, Dept Chem, Basel, Switzerland.
RP Engstler, M (corresponding author), Univ Wurzburg, Dept Cell & Dev Biol, Biozentrum, D-97070 Wurzburg, Germany.
RI Pfohl, Thomas/D-7296-2016
OI Pfohl, Thomas/0000-0002-7879-5216; Kruger, Timothy/0000-0001-5544-1098
CR Afzelius BA, 1999, INT J DEV BIOL, V43, P283
   ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653
   Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010
   BLOODGOOD RA, 1979, J CELL BIOL, V82, P664, DOI 10.1083/jcb.82.3.664
   Brokaw C.J., 1982, Progress in Clinical and Biological Research, V80, P137
   Carrington M, 1996, MOL BIOCHEM PARASIT, V81, P119, DOI 10.1016/0166-6851(96)02706-5
   Davis S, 2011, PARASITOLOGY, V138, P516, DOI 10.1017/S0031182010001496
   Egorova A.D., 2011, DIFFERENTIATION RES, DOI [10.1016/j.diff.2011.11.007, DOI 10.1016/J.DIFF.2011.11.007]
   Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404
   Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046
   Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014
   Field MC, 2009, INT REV CEL MOL BIO, V278, P1, DOI 10.1016/S1937-6448(09)78001-3
   FIELD MC, 2004, OFFICIAL J MICROSCOP, V10, P621, DOI DOI 10.1017/S1431927604040942
   Fliegauf M, 2006, TRENDS GENET, V22, P241, DOI 10.1016/j.tig.2006.03.002
   Heddergott M., 2011, THESIS U WUERZBURG
   Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067
   Horn D, 2010, CURR OPIN MICROBIOL, V13, P700, DOI 10.1016/j.mib.2010.08.009
   Howard J., 2001, MECH MOTOR PROTEINS
   Koster S, 2009, CELL MOTIL CYTOSKEL, V66, P771, DOI 10.1002/cm.20336
   Lindemann CB, 2010, J CELL SCI, V123, P519, DOI 10.1242/jcs.051326
   Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x
   MILES CA, 1971, BIOPHYS J, V11, P851, DOI 10.1016/S0006-3495(71)86259-8
   Mitchison TJ, 2010, NATURE, V463, P308, DOI 10.1038/463308a
   Overath P, 2001, INT J PARASITOL, V31, P468, DOI 10.1016/S0020-7519(01)00152-7
   Paliwal Sarvesh K, 2011, Sci Pharm, V79, P389, DOI 10.3797/scipharm.1012-08
   PARSONS M, 1990, MOL BIOCHEM PARASIT, V42, P197, DOI 10.1016/0166-6851(90)90162-F
   Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353
   Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106
   SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111
   Salisbury JL, 2004, CURR BIOL, V14, pR765, DOI 10.1016/j.cub.2004.09.016
   SINGER SJ, 1971, AM J PATHOL, V65, P427
   STAHL N, 1963, SCIENCE, V141, P1282, DOI 10.1126/science.141.3587.1282
   Stellamanns E., 2011, THESIS U GOTTINGEN
   THOMAS JR, 1990, BIOCHEMISTRY-US, V29, P5413, DOI 10.1021/bi00475a001
   Uppaluri S., 2011, THESIS U GOTTINGEN
   Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058
   YAGI T, 1995, CELL MOTIL CYTOSKEL, V31, P207, DOI 10.1002/cm.970310304
   Zaburdaev V, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.208103
NR 38
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1612-2909
BN 978-3-642-28301-7
J9 NOTES NUMER FLUID ME
PY 2012
VL 119
BP 43
EP 61
D2 10.1007/978-3-642-28301-7
PG 19
WC Engineering, Multidisciplinary
SC Engineering
GA BHH58
UT WOS:000325437700004
DA 2021-01-25
ER

PT J
AU Saini, N
   Reichert, H
AF Saini, Nidhi
   Reichert, Heinrich
TI Neural Stem Cells in Drosophila: Molecular Genetic Mechanisms Underlying
   Normal Neural Proliferation and Abnormal Brain Tumor Formation
SO STEM CELLS INTERNATIONAL
LA English
DT Review
ID REGULATES SPINDLE ORIENTATION; II NEUROBLAST LINEAGES; SELF-RENEWAL;
   ASYMMETRIC DIVISION; SIGNALING PATHWAYS; NERVOUS-SYSTEM; DAUGHTER CELL;
   G-PROTEIN; POSTEMBRYONIC NEUROBLASTS; NEURONAL DIFFERENTIATION
AB Neural stem cells in Drosophila are currently one of the best model systems for understanding stem cell biology during normal development and during abnormal development of stem cell-derived brain tumors. In Drosophila brain development, the proliferative activity of neural stem cells called neuroblasts gives rise to both the optic lobe and the central brain ganglia, and asymmetric cell divisions are key features of this proliferation. The molecular mechanisms that underlie the asymmetric cell divisions by which these neuroblasts self-renew and generate lineages of differentiating progeny have been studied extensively and involve two major protein complexes, the apical complex which maintains polarity and controls spindle orientation and the basal complex which is comprised of cell fate determinants and their adaptors that are segregated into the differentiating daughter cells during mitosis. Recent molecular genetic work has established Drosophila neuroblasts as a model for neural stem cell-derived tumors in which perturbation of key molecular mechanisms that control neuroblast proliferation and the asymmetric segregation of cell fate determinants lead to brain tumor formation. Identification of novel candidate genes that control neuroblast self-renewal and differentiation as well as functional analysis of these genes in normal and tumorigenic conditions in a tissue-specific manner is now possible through genome-wide transgenic RNAi screens. These cellular and molecular findings in Drosophila are likely to provide valuable genetic links for analyzing mammalian neural stem cells and tumor biology.
C1 [Saini, Nidhi; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Saini, N (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM nidhi.saini@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); National Research Program 63 Stem Cells and Regenerative
   Medicine [406340 128006/1]
FX The authors thank Boris Egger for comments on the manuscript. This work
   was supported by the Swiss National Science Foundation and National
   Research Program 63 Stem Cells and Regenerative Medicine (406340
   128006/1).
CR Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056
   Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26
   Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Boulay JL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-71
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Brand AH, 2011, NEURON, V70, P719, DOI 10.1016/j.neuron.2011.05.016
   Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334
   Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009
   Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029
   Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632
   Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110
   Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159
   Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015
   Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1
   Egger B, 2011, FLY, V5, P237, DOI 10.4161/fly.5.3.15640
   Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250
   FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0
   Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8
   GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y
   GATEFF E, 1994, INT J DEV BIOL, V38, P565
   GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525
   Glotzer M, 2004, J CELL BIOL, V164, P347, DOI 10.1083/jcb.200310112
   Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388
   Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103
   GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712
   Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0
   Harris H, 2005, BIOESSAYS, V27, P833, DOI 10.1002/bies.20263
   HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871
   Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070
   HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0
   HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393
   IkeshimaKataoka H, 1997, NATURE, V390, P625
   Ito K, 1997, DEVELOPMENT, V124, P761
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162
   Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409
   Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481
   Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7
   KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0
   Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0
   Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052
   Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922
   Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017
   Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Loop T, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-24
   Matsuzaki F, 1998, DEVELOPMENT, V125, P4089
   Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009
   Morante J, 2011, DEVELOPMENT, V138, P687, DOI 10.1242/dev.056069
   Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014
   Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022
   Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809
   Ngo KT, 2010, DEV BIOL, V346, P284, DOI 10.1016/j.ydbio.2010.07.036
   O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0
   Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087
   Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140
   Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094
   Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550
   Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020
   Potter CJ, 2000, TRENDS GENET, V16, P33, DOI 10.1016/S0168-9525(99)01878-8
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021
   Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974
   Reddy BVVG, 2010, DEVELOPMENT, V137, P2397, DOI 10.1242/dev.050013
   RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0
   Richter C, 2011, NAT CELL BIOL, V13, P1029, DOI 10.1038/ncb2306
   Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079
   Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345
   Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221
   Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2
   Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9
   Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135
   Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847
   Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024
   Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801
   Southall TD, 2008, COLD SH Q B, V73, P523, DOI 10.1101/sqb.2008.73.051
   Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309
   SPANA EP, 1995, DEVELOPMENT, V121, P3187
   SPANA EP, 1995, DEVELOPMENT, V121, P3489
   Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959
   Truman James W., 1993, P1245
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Wang W, 2011, DEV BIOL, V350, P414, DOI 10.1016/j.ydbio.2010.12.002
   Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007
   WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5
   Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361
   Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128
   Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003
   Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005
   Wu PS, 2008, SEMIN CELL DEV BIOL, V19, P283, DOI 10.1016/j.semcdb.2008.01.007
   Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938
   Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795
   Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117
   Yasugi T, 2010, DEVELOPMENT, V137, P3193, DOI 10.1242/dev.048058
   Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505
   Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5
   Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174
NR 111
TC 12
Z9 13
U1 0
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PY 2012
VL 2012
AR 486169
DI 10.1155/2012/486169
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 209OZ
UT WOS:000323769800001
PM 22737173
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT S
AU Hiller, S
   Wider, G
AF Hiller, Sebastian
   Wider, Gerhard
BE Billeter, M
   Orekhov, V
TI Automated Projection Spectroscopy and Its Applications
SO NOVEL SAMPLING APPROACHES IN HIGHER DIMENSIONAL NMR
SE Topics in Current Chemistry-Series
LA English
DT Review; Book Chapter
DE APSY; Automated peak picking; Automated resonance assignment; GAPRO;
   NMR; Projection spectroscopy; Protein backbone; Protein side chains
ID SIDE-CHAIN RESONANCES; NMR-SPECTROSCOPY; REDUCED-DIMENSIONALITY;
   MULTIDIMENSIONAL NMR; BIOLOGICAL MACROMOLECULES; DENATURED STATES;
   APSY-NMR; GFT-NMR; PROTEIN; ASSIGNMENT
AB This chapter presents the NMR technique APSY (automated projection spectroscopy) and its applications for sequence-specific resonance assignments of proteins. The result of an APSY experiment is a list of chemical shift correlations for an N-dimensional NMR spectrum (N >= 3). This list is obtained in a fully automated way by the dedicated algorithm GAPRO (geometric analysis of projections) from a geometric analysis of experimentally recorded, low-dimensional projections. Because the positions of corresponding peaks in multiple projections are correlated, thermal noise and other uncorrelated artifacts are efficiently suppressed. We describe the theoretical background of the APSY method and discuss technical aspects that guide its optimal use. Further, applications of APSY-NMR spectroscopy for fully automated sequence-specific backbone and side chain assignments of proteins are described. We discuss the choice of suitable experiments for this purpose and show several examples. APSY is of particular interest for the assignment of soluble unfolded proteins, which is a time-consuming task by conventional means. With this class of proteins, APSY-NMR experiments with up to seven dimensions have been recorded. Sequence-specific assignments of protein side chains in turn are obtained from a 5D TOCSY-APSY-NMR experiment.
C1 [Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Wider, Gerhard] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.
RP Wider, G (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.
EM sebastian.hiller@unibas.ch; gsw@mol.biol.ethz.ch
RI Hiller, Sebastian/B-3573-2008
OI Hiller, Sebastian/0000-0002-6709-4684; Wider,
   Gerhard/0000-0001-9366-7645
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); ETH ZurichETH Zurich; NCCR Structural BiologySwiss National
   Science Foundation (SNSF); Biozentrum Basel
FX Financial support from the Swiss National Science Foundation, the ETH
   Zurich, the NCCR Structural Biology, and the Biozentrum Basel is
   gratefully acknowledged.
CR ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223
   Baran MC, 2004, CHEM REV, V104, P3541, DOI 10.1021/cr030408p
   Bartels C, 1997, J COMPUT CHEM, V18, P139, DOI 10.1002/(SICI)1096-987X(19970115)18:1<139::AID-JCC13>3.0.CO;2-H
   BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001
   Bracewell R.N., 1956, Australian Journal of Physics, V9, P198
   BRAUN D, 1994, J AM CHEM SOC, V116, P8466, DOI 10.1021/ja00098a005
   BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3
   Brutscher B, 1995, J MAGN RESON SER B, V109, P238
   CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027
   Coggins BE, 2006, J BIOMOL NMR, V34, P179, DOI 10.1007/s10858-006-0020-z
   Cornilescu G, 2007, J BIOMOL NMR, V38, P341, DOI 10.1007/s10858-007-9173-7
   Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Dyson HJ, 2001, METHOD ENZYMOL, V339, P258
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Eghbalnia HR, 2005, J AM CHEM SOC, V127, P12528, DOI 10.1021/ja052120I
   EMSLEY L, 1990, CHEM PHYS LETT, V165, P469, DOI 10.1016/0009-2614(90)87025-M
   Ernst R.R., 1987, PRINCIPLES NUCL MAGN
   Etezady-Esfarjani T, 2003, J BIOMOL NMR, V25, P167, DOI 10.1023/A:1022215901456
   Fiorito F, 2006, J BIOMOL NMR, V35, P27, DOI 10.1007/s10858-006-0030-x
   Freeman R, 2004, CONCEPT MAGN RESON A, V23A, P63, DOI 10.1002/cmr.a.20021
   GEEN H, 1991, J MAGN RESON, V93, P93, DOI 10.1016/0022-2364(91)90034-Q
   Gossert AD, 2011, J AM CHEM SOC, V133, P210, DOI 10.1021/ja108383x
   GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   Guntert P, 2000, J BIOMOL NMR, V18, P129, DOI 10.1023/A:1008318805889
   Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432
   Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102
   Hiller S, 2008, J BIOMOL NMR, V42, P179, DOI 10.1007/s10858-008-9266-y
   Hiller S, 2008, J AM CHEM SOC, V130, P12073, DOI 10.1021/ja803161d
   Hiller S, 2007, J AM CHEM SOC, V129, P10823, DOI 10.1021/ja072564+
   Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o
   Jiang L, 2005, J MAGN RESON, V175, P170, DOI 10.1016/j.jmr.2005.03.014
   Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X
   Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d
   Koradi R, 1998, J MAGN RESON, V135, P288, DOI 10.1006/jmre.1998.1570
   Kozminski W, 2003, J BIOMOL NMR, V26, P157, DOI 10.1023/A:1023550224391
   Kupce E, 2004, J AM CHEM SOC, V126, P6429, DOI 10.1021/ja049432q
   Kupce E, 2004, J BIOMOL NMR, V28, P391, DOI 10.1023/B:JNMR.0000015421.60023.e5
   Kupce E, 2003, J AM CHEM SOC, V125, P13958, DOI 10.1021/ja038297z
   Kupce E, 2003, J BIOMOL NMR, V27, P383, DOI 10.1023/A:1025819517642
   Kupce E, 2006, J AM CHEM SOC, V128, P6020, DOI 10.1021/ja0609598
   LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0
   Lescop E, 2007, J AM CHEM SOC, V129, P11916, DOI 10.1021/ja0751577
   Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008
   LOGAN TM, 1992, FEBS LETT, V314, P413, DOI 10.1016/0014-5793(92)81517-P
   Luan T, 2005, J BIOMOL NMR, V33, P1, DOI 10.1007/s10858-005-1363-6
   Malmodin D, 2005, J AM CHEM SOC, V127, P13486, DOI 10.1021/ja0545822
   Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428
   MERSEREAU RM, 1974, P IEEE, V62, P1319, DOI 10.1109/PROC.1974.9625
   Mishkovsky M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2748768
   MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051
   MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058
   Moseley HNB, 2004, J MAGN RESON, V170, P263, DOI 10.1016/j.jmr.2004.06.015
   NAGAYAMA K, 1978, J MAGN RESON, V31, P133, DOI 10.1016/0022-2364(78)90176-2
   Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f
   OH BH, 1988, SCIENCE, V240, P908, DOI 10.1126/science.3129784
   Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Plaxco KW, 1997, NATURE, V386, P657, DOI 10.1038/386657a0
   RICHARZ R, 1978, BIOPOLYMERS, V17, P2133, DOI 10.1002/bip.1978.360170908
   Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516
   SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X
   SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3
   SHORTLE D, 1993, CURR OPIN STRUC BIOL, V3, P66, DOI 10.1016/0959-440X(93)90204-X
   Sun ZYJ, 2005, J BIOMOL NMR, V32, P55, DOI 10.1007/s10858-005-3339-y
   Szyperski T, 2002, P NATL ACAD SCI USA, V99, P8009, DOI 10.1073/pnas.122224599
   SZYPERSKI T, 1993, J AM CHEM SOC, V115, P9307, DOI 10.1021/ja00073a064
   Szyperski T, 2006, MAGN RESON CHEM, V44, pS51, DOI 10.1002/mrc.1817
   Tafer H, 2004, BIOCHEMISTRY-US, V43, P860, DOI 10.1021/bi0356606
   Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t
   Wider G, 1998, PROG NUCL MAG RES SP, V32, P193, DOI 10.1016/S0079-6565(98)00014-4
   WUTHRICH K, 1994, CURR OPIN STRUC BIOL, V4, P93, DOI 10.1016/S0959-440X(94)90065-5
   Wuthrich K, 2003, ANGEW CHEM INT EDIT, V42, P3340, DOI 10.1002/anie.200300595
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Xia YL, 2004, J BIOMOL NMR, V29, P467
   Zhang Q, 2008, J BIOMOL NMR, V40, P157, DOI 10.1007/s10858-008-9224-8
NR 80
TC 15
Z9 15
U1 0
U2 13
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0340-1022
EI 1436-5049
BN 978-3-642-27160-1; 978-3-642-27159-5
J9 TOP CURR CHEM
JI Top. Curr. Chem.
PY 2012
VL 316
BP 21
EP 47
DI 10.1007/128_2011_189
D2 10.1007/978-3-642-27160-1
PG 27
WC Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
SC Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA BFV76
UT WOS:000321578100003
PM 21710379
DA 2021-01-25
ER

PT J
AU Jaskiewicz, L
   Zavolan, M
AF Jaskiewicz, Lukasz
   Zavolan, Mihaela
TI Dicer partners expand the repertoire of miRNA targets
SO GENOME BIOLOGY
LA English
DT Editorial Material
ID PROTEINS; PATHWAY
AB Processing of pre-miRNAs by Dicer is regulated by its dsRNA-binding protein partner, and leads to the generation of alternative miRNA forms with distinct target sets.
C1 [Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041
CR Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236
   Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112
   Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710
   Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755
NR 10
TC 1
Z9 1
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1474-7596
J9 GENOME BIOL
JI Genome Biol.
PY 2012
VL 13
IS 11
AR 179
DI 10.1186/gb-2012-13-11-179
PG 4
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 102UC
UT WOS:000315868700013
PM 23194401
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT S
AU Arber, W
AF Arber, Werner
BE Piguet, P
   Poindron, P
TI Restriction Enzymes: From Their Discovery to Their Applications
SO GENETICALLY MODIFIED ORGANISMS AND GENETIC ENGINEERING IN RESEARCH AND
   THERAPY
SE BIOVALLEY MONOGRAPHS
LA English
DT Article; Book Chapter
ID HOST-CONTROLLED MODIFICATION; ESCHERICHIA-COLI; DNA RESTRICTION;
   SPECIFICITY; BACTERIOPHAGE; LAMBDA
AB As a contribution to the history of science, the discovery and the functions of bacterial restriction endonucleases, as well as their applications in molecular genetic analysis and in biotechnological innovations, including genetic engineering, are described here from the personal viewpoint of the author. Copyright (C) 2012 S. Karger AG, Basel
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelgerbstr 70, CH-4056 Basel, Switzerland.
EM Werner.Arber@unibas.ch
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8
   ARBER W, 1965, ANNU REV MICROBIOL, V19, P365, DOI 10.1146/annurev.mi.19.100165.002053
   ARBER W, 1965, J MOL BIOL, V11, P247, DOI 10.1016/S0022-2836(65)80055-9
   ARBER W, 1965, GENETICS, V51, P137
   ARBER W, 1979, SCIENCE, V205, P361, DOI 10.1126/science.377489
   ARBER W, 1969, ANNU REV BIOCHEM, V38, P467, DOI 10.1146/annurev.bi.38.070169.002343
   Arber W, 1974, Prog Nucleic Acid Res Mol Biol, V14, P1, DOI 10.1016/S0079-6603(08)60204-4
   Arber W, 2007, GENOMICS GENETICS, V1, P385
   BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993
   DUSSOIX D, 1962, J MOL BIOL, V5, P37, DOI 10.1016/S0022-2836(62)80059-X
   Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874
   SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X
NR 13
TC 0
Z9 0
U1 3
U2 20
PU KARGER
PI BASEL
PA POSTFACH, CH-4009 BASEL, SWITZERLAND
SN 1660-8984
BN 978-3-8055-9065-5
J9 BIOVALLEY MONOGR
JI Biovalley Monogr.
PY 2012
VL 3
BP 33
EP 38
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BCW25
UT WOS:000311650500003
DA 2021-01-25
ER

PT B
AU Papassotiropoulos, A
AF Papassotiropoulos, Andreas
BE Pfleiderer, G
   Battegay, M
   Lindpaintner, K
TI Related to Human Cognition: Is Personalization Feasible and Desirable?
SO KNOWING ONE'S MEDICAL FATE IN ADVANCE: CHALLENGES FOR DIAGNOSIS AND
   TREATMENT, PHILOSOPHY, ETHICS AND RELIGION
LA English
DT Article; Book Chapter
ID GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; MEMORY PERFORMANCE; RISK;
   ALLELES; CLUSTER
C1 Univ Basel, Biozentrum, Life Sci Training Facil, Div Mol Psychol, CH-4055 Basel, Switzerland.
RP Papassotiropoulos, A (corresponding author), Univ Basel, Biozentrum, Life Sci Training Facil, Div Mol Psychol, Birmannsgasse 8, CH-4055 Basel, Switzerland.
CR Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440
   Hayden EC, 2009, NATURE          1123, DOI 10.1038/ news.2009.1102
   Huentelman MJ, 2009, BEHAV NEUROSCI, V123, P218, DOI 10.1037/a0014260
   Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331
   Papassotiropoulos A, 2005, J CLIN PSYCHIAT, V66, P940, DOI 10.4088/JCP.v66n0720
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA POSTFACH, CH-4009 BASEL, SWITZERLAND
BN 978-3-8055-9649-7
PY 2012
BP 15
EP 25
PG 11
WC Social Sciences, Biomedical
SC Biomedical Social Sciences
GA BCO97
UT WOS:000310935700003
DA 2021-01-25
ER

PT J
AU Burmann, BM
   Hiller, S
AF Burmann, Bjoern M.
   Hiller, Sebastian
TI Solution NMR Studies of Membrane-Protein-Chaperone Complexes
SO CHIMIA
LA English
DT Article
DE beta-Barrel membrane proteins; Membrane biogenesis; Molecular
   chaperones; NMR spectroscopy; Protein complexes; Protein folding
ID TRIGGER FACTOR; MOLECULAR CHAPERONE; RESIDUAL STRUCTURE;
   CRYSTAL-STRUCTURE; DENATURED STATE; SURA; SKP; SUBSTRATE; PEPTIDES;
   BINDING
AB The biosynthesis of the bacterial outer membrane depends on molecular chaperones that protect hydrophobic membrane proteins against aggregation while transporting them across the periplasm. In our ongoing research, we use high-resolution NMR spectroscopy in aqueous solution as the main technique to characterize the structures and biological functions of these membrane-protein chaperone complexes. Here, we describe NMR studies addressing three functional aspects of periplasmic membrane-protein chaperone complexes. Firstly, the Escherichia coli outer membrane protein OmpX binds to each of the two chaperones, Skp and SurA, in structurally at least partially similar states despite fundamental differences between the three-dimensional structures of the chaperones. Secondly, we show that the Skp-bound state of OmpX is equivalent to a chemically denatured state in terms of its refolding competence into detergent micelles in vitro. Thirdly, we use amino acid mutation analysis to show that the interaction of OmpX to Skp is not dominated by the two most hydrophobic segments of OmpX.
C1 [Burmann, Bjoern M.; Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hiller, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sebastian.hiller@unibas.ch
RI Burmann, Bjorn/AAR-7399-2020; Hiller, Sebastian/B-3573-2008; Burmann,
   Bjorn/M-8913-2015
OI Hiller, Sebastian/0000-0002-6709-4684; Burmann,
   Bjorn/0000-0002-3135-7964
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00P3_128419]; European Research CommissionEuropean
   CommissionEuropean Commission Joint Research Centre [MOMP 281764];
   Novartis FoundationNovartis
FX We thank Christian Opitz for help with the sequence-specific resonance
   assignment of folded OmpX in LDAO micelles. This work was supported by
   the Swiss National Science Foundation (Grant PP00P3_128419) and the
   European Research Commission (FP7 contract MOMP 281764). B. M. B.
   acknowledges a personal fellowship by the Novartis Foundation.
CR Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214
   Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200
   Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105
   Bechtluft P, 2010, MOL BIOSYST, V6, P620, DOI 10.1039/b915435c
   Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285
   Bitto E, 2004, FEBS LETT, V568, P94, DOI 10.1016/j.febslet.2004.05.014
   Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200
   Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8
   Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245
   Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5
   Bulieris PV, 2003, J BIOL CHEM, V278, P9092, DOI 10.1074/jbc.M211177200
   Burmann B.M., 2012, UNPUB
   CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216
   Crowhurst KA, 2003, BIOCHEMISTRY-US, V42, P8687, DOI 10.1021/bi034601p
   Demarest SJ, 1999, BIOCHEMISTRY-US, V38, P7380, DOI 10.1021/bi990320z
   Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005
   Fernandez C, 2004, J MOL BIOL, V336, P1211, DOI 10.1016/j.jmb.2003.09.014
   Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x
   Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611
   Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919
   Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200
   Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302
   Hiller S, 2008, ANGEW CHEM INT EDIT, V47, P977, DOI 10.1002/anie.200703367
   Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005
   Hodsdon ME, 2001, BIOCHEMISTRY-US, V40, P732, DOI 10.1021/bi001518i
   Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499
   Jarchow S, 2008, PROTEOMICS, V8, P4987, DOI 10.1002/pmic.200800288
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069
   Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828
   Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996
   Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104
   Ludlam AV, 2004, P NATL ACAD SCI USA, V101, P13436, DOI 10.1073/pnas.0405868101
   Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044
   Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366
   Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020
   Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322
   Schlapschy M, 2011, METHODS MOL BIOL, V705, P211, DOI 10.1007/978-1-61737-967-3_12
   Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o
   Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007
   Smith LJ, 1996, FOLD DES, V1, pR95, DOI 10.1016/S1359-0278(96)00046-6
   Stirling PC, 2006, NAT STRUCT MOL BIOL, V13, P865, DOI 10.1038/nsmb1153
   Tafer H, 2004, BIOCHEMISTRY-US, V43, P860, DOI 10.1021/bi0356606
   TORMO A, 1990, J BACTERIOL, V172, P4339, DOI 10.1128/jb.172.8.4339-4347.1990
   Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794
   Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5
   Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z
   Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023
   Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106
   Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069
   Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335
NR 53
TC 10
Z9 10
U1 1
U2 11
PU SWISS CHEMICAL SOC
PI BERN
PA SCHWARZTORSTRASSE 9, CH-3007 BERN, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2012
VL 66
IS 10
BP 759
EP 763
DI 10.2533/chimia.2012.759
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 033VI
UT WOS:000310828800006
PM 23146261
OA Green Accepted
DA 2021-01-25
ER

PT B
AU Bumann, D
AF Bumann, Dirk
BE Robertson, BD
   Wren, BW
TI Systems Biology of Infection: The Pathogen Perspective
SO SYSTEMS MICROBIOLOGY: CURRENT TOPICS AND APPLICATIONS
LA English
DT Article; Book Chapter
ID SALMONELLA; DISCOVERY; MUTANTS; REVEALS; PROTEIN; BUGS
AB Microbial infections still cause around one-quarter of all deaths globally, despite the advances that have been made in the treatment of infectious disease. The increasing occurrence of drug resistant pathogens, both old and new, coupled with an increasingly mobile human population has created many novel opportunities for potential pathogens to meet new human hosts. All of this requires new prevention and control strategies but progress has been slow, despite recent technological advances and increased investment. The rapid increase in data proved difficult to translate into practical applications for human health care, and new approaches and analyses are needed to make the most of new opportunities. One of these is the use of the new tools of systems biology and this chapter will review the application of these to microbial pathogens.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Bumann, D (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM dirk.bumann@unibas.ch
CR Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Bellamy R, 1999, MICROBES INFECT, V1, P23, DOI 10.1016/S1286-4579(99)80010-0
   Bumann D, 2010, J PROTEOMICS, V73, P2267, DOI 10.1016/j.jprot.2010.08.004
   Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018
   Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545
   Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326
   Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008
   Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106
   Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107
   Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143
   Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027
   Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109
   Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984
   Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77
   Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201
   Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002
   Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884
   Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687
   Yoon H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-100
NR 24
TC 0
Z9 0
U1 0
U2 0
PU CAISTER ACADEMIC PRESS
PI WYMONDHAM
PA 32 HEWITTS LANE, WYMONDHAM NR 18 0JA, ENGLAND
BN 978-1-908230-02-7
PY 2012
BP 69
EP 75
PG 7
WC Biology; Microbiology
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA BAY26
UT WOS:000306024200004
DA 2021-01-25
ER

PT S
AU Melchers, F
AF Melchers, Fritz
BE Paul, WE
TI The Basel Institute for Immunology
SO ANNUAL REVIEW OF IMMUNOLOGY, VOL 30
SE Annual Review of Immunology
LA English
DT Review; Book Chapter
DE BII; Roche; academic freedom; BII scientific members; BII history
AB At the Centennial Exhibition of the Nobel Prize, the Nobel Foundation called it one of the ten cradles of creativity (1). The journal Nature likened its ideals to those of the French revolution-Liberte, Egalite, Fraternite-and called it a paradise (2) devoted to the science of immune systems: the Basel Institute for Immunology (BII). Founded by Roche in 1968, inaugurated in 1971, and closed in 2000, it was home to almost 450 scientific members, over 1,000 scientific visitors, and nearly 100 scientific advisors from more than 30 countries who worked in complete academic freedom and without commercial motives on over 3,500 projects, publishing more than 3,200 scientific papers, almost all of them on the structure and functions of immune systems of different species. This review contains a first collection of historical facts and dates that describe the background of the exceptionally successful performance and the strong scientific impact of the institute on the field of immunology.
C1 [Melchers, Fritz] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Melchers, Fritz] Max Planck Inst Infect Biol, Res Grp Lymphocyte Differentiat, D-10117 Berlin, Germany.
RP Melchers, F (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM fritz.melchers@unibas.ch
CR Abbott A, 2000, NATURE, V405, P605, DOI 10.1038/35015238
   [Anonymous], 1991, HANDELSREGIST KANTON
   [Anonymous], 2003, HANDELSREGIST KANTON
   [Anonymous], 1971, BASLER VOLKSBLA 0618
   [Anonymous], 2001, HANDELSREGIST KANTON
   [Anonymous], 1971, BASLER NACHRICH 0618
   [Anonymous], 1968, HANDELSREGIST KANTON
   [Anonymous], 1997, HANDELSREGIST KANTON
   [Anonymous], 2000, NAT IMMUNOL, V1, DOI [10.1038/77869, DOI 10.1038/77869]
   [Anonymous], 1996, BASLER ZEITUNG  0617
   [Anonymous], 1971, ROCHE ZEITUNG, V3, P1
   [Anonymous], 1980, HANDELSREGIST KANTON
   [Anonymous], 2001, HIST MILESTONES PRES
   Dickman S., 1988, NATURE, V326, P335
   Enthalt S, 2001, CULTURES CREATIVITY, P177
   JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102
   JERNE NK, 1967, COLD SPRING HARB SYM, V32, P591
   JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373
   Jerne NK, 1996, 25 YEARS BASEL I IMM
   Jerne NK, 1955, P NATL ACAD SCI USA, V41, P819
   Jerne NK, 1981, BASLER ZEITUNG, V138, P176
   Jerne NK, 1981, BASLER ZEITUNG  0617
   Melchers F, 1997, P AM PHILOS SOC, V141, P89
   Melchers F, 2011, S OESTERR AKAD WISS, P6
   Melchers F, 2003, LABORJOURNAL, V10, P28
   Melchers F, 2008, GENETICISTS BERLIN, P4
   Melchers F, 1990, C HIGH TECHN SOC, P35
   Neumann R, 2000, LABORJOURNAL    0615
   Tschudin M, 1996, ROCHE NACHRICHTEN
NR 29
TC 2
Z9 2
U1 0
U2 4
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0732-0582
BN 978-0-8243-3030-9
J9 ANNU REV IMMUNOL
JI Annu. Rev. Immunol.
PY 2012
VL 30
BP 23
EP +
DI 10.1146/annurev-immunol-020711-074912
PG 90
WC Immunology
SC Immunology
GA BAH94
UT WOS:000304198100002
PM 22136166
DA 2021-01-25
ER

PT J
AU Gehring, WJ
AF Gehring, Walter J.
TI The animal body plan, the prototypic body segment, and eye evolution
SO EVOLUTION & DEVELOPMENT
LA English
DT Article
ID DROSOPHILA HOMEOTIC GENES; EARLY EMBRYOGENESIS; HOMEOBOX GENES; ECTOPIC
   EYES; EYELESS GENE; PAX GENES; COMPLEX; CONSERVATION; PROTEIN;
   MELANOGASTER
AB Developmental genetics of Drosophila continue to have a great impact on our understanding of evolution. The specification of the body plan involves four conceptual steps: 1) Localization of maternal mRNAs in the egg cytoplasm. 2) Translation of these RNAs and formation of morphogen gradients. 3) Subdivision of the antero-posterior gradient into a repetitive pattern of body segments. 4) Assignment of a specific identity to each segment by the Hox genes. The discovery of the Hox genes has uncovered a universal principle shared by all bilaterians; they serve as master control genes specifying organization along the antero-posterior axis. The ancestral arthropods presumably consisted of a series of more or less identical segments, which may be represented by recently discovered precambrian Lobopodia which have a pair of legs and a pair of eyes in each segment. The progressive divergence of Hox genes has led to progressive cephalization and caudalization. From the amino acid sequences of the clustered homeodomains we can deduce that the mesothoracic segment represents the prototype from the more anterior and the more posterior segments evolved. Pax6 has been identified as a master control gene for eye development in all bilaterians. Since Pax6 is involved in eye development in all bilaterian phyla, this argues strongly for a monophyletic origin of the metazoan eye. With the same tool box of transcription factors all the different eye-types can be constructed.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Walter.Gehring@unibas.ch
CR Arnheiter H, 1998, NATURE, V391, P632, DOI 10.1038/35487
   Averof M, 1997, NATURE, V385, P627, DOI 10.1038/385627a0
   Blanco J, 2008, GENE EXPR PATTERNS, V8, P523, DOI 10.1016/j.gep.2008.06.002
   Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027
   BONCINELLI E, 1989, GENOME, V31, P745, DOI 10.1139/g89-133
   CARRASCO AE, 1984, CELL, V37, P409, DOI 10.1016/0092-8674(84)90371-4
   CARROLL SB, 2005, DNA DIVERSITY
   Clarkson E. N. K., 2008, INVERTEBRATE PALAEON
   Clements J, 2008, P NATL ACAD SCI USA, V105, P8968, DOI 10.1073/pnas.0803254105
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Darwin C. R., 1872, ORIGIN SPECIES MEANS
   DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x
   Dzik J, 2003, PALAEONTOLOGY, V46, P93, DOI 10.1111/1475-4983.00289
   Estrada B, 2001, DEVELOPMENT, V128, P331
   Gehring W, 2010, ITAL J ZOOL, V77, P124, DOI 10.1080/11250001003795350
   Gehring WJ, 2011, GENOME BIOL EVOL, V3, P1053, DOI 10.1093/gbe/evr061
   Gehring WJ, 2009, CURR TOP DEV BIOL, V88, P35, DOI 10.1016/S0070-2153(09)88002-2
   Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   Glardon S, 1997, DEVELOPMENT, V124, P817
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T
   Hou X. G., 2007, CAMBRIAN FOSSILS CHE
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   KAUFMAN TC, 1980, GENETICS, V94, P115
   Kmita-Cunisse M, 1998, P NATL ACAD SCI USA, V95, P3030, DOI 10.1073/pnas.95.6.3030
   Kowalevsky A., 1870, ANATOMIE, V7, P101
   Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3
   Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105
   Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834
   Lee MSY, 2011, NATURE, V474, P631, DOI 10.1038/nature10097
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Lewis EB, 2003, CURR BIOL, V13, pR587, DOI 10.1016/S0960-9822(03)00520-7
   Mayr E., 2001, WHAT EVOLUTION IS
   MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2
   Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100
   Monod J, 1970, HAZARD NECESSITE
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999
   PULTZ MA, 1988, GENE DEV, V2, P901, DOI 10.1101/gad.2.7.901
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   Steinmetz PRH, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-14
   Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107
   Wehner R., 2007, ZOOLOGIE, V24, P250
NR 44
TC 14
Z9 14
U1 1
U2 52
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1520-541X
J9 EVOL DEV
JI Evol. Dev.
PD JAN-FEB
PY 2012
VL 14
IS 1
BP 34
EP 46
DI 10.1111/j.1525-142X.2011.00528.x
PG 13
WC Evolutionary Biology; Developmental Biology; Genetics & Heredity
SC Evolutionary Biology; Developmental Biology; Genetics & Heredity
GA 922IO
UT WOS:000302540800006
PM 23016973
DA 2021-01-25
ER

PT J
AU Huber, M
   Bockmann, A
   Hiller, S
   Meier, BH
AF Huber, Matthias
   Boeckmann, Anja
   Hiller, Sebastian
   Meier, Beat H.
TI 4D solid-state NMR for protein structure determination
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID ANGLE-SPINNING NMR; AUTOMATED NOE ASSIGNMENT; AMYLOID FIBRILS;
   HIGH-RESOLUTION; RESONANCE ASSIGNMENT; MAGNETIC-RESONANCE;
   ATOMIC-RESOLUTION; SPECTROSCOPY; SPECTRA; DECOMPOSITION
AB Solid-state NMR offers the chance to extend structural studies to proteins that are otherwise difficult to study at atomic resolution, such as protein fibrils, membrane proteins or poorly diffracting crystals. As two-dimensional spatial correlation NMR spectra of proteins suffer from severe resonance overlap, we analyze in this perspective article the potential of higher-dimensional (3D and 4D) proton-detected experiments, which have an increased number of identifiable and assignable distance restraints for solid-state structural studies. We discuss practical considerations for the NMR measurements and the preparation of suitable protein samples and show results of structure calculations from 4D solid-state NMR spectra.
C1 [Boeckmann, Anja] Univ Lyon, Inst Biol & Chim Prot, CNRS, F-69367 Lyon, France.
   [Huber, Matthias; Meier, Beat H.] ETH, CH-8093 Zurich, Switzerland.
   [Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bockmann, A (corresponding author), Univ Lyon, Inst Biol & Chim Prot, CNRS, 7 Passage Vercors, F-69367 Lyon, France.
EM a.bockmann@ibcp.ch; sebastian.hiller@unibas.ch; beme@ethz.ch
RI Meier, Beat H/K-4066-2016; Hiller, Sebastian/B-3573-2008
OI Meier, Beat H/0000-0002-9107-4464; Hiller, Sebastian/0000-0002-6709-4684
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [200020_134681, PP00P3_128419]; CNRSCentre National de la
   Recherche Scientifique (CNRS); French Agence Nationale de la
   RechercheFrench National Research Agency (ANR) [ANR-PCV08 321323];
   European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [Bio-NMR 261863, MOMP 281764]
FX This work was supported by the Swiss National Science Foundation (Grant
   200020_134681 and PP00P3_128419), the CNRS and the French Agence
   Nationale de la Recherche (ANR-PCV08 321323), and the European
   Commission under the Seventh Frame-work Program (FP7), contracts Bio-NMR
   261863 and MOMP 281764.
CR Agarwal V, 2006, J AM CHEM SOC, V128, P12620, DOI 10.1021/ja064379m
   Akbey U, 2010, J BIOMOL NMR, V46, P67, DOI 10.1007/s10858-009-9369-0
   Asami S, 2010, J AM CHEM SOC, V132, P15133, DOI 10.1021/ja106170h
   Bayro MJ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3089370
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Bockmann A, 2008, ANGEW CHEM INT EDIT, V47, P6110, DOI 10.1002/anie.200801352
   Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722
   Chevelkov V, 2006, ANGEW CHEM INT EDIT, V45, P3878, DOI 10.1002/anie.200600328
   De Paepe G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3036928
   Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u
   Ernst R.R., 1987, PRINCIPLES NUCL MAGN
   Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236
   Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284
   Habenstein B, 2011, J BIOMOL NMR, V51, P235, DOI 10.1007/s10858-011-9530-4
   HAEBERLEN U, 1968, PHYS REV, V175, P453, DOI 10.1103/PhysRev.175.453
   Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3
   Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102
   Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302
   Hiller S, 2007, J AM CHEM SOC, V129, P10823, DOI 10.1021/ja072564+
   Hiller S, 2009, J AM CHEM SOC, V131, P12970, DOI 10.1021/ja902012x
   Huber M, 2011, CHEMPHYSCHEM, V12, P915, DOI 10.1002/cphc.201100062
   Hyberts SG, 2009, J BIOMOL NMR, V45, P283, DOI 10.1007/s10858-009-9368-1
   Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o
   JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208
   Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891
   Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d
   Knight MJ, 2011, ANGEW CHEM INT EDIT, V50, P11697, DOI 10.1002/anie.201106340
   Lewandowski JR, 2011, J PHYS CHEM LETT, V2, P2205, DOI 10.1021/jz200844n
   Mainz A, 2009, J AM CHEM SOC, V131, P15968, DOI 10.1021/ja904733v
   Malmodin D, 2005, J AM CHEM SOC, V127, P13486, DOI 10.1021/ja0545822
   Manolikas T, 2008, J AM CHEM SOC, V130, P3959, DOI 10.1021/ja078039s
   Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722
   Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499
   Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0
   Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589
   Rovnyak D, 2004, J BIOMOL NMR, V30, P1, DOI 10.1023/B:JNMR.0000042946.04002.19
   Schanda P, 2011, ANGEW CHEM INT EDIT, V50, P11005, DOI 10.1002/anie.201103944
   Schuetz A, 2010, CHEMBIOCHEM, V11, P1543, DOI 10.1002/cbic.201000124
   Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276
   SORENSEN OW, 1990, J MAGN RESON, V89, P210
   Sperling LJ, 2010, J MOL BIOL, V399, P268, DOI 10.1016/j.jmb.2010.04.012
   Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6
   Tugarinov V, 2005, P NATL ACAD SCI USA, V102, P622, DOI 10.1073/pnas.0407792102
   Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]
   Verel R, 2001, J MAGN RESON, V150, P81, DOI 10.1006/jmre.2001.2310
   Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839
NR 46
TC 33
Z9 33
U1 0
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2012
VL 14
IS 15
BP 5239
EP 5246
DI 10.1039/c2cp23872a
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 914NQ
UT WOS:000301957900024
PM 22402636
DA 2021-01-25
ER

PT J
AU Duran, RV
   Hall, MN
AF Duran, Raul V.
   Hall, Michael N.
TI Regulation of TOR by small GTPases
SO EMBO REPORTS
LA English
DT Review
DE TOR; Rheb; Rag; RalA; Rac1; Ryh1
ID COMPLEX 1 MTORC1; MAMMALIAN TARGET; PHOSPHOLIPASE-D;
   SACCHAROMYCES-CEREVISIAE; AMINO-ACIDS; FISSION YEAST; CELL-GROWTH;
   MEDIATED PHOSPHORYLATION; RAPAMYCIN-RESISTANCE; ACTIN CYTOSKELETON
AB TOR is a conserved serine/threonine kinase that responds to nutrients, growth factors, the bioenergetic status of the cell and cellular stress to control growth, metabolism and ageing. A diverse group of small GTPases including Rheb, Rag, Rac1, RalA and Ryh1 play a variety of roles in the regulation of TOR. For example, while Rheb binds to and activates TOR directly, Rag and Rac1 regulate its localization and RalA activates it indirectly through the production of phosphatidic acid. Here, we review recent findings on the regulation of TOR by small GTPases.
C1 [Duran, Raul V.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
RI Duran, Raul/E-4764-2011
OI Duran, Raul/0000-0002-2249-9215
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX We acknowledge support from the Swiss National Science Foundation. We
   apologize for the many primary publications we could not cite due to
   space limitations.
CR Agola JO, 2011, CLIN GENET, V80, P305, DOI 10.1111/j.1399-0004.2011.01724.x
   Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008
   Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105
   Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151
   Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033
   Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018
   Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119
   Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565
   Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003
   Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005
   Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518
   Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532
   Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020
   Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038
   Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015
   Fernandes H, 2009, BIOCHEM SOC T, V37, P1037, DOI 10.1042/BST0371037
   Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881
   Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419
   Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011
   Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10
   Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200
   Hirose E, 1998, J CELL SCI, V111, P11
   Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0
   Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414
   Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483
   Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200
   Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004
   Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053
   Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200
   Ly TK, 2010, J BIOL CHEM, V285, P5815, DOI 10.1074/jbc.M109.071886
   Mach KE, 2000, GENETICS, V155, P611
   Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200
   Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931
   MASANORI BY, 1992, MOL CELL BIOL, V12, P2958, DOI 10.1128/MCB.12.7.2958
   Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298
   Meijer AJ, 2004, BIOCHEM BIOPH RES CO, V313, P397, DOI 10.1016/j.bbrc.2003.07.012
   Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308
   Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319
   Nakashima N, 1999, GENETICS, V152, P853
   Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407
   Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271
   Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06
   Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046
   Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106
   Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057
   Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106
   Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200
   Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007
   Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105
   Tatebe Hisashi, 2010, Small GTPases, V1, P180, DOI 10.4161/sgtp.1.3.14936
   Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026
   Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217
   Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08
   Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x
   Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020
   Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547
   Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200
   Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118
   Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631
   Xu LZ, 2003, MOL CELL BIOL, V23, P645, DOI 10.1128/MCB.23.2.645-654.2003
   YAMAGATA K, 1994, J BIOL CHEM, V269, P16333
   Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031
   Yee WM, 1997, MOL CELL BIOL, V17, P921, DOI 10.1128/MCB.17.2.921
   Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033
   Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014
   Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055
   Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
   Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
   Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020
   Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835
NR 90
TC 63
Z9 68
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD JAN
PY 2012
VL 13
IS 2
BP 121
EP 128
DI 10.1038/embor.2011.257
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 894DK
UT WOS:000300407000009
PM 22240970
OA Green Published
DA 2021-01-25
ER

PT J
AU Zocher, M
   Roos, C
   Wegmann, S
   Bosshart, PD
   Dotsch, V
   Bernhard, F
   Muller, DJ
AF Zocher, Michael
   Roos, Christian
   Wegmann, Susanne
   Bosshart, Patrick D.
   Doetsch, Volker
   Bernhard, Frank
   Mueller, Daniel J.
TI Single-Molecule Force Spectroscopy from Nanodiscs: An Assay to Quantify
   Folding, Stability, and Interactions of Native Membrane Proteins
SO ACS NANO
LA English
DT Article
DE AFM; atomic force microscopy; bacteriorhodopsin; circular dichroism;
   DMPC; membrane scaffold protein 1; purple membrane; reconstitution;
   SMFS; unfolding intermediates; unfolding pathways
ID DYNAMIC ENERGY LANDSCAPE; UNFOLDING PATHWAYS; BACTERIORHODOPSIN;
   BINDING; LIPIDS; RHODOPSIN; RECONSTITUTION; DENATURATION; BILAYERS;
   LATTICE
AB Single-molecule force spectroscopy (SMFS) can quantify and localize inter- and intramolecular interactions that determine the folding, stability, and functional state of membrane proteins. To conduct SMFS the membranes embedding the membrane proteins must be Imaged and localized in a rather time-consuming manner. Toward simplifying the investigation of membrane proteins by SMFS, we reconstituted the light-driven proton pump bacteriorhodopsin into lipid nanodiscs. The advantage of using nanodiscs Is that membrane proteins can be handled like water-soluble proteins and characterized with similar ease. SMFS characterization of bacteriorhodopsin in native purple membranes and in nanodiscs reveals no significant alterations of structure, function, unfolding intermediates, and strengths of inter- and intramolecular interactions. This demonstrates that lipid nanodiscs provide a unique approach for in vitro studies of native membrane proteins using SMFS and open an avenue to characterize membrane proteins by a wide variety of SMFS approaches that have been established on water-soluble proteins.
C1 [Zocher, Michael; Wegmann, Susanne; Bosshart, Patrick D.; Mueller, Daniel J.] Swiss Fed Inst Technol, CH-4058 Basel, Switzerland.
   [Zocher, Michael] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Roos, Christian; Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany.
RP Muller, DJ (corresponding author), Swiss Fed Inst Technol, Mattenstr 26, CH-4058 Basel, Switzerland.
EM daniel.mueller@bsse.ethz.ch
RI Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665; Bernhard,
   Frank/0000-0002-4860-1783; Dotsch, Volker/0000-0001-5720-212X
FU European CommunityEuropean Community (EC) [211800]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG)
FX The European Community's Seventh Framework Programme ([FP7/2007-2013]
   under grant agreement no. 211800) and the Deutsche
   Forschungsgemeinschaft supported this work. We thank C. Bippes for
   assistance and for critical reading of the manuscript and G. Buldt for
   kindly providing purple membrane.
CR Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661
   Alberts B., 2007, MOL BIOL CELL, P629
   Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503
   Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k
   Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599
   Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013
   Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043
   Bippes CA, 2009, J BIOL CHEM, V284, P18651, DOI 10.1074/jbc.M109.004267
   Boldog T, 2006, P NATL ACAD SCI USA, V103, P11509, DOI 10.1073/pnas.0604988103
   Borch J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.006775
   Bosshart PD, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384014
   Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395
   BROUILLETTE CG, 1987, BIOCHEMISTRY-US, V26, P7431, DOI 10.1021/bi00397a035
   BROUILLETTE CG, 1989, PROTEINS, V5, P38, DOI 10.1002/prot.340050106
   BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001
   Cartailler JP, 2003, ANNU REV BIOPH BIOM, V32, P285, DOI 10.1146/annurev.biophys.32.110601.142516
   Cisneros DA, 2008, STRUCTURE, V16, P1206, DOI 10.1016/j.str.2008.04.014
   Damaghi M, 2010, J MOL BIOL, V397, P878, DOI 10.1016/j.jmb.2010.02.023
   Dencher NA, 2000, BBA-BIOENERGETICS, V1460, P192, DOI 10.1016/S0005-2728(00)00139-0
   Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574
   Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10
   Dufrene YF, 2011, NAT METHODS, V8, P123, DOI 10.1038/nmeth0211-123
   Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450
   Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394
   Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2
   Favre M, 2011, J MOL RECOGNIT, V24, P446, DOI 10.1002/jmr.1119
   FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C
   Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108
   Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367
   Heyes CD, 2002, J BIOL CHEM, V277, P29437, DOI 10.1074/jbc.M203435200
   HEYN MP, 1981, BIOCHEMISTRY-US, V20, P840, DOI 10.1021/bi00507a029
   Hirai T, 2009, CURR OPIN STRUC BIOL, V19, P433, DOI 10.1016/j.sbi.2009.07.009
   HUANG KS, 1981, J BIOL CHEM, V256, P3802
   Hunte C, 2005, BIOCHEM SOC T, V33, P938, DOI 10.1042/BST0330938
   Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008
   Isenbarger TA, 2001, BIOCHEMISTRY-US, V40, P11923, DOI 10.1021/bi0106585
   Janovjak H, 2004, STRUCTURE, V12, P871, DOI 10.1016/S0969-2126(04)00098-X
   Janovjak H, 2003, EMBO J, V22, P5220, DOI 10.1093/emboj/cdg509
   Janovjak H, 2008, CHEMPHYSCHEM, V9, P954, DOI 10.1002/cphc.200700662
   Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455
   Kedrov A, 2008, J MOL BIOL, V375, P1258, DOI 10.1016/j.jmb.2007.11.032
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Kedrov A, 2010, STRUCTURE, V18, P39, DOI 10.1016/j.str.2009.11.009
   Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023
   Kijac A, 2010, BIOCHEMISTRY-US, V49, P9190, DOI 10.1021/bi1013722
   Kijac AZ, 2007, BIOCHEMISTRY-US, V46, P13696, DOI 10.1021/bi701411g
   King GM, 2009, NANO LETT, V9, P1451, DOI 10.1021/nl803298q
   Kobayashi K, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3557416
   Lang HP, 2005, MATER TODAY, V8, P30, DOI 10.1016/S1369-7021(05)00792-3
   Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012
   Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169
   Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621
   Mukai Y, 1999, PROTEIN ENG, V12, P755, DOI 10.1093/protein/12.9.755
   Muller DJ, 2002, BIOPHYS J, V83, P3578, DOI 10.1016/S0006-3495(02)75358-7
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Oesterhelt D, 1974, Methods Enzymol, V31, P667
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3
   Park PSH, 2007, J BIOL CHEM, V282, P11377, DOI 10.1074/jbc.M610341200
   POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7
   Raschle T, 2009, J AM CHEM SOC, V131, P17777, DOI 10.1021/ja907918r
   REHOREK M, 1979, BIOCHEMISTRY-US, V18, P4977, DOI 10.1021/bi00589a027
   Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466
   Sahin O, 2007, NAT NANOTECHNOL, V2, P507, DOI 10.1038/nnano.2007.226
   Sapra KT, 2008, BIOPHYS J, V95, P3407, DOI 10.1529/biophysj.108.131904
   Sapra KT, 2008, J MOL BIOL, V376, P1076, DOI 10.1016/j.jmb.2007.12.027
   Sapra KT, 2008, LANGMUIR, V24, P1330, DOI 10.1021/la702299z
   Sapra KT, 2006, J MOL BIOL, V358, P255, DOI 10.1016/j.jmb.2006.02.008
   Sapra KT, 2006, J MOL BIOL, V355, P640, DOI 10.1016/j.jmb.2005.10.080
   Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011
   Sligar SG, 2003, BIOCHEM BIOPH RES CO, V312, P115, DOI 10.1016/j.bbrc.2003.09.188
   Stahl SW, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3157466
   Struckmeier J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384020
   Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420
   White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319
   Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104
NR 76
TC 33
Z9 35
U1 3
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JAN
PY 2012
VL 6
IS 1
BP 961
EP 971
DI 10.1021/nn204624p
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 879YH
UT WOS:000299368300114
PM 22196235
DA 2021-01-25
ER

PT J
AU Boudko, SP
   Engel, J
   Bachinger, HP
AF Boudko, Sergei P.
   Engel, Juergen
   Baechinger, Hans Peter
TI The crucial role of trimerization domains in collagen folding
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Review
DE Protein folding; Collagen triple helix; Trimerization domain; Protein
   structure; Chain selection
ID CARBOXYL-TERMINAL PROPEPTIDE; SCHMID METAPHYSEAL CHONDRODYSPLASIA;
   EHLERS-DANLOS-SYNDROME; HUMAN TYPE-I; CRYSTAL-STRUCTURE; X COLLAGEN;
   BASEMENT-MEMBRANE; TRIPLE-HELIX; COILED-COIL; VII COLLAGEN
AB Collagens contain large numbers of Gly-Xaa-Yaa peptide repeats that form the characteristic triple helix, where the individual chains fold into a polyproline II helix and three of these helices form a right-handed triple helix. For the proper folding of the triple helix collagens contain trimerization domains. These domains ensure a single starting point for triple helix formation and are also responsible for the chain selection in heterotrimeric collagens. Trimerization domains are non-collagenous domains of very different structures. The size of trimerization domains varies from 35 residues in type IX collagen to around 250 residues for the fibrillar collagens. These domains are not only crucial for biological functions, but they are also attractive tools for generating recombinant collagen fragments of interest as well as for general use in protein engineering and biomaterial design. Here we review the current knowledge of the structure and function of these trimerization domains. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Boudko, Sergei P.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
   [Boudko, Sergei P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM juergen.engel@unibas.ch; hpb@shcc.org
CR Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219
   AHMAD NN, 1995, ARCH OPHTHALMOL-CHIC, V113, P1454, DOI 10.1001/archopht.1995.01100110114034
   Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005
   BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x
   Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0
   Ball SG, 2001, J BIOL CHEM, V276, P7422, DOI 10.1074/jbc.M002816200
   BATEMAN JF, 1989, J BIOL CHEM, V264, P10960
   Bateman JF, 2005, HUM MUTAT, V25, P525, DOI 10.1002/humu.20183
   Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012
   Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   Boudko SP, 2010, J BIOL CHEM, V285, P23721, DOI 10.1074/jbc.M110.128405
   Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057
   Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200
   Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200
   BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x
   BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551
   Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694
   Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014
   Chen M, 2001, J BIOL CHEM, V276, P21649, DOI 10.1074/jbc.M100180200
   Chen M, 2000, J BIOL CHEM, V275, P24429, DOI 10.1074/jbc.M003440200
   CHESSLER SD, 1993, J BIOL CHEM, V268, P18218
   David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001
   DAVIS JM, 1989, J BIOL CHEM, V264, P8956
   DePaepe A, 1997, AM J HUM GENET, V60, P547
   DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x
   EFIMOV VP, 1994, J MOL BIOL, V242, P470, DOI 10.1006/jmbi.1994.1595
   ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137
   ENGEL J, 1985, ANN NY ACAD SCI, V460, P25, DOI 10.1111/j.1749-6632.1985.tb51154.x
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   EXPOSITO JY, 1993, J MOL EVOL, V37, P254, DOI 10.1007/BF00175502
   Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200
   Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200
   Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200
   GIBSON GJ, 1985, J CELL BIOL, V101, P277, DOI 10.1083/jcb.101.1.277
   Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575
   GRANT WT, 1987, J BIOL CHEM, V262, P9844
   Greenhill NS, 2000, MATRIX BIOL, V19, P19, DOI 10.1016/S0945-053X(99)00053-0
   Grond-Ginsbach C, 2002, NEUROLOGY, V58, P1103, DOI 10.1212/WNL.58.7.1103
   Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404
   Hayward C P, 1995, Curr Opin Hematol, V2, P339
   HAYWARD CPM, 1995, J BIOL CHEM, V270, P18246, DOI 10.1074/jbc.270.31.18246
   HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7
   Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843
   Jeschke G, 2006, ANGEW CHEM INT EDIT, V45, P1058, DOI 10.1002/anie.200503720
   Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200
   KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545
   Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9
   KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2
   Kuo CJ, 2001, J CELL BIOL, V152, P1233, DOI 10.1083/jcb.152.6.1233
   Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1
   KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597
   LABERMEIER U, 1983, EXP EYE RES, V37, P225, DOI 10.1016/0014-4835(83)90157-4
   LABOURDETTE L, 1993, FEBS LETT, V320, P211, DOI 10.1016/0014-5793(93)80588-L
   Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200
   LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642
   Lamande SR, 2002, J BIOL CHEM, V277, P1949, DOI 10.1074/jbc.M109932200
   Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Malone JP, 2005, BIOCHEMISTRY-US, V44, P15269, DOI 10.1021/bi0508338
   Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev
   MAZZORANA M, 1993, J BIOL CHEM, V268, P3029
   Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200
   McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200
   Mechling DE, 1996, J BIOL CHEM, V271, P13781, DOI 10.1074/jbc.271.23.13781
   Meier S, 2007, J MOL BIOL, V368, P718, DOI 10.1016/j.jmb.2007.02.026
   Milbradt AG, 2005, J MOL BIOL, V354, P591, DOI 10.1016/j.jmb.2005.09.080
   Mitchell AL, 2009, HUM MUTAT, V30, P995, DOI 10.1002/humu.21000
   Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019
   Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028
   MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721
   MYERS JC, 1992, P NATL ACAD SCI USA, V89, P10144, DOI 10.1073/pnas.89.21.10144
   Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   NINOMIYA Y, 1986, J BIOL CHEM, V261, P5041
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Ozbek S, 2004, J BIOL CHEM, V279, P52016, DOI 10.1074/jbc.M407613200
   Ozbek S, 2002, J BIOL CHEM, V277, P49200, DOI 10.1074/jbc.M209401200
   Pace JM, 2008, J BIOL CHEM, V283, P16061, DOI 10.1074/jbc.M801982200
   Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443
   Pakkanen O, 2003, J BIOL CHEM, V278, P32478, DOI 10.1074/jbc.M304405200
   Papanikolopoulou Katerina, 2008, V474, P15, DOI 10.1007/978-1-59745-480-3_2
   Pickup MJ, 2011, FORENSIC SCI MED PAT, V7, P192, DOI 10.1007/s12024-010-9205-6
   PIHLAJANIEMI T, 1995, PROG NUCLEIC ACID RE, V50, P225, DOI 10.1016/S0079-6603(08)60816-8
   Pokidysheva E, 2004, J BIOL CHEM, V279, P30395, DOI 10.1074/jbc.M403734200
   Pope F. M., 2010, J MED GENET S1, V47, P20
   Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007
   REHN M, 1994, J BIOL CHEM, V269, P13929
   REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234
   Rety S, 2005, J BIOL CHEM, V280, P43073, DOI 10.1074/jbc.M510087200
   Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024
   RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x
   SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577
   Lobo VJSA, 2006, INT J CANCER, V119, P455, DOI 10.1002/ijc.21851
   Sasaki T, 2000, J MOL BIOL, V301, P1179, DOI 10.1006/jmbi.2000.3996
   Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249
   SCHMID TM, 1983, J BIOL CHEM, V258, P9504
   Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123
   Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2
   Shuttleworth CA, 1997, INT J BIOCHEM CELL B, V29, P1145, DOI 10.1016/S1357-2725(97)00033-2
   Stephan S, 2004, J BIOL CHEM, V279, P21469, DOI 10.1074/jbc.M305805200
   Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X
   Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499
   TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x
   UITTO J, 1994, ARCH DERMATOL RES, V287, P16, DOI 10.1007/BF00370713
   Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200
   Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811
   Verdone G, 2008, J BIOL CHEM, V283, P18947, DOI 10.1074/jbc.M801085200
   Verdone G, 2009, J BIOMOL NMR, V43, P79, DOI 10.1007/s10858-008-9290-y
   VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715
   WEBER S, 1988, EUR J BIOCHEM, V175, P229, DOI 10.1111/j.1432-1033.1988.tb14188.x
   Wilson R, 2005, J BIOL CHEM, V280, P15544, DOI 10.1074/jbc.M410758200
   Wirz JA, 2011, MATRIX BIOL, V30, P9, DOI 10.1016/j.matbio.2010.09.005
   Woolfson DN, 2010, BIOPOLYMERS, V94, P118, DOI 10.1002/bip.21345
   YURCHENCO PD, 1990, FASEB J, V4, P1577
   Zhang Y, 1999, J BIOL CHEM, V274, P22409, DOI 10.1074/jbc.274.32.22409
NR 122
TC 39
Z9 43
U1 4
U2 40
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD JAN
PY 2012
VL 44
IS 1
BP 21
EP 32
DI 10.1016/j.biocel.2011.09.009
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 888CW
UT WOS:000299982400005
PM 22001560
DA 2021-01-25
ER

PT J
AU Howell, M
   Wirz, D
   Daniels, AU
   Braissant, O
AF Howell, M.
   Wirz, D.
   Daniels, A. U.
   Braissant, O.
TI Application of a Microcalorimetric Method for Determining Drug
   Susceptibility in Mycobacterium Species
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID NITRATE REDUCTASE ASSAY; IN-VITRO; ISOTHERMAL MICROCALORIMETRY;
   COLORIMETRIC METHOD; RAPID DETECTION; TUBERCULOSIS; SMEGMATIS;
   MOXIFLOXACIN; RELIABILITY; RESISTANCE
AB Mycobacterium tuberculosis is a global public health concern, particularly with the emergence of drug-resistant strains. Immediate identification of drug-resistant strains is crucial to administering appropriate treatment before the bacteria are allowed to spread. However, developing countries, which are most affected by drug resistance, are struggling to combat the disease without the facilities or funds for expensive diagnostics. Recent studies have emphasized the suitability of isothermal microcalorimetry (IMC) for the rapid detection of mycobacteria. In this study, we investigate its suitability for rapid and reliable M. tuberculosis drug susceptibility testing. Specifically, IMC was used to determine the MICs of three drugs, namely, isoniazid, ethambutol, and moxifloxacin, against three mycobacteria, namely, Mycobacterium smegmatis, Mycobacterium avium, and Mycobacterium tuberculosis. The Richards growth model was used to calculate growth parameters, namely, the maximum bacterial growth rate and the lag phase duration from integrated heat flow-versus-time results. For example, MICs of isoniazid, ethambutol, and moxifloxacin were determined to be 1.00, 8.00, and 0.25 mu g/ml, respectively. IMC, as described here, could be used not just in industrialized countries but also in developing countries because inexpensive and sensitive microcalorimeters are now available.
C1 [Howell, M.; Wirz, D.; Daniels, A. U.; Braissant, O.] Univ Basel, Lab Biomechan & Biocalorimetry, Biozentrum, Pharmazentrum, Basel, Switzerland.
   [Howell, M.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.
   [Braissant, O.] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.
RP Braissant, O (corresponding author), Univ Basel, Lab Biomechan & Biocalorimetry, Biozentrum, Pharmazentrum, LOB2, Basel, Switzerland.
EM Olivier.braissant@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR Angeby KAK, 2002, J CLIN MICROBIOL, V40, P553, DOI 10.1128/JCM.40.2.553-555.2002
   Bastian I, 2001, ANTIMICROB AGENTS CH, V45, P1934, DOI 10.1128/AAC.45.6.1934-1936.2001
   Braissant O, 2010, SENSORS-BASEL, V10, P9369, DOI 10.3390/s101009369
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Caviedes L, 2002, J CLIN MICROBIOL, V40, P1873, DOI 10.1128/JCM.40.5.1873-1874.2002
   Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08
   De Logu A, 2005, INT J ANTIMICROB AG, V26, P28, DOI 10.1016/j.ijantimicag.2005.03.005
   HEYM B, 1992, RES MICROBIOL, V143, P721, DOI 10.1016/0923-2508(92)90067-X
   Ji BH, 1998, ANTIMICROB AGENTS CH, V42, P2066, DOI 10.1128/AAC.42.8.2066
   Kahm M, 2010, J STAT SOFTW, V33, P1
   Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304
   Kumar M, 2005, DIAGN MICR INFEC DIS, V53, P121, DOI 10.1016/j.diagmicrobio.2005.05.011
   Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003
   Maskow T, 2006, J BIOTECHNOL, V122, P431, DOI 10.1016/j.jbiotec.2005.10.008
   Mshana RN, 1998, J CLIN MICROBIOL, V36, P1214, DOI 10.1128/JCM.36.5.1214-1219.1998
   Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10
   Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x
   Petrini B, 2006, SCAND J INFECT DIS, V38, P246, DOI 10.1080/00365540500444652
   Piersimoni C, 2007, DIAGN MICR INFEC DIS, V57, P283, DOI 10.1016/j.diagmicrobio.2006.08.018
   Ren H, 2006, ANTIMICROB AGENTS CH, V50, P250, DOI 10.1128/AAC.50.1.250-255.2006
   Rodriguez D, 2011, J APPL MICROBIOL, V111, P1016, DOI 10.1111/j.1365-2672.2011.05117.x
   Rodriguez JC, 2002, INT J ANTIMICROB AG, V20, P464, DOI 10.1016/S0924-8579(02)00239-X
   Stephan J, 2004, ANTIMICROB AGENTS CH, V48, P4163, DOI 10.1128/AAC.48.11.4163-4170.2004
   Van Deun A, 2010, INT J TUBERC LUNG D, V14, P131
   von Ah U, 2008, J CLIN MICROBIOL, V46, P2083, DOI 10.1128/JCM.00611-08
   WAYNE LG, 1992, CLIN MICROBIOL REV, V5, P1
   WOODS GL, 1987, REV INFECT DIS, V9, P275
   World Health Organization, 2010, GLOB TUB CONTR WHO R
   ZIMMER BL, 1982, ANTIMICROB AGENTS CH, V22, P148, DOI 10.1128/AAC.22.1.148
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 30
TC 36
Z9 36
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JAN
PY 2012
VL 50
IS 1
BP 16
EP 20
DI 10.1128/JCM.05556-11
PG 5
WC Microbiology
SC Microbiology
GA 888IH
UT WOS:000299996600005
PM 22090404
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Lim, RYH
   Herrmann, H
AF Lim, Roderick Y. H.
   Herrmann, Harald
TI From structural architecture to cellular organization: Celebrating the
   scientific contributions of Ueli Aebi on the occasion of his retirement
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Editorial Material
C1 [Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4003 Basel, Switzerland.
   [Herrmann, Harald] German Canc Res Ctr, Heidelberg, Germany.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM roderick.lim@unibas.ch
OI Lim, Roderick/0000-0001-5015-6087
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN
PY 2012
VL 177
IS 1
SI SI
BP 1
EP 2
DI 10.1016/j.jsb.2011.12.011
PG 2
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 880ZK
UT WOS:000299448900001
PM 22227641
DA 2021-01-25
ER

PT J
AU Muller, SA
   Engel, A
AF Mueller, Shirley A.
   Engel, Andreas
TI Looking back at a quarter-century of research at the Maurice E. Muller
   Institute for Structural Biology
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Actin; Aquaporins; Atomic force microscope; Intermediate filament;
   Nuclear pore complex; Scanning transmission electron microscope;
   Scanning tunneling microscope
ID ATOMIC-FORCE MICROSCOPY; NUCLEAR-PORE COMPLEX; TRANSMISSION
   ELECTRON-MICROSCOPY; INTERMEDIATE-FILAMENT PROTEINS;
   PHENYLALANINE-GLYCINE NUCLEOPORINS; SCANNING TUNNELING MICROSCOPE; I
   REACTION-CENTER; ESCHERICHIA-COLI; 2D CRYSTALLIZATION; MEMBRANE-PROTEIN
AB The Maurice E. Muller Institute, embedded in the infrastructure of the Biozentrum, University of Basel, was founded in 1985 and financed by the Maurice E. Muller Foundation of Switzerland. For 26 years its two founders, Ueli Aebi and Andreas Engel, pursued the vision of integrated structural biology. This paper reviews selected publications issuing from the Maurice E. Muller Institute for Structural Biology and marks the end of this era. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA.
   [Mueller, Shirley A.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, CH-4058 Basel, Switzerland.
   [Mueller, Shirley A.; Engel, Andreas] Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA.
EM ahe13@case.edu
FU Maurice E. Muller Foundation; Swiss National Foundation for Scientific
   ResearchSwiss National Science Foundation (SNSF); European UnionEuropean
   Union (EU)
FX The authors are indebted to Ueli Aebi for his friendship, loyalty,
   perseverance, and for the scientific insights he shared with all his
   colleagues. We are thankful to the Maurice E. Muller Foundation for the
   generous support that made the many years of research possible. Without
   Werner Arber and Jeff Schatz who initiated and pursued the discussion
   between Maurice E. Muller and the University of Basel the MIH would not
   have come to life. The Swiss National Foundation for Scientific Research
   and the European Union also supported many of the projects reviewed
   here, and the University of Basel has provided an excellent environment
   for teaching and basic research over all these years.
CR AEBI U, 1980, NATURE, V288, P296, DOI 10.1038/288296a0
   AEBI U, 1986, ANN NY ACAD SCI, V483, P100, DOI 10.1111/j.1749-6632.1986.tb34502.x
   AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818
   Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   Ballweber E, 2002, J MOL BIOL, V315, P613, DOI 10.1006/jmbi.2001.5281
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   BESOCKE K, 1987, SURF SCI, V181, P145, DOI 10.1016/0039-6028(87)90151-8
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   BYRD DA, 1994, J CELL BIOL, V127, P1515, DOI 10.1083/jcb.127.6.1515
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Cicicopol C, 1999, J MOL BIOL, V290, P347, DOI 10.1006/jmbi.1999.2878
   Coudray N, 2011, J STRUCT BIOL, V173, P365, DOI 10.1016/j.jsb.2010.09.019
   De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390
   DENKER BM, 1988, J BIOL CHEM, V263, P15634
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008
   Ducret A, 1998, J MOL BIOL, V278, P369, DOI 10.1006/jmbi.1998.1678
   Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130
   ENGEL A, 1985, NATURE, V317, P643, DOI 10.1038/317643a0
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   ENGEL A, 1995, SCIENCE, V269, P832, DOI 10.1126/science.7638600
   ENGEL A, 1976, J ULTRA MOL STRUCT R, V57, P322, DOI 10.1016/S0022-5320(76)80120-7
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1
   Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675
   Foeger N, 2006, J STRUCT BIOL, V155, P340, DOI 10.1016/j.jsb.2006.03.026
   FORD RC, 1990, EMBO J, V9, P3067, DOI 10.1002/j.1460-2075.1990.tb07503.x
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   GOLDIE KN, 1994, J VAC SCI TECHNOL B, V12, P1482, DOI 10.1116/1.587321
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   Goldsbury C, 2011, J STRUCT BIOL, V173, P1, DOI 10.1016/j.jsb.2010.09.018
   Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458
   Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200
   GUAN TL, 1995, MOL BIOL CELL, V6, P1591
   Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030
   HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517
   HEITLINGER E, 1992, J STRUCT BIOL, V108, P74, DOI 10.1016/1047-8477(92)90009-Y
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119
   Huang NP, 2010, J STRUCT BIOL, V171, P154, DOI 10.1016/j.jsb.2010.04.004
   Iacovache I, 2010, J STRUCT BIOL, V169, P370, DOI 10.1016/j.jsb.2009.12.001
   Imer R, 2006, JPN J APPL PHYS 1, V45, P2319, DOI 10.1143/JJAP.45.2319
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   JARNIK M, 1991, J STRUCT BIOL, V107, P291, DOI 10.1016/1047-8477(91)90054-Z
   KARRASCH S, 1994, P NATL ACAD SCI USA, V91, P836, DOI 10.1073/pnas.91.3.836
   Karrasch S, 1996, J MOL BIOL, V262, P336, DOI 10.1006/jmbi.1996.0517
   Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826
   Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   LORENTZ M, 1993, J MOL BIOL, V234, P926
   Lussi YC, 2011, MOL BIOL CELL, V22, P1080, DOI 10.1091/mbc.E10-05-0463
   Machaidze G, 2010, J MOL BIOL, V403, P529, DOI 10.1016/j.jmb.2010.09.017
   Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067
   MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013
   Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1996, J BACTERIOL, V178, P3025
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365
   Muller DJ, 1999, J MOL BIOL, V285, P1903, DOI 10.1006/jmbi.1998.2441
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Muller S, 1998, J MOL BIOL, V283, P383, DOI 10.1006/jmbi.1998.2078
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Muller SA, 2001, J MOL BIOL, V305, P1035, DOI 10.1006/jmbi.2000.4363
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Panne D, 2001, EMBO J, V20, P3210, DOI 10.1093/emboj/20.12.3210
   Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729
   Pante N, 1997, RNA, V3, P498
   PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032
   Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032
   Plodinec M, 2011, J STRUCT BIOL, V174, P476, DOI 10.1016/j.jsb.2011.03.011
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   PUHLER G, 1992, EMBO J, V11, P1607, DOI 10.1002/j.1460-2075.1992.tb05206.x
   Radmacher M, 2007, METHOD CELL BIOL, V83, P347, DOI 10.1016/S0091-679X(07)83015-9
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Reichelt R., 1987, P 45 ANN M MICR SOC, P116
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200
   Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031
   Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133
   SCHABERT F, 1994, ULTRAMICROSCOPY, V53, P147, DOI 10.1016/0304-3991(94)90005-1
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003
   Seelert H, 2000, NATURE, V405, P418
   Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011
   Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41
   Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7
   Steinmetz MO, 2008, J MOL BIOL, V376, P898, DOI 10.1016/j.jmb.2007.11.100
   Steinmetz MO, 2000, J MOL BIOL, V303, P171, DOI 10.1006/jmbi.2000.4129
   Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529
   STEMMER A, 1989, ULTRAMICROSCOPY, V30, P263, DOI 10.1016/0304-3991(89)90056-9
   STEMMER A, 1991, ULTRAMICROSCOPY, V35, P255, DOI 10.1016/0304-3991(91)90077-J
   Stock A, 1999, EMBO J, V18, P5274, DOI 10.1093/emboj/18.19.5274
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stolz M, 2007, NANOMED-NANOTECHNOL, V3, P53, DOI 10.1016/j.nano.2007.01.001
   Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512
   White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066
   Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004
   Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105
   Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200
   Wohnsland F, 2000, BIOPHYS CHEM, V85, P169, DOI 10.1016/S0301-4622(00)00113-7
   YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0
NR 133
TC 0
Z9 0
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN
PY 2012
VL 177
IS 1
SI SI
BP 3
EP 13
DI 10.1016/j.jsb.2011.11.013
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 880ZK
UT WOS:000299448900002
PM 22115996
DA 2021-01-25
ER

PT J
AU Lichtenstern, T
   Mucke, N
   Aebi, U
   Mauermann, M
   Herrmann, H
AF Lichtenstern, Tanja
   Muecke, Norbert
   Aebi, Ueli
   Mauermann, Monika
   Herrmann, Harald
TI Complex formation and kinetics of filament assembly exhibited by the
   simple epithelial keratins K8 and K18
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Analytical ultracentrifugation; Assembly kinetics; Electron microscopy;
   Intermediate filament; Recombinant keratins
ID ATOMIC-FORCE MICROSCOPY; INTERMEDIATE-FILAMENTS; VIMENTIN; INVITRO;
   UNITS; SCAFFOLDS; MECHANISM; DISEASE; DESMIN; DIMER
AB We have generated human recombinant keratins K8 and K18 and describe conditions to quantitatively follow their assembly into filaments. When renatured individually from 8 M urea into a low ionic strength/high pH-buffer, K8 was present in a dimeric to tetrameric form as revealed by analytical ultracentrifugation. In contrast, K18 sedimented as a monomer. When mixed in 8 M urea and renatured together, K8 and K18 exhibited s-value profiles compatible with homogeneous tetrameric complexes. This finding was confirmed by sedimentation equilibrium centrifugation. Subsequently, these tetrameric starter units were subjected to assembly experiments at various protein concentrations. At low values such as 0.0025 g/l, unit-length filaments were abundantly present after 2 s of assembly. During the following 5 min, filaments grew rapidly and by measuring the length of individual filaments we were able to generate time-dependent length profiles. These data revealed that keratins K8/K8 assemble several times faster than vimentin and desmin. In addition, we determined the persistence length l(p) of K8/K18 filaments to be in the range of 300 nm. Addition of 1 mM MgCl2 increases l(p) to 480 nm indicating that magnesium ions affect the interaction of keratin subunits within the filament during assembly to some extent. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Lichtenstern, Tanja; Mauermann, Monika; Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany.
   [Muecke, Norbert] German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany.
   [Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Herrmann, H (corresponding author), German Canc Res Ctr, Div Mol Genet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
EM h.herrmann@dkfz-heidelberg.de
FU German Research Foundation (DFG)German Research Foundation (DFG) [HE
   1853]
FX This work was supported by the German Research Foundation (DFG HE 1853).
   We thank Dr. Stephanie Portet, Dr. Michael Beil and Dipl. Ing. Stefan
   Winheim for helpful discussion.
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153
   Douglas JF, 2009, LANGMUIR, V25, P8386, DOI 10.1021/la9016245
   EICHNER R, 1985, ANN NY ACAD SCI, V455, P381, DOI 10.1111/j.1749-6632.1985.tb50424.x
   Erber A, 1999, J MOL EVOL, V49, P260, DOI 10.1007/PL00006548
   FRANKE WW, 1982, BIOL CELL, V46, P257
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   Hofmann I, 1997, EUR J CELL BIOL, V72, P122
   IP W, 1985, ANN NY ACAD SCI, V455, P185, DOI 10.1111/j.1749-6632.1985.tb50412.x
   IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5
   Kapinos LE, 2010, J MOL BIOL, V396, P719, DOI 10.1016/j.jmb.2009.12.001
   Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107
   Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200
   Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Mucke N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007756
   Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440
   Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012
   Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762
   PARRY DAD, 1995, INTERMEDIATE FILAMEN, P1
   Portet S, 2009, LANGMUIR, V25, P8817, DOI 10.1021/la900509r
   STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2
   STEINERT PM, 1991, J STRUCT BIOL, V107, P175, DOI 10.1016/1047-8477(91)90020-W
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Winheim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019202
NR 32
TC 36
Z9 36
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN
PY 2012
VL 177
IS 1
SI SI
BP 54
EP 62
DI 10.1016/j.jsb.2011.11.003
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 880ZK
UT WOS:000299448900008
PM 22085677
DA 2021-01-25
ER

PT J
AU Silvan, U
   Boiteux, C
   Sutterlin, R
   Schroeder, U
   Mannherz, HG
   Jockusch, BM
   Berneche, S
   Aebi, U
   Schoenenberger, CA
AF Silvan, Unai
   Boiteux, Celine
   Suetterlin, Rosmarie
   Schroeder, Ulrich
   Mannherz, Hans Georg
   Jockusch, Brigitte M.
   Berneche, Simon
   Aebi, Ueli
   Schoenenberger, Cora-Ann
TI An antiparallel actin dimer is associated with the endocytic pathway in
   mammalian cells
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Antiparallel actin; Actin antibody; Lower dimer; Actin patterning;
   Endocytosis
ID STRUCTURAL BASIS; ARP2/3 COMPLEX; FILAMENTS; DYNAMICS; NUCLEAR;
   POLYMERIZATION; CYTOSKELETON; POLYMORPHISM; NETWORKS; REVEALS
AB The dynamic rearrangement of the actin cytoskeleton plays a key role in several cellular processes such as cell motility, endocytosis, RNA processing and chromatin organization. However, the supramolecular actin structures involved in the different processes remain largely unknown. One of the less studied forms of actin is the lower dimer (LD). This unconventional arrangement of two actin molecules in an antiparallel orientation can be detected by chemical crosslinking at the onset of polymerization in vitro. Moreover, evidence for a transient incorporation of LD into growing filaments and its ability to inhibit nucleation of F-actin filament assembly implicate that the LD pathway contributes to supramolecular actin patterning. However, a clear link from this actin species to a specific cellular function has not yet been established. We have developed an antibody that selectively binds to LD configurations in supramolecular actin structures assembled in vitro. This antibody allowed us to unveil the LD in different mammalian cells. In particular, we show an association of the antiparallel actin arrangement with the endocytic compartment at the cellular and ultrastructural level. Taken together, our results strongly support a functional role of LD in the patterning of supramolecular actin assemblies in mammalian cells. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Silvan, Unai; Suetterlin, Rosmarie; Schroeder, Ulrich; Aebi, Ueli; Schoenenberger, Cora-Ann] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Boiteux, Celine; Berneche, Simon] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Mannherz, Hans Georg] Ruhr Univ Bochum, Dept Anat & Mol Embryol, D-44780 Bochum, Germany.
   [Mannherz, Hans Georg] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany.
   [Jockusch, Brigitte M.] Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany.
RP Schoenenberger, CA (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Cora-ann.schoenenberger@unibas.ch
RI Silvan, Unai/J-7376-2013; Berneche, Simon/L-6389-2013
OI Berneche, Simon/0000-0002-6274-4094; Silvan, Unai/0000-0003-0757-3621;
   Mannherz, Hans Georg/0000-0001-8158-5722
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [31003A, 118928]; M.E. Muller Foundation; Deutsche
   Forschungsgemeinschaft (DFG)German Research Foundation (DFG)
FX We would like to thank Gianni Morson, Ursula Sauder and Vesna Olivieri
   for their help in EM sample preparation and imaging. The work was
   supported by the Swiss National Science Foundation (SNF Grant 31003A to
   C.A.S. and SNF-Professorship No. 118928 to S.B.), the M.E. Muller
   Foundation and the Deutsche Forschungsgemeinschaft (DFG).
CR AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340
   BENNETT MK, 1988, EMBO J, V7, P4075, DOI 10.1002/j.1460-2075.1988.tb03301.x
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Bubb MR, 2002, J BIOL CHEM, V277, P20999, DOI 10.1074/jbc.M201371200
   BUBB MR, 1995, BIOCHEMISTRY-US, V34, P3921, DOI 10.1021/bi00012a008
   Bubb MR, 1998, CELL MOTIL CYTOSKEL, V39, P134, DOI 10.1002/(SICI)1097-0169(1998)39:2<134::AID-CM4>3.0.CO;2-6
   Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110
   Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048
   Cruz JR, 2009, CHROMOSOMA, V118, P193, DOI 10.1007/s00412-008-0188-y
   Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437
   Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118
   FOWLER WE, 1982, J CELL BIOL, V93, P452, DOI 10.1083/jcb.93.2.452
   FRANCIS NR, 1990, BIOPHYS J, V58, P771, DOI 10.1016/S0006-3495(90)82419-X
   Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006
   Gonsior SM, 1999, J CELL SCI, V112, P797
   Grintsevich EE, 2010, BIOCHEMISTRY-US, V49, P3919, DOI 10.1021/bi1002663
   HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x
   Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060
   Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006
   Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940
   Lee SH, 2007, P NATL ACAD SCI USA, V104, P16122, DOI 10.1073/pnas.0705794104
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101
   Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015
   MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785
   Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181
   Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034
   Obrdlik A, 2011, NUCLEUS-PHILA, V2, P72, DOI 10.4161/nucl.2.1.14508
   Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102
   Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2
   Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092
   SANGER JM, 1980, J CELL BIOL, V86, P568, DOI 10.1083/jcb.86.2.568
   Schoenenberger CA, 1999, MICROSC RES TECHNIQ, V47, P38, DOI 10.1002/(SICI)1097-0029(19991001)47:1<38::AID-JEMT4>3.0.CO;2-5
   Schoenenberger CA, 2002, FEBS LETT, V529, P27, DOI 10.1016/S0014-5793(02)03267-2
   Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003
   Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023
   Steinmetz MO, 1998, J MOL BIOL, V278, P703, DOI 10.1006/jmbi.1998.1717
   Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559
   Suetsugu S, 2009, FEBS LETT, V583, P3401, DOI 10.1016/j.febslet.2009.10.019
   Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397
   Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044
   Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774
NR 42
TC 10
Z9 10
U1 1
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN
PY 2012
VL 177
IS 1
SI SI
BP 70
EP 80
DI 10.1016/j.jsb.2011.09.010
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 880ZK
UT WOS:000299448900010
PM 21970948
DA 2021-01-25
ER

PT J
AU Chatel, G
   Desai, SH
   Mattheyses, AL
   Powers, MA
   Fahrenkrog, B
AF Chatel, Guillaume
   Desai, Sachin H.
   Mattheyses, Alexa L.
   Powers, Maureen A.
   Fahrenkrog, Birthe
TI Domain topology of nucleoporin Nup98 within the nuclear pore complex
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Nuclear pore complex; Nucleoporin; Nup98; FG repeats; Permeability
   barrier; Electron microscopy; SIM
ID MESSENGER-RNA EXPORT; NUCLEOCYTOPLASMIC TRANSPORT; FACILITATED
   TRANSPORT; PROTEIN EXPORT; CELLS; RESOLUTION; NUP153; SITE;
   ARCHITECTURE; BIOGENESIS
AB Nuclear pore complexes (NPCs) facilitate selective transport of macromolecules across the nuclear envelope in interphase eukaryotic cells. NPCs are composed of roughly 30 different proteins (nucleoporins) of which about one third are characterized by the presence of phenylalanine-glycine (FG) repeat domains that allow the association of soluble nuclear transport receptors with the NPC. Two types of FG (FG/FxFG and FG/GLFG) domains are found in nucleoporins and Nup98 is the sole vertebrate nucleoporin harboring the GLFG-type repeats. By immuno-electron microscopy using isolated nuclei from Xenopus oocytes we show here the localization of distinct domains of Nup98. We examined the localization of the C- and N-terminal domain of Nup98 by immunogold-labeling using domain-specific antibodies against Nup98 and by expressing epitope tagged versions of Nup98. Our studies revealed that anchorage of Nup98 to NPCs through its C-terminal autoproteolytic domain occurs in the center of the NPC, whereas its N-terminal GLFG domain is more flexible and is detected at multiple locations within the NPC. Additionally, we have confirmed the central localization of Nup98 within the NPC using super resolution structured illumination fluorescence microscopy (SIM) to position Nup98 domains relative to markers of cytoplasmic filaments and the nuclear basket. Our data support the notion that Nup98 is a major determinant of the permeability barrier of NPCs. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Chatel, Guillaume; Fahrenkrog, Birthe] Univ Libre Bruxelles, Inst Mol Biol & Med, Charleroi, Belgium.
   [Desai, Sachin H.; Mattheyses, Alexa L.; Powers, Maureen A.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA.
   [Fahrenkrog, Birthe] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4003 Basel, Switzerland.
RP Powers, MA (corresponding author), Rue Prof Jenner & Brachet 12, B-60141 Charleroi, Belgium.
EM mpowers@emory.edu; bfahrenk@ulb.ac.be
OI Fahrenkrog, Birthe/0000-0003-4080-9413; Mattheyses, Alexa
   L/0000-0002-5119-7750
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); FNRS BelgiumFonds de la Recherche Scientifique - FNRS; M.E.
   Muller Foundation; Kanton Basel Stadt; Emory Neuroscience NINDS
   [P30NS055077]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1
   GM-059975]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM059975, R01GM059975, R01GM059975, R01GM059975, R01GM059975,
   R01GM059975, R01GM059975, R01GM059975, R01GM059975, R01GM059975] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077] Funding Source: NIH RePORTER
FX B.F. is very grateful to Ueli Aebi for his faith and continuous support
   in all the years at the MIH, for being a great scientific advisor, the
   many creative discussions and for his friendship. The authors thank
   Ursula Sauder and Vesna Oliveri for expert technical assistance, Katie
   Ullman and Mary Dasso for kind gifts of antibodies, and acknowledge
   Nikon Instruments, Inc. (Melville, NY) for providing the Ti-E N-SIM
   Structured Illumination Super Resolution Microscope System as part of
   our Partner in Research agreement. This worked was supported by research
   Grants to B.F. from the Swiss National Science Foundation and the FNRS
   Belgium, by the M.E. Muller Foundation and the Kanton Basel Stadt, by
   the Microcopy Core of the Emory Neuroscience NINDS Core Facilities
   grant, P30NS055077, and by National Institutes of Health, RO1 GM-059975
   to M.A.P. G.C. is a "collaborateur scientifique" of the FNRS Belgium.
CR Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200
   Bodoor K, 1999, J CELL SCI, V112, P2253
   Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054
   Cross MK, 2011, MOL BIOL CELL, V22, P661, DOI 10.1091/mbc.E10-06-0478
   D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Feldherr CM, 1997, J CELL SCI, V110, P3065
   Fiserova J, 2010, J CELL SCI, V123, P2773, DOI 10.1242/jcs.070730
   Fiserova J, 2009, PLANT J, V59, P243, DOI 10.1111/j.1365-313X.2009.03865.x
   Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200
   Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097
   Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010
   Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3
   Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046
   Fukuhara T, 2005, HYBRIDOMA, V24, P244, DOI 10.1089/hyb.2005.24.244
   Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.E03-10-0743
   Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582
   Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538
   Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345
   Gustafsson MGL, 2000, PROC SPIE, V3919, P141, DOI 10.1117/12.384189
   Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3
   Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833
   Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0
   Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221
   Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031
   Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011
   Keminer O, 1999, P NATL ACAD SCI USA, V96, P11842, DOI 10.1073/pnas.96.21.11842
   Kowalczyk SW, 2011, NAT NANOTECHNOL, V6, P433, DOI [10.1038/NNANO.2011.88, 10.1038/nnano.2011.88]
   Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012
   Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x
   Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006
   Lussi YC, 2011, MOL BIOL CELL, V22, P1080, DOI 10.1091/mbc.E10-05-0463
   Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883
   Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200
   Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200
   Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Paulillo SM, 2006, J MOL BIOL, V363, P39, DOI 10.1016/j.jmb.2006.08.021
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721
   Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241
   Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237
   RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3
   Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370
   Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003
   Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030
   SLOT JW, 1985, EUR J CELL BIOL, V38, P87
   Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174
   Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007
   Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001
   Walde S., 2011, TRAFFIC
   Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6
   Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201
   Yoshida K, 2011, P NATL ACAD SCI USA, V108, P16571, DOI 10.1073/pnas.1112846108
   Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999
NR 63
TC 40
Z9 41
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN
PY 2012
VL 177
IS 1
SI SI
BP 81
EP 89
DI 10.1016/j.jsb.2011.11.004
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 880ZK
UT WOS:000299448900011
PM 22100335
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Kemmerling, S
   Ziegler, J
   Schweighauser, G
   Arnold, SA
   Giss, D
   Muller, SA
   Ringler, P
   Goldie, KN
   Goedecke, N
   Hierlemann, A
   Stahlberg, H
   Engel, A
   Braun, T
AF Kemmerling, Simon
   Ziegler, Joerg
   Schweighauser, Gabriel
   Arnold, Stefan A.
   Giss, Dominic
   Mueller, Shirley A.
   Ringler, Philippe
   Goldie, Kenneth N.
   Goedecke, Nils
   Hierlemann, Andreas
   Stahlberg, Henning
   Engel, Andreas
   Braun, Thomas
TI Connecting mu-fluidics to electron microscopy
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Electron microscopy; Microfluidics; Single-molecule analysis; Mass and
   shape; Systems biology
ID SYSTEMS BIOLOGY; CELLS
AB A versatile methodology for electron microscopy (EM) grid preparation enabling total content sample analysis is presented. A microfluidic-dialysis conditioning module to desalt or mix samples with negative stain solution is used, combined with a robotic writing table to micro-pattern the EM grids. The method allows heterogeneous samples of minute volumes to be processed at physiological pH for structure and mass analysis, and allows the preparation characteristics to be finely tuned. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Kemmerling, Simon; Ziegler, Joerg; Schweighauser, Gabriel; Arnold, Stefan A.; Giss, Dominic; Mueller, Shirley A.; Ringler, Philippe; Goldie, Kenneth N.; Stahlberg, Henning; Engel, Andreas; Braun, Thomas] Univ Basel, Biozentrum, C CINA, CH-4058 Basel, Switzerland.
   [Goedecke, Nils; Hierlemann, Andreas] ETHZ, Dept Biosyst Sci & Engn D BSSE, Basel, Switzerland.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
RP Braun, T (corresponding author), Univ Basel, Biozentrum, C CINA, Mattenstr 26, CH-4058 Basel, Switzerland.
EM thomas.braun@unibas.ch
RI Hierlemann, Andreas/A-7046-2008; Stahlberg, Henning/H-1868-2011
OI Hierlemann, Andreas/0000-0002-3838-2468; Stahlberg,
   Henning/0000-0002-1185-4592
FU SystemsX.ch initiative (CINA); Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [3100A0-108299]; NCCR
   NanoscienceSwiss National Science Foundation (SNSF)
FX We thank Mohamed Chami, Christopher Bleck (C-CINA), and the mechanical
   work-shop of the Biozentrum of the University Basel for their
   discussions and aid. The project is supported by the SystemsX.ch
   initiative (CINA, granted to A.E. and H.S.); the STEM microscopy by the
   Swiss National Science Foundation (Grant 3100A0-108299 to A.E. and the
   NCCR Nanoscience).
CR Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020
   Adiga U, 2005, J STRUCT BIOL, V152, P211, DOI 10.1016/j.jsb.2005.09.007
   Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   AEBI U, 1987, J ELECTRON MICR TECH, V7, P29, DOI 10.1002/jemt.1060070104
   Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859
   Barcena M, 2009, SEMIN CELL DEV BIOL, V20, P920, DOI 10.1016/j.semcdb.2009.07.008
   Ben-Harush K, 2010, J CELL SCI, V123, P7, DOI 10.1242/jcs.060111
   Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097
   BREMER A, 1992, ULTRAMICROSCOPY, V46, P85, DOI 10.1016/0304-3991(92)90008-8
   Coudray N, 2007, LECT NOTES COMPUT SC, V4633, P1005
   Engel A, 2010, SPRINGER SERIES CHEM, V96, P417, DOI 10.1007/978-3-642-02597-6_21
   Forster F, 2010, METHOD ENZYMOL, V483, P215, DOI 10.1016/S0076-6879(10)83011-3
   Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1
   Huang Z, 2004, J STRUCT BIOL, V145, P29, DOI 10.1016/j.jsb.2003.11.004
   Kherlopian AR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-74
   Kireev I, 2008, NAT METHODS, V5, P311, DOI [10.1038/nmeth.1196, 10.1038/NMETH.1196]
   Krzyzanek V, 2009, J STRUCT BIOL, V165, P78, DOI 10.1016/j.jsb.2008.10.006
   Leis A, 2009, TRENDS BIOCHEM SCI, V34, P60, DOI 10.1016/j.tibs.2008.10.011
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   Matthewson MJ, 1997, J LIGHTWAVE TECHNOL, V15, P490, DOI 10.1109/50.557565
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
NR 23
TC 18
Z9 18
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN
PY 2012
VL 177
IS 1
SI SI
BP 128
EP 134
DI 10.1016/j.jsb.2011.11.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 880ZK
UT WOS:000299448900017
PM 22094535
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Yang, YK
   Ringler, P
   Muller, SA
   Burkhard, P
AF Yang, Yongkun
   Ringler, Philippe
   Mueller, Shirley A.
   Burkhard, Peter
TI Optimizing the refolding conditions of self-assembling polypeptide
   nanoparticles that serve as repetitive antigen display systems
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Self-assembly; Peptide nanoparticles; Coiled coils; Protein folding;
   Mass measurement; Scanning transmission electron microscopy
ID COILED-COIL; PEPTIDE NANOPARTICLES; BIOLOGICAL-MATERIALS; IONIC
   INTERACTIONS; CRYSTAL-STRUCTURE; BUILDING-BLOCKS; DESIGN; PROTEINS;
   DOMAIN; DETERMINANTS
AB Nanoparticles show great promise as potent vaccine candidates since they are readily taken up by the antigen presenting cells of the immune system. The particle size and the density of the B cell epitopes on the surface of the particles greatly influences the strength of the humoral immune response. We have developed a novel type of nanoparticle composed of peptide building blocks (Raman et al., 2006) and have used such particles to design vaccines against malaria and SARS (Kaba et al., 2009; Pimentel et al., 2009). Here we investigate the biophysical properties and the refolding conditions of a prototype of these self-assembling polypeptide nanoparticles (SAPNs). SAPNs are formed from a peptide containing a pentameric and a trimeric coiled-coil domain. At near physiological conditions the peptide self-assembles into about 27 nm, roughly spherical SAPNs. The average size of the SAPNs increases with the salt concentration. The optimal pH for their formation is between 7.5 and 8.5, while aggregation occurs at lower and higher values. A glycerol concentration of about 5% v/v is required for the formation of SAPNs with regular spherical shapes. These studies will help to optimize the immunological properties of SAPNs. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Yang, Yongkun; Burkhard, Peter] Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.
   [Ringler, Philippe; Mueller, Shirley A.] Univ Basel, Biozentrum, Maurice E Muller Inst High Resolut Electron Micro, CH-4054 Basel, Switzerland.
   [Burkhard, Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.
RP Burkhard, P (corresponding author), Univ Connecticut, Inst Mat Sci, 97 N Eagleville Rd, Storrs, CT 06269 USA.
EM peter.burkhard@uconn.edu
FU Institute of Materials Science; University of Connecticut; Maurice E.
   Muller Foundation of Switzerland; Swiss National FoundationSwiss
   National Science Foundation (SNSF) [3100A0-108299]
FX The authors thank the Institute of Materials Science and the Polymer
   Program at the University of Connecticut for support of YY. The STEM
   microscopy was funded by the Maurice E. Muller Foundation of Switzerland
   and Swiss National Foundation Grant 3100A0-108299 to Andreas Engel; SM
   and PR thank Andreas Engel and Henning Stahlberg for supporting this
   STEM project.
CR AEBI U, 1977, P NATL ACAD SCI USA, V74, P5514, DOI 10.1073/pnas.74.12.5514
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Carlson JCT, 2006, J AM CHEM SOC, V128, P7630, DOI 10.1021/ja060631e
   DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671
   DREXLER KE, 1981, P NATL ACAD SCI USA, V78, P5275, DOI 10.1073/pnas.78.9.5275
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Fehr T, 1998, P NATL ACAD SCI USA, V95, P9477, DOI 10.1073/pnas.95.16.9477
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957
   Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419
   Krzyzanek V, 2009, J STRUCT BIOL, V165, P78, DOI 10.1016/j.jsb.2008.10.006
   Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761
   Meier M, 2002, J STRUCT BIOL, V137, P65, DOI 10.1006/jsbi.2002.4467
   Meier M, 2006, J STRUCT BIOL, V155, P116, DOI 10.1016/j.jsb.2006.02.019
   Meier M, 2010, J STRUCT BIOL, V170, P192, DOI 10.1016/j.jsb.2010.03.003
   Meng FG, 2001, INT J BIOCHEM CELL B, V33, P701, DOI 10.1016/S1357-2725(01)00048-6
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pimentel TAPF, 2009, CHEM BIOL DRUG DES, V73, P53, DOI 10.1111/j.1747-0285.2008.00746.x
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Raman S., 2009, OPEN NANOMED J, V2, P15, DOI DOI 10.2174/1875933500902010015
   Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007
   Rapaport H, 2000, J AM CHEM SOC, V122, P12523, DOI 10.1021/ja002238t
   Rasband W.S., IMAGEJ, V1997
   Scanlon S, 2008, NANO TODAY, V3, P22, DOI 10.1016/S1748-0132(08)70041-0
   SCHEIN CH, 1990, BIO-TECHNOL, V8, P308, DOI 10.1038/nbt0490-308
   Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023
   Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006
   Subramani K, 2008, CURR NANOSCI, V4, P201, DOI 10.2174/157341308784340831
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Toksoz S, 2009, NANO TODAY, V4, P458, DOI 10.1016/j.nantod.2009.09.002
   Tsai CJ, 2007, PROTEINS, V68, P1, DOI 10.1002/prot.21413
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Zandi R, 2004, P NATL ACAD SCI USA, V101, P15556, DOI 10.1073/pnas.0405844101
   Zanuy D., 2006, PHYS BIOL, V3
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 46
TC 25
Z9 25
U1 0
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN
PY 2012
VL 177
IS 1
SI SI
BP 168
EP 176
DI 10.1016/j.jsb.2011.11.011
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 880ZK
UT WOS:000299448900022
PM 22115997
OA Green Published
DA 2021-01-25
ER

PT J
AU Pradat, PF
   Dubourg, O
   de Tapia, M
   di Scala, F
   Dupuis, L
   Lenglet, T
   Bruneteau, G
   Salachas, F
   Lacomblez, L
   Corvol, JC
   Demougin, P
   Primig, M
   Meininger, V
   Loeffler, JP
   de Aguilar, JLG
AF Pradat, Pierre-Francois
   Dubourg, Odile
   de Tapia, Marc
   di Scala, Franck
   Dupuis, Luc
   Lenglet, Timothee
   Bruneteau, Gaelle
   Salachas, Francois
   Lacomblez, Lucette
   Corvol, Jean-Christophe
   Demougin, Philippe
   Primig, Michael
   Meininger, Vincent
   Loeffler, Jean-Philippe
   de Aguilar, Jose-Luis Gonzalez
TI Muscle Gene Expression Is a Marker of Amyotrophic Lateral Sclerosis
   Severity
SO NEURODEGENERATIVE DISEASES
LA English
DT Article
DE Amyotrophic lateral sclerosis; Surrogate marker; Human; Skeletal muscle;
   Transcriptome
ID SKELETAL-MUSCLE; AXONAL DEGENERATION; CEREBROSPINAL-FLUID;
   MOTOR-NEURONS; MOUSE MODEL; BIOMARKERS; ALS; DENERVATION; DIAGNOSIS;
   CRITERIA
AB Background: Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset degenerative disease characterized by the loss of upper and lower motor neurons leading to progressive muscle atrophy and paralysis. The lack of molecular markers of the progression of disease is detrimental to clinical practice and therapeutic trials. Objective: This study was designed to identify gene expression changes in skeletal muscle that could reliably define the degree of disease severity. Methods: Gene expression profiles were obtained from the deltoid muscles of ALS patients and healthy subjects. Changes in differentially expressed genes were compared to the status of deltoid muscle disability, as determined by manual muscle testing, electrophysiology and the degree of myofiber atrophy. Functionally related genes were grouped by annotation analysis, and deltoid muscle injury was predicted using binary tree classifiers. Results: Two sets of 25 and 70 transcripts appeared differentially regulated exclusively in early and advanced states of deltoid muscle impairment, respectively. The expression of another set of 198 transcripts correlated with a composite score of muscle injury combining manual muscle testing and histological examination. From the totality of these expression changes, 155 transcripts distinguished advanced from early deltoid muscle impairment with 80% sensitivity and 100% specificity. Nine of these transcripts, known also to be regulated in ALS mouse and surgically denervated muscle, predicted the advanced disease status with 100% sensitivity and specificity. Conclusion: We provide robust gene expression changes that can be of practical use when monitoring ALS status and the effects of disease-modifying drugs. Copyright (C) 2011 S. Karger AG, Basel
C1 [de Aguilar, Jose-Luis Gonzalez] Univ Strasbourg, Fac Med, Lab Signalisat Mol & Neurodegenerescence, INSERM,U692, FR-67085 Strasbourg, France.
   [Pradat, Pierre-Francois; Lenglet, Timothee; Bruneteau, Gaelle; Salachas, Francois; Lacomblez, Lucette; Meininger, Vincent] Hop La Pitie Salpetriere, AP HP, Ctr Referent Maladie Rare SLA, Paris, France.
   [Dubourg, Odile] Hop La Pitie Salpetriere, AP HP, Serv Neuropathol, Paris, France.
   [Lacomblez, Lucette; Corvol, Jean-Christophe; Meininger, Vincent] Univ Paris 06, Serv Pharmacol, Paris, France.
   [Lacomblez, Lucette] INSERM, U678, Paris, France.
   [Corvol, Jean-Christophe] INSERM, CIC 9503, DHOS, Ctr Invest Clin, Paris, France.
   [Corvol, Jean-Christophe] UPMC, CNRS, CR ICM, INSERM,UMRS975, Paris, France.
   [de Tapia, Marc; di Scala, Franck; Dupuis, Luc; Loeffler, Jean-Philippe; de Aguilar, Jose-Luis Gonzalez] Univ Strasbourg, UMRS692, FR-67085 Strasbourg, France.
   [Demougin, Philippe; Primig, Michael] Univ Basel, Biozentrum, Basel, Switzerland.
   [Demougin, Philippe; Primig, Michael] Swiss Inst Bioinformat, Basel, Switzerland.
RP de Aguilar, JLG (corresponding author), Univ Strasbourg, Fac Med, Lab Signalisat Mol & Neurodegenerescence, INSERM,U692, Batiment 3,Etage 8,11 Rue Humann, FR-67085 Strasbourg, France.
EM gonzalez@unistra.fr
RI Dupuis, Luc/A-6981-2012; corvol, jean-christophe/I-6387-2012; Corvol,
   Jean-Christophe/F-2124-2017; Primig, Michael/G-3175-2013; LOEFFLER,
   Jean-Philippe/AAS-4401-2020
OI corvol, jean-christophe/0000-0001-7325-0199; Corvol,
   Jean-Christophe/0000-0001-7325-0199; Primig,
   Michael/0000-0002-2061-0119; BRUNETEAU, GAELLE/0000-0002-1905-7985
FU Alsace BiovalleyRegion Grand-Est; European CommunityEuropean Community
   (EC) [259867]; Thierry Latran Foundation [FTL AAP09150135];
   INSERM/Universite de StrasbourgInstitut National de la Sante et de la
   Recherche Medicale (Inserm)
FX This study was supported by Alsace Biovalley, the European Community's
   Health Seventh Framework Programme (FP7/2007-2013) under grant agreement
   No. 259867, and the Thierry Latran Foundation (grant No. FTL
   AAP09150135). J.-L.G.d.A. is recipient of a Chaire INSERM/Universite de
   Strasbourg. Orthopaedic muscle biopsies were received from the Banque de
   Tissu pour la Recherche (Association Francaise contre les Myopathies,
   France). We thank Vanessa Pibiri and Renee Fouchet for excellent
   technical assistance. We also acknowledge the patients and their
   families.
CR Arts IMP, 2008, ULTRASOUND MED BIOL, V34, P354, DOI 10.1016/j.ultrasmedbio.2007.08.013
   Brettschneider J, 2008, NEUROCHEM RES, V33, P2358, DOI 10.1007/s11064-008-9742-5
   Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536
   Bryan WW, 1998, NEUROLOGY, V51, P110, DOI 10.1212/WNL.51.1.110
   Caiozzo VJ, 2004, ARCH OTOLARYNGOL, V130, P1056, DOI 10.1001/archotol.130.9.1056
   Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5
   Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903
   de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007
   de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Dewil M, 2007, NEUROBIOL DIS, V26, P332, DOI 10.1016/j.nbd.2006.12.023
   Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021
   DRACHMAN DB, 1976, ARCH NEUROL-CHICAGO, V33, P485, DOI 10.1001/archneur.1976.00500070027005
   Dubowitz V., 2007, MUSCLE BIOPSY PRACTI
   Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101
   EDWARDS RHT, 1983, MUSCLE NERVE, V6, P676, DOI 10.1002/mus.880060910
   EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349
   Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704
   Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3
   Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006
   Halter B, 2010, FREE RADICAL BIO MED, V48, P915, DOI 10.1016/j.freeradbiomed.2010.01.014
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jackson RS, 2006, CELL CYCLE, V5, P2889, DOI 10.4161/cc.5.24.3539
   Jimi T, 2004, PATHOL RES PRACT, V200, P203, DOI 10.1016/j.prp.2004.01.011
   Jokic N, 2005, ANN NEUROL, V57, P553, DOI 10.1002/ana.20420
   Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am
   Nakamura K, 2002, PATHOBIOLOGY, V70, P197, DOI 10.1159/000069329
   Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07
   Pradat PF, 2009, MOL DIAGN THER, V13, P115, DOI 10.2165/01250444-200913020-00005
   Raffaello A, 2006, PHYSIOL GENOMICS, V25, P60, DOI 10.1152/physiolgenomics.00051.2005
   Ranganathan S, 2007, AMYOTROPH LATERAL SC, V8, P373, DOI 10.1080/17482960701549681
   Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007
   Rutkove SB, 2007, CLIN NEUROPHYSIOL, V118, P2413, DOI 10.1016/j.clinph.2007.08.004
   SAGOT Y, 1995, J NEUROSCI, V15, P7727
   Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405
   Shefner JM, 2004, NEUROLOGY, V63, P1656, DOI 10.1212/01.WNL.0000142992.81995.F0
   Simon R. M., 2003, DESIGN ANAL DNA MICR
   Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689
   Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X
   Wojcik S, 2006, Acta Myol, V25, P116
   Zar J.H., 2010, BIOSTATISTICAL ANAL
NR 41
TC 25
Z9 25
U1 0
U2 7
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1660-2854
EI 1660-2862
J9 NEURODEGENER DIS
JI Neurodegener. Dis.
PY 2012
VL 9
IS 1
BP 38
EP 52
DI 10.1159/000329723
PG 15
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 878CG
UT WOS:000299229300006
PM 21934272
DA 2021-01-25
ER

PT J
AU Summermatter, S
   Thurnheer, R
   Santos, G
   Mosca, B
   Baum, O
   Treves, S
   Hoppeler, H
   Zorzato, F
   Handschin, C
AF Summermatter, Serge
   Thurnheer, Raphael
   Santos, Gesa
   Mosca, Barbara
   Baum, Oliver
   Treves, Susan
   Hoppeler, Hans
   Zorzato, Francesco
   Handschin, Christoph
TI Remodeling of calcium handling in skeletal muscle through PGC-1 alpha:
   impact on force, fatigability, and fiber type
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE muscle plasticity
ID TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; SARCOPLASMIC-RETICULUM;
   SLOW-TWITCH; THYROID-HORMONE; SIGNALING PATHWAYS; ENERGY-METABOLISM;
   CA2+ UPTAKE; EXERCISE; EXPRESSION; FATIGUE
AB Summermatter S, Thurnheer R, Santos G, Mosca B, Baum O, Treves S, Hoppeler H, Zorzato F, Handschin C. Remodeling of calcium handling in skeletal muscle through PGC-1 alpha: impact on force, fatigability, and fiber type. Am J Physiol Cell Physiol 302: C88-C99, 2012. First published September 14, 2011; doi:10.1152/ajpcell.00190.2011.-Regular endurance exercise remodels skeletal muscle, largely through the peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha). PGC-1 alpha promotes fiber type switching and resistance to fatigue. Intracellular calcium levels might play a role in both adaptive phenomena, yet a role for PGC-1 alpha in the adaptation of calcium handling in skeletal muscle remains unknown. Using mice with transgenic overexpression of PGC-1 alpha, we now investigated the effect of PGC-1 alpha on calcium handling in skeletal muscle. We demonstrate that PGC-1 alpha induces a quantitative reduction in calcium release from the sarcoplasmic reticulum by diminishing the expression of calcium-releasing molecules. Concomitantly, maximal muscle force is reduced in vivo and ex vivo. In addition, PGC-1 alpha overexpression delays calcium clearance from the myoplasm by interfering with multiple mechanisms involved in calcium removal, leading to higher myoplasmic calcium levels following contraction. During prolonged muscle activity, the delayed calcium clearance might facilitate force production in mice overexpressing PGC-1 alpha. Our results reveal a novel role of PGC-1 alpha in altering the contractile properties of skeletal muscle by modulating calcium handling. Importantly, our findings indicate PGC-1 alpha to be both down- as well as upstream of calcium signaling in this tissue. Overall, our findings suggest that in the adaptation to chronic exercise, PGC-1 alpha reduces maximal force, increases resistance to fatigue, and drives fiber type switching partly through remodeling of calcium transients, in addition to promoting slow-type myofibrillar protein expression and adequate energy supply.
C1 [Summermatter, Serge; Santos, Gesa; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   [Thurnheer, Raphael; Treves, Susan; Zorzato, Francesco] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland.
   [Thurnheer, Raphael; Treves, Susan; Zorzato, Francesco] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Mosca, Barbara; Zorzato, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy.
   [Baum, Oliver; Hoppeler, Hans] Univ Bern, Inst Anat, Bern, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Baum, Oliver/E-6367-2012; Handschin, Christoph/E-6886-2015
OI Baum, Oliver/0000-0001-5706-0942; Handschin,
   Christoph/0000-0003-0603-1097
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF PP00A-110746]; Muscular Dystrophy Association USAMuscular
   Dystrophy Association; SwissLife "Jubilaumsstiftung fur Volksgesundheit
   und medizinische Forschung"; Swiss Society for Research on Muscle
   Diseases (SSEM); Swiss Diabetes Association; Roche Research Foundation;
   United Mitochondrial Disease Foundation; Association Francaise contre
   les MyopathiesAssociation Francaise contre les Myopathies; University of
   Basel
FX This project was funded by the Swiss National Science Foundation (SNF
   PP00A-110746), the Muscular Dystrophy Association USA, the SwissLife
   "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung," the
   Swiss Society for Research on Muscle Diseases (SSEM), the Swiss Diabetes
   Association, the Roche Research Foundation, the United Mitochondrial
   Disease Foundation, the Association Francaise contre les Myopathies, and
   the University of Basel.
CR Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200
   Baar K, 2010, ACTA PHYSIOL, V199, P477, DOI 10.1111/j.1748-1716.2010.02121.x
   Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622
   Baylor SM, 2003, J PHYSIOL-LONDON, V551, P125, DOI 10.1113/jphysiol.2003.041608
   Beard NA, 2009, EUR BIOPHYS J BIOPHY, V39, P27, DOI 10.1007/s00249-009-0449-6
   BERS DM, 1989, CIRC RES, V65, P334, DOI 10.1161/01.RES.65.2.334
   Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783
   Booth FW, 2010, J APPL PHYSIOL, V108, P219, DOI 10.1152/japplphysiol.00125.2009
   Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7
   Calderon JC, 2010, J PHYSIOL-LONDON, V588, P267, DOI 10.1113/jphysiol.2009.180893
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Delbono O, 2007, P NATL ACAD SCI USA, V104, P20108, DOI 10.1073/pnas.0707389104
   Dirksen RT, 2009, APPL PHYSIOL NUTR ME, V34, P389, DOI 10.1139/H09-044
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7
   Froemming GR, 2000, BBA-BIOMEMBRANES, V1466, P151, DOI 10.1016/S0005-2736(00)00195-4
   Gonzalez E, 2001, MECH AGEING DEV, V122, P1019, DOI 10.1016/S0047-6374(01)00229-9
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Handschin C, 2010, J APPL PHYSIOL, V108, P223, DOI 10.1152/japplphysiol.01233.2009
   Hollingworth S, 2009, BIOPHYS J, V97, P1864, DOI 10.1016/j.bpj.2009.07.021
   HOPPELER H, 1985, J APPL PHYSIOL, V59, P320
   Isaeva EV, 2005, J PHYSIOL-LONDON, V565, P855, DOI 10.1113/jphysiol.2005.086280
   Isaeva EV, 2003, J PHYSIOL-LONDON, V547, P453, DOI 10.1113/jphysiol.2002.036129
   Johansson C, 2000, AM J PHYSIOL-REG I, V278, pR598
   Jordan T, 2004, J CELL SCI, V117, P6175, DOI 10.1242/jcs.01543
   LEBERER E, 1986, EUR J BIOCHEM, V156, P489, DOI 10.1111/j.1432-1033.1986.tb09607.x
   Li JL, 2002, J APPL PHYSIOL, V92, P912, DOI 10.1152/japplphysiol.00643.2000
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571
   METZGER JM, 1990, J PHYSIOL-LONDON, V428, P737, DOI 10.1113/jphysiol.1990.sp018238
   MOSS RL, 1985, J GEN PHYSIOL, V86, P585, DOI 10.1085/jgp.86.4.585
   Mu XD, 2007, PHYSIOL GENOMICS, V30, P300, DOI 10.1152/physiolgenomics.00286.2006
   Oh M, 2005, MOL CELL BIOL, V25, P6629, DOI 10.1128/MCB.25.15.6629-6638.2005
   Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358
   Sheridan DC, 2006, P NATL ACAD SCI USA, V103, P19760, DOI 10.1073/pnas.0609473103
   Simonides WS, 2008, THYROID, V18, P205, DOI 10.1089/thy.2007.0256
   SIMONIDES WS, 1990, ANAL BIOCHEM, V191, P321, DOI 10.1016/0003-2697(90)90226-Y
   Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x
   Summermatter S, 2008, FASEB J, V22, P774, DOI 10.1096/fj.07-8972com
   Summermatter S, 2011, BIOCHEM BIOPH RES CO, V408, P180, DOI 10.1016/j.bbrc.2011.04.012
   Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995
   Summermatter S, 2009, DIABETES, V58, P2228, DOI 10.2337/db08-1793
   Thelen MHM, 1997, BIOCHEM J, V321, P845, DOI 10.1042/bj3210845
   Treves S, 2010, J CELL SCI, V123, P4170, DOI 10.1242/jcs.068387
   Trinh HH, 2006, CLIN EXP PHARMACOL P, V33, P591, DOI 10.1111/j.1440-1681.2006.04412.x
   Tupling AR, 2002, J BIOL CHEM, V277, P44740, DOI 10.1074/jbc.M206171200
   Vendelin M, 2005, AM J PHYSIOL-CELL PH, V288, pC757, DOI 10.1152/ajpcell.00281.2004
   Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X
   Westerblad H, 2010, EXP CELL RES, V316, P3093, DOI 10.1016/j.yexcr.2010.05.019
   Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963
NR 55
TC 31
Z9 32
U1 0
U2 13
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6143
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD JAN
PY 2012
VL 302
IS 1
BP C88
EP C99
DI 10.1152/ajpcell.00190.2011
PG 12
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 866IN
UT WOS:000298374100012
PM 21918181
DA 2021-01-25
ER

PT J
AU Krutzfeldt, J
   Rosch, N
   Hausser, J
   Manoharan, M
   Zavolan, M
   Stoffel, M
AF Kruetzfeldt, Jan
   Roesch, Nora
   Hausser, Jean
   Manoharan, Muthiah
   Zavolan, Mihaela
   Stoffel, Markus
TI MicroRNA-194 is a target of transcription factor 1 (Tcf1, HNF1 alpha) in
   adult liver and controls expression of frizzled-6
SO HEPATOLOGY
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; SUPPRESSES METASTASIS; GENE-EXPRESSION;
   PATHWAY; INACTIVATION; HNF-1-ALPHA; DISRUPTION; ADENOMA; MOUSE; LEADS
AB Transcription factor 1 (Tcf1; hepatocyte nuclear factor 1a [HNF1a]) is critical for hepatocyte development and function. Whether Tcf1 also regulates hepatic microRNAs (miRNAs) has not been investigated yet. Here we analyzed Tcf1-dependent miRNA expression in adult mice in which this transcription factor had been genetically deleted (Tcf1-/-) using miRNA microarray analysis. The miR-192/-194 cluster was markedly down-regulated in liver of Tcf1-/- mice. MiR-192/-194 levels were also decreased in two other tissues that express Tcf1, kidney and small intestine, although to a lesser extent than in liver. In order to identify targets of miR-192/-194 in vivo we combined Affymetrix gene analysis of liver in which miR-192/-194 had been silenced or overexpressed, respectively, and tested regulated messenger RNAs (mRNAs) with multiple binding sites for these miRNAs. This approach revealed frizzled-6 (Fzd6) as a robust endogenous target of miR-194. MiR-194 also targets human FZD6 and expression of miR-194 and Fzd6 are inversely correlated in a mouse model of hepatocellular carcinoma (Dgcr8flox/flox p53flox/flox x Alb-Cre). Conclusion: Our results support a role of miR-194 in liver tumorigenesis through its endogenous target Fzd6. These results may have important implications for Tcf1-mediated liver proliferation. (HEPATOLOGY 2012;55:98107)
C1 [Stoffel, Markus] ETH, Swiss Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Kruetzfeldt, Jan; Roesch, Nora; Stoffel, Markus] ETH, Competence Ctr Syst Biol & Metab Dis, CH-8093 Zurich, Switzerland.
   [Kruetzfeldt, Jan] Univ Hosp Bern, Inselspital, Div Endocrinol Diabetol & Clin Nutr, CH-3010 Bern, Switzerland.
   [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
   [Manoharan, Muthiah] Alnylam Pharmaceut Inc, Cambridge, MA USA.
RP Stoffel, M (corresponding author), ETH, Swiss Inst Technol, Inst Mol Syst Biol, HPT E73,Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.
EM stoffel@imsb.biol.ethz.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; Hausser, Jean/0000-0002-3321-7199
FU Swiss National Science Foundation (LiverX)Swiss National Science
   Foundation (SNSF); ERCEuropean Research Council (ERC)
FX Supported in part by the Swiss National Science Foundation (LiverX) and
   ERC grant Metabolomirs (to M.S.).
CR Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Behari J, 2010, EXPERT REV GASTROENT, V4, P745, DOI 10.1586/EGH.10.74
   Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422
   Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015
   Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001
   Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160
   Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101
   Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208
   Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660
   Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193
   Ji JF, 2010, J HEPATOL, V52, P690, DOI 10.1016/j.jhep.2009.12.025
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256
   Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lee HC, 2006, FRONT BIOSCI-LANDMRK, V11, P1901, DOI 10.2741/1933
   Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693
   Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904
   Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915
   Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769
   Pelletier L, 2010, HEPATOLOGY, V51, P557, DOI 10.1002/hep.23362
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Rebouissou S, 2007, J BIOL CHEM, V282, P14437, DOI 10.1074/jbc.M610725200
   Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131
   Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067
   Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08
   Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871
   Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459
   Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468
   Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105
   Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008
   Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068
NR 38
TC 39
Z9 43
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JAN
PY 2012
VL 55
IS 1
BP 98
EP 107
DI 10.1002/hep.24658
PG 10
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 867WS
UT WOS:000298486100013
PM 21887698
DA 2021-01-25
ER

PT J
AU Orwick, MC
   Judge, PJ
   Procek, J
   Lindholm, L
   Graziadei, A
   Engel, A
   Grobner, G
   Watts, A
AF Orwick, Marcella C.
   Judge, Peter J.
   Procek, Jan
   Lindholm, Ljubica
   Graziadei, Andrea
   Engel, Andreas
   Grobner, Gerhard
   Watts, Anthony
TI Detergent-Free Formation and Physicochemical Characterization of
   Nanosized Lipid-Polymer Complexes: Lipodisq
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE calorimetry; EPR spectroscopy; lipids; membranes; polymers
ID HIGH-DENSITY-LIPOPROTEINS; MEMBRANE-PROTEINS; PHASE-TRANSITIONS;
   BILAYER; FLUORESCENCE; INTACT
C1 [Orwick, Marcella C.; Judge, Peter J.; Graziadei, Andrea; Watts, Anthony] Univ Oxford, Dept Biochem, Biomembrane Struct Unit, Oxford OX1 3QU, England.
   [Procek, Jan] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland.
   [Lindholm, Ljubica] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.
   [Grobner, Gerhard] Umea Univ, Dept Chem, S-9087 Umea, Sweden.
   [Engel, Andreas] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Watts, A (corresponding author), Univ Oxford, Dept Biochem, Biomembrane Struct Unit, Oxford OX1 3QU, England.
EM anthony.watts@bioch.ox.ac.uk
OI Graziadei, Andrea/0000-0001-7709-6002
FU EPSRC (CAESR)Engineering & Physical Sciences Research Council (EPSRC);
   EPSRC-NPL; ORS; University of Oxford, Biochemistry Department;
   BBSRCBiotechnology and Biological Sciences Research Council (BBSRC);
   CAESR; Malvern Cosmeceutics; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; Engineering and
   Physical Sciences Research CouncilEngineering & Physical Sciences
   Research Council (EPSRC) [EP/I029516/1, EP/F068085/1, EP/D048559/1]
   Funding Source: researchfish
FX We acknowledge Dr. Jeffrey Harmer and Peter Fisher for technical
   assistance. Funding was provided by the EPSRC (CAESR), and the EPSRC-NPL
   postdoctoral research partnership (to P.J.J.), the ORS, and the
   University of Oxford, Biochemistry Department (M.O.), BBSRC, CAESR,
   Malvern Cosmeceutics, and the NIH-funded TEMIMPS consortium. Lipodisq is
   a registered trademark.
CR Almgren M, 2000, BBA-BIOMEMBRANES, V1508, P146, DOI 10.1016/S0005-2736(00)00309-6
   Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c
   Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503
   Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024
   HUBBELL WL, 1971, J AM CHEM SOC, V93, P314
   Jamshad M, 2011, BIOCHEM SOC T, V39, P813, DOI 10.1042/BST0390813
   Knowles P.F., 1976, MAGNETIC RESONANCE B
   Knowles TJ, 2009, J AM CHEM SOC, V131, P7484, DOI 10.1021/ja810046q
   Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169
   LENTZ BR, 1978, BIOCHEMISTRY-US, V17, P4475, DOI 10.1021/bi00614a018
   MARSH D, 1982, BIOPHYS J, V37, P265, DOI 10.1016/S0006-3495(82)84675-4
   MARSH D, 1977, BIOCHIM BIOPHYS ACTA, V465, P500, DOI 10.1016/0005-2736(77)90268-1
   MASSEY JB, 1981, BIOCHEMISTRY-US, V20, P1575, DOI 10.1021/bi00509a026
   Shaw AW, 2004, FEBS LETT, V556, P260, DOI 10.1016/S0014-5793(03)01400-5
   SHIMSHICK EJ, 1973, BIOCHEMISTRY-US, V12, P2351, DOI 10.1021/bi00736a026
   Tonge S. R., 2006, UK Pat, Patent No. [WO/2006/129127, 2006129127]
   Tonge S. R., 2007, Patent, Patent No. [GB 2426703, 2426703]
   WALD JH, 1990, J BIOL CHEM, V265, P20044
   WATTS A, 1978, BIOCHIM BIOPHYS ACTA, V510, P63, DOI 10.1016/0005-2736(78)90130-X
NR 19
TC 108
Z9 109
U1 4
U2 86
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2012
VL 51
IS 19
BP 4653
EP 4657
DI 10.1002/anie.201201355
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 935GJ
UT WOS:000303506800027
PM 22473824
DA 2021-01-25
ER

PT S
AU Schatz, G
AF Schatz, Gottfried
BE Kornberg, RD
TI The Fires of Life
SO ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81
SE Annual Review of Biochemistry
LA English
DT Review; Book Chapter
DE European science; mitochondrial formation; oxidative phosphorylation
ID CYTOCHROME-C-OXIDASE; CATALYZING OXIDATIVE-PHOSPHORYLATION; IMPORTED
   MITOCHONDRIAL PROTEIN; ANAEROBICALLY GROWN YEAST; CYTOSOLIC
   DIHYDROFOLATE-REDUCTASE; RESPIRATION-DEFICIENT MUTANTS; OUTER-MEMBRANE
   PROTEIN; ADENOSINE-TRIPHOSPHATASE; PARTIAL RESOLUTION; BAKERS-YEAST
AB This retrospective recounts the hunt for the mechanism of mitochondrial ATP synthesis, the early days of research on mitochondrial formation, and some of the colorful personalities dominating these often dramatic and emotional efforts. The narrative is set against the backdrop of postwar Austria and Germany and the stream of young scientists who had to leave their countries to receive postdoctoral training abroad. Many of them-including the author-chose the laboratory of a scientist their country had expelled a few decades before. The article concludes with some thoughts on the uniqueness of U.S. research universities and a brief account of the struggles to revive science in Europe.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM gottfried.schatz@unibas.ch
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ATTARDI G, 1986, COLD SPRING HARB SYM, V51, P103, DOI 10.1101/SQB.1986.051.01.013
   BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0
   Beinert H, 2003, BIOGRAPHICAL MEMOIRS, V84, P1
   Bomer U, 1997, J BIOL CHEM, V272, P30439, DOI 10.1074/jbc.272.48.30439
   BOYER PD, 1977, ANNU REV BIOCHEM, V46, P955, DOI 10.1146/annurev.bi.46.070177.004515
   CABRAL F, 1978, J BIOL CHEM, V253, P297
   Costanzo MC, 1985, ACHIEVEMENTS PERSPEC, P355
   CRIDDLE RS, 1969, BIOCHEMISTRY-US, V8, P322, DOI 10.1021/bi00829a045
   EBNER E, 1973, J BIOL CHEM, V248, P5369
   EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0
   Ephrussi Boris, 1953, NUCLEOCYTOPLASMIC RE
   ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s
   FOX TD, 1979, P NATL ACAD SCI USA, V76, P6534, DOI 10.1073/pnas.76.12.6534
   FOX TD, 1986, TRENDS GENET, V2, P97, DOI 10.1016/0168-9525(86)90192-7
   GASSER SM, 1982, P NATL ACAD SCI-BIOL, V79, P267, DOI 10.1073/pnas.79.2.267
   GASSER SM, 1982, J BIOL CHEM, V257, P3034
   GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K
   HALLERMAYER G, 1977, EUR J BIOCHEM, V81, P523, DOI 10.1111/j.1432-1033.1977.tb11978.x
   HARMEY MA, 1977, EUR J BIOCHEM, V81, P533, DOI 10.1111/j.1432-1033.1977.tb11979.x
   HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7
   HURT EC, 1985, EMBO J, V4, P2061, DOI 10.1002/j.1460-2075.1985.tb03892.x
   HURT EC, 1984, FEBS LETT, V178, P306, DOI 10.1016/0014-5793(84)80622-5
   Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141
   KUZELA S, 1969, EXPERIENTIA, V25, P1042, DOI 10.1007/BF01901416
   LEMIRE BD, 1989, J BIOL CHEM, V264, P20206
   LINNANE AW, 1962, J CELL BIOL, V13, P345, DOI 10.1083/jcb.13.2.345
   MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343
   MASON TL, 1973, J BIOL CHEM, V248, P1355
   Mason TL, 1972, MITOCHONDRIA BIOGENE, P53
   MCLEAN JR, 1958, J BIOL CHEM, V233, P657
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   OHASHI A, 1982, J BIOL CHEM, V257, P3042
   PENEFSKY HS, 1960, J BIOL CHEM, V235, P3330
   PLATTNER H, 1969, BIOCHEMISTRY-US, V8, P339, DOI 10.1021/bi00829a047
   PLATTNER H, 1970, P NATL ACAD SCI USA, V66, P1252, DOI 10.1073/pnas.66.4.1252
   POYTON RO, 1975, J BIOL CHEM, V250, P762
   PULLMAN ME, 1960, J BIOL CHEM, V235, P3322
   PULLMAN ME, 1967, ANNU REV BIOCHEM, V36, P539, DOI 10.1146/annurev.bi.36.070167.002543
   RIEZMAN H, 1983, EMBO J, V2, P1113, DOI 10.1002/j.1460-2075.1983.tb01554.x
   ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x
   RUBIN MS, 1973, J BIOL CHEM, V248, P4275
   Schatz G, 1998, SCIENCE, V281, P1810, DOI 10.1126/science.281.5384.1810
   SCHATZ G, 1969, BIOCHEM BIOPH RES CO, V37, P996, DOI 10.1016/0006-291X(69)90230-7
   SCHATZ G, 1967, J BIOL CHEM, V242, P2552
   Schatz G, 1997, PROTEIN SCI, V6, P728
   SCHATZ G, 1968, J BIOL CHEM, V243, P2192
   SCHATZ G, 1964, BIOCHEM BIOPH RES CO, V15, P127, DOI 10.1016/0006-291X(64)90311-0
   Schatz G, 2011, MATTER WONDER
   Schatz G, 2005, JEFFS VIEW SCI SCI
   Schatz G, 2008, JENSEITS GENE
   Schatz G., 2011, FEUERSUCHER JAGD NAC
   Schatz G, 2000, COMPREHENSIVE BIOCH, V41, P449
   Schatz G, 2009, NAT CELL BIOL, V11, P364, DOI 10.1038/ncb0409-364
   Schatz Gottfried, 1993, P241
   SLONIMSKI P, 1953, FORMATION ENZYMES RE
   Swift H, 1968, BIOCHEMICAL ASPECTS, P3
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   TZAGOLOFF A, 1971, J BIOL CHEM, V246, P3050
   TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236
   VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9
   VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0
   WALLACE PG, 1964, NATURE, V201, P1191, DOI 10.1038/2011191a0
   WEISS H, 1971, EUR J BIOCHEM, V22, P19, DOI 10.1111/j.1432-1033.1971.tb01509.x
   YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819
   YANG M, 1988, EMBO J, V7, P3857, DOI 10.1002/j.1460-2075.1988.tb03271.x
NR 67
TC 3
Z9 3
U1 0
U2 2
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0066-4154
EI 1545-4509
BN 978-0-8243-0881-0
J9 ANNU REV BIOCHEM
JI Annu. Rev. Biochem..
PY 2012
VL 81
BP 35
EP 59
DI 10.1146/annurev-biochem-081009-125448
PG 25
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BAW66
UT WOS:000305765500003
PM 22224564
OA Bronze
DA 2021-01-25
ER

PT S
AU Meyer, RP
AF Meyer, Ralf P.
BE Koch, SC
   Fuchs, T
   Summa, M
   Muller, C
TI The memory of the cell
SO BODY MEMORY, METAPHOR AND MOVEMENT
SE Advances in Consciousness Research
LA English
DT Article; Book Chapter
DE body memory; brain; cell memory; epigenetics; neurobiology; neuronal
   network; steroid hormones
ID MIRROR NEURON SYSTEM; RECEPTOR EXPRESSION; BRAIN; ANDROGEN;
   NEUROGENESIS; HIPPOCAMPUS; MECHANISMS; SYNCHRONY; STRESS; MICE
AB Body memory and neurobiology - two faces of the same coin? Our genome serves as a basis for cellular development. Ensuing proliferation and differentiation of the cells are regulated by epigenetic factors and specific hormones, and are characterized by external influence like nutrition, environment, and education. This is an important process in adoption. The brain cells further integrate into a complex and stressable network by synaptogenesis and plasticity - a prerequisite in higher brain function. Brain's limbic system conducts memory, cognition, and emotion and interacts with the visual and prefrontal cortex, the frontal and temporal lobes. Perception and imitation are main factors in learning, memory, and emotional reaction. Body memory in neurobiological context may be hypothesized as a concept influenced by (epi)genetics, environmental input (hormones), cultural influence (network building), cognition, and emotion.
C1 [Meyer, Ralf P.] Univ Freiburg, Freiburg, Germany.
   [Meyer, Ralf P.] Merian Sch Biotechnol, Freiburg, Germany.
   [Meyer, Ralf P.] Karolinska Inst, Stockholm, Sweden.
   [Meyer, Ralf P.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Meyer, RP (corresponding author), Merian Sch Freiburg, Rheinstr 3, D-79104 Freiburg, Germany.
EM ralf.meyer@klinikum.uni-freiburg.de
CR Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455
   Berg D, 2008, NEURODEGENER DIS, V5, P133, DOI 10.1159/000113682
   Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001
   Conn PM, 2000, NEUROENDOCRINOLOGY P
   de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683
   Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565
   Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0
   Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06
   Hagemeyer CE, 2000, J NEUROSCI RES, V60, P106, DOI 10.1002/(SICI)1097-4547(20000401)60:1<106::AID-JNR11>3.0.CO;2-#
   Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006
   Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024
   Killer N, 2009, EPILEPSIA, V50, P1875, DOI 10.1111/j.1528-1167.2009.02161.x
   Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809
   Kold B., 1996, FUNDAMENTALS HUMAN N
   Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604
   Mainz U., 2010, MOLEKULARGENETIK EUK
   MCEWEN BS, 1992, HORM RES, V37, P1, DOI 10.1159/000182393
   McLachlan R. S, 2009, CANADIAN J NEUROL S2, V36, P84
   Meyer RP, 2010, VITAM HORM, V82, P87, DOI 10.1016/S0083-6729(10)82005-9
   Meyer RP, 2009, J NEUROCHEM, V109, P670, DOI 10.1111/j.1471-4159.2009.05994.x
   Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911
   Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317
   Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178
   Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001
   Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651
   ROSTENE W, 1995, J PSYCHIATR NEUROSCI, V20, P349
   Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1
   Singer Wolf, 2002, BEOBACHTER GEHIRN ES
   Wang L, 2003, P NATL ACAD SCI USA, V100, P703, DOI 10.1073/pnas.242735799
   Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011
NR 30
TC 0
Z9 0
U1 0
U2 2
PU JOHN BENJAMINS B V PUBL
PI AMSTERDAM ME
PA PO BOX 36224, 1020 AMSTERDAM ME, NETHERLANDS
SN 1381-589X
BN 978-90-272-8167-8; 978-90-272-1350-1
J9 ADV CONSC RES
PY 2012
VL 84
BP 243
EP 251
D2 10.1075/aicr.84
PG 9
WC Psychology, Experimental
SC Psychology
GA BB5ZM
UT WOS:000344247200016
DA 2021-01-25
ER

PT J
AU Harms, A
   Dehio, C
AF Harms, Alexander
   Dehio, Christoph
TI Intruders below the Radar: Molecular Pathogenesis of Bartonella spp.
SO CLINICAL MICROBIOLOGY REVIEWS
LA English
DT Review
ID CAT-SCRATCH DISEASE; ENDOTHELIAL GROWTH-FACTOR; OUTER-MEMBRANE PROTEINS;
   IV SECRETION SYSTEMS; NF-KAPPA-B; VINSONII SUBSP BERKHOFFII;
   INVASION-ASSOCIATED-LOCUS; NATURALLY INFECTED CATS; BRONCHISEPTICA
   FILAMENTOUS HEMAGGLUTININ; PARASITE PLASMODIUM-FALCIPARUM
AB Bartonella spp. are facultative intracellular pathogens that employ a unique stealth infection strategy comprising immune evasion and modulation, intimate interaction with nucleated cells, and intraerythrocytic persistence. Infections with Bartonella are ubiquitous among mammals, and many species can infect humans either as their natural host or incidentally as zoonotic pathogens. Upon inoculation into a naive host, the bartonellae first colonize a primary niche that is widely accepted to involve the manipulation of nucleated host cells, e. g., in the microvasculature. Consistently, in vitro research showed that Bartonella harbors an ample arsenal of virulence factors to modulate the response of such cells, gain entrance, and establish an intracellular niche. Subsequently, the bacteria are seeded into the bloodstream where they invade erythrocytes and give rise to a typically asymptomatic intraerythrocytic bacteremia. While this course of infection is characteristic for natural hosts, zoonotic infections or the infection of immunocompromised patients may alter the path of Bartonella and result in considerable morbidity. In this review we compile current knowledge on the molecular processes underlying both the infection strategy and pathogenesis of Bartonella and discuss their connection to the clinical presentation of human patients, which ranges from minor complaints to life-threatening disease.
C1 [Harms, Alexander; Dehio, Christoph] Univ Basel, Biozentrum, Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019; Harms,
   Alexander/J-5710-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Harms, Alexander/0000-0003-2106-1286
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100-061777]; (InfectX) in the frame of the SystemsX.ch Swiss
   Initiative for Systems Biology [51RT 0_ 126008]
FX This work was supported by grant 3100-061777 from the Swiss National
   Science Foundation (to C.D.) and grant 51RT 0_126008 (InfectX) in the
   frame of the SystemsX.ch Swiss Initiative for Systems Biology (to C.D.).
   A.H. is a fellow of the Werner Siemens Foundation.
CR Abbott RC, 1997, COMP IMMUNOL MICROB, V20, P41, DOI 10.1016/S0147-9571(96)00025-2
   Abramson T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003825
   ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748
   ALEXANDER B, 1995, AM J TROP MED HYG, V52, P354, DOI 10.4269/ajtmh.1995.52.354
   ALLISON MJ, 1974, AM J PHYS ANTHROPOL, V41, P295, DOI 10.1002/ajpa.1330410212
   Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09
   Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0
   Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008
   Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102
   ANDERSON B, 1994, MOL MICROBIOL, V13, P67, DOI 10.1111/j.1365-2958.1994.tb00402.x
   Anderson B, 1997, DNA CELL BIOL, V16, P1223, DOI 10.1089/dna.1997.16.1223
   Andersson SGE, 2000, INT J MED MICROBIOL, V290, P135
   Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202
   Arruda MA, 2004, J IMMUNOL, V173, P2023, DOI 10.4049/jimmunol.173.3.2023
   Arvand M, 2001, INFECT IMMUN, V69, P6427, DOI 10.1128/IAI.69.10.6427-6433.2001
   Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353
   Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498
   Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002
   Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x
   Bai Y, 2008, MICROB ECOL, V56, P373, DOI 10.1007/s00248-007-9355-6
   Bandara AB, 2005, J BACTERIOL, V187, P5767, DOI 10.1128/JB.187.16.5767-5775.2005
   Barbian KD, 2000, MICROBIOL-UK, V146, P599, DOI 10.1099/00221287-146-3-599
   BATTERMAN HJ, 1995, INFECT IMMUN, V63, P4553, DOI 10.1128/IAI.63.11.4553-4556.1995
   Battisti JM, 2007, INFECT IMMUN, V75, P4373, DOI 10.1128/IAI.00497-07
   Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06
   BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623
   Belanger L, 2009, MOL MICROBIOL, V74, P1223, DOI 10.1111/j.1365-2958.2009.06931.x
   Beldomenico PM, 2005, VECTOR-BORNE ZOONOT, V5, P110, DOI 10.1089/vbz.2005.5.110
   Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028
   BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986
   Berglund EC, 2010, MOL ECOL, V19, P2241, DOI 10.1111/j.1365-294X.2010.04646.x
   Berglund EC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-152
   Berglund EC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000546
   Bergonzelli GE, 2006, INFECT IMMUN, V74, P425, DOI 10.1128/IAI.74.1.425-434.2006
   Bermond D, 2002, INT J SYST EVOL MICR, V52, P383, DOI 10.1099/00207713-52-2-383
   Berrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020204
   Bessman MJ, 2001, J BIOL CHEM, V276, P37834
   Bhutto Abdul Manan, 1994, Journal of Dermatology (Tokyo), V21, P178
   Billeter SA, 2009, EXP APPL ACAROL, V49, P193, DOI 10.1007/s10493-009-9255-1
   Blanc L, 2010, BIOCHEMISTRY-US, V49, P4516, DOI 10.1021/bi1003684
   Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7
   Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06
   Bouchouicha R, 2009, EMERG INFECT DIS, V15, P813, DOI 10.3201/eid1505.080995
   Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009
   Boulouis HJ, 2001, INFECT IMMUN, V69, P5313, DOI 10.1128/IAI.69.9.5313-5317.2001
   Bowers TJ, 1998, GENE, V206, P49, DOI 10.1016/S0378-1119(97)00580-5
   BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994
   Breitschwerdt EB, 2008, J CLIN MICROBIOL, V46, P2856, DOI 10.1128/JCM.00832-08
   Breitschwerdt EB, 2004, J AM ANIM HOSP ASSOC, V40, P92, DOI 10.5326/0400092
   Breitschwerdt EB, 2000, CLIN MICROBIOL REV, V13, P428, DOI 10.1128/CMR.13.3.428-438.2000
   BREITSCHWERDT EB, 1995, J CLIN MICROBIOL, V33, P154, DOI 10.1128/JCM.33.1.154-160.1995
   Breitschwerdt EB, 1999, J CLIN MICROBIOL, V37, P3618, DOI 10.1128/JCM.37.11.3618-3626.1999
   Breitschwerdt EB, 2007, EMERG INFECT DIS, V13, P938, DOI 10.3201/eid1306.061337
   Breitschwerdt EB, 2007, J CLIN MICROBIOL, V45, P270, DOI 10.1128/JCM.01451-06
   Breitschwerdt EB, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-76
   Breitschwerdt EB, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-29
   Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001
   Brouqui P, 1996, RES MICROBIOL, V147, P719, DOI 10.1016/S0923-2508(97)85119-4
   Brouqui P, 1999, NEW ENGL J MED, V340, P184, DOI 10.1056/NEJM199901213400303
   Buchmann AU, 2010, VET PATHOL, V47, P163, DOI 10.1177/0300985809354347
   Buchmann AU, 2010, J CLIN MICROBIOL, V48, P3295, DOI 10.1128/JCM.00750-10
   Buckles EL, 2000, MICROB PATHOGENESIS, V29, P165, DOI 10.1006/mpat.2000.0381
   Burgess AWO, 1998, MICROB PATHOGENESIS, V25, P157, DOI 10.1006/mpat.1998.0223
   Burgess AWO, 2000, MICROB PATHOGENESIS, V29, P73, DOI 10.1006/mpat.2000.0366
   Byam W, 1920, Proc R Soc Med, V13, P1
   Caceres Abraham G., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P51, DOI 10.1590/S0036-46651997000100011
   CACERESRIOS H, 1995, CRIT REV ONCOGENESIS, V6, P47, DOI 10.1615/CritRevOncog.v6.i1.40
   Callison JA, 2005, GENE, V359, P53, DOI 10.1016/j.gene.2005.06.031
   CANGELOSI GA, 1989, J BACTERIOL, V171, P1609, DOI 10.1128/jb.171.3.1609-1615.1989
   Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x
   Capo C, 2003, J INFECT DIS, V187, P837, DOI 10.1086/368384
   CARITHERS HA, 1991, AM J DIS CHILD, V145, P98, DOI 10.1001/archpedi.1991.02160010104026
   Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07
   Carroll JA, 2000, INFECT IMMUN, V68, P6750, DOI 10.1128/IAI.68.12.6750-6757.2000
   Cartwright JL, 1999, BIOCHEM BIOPH RES CO, V256, P474, DOI 10.1006/bbrc.1999.0354
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Castle KT, 2004, AM J TROP MED HYG, V70, P429, DOI 10.4269/ajtmh.2004.70.429
   Castro OA, 1996, J BACTERIOL, V178, P6043, DOI 10.1128/jb.178.20.6043-6048.1996
   Cerimele F, 2003, AM J PATHOL, V163, P1321, DOI 10.1016/S0002-9440(10)63491-8
   Chamberlin J, 2002, J INFECT DIS, V186, P983, DOI 10.1086/344054
   Chang CC, 2002, J INFECT DIS, V186, P1733, DOI 10.1086/345764
   Chang CC, 2011, VET MICROBIOL, V149, P147, DOI 10.1016/j.vetmic.2010.09.033
   Chenoweth MR, 2004, INFECT IMMUN, V72, P3097, DOI 10.1128/IAI.72.6.3097-3105.2004
   Chenoweth MR, 2004, APPL ENVIRON MICROB, V70, P656, DOI 10.1128/AEM.70.2.656-663.2004
   Chian CA, 2002, INT J DERMATOL, V41, P461, DOI 10.1046/j.1365-4362.2002.01489.x
   Chinga-Alayo E, 2004, T ROY SOC TROP MED H, V98, P116, DOI 10.1016/S0035-9203(03)00017-8
   Chomel BB, 2006, EMERG INFECT DIS, V12, P389, DOI 10.3201/eid1203.050931
   Chomel BB, 2002, VET RES, V33, P205, DOI 10.1051/vetres:2002008
   CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995
   Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009010
   Chomel BB, 2009, ANN NY ACAD SCI, V1166, P120, DOI 10.1111/j.1749-6632.2009.04523.x
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011
   Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630
   Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860
   COCKERELL CJ, 1990, J AM ACAD DERMATOL, V22, P501, DOI 10.1016/0190-9622(90)70071-O
   Cockwill KR, 2007, CAN VET J, V48, P839
   Coleman SA, 2003, MICROB PATHOGENESIS, V34, P179, DOI 10.1016/S0882-4010(03)00005-6
   Coleman SA, 2001, INFECT IMMUN, V69, P4373, DOI 10.1128/IAI.69.7.4373-4381.2001
   Conyers GB, 1999, J BIOL CHEM, V274, P1203, DOI 10.1074/jbc.274.3.1203
   Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004
   Cotter SE, 2006, J BACTERIOL, V188, P5400, DOI 10.1128/JB.00164-06
   Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771
   Cross AS, 2008, CRIT CARE, V12, DOI 10.1186/cc7127
   Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11
   Dabo SM, 2006, MICROB PATHOGENESIS, V41, P10, DOI 10.1016/j.micpath.2006.04.003
   Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006
   Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233
   Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626
   Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07
   De Iannino NI, 1998, J BACTERIOL, V180, P4392
   DEGUERCY A, 1990, MOL BIOCHEM PARASIT, V38, P233, DOI 10.1016/0166-6851(90)90026-I
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, J CLIN MICROBIOL, V42, P5320, DOI 10.1128/JCM.42.11.5320-5323.2004
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Dehio C, 2001, INT J SYST EVOL MICR, V51, P1557, DOI 10.1099/00207713-51-4-1557
   Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Dehio M, 2005, THROMB HAEMOSTASIS, V94, P347, DOI 10.1160/TH05-02-0106
   DEMAAGD RA, 1992, J BACTERIOL, V174, P214, DOI 10.1128/JB.174.1.214-221.1992
   Derrick SC, 2001, BLOOD CELL MOL DIS, V27, P1013, DOI 10.1006/bcmd.2001.0475
   Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316
   Edelstein PH, 2005, INFECT IMMUN, V73, P6567, DOI 10.1128/IAI.73.10.6567-6576.2005
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002
   El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119
   Ellis BA, 1999, AM J TROP MED HYG, V61, P344
   Engel P, 2009, GENOME DYNAM, V6, P158, DOI 10.1159/000235769
   Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296
   Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07
   Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987
   FACER CA, 1983, B SOC PATHOL EXOT, V76, P463
   Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200
   Finkelstein JL, 2002, J MED ENTOMOL, V39, P915, DOI 10.1603/0022-2585-39.6.915
   Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034
   Fiori PL, 1997, INFECT IMMUN, V65, P5142, DOI 10.1128/IAI.65.12.5142-5148.1997
   Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608
   Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897
   Foulongne V, 2000, INFECT IMMUN, V68, P1297, DOI 10.1128/IAI.68.3.1297-1303.2000
   Fournier PE, 2001, INFECT IMMUN, V69, P1876, DOI 10.1128/IAI.69.3.1876-1879.2001
   Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124
   Franzoso S, 2008, J LEUKOCYTE BIOL, V83, P1100, DOI 10.1189/jlb.1207810
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   Galdiero M, 1997, INFECT IMMUN, V65, P699, DOI 10.1128/IAI.65.2.699-707.1997
   GARCIA FU, 1990, AM J PATHOL, V136, P1125
   GARCIA FU, 1992, J INFECT DIS, V165, P1138, DOI 10.1093/infdis/165.6.1138
   GARCIACACERES U, 1991, AM J CLIN PATHOL, V95, pS58
   Garduno RA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00122
   Gaywee J, 2002, INFECT IMMUN, V70, P6346, DOI 10.1128/IAI.70.11.6346-6354.2002
   Gazineo Jorge L. D., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P1, DOI 10.1590/S0036-46652001000100001
   Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x
   Gilmore RD, 2005, INFECT IMMUN, V73, P3128, DOI 10.1128/IAI.73.5.3128-3136.2005
   Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100
   Goodman RA, 2005, AM J VET RES, V66, P2060, DOI 10.2460/ajvr.2005.66.2060
   Goosen N, 2001, RES MICROBIOL, V152, P401, DOI 10.1016/S0923-2508(01)01211-6
   Greene CE, 1996, J CLIN MICROBIOL, V34, P1682, DOI 10.1128/JCM.34.7.1682-1685.1996
   Greub G, 2002, J MED MICROBIOL, V51, P915, DOI 10.1099/0022-1317-51-11-915
   Gudlavalleti SK, 2003, J BIOL CHEM, V278, P3957, DOI 10.1074/jbc.M210491200
   GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x
   Guptill L, 2004, J CLIN MICROBIOL, V42, P652, DOI 10.1128/JCM.42.2.652-659.2004
   Guptill L, 1997, J INFECT DIS, V176, P206, DOI 10.1086/514026
   Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2
   Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007
   Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765
   Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005
   Hanspal M, 2002, BLOOD, V100, P1048, DOI 10.1182/blood-2002-01-0101
   HEFFERNAN EJ, 1992, J BACTERIOL, V174, P84, DOI 10.1128/jb.174.1.84-91.1992
   Heller R, 1997, J CLIN MICROBIOL, V35, P1327, DOI 10.1128/JCM.35.6.1327-1331.1997
   Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05
   Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x
   Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004
   Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001
   Hendrix LR, 2003, ANN NY ACAD SCI, V990, P596, DOI 10.1111/j.1749-6632.2003.tb07433.x
   Hendrix LR, 2000, FEMS MICROBIOL LETT, V182, P119, DOI 10.1111/j.1574-6968.2000.tb08884.x
   Henriquez C, 2004, AM J TROP MED HYG, V71, P53, DOI 10.4269/ajtmh.2004.71.53
   Hickey TBM, 2010, CELL MICROBIOL, V12, P1634, DOI 10.1111/j.1462-5822.2010.01496.x
   HILL EM, 1992, INFECT IMMUN, V60, P4051, DOI 10.1128/IAI.60.10.4051-4058.1992
   Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367
   Hinode D, 1998, FEMS MICROBIOL LETT, V167, P1
   Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989
   Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013
   Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013
   Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000256
   Huang RT, 2011, EMERG INFECT DIS, V17, P1707, DOI 10.3201/eid1709.110133
   Huarcaya Erick, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P335, DOI 10.1590/S0036-46652007000500012
   Huarcaya E, 2011, REV INST MED TROP SP, V53, P149, DOI 10.1590/S0036-46652011000300006
   Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]
   Inatsuka CS, 2005, P NATL ACAD SCI USA, V102, P18578, DOI 10.1073/pnas.0507910102
   Infante Beronica, 2008, BMC Res Notes, V1, P103, DOI 10.1186/1756-0500-1-103
   Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003
   Iredell J, 2002, J CLIN MICROBIOL, V40, P4397, DOI 10.1128/JCM.40.11.4397-4398.2002
   Ishijima N, 2011, J BIOL CHEM, V286, P25256, DOI 10.1074/jbc.M111.233601
   Ismail TM, 2003, J BIOL CHEM, V278, P32602, DOI 10.1074/jbc.M305994200
   Iwaki-Egawa S, 1997, FEMS MICROBIOL LETT, V157, P207, DOI 10.1111/j.1574-6968.1997.tb12775.x
   Jackson LA, 1996, J INFECT DIS, V173, P1023, DOI 10.1093/infdis/173.4.1023
   JACKSON LA, 1993, AM J PUBLIC HEALTH, V83, P1707, DOI 10.2105/AJPH.83.12.1707
   Jacob-Dubuisson F, 2000, MICROBIOL-SGM, V146, P1211, DOI 10.1099/00221287-146-5-1211
   Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x
   JAMESON P, 1995, J INFECT DIS, V172, P1145, DOI 10.1093/infdis/172.4.1145
   Janczarek M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-284
   Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.001
   Jay DG, 1996, CELL, V86, P853, DOI 10.1016/S0092-8674(00)80160-9
   Jonson Ann-Beth, 2005, V12, P67, DOI 10.1159/000081690
   Kabeya H, 2006, MICROBIOL IMMUNOL, V50, P171, DOI 10.1111/j.1348-0421.2006.tb03783.x
   Kabeya H, 2003, J VET MED SCI, V65, P479, DOI 10.1292/jvms.65.479
   Kabeya H, 2002, VET MICROBIOL, V89, P211, DOI 10.1016/S0378-1135(02)00175-X
   Kabeya H, 2007, VET MICROBIOL, V119, P290, DOI 10.1016/j.vetmic.2006.08.010
   Kabeya H, 2009, MICROBES INFECT, V11, P716, DOI 10.1016/j.micinf.2009.03.008
   Kaiser PO, 2008, CELL MICROBIOL, V10, P2223, DOI 10.1111/j.1462-5822.2008.01201.x
   Kaiser PO, 2011, INT J MED MICROBIOL, V301, P7, DOI 10.1016/j.ijmm.2010.06.004
   Karem KL, 1999, IMMUNOLOGY, V97, P352, DOI 10.1046/j.1365-2567.1999.00750.x
   Karem KL, 2000, CRIT REV MICROBIOL, V26, P133, DOI 10.1080/10408410008984173
   Karem KL, 2000, MICROBES INFECT, V2, P1193, DOI 10.1016/S1286-4579(00)01273-9
   Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x
   Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7
   Kempf VAJ, 2005, CELL MICROBIOL, V7, P91, DOI 10.1111/j.1462-5822.2004.00440.x
   Kempf VAJ, 2002, TRENDS MICROBIOL, V10, P269, DOI 10.1016/S0966-842X(02)02372-7
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Kitchell BE, 2000, J AM VET MED ASSOC, V216, P519, DOI 10.2460/javma.2000.216.519
   Klein S, 2002, MOL CELL BIOL, V22, P5912, DOI 10.1128/MCB.22.16.5912-5922.2002
   KNOBLOCH J, 1990, AM J TROP MED HYG, V43, P373, DOI 10.4269/ajtmh.1990.43.373
   KNOBLOCH J, 1985, TROP MED PARASITOL, V36, P183
   Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069
   Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   KORDICK DL, 1995, J CLIN MICROBIOL, V33, P1655, DOI 10.1128/JCM.33.6.1655-1656.1995
   Kordick DL, 1997, J CLIN MICROBIOL, V35, P1813, DOI 10.1128/JCM.35.7.1813-1818.1997
   Kordick DL, 1998, EMERG INFECT DIS, V4, P325, DOI 10.3201/eid0402.980225
   KORDICK DL, 1995, J CLIN MICROBIOL, V33, P3245, DOI 10.1128/JCM.33.12.3245-3251.1995
   Kordick DL, 1999, J CLIN MICROBIOL, V37, P1536, DOI 10.1128/JCM.37.5.1536-1547.1999
   Kosek M, 2000, J INFECT DIS, V182, P865, DOI 10.1086/315797
   Kosoy M, 2004, VECTOR-BORNE ZOONOT, V4, P285, DOI 10.1089/vbz.2004.4.285
   Kosoy M, 2010, EMERG INFECT DIS, V16, P1875, DOI 10.3201/eid1612.100601
   Kosoy MY, 2000, COMP IMMUNOL MICROB, V23, P221, DOI 10.1016/S0147-9571(99)00075-2
   Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413
   Kunz S, 2008, AM J PATHOL, V172, P1005, DOI 10.2353/ajpath.2008.070591
   Kyme P, 2003, MICROBIOL-SGM, V149, P621, DOI 10.1099/mic.0.26014-0
   Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x
   La Scola B, 2002, J CLIN MICROBIOL, V40, P2002, DOI 10.1128/JCM.40.6.2002-2008.2002
   Laarmann S, 2002, MOL MICROBIOL, V46, P731, DOI 10.1046/j.1365-2958.2002.03189.x
   Laloux G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013274
   Lamps Laura W, 2004, Am J Clin Pathol, V121 Suppl, pS71
   Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001
   Lawrenz MB, 2009, INFECT IMMUN, V77, P317, DOI 10.1128/IAI.01206-08
   Leatham MP, 2005, INFECT IMMUN, V73, P8039, DOI 10.1128/IAI.73.12.8039-8049.2005
   LEBOIT PE, 1988, LANCET, V1, P960
   Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x
   Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003
   Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369
   Liberto MC, 2004, DIAGN MICR INFEC DIS, V50, P159, DOI 10.1016/j.diagmicrobio.2004.06.016
   Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299
   Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005
   Litwin CM, 2007, INFECT IMMUN, V75, P5255, DOI 10.1128/IAI.00533-07
   Litwin CM, 2005, INFECT IMMUN, V73, P4205, DOI 10.1128/IAI.73.7.4205-4213.2005
   Liu ZY, 2001, J BACTERIOL, V183, P3310, DOI 10.1128/JB.183.11.3310-3317.2001
   Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899
   Lund PA, 2001, ADV MICROB PHYSIOL, V44, P93, DOI 10.1016/S0065-2911(01)44012-4
   Lydy SL, 2008, J CLIN MICROBIOL, V46, P627, DOI 10.1128/JCM.01207-07
   MacKichan JK, 2008, INFECT IMMUN, V76, P788, DOI 10.1128/IAI.01174-07
   Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315
   Maggi RG, 2005, J MOL MICROB BIOTECH, V9, P44, DOI 10.1159/000088145
   Maggi RG, 2008, J WILDLIFE DIS, V44, P871, DOI 10.7589/0090-3558-44.4.871
   Maguina C, 2001, CLIN INFECT DIS, V33, P772, DOI 10.1086/322614
   Maguina C, 2009, CLIN DERMATOL, V27, P271, DOI 10.1016/j.clindermatol.2008.10.006
   Manders SM, 1996, CLIN DERMATOL, V14, P295, DOI 10.1016/0738-081X(96)00015-6
   Mandle T, 2005, BLOOD, V106, P1215, DOI 10.1182/blood-2004-12-4670
   Marignac G, 2010, COMP IMMUNOL MICROB, V33, P95, DOI 10.1016/j.cimid.2008.07.011
   Martin-Martin AI, 2008, MICROBES INFECT, V10, P706, DOI 10.1016/j.micinf.2008.02.013
   Matera G, 2003, INT IMMUNOPHARMACOL, V3, P853, DOI 10.1016/S1567-5769(03)00059-6
   Matera G, 2008, EUR CYTOKINE NETW, V19, P113, DOI 10.1684/ecn.2008.0128
   Matsumoto K, 2008, VECTOR-BORNE ZOONOT, V8, P549, DOI 10.1089/vbz.2007.0244
   Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106
   Mazar J, 2006, MOL MICROBIOL, V62, P641, DOI 10.1111/j.1365-2958.2006.05392.x
   McCord AM, 2005, INFECT IMMUN, V73, P5735, DOI 10.1128/IAI.73.9.5735-5742.2005
   McCord AM, 2007, DNA CELL BIOL, V26, P657, DOI 10.1089/dna.2007.0592
   McCord AM, 2006, INFECT IMMUN, V74, P5185, DOI 10.1128/IAI.00622-06
   Mehock JR, 1998, INFECT IMMUN, V66, P3462, DOI 10.1128/IAI.66.7.3462-3466.1998
   Meng G, 2008, J MOL BIOL, V384, P824, DOI 10.1016/j.jmb.2008.09.085
   MERNAUGH G, 1992, INFECT IMMUN, V60, P937, DOI 10.1128/IAI.60.3.937-943.1992
   Merrell DS, 2004, NATURE, V430, P250, DOI 10.1038/nature02760
   MILLER LH, 1994, P NATL ACAD SCI USA, V91, P2415, DOI 10.1073/pnas.91.7.2415
   Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068
   Miller SI, 2003, CELL, V115, P2, DOI 10.1016/S0092-8674(03)00767-0
   MINNICK MF, 1994, INFECT IMMUN, V62, P2644, DOI 10.1128/IAI.62.6.2644-2648.1994
   Minnick MF, 2003, INFECT IMMUN, V71, P6933, DOI 10.1128/IAI.71.12.6933-6942.2003
   Minnick MF, 2003, INFECT IMMUN, V71, P814, DOI 10.1128/IAI.71.2.814-821.2003
   Minnick MF, 1996, TRENDS MICROBIOL, V4, P343, DOI 10.1016/0966-842X(96)10055-X
   Minnick MF, 2006, PROTEOBACTERIA ALPHA, P476
   Minnick MF, 2009, FUTURE MICROBIOL, V4, P743, DOI [10.2217/fmb.09.41, 10.2217/FMB.09.41]
   Mistry D, 2006, INT J BIOCHEM CELL B, V38, P1244, DOI 10.1016/j.biocel.2005.10.005
   MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995
   Mitchell SJ, 1997, MICROBIOL-SGM, V143, P1221, DOI 10.1099/00221287-143-4-1221
   Mogollon-Pasapera E, 2009, INT J INFECT DIS, V13, P3, DOI 10.1016/j.ijid.2008.04.002
   Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166
   Mohindas N, 2006, TRANSFUS CLIN BIOL, V13, P29, DOI 10.1016/j.tracli.2006.02.017
   MohleBoetani JC, 1996, CLIN INFECT DIS, V22, P794, DOI 10.1093/clinids/22.5.794
   Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200
   Muller NF, 2011, INFECT IMMUN, V79, P2544, DOI 10.1128/IAI.01309-10
   Munana KR, 2001, INFECT IMMUN, V69, P564, DOI 10.1128/IAI.69.1.564-569.2001
   Murphy SC, 2007, BLOOD, V110, P2132, DOI 10.1182/blood-2007-04-083873
   Musso T, 2001, INFECT IMMUN, V69, P5974, DOI 10.1128/IAI.69.10.5974-5980.2001
   Nagele V, 2011, J BIOL CHEM, V286, P20536, DOI 10.1074/jbc.M110.188326
   Namekata DY, 2010, VET MICROBIOL, V146, P371, DOI 10.1016/j.vetmic.2010.05.034
   Nicholson TL, 2009, INFECT IMMUN, V77, P2136, DOI 10.1128/IAI.01379-08
   Noguchi H, 1926, J EXP MED, V44, P697, DOI 10.1084/jem.44.5.697
   Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247
   Nor JE, 2001, CANCER RES, V61, P2183
   Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252
   O'Reilly KL, 2001, INFECT IMMUN, V69, P1880, DOI 10.1128/IAI.69.3.1880-1882.2001
   O'Rourke F, 2011, ADV EXP MED BIOL, V715, P51, DOI 10.1007/978-94-007-0940-9_4
   Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500
   Ohl ME, 2000, CLIN INFECT DIS, V31, P131, DOI 10.1086/313890
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Oliver KM, 2009, ANTIOXID REDOX SIGN, V11, P2057, DOI [10.1089/ars.2008.2400, 10.1089/ARS.2008.2400]
   Ostberg Y, 2004, J BACTERIOL, V186, P2074, DOI 10.1128/JB.186.7.2074-2084.2004
   Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200
   Pachas P, 2000, EPIDEMIOLOGIA BARTON
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581
   Papadopoulos NG, 2001, CLIN INFECT DIS, V33, pE54, DOI 10.1086/322596
   Pappalardo BL, 2001, VET IMMUNOL IMMUNOP, V83, P125, DOI 10.1016/S0165-2427(01)00372-5
   Pappalardo BL, 2000, VET IMMUNOL IMMUNOP, V75, P43, DOI 10.1016/S0165-2427(00)00182-3
   Parrow NL, 2009, INFECT IMMUN, V77, P307, DOI 10.1128/IAI.01194-08
   PATEL VP, 1986, J BIOL CHEM, V261, P3170
   Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099
   Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8
   Paziewska A, 2011, MICROB ECOL, V61, P134, DOI 10.1007/s00248-010-9735-1
   Perez C, 2011, J VET INTERN MED, V25, P805, DOI 10.1111/j.1939-1676.2011.0736.x
   PERRY RD, 1993, INFECT IMMUN, V61, P32, DOI 10.1128/IAI.61.1.32-39.1993
   Pinne M, 2004, MICROBIOL-SGM, V150, P549, DOI 10.1099/mic.0.26728-0
   Plettenberg A, 2000, DERMATOLOGY, V201, P326, DOI 10.1159/000051547
   Popa C, 2007, INFECT IMMUN, V75, P4831, DOI 10.1128/IAI.00237-07
   Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x
   Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106
   Prell J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013933
   Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677
   Putnoky P, 1998, MOL MICROBIOL, V28, P1091, DOI 10.1046/j.1365-2958.1998.00868.x
   Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   Radford SE, 2006, CELL, V125, P831, DOI 10.1016/j.cell.2006.05.021
   Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539
   Raoult D, 2006, J INFECT DIS, V193, P112, DOI 10.1086/498534
   Raoult D, 1996, ANN INTERN MED, V125, P646, DOI 10.7326/0003-4819-125-8-199610150-00004
   REARDEN A, 1993, J BIOL CHEM, V268, P2260
   Reiling SA, 2005, MICROBIOL-SGM, V151, P2251, DOI 10.1099/mic.0.27772-0
   Reis C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001186
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   REYNAFARJE C, 1961, BLOOD, V17, P562, DOI 10.1182/blood.V17.5.562.562
   Rhomberg TA, 2004, PROTEOMICS, V4, P3021, DOI 10.1002/pmic.200400933
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   RICKETTS WE, 1948, BLOOD, V3, P1025, DOI 10.1182/blood.V3.9.1025.1025
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Riess T, 2007, INFECT IMMUN, V75, P35, DOI 10.1128/IAI.00963-06
   RODRIGUEZBARRADAS MC, 1995, INFECT IMMUN, V63, P2367, DOI 10.1128/IAI.63.6.2367-2370.1995
   Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003
   Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699
   Rolain JM, 2003, ANN NY ACAD SCI, V990, P581, DOI 10.1111/j.1749-6632.2003.tb07430.x
   Rolain JM, 2003, ANN NY ACAD SCI, V990, P485, DOI 10.1111/j.1749-6632.2003.tb07414.x
   Rolain JM, 2004, ANTIMICROB AGENTS CH, V48, P1921, DOI 10.1128/AAC.48.6.1921-1933.2004
   Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278
   Rolain JM, 2002, LANCET, V360, P226, DOI 10.1016/S0140-6736(02)09462-X
   Rolain JM, 2001, J CLIN MICROBIOL, V39, P2978, DOI 10.1128/JCM.39.8.2978-2980.2001
   Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14
   Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013
   Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102
   Salvatore P, 2008, P NATL ACAD SCI USA, V105, P9427, DOI 10.1073/pnas.0803602105
   Sander A, 2000, J CLIN MICROBIOL, V38, P2943, DOI 10.1128/JCM.38.8.2943-2948.2000
   Sander A, 2000, FEMS MICROBIOL LETT, V189, P55, DOI 10.1111/j.1574-6968.2000.tb09205.x
   SASARMAN S, 1968, J BACTERIOL, V96, P570
   Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Scheidegger F, 2011, CELL MICROBIOL, V13, P419, DOI 10.1111/j.1462-5822.2010.01545.x
   SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schmid Y, 2004, INFECT IMMUN, V72, P6780, DOI 10.1128/IAI.72.12.6780-6789.2004
   Schmiederer M, 2000, DNA CELL BIOL, V19, P141, DOI 10.1089/104454900314528
   Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06
   SCHRIER SL, 1987, METHOD ENZYMOL, V149, P260
   SCHRIER SL, 1992, BLOOD, V79, P782
   Schroder G, 2011, P NATL ACAD SCI USA, V108, P14643, DOI 10.1073/pnas.1019074108
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Schulte B, 2006, INFECT IMMUN, V74, P5003, DOI 10.1128/IAI.00663-06
   Schultz MG, 2010, EMERG INFECT DIS, V16, P1026, DOI 10.3201/eid1606.091937
   Schweyer S, 2002, J PATHOL, V198, P534, DOI 10.1002/path.1229
   Seki N, 2006, JPN J INFECT DIS, V59, P31
   Seki N, 2007, AM J TROP MED HYG, V77, P562, DOI 10.4269/ajtmh.2007.77.562
   Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Seubert A, 2003, PLASMID, V49, P44, DOI 10.1016/S0147-619X(02)00103-8
   Seubert A, 2002, INT J MED MICROBIOL, V291, P555
   SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457
   Smalley JW, 2000, FEMS MICROBIOL LETT, V183, P159, DOI 10.1016/S0378-1097(99)00660-6
   Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681
   Smitherman LS, 2005, ANN NY ACAD SCI, V1063, P286, DOI 10.1196/annals.1355.046
   Stanton TB, 2007, ANAEROBE, V13, P43, DOI 10.1016/j.anaerobe.2007.03.004
   STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F
   Sweger D, 2000, CLIN DIAGN LAB IMMUN, V7, P251, DOI 10.1128/CDLI.7.2.251-257.2000
   Sykes JE, 2007, VET IMMUNOL IMMUNOP, V116, P104, DOI 10.1016/j.vetimm.2006.12.004
   Sykes JE, 2010, J CLIN MICROBIOL, V48, P3782, DOI 10.1128/JCM.01029-10
   Szczesny P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000119
   Tarazona-Santos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016123
   Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669
   Thompson SA, 1998, J BACTERIOL, V180, P6450, DOI 10.1128/JB.180.24.6450-6458.1998
   Ticona E, 2010, MED HYPOTHESES, V74, P45, DOI 10.1016/j.mehy.2009.06.054
   Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033
   Truttmann MC, 2011, J CELL SCI, V124, P3591, DOI 10.1242/jcs.084459
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   UMEMORI E, 1992, MICROBIOL IMMUNOL, V36, P731, DOI 10.1111/j.1348-0421.1992.tb02075.x
   Urick T, 2005, J BACTERIOL, V187, P5809, DOI 10.1128/JB.187.16.5809-5817.2005
   Valentine KH, 2007, EMERG INFECT DIS, V13, P949, DOI 10.3201/eid1306.061551
   Van Audenhove A, 2001, BRIT J HAEMATOL, V115, P924, DOI 10.1046/j.1365-2141.2001.03165.x
   van Putten JPM, 1998, MOL MICROBIOL, V29, P369, DOI 10.1046/j.1365-2958.1998.00951.x
   van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Verma A, 2000, INFECT IMMUN, V68, P5960, DOI 10.1128/IAI.68.10.5960-5969.2000
   Verma A, 2002, CELL MICROBIOL, V4, P557, DOI 10.1046/j.1462-5822.2002.00217.x
   Verma A, 2001, CELL MICROBIOL, V3, P169, DOI 10.1046/j.1462-5822.2001.00104.x
   Vermi W, 2006, BLOOD, V107, P454, DOI 10.1182/blood-2005-04-1342
   Vigil A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011447
   Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2
   WALKER TS, 1981, INFECT IMMUN, V31, P480, DOI 10.1128/IAI.31.1.480-486.1981
   Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x
   Wan YY, 2009, J MOL CELL BIOL, V1, P20, DOI 10.1093/jmcb/mjp001
   Wang HY, 2003, MOL BIOL EVOL, V20, P1795, DOI 10.1093/molbev/msg185
   Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576
   Williams-Bouyer NM, 1999, FEMS MICROBIOL LETT, V171, P191, DOI 10.1111/j.1574-6968.1999.tb13432.x
   XU YH, 1995, BBA-BIOMEMBRANES, V1234, P173, DOI 10.1016/0005-2736(94)00271-P
   Yager JA, 2010, VET DERMATOL, V21, P420, DOI 10.1111/j.1365-3164.2010.00879.x
   Yamamoto K, 2003, VET MICROBIOL, V92, P73, DOI 10.1016/S0378-1135(02)00347-4
   Yamamoto K, 2002, J CLIN MICROBIOL, V40, P466, DOI 10.1128/JCM.40.2.466-474.2002
   Yamamoto K, 1998, VET IMMUNOL IMMUNOP, V65, P191, DOI 10.1016/S0165-2427(98)00154-8
   Yoshiji H, 2005, GUT, V54, P1768, DOI 10.1136/gut.2005.067900
   Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005
   Zahringer U, 1995, Prog Clin Biol Res, V392, P113
   Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200
   Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
   Zhang XY, 2009, J INFECT DIS, V200, P1318, DOI 10.1086/605846
   Zhao SQ, 2005, BIOMED ENVIRON SCI, V18, P341
   Zimmermann R, 2003, J BACTERIOL, V185, P1739, DOI 10.1128/JB.185.5.1739-1744.2003
NR 453
TC 118
Z9 122
U1 0
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0893-8512
EI 1098-6618
J9 CLIN MICROBIOL REV
JI Clin. Microbiol. Rev.
PD JAN
PY 2012
VL 25
IS 1
BP 42
EP 78
DI 10.1128/CMR.05009-11
PG 37
WC Microbiology
SC Microbiology
GA 876WC
UT WOS:000299137400002
PM 22232371
OA Bronze, Green Published
DA 2021-01-25
ER

PT S
AU Doyle, M
   Jaskiewicz, L
   Filipowicz, W
AF Doyle, Michael
   Jaskiewicz, Lukasz
   Filipowicz, Witold
BE Guo, F
   Tamanoi, F
TI Dicer Proteins and Their Role in Gene Silencing Pathways
SO ENZYMES, VOL 32: EUKARYOTIC RNASES AND THEIR PARTNERS IN RNA DEGRADATION
   AND BIOGENESIS, PT B
SE Enzymes
LA English
DT Article; Book Chapter
ID DOUBLE-STRANDED-RNA; EMBRYONIC STEM-CELLS; COLI RIBONUCLEASE-III; SHORT
   INTERFERING RNA; DSRNA-BINDING DOMAIN; RISC-LOADING COMPLEX; FISSION
   YEAST DICER; RECEPTOR RIG-I; C-ELEGANS; HELICASE DOMAIN
AB The RNase III family endoribonuclease Dicer is the key enzyme involved in the RNA interference (RNAi) and microRNA (miRNA) pathways. Apart from its function in biogenesis of miRNAs and short interfering RNAs (siRNAs), Dicer also plays a role in the assembly of the RNA-induced silencing complex (RISC), which functions as an effector complex in RNAi and miRNA repression. In this chapter, we review our current knowledge of Dicer from various organisms. We focus on the functions of individual domains of Dicer, how the enzyme recognizes and processes its substrates, and provide information on Dicer-associated proteins and their role in small RNA biogenesis and RISC assembly. We also discuss Dicer's role in gene and chromatin regulation processes in the cell nucleus.
C1 [Doyle, Michael] Med Univ Vienna, Ctr Brain Res, Vienna, Austria.
   [Jaskiewicz, Lukasz] Univ Basel, Biozentrum, Basel, Switzerland.
   [Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
RP Doyle, M (corresponding author), Med Univ Vienna, Ctr Brain Res, Vienna, Austria.
EM michael.doyle@meduniwien.ac.at; witold.filipowicz@fmi.ch
CR Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035
   Ando Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023385
   Banez-Coronel M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002481
   Barraud P, 2011, EMBO J, V30, P4223, DOI 10.1038/emboj.2011.300
   Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038
   Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Betancur JG, 2012, RNA, V18, P24, DOI 10.1261/rna.029785.111
   Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2
   Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003
   Buhler M, 2009, CHROMOSOMA, V118, P141, DOI 10.1007/s00412-008-0195-z
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002
   Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492
   Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030
   Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092
   Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868
   Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809
   Clery A, 2012, RNA BINDING PROTEINS, P139
   Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409
   Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007
   Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032
   Dlakic M, 2006, BIOINFORMATICS, V22, P2711, DOI 10.1093/bioinformatics/btl468
   Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105
   Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945
   Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105
   Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]
   Eamens AL, 2012, PLANT SIGNAL BEHAV, V7, P1224, DOI 10.4161/psb.21518
   Eamens AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035933
   Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011
   Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056
   Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236
   Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155
   Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034
   Gan J, 2008, MOL MICROBIOL, V67, P143, DOI 10.1111/j.1365-2958.2007.06032.x
   Gredell JA, 2010, BIOCHEMISTRY-US, V49, P3148, DOI 10.1021/bi902189s
   Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022
   Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Gullerova M., 2011, COLD SPRING HARB SYM, V75, P299
   Gullerova M, 2011, GENE DEV, V25, P556, DOI 10.1101/gad.618611
   Gurtan AM, 2012, RNA, V18, P1116, DOI 10.1261/rna.032680.112
   Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509
   Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464
   Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504
   Handa V, 2003, NUCLEIC ACIDS RES, V31, P6243, DOI 10.1093/nar/gkg818
   Haussecker D, 2005, MOL CELL BIOL, V25, P9724, DOI 10.1128/MCB.25.21.9724-9733.2005
   Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006
   Heravi-Moussavi A, 2012, NEW ENGL J MED, V366, P234, DOI 10.1056/NEJMoa1102903
   Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5
   Irvin-Wilson CV, 2005, BREAST CANCER RES, V7, pR563, DOI 10.1186/bcr1043
   Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77
   Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537
   Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755
   Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830
   Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505
   Kanellopoulou C, 2009, P NATL ACAD SCI USA, V106, P1122, DOI 10.1073/pnas.0812210106
   Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630
   Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200
   Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039
   Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303
   Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843
   Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031
   Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407
   Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069
   Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268
   Lau PW, 2009, STRUCTURE, V17, P1326, DOI 10.1016/j.str.2009.08.013
   Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Lejeune E, 2011, CURR OPIN CELL BIOL, V23, P258, DOI 10.1016/j.ceb.2011.03.005
   Liang XH, 2011, NUCLEIC ACIDS RES, V39, P4875, DOI 10.1093/nar/gkr076
   Liu FQ, 2012, SCIENCE, V335, P1621, DOI 10.1126/science.1214402
   Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513
   Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710
   Liu X, 2007, RNA, V13, P2324, DOI 10.1261/rna.723707
   Liu XH, 2012, MOL CELL, V46, P507, DOI 10.1016/j.molcel.2012.03.010
   Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x
   Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023
   Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005
   Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009
   MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105
   MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293
   MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638
   Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005
   Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735
   Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500
   Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317
   Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194
   Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307
   Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102
   Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374
   Nesterova TB, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-2
   Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1111/j.1574-6976.1999.tb00405.x
   Noland CL, 2011, MOL CELL, V43, P110, DOI 10.1016/j.molcel.2011.05.028
   Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676
   Ohishi K, 2012, FEBS J, V279, P832, DOI 10.1111/j.1742-4658.2012.08474.x
   Okamura K, 2011, WILEY INTERDISCIP RE, V3, P351, DOI [10.1002/wrna.113, DOI 10.1002/WRNA.113)]
   Okamura K, 2011, MOL CELL BIOL, V31, P884, DOI 10.1128/MCB.01141-10
   Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198
   Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5
   Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002
   Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706
   Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044
   Pelissier T, 2011, RNA, V17, P1502, DOI 10.1261/rna.2680711
   Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200
   Potenza N, 2010, FEBS LETT, V584, P3452, DOI 10.1016/j.febslet.2010.06.045
   Preall JB, 2006, CURR BIOL, V16, P530, DOI 10.1016/j.cub.2006.01.061
   Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578
   Qin HN, 2010, RNA, V16, P474, DOI 10.1261/rna.1965310
   Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402
   Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004
   Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918
   Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732
   Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505
   Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235
   Sawh AN, 2012, NAT STRUCT MOL BIOL, V19, P365, DOI 10.1038/nsmb.2275
   Shi HF, 2006, RNA, V12, P2063, DOI 10.1261/rna.246906
   Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391
   Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175
   Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766
   Soifer HS, 2008, NUCLEIC ACIDS RES, V36, P6511, DOI 10.1093/nar/gkn687
   Sun W, 2005, NUCLEIC ACIDS RES, V33, P807, DOI 10.1093/nar/gki197
   Sun WM, 2001, BIOCHEMISTRY-US, V40, P14976, DOI 10.1021/bi011570u
   Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X
   Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6
   Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909
   Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070
   Takeshita D, 2007, J MOL BIOL, V374, P106, DOI 10.1016/j.jmb.2007.08.069
   Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036
   Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848
   Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755
   Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057
   Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125
   Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046
   Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973
   Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673
   WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8
   Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021
   Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005
   Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010
   Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228
   Woolcock KJ, 2012, GENE DEV, V26, P683, DOI 10.1101/gad.186866.112
   Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935
   Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104
   Yan F, 2009, PLANT CELL REP, V28, P241, DOI 10.1007/s00299-008-0639-1
   Ye XC, 2007, J BIOL CHEM, V282, P28373, DOI 10.1074/jbc.M705208200
   Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033
   Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017
   Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582
   Zhang HM, 2012, GENE DEV, V26, P1769, DOI 10.1101/gad.200410.112
NR 156
TC 7
Z9 8
U1 0
U2 6
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1874-6047
BN 978-0-12-404744-0; 978-0-12-404741-9
J9 ENZYMES
JI Enzymes
PY 2012
VL 32
BP 1
EP 35
DI 10.1016/B978-0-12-404741-9.00001-5
PG 35
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BA3CG
UT WOS:000334104000002
DA 2021-01-25
ER

PT J
AU Oehring, SC
   Woodcroft, BJ
   Moes, S
   Wetzel, J
   Dietz, O
   Pulfer, A
   Dekiwadia, C
   Maeser, P
   Flueck, C
   Witmer, K
   Brancucci, NMB
   Niederwieser, I
   Jenoe, P
   Ralph, SA
   Voss, TS
AF Oehring, Sophie C.
   Woodcroft, Ben J.
   Moes, Suzette
   Wetzel, Johanna
   Dietz, Olivier
   Pulfer, Andreas
   Dekiwadia, Chaitali
   Maeser, Pascal
   Flueck, Christian
   Witmer, Kathrin
   Brancucci, Nicolas M. B.
   Niederwieser, Igor
   Jenoe, Paul
   Ralph, Stuart A.
   Voss, Till S.
TI Organellar proteomics reveals hundreds of novel nuclear proteins in the
   malaria parasite Plasmodium falciparum
SO GENOME BIOLOGY
LA English
DT Article
DE Malaria; Plasmodium falciparum; Nucleus; Proteomics; Bioinformatics;
   IFA; Transcription; Nucleolus; Nuclear pore; Transfection
ID MUTUALLY EXCLUSIVE EXPRESSION; ANTIMALARIAL-DRUG DISCOVERY; TANDEM
   MASS-SPECTROMETRY; NIMA-RELATED KINASE; RNA-POLYMERASE-II; LIFE-CYCLE;
   TRANSCRIPTION FACTORS; ANTIGENIC VARIATION; TOXOPLASMA-GONDII; VIRULENCE
   GENES
AB Background: The post-genomic era of malaria research provided unprecedented insights into the biology of Plasmodium parasites. Due to the large evolutionary distance to model eukaryotes, however, we lack a profound understanding of many processes in Plasmodium biology. One example is the cell nucleus, which controls the parasite genome in a development-and cell cycle-specific manner through mostly unknown mechanisms. To study this important organelle in detail, we conducted an integrative analysis of the P. falciparum nuclear proteome.
   Results: We combined high accuracy mass spectrometry and bioinformatic approaches to present for the first time an experimentally determined core nuclear proteome for P. falciparum. Besides a large number of factors implicated in known nuclear processes, one-third of all detected proteins carry no functional annotation, including many phylum-or genus-specific factors. Importantly, extensive experimental validation using 30 transgenic cell lines confirmed the high specificity of this inventory, and revealed distinct nuclear localization patterns of hitherto uncharacterized proteins. Further, our detailed analysis identified novel protein domains potentially implicated in gene transcription pathways, and sheds important new light on nuclear compartments and processes including regulatory complexes, the nucleolus, nuclear pores, and nuclear import pathways.
   Conclusion: Our study provides comprehensive new insight into the biology of the Plasmodium nucleus and will serve as an important platform for dissecting general and parasite-specific nuclear processes in malaria parasites. Moreover, as the first nuclear proteome characterized in any protist organism, it will provide an important resource for studying evolutionary aspects of nuclear biology.
C1 [Oehring, Sophie C.; Wetzel, Johanna; Dietz, Olivier; Pulfer, Andreas; Maeser, Pascal; Flueck, Christian; Witmer, Kathrin; Brancucci, Nicolas M. B.; Niederwieser, Igor; Voss, Till S.] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4051 Basel, Switzerland.
   [Oehring, Sophie C.; Wetzel, Johanna; Dietz, Olivier; Pulfer, Andreas; Maeser, Pascal; Flueck, Christian; Witmer, Kathrin; Brancucci, Nicolas M. B.; Niederwieser, Igor; Voss, Till S.] Univ Basel, CH-4003 Basel, Switzerland.
   [Woodcroft, Ben J.; Dekiwadia, Chaitali; Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.
   [Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Voss, TS (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Socinstr 57, CH-4051 Basel, Switzerland.
EM till.voss@unibas.ch
RI ; Ralph, Stuart/C-8590-2014
OI Brancucci, Nicolas/0000-0003-0655-3266; Woodcroft,
   Ben/0000-0003-0670-7480; Witmer, Kathrin/0000-0002-3159-7386; Ralph,
   Stuart/0000-0003-0114-7808; Flueck, Christian/0000-0001-9145-9324
FU University of Melbourne MRS scholarship; Australian Research
   CouncilAustralian Research Council [FT0990350]; Boehringer Ingelheim PhD
   fellowshipBoehringer Ingelheim; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [PP00A-110835, PP00P3_130203];
   Novartis Foundation for Medicine and Biology [08C46];
   Emilia-Guggenheim-Schnurr Foundation; Rudolf Geigy Foundation
FX The authors would like to thank Terry Speed and James Bailey for helpful
   comments. We are grateful to Tim-Wolf Gilberger, Mike Duffy, Michael
   Terns, and Geoff McFadden for providing antibodies. BJW is funded by a
   University of Melbourne MRS scholarship. SAR is funded by an Australian
   Research Council Future Fellowship (FT0990350). NMBB received a
   Boehringer Ingelheim PhD fellowship. This work was supported by the
   Swiss National Science Foundation (PP00A-110835; PP00P3_130203), the
   Novartis Foundation for Medicine and Biology (08C46), the
   Emilia-Guggenheim-Schnurr Foundation, and the Rudolf Geigy Foundation.
   The funders had no role in study design, data collection, analysis, and
   interpretation, the decision to publish, or preparation of the
   manuscript.
CR AIKAWA M, 1966, AM J TROP MED HYG, V15, P449, DOI 10.4269/ajtmh.1966.15.449
   Albrethsen J, 2009, J PROTEOMICS, V72, P71, DOI 10.1016/j.jprot.2008.09.005
   Altschul SF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000852
   Aly NSM, 2007, PARASITOL RES, V100, P1119, DOI 10.1007/s00436-007-0460-8
   Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207
   [Anonymous], APILOC DAT PUBL PROT
   Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7
   Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814
   Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202
   Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709
   Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5
   Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088
   Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001
   Bischoff E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-34
   Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184
   Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005
   Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141
   Briquet S, 2006, EUKARYOT CELL, V5, P672, DOI 10.1128/EC.5.4.672-682.2006
   Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205
   Calvert MEK, 2008, MOL CELL BIOL, V28, P1313, DOI 10.1128/MCB.01035-07
   Camarda G, 2010, INT J PARASITOL, V40, P663, DOI 10.1016/j.ijpara.2009.11.006
   Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165
   Chandra BR, 2005, MOL BIOCHEM PARASIT, V142, P237, DOI 10.1016/j.molbiopara.2005.04.006
   Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004
   Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014
   COHN ZA, 1960, J EXP MED, V112, P983, DOI 10.1084/jem.112.6.983
   Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092
   Coleman BI, 2008, CELL MICROBIOL, V10, P1935, DOI 10.1111/j.1462-5822.2008.01203.x
   Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009
   Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107
   Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604
   CRAWLEY JCW, 1963, EXP CELL RES, V31, P70, DOI 10.1016/0014-4827(63)90156-3
   Cui LW, 2010, EUKARYOT CELL, V9, P1138, DOI 10.1128/EC.00036-10
   Cui L, 2008, EUKARYOT CELL, V7, P1200, DOI 10.1128/EC.00063-08
   Cui L, 2007, EUKARYOT CELL, V6, P1219, DOI 10.1128/EC.00062-07
   Dastidar EG, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-5
   Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135
   De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105
   Doerig C, 2007, EXPERT OPIN THER TAR, V11, P279, DOI 10.1517/14728222.11.3.279
   Dorin D, 1999, J BIOL CHEM, V274, P29912, DOI 10.1074/jbc.274.42.29912
   Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x
   Dorin-Semblat D, 2007, MOL MICROBIOL, V65, P1170, DOI 10.1111/j.1365-2958.2007.05859.x
   Dorin-Semblat D, 2011, MICROBIOL-SGM, V157, P2785, DOI 10.1099/mic.0.049023-0
   Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036
   Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7
   Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7
   Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1
   Fink J. Lynn, 2007, In Silico Biology, V7, P145
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007
   Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107
   Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784
   Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569
   Frankel MB, 2009, DNA CELL BIOL, V28, P277, DOI 10.1089/dna.2009.0853
   Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Gauci S, 2009, J PROTEOME RES, V8, P3451, DOI 10.1021/pr9000948
   Gissot M, 2005, J MOL BIOL, V346, P29, DOI 10.1016/j.jmb.2004.11.045
   Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007
   Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717
   Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290
   Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737
   Holland Z, 2009, EUKARYOT CELL, V8, P388, DOI 10.1128/EC.00334-08
   Horrocks P, 2009, MOL BIOCHEM PARASIT, V164, P9, DOI 10.1016/j.molbiopara.2008.11.010
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Iborra FJ, 2004, J CELL SCI, V117, P5713, DOI 10.1242/jcs.01538
   Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216
   Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018
   Jirage D, 2010, MOL BIOCHEM PARASIT, V172, P9, DOI 10.1016/j.molbiopara.2010.03.009
   Jirage Dayadevi, 2010, Infectious Disorders - Drug Targets, V10, P134
   Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n
   Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027
   Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106
   KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z
   Lal K, 2009, PROTEOMICS, V9, P1142, DOI 10.1002/pmic.200800404
   Lamarque M, 2008, PROTEOM CLIN APPL, V2, P1361, DOI 10.1002/prca.200700112
   LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287
   Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111
   Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195
   Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904
   Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025
   Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015
   Lindner SE, 2010, J MOL BIOL, V395, P558, DOI 10.1016/j.jmb.2009.11.004
   Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517
   Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032
   Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012
   MacNicol AM, 2008, BIOCHEM SOC T, V36, P528, DOI 10.1042/BST0360528
   Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129
   Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767
   Mancio-Silva L, 2008, J CELL SCI, V121, P2046, DOI 10.1242/jcs.026427
   Mancio-Silva L, 2010, P NATL ACAD SCI USA, V107, P15117, DOI 10.1073/pnas.1001045107
   Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013
   Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452
   Meissner M, 2005, MICROBES INFECT, V7, P1376, DOI 10.1016/j.micinf.2005.04.019
   Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100
   Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025
   Neumann N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013241
   Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x
   Peleg O, 2010, BIOL CHEM, V391, P719, DOI 10.1515/BC.2010.092
   Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115
   Radfar A, 2008, FREE RADICAL BIO MED, V44, P2034, DOI 10.1016/j.freeradbiomed.2008.03.010
   Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102
   Rangarajan R, 2005, EMBO REP, V6, P464, DOI 10.1038/sj.embor.7400404
   Richard D, 2011, J BIOL CHEM, V286, P11746, DOI 10.1074/jbc.M110.198499
   Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003
   Roobsoong W, 2011, J PROTEOMICS, V74, P1701, DOI 10.1016/j.jprot.2011.03.035
   Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106
   Sam-Yellowe TY, 2004, J PROTEOME RES, V3, P995, DOI 10.1021/pr049926m
   Sharma A, 2003, NAT STRUCT BIOL, V10, P197, DOI 10.1038/nsb899
   Shaw P, 2005, CELL CYCLE, V4, P102, DOI 10.4161/cc.4.1.1467
   Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200
   Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078
   Struck NS, 2008, MOL MICROBIOL, V67, P1320, DOI 10.1111/j.1365-2958.2008.06125.x
   Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240
   Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X
   Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084
   Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009
   TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0
   Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004
   Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005
   van Brummelen AC, 2009, J BIOL CHEM, V284, P4635, DOI 10.1074/jbc.M807085200
   Vincensini L, 2005, MOL CELL PROTEOMICS, V4, P582, DOI 10.1074/mcp.M400176-MCP200
   Volz J, 2010, INT J PARASITOL, V40, P109, DOI 10.1016/j.ijpara.2009.09.002
   Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407
   Waters AP, 2008, CELL HOST MICROBE, V3, P280, DOI 10.1016/j.chom.2008.04.005
   Weiner A, 2011, CELL MICROBIOL, V13, P967, DOI 10.1111/j.1462-5822.2011.01592.x
   White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889
   WHO, 2010, WORLD MALARIA REPORT 2010, P1
   Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104
   Witmer K, 2012, MOL MICROBIOL, V84, P243, DOI 10.1111/j.1365-2958.2012.08019.x
   Yang JM, 2001, CLIN IMMUNOL, V101, P38, DOI 10.1006/clim.2001.5099
   Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x
   Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x
NR 134
TC 73
Z9 74
U1 0
U2 32
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PY 2012
VL 13
IS 11
AR R108
DI 10.1186/gb-2012-13-11-r108
PG 21
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 102UC
UT WOS:000315868700008
PM 23181666
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Kolla, V
   Jeno, P
   Moes, S
   Lapaire, O
   Hoesli, I
   Hahn, S
AF Kolla, Varaprasad
   Jenoe, Paul
   Moes, Suzette
   Lapaire, Olav
   Hoesli, Irene
   Hahn, Sinuhe
TI Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma
   Samples in Pregnancies at Risk for Preeclampsia
SO JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
ID PLACENTAL PROTEIN 13; ISOBARIC TAGS; SERUM; WOMEN; PREDICTION;
   FIBRINOGEN; SEQUENCE; CELLS
AB A current major obstacle is that no reliable screening markers exist to detect pregnancies at risk for preeclampsia. Quantitative proteomic analysis employing isobaric labelling (iTRAQ) has been suggested to be suitable for the detection of potential plasma biomarkers, a feature we recently verified in analysis of pregnancies with Down syndrome foetuses. We have now examined whether this approach could yield biomarkers to screen pregnancies at risk for preeclampsia. In our study, we used maternal plasma samples obtained at 12 weeks of gestation, six from women who subsequently developed preeclampsia and six with uncomplicated deliveries. In our analysis, we observed elevations in 10 proteins out of 64 proteins in the preeclampsia study group when compared to the healthy control group. These proteins included clusterin, fibrinogen, fibronectin, and angiotensinogen, increased levels of which are known to be associated with preeclampsia. An elevation in the immune-modulatory molecule, galectin 3 binding protein, was also noted. Our pilot study, therefore, indicates that quantitative proteomic iTRAQ analysis could be a useful tool for the detection of new preeclampsia screening markers.
C1 [Hahn, Sinuhe] Univ Womens Hosp, Dept Biomed, Lab Prenatal Med, CH-4031 Basel, Switzerland.
   [Jenoe, Paul; Moes, Suzette] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hahn, S (corresponding author), Univ Womens Hosp, Dept Biomed, Lab Prenatal Med, Hebelstr 20, CH-4031 Basel, Switzerland.
EM shahn@uhbs.ch
FU PREGENESYS [37244]
FX The authors thank Mrs. Vivian Kiefer for her technical assistance and
   Professor E. Palmer and Dr. D. Huang for the proof reading of the paper.
   This study was supported by PREGENESYS (ref. no. 37244), Sixth Frame
   Work (FP6) grant.
CR Akolekar R, 2009, PRENATAL DIAG, V29, P1103, DOI 10.1002/pd.2375
   Anton L, 2008, HYPERTENSION, V51, P1066, DOI 10.1161/HYPERTENSIONAHA.107.103861
   Atkinson KR, 2009, J LIPID RES, V50, P71, DOI 10.1194/jlr.M800296-JLR200
   Benoit C, 2007, PLACENTA, V28, P498, DOI 10.1016/j.placenta.2006.09.002
   Blumenstein M, 2009, PROTEOMICS, V9, P2929, DOI 10.1002/pmic.200800625
   Chong PK, 2006, J PROTEOME RES, V5, P1232, DOI 10.1021/pr060018u
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i
   Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x
   Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1
   Jim B, 2010, CARDIOL REV, V18, P178, DOI 10.1097/CRD.0b013e3181c60ca6
   Khalil A, 2009, PRENATAL DIAG, V29, P781, DOI 10.1002/pd.2287
   Kim SY, 2007, J KOREAN MED SCI, V22, P873, DOI 10.3346/jkms.2007.22.5.873
   Kim SY, 2006, J KOREAN MED SCI, V21, P452, DOI 10.3346/jkms.2006.21.3.452
   KIRSCHBAUM NE, 1992, BLOOD, V79, P2643
   Kolla V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/952047
   Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61
   Leeflang MMG, 2007, EUR J OBSTET GYN R B, V133, P12, DOI 10.1016/j.ejogrb.2007.01.003
   Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Norwitz ER, 2006, REPROD BIOMED ONLINE, V13, P591, DOI 10.1016/S1472-6483(10)60649-9
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200
   Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200
   Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013
   Skornicka EL, 2004, CELL IMMUNOL, V232, P144, DOI 10.1016/j.cellimm.2005.03.007
   Song XM, 2008, J PROTEOME RES, V7, P2952, DOI 10.1021/pr800072x
   Spencer K, 2008, PRENATAL DIAG, V28, P7, DOI 10.1002/pd.1890
   Spencer K, 2008, PRENATAL DIAG, V28, P212, DOI 10.1002/pd.1957
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P924, DOI 10.1074/mcp.M400193-MCP200
NR 31
TC 38
Z9 40
U1 0
U2 8
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1110-7243
EI 1110-7251
J9 J BIOMED BIOTECHNOL
JI J. Biomed. Biotechnol.
PY 2012
AR 305964
DI 10.1155/2012/305964
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 938IH
UT WOS:000303726700001
PM 22570525
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Goto, H
   Kasahara, K
   Izawa, I
   Kiyono, T
   Watanabe, N
   Elowe, S
   Nigg, EA
   Inagaki, M
AF Goto, H.
   Kasahara, K.
   Izawa, I.
   Kiyono, T.
   Watanabe, N.
   Elowe, S.
   Nigg, E. A.
   Inagaki, M.
TI Novel mitotic signalling crosstalk between PI3K-Akt pathway and Plk1.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Goto, H.; Kasahara, K.; Izawa, I.; Inagaki, M.] Aichi Canc Ctr Res Inst, Div Biochem, Nagoya, Aichi, Japan.
   [Goto, H.; Inagaki, M.] Nagoya Univ Grad Sch Med, Dept Cell Oncol, Nagoya, Aichi, Japan.
   [Kasahara, K.] Nagoya City Univ, Grad Sch Pharma Sci, Dept Oncol, Nagoya, Aichi, Japan.
   [Kiyono, T.] Natl Canc Ctr, Div Virol, Tokyo, Japan.
   [Watanabe, N.] Riken ASI, Dept Biol Chem, Chem Biol Core Fac, Wako, Saitama, Japan.
   [Elowe, S.] CHUQ, Ctr Rech, Montreal, PQ, Canada.
   [Nigg, E. A.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Watanabe, Nobumoto/N-6959-2015
OI Watanabe, Nobumoto/0000-0002-2130-1334
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2012
VL 23
MA 1112
PG 1
WC Cell Biology
SC Cell Biology
GA V38MX
UT WOS:000209348603298
DA 2021-01-25
ER

PT J
AU Holland, AJ
   Fachinetti, D
   Zhu, Q
   Bauer, M
   Verma, I
   Nigg, E
   Cleveland, D
AF Holland, A. J.
   Fachinetti, D.
   Zhu, Q.
   Bauer, M.
   Verma, I.
   Nigg, E.
   Cleveland, D.
TI The autoregulated instability of Polo-like kinase 4 limits centrosome
   duplication to once per cell cycle.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Holland, A. J.; Fachinetti, D.; Cleveland, D.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.
   [Zhu, Q.; Verma, I.] Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA.
   [Bauer, M.; Nigg, E.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2012
VL 23
MA 1871
PG 2
WC Cell Biology
SC Cell Biology
GA V38MX
UT WOS:000209348605239
DA 2021-01-25
ER

PT J
AU Kuhbacher, A
   Emmenlauer, M
   Ramo, P
   Dehio, C
   Cossart, P
   Pizarro-Cerda, J
AF Kuehbacher, A.
   Emmenlauer, M.
   Raemoe, P.
   Dehio, C.
   Cossart, P.
   Pizarro-Cerda, J.
TI Integrated analysis by RNAi screening of mammalian cell invasion by the
   bacterial pathogen Listeria monocytogenes.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Kuehbacher, A.; Cossart, P.; Pizarro-Cerda, J.] Pasteur Intitute, Unite Interact Bacteries Cellules, Paris, France.
   [Kuehbacher, A.; Cossart, P.; Pizarro-Cerda, J.] INRA, USC2020, Paris, France.
   [Kuehbacher, A.; Cossart, P.; Pizarro-Cerda, J.] INSERM, U604, Paris, France.
   [Emmenlauer, M.; Raemoe, P.; Dehio, C.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2012
VL 23
MA 2452
PG 2
WC Cell Biology
SC Cell Biology
GA V38MX
UT WOS:000209348607338
DA 2021-01-25
ER

PT J
AU Plodinec, M
   Loparic, M
   Monnier, CA
   Obermann, E
   Zanetti-Daellenbach, R
   Oertle, P
   Hyotyla, JT
   Aebi, U
   Bentires-Alj, M
   Schoenenberger, CA
   Lim, RY
AF Plodinec, M.
   Loparic, M.
   Monnier, C. A.
   Obermann, E.
   Zanetti-Daellenbach, R.
   Oertle, P.
   Hyotyla, J. T.
   Aebi, U.
   Bentires-Alj, M.
   Schoenenberger, C-A
   Lim, R. Y.
TI The Nanomechanical Signature of Breast Cancer
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Plodinec, M.; Loparic, M.; Monnier, C. A.; Oertle, P.; Hyotyla, J. T.; Schoenenberger, C-A; Lim, R. Y.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Plodinec, M.; Loparic, M.; Monnier, C. A.; Oertle, P.; Hyotyla, J. T.; Schoenenberger, C-A; Lim, R. Y.] Univ Basel, Swiss Nanosci Inst, Basel, Switzerland.
   [Obermann, E.] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland.
   [Zanetti-Daellenbach, R.] Univ Basel, Univ Basel Hosp, Dept Gynecol & Gynecol Oncol, Basel, Switzerland.
   [Aebi, U.; Schoenenberger, C-A] Univ Basel, Biozentrum, Maurice E Mueller Inst Struct Biol, Basel, Switzerland.
   [Bentires-Alj, M.] Friedrich Miescher Inst Biomed Res, Mech Canc, Basel, Switzerland.
RI Mohamed, Bentires-Alj/F-4484-2015
OI Mohamed, Bentires-Alj/0000-0001-6344-1127
NR 0
TC 0
Z9 0
U1 0
U2 5
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2012
VL 23
MA 2413
PG 1
WC Cell Biology
SC Cell Biology
GA V38MX
UT WOS:000209348607299
DA 2021-01-25
ER

PT J
AU Solinger, JA
   Spang, A
AF Solinger, J. A.
   Spang, A.
TI CORVET and HOPS functions in C. elegans
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Solinger, J. A.; Spang, A.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2012
VL 23
MA 88
PG 2
WC Cell Biology
SC Cell Biology
GA V38MX
UT WOS:000209348601088
DA 2021-01-25
ER

PT J
AU Zugschwerdt, P
   Mucke, N
   Aebi, U
   Herrmann, H
AF Zugschwerdt, P.
   Muecke, N.
   Aebi, U.
   Herrmann, H.
TI Recombinant synemin-L caps growing and severs mature intermediate
   filaments of the desmin- and vimentin-type.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Zugschwerdt, P.; Herrmann, H.] DKFZ, Funct Architecture Cell, Heidelberg, Germany.
   [Muecke, N.] DKFZ, Phys Macromol, Heidelberg, Germany.
   [Aebi, U.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2012
VL 23
MA 1279
PG 2
WC Cell Biology
SC Cell Biology
GA V38MX
UT WOS:000209348604095
DA 2021-01-25
ER

PT S
AU Cybulski, N
   Zinzalla, V
   Hall, MN
AF Cybulski, Nadine
   Zinzalla, Vittoria
   Hall, Michael N.
BE Weichhart, T
TI Inducible raptor and rictor Knockout Mouse Embryonic Fibroblasts
SO MTOR: METHODS AND PROTOCOLS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE mTOR; Raptor; Rictor; Signaling; Mouse embryonic fibroblasts; Knockout;
   iRapKO; iRicKO
ID MTOR COMPLEX 2; BINDING PARTNER; GROWTH; MICE; PHOSPHORYLATION; KINASE;
   TOR; AKT; CYTOSKELETON; DISRUPTION
AB The mammalian Target of Rapamycin (mTOR.) kinase functions within two structurally and functionally distinct multiprotein complexes termed mTOR complex 1 (mTORC1) and mTORC2. The immunosuppressant and anticancer drug rapamycin is commonly used in basic research as a tool to study mTOR signaling. However, rapamycin inhibits only, and only incompletely, mTORC1, and no mTORC2-specific inhibitor is available. Hence, a full understanding of mTOR signaling in vivo, including the function of both complexes, requires genetic inhibition in addition to pharmacological inhibition. Taking advantage of the Cre/LoxP system, we generated inducible knockout mouse embryonic fibroblasts (MEFs) deficient for either the mTORC1-specific component raptor (iRapKO) or the mTORC2-specific component rictor (iRicKO). Inducibility of the knockout was important because mTOR complex components are essential. Induction of either raptor or rictor knockout eliminated raptor or rictor expression, respectively, and impaired the corresponding mTOR signaling branch. The described knockout MEFs are a valuable tool to study the full function of the two mTOR complexes individually.
C1 [Cybulski, Nadine; Zinzalla, Vittoria; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Cybulski, N (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
CR Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106
   Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120
   Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887
   Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B
   Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Soulard A, 2007, CELL, V129, P434, DOI 10.1016/j.cell.2007.04.010
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
NR 29
TC 24
Z9 24
U1 0
U2 2
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
BN 978-1-61779-429-2
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2012
VL 821
BP 267
EP 278
DI 10.1007/978-1-61779-430-8_16
D2 10.1007/978-1-61779-430-8
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BYN18
UT WOS:000299398200016
PM 22125071
DA 2021-01-25
ER

PT J
AU Caussinus, E
   Kanca, O
   Affolter, M
AF Caussinus, Emmanuel
   Kanca, Oguz
   Affolter, Markus
TI Fluorescent fusion protein knockout mediated by anti-GFP nanobody
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID NONMUSCLE MYOSIN; SIGNALING PATHWAYS; CELLULAR-PROTEINS; DROSOPHILA;
   CELLS; TRAP; GENE; UBIQUITINATION; EFFICIENT; TARGET
AB The use of genetic mutations to study protein functions in vivo is a central paradigm of modern biology. Recent advances in reverse genetics such as RNA interference and morpholinos are widely used to further apply this paradigm. Nevertheless, such systems act upstream of the proteic level, and protein depletion depends on the turnover rate of the existing target proteins. Here we present deGradFP, a genetically encoded method for direct and fast depletion of target green fluorescent protein (GFP) fusions in any eukaryotic genetic system. This method is universal because it relies on an evolutionarily highly conserved eukaryotic function, the ubiquitin pathway. It is traceable, because the GFP tag can be used to monitor the protein knockout. In many cases, it is a ready-to-use solution, as GFP protein-trap stock collections are being generated in Drosophila melanogaster and in Danio rerio.
C1 [Caussinus, Emmanuel; Kanca, Oguz; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
RP Caussinus, E (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM emmanuel.caussinus@unibas.ch; markus.affolter@unibas.ch
RI Kanca, Oguz/I-6672-2015
OI Kanca, Oguz/0000-0001-5438-0879; Affolter, Markus/0000-0002-5171-0016
FU EMBOEuropean Molecular Biology Organization (EMBO) [ALTF 737-2005];
   Kantons Basel-Stadt and Basel-Land; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); SystemsX.ch
   initiative
FX We thank A. Santamaria, L. Fava and M. Muller for technical assistance;
   A. Olichon (Paul Sabatier University) for providing pAOD2-vhhGFP4; Y.
   Blum (University of Basel, UB) for providing pcDNA3_EGFP-3xNLS; E. Nigg
   (UB) for providing the HeLa S3 cell line expressing H2B-GFP; B. Bello
   (UB), W. Gehring (UB), C. Gonzalez (Institute for Research in
   Biomedicine), R. Karess (Institut Jacques Monod), T. Kornberg
   (University of California, San Francisco), Y. Hong (University of
   Pittsburgh), H. Oda (Biohistory Research Hall), R. Schuh (Max Planck
   Institute for Biophysical Chemistry) and the Bloomington Drosophila
   stock center (Indiana University), for providing fly stocks. E. C. was
   supported by an EMBO long-term postdoctoral fellowship (ALTF 737-2005).
   Work in our laboratory is supported by grants from the Kantons
   Basel-Stadt and Basel-Land, the Swiss National Science Foundation and
   the SystemsX.ch initiative within the framework of the WingX project.
CR Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004
   Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961
   Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062
   Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004
   Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151
   DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109
   Gohl D, 2008, GENETICS, V178, P127, DOI 10.1534/genetics.107.077768
   Harder B, 2008, BIOTECHNIQUES, V44, P765, DOI 10.2144/000112884
   Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020
   Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106
   Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763
   Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154
   KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O
   Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105
   Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014
   Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471
   Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198
   Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401
   Oda H, 2001, J CELL SCI, V114, P493
   Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009
   Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995
   Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200
   Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953
   Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440
   Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038
   Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798
   Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
   TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635
   Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25
   Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035
   Wodarz Andreas, 2008, V420, P335, DOI 10.1007/978-1-59745-583-1_21
   YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29
   Zhang JX, 2003, P NATL ACAD SCI USA, V100, P14127, DOI 10.1073/pnas.2233012100
   Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5
NR 39
TC 224
Z9 225
U1 9
U2 85
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD JAN
PY 2012
VL 19
IS 1
BP 117
EP U142
DI 10.1038/nsmb.2180
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 875PW
UT WOS:000299046000020
PM 22157958
DA 2021-01-25
ER

PT J
AU Willmann, R
   De Luca, A
   Benatar, M
   Grounds, M
   Dubach, J
   Raymackers, JM
   Nagaraju, K
AF Willmann, Raffaella
   De Luca, Annamaria
   Benatar, Michael
   Grounds, Miranda
   Dubach, Judith
   Raymackers, Jean-Marc
   Nagaraju, Kanneboyina
CA TREAT-NMD Neuromuscular Network
TI Enhancing translation: Guidelines for standard pre-clinical experiments
   in mdx mice
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE DMD; mdx; Methods; Standard operating procedures; Pre-clinical
   experiments
ID DUCHENNE-MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ENVIRONMENTAL ENRICHMENT;
   MOUSE; MODEL; TRIALS; IDENTIFICATION; EXPRESSION; UTROPHIN; THERAPY
AB Duchenne Muscular Dystrophy is an X-linked disorder that affects boys and leads to muscle wasting and death due to cardiac involvement and respiratory complications. The cause is the absence of dystrophin, a large structural protein indispensable for muscle cell function and viability. The mdx mouse has become the standard animal model for pre-clinical evaluation of potential therapeutic treatments. Recent years have seen a rapid increase in the number Of experimental compounds being evaluated in the mdx mouse. There is, however, much variability in the design of these pre-clinical experimental studies. This has made it difficult to interpret and compare published data from different laboratories and to evaluate the potential of a treatment for application to patients. The authors therefore propose the introduction of a standard study design for the mdx mouse model. Several aspects, including animal care, sampling times and choice of tissues, as well as recommended endpoints and methodologies are addressed and, for each aspect, a standard procedure is proposed. Testing of all new molecules/drugs using a widely accepted and agreed upon standard experimental protocol would greatly improve the power of pre-clinical experimentations and help identifying promising therapies for the translation into clinical trials for boys with Duchenne Muscular Dystrophy. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Willmann, Raffaella] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [De Luca, Annamaria] Univ Bari, Fac Farm, Dipartimento Farmacobiol, Sez Farmacol, I-70121 Bari, Italy.
   [Benatar, Michael] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Grounds, Miranda] Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia.
   [Dubach, Judith] Santhera Pharmaceut, Liestal, Switzerland.
   [Raymackers, Jean-Marc] Catholic Univ Louvain, Inst Neurosci, B-1348 Louvain, Belgium.
   [Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.
RP Willmann, R (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM raffaella.willmann@unibas.ch
RI Raymackers, Jean-Marc/I-6079-2015; Benatar, Michael/AAF-6605-2019
OI Raymackers, Jean-Marc/0000-0003-4377-8966; Benatar,
   Michael/0000-0003-4241-5135; De Luca, Annamaria/0000-0002-5652-7341;
   Grounds, Miranda/0000-0002-4530-9402
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [U54 HD053177-05,
   U54 HD053177] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL
   INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [U54HD053177, U54HD053177, U54HD053177, U54HD053177,
   U54HD053177, U54HD053177, U54HD053177, U54HD053177, U54HD053177,
   U54HD053177, U54HD053177, U54HD053177, U54HD053177, U54HD053177,
   U54HD053177, U54HD053177, U54HD053177, U54HD053177, U54HD053177,
   U54HD053177, U54HD053177, U54HD053177, U54HD053177, U54HD053177,
   U54HD053177, U54HD053177, U54HD053177, U54HD053177] Funding Source: NIH
   RePORTER
CR Archer JD, 2006, FASEB J, V20, P738, DOI 10.1096/fj.05-4821fje
   BEGGS AH, 1991, AM J HUM GENET, V49, P54
   Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015
   Bizario JCS, 2007, NEUROMUSCULAR DISORD, V17, P269, DOI 10.1016/j.nmd.2007.02.004
   Block KI, 2009, INTEGR CANCER THER, V8, P371, DOI 10.1177/1534735409352028
   Burdi R, 2009, J APPL PHYSIOL, V106, P1311, DOI 10.1152/japplphysiol.90985.2008
   Chamberlain JS, 1997, BASIC APPL MYOL, V7, P251
   Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4
   De Luca A, 2002, NEUROMUSCULAR DISORD, V12, pS142, DOI 10.1016/S0960-8966(02)00100-1
   De Luca A, 2008, NEUROBIOL DIS, V32, P243, DOI 10.1016/j.nbd.2008.07.009
   Deconinck N, 1997, NAT MED, V3, P1216, DOI 10.1038/nm1197-1216
   FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104
   Gillis JM, 2002, NEUROMUSCULAR DISORD, V12, pS90, DOI 10.1016/S0960-8966(02)00088-3
   Granchelli JA, 2000, NEUROMUSCULAR DISORD, V10, P235, DOI 10.1016/S0960-8966(99)00126-1
   Grounds MD, 2008, CELL MOL LIFE SCI, V65, P1621, DOI 10.1007/s00018-008-7574-8
   Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008
   Hoffman E, 2003, MOL CELL BIOL MUSCUL, P12
   Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833
   Hubner C, 1996, PEDIATR RES, V40, P444, DOI 10.1203/00006450-199609000-00013
   Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P2
   Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334
   Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024
   McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007
   McLennan IS, 2004, LAB ANIM-UK, V38, P384, DOI 10.1258/0023677041958927
   Nagaraju Kanneboyina, 2009, Neuromuscul Disord, V19, P502, DOI 10.1016/j.nmd.2009.05.003
   Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005
   PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251
   Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263
   Rudel R, 2002, Neuromuscul Disord, V12, P415, DOI 10.1016/S0960-8966(01)00327-3
   Rudic RD, 2009, CIRCULATION, V120, P1714, DOI 10.1161/CIRCULATIONAHA.109.853002
   Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300
   Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211
   STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0
   Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151
   Sztainberg Y, 2010, NAT PROTOC, V5, P1535, DOI 10.1038/nprot.2010.114
   Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015
   Xu J, 2008, AAPS J, V10, P331, DOI 10.1208/s12248-008-9038-3
NR 37
TC 46
Z9 46
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JAN
PY 2012
VL 22
IS 1
BP 43
EP 49
DI 10.1016/j.nmd.2011.04.012
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 901ZW
UT WOS:000301009400006
PM 21737275
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Silander, OK
   Nikolic, N
   Zaslaver, A
   Bren, A
   Kikoin, I
   Alon, U
   Ackermann, M
AF Silander, Olin K.
   Nikolic, Nela
   Zaslaver, Alon
   Bren, Anat
   Kikoin, Ilya
   Alon, Uri
   Ackermann, Martin
TI A Genome-Wide Analysis of Promoter-Mediated Phenotypic Noise in
   Escherichia coli
SO PLOS GENETICS
LA English
DT Article
ID STOCHASTIC GENE-EXPRESSION; SINGLE-CELL; NATURAL-SELECTION; EVOLUTION;
   SURVIVAL; CONSEQUENCES; DIVERSITY; STRESS; HETEROGENEITY; DIVERGENCE
AB Gene expression is subject to random perturbations that lead to fluctuations in the rate of protein production. As a consequence, for any given protein, genetically identical organisms living in a constant environment will contain different amounts of that particular protein, resulting in different phenotypes. This phenomenon is known as "phenotypic noise." In bacterial systems, previous studies have shown that, for specific genes, both transcriptional and translational processes affect phenotypic noise. Here, we focus on how the promoter regions of genes affect noise and ask whether levels of promoter-mediated noise are correlated with genes' functional attributes, using data for over 60% of all promoters in Escherichia coli. We find that essential genes and genes with a high degree of evolutionary conservation have promoters that confer low levels of noise. We also find that the level of noise cannot be attributed to the evolutionary time that different genes have spent in the genome of E. coli. In contrast to previous results in eukaryotes, we find no association between promoter-mediated noise and gene expression plasticity. These results are consistent with the hypothesis that, in bacteria, natural selection can act to reduce gene expression noise and that some of this noise is controlled through the sequence of the promoter region alone.
C1 [Silander, Olin K.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Silander, Olin K.; Nikolic, Nela; Ackermann, Martin] ETH, Dept Environm Sci, Zurich, Switzerland.
   [Silander, Olin K.; Nikolic, Nela; Ackermann, Martin] Eawag, Dept Environm Microbiol, Dubendorf, Switzerland.
   [Zaslaver, Alon] CALTECH, Div Biol, Pasadena, CA 91125 USA.
   [Bren, Anat; Kikoin, Ilya; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.
   [Bren, Anat; Kikoin, Ilya; Alon, Uri] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.
RP Silander, OK (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM olinsilander@gmail.com
RI Ackermann, Martin/V-4554-2017
OI Ackermann, Martin/0000-0003-0087-4819; Silander,
   Olin/0000-0003-4105-8316; Nikolic, Nela/0000-0001-9068-6090
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Swiss National FoundationSwiss National Science Foundation
   (SNSF)
FX OKS, NN, and MA were supported by a grant from the Swiss National
   Science Foundation to MA. OKS was additionally supported by an Ambizione
   fellowship from the Swiss National Foundation. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110
   Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067
   Alon U, 1999, NATURE, V397, P168
   Arkin A, 1998, GENETICS, V149, P1633
   Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807
   Batada NN, 2007, NAT GENET, V39, P945, DOI 10.1038/ng2071
   Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44
   Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504
   Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106
   Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199
   Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x
   Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003
   Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546
   Bollenbach T, 2011, MOL CELL, V42, P413, DOI 10.1016/j.molcel.2011.04.016
   Booth IR, 2002, INT J FOOD MICROBIOL, V78, P19, DOI 10.1016/S0168-1605(02)00239-8
   Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198
   Conway T, 2009, OKLAHOMA U E COLI GE
   Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904
   Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601
   Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554
   Donaldson-Matasci MC, 2008, EVOL ECOL RES, V10, P493
   Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919
   Freed NE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000307
   Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994
   Gasch AP, 2002, GENOME BIOL, V3
   Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002
   Hahne F, 2009, BMC BIOINFORMATICS, P10
   Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702
   Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615
   Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174
   Kovacs K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000115
   Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103
   Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160
   Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352
   Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383
   Lehner B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001185
   Lehner B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.11
   Lemos B, 2005, EVOLUTION, V59, P126
   Levine E, 2007, P NATL ACAD SCI USA, V104, P9224, DOI 10.1073/pnas.0610987104
   Lobner-Olesen A, 1999, EMBO J, V18, P1712, DOI 10.1093/emboj/18.6.1712
   McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814
   McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39
   Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785
   Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869
   Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663
   Peterson J, 2008, PLASMID, V59, P193, DOI 10.1016/j.plasmid.2008.01.004
   R Development Core Team, 2007, R LANG ENV STAT COMP
   Ragan MA, 2006, TRENDS MICROBIOL, V14, P4, DOI 10.1016/j.tim.2005.11.004
   Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309
   Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258
   Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891
   Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641
   Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086
   Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914
   Salis HM, 2010, GENOME WIDE PREDICIT
   Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568
   Serres Margrethe Hauge, 2000, Microbial and Comparative Genomics, V5, P205, DOI 10.1089/omi.1.2000.5.205
   Silander Olin K, 2009, BMC Res Notes, V2, P2, DOI 10.1186/1756-0500-2-2
   Silverman B. W., 1986, DENSITY ESTIMATION
   Sumner ER, 2002, MICROBIOL-SGM, V148, P345, DOI 10.1099/00221287-148-2-345
   Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399
   Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308
   Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598
   Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523
   Thiel H, 1950, P KONINKLIJKE NEDERL, P1897
   Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819
   Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344
   Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002
   Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213
   Wang Z, 2011, P NATL ACAD SCI USA, V108, pE67, DOI 10.1073/pnas.1100059108
   Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895
NR 71
TC 83
Z9 84
U1 0
U2 33
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD JAN
PY 2012
VL 8
IS 1
AR e1002443
DI 10.1371/journal.pgen.1002443
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA 891NH
UT WOS:000300223400011
PM 22275871
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Meinen, S
   Lin, S
   Ruegg, MA
AF Meinen, Sarina
   Lin, Shuo
   Ruegg, Markus A.
TI Angiotensin II type 1 receptor antagonists alleviate muscle pathology in
   the mouse model for laminin-alpha 2-deficient congenital muscular
   dystrophy (MDC1A)
SO SKELETAL MUSCLE
LA English
DT Article
DE TGF-beta; Smad2/3; Notexin; Skeletal muscle; Fibrosis; Muscle
   regeneration; losartan; Angiotensin II
AB Background: Laminin-alpha 2-deficient congenital muscular dystrophy (MDC1A) is a severe muscle-wasting disease for which no curative treatment is available. Antagonists of the angiotensin II receptor type 1 (AT1), including the anti-hypertensive drug losartan, have been shown to block also the profibrotic action of transforming growth factor (TGF)-beta and thereby ameliorate disease progression in mouse models of Marfan syndrome. Because fibrosis and failure of muscle regeneration are the main reasons for the severe disease course of MDC1A, we tested whether L-158809, an analog derivative of losartan, could ameliorate the dystrophy in dy(W)/dy(W) mice, the best-characterized model of MDC1A.
   Methods: L-158809 was given in food to dy(W)/dy(W) mice at the age of 3 weeks, and the mice were analyzed at the age of 6 to 7 weeks. We examined the effect of L-158809 on muscle histology and on muscle regeneration after injury as well as the locomotor activity and muscle strength of the mice.
   Results: We found that TGF-beta signaling in the muscles of the dy(W)/dy(W) mice was strongly increased, and that L-158809 treatment suppressed this signaling. Consequently, L-158809 reduced fibrosis and inflammation in skeletal muscle of dy(W)/dy(W) mice, and largely restored muscle regeneration after toxin-induced injury. Mice showed improvement in their locomotor activity and grip strength, and their body weight was significantly increased.
   Conclusion: These data provide evidence that AT1 antagonists ameliorate several hallmarks of MDC1A in dy(W)/dy(W) mice, the best-characterized mouse model for this disease. Because AT1 antagonists are well tolerated in humans and widely used in clinical practice, these results suggest that losartan may offer a potential future treatment of patients with MDC1A.
C1 [Meinen, Sarina; Lin, Shuo; Ruegg, Markus A.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Neuromuscular Research Association Basel (NeRAB); Swiss Foundation for
   Research on Muscle Diseases
FX We thank Merck for generously providing us with L-158809, a highly
   potent AT1 antagonist and derivative of losartan. This work was
   supported by the Neuromuscular Research Association Basel (NeRAB) and
   the The Swiss Foundation for Research on Muscle Diseases.
CR ALLEN RE, 1987, J CELL PHYSIOL, V133, P567, DOI 10.1002/jcp.1041330319
   Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com
   Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5
   Bish LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020856
   Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008
   Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19
   Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227
   Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034
   Carmignac V, 2011, HUM MOL GENET, V20, P4891, DOI 10.1093/hmg/ddr427
   Carmignac V, 2011, HUM MOL GENET, V20, P541, DOI 10.1093/hmg/ddq499
   COHEN SA, 1986, NATURE, V320, P769, DOI 10.1038/320769a0
   Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536
   DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0
   Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095
   Elbaz M, 2012, ANN NEUROL, V71, P699, DOI 10.1002/ana.22694
   Erb M, 2009, J PHARMACOL EXP THER, V331, P787, DOI 10.1124/jpet.109.160754
   Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190
   Gawlik KI, 2010, MUSCLE NERVE, V42, P30, DOI 10.1002/mus.21616
   Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928
   Girgenrath M, 2009, ANN NEUROL, V65, P47, DOI 10.1002/ana.21523
   Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150
   Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3
   Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287
   HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Ishitobi M, 2000, NEUROREPORT, V11, P4033, DOI 10.1097/00001756-200012180-00026
   Kuang W, 1998, EXP CELL RES, V241, P117, DOI 10.1006/excr.1998.4025
   Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705
   Kuang W, 1999, LAB INVEST, V79, P1601
   Kumar A, 2011, HUM MOL GENET, V20, P2333, DOI 10.1093/hmg/ddr126
   Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4
   Luna L., 1968, MANUAL HISTOLOGIC ST, P94
   Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152
   Meinen S, 2011, EMBO MOL MED, V3, P465, DOI 10.1002/emmm.201100151
   Miller R, 2007, NEUROLOGY, V69, P776, DOI 10.1212/01.wnl.0000269676.07319.09
   Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7
   Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Muntoni F, 2004, NAT MED, V10, P676, DOI 10.1038/nm0704-676
   Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003
   Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116
   Nevo Y, 2010, MUSCLE NERVE, V42, P218, DOI 10.1002/mus.21706
   Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0
   Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507
   Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102
   Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501
   Rooney JE, 2012, AM J PATHOL, V180, P1593, DOI 10.1016/j.ajpath.2011.12.019
   Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537
   SIEGL PKS, 1992, J PHARMACOL EXP THER, V262, P139
   Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757
   YAMAZAKI M, 1994, AM J PATHOL, V144, P221
   Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328
   Zhou Y, 2006, BIOCHEM BIOPH RES CO, V339, P633, DOI 10.1016/j.bbrc.2005.11.060
NR 53
TC 36
Z9 37
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2044-5040
J9 SKELET MUSCLE
JI Skeletal Muscle
PY 2012
VL 2
AR 18
DI 10.1186/2044-5040-2-18
PG 13
WC Cell Biology
SC Cell Biology
GA V39PM
UT WOS:000209422900017
PM 22943509
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Iijima, T
   Wu, KR
   Witte, H
   Hanno-Iijima, Y
   Glatter, T
   Richard, S
   Scheiffele, P
AF Iijima, Takatoshi
   Wu, Karen
   Witte, Harald
   Hanno-Iijima, Yoko
   Glatter, Timo
   Richard, Stephane
   Scheiffele, Peter
TI SAM68 Regulates Neuronal Activity-Dependent Alternative Splicing of
   Neurexin-1
SO CELL
LA English
DT Article
ID RNA-BINDING PROTEIN; SYNAPSE DEVELOPMENT; ALPHA-NEUREXINS; STRUCTURAL
   BASIS; BETA-NEUREXINS; GRANULE CELLS; KINASE; RECEPTOR; PHOSPHORYLATION;
   CEREBELLUM
AB The assembly of synapses and neuronal circuits relies on an array of molecular recognition events and their modification by neuronal activity. Neurexins are a highly polymorphic family of synaptic receptors diversified by extensive alternative splicing. Neurexin variants exhibit distinct isoform-specific biochemical interactions and synapse assembly functions, but the mechanisms governing splice isoform choice are not understood. We demonstrate that Nrxn1 alternative splicing is temporally and spatially controlled in the mouse brain. Neuronal activity triggers a shift in Nrxn1 splice isoform choice via calcium/calmodulin-dependent kinase IV signaling. Activity-dependent alternative splicing of Nrxn1 requires the KH-domain RNA-binding protein SAM68 that associates with RNA response elements in the Nrxn1 pre-mRNA. Our findings uncover SAM68 as a key regulator of dynamic control of Nrxn1 molecular diversity and activity-dependent alternative splicing in the central nervous system.
C1 [Iijima, Takatoshi; Witte, Harald; Hanno-Iijima, Yoko; Glatter, Timo; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Wu, Karen; Scheiffele, Peter] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.
   [Wu, Karen; Scheiffele, Peter] Columbia Univ, Dept Neurosci, New York, NY 10032 USA.
   [Richard, Stephane] McGill Univ, Segal Canc Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.
   [Richard, Stephane] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada.
   [Richard, Stephane] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada.
RP Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM peter.scheiffele@unibas.ch
OI Glatter, Timo/0000-0001-8716-8516
FU Jane Coffin Childs Fund; Uehara Memorial FoundationUehara Memorial
   Foundation; KANAE Foundation for the Promotion of Medical Science;
   Astellas Foundation for Research on Metabolic Disorders; Canadian
   Institutes of Health ResearchCanadian Institutes of Health Research
   (CIHR); NINDSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R21 NS53936]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Kanton Basel-Stadt;
   NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R21NS053936, R21NS053936] Funding Source: NIH RePORTER
FX We are grateful to Dr. Jane Dodd for generously sharing lab space and
   resources, to Dr. Leora Gollan who contributed initial findings, to Drs.
   Yves Barde, Olivier Pertz, Oguz Kanca, Stephane Baudouin, and
   Thi-Minh-Phuc Nguyen for comments on the manuscript, to Drs.
   Boukhtouche, Cocas, and Sommer and Ms. Stiefvater for help with in utero
   electroporations, to Dr. Alex Schmidt for help with proteomics, to
   Laetitia Burkle and Caroline Bornmann for excellent technical support,
   to Prof. Michisuke Yuzaki for advice and for generously sharing a GluD2
   expression vector, to Dr. Kyo-ichi Emi for advice on cerebellar
   injections, and to Gillian Vogel and members of the Scheiffele Lab for
   valuable discussions. We thank Drs. Chabot, Darnell, Ghosh, Konig,
   Smith, Sette, and Soderling and the Developmental Studies Hybridoma
   Bank, University of Iowa, for making important reagents available. K. W.
   is the recipient of a Jane Coffin Childs Fund postdoctoral fellowship
   award. T. I. was supported by the Uehara Memorial Foundation, KANAE
   Foundation for the Promotion of Medical Science and Astellas Foundation
   for Research on Metabolic Disorders. S. R. is funded by the Canadian
   Institutes of Health Research, and the project was funded by support to
   P.S. from NINDS (R21 NS53936), the Swiss National Science Foundation,
   and the Kanton Basel-Stadt.
CR An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036
   Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030
   Baudouin S, 2010, CELL, V141, P908, DOI 10.1016/j.cell.2010.05.024
   Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006
   Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026
   Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107
   Chawla G, 2009, MOL CELL BIOL, V29, P201, DOI 10.1128/MCB.01349-08
   Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777
   Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005
   Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235
   Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011
   Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751
   de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019
   Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074
   Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710
   Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310
   Galarneau A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-47
   Grange J, 2004, J NEUROSCI RES, V75, P654, DOI 10.1002/jnr.20003
   Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024
   Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008
   Huot ME, 2009, MOL CELL BIOL, V29, P1933, DOI 10.1128/MCB.01707-08
   ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8
   Iijima T, 2009, J NEUROSCI, V29, P5425, DOI 10.1523/JNEUROSCI.4473-08.2009
   Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200
   Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969
   Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001
   Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040
   Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002
   Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237
   Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274
   Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017
   Lukong KE, 2008, BEHAV BRAIN RES, V189, P357, DOI 10.1016/j.bbr.2008.01.010
   Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x
   Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152
   Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153
   Mellor JR, 1998, J NEUROSCI, V18, P2822
   Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755
   OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866
   Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005
   Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105
   Resnick M, 2008, NEUROSCI LETT, V439, P235, DOI 10.1016/j.neulet.2008.05.034
   Richard S, 2005, PLOS GENET, V1, P676, DOI 10.1371/journal.pgen.0010074
   Rossi P, 1998, J NEUROSCI, V18, P3537
   Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734
   Rozic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018579
   Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008
   Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351
   Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6
   Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1
   Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010
   Songyang Z, 1996, MOL CELL BIOL, V16, P6486
   Stoss O, 2004, MOL CELL NEUROSCI, V27, P8, DOI 10.1016/j.mcn.2004.04.011
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780
   Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418
   Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200
   Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035
   Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610
   USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094
   Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073
   Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009
   Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549
   Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021
   Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021
   Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941
   Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593
   Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205
   Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108
NR 68
TC 159
Z9 164
U1 0
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
J9 CELL
JI Cell
PD DEC 23
PY 2011
VL 147
IS 7
BP 1601
EP 1614
DI 10.1016/j.cell.2011.11.028
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 866SP
UT WOS:000298403400023
PM 22196734
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Heck, A
   Vogler, C
   Gschwind, L
   Ackermann, S
   Auschra, B
   Spalek, K
   Rasch, B
   de Quervain, D
   Papassotiropoulos, A
AF Heck, Angela
   Vogler, Christian
   Gschwind, Leo
   Ackermann, Sandra
   Auschra, Bianca
   Spalek, Klara
   Rasch, Bjoern
   de Quervain, Dominique
   Papassotiropoulos, Andreas
TI Statistical Epistasis and Functional Brain Imaging Support a Role of
   Voltage-Gated Potassium Channels in Human Memory
SO PLOS ONE
LA English
DT Article
ID DIFFERENTIAL AMYGDALA ACTIVATION; CASE-CONTROL ASSOCIATION; GENE-GENE
   INTERACTIONS; K+ CHANNEL; POPULATION STRATIFICATION;
   HIPPOCAMPAL-NEURONS; EXPRESSION; IDENTIFICATION; LOCALIZATION;
   METHYLATION
AB Despite the current progress in high-throughput, dense genome scans, a major portion of complex traits' heritability still remains unexplained, a phenomenon commonly termed "missing heritability." The negligence of analytical approaches accounting for gene-gene interaction effects, such as statistical epistasis, is probably central to this phenomenon. Here we performed a comprehensive two-way SNP interaction analysis of human episodic memory, which is a heritable complex trait, and focused on 120 genes known to show differential, memory-related expression patterns in rat hippocampus. Functional magnetic resonance imaging was also used to capture genotype-dependent differences in memory-related brain activity. A significant, episodic memory-related interaction between two markers located in potassium channel genes (KCNB2 and KCNH5) was observed (P-nominal combined = 0.000001). The epistatic interaction was robust, as it was significant in a screening (P-nominal = 0.0000012) and in a replication sample (P-nominal = 0.01). Finally, we found genotype-dependent activity differences in the parahippocampal gyrus (P-nominal = 0.001) supporting the behavioral genetics finding. Our results demonstrate the importance of analytical approaches that go beyond single marker statistics of complex traits.
C1 [Heck, Angela; Vogler, Christian; Gschwind, Leo; Ackermann, Sandra; Auschra, Bianca; Rasch, Bjoern; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.
   [Vogler, Christian; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Univ Psychiat Clin, Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil, Dept Biozentrum, Basel, Switzerland.
   [Spalek, Klara; Rasch, Bjoern; de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, Dept Psychol, Basel, Switzerland.
   [de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, Univ Psychiat Clin, Basel, Switzerland.
RP Heck, A (corresponding author), Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.
EM angela.heck@unibas.ch
RI Rasch, Bjorn/A-3119-2015
OI Rasch, Bjorn/0000-0001-7607-3415; Vogler, Christian/0000-0003-3922-109X;
   de Quervain, Dominique/0000-0001-7131-2464; Heck,
   Angela/0000-0002-1543-3197; Spalek, Klara/0000-0002-4244-6495;
   Papassotiropoulos, Andreas/0000-0002-2210-9651
FU Swiss National Science Foundation (SNSF) SinergiaSwiss National Science
   Foundation (SNSF) [CRSIKO_122691, CRSI33_130080]; National Centre of
   Competence in Research (NCCR) SynapsySwiss National Science Foundation
   (SNSF); European Union (ADAMS) [242257]
FX This work was supported in part by the Swiss National Science Foundation
   (SNSF) Sinergia grants [CRSIKO_122691, CRSI33_130080 to D. Q. and A.
   P.]; the National Centre of Competence in Research (NCCR) Synapsy, and
   the 7th framework programme of the European Union (ADAMS) [242257,
   FP7-HEALTH-2009 to D. Q. and A. P.]. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bertolino A, 2008, BIOL PSYCHIAT, V64, P226, DOI 10.1016/j.biopsych.2008.02.001
   Bertolino A, 2009, J NEUROSCI, V29, P1224, DOI 10.1523/JNEUROSCI.4858-08.2009
   Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2
   Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199
   Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed.
   Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   Deng HW, 2001, GENETICS, V159, P1319
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Engel JE, 1998, J NEUROSCI, V18, P2254
   Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52
   Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554
   Giubilei F, 2008, AGE AGEING, V37, P640, DOI 10.1093/ageing/afn132
   Greenwood PM, 2009, P NATL ACAD SCI USA, V106, P3633, DOI 10.1073/pnas.0807891106
   GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044
   Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454
   HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710
   HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I
   Ikeda M, 2010, BIOL PSYCHIAT, V67, P263, DOI 10.1016/j.biopsych.2009.08.030
   Jeng CJ, 2005, NEUROREPORT, V16, P229, DOI 10.1097/00001756-200502280-00005
   JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X
   LANG PJ, 2008, INT AFFECTICVE PICTU
   MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840
   Mandzia JL, 2004, HUM BRAIN MAPP, V21, P1, DOI 10.1002/hbm.10140
   McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560
   Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022
   Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560
   Nyholt DR, 2008, HUM MOL GENET, V17, P3318, DOI 10.1093/hmg/ddn227
   PAPASSOTIROPOUL.A, 2009, MOL PSYCHIAT
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005
   Pollard KS, 2005, STAT BIOL HEALTH, P249
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Rasch B, 2010, NEUROIMAGE, V53, P870, DOI 10.1016/j.neuroimage.2010.01.001
   Rasch B, 2010, NEUROIMAGE, V52, P1712, DOI 10.1016/j.neuroimage.2010.05.054
   Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106
   Rombouts SARB, 2001, NEUROIMAGE, V14, P67, DOI 10.1006/nimg.2001.0799
   Saganich MJ, 1999, J NEUROSCI, V19, P10789
   Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7
   Steffens M, 2010, HUM HERED, V69, P268, DOI 10.1159/000295896
   Stelzel C, 2009, EUR J NEUROSCI, V29, P1056, DOI 10.1111/j.1460-9568.2009.06647.x
   Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660
   Tan H.Y., 2011, MOL PSYCHIAT
   Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328
   TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764
   Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011
   Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2
   Wang YT, 2004, GENET EPIDEMIOL, V27, P14, DOI 10.1002/gepi.20003
   Westfall PH, 1993, RESAMPLING BASED MUL
   Zhong CB, 2005, NEUROSCI LETT, V373, P99, DOI 10.1016/j.neulet.2004.09.069
NR 52
TC 5
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 21
PY 2011
VL 6
IS 12
AR e29337
DI 10.1371/journal.pone.0029337
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 876NF
UT WOS:000299113600079
PM 22216252
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Romanino, K
   Mazelin, L
   Albert, V
   Conjard-Duplany, A
   Lin, S
   Bentzinger, CF
   Handschin, C
   Puigserver, P
   Zorzato, F
   Schaeffer, L
   Gangloff, YG
   Ruegg, MA
AF Romanino, Klaas
   Mazelin, Laetitia
   Albert, Verena
   Conjard-Duplany, Agnes
   Lin, Shuo
   Bentzinger, C. Florian
   Handschin, Christoph
   Puigserver, Pere
   Zorzato, Francesco
   Schaeffer, Laurent
   Gangloff, Yann-Gael
   Rueegg, Markus A.
TI Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1)
   inactivation is not reversed by restoring mitochondrial function
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; SKELETAL-MUSCLE; PROTECTS;
   ACTIVATION; AUTOPHAGY; ATROPHY; GROWTH
AB Mammalian target of rapamycin complex 1 (mTORC1) is central to the control of cell, organ, and body size. Skeletal muscle-specific inactivation of mTORC1 in mice results in smaller muscle fibers, fewer mitochondria, increased glycogen stores, and a progressive myopathy that causes premature death. In mTORC1-deficient muscles, peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha), which regulates mitochondrial biogenesis and glucose homeostasis, is strongly down-regulated. Here we tested whether induction of mitochondrial biogenesis pharmacologically or by the overexpression of PGC-1 alpha is sufficient to reverse the phenotype of mice deficient for mTORC1. We show that both approaches normalize mitochondrial function, such as oxidative capacity and expression of mitochondrial genes. However, they do not prevent or delay the progressive myopathy. In addition, we find that mTORC1 has a much stronger effect than PGC-1 alpha on the glycogen content in muscle. This effect is based on the strong activation of PKB/Akt in mTORC1-deficient mice. We also show that activation of PKB/Akt not only affects glycogen synthesis but also diminishes glycogen degradation. Thus, our work provides strong functional evidence that mitochondrial dysfunction in mice with inactivated mTORC1 signaling is caused by the down-regulation of PGC-1 alpha. However, our data also show that the impairment of mitochondria does not lead directly to the lethal myopathy.
C1 [Romanino, Klaas; Albert, Verena; Lin, Shuo; Bentzinger, C. Florian; Handschin, Christoph; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Mazelin, Laetitia; Schaeffer, Laurent; Gangloff, Yann-Gael] Univ Lyon 1, Ctr Natl Rech Sci, Unite Mixte Rech 5239, Ecole Normale Super Lyon,Lab Biol Mol Cellule,Equ, F-69365 Lyon, France.
   [Conjard-Duplany, Agnes] Univ Lyon, Lab Biochim & Physiopathol Metab, Equipe Accueil Univ, Fac Med Lyon Est, F-69372 Lyon 8, France.
   [Puigserver, Pere] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.
   [Zorzato, Francesco] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland.
   [Zorzato, Francesco] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019; Handschin, Christoph/E-6886-2015; GANGLOFF,
   Yann-Gael/I-2161-2014; Bentzinger, C. Florian/A-1151-2015; Mazelin,
   Laetitia/AAD-9319-2020
OI Ruegg, Markus/0000-0002-4974-9384; Handschin,
   Christoph/0000-0003-0603-1097; GANGLOFF, Yann-Gael/0000-0001-9031-1184;
   Mazelin, Laetitia/0000-0002-4001-2132; Bentzinger, C.
   Florian/0000-0003-0422-9622; Duplany, Agnes/0000-0002-3485-1597
FU Cantons of Basel-Stadt and Baselland; Swiss Foundation for Research on
   Muscle Disease; Swiss Life; Association Francaise Contres les
   Myopathies; Agence Nationale de la RechercheFrench National Research
   Agency (ANR)
FX We thank Arnaud Ferry from the Universite Pierre et Marie Curie-Paris
   for measurement of muscle force of the mTOR<SUP>-</SUP> mice. We are
   indebted to the animal (Le Plateau de Biologie Experimental de la
   Souris) and microscopy (Plateau Technique Imagerie/Microscopie)
   facilities of the Institut Federatif de Recherche 128 Biosciences. This
   work was supported by grants from the Cantons of Basel-Stadt and
   Baselland, the Swiss Foundation for Research on Muscle Disease, and
   Swiss Life (to M.A.R.) and from the Association Francaise Contres les
   Myopathies (to M.A.R., L.S., and Y.-G.G.) and the Agence Nationale de la
   Recherche (to L.S. and Y.-G.G.).
CR Aiston S, 2006, DIABETOLOGIA, V49, P174, DOI 10.1007/s00125-005-0068-4
   Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018
   Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131
   Sakamoto K, 2002, J APPL PHYSIOL, V93, P369, DOI 10.1152/japplphysiol.00167.2002
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 23
TC 31
Z9 32
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 20
PY 2011
VL 108
IS 51
BP 20808
EP 20813
DI 10.1073/pnas.1111448109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 865CW
UT WOS:000298289400105
PM 22143799
OA Green Accepted, Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Bigalke, JM
   Dames, SA
   Blankenfeldt, W
   Grzesiek, S
   Geyer, M
AF Bigalke, Janna M.
   Dames, Sonja A.
   Blankenfeldt, Wulf
   Grzesiek, Stephan
   Geyer, Matthias
TI Structure and Dynamics of a Stabilized Coiled-Coil Domain in the P-TEFb
   Regulator Hexim1
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE Hexim1; P-TEFb; coiled coil; crystal structure; transcription elongation
ID RNA-POLYMERASE-II; T-BINDING DOMAIN; BROMODOMAIN PROTEIN BRD4; SUBUNIT
   CYCLIN T1; TRANSCRIPTIONAL ELONGATION; 7SK SNRNP; HIV-1 TAT; BACKBONE
   DYNAMICS; CRYSTAL-STRUCTURE; COMPLEX
AB The positive transcription elongation factor P-TEFb mediates the transition from transcription initiation to productive elongation by phosphorylation of the C-terminal domain of RNA polymerase II. P-TEFb is negatively regulated by the cerlular protein Hexim1 (hexamethylene bisacetarnide-inducible protein 1), which is highly conserved in higher eukaryotes. The C-terminal coiled-coil domain of Hexim1 recognizes the Cyclin T subunit of P-TEFb, whereas a central PYNT motif is required to inhibit the cyclin-dependent kinase Cdk9 by a yet unknown mechanism. Here, the crystal structure of the Cyclin T-binding domain (TBD) of human Hexim1 was determined at 2.1 angstrom resolution using a deletion mutant of three residues in its central stammer motif. The structure showed a continuous parallel coiled-coil domain of nine hepta-repeats with a preceding helix encompassing up to 15 residues. Two uncommon residues at heptad a positions in the N-terminal part of the coiled-coil structure, Lys284 and Tyr291, stabilize the preceding helix by a tight intermolecular hydrogen bond network with residues of the opposing chain. These interactions delineate a characteristic turn between both helices that is supposed to mediate binding to Cyclin T1. Stabilization of the coiled-coil domain by deletion of the stammer region was confirmed by NMR spectroscopic and backbone dynamic analyses analyzing wild-type TBD and three mutant variants. This study thus provides structural insights into the recognition of the regulator protein Hexim1 by P-TEFb and the modulation of coiled-coil dynamics by specific discontinuities. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Bigalke, Janna M.; Blankenfeldt, Wulf; Geyer, Matthias] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany.
   [Dames, Sonja A.; Grzesiek, Stephan] Univ Basel, Biozentrum Basel, Dept Biol Struct, CH-4056 Basel, Switzerland.
   [Dames, Sonja A.] Tech Univ Munich, Dept Chem, D-85748 Garching, Germany.
RP Geyer, M (corresponding author), Max Planck Inst Mol Physiol, Phys Biochem Abt, Otto Hahn Str 11, D-44227 Dortmund, Germany.
EM matthias.geyer@mpi-dortmund.mpg.de
RI Blankenfeldt, Wulf/F-8877-2010
OI Blankenfeldt, Wulf/0000-0001-9886-9668; Grzesiek,
   Stephan/0000-0003-1998-4225; Dames, Sonja/0000-0001-7495-6943; Geyer,
   Matthias/0000-0002-7718-5002
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [GE-976/5]; Schweizer Nationalfonds [31-109712]; Treubel Fonds (Basel,
   Switzerland)
FX We thank Diana Ludwig and Karin Vogel-Bach-mayr for excellent technical
   assistance, Antje Schulte for initial help with crystallization, the Max
   Planck Institute Dortmund-Heidelberg X-ray communities for diffraction
   data collection and the staff at the Paul Scherrer Institute, Villigen,
   Switzerland, for access to beamline X10SA. This work was supported by
   grants from the Deutsche Forschungsgemeinschaft to M.G. (GE-976/5) and
   from the Schweizer Nationalfonds to S.G. (grant 31-109712). S.A.D. was
   supported by a fellowship from the Treubel Fonds (Basel, Switzerland).
CR Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016
   Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513
   Anand K, 2007, J MOL BIOL, V370, P826, DOI 10.1016/j.jmb.2007.04.077
   Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063
   Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210
   Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121
   Baumli S, 2010, CHEM BIOL, V17, P931, DOI 10.1016/j.chembiol.2010.07.012
   Belanger F, 2009, J MOL BIOL, V386, P1094, DOI 10.1016/j.jmb.2009.01.015
   Bigalke JM, 2011, METHODS, V53, P78, DOI 10.1016/j.ymeth.2010.04.001
   Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104
   Brown JH, 1996, PROTEINS, V26, P134
   Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99
   Czudnochowski N, 2010, J MOL BIOL, V395, P28, DOI 10.1016/j.jmb.2009.10.055
   Dames SA, 2007, P NATL ACAD SCI USA, V104, P14312, DOI 10.1073/pnas.0701848104
   Dames SA, 2006, J BIOMOL NMR, V36, P39, DOI 10.1007/s10858-006-9010-4
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Fraldi A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-42
   Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449
   Galatioto J, 2010, J CELL SCI, V123, P3789, DOI 10.1242/jcs.073387
   Ghatpande S, 1999, MOL CELL BIOCHEM, V196, P93, DOI 10.1023/A:1006974330613
   GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003
   He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013
   Huang FC, 2002, GENE, V292, P245, DOI 10.1016/S0378-1119(02)00596-6
   Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027
   Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061
   Lebars I, 2010, NUCLEIC ACIDS RES, V38, P7749, DOI 10.1093/nar/gkq660
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073
   Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781
   Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105
   Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275
   Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Ogba N, 2010, ONCOGENE, V29, P3639, DOI 10.1038/onc.2010.110
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x
   Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014
   Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06
   Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778
   Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678
   Schonichen A, 2010, BIOCHEMISTRY-US, V49, P3083, DOI 10.1021/bi902072f
   Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200
   Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131
   Vollmuth F, 2010, ANGEW CHEM INT EDIT, V49, P6768, DOI 10.1002/anie.201002724
   Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712
   Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728
   Xue YH, 2010, NUCLEIC ACIDS RES, V38, P360, DOI 10.1093/nar/gkp977
   Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029
   Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5
NR 61
TC 8
Z9 8
U1 0
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 16
PY 2011
VL 414
IS 5
BP 639
EP 653
DI 10.1016/j.jmb.2011.10.022
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 868MG
UT WOS:000298526800001
PM 22033481
DA 2021-01-25
ER

PT J
AU Ma, CHE
   Brenner, GJ
   Omura, T
   Samad, OA
   Costigan, M
   Inquimbert, P
   Niederkofler, V
   Salie, R
   Sun, CC
   Lin, HY
   Arber, S
   Coppola, G
   Woolf, CJ
   Samad, TA
AF Ma, Chi H. E.
   Brenner, Gary J.
   Omura, Takao
   Samad, Omar A.
   Costigan, Michael
   Inquimbert, Perrine
   Niederkofler, Vera
   Salie, Rishard
   Sun, Chia Chi
   Lin, Herbert Y.
   Arber, Silvia
   Coppola, Giovanni
   Woolf, Clifford J.
   Samad, Tarek A.
TI The BMP Coreceptor RGMb Promotes While the Endogenous BMP Antagonist
   Noggin Reduces Neurite Outgrowth and Peripheral Nerve Regeneration by
   Modulating BMP Signaling
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID REPULSIVE GUIDANCE MOLECULE; SPINAL-CORD-INJURY; MORPHOGENETIC PROTEIN
   CORECEPTOR; AXONAL GROWTH; SENSORY NEURONS; HUMAN BRAIN; IN-VITRO; BONE;
   EXPRESSION; INHIBITION
AB Repulsive guidance molecule b(RGMb) is a bone morphogenetic protein(BMP) coreceptor and sensitizer of BMP signaling, highly expressed in adult dorsal root ganglion(DRG) sensory neurons. We used a murine RGMb knock-out to gain insight into the physiological role of RGMb in the DRG, and address whether RGMb-mediated modulation of BMP signaling influences sensory axon regeneration. No evidence for altered development of the PNS and CNS was detected in RGMb(-/-) mice. However, both cultured neonatal whole DRG explants and dissociated DRG neurons from RGMb(-/-) mice exhibited significantly fewer and shorter neurites than those from wild-type littermates, aphenomenon that could be fully rescued by BMP-2. Moreover, Noggin, an endogenous BMP signaling antagonist, inhibited neurite outgrowth in wild-type DRG explants from naive as well as nerve injury-preconditioned mice. Noggin is downregulated in the DRG after nerve injury, and its expression is highly correlated and inversely associated with the known regeneration-associated genes, which are induced in the DRG by peripheral axonal injury. We show that diminished BMP signaling in vivo, achieved either through RGMb deletion or BMP inhibition with Noggin, retarded early axonal regeneration after sciatic nerve crush injury. Our data suggest a positive modulatory contribution of RGMb and BMP signaling to neurite extension in vitro and early axonal regrowth after nerve injury in vivo and a negative effect of Noggin.
C1 [Samad, Tarek A.] Pfizer Inc, Neurosci Res Unit, Groton, CT 06340 USA.
   [Ma, Chi H. E.; Omura, Takao; Costigan, Michael; Inquimbert, Perrine; Woolf, Clifford J.] Harvard Univ, Childrens Hosp Boston, Sch Med, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.
   [Brenner, Gary J.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.
   [Sun, Chia Chi; Lin, Herbert Y.] Massachusetts Gen Hosp, Dept Med, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA.
   [Sun, Chia Chi; Lin, Herbert Y.] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA.
   [Sun, Chia Chi; Lin, Herbert Y.] Harvard Univ, Sch Med, Boston, MA 02114 USA.
   [Samad, Omar A.; Arber, Silvia] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA.
   [Samad, Omar A.; Arber, Silvia] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06520 USA.
   [Niederkofler, Vera; Salie, Rishard] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Niederkofler, Vera; Salie, Rishard] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Neurol, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.
   [Ma, Chi H. E.] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China.
RP Samad, TA (corresponding author), Pfizer Inc, Neurosci Res Unit, Groton, CT 06340 USA.
EM Gjbrenner@partners.org; Tarek.samad@pfizer.com
RI samad, omar/K-1921-2012; Brenner, Gary/AAI-1293-2019; Woolf,
   Clifford/A-9784-2010
OI Brenner, Gary/0000-0002-4586-1723; MA, Chi Him
   Eddie/0000-0003-2054-0445; Arber, Silvia/0000-0002-6261-250X;
   Inquimbert, Perrine/0000-0003-2625-1468
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NS038253, RDE017821A, NS044139]; Dr.
   Miriam and Sheldon G. Adelson Medical Research Foundation; Hong Kong
   Croucher Foundation; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); European Research CouncilEuropean Research
   Council (ERC); IRP-IFP Switzerland; NATIONAL INSTITUTE OF DENTAL
   &CRANIOFACIAL RESEARCHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Dental & Craniofacial Research (NIDCR) [R01DE017821, R01DE017821,
   R01DE017821, R01DE017821, R01DE017821, R01DE017821, R01DE017821,
   R01DE017821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [R01NS038253,
   K08NS044139, R01NS038253, R01NS038253, R01NS038253, R01NS038253,
   R01NS038253, K08NS044139, R01NS038253, R01NS038253, R01NS038253,
   R01NS038253, R01NS038253, R01NS038253, R01NS038253, R01NS038253,
   R01NS038253, K08NS044139, R01NS038253, R01NS038253, R01NS038253,
   R01NS038253, K08NS044139, K08NS044139, R01NS038253, R01NS038253,
   R01NS038253] Funding Source: NIH RePORTER
FX This work was supported by the NIH [Grants NS038253 and RDE017821A
   (C.J.W.), and NS044139 (G.J.B.)], the Dr. Miriam and Sheldon G. Adelson
   Medical Research Foundation, the Hong Kong Croucher Foundation
   Fellowship (C. H. E. M.), the Swiss National Science Foundation, an
   European Research Council Advanced Grant (S.A., V.N. and R. S.), and the
   IRP-IFP Switzerland (M. C., G. C.). We thank Yin Xia, Qiufu Ma, Kenneth
   Bloch, and Robert Griffin for their helpful input.
CR Ai XB, 1999, MOL CELL NEUROSCI, V14, P506, DOI 10.1006/mcne.1999.0798
   Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777
   Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779
   Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8
   Blackshaw S, 1997, J NEUROSCI, V17, P8083
   Brenner GJ, 2004, EUR J NEUROSCI, V20, P375, DOI 10.1111/j.1460-9568.2004.03506.x
   Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200
   Conrad S, 2010, MOL CELL NEUROSCI, V43, P222, DOI 10.1016/j.mcn.2009.11.003
   Court FA, 2004, NATURE, V431, P191, DOI 10.1038/nature02841
   Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143
   Hocking JC, 2009, DEV BIOL, V330, P273, DOI 10.1016/j.ydbio.2009.03.027
   Hodge LK, 2007, NEURON, V55, P572, DOI 10.1016/j.neuron.2007.07.010
   Koeberle PD, 2010, NEUROSCIENCE, V169, P495, DOI 10.1016/j.neuroscience.2010.04.079
   Lewis SE, 1999, J NEUROSCI, V19, P8945, DOI 10.1523/JNEUROSCI.19-20-08945.1999
   Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805
   Liu XX, 2009, BIOCHEM BIOPH RES CO, V382, P795, DOI 10.1016/j.bbrc.2009.03.115
   Ma CHE, 2011, J CLIN INVEST, V121, P4332, DOI 10.1172/JCI58675
   Ma QF, 1997, J NEUROSCI, V17, P3644
   Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006
   Matsuura I, 2008, J NEUROCHEM, V105, P1471, DOI 10.1111/j.1471-4159.2008.05251.x
   Matsuura I, 2007, BIOCHEM BIOPH RES CO, V360, P868, DOI 10.1016/j.bbrc.2007.06.157
   Mills CD, 2005, MOL CELL NEUROSCI, V30, P228, DOI 10.1016/j.mcn.2005.07.010
   Mills CD, 2007, MOL CELL NEUROSCI, V36, P185, DOI 10.1016/j.mcn.2007.06.011
   Moon JI, 2008, DEV BIOL, V315, P404, DOI 10.1016/j.ydbio.2007.12.041
   Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004
   Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683
   Oldekamp J, 2004, GENE EXPR PATTERNS, V4, P283, DOI 10.1016/j.modgep.2003.11.008
   Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207
   Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103
   Qi XA, 2010, EXP NEUROL, V221, P353, DOI 10.1016/j.expneurol.2009.12.003
   Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005
   Samad OA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-45
   Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200
   Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004
   Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063
   Schwab JM, 2005, ARCH NEUROL-CHICAGO, V62, P1561, DOI 10.1001/archneur.62.10.1561
   Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007
   Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005
   Severyn CJ, 2009, BIOCHEM J, V422, P393, DOI 10.1042/BJ20090978
   SJOBERG J, 1990, BRAIN RES, V529, P79, DOI 10.1016/0006-8993(90)90812-P
   Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2
   Tsujii M, 2009, CLIN ORTHOP RELAT R, V467, P3183, DOI 10.1007/s11999-009-1009-1
   Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012
   Xia Y, 2005, ENDOCRINOLOGY, V146, P3614, DOI 10.1210/en.2004-1676
   Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047
   Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511
   Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167
   Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009
NR 48
TC 49
Z9 53
U1 0
U2 9
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD DEC 14
PY 2011
VL 31
IS 50
BP 18391
EP 18400
DI 10.1523/JNEUROSCI.4550-11.2011
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 861YA
UT WOS:000298055600017
PM 22171041
OA Green Accepted, Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Higdon, R
   Reiter, L
   Hather, G
   Haynes, W
   Kolker, N
   Stewart, E
   Bauman, AT
   Picotti, P
   Schmidt, A
   van Belle, G
   Aebersold, R
   Kolker, E
AF Higdon, Roger
   Reiter, Lukas
   Hather, Gregory
   Haynes, Winston
   Kolker, Natali
   Stewart, Elizabeth
   Bauman, Andrew T.
   Picotti, Paola
   Schmidt, Alexander
   van Belle, Gerald
   Aebersold, Ruedi
   Kolker, Eugene
TI IPM: An integrated protein model for false discovery rate estimation and
   identification in high-throughput proteomics
SO JOURNAL OF PROTEOMICS
LA English
DT Article
DE Protein identification; False discovery rate; Mass spectrometry; Decoy
   database
ID IDENTIFYING PROTEINS; SEQUENCE DATABASES; STATISTICAL-MODEL; MASS;
   PEPTIDE; SEARCH; MS/MS; EXPRESSION
AB In high-throughput mass spectrometry proteomics, peptides and proteins are not simply identified as present or not present in a sample, rather the identifications are associated with differing levels of confidence. The false discovery rate (FDR) has emerged as an accepted means for measuring the confidence associated with identifications. We have developed the Systematic Protein Investigative Research Environment (SPIRE) for the purpose of integrating the best available proteomics methods. Two successful approaches to estimating the FDR for MS protein identifications are the MAYU and our current SPIRE methods. We present here a method to combine these two approaches to estimating the FDR for MS protein identifications into an integrated protein model (IPM). We illustrate the high quality performance of this IPM approach through testing on two large publicly available proteomics datasets. MAYU and SPIRE show remarkable consistency in identifying proteins in these datasets. Still, IPM results in a more robust FDR estimation approach and additional identifications, particularly among low abundance proteins. IPM is now implemented as a part of the SPIRE system. (C) 2011 Published by Elsevier B.V.
C1 [Higdon, Roger; Hather, Gregory; Kolker, Natali; Stewart, Elizabeth; Bauman, Andrew T.; Kolker, Eugene] SCRI, Seattle, WA 98101 USA.
   [Higdon, Roger; Hather, Gregory; Haynes, Winston; Stewart, Elizabeth; Bauman, Andrew T.; Kolker, Eugene] Bioinformat & High Throughput Anal Lab, Seattle, WA USA.
   [Higdon, Roger; Kolker, Natali; Kolker, Eugene] Seattle Childrens Hosp, Seattle, WA USA.
   [Reiter, Lukas] Univ Zurich, Inst Mol Biol, Zurich, Switzerland.
   [Reiter, Lukas] Univ Zurich, Ctr Model Organism Proteomes, Zurich, Switzerland.
   [Reiter, Lukas] Univ Zurich, PhD Program Mol Life Sci Zurich, Zurich, Switzerland.
   [Reiter, Lukas; Picotti, Paola; Schmidt, Alexander; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.
   [Haynes, Winston] Hendrix Coll, Conway, AR USA.
   [Schmidt, Alexander] Univ Basel, Biozentrum, Basel, Switzerland.
   [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, Zurich, Switzerland.
   [van Belle, Gerald] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [van Belle, Gerald] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland.
   [Aebersold, Ruedi] Inst Syst Biol, Seattle, WA USA.
RP Higdon, R (corresponding author), SCRI, 1900 9th Ave, Seattle, WA 98101 USA.
EM Roger.Higdon@seattlechildrens.org
RI Kolker, Eugene/C-6711-2008
OI Haynes, Winston/0000-0002-2376-0630
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5R01 GM076680-02, UO1 DK072473];
   NSFNational Science Foundation (NSF) [0544757, 07140]; SCRI; Swiss
   National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [31000-10767]; European Research CouncilEuropean Research Council
   (ERC) [ERC-20089-AdG 233226]; SystemsX.ch; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [U01DK072473, U01DK072473, U01DK072473, U01DK072473, U01DK072473,
   U01DK072473, U01DK072473, U01DK072473, U01DK072473, U01DK072473,
   U01DK072473, U01DK072473, U01DK072473, U01DK072473, U01DK072473,
   U01DK072473, U01DK072473, U01DK072473] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM076680,
   R01GM076680, R01GM076680, R01GM076680] Funding Source: NIH RePORTER
FX We would like to thank Manfred Claassen, Evelyne Kolker, Arnold Smith,
   and Charles Smith for their critical reading and insightful discussions.
   The support from NIH (under NIGMS grant 5R01 GM076680-02 and NIDDK grant
   UO1 DK072473), NSF (under DBI grant 0544757 and ABI grant 07140), and
   SCRI Internal Funds to E.K., and from the Swiss National Science
   Foundation (SNF, under grant 31000-10767), the European Research Council
   (under grant ERC-20089-AdG 233226) and SystemsX.ch to R.A. is greatly
   appreciated.
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Choi H, 2008, J PROTEOME RES, V7, P286, DOI 10.1021/pr7006818
   CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282
   Corraless F., 2011, J PROT
   Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Fenyo D, 2003, ANAL CHEM, V75, P768, DOI 10.1021/ac0258709
   Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Griffin TJ, 2001, CURR OPIN BIOTECH, V12, P607, DOI 10.1016/S0958-1669(01)00268-3
   Hather G, 2010, PROTEOMICS, V10, P2369, DOI 10.1002/pmic.200900619
   Higdon R, 2005, OMICS, V9, P364, DOI 10.1089/omi.2005.9.364
   Higdon R, 2004, OMICS, V8, P357, DOI 10.1089/omi.2004.8.357
   Higdon R., 2011, J PROTEOMICS
   Higdon R, 2007, BIOINFORMATICS, V23, P277, DOI 10.1093/bioinformatics/btl595
   Higdon R, 2010, OMICS, V14, P309, DOI 10.1089/omi.2010.0034
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   King NL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r106
   Kolker E, 2006, TRENDS MICROBIOL, V14, P229, DOI 10.1016/j.tim.2006.03.005
   Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200
   Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
NR 30
TC 10
Z9 10
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD DEC 10
PY 2011
VL 75
IS 1
SI SI
BP 116
EP 121
DI 10.1016/j.jprot.2011.06.003
PG 6
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 871AQ
UT WOS:000298710400012
PM 21718813
DA 2021-01-25
ER

PT J
AU Mazumder, S
   Maji, M
   Ali, N
AF Mazumder, Saumyabrata
   Maji, Mithun
   Ali, Nahid
TI Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote
   Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MONOPHOSPHORYL-LIPID-A; LEISHMANIA-DONOVANI INFECTION; TUBERCULOSIS
   SUBUNIT VACCINE; MAJOR SURFACE GLYCOPROTEIN; SUSCEPTIBLE BALB/C MICE;
   CD4+ T-CELLS; IMMUNE-RESPONSE; VISCERAL LEISHMANIASIS; POLYPROTEIN
   VACCINE; DENDRITIC CELLS
AB Background: Vaccines that activate strong specific Th1-predominant immune responses are critically needed for many intracellular pathogens, including Leishmania. The requirement for sustained and efficient vaccination against leishmaniasis is to formulate the best combination of immunopotentiating adjuvant with the stable antigen (Ag) delivery system. The aim of the present study is to evaluate the effectiveness of an immunomodulator on liposomal Ag through subcutaneous (s.c.) route of immunization, and its usefulness during prime/boost against visceral leishmaniasis (VL) in BALB/c mice.
   Methodology/Principal Findings: Towards this goal, we formulated recombinant GP63 (rGP63)-based vaccines either with monophosphoryl lipid A-trehalose dicorynomycolate (MPL-TDM) or entrapped within cationic liposomes or both. Combinatorial administration of liposomes with MPL-TDM during prime confers activation of dendritic cells, and induces an early robust T cell response. To investigate whether the combined formulation is required for optimum immune response during boost as well, we chose to evaluate the vaccine efficacy in mice primed with combined adjuvant system followed by boosting with either rGP63 alone, in association with MPL-TDM, liposomes or both. We provide evidences that the presence of either liposomal rGP63 or combined formulations during boost is necessary for effective Th1 immune responses (IFN-gamma, IL-12, NO) before challenge infection. However, boosting with MPL-TDM in conjugation with liposomal rGP63 resulted in a greater number of IFN-gamma producing effector T cells, significantly higher levels of splenocyte proliferation, and Th1 responses compared to mice boosted with liposomal rGP63, after virulent Leishmania donovani (L. donovani) challenge. Moreover, combined formulations offered superior protection against intracellular amastigote replication in macrophages in vitro, and hepatic and splenic parasite load in vivo.
   Conclusion: Our results define the immunopotentiating effect of MPL-TDM on protein Ag encapsulated in a controlled release system against experimental VL.
C1 [Mazumder, Saumyabrata; Maji, Mithun; Ali, Nahid] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, India.
RP Mazumder, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM nali@iicb.res.in
RI Maji, Mithun/D-3734-2012; bhattacharyya, Anirban/F-6067-2015
FU Department of Science and Technology, Government of IndiaDepartment of
   Science & Technology (India); Council of Scientific and Industrial
   Research, Government of IndiaCouncil of Scientific & Industrial Research
   (CSIR) - India
FX This work was supported through grants from the Department of Science
   and Technology, Government of India. S.M. was a Senior Research Fellow
   supported by Council of Scientific and Industrial Research, Government
   of India. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002
   Afrin F, 1997, INFECT IMMUN, V65, P2371, DOI 10.1128/IAI.65.6.2371-2377.1997
   Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116
   Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009
   Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
   Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129
   Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081
   Bhowmick S, 2008, EXPERT OPIN DRUG DEL, V5, P789, DOI [10.1517/17425247.5.7.789, 10.1517/17425247.5.7.789 ]
   Bhowmick S, 2009, INFECT IMMUN, V77, P1514, DOI 10.1128/IAI.01739-07
   Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07
   Bhowmick S, 2010, J CONTROL RELEASE, V141, P199, DOI 10.1016/j.jconrel.2009.09.018
   Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748
   Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107
   Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07
   Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006
   Coler RN, 2002, INFECT IMMUN, V70, P4215, DOI 10.1128/IAI.70.8.4215-4225.2002
   De Becker G, 2000, INT IMMUNOL, V12, P807, DOI 10.1093/intimm/12.6.807
   Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981
   Desombere I, 2002, VACCINE, V20, P2597, DOI 10.1016/S0264-410X(02)00150-0
   Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332
   Dietrich J, 2007, J IMMUNOL, V178, P3721, DOI 10.4049/jimmunol.178.6.3721
   FRIES LF, 1992, P NATL ACAD SCI USA, V89, P358, DOI 10.1073/pnas.89.1.358
   Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723
   HALDAR JP, 1983, INFECT IMMUN, V42, P702, DOI 10.1128/IAI.42.2.702-707.1983
   Holten-Andersen L, 2004, INFECT IMMUN, V72, P1608, DOI 10.1128/IAI.72.3.1608-1617.2004
   Hovav AH, 2004, INFECT IMMUN, V72, P3383, DOI 10.1128/IAI.72.6.3383-3390.2004
   Hovav AH, 2007, J VIROL, V81, P12793, DOI 10.1128/JVI.01519-07
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Jaafari MR, 2007, VACCINE, V25, P6107, DOI 10.1016/j.vaccine.2007.05.009
   Jaafari MR, 2006, VACCINE, V24, P5708, DOI 10.1016/j.vaccine.2006.04.062
   KAHL LP, 1990, INFECT IMMUN, V58, P3233, DOI 10.1128/IAI.58.10.3233-3241.1990
   Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010
   Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831
   Lehmann J, 2000, J INTERF CYTOK RES, V20, P63, DOI 10.1089/107999000312748
   LIEW FY, 1990, J IMMUNOL, V144, P4794
   Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016
   MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119
   Mazumdar T, 2004, VACCINE, V22, P1162, DOI 10.1016/j.vaccine.2003.09.030
   Mazumder S, 2007, VACCINE, V25, P8771, DOI 10.1016/j.vaccine.2007.10.028
   Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644
   Mazumder S, 2010, BIOCHIMIE, V92, P1876, DOI 10.1016/j.biochi.2010.07.014
   Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T
   Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741
   Costa CHN, 2011, PLOS NEGLECT TROP D, V5, DOI [10.1371/journal.pntd.0000943, 10.1371/journal.pntd.0000965]
   Nordly P, 2011, PHARM RES-DORDR, V28, P553, DOI 10.1007/s11095-010-0301-9
   Okwor I, 2010, VACCINE, V28, P5451, DOI 10.1016/j.vaccine.2010.05.077
   Oscherwitz J, 2006, VACCINE, V24, P3018, DOI 10.1016/j.vaccine.2005.10.046
   Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238
   Ravindran R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-181
   SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188
   Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618
   Skeiky YAW, 2002, VACCINE, V20, P3292, DOI 10.1016/S0264-410X(02)00302-X
   Suzue K, 2008, INT IMMUNOL, V20, P337, DOI 10.1093/intimm/dxm147
   Suzuki Y, 2004, CANCER RES, V64, P8754, DOI 10.1158/0008-5472.CAN-04-1691
   TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x
   Ulrich J T, 1995, Pharm Biotechnol, V6, P495
   Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967
NR 57
TC 37
Z9 38
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2011
VL 5
IS 12
AR e1429
DI 10.1371/journal.pntd.0001429
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 870KI
UT WOS:000298667700034
PM 22206029
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Hall, MN
AF Hall, Michael N.
TI Growth grows up COCB themed issue on cell division, growth, and death
SO CURRENT OPINION IN CELL BIOLOGY
LA English
DT Editorial Material
C1 Univ Basel, Biochem Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biochem Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0955-0674
J9 CURR OPIN CELL BIOL
JI Curr. Opin. Cell Biol.
PD DEC
PY 2011
VL 23
IS 6
BP 705
EP 706
DI 10.1016/j.ceb.2011.09.008
PG 2
WC Cell Biology
SC Cell Biology
GA 873PB
UT WOS:000298894200009
PM 22018538
DA 2021-01-25
ER

PT J
AU Michaut, L
   Jansen, HJ
   Bardine, N
   Durston, AJ
   Gehring, WJ
AF Michaut, Lydia
   Jansen, Hans J.
   Bardine, Nabila
   Durston, Antony J.
   Gehring, Walter J.
TI Analyzing the function of a hox gene: An evolutionary approach
SO DEVELOPMENT GROWTH & DIFFERENTIATION
LA English
DT Article
DE Drosophila; gastrulation; Hox; targets; Xenopus
ID HOMEOBOX GENES; NEURAL CREST; VERTEBRATE; GASTRULATION; TRANSCRIPTION;
   SEGMENTATION; COLINEARITY; ACTIVATION; EXPRESSION; MESODERM
AB We present an evolutionary approach to dissecting conserved developmental mechanisms. We reason that important mechanisms for making the bodyplan will act early, to generate the major features of the body and that they will be conserved in evolution across many metazoa, and thus, that they will be available in very different animals. This led to our specific approach of microarrays to screen for very early conserved developmental regulators in parallel in an insect, Drosophila and a vertebrate, Xenopus. We screened for the earliest conserved targets of the ectopically expressed hox gene Hoxc6/Antennapedia in both species and followed these targets up, using in situ hybridization, in the Xenopus system. The results indicate that relatively few of the early Hox target genes are conserved: these are mainly involved in the specification of the antero-posterior body axis and in gastrulation.
C1 [Jansen, Hans J.; Bardine, Nabila; Durston, Antony J.] Leiden Univ, Inst Biol, NL-2333 BE Leiden, Netherlands.
   [Michaut, Lydia; Gehring, Walter J.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Durston, AJ (corresponding author), Leiden Univ, Inst Biol, Wassenaarseweg 72, NL-2333 BE Leiden, Netherlands.
EM a.j.durston@biology.leidenuniv.nl
OI Jansen, Hans/0000-0002-8563-4146; Bardine, Nabila/0000-0002-4365-5336
FU European UnionEuropean Union (EU) [LSHM-CT-2003-504468]
FX We acknowledge support from the European Union, Grant No.:
   LSHM-CT-2003-504468.
CR Akam M, 1998, CURR BIOL, V8, pR676, DOI 10.1016/S0960-9822(98)70433-6
   Alexandre D, 1996, DEVELOPMENT, V122, P735
   Bailey WJ, 1997, MOL BIOL EVOL, V14, P843, DOI 10.1093/oxfordjournals.molbev.a025825
   BURKE AC, 1995, DEVELOPMENT, V121, P333
   CARRASCO AE, 1984, CELL, V37, P409, DOI 10.1016/0092-8674(84)90371-4
   Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115
   COLETTA PL, 1994, J ANAT, V184, P15
   DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5
   Durston AJ, 2010, GENOMICS, V95, P250, DOI 10.1016/j.ygeno.2009.11.002
   Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573
   GARBER RL, 1983, EMBO J, V2, P2027, DOI 10.1002/j.1460-2075.1983.tb01696.x
   GAUNT SJ, 1988, DEVELOPMENT, V103, P135
   Gaunt SJ, 1996, DEV DYNAM, V207, P270, DOI 10.1002/(SICI)1097-0177(199611)207:3<270::AID-AJA4>3.0.CO;2-E
   Gehring WJ, 2009, CURR TOP DEV BIOL, V88, P35, DOI 10.1016/S0070-2153(09)88002-2
   Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077
   HARDING KW, 1995, GENETICS, V140, P1339
   HARLAND RM, 1991, METHOD CELL BIOL, V36, P685
   HARVEY RP, 1988, CELL, V53, P687, DOI 10.1016/0092-8674(88)90087-6
   Hooiveld MHW, 1999, INT J DEV BIOL, V43, P665
   Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838
   KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7
   LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5
   Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356
   MANAK JR, 1994, DEVELOPMENT, P61
   Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740
   MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872
   Nieuwkoop P.D., 1956, NORMAL TABLE XENOPUS
   NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P83, DOI 10.1002/jez.1401200104
   Peres JN, 2006, MECH DEVELOP, V123, P321, DOI 10.1016/j.mod.2006.03.001
   Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802
   Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105
   Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012
   RUDDLE FH, 1994, ANNU REV GENET, V28, P423, DOI 10.1146/annurev.ge.28.120194.002231
   SCHUGHART K, 1989, P NATL ACAD SCI USA, V86, P7067, DOI 10.1073/pnas.86.18.7067
   Sive H, 1998, EARLY DEV XENOPUS LA
   Spemann H, 1931, W ROUX ARCH ENTWICKL, V123, P390
   Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8
   van den Akker WMR, 2010, INT J DEV BIOL, V54, P55, DOI 10.1387/ijdb.082678wv
   Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022
   Woltering J. M., 2008, PLOS ONE, V2008, P3
NR 42
TC 6
Z9 6
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0012-1592
EI 1440-169X
J9 DEV GROWTH DIFFER
JI Dev. Growth Diff.
PD DEC
PY 2011
VL 53
IS 9
BP 982
EP 993
DI 10.1111/j.1440-169X.2011.01307.x
PG 12
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 862AT
UT WOS:000298062900003
PM 22150153
DA 2021-01-25
ER

PT J
AU Lanz, MA
   Klostermeier, D
AF Lanz, Martin A.
   Klostermeier, Dagmar
TI Guiding strand passage: DNA-induced movement of the gyrase C-terminal
   domains defines an early step in the supercoiling cycle
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID BACILLUS-SUBTILIS DNA; ATP-OPERATED CLAMP; CLOSED CONFORMATION;
   CRYSTAL-STRUCTURE; BINDING; MECHANISM; MODEL; GATE; BOX; TOPOISOMERASE
AB DNA gyrase catalyzes ATP-dependent negative supercoiling of DNA in a strand passage mechanism. A double-stranded segment of DNA, the T-segment, is passed through the gap in a transiently cleaved G-segment by coordinated closing and opening of three protein interfaces in gyrase. T-segment capture is thought to be guided by the C-terminal domains of the GyrA subunit of gyrase that wrap DNA around their perimeter and cause a DNA-crossing with a positive handedness. We show here that the C-terminal domains are in a downward-facing orientation in the absence of DNA, but swing up and rotate away from the gyrase body when DNA binds. The upward movement of the C-terminal domains is an early event in the catalytic cycle of gyrase that is triggered by binding of a G-segment, and first contacts of the DNA with the C-terminal domains, and contributes to T-segment capture and subsequent strand passage.
C1 [Lanz, Martin A.; Klostermeier, Dagmar] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@uni-muenster.de
FU VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); NCCR Nanoscale Sciences; University
   of Basel
FX The VolkswagenStiftung; the Swiss National Science Foundation; the NCCR
   Nanoscale Sciences. Funding for open access charge: University of Basel.
CR Baker NM, 2011, NUCLEIC ACIDS RES, V39, P755, DOI 10.1093/nar/gkq799
   BASHKIROV VI, 1991, GENETICA, V85, P3, DOI 10.1007/BF00056101
   Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294
   Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101
   Costenaro L, 2005, STRUCTURE, V13, P287, DOI 10.1016/j.str.2004.12.011
   Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396
   Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872
   Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055
   GUBAEV A, 2011, P NATL ACAD IN PRESS
   Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106
   Heddle JG, 2004, J MOL BIOL, V337, P597, DOI 10.1016/j.jmb.2004.01.049
   Hilbert M, 2011, NUCLEIC ACIDS RES, V39, P2260, DOI 10.1093/nar/gkq1127
   Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416
   Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414
   Karow AR, 2010, J MOL BIOL, V402, P629, DOI 10.1016/j.jmb.2010.07.049
   KIRCHHAUSEN T, 1985, CELL, V41, P933, DOI 10.1016/S0092-8674(85)80074-X
   Kramlinger VM, 2006, J BIOL CHEM, V281, P3738, DOI 10.1074/jbc.M511160200
   REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399
   Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200
   Schoeffler AJ, 2010, NUCLEIC ACIDS RES, V38, P7830, DOI 10.1093/nar/gkq665
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Tennyson RB, 1997, BIOCHEMISTRY-US, V36, P6107, DOI 10.1021/bi970152f
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868
   Tretter EM, 2010, P NATL ACAD SCI USA, V107, P22055, DOI 10.1073/pnas.1012938107
   Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x
   WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0
   Williams NL, 2001, J MOL BIOL, V306, P969, DOI 10.1006/jmbi.2001.4468
   Williams NL, 1999, BIOCHEMISTRY-US, V38, P14157, DOI 10.1021/bi991478m
   Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488
NR 32
TC 23
Z9 23
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD DEC
PY 2011
VL 39
IS 22
BP 9681
EP 9694
DI 10.1093/nar/gkr680
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 863RT
UT WOS:000298186000025
PM 21880594
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Mysore, K
   Flister, S
   Muller, P
   Rodrigues, V
   Reichert, H
AF Mysore, Keshava
   Flister, Susanne
   Mueller, Pie
   Rodrigues, Veronica
   Reichert, Heinrich
TI Brain development in the yellow fever mosquito Aedes aegypti: a
   comparative immunocytochemical analysis using cross-reacting antibodies
   from Drosophila melanogaster
SO DEVELOPMENT GENES AND EVOLUTION
LA English
DT Article
DE Aedes aegypti; Fruitfly; Brain development; Optic lobes; Subesophageal
   ganglion
ID OLFACTORY RECEPTOR NEURONS; ANOPHELES-GAMBIAE; NERVOUS-SYSTEM;
   POSTEMBRYONIC DEVELOPMENT; GLUTAMINE-SYNTHETASE; MALARIA MOSQUITO; MODEL
   SYSTEM; SEROTONIN; LOCALIZATION; PROJECTIONS
AB Considerable effort has been directed towards understanding the organization and function of peripheral and central nervous system of disease vector mosquitoes such as Aedes aegypti. To date, all of these investigations have been carried out on adults but none of the studies addressed the development of the nervous system during the larval and pupal stages in mosquitoes. Here, we first screen a set of 30 antibodies, which have been used to study brain development in Drosophila, and identify 13 of them cross-reacting and labeling epitopes in the developing brain of Aedes. We then use the identified antibodies in immunolabeling studies to characterize general neuroanatomical features of the developing brain and compare them with the well-studied model system, Drosophila melanogaster, in larval, pupal, and adult stages. Furthermore, we use immunolabeling to document the development of specific components of the Aedes brain, namely the optic lobes, the subesophageal neuropil, and serotonergic system of the subesophageal neuropil in more detail. Our study reveals prominent differences in the developing brain in the larval stage as compared to the pupal (and adult) stage of Aedes. The results also uncover interesting similarities and marked differences in brain development of Aedes as compared to Drosophila. Taken together, this investigation forms the basis for future cellular and molecular investigations of brain development in this important disease vector.
C1 [Mysore, Keshava; Flister, Susanne; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Mueller, Pie] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland.
   [Mueller, Pie] Univ Basel, CH-4003 Basel, Switzerland.
   [Rodrigues, Veronica] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum, Klinglebergstr 50, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch
RI Mysore, Keshava/P-6248-2019; Muller, Pie/R-7275-2018
OI Mysore, Keshava/0000-0003-2794-7029; Muller, Pie/0000-0003-0181-5781
FU Indo-Swiss Joint Research Project (ISJRP)
FX We are very grateful to GM Technau, JB Skeath, CY Lee, J Pielage, and
   the Developmental Studies Hybridoma Bank (DSHB) for the antibodies. We
   also thank all the members of the Reichert lab for discussions and
   assistance. We are very thankful to the two unknown reviewers for their
   valuable comments on the previous version of the manuscript, their
   constructive criticism have greatly improved the manuscript. We are very
   grateful to Danica Jancariova and Mohamad Sater at Vector Control
   Centre, STPHI, Basel, Switzerland for insect rearing. This work was
   supported by the Indo-Swiss Joint Research Project (ISJRP).
CR Anton S, 2003, ARTHROPOD STRUCT DEV, V32, P319, DOI 10.1016/j.asd.2003.09.002
   Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793
   Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x
   Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834
   CHITNIS AB, 1990, J NEUROSCI, V10, P1892
   Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076
   DAVIS NT, 1987, J COMP NEUROL, V259, P604, DOI 10.1002/cne.902590409
   Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X
   Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0
   Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998
   Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133
   Ghaninia M, 2007, EUR J NEUROSCI, V26, P1611, DOI 10.1111/j.1460-9568.2007.05786.x
   Ghaninia M, 2007, ARTHROPOD STRUCT DEV, V36, P23, DOI 10.1016/j.asd.2006.06.004
   Groh C, 2008, ARTHROPOD STRUCT DEV, V37, P459, DOI 10.1016/j.asd.2008.04.001
   HALTER DA, 1995, DEVELOPMENT, V121, P317
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Harzsch S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-58
   Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196
   HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393
   Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800
   Ignell R, 2005, J COMP NEUROL, V492, P214, DOI 10.1002/cne.20691
   Ishii Y, 2005, ZOOL SCI, V22, P743, DOI 10.2108/zsj.22.743
   Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9
   Klagges BRE, 1996, J NEUROSCI, V16, P3154
   Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103
   LANGE AB, 1988, ARCH INSECT BIOCHEM, V8, P187, DOI 10.1002/arch.940080305
   Larsen C, 2009, DEV BIOL, V335, P289, DOI 10.1016/j.ydbio.2009.06.015
   Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062
   MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400
   Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-255
   Meinertzhagen Ian A., 1993, P1363
   Mellanby K., 1958, Entomologia Experimentalis et Applicata, V1, P153, DOI 10.1007/BF00291058
   Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041
   MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025
   Mysore K, 2010, ARTHROPOD STRUCT DEV, V39, P310, DOI 10.1016/j.asd.2010.04.003
   NASSEL DR, 1984, NEUROSCI LETT, V48, P203, DOI 10.1016/0304-3940(84)90020-X
   Oland LA, 1996, J NEUROBIOL, V30, P92
   Olsson B, 1998, J INSECT BEHAV, V11, P593, DOI 10.1023/A:1022375632171
   Pereanu W, 2011, J COMP NEUROL, V519, P661, DOI 10.1002/cne.22542
   Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176
   Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5
   Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6
   Siju KP, 2008, ARTHROPOD STRUCT DEV, V37, P248, DOI 10.1016/j.asd.2007.12.001
   SNOW PM, 1987, J NEUROSCI, V7, P4137
   Spindler SR, 2010, DEV GENES EVOL, V220, P1, DOI 10.1007/s00427-010-0323-7
   Sprecher SG, 2011, DEV BIOL, V358, P33, DOI 10.1016/j.ydbio.2011.07.006
   van der Hel WS, 2005, NEUROLOGY, V64, P326, DOI 10.1212/01.WNL.0000149636.44660.99
   VANHAEFTEN T, 1993, CELL TISSUE RES, V273, P327, DOI 10.1007/BF00312835
   Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107
   Ward MM, 2004, CELL TISSUE RES, V315, P305, DOI 10.1007/s00441-003-0849-3
   Yeates DK, 1999, ANNU REV ENTOMOL, V44, P397, DOI 10.1146/annurev.ento.44.1.397
   Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061
   ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2
NR 54
TC 18
Z9 18
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0949-944X
J9 DEV GENES EVOL
JI Dev. Genes Evol.
PD DEC
PY 2011
VL 221
IS 5-6
BP 281
EP 296
DI 10.1007/s00427-011-0376-2
PG 16
WC Cell Biology; Evolutionary Biology; Developmental Biology
SC Cell Biology; Evolutionary Biology; Developmental Biology
GA 859YN
UT WOS:000297911900002
PM 21956584
DA 2021-01-25
ER

PT J
AU Montagner, C
   Arquint, C
   Cornelis, GR
AF Montagner, Caroline
   Arquint, Christian
   Cornelis, Guy R.
TI Translocators YopB and YopD from Yersinia enterocolitica Form a
   Multimeric Integral Membrane Complex in Eukaryotic Cell Membranes
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID III SECRETION SYSTEM; ENTEROPATHOGENIC ESCHERICHIA-COLI; BLUE NATIVE
   ELECTROPHORESIS; PSEUDOMONAS-AERUGINOSA; SHIGELLA-FLEXNERI; HOST
   MEMBRANES; TIP COMPLEX; PROTEIN TRANSLOCATION; PLASMA-MEMBRANE; PORE
   FORMATION
AB The type III secretion systems are contact-activated secretion systems that allow bacteria to inject effector proteins across eukaryotic cell membranes. The secretion apparatus, called injectisome or needle complex, includes a needle that terminates with a tip structure. The injectisome exports its own distal components, like the needle subunit and the needle tip. Upon contact, it exports two hydrophobic proteins called translocators (YopB and YopD in Yersinia enterocolitica) and the effectors. The translocators, assisted by the needle tip, form a pore in the target cell membrane, but the structure of this pore remains elusive. Here, we purified the membranes from infected sheep erythrocytes, and we show that they contain integrated and not simply adherent YopB and YopD. In blue native PAGE, these proteins appeared as a multimeric 500-to 700-kDa complex. This heteropolymeric YopBD complex could be copurified after solubilization in 0.5% dodecyl maltoside but not visualized in the electron microscope. We speculate that this complex may not be stable and rigid but only transient.
C1 [Montagner, Caroline; Arquint, Christian; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310000-313333/1]
FX This work was supported by grant 310000-313333/1 to G.R.C. from the
   Swiss National Science Foundation.
CR Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x
   Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+
   Fields KA, 1999, INFECT IMMUN, V67, P4801, DOI 10.1128/IAI.67.9.4801-4813.1999
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   HAKANSSON S, 1993, INFECT IMMUN, V61, P71
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x
   Ivanov MI, 2008, INFECT IMMUN, V76, P5181, DOI 10.1128/IAI.00189-08
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2
   Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200
   Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005
   Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x
   SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112
   Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499
   Shaw RK, 2001, CELL MICROBIOL, V3, P213, DOI 10.1046/j.1462-5822.2001.00105.x
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3
   Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793
   Thorslund SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016784
   Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x
   Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999
NR 35
TC 34
Z9 34
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD DEC
PY 2011
VL 193
IS 24
BP 6923
EP 6928
DI 10.1128/JB.05555-11
PG 6
WC Microbiology
SC Microbiology
GA 858ON
UT WOS:000297810500014
PM 22001511
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Nigg, EA
AF Nigg, Erich A.
TI Editorial Note on Carlberg and Seuter (2010) Dynamics of nuclear
   receptor target gene regulation, Chromosoma (2010) 119: 479-484
SO CHROMOSOMA
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erich.nigg@unibas.ch
CR Degenhardt T, 2009, CELL, V138, P489, DOI 10.1016/j.cell.2009.05.029
   2010, CELL, V143, P651, DOI DOI 10.1111/J.1600-0889.2007.00331.X
NR 2
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-5915
EI 1432-0886
J9 CHROMOSOMA
JI Chromosoma
PD DEC
PY 2011
VL 120
IS 6
BP 531
EP 531
DI 10.1007/s00412-011-0345-6
PG 1
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 852NB
UT WOS:000297363600001
PM 22006668
OA Bronze
DA 2021-01-25
ER

PT J
AU Jastrzebska, B
   Ringler, P
   Lodowski, DT
   Moiseenkova-Bell, V
   Golczak, M
   Muller, SA
   Palczewski, K
   Engel, A
AF Jastrzebska, Beata
   Ringler, Philippe
   Lodowski, David T.
   Moiseenkova-Bell, Vera
   Golczak, Marcin
   Mueller, Shirley A.
   Palczewski, Krzysztof
   Engel, Andreas
TI Rhodopsin-transducin heteropentamer: Three-dimensional structure and
   biochemical characterization
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE G protein-coupled receptor; Heterotrimeric G protein; Photoactivated
   rhodopsin; Scanning transmission electron microscopy; Transducin
ID PROTEIN-COUPLED RECEPTOR; SINGLE-PARTICLE RECONSTRUCTIONS; ANGSTROM
   CRYSTAL-STRUCTURE; NATIVE DISC MEMBRANES; PHOTOACTIVATED RHODOPSIN;
   ELECTRON-MICROSCOPY; ALPHA-SUBUNIT; GAMMA-SUBUNIT; CONFORMATION;
   ACTIVATION
AB The process of vision is initiated when the G protein-coupled receptor, rhodopsin (Rho), absorbs a photon and transitions to its activated Rho* form. Rho* binds the heterotrimeric G protein, transducin (G(t)) inducing GDP to GTP exchange and G(t) dissociation. Using nucleotide depletion and affinity chromatography, we trapped and purified the resulting nucleotide-free Rho*.G(t) complex. Quantitative SDS-PAGE suggested a 2:1 molar ratio of Rho* to G(t) in the complex and its mass determined by scanning transmission electron microscopy was 221 +/- 12 kDa. A 21.6 angstrom structure was calculated from projections of negatively stained Rho*.G(t) complexes. The molecular envelope thus determined accommodated two Rho molecules together with one G(t) heterotrimer, corroborating the heteropentameric structure of the Rho*.G(t) complex. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Jastrzebska, Beata; Lodowski, David T.; Moiseenkova-Bell, Vera; Golczak, Marcin; Palczewski, Krzysztof; Engel, Andreas] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Ringler, Philippe; Mueller, Shirley A.; Engel, Andreas] Univ Basel, Biozentrum, C CINA, CH-4058 Basel, Switzerland.
RP Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM bxj27@case.edu; kxp65@case.edu; andreas.engel@case.edu
FU National Institutes of Health, Foundation Fighting BlindnessUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Neurological Disorders &
   Stroke (NINDS) [EY008061, EY019718, GM079191, P30EY11373]; Amgen
   Inc.Amgen; Swiss National FoundationSwiss National Science Foundation
   (SNSF) [3100A0-108299]; NATIONAL EYE INSTITUTEUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, R01EY008061, R01EY008061, P30EY011373,
   P30EY011373, P30EY011373, R29EY008061, R01EY008061, P30EY011373,
   R01EY008061, P30EY011373, P30EY011373, R01EY008061, P30EY011373,
   R01EY008061, P30EY011373, P30EY011373, P30EY011373, R01EY008061,
   R01EY008061, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   R01EY008061, R01EY019478, P30EY011373, R01EY008061, P30EY011373,
   R00EY019718, R01EY008061, P30EY011373, P30EY011373, R01EY008061,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, K99EY019718, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, R29EY008061, P30EY011373,
   P30EY011373, P30EY011373, R29EY008061, P30EY011373, P30EY011373,
   R00EY019718, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   R01EY008061, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, R01EY008061,
   P30EY011373, R01EY008061, R01EY008061, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   R00EY019718, R01EY008061, P30EY011373, P30EY011373, R01EY008061,
   P30EY011373, P30EY011373, P30EY011373, R01EY008061, P30EY011373,
   P30EY011373, P30EY011373, R29EY008061, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, K99EY019718,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, R29EY008061,
   P30EY011373, R01EY008061, P30EY011373, P30EY011373, R01EY019478,
   P30EY011373, R01EY008061, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, R01EY008061,
   P30EY011373, P30EY011373, R01EY008061, R01EY019478, R29EY008061,
   P30EY011373, P30EY011373, R01EY019478, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, R01EY019478] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   R01GM079191, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   R01GM079191, U54GM094598, U54GM094598, R01GM079191, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, R01GM079191, R01GM079191, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598] Funding
   Source: NIH RePORTER
FX This research was supported in part by grants EY008061, EY019718,
   GM079191, P30EY11373 from the National Institutes of Health, Foundation
   Fighting Blindness, an unrestricted grant from Amgen Inc., and the Swiss
   National Foundation grant 3100A0-108299 to A.E. K.P. is John H. Hord
   Professor of Pharmacology.
CR Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314
   Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200
   BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613
   Cheng YF, 2006, J MOL BIOL, V355, P1048, DOI 10.1016/j.jmb.2005.11.021
   Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789
   Dell'Orco D, 2011, BIOCH J
   Dell'Orco D, 2008, J PHYS CHEM B, V112, P4419, DOI 10.1021/jp709963f
   Downs MA, 2006, VISION RES, V46, P4442, DOI 10.1016/j.visres.2006.07.021
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Govardovskii VI, 2009, MOL VIS, V15, P1717
   Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199
   Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005
   Jastrzebska B, 2011, PROG LIPID RES, V50, P267, DOI 10.1016/j.plipres.2011.03.002
   Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x
   Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835
   Kisselev OG, 2006, BIOCHEMISTRY-US, V45, P9386, DOI 10.1021/bi060806x
   Krzyzanek V, 2009, J STRUCT BIOL, V165, P78, DOI 10.1016/j.jsb.2008.10.006
   KUHN H, 1981, P NATL ACAD SCI-BIOL, V78, P6873, DOI 10.1073/pnas.78.11.6873
   Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Rasmussen S.G., 2011, NATURE
   Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106
   Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348
   Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200
   Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330
   Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795
   Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108
   WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P12444
   Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200
NR 39
TC 44
Z9 44
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD DEC
PY 2011
VL 176
IS 3
BP 387
EP 394
DI 10.1016/j.jsb.2011.08.016
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 848XS
UT WOS:000297089000014
PM 21925606
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Dazert, E
   Hall, MN
AF Dazert, Eva
   Hall, Michael N.
TI mTOR signaling in disease
SO CURRENT OPINION IN CELL BIOLOGY
LA English
DT Article
ID DIET-INDUCED OBESITY; T-CELL-ACTIVATION; EXTENDS LIFE-SPAN; MAMMALIAN
   TARGET; HIGH-FREQUENCY; PIK3CA GENE; DIABETIC-NEPHROPATHY;
   INSULIN-RESISTANCE; EGFR AMPLIFICATION; PTEN EXPRESSION
AB The target of rapamycin (TOR) is a highly conserved serine/threonine kinase and a central controller of cell growth, metabolism and aging. Mammalian TOR (mTOR) is activated in response to nutrients, growth factors and cellular energy. Dysregulated mTOR signaling has been implicated in major disease. Here we review recent findings on the role of mTOR in cancer, metabolic disorders, neurological diseases, and inflammation.
C1 [Dazert, Eva; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Dazert, E (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
FU Canton of Basel; Swiss Cancer League; Louis-Jeantet Foundation; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
FX We acknowledge support from the Canton of Basel, the Swiss Cancer
   League, the Louis-Jeantet Foundation and the Swiss National Science
   Foundation.
CR Allen A, 2004, J IMMUNOL, V172, P4797, DOI 10.4049/jimmunol.172.8.4797
   Alvarado Y, 2011, TARGET ONCOL, V6, P69, DOI 10.1007/s11523-011-0178-5
   Aoyagi T, 2011, CURRENT PHARM DESIGN
   Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117
   Arteaga CL, 2006, CANCER CELL, V9, P421, DOI 10.1016/j.ccr.2006.05.014
   Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226
   Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012
   Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005
   Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769
   Benito R, 2010, NEUROPATHOLOGY, V30, P392, DOI 10.1111/j.1440-1789.2009.01081.x
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Birck A, 2000, J INVEST DERMATOL, V114, P277, DOI 10.1046/j.1523-1747.2000.00877.x
   Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564
   Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766
   Blagosklonny MV, 2009, AGING-US, V1, P357, DOI 10.18632/aging.100040
   BOS JL, 1989, CANCER RES, V49, P4682
   Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009
   Brown KA, 2010, BREAST CANCER RES TR, V123, P591, DOI 10.1007/s10549-010-0834-y
   Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933
   Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346
   Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645
   Care RS, 2003, BRIT J HAEMATOL, V121, P775, DOI 10.1046/j.1365-2141.2003.04362.x
   Catania C, 2011, INT J OBESITY, V35, P751, DOI 10.1038/ijo.2010.208
   Chapuis N, 2010, LEUKEMIA, V24, P1686, DOI 10.1038/leu.2010.170
   Chen WN, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-292
   CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267
   Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105
   Chua TC, 2012, INT J CANCER, V130, P2845, DOI 10.1002/ijc.26292
   Colombi M, 2011, ONCOGENE, V30, P1551, DOI 10.1038/onc.2010.539
   Cornu M, 2010, ENZYMES, V28, P263, DOI 10.1016/S1874-6047(10)28013-7
   Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9
   Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213
   De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545
   Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI200523621, 10.1172/JCI23621]
   Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969
   Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756
   Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788
   Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002
   Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879
   Farooq A, 2010, CANCER TREAT REV, V36, P577, DOI 10.1016/j.ctrv.2010.04.002
   Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038
   Fernandez D, 2006, ARTHRITIS RHEUM-US, V54, P2983, DOI 10.1002/art.22085
   Fernandez D, 2010, DISCOV MED, V9, P173
   Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200
   Garelick MG, 2011, EXP GERONTOL, V46, P155, DOI 10.1016/j.exger.2010.08.030
   Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022
   Giordano A, 2011, CURR OPIN PHARMACOL, V11, P372, DOI 10.1016/j.coph.2011.03.006
   Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774
   Gomez-Cambronero J, 2003, J IMMUNOL, V171, P6846, DOI 10.4049/jimmunol.171.12.6846
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Han W, 2009, CANCER PREV RES, V2, P370, DOI 10.1158/1940-6207.CAPR-08-0209
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Herrmann JL, 2011, CANCER LETT, V306, P1, DOI 10.1016/j.canlet.2011.01.014
   Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977
   Ho VW, 2011, CANCER RES, V71, P4484, DOI 10.1158/0008-5472.CAN-10-3973
   Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003
   Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055
   Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001
   Kelly KR, 2011, TARGET ONCOL, V6, P53, DOI 10.1007/s11523-011-0175-8
   Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075
   Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921
   Kharas MG, 2004, BLOOD, V103, P4268, DOI 10.1182/blood-2003-07-2193
   Kim MS, 2008, J IMMUNOL, V180, P4586, DOI 10.4049/jimmunol.180.7.4586
   Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r
   Krab LC, 2008, TRENDS GENET, V24, P498, DOI 10.1016/j.tig.2008.07.005
   Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061
   Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528
   Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304
   Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287
   Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107
   Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255
   Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Ly C, 2003, CANCER RES, V63, P5716
   Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017
   Malagelada C, 2006, J NEUROSCI, V26, P9996, DOI 10.1523/JNEUROSCI.3292-06.2006
   Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010
   Memmott RM, 2010, CLIN CANCER RES, V16, P4, DOI 10.1158/1078-0432.CCR-09-0234
   Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352
   Mizuguchi M, 2001, BRAIN DEV-JPN, V23, P508, DOI 10.1016/S0387-7604(01)00304-7
   Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477
   Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005
   Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
   Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924
   Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751
   Neasta J, 2010, P NATL ACAD SCI USA, V107, P20093, DOI 10.1073/pnas.1005554107
   Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005
   Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002
   Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620
   Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271
   Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63
   Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566
   Peck-Radosavljevic Markus, 2010, Therap Adv Gastroenterol, V3, P259, DOI 10.1177/1756283X10362278
   Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711
   Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977
   Pignataro G, 2011, CURR OPIN PHARMACOL, V11, P378, DOI 10.1016/j.coph.2011.05.003
   Piha-Paul SA, 2011, J CLIN ONCOL, V29, pE333, DOI 10.1200/JCO.2010.32.5928
   Pitkanen A, 2010, EPILEPSIA, V51, P2, DOI 10.1111/j.1528-1167.2010.02602.x
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054
   Pollock PM, 2002, MELANOMA RES, V12, P565, DOI 10.1097/00008390-200212000-00006
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002
   Qiu WL, 2006, CLIN CANCER RES, V12, P1441, DOI 10.1158/1078-0432.CCR-05-2173
   Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105
   RAFFELD M, 1991, BLOOD, V78, P259
   Rasheed BKA, 1997, CANCER RES, V57, P4187
   Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362
   Reifenberger J, 2000, VIRCHOWS ARCH, V436, P487, DOI 10.1007/s004280050477
   Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422
   Ruggeri BA, 1998, MOL CARCINOGEN, V21, P81, DOI 10.1002/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.3.CO;2-K
   Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x
   Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sastry SK, 2011, BIOCHEM PHARMACOL, V82, P435, DOI 10.1016/j.bcp.2011.06.016
   Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28
   Sauter G, 1996, AM J PATHOL, V148, P1047
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869
   Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066
   Sieben NLG, 2004, J PATHOL, V202, P336, DOI 10.1002/path.1521
   Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130
   Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246
   Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979
   Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296
   Tashiro H, 1997, CANCER RES, V57, P3935
   Terakawa N, 2003, ENDOCR-RELAT CANCER, V10, P203, DOI 10.1677/erc.0.0100203
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Wang SI, 1997, CANCER RES, V57, P4183
   Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012
   Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002
   Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236
   Wich C, 2010, WORLD J GASTROENTERO, V16, P3592, DOI 10.3748/wjg.v16.i28.3592
   Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978
   Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429
   Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002
   Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158
   Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6
   Yu Jane, 2010, Proc Am Thorac Soc, V7, P48, DOI 10.1513/pats.200909-104JS
   Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299
   Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245
   Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008
   Zhang YJ, 2011, DRUG DISCOV TODAY, V16, P325, DOI 10.1016/j.drudis.2011.02.008
   Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163
   Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 168
TC 301
Z9 323
U1 2
U2 36
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0955-0674
EI 1879-0410
J9 CURR OPIN CELL BIOL
JI Curr. Opin. Cell Biol.
PD DEC
PY 2011
VL 23
IS 6
BP 744
EP 755
DI 10.1016/j.ceb.2011.09.003
PG 12
WC Cell Biology
SC Cell Biology
GA 873PB
UT WOS:000298894200015
PM 21963299
DA 2021-01-25
ER

PT J
AU Loewith, R
   Hall, MN
AF Loewith, Robbie
   Hall, Michael N.
TI Target of Rapamycin (TOR) in Nutrient Signaling and Growth Control
SO GENETICS
LA English
DT Article
ID NITROGEN CATABOLITE REPRESSION; POLYMERASE-III TRANSCRIPTION; LIFE-SPAN
   EXTENSION; PROTEIN-KINASE-A; SENSITIVE PHOSPHOPROTEOME REVEALS;
   PLASMA-MEMBRANE LOCALIZATION; CELL INTEGRITY PATHWAY; P70 S6 KINASE;
   SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON
AB TOR (Target Of Rapamycin) is a highly conserved protein kinase that is important in both fundamental and clinical biology. In fundamental biology, TOR is a nutrient-sensitive, central controller of cell growth and aging. In clinical biology, TOR is implicated in many diseases and is the target of the drug rapamycin used in three different therapeutic areas. The yeast Saccharomyces cerevisiae has played a prominent role in both the discovery of TOR and the elucidation of its function. Here we review the TOR signaling network in S. cerevisiae.
C1 [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Loewith, Robbie] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland.
   [Loewith, Robbie] Univ Geneva, Natl Ctr Competence Res & Frontiers Genet, CH-1211 Geneva, Switzerland.
   [Loewith, Robbie] Univ Geneva, Natl Ctr Chem Biol, CH-1211 Geneva, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Robbie.Loewith@unige.ch; m.hall@unibas.ch
RI Loewith, Robbie/S-6289-2016
OI Loewith, Robbie/0000-0002-2482-603X
FU Cantons of Basel and Geneva, SystemsX.ch; Frontiers in Genetics and
   Chemical Biology National Centers for Competence in Research; European
   Research CouncilEuropean Research Council (ERC); Louis-Jeantet and
   Leenaards Foundations; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF)
FX We thank Claudio De Virgilio and Michael Stahl for comments on the
   manuscript. We acknowledge support from the Cantons of Basel and Geneva,
   SystemsX.ch, the Frontiers in Genetics and Chemical Biology National
   Centers for Competence in Research, the European Research Council, the
   Louis-Jeantet and Leenaards Foundations, and the Swiss National Science
   Foundation.
CR Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483
   Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040
   Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0
   Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531
   Albig AR, 2001, MOL BIOL CELL, V12, P3428, DOI 10.1091/mbc.12.11.3428
   ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115
   Araki T, 2005, GENES GENET SYST, V80, P325, DOI 10.1266/ggs.80.325
   Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015
   Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274
   Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384
   Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001
   Berger AB, 2007, MOL CELL BIOL, V27, P8015, DOI 10.1128/MCB.01102-07
   Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264
   Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200
   Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266
   Bharucha N, 2008, MOL BIOL CELL, V19, P2708, DOI 10.1091/mbc.E07-11-1199
   Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235
   Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033
   Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010
   Blagosklonny MV, 2009, AGING-US, V1, P357, DOI 10.18632/aging.100040
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495
   Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0
   Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05
   Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287
   CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012
   Calvert MEK, 2008, MOL CELL BIOL, V28, P1313, DOI 10.1128/MCB.01035-07
   Cardenas ME, 1999, CLIN MICROBIOL REV, V12, P583, DOI 10.1128/CMR.12.4.583
   Caron E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.108
   Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200
   Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008
   Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141
   CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947
   Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576
   Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003
   CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574
   Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239
   Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594
   Cohen A, 2009, CELL, V136, P399, DOI 10.1016/j.cell.2009.01.021
   Cook M, 2007, CURR OPIN BIOTECH, V18, P341, DOI 10.1016/j.copbio.2007.07.006
   Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000
   Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599
   Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200
   Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06
   DAVIS ES, 1992, P NATL ACAD SCI USA, V89, P11169, DOI 10.1073/pnas.89.23.11169
   De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200
   De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884
   deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323
   deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135
   Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787
   DEVIRGILIO C, 2011, FEMS MICROB IN PRESS
   DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904
   Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093
   Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020
   Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4
   Ecker N, 2010, AUTOPHAGY, V6, P879, DOI 10.4161/auto.6.7.12753
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497
   Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.E04-07-0564
   Fingerman I, 2003, EUKARYOT CELL, V2, P1061, DOI 10.1128/EC.2.5.1061-1068.2003
   Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756
   Freckleton G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000449
   Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783
   Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2
   Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051
   Georis I, 2009, MOL CELL BIOL, V29, P3803, DOI 10.1128/MCB.00399-09
   Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011
   Goranov AI, 2010, CURR OPIN CELL BIOL, V22, P795, DOI 10.1016/j.ceb.2010.06.004
   Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004
   Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128
   Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006
   Hall MN, 1996, BIOCHEM SOC T, V24, P234, DOI 10.1042/bst0240234
   Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Hardt M, 2011, GENES CELLS, V16, P141, DOI 10.1111/j.1365-2443.2010.01482.x
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948
   HEITMAN J, 1992, NEW BIOL, V4, P448
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Helliwell SB, 1998, GENETICS, V148, P99
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833
   Honma Y, 2006, EMBO J, V25, P3832, DOI 10.1038/sj.emboj.7601262
   Hou HT, 2005, P NATL ACAD SCI USA, V102, P17366, DOI 10.1073/pnas.0508885102
   Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221
   Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109
   Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060
   Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200
   Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804
   Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x
   Kaizu K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.73
   Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005
   Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001
   KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50
   Kijanska M, 2010, AUTOPHAGY, V6, P1168, DOI 10.4161/auto.6.8.13849
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414
   Kogan K, 2010, J MOL BIOL, V402, P388, DOI 10.1016/j.jmb.2010.07.034
   KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718
   Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863
   Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1
   Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330
   KUNZ J, 1993, TRENDS BIOCHEM SCI, V18, P334, DOI 10.1016/0968-0004(93)90069-Y
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x
   Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106
   Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200
   Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090
   Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034
   Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002
   Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005
   Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020
   Liko D, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704762200
   Liko D, 2010, GENETICS, V185, P797, DOI 10.1534/genetics.110.116665
   Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025
   Lippman SI, 2009, P NATL ACAD SCI USA, V106, P19928, DOI 10.1073/pnas.0907027106
   Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200
   Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Loewith Robbie, 2004, VVolume 42, P139
   Loewith R, 2011, BIOCHEM SOC T, V39, P437, DOI 10.1042/BST0390437
   Loewith R, 2010, ENZYMES, V27, P147, DOI 10.1016/S1874-6047(10)27009-9
   LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531
   Luo XA, 2011, RNA BIOL, V8, P14, DOI 10.4161/rna.8.1.13483
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Madeo F, 2010, AUTOPHAGY, V6, P160, DOI 10.4161/auto.6.1.10600
   Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9
   Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101
   Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047
   Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298
   Michels AA, 2011, BIOCHEM SOC T, V39, P487, DOI 10.1042/BST0390487
   Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167
   Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200
   Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223
   Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708
   Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x
   Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199
   O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636
   Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008
   Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200
   Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018
   Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822
   Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Powers T, 2007, CELL METAB, V6, P1, DOI 10.1016/j.cmet.2007.06.009
   Powers T, 2010, ENZYMES, V27, P177, DOI 10.1016/S1874-6047(10)27010-5
   Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372
   Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134
   Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200
   Reiter A, 2011, MOL CELL BIOL, V31, P803, DOI 10.1128/MCB.01227-10
   Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0
   Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201
   Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200
   Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
   Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904
   Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6
   Shen CX, 2007, MOL CELL BIOL, V27, P7007, DOI 10.1128/MCB.00290-07
   Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106
   Shin CS, 2009, J CELL SCI, V122, P2089, DOI 10.1242/jcs.047191
   Singh J, 2009, GENE DEV, V23, P1944, DOI 10.1101/gad.1804409
   Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200
   Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409
   Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182
   Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007
   STAN R, 1994, J BIOL CHEM, V269, P32027
   Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037
   Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08
   Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e
   Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000
   Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05
   Talarek N, 2010, MOL CELL, V38, P345, DOI 10.1016/j.molcel.2010.02.039
   TANIDA I, 1991, TRANSPL P, V23, P2856
   Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712
   Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200
   Teixeira MC, 2011, MICROBIOL-SGM, V157, P945, DOI 10.1099/mic.0.043661-0
   Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6
   Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200
   Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0
   Unal E, 2011, SCIENCE, V332, P1554, DOI 10.1126/science.1204349
   Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6
   Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104
   Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020
   Van Belle D, 2001, CURR OPIN CELL BIOL, V13, P389, DOI 10.1016/S0955-0674(00)00226-X
   Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175
   Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889
   Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x
   Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013
   Wei YH, 2010, NUCLEUS-PHILA, V1, P162, DOI 10.4161/nucl.1.2.11179
   Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179
   Weindruch R, 1988, RETARDATION AGING DI
   WIEDERRECHT G, 1991, P NATL ACAD SCI USA, V88, P1029, DOI 10.1073/pnas.88.3.1029
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
   Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239
   Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814
   Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566
   Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017
   Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
   ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6
   Zheng Y, 2005, MOL BIOL CELL, V16, P2119, DOI 10.1091/mbc.E04-09-0797
   Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
   Zinzalla V, 2010, ENZYMES, V27, P1, DOI 10.1016/S1874-6047(10)27001-4
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
   Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005
   Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835
NR 256
TC 496
Z9 504
U1 5
U2 66
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD DEC
PY 2011
VL 189
IS 4
BP 1177
EP 1201
DI 10.1534/genetics.111.133363
PG 25
WC Genetics & Heredity
SC Genetics & Heredity
GA 866UW
UT WOS:000298412100005
PM 22174183
OA Green Published, Green Accepted, Bronze
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Suffert, G
   Malterer, G
   Hausser, J
   Viiliainen, J
   Fender, A
   Contrant, M
   Ivacevic, T
   Benes, V
   Gros, F
   Voinnet, O
   Zavolan, M
   Ojala, PM
   Haas, JG
   Pfeffer, S
AF Suffert, Guillaume
   Malterer, Georg
   Hausser, Jean
   Viiliainen, Johanna
   Fender, Aurelie
   Contrant, Maud
   Ivacevic, Tomi
   Benes, Vladimir
   Gros, Frederic
   Voinnet, Olivier
   Zavolan, Mihaela
   Ojala, Paivi M.
   Haas, Juergen G.
   Pfeffer, Sebastien
TI Kaposi's Sarcoma Herpesvirus microRNAs Target Caspase 3 and Regulate
   Apoptosis
SO PLOS PATHOGENS
LA English
DT Article
ID CELL-LINE; EXPRESSION; PROTEIN; IDENTIFICATION; BIOGENESIS; DEATH;
   ESTABLISHMENT; REPLICATION; RECEPTORS; INFECTION
AB Kaposi's sarcoma herpesvirus (KSHV) encodes a cluster of twelve micro (mi)RNAs, which are abundantly expressed during both latent and lytic infection. Previous studies reported that KSHV is able to inhibit apoptosis during latent infection; we thus tested the involvement of viral miRNAs in this process. We found that both HEK293 epithelial cells and DG75 cells stably expressing KSHV miRNAs were protected from apoptosis. Potential cellular targets that were significantly down-regulated upon KSHV miRNAs expression were identified by microarray profiling. Among them, we validated by luciferase reporter assays, quantitative PCR and western blotting caspase 3 (Casp3), a critical factor for the control of apoptosis. Using site-directed mutagenesis, we found that three KSHV miRNAs, miR-K12-1, 3 and 4-3p, were responsible for the targeting of Casp3. Specific inhibition of these miRNAs in KSHV-infected cells resulted in increased expression levels of endogenous Casp3 and enhanced apoptosis. Altogether, our results suggest that KSHV miRNAs directly participate in the previously reported inhibition of apoptosis by the virus, and are thus likely to play a role in KSHV-induced oncogenesis.
C1 [Suffert, Guillaume; Fender, Aurelie; Contrant, Maud; Pfeffer, Sebastien] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, Architecture & React ARN, Strasbourg, France.
   [Malterer, Georg; Haas, Juergen G.] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany.
   [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
   [Hausser, Jean; Zavolan, Mihaela] Swiss Inst Bioinformat, Basel, Switzerland.
   [Viiliainen, Johanna; Ojala, Paivi M.] Univ Helsinki, Biomedicum Helsinki, Genome Scale Biol Program, Helsinki, Finland.
   [Viiliainen, Johanna; Ojala, Paivi M.] Univ Helsinki, Inst Biomed, Helsinki, Finland.
   [Ivacevic, Tomi; Benes, Vladimir] EMBL, GeneCore Genom Core Facil, Heidelberg, Germany.
   [Gros, Frederic] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, Immunol & Chim Therapeut UPR 9021, Strasbourg, France.
   [Voinnet, Olivier] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France.
   [Ojala, Paivi M.] Fdn Finnish Canc Inst, Helsinki, Finland.
   [Haas, Juergen G.] Univ Edinburgh, Sch Med, Div Pathway Med, Edinburgh, Midlothian, Scotland.
RP Suffert, G (corresponding author), Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, Architecture & React ARN, Strasbourg, France.
EM Paivi.Ojala@helsinki.fi; juergen.haas@ed.ac.uk;
   s.pfeffer@ibmc-cnrs.unistra.fr
RI GROS, Frederic/G-6332-2013; Pfeffer, Sebastien/H-3212-2019; Zavolan,
   Mihaela/S-3888-2016; Ojala, Paivi M/J-3266-2014; Pfeffer,
   Sebastien/A-6512-2010
OI GROS, Frederic/0000-0002-6252-4323; Pfeffer,
   Sebastien/0000-0002-8458-348X; Pfeffer, Sebastien/0000-0002-8458-348X;
   Zavolan, Mihaela/0000-0002-8832-2041; Ojala, Paivi/0000-0001-9065-1832;
   Benes, Vladimir/0000-0002-0352-2547; Voinnet,
   Olivier/0000-0001-6982-9544; Viiliainen, Johanna/0000-0002-5527-4266
FU Helsinki Biomedical Graduate School; European CommissionEuropean
   CommissionEuropean Commission Joint Research Centre [FP7-268301,
   LSHG-CT-2006-037900]; Fondation pour la Recherche MedicaleFondation pour
   la Recherche Medicale; Swiss National FundSwiss National Science
   Foundation (SNSF) [3100A0-114001]; Academy of Finland for the Center of
   Excellence in Translational Genome-Scale BiologyAcademy of Finland;
   Finnish Cancer Foundation; Sigrid Juselius FoundationSigrid Juselius
   Foundation; University of Helsinki Foundations; European UnionEuropean
   Union (EU) [LSHC-CT-2005-018704]; DFGGerman Research Foundation (DFG)
   [SFB 576, HA1754-6]; BMBFFederal Ministry of Education & Research (BMBF)
   [01GS0801]; MRCMedical Research Council UK (MRC) [G0501453]; European
   Research Council (ERC)European Research Council (ERC) [260767];
   CNRSCentre National de la Recherche Scientifique (CNRS); Ligue Nationale
   contre le CancerLigue nationale contre le cancer; Medical Research
   CouncilMedical Research Council UK (MRC) [G0501453] Funding Source:
   researchfish
FX This work was supported by Helsinki Biomedical Graduate School (J.
   Viiliainen); European Commission FP7 (Reintegration Grant FP7-268301)
   and the Fondation pour la Recherche Medicale (A. Fender); European
   Commission FP6 Integrated Project SIROCCO LSHG-CT-2006-037900 (O.
   Voinnet); Swiss National Fund grant 3100A0-114001 (M. Zavolan); grants
   from the Academy of Finland for the Center of Excellence in
   Translational Genome-Scale Biology, the Finnish Cancer Foundation,
   Sigrid Juselius Foundation, University of Helsinki Foundations and from
   the European Union FP6 INCA project LSHC-CT-2005-018704 (P.M. Ojala);
   DFG (SFB 576, HA1754-6), BMBF (NGFN-Plus, 01GS0801) and MRC (G0501453)
   (J. Haas); and the European Research Council (ERC Starting Grant
   ncRNAVIR 260767), an ATIP starting grant from CNRS and the Ligue
   Nationale contre le Cancer (S. Pfeffer). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abend JR, 2010, J VIROL, V84, P12139, DOI 10.1128/JVI.00884-10
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648
   Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105
   BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795
   Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102
   Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059
   da Silva SR, 2007, AM J CLIN PATHOL, V128, P794, DOI 10.1309/TFU2FXK3AP0C9R2X
   Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558
   Dieker J, 2008, CELL DEATH DIFFER, V15, P793, DOI 10.1038/sj.cdd.4402312
   Dolken L, 2007, J VIROL, V81, P13771, DOI 10.1128/JVI.01313-07
   Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008
   Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024
   Gabay C, 1999, EUR J HAEMATOL, V63, P180
   Ganem D., 2007, FIELDS VIROLOGY, V5th, P2847
   Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992
   Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10
   Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534
   Kedes DH, 1997, J CLIN INVEST, V99, P2082, DOI 10.1172/JCI119380
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Koopal S, 2007, PLOS PATHOG, V3, P1348, DOI 10.1371/journal.ppat.0030140
   KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415
   Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910
   Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873
   Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104
   Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888
   Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025
   Moore PS, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P540
   Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786
   Okamura K, 2008, CELL CYCLE, V7, P2840, DOI 10.4161/cc.7.18.6734
   Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Pfeffer S, 2008, FUTURE VIROL, V3, P291, DOI 10.2217/17460794.3.3.291
   Pfeffer S, 2007, METHOD ENZYMOL, V427, P51, DOI 10.1016/S0076-6879(07)27003-X
   Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007
   Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153
   Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889
   Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005
   Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065
   SEGALBENDIRDJIAN E, 1995, EXP CELL RES, V218, P201, DOI 10.1006/excr.1995.1148
   Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010
   Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07
   Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243
   Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956
   Sun Y, 2005, BLOOD, V105, P4070, DOI 10.1182/blood-2004-10-4075
   Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299
   Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049
   Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105
   Wang HM, 2004, J ADV MATER-COVINA, V36, P36
   Wang L, 2008, CANCER RES, V68, P4640, DOI 10.1158/0008-5472.CAN-07-5988
   Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002
   Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266
NR 64
TC 74
Z9 82
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD DEC
PY 2011
VL 7
IS 12
AR e1002405
DI 10.1371/journal.ppat.1002405
PG 18
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 876LH
UT WOS:000299108500018
PM 22174674
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Herwig, L
   Blum, Y
   Krudewig, A
   Ellertsdottir, E
   Lenard, A
   Belting, HG
   Affolter, M
AF Herwig, Lukas
   Blum, Yannick
   Krudewig, Alice
   Ellertsdottir, Elin
   Lenard, Anna
   Belting, Heinz-Georg
   Affolter, Markus
TI Distinct Cellular Mechanisms of Blood Vessel Fusion in the Zebrafish
   Embryo
SO CURRENT BIOLOGY
LA English
DT Article
ID DROSOPHILA TRACHEA; LUMEN FORMATION; MORPHOGENESIS; GTPASE
AB Although many of the cellular and molecular mechanisms of angiogenesis have been intensely studied [1], little is known about the processes that underlie vascular anastomosis. We have generated transgenic fish lines expressing an EGFP-tagged version of the junctional protein zona occludens 1 (ZO1) to visualize individual cell behaviors that occur during vessel fusion and lumen formation in vivo. These life observations show that endothelial cells (ECs) use two distinct morphogenetic mechanisms, cell membrane invagination and cord hollowing to generate different types of vascular tubes. During initial steps of anastomosis, cell junctions that have formed at the initial site of cell contacts expand into rings, generating a cellular interface of apical membrane compartments, as defined by the localization of the apical marker podocalyxin-2 (Pdxl2). During the cord hollowing process, these apical membrane compartments are brought together via cell rearrangements and extensive junctional remodeling, resulting in lumen coalescence and formation of a multicellular tube. Vessel fusion by membrane invagination occurs adjacent to a preexisting lumen in a proximal to distal direction and is blood-flow dependent. Here, the invaginating inner cell membrane undergoes concomitant apicobasal polarization and the vascular lumen is formed by the extension of a transcellular lumen through the EC, which forms a unicellular or seamless tube.
C1 [Herwig, Lukas; Blum, Yannick; Krudewig, Alice; Ellertsdottir, Elin; Lenard, Anna; Belting, Heinz-Georg; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Belting, HG (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM heinz-georg.belting@unibas.ch; markus.affolter@unibas.ch
OI Belting, Heinz-Georg/0000-0002-1538-4364; Affolter,
   Markus/0000-0002-5171-0016
FU Werner-Siemens-Foundation (Zug); Kantons Basel-Stadt and Basel-Land;
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX We thank Holger Gerhardt for continuous and valuable discussions, Koichi
   Kawakami for providing tol2-plasmids and Tg(UAS:RFP) fish, Chi-Bin Chien
   for providing pDestTol2CG2, Reinhard Koster for providing UAS-plasmids,
   Kumuthini Kulendra for fish care, and members of the Affolter group for
   critically reading the manuscript. A.K. and A.L. are supported by a
   fellowship from the Werner-Siemens-Foundation (Zug). This work has been
   supported by the Kantons Basel-Stadt and Basel-Land and by a grant from
   the Swiss National Science Foundation to M.A.
CR Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Dong B, 2009, DEV BIOL, V330, P237, DOI 10.1016/j.ydbio.2009.03.015
   Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176
   Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733
   Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Lee S, 2002, DEVELOPMENT, V129, P1509
   Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001
   Munson C, 2008, DEV BIOL, V324, P41, DOI 10.1016/j.ydbio.2008.08.033
   Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875
   Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4
   Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011
   TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697
   Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722
NR 17
TC 130
Z9 132
U1 0
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD NOV 22
PY 2011
VL 21
IS 22
BP 1942
EP 1948
DI 10.1016/j.cub.2011.10.016
PG 7
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 852XY
UT WOS:000297392000027
PM 22079115
DA 2021-01-25
ER

PT J
AU Geier, F
   Fengos, G
   Iber, D
AF Geier, Florian
   Fengos, Georgios
   Iber, Dagmar
TI A Computational Analysis of the Dynamic Roles of Talin, Dok1, and PIPKI
   for Integrin Activation
SO PLOS ONE
LA English
DT Article
ID PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; STRUCTURAL BASIS; AFFINITY
   MODULATION; BINDING; PHOSPHORYLATION; LOCALIZATION; ADHESION; SYSTEMS;
   MUSCLE; DOMAIN
AB Integrin signaling regulates cell migration and plays a pivotal role in developmental processes and cancer metastasis. Integrin signaling has been studied extensively and much data is available on pathway components and interactions. Yet the data is fragmented and an integrated model is missing. We use a rule-based modeling approach to integrate available data and test biological hypotheses regarding the role of talin, Dok1 and PIPKI in integrin activation. The detailed biochemical characterization of integrin signaling provides us with measured values for most of the kinetics parameters. However, measurements are not fully accurate and the cellular concentrations of signaling proteins are largely unknown and expected to vary substantially across different cellular conditions. By sampling model behaviors over the physiologically realistic parameter range we find that the model exhibits only two different qualitative behaviors and these depend mainly on the relative protein concentrations, which offers a powerful point of control to the cell. Our study highlights the necessity to characterize model behavior not for a single parameter optimum, but to identify parameter sets that characterize different signaling modes.
C1 [Geier, Florian; Fengos, Georgios; Iber, Dagmar] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn D BSSE, Basel, Switzerland.
RP Geier, F (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM dagmar.iber@bsse.ethz.ch
RI Iber, Dagmar/V-2846-2019
OI Iber, Dagmar/0000-0001-8051-1035
FU SystemsX.ch, the Swiss Initiative for Systems Biology;  [51RT-0-126008
   (InfectX)]
FX The project was financially supported by grants 51RT-0-126008 (InfectX)
   and an iPhD grant from SystemsX.ch, the Swiss Initiative for Systems
   Biology (www.systemsx.ch). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AKIYAMA SK, 1985, J BIOL CHEM, V260, P3256
   Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200
   Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100
   Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217
   Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229
   Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200
   Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200
   Campbell ID, 2008, BIOCHEM SOC T, V36, P263, DOI 10.1042/BST0360263
   de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200
   Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5
   FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155
   Geier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024808
   Giudici ML, 2006, FEBS LETT, V580, P6933, DOI 10.1016/j.febslet.2006.11.052
   Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011
   GOLDMANN WH, 1995, FEBS LETT, V368, P516, DOI 10.1016/0014-5793(95)00678-3
   Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189
   Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200
   Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014
   Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143
   Iber D, 2006, B MATH BIOL, V68, P945, DOI 10.1007/s11538-005-9049-5
   Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330
   Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067
   Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082
   Ling Y, 2005, J BIOL CHEM, V280, P3151, DOI 10.1074/jbc.M411035200
   Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200
   Melke P, 2006, BIOPHYS J, V91, P4368, DOI [10.1529/biophysj.105.080408, 10.1529/biophysj.106.080408]
   Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865
   Nag A, 2010, J IMMUNOL, V185, P3268, DOI 10.4049/jimmunol.1000326
   NEFF NT, 1982, J CELL BIOL, V95, P654, DOI 10.1083/jcb.95.2.654
   Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200
   Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609
   PAOLO GD, 2002, NATURE, V420, P85
   Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9
   Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171
   SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0
   Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012
   Suehiro K, 2000, J BIOCHEM, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804
   Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652
   Vitte J, 2004, BIOPHYS J, V86, P4059, DOI 10.1529/biophysj.103.038778
   Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048
   Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416
   Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200
   Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765
NR 43
TC 15
Z9 16
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 16
PY 2011
VL 6
IS 11
AR e24808
DI 10.1371/journal.pone.0024808
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 855HV
UT WOS:000297555400003
PM 22110576
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Kouki, A
   Haataja, S
   Loimaranta, V
   Pulliainen, AT
   Nilsson, UJ
   Finne, J
AF Kouki, Annika
   Haataja, Sauli
   Loimaranta, Vuokko
   Pulliainen, Arto T.
   Nilsson, Ulf J.
   Finne, Jukka
TI Identification of a Novel Streptococcal Adhesin P (SadP) Protein
   Recognizing Galactosyl-alpha 1-4-galactose-containing Glycoconjugates
   CONVERGENT EVOLUTION OF BACTERIAL PATHOGENS TO BINDING OF THE SAME HOST
   RECEPTOR
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SITE-DIRECTED MUTAGENESIS; SUIS SEROTYPE-2; GLYCOLIPID BINDING;
   ENDOTHELIAL-CELLS; STRUCTURAL BASIS; H2O2 RESISTANCE; SURFACE PROTEIN;
   GORDONII DL1; SIALIC-ACID; E. COLI
AB Bacterial adhesion is often a prerequisite for infection, and host cell surface carbohydrates play a major role as adhesion receptors. Streptococci are a leading cause of infectious diseases. However, only few carbohydrate-specific streptococcal adhesins are known. Streptococcus suis is an important pig pathogen and a zoonotic agent causing meningitis in pigs and humans. In this study, we have identified an adhesin that mediates the binding of S. suis to galactosyl-alpha 1-4-galactose (Gal alpha 1-4Gal)-containing host receptors. A functionally unknown S. suis cell wall protein (SSU0253), designated here as SadP (streptococcal adhesin P), was identified using a Gal alpha 1-4Gal-containing affinity matrix and LC-ESI mass spectrometry. Although the function of the protein was not previously known, it was recently identified as an immunogenic cell wall protein in a proteomic study. Insertional inactivation of the sadP gene abolished S. suis Gal alpha 1-4Gal-dependent binding. The adhesin gene sadP was cloned and expressed in Escherichia coli. Characterization of its binding specificity showed that SadP recognizes Gal alpha 1-4Gal-oligosaccharides and binds its natural glycolipid receptor, GbO(3) (CD77). The N terminus of SadP was shown to contain a Gal alpha 1-Gal-binding site and not to have apparent sequence similarity to other bacterial adhesins, including the E. coli P fimbrial adhesins, or to E. coli verotoxin or Pseudomonas aeruginosa lectin I also recognizing the same Gal alpha 1-4Gal disaccharide. The SadP and E. coli P adhesins represent a unique example of convergent evolution toward binding to the same host receptor structure.
C1 [Kouki, Annika; Haataja, Sauli; Loimaranta, Vuokko; Pulliainen, Arto T.] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland.
   [Finne, Jukka] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FI-00014 Helsinki, Finland.
   [Pulliainen, Arto T.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Nilsson, Ulf J.] Lund Univ, SE-22100 Lund, Sweden.
RP Haataja, S (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FI-20520 Turku, Finland.
EM sauli.haataja@utu.fi
RI Finne, Jukka/B-6881-2008; Haataja, Sauli/AAR-5103-2020; Nilsson, Ulf
   J./L-3219-2014
OI Finne, Jukka/0000-0002-8076-3344; Nilsson, Ulf J./0000-0001-5815-9522;
   Pulliainen, Arto Tapio/0000-0002-9361-8963
FU Finnish AcademyAcademy of Finland [114100]; Turku University Foundation;
   Duodecim Society of Turunmaa; Finnish Graduate School of Glycosciences
FX This study was supported by Finnish Academy Grant 114100, the Turku
   University Foundation, the Duodecim Society of Turunmaa and the Finnish
   Graduate School of Glycosciences.
CR Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200
   Berthelot-Herault F, 2005, CAN J VET RES, V69, P236
   Berthelot-Herault F, 2001, CAN J VET RES, V65, P196
   Blanchard B, 2008, J MOL BIOL, V383, P837, DOI 10.1016/j.jmb.2008.08.028
   BOYD B, 1993, J EXP MED, V177, P1745, DOI 10.1084/jem.177.6.1745
   Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325
   Chen B, 2010, FEMS MICROBIOL LETT, V307, P12, DOI 10.1111/j.1574-6968.2010.01944.x
   Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315
   de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002
   Devenica D., 2010, MED ONCOL IN PRESS
   Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9
   Duensing TD, 1999, INFECT IMMUN, V67, P4463, DOI 10.1128/IAI.67.9.4463-4468.1999
   Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003
   Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x
   FRANCOISGERARD C, 1979, BIOCHEM J, V177, P679, DOI 10.1042/bj1770679
   Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x
   Gu HW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-201
   HAATAJA S, 1993, J BIOL CHEM, V268, P4311
   HAATAJA S, 1994, J BIOL CHEM, V269, P27466
   Hansen HC, 1997, J AM CHEM SOC, V119, P6974, DOI 10.1021/ja970859p
   HIGGINS R, 2005, DIS SWINE, P769
   Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005
   Joosten JAF, 2004, J MED CHEM, V47, P6499, DOI 10.1021/jm049476+
   KARLSSON KA, 1986, CHEM PHYS LIPIDS, V42, P153, DOI 10.1016/0009-3084(86)90050-2
   Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102
   KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157
   KURL DN, 1989, INFECT IMMUN, V57, P384, DOI 10.1128/IAI.57.2.384-389.1989
   Li W, 2010, INT J MED MICROBIOL, V300, P482, DOI 10.1016/j.ijmm.2010.04.018
   LINDBERG AA, 1987, J BIOL CHEM, V262, P1779
   Lingwood CA, 2010, FEBS LETT, V584, P1879, DOI 10.1016/j.febslet.2009.11.089
   LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834
   LIUKKONEN J, 1992, J BIOL CHEM, V267, P21105
   Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005
   Mandanici F, 2010, J PROTEOMICS, V73, P2365, DOI 10.1016/j.jprot.2010.07.009
   Moschioni M, 2010, INFECT IMMUN, V78, P5033, DOI 10.1128/IAI.00601-10
   Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135
   Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385
   Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09
   Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1
   Ohlsson J, 2005, ORG BIOMOL CHEM, V3, P886, DOI 10.1039/b416878j
   Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002
   Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09
   Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012
   Pulliainen AT, 2008, J BACTERIOL, V190, P3225, DOI 10.1128/JB.01843-07
   Pulliainen AT, 2005, MOL MICROBIOL, V57, P1086, DOI 10.1111/j.1365-2958.2005.04756.x
   Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200
   SCHMIDT KH, 1993, ZBL BAKT-INT J MED M, V279, P472, DOI 10.1016/S0934-8840(11)80419-6
   Schweppe CH, 2008, GLYCOCONJUGATE J, V25, P291, DOI 10.1007/s10719-007-9091-7
   Sharon N, 2000, GLYCOCONJUGATE J, V17, P659, DOI 10.1023/A:1011091029973
   Sikora S, 2005, TRENDS MICROBIOL, V13, P522, DOI 10.1016/j.tim.2005.08.010
   Smith HE, 1999, INFECT IMMUN, V67, P1750
   STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x
   STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340
   Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200
   Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006
   Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013
   Tan C, 2008, FEMS MICROBIOL LETT, V278, P108, DOI 10.1111/j.1574-6968.2007.00980.x
   TIKKANEN K, 1995, J BIOL CHEM, V270, P28874, DOI 10.1074/jbc.270.48.28874
   TYRRELL GJ, 1992, P NATL ACAD SCI USA, V89, P524, DOI 10.1073/pnas.89.2.524
   Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386
   Urano-Tashiro Y, 2008, INFECT IMMUN, V76, P4686, DOI 10.1128/IAI.00238-08
   Vanier G, 2008, VET MICROBIOL, V127, P417, DOI 10.1016/j.vetmic.2007.08.032
   Wilson TL, 2007, VET MICROBIOL, V122, P135, DOI 10.1016/j.vetmic.2006.12.025
   WINTERS BD, 1993, INFECT IMMUN, V61, P3259, DOI 10.1128/IAI.61.8.3259-3264.1993
   Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x
   Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370
   Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194
   Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007
NR 68
TC 29
Z9 31
U1 0
U2 11
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 11
PY 2011
VL 286
IS 45
BP 38854
EP 38864
DI 10.1074/jbc.M111.260992
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 844PO
UT WOS:000296759800004
PM 21908601
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Radpour, R
   Barekati, Z
   Kohler, C
   Schumacher, MM
   Grussenmeyer, T
   Jenoe, P
   Hartmann, N
   Moes, S
   Letzkus, M
   Bitzer, J
   Lefkovits, I
   Staedtler, F
   Zhong, XY
AF Radpour, Ramin
   Barekati, Zeinab
   Kohler, Corina
   Schumacher, Martin M.
   Grussenmeyer, Thomas
   Jenoe, Paul
   Hartmann, Nicole
   Moes, Suzette
   Letzkus, Martin
   Bitzer, Johannes
   Lefkovits, Ivan
   Staedtler, Frank
   Zhong, Xiao Yan
TI Integrated Epigenetics of Human Breast Cancer: Synoptic Investigation of
   Targeted Genes, MicroRNAs and Proteins upon Demethylation Treatment
SO PLOS ONE
LA English
DT Article
ID DNA METHYLATION; TUMOR-SUPPRESSOR; MYELODYSPLASTIC SYNDROMES;
   POOR-PROGNOSIS; LUNG-CANCER; CELL-LINES; PHASE-III; IN-VIVO; EXPRESSION;
   METASTASIS
AB Background: The contribution of aberrant DNA methylation in silencing of tumor suppressor genes (TSGs) and microRNAs has been investigated. Since these epigenetic alterations are reversible, it became of interest to determine the effects of the 5-aza-2'-deoxycytidine (DAC) demethylation therapy in breast cancer at different molecular levels.
   Methods and Findings: Here we investigate a synoptic model to predict complete DAC treatment effects at the level of genes, microRNAs and proteins for several human breast cancer lines. The present study assessed an effective treatment dosage based on the cell viability, cytotoxicity, apoptosis and methylation assays for the investigated cell lines. A highly aggressive and a non-aggressive cell line were investigated using omics approaches such as MALDI-TOF MS, mRNA- and microRNA expression arrays, 2-D gel electrophoresis and LC-MS-MS. Complete molecular profiles including the biological interaction and possible early and late systematic stable or transient effects of the methylation inhibition were determined. Beside the activation of several epigenetically suppressed TSGs, we also showed significant dysregulation of some important oncogenes, oncomiRs and oncosuppressors miRNAs as well as drug tolerance genes/miRNAs/proteins.
   Conclusions: In the present study, the results denote some new molecular DAC targets and pathways based on the chemical modification of DNA methylation in breast cancer. The outlined approach might prove to be useful as an epigenetic treatment model also for other human solid tumors in the management of cancer patients.
C1 [Radpour, Ramin; Barekati, Zeinab; Kohler, Corina; Zhong, Xiao Yan] Univ Basel, Lab Gynecol Oncol, Womens Hosp, Dept Biomed, Basel, Switzerland.
   [Schumacher, Martin M.; Hartmann, Nicole; Letzkus, Martin; Staedtler, Frank] Novartis Pharma AG, Biomarker Dev, Novartis Inst BioMed Res, Basel, Switzerland.
   [Grussenmeyer, Thomas; Lefkovits, Ivan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Grussenmeyer, Thomas; Lefkovits, Ivan] Univ Basel Hosp, Dept Cardiac Surg, CH-4031 Basel, Switzerland.
   [Jenoe, Paul; Moes, Suzette] Univ Basel, Biozentrum, Basel, Switzerland.
   [Bitzer, Johannes] Univ Basel, Dept Obstet & Gynecol, Womens Hosp, Basel, Switzerland.
RP Radpour, R (corresponding author), Univ Basel, Lab Gynecol Oncol, Womens Hosp, Dept Biomed, Basel, Switzerland.
EM ivan.lefkovits@unibas.ch; frank.staedtler@novartis.com; zhongx@uhbs.ch
RI Radpour, Ramin/J-4949-2014; Lefkovits, Ivan/B-9777-2009
OI Radpour, Ramin/0000-0002-5632-7833; Lefkovits, Ivan/0000-0003-1783-8881
FU Swiss National Science Foundation Basel, Switzerland [320000-119722/1,
   320030_124958/1]
FX This work was supported in part by Swiss National Science Foundation
   (320000-119722/1 and 320030_124958/1) Basel, Switzerland. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bachmeier BE, 2008, CARCINOGENESIS, V29, P779, DOI 10.1093/carcin/bgm248
   Barekati Z, 2010, HUM MOL GENET, V19, P2936, DOI 10.1093/hmg/ddq199
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   Burfeind P, 1996, P NATL ACAD SCI USA, V93, P7263, DOI 10.1073/pnas.93.14.7263
   Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137
   CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870
   Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840
   Fabbri M, 2007, EXPERT OPIN BIOL TH, V7, P1009, DOI 10.1517/14712598.7.7.1009
   Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104
   Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8
   Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004
   Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200
   Fujita T, 2006, CYTOKINE, V34, P271, DOI 10.1016/j.cyto.2006.06.002
   Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104
   Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781
   Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999
   Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783
   Issa Jean-Pierre, 2003, Current Opinion in Oncology, V15, P446, DOI 10.1097/00001622-200311000-00007
   Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640
   Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792
   Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806
   Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045
   Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864
   Li JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-354
   Li Min, 2005, Archives of Gynecology and Obstetrics, V272, P48, DOI 10.1007/s00404-004-0708-9
   Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022
   LittlewoodEvans AJ, 1997, CANCER RES, V57, P5386
   Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72
   Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218
   Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18
   Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174
   Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200
   Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416
   Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544
   Moggs JG, 2004, TOXICOL APPL PHARM, V196, P422, DOI 10.1016/j.taap.2004.01.009
   Momparler RL, 2005, SEMIN ONCOL, V32, P443, DOI 10.1053/j.seminoncol.2005.07.008
   Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016
   MUSGROVE EA, 1995, INT J CANCER, V63, P584, DOI 10.1002/ijc.2910630420
   Plante I., 2010, ONCOGENE
   POLLACK MS, 1981, J NATL CANCER I, V66, P1003, DOI 10.1093/jnci/66.6.1003
   Radpour R, 2009, ONCOGENE, V28, P2969, DOI 10.1038/onc.2009.149
   Radpour R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016080
   Radpour R, 2009, J PROTEOME RES, V8, P5264, DOI 10.1021/pr900591w
   Radpour R, 2009, GENET TEST MOL BIOMA, V13, P565, DOI 10.1089/gtmb.2009.0060
   Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070
   Rivenbark AG, 2007, EXP MOL PATHOL, V83, P188, DOI 10.1016/j.yexmp.2007.03.008
   Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1
   Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446
   Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709
   Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237
   Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200
   Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665
   Simstein R, 2003, EXP BIOL MED, V228, P995
   SMITH HS, 1979, J NATL CANCER I, V62, P225
   Subramaniam Deepa S, 2005, Curr Treat Options Oncol, V6, P147, DOI 10.1007/s11864-005-0022-1
   Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341
   Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329
   Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403
   Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675
   Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396
   Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808
   Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930
   Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973
   Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24
NR 70
TC 35
Z9 36
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 4
PY 2011
VL 6
IS 11
AR e27355
DI 10.1371/journal.pone.0027355
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 850MH
UT WOS:000297198200068
PM 22076154
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Tripodi, M
   Stepien, AE
   Arber, S
AF Tripodi, Marco
   Stepien, Anna E.
   Arber, Silvia
TI Motor antagonism exposed by spatial segregation and timing of
   neurogenesis
SO NATURE
LA English
DT Article
ID FUNCTIONALLY COMPLEX MUSCLES; SPINAL-CORD; MODULAR ORGANIZATION;
   FLUORESCENT PROTEIN; LOCOMOTOR-ACTIVITY; GENE-EXPRESSION; CAT HINDLIMB;
   NEURONS; PATTERN; MOTONEURONS
AB Walking is a key motor behaviour of limbed animals, executed by contraction of functionally antagonistic muscle groups during swing and stance phases. Nevertheless, neuronal circuits regulating the activation of antagonistic extensor-flexor muscles remain poorly understood. Here we use monosynaptically restricted trans-synaptic viruses to elucidate premotor anatomical substrates for extensor-flexor control in mice. We observe a medio-lateral spatial segregation between extensor and flexor premotor interneurons in the dorsal spinal cord. These premotor interneuron populations are derived from common progenitor domains, but segregate by timing of neurogenesis. We find that proprioceptive sensory feedback from the periphery is targeted to medial extensor premotor populations and is required for extensor-specific connectivity profiles during development. Our findings provide evidence for a discriminating anatomical basis of antagonistic circuits at the level of premotor interneurons, and point to synaptic input and developmental ontogeny as key factors in the establishment of circuits regulating motor behavioural dichotomy.
C1 [Tripodi, Marco; Stepien, Anna E.; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Tripodi, Marco; Stepien, Anna E.; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X; Tripodi, Marco/0000-0002-6827-6690
FU EMBO long-term fellowshipEuropean Molecular Biology Organization (EMBO);
   ERC Advanced Grant; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); Kanton Basel-Stadt; EU Framework Program 7;
   Novartis Research Foundation
FX We are grateful to M. Sigrist for the generation of
   Tau<SUP>lox-stop-lox-SynGFP</SUP> mice, M. Mielich for help in the
   production of viruses, P. Schwarb, L. Gelman, A. Ponti and M. Stadler
   for help and advice with image acquisition and statistical analysis, and
   to P. Caroni, G. Courtine, T. Jessell, B. Roska and P. Scheiffele for
   discussions and comments on the manuscript. We thank E. Callaway and K.
   Conzelmann for advice on virus work, and C. Birchmeier for
   Lbx1<SUP>cre</SUP> mice and Tlx3 antibodies. M. T. was supported by an
   EMBO long-term fellowship, M. T., A. E. S. and S. A. by an ERC Advanced
   Grant, the Swiss National Science Foundation, the Kanton Basel-Stadt, EU
   Framework Program 7 and the Novartis Research Foundation.
CR Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006
   Angel MJ, 2005, J PHYSIOL-LONDON, V563, P597, DOI 10.1113/jphysiol.2004.076034
   Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   BAEV K V, 1979, Neirofiziologiya, V11, P329
   Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004
   Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077
   Carrier L, 1997, J NEUROPHYSIOL, V77, P1979
   CHANAUD CM, 1991, EXP BRAIN RES, V85, P271, DOI 10.1007/BF00229406
   Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006
   Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221
   CONWAY BA, 1987, EXP BRAIN RES, V68, P643
   de Leon RD, 1999, J NEUROPHYSIOL, V82, P359
   Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768
   ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794
   ECCLES RM, 1958, J PHYSIOL-LONDON, V144, P271, DOI 10.1113/jphysiol.1958.sp006101
   Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106
   Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608
   Greene E.C., 1935, ANATOMY RAT
   GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313
   Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008
   Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6
   Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2
   Hiebert GW, 1999, J NEUROPHYSIOL, V81, P758
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P613, DOI 10.1113/jphysiol.1971.sp009488
   Imamura F, 2011, NAT NEUROSCI, V14, P331, DOI 10.1038/nn.2754
   Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2
   JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9
   JONES CL, 1979, J MORPHOL, V162, P275, DOI 10.1002/jmor.1051620207
   Kaneko K, 2008, NEUROSCIENCE, V157, P781, DOI 10.1016/j.neuroscience.2008.09.029
   Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004
   Kjaerulff O, 1996, J NEUROSCI, V16, P5777
   LLOYD DPC, 1946, J NEUROPHYSIOL, V9, P439
   Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003
   Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001
   McCrea DA, 1998, ANN NY ACAD SCI, V860, P216, DOI 10.1111/j.1749-6632.1998.tb09051.x
   McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006
   MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082
   McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588
   Mears SC, 1997, J NEUROSCI, V17, P3128
   Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105
   Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X
   NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1
   Pearson KG, 1998, ANN NY ACAD SCI, V860, P203, DOI 10.1111/j.1749-6632.1998.tb09050.x
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   PRATT CA, 1991, EXP BRAIN RES, V85, P281, DOI 10.1007/BF00229407
   Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005
   Schouenborg J, 2002, BRAIN RES REV, V40, P80, DOI 10.1016/S0165-0173(02)00191-1
   Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28
   Sieber MA, 2007, J NEUROSCI, V27, P4902, DOI 10.1523/JNEUROSCI.0717-07.2007
   Stein PSG, 2008, BRAIN RES REV, V57, P118, DOI 10.1016/j.brainresrev.2007.07.008
   Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019
   Stuart DG, 2008, BRAIN RES REV, V59, P74, DOI 10.1016/j.brainresrev.2008.06.001
   TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wang Z, 2008, J NEUROPHYSIOL, V100, P185, DOI 10.1152/jn.90354.2008
   Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033
   Wilson JM, 2010, J NEUROSCI, V30, P1137, DOI 10.1523/JNEUROSCI.1401-09.2010
   Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010
   Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
   Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349
   Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012
NR 63
TC 102
Z9 102
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD NOV 3
PY 2011
VL 479
IS 7371
BP 61
EP U84
DI 10.1038/nature10538
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 840FA
UT WOS:000296422600032
PM 22012263
DA 2021-01-25
ER

PT J
AU Glatter, T
   Schittenhelm, RB
   Rinner, O
   Roguska, K
   Wepf, A
   Junger, MA
   Kohler, K
   Jevtov, I
   Choi, H
   Schmidt, A
   Nesvizhskii, AI
   Stocker, H
   Hafen, E
   Aebersold, R
   Gstaiger, M
AF Glatter, Timo
   Schittenhelm, Ralf B.
   Rinner, Oliver
   Roguska, Katarzyna
   Wepf, Alexander
   Juenger, Martin A.
   Koehler, Katja
   Jevtov, Irena
   Choi, Hyungwon
   Schmidt, Alexander
   Nesvizhskii, Alexey I.
   Stocker, Hugo
   Hafen, Ernst
   Aebersold, Ruedi
   Gstaiger, Matthias
TI Modularity and hormone sensitivity of the Drosophila melanogaster
   insulin receptor/target of rapamycin interaction proteome
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE cell growth; InR/TOR pathway; interaction proteome; quantitative mass
   spectrometry; signaling
ID INTERACTION NETWORK; STATISTICAL-MODEL; MAMMALIAN TARGET; INTERACTION
   MAP; CELL-GROWTH; MTOR; COMPLEX; ORGANIZATION; PROTEINS; TEL2
AB Genetic analysis in Drosophila melanogaster has been widely used to identify a system of genes that control cell growth in response to insulin and nutrients. Many of these genes encode components of the insulin receptor/target of rapamycin (InR/TOR) pathway. However, the biochemical context of this regulatory system is still poorly characterized in Drosophila. Here, we present the first quantitative study that systematically characterizes the modularity and hormone sensitivity of the interaction proteome underlying growth control by the dInR/TOR pathway. Applying quantitative affinity purification and mass spectrometry, we identified 97 high confidence protein interactions among 58 network components. In all, 22% of the detected interactions were regulated by insulin affecting membrane proximal as well as intracellular signaling complexes. Systematic functional analysis linked a subset of network components to the control of dTORC1 and dTORC2 activity. Furthermore, our data suggest the presence of three distinct dTOR kinase complexes, including the evolutionary conserved dTTT complex (Drosophila TOR, TELO2, TTI1). Subsequent genetic studies in flies suggest a role for dTTT in controlling cell growth via a dTORC1- and dTORC2-dependent mechanism. Molecular Systems Biology 7: 547; published online 8 November 2011; doi:10.1038/msb.2011.79
C1 [Glatter, Timo; Schittenhelm, Ralf B.; Rinner, Oliver; Roguska, Katarzyna; Wepf, Alexander; Juenger, Martin A.; Koehler, Katja; Jevtov, Irena; Stocker, Hugo; Hafen, Ernst; Aebersold, Ruedi; Gstaiger, Matthias] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Glatter, Timo; Wepf, Alexander; Jevtov, Irena; Stocker, Hugo; Hafen, Ernst; Aebersold, Ruedi; Gstaiger, Matthias] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland.
   [Glatter, Timo; Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, Basel, Switzerland.
   [Jevtov, Irena] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Choi, Hyungwon; Nesvizhskii, Alexey I.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland.
RP Gstaiger, M (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.
EM gstaiger@imsb.biol.ethz.ch
RI Stoecker, Horst/F-8382-2012; Nesvizhskii, Alexey/A-5410-2012; Choi,
   Hyungwon/S-8824-2019
OI Stoecker, Horst/0000-0002-3282-3664; Nesvizhskii,
   Alexey/0000-0002-2806-7819; Choi, Hyungwon/0000-0002-6687-3088; Glatter,
   Timo/0000-0001-8716-8516; Roguska, Katarzyna/0000-0002-3509-4073;
   Schittenhelm, Ralf/0000-0001-8738-1878
FU ETH ZurichETH Zurich; Roche Research Foundation; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG); SystemsX.ch
   (WingX); Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); F Hoffmann-La Roche Ltd (Basel,
   Switzerland)Hoffmann-La Roche; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM094231, R01GM094231, R01GM094231,
   R01GM094231, R01GM094231, R01GM094231, R01GM094231, R01GM094231,
   R01GM094231, R01GM094231] Funding Source: NIH RePORTER
FX TG was supported by a TH grant of the ETH Zurich and a fellowship from
   the Roche Research Foundation. OR was supported by fellowships of the
   Deutsche Forschungsgemeinschaft and the Roche Research Foundation. This
   work was supported by grants from SystemsX.ch (WingX), the Swiss
   National Science Foundation and by grants from F Hoffmann-La Roche Ltd
   (Basel, Switzerland) provided to the Competence Center for Systems
   Physiology and Metabolic Disease (AW and AS).
CR Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878
   Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020
   Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723
   Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495
   Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059
   Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239
   Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541
   Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104
   Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09
   Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289
   Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401
   Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084
   Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x
   Hazelett DJ, 1998, DEVELOPMENT, V125, P3741
   Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037
   Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670
   Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343
   Lee JH, 2009, DEV BIOL, V331, P1, DOI 10.1016/j.ydbio.2009.03.029
   Lores P, 2010, FEBS J, V277, P1453, DOI 10.1111/j.1742-4658.2010.07575.x
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888
   Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848
   Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003
   Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Newsome TP, 2000, DEVELOPMENT, V127, P851
   Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700
   Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200
   Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40
   Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289
   Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747
   Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200
   Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200
   Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96
   Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029
   Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995
   Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200
   Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052
   Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410
   van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053
   Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547
   Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   XU T, 1993, DEVELOPMENT, V117, P1223
   Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017
   Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 58
TC 46
Z9 46
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD NOV
PY 2011
VL 7
AR 547
DI 10.1038/msb.2011.79
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 857AK
UT WOS:000297685900003
PM 22068330
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Truttmann, MC
   Misselwitz, B
   Huser, S
   Hardt, WD
   Critchley, DR
   Dehio, C
AF Truttmann, Matthias C.
   Misselwitz, Benjamin
   Huser, Sonja
   Hardt, Wolf-Dietrich
   Critchley, David R.
   Dehio, Christoph
TI Bartonella henselae engages inside-out and outside-in signaling by
   integrin beta 1 and talin1 during invasome-mediated bacterial uptake
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Bartonella henselae; Type IV secretion system; Integrins; Invasome
   formation; Talins
ID FOCAL ADHESION KINASE; IV SECRETION SYSTEM; ENDOTHELIAL-CELLS;
   STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; STRUCTURAL BASIS; PROTEIN;
   ACTIVATION; INFECTION; BINDING
AB The VirB/D4 type IV secretion system (T4SS) of the bacterial pathogen Bartonella henselae (Bhe) translocates seven effector proteins (BepA-BepG) into human cells that subvert host cellular functions. Two redundant pathways dependent on BepG or the combination of BepC and BepF trigger the formation of a bacterial uptake structure termed the invasome. Invasome formation is a multi-step process consisting of bacterial adherence, effector translocation, aggregation of bacteria on the cell surface and engulfment, and eventually, complete internalization of the bacterial aggregate occurs in an F-actin-dependent manner. In the present study, we show that Bhe-triggered invasome formation depends on integrin-beta 1-mediated signaling cascades that enable assembly of the F-actin invasome structure. We demonstrate that Bhe interacts with integrin beta 1 in a fibronectin- and VirB/D4 T4SS-independent manner and that activated integrin beta 1 is essential for both effector translocation and the actin rearrangements leading to invasome formation. Furthermore, we show that talin1, but not talin2, is required for inside-out activation of integrin beta 1 during invasome formation. Finally, integrin-beta 1-mediated outside-in signaling by FAK, Src, paxillin and vinculin is necessary for invasome formation. This is the first example of a bacterial entry process that fully exploits the bi-directional signaling capacity of integrin receptors in a talin1-specific manner.
C1 [Truttmann, Matthias C.; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
   [Misselwitz, Benjamin; Hardt, Wolf-Dietrich] Swiss Fed Inst Technol Zurich, Inst Microbiol, CH-8093 Zurich, Switzerland.
   [Huser, Sonja] Univ Basel, Biozentrum, Focal Area Growth & Dev, CH-4056 Basel, Switzerland.
   [Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Misselwitz, Benjamin/L-7193-2016; Dehio,
   Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Misselwitz,
   Benjamin/0000-0002-8719-5175; Dehio, Christoph/0000-0001-7288-1052;
   Hardt, Wolf-Dietrich/0000-0002-9892-6420
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-1329790]; SystemsX.ch, the Swiss Initiative for Systems
   Biology [51RT-0_126008 (InfectX)]
FX This work was supported by the Swiss National Science Foundation [grant
   number 31003A-1329790] and SystemsX.ch, the Swiss Initiative for Systems
   Biology [grant number 51RT-0_126008 (InfectX)].
CR Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328
   Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200
   Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287
   Armulik A, 2000, EXP CELL RES, V254, P55, DOI 10.1006/excr.1999.4722
   Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556
   BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557
   Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770
   Cantarelli VV, 2001, CELL MICROBIOL, V3, P745, DOI 10.1046/j.1462-5822.2001.00156.x
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017
   Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744
   Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044
   Debrand E, 2009, FEBS J, V276, P1610, DOI 10.1111/j.1742-4658.2009.06893.x
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 1997, J CELL SCI, V110, P2141
   DeMali KA, 2006, J BIOL CHEM, V281, P39534, DOI 10.1074/jbc.M605939200
   Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979
   Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897
   Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175
   Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965
   Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868
   Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446
   Isberg RR, 2001, J CELL SCI, V114, P21
   ISHIBASHI Y, 1994, J EXP MED, V180, P1225, DOI 10.1084/jem.180.4.1225
   Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684
   Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003
   Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lim YM, 2004, J BIOL CHEM, V279, P29060, DOI 10.1074/jbc.M401183200
   Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618
   Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005
   Misselwitz B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-30
   Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365
   NHIEU GTV, 1991, J BIOL CHEM, V266, P24367
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Riess T, 2007, INFECT IMMUN, V75, P35, DOI 10.1128/IAI.00963-06
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Scheidegger F, 2011, CELL MICROBIOL, V13, P419, DOI 10.1111/j.1462-5822.2010.01545.x
   SCHLAEPFER DD, 1994, NATURE, V372, P786
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004
   Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173
   Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871
   Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707
   Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652
   Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048
   Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295
   Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227
   Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858
   Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004
NR 64
TC 17
Z9 17
U1 0
U2 4
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD NOV 1
PY 2011
VL 124
IS 21
BP 3591
EP 3602
DI 10.1242/jcs.084459
PG 12
WC Cell Biology
SC Cell Biology
GA 847LV
UT WOS:000296975300008
PM 22045736
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Bravo, D
   Braissant, O
   Solokhina, A
   Clerc, M
   Daniels, AU
   Verrecchia, E
   Junier, P
AF Bravo, Daniel
   Braissant, Olivier
   Solokhina, Anna
   Clerc, Martin
   Daniels, Alma U.
   Verrecchia, Eric
   Junier, Pilar
TI Use of an isothermal microcalorimetry assay to characterize microbial
   oxalotrophic activity
SO FEMS MICROBIOLOGY ECOLOGY
LA English
DT Article
DE isothermal microcalorimetry (IMC); oxalotrophic activity; oxalotrophic
   bacteria
ID PSEUDOMONAS-OXALATICUS OX1; CARBON ASSIMILATION; CALCIUM-OXALATE;
   GROWTH; SOIL; DIVERSITY; TAXONOMY; BIOMINERALIZATION; IDENTIFICATION;
   METABOLISM
AB Isothermal microcalorimetry (IMC) has been used in the past to monitor metabolic activities in living systems. A few studies have used it on ecological research. In this study, IMC was used to monitor oxalotrophic activity, a widespread bacterial metabolism found in the environment, and particularly in soils. Six model strains were inoculated in solid angle media with K-oxalate as the sole carbon source. Cupriavidus oxalaticus, Cupriavidus necator, and Streptomyces violaceoruber presented the highest activity (91, 40, and 55 mu W, respectively) and a maximum growth rate (mu max h(-1)) of 0.264, 0.185, and 0.199, respectively, among the strains tested. These three strains were selected to test the incidence of different oxalate sources (Ca, Cu, and Fe-oxalate salts) in the metabolic activity. The highest activity was obtained in Ca-oxalate for C. oxalaticus. Similar experiments were carried out with a model soil to test whether this approach can be used to measure oxalotrophic activity in field samples. Although measuring oxalotrophic activity in a soil was challenging, there was a clear effect of the amendment with oxalate on the metabolic activity measured in soil. The correlation between heat flow and growth suggests that IMC analysis is a powerful method to monitor bacterial oxalotrophic activity.
C1 [Bravo, Daniel; Clerc, Martin; Junier, Pilar] Univ Neuchatel, Inst Biol, Microbiol Lab, CH-2000 Neuchatel, Switzerland.
   [Braissant, Olivier; Solokhina, Anna; Daniels, Alma U.] Univ Basel, Lab Biomech & Biocalorimetry LOB2, Biozentrum Pharmazentrum, Basel, Switzerland.
   [Verrecchia, Eric] Univ Lausanne, Inst Geol & Paleontol, Biogeosci Lab, Lausanne, Switzerland.
RP Junier, P (corresponding author), Univ Neuchatel, Inst Biol, Microbiol Lab, POB 158, CH-2000 Neuchatel, Switzerland.
EM pilar.junier@unine.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X; Bravo, Daniel/0000-0003-3155-9707
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX We would like to thank N. Jeanneret (Universite de Neuchatel) for help
   and advice during the work. This research was supported by the Swiss
   National Science Foundation. We would like to thank Sylvie Cario, Edith
   Joseph, and Daniel Job (all at Universite de Neuchatel) for providing
   the copper and iron oxalates.
CR ANGLE JS, 1991, APPL ENVIRON MICROB, V57, P3674, DOI 10.1128/AEM.57.12.3674-3676.1991
   Aragno M, 1991, PROKARYOTES, p344 
   BLACKMOR.MA, 1970, BIOCHEM J, V118, P53, DOI 10.1042/bj1180053
   BLACKMORE MA, 1968, BIOCHEM J, V107, P705, DOI 10.1042/bj1070705
   BOE I, 1990, BIOTECHNOL BIOENG, V35, P1, DOI 10.1002/bit.260350102
   Braissant O, 2010, TUBERCULOSIS, V90, P57, DOI 10.1016/j.tube.2009.11.001
   Braissant O, 2002, NATURWISSENSCHAFTEN, V89, P366, DOI 10.1007/s00114-002-0340-0
   Braissant O, 2004, GEOBIOLOGY, V2, P59, DOI 10.1111/j.1472-4677.2004.00019.x
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Cailleau G, 2005, CATENA, V59, P1, DOI 10.1016/j.catena.2004.06.002
   Cailleau G, 2004, NATURWISSENSCHAFTEN, V91, P191, DOI 10.1007/s00114-004-0512-1
   Chen L, 2007, EUR J INORG CHEM, P3201, DOI 10.1002/ejic.200700212
   Cooper MA, 2003, ANAL BIOANAL CHEM, V377, P834, DOI 10.1007/s00216-003-2111-y
   Cromack Jr K, 1977, ECOL B STOCKHOLM, V25, P246
   DAVID R, 1960, B SOC CHIM FR, P719
   Dean J. A., 1999, LANGES HDB CHEM
   DIJKHUIZEN L, 1977, ARCH MICROBIOL, V115, P229, DOI 10.1007/BF00406379
   Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005
   Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106
   FRIEDRICH CG, 1979, J GEN MICROBIOL, V115, P185, DOI 10.1099/00221287-115-1-185
   Gruez A, 2004, J MOL BIOL, V343, P29, DOI 10.1016/j.jmb.2004.08.030
   Guo XF, 2008, BIOTECHNOL BIOENG, V99, P929, DOI 10.1002/bit.21652
   HEIJNEN JJ, 1992, BIOTECHNOL BIOENG, V40, P1139
   Hofmann BA, 1998, CHEM GEOL, V149, P127, DOI 10.1016/S0009-2541(98)00043-6
   HYDE C, 1966, AM MINERAL, V51, P228
   JAYASURIYA GCN, 1955, J GEN MICROBIOL, V12, P419, DOI 10.1099/00221287-12-3-419
   Khammar N, 2009, J MICROBIOL METH, V76, P120, DOI 10.1016/j.mimet.2008.09.020
   Milardovic S, 2000, ELECTROANAL, V12, P1051, DOI 10.1002/1521-4109(200009)12:13<1051::AID-ELAN1051>3.3.CO;2-Q
   Milleret R, 2009, PLANT SOIL, V316, P1, DOI 10.1007/s11104-008-9753-7
   Mortensen U, 1973, B ECOL RES COMMUN ST, V17, P189
   QUAYLE JR, 1961, BIOCHEM J, V78, P225, DOI 10.1042/bj0780225
   QUAYLE JR, 1959, BIOCHEM J, V72, P623, DOI 10.1042/bj0720623
   QUAYLE JR, 1960, BIOCHEM J, V75, P515, DOI 10.1042/bj0750515
   QUAYLE JR, 1963, BIOCHEM J, V87, P368, DOI 10.1042/bj0870368
   ROBBEL L, 1973, NATURWISSENSCHAFTEN, V60, P351, DOI 10.1007/BF00599906
   Rong XM, 2007, PEDOSPHERE, V17, P137, DOI 10.1016/S1002-0160(07)60019-8
   Sahin N, 2003, RES MICROBIOL, V154, P399, DOI 10.1016/S0923-2508(03)00112-8
   Sahin N, 2002, J MICROBIOL, V40, P109
   Schilling JS, 2004, HOLZFORSCHUNG, V58, P682, DOI 10.1515/HF.2004.124
   Sidhu H, 1997, J CLIN MICROBIOL, V35, P350, DOI 10.1128/JCM.35.2.350-353.1997
   TAMER A U, 1980, Bulletin de la Societe Neuchateloise des Sciences Naturelles, V103, P91
   Tamer AU, 2002, SYST APPL MICROBIOL, V25, P513, DOI 10.1078/07232020260517643
   Toyota CG, 2008, J BACTERIOL, V190, P2556, DOI 10.1128/JB.01823-07
   Trinchant JC, 1996, J EXP BOT, V47, P1865, DOI 10.1093/jxb/47.12.1865
   Turroni S, 2007, J APPL MICROBIOL, V103, P1600, DOI 10.1111/j.1365-2672.2007.03388.x
   Vandamme P, 2004, INT J SYST EVOL MICR, V54, P2285, DOI 10.1099/ijs.0.63247-0
   VANHERWAARDEN S, 2000, MECH VARIABLES MEASU, P664
   Verrecchia E., 2006, FUNGI BIOGEOCHEMICAL, P289, DOI [DOI 10.1017/CBO9780511550522.013, 10.1017/CBO9780511550522.013]
   VERRECCHIA EP, 1990, GEOMICROBIOL J, V8, P87, DOI 10.1080/01490459009377882
   Vor T, 2002, BIOL FERT SOILS, V36, P66, DOI 10.1007/s00374-002-0510-4
   Wadso I, 2001, PURE APPL CHEM, V73, P1625, DOI 10.1351/pac200173101625
   Wadso I, 2009, J THERM ANAL CALORIM, V95, P843, DOI 10.1007/s10973-008-9467-3
   Wang G, 2010, ENVIRON MICROBIOL, V12, P1363, DOI 10.1111/j.1462-2920.2010.02180.x
   Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002
   Zhou JZ, 2004, APPL ENVIRON MICROB, V70, P1723, DOI 10.1128/AEM.70.3.1723-1734.2004
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 56
TC 21
Z9 23
U1 0
U2 25
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0168-6496
EI 1574-6941
J9 FEMS MICROBIOL ECOL
JI FEMS Microbiol. Ecol.
PD NOV
PY 2011
VL 78
IS 2
BP 266
EP 274
DI 10.1111/j.1574-6941.2011.01158.x
PG 9
WC Microbiology
SC Microbiology
GA 845UN
UT WOS:000296849000008
PM 21696406
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Fernandez-Gonzalez, E
   de Paz, HD
   Alperi, A
   Agundez, L
   Faustmann, M
   Sangari, FJ
   Dehio, C
   Llosa, M
AF Fernandez-Gonzalez, Esther
   de Paz, Hector D.
   Alperi, Anabel
   Agundez, Leticia
   Faustmann, Marco
   Sangari, Felix J.
   Dehio, Christoph
   Llosa, Matxalen
TI Transfer of R388 Derivatives by a Pathogenesis-Associated Type IV
   Secretion System into both Bacteria and Human Cells
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID SITE-SPECIFIC RECOMBINATION; INCW PLASMID R388; BARTONELLA-HENSELAE; DNA
   TRANSFER; CONJUGATIVE RELAXASE; EFFECTOR PROTEINS; COUPLING PROTEIN;
   SIGNAL; TRWC; ORIT
AB Bacterial type IV secretion systems (T4SSs) are involved in processes such as bacterial conjugation and protein translocation to animal cells. In this work, we have switched the substrates of T4SSs involved in pathogenicity for DNA transfer. Plasmids containing part of the conjugative machinery of plasmid R388 were transferred by the T4SS of human facultative intracellular pathogen Bartonella henselae to both recipient bacteria and human vascular endothelial cells. About 2% of the human cells expressed a green fluorescent protein (GFP) gene from the plasmid. Plasmids of different sizes were transferred with similar efficiencies. B. henselae codes for two T4SSs: VirB/VirD4 and Trw. A Delta virB mutant strain was transfer deficient, while a Delta trwE mutant was only slightly impaired in DNA transfer. DNA transfer was in all cases dependent on protein TrwC of R388, the conjugative relaxase, implying that it occurs by a conjugation-like mechanism. A DNA helicase-deficient mutant of TrwC could not promote DNA transfer. In the absence of TrwB, the coupling protein of R388, DNA transfer efficiency dropped 1 log. The same low efficiency was obtained with a TrwB point mutation in the region involved in interaction with the T4SS. TrwB interacted with VirB10 in a bacterial two-hybrid assay, suggesting that it may act as the recruiter of the R388 substrate for the VirB/VirD4 T4SS. A TrwB ATPase mutant behaved as dominant negative, dropping DNA transfer efficiency to almost null levels. B. henselae bacteria recovered from infected human cells could transfer the mobilizable plasmid into recipient Escherichia coli under certain conditions, underscoring the versatility of T4SSs.
C1 [Fernandez-Gonzalez, Esther; de Paz, Hector D.; Alperi, Anabel; Agundez, Leticia; Sangari, Felix J.; Llosa, Matxalen] Univ Cantabria, Dept Biol Mol, Fac Med, Santander 39011, Spain.
   [Fernandez-Gonzalez, Esther; de Paz, Hector D.; Alperi, Anabel; Agundez, Leticia; Sangari, Felix J.; Llosa, Matxalen] UC SODERCAN CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander 39011, Spain.
   [Faustmann, Marco; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
RP Llosa, M (corresponding author), Univ Cantabria, Dept Biol Mol, Fac Med, C Herrera Oria S-N, Santander 39011, Spain.
EM llosam@unican.es
RI Dehio, Christoph/R-8277-2016; , matxalen/ABG-5541-2020; Fernandez
   Gonzalez, Esther/I-6457-2015; Sangari, Felix J/K-9104-2014; Dehio,
   Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; , matxalen/0000-0002-4826-2240;
   Fernandez Gonzalez, Esther/0000-0001-5586-4373; Sangari, Felix
   J/0000-0002-3298-6076; Dehio, Christoph/0000-0001-7288-1052; de Paz
   Fernandez, Hector David/0000-0002-4190-5063
FU Spanish Ministry of Science and InnovationSpanish Government
   [BIO2008-00133, BIO2007-63656]; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [31003A-109925]
FX This work was supported by grants BIO2008-00133 and BIO2007-63656 from
   the Spanish Ministry of Science and Innovation to M.L. and F.J.S.,
   respectively, and by grant 31003A-109925 from the Swiss National Science
   Foundation to C.D.
CR Agundez L, 2011, APPL ENVIRON MICROB, V77, P201, DOI 10.1128/AEM.01371-10
   Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09
   BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990
   BUCHANANWOLLASTON V, 1987, NATURE, V328, P172, DOI 10.1038/328172a0
   Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432
   Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x
   Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101
   Cesar CE, 2006, MOL MICROBIOL, V62, P984, DOI 10.1111/j.1365-2958.2006.05437.x
   de Paz HD, 2005, MICROBIOL-SGM, V151, P3505, DOI 10.1099/mic.0.28410-0
   de Paz HD, 2010, J BACTERIOL, V192, P2655, DOI 10.1128/JB.01692-09
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102
   GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x
   Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425
   GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645
   Hamilton CM, 2000, J BACTERIOL, V182, P1541, DOI 10.1128/JB.182.6.1541-1548.2000
   HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0
   Jurik A, 2010, INFECT IMMUN, V78, P5244, DOI 10.1128/IAI.00796-10
   Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73
   Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451
   Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x
   Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100
   LLOSA M, 1994, J BACTERIOL, V176, P3210, DOI 10.1128/jb.176.11.3210-3217.1994
   Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x
   Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101
   MARTINEZ E, 1988, MOL GEN GENET, V211, P320, DOI 10.1007/BF00330610
   Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117
   Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   SADLER JR, 1980, GENE, V8, P279, DOI 10.1016/0378-1119(80)90005-0
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Salgado-Pabon W, 2007, MOL MICROBIOL, V66, P930, DOI 10.1111/j.1365-2958.2007.05966.x
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002
   Schroder G, 2011, P NATL ACAD SCI USA, V108, P14643, DOI 10.1073/pnas.1019074108
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102
   Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08
   Waters VL, 2001, NAT GENET, V29, P375, DOI 10.1038/ng779
NR 46
TC 30
Z9 30
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD NOV
PY 2011
VL 193
IS 22
BP 6257
EP 6265
DI 10.1128/JB.05905-11
PG 9
WC Microbiology
SC Microbiology
GA 843XF
UT WOS:000296709600016
PM 21908662
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Krahenbuhl, B
   Hiller, S
   Wider, G
AF Kraehenbuehl, Barbara
   Hiller, Sebastian
   Wider, Gerhard
TI 4D APSY-HBCB(CG)CDHD experiment for automated assignment of aromatic
   amino acid side chains in proteins
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE Protein NMR; Aromatic resonances; Projection spectroscopy; APSY; GAPRO;
   Automated assignment
ID SEQUENTIAL RESONANCE ASSIGNMENTS; NMR ASSIGNMENT;
   REDUCED-DIMENSIONALITY; CHEMICAL-SHIFTS; APSY-NMR; SPECTRA; H-1;
   SPECTROSCOPY; HISTIDINE; RESIDUES
AB A four-dimensional (4D) APSY (automated projection spectroscopy)-HBCB(CG)CDHD experiment is presented. This 4D experiment correlates aromatic with aliphatic carbon and proton resonances from the same amino acid side chain of proteins in aqueous solution. It thus allows unambiguous sequence-specific assignment of aromatic amino acid ring signals based on backbone assignments. Compared to conventional 2D approaches, the inclusion of evolution periods on H-1(beta) and C-13(delta) efficiently removes overlaps, and provides two additional frequencies for consequent automated or manual matching. The experiment was successfully applied to three proteins with molecular weights from 6 to 13 kDa. For the complementation of the assignment of the aromatic resonances, TOCSY- or COSY-based versions of a 4D APSY-HCCHaro sequence are proposed.
C1 [Kraehenbuehl, Barbara; Wider, Gerhard] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.
   [Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Wider, G (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.
EM gsw@mol.biol.ethz.ch
RI Hiller, Sebastian/B-3573-2008
OI Hiller, Sebastian/0000-0002-6709-4684; Wider,
   Gerhard/0000-0001-9366-7645
FU Swiss National Fund (SNF)Swiss National Science Foundation (SNSF)
   [200021 120048, 3100A0-113730]
FX We thank Prof. Kurt Wuthrich for the provision of TM1290, and Dr. Daniel
   Burschowsky for support with the expression of ubiquitin. The Swiss
   National Fund (SNF) is gratefully acknowledged for financial support
   (projects 200021 120048 and 3100A0-113730).
CR BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K
   BILLETER M, 1982, J MOL BIOL, V155, P321, DOI 10.1016/0022-2836(82)90008-0
   Burschowsky D, 2011, J BIOL CHEM, V286, P1364, DOI 10.1074/jbc.M110.135038
   Carlomagno T, 1996, J BIOMOL NMR, V8, P161, DOI 10.1007/BF00211162
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   EMSLEY L, 1990, CHEM PHYS LETT, V165, P469, DOI 10.1016/0009-2614(90)87025-M
   Etezady-Esfarjani T, 2004, J BIOMOL NMR, V29, P403, DOI 10.1023/B:JNMR.0000032615.51536.1a
   Etezady-Esfarjani T, 2003, J BIOMOL NMR, V25, P167, DOI 10.1023/A:1022215901456
   Fiorito F, 2006, J BIOMOL NMR, V35, P27, DOI 10.1007/s10858-006-0030-x
   Frueh DP, 2005, J BIOMOL NMR, V33, P187, DOI 10.1007/s10858-005-3204-z
   Gossert AD, 2007, J BIOMOL NMR, V38, P195, DOI 10.1007/s10858-006-9123-9
   Gossert AD, 2011, J AM CHEM SOC, V133, P210, DOI 10.1021/ja108383x
   GRZESIEK S, 1995, J AM CHEM SOC, V117, P6527, DOI 10.1021/ja00129a016
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850
   Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102
   Hiller S, 2008, J BIOMOL NMR, V42, P179, DOI 10.1007/s10858-008-9266-y
   Hiller S, 2008, J AM CHEM SOC, V130, P12073, DOI 10.1021/ja803161d
   Hiller S, 2007, J AM CHEM SOC, V129, P10823, DOI 10.1021/ja072564+
   Kupce E, 2003, J AM CHEM SOC, V125, P13958, DOI 10.1021/ja038297z
   Lohr F, 2007, J BIOMOL NMR, V37, P205, DOI 10.1007/s10858-006-9128-4
   LOGAN TM, 1993, J BIOMOL NMR, V3, P225
   Lohr F, 2005, J BIOMOL NMR, V32, P309, DOI 10.1007/s10858-005-1195-4
   Lohr F, 2002, J BIOMOL NMR, V22, P153, DOI 10.1023/A:1014271204953
   MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2
   MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058
   Ranjan N, 2011, J MOL BIOL, V405, P1040, DOI 10.1016/j.jmb.2010.11.040
   SACHS DH, 1971, J BIOL CHEM, V246, P6576
   SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X
   Szyperski T, 2002, P NATL ACAD SCI USA, V99, P8009, DOI 10.1073/pnas.122224599
   SZYPERSKI T, 1993, J AM CHEM SOC, V115, P9307, DOI 10.1021/ja00073a064
   Takeuchi K, 2010, J BIOMOL NMR, V47, P55, DOI 10.1007/s10858-010-9410-3
   Torizawa T, 2005, J AM CHEM SOC, V127, P12620, DOI 10.1021/ja051386m
   WAGNER G, 1982, J MOL BIOL, V155, P347, DOI 10.1016/0022-2836(82)90009-2
   Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t
   YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099
   Zerbe O, 1996, J BIOMOL NMR, V7, P99, DOI 10.1007/BF00203820
NR 37
TC 5
Z9 5
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD NOV
PY 2011
VL 51
IS 3
BP 313
EP 318
DI 10.1007/s10858-011-9572-7
PG 6
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 834TY
UT WOS:000295988200011
PM 21947871
OA Green Published
DA 2021-01-25
ER

PT J
AU Hoang, HH
   Nickerson, NN
   Lee, VT
   Kazimirova, A
   Chami, M
   Pugsley, AP
   Lory, S
AF Hoang, Hanh H.
   Nickerson, Nicholas N.
   Lee, Vincent T.
   Kazimirova, Anastasia
   Chami, Mohamed
   Pugsley, Anthony P.
   Lory, Stephen
TI Outer Membrane Targeting of Pseudomonas aeruginosa Proteins Shows
   Variable Dependence on the Components of Bam and Lol Machineries
SO MBIO
LA English
DT Article
ID ESCHERICHIA-COLI; SECRETIN PULD; PILUS BIOGENESIS; MULTIMERIZATION;
   YAET; IDENTIFICATION; ASSEMBLES; PILOTIN; COMPLEX
AB In Gram-negative bacteria, the Lol and Bam machineries direct the targeting of lipidated and nonlipidated proteins, respectively, to the outer membrane (OM). Using Pseudomonas aeruginosa strains with depleted levels of specific Bam and Lol proteins, we demonstrated a variable dependence of different OM proteins on these targeting pathways. Reduction in the level of BamA significantly affected the ability of the beta-barrel membrane protein OprF to localize to the OM, while the targeting of three secretins that are functionally related OM proteins was less affected (PilQ and PscC) or not at all affected (XcpQ). Depletion of LolB affected all lipoproteins examined and had a variable effect on the nonlipidated proteins. While the levels of OprF, PilQ, and PscC were significantly reduced by LolB depletion, XcpQ was unaffected and was correctly localized to the OM. These results suggest that certain beta-barrel proteins such as OprF primarily utilize the complete Bam machinery. The Lol machinery participates in the OM targeting of secretins to variable degrees, likely through its involvement in the assembly of lipidated Bam components. XcpQ, but not PilQ or PscC, was shown to assemble spontaneously into liposomes as multimers. This work raises the possibility that there is a gradient of utilization of Bam and Lol insertion and targeting machineries. Structural features of individual proteins, including their beta-barrel content, may determine the propensity of these proteins for folding (or misfolding) during periplasmic transit and OM insertion, thereby influencing the extent of utilization of the Bam targeting machinery, respectively.
   IMPORTANCE Targeting of lipidated and nonlipidated proteins to the outer membrane (OM) compartment in Gram-negative bacteria involves the transfer across the periplasm utilizing the Lol and Bam machineries, respectively. We show that depletion of Bam and Lol components in Pseudomonas aeruginosa does not lead to a general OM protein translocation defect, but the severity (and therefore, Lol and Bam dependence), varies with individual proteins. XcpQ, the secretin component of the type II secretion apparatus, is translocated into the OM without the assistance of Bam or Lol machineries. The hypothesis that XcpQ, after secretion across the cytoplasmic membrane, does not utilize the OM targeting machineries was supported by demonstrating that in vitro-synthesized XcpQ (but not the other P. aeruginosa secretins) can spontaneously incorporate into lipid vesicles. Therefore, the requirement for ancillary factors appears to be, in certain instances, dictated by the intrinsic properties of individual OM proteins, conceivably reflecting their propensities to misfold during periplasmic transit.
C1 [Hoang, Hanh H.; Lee, Vincent T.; Kazimirova, Anastasia; Lory, Stephen] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.
   [Nickerson, Nicholas N.; Pugsley, Anthony P.] Inst Pasteur, Mol Genet Unit, Paris, France.
   [Nickerson, Nicholas N.; Pugsley, Anthony P.] CNRS, URA2172, Paris, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, Basel, Switzerland.
RP Lory, S (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.
EM stephen_lory@hms.harvard.edu
OI Lee, Vincent T./0000-0002-3593-0318
FU Cystic Fibrosis Foundation; Canadian Louis Pasteur Foundation; ANRFrench
   National Research Agency (ANR) [ANR-09-BLAN-0291]
FX H. H. Hoang was supported by a Cystic Fibrosis Foundation postdoctoral
   fellowship, and N. N. Nickerson was supported by a postdoctoral
   fellowship from the Canadian Louis Pasteur Foundation. This study was
   also supported by a research grant from the Cystic Fibrosis Foundation
   to S. Lory and by ANR grant ANR-09-BLAN-0291 to A. P. Pugsley.
CR Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x
   Bitter W, 2003, ARCH MICROBIOL, V179, P307, DOI 10.1007/s00203-003-0541-8
   Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x
   Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09
   Carbonnelle E, 2005, MOL MICROBIOL, V55, P54, DOI 10.1111/j.1365-2958.2004.04364.x
   Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x
   Collin S, 2011, MOL MICROBIOL, V80, P655, DOI 10.1111/j.1365-2958.2011.07596.x
   Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006
   Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106
   Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07
   Kim K, 2006, BIOCHEM BIOPH RES CO, V340, P1028, DOI 10.1016/j.bbrc.2005.12.108
   Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08
   Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784
   Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0
   Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104
   Tashiro Y, 2008, J BACTERIOL, V190, P3969, DOI 10.1128/JB.02004-07
   Tokuda Hajime, 2004, Biochim Biophys Acta, V1694, pIN1
   Tokuda H, 2009, BIOSCI BIOTECH BIOCH, V73, P465, DOI 10.1271/bbb.80778
   Viarre V, 2009, J BIOL CHEM, V284, P33815, DOI 10.1074/jbc.M109.065938
   Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015
NR 24
TC 34
Z9 35
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD NOV-DEC
PY 2011
VL 2
IS 6
AR e00246-11
DI 10.1128/mBio.00246-11
PG 8
WC Microbiology
SC Microbiology
GA 888GV
UT WOS:000299992700016
PM 22147293
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Beck, M
   Schmidt, A
   Malmstroem, J
   Claassen, M
   Ori, A
   Szymborska, A
   Herzog, F
   Rinner, O
   Ellenberg, J
   Aebersold, R
AF Beck, Martin
   Schmidt, Alexander
   Malmstroem, Johan
   Claassen, Manfred
   Ori, Alessandro
   Szymborska, Anna
   Herzog, Franz
   Rinner, Oliver
   Ellenberg, Jan
   Aebersold, Ruedi
TI The quantitative proteome of a human cell line
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE mass spectrometry; protein abundance; proteomics
ID ABSOLUTE QUANTIFICATION; COVERAGE PREDICTION; MESSENGER-RNA; PROTEINS;
   GENOME; EXPRESSION; IDENTIFICATIONS; FRACTIONATION; SEQUENCES; PEPTIDES
AB The generation of mathematical models of biological processes, the simulation of these processes under different conditions, and the comparison and integration of multiple data sets are explicit goals of systems biology that require the knowledge of the absolute quantity of the system's components. To date, systematic estimates of cellular protein concentrations have been exceptionally scarce. Here, we provide a quantitative description of the proteome of a commonly used human cell line in two functional states, interphase and mitosis. We show that these human cultured cells express at least similar to 10 000 proteins and that the quantified proteins span a concentration range of seven orders of magnitude up to 20 000 000 copies per cell. We discuss how protein abundance is linked to function and evolution. Molecular Systems Biology 7: 549; published online 8 November 2011; doi:10.1038/msb.2011.82
C1 [Herzog, Franz; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Beck, Martin; Ori, Alessandro; Szymborska, Anna; Ellenberg, Jan] European Mol Biol Lab, Heidelberg, Germany.
   [Schmidt, Alexander] Univ Basel, Biozentrum, Basel, Switzerland.
   [Malmstroem, Johan] BMC, Dept Immunotechnol, Lund, Sweden.
   [Malmstroem, Johan; Rinner, Oliver] Biognosys AG, Schlieren, Switzerland.
   [Claassen, Manfred] ETH, Dept Comp Sci, CH-8093 Zurich, Switzerland.
   [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, Zurich, Switzerland.
   [Aebersold, Ruedi] Univ Zurich, Dept Sci, Zurich, Switzerland.
RP Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.
EM aebersold@imsb.biol.ethz.ch
RI Ellenberg, Jan/I-4688-2014; Ori, Alessandro/M-8586-2019; Herzog,
   Franz/G-4832-2012; Beck, Martin/B-5589-2011; Ori,
   Alessandro/B-7067-2011; Malmstrom, Johan A/B-7660-2009
OI Ellenberg, Jan/0000-0001-5909-701X; Ori, Alessandro/0000-0002-3046-0871;
   Beck, Martin/0000-0002-7397-1321; Ori, Alessandro/0000-0002-3046-0871;
   Malmstrom, Johan A/0000-0002-2889-7169; Szymborska-Mell,
   Anna/0000-0003-1741-4106; Claassen, Manfred/0000-0002-4583-9083
FU ETH ZurichETH Zurich; SystemsX.ch; Swiss initiative for systems biology;
   European UnionEuropean Union (EU) [HEALTH-F4-2008-201648]; European
   Research CouncilEuropean Research Council (ERC) [ERC-2008-AdG 233226];
   Swedish Society of Medical Research (SSMF); European Molecular Biology
   OrganizationEuropean Molecular Biology Organization (EMBO); European
   CommissionEuropean CommissionEuropean Commission Joint Research Centre;
   Competence Center for Systems Physiology and Metabolic Diseases;
   Alexander von Humboldt FoundationAlexander von Humboldt Foundation
FX Jean-Karim Heriche and Thomas Walter (EMBL) are acknowledged for help in
   preparing Supplementary Figure S3. This project was funded in part by
   ETH Zurich, SystemsX.ch, the Swiss initiative for systems biology
   (project PhosphonetX) and by the European Union Seventh Framework
   Program PROSPECTS (Proteomics Specification in Space and Time Grant
   HEALTH-F4-2008-201648). RA is supported by the European Research Council
   (Grant # ERC-2008-AdG 233226). JM was supported by a fellowship from the
   Swedish Society of Medical Research (SSMF), MB was supported by a
   long-term fellowship of the European Molecular Biology Organization and
   a Marie Curie fellowship of the European Commission, AS was supported by
   the Competence Center for Systems Physiology and Metabolic Diseases. AO
   is supported by a postdoctoral fellowship from the Alexander von
   Humboldt Foundation.
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]
   Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182
   Claassen M, 2011, J COMPUT BIOL, V18, P283, DOI 10.1089/cmb.2010.0261
   Claassen M, 2009, BIOINFORMATICS, V25, pI154, DOI 10.1093/bioinformatics/btp233
   de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341
   Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080
   Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200
   Jaffe JD, 2008, MOL CELL PROTEOMICS, V7, P1952, DOI 10.1074/mcp.M800218-MCP200
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024
   Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683
   Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486
   Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106
   Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Malmstrom J, 2006, J PROTEOME RES, V5, P2241, DOI 10.1021/pr0600632
   Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869
   Niforou Katerina N., 2008, Cancer Genomics & Proteomics, V5, P63
   Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200
   Scherl A, 2008, ANAL CHEM, V80, P1182, DOI 10.1021/ac701680f
   Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200
   Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944
   Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048
   Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59
   Weiss M, 2010, PROTEOMICS, V10, P1297, DOI 10.1002/pmic.200900414
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
   YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016
   Yi EC, 2002, ELECTROPHORESIS, V23, P3205, DOI 10.1002/1522-2683(200209)23:18<3205::AID-ELPS3205>3.0.CO;2-Y
NR 40
TC 483
Z9 489
U1 2
U2 86
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD NOV
PY 2011
VL 7
AR 549
DI 10.1038/msb.2011.82
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 857AK
UT WOS:000297685900006
PM 22068332
OA DOAJ Gold, Green Published
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Benjamin, D
   Colombi, M
   Moroni, C
   Hall, MN
AF Benjamin, Don
   Colombi, Marco
   Moroni, Christoph
   Hall, Michael N.
TI Rapamycin passes the torch: a new generation of mTOR inhibitors
SO NATURE REVIEWS DRUG DISCOVERY
LA English
DT Review
ID P70 S6 KINASE; SENSITIVE PHOSPHOPROTEOME REVEALS; TUBEROUS SCLEROSIS
   COMPLEX; REDUCES TUMOR-GROWTH; MAMMALIAN TARGET; CELL-GROWTH; LIFE-SPAN;
   ANTITUMOR-ACTIVITY; PALOMID 529; 3-KINASE/MAMMALIAN TARGET
AB Mammalian target of rapamycin (mTOR) is an atypical protein kinase that controls growth and metabolism in response to nutrients, growth factors and cellular energy levels, and it is frequently dysregulated in cancer and metabolic disorders. Rapamycin is an allosteric inhibitor of mTOR, and was approved as an immunosuppressant in 1999. In recent years, interest has focused on its potential as an anticancer drug. However, the performance of rapamycin and its analogues (rapalogues) has been undistinguished despite isolated successes in subsets of cancer, suggesting that the full therapeutic potential of targeting mTOR has yet to be exploited. A new generation of ATP-competitive inhibitors that directly target the mTOR catalytic site display potent and comprehensive mTOR inhibition and are in early clinical trials.
C1 [Benjamin, Don; Colombi, Marco; Moroni, Christoph; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
FU Canton of Basel; Louis-Jeantet Foundation; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF)
FX We acknowledge support from the Canton of Basel, the Louis-Jeantet
   Foundation and the Swiss National Science Foundation.
CR Abdelnour-Berchtold E, 2010, ANTICANCER RES, V30, P799
   Andoh TF, 1996, KIDNEY INT, V50, P1110, DOI 10.1038/ki.1996.417
   Apsel B, 2008, CHEM BIOL, V4, P691
   Ayral-Kaloustian S, 2010, J MED CHEM, V53, P452, DOI 10.1021/jm901427g
   Aziz SA, 2010, CLIN CANCER RES, V16, P6029, DOI 10.1158/1078-0432.CCR-10-1490
   Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Baumann P, 2009, ANTI-CANCER DRUG, V20, P259, DOI 10.1097/CAD.0b013e328328d18b
   Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x
   Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564
   Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99
   Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910
   Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432
   Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346
   Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107
   Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200
   CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574
   Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239
   Chong CR, 2009, ONCOLOGIST, V14, P1178, DOI 10.1634/theoncologist.2009-0286
   Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P374, DOI 10.4161/oxim.3.6.14787
   Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105
   Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751
   Cirstea D, 2010, MOL CANCER THER, V9, P963, DOI 10.1158/1535-7163.MCT-09-0763
   Colombi M, 2011, ONCOGENE, V30, P1551, DOI 10.1038/onc.2010.539
   Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6
   Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106
   Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200
   Diaz R, 2009, BRIT J CANCER, V100, P932, DOI 10.1038/sj.bjc.6604938
   Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532
   Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890
   Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7
   Falcon BL, 2011, CANCER RES, V71, P1573, DOI 10.1158/0008-5472.CAN-10-3126
   Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029
   Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015
   Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038
   Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802
   Gabardi S, 2010, PHARMACOTHERAPY, V30, P1044, DOI 10.1592/phco.30.10.1044
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847
   Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X
   Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669
   Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774
   Gravina GL, 2011, ENDOCR-RELAT CANCER, V18, P385, DOI 10.1530/ERC-11-0045
   Gu YY, 2011, DIABETES, V60, P827, DOI 10.2337/db10-1194
   Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Harrington L. S, 2004, J CELL BIOL, V166, P213
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977
   HOLT SV, 2010, 22 EORTC NCI AACR S
   HOUCHENS DP, 1983, EUR J CANCER CLIN ON, V19, P799, DOI 10.1016/0277-5379(83)90012-3
   HOWARD Z, 2010, NCRI C LIV UK 7 10 N
   Hsieh AC, 2010, CLIN CANCER RES, V16, P4914, DOI 10.1158/1078-0432.CCR-10-0433
   Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021
   Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498
   Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109
   Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838
   Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119
   Ikezoe T, 2007, LEUKEMIA RES, V31, P673, DOI 10.1016/j.leukres.2006.08.001
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003
   Jaafar R, 2011, J BIOL CHEM, V286, P22609, DOI 10.1074/jbc.M110.203885
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091
   Jessen K, 2009, MOL CANCER THER, V8, pB148
   Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410
   Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035
   Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525
   Leone M, 2006, BIOCHEMISTRY-US, V45, P10294, DOI 10.1021/bi060976+
   Lewis GP, 2009, INVEST OPHTH VIS SCI, V50, P4429, DOI 10.1167/iovs.09-3445
   Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013
   Li T, 2010, J PHARMACOL EXP THER, V334, P830, DOI 10.1124/jpet.110.167940
   Liang J, 1999, ACTA CRYSTALLOGR D, V55, P736, DOI 10.1107/S0907444998014747
   Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175
   Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Mallon R, 2010, MOL CANCER THER, V9, P976, DOI 10.1158/1535-7163.MCT-09-0954
   Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816
   Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3
   Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366
   Marshall G, 2011, BIOCHEM SOC T, V39, P456, DOI 10.1042/BST0390456
   MARTEL RR, 1977, CAN J PHYSIOL PHARM, V55, P48, DOI 10.1139/y77-007
   McMahon LP, 2005, MOL ENDOCRINOL, V19, P175, DOI 10.1210/me.2004-0305
   Mita M, 2008, EXPERT OPIN INV DRUG, V17, P1947, DOI [10.1517/13543780802556485, 10.1517/13543780802556485 ]
   Molckovsky A, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-20
   Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Nardella C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000189
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925
   Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840
   Rao RD, 2005, NEOPLASIA, V7, P921, DOI 10.1593/neo.05361
   Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200
   Rini BI, 2008, CLIN CANCER RES, V14, P1286, DOI 10.1158/1078-0432.CCR-07-4719
   Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Sarbassov D. D., 2005, SCIENCE, V307, P1098
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780
   Secchiero P, 2011, CURR PHARM DESIGN, V17, P569, DOI 10.2174/138161211795222586
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026
   Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007
   Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066
   Sini P, 2010, AUTOPHAGY, V6, P553, DOI 10.4161/auto.6.4.11671
   Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182
   Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e
   Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482
   Tan DS, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3006
   Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2
   Thompson CA, 2003, AM J HEALTH-SYST PH, V60, P1210, DOI 10.1093/ajhp/60.12.1210
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693
   VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721
   Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261
   Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
   Xiang T, 2011, ONCOGENE, V30, P2443, DOI 10.1038/onc.2010.603
   Xue Q, 2008, CANCER RES, V68, P9551, DOI 10.1158/0008-5472.CAN-08-2058
   Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290
   Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017
   Yu K, 2010, CANCER RES, V70, P621, DOI 10.1158/0008-5472.CAN-09-2340
   Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299
   Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484
   Zask A, 2011, EXPERT OPIN THER PAT, V21, P1109, DOI 10.1517/13543776.2011.584871
   Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999
   Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979
   Zhang YJ, 2011, DRUG DISCOV TODAY, V16, P325, DOI 10.1016/j.drudis.2011.02.008
   Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 163
TC 554
Z9 566
U1 5
U2 102
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1776
EI 1474-1784
J9 NAT REV DRUG DISCOV
JI Nat. Rev. Drug Discov.
PD NOV
PY 2011
VL 10
IS 11
BP 868
EP 880
DI 10.1038/nrd3531
PG 13
WC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
GA 842IR
UT WOS:000296592100024
PM 22037041
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Biallas, M
   Trajkovic, I
   Hagmann, C
   Scholkmann, F
   Holper, L
   Beck, A
   Jenny, C
   Wolf, M
AF Biallas, M.
   Trajkovic, I.
   Hagmann, C.
   Scholkmann, F.
   Holper, L.
   Beck, A.
   Jenny, C.
   Wolf, M.
TI MULTIMODAL RECORDING OF BRAIN ACTIVITY IN HEATLHY TERM NEONATES DURING
   PHOTIC STIMULATION BY NEAR-INFRARED IMAGING AND ELECTROENCEPHALOGRAPHY
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
C1 [Biallas, M.; Trajkovic, I.; Hagmann, C.; Scholkmann, F.; Holper, L.; Beck, A.; Jenny, C.; Wolf, M.] Univ Zurich Hosp, Div Neonatol, CH-8091 Zurich, Switzerland.
   [Biallas, M.; Trajkovic, I.] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland.
   [Holper, L.] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.
   [Holper, L.] ETH, Zurich, Switzerland.
   [Beck, A.] Univ Basel, Core Program Struct Biol & Biophys, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD NOV
PY 2011
VL 70
SU 5
MA 222
BP 222
EP 222
DI 10.1038/pr.2011.447
PG 1
WC Pediatrics
SC Pediatrics
GA V31FS
UT WOS:000208870100223
OA Bronze
DA 2021-01-25
ER

PT J
AU Marz, M
   Gruber, AR
   Siederdissen, CHZ
   Amman, F
   Badelt, S
   Bartschat, S
   Bernhart, SH
   Beyer, W
   Kehr, S
   Lorenz, R
   Tanzer, A
   Yusuf, D
   Tafer, H
   Hofacker, IL
   Stadler, PF
AF Marz, Manja
   Gruber, Andreas R.
   Siederdissen, Christian Hoener Zu
   Amman, Fabian
   Badelt, Stefan
   Bartschat, Sebastian
   Bernhart, Stephan H.
   Beyer, Wolfgang
   Kehr, Stephanie
   Lorenz, Ronny
   Tanzer, Andrea
   Yusuf, Dilmurat
   Tafer, Hakim
   Hofacker, Ivo L.
   Stadler, Peter F.
TI Animal snoRNAs and scaRNAs with exceptional structures
SO RNA BIOLOGY
LA English
DT Article
DE box C/D; boxH/ACA; scaRNA; evolution; secondary structure
ID PSEUDOURIDYLATION GUIDE RNA; EFFICIENT TARGET PREDICTION; SMALL
   NUCLEOLAR RNAS; BOX-C/D; SYSTEMATIC IDENTIFICATION; COMPUTATIONAL
   SCREEN; EVOLUTION; GENES; LOCALIZATION; METHYLATION
AB The overwhelming majority of small nucleolar RNAs (snoRNAs) fall into two clearly defined classes characterized by distinctive secondary structures and sequence motifs. A small group of diverse ncRNAs, however, shares the hallmarks of one or both classes of snoRNAs but differs substantially from the norm in some respects. Here, we compile the available information on these exceptional cases, conduct a thorough homology search throughout the available metazoan genomes, provide improved and expanded alignments, and investigate the evolutionary histories of these ncRNA families as well as their mutual relationships.
C1 [Gruber, Andreas R.; Siederdissen, Christian Hoener Zu; Amman, Fabian; Badelt, Stefan; Bernhart, Stephan H.; Beyer, Wolfgang; Lorenz, Ronny; Hofacker, Ivo L.; Stadler, Peter F.] Univ Vienna, Dept Theoret Chem, Vienna, Austria.
   [Marz, Manja] Univ Marburg, Inst Pharmazeut Chem, RNA Bioinformat Grp, D-3550 Marburg, Germany.
   [Yusuf, Dilmurat] Lund Univ, Dept Oncol, Lund, Sweden.
   [Yusuf, Dilmurat] Lund Univ, CREATE Hlth Strateg Ctr Clin Canc Res, Lund, Sweden.
   [Bartschat, Sebastian; Kehr, Stephanie; Tafer, Hakim; Stadler, Peter F.] Univ Leipzig, Bioinformat Grp, Dept Comp Sci, Leipzig, Germany.
   [Bartschat, Sebastian; Kehr, Stephanie; Tafer, Hakim; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany.
   [Gruber, Andreas R.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Gruber, Andreas R.] Swiss Inst Bioinformat, Basel, Switzerland.
   [Tanzer, Andrea] PRBB, Ctr Regulacio Genom, Bioinformat & Genom Grp, Barcelona, Spain.
   [Stadler, Peter F.] Max Planck Inst Math Sci, Leipzig, Germany.
   [Stadler, Peter F.] Fraunhofer Inst Zelltherapie & Immunol, Leipzig, Germany.
   [Hofacker, Ivo L.] Univ Copenhagen, Ctr Noncoding RNA Technol & Hlth, Frederiksberg C, Denmark.
   [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA.
RP Stadler, PF (corresponding author), Univ Vienna, Dept Theoret Chem, Vienna, Austria.
EM studla@bioinf.uni-leipzig.de
RI Hofacker, Ivo L/A-2378-2013; Stadler, Peter F. F/L-7857-2015; Canzler,
   Sebastian/AAW-6420-2020; Lorenz, Ronny/A-6713-2015; Tanzer,
   Andrea/L-3147-2015; Canzler, Sebastian/AAT-8249-2020
OI Hofacker, Ivo L/0000-0001-7132-0800; Stadler, Peter F.
   F/0000-0002-5016-5191; Lorenz, Ronny/0000-0002-2144-698X; Tanzer,
   Andrea/0000-0003-2873-4236; Canzler, Sebastian/0000-0001-7935-9582;
   Kehr, Stephanie/0000-0001-8461-5763; Yusuf,
   Dilmurat/0000-0001-8683-7845; Honer zu Siederdissen,
   Christian/0000-0001-9517-5839; , Stephan/0000-0002-5928-9449; Amman,
   Fabian/0000-0002-8646-859X; Badelt, Stefan/0000-0003-2636-5801; Tafer,
   Hakim/0000-0002-6252-9802
FU Austrian FWFAustrian Science Fund (FWF); Austrian GEN-AU; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [MA-5082/1];
   European UnionEuropean Union (EU)
FX The research reported here is the outcome of a graduate course on RNA
   bioinformatics taught at the University of Vienna in 2009. We thank
   Stefanie Wehner for help with preparing Table 2 and carefully reading
   the manuscript. This work has been funded, in part, by the Austrian FWF,
   project "SFB F43 RNA regulation of the transcriptome" (CHzS), the
   Austrian GEN-AU projects "bioinformatics integration network III" and
   "regulatory ncRNAs" (ARG, CHzS, RL), the Deutsche
   Forschungsgemeinschaft, the DFG project MA-5082/1 and the European Union
   FP-7 project QUANTOMICS (PFS).
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5
   Bazeley PS, 2008, GENE, V408, P172, DOI 10.1016/j.gene.2007.10.037
   Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474
   Chen CL, 2008, GENETICS, V179, P21, DOI 10.1534/genetics.107.086025
   Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746
   Deng W, 2006, GENOME RES, V16, P20, DOI 10.1101/gr.4139206
   Edvardsson S, 2003, BIOINFORMATICS, V19, P865, DOI 10.1093/bioinformatics/btg080
   Fedorov A, 2005, NUCLEIC ACIDS RES, V33, P4578, DOI 10.1093/nar/gki754
   Frey MR, 1997, HISTOCHEM CELL BIOL, V108, P365, DOI 10.1007/s004180050177
   Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394
   Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262
   Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107
   Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349
   Griffiths-Jones S, 2005, BIOINFORMATICS, V21, P257, DOI 10.1093/bioinformatics/bth489
   Henras AK, 2004, CURR OPIN STRUC BIOL, V14, P335, DOI 10.1016/j.sbi.2004.05.006
   Hertel J, 2008, BIOINFORMATICS, V24, P158, DOI 10.1093/bioinformatics/btm464
   HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163
   Huang ZP, 2007, GENOMICS, V89, P490, DOI 10.1016/j.ygeno.2006.12.002
   Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943
   Jady BE, 2001, EMBO J, V20, P541, DOI 10.1093/emboj/20.3.541
   Kehr S, 2011, BIOINFORMATICS, V27, P279, DOI 10.1093/bioinformatics/btq642
   Kiss AM, 2004, MOL CELL BIOL, V24, P5797, DOI 10.1128/MCB.24.13.5797-5807.2004
   Kiss AM, 2002, NUCLEIC ACIDS RES, V30, P4643, DOI 10.1093/nar/gkf592
   Langenberger D, 2010, BIOCOMPUT-PAC SYM, P80
   Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002
   Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168
   Marz M, 2009, RNA BIOL, V6, P503, DOI 10.4161/rna.6.5.9607
   Marz M, 2008, J MOL EVOL, V67, P594, DOI 10.1007/s00239-008-9149-6
   Murchison EP, 2008, GENOME RES, V18, P995, DOI 10.1101/gr.073056.107
   Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157
   Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X
   Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172
   Richard P, 2003, EMBO J, V22, P4283, DOI 10.1093/emboj/cdg394
   Samarsky DA, 1998, EMBO J, V17, P3747, DOI 10.1093/emboj/17.13.3747
   Schattner P, 2004, NUCLEIC ACIDS RES, V32, P4281, DOI 10.1093/nar/gkh768
   Schattner P, 2006, RNA, V12, P15, DOI 10.1261/rna.2210406
   Schmitz J, 2008, GENOME RES, V18, P1005, DOI 10.1101/gr.7177908
   Shao P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-86
   Siederdissen CHZ, 2010, BIOINFORMATICS, V26, pi453, DOI 10.1093/bioinformatics/btq370
   Spudich GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-295
   Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112
   Tafer H, 2010, BIOINFORMATICS, V26, P610, DOI 10.1093/bioinformatics/btp680
   Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tycowski KT, 2004, CURR BIOL, V14, P1985, DOI 10.1016/j.cub.2004.11.003
   TYCOWSKI KT, 1994, SCIENCE, V266, P1558, DOI 10.1126/science.7985025
   Tycowski KT, 1998, MOL CELL, V2, P629, DOI 10.1016/S1097-2765(00)80161-6
   Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0
   Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3
   Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065
   Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672
   Zemann A, 2006, NUCLEIC ACIDS RES, V34, P2676, DOI 10.1093/nar/gkl359
   Zhang Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-61
   Zhang Y, 2009, NUCLEIC ACIDS RES, V37, P6562, DOI 10.1093/nar/gkp704
NR 55
TC 20
Z9 20
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1547-6286
EI 1555-8584
J9 RNA BIOL
JI RNA Biol.
PD NOV-DEC
PY 2011
VL 8
IS 6
BP 938
EP 946
DI 10.4161/rna.8.6.16603
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 869WV
UT WOS:000298630600001
PM 21955586
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kimmel, RA
   Onder, L
   Wilfinger, A
   Ellertsdottir, E
   Meyer, D
AF Kimmel, Robin A.
   Onder, Lucas
   Wilfinger, Armin
   Ellertsdottir, Elin
   Meyer, Dirk
TI Requirement for Pdx1 in specification of latent endocrine progenitors in
   zebrafish
SO BMC BIOLOGY
LA English
DT Article
ID EXOCRINE PANCREAS; BETA-CELLS; DIFFERENTIATION; MICE; MORPHOGENESIS;
   GENES; ISLET; FATE; ORGANOGENESIS; NEUROGENIN3
AB Background: Insulin-producing beta cells emerge during pancreas development in two sequential waves. Recently described later-forming beta cells in zebrafish show high similarity to second wave mammalian beta cells in developmental capacity. Loss-of-function studies in mouse and zebrafish demonstrated that the homeobox transcription factors Pdx1 and Hb9 are both critical for pancreas and beta cell development and discrete stage-specific requirements for these genes have been uncovered. Previously, exocrine and endocrine cell recovery was shown to follow loss of pdx1 in zebrafish, but the progenitor cells and molecular mechanisms responsible have not been clearly defined. In addition, interactions of pdx1 and hb9 in beta cell formation have not been addressed.
   Results: To learn more about endocrine progenitor specification, we examined beta cell formation following morpholino-mediated depletion of pdx1 and hb9. We find that after early beta cell reduction, recovery occurs following loss of either pdx1 or hb9 function. Unexpectedly, simultaneous knockdown of both hb9 and pdx1 leads to virtually complete and persistent beta cell deficiency. We used a NeuroD:EGFP transgenic line to examine endocrine cell behavior in vivo and developed a novel live-imaging technique to document emergence and migration of late-forming endocrine precursors in real time. Our data show that Notch-responsive progenitors for late-arising endocrine cells are predominantly post mitotic and depend on pdx1. By contrast, early-arising endocrine cells are specified and differentiate independent of pdx1.
   Conclusions: The nearly complete beta cell deficiency after combined loss of hb9 and pdx1 suggests functional cooperation, which we clarify as distinct roles in early and late endocrine cell formation. A novel imaging approach permitted visualization of the emergence of late endocrine cells within developing embryos for the first time. We demonstrate a pdx1-dependent progenitor population essential for the formation of duct-associated, second wave endocrine cells. We further reveal an unexpectedly low mitotic activity in these progenitor cells, indicating that they are set aside early in development.
C1 [Kimmel, Robin A.; Wilfinger, Armin; Meyer, Dirk] Leopold Francis Univ, Inst Mol Biology CMBI, A-6020 Innsbruck, Austria.
   [Onder, Lucas] Kantonsspital St Gallen, Inst Immunobiol, LFA, CH-6900 St Gallen, Switzerland.
   [Ellertsdottir, Elin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Kimmel, RA (corresponding author), Leopold Francis Univ, Inst Mol Biology CMBI, Technikerstr 25, A-6020 Innsbruck, Austria.
EM Robin.Kimmel@uibk.ac.at; dirk.meyer@uibk.ac.at
RI Kimmel, Robin/AAP-5821-2020
OI Kimmel, Robin/0000-0002-9283-1252; Meyer, Dirk/0000-0002-4020-4484
FU University of Freiburg; Austrian Science Fund (FWF)Austrian Science Fund
   (FWF) [P20492, M1150]; Austrian Science Fund (FWF)Austrian Science Fund
   (FWF) [P 20492] Funding Source: researchfish
FX We thank Wolfgang Driever for general support during the initial phase
   of this project and for the Tg(ins:dsRed)m1018 fish line, Julian Lewis
   for the 2F11 antibody, Teresa Nicolson for the TgBAC(NeuroD:EGFP)nl1
   fish line, Petra Haas and Darren Gilmour for the
   Tg(-8.0cldnb:lynEGFP)zf106 fish line, and Chris Wright for the Pdx1
   antibody. We are grateful to Mayra Eduardoff for technical assistance,
   Tanja Walsen, Sonja Toechterle and Dzenana Tufegdzic for transgenic
   zebrafish care, and Pia Aanstad and Carmen Birchmeier for critical
   reading of the manuscript and helpful discussions. This work was funded
   by the University of Freiburg and Austrian Science Fund (FWF) grants
   P20492 and M1150 to DM and RAK, respectively.
CR Ahlgren U, 1996, DEVELOPMENT, V122, P1409
   Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763
   Apelqvist A, 1999, NATURE, V400, P877
   Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3
   Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984
   Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb
   Burlison JS, 2008, DEV BIOL, V316, P74, DOI 10.1016/j.ydbio.2008.01.011
   Chen S, 2007, PANCREAS, V34, P120, DOI 10.1097/01.mpa.0000246661.23128.8c
   Chung WS, 2008, DEV CELL, V15, P738, DOI 10.1016/j.devcel.2008.08.019
   Chung WS, 2008, DEV CELL, V14, P582, DOI 10.1016/j.devcel.2008.02.012
   Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961
   Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7
   Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106
   Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038
   Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607
   Guney MA, 2009, BIRTH DEFECTS RES C, V87, P232, DOI 10.1002/bdrc.20156
   Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019
   Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026
   Harrison KA, 1999, NAT GENET, V23, P71
   Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106
   Huang HG, 2001, GENESIS, V30, P134, DOI 10.1002/gene.1048
   Itkin-Ansari P, 2005, DEV DYNAM, V233, P946, DOI 10.1002/dvdy.20443
   Kim W, 2010, BIOCHEM BIOPH RES CO, V392, P247, DOI 10.1016/j.bbrc.2009.12.115
   Kimmel RA, 2010, METHOD CELL BIOL, V100, P261, DOI 10.1016/B978-0-12-384892-5.00010-4
   Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499
   Langenberg T, 2003, DEV DYNAM, V228, P464, DOI 10.1002/dvdy.10395
   Li H, 1999, NAT GENET, V23, P67
   Lin JW, 2004, DEV BIOL, V270, P474, DOI 10.1016/j.ydbio.2004.02.023
   Moro E, 2009, DEV BIOL, V332, P299, DOI 10.1016/j.ydbio.2009.05.576
   Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770
   Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323
   Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008
   Offield MF, 1996, DEVELOPMENT, V122, P983
   Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028
   Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584
   Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002
   Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024
   Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005
   Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533
   Shin D, 2011, DEVELOPMENT, V138, P1339, DOI 10.1242/dev.054395
   Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003
   Soyer J, 2010, DEVELOPMENT, V137, P203, DOI 10.1242/dev.041673
   Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514
   Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016
   Wang YY, 2011, DEVELOPMENT, V138, P609, DOI 10.1242/dev.059097
   Ward AB, 2007, DEV DYNAM, V236, P1558, DOI 10.1002/dvdy.21168
   Wendik B, 2004, DEV BIOL, V268, P372, DOI 10.1016/j.ydbio.2003.12.026
   Yee NS, 2001, GENESIS, V30, P137, DOI 10.1002/gene.1049
   Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041
NR 49
TC 28
Z9 29
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD OCT 31
PY 2011
VL 9
AR 75
DI 10.1186/1741-7007-9-75
PG 14
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 848IL
UT WOS:000297045100001
PM 22034951
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Lewandowski, JR
   Sass, HJ
   Grzesiek, S
   Blackledge, M
   Emsley, L
AF Lewandowski, Jozef R.
   Sass, Hans Juergen
   Grzesiek, Stephan
   Blackledge, Martin
   Emsley, Lyndon
TI Site-Specific Measurement of Slow Motions in Proteins
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SPIN-LATTICE-RELAXATION; ROTATING-FRAME RELAXATION; STATE
   NMR-SPECTROSCOPY; BACKBONE DYNAMICS; CRYSTALLINE PROTEIN; ROTARY
   RESONANCE; ORDER PARAMETERS; MODEL; C-13; SYSTEMS
AB We demonstrate that a quantitative measure of slow molecular motions in solid proteins can be accessed by measuring site-specific N-15 rotating-frame relaxation rates at high magic-angle-spinning frequencies.
C1 [Lewandowski, Jozef R.; Emsley, Lyndon] Univ Lyon, CNRS, ENS Lyon, UCB Lyon 1,Ctr RMN Tres Hauts Champs, F-69100 Villeurbanne, France.
   [Sass, Hans Juergen; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Blackledge, Martin] UJF, CEA, CNRS, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38027 Grenoble, France.
RP Emsley, L (corresponding author), Univ Lyon, CNRS, ENS Lyon, UCB Lyon 1,Ctr RMN Tres Hauts Champs, F-69100 Villeurbanne, France.
EM lyndon.emsley@ens-lyon.fr
RI Emsley, Lyndon/C-6108-2008; Lewandowski, Jozef/F-3480-2011; Emsley,
   Lyndon/AAS-6384-2020
OI Emsley, Lyndon/0000-0003-1360-2572; Lewandowski,
   Jozef/0000-0001-6525-7083; Emsley, Lyndon/0000-0003-1360-2572; Grzesiek,
   Stephan/0000-0003-1998-4225
FU Agence Nationale de la Recherche (ANR)French National Research Agency
   (ANR); ECEuropean CommissionEuropean Commission Joint Research
   CentreEuropean Community (EC) [BioNMR 261863]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [31-132857];
   EUEuropean Union (EU) [PIRG03-GA-2008-231026]
FX We thank Hartmut Oschkinat and Anna Diehl for providing the SH3 samples.
   We acknowledge support from Agence Nationale de la Recherche (ANR PCV
   2007 Protein Motion), the Access to Research Infrastructures Activity in
   the Seventh Framework Program of the EC (BioNMR 261863), and Swiss
   National Science Foundation Grant 31-132857. J.R.L. acknowledges support
   from EU IRG (PIRG03-GA-2008-231026).
CR AKASAKA K, 1983, J CHEM PHYS, V78, P3567, DOI 10.1063/1.445183
   Bremi T, 1997, J AM CHEM SOC, V119, P6672, DOI 10.1021/ja9708676
   BRUSCHWEILER R, 1994, J AM CHEM SOC, V116, P8426
   Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1
   Chevelkov V, 2007, MAGN RESON CHEM, V45, pS156, DOI 10.1002/mrc.2129
   Chevelkov V, 2009, J BIOMOL NMR, V45, P197, DOI 10.1007/s10858-009-9348-5
   DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691
   Giraud N, 2005, J AM CHEM SOC, V127, P18190, DOI 10.1021/ja055182h
   Giraud N, 2004, J AM CHEM SOC, V126, P11422, DOI 10.1021/ja046578g
   Idiyatullin D, 2003, J PHYS CHEM B, V107, P2602, DOI 10.1021/jp022294b
   Krushelnitsky A, 2010, J AM CHEM SOC, V132, P11850, DOI 10.1021/ja103582n
   Lesage A, 1999, J AM CHEM SOC, V121, P10987, DOI 10.1021/ja992272b
   LEVITT MH, 1988, ISRAEL J CHEM, V28, P271
   Lewandowski JR, 2010, J AM CHEM SOC, V132, P8252, DOI 10.1021/ja102744b
   Lewandowski JR, 2010, J AM CHEM SOC, V132, P1246, DOI 10.1021/ja907067j
   Lienin S. F, 1998, EIDGENOSSISCHE TH
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   NIELSEN NC, 1994, J CHEM PHYS, V101, P1805, DOI 10.1063/1.467759
   OAS TG, 1988, J CHEM PHYS, V89, P692, DOI 10.1063/1.455191
   PENG JW, 1991, J MAGN RESON, V94, P82, DOI 10.1016/0022-2364(91)90296-6
   Salmon L, 2009, ANGEW CHEM INT EDIT, V48, P4154, DOI 10.1002/anie.200900476
   VANDERHART DL, 1979, J CHEM PHYS, V71, P2773, DOI 10.1063/1.438682
   WIGLEY DB, 1990, FEBS LETT, V277, P267, DOI 10.1016/0014-5793(90)80862-D
NR 23
TC 74
Z9 74
U1 4
U2 58
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD OCT 26
PY 2011
VL 133
IS 42
BP 16762
EP 16765
DI 10.1021/ja206815h
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 843NH
UT WOS:000296678200014
PM 21923156
DA 2021-01-25
ER

PT J
AU Dames, SA
   Junemann, A
   Sass, HJ
   Schonichen, A
   Stopschinski, BE
   Grzesiek, S
   Faix, J
   Geyer, M
AF Dames, Sonja A.
   Junemann, Alexander
   Sass, Hans J.
   Schoenichen, Andre
   Stopschinski, Barbara E.
   Grzesiek, Stephan
   Faix, Jan
   Geyer, Matthias
TI Structure, Dynamics, Lipid Binding, and Physiological Relevance of the
   Putative GTPase-binding Domain of Dictyostelium Formin C
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; 3-DIMENSIONAL STRUCTURE; PROTEIN
   STRUCTURES; DIPOLAR COUPLINGS; CLEAVAGE FURROW; RAS-BINDING; FH1 DOMAIN;
   NMR; PHAGOCYTOSIS; ACTIVATION
AB Dictyostelium Formin C (ForC) is involved in the regulation of local actin cytoskeleton reorganization (e.g. during cellular adhesion or migration). ForC contains formin homology 2 and 3 (FH2 and -3) domains and an N-terminal putative GTPase-binding domain (GBD) but lacks a canonical FH1 region. To better understand the role of the GBD, its structure, dynamics, lipid-binding properties, and cellular functions were analyzed by NMR and CD spectroscopy and by in vivo fluorescence microscopy. Moreover, the program CS-Rosetta was tested for the structure prediction based on chemical shift data only. The ForC GBD adopts an ubiquitin-like alpha/beta-roll fold with an unusually long loop between beta-strands 1 and 2. Based on the lipid-binding data, the presence of DPC micelles induces the formation of alpha-helical secondary structure and a rearrangement of the tertiary structure. Lipid-binding studies with a mutant protein and a peptide suggest that the beta 1-beta 2 loop is not relevant for these conformational changes. Whereas small amounts of negatively charged phosphoinositides (1,2-dioctanoyl-sn-glycero-3(phosphoinositol 4,5-bisphosphate) and 1,2-dihexanoyl-sn-glycero-3-(phosphoinositol 3,4,5-trisphosphate)) lower the micelle concentration necessary to induce the observed spectral changes, other negatively charged phospholipids (1,2-dihexanoyl-sn-glycero-3-(phospho-L-serine) and 1,2-dihexanoyl-snglycero-3-phospho-(1'-rac-glycerol)) had no such effect. Interestingly, bicelles and micelles composed of diacylphospho-cholines had no effect on the GBD structure. Our data suggest a model in which part of the large positively charged surface area of the GBD mediates localization to specific membrane patches, thereby regulating interactions with signaling proteins. Our cellular localization studies show that both the GBD and the FH3 domain are required for ForC targeting to cell-cell contacts and early phagocytic cups and macropinosomes.
C1 [Dames, Sonja A.] Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, D-85747 Garching, Germany.
   [Junemann, Alexander; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-30623 Hannover, Germany.
   [Sass, Hans J.; Grzesiek, Stephan] Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   [Schoenichen, Andre; Stopschinski, Barbara E.; Geyer, Matthias] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany.
RP Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.
EM sonja.dames@tum.de
OI Grzesiek, Stephan/0000-0003-1998-4225; Geyer,
   Matthias/0000-0002-7718-5002; Dames, Sonja/0000-0001-7495-6943
FU German Research FoundationGerman Research Foundation (DFG) [DA 1195/3-1,
   FA 330-6-1, GE 976/4-2]; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [31-109712]
FX This work was supported by German Research Foundation Grants DA 1195/3-1
   (to S. A. D.), FA 330-6-1 (to J. F.), and GE 976/4-2 (to M. G.) and
   Swiss National Science Foundation Grant 31-109712 (to S. G.).
CR Ahn HC, 2006, J AM CHEM SOC, V128, P4398, DOI 10.1021/ja057773d
   Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8
   Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002
   BRUNE D, 1993, P NATL ACAD SCI USA, V90, P3835, DOI 10.1073/pnas.90.9.3835
   Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200
   Clarke M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-154
   Dames SA, 2011, BIOMOL NMR ASSIGN, V5, P47, DOI 10.1007/s12104-010-9264-3
   Dames SA, 2010, J BIOL CHEM, V285, P7766, DOI 10.1074/jbc.M109.058404
   Dames Sonja A, 2008, J Biol Chem, V283, P23485, DOI 10.1074/jbc.M708335200
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185
   Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579
   Dumontier M, 2000, J CELL SCI, V113, P2253
   Faix J, 2001, EMBO J, V20, P3705, DOI 10.1093/emboj/20.14.3705
   Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001
   Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866
   Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0
   Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694
   Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647
   Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256
   Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449
   Han YY, 2009, J BIOL CHEM, V284, P33409, DOI 10.1074/jbc.M109.060699
   Harris E, 2002, J CELL SCI, V115, P3703, DOI 10.1242/jcs.00050
   Hauser H, 2000, BBA-BIOMEMBRANES, V1508, P164, DOI 10.1016/S0304-4157(00)00008-3
   Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014
   Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609
   Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895
   Kessin RH, 2000, NATURE, V408, P917, DOI 10.1038/35050184
   Kitayama C, 2003, J CELL SCI, V116, P711, DOI 10.1242/jcs.00265
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200
   Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801
   Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299
   Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v
   Lucas LH, 2004, CONCEPT MAGN RESON A, V20A, P24, DOI 10.1002/cmr.a.10094
   Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h
   Morris Andrew J., 1999, Trends in Pharmacological Sciences, V20, P393, DOI 10.1016/S0165-6147(99)01390-5
   Nabuurs SB, 2004, PROTEINS, V55, P483, DOI 10.1002/prot.20118
   Oldfield E, 2002, ANNU REV PHYS CHEM, V53, P349, DOI 10.1146/annurev.physchem.53.082201.124235
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3
   Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062
   RAGHUNATHAN V, 1992, FEBS LETT, V297, P46, DOI 10.1016/0014-5793(92)80324-A
   Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001
   Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649
   Rivero F, 1999, MOL BIOL CELL, V10, P1205, DOI 10.1091/mbc.10.4.1205
   Rivero F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-28
   Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604
   Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h
   Rupper A, 2001, J CELL SCI, V114, P2449
   Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014
   Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200
   Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364
   Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   SERTH J, 1991, EMBO J, V10, P1325, DOI 10.1002/j.1460-2075.1991.tb07651.x
   Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105
   Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5
   Somesh BP, 2006, EUKARYOT CELL, V5, P1648, DOI 10.1128/EC.00221-06
   TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9
   Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
   Weber I, 1999, EMBO J, V18, P586, DOI 10.1093/emboj/18.3.586
   Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8
   Xian WJ, 2002, J MOL BIOL, V322, P755, DOI 10.1016/S0022-2836(02)00841-0
   Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006
NR 72
TC 19
Z9 19
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 21
PY 2011
VL 286
IS 42
BP 36907
EP 36920
DI 10.1074/jbc.M111.225052
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 841UC
UT WOS:000296538300070
PM 21846933
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Gutnick, A
   Blechman, J
   Kaslin, J
   Herwig, L
   Belting, HG
   Affolter, M
   Bonkowsky, JL
   Levkowitz, G
AF Gutnick, Amos
   Blechman, Janna
   Kaslin, Jan
   Herwig, Lukas
   Belting, Heinz-Georg
   Affolter, Markus
   Bonkowsky, Joshua L.
   Levkowitz, Gil
TI The Hypothalamic Neuropeptide Oxytocin Is Required for Formation of the
   Neurovascular Interface of the Pituitary
SO DEVELOPMENTAL CELL
LA English
DT Article
ID ARGININE VASOTOCIN; ARTERIAL DIFFERENTIATION; COMPARATIVE PHYSIOLOGY;
   ENDOTHELIAL-CELLS; DEFICIENT MICE; BLOOD-PRESSURE; ZEBRAFISH;
   HYPOPHYSECTOMY; EXPRESSION; GENE
AB The hypothalamo-neurohypophyseal system (HNS) is the neurovascular structure through which the hypothalamic neuropeptides oxytocin and argininevasopressin exit the brain into the bloodstream, where they go on to affect peripheral physiology. Here, we investigate the molecular cues that regulate the neurovascular contact between hypothalamic axons and neurohypophyseal capillaries of the zebrafish. We developed a transgenic system in which both hypothalamic axons and neurohypophyseal vasculature can be analyzed in vivo. We identified the cellular organization of the zebrafish HNS as well as the dynamic processes that contribute to formation of the HNS neurovascular interface. We show that formation of this interface is regulated during development by local release of oxytocin, which affects endothelial morphogenesis. This cell communication process is essential for the establishment of a tight axovasal interface between the neurons and blood vessels of the HNS. We present a unique example of axons affecting endothelial morphogenesis through secretion of a neuropeptide.
C1 [Gutnick, Amos; Blechman, Janna; Levkowitz, Gil] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.
   [Kaslin, Jan] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia.
   [Herwig, Lukas; Belting, Heinz-Georg; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Bonkowsky, Joshua L.] Univ Utah, Dept Pediat, Salt Lake City, UT 84132 USA.
   [Bonkowsky, Joshua L.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.
RP Levkowitz, G (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, POB 26, IL-76100 Rehovot, Israel.
EM gil.levkowitz@weizmann.ac.il
RI Levkowitz, Gil/AAB-9441-2019
OI Levkowitz, Gil/0000-0002-3896-1881; Kaslin, Jan/0000-0002-6207-1889;
   Affolter, Markus/0000-0002-5171-0016; Belting,
   Heinz-Georg/0000-0002-1538-4364
FU Israel Science FoundationIsrael Science Foundation; Minerva Foundation;
   Kirk Center for Childhood Cancer and Immunological Disorders; Irvin
   Green Alzheimer's Research Fund; NATIONAL INSTITUTE ON DRUG ABUSEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)
   [K08DA024753, K08DA024753, K08DA024753, K08DA024753, K08DA024753]
   Funding Source: NIH RePORTER
FX Thanks are due to Helit Nabel-Rosen for her initial observation of HN
   projections; Shifra Ben Dor for phylogenetic and genomic analyses; Genia
   Brodsky for help with figure graphics; Yossy Machluf and Liron Gibbs for
   FACS technical advice. Chi-Bin Chien for the Tol2kit plasmid vectors;
   Didier Stainier, Wiebke Herzog, Nathan Lawson, Michael Parsons, and
   Shlomo Melmed for transgenic lines. The research in the Levkowitz lab is
   supported by the Israel Science Foundation; Minerva Foundation; Kirk
   Center for Childhood Cancer and Immunological Disorders; Irvin Green
   Alzheimer's Research Fund. G.L. is an incumbent of the Tauro Career
   Development Chair in Biomedical Research. We declare that we have no
   conflicting interests. A.G. and J.B. designed and performed most of the
   experiments and collected and analyzed the data. J.K. performed the
   colocalization experiment of oxytocin and EGFP in adult fish. J.L.B.
   generated the otpb:Gal4 line and performed the analysis of Otp+ HN
   projections. L.H., H.-G.B., and M.A. generated the fli1:Gal4;UAS: Kaede
   line. G.L. initiated and headed the project and helped with data
   interpretation. G.L. and A.G. prepared the manuscript and figures.
CR Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787
   Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875
   AMER S, 1995, AM J PHYSIOL-REG I, V269, pR775
   BARGMANN W, 1949, J MOL MED, V27, P617
   Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970
   BILLENSTIEN DC, 1955, ENDOCRINOLOGY, V56, P704, DOI 10.1210/endo-56-6-704
   BLECHMAN J, 2011, J NEUROSCI IN PRESS
   Blechman J, 2007, DEVELOPMENT, V134, P4417, DOI 10.1242/dev.011262
   BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132
   Burbach JPH, 2001, PHYSIOL REV, V81, P1197
   CAJAL SRY, 1911, HISTOLOGIE SYSTEME N
   Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875
   Cassoni P, 2006, MOL CANCER RES, V4, P351, DOI 10.1158/1541-7786.MCR-06-0024
   Cattaneo MG, 2008, BRIT J PHARMACOL, V153, P728, DOI 10.1038/sj.bjp.0707609
   Cattaneo MG, 2009, EXP CELL RES, V315, P3210, DOI 10.1016/j.yexcr.2009.06.022
   CHAN DKO, 1977, AM ZOOL, V17, P751
   Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408
   Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58
   DANIEL PM, 1972, BRAIN, V95, P813, DOI 10.1093/brain/95.4.813
   Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033
   EURENIUS L, 1977, ANAT EMBRYOL, V152, P89, DOI 10.1007/BF00341437
   FINK G, 1971, Z ZELLFORSCH MIK ANA, V119, P208, DOI 10.1007/BF00324522
   Fujimoto E, 2011, DEV BIOL, V352, P393, DOI 10.1016/j.ydbio.2011.01.023
   GALABOV PG, 1983, CELL TISSUE RES, V228, P685
   Gelfand MV, 2009, TRENDS CELL BIOL, V19, P99, DOI 10.1016/j.tcb.2009.01.001
   Gimpl G, 2001, PHYSIOL REV, V81, P629
   HARRIS GW, 1948, PHYSIOL REV, V28, P139
   HARRIS GW, 1948, J PHYSIOL-LONDON, V107, P436, DOI 10.1113/jphysiol.1948.sp004288
   HARRIS GW, 1955, NEURAL CONTROL PITUI, V3
   Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995
   Jankowski M, 2004, P NATL ACAD SCI USA, V101, P13074, DOI 10.1073/pnas.0405324101
   Kasahara Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3122, DOI 10.1271/bbb.70498
   Kobayashi H, 2009, J CARDIOVASC PHARM, V54, P510, DOI 10.1097/FJC.0b013e3181bfac02
   Kulczykowska E, 1998, EXP PHYSIOL, V83, P809, DOI 10.1113/expphysiol.1998.sp004161
   Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343
   LAPOINTE J, 1977, AM ZOOL, V17, P763
   LEMEVEL JC, 1993, BRAIN RES, V610, P82, DOI 10.1016/0006-8993(93)91220-M
   Lim AH, 2011, DEVELOPMENT, V138, P3847, DOI 10.1242/dev.068403
   Liu NA, 2006, MOL ENDOCRINOL, V20, P871, DOI 10.1210/me.2005-0403
   Liu NA, 2003, MOL ENDOCRINOL, V17, P959, DOI 10.1210/me.2002-0392
   MACFARLANE NA, 1974, GEN COMP ENDOCR, V22, P77, DOI 10.1016/0016-6480(74)90090-2
   Machluf Y, 2011, ANN NY ACAD SCI, V1220, P93, DOI 10.1111/j.1749-6632.2010.05945.x
   Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859
   Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200
   MOLL J, 1957, Z ZELLFORSCH MIK ANA, V46, P686, DOI 10.1007/BF00339372
   MOLL JOHANNES, 1958, J MORPH, V102, P1, DOI 10.1002/jmor.1051020102
   Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2
   Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675
   OKADO N, 1980, AM J ANAT, V159, P261, DOI 10.1002/aja.1001590303
   Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499
   PETER RE, 1983, ENDOCRINE FUNCTIONS, V2
   Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338
   Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232
   SATHYANESAN AG, 1965, GEN COMP ENDOCR, V5, P456, DOI 10.1016/0016-6480(65)90106-1
   Scharrer E, 1928, Z VERGL PHYSIOL, V7, P1, DOI DOI 10.1007/BF00341151
   STAINIER DYR, 1995, DEVELOPMENT, V121, P3141
   STUTINSKY F, 1951, CR SOC BIOL, V145, P367
   Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9
   Thibonnier M, 1999, ENDOCRINOLOGY, V140, P1301, DOI 10.1210/en.140.3.1301
   Unger JL, 2003, GENE EXPR PATTERNS, V3, P105, DOI 10.1016/S1567-133X(02)00064-9
   Verbalis JG, 2007, J AM SOC NEPHROL, V18, P3056, DOI 10.1681/ASN.2007070825
   Wakasa T, 2009, GYNECOL OBSTET INVES, V67, P137, DOI 10.1159/000172805
   Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902
   Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033
NR 64
TC 28
Z9 28
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD OCT 18
PY 2011
VL 21
IS 4
BP 642
EP 654
DI 10.1016/j.devcel.2011.09.004
PG 13
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 839LA
UT WOS:000296366000009
PM 22014522
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Carinhas, N
   Robitaille, AM
   Moes, S
   Carrondo, MJT
   Jenoe, P
   Oliveira, R
   Alves, PM
AF Carinhas, Nuno
   Robitaille, Aaron Mark
   Moes, Suzette
   Teixeira Carrondo, Manuel Jose
   Jenoe, Paul
   Oliveira, Rui
   Alves, Paula Marques
TI Quantitative Proteomics of Spodoptera frugiperda Cells during Growth and
   Baculovirus Infection
SO PLOS ONE
LA English
DT Article
ID NUCLEAR POLYHEDROSIS-VIRUS; HEPATITIS-C VIRUS; MESSENGER-RNA; INSECT;
   GENE; NUCLEOPOLYHEDROVIRUS; SEQUENCE; DENSITY; COMPLEX; SYSTEMS
AB Baculovirus infection of Spodoptera frugiperda cells is a system of choice to produce a range of recombinant proteins, vaccines and, potentially, gene therapy vectors. While baculovirus genomes are well characterized, the genome of S. frugiperda is not sequenced and the virus-host molecular interplay is sparsely known. Herein, we describe the application of stable isotope labeling by amino acids in cell culture (SILAC) to obtain the first comparative proteome quantitation of S. frugiperda cells during growth and early baculovirus infection. The proteome coverage was maximized by compiling a search database with protein annotations from insect species. Of interest were differentially proteins related to energy metabolism, endoplasmic reticulum and oxidative stress, yet not investigated in the scope of baculovirus infection. Further, the reduced expression of key viral-encoded proteins early in the infection cycle is suggested to be related with decreased viral replication at high cell density culture. These findings have implications for virological research and improvement of baculovirus-based bioprocesses.
C1 [Carinhas, Nuno; Teixeira Carrondo, Manuel Jose; Alves, Paula Marques] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Inst Biol Expt & Tecnol, Oeiras, Portugal.
   [Robitaille, Aaron Mark; Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland.
   [Oliveira, Rui] Univ Nova Lisboa, Dept Quim, Fac Ciencias & Tecnol, REQUIMTE,Syst Biol & Engn Grp SBE, Caparica, Portugal.
RP Carinhas, N (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Inst Biol Expt & Tecnol, Oeiras, Portugal.
EM marques@itqb.unl.pt
RI Oliveira, Rui/D-8815-2013; Carrondo, Manuel/C-8155-2011; Alves, Paula
   M/C-1070-2008
OI Alves, Paula M/0000-0003-1445-3556; Oliveira, Rui/0000-0001-8077-4177;
   Carrondo, Manuel/0000-0002-4550-4574; Robitaille, Aaron
   Mark/0000-0003-2774-2066; Carinhas, Nuno/0000-0002-3321-1221
FU BACULOGENES [FP6 LHSB-CT-2006-037541]; CLINIGENE-NoEEuropean Union (EU)
   [FP6 LSHB-CT-2004-018933]; Fundacao para a Ciencia e a Tecnologia
   (FCT)Portuguese Foundation for Science and Technology
   [SFRH/BD/36676/2007]
FX This work was partially supported by the European Project BACULOGENES
   (FP6 LHSB-CT-2006-037541) and CLINIGENE-NoE (FP6 LSHB-CT-2004-018933).
   NC acknowledges Fundacao para a Ciencia e a Tecnologia (FCT) for his
   Ph.D. grant (SFRH/BD/36676/2007). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Acharya A, 2002, CURR SCI INDIA, V83, P455
   Adam Petra, 2005, BMC Biochem, V6, P24, DOI 10.1186/1471-2091-6-24
   BEIDLER DR, 1995, J BIOL CHEM, V270, P16526, DOI 10.1074/jbc.270.28.16526
   Bernal V, 2009, BIOTECHNOL BIOENG, V104, P162, DOI 10.1002/bit.22364
   Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855
   Carinhas N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-34
   Carinhas N, 2010, METAB ENG, V12, P39, DOI 10.1016/j.ymben.2009.08.008
   Carinhas N, 2009, APPL MICROBIOL BIOT, V81, P1041, DOI 10.1007/s00253-008-1727-4
   CARSTENS EB, 1979, VIROLOGY, V99, P386, DOI 10.1016/0042-6822(79)90017-5
   Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10
   Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719
   Doverskog M, 1997, J BIOTECHNOL, V59, P103, DOI 10.1016/S0168-1656(97)00172-7
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348
   Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P1697, DOI 10.1074/mcp.M500190-MCP200
   GRULA MA, 1981, J VIROL, V38, P916, DOI 10.1128/JVI.38.3.916-921.1981
   Harvey AJ, 1997, MOL CELL BIOL, V17, P2835, DOI 10.1128/MCB.17.5.2835
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Ikonomou L, 2003, APPL MICROBIOL BIOT, V62, P1, DOI 10.1007/s00253-003-1223-9
   Imami K, 2010, MOL BIOSYST, V6, P594, DOI 10.1039/b921379a
   Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095
   Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200
   Landais I, 2003, BIOINFORMATICS, V19, P2343, DOI 10.1093/bioinformatics/btg324
   Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105
   Lucas M, 2001, INT J EXP PATHOL, V82, P269, DOI 10.1046/j.1365-2613.2001.00204.x
   Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067
   Mannova P, 2006, MOL CELL PROTEOMICS, V5, P2319, DOI 10.1074/mcp.M600121-MCP200
   Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625
   Maynard ND, 2010, BIOTECHNOL J, V5, P686, DOI 10.1002/biot.201000080
   Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322
   Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0
   Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162
   Okano K, 2006, VIROLOGY, V344, P77, DOI 10.1016/j.virol.2005.09.019
   Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200
   OOI BG, 1988, VIROLOGY, V166, P515, DOI 10.1016/0042-6822(88)90522-3
   OReilly D.R., 1992, BACULOVIRUS EXPRESSI
   Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056
   Popham HJR, 2010, J INSECT PHYSIOL, V56, P1237, DOI 10.1016/j.jinsphys.2010.03.024
   Prikhodko EA, 1998, J VIROL, V72, P684
   Ramachandran A, 2001, CURR SCI INDIA, V81, P998
   Sah NK, 1999, P NATL ACAD SCI USA, V96, P4838, DOI 10.1073/pnas.96.9.4838
   Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006
   Scheper GC, 1997, J GEN VIROL, V78, P687, DOI 10.1099/0022-1317-78-3-687
   Schultz KLW, 2009, J VIROL, V83, P11123, DOI 10.1128/JVI.01199-09
   Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004
   van Oers MM, 2001, INSECT MOL BIOL, V10, P255, DOI 10.1046/j.1365-2583.2001.00263.x
   vanStrien EA, 1997, J GEN VIROL, V78, P2365, DOI 10.1099/0022-1317-78-9-2365
   Wang Y, 2001, FREE RADICAL BIO MED, V31, P1448, DOI 10.1016/S0891-5849(01)00728-6
   Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097
   Wu CH, 2001, NUCLEIC ACIDS RES, V29, P52, DOI 10.1093/nar/29.1.52
   Xiao W, 2009, VIROLOGY, V391, P83, DOI 10.1016/j.virol.2009.06.007
NR 53
TC 20
Z9 21
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 18
PY 2011
VL 6
IS 10
AR e26444
DI 10.1371/journal.pone.0026444
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 837ID
UT WOS:000296186900064
PM 22039490
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Truttmann, MC
   Guye, P
   Dehio, C
AF Truttmann, Matthias C.
   Guye, Patrick
   Dehio, Christoph
TI BID-F1 and BID-F2 Domains of Bartonella henselae Effector Protein BepF
   Trigger Together with BepC the Formation of Invasome Structures
SO PLOS ONE
LA English
DT Article
ID RHO-PROTEINS; BACTERIAL; FAMILY; BINDING; GTPASES; GLUCOSYLATION;
   LAMELLIPODIA; CYTOSKELETON; PREDICTION; SEQUENCE
AB The gram-negative, zoonotic pathogen Bartonella henselae (Bhe) translocates seven distinct Bartonella effector proteins (Beps) via the VirB/VirD4 type IV secretion system (T4SS) into human cells, thereby interfering with host cell signaling [1,2]. In particular, the effector protein BepG alone or the combination of effector proteins BepC and BepF trigger massive F-actin rearrangements that lead to the establishment of invasome structures eventually resulting in the internalization of entire Bhe aggregates [2,3]. In this report, we investigate the molecular function of the effector protein BepF in the eukaryotic host cell. We show that the N-terminal [E/T]PLYAT tyrosine phosphorylation motifs of BepF get phosphorylated upon translocation but do not contribute to invasome-mediated Bhe uptake. In contrast, we found that two of the three BID domains of BepF are capable to trigger invasome formation together with BepC, while a mutation of the WxxxE motif of the BID-F1 domain inhibited its ability to contribute to the formation of invasome structures. Next, we show that BepF function during invasome formation can be replaced by the over-expression of constitutive-active Rho GTPases Rac1 or Cdc42. Finally we demonstrate that BID-F1 and BID-F2 domains promote the formation of filopodia-like extensions in NIH 3T3 and HeLa cells as well as membrane protrusions in HeLa cells, suggesting a role for BepF in Rac1 and Cdc42 activation during the process of invasome formation.
C1 [Truttmann, Matthias C.; Guye, Patrick; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Guye, Patrick] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
RP Truttmann, MC (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
EM Christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; truttmann, matthias/0000-0002-0536-7923
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-132979]; Howard Hughes Medical InstituteHoward Hughes
   Medical Institute; SystemsX.ch [51RT-0_126008]; Swiss Initiative for
   Systems Biology;  [5500550]
FX This work was supported by grant 31003A-132979 from the Swiss National
   Science Foundation, grant 5500550 and from the Howard Hughes Medical
   Institute and grant 51RT-0_126008 (InfectX) from SystemsX.ch, the Swiss
   Initiative for Systems Biology. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031
   Arbeloa A, 2010, CELL MICROBIOL, V12, P654, DOI 10.1111/j.1462-5822.2009.01423.x
   Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310
   Bulgin R, 2010, INFECT IMMUN, V78, P1417, DOI 10.1128/IAI.01250-09
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Fiorentini C, 1997, J BIOL CHEM, V272, P19532, DOI 10.1074/jbc.272.31.19532
   Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897
   Guillou H, 2008, EXP CELL RES, V314, P478, DOI 10.1016/j.yexcr.2007.10.026
   Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4
   Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0
   Litvak Y, 2003, TRENDS BIOCHEM SCI, V28, P628, DOI 10.1016/j.tibs.2003.10.001
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584
   Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, TRANSLOCATED BACTERI
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c
   Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004
   Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282
   Sun JJ, 2004, J BIOL CHEM, V279, P42936, DOI 10.1074/jbc.M406493200
   TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606
   Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382
NR 33
TC 14
Z9 14
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 17
PY 2011
VL 6
IS 10
AR e25106
DI 10.1371/journal.pone.0025106
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 834SM
UT WOS:000295984400007
PM 22043280
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Panzanelli, P
   Gunn, BG
   Schlatter, MC
   Benke, D
   Tyagarajan, SK
   Scheiffele, P
   Belelli, D
   Lambert, JJ
   Rudolph, U
   Fritschy, JM
AF Panzanelli, Patrizia
   Gunn, Benjamin G.
   Schlatter, Monika C.
   Benke, Dietmar
   Tyagarajan, Shiva K.
   Scheiffele, Peter
   Belelli, Delia
   Lambert, Jeremy J.
   Rudolph, Uwe
   Fritschy, Jean-Marc
TI Distinct mechanisms regulate GABA(A) receptor and gephyrin clustering at
   perisomatic and axo-axonic synapses on CA1 pyramidal cells
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
ID INITIAL SEGMENT; INHIBITORY SYNAPSES; GABAERGIC SYNAPSES; A-RECEPTORS;
   GABA(A)-RECEPTOR SUBTYPES; GLYCOPROTEIN COMPLEX; HIPPOCAMPAL-NEURONS;
   MOUSE HIPPOCAMPAL; PURKINJE-CELLS; RAT-BRAIN
AB Pyramidal cells express various GABA(A) receptor (GABA(A)R) subtypes, possibly to match inputs from functionally distinct interneurons targeting specific subcellular domains. Postsynaptic anchoring of GABA(A)Rs is ensured by a complex interplay between the scaffolding protein gephyrin, neuroligin-2 and collybistin. Direct interactions between these proteins and GABA(A)R subunits might contribute to synapse-specific distribution of GABA(A)R subtypes. In addition, the dystrophin-glycoprotein complex, mainly localized at perisomatic synapses, regulates GABA(A)R postsynaptic clustering at these sites. Here, we investigated how the functional and molecular organization of GABAergic synapses in CA1 pyramidal neurons is altered in mice lacking the GABA(A)R alpha 2 subunit (alpha 2-KO). We report a marked, layer-specific loss of postsynaptic gephyrin and neuroligin-2 clusters, without changes in GABAergic presynaptic terminals. Whole-cell voltage-clamp recordings in slices from alpha 2-KO mice show a 40% decrease in GABAergic mIPSC frequency, with unchanged amplitude and kinetics. Applying low/high concentrations of zolpidem to discriminate between alpha 1- and alpha 2/alpha 3-GABA(A)Rs demonstrates that residual mIPSCs in alpha 2-KO mice are mediated by alpha 1-GABA(A)Rs. Immunofluorescence analysis reveals maintenance of alpha 1-GABA(A)R and neuroligin-2 clusters, but not gephyrin clusters, in perisomatic synapses of mutant mice, along with a complete loss of these three markers on the axon initial segment. This striking subcellular difference correlates with the preservation of dystrophin clusters, colocalized with neuroligin-2 and alpha 1-GABA(A)Rs on pyramidal cell bodies of mutant mice. Dystrophin was not detected on the axon initial segment in either genotype. Collectively, these findings reveal synapse-specific anchoring of GABA(A)Rs at postsynaptic sites and suggest that the dystrophin-glycoprotein complex contributes to stabilize alpha 1-GABA(A)R and neuroligin-2, but not gephyrin, in perisomatic postsynaptic densities.
C1 [Schlatter, Monika C.; Benke, Dietmar; Tyagarajan, Shiva K.; Fritschy, Jean-Marc] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland.
   [Panzanelli, Patrizia] Univ Turin, Dept Anat Pharmacol & Forens Med, I-10124 Turin, Italy.
   [Panzanelli, Patrizia] Univ Turin, Natl Inst Neurosci Italy, I-10124 Turin, Italy.
   [Gunn, Benjamin G.; Belelli, Delia; Lambert, Jeremy J.] Univ Dundee, Med Res Inst, Ninewells Hosp & Med Sch, Ctr Neurosci, Dundee DD1 9SY, Scotland.
   [Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Rudolph, Uwe] Harvard Univ, McLean Hosp, Sch Med, Lab Genet Neuropharmacol, Belmont, MA 02478 USA.
   [Rudolph, Uwe] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA.
RP Fritschy, JM (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM fritschy@pharma.uzh.ch
RI Tyagarajan, Shiva/P-3135-2015
OI Tyagarajan, Shiva/0000-0003-0074-1805; Fritschy,
   Jean-Marc/0000-0002-8552-3702; Belelli, Delia/0000-0001-7912-8637;
   Panzanelli, Patrizia/0000-0002-5127-2757
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_130495, 31003A-125209]; Compagnia di San PaoloCompagnia
   di San Paolo; University of Turin; MRCMedical Research Council UK (MRC)
   [G1000008]; Medical Research CouncilMedical Research Council UK (MRC)
   [G0802715, G1000008] Funding Source: researchfish
FX The study was supported by the Swiss National Science Foundation (grant
   31003A_130495 to J.-M.F. and grant 31003A-125209 to P.S.), the
   'Compagnia di San Paolo' and the World Wide Style Program (University of
   Turin). Studies in the D.B. and J.J.L. lab were in part funded by the
   MRC (G1000008). We are grateful to Ruth Keist for her role in the
   generation of alpha 2-KO mice, Franziska Parpan for mouse genotyping,
   and Corinne Sidler, Thomas Grampp and Smitha Punnakkal for technical
   help.
CR Anderson JL, 2004, BRAIN RES, V1019, P289, DOI 10.1016/j.brainres.2004.06.011
   Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004
   Arancibia-Carcamo IL, 2009, PHARMACOL THERAPEUT, V123, P17, DOI 10.1016/j.pharmthera.2009.03.012
   Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018
   Brunig I, 2002, J NEUROSCI, V22, P4805, DOI 10.1523/JNEUROSCI.22-12-04805.2002
   Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102
   Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x
   CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H
   COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0
   Dixon CI, 2008, PHARMACOL BIOCHEM BE, V90, P1, DOI 10.1016/j.pbb.2008.01.015
   Dixon CI, 2010, P NATL ACAD SCI USA, V107, P2289, DOI 10.1073/pnas.0910117107
   EWERT M, 1990, J CELL BIOL, V110, P2043, DOI 10.1083/jcb.110.6.2043
   Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625
   Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321
   Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799
   Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012
   Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3
   Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006
   FRITSCHY JM, 1994, J NEUROSCI, V14, P5302
   FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111
   Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006
   Fritschy JM, 1998, NEUROSCI LETT, V249, P99, DOI 10.1016/S0304-3940(98)00397-8
   Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034
   Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265
   Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008
   GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749
   Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0
   Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119
   Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008
   Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100
   Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x
   Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381
   Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x
   Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866
   Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191
   Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002
   Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008
   Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131
   Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003
   MARKSITZER R, 1993, J RECEPTOR RES, V13, P467, DOI 10.3109/10799899309073673
   Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x
   Panzanelli P, 2009, J NEUROSCI, V29, P15039, DOI 10.1523/JNEUROSCI.3034-09.2009
   Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006
   Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105
   Paysan J, 1997, P NATL ACAD SCI USA, V94, P6995, DOI 10.1073/pnas.94.13.6995
   Peden DR, 2008, J PHYSIOL-LONDON, V586, P965, DOI 10.1113/jphysiol.2007.145375
   Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210
   Perronnet C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/849426
   Pilgram GSK, 2010, MOL NEUROBIOL, V41, P1, DOI 10.1007/s12035-009-8089-5
   Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023
   Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006
   Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852
   Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368
   SCHWALLER B, 1993, CELL CALCIUM, V14, P639, DOI 10.1016/0143-4160(93)90089-O
   Schwarzer C, 2001, J COMP NEUROL, V433, P526, DOI 10.1002/cne.1158
   Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115
   Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003
   Sumita K, 2007, J NEUROCHEM, V100, P154, DOI 10.1111/j.1471-4159.2006.04170.x
   Thomson AM, 2010, EUR J NEUROSCI, V31, P2193, DOI 10.1111/j.1460-9568.2010.07252.x
   Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008
   Vaillend C, 2004, NEUROBIOL DIS, V17, P10, DOI 10.1016/j.nbd.2004.05.004
   Vollenweider I, 2011, BEHAV BRAIN RES, V217, P77, DOI 10.1016/j.bbr.2010.10.009
   Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x
NR 65
TC 91
Z9 92
U1 0
U2 16
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-3751
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD OCT 15
PY 2011
VL 589
IS 20
BP 4959
EP 4980
DI 10.1113/jphysiol.2011.216028
PG 22
WC Neurosciences; Physiology
SC Neurosciences & Neurology; Physiology
GA 835AF
UT WOS:000296004900014
PM 21825022
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Vogt, KE
   Gerharz, S
   Graham, J
   Canepari, M
AF Vogt, Kaspar E.
   Gerharz, Stephan
   Graham, Jeremy
   Canepari, Marco
TI Combining Membrane Potential Imaging with L-Glutamate or GABA
   Photorelease
SO PLOS ONE
LA English
DT Article
ID METABOTROPIC SLOW EPSC; CA1 PYRAMIDAL NEURONS; INOSITOL TRISPHOSPHATE;
   PURKINJE NEURONS; LASER PHOTOLYSIS; CAGED COMPOUNDS; RAT; VOLTAGE;
   RECEPTORS; RELEASE
AB Combining membrane potential imaging using voltage sensitive dyes with photolysis of L-glutamate or GABA allows the monitoring of electrical activity elicited by the neurotransmitter at different sub-cellular sites. Here we describe a simple system and some basic experimental protocols to achieve these measurements. We show how to apply the neurotransmitter and how to vary the dimension of the area of photolysis. We assess the localisation of photolysis and of the recorded membrane potential changes by depolarising the dendrites of cerebellar Purkinje neurons with L-glutamate photorelease using different experimental protocols. We further show in the apical dendrites of CA1 hippocampal pyramidal neurons how L-glutamate photorelease can be used to calibrate fluorescence changes from voltage sensitive dyes in terms of membrane potential changes (in mV) and how GABA photorelease can be used to investigate the phenomenon of shunting inhibition. We also show how GABA photorelease can be used to measure chloride-mediated changes of membrane potential under physiological conditions originating from different regions of a neuron, providing important information on the local intracellular chloride concentrations. The method and the proof of principle reported here open the gateway to a variety of important applications where the advantages of this approach are necessary.
C1 [Vogt, Kaspar E.; Gerharz, Stephan; Canepari, Marco] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland.
   [Graham, Jeremy] CAIRN Res Ltd, Faversham, England.
   [Canepari, Marco] INSERM, U836, Team 3, Grenoble, France.
   [Canepari, Marco] Univ Grenoble 1, Inst Neurosci, Grenoble, France.
RP Vogt, KE (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland.
EM marco.canepari@ujf-grenoble.fr
RI Canepari, Marco/H-6772-2012
OI Canepari, Marco/0000-0001-9759-2388; Vogt, Kaspar/0000-0002-0859-876X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0_122000]; Agence nationale de la rechercheFrench National
   Research Agency (ANR) [Voltimagmicro, Emergence-10]
FX The experiments (new equipment and running costs) were purchased with
   the grant of the Swiss National Science Foundation (grant
   3100A0_122000). The publication fee is covered by the grant of the
   Agence nationale de la recherche (grant: Voltimagmicro, Emergence-10).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0
   Canepari M, 2004, J NEUROSCI, V24, P3563, DOI 10.1523/JNEUROSCI.5374-03.2004
   Canepari M, 2003, J NEUROSCI, V23, P4066
   Canepari M, 2001, J PHYSIOL-LONDON, V533, P765, DOI 10.1111/j.1469-7793.2001.00765.x
   Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4
   Canepari M, MEMBRANE POTENTIAL I
   Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005
   Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770
   Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024
   Canepari M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004011
   Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y
   Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013
   Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3
   CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D
   Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004
   Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503
   Graham BP, 2001, NETWORK-COMP NEURAL, V12, P473, DOI 10.1088/0954-898X/12/4/304
   Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7
   Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008
   KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884
   KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976
   Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381
   Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209
   Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003
   Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736
   Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/NCHEMBIO.321, 10.1038/nchembio.321]
   MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.bb.18.060189.001323
   Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X
   Pettit DL, 2000, J NEUROPHYSIOL, V84, P28
   Routh BN, 2009, J NEUROPHYSIOL, V102, P2288, DOI 10.1152/jn.00082.2009
   Sobie EA, 2007, PFLUG ARCH EUR J PHY, V454, P663, DOI 10.1007/s00424-007-0229-z
   STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X
   Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325
   Trigo FF, 2010, NEURON, V66, P235, DOI 10.1016/j.neuron.2010.03.030
   Trigo FF, 2009, J NEUROSCI METH, V181, P159, DOI 10.1016/j.jneumeth.2009.04.022
   Trigo FF, 2009, J NEUROSCI METH, V180, P9, DOI 10.1016/j.jneumeth.2009.01.032
   Vogt KE, 2011, J PHYSIOL-LONDON, V589, P489, DOI 10.1113/jphysiol.2010.200220
   WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1
NR 38
TC 20
Z9 20
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 11
PY 2011
VL 6
IS 10
AR e24911
DI 10.1371/journal.pone.0024911
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 834OZ
UT WOS:000295973200003
PM 22022367
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Franosch, T
   Grimm, M
   Belushkin, M
   Mor, FM
   Foffi, G
   Forro, L
   Jeney, S
AF Franosch, Thomas
   Grimm, Matthias
   Belushkin, Maxim
   Mor, Flavio M.
   Foffi, Giuseppe
   Forro, Laszlo
   Jeney, Sylvia
TI Resonances arising from hydrodynamic memory in Brownian motion
SO NATURE
LA English
DT Article
ID OPTICAL-TWEEZERS; COMPLEX FLUIDS; ACTIN NETWORKS; SINGLE CELLS;
   TECHNOLOGIES
AB Observation of the Brownian motion of a small probe interacting with its environment provides one of the main strategies for characterizing soft matter(1-4). Essentially, two counteracting forces govern the motion of the Brownian particle. First, the particle is driven by rapid collisions with the surrounding solvent molecules, referred to as thermal noise. Second, the friction between the particle and the viscous solvent damps its motion. Conventionally, the thermal force is assumed to be random and characterized by a Gaussian white noise spectrum. The friction is assumed to be given by the Stokes drag, suggesting that motion is overdamped at long times in particle tracking experiments, when inertia becomes negligible. However, as the particle receives momentum from the fluctuating fluid molecules, it also displaces the fluid in its immediate vicinity. The entrained fluid acts back on the particle and gives rise to long-range correlations(5,6). This hydrodynamic 'memory' translates to thermal forces, which have a coloured, that is, non-white, noise spectrum. One hundred years after Perrin's pioneering experiments on Brownian motion(7-9), direct experimental observation of this colour is still elusive(10). Here we measure the spectrum of thermal noise by confining the Brownian fluctuations of a microsphere in a strong optical trap. We show that hydrodynamic correlations result in a resonant peak in the power spectral density of the sphere's positional fluctuations, in strong contrast to overdamped systems. Furthermore, we demonstrate different strategies to achieve peak amplification. By analogy with microcantilever-based sensors(11,12), our results reveal that the particle-fluid-trap system can be considered a nanomechanical resonator in which the intrinsic hydrodynamic backflow enhances resonance. Therefore, instead of being treated as a disturbance, details in thermal noise could be exploited for the development of new types of sensor and particle-based assay in lab-on-a-chip applications(13,14).
C1 [Grimm, Matthias; Jeney, Sylvia] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Franosch, Thomas] Univ Erlangen Nurnberg, Inst Theoret Phys, D-91058 Erlangen, Germany.
   [Grimm, Matthias; Mor, Flavio M.; Forro, Laszlo; Jeney, Sylvia] Ecole Polytech Fed Lausanne, Lab Phys Complex Matter, CH-1015 Lausanne, Switzerland.
   [Belushkin, Maxim; Foffi, Giuseppe] Ecole Polytech Fed Lausanne, Inst Theoret Phys, CH-1015 Lausanne, Switzerland.
RP Jeney, S (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sylvia.jeney@epfl.ch
RI Foffi, Giuseppe/C-3923-2009
OI Foffi, Giuseppe/0000-0002-7444-1453
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [200021-113529, 206021-121396]; NCCR Nanoscale ScienceSwiss
   National Science Foundation (SNSF); German Academic Exchange Service
   (DAAD)Deutscher Akademischer Austausch Dienst (DAAD); National
   Competence Center in Biomedical Imaging (NCCBI); SNF [PP0022_119006]
FX S.J. acknowledges the Swiss National Science Foundation (SNF; grant nos
   200021-113529 and 206021-121396). M. G. is supported by NCCR Nanoscale
   Science and the German Academic Exchange Service (DAAD) and F. M. M. is
   supported by the National Competence Center in Biomedical Imaging
   (NCCBI). M. B. and G. F. acknowledge support from the SNF (grant no.
   PP0022_119006). We thank W. Offner and R. Koszali for technical help and
   U. Aebi, B. U. Felderhof, H. Flyvbjerg, S. Melchionna, E. Sackmann and
   R. G. Winkler for discussions.
CR ALDER BJ, 1967, PHYS REV LETT, V18, P988, DOI 10.1103/PhysRevLett.18.988
   ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0
   Berg-Sorensen K, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/038
   Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654
   Bormuth V, 2008, OPT EXPRESS, V16, P13831, DOI 10.1364/OE.16.013831
   Braeckmans K, 2002, NAT REV DRUG DISCOV, V1, P447, DOI 10.1038/nrd817
   Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741
   Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459
   CLERCX HJH, 1992, PHYS REV A, V46, P1942, DOI 10.1103/PhysRevA.46.1942
   Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061
   Di Leonardo R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.010601
   Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806
   Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316
   Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087
   Gompper G, 2009, ADV POLYM SCI, V221, P1, DOI 10.1007/12_2008_5
   Hanggi P, 2005, CHAOS, V15, DOI 10.1063/1.1895505
   HINCH EJ, 1975, J FLUID MECH, V72, P499, DOI 10.1017/S0022112075003102
   Huang RX, 2011, NAT PHYS, V7, P576, DOI [10.1038/nphys1953, 10.1038/NPHYS1953]
   Jeney S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/25/255102
   Jeney S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240604
   Lukic B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011112
   MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Pedersen L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.189801
   Perrin J, 1909, ANN CHIM PHYS, V18, P5
   Perrin J, 1920, ATOMS
   Peterman EJG, 2003, REV SCI INSTRUM, V74, P3246, DOI 10.1063/1.1584085
   Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z
   Vladimirsky V., 1945, ZH EKSP TEOR FIZ, V15, P258
   WANG MC, 1945, REV MOD PHYS, V17, P323, DOI 10.1103/RevModPhys.17.323
   ZERBE C, 1994, PHYS REV E, V49, P3626, DOI 10.1103/PhysRevE.49.3626
NR 31
TC 221
Z9 223
U1 4
U2 187
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD OCT 6
PY 2011
VL 478
IS 7367
BP 85
EP 88
DI 10.1038/nature10498
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 829JN
UT WOS:000295575400039
PM 21979048
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Heyden, A
   Ionescu, MCS
   Romorini, S
   Kracht, B
   Ghiglieri, V
   Calabresi, P
   Seidenbecher, C
   Angenstein, F
   Gundelfinger, ED
AF Heyden, Alexandra
   Ionescu, Mihai-Constantin S.
   Romorini, Stefano
   Kracht, Bettina
   Ghiglieri, Veronica
   Calabresi, Paolo
   Seidenbecher, Constanze
   Angenstein, Frank
   Gundelfinger, Eckart D.
TI Hippocampal enlargement in Bassoon-mutant mice is associated with
   enhanced neurogenesis, reduced apoptosis, and abnormal BDNF levels
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Brain-derived neurotrophic factor; Epilepsy; Hippocampus; Presynapse;
   Mouse (Bsn mutant)
ID TEMPORAL-LOBE EPILEPSY; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; ADULT
   NEUROGENESIS; STATUS EPILEPTICUS; NEURONAL INJURY; GRANULE CELLS;
   NETWORK REORGANIZATION; PRESYNAPTIC CYTOMATRIX; EXCITATORY SYNAPSES
AB Mice mutant for the presynaptic protein Bassoon develop epileptic seizures and an altered pattern of neuronal activity that is accompanied by abnormal enlargement of several brain structures, with the strongest size increase in hippocampus and cortex. Using manganese-enhanced magnetic resonance imaging, an abnormal brain enlargement was found, which is first detected in the hippocampus 1 month after birth and amounts to an almost 40% size increase of this structure after 3 months. Stereological quantification of cell numbers revealed that enlargement of the dentate gyrus and the hippocampus proper is associated with larger numbers of principal neurons and of astrocytes. In search for the underlying mechanisms, an approximately 3-fold higher proportion of proliferation and survival of new-born cells in the dentate gyrus was found to go hand in hand with similarly larger numbers of doublecortin-positive cells and reduced numbers of apoptotic cells in the dentate gyrus and the hippocampus proper. Enlargement of the hippocampus and of other forebrain structures was accompanied by increased levels of brain-derived neurotrophic factor (BDNF). These data show that hippocampal overgrowth in Bassoon-mutant mice arises from a dysregulation of neurogenesis and apoptosis that might be associated with unbalanced BDNF levels.
C1 [Angenstein, Frank] Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, D-39118 Magdeburg, Germany.
   [Heyden, Alexandra; Romorini, Stefano; Kracht, Bettina; Seidenbecher, Constanze; Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany.
   [Heyden, Alexandra] DZNE, Magdeburg, Germany.
   [Ionescu, Mihai-Constantin S.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Ghiglieri, Veronica; Calabresi, Paolo] IRCCS, Fdn Santa Lucia, Lab Neurofisiol, Rome, Italy.
   [Angenstein, Frank] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany.
RP Angenstein, F (corresponding author), Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, Brenneckestr 6, D-39118 Magdeburg, Germany.
EM as.heyden@googlemail.com; angenstein@ifn-magdeburg.de
RI Calabresi, Paolo/G-8496-2011; Ghiglieri, Veronica/G-7076-2011
OI Ghiglieri, Veronica/0000-0003-2885-8298; Calabresi,
   Paolo/0000-0003-0326-5509
FU Pakt fur Forschung und Innovation of the Leibniz Society; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 779];
   ECEuropean CommissionEuropean Commission Joint Research CentreEuropean
   Community (EC) [222918]
FX This work was supported by the Pakt fur Forschung und Innovation of the
   Leibniz Society, the Deutsche Forschungsgemeinschaft (SFB 779) and the
   EC contract number 222918 (REPLACES) FP7 - Thematic priority HEALTH.
CR Almgren M, 2008, EUR J PAEDIATR NEURO, V12, P438, DOI 10.1016/j.ejpn.2007.11.008
   Almgren M, 2007, HIPPOCAMPUS, V17, P292, DOI 10.1002/hipo.20268
   Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885
   Altar CA, 2003, BIOL PSYCHIAT, V54, P703, DOI 10.1016/S0006-3223(03)00073-8
   ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302
   Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6
   AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508
   Angenstein F, 2007, CEREB CORTEX, V17, P28, DOI 10.1093/cercer/bhj121
   ANGEVINE JB, 1965, EXP NEUROL, VS, P1
   Baraban SC, 2007, CURR OPIN NEUROL, V20, P164, DOI 10.1097/WCO.0b013e328042bae0
   BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107
   Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3
   Ben-Ari Y, 2008, TRENDS NEUROSCI, V31, P626, DOI 10.1016/j.tins.2008.09.002
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9
   BLACKSTAD TW, 1956, J COMP NEUROL, V105, P417, DOI 10.1002/cne.901050305
   Blumcke I, 2002, BRAIN PATHOL, V12, P199
   Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778
   de No RL, 1934, J PSYCHOL NEUROL, V46, P113
   Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499
   Diez M, 2003, EUR J NEUROSCI, V18, P3218, DOI 10.1111/j.1460-9568.2003.02994.x
   Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144
   Donahue LR, 1996, MAMM GENOME, V7, P871, DOI 10.1007/s003359900259
   Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781
   Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3
   Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4
   Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5
   Ghiglieri V, 2010, NEUROPSYCHOPHARMACOL, V35, P1531, DOI 10.1038/npp.2010.23
   Ghiglieri V, 2009, EUR J NEUROSCI, V29, P1979, DOI 10.1111/j.1460-9568.2009.06733.x
   Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147
   Gozlan H, 2003, CEREB CORTEX, V13, P684, DOI 10.1093/cercor/13.6.684
   GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x
   Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026
   Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024
   Houser C R, 1999, Adv Neurol, V79, P743
   HOUSER CR, 1991, NEUROCHEM RES, V16, P295, DOI 10.1007/BF00966093
   Jeffreys JGR, 1999, BRAIN, V122, P1007, DOI 10.1093/brain/122.6.1007
   Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010
   Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005
   Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007
   Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704
   Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x
   Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x
   Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867
   Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038
   Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459
   Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   Parent JM, 1997, J NEUROSCI, V17, P3727
   Pencea V, 2001, J NEUROSCI, V21, P6706
   Petersson S, 2000, NEUROSCIENCE, V100, P297, DOI 10.1016/S0306-4522(00)00285-2
   Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010
   Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5
   Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2
   Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016
   Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050
   Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001
   Sgobio C, 2010, BIOL PSYCHIAT, V67, P567, DOI 10.1016/j.biopsych.2009.11.008
   Sloviter RS, 1999, EPILEPSIA, V40, pS34, DOI 10.1111/j.1528-1157.1999.tb00876.x
   Smalla KH, 2000, P NATL ACAD SCI USA, V97, P4327, DOI 10.1073/pnas.080389297
   SORIANO E, 1986, DEV BRAIN RES, V30, P88, DOI 10.1016/0165-3806(86)90134-3
   Stringer JL, 1996, BRAIN RES, V717, P147, DOI 10.1016/0006-8993(96)00059-5
   Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004
   Unsain N, 2008, NEUROSCIENCE, V154, P978, DOI 10.1016/j.neuroscience.2008.04.038
   Unsain N, 2009, J NEUROCHEM, V111, P428, DOI 10.1111/j.1471-4159.2009.06342.x
   van Vliet EA, 2004, EXP NEUROL, V187, P367, DOI 10.1016/j.expneurol.2004.01.016
   von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4
   Wittner L, 2005, BRAIN, V128, P138, DOI 10.1093/brain/awh339
   Wyneken U, 2003, EPILEPSIA, V44, P243, DOI 10.1046/j.1528-1157.2003.17602.x
   Yokoi Toshiaki, 2007, Osaka City Med J, V53, P63
   Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739
   Zhai R, 2000, MOL CELL NEUROSCI, V15, P417, DOI 10.1006/mcne.2000.0839
   Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4
   Zhang W, 2009, J NEUROSCI, V29, P14247, DOI 10.1523/JNEUROSCI.3842-09.2009
   Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684
NR 75
TC 13
Z9 14
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD OCT
PY 2011
VL 346
IS 1
BP 11
EP 26
DI 10.1007/s00441-011-1233-3
PG 16
WC Cell Biology
SC Cell Biology
GA 849KA
UT WOS:000297123200002
PM 21935677
DA 2021-01-25
ER

PT J
AU Hamaratoglu, F
   de Lachapelle, AM
   Pyrowolakis, G
   Bergmann, S
   Affolter, M
AF Hamaratoglu, Fisun
   de Lachapelle, Aitana Morton
   Pyrowolakis, George
   Bergmann, Sven
   Affolter, Markus
TI Dpp Signaling Activity Requires Pentagone to Scale with Tissue Size in
   the Growing Drosophila Wing Imaginal Disc
SO PLOS BIOLOGY
LA English
DT Article
ID MORPHOGEN GRADIENT; PATTERN-FORMATION; GROWTH-REGULATION; BRINKER;
   PROLIFERATION; REPRESSION; PROTEIN; EXPRESSION; RECEPTORS; ALLOMETRY
AB The wing of the fruit fly, Drosophila melanogaster, with its simple, two-dimensional structure, is a model organ well suited for a systems biology approach. The wing arises from an epithelial sac referred to as the wing imaginal disc, which undergoes a phase of massive growth and concomitant patterning during larval stages. The Decapentaplegic (Dpp) morphogen plays a central role in wing formation with its ability to co-coordinately regulate patterning and growth. Here, we asked whether the Dpp signaling activity scales, i.e. expands proportionally, with the growing wing imaginal disc. Using new methods for spatial and temporal quantification of Dpp activity and its scaling properties, we found that the Dpp response scales with the size of the growing tissue. Notably, scaling is not perfect at all positions in the field and the scaling of target gene domains is ensured specifically where they define vein positions. We also found that the target gene domains are not defined at constant concentration thresholds of the downstream Dpp activity gradients P-Mad and Brinker. Most interestingly, Pentagone, an important secreted feedback regulator of the pathway, plays a central role in scaling and acts as an expander of the Dpp gradient during disc growth.
C1 [Hamaratoglu, Fisun; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
   [de Lachapelle, Aitana Morton; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.
   [de Lachapelle, Aitana Morton; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland.
   [Pyrowolakis, George] Univ Freiburg, Inst Biol 1, D-7800 Freiburg, Germany.
   [Pyrowolakis, George] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, Freiburg, Germany.
RP Hamaratoglu, F (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM fisun.hamaratoglu@unibas.ch; Sven.Bergmann@unil.ch;
   Markus.Affolter@unibas.ch
OI Lebrand Neves, Aitana/0000-0002-3984-6842; Hamaratoglu,
   Fisun/0000-0002-1461-9248; Affolter, Markus/0000-0002-5171-0016;
   Bergmann, Sven/0000-0002-6785-9034
FU WingX RTD; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Kantons of Basel-Stadt and Basel-Land; International
   Human Frontier Science Program OrganizationHuman Frontier Science
   Program [LT000234-2009]; NICHDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD);
   SystemsX.ch
FX SystemsX.ch within the framework of the WingX RTD, the Swiss National
   Science Foundation, the Kantons of Basel-Stadt and Basel-Land and the
   International Human Frontier Science Program Organization
   (LT000234-2009) supported this work. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; We thank Thomas Schaffter, Simon
   Restrepo, and Konrad Basler for their input during the initial setup of
   this project. We are grateful to Vincent Dion, Georg Halder, Amanda
   Ochoa-Espinosa, and Gerald Schwank for critical reading of the
   manuscript, and to Oguz Kanca and Heinz-Georg Belting for discussions.
   Laurent Gelman (FAIM, FMI, Basel) provided us with valuable advice
   regarding linear imaging, and Emmanuel Caussinus wrote a macro for
   ImageJ. We thank Stefan Harmansa for the Dpp-GFP image. The Ptc and Wg
   monoclonal antibodies developed by I Guerrero and SM Cohen,
   respectively, were obtained from the Developmental Studies Hybridoma
   Bank developed under the auspices of the NICHD and maintained by The
   University of Iowa, Department of Biology, Iowa City, Iowa.
CR Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166
   Barkai N, 2009, FEBS J, V276, P1196, DOI 10.1111/j.1742-4658.2008.06854.x
   Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101
   Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031
   Ben-Zvi D, 2010, P NATL ACAD SCI USA, V107, P6924, DOI 10.1073/pnas.0912734107
   Biehs B, 1998, DEVELOPMENT, V125, P4245
   Birdsall K, 2000, EVOL DEV, V2, P16, DOI 10.1046/j.1525-142x.2000.00034.x
   Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606
   Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062
   Burke R, 1996, DEVELOPMENT, V122, P2261
   Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5
   Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100
   de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0
   de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258
   de Lachapelle AM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.7
   Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989
   Foronda D, 2009, MECH DEVELOP, V126, P99, DOI 10.1016/j.mod.2008.12.002
   Funakoshi Y, 2001, DEVELOPMENT, V128, P67
   Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200
   Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636
   Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104
   Huxley J., 1972, PROBLEMS RELATIVE GR, V2nd ed.
   Jazwinska A, 1999, DEVELOPMENT, V126, P3323
   Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774
   KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x
   Lin XH, 1999, NATURE, V400, P281
   Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385
   Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003
   Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383
   Mesquita D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000566
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Moser M, 2005, DEV BIOL, V286, P647, DOI 10.1016/j.ydbio.2005.08.036
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Nijhout HF, 2010, SCIENCE, V330, P1693, DOI 10.1126/science.1197292
   Ninov N, 2010, CURR BIOL, V20, P513, DOI 10.1016/j.cub.2010.01.063
   PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0
   Parker NF, 2011, DEV BIOL
   Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5
   Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008
   Schwank G, 2011, DEV CELL, V20, P123, DOI 10.1016/j.devcel.2010.11.007
   Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635
   Shen J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-23
   Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584
   Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162
   Stern DL, 1999, DEVELOPMENT, V126, P1091
   Sturtevant MA, 1997, DEVELOPMENT, V124, P21
   Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7
   Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9
   Thompson DA. W., 1942, GROWTH FORM
   Tsuda M, 1999, NATURE, V400, P276
   Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362
   Verkhusha VV, 2003, BIOCHEMISTRY-US, V42, P7879, DOI 10.1021/bi034555t
   Vuilleumier R, 2011, FLY, V5, P210, DOI 10.4161/fly.5.3.15311
   Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064
   Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037
   Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715
   WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0
   WOLPERT L, 1998, PRINCIPLES DEV
   Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561
   ZECCA M, 1995, DEVELOPMENT, V121, P2265
NR 60
TC 64
Z9 64
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD OCT
PY 2011
VL 9
IS 10
AR e1001182
DI 10.1371/journal.pbio.1001182
PG 17
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 844GJ
UT WOS:000296735400011
PM 22039350
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Pantelic, RS
   Suk, JW
   Hao, YF
   Ruoff, RS
   Stahlberg, H
AF Pantelic, Radosav S.
   Suk, Ji Won
   Hao, Yufeng
   Ruoff, Rodney S.
   Stahlberg, Henning
TI Oxidative Doping Renders Graphene Hydrophilic, Facilitating Its Use As a
   Support in Biological TEM
SO NANO LETTERS
LA English
DT Article
DE Graphene; electron microscopy; cryo-EM; crystallography
ID ELECTRON-MICROSCOPY; RESOLUTION; FILMS; OXIDE
AB Graphene represents the first practical realization of crystalline supports in biological transmission electron microscopy (TEM) since their introduction over 30 years ago. The high transparency, minimal inelastic cross-section, and electrical conductivity of graphene are highly desirable characteristics for a TEM support. However, without a suitable method for rendering graphene supports, hydrophilic applications are limited. This work describes the in situ functionalization of graphene with minimal structural degradation, rendering TEM supports sufficiently hydrophilic for the mounting of biological samples.
C1 [Pantelic, Radosav S.; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, Basel, Switzerland.
   [Suk, Ji Won; Hao, Yufeng; Ruoff, Rodney S.] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.
   [Suk, Ji Won; Hao, Yufeng; Ruoff, Rodney S.] Univ Texas Austin, Mat Sci & Engn Program, Austin, TX 78712 USA.
RP Pantelic, RS (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, Basel, Switzerland.
EM Radosav.Pantelic@unibas.ch; R.Ruoff@mail.utexas.edu;
   Henning.Stahlberg@unibas.ch
RI Ruoff, Rodney/ABE-6532-2020; Suk, Ji Won/D-6073-2013; hao,
   yufeng/B-9178-2013; Stahlberg, Henning/H-1868-2011
OI Ruoff, Rodney/0000-0002-6599-6764; Suk, Ji Won/0000-0002-3953-6617;
   Stahlberg, Henning/0000-0002-1185-4592
FU NSFNational Science Foundation (NSF) [0969106]; Office of Naval
   ResearchOffice of Naval Research; Swiss initiative for Systems Biology
   (SystemsX.ch) [CINA]; Swiss National Science Foundation (NCCR TransCure,
   NCCR Structural Biology, and NCCR Nano)Swiss National Science Foundation
   (SNSF)
FX TMV was a kind gift from Dr. Ruben Diaz-Avalos (New York Structural
   Biology Center, USA) and Dr Philippe Ringler (C-CINA, Basel,
   Switzerland). We thank Gerardo Algara-Siller and Prof. Ute Kaiser (Group
   of Electron Microscopy of Materials Science, Central Facility of
   Electron Microscopy, University of Ulm, Ulm, Germany) for their
   assistance in the investigation of doped samples by Cs corrected TEM.
   The group of Prof. Rod Ruoff appreciates support from NSF award no.
   0969106 and the Office of Naval Research. This work was in part
   supported by the Swiss initiative for Systems Biology (SystemsX.ch,
   grant CINA) and the Swiss National Science Foundation (NCCR TransCure,
   NCCR Structural Biology, and NCCR Nano).
CR Aleman B, 2010, ACS NANO, V4, P4762, DOI 10.1021/nn100459u
   Benesch JLP, 2010, J STRUCT BIOL, V172, P161, DOI 10.1016/j.jsb.2010.03.004
   Chen JH, 2008, NAT PHYS, V4, P377, DOI 10.1038/nphys935
   DOBELLE WH, 1968, J CELL BIOL, V39, P733, DOI 10.1083/jcb.39.3.733
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   Evans JE, 2011, NANO LETT, V11, P2809, DOI 10.1021/nl201166k
   HAHN M, 1974, BIOCHIM BIOPHYS ACTA, V371, P267, DOI 10.1016/0005-2795(74)90176-7
   Jung I, 2008, NANO LETT, V8, P4283, DOI 10.1021/nl8019938
   Kelly DF, 2008, P NATL ACAD SCI USA, V105, P4703, DOI 10.1073/pnas.0800867105
   Li XS, 2010, NANO LETT, V10, P4328, DOI 10.1021/nl101629g
   Li XS, 2009, NANO LETT, V9, P4359, DOI 10.1021/nl902623y
   Li XS, 2009, NANO LETT, V9, P4268, DOI 10.1021/nl902515k
   Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245
   Liu L, 2008, NANO LETT, V8, P1965, DOI 10.1021/nl0808684
   Liu ZF, 2010, ADV FUNCT MATER, V20, P2857, DOI 10.1002/adfm.201000761
   Massover WH, 2011, MICRON, V42, P141, DOI 10.1016/j.micron.2010.05.006
   Mitsuoka K, 2011, MICRON, V42, P100, DOI 10.1016/j.micron.2010.08.006
   Mutus JY, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/063011
   Pantelic RS, 2011, J STRUCT BIOL, V174, P234, DOI 10.1016/j.jsb.2010.10.002
   Pantelic RS, 2010, J STRUCT BIOL, V170, P152, DOI 10.1016/j.jsb.2009.12.020
   Rhinow D, 2011, ULTRAMICROSCOPY, V111, P342, DOI 10.1016/j.ultramic.2011.01.028
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088
   Stahlberg H, 2008, ACS CHEM BIOL, V3, P268, DOI 10.1021/cb800037d
   Suk JW, 2011, ACS NANO, V5, P6916, DOI 10.1021/nn201207c
   Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291
   Westenfelder B, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/5/055502
   Ziegler K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266802
NR 29
TC 40
Z9 40
U1 6
U2 49
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
EI 1530-6992
J9 NANO LETT
JI Nano Lett.
PD OCT
PY 2011
VL 11
IS 10
BP 4319
EP 4323
DI 10.1021/nl202386p
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 830OT
UT WOS:000295667000051
PM 21910506
DA 2021-01-25
ER

PT J
AU Arnold, AS
   Christe, M
   Handschin, C
AF Arnold, A. S.
   Christe, M.
   Handschin, C.
TI The miRNA profile of human SMA samples
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 16th International Congress of the World-Muscle-Society
CY OCT 18-22, 2011
CL Algarve, PORTUGAL
SP World Muscle Soc
C1 [Arnold, A. S.; Christe, M.; Handschin, C.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Arnold, Anne-Sophie/A-9234-2014; Handschin, Christoph/E-6886-2015
OI Arnold, Anne-Sophie/0000-0002-2435-0297; Handschin,
   Christoph/0000-0003-0603-1097
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2011
VL 21
IS 9-10
BP 681
EP 681
DI 10.1016/j.nmd.2011.06.891
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 834JP
UT WOS:000295955900140
DA 2021-01-25
ER

PT J
AU Willmann, R
AF Willmann, R.
TI Standard operating procedures for preclinical efficacy studies in animal
   models of neuromuscular disease
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 16th International Congress of the World-Muscle-Society
CY OCT 18-22, 2011
CL Algarve, PORTUGAL
SP World Muscle Soc
C1 [Willmann, R.] Univ Basel, Biozentrum, TREAT NMD, Basel, Switzerland.
RI ; Sendtner, Michael/M-8137-2014
OI Gillingwater, Thomas/0000-0002-0306-5577; Burghes,
   Arthur/0000-0001-9031-1555; Wirth, Brunhilde/0000-0003-4051-5191;
   Sendtner, Michael/0000-0002-4737-2974; Parson, Simon/0000-0002-8848-8738
NR 0
TC 11
Z9 11
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2011
VL 21
IS 9-10
BP 722
EP 722
DI 10.1016/j.nmd.2011.06.1024
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 834JP
UT WOS:000295955900273
PM 21115346
DA 2021-01-25
ER

PT J
AU Arnold, AS
   Christe, M
   Handschin, C
AF Arnold, A. S.
   Christe, M.
   Handschin, C.
TI The role of PGC-1 alpha in the stabilization of the neuromuscular
   junction
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 16th International Congress of the World-Muscle-Society
CY OCT 18-22, 2011
CL Algarve, PORTUGAL
SP World Muscle Soc
C1 [Arnold, A. S.; Christe, M.; Handschin, C.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Handschin, Christoph/E-6886-2015; Arnold, Anne-Sophie/A-9234-2014
OI Handschin, Christoph/0000-0003-0603-1097; Arnold,
   Anne-Sophie/0000-0002-2435-0297
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2011
VL 21
IS 9-10
BP 746
EP 746
DI 10.1016/j.nmd.2011.06.1102
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 834JP
UT WOS:000295955900351
DA 2021-01-25
ER

PT J
AU Diaz-Troya, S
   Perez-Perez, ME
   Perez-Martin, M
   Moes, S
   Jeno, P
   Florencio, FJ
   Crespo, JL
AF Diaz-Troya, Sandra
   Esther Perez-Perez, Maria
   Perez-Martin, Marta
   Moes, Suzette
   Jeno, Paul
   Florencio, Francisco J.
   Crespo, Jose L.
TI Inhibition of Protein Synthesis by TOR Inactivation Revealed a Conserved
   Regulatory Mechanism of the BiP Chaperone in Chlamydomonas
SO PLANT PHYSIOLOGY
LA English
DT Article
ID AMINO-ACID-SEQUENCE; CELL-GROWTH CONTROL; SACCHAROMYCES-CEREVISIAE;
   BINDING-PROTEIN; PLANT-GROWTH; TRANSLATION INITIATION;
   ENDOPLASMIC-RETICULUM; DISTINCT ROLES; GENE-PRODUCTS; HEAT-SHOCK
AB The target of rapamycin (TOR) kinase integrates nutritional and stress signals to coordinately control cell growth in all eukaryotes. TOR associates with highly conserved proteins to constitute two distinct signaling complexes termed TORC1 and TORC2. Inactivation of TORC1 by rapamycin negatively regulates protein synthesis in most eukaryotes. Here, we report that down-regulation of TOR signaling by rapamycin in the model green alga Chlamydomonas reinhardtii resulted in pronounced phosphorylation of the endoplasmic reticulum chaperone BiP. Our results indicated that Chlamydomonas TOR regulates BiP phosphorylation through the control of protein synthesis, since rapamycin and cycloheximide have similar effects on BiP modification and protein synthesis inhibition. Modification of BiP by phosphorylation was suppressed under conditions that require the chaperone activity of BiP, such as heat shock stress or tunicamycin treatment, which inhibits N-linked glycosylation of nascent proteins in the endoplasmic reticulum. A phosphopeptide localized in the substrate-binding domain of BiP was identified in Chlamydomonas cells treated with rapamycin. This peptide contains a highly conserved threonine residue that might regulate BiP function, as demonstrated by yeast functional assays. Thus, our study has revealed a regulatory mechanism of BiP in Chlamydomonas by phosphorylation/dephosphorylation events and assigns a role to the TOR pathway in the control of BiP modification.
C1 [Diaz-Troya, Sandra; Esther Perez-Perez, Maria; Perez-Martin, Marta; Florencio, Francisco J.; Crespo, Jose L.] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain.
   [Moes, Suzette; Jeno, Paul] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Crespo, JL (corresponding author), Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain.
EM crespo@ibvf.csic.es
RI Diaz-Troya, Sandra/G-3382-2015; Perez Perez, Maria Esther/P-5892-2014;
   Florencio, Francisco J/K-7716-2014; Crespo, Jose L/L-3977-2014
OI Diaz-Troya, Sandra/0000-0002-5878-9062; Perez Perez, Maria
   Esther/0000-0003-0779-6665; Florencio, Francisco J/0000-0002-2068-7861;
   Crespo, Jose L/0000-0003-3514-1025
FU Spanish Ministry of Science and InnovationSpanish Government; Fondo
   Social EuropeoEuropean Social Fund (ESF) [BFU2009-07368, BFU2010-15708]
FX This study was supported by the Spanish Ministry of Science and
   Innovation and Fondo Social Europeo (grant nos. BFU2009-07368 to J.L.C.
   and BFU2010-15708 to F.J.F.).
CR Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12
   ANDERSON JV, 1994, PLANT PHYSIOL, V104, P1371, DOI 10.1104/pp.104.4.1371
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x
   Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771
   BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95
   Brodsky JL, 1998, FEBS LETT, V435, P183, DOI 10.1016/S0014-5793(98)01065-5
   CARLSSON L, 1983, P NATL ACAD SCI-BIOL, V80, P4664, DOI 10.1073/pnas.80.15.4664
   CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q
   Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993
   Crespo JL, 2005, PLANT PHYSIOL, V139, P1736, DOI 10.1104/pp.105.070847
   Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002
   De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884
   DENECKE J, 1991, PLANT CELL, V3, P1025, DOI 10.1105/tpc.3.9.1025
   Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117
   Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043
   Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555
   Diaz-Troya S, 2008, EUKARYOT CELL, V7, P212, DOI 10.1128/EC.00361-07
   Dobrenel T, 2011, BIOCHEM SOC T, V39, P477, DOI 10.1042/BST0390477
   Perez-Perez ME, 2010, ENZYMES, V28, P245, DOI 10.1016/S1874-6047(10)28012-5
   Perez-Perez ME, 2010, AUTOPHAGY, V6, P562, DOI 10.4161/auto.6.4.11822
   Perez-Perez ME, 2010, PLANT PHYSIOL, V152, P1874, DOI 10.1104/pp.109.152520
   FONTES EBP, 1991, PLANT CELL, V3, P483, DOI 10.1105/tpc.3.5.483
   FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x
   Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Gaut JR, 1997, CELL STRESS CHAPERON, V2, P252, DOI 10.1379/1466-1268(1997)002<0252:IVTPOI>2.3.CO;2
   Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Harris E. H., 1989, CHLAMYDOMONAS SOURCE
   HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Leiber RM, 2010, PLANT CELL, V22, P1898, DOI 10.1105/tpc.109.073007
   Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011883
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672
   Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931
   Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899
   Moreau M, 2010, ENZYMES, V27, P285, DOI 10.1016/S1874-6047(10)27015-4
   MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7
   Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7
   Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008
   Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]
   PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x
   Qian SB, 2010, J BIOL CHEM, V285, P27385, DOI 10.1074/jbc.M110.120295
   Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434
   Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x
   ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5
   SATOH M, 1993, EXP CELL RES, V205, P76, DOI 10.1006/excr.1993.1060
   Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996
   Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y
   Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Sormani R, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-26
   STAVIS RL, 1973, J CELL BIOL, V59, P367, DOI 10.1083/jcb.59.2.367
   Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2
   Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020
   VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   WELCH WJ, 1983, J BIOL CHEM, V258, P7102
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Xu Q, 1998, PLANT J, V15, P511, DOI 10.1046/j.1365-313X.1998.00232.x
   Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999
NR 67
TC 27
Z9 29
U1 0
U2 11
PU AMER SOC PLANT BIOLOGISTS
PI ROCKVILLE
PA 15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA
SN 0032-0889
EI 1532-2548
J9 PLANT PHYSIOL
JI Plant Physiol.
PD OCT
PY 2011
VL 157
IS 2
BP 730
EP 741
DI 10.1104/pp.111.179861
PG 12
WC Plant Sciences
SC Plant Sciences
GA 829ZJ
UT WOS:000295625700018
PM 21825107
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Schulz, JG
   Ceulemans, H
   Caussinus, E
   Baietti, MF
   Affolter, M
   Hassan, BA
   David, G
AF Schulz, Joachim G.
   Ceulemans, Helga
   Caussinus, Emmanuel
   Baietti, Maria F.
   Affolter, Markus
   Hassan, Bassem A.
   David, Guido
TI Drosophila syndecan regulates tracheal cell migration by stabilizing
   Robo levels
SO EMBO REPORTS
LA English
DT Article
DE cell migration; Drosophila; heparan sulphate; Robo; tracheal system
ID HEPARAN-SULFATE PROTEOGLYCAN; BRANCHING MORPHOGENESIS; AXON GUIDANCE;
   SLIT; SURFACE; MIDLINE; COMMISSURELESS; ANGIOGENESIS; ACTIVATION;
   MECHANISMS
AB Here we identify a new role for Syndecan (Sdc), the only transmembrane heparan sulphate proteoglycan in Drosophila, in tracheal development. Sdc is required cell autonomously for efficient directed migration and fusion of dorsal branch cells, but not for dorsal branch formation per se. The cytoplasmic domain of Sdc is dispensable, indicating that Sdc does not transduce a signal by itself. Although the branch-specific phenotype of sdc mutants resembles those seen in the absence of Slit/Robo2 signalling, genetic interaction experiments indicate that Sdc also helps to suppress Slit/Robo2 signalling. We conclude that Sdc cell autonomously regulates Slit/Robo2 signalling in tracheal cells to guarantee ordered directional migration and branch fusion.
C1 [Schulz, Joachim G.; Ceulemans, Helga; Baietti, Maria F.; David, Guido] Katholieke Univ Leuven, Lab Glycobiol & Dev Genet, B-3000 Louvain, Belgium.
   [Schulz, Joachim G.; Hassan, Bassem A.] Katholieke Univ Leuven VIB, Neurogenet Lab, B-3000 Louvain, Belgium.
   [Schulz, Joachim G.; Ceulemans, Helga; Baietti, Maria F.; Hassan, Bassem A.; David, Guido] Katholieke Univ Leuven, Dept Human Genet, Ctr Human Genet, B-3000 Louvain, Belgium.
   [Caussinus, Emmanuel; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hassan, BA (corresponding author), Katholieke Univ Leuven, Lab Glycobiol & Dev Genet, Herestr 49,Bus 602, B-3000 Louvain, Belgium.
EM bassem.hassan@cme.vib-kuleuven.be; guido.david@cme.vib-kuleuven.be
RI Baietti, Maria Francesca/AAA-6749-2019; Hassan, Bassem A/D-5221-2012;
   Schulz, Joachim/H-2430-2011
OI Hassan, Bassem A/0000-0001-9533-4908; Affolter,
   Markus/0000-0002-5171-0016; Baietti, Maria Francesca/0000-0002-1495-226X
FU National Fund for Scientific Research - Flanders (FWO)FWO; Flanders
   Institute for Biotechnology; Belgian Federal Government; FEBS;
   EMBOEuropean Molecular Biology Organization (EMBO); Kantons Basel-Stadt
   and Basel-Land; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); European CommunityEuropean Community (EC)
FX We thank J. Lincecum (Boston) for providing sdc complementary DNA and
   antibody, and D. Smith (University of Texas, Dallas), G. Vorbruggen (MPI
   Gottingen), G. Struhl (Columbia University), M. Krasnow (Stanford
   University), B. Dickson (IMP Wien), S. Selleck (University of
   Minnesota), J. Knoblich (IMBA Wien), M. Llimargas (IBMB Barcelona), A.
   Spradling (Flytrap), the Bloomington Drosophila Stock Center (University
   of Indiana) and R. Ueda (National Institute of Genetics, Shizuoka) for
   providing fly stocks. This work was supported by grants from the
   National Fund for Scientific Research - Flanders (FWO) to G.D. and
   B.A.H.; Flanders Institute for Biotechnology (VIB) to G.D. and B.A.H.;
   Interuniversity Attraction Poles Program of the Belgian Federal
   Government to G.D.; and K.U. Leuven to G.D. (GOA) and B.A.H. (Impuls,
   CREA, GOA), a FEBS fellowship and an EMBO long-term postdoctoral
   fellowship to E.C., and grants from the Kantons Basel-Stadt and
   Basel-Land, from the Swiss National Science Foundation and a Network of
   Excellence grant 'Cells into Organs' from the Framework Program 6 of the
   European Community to the laboratory of M.A.
CR Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498
   Affolter M, 2009, NAT REV MOL CELL BIO, V10, P831, DOI 10.1038/nrm2797
   Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278
   Chanana B, 2009, P NATL ACAD SCI USA, V106, P11984, DOI 10.1073/pnas.0901148106
   Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783
   De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165
   Dedkov EI, 2007, DEV DYNAM, V236, P2004, DOI 10.1002/dvdy.21201
   Englund C, 2002, DEVELOPMENT, V129, P4941
   EPSTEIN EA, 2002, A DROS RES C, V43, pA445
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829
   Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005
   Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976
   Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388
   Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7
   Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6
   Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766
   Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798
   Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783
   Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X
   Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973
   Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015
   Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042
   Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602
   Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Schulz JG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp450
   SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334
   Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006
   TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697
   Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011
NR 35
TC 7
Z9 7
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1469-221X
J9 EMBO REP
JI EMBO Rep.
PD OCT
PY 2011
VL 12
IS 10
BP 1039
EP 1046
DI 10.1038/embor.2011.153
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 827WI
UT WOS:000295459700015
PM 21836636
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Rodriguez, D
   Daniels, AU
   Urrusti, JL
   Wirz, D
   Braissant, O
AF Rodriguez, D.
   Daniels, A. U.
   Urrusti, J. L.
   Wirz, D.
   Braissant, O.
TI Evaluation of a low-cost calorimetric approach for rapid detection of
   tuberculosis and other mycobacteria in culture
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE microcalorimetry; Mycobacterium avium; Mycobacterium smegmatis;
   Mycobacterium tuberculosis
ID ISOTHERMAL MICROCALORIMETRY; MIC DETERMINATIONS; BACTERIAL-GROWTH;
   SYSTEM; REDUCTION; DIAGNOSIS; AGENTS
AB Aims: The objective of this study was to evaluate the effectiveness of microcalorimetry in rapid detection of mycobacterium species using an inexpensive Isothermal microcalorimetry (IMC) instrument. In addition, we compared microcalorimetry with conventional monitoring techniques.
   Methods and Results: Isothermal microcalorimetry measures heat production rate and can provide rapid detection of living mycobacteria in clinical specimens. Using liquid medium showed that bacterial activity measured by IMC using a TAM Air (R) agreed with the triphenyl tetrazolium chloride (TTC) assay. Using solid medium to enhance growth, fast-growing mycobacteria detection was achieved between 26 and 53 h and slow-growing mycobacteria detection was achieved between 54 and 298 h. In addition, the calorimetric data were analysed to estimate the growth rate and generation time of the mycobacteria monitored.
   Significance and Impact of the Study: Infections caused by mycobacteria are severe and difficult to treat. With 9.27 million new cases of tuberculosis in 2007, developing countries experience severe health and economic consequences owing to the lack of an affordable, fast detection method. Research-grade IMC instruments are too expensive to use in developing countries. Our study demonstrates that less-expensive instruments such as the TAM air (R) are adequate for mycobacteria detection and therefore establishes a clear proof of concept.
C1 [Daniels, A. U.; Wirz, D.; Braissant, O.] Univ Basel, Lab Biomech & Biocalorimetry LOB2, CH-4056 Basel, Switzerland.
   Iberoamericana Univ Mexico City, Dept Engn, Mexico City, DF, Mexico.
RP Braissant, O (corresponding author), Univ Basel, Lab Biomech & Biocalorimetry LOB2, C-O Biozentrum Pharmazentrum,Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Olivier.Braissant@unibas.ch
RI Braissant, Olivier/AAO-2371-2020; Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR *B DICK CO, 2005, BACT MGIT MYC GROWTH
   Barbeau J, 1998, CAN J MICROBIOL, V44, P1019, DOI 10.1139/cjm-44-11-1019
   Braissant O, 2010, TUBERCULOSIS, V90, P57, DOI 10.1016/j.tube.2009.11.001
   Braissant O, 2010, SENSORS-BASEL, V10, P9369, DOI 10.3390/s101009369
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Chadha R, 1998, PEDIATR SURG INT, V13, P406, DOI 10.1007/s003830050350
   Cook GM, 2009, ADV MICROB PHYSIOL, V55, P81, DOI 10.1016/S0065-2911(09)05502-7
   Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677
   Feldman Evan M, 2009, J Plast Reconstr Aesthet Surg, V62, pe330, DOI 10.1016/j.bjps.2007.11.058
   GADAGKAR R, 1980, J BIOSCIENCE, V2, P337, DOI 10.1007/BF02716867
   GANGULY NK, 2002, ICMR B, V32, P1
   JENSEN K. A., 1932, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, V125, P222
   Kahm M, 2010, J STAT SOFTW, V33, P1
   Lerchner J, 2008, CHEM ENG PROCESS, V47, P991, DOI 10.1016/j.cep.2007.02.014
   LOWENSTEIN E, 1931, ZENTRALB BAKTERIOL P, V120, P127
   Mohammadzadeh A, 2006, J MED MICROBIOL, V55, P1657, DOI 10.1099/jmm.0.46442-0
   Montoro E, 2005, J ANTIMICROB CHEMOTH, V55, P500, DOI 10.1093/jac/dki023
   Mshana RN, 1998, J CLIN MICROBIOL, V36, P1214, DOI 10.1128/JCM.36.5.1214-1219.1998
   Organization WH, 2008, WHO REP 2008 GLOB TU
   Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10
   Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x
   R Development Core Team, 2010, R LANG ENV STAT COMP
   RASTOGI N, 1981, J GEN MICROBIOL, V126, P77
   Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X
   Relexans JC, 1996, MAR ECOL PROG SER, V136, P277, DOI 10.3354/meps136277
   Rodrigues C, 2009, INDIAN J MED MICROBI, V27, P217, DOI 10.4103/0255-0857.53203
   Rohner P, 2000, EUR J CLIN MICROBIOL, V19, P715, DOI 10.1007/s100960000344
   TENGERDY RP, 1967, APPL MICROBIOL, V15, P954, DOI 10.1128/AEM.15.4.954-955.1967
   van der Werf TS, 1999, LANCET, V354, P1013, DOI 10.1016/S0140-6736(99)01156-3
   VANHERWAARDEN S, 2000, MECH VARIABLES MEASU
   von Ah U, 2008, J CLIN MICROBIOL, V46, P2083, DOI 10.1128/JCM.00611-08
   von Ah U, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-106
   Wadso I, 2002, THERMOCHIM ACTA, V394, P305, DOI 10.1016/S0040-6031(02)00263-0
   WAYNE LG, 1992, CLIN MICROBIOL REV, V5, P1
   *WHO, 2008, ANT DRUG RES WORLD 4
   WOODS GL, 1987, REV INFECT DIS, V9, P275
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 37
TC 14
Z9 14
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD OCT
PY 2011
VL 111
IS 4
BP 1016
EP 1024
DI 10.1111/j.1365-2672.2011.05117.x
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 827LE
UT WOS:000295429200024
PM 21797951
OA Bronze
DA 2021-01-25
ER

PT J
AU Manfredi, P
   Pagni, M
   Cornelis, GR
AF Manfredi, Pablo
   Pagni, Marco
   Cornelis, Guy R.
TI Complete Genome Sequence of the Dog Commensal and Human Pathogen
   Capnocytophaga canimorsus Strain 5
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID RNA GENES; ANNOTATION; BACTERIA; VIEW
AB Capnocytophaga canimorsus is a commensal Gram-negative bacterium, originally isolated from a dog's mouth, that causes septicemia in humans. C. canimorsus has the unusual ability to feed on host cells, including phagocytes. This capacity depends on surface-exposed glycan-foraging systems. Here we present the first complete genome sequence of a C. canimorsus strain (Cc5).
C1 [Manfredi, Pablo; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Pagni, Marco] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Pagni, Marco/0000-0001-9292-9463
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-128659]; Novartis Stiftung
FX This project was supported by the Swiss National Science Foundation
   (grant 3100A0-128659) and the Novartis Stiftung.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095
   BRENNER DJ, 1989, J CLIN MICROBIOL, V27, P231, DOI 10.1128/JCM.27.2.231-235.1989
   Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847
   Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009
   Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186
   Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175
   Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703
   Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160
   Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108
   Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955
   Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164
   Manfredi P, 2011, MOL MICROBIOL, V81, P1050, DOI 10.1111/j.1365-2958.2011.07750.x
   Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848
   MAVROMATIS K, 2010, COMPLETE GENOME SEQU
   McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09
   Meyer S, 2008, IMMUNOBIOLOGY, V213, P805, DOI 10.1016/j.imbio.2008.07.019
   Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157
   Renzi F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002118
   Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243
   Shin H, 2009, INFECT IMMUN, V77, P2262, DOI 10.1128/IAI.01324-08
   Tierney DM, 2006, J CLIN MICROBIOL, V44, P649, DOI 10.1128/JCM.44.2.649-651.2006
   Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029
   Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847
NR 26
TC 15
Z9 16
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD OCT
PY 2011
VL 193
IS 19
BP 5558
EP 5559
DI 10.1128/JB.05853-11
PG 2
WC Microbiology
SC Microbiology
GA 819LE
UT WOS:000294826200070
PM 21914877
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Schoenenberger, CA
   Mannherz, HG
   Jockusch, BM
AF Schoenenberger, Cora-Ann
   Mannherz, Hans Georg
   Jockusch, Brigitte M.
TI Actin: From structural plasticity to functional diversity
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Review
DE Actin structure; Actin localization; Actin antibodies; Antiparallel
   actin dimer; G-actin; F-actin; Nuclear actin
ID SKELETAL-MUSCLE ACTIN; NUCLEAR-MYOSIN-I; BETA-ACTIN; COMPLEX;
   VISUALIZATION; MECHANISM; GELSOLIN; DEOXYRIBONUCLEASE; POLYMERIZATION;
   TRANSCRIPTION
AB This article addresses the multiple activities of actin. Starting out with the history of actin's discovery, purification and structure, it emphasizes the close relation between structure and function. In this context, we also point to unconventional actin conformations. Their existence in living cells is not yet well documented, however, they seem to play a special role in the supramolecular patterning that underlies some of the physiological functions of actin. Conceivably, such conformations may contribute to actin's diverse activities in the nucleus that are poorly understood so far. (C) 2011 Elsevier GmbH. All rights reserved.
C1 [Schoenenberger, Cora-Ann] Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Mannherz, Hans Georg] Ruhr Univ Bochum, Dept Anat & Mol Embryol, D-44780 Bochum, Germany.
   [Mannherz, Hans Georg] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany.
   [Jockusch, Brigitte M.] Tech Univ Carolo Wilhelmina Braunschweig, D-38092 Braunschweig, Germany.
RP Jockusch, BM (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Spielmannstr 7, D-38106 Braunschweig, Germany.
EM bmj@tu-bs.de
OI Mannherz, Hans Georg/0000-0001-8158-5722
FU Swiss National; M. E. Muller Foundation; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG); Fonds der
   Chemischen IndustrieFonds der Chemischen Industrie
FX The work of the authors, as reported in this article, was supported by
   the Swiss National and the M. E. Muller Foundation (CAS), the Deutsche
   Forschungsgemeinschaft (HGM and BMJ) and the Fonds der Chemischen
   Industrie (BMJ). We apologize to the many authors of papers relevant to
   this article whose work could not be cited due to space limitations.
CR AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340
   Aktories K., 2011, FEBS LETT, P1742
   Ballweber E, 2002, J MOL BIOL, V315, P613, DOI 10.1006/jmbi.2001.5281
   BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   Bubb MR, 2002, J BIOL CHEM, V277, P20999, DOI 10.1074/jbc.M201371200
   Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849
   CARLSSON L, 1976, J MOL BIOL, V105, P353, DOI 10.1016/0022-2836(76)90098-X
   Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001
   Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602
   Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7
   Cruz JR, 2009, CHROMOSOMA, V118, P193, DOI 10.1007/s00412-008-0188-y
   Dingova H, 2009, HISTOCHEM CELL BIOL, V131, P425, DOI 10.1007/s00418-008-0539-z
   Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359
   dos Remedios C G, 1978, Nature, V276, P731, DOI 10.1038/276731a0
   ELZINGA M, 1973, P NATL ACAD SCI USA, V70, P2687, DOI 10.1073/pnas.70.9.2687
   Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930
   Gonsior SM, 1999, J CELL SCI, V112, P797
   Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001
   HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x
   HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356
   Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704
   Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006
   KABSCH W, 1995, FASEB J, V9, P167
   Kirschner M W, 1978, Int Rev Cytol, V54, P1, DOI 10.1016/S0074-7696(08)60164-3
   Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557
   LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P2268, DOI 10.1073/pnas.71.6.2268
   LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P4742, DOI 10.1073/pnas.71.12.4742
   LINDBERG U, 1967, BIOCHEMISTRY-US, V6, P323, DOI 10.1021/bi00853a049
   LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628
   MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107
   MANNHERZ HG, 1977, FEBS LETT, V73, P141, DOI 10.1016/0014-5793(77)80966-6
   McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101
   McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771
   MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0
   MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785
   Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685
   Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100
   Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2
   Pendleton A, 2003, J BIOL CHEM, V278, P14394, DOI 10.1074/jbc.M206393200
   REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x
   SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X
   Schleicher M, 2008, HISTOCHEM CELL BIOL, V129, P695, DOI 10.1007/s00418-008-0430-y
   Schoenenberger CA, 2002, FEBS LETT, V529, P27, DOI 10.1016/S0014-5793(02)03267-2
   Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003
   SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0
   Steinmetz MO, 1998, J MOL BIOL, V278, P703, DOI 10.1006/jmbi.1998.1717
   Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559
   Steinmetz MO, 1997, J STRUCT BIOL, V119, P295, DOI 10.1006/jsbi.1997.3873
   Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009
   Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007
   SUCK D, 1981, P NATL ACAD SCI-BIOL, V78, P4319, DOI 10.1073/pnas.78.7.4319
   van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500
   Wade RH, 1997, CURR OPIN CELL BIOL, V9, P12, DOI 10.1016/S0955-0674(97)80146-9
   WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3
   WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498
   Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908
   YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409
NR 58
TC 27
Z9 28
U1 1
U2 30
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0171-9335
EI 1618-1298
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD OCT
PY 2011
VL 90
IS 10
BP 797
EP 804
DI 10.1016/j.ejcb.2011.05.002
PG 8
WC Cell Biology
SC Cell Biology
GA 836NZ
UT WOS:000296119700002
PM 21820202
DA 2021-01-25
ER

PT J
AU Diepold, A
   Wiesand, U
   Cornelis, GR
AF Diepold, Andreas
   Wiesand, Ulrich
   Cornelis, Guy R.
TI The assembly of the export apparatus (YscR,S,T,U,V) of the Yersinia type
   III secretion apparatus occurs independently of other structural
   components and involves the formation of an YscV oligomer
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID FLAGELLAR PROTEIN EXPORT; ENTEROPATHOGENIC ESCHERICHIA-COLI; PROTON
   MOTIVE FORCE; NEEDLE COMPLEX; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI;
   CYTOPLASMIC DOMAIN; TIP COMPLEX; SUPRAMOLECULAR STRUCTURE; MEMBRANE
   COMPONENT
AB YscV (FlhA in the flagellum) is an essential component of the inner membrane (IM) export apparatus of the type III secretion injectisome. It contains eight transmembrane helices and a large C-terminal cytosolic domain. YscV was expressed at a significantly higher level than the other export apparatus components YscR, YscS, YscT, and YscU, and YscV-EGFP formed bright fluorescent spots at the bacterial periphery, colocalizing in most cases with YscC-mCherry. This suggested that YscV is the only protein of the export apparatus that oligomerizes. Oligomerization required the cytosolic domain of YscV, as well as YscR, -S, -T, but no other Ysc protein, indicating that an IM platform can assemble independently from the membrane-ring forming proteins YscC, -D, -J. However, in the absence of YscC, -D, -J, this IM platform moved laterally at the bacterial surface. YscJ, but not YscD could be recruited to the IM platform in the absence of the secretin YscC. As YscJ was shown earlier to be also recruited by the outer membrane (OM) platform made of YscC and YscD, we infer that assembly of the injectisome proceeds through the independent assembly of an IM and an OM platform that merge through YscJ.
C1 [Diepold, Andreas; Wiesand, Ulrich; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Diepold, Andreas/0000-0002-4475-3923
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-128659]
FX We thank Marlise Amstutz for helpful discussions and critical reading of
   this MS. This work was supported by the Swiss National Science
   Foundation (Grant 3100A0-128659).
CR ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x
   Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992
   Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8
   Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731
   Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107
   Berger C, 2010, MICROBIOL-SGM, V156, P1963, DOI 10.1099/mic.0.039248-0
   Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Botteaux A, 2010, MICROBIOL-SGM, V156, P2807, DOI 10.1099/mic.0.039651-0
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004
   Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Crepin VF, 2005, MOL MICROBIOL, V55, P1658, DOI 10.1111/j.1365-2958.2005.04508.x
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103
   Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0
   Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84
   DRIKS A, 1990, J MOL BIOL, V211, P669, DOI 10.1016/0022-2836(90)90063-R
   Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003
   Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x
   Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251
   Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449
   Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599
   Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104
   Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x
   Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   KHAN IH, 1992, P NATL ACAD SCI USA, V89, P5956, DOI 10.1073/pnas.89.13.5956
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Kubori T, 1997, J BACTERIOL, V179, P813, DOI 10.1128/jb.179.3.813-817.1997
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476
   Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002
   Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x
   Lilic M, 2010, ACTA CRYSTALLOGR D, V66, P709, DOI 10.1107/S0907444910010796
   Lux R, 2000, J MOL BIOL, V298, P577, DOI 10.1006/jmbi.2000.3703
   Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   McMurry JL, 2004, J BACTERIOL, V186, P7586, DOI 10.1128/JB.186.22.7586-7592.2004
   McMurry JL, 2006, BIOCHEMISTRY-US, V45, P11790, DOI 10.1021/bi0605890
   Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x
   Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449
   Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h
   Moore SA, 2010, J BIOL CHEM, V285, P21060, DOI 10.1074/jbc.M110.119412
   Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200
   Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329
   Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x
   Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497
   PLANO GV, 1991, J BACTERIOL, V173, P7293, DOI 10.1128/jb.173.22.7293-7303.1991
   Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200
   Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910
   Ross JA, 2011, J BACTERIOL, V193, P2276, DOI 10.1128/JB.01137-10
   Saijo-Hamano Y, 2004, J MOL BIOL, V343, P457, DOI 10.1016/j.jmb.2004.08.067
   Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007
   Sanowar S, 2010, MBIO, V1, DOI 10.1128/mBio.00158-10
   Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102
   Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358
   Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Silva-Herzog E, 2008, MICROBIOL-SGM, V154, P593, DOI 10.1099/mic.0.2007/013045-0
   Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731
   Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603
   Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876
   Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06
   VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x
   Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x
   Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107
   Wiesand U, 2009, J MOL BIOL, V385, P854, DOI 10.1016/j.jmb.2008.10.034
   Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Worrall LJ, 2010, PROTEIN SCI, V19, P1091, DOI 10.1002/pro.382
   Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554
   Young HS, 2003, BIOPHYS J, V84, P571, DOI 10.1016/s0006-3495(03)74877-2
   Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832
   Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196
   Zhu K, 2002, BIOCHEMISTRY-US, V41, P9516, DOI 10.1021/bi0203280
NR 94
TC 59
Z9 59
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD OCT
PY 2011
VL 82
IS 2
BP 502
EP 514
DI 10.1111/j.1365-2958.2011.07830.x
PG 13
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 847YG
UT WOS:000297011100020
PM 21923772
OA Bronze
DA 2021-01-25
ER

PT J
AU Nigg, EA
   Stearns, T
AF Nigg, Erich A.
   Stearns, Tim
TI The centrosome cycle: Centriole biogenesis, duplication and inherent
   asymmetries
SO NATURE CELL BIOLOGY
LA English
DT Review
ID C. ELEGANS EMBRYOS; DE-NOVO FORMATION; CELL-CYCLE; DAUGHTER CENTRIOLE;
   REGULATED PROTEIN; PERICENTRIOLAR MATERIAL; DROSOPHILA NEUROBLASTS;
   EXTRA CENTROSOMES; VERTEBRATE CELLS; 9-FOLD SYMMETRY
AB Centrosomes are microtubule-organizing centres of animal cells. They influence the morphology of the microtubule cytoskeleton, function as the base for the primary cilium and serve as a nexus for important signalling pathways. At the core of a typical centrosome are two cylindrical microtubule-based structures termed centrioles, which recruit a matrix of associated pericentriolar material. Cells begin the cell cycle with exactly one centrosome, and the duplication of centrioles is constrained such that it occurs only once per cell cycle and at a specific site in the cell. As a result of this duplication mechanism, the two centrioles differ in age and maturity, and thus have different functions; for example, the older of the two centrioles can initiate the formation of a ciliary axoneme. We discuss spatial aspects of the centrosome duplication cycle, the mechanism of centriole assembly and the possible consequences of the inherent asymmetry of centrioles and centrosomes.
C1 [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA.
   [Stearns, Tim] Stanford Univ, Dept Genet, Stanford Sch Med, Stanford, CA 94305 USA.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erich.nigg@unibas.ch; stearns@stanford.edu
OI Stearns, Tim/0000-0002-0671-6582; nigg, erich/0000-0003-4835-5719
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); National Institutes of HealthUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM052022, R01GM052022,
   R01GM052022, R01GM052022, R01GM052022, R01GM052022, R01GM052022,
   R01GM052022, R01GM052022, R01GM052022, R01GM052022, R01GM052022,
   R01GM052022, R01GM052022, R01GM052022, R01GM052022, R01GM052022,
   R01GM052022, R01GM052022, R01GM052022, R01GM052022, R01GM052022,
   R01GM052022, R01GM052022] Funding Source: NIH RePORTER
FX We thank the members of the Nigg and Stearns labs for helpful discussion
   and apologise to our colleagues whose work we were unable to cite for
   space limitations. E.A.N. was supported by the Swiss National Science
   Foundation and T. S. was supported by the National Institutes of Health.
CR Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166
   Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034
   Avidor-Reiss T, 2010, SEMIN CELL DEV BIOL, V21, P139, DOI 10.1016/j.semcdb.2010.01.014
   Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010
   Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082
   Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107
   BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105
   Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039
   Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025
   Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042
   Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004
   Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3
   Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152
   Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107
   Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011
   Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037
   D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140
   Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015
   Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102
   Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224
   Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445
   Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563
   Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105
   Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136
   Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774
   Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627
   Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248
   Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181
   Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500
   Hardy PA, 2005, CELL BIOL INT, V29, P983, DOI 10.1016/j.cellbi.2005.10.001
   Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049
   Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509
   Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020
   Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102
   Hoyer-Fender S, 2010, SEMIN CELL DEV BIOL, V21, P142, DOI 10.1016/j.semcdb.2009.07.002
   Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510
   Inanc B, 2010, MOL BIOL CELL, V21, P3866, DOI 10.1091/mbc.E10-02-0124
   Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63
   Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245
   Januschke J, 2010, J CELL BIOL, V188, P693, DOI 10.1083/jcb.200905024
   Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102
   Kitagawa D, 2011, DEV CELL, V20, P550, DOI 10.1016/j.devcel.2011.02.005
   Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008
   Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018
   Korzeniewski N, 2010, MOL BIOL CELL, V21, P3942, DOI 10.1091/mbc.E09-12-1049
   Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165
   Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908
   Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241
   Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694
   Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050
   Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100
   Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009
   Mardin BR, 2011, CURR BIOL, V21, P1145, DOI 10.1016/j.cub.2011.05.047
   Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120
   Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008
   Matsuyama M, 2011, J CELL SCI, V124, P2113, DOI 10.1242/jcs.086488
   Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837
   Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046
   Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924
   Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X
   Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036
   Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318
   Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317
   Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330
   Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282
   Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021
   Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950
   Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034
   Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049
   Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140
   Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016
   Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280
   Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041
   Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564
   Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505
   Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022
   Song MH, 2011, DEV CELL, V20, P563, DOI 10.1016/j.devcel.2011.03.007
   Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027
   Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010
   Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016
   Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004
   Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004
   Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889
   Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179
   Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004
   Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985
   Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015
   Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6
   van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325
   Vaughan S, 2011, TRENDS CELL BIOL, V21, P57, DOI 10.1016/j.tcb.2010.09.004
   Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109
   Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435
   Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795
   Yang J, 2006, MOL BIOL CELL, V17, P1033, DOI 10.1091/mbc.E05-10-0943
NR 100
TC 350
Z9 355
U1 3
U2 70
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD OCT
PY 2011
VL 13
IS 10
BP 1154
EP 1160
DI 10.1038/ncb2345
PG 7
WC Cell Biology
SC Cell Biology
GA 829WY
UT WOS:000295617900003
PM 21968988
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Morin, S
AF Morin, Sebastien
TI A practical guide to protein dynamics from N-15 spin relaxation in
   solution
SO PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
LA English
DT Review
DE Protein dynamics; Spin relaxation; Model-free formalism; ps-ns/mu s-ms
   timescales; Consistency tests
ID NUCLEAR-MAGNETIC-RESONANCE; ANISOTROPIC ROTATIONAL DIFFUSION; MODEL-FREE
   APPROACH; HETERONUCLEAR NMR-SPECTROSCOPY; SPECTRAL DENSITY-FUNCTIONS;
   CHEMICAL-SHIFT ANISOTROPY; LOCAL BACKBONE DYNAMICS; MOLECULAR-DYNAMICS;
   ORDER PARAMETERS; MULTIPLE FIELDS
C1 Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
RP Morin, S (corresponding author), Univ Basel, Dept Biol Struct, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sebastien.morin@unibas.ch
OI Morin, Sebastien/0000-0003-4426-326X
FU PROTEO (The Quebec Research Network on Protein Function, Structure and
   Engineering); Department of Biochemistry, Microbiology, and
   Bioinformatics; Faculty of Science and Engineering at Universite Laval;
   EMBOEuropean Molecular Biology Organization (EMBO)
FX This work has been partly supported both by Ph.D. fellowships from
   PROTEO (The Quebec Research Network on Protein Function, Structure and
   Engineering), the Department of Biochemistry, Microbiology, and
   Bioinformatics, as well as the Faculty of Science and Engineering at
   Universite Laval, and by a postdoctoral fellowship from EMBO.
CR Abragam A, 1961, PRINCIPLES NUCL MAGN
   Akaike H., 1973, INT S INFORMATION TH, P267
   AKKE M, 1993, BIOCHEMISTRY-US, V32, P9832, DOI 10.1021/bi00088a039
   Akke M, 2002, CURR OPIN STRUC BIOL, V12, P642, DOI 10.1016/S0959-440X(02)00369-X
   ALLERHAN.A, 1971, J AM CHEM SOC, V93, P544, DOI 10.1021/ja00731a053
   Berjanskii M, 2006, NAT PROTOC, V1, P683, DOI 10.1038/nprot.2006.108
   Berjanskii MV, 2007, NUCLEIC ACIDS RES, V35, pW531, DOI 10.1093/nar/gkm328
   Berjanskii MV, 2008, J BIOMOL NMR, V40, P31, DOI 10.1007/s10858-007-9208-0
   Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f
   Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002
   Blackledge M, 1998, J AM CHEM SOC, V120, P4538, DOI 10.1021/ja9742646
   BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679
   Branden C., 1999, INTRO PROTEIN STRUCT
   BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375
   Buck M, 1999, J AM CHEM SOC, V121, P9645, DOI 10.1021/ja991309p
   Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154
   Burnham K.P., 1998, MODEL SELECTION INFE
   Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1
   CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006
   CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070
   Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134
   Cordier F, 1998, J MOL BIOL, V281, P341, DOI 10.1006/jmbi.1998.1950
   d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3
   d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2
   d'Auvergne EJ, 2007, MOL BIOSYST, V3, P483, DOI 10.1039/b702202f
   d'Auvergne EJ, 2006, J BIOMOL NMR, V35, P117, DOI 10.1007/s10858-006-9007-z
   d'Auvergne EJ, 2003, J BIOMOL NMR, V25, P25, DOI 10.1023/A:1021902006114
   DAUVERGNE EJ, 2006, THESIS U MELBOURNE
   Dayie KT, 1996, ANNU REV PHYS CHEM, V47, P243, DOI 10.1146/annurev.physchem.47.1.243
   DELLWO MJ, 1989, J AM CHEM SOC, V111, P4571, DOI 10.1021/ja00195a007
   Devore J., 1982, PROBABILITY STAT ENG
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Einstein A, 1905, ANN PHYS-BERLIN, V17, P891
   Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517
   Eyles SJ, 2004, METHODS, V34, P88, DOI 10.1016/j.ymeth.2004.03.015
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779
   Fischer MWF, 1998, PROG NUCL MAG RES SP, V33, P207, DOI 10.1016/S0079-6565(98)00023-5
   Fisette O, 2010, BIOPHYS J, V98, P637, DOI 10.1016/j.bpj.2009.08.061
   Fushman D, 1999, J AM CHEM SOC, V121, P8577, DOI 10.1021/ja9904991
   Fushman D, 1998, J AM CHEM SOC, V120, P10947, DOI 10.1021/ja981686m
   Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771
   Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840
   Gagne SM, 1998, J MOL BIOL, V278, P667, DOI 10.1006/jmbi.1998.1723
   Gong QG, 2007, J BIOMOL NMR, V37, P147, DOI 10.1007/s10858-006-9125-7
   HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580
   Hansen DF, 2007, J AM CHEM SOC, V129, P11468, DOI 10.1021/ja072717t
   HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663
   Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963
   Ishima R, 1999, J BIOMOL NMR, V14, P369, DOI 10.1023/A:1008324025406
   Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p
   Karplus M, 2003, BIOPOLYMERS, V68, P350, DOI 10.1002/bip.10266
   Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021
   Kay LE, 1998, BIOCHEM CELL BIOL, V76, P145, DOI 10.1139/bcb-76-2-3-145
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088
   Kempf JG, 2003, CELL BIOCHEM BIOPHYS, V37, P187
   Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008
   Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k
   Koller AN, 2008, BIOPHYS J, V95, pL4, DOI 10.1529/biophysj.108.132811
   Korzhnev DM, 2001, PROG NUCL MAG RES SP, V38, P197, DOI 10.1016/S0079-6565(00)00028-5
   Krizova H, 2004, J BIOMOL NMR, V28, P369, DOI 10.1023/B:JNMR.0000015404.61574.65
   Krushelnitsky A, 2005, PROG NUCL MAG RES SP, V47, P1, DOI 10.1016/j.pnmrs.2005.04.001
   KURIYAN J, 1986, J MOL BIOL, V190, P227, DOI 10.1016/0022-2836(86)90295-0
   Lee AL, 1997, J BIOMOL NMR, V9, P437, DOI 10.1023/A:1018311013338
   Lee AL, 1999, J BIOMOL NMR, V13, P101, DOI 10.1023/A:1008304220445
   Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802
   Levitt M. H., 2001, SPIN DYNAMICS
   Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Luginbuhl P, 1997, BIOCHEMISTRY-US, V36, P7305, DOI 10.1021/bi963161h
   Ma LX, 2003, BIOCHEMISTRY-US, V42, P320, DOI 10.1021/bi020553h
   Mack JW, 2000, BIOPOLYMERS, V53, P9, DOI 10.1002/(SICI)1097-0282(200001)53:1<9::AID-BIP2>3.3.CO;2-Y
   MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073
   Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k
   Maragakis P, 2008, J PHYS CHEM B, V112, P6155, DOI 10.1021/jp077018h
   Meirovitch E, 2010, PROG NUCL MAG RES SP, V56, P360, DOI 10.1016/j.pnmrs.2010.03.002
   Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y
   Moffat K, 2001, CHEM REV, V101, P1569, DOI 10.1021/cr990039q
   Morin S, 2009, J BIOMOL NMR, V45, P361, DOI 10.1007/s10858-009-9381-4
   Morin S, 2009, BIOPHYS J, V96, P4681, DOI 10.1016/j.bpj.2009.02.068
   Orekhov VY, 1999, J BIOMOL NMR, V14, P345, DOI 10.1023/A:1008356809071
   Orekhov VY, 1995, APPL MAGN RESON, V9, P581, DOI 10.1007/BF03162365
   Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129
   PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001
   Pawley NH, 2001, J BIOMOL NMR, V20, P149, DOI 10.1023/A:1011249816560
   Peng JW, 1995, BIOCHEMISTRY-US, V34, P16733, DOI 10.1021/bi00051a023
   PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T
   Phan IQH, 1996, J BIOMOL NMR, V8, P369, DOI 10.1007/BF00228140
   Prompers JJ, 2002, J AM CHEM SOC, V124, P4522, DOI 10.1021/ja012750u
   Reddy T, 2010, BIOCHEM CELL BIOL, V88, P131, DOI [10.1139/O09-152, 10.1139/o09-152]
   Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220
   Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q
   SAXENA A, 2005, FLUORESCENCE SPECTRO
   SCHURR JM, 1994, J MAGN RESON SER B, V105, P211, DOI 10.1006/jmrb.1994.1127
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
   Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0
   Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326
   Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020
   Tolman JR, 2001, CURR OPIN STRUC BIOL, V11, P532, DOI 10.1016/S0959-440X(00)00245-1
   Tsan P, 2000, J AM CHEM SOC, V122, P5603, DOI 10.1021/ja993654k
   Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957
   Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926
   WANG AC, 1993, J BIOMOL NMR, V3, P715
   Wang CY, 2003, MAGN RESON CHEM, V41, P866, DOI 10.1002/mrc.1262
   Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b
   Wishart DS, 2011, PROG NUCL MAG RES SP, V58, P62, DOI 10.1016/j.pnmrs.2010.07.004
   Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581
   Yang DW, 1997, J MOL BIOL, V272, P790, DOI 10.1006/jmbi.1997.1285
   Yon JM, 1998, BIOCHIMIE, V80, P33, DOI 10.1016/S0300-9084(98)80054-0
   Zerbetto M, 2010, INT J QUANTUM CHEM, V110, P387, DOI 10.1002/qua.22289
   Zhang FL, 2002, J AM CHEM SOC, V124, P12654, DOI 10.1021/ja027847a
   Zhuravleva AV, 2004, J MOL BIOL, V342, P1599, DOI 10.1016/j.jmb.2004.08.001
NR 116
TC 30
Z9 30
U1 1
U2 62
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6565
J9 PROG NUCL MAG RES SP
JI Prog. Nucl. Magn. Reson. Spectrosc.
PD OCT
PY 2011
VL 59
IS 3
BP 245
EP 262
DI 10.1016/j.pnmrs.2010.12.003
PG 18
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical; Spectroscopy
SC Chemistry; Physics; Spectroscopy
GA 831RV
UT WOS:000295749700004
PM 21920220
DA 2021-01-25
ER

PT J
AU Vermot, J
   Affolter, M
AF Vermot, Julien
   Affolter, Markus
TI Modeling new conceptual interpretations of development
SO DEVELOPMENT
LA English
DT Review
DE Cell biology; Cell migration; Development; Drosophila; Force; Zebrafish
ID DORSAL CLOSURE; CELL DIVISIONS; HIPPO PATHWAY; F-ACTIN; DROSOPHILA;
   FORCES; ORGANIZATION; MIGRATION; GROWTH
AB In April 2011, researchers from diverse background met at the Gulbenkian Institute (Oeiras, Portugal) to discuss the emerging input of biophysics into the field of developmental biology. The scope of the workshop was to bring together scientists working in different model systems and to discuss some of the most recent advances towards understanding how physical forces affect embryonic development. Discussions and talks highlighted two main trends: that many aspects of embryogenesis can be accurately quantified and translated into a limited number of physical forces and biochemical parameters; and that simulations and modeling provide new conceptual interpretations of classical developmental questions.
C1 [Vermot, Julien] Univ Strasbourg, IGBMC, INSERM, U964,CNRS,UMR7104, F-67404 Illkirch Graffenstaden, France.
   [Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Vermot, J (corresponding author), Univ Strasbourg, IGBMC, INSERM, U964,CNRS,UMR7104, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.
EM julien@igbmc.fr
RI Vermot, Julien/I-6568-2016
OI Affolter, Markus/0000-0002-5171-0016; , Julien/0000-0002-8924-732X
FU HFSPHuman Frontier Science Program; INSERMInstitut National de la Sante
   et de la Recherche Medicale (Inserm); European CommunitiesEuropean Union
   (EU)European Community (EC); University of Basel; Kantons Basel-Stadt
   and Basel-Land; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Swiss Initiative of Systems Biology
FX J.V. is supported by HFSP, INSERM and the European Communities Seventh
   Framework Programme. M.A. is supported by the University of Basel, the
   Kantons Basel-Stadt and Basel-Land, the Swiss National Science
   Foundation, as well as the Swiss Initiative of Systems Biology through
   the WingX project.
CR Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062
   Boehm B, 2011, DEVELOPMENT, V138, P1227, DOI 10.1242/dev.057547
   Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420
   Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002
   Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006
   Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545
   Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064
   Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552
   Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149
   Krahling H, 2009, PFLUG ARCH EUR J PHY, V458, P1069, DOI 10.1007/s00424-009-0694-7
   Layton AT, 2009, HFSP J, V3, P441, DOI 10.2976/1.3266062
   Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511
   Meinhardt H, 2004, NAT REV NEUROSCI, V5, P502, DOI 10.1038/nrn1410
   Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5
   Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114
   NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0
   Sander K, 2001, INT J DEV BIOL, V45, P1
   Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157
   Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050
   Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037
   Wu D, 2011, DEV CELL, V20, P271, DOI 10.1016/j.devcel.2010.12.006
   Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009
NR 22
TC 1
Z9 1
U1 0
U2 7
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD OCT 1
PY 2011
VL 138
IS 19
BP 4111
EP 4115
DI 10.1242/dev.066084
PG 5
WC Developmental Biology
SC Developmental Biology
GA 815SB
UT WOS:000294547200004
PM 21896626
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Totong, R
   Schell, T
   Lescroart, F
   Ryckebusch, L
   Lin, YF
   Zygmunt, T
   Herwig, L
   Krudewig, A
   Gershoony, D
   Belting, HG
   Affolter, M
   Torres-Vazquez, J
   Yelon, D
AF Totong, Ronald
   Schell, Thomas
   Lescroart, Fabienne
   Ryckebuesch, Lucile
   Lin, Yi-Fan
   Zygmunt, Tomasz
   Herwig, Lukas
   Krudewig, Alice
   Gershoony, Dafna
   Belting, Heinz-Georg
   Affolter, Markus
   Torres-Vazquez, Jesus
   Yelon, Deborah
TI The novel transmembrane protein Tmem2 is essential for coordination of
   myocardial and endocardial morphogenesis
SO DEVELOPMENT
LA English
DT Article
DE Zebrafish; Heart development; Atrioventricular canal; Cardiac fusion
ID ZEBRAFISH; MIGRATION; TRANSGENESIS; CUSHION; FUSION; GENE
AB Coordination between adjacent tissues plays a crucial role during the morphogenesis of developing organs. In the embryonic heart, two tissues - the myocardium and the endocardium - are closely juxtaposed throughout their development. Myocardial and endocardial cells originate in neighboring regions of the lateral mesoderm, migrate medially in a synchronized fashion, collaborate to create concentric layers of the heart tube, and communicate during formation of the atrioventricular canal. Here, we identify a novel transmembrane protein, Tmem2, that has important functions during both myocardial and endocardial morphogenesis. We find that the zebrafish mutation frozen ventricle (frv) causes ectopic atrioventricular canal characteristics in the ventricular myocardium and endocardium, indicating a role of frv in the regional restriction of atrioventricular canal differentiation. Furthermore, in maternal-zygotic frv mutants, both myocardial and endocardial cells fail to move to the midline normally, indicating that frv facilitates cardiac fusion. Positional cloning reveals that the frv locus encodes Tmem2, a predicted type II single-pass transmembrane protein. Homologs of Tmem2 are present in all examined vertebrate genomes, but nothing is known about its molecular or cellular function in any context. By employing transgenes to drive tissue-specific expression of tmem2, we find that Tmem2 can function in the endocardium to repress atrioventricular differentiation within the ventricle. Additionally, Tmem2 can function in the myocardium to promote the medial movement of both myocardial and endocardial cells. Together, our data reveal that Tmem2 is an essential mediator of myocardium-endocardium coordination during cardiac morphogenesis.
C1 [Totong, Ronald; Schell, Thomas; Lescroart, Fabienne; Lin, Yi-Fan; Zygmunt, Tomasz; Torres-Vazquez, Jesus; Yelon, Deborah] NYU, Sch Med, Dev Genet Program, Kimmel Ctr Biol & Med,Skirball Inst Biomol Med, New York, NY 10016 USA.
   [Totong, Ronald; Schell, Thomas; Lescroart, Fabienne; Lin, Yi-Fan; Zygmunt, Tomasz; Torres-Vazquez, Jesus; Yelon, Deborah] NYU, Sch Med, Dept Cell Biol, Kimmel Ctr Biol & Med,Skirball Inst Biomol Med, New York, NY 10016 USA.
   [Ryckebuesch, Lucile; Lin, Yi-Fan; Yelon, Deborah] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.
   [Herwig, Lukas; Krudewig, Alice; Belting, Heinz-Georg; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Gershoony, Dafna] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA.
RP Yelon, D (corresponding author), NYU, Sch Med, Dev Genet Program, Kimmel Ctr Biol & Med,Skirball Inst Biomol Med, New York, NY 10016 USA.
EM dyelon@ucsd.edu
OI Torres-Vazquez, Jesus/0000-0002-3808-3978; Belting,
   Heinz-Georg/0000-0002-1538-4364; Lescroart,
   Fabienne/0000-0003-4942-7921; Affolter, Markus/0000-0002-5171-0016
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; American Heart
   AssociationAmerican Heart Association; March of DimesMarch of Dimes;
   NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL069594, R01HL069594,
   R01HL092263, R01HL092263, R01HL069594, R01HL069594, R01HL069594,
   R01HL092263, R01HL092263, R01HL092263, R01HL069594, R01HL069594,
   R01HL092263, R01HL069594, R01HL069594, R01HL092263, R01HL069594,
   R01HL069594, R01HL069594] Funding Source: NIH RePORTER
FX Work in the Yelon laboratory is supported by grants from the National
   Institutes of Health, American Heart Association and March of Dimes.
   Deposited in PMC for release after 12 months.
CR Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.0.CO;2-2
   Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da
   Arrington CB, 2009, DEVELOPMENT, V136, P3143, DOI 10.1242/dev.031492
   Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970
   Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140
   Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408
   Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999
   Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E
   Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230
   Garavito-Aguilar ZV, 2010, DEVELOPMENT, V137, P3215, DOI 10.1242/dev.052225
   Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079
   Guo JH, 2006, FEBS LETT, V580, P581, DOI 10.1016/j.febslet.2005.12.076
   He QY, 2006, BIOINFORMATICS, V22, P2189, DOI 10.1093/bioinformatics/btl123
   Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145
   Holtzman NG, 2007, DEVELOPMENT, V134, P2379, DOI 10.1242/dev.02857
   Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028
   Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301
   Kupperman E, 2000, NATURE, V406, P192
   Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343
   MJAATVEDT CH, 1987, DEV BIOL, V119, P59, DOI 10.1016/0012-1606(87)90206-5
   Moreno-Rodriguez RA, 2006, DEV DYNAM, V235, P191, DOI 10.1002/dvdy.20601
   Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012
   Scott DA, 2000, GENE, V246, P265, DOI 10.1016/S0378-1119(00)00090-1
   Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O
   Smith KA, 2011, DEVELOPMENT, V138, P4193, DOI 10.1242/dev.065375
   Trinh LA, 2004, DEV CELL, V6, P371
   Verhoeven MC, 2011, BIRTH DEFECTS RES A, V91, P435, DOI 10.1002/bdra.20804
   Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354
   Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670
   ZYGMUNT T, 2011, DEV CELL IN PRESS
NR 30
TC 40
Z9 41
U1 0
U2 10
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD OCT 1
PY 2011
VL 138
IS 19
BP 4199
EP 4205
DI 10.1242/dev.064261
PG 7
WC Developmental Biology
SC Developmental Biology
GA 815SB
UT WOS:000294547200013
PM 21896630
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Hartmann, C
   Engel, A
AF Hartmann, Claudia
   Engel, Andreas
TI Cloning, expression, purification, and characterization of the membrane
   protein UncI from Escherichia coli
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE Membrane protein expression; UncI; ATP synthase; Detergent screen; Gel
   filtration
ID ADENOSINE-TRIPHOSPHATASE COMPLEX; ATP-SYNTHASE; NUCLEOTIDE-SEQUENCE; 1ST
   GENE; OPERON; SUBUNIT; PRODUCT
AB The Escherichia coli unc-operon encodes the genes for the subunits of the F0F1-ATP synthase and an integral membrane protein of unknown function called UncI. UncI influences the cell-growth and activity of F0F1, but its exact function is still unknown. The expression level is too low to extract milligram amounts of UncI from E. coli membranes and the existing purification protocol based on methanol/chloroform is not suitable for structural and functional studies. Here we present protocols to increase the expression level, to purify UncI in a detergent where UncI is monodisperse, and we characterize its oligomeric state. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Hartmann, Claudia; Engel, Andreas] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, CH-4058 Basel, Switzerland.
RP Engel, A (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
EM andreas.engel@case.edu
FU European UnionEuropean Union (EU); Swiss National Science Foundation
   (SNF)Swiss National Science Foundation (SNSF) [3100A0-108299]
FX The authors thank Patrick Bosshard for helpful discussions. This work
   was supported by the European Union (NANOMOT) and the Swiss National
   Science Foundation (SNF Grant No. 3100A0-108299).
CR BRUSILOW WSA, 1983, J BACTERIOL, V155, P1265, DOI 10.1128/JB.155.3.1265-1270.1983
   DOWNIE JA, 1980, J BACTERIOL, V143, P8, DOI 10.1128/JB.143.1.8-17.1980
   DOWNIE JA, 1981, J BACTERIOL, V145, P200, DOI 10.1128/JB.145.1.200-210.1981
   GAY NJ, 1981, NUCLEIC ACIDS RES, V9, P3919, DOI 10.1093/nar/9.16.3919
   GAY NJ, 1984, J BACTERIOL, V158, P820, DOI 10.1128/JB.158.3.820-825.1984
   GAY NJ, 1981, NUCLEIC ACIDS RES, V9, P2187, DOI 10.1093/nar/9.9.2187
   KANAZAWA H, 1980, P NATL ACAD SCI-BIOL, V77, P7005, DOI 10.1073/pnas.77.12.7005
   Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193
   Kol S, 2009, J MOL BIOL, V390, P893, DOI 10.1016/j.jmb.2009.05.074
   MCCARTHY JEG, 1988, J BIOENERG BIOMEMBR, V20, P19, DOI 10.1007/BF00762136
   Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170
   SARASTE M, 1981, NUCLEIC ACIDS RES, V9, P5287, DOI 10.1093/nar/9.20.5287
   SCHAEFER EM, 1989, J BACTERIOL, V171, P3901, DOI 10.1128/jb.171.7.3901-3908.1989
   SCHNEPPE B, 1991, J BIOL CHEM, V266, P21090
   SCHNEPPE B, 1990, J BIOL CHEM, V265, P389
   SCHNEPPE B, 1991, FEBS LETT, V292, P145, DOI 10.1016/0014-5793(91)80853-U
   SOLOMON KA, 1989, J BACTERIOL, V171, P3039, DOI 10.1128/jb.171.6.3039-3045.1989
   Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105
   van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100
   WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X
NR 20
TC 3
Z9 3
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD OCT
PY 2011
VL 79
IS 2
BP 187
EP 190
DI 10.1016/j.pep.2011.05.017
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 810AO
UT WOS:000294098000003
PM 21664273
DA 2021-01-25
ER

PT J
AU Huber, C
   Nuesch, C
   Gopfert, B
   Cattin, PC
   von Tscharner, V
AF Huber, Cora
   Nueesch, Corina
   Goepfert, Beat
   Cattin, Philippe C.
   von Tscharner, Vinzenz
TI Muscular timing and inter-muscular coordination in healthy females while
   walking
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Thigh muscles; Gait; EMG; Wavelet analysis; Rhythmicity
ID MOTOR UNIT SYNCHRONIZATION; INTERINDIVIDUAL VARIABILITY; MUSCLE
   SYNERGIES; PIPER RHYTHM; EMG PATTERNS; SURFACE EMG; LOCOMOTION;
   WAVELETS; ANTERIOR; PAIN
AB The dynamic interplay between muscles surrounding the knee joint, the central nervous system and external factors require a control strategy to generate and stabilise the preferred gait pattern. The electromyographic (EMG) signal is a common measure reflecting the neuromuscular control strategies during dynamic tasks. Neuromuscular control mechanisms, found in processed EMG signals, showed a precise pacing with a pacing rhythm and a tight control of muscle activity in running and maximally contracted muscles. The purpose of this study was to provide an insight how muscles get activated during walking. The EMG power, extracted by the wavelet transform (92-395 Hz), over a time period encompassing 250 ms before and 250 ms after heel strike was analysed. The study showed that the wavelet-based analysis of EMG signals was sufficiently sensitive to detect a synchronisation of the activation of thigh muscles while walking. The results within each single subject and within the group consisting of 10 healthy females showed that, although there was a lot of jitter in the locations of the intensity peaks, the muscle activation is controlled, on average, by a neuromuscular activity paced at about 40 ms, however with variable amplitudes. Albeit the jitter of the signal, the results resolved the temporal dependency of intensity peaks within muscles surrounding the knee and provided an insight into neural control of locomotion. The methodology to assess the stabilising muscle activation pattern may provide a way to discriminate subjects with normal gait pattern form those with a deteriorated neuromuscular control strategy. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Huber, Cora; Goepfert, Beat] Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Nueesch, Corina] Univ Basel Hosp, Dept Orthopaed, CH-4031 Basel, Switzerland.
   [Cattin, Philippe C.] Univ Basel, Univ Basel Hosp, Med Image Anal Ctr, CH-4031 Basel, Switzerland.
   [von Tscharner, Vinzenz] Univ Calgary, Human Performance Lab, Calgary, AB T2N 1N4, Canada.
RP Huber, C (corresponding author), Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM cora.huber@unibas.ch; cnueesch@uhbs.ch; beat.goepfert@unibas.ch;
   philippe.cattin@unibas.ch; vincent@kin.ucalgary.ca
RI Cattin, Philippe/B-1301-2009
OI Nuesch, Corina/0000-0002-7526-9536
FU Emilia Guggenheim-Schnurr foundation; ProMotio foundation for
   biomechanical research Basel
FX The authors acknowledge the Laboratory for Movement Analysis of the
   Children's University Hospital Basel and the Orthopaedic Department of
   the University Hospital of Basel for using their gait analysis
   equipment. This study was financially supported by grants from the
   Emilia Guggenheim-Schnurr foundation, the ProMotio foundation for
   biomechanical research Basel, and the donation of Dr. H.J. Wyss to the
   University of Basel in 2004.
CR ARSENAULT AB, 1986, MED BIOL ENG COMPUT, V24, P337, DOI 10.1007/BF02442685
   Boyer KA, 2004, J BIOMECH, V37, P1583, DOI 10.1016/j.jbiomech.2004.01.002
   Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5
   Brown P, 1998, J NEUROPHYSIOL, V80, P2911
   Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009
   Cowan SM, 2001, ARCH PHYS MED REHAB, V82, P183, DOI 10.1053/apmr.2001.19022
   DeMont RG, 2004, BRIT J SPORT MED, V38, P120, DOI 10.1136/bjsm.2002.000195
   Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003
   Gizzi L, 2011, J NEUROPHYSIOL, V106, P202, DOI 10.1152/jn.00727.2010
   GRILLNER S, 1984, ACTA PHYSIOL SCAND, V120, P393, DOI 10.1111/j.1748-1716.1984.tb07400.x
   GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313
   Guidetti L, 1996, J ELECTROMYOGR KINES, V6, P37, DOI 10.1016/1050-6411(95)00015-1
   Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4
   Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183
   Hof AL, 2003, J BIOMECH, V36, P1031, DOI 10.1016/S0021-9290(03)00036-8
   Huber C, 2010, J STRENGTH COND RES, V24, P1527, DOI 10.1519/JSC.0b013e3181dc42f6
   Hug F, 2010, J APPL PHYSIOL, V108, P1727, DOI 10.1152/japplphysiol.01305.2009
   KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310
   Kellis E, 1998, SPORTS MED, V25, P37, DOI 10.2165/00007256-199825010-00004
   Mellor R, 2006, J ORTHOP RES, V24, P1420, DOI 10.1002/jor.20161
   Mellor R, 2005, J PAIN, V6, P550, DOI 10.1016/j.jpain.2005.03.006
   Mellor R, 2005, CLIN NEUROPHYSIOL, V116, P1585, DOI 10.1016/j.clinph.2005.04.004
   Monaco V, 2010, J NEUROPHYSIOL, V104, P2092, DOI 10.1152/jn.00525.2009
   Neptune RR, 2000, CLIN BIOMECH, V15, P611, DOI 10.1016/S0268-0033(00)00028-0
   Nigg B M, 2001, Exerc Sport Sci Rev, V29, P37, DOI 10.1097/00003677-200101000-00008
   Nigg BM, 2001, CLIN J SPORT MED, V11, P2, DOI 10.1097/00042752-200101000-00002
   Pal S, 2011, AM J SPORT MED, V39, P590, DOI 10.1177/0363546510384233
   Rutherford DJ, 2010, OSTEOARTHR CARTILAGE, V18, P654, DOI 10.1016/j.joca.2010.01.005
   Salenius S, 1996, NEUROSCI LETT, V213, P75, DOI 10.1016/0304-3940(96)12796-8
   Salenius S, 1997, J NEUROPHYSIOL, V77, P3401
   Stirling LM, 2011, J ELECTROMYOGR KINES, V21, P178, DOI 10.1016/j.jelekin.2010.06.007
   VALLBO AB, 1993, J PHYSIOL-LONDON, V469, P673, DOI 10.1113/jphysiol.1993.sp019837
   von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4
   von Tscharner V, 2003, J BIOMECH, V36, P1169, DOI 10.1016/S0021-9290(03)00086-1
   von Tscharner V, 2011, J ELECTROMYOGR KINES, V21, P184, DOI 10.1016/j.jelekin.2010.10.004
   von Tscharner V, 2011, J ELECTROMYOGR KINES, V21, P190, DOI 10.1016/j.jelekin.2010.10.005
   von Tscharner V, 2010, J ELECTROMYOGR KINES, V20, P676, DOI 10.1016/j.jelekin.2009.11.005
   Wakeling JM, 2009, J ELECTROMYOGR KINES, V19, P199, DOI 10.1016/j.jelekin.2007.09.006
   Wakeling JM, 2002, J EXP BIOL, V205, P359
   Wong YM, 2009, PHYS THER SPORT, V10, P71, DOI 10.1016/j.ptsp.2009.02.001
   Zebis MK, 2008, CLIN J SPORT MED, V18, P329, DOI 10.1097/JSM.0b013e31817f3e35
NR 41
TC 10
Z9 10
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0270
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD SEP 30
PY 2011
VL 201
IS 1
BP 27
EP 34
DI 10.1016/j.jneumeth.2011.07.008
PG 8
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 828LY
UT WOS:000295503700004
PM 21784101
DA 2021-01-25
ER

PT J
AU Rieker, C
   Dev, KK
   Lehnhoff, K
   Barbieri, S
   Ksiazek, I
   Kauffmann, S
   Danner, S
   Schell, H
   Boden, C
   Ruegg, MA
   Kahle, PJ
   van der Putten, H
   Shimshek, DR
AF Rieker, Claus
   Dev, Kumlesh K.
   Lehnhoff, Katja
   Barbieri, Samuel
   Ksiazek, Iwona
   Kauffmann, Sabine
   Danner, Simone
   Schell, Heinrich
   Boden, Cindy
   Ruegg, Markus A.
   Kahle, Philipp J.
   van der Putten, Herman
   Shimshek, Derya R.
TI Neuropathology in Mice Expressing Mouse Alpha-Synuclein
SO PLOS ONE
LA English
DT Article
ID IMMOBILIZED PH GRADIENTS; LEWY BODY DISEASE; PARKINSONS-DISEASE;
   ALZHEIMERS-DISEASE; SUBCELLULAR-LOCALIZATION; PROTEINASE K; BODIES;
   BRAIN; MODEL; INSOLUBILITY
AB alpha-Synuclein (alpha SN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (m alpha SN), which carries a threonine at position 53 like the A53T human mutant version that is genetically linked to PD, were never reported. To this end we generated mouse lines that express m alpha SN in central neurons at levels reaching up to six-fold compared to endogenous m alpha SN. Unlike transgenic mice expressing human wildtype or mutant forms of alpha SN, these m alpha SN transgenic mice showed pronounced ubiquitin immunopathology in spinal cord and brainstem. Isoelectric separation of m alpha SN species revealed multiple isoforms including two Ser129-phosphorylated species in the most severely affected brain regions. Neuronal Ser129-phosphorylated alpha SN occured in granular and small fibrillar aggregates and pathological staining patterns in neurites occasionally revealed a striking ladder of small alternating segments staining either for Ser129-phosphorylated alpha SN or ubiquitin but not both. Axonal degeneration in long white matter tracts of the spinal cord, with breakdown of myelin sheaths and degeneration of neuromuscular junctions with loss of integrity of the presynaptic neurofilament network in m alpha SN transgenic mice, was similar to what we have reported for mice expressing human alpha SN wildtype or mutant forms. In hippocampal neurons, the m alpha SN protein accumulated and was phosphorylated but these neurons showed no ubiquitin immunopathology. In contrast to the early-onset motor abnormalities and muscle weakness observed in mice expressing human alpha SN, m alpha SN transgenic mice displayed only end-stage phenotypic alterations that manifested alongside with neuropathology. Altogether these findings show that increased levels of wildtype m alpha SN does not induce early-onset behavior changes, but drives end-stage pathophysiological changes in murine neurons that are strikingly similar to those evoked by expression of human wildtype or mutant forms.
C1 [Rieker, Claus; Lehnhoff, Katja; Barbieri, Samuel; Kauffmann, Sabine; Danner, Simone; van der Putten, Herman; Shimshek, Derya R.] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland.
   [Dev, Kumlesh K.] Trinity Coll Dublin, Sch Med, Dept Physiol, Dublin, Ireland.
   [Ksiazek, Iwona; Ruegg, Markus A.] Univ Basel, Neurobiol Biozentrum, Basel, Switzerland.
   [Schell, Heinrich; Boden, Cindy; Kahle, Philipp J.] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany.
   [Schell, Heinrich; Boden, Cindy; Kahle, Philipp J.] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany.
RP Rieker, C (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland.
EM derya.shimshek@novartis.com
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Dev, Kumlesh/0000-0003-4274-9119;
   Shimshek, Derya/0000-0001-8602-7850
FU Novartis Pharma AG
FX The study was funded by Novartis Pharma AG, who, through the employment
   of Claus Rieker, Katja Lehnhoff, Samuel Barbieri, Sabine Kauffmann,
   Simone Danner Herman van der Putten and Derya Shimshek, had a role in
   conceiving, designing and performing the experiments and analyzing the
   data.
CR Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421
   Braak H, 2000, NERVENARZT, V71, P459, DOI 10.1007/s001150050607
   Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034
   Dev KK, 2003, NEUROPHARMACOLOGY, V45, P1, DOI 10.1016/S0028-3908(02)00337-4
   Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0
   Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3
   Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001
   Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748
   Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7
   Gomez-Tortosa E, 2000, ACTA NEUROPATHOL, V99, P352, DOI 10.1007/s004010051135
   Gomez-Tortosa E, 2000, ANN NY ACAD SCI, V920, P9
   Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200
   Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109
   Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6
   Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000
   Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002
   Klein RL, 2002, HUM GENE THER, V13, P605, DOI 10.1089/10430340252837206
   Lee FKM, 2009, J NEUROCHEM, V110, P208, DOI 10.1111/j.1471-4159.2009.06124.x
   Luthi A, 1997, J NEUROSCI, V17, P4688
   Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265
   McLean PJ, 2000, J NEURAL TRANSM-SUPP, P53
   Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777
   Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200
   Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303
   Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4
   Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Takahashi N, 2002, BBA-PROTEINS PROTEOM, V1601, P110, DOI 10.1016/S1570-9639(02)00435-1
   Takeda A, 1998, LAB INVEST, V78, P1169
   Towbin H, 2001, ELECTROPHORESIS, V22, P1887, DOI 10.1002/1522-2683(200106)22:10<1887::AID-ELPS1887>3.0.CO;2-Q
   van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000
   Wakabayashi K, 1997, ACTA NEUROPATHOL, V93, P7, DOI 10.1007/s004010050576
   Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n
NR 33
TC 31
Z9 32
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2011
VL 6
IS 9
AR e24834
DI 10.1371/journal.pone.0024834
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 834BK
UT WOS:000295932100005
PM 21966373
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Johannessen, M
   Walquist, M
   Gerits, N
   Dragset, M
   Spang, A
   Moens, U
AF Johannessen, Mona
   Walquist, Mari
   Gerits, Nancy
   Dragset, Marte
   Spang, Anne
   Moens, Ugo
TI BKV Agnoprotein Interacts with alpha-Soluble N-Ethylmaleimide-Sensitive
   Fusion Attachment Protein, and Negatively Influences Transport of
   VSVG-EGFP
SO PLOS ONE
LA English
DT Article
ID HUMAN POLYOMAVIRUS BK; JC VIRUS AGNOPROTEIN; MHC CLASS-I; ANTIGEN
   PRESENTATION; LIPID DROPLETS; PHOSPHORYLATION; IDENTIFICATION;
   TRANSCRIPTION; DISSOCIATION; SECRETION
AB Background: The human polyomavirus BK (BKV) infects humans worldwide and establishes a persistent infection in the kidney. The BK virus genome encodes three regulatory proteins, large and small tumor-antigen and the agnoprotein, as well as the capsid proteins VP1 to VP3. Agnoprotein is conserved among BKV, JC virus (JCV) and SV40, and agnoprotein-deficient mutants reveal reduced viral propagation. Studies with JCV and SV40 indicate that their agnoproteins may be involved in transcription, replication and/or nuclear and cellular release of the virus. However, the exact function(s) of agnoprotein of BK virus remains elusive.
   Principal Findings: As a strategy of exploring the functions of BKV agnoprotein, we decided to look for cellular interaction partners for the viral protein. Several partners were identified by yeast two-hybrid assay, among them alpha-SNAP which is involved in disassembly of vesicles during secretion. BKV agnoprotein and alpha-SNAP were found to partially co-localize in cells, and a complex consisting of agnoprotein and alpha-SNAP could be co-immunoprecipitated from cells ectopically expressing the proteins as well as from BKV-transfected cells. The N-terminal part of the agnoprotein was sufficient for the interaction with alpha-SNAP. Finally, we could show that BKV agnoprotein negatively interferes with secretion of VSVG-EGFP reporter suggesting that agnoprotein may modulate exocytosis.
   Conclusions: We have identified the first cellular interaction partner for BKV agnoprotein. The most N-terminal part of BKV agnoprotein is involved in the interaction with alpha-SNAP. Presence of BKV agnoprotein negatively interferes with secretion of VSVG-EGFP reporter.
C1 [Johannessen, Mona; Walquist, Mari; Gerits, Nancy; Dragset, Marte; Moens, Ugo] Univ Tromso, Res Grp Host Microbe Interact, Dept Med Biol, Fac Hlth Sci, Tromso, Norway.
   [Spang, Anne] Univ Basel, Biozentrum, Basel, Switzerland.
RP Johannessen, M (corresponding author), Univ Tromso, Res Grp Host Microbe Interact, Dept Med Biol, Fac Hlth Sci, Tromso, Norway.
EM mona.johannessen@uit.no
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU Norwegian Cancer SocietyNorwegian Cancer Society [A20240];
   Aakre-Foundation [A20308]; Mohn-Foundation [A20242]
FX The work was supported by grants from the Norwegian Cancer Society
   (A20240), the Aakre-Foundation (A20308) and the Mohn-Foundation
   (A20242). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07
   Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5
   Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648
   Daniels R, 2007, PLOS PATHOG, V3, P928, DOI 10.1371/journal.ppat.0030098
   Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097
   Delbue S, 2008, J CLIN MICROBIOL, V46, P2461, DOI 10.1128/JCM.00381-08
   Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001
   DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x
   Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x
   Easha S, 2006, CELL MOL LIFE SCI, V63, P865, DOI 10.1007/s00018-005-5454-z
   Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586
   Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064
   Grinde B, 2007, VIRUS RES, V123, P86, DOI 10.1016/j.virusres.2006.08.005
   Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575
   HEY AW, 1994, J IMMUNOL METHODS, V173, P149, DOI 10.1016/0022-1759(94)90294-1
   Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945
   Hirsch HH, 2005, CLIN INFECT DIS, V41, P354, DOI 10.1086/431488
   Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002
   Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027
   Johannessen M, 2008, VIROLOGY, V379, P97, DOI 10.1016/j.virol.2008.06.007
   Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200
   Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363
   Khalili K, 2005, J CELL PHYSIOL, V204, P1, DOI 10.1002/jcp.20266
   Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200
   Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200
   MOENS U, 2001, HUMAN POLYOMAVIRUSES, P359
   Moens U, 2007, NEW RES ONCOGENIC VI, P1
   Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333
   Okada Y, 2005, EMBO REP, V6, P452, DOI 10.1038/sj.embor.7400406
   Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323
   Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200
   Patel NC, 2008, J CLIN VIROL, V43, P66, DOI 10.1016/j.jcv.2008.04.011
   Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001
   RESNICK J, 1986, J VIROL, V60, P1098, DOI 10.1128/JVI.60.3.1098-1106.1986
   Rinaldo CH, 2003, VIRUS RES, V93, P181, DOI 10.1016/S0168-1702(03)00096-0
   Rinaldo CH, 1998, J VIROL, V72, P6233, DOI 10.1128/JVI.72.7.6233-6236.1998
   Rinaldo CH, 2007, EXPERT REV ANTI-INFE, V5, P105, DOI 10.1586/14787210.5.1.105
   Safak M, 2001, J VIROL, V75, P1476, DOI 10.1128/JVI.75.3.1476-1486.2001
   Sambrook J., 2004, NAT METHODS, V1, P275, DOI [10.1038/nmeth1204-275, DOI 10.1038/NMETH1204-275]
   Sariyer IK, 2006, J VIROL, V80, P3893, DOI 10.1128/JVI.80.8.3893-3903.2006
   Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006
   Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10
   Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200
   Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801
   Unterstab G, 2010, VIROLOGY, V399, P322, DOI 10.1016/j.virol.2010.01.011
   van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024
   Viscidi RP, 2008, SCIENCE, V319, P1049, DOI 10.1126/science.1155048
   Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032
NR 48
TC 17
Z9 17
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 12
PY 2011
VL 6
IS 9
AR e24489
DI 10.1371/journal.pone.0024489
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 819CO
UT WOS:000294803200022
PM 21931730
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Erb, I
   van Nimwegen, E
AF Erb, Ionas
   van Nimwegen, Erik
TI Transcription Factor Binding Site Positioning in Yeast: Proximal
   Promoter Motifs Characterize TATA-Less Promoters
SO PLOS ONE
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; IN-VIVO; REGULATORY NETWORK; GENE-EXPRESSION;
   SEQUENCE PREFERENCES; COMPARATIVE GENOMICS; MESSENGER-RNA; CORE
   PROMOTER; CELL-CYCLE; ELEMENTS
AB The availability of sequence specificities for a substantial fraction of yeast's transcription factors and comparative genomic algorithms for binding site prediction has made it possible to comprehensively annotate transcription factor binding sites genome-wide. Here we use such a genome-wide annotation for comprehensively studying promoter architecture in yeast, focusing on the distribution of transcription factor binding sites relative to transcription start sites, and the architecture of TATA and TATA-less promoters. For most transcription factors, binding sites are positioned further upstream and vary over a wider range in TATA promoters than in TATA-less promoters. In contrast, a group of 6 'proximal promoter motifs' (GAT1/GLN3/DAL80, FKH1/2, PBF1/2, RPN4, NDT80, and ROX1) occur preferentially in TATA-less promoters and show a strong preference for binding close to the transcription start site in these promoters. We provide evidence that suggests that pre-initiation complexes are recruited at TATA sites in TATA promoters and at the sites of the other proximal promoter motifs in TATA-less promoters. TATA-less promoters can generally be classified by the proximal promoter motif they contain, with different classes of TATA-less promoters showing different patterns of transcription factor binding site positioning and nucleosome coverage. These observations suggest that different modes of regulation of transcription initiation may be operating in the different promoter classes. In addition we show that, across all promoter classes, there is a close match between nucleosome free regions and regions of highest transcription factor binding site density. This close agreement between transcription factor binding site density and nucleosome depletion suggests a direct and general competition between transcription factors and nucleosomes for binding to promoters.
C1 [Erb, Ionas] Ctr Genom Regulat, Bioinformat & Genom Program, Barcelona, Spain.
   [Erb, Ionas] Pompeu Fabra Univ, Barcelona, Spain.
   [van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland.
   [van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland.
RP Erb, I (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Program, Barcelona, Spain.
EM erik.vannimwegen@unibas.ch
OI van Nimwegen, Erik/0000-0001-6338-1312; Erb, Ionas/0000-0002-2331-9714
FU SNF (Swiss National Science Foundation)Swiss National Science Foundation
   (SNSF) [31003A-118318]
FX The work of IE and EvN was supported by SNF (Swiss National Science
   Foundation) grant 31003A-118318. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029
   Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200
   Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789
   Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337
   Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997
   Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200
   David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103
   ERB I, 2006, IEE P 1 INT C COMP S, P112
   Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208
   Graber JH, 2002, NUCLEIC ACIDS RES, V30, P1851, DOI 10.1093/nar/30.8.1851
   Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873
   Guo ZJ, 1996, TRENDS BIOCHEM SCI, V21, P477, DOI 10.1016/S0968-0004(96)10057-8
   Hampsey M, 2006, NAT STRUCT MOL BIOL, V13, P564, DOI 10.1038/nsmb0706-564
   Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800
   Hollenhorst PC, 2001, GENE DEV, V15, P2445, DOI 10.1101/gad.906201
   Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878
   Kaplan N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-140
   Kastaniotis AJ, 2000, ADV EXP MED BIOL, V475, P185
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   Kim SK, 1996, MOL MICROBIOL, V22, P135, DOI 10.1111/j.1365-2958.1996.tb02663.x
   Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200
   Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247
   Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090
   Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117
   Lippman SI, 2009, P NATL ACAD SCI USA, V106, P19928, DOI 10.1073/pnas.0907027106
   Locke G, 2010, P NATL ACAD SCI USA, V107, P20998, DOI 10.1073/pnas.1003838107
   MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113
   Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9
   Maslov S, 2005, PHYS BIOL, V2, pS94, DOI 10.1088/1478-3975/2/4/S03
   Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108
   Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103
   Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411
   Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857
   Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003
   Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002
   Sherriff JA, 2007, MOL CELL BIOL, V27, P2848, DOI 10.1128/MCB.01798-06
   Shin ME, 2010, MOL CELL BIOL, V30, P2996, DOI 10.1128/MCB.01682-09
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520
   Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043
   Sudarsanam P, 2002, GENOME RES, V12, P1723, DOI 10.1101/gr.301202
   Sugihara F, 2011, NUCLEIC ACIDS RES, V39, P59, DOI 10.1093/nar/gkq741
   Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108
   van Helden J, 2000, NUCLEIC ACIDS RES, V28, P1000
   van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399
   van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4
   Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108
   Wade C, 2001, MOL CELL BIOL, V21, P8638, DOI 10.1128/MCB.21.24.8638-8650.2001
   Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524
   Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298
   Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029
   Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636
   Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583
   Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108
   Zhu GF, 2000, NATURE, V406, P90
   Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607
NR 60
TC 23
Z9 24
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2011
VL 6
IS 9
AR e24279
DI 10.1371/journal.pone.0024279
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 819CN
UT WOS:000294803100016
PM 21931670
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU McPhee, JS
   Perez-Schindler, J
   Degens, H
   Tomlinson, D
   Hennis, P
   Baar, K
   Williams, AG
AF McPhee, J. S.
   Perez-Schindler, J.
   Degens, H.
   Tomlinson, D.
   Hennis, P.
   Baar, K.
   Williams, A. G.
TI HIF1A P582S gene association with endurance training responses in young
   women
SO EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE Exercise; Hypoxia; Oxygen uptake; Polymorphism; Skeletal muscle
ID INDUCIBLE FACTOR-I; HUMAN SKELETAL-MUSCLE; CARDIOVASCULAR-RESPONSES;
   FACTOR-1-ALPHA GENE; PHYSICAL-FITNESS; AEROBIC CAPACITY; OXYGEN-UPTAKE;
   NITRIC-OXIDE; LEG MUSCLES; HYPOXIA
AB Sequence variations in the gene encoding the hypoxia-inducible factor-1alpha, HIF1A, have been associated with physiologic function and could be associated with exercise responses. In the HIF1A P582S gene polymorphism (C1772T; rs 11549465 C/T), a single nucleotide transition from C -> T alters the codon sequence from the usual amino acid; proline (C-allele), to serine (T-allele). This polymorphism was examined for association with endurance training responses in 58 untrained young women who completed a 6-week laboratory-based endurance training programme. Participant groups were defined as CC homozygotes versus carriers of a T-allele (CC vs. CT genotypes). Adaptations were examined at the systemic-level, by measuring (V)over dotO(2max); and the molecular-level by measuring enzymes determined from vastus lateralis (n = 20): 3-hydroacyl-CoA-dehydrogenase (HAD), which regulates mitochondrial fatty acid oxidation; cytochrome C oxidase (COX-1), a marker of mitochondrial density; and phosphofructokinase (PFK), a marker of glycolytic capacity. CT genotypes showed 45% higher training-induced gains in (V)over dotO(2max) compared with CC genotypes (P < 0.05). At the molecular level, CT increased the ratios PFK/HAD and PFK/COX-1 (47 and 3%, respectively), while in the CC genotypes these ratios were decreased (-26 and -54%, respectively). In conclusion, the T-allele of HIF1A P582S was associated with greater gains in (V)over dotO(2max) following endurance training in young women. In a sub-group we also provide preliminary evidence of differential muscle metabolic adaptations between genotypes.
C1 [McPhee, J. S.; Degens, H.; Tomlinson, D.] Manchester Metropolitan Univ, Inst Biomed Res Human Movement & Hlth, Manchester M1 5GD, Lancs, England.
   [Perez-Schindler, J.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Hennis, P.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England.
   [Baar, K.] Univ Calif Davis, Funct Mol Biol Lab, Davis, CA 95616 USA.
   [Williams, A. G.] Manchester Metropolitan Univ, Inst Performance Res, Crewe, England.
RP McPhee, JS (corresponding author), Manchester Metropolitan Univ, Inst Biomed Res Human Movement & Hlth, John Dalton Bldg,Room 216,Oxford Rd, Manchester M1 5GD, Lancs, England.
EM j.s.mcphee@mmu.ac.uk
RI Williams, Alun G/B-6817-2008
OI Williams, Alun G/0000-0002-8052-8184; Tomlinson,
   David/0000-0003-1349-1024; Perez-Schindler, Joaquin/0000-0003-3141-8859;
   McPhee, Jamie/0000-0002-3659-0773; Baar, Keith/0000-0001-9337-6186
CR Ahmetov II, 2008, B EXP BIOL MED+, V146, P351, DOI 10.1007/s10517-008-0291-3
   Ahmetov II, 2009, HUM GENET, V126, P751, DOI 10.1007/s00439-009-0728-4
   Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje
   BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
   BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093
   BOOTH FW, 1994, MED SCI SPORT EXER, V26, P556
   Bouchard C, 2000, J APPL PHYSIOL, V88, P551
   Bouchard C, 1999, J APPL PHYSIOL, V87, P1003
   Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013
   Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010
   Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179
   Coulet F, 2003, J BIOL CHEM, V278, P46230, DOI 10.1074/jbc.M305420200
   DAVIES CTM, 1974, J APPL PHYSIOL, V36, P142
   Day SH, 2007, EUR J APPL PHYSIOL, V99, P11, DOI 10.1007/s00421-006-0309-3
   Dietrichson P, 1980, J Oslo City Hosp, V30, P73
   DOERING F, 2010, J APPL PHYSIOL, DOI DOI 10.1152/JAPPLPHYSIOL.01165
   Erikssen G, 2001, SPORTS MED, V31, P571, DOI 10.2165/00007256-200131080-00001
   Formenti F, 2010, P NATL ACAD SCI USA, V107, P12722, DOI 10.1073/pnas.1002339107
   Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
   Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190
   Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009
   HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278
   Huang YC, 2006, AM J PHYSIOL-CELL PH, V291, pC11, DOI 10.1152/ajpcell.00366.2005
   Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172
   Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002
   Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197
   KLAUSEN K, 1982, J APPL PHYSIOL, V52, P976
   Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629
   Linossier MT, 1997, ACTA PHYSIOL SCAND, V161, P439, DOI 10.1046/j.1365-201X.1997.00244.x
   Marti HH, 2005, EXP SUPPL, V94, P163
   Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288
   McGuire DK, 2001, CIRCULATION, V104, P1358, DOI 10.1161/hc3701.096099
   McPhee JS, 2010, EUR J APPL PHYSIOL, V109, P1111, DOI 10.1007/s00421-010-1454-2
   McPhee JS, 2009, EXP PHYSIOL, V94, P684, DOI 10.1113/expphysiol.2008.045658
   Melby CL, 2000, INT J OBESITY, V24, P1514, DOI 10.1038/sj.ijo.0801413
   Murias JM, 2010, MED SCI SPORT EXER, V42, P1891, DOI 10.1249/MSS.0b013e3181dd0bba
   OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494
   Ollerenshaw M, 2004, CANCER GENET CYTOGEN, V153, P122, DOI 10.1016/j.cancergencyto.2004.01.014
   Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012
   Pisani DF, 2005, J GEN PHYSIOL, V126, P173, DOI 10.1085/jgp.200509265
   Prior SJ, 2003, PHYSIOL GENOMICS, V15, P20, DOI 10.1152/physiolgenomics.00061.2003
   Rankinen T, 2000, J APPL PHYSIOL, V88, P1029
   Richardson RS, 1999, J APPL PHYSIOL, V86, P1048
   Richardson RS, 2001, J APPL PHYSIOL, V91, P2679
   Saltin B, 2006, J APPL PHYSIOL, V100, P744, DOI 10.1152/japplphysiol.01395.2005
   Schmidt W, 2010, EXERC SPORT SCI REV, V38, P68, DOI 10.1097/JES.0b013e3181d4957a
   SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447
   Sonna LA, 2001, J APPL PHYSIOL, V91, P1355
   STRATTON JR, 1994, CIRCULATION, V89, P1648, DOI 10.1161/01.CIR.89.4.1648
   Swallow EB, 2007, J APPL PHYSIOL, V103, P739, DOI 10.1152/japplphysiol.00025.2007
   Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132
   Timmons JA, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-19
   Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009
   Ukkola O, 2003, J APPL PHYSIOL, V94, P1870, DOI 10.1152/japplphysiol.00942.2002
   Vollaard NBJ, 2009, J APPL PHYSIOL, V106, P1479, DOI 10.1152/japplphysiol.91453.2008
   Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887
   Woods DR, 2002, EUR J APPL PHYSIOL, V86, P240, DOI 10.1007/s00421-001-0545-5
   Yamada N, 2005, J CLIN ENDOCR METAB, V90, P5841, DOI 10.1210/jc.2005-0991
   Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818
NR 59
TC 7
Z9 9
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1439-6319
EI 1439-6327
J9 EUR J APPL PHYSIOL
JI Eur. J. Appl. Physiol.
PD SEP
PY 2011
VL 111
IS 9
BP 2339
EP 2347
DI 10.1007/s00421-011-1869-4
PG 9
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA 821GM
UT WOS:000294963000041
PM 21344271
DA 2021-01-25
ER

PT J
AU Papassotiropoulos, A
   de Quervain, DJF
AF Papassotiropoulos, Andreas
   de Quervain, Dominique J. -F.
TI Genetics of human episodic memory: dealing with complexity
SO TRENDS IN COGNITIVE SCIENCES
LA English
DT Review
ID LONG-TERM-MEMORY; IMAGING GENETICS; WORKING-MEMORY; GENOME-WIDE;
   HIPPOCAMPAL ACTIVITY; COGNITIVE-ABILITIES; COMMON SNPS; KIBRA GENE;
   PERFORMANCE; ASSOCIATION
AB Episodic memory is a polygenic behavioral trait with substantial heritability estimates. Despite its complexity, recent empirical evidence supports the notion that behavioral genetic studies of episodic memory might successfully identify trait-associated molecules and pathways. The development of high-throughput genotyping methods, of elaborated statistical analyses and of phenotypic assessment methods at the neural systems level will facilitate the reliable identification of novel memory-related genes. Importantly, a necessary crosstalk between behavioral genetic studies and investigation of causality by molecular genetic studies will ultimately pave the way towards the identification of biologically important, and hopefully druggable, genes and molecular pathways related to human episodic memory.
C1 [Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.
   [Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.] Univ Basel, Univ Psychiat Clin, Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Biozentrum, Life Sci Training Facil, Basel, Switzerland.
   [de Quervain, Dominique J. -F.] Univ Basel, Div Cognit Neurosci, Dept Psychol, Basel, Switzerland.
RP Papassotiropoulos, A (corresponding author), Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.
EM andreas.papas@unibas.ch; dominique.dequervain@unibas.ch
OI Papassotiropoulos, Andreas/0000-0002-2210-9651; de Quervain,
   Dominique/0000-0001-7131-2464
CR Alarcon M, 1998, BEHAV GENET, V28, P255, DOI 10.1023/A:1021667213066
   Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050
   Bertolino A, 2008, BIOL PSYCHIAT, V64, P226, DOI 10.1016/j.biopsych.2008.02.001
   BOUCHARD TJ, 1990, ACTA GENET MED GEMEL, V39, P193, DOI 10.1017/S0001566000005420
   Buhot MC, 1997, CURR OPIN NEUROBIOL, V7, P243, DOI 10.1016/S0959-4388(97)80013-X
   CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0
   Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579
   De Blasi S, 2009, EXP GERONTOL, V44, P224, DOI 10.1016/j.exger.2008.11.005
   de Frias CM, 2004, BEHAV GENET, V34, P533, DOI 10.1023/B:BEGE.0000038491.06972.8c
   de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103
   de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   Demirkan A, 2011, MOL PSYCHIATR, V16, P773, DOI 10.1038/mp.2010.65
   Dempster EL, 2006, AM J PSYCHIAT, V163, P1832, DOI 10.1176/appi.ajp.163.10.1832
   Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7
   Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809
   FINKEL D, 1995, PSYCHOL AGING, V10, P437, DOI 10.1037/0882-7974.10.3.437
   Fisher R. A., 1918, PHILOS T ROYAL SOC E, V52, P399, DOI DOI 10.1017/S0080456800012163
   Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554
   Greenwood PM, 2009, P NATL ACAD SCI USA, V106, P3633, DOI 10.1073/pnas.0807891106
   Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869
   Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005
   Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003
   Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001
   Huentelman MJ, 2007, HUM MOL GENET, V16, P1469, DOI 10.1093/hmg/ddm097
   Jablensky A, 2011, GENES BRAIN BEHAV, V10, P410, DOI 10.1111/j.1601-183X.2011.00679.x
   Johansson B, 1999, J GERONTOL B-PSYCHOL, V54, pP173, DOI 10.1093/geronb/54B.3.P173
   Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020
   Kolsch H, 2009, J NEURAL TRANSM, V116, P897, DOI 10.1007/s00702-009-0238-5
   Krug A, 2010, NEUROIMAGE, V53, P985, DOI 10.1016/j.neuroimage.2009.12.062
   Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051
   Mattay VS, 2008, BIOL PSYCHOL, V79, P9, DOI 10.1016/j.biopsycho.2008.03.015
   McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560
   McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9
   Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103
   Need AC, 2008, AM J MED GENET B, V147B, P667, DOI 10.1002/ajmg.b.30658
   Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413
   Ozaki N, 1996, BIOL PSYCHIAT, V40, P1267, DOI 10.1016/0006-3223(95)00649-4
   Ozaki N, 1997, J NEUROCHEM, V68, P2186
   Panizzon MS, 2011, NEUROPSYCHOLOGY, V25, P488, DOI 10.1037/a0022569
   Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Papassotiropoulos A, 2006, J CLIN PSYCHIAT, V67, P652, DOI 10.4088/JCP.v67n0418
   Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004
   Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Rasch B, 2010, NEUROIMAGE, V53, P870, DOI 10.1016/j.neuroimage.2010.01.001
   Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001
   Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006
   Sheline YI, 2002, AM J PSYCHIAT, V159, P430, DOI 10.1176/appi.ajp.159.3.430
   Shobe J, 2002, NEUROBIOL LEARN MEM, V77, P291, DOI 10.1006/nlme.2001.4022
   Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I
   Steffens M, 2010, HUM HERED, V69, P268, DOI 10.1159/000295896
   Stelzel C, 2009, EUR J NEUROSCI, V29, P1056, DOI 10.1111/j.1460-9568.2009.06647.x
   Swan GE, 1999, ARCH NEUROL-CHICAGO, V56, P1127, DOI 10.1001/archneur.56.9.1127
   Tan HY, 2007, P NATL ACAD SCI USA, V104, P12536, DOI 10.1073/pnas.0610125104
   Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243
   Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114
   Tulving E., 1972, ORG MEMORY, P381, DOI DOI 10.1017/S0140525X00047257
   Urner M, 2011, HUM BRAIN MAPP, V32, P2096, DOI 10.1002/hbm.21171
   Vogler C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.004.2009
   Volk HE, 2006, TWIN RES HUM GENET, V9, P623, DOI 10.1375/183242706778553462
   Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4
   Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608
   Yasuda Y, 2010, WORLD J BIOL PSYCHIA, V11, P852, DOI 10.3109/15622971003797258
   Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324
NR 68
TC 48
Z9 48
U1 0
U2 22
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1364-6613
J9 TRENDS COGN SCI
JI TRENDS COGN. SCI.
PD SEP
PY 2011
VL 15
IS 9
SI SI
BP 381
EP 387
DI 10.1016/j.tics.2011.07.005
PG 7
WC Behavioral Sciences; Neurosciences; Psychology, Experimental
SC Behavioral Sciences; Neurosciences & Neurology; Psychology
GA 820CD
UT WOS:000294882200003
PM 21835680
DA 2021-01-25
ER

PT J
AU Astasov-Frauenhoffer, M
   Braissant, O
   Hauser-Gerspach, I
   Daniels, AU
   Wirz, D
   Weiger, R
   Waltimo, T
AF Astasov-Frauenhoffer, Monika
   Braissant, Olivier
   Hauser-Gerspach, Irmgard
   Daniels, A. U.
   Wirz, Dieter
   Weiger, Roland
   Waltimo, Tuomas
TI Quantification of vital adherent Streptococcus sanguinis cells on
   protein-coated titanium after disinfectant treatment
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ISOTHERMAL MICROCALORIMETRY; IN-VITRO; BACTERIAL IDENTIFICATION; BIOFILM
   FORMATION; CHLORHEXIDINE; GROWTH; VIABILITY; EFFICACY; OCTENIDINE;
   ADHESION
AB The quantification of vital adherent bacteria is challenging, especially when efficacy of antimicrobial agents is to be evaluated. In this study three different methods were compared in order to quantify vital adherent Streptococcus sanguinis cells after exposure to disinfectants. An anaerobic flow chamber model accomplished initial adhesion of S. sanguinis on protein-coated titanium. Effects of chlorhexidine, Betadine(A (R)), Octenidol(A (R)), and ProntOral(A (R)) were assessed by quantifying vital cells using Live/Dead BacLight((TM)), conventional culturing and isothermal microcalorimetry (IMC). Results were analysed by Kruskal-Wallis one-way analysis of variance. Live/dead staining revealed highest vital cell counts (P < 0.05) and demonstrated dose-dependent effect for all disinfectants. Microcalorimetry showed time-delayed heat flow peaks that were proportioned to the remaining number of viable cells. Over 48 h there was no difference in total heat between treated and untreated samples (P > 0.05), indicating equivalent numbers of bacteria were created and disinfectants delayed growth but did not eliminate it. In conclusion, contrary to culturing, live/dead staining enables detection of cells that may be viable but non-cultivable. Microcalorimetry allows unique evaluation of relative disinfectant effects by quantifying differences in time delay of regrowth of remaining vital cells.
C1 [Astasov-Frauenhoffer, Monika; Hauser-Gerspach, Irmgard; Waltimo, Tuomas] Univ Basel, Sch Dent Med, Inst Prevent Dent & Oral Microbiol, CH-4056 Basel, Switzerland.
   [Braissant, Olivier; Daniels, A. U.; Wirz, Dieter] Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Weiger, Roland] Univ Basel, Clin Periodontol Endodontol & Cariol, CH-4056 Basel, Switzerland.
RP Astasov-Frauenhoffer, M (corresponding author), Univ Basel, Sch Dent Med, Inst Prevent Dent & Oral Microbiol, Hebelstr 3, CH-4056 Basel, Switzerland.
EM m.astasov-frauenhoffer@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X; Astasov-Frauenhoffer,
   Monika/0000-0001-9638-3939
CR Auschill TM, 2005, J CLIN PERIODONTOL, V32, P147, DOI 10.1111/j.1600-051X.2005.00650.x
   BACKMAN P, 1991, J BIOCHEM BIOPH METH, V23, P283, DOI 10.1016/0165-022X(91)90003-F
   Bandara HMHN, 2009, J MED MICROBIOL, V58, P1623, DOI 10.1099/jmm.0.012989-0
   BOLING EA, 1973, NATURE, V241, P472, DOI 10.1038/241472a0
   Braissant O, 2010, SENSORS-BASEL, V10, P9369, DOI 10.3390/s101009369
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   BUNKER JC, 1986, MICROBIOS, V47, P177
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Cousido MC, 2010, CLIN ORAL INVEST, V14, P397, DOI 10.1007/s00784-009-0320-2
   Decker EM, 2001, LETT APPL MICROBIOL, V33, P188, DOI 10.1046/j.1472-765x.2001.00971.x
   Decker EM, 2008, QUINTESSENCE INT, V39, P17
   Gompertz B., 1825, PHILOS T ROY SOC LON, V115, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]
   Hauser-Gerspach I, 2008, J BIOMED MATER RES B, V85B, P42, DOI 10.1002/jbm.b.30914
   Hauser-Gerspach I, 2007, DENT MATER J, V26, P361, DOI 10.4012/dmj.26.361
   Higuera-Guisset J, 2005, THERMOCHIM ACTA, V427, P187, DOI 10.1016/j.tca.2004.09.010
   Hope CK, 2004, ANTIMICROB AGENTS CH, V48, P1461, DOI 10.1128/AAC.48.5.1461-1468.2004
   Kim J, 2008, ANTIMICROB AGENTS CH, V52, P1446, DOI 10.1128/AAC.00054-07
   LOPEZ D, 1987, CAN J MICROBIOL, V33, P6, DOI 10.1139/m87-002
   McBain AJ, 2003, APPL ENVIRON MICROB, V69, P4770, DOI 10.1128/AEM.69.8.4770-4776.2003
   MONK P, 1975, J APPL BACTERIOL, V38, P71, DOI 10.1111/j.1365-2672.1975.tb00504.x
   Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x
   Pan PC, 2010, J DENT, V38, pS16, DOI 10.1016/S0300-5712(10)70006-3
   Postollec F, 2003, J MICROBIOL METH, V55, P241, DOI 10.1016/S0167-7012(03)00145-3
   Rohrer N, 2010, INFECT CONT HOSP EP, V31, P733, DOI 10.1086/653822
   Sand W, 1999, METHOD ENZYMOL, V310, P361
   Shen Y, 2010, J ENDODONT, V36, P1820, DOI 10.1016/j.joen.2010.08.029
   Tandjung L, 2007, INT ENDOD J, V40, P845, DOI 10.1111/j.1365-2591.2007.01279.x
   Vine GJ, 2005, CURR PHARM BIOTECHNO, V6, P223, DOI 10.2174/1389201054022878
   Wadso I, 2002, THERMOCHIM ACTA, V394, P305, DOI 10.1016/S0040-6031(02)00263-0
   Weiger R, 2002, INT ENDOD J, V35, P166, DOI 10.1046/j.1365-2591.2002.00465.x
   XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671
   Zhao RM, 2000, J BIOCHEM BIOPH METH, V46, P1
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 33
TC 11
Z9 11
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2011
VL 22
IS 9
BP 2045
EP 2051
DI 10.1007/s10856-011-4377-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 817XG
UT WOS:000294709900007
PM 21670995
DA 2021-01-25
ER

PT J
AU Finlayson, MR
   Helfer-Hungerbuhler, AK
   Philippsen, P
AF Finlayson, Mark R.
   Helfer-Hungerbuehler, A. Katrin
   Philippsen, Peter
TI Regulation of exit from mitosis in multinucleate Ashbya gossypii cells
   relies on a minimal network of genes
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID SPINDLE POLE BODY; MITOTIC-EXIT; SACCHAROMYCES-CEREVISIAE; BUDDING
   YEAST; CDC14 PHOSPHATASE; NUCLEAR DIVISION; EARLY ANAPHASE; FEAR
   NETWORK; LOCALIZATION; CYTOKINESIS
AB In Saccharomyces cerevisiae, mitosis is coupled to cell division by the action of the Cdc fourteen early anaphase release (FEAR) and mitotic exit network (MEN) regulatory networks, which mediate exit from mitosis by activation of the phosphatase Cdc14. The closely related filamentous ascomycete Ashbya gossypii provides a unique cellular setting to study the evolution of these networks. Within its multinucleate hyphae, nuclei are free to divide without the spatial and temporal constraints described for budding yeast. To investigate how this highly conserved system has adapted to these circumstances, we constructed a series of mutants lacking homologues of core components of MEN and FEAR and monitored phenomena such as progression through mitosis and Cdc14 activation. MEN homologues in A. gossypii were shown to have diverged from their anticipated role in Cdc14 release and exit from mitosis. We observed defects in septation, as well as a partial metaphase arrest, in Agtem1 Delta, Agcdc15 Delta, Agdbf2/dbf20 Delta, and Agmob1 Delta. A. gossypii homologues of the FEAR network, on the other hand, have a conserved and more pronounced role in regulation of the M/G1 transition. Agcdc55 Delta mutants are unable to sequester AgCdc14 throughout interphase. We propose a reduced model of the networks described in yeast, with a low degree of functional redundancy, convenient for further investigations into these networks.
C1 [Finlayson, Mark R.; Helfer-Hungerbuehler, A. Katrin; Philippsen, Peter] Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
EM Peter.Philippsen@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-112688]
FX We thank Valentin Tilloy, Celine Correia, and Anais Sengler for help
   with strain construction. We are grateful to Frank Uhlmann and Anne
   Spang for their many helpful suggestions. We especially thank Sandrine
   Grava for discussions and the Agbub2 Delta. strain. We also acknowledge
   the help of the Philippsen laboratory, as well as the A. gossypii
   research community. This work was supported by Swiss National Science
   Foundation Grant 3100A0-112688 (to P.P.).
CR Alberti-Segui C, 2001, J CELL SCI, V114, P975
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6
   Bosl WJ, 2005, CELL, V121, P325, DOI 10.1016/j.cell.2005.04.006
   CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081
   Corbett M, 2006, EUR J CELL BIOL, V85, P1201, DOI 10.1016/j.ejcb.2006.08.001
   De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Gattiker A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-9
   GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050
   Jin FZ, 2008, P NATL ACAD SCI USA, V105, P16177, DOI 10.1073/pnas.0808719105
   Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08
   Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002
   Lang C, 2010, MOL BIOL CELL, V21, P753, DOI 10.1091/mbc.E09-07-0555
   Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063
   Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021
   MCGREW JT, 1992, MOL BIOL CELL, V3, P1443
   Meitinger F, 2010, J CELL SCI, V123, P1851, DOI 10.1242/jcs.063891
   Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022
   Nash R, 2007, NUCLEIC ACIDS RES, V35, pD468, DOI 10.1093/nar/gkl931
   Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(00)00002-2
   Queralt E, 2008, J CELL BIOL, V182, P873, DOI 10.1083/jcb.200801054
   Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038
   Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003
   Rock JM, 2009, CURR BIOL, V19, pR1063, DOI 10.1016/j.cub.2009.10.002
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Seshan A, 2002, CURR BIOL, V12, P2098, DOI 10.1016/S0960-9822(02)01388-X
   Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9
   Stegmeier F, 2004, CURR BIOL, V14, P467, DOI 10.1016/j.cub.2004.03.009
   Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5
   Tomson BN, 2009, CURR BIOL, V19, P449, DOI 10.1016/j.cub.2009.02.024
   Visintin R, 1999, NATURE, V398, P818
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2000, J CELL SCI, V113, P1611
   Yoshida S, 2002, CURR BIOL, V12, P944, DOI 10.1016/S0960-9822(02)00870-9
NR 37
TC 8
Z9 8
U1 0
U2 2
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD SEP 1
PY 2011
VL 22
IS 17
BP 3081
EP 3093
DI 10.1091/mbc.E10-12-1006
PG 13
WC Cell Biology
SC Cell Biology
GA 814BL
UT WOS:000294419300009
PM 21737675
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Kolb, T
   Maass, K
   Hergt, M
   Aebi, U
   Herrmann, H
AF Kolb, Thorsten
   Maass, Kendra
   Hergt, Michaela
   Aebi, Ueli
   Herrmann, Harald
TI Lamin A and lamin C form homodimers and coexist in higher complex forms
   both in the nucleoplasmic fraction and in the lamina of cultured human
   cells
SO NUCLEUS
LA English
DT Article
DE cell culture; detergent extraction; immunoprecipitation; intermediate
   filament proteins; lamins; nuclear envelope
ID MAMMALIAN-CELLS; NUCLEAR; IDENTIFICATION; EXPRESSION; PROTEINS; PLECTIN;
   ORGANIZATION; NETWORKS; VIMENTIN; MUTANTS
AB We have investigated and quantified the nuclear A-type lamin pool from human HeLa S3 suspension cells with respect to their distribution to detergent soluble and insoluble fractions. We devised a sequential extraction protocol and found that maximally 10% of A-type lamins are recovered in the soluble fraction. Notably, lamin C is enriched in low detergent fractions and only with 0.5% Nonidet P-40 lamin A and C are recovered in ratios nearly equivalent to those found in whole cell extracts and in the lamina fraction. Authentic nucleoplasmic proteins such as LAP2 alpha, pRB and p53 are co-extracted to a large part together with the A-type lamins in these fractions. By sucrose density centrifugation we revealed that the majority of lamins co-sedimented with human IgG indicating they form rather small complexes in the range of dimers and slightly larger complexes. Some lamin A-but not lamin C-is obtained in addition in a much faster sedimenting fraction. Authentic nuclear proteins such as PCNA, p53 and LAP2 alpha were found both in the light and the heavy sucrose fractions together with lamin A. Last but not least, immunoprecipitation experiments from both soluble fractions and from RIPA lysates of whole cells revealed that lamin A and lamin C do not form heterodimers but segregate practically completely. Correspondingly, immunofluorescence microscopy of formaldehyde-fixed cells clearly demonstrated that lamin A and C are localized at least in part to distinct patches within the lamina. Hence, the structural segregation of lamin A and C is indeed retained in the nuclear envelope to some extent too.
C1 [Kolb, Thorsten; Maass, Kendra; Hergt, Michaela; Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany.
   [Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Herrmann, H (corresponding author), German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany.
EM h.herrmann@dkfz-heidelberg.de
FU German-Israeli-Foundation for Scientific Research and Development
   (GIF)German-Israeli Foundation for Scientific Research and Development
   [111/2007]; German Research Foundation (DFG)German Research Foundation
   (DFG) [HE 1853]; M.E. Muller Foundation of Switzerland; Canton
   Basel-Stadt
FX We thank Bettina Fiege for initial help with cell fractionation. H.H.
   was supported by the German-Israeli-Foundation for Scientific Research
   and Development (GIF, grant 111/2007) and the German Research Foundation
   (DFG, HE 1853); U.A. received support from the M.E. Muller Foundation of
   Switzerland and the Canton Basel-Stadt.
CR ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807
   Alsheimer M, 2000, P NATL ACAD SCI USA, V97, P13120, DOI 10.1073/pnas.240466597
   Bar H, 2006, EXP CELL RES, V312, P1554, DOI 10.1016/j.yexcr.2006.01.021
   Dechat T, 2010, COLD SH Q B, V75, P533, DOI 10.1101/sqb.2010.75.018
   Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708
   Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125
   Geiger SK, 2008, J MOL MED-JMM, V86, P281, DOI 10.1007/s00109-007-0275-1
   GILEAD Z, 1976, NATURE, V264, P263, DOI 10.1038/264263a0
   Gotic I, 2010, NUCLEUS-PHILA, V1, P397, DOI 10.4161/nucl.1.5.12394
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   HERRMANN H, 1983, J BIOL CHEM, V258, P4610
   HERRMANN H, 1987, J BIOL CHEM, V262, P1320
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020507
   Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067
   Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793
   Schumacher J, 2006, FEBS LETT, V580, P6211, DOI 10.1016/j.febslet.2006.10.023
   Sharma S, 2009, J MOL MED, V87, P1207, DOI 10.1007/s00109-009-0521-9
   Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208
   Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000
   Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913
   Vlcek S, 2007, BBA-MOL CELL RES, V1773, P661, DOI 10.1016/j.bbamcr.2006.07.002
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028
   ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7
   Zwerger M, 2010, MOL BIOL CELL, V21, P354, DOI 10.1091/mbc.E09-08-0739
NR 27
TC 72
Z9 74
U1 0
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1949-1034
EI 1949-1042
J9 NUCLEUS-PHILA
JI Nucleus
PD SEP-OCT
PY 2011
VL 2
IS 5
SI SI
BP 425
EP 433
DI 10.4161/nucl.2.5.17765
PG 9
WC Cell Biology
SC Cell Biology
GA V28GL
UT WOS:000208669200011
PM 22033280
OA Bronze
DA 2021-01-25
ER

PT J
AU Al-Haboubi, T
   Shumaker, DK
   Koser, J
   Wehnert, M
   Fahrenkrog, B
AF Al-Haboubi, Teiba
   Shumaker, Dale K.
   Koeser, Joachim
   Wehnert, Manfred
   Fahrenkrog, Birthe
TI Distinct association of the nuclear pore protein Nup153 with A- and
   B-type lamins
SO NUCLEUS
LA English
DT Article
DE nuclear lamins; nucleoporin; Nup153; Ig-fold; nuclear pore complex
ID NUCLEOPORIN NUP153; STRUCTURAL ORGANIZATION; SACCHAROMYCES-CEREVISIAE;
   LOCALIZATION SIGNAL; COMPLEX PROTEIN; ENVELOPE; IMPORT; DOMAIN; BASKET;
   ARCHITECTURE
AB The nuclear envelope (NE) is a double membrane physical barrier, which separates the nucleus from the cytoplasm. Underlying the NE are the nuclear lamins, which in combination with inner nuclear membrane proteins form the lamina. The lamina is crucial for maintaining the structural integrity of the nucleus and for positioning of nuclear pore complexes (NPCs) within the NE. The nucleoporin Nup153 has previously been reported to bind to B-type lamins. However, the specificity of this interaction is not well established. Here we show that Nup153 exhibits multiple binding sites for A- and B-type lamins. Using GST-pull down assays, we found that both the N-terminal domain of Nup153 and its C terminus associate with the Ig-fold domain of A-and B-type lamins. By employing purified Nup153 and lamin proteins in blot overlay assays we revealed that both the N-terminal and the C-terminal domain of Nup153 are directly interacting with the lamins. Moreover, we provide evidence that mutations in the lamin A Ig-fold domain selectively affect Nup153-binding, suggesting that Nup153 may play a role in lamin-associated diseases, known as laminopathies. Together our results indicate a far more intricate interplay between Nup153 and nuclear lamins than previously accepted.
C1 [Al-Haboubi, Teiba; Koeser, Joachim; Fahrenkrog, Birthe] Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, Basel, Switzerland.
   [Shumaker, Dale K.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.
   [Wehnert, Manfred] Ernst Moritz Arndt Univ Greifswald, Inst Human Genet, Greifswald, Germany.
   [Fahrenkrog, Birthe] Univ Libre Bruxelles, Inst Mol Biol & Med, Brussels, Belgium.
RP Fahrenkrog, B (corresponding author), Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, Basel, Switzerland.
EM bfahrenk@ulb.ac.be
OI Fahrenkrog, Birthe/0000-0003-4080-9413
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Fonds de la Recherche Scientifique-FNRS BelgiumFonds de la
   Recherche Scientifique - FNRS; M.E. Muller Foundation of Switzerland;
   Kanton Basel-Stadt; German Network on muscular dystrophies; German
   Ministry of Education and ResearchFederal Ministry of Education &
   Research (BMBF) [BMBF 01GM0302]
FX The authors thank Drs. Robert D. Goldman, Brian Burke and Volker Cordes
   for antibodies and Drs. Robert D. Goldman and Katie Ullman for plasmids.
   Drs. Larisa Kapinos is acknowledged for providing purified lamin
   fragments and Unai Silvan for purified coiled-coil peptide. This work
   was supported by grants from the Swiss National Science Foundation (to
   B.F.) and the Fonds de la Recherche Scientifique-FNRS Belgium (to B.F.)
   as well as by the M.E. Muller Foundation of Switzerland and the Kanton
   Basel-Stadt. M.W. was supported by the German Network on muscular
   dystrophies funded by the German Ministry of Education and Research
   (BMBF 01GM0302).
CR Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200
   Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122
   Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3
   Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Bodoor K, 1999, J CELL SCI, V112, P2253
   Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J
   CORDES VC, 1993, J CELL BIOL, V123, P1333, DOI 10.1083/jcb.123.6.1333
   D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009
   Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089
   Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708
   Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   Dorner D, 2007, FEBS J, V274, P1362, DOI 10.1111/j.1742-4658.2007.05695.x
   Enarson P, 1998, CHROMOSOMA, V107, P228, DOI 10.1007/s004120050301
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.E03-10-0743
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3
   HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Hubner S, 2006, J CELL BIOCHEM, V98, P810, DOI 10.1002/jcb.20791
   Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625
   Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x
   Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Lim RYH, 2006, CHROMOSOMA, V115, P15, DOI 10.1007/s00412-005-0037-1
   LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036
   LIN F, 1993, J BIOL CHEM, V268, P16321
   Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4
   LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x
   Lussi YC, 2010, NUCLEUS-AUSTIN, V1, P71, DOI 10.4161/nucl.1.1.10244
   LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000
   Mackay DR, 2010, J CELL BIOL, V191, P923, DOI 10.1083/jcb.201007124
   Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883
   Maraldi Nadir M, 2007, Acta Biomed, V78 Suppl 1, P207
   MCMORROW I, 1994, BBA-GENE STRUCT EXPR, V1217, P219, DOI 10.1016/0167-4781(94)90040-X
   Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007
   MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201
   MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532
   Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982
   Orlic M, 2006, GENE CHROMOSOME CANC, V45, P72, DOI 10.1002/gcc.20263
   Palacios I, 1996, J CELL BIOL, V133, P485, DOI 10.1083/jcb.133.3.485
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   Salina D, 2001, BIOCHEM CELL BIOL, V79, P533, DOI 10.1139/bcb-79-5-533
   Schmidt HHJ, 2001, J CLIN ENDOCR METAB, V86, P2289, DOI 10.1210/jc.86.5.2289
   Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003
   Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31
   Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208
   Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155
   Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102
   Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918
   Stierle VN, 2003, BIOCHEMISTRY-US, V42, P4819, DOI 10.1021/bi020704g
   Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649
   Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846
   Vaughan OA, 2000, PROTOPLASMA, V211, P1, DOI 10.1007/BF01279893
   Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028
   ZEWE M, 1991, EUR J CELL BIOL, V56, P342
NR 61
TC 42
Z9 43
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1949-1034
EI 1949-1042
J9 NUCLEUS-PHILA
JI Nucleus
PD SEP-OCT
PY 2011
VL 2
IS 5
SI SI
BP 500
EP 509
DI 10.4161/nucl.2.5.17913
PG 10
WC Cell Biology
SC Cell Biology
GA V28GL
UT WOS:000208669200018
PM 21983083
OA Bronze
DA 2021-01-25
ER

PT J
AU Rammelt, C
   Bilen, B
   Zavolan, M
   Keller, W
AF Rammelt, Christiane
   Bilen, Biter
   Zavolan, Mihaela
   Keller, Walter
TI PAPD5, a noncanonical poly(A) polymerase with an unusual RNA-binding
   motif
SO RNA
LA English
DT Article
DE polyadenylation; noncanonical poly(A) polymerase; TRAMP4; RNA
   surveillance
ID QUALITY-CONTROL; POLYADENYLATION; DEGRADATION; SURVEILLANCE;
   TRANSCRIPTS; EXOSOME; TRAMP; IDENTIFICATION; ACCUMULATION; EXPRESSION
AB PAPD5 is one of the seven members of the family of noncanonical poly(A) polymerases in human cells. PAPD5 was shown to polyadenylate aberrant pre-ribosomal RNAs in vivo, similar to degradation-mediating polyadenylation by the noncanonical poly(A) polymerase Trf4p in yeast. PAPD5 has been reported to be also involved in the uridylation-dependent degradation of histone mRNAs. To test whether PAPD5 indeed catalyzes adenylation as well as uridylation of RNA substrates, we analyzed the in vitro properties of recombinant PAPD5 expressed in mammalian cells as well as in bacteria. Our results show that PAPD5 catalyzes the polyadenylation of different types of RNA substrates in vitro. Interestingly, PAPD5 is active without a protein cofactor, whereas its yeast homolog Trf4p is the catalytic subunit of a bipartite poly(A) polymerase in which a separate RNA-binding subunit is needed for activity. In contrast to the yeast protein, the C terminus of PAPD5 contains a stretch of basic amino acids that is involved in binding the RNA substrate.
C1 [Rammelt, Christiane] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Germany.
   [Bilen, Biter; Zavolan, Mihaela; Keller, Walter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Rammelt, C (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Germany.
EM christiane.rammelt@biochemtech.uni-halle.de; walter.keller@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; Bilen, Biter/0000-0001-9452-3512
FU University of Basel; Louis-Jeantet Foundation for Medicine; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [3100A0-102132/2]; Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG) [RA 1892/1-1]; Werner-Siemens-Foundation
FX We are grateful to Markus Landthaler and Thomas Tuschl for their
   generous help with the CLIP experiments and to Georges Martin and Elmar
   Wahle for discussions and critical reading of the manuscript. We also
   thank Bruno Senger and Gerard Keith for clones and native tRNA samples.
   The work was supported by the University of Basel, the Louis-Jeantet
   Foundation for Medicine, the Swiss National Science Foundation (grant
   Nr. 3100A0-102132/2 to W.K.), and the Deutsche Forschungsgemeinschaft
   (grant Nr. RA 1892/1-1 to C. R.). B. B. is supported by a PhD fellowship
   from the Werner-Siemens-Foundation.
CR Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   Betat H, 2004, MOL CELL, V15, P389, DOI 10.1016/j.molcel.2004.06.026
   Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481
   Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396
   Carneiro T, 2007, MOL CELL BIOL, V27, P4157, DOI 10.1128/MCB.00120-07
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103
   Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035
   Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hamill S, 2010, P NATL ACAD SCI USA, V107, P15045, DOI 10.1073/pnas.1003505107
   Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921
   Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406
   Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804
   LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029
   Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002
   Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132
   Li ZW, 1998, P NATL ACAD SCI USA, V95, P12158, DOI 10.1073/pnas.95.21.12158
   Martin G, 2004, J MOL BIOL, V341, P911, DOI 10.1016/j.jmb.2004.06.047
   Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807
   Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708
   Nakamura R, 2008, MOL CELL BIOL, V28, P6620, DOI 10.1128/MCB.00448-08
   Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555
   Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025
   Schmidt MJ, 2010, WIRES RNA, V1, P142, DOI 10.1002/wrna.16
   Schmidt MJ, 2011, RNA, V17, P39, DOI 10.1261/rna.2252511
   Shcherbik N, 2010, EMBO REP, V11, P106, DOI 10.1038/embor.2009.271
   Slomovic S, 2010, P NATL ACAD SCI USA, V107, P7407, DOI 10.1073/pnas.0910621107
   SMIT AFA, 1996, REPEATMASKER OPEN 3
   Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101
   Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189
   Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006
   Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97
   Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030
   Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158
   Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244
NR 38
TC 51
Z9 54
U1 0
U2 3
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD SEP
PY 2011
VL 17
IS 9
BP 1737
EP 1746
DI 10.1261/rna.2787011
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 808GF
UT WOS:000293964600012
PM 21788334
OA Green Published, Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Kilchert, C
   Spang, A
AF Kilchert, Cornelia
   Spang, Anne
TI Cotranslational transport of ABP140 mRNA to the distal pole of S.
   cerevisiae
SO EMBO JOURNAL
LA English
DT Article
DE cotranslational; localization; mRNA
ID BINDING PROTEIN ABP140; GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE;
   ACTIN CYTOSKELETON; BUDDING YEAST; ASYMMETRIC LOCALIZATION;
   ENDOPLASMIC-RETICULUM; SPINDLE ORIENTATION; SECRETORY PATHWAY; SPATIAL
   LANDMARK
AB In budding yeast, several mRNAs are selectively transported into the daughter cell in an actin-dependent manner by a specialized myosin system, the SHE machinery. With ABP140 mRNA, we now describe the first mRNA that is transported in the opposite direction and localizes to the distal pole of the mother cell, independent of the SHE machinery. Distal pole localization is not observed in mutants devoid of actin cables and can be disrupted by latrunculin A. Furthermore, localization of ABP140 mRNA requires the N-terminal actin-binding domain of Abp140p to be expressed. By replacing the N-terminal localization motif, ABP140 mRNA can be retargeted to different subcellular structures. In addition, accumulation of the mRNA at the distal pole can be prevented by disruption of polysomes. Using the MS2 system, the mRNA was found to associate with actin cables and to follow actin cable dynamics. We therefore propose a model of translational coupling, in which ABP140 mRNA is tethered to actin cables via its nascent protein product and is transported to the distal pole by actin retrograde flow. The EMBO Journal (2011) 30, 3567-3580. doi:10.1038/emboj.2011.247; Published online 26 July 2011
C1 [Kilchert, Cornelia; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Kilchert, Cornelia/0000-0001-6834-0704
FU Boehringer Ingelheim FondsBoehringer Ingelheim; Human Frontier Science
   ProgramHuman Frontier Science Program; Swiss National FundSwiss National
   Science Foundation (SNSF); University of Basel
FX We are very grateful to P Lappalainen, C-A Schonenberger, U Silvan, R
   Wedlich-Soldner, and members of the Spang laboratory for discussions. We
   also appreciate the contribution of P Demougin, who helped with the qPCR
   experiment, and of J Weidner, who optimized the protocol for the
   combined FISH/immunofluorescence. The Sec63p-RFP plasmid was kindly
   provided by S Michaelis and pYM-4GFP-Kan was a gift of C Taxis. We thank
   B Glick, P Chartrand, J Hegemann, M Knop, A Nakano, R Parker, MA
   Resnick, S Rospert, E Schiebel, and P Silver for strains and reagents.
   This work was supported by the Boehringer Ingelheim Fonds (CK), the
   Human Frontier Science Program, the Swiss National Fund, and the
   University of Basel.
CR Ahmed AU, 2009, INT REV CEL MOL BIO, V273, P49, DOI 10.1016/S1937-6448(08)01802-9
   Aronov S, 2004, J BIOL CHEM, V279, P36962, DOI 10.1074/jbc.M402068200
   Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06
   Asakura T, 1998, ONCOGENE, V16, P121, DOI 10.1038/sj.onc.1201487
   Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399
   Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3
   Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4
   Bi J, 2007, P NATL ACAD SCI USA, V104, P13810, DOI 10.1073/pnas.0703805104
   Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163
   Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049
   Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059
   Cepeda-Garcia C, 2010, MOL BIOL CELL, V21, P2685, DOI 10.1091/mbc.E10-03-0197
   Chang F, 2003, NAT CELL BIOL, V5, P294, DOI 10.1038/ncb0403-294
   Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033
   Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823
   COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2
   Cullen PJ, 2002, MOL BIOL CELL, V13, P2990, DOI 10.1091/mbc.E02-03-0151
   Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007
   D'Silva S, 2011, RNA, V17, P1100, DOI 10.1261/rna.2652611
   D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910
   delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201
   Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603
   Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886
   Farabaugh PJ, 2006, J MOL EVOL, V63, P545, DOI 10.1007/s00239-005-0311-0
   Gao LN, 2008, MOL BIOL CELL, V19, P1474, DOI 10.1091/mbc.E07-05-0520
   Garcia M, 2010, EMBO REP, V11, P285, DOI 10.1038/embor.2010.17
   Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187
   Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23
   Halbach A, 2009, EMBO J, V28, P2959, DOI 10.1038/emboj.2009.240
   Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497
   HARTWELL LH, 1969, P NATL ACAD SCI USA, V62, P468, DOI 10.1073/pnas.62.2.468
   Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488
   Huckaba TM, 2006, J CELL BIOL, V175, P957, DOI 10.1083/jcb.200609155
   Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173
   Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030
   Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607
   Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142
   Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3
   Kang PJ, 2001, SCIENCE, V292, P1376, DOI 10.1126/science.1060360
   Kilchert C, 2010, MOL BIOL CELL, V21, P2624, DOI 10.1091/mbc.E10-02-0099
   Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W
   KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x
   Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003
   LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303
   Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403
   LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305
   LIU H, 1989, CELL, V57, P233, DOI 10.1016/0092-8674(89)90961-6
   Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383
   Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025
   Meignin C, 2010, CURR OPIN CELL BIOL, V22, P112, DOI 10.1016/j.ceb.2009.11.011
   Michelot A, 2010, CURR BIOL, V20, P1890, DOI 10.1016/j.cub.2010.10.016
   Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888
   Morris DK, 1997, CURR BIOL, V7, P969, DOI 10.1016/S0960-9822(06)00416-7
   MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7
   Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002
   Noma A, 2011, RNA, V17, P1111, DOI 10.1261/rna.2653411
   PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x
   Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108
   Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220
   Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293
   Schenkman LR, 2002, J CELL BIOL, V156, P829, DOI 10.1083/jcb.200107041
   SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091
   Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Slobodin B, 2010, RNA, V16, P2277, DOI 10.1261/rna.2091710
   Stahl G, 2004, EUKARYOT CELL, V3, P331, DOI 10.1128/EC.3.2.331-338.2004
   Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837
   Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015
   Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294
   Theesfeld CL, 1999, J CELL BIOL, V146, P1019, DOI 10.1083/jcb.146.5.1019
   Trautwein M, 2004, MOL BIOL CELL, V15, P5021, DOI 10.1091/mbc.E04-05-0411
   Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671
   WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495
   WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557
   Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142
   Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033
   Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899
   Yang S, 1997, J CELL BIOL, V136, P111, DOI 10.1083/jcb.136.1.111
   Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038
   Zhang G, 2010, NUCLEIC ACIDS RES, V38, P4778, DOI 10.1093/nar/gkq196
   Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x
   Zipor G, 2009, P NATL ACAD SCI USA, V106, P19848, DOI 10.1073/pnas.0910754106
NR 82
TC 29
Z9 30
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD AUG 31
PY 2011
VL 30
IS 17
BP 3567
EP 3580
DI 10.1038/emboj.2011.247
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 814MR
UT WOS:000294460000011
PM 21792172
OA Green Published
DA 2021-01-25
ER

PT J
AU Schmidt, FI
   Bleck, CKE
   Helenius, A
   Mercer, J
AF Schmidt, Florian Ingo
   Bleck, Christopher Karl Ernst
   Helenius, Ari
   Mercer, Jason
TI Vaccinia extracellular virions enter cells by macropinocytosis and
   acid-activated membrane rupture
SO EMBO JOURNAL
LA English
DT Article
DE acid-activated rupture; extracellular virion; macropinocytosis;
   poxvirus; vaccinia virus
ID PROTEIN-KINASE-C; VIRUS ENTRY; ENVELOPED VIRUS; DENDRITIC CELLS;
   APOPTOTIC MIMICRY; PROGENY VIRIONS; OUTER-MEMBRANE; POXVIRUS ENTRY;
   MATURE VIRIONS; IN-VITRO
AB Vaccinia virus (VACV), the model poxvirus, produces two types of infectious particles: mature virions (MVs) and extracellular virions (EVs). EV particles possess two membranes and therefore require an unusual cellular entry mechanism. By a combination of fluorescence and electron microscopy as well as flow cytometry, we investigated the cellular processes that EVs required to infect HeLa cells. We found that EV particles were endocytosed, and that internalization and infection depended on actin re-arrangements, activity of Na(+)/H(+) exchangers, and signalling events typical for the macropinocytic mechanism of endocytosis. To promote their internalization, EVs were capable of actively triggering macropinocytosis. EV infection also required vacuolar acidification, and acid exposure in endocytic vacuoles was needed to disrupt the outer EV membrane. Once exposed, the underlying MV-like particle presumably fused its single membrane with the limiting vacuolar membrane. Release of the viral core into the host cell cytosol allowed for productive infection. The EMBO Journal (2011) 30, 3647-3661. doi:10.1038/emboj.2011.245; Published online 26 July 2011
C1 [Mercer, Jason] ETH, ETH Hoenggerberg, Inst Biochem, CH-8093 Zurich, Switzerland.
   [Bleck, Christopher Karl Ernst] Univ Basel, Ctr Cellular Imaging & Nano Analyt C CINA, Biozentrum, Basel, Switzerland.
RP Mercer, J (corresponding author), ETH, ETH Hoenggerberg, Inst Biochem, HPM E9-1,Schafmattstr 18, CH-8093 Zurich, Switzerland.
EM jason.mercer@bc.biol.ethz.ch
RI Schmidt, Florian/H-7372-2012; Schmidt, Florian Ingo/J-1672-2019
OI Schmidt, Florian/0000-0002-9979-9769; Schmidt, Florian
   Ingo/0000-0002-9979-9769; Bleck, Christopher/0000-0003-1029-3444
FU EMBOEuropean Molecular Biology Organization (EMBO); ETH ZurichETH
   Zurich; Swiss National Foundation (InfectX, Sinergia)Swiss National
   Science Foundation (SNSF); Boehringer Ingelheim PhD fellowship
FX We thank Veronika Graml for help with image analysis, Stefan Kalin for
   help with dextran uptake experiments, and the Light Microscopy Center
   (LMC), ETH Zurich, for microscopy support. We are grateful to Lucia Reh,
   Andrea Rothballer, and Yohei Yamauchi for critical reading of the
   manuscript. This work was in part funded by grants from EMBO, ETH
   Zurich, and the Swiss National Foundation (InfectX, Sinergia). FIS was
   supported by a Boehringer Ingelheim PhD fellowship.
CR Aldaz-Carroll L, 2005, J VIROL, V79, P6260, DOI 10.1128/JVI.79.10.6260-6271.2005
   Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38
   BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995
   Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08
   Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07
   Chang SJ, 2010, J VIROL, V84, P8422, DOI 10.1128/JVI.00599-10
   Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003
   Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102
   DAMON IK, 2007, FIELDS VIROLOGY, V75, P2947
   Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095
   Earley AK, 2008, J VIROL, V82, P2161, DOI 10.1128/JVI.01971-07
   Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747
   GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199
   Hollinshead M, 1999, J VIROL, V73, P1503, DOI 10.1128/JVI.73.2.1503-1517.1999
   Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08
   Husain M, 2007, VIROLOGY, V366, P424, DOI 10.1016/j.virol.2007.05.015
   Ichihashi Y, 1996, VIROLOGY, V217, P478, DOI 10.1006/viro.1996.0142
   ICHIHASHI Y, 1983, VIROLOGY, V130, P306, DOI 10.1016/0042-6822(83)90085-5
   Kalin S, 2010, J VIROL, V84, P5336, DOI 10.1128/JVI.02494-09
   Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094
   Kayali AG, 2002, ENDOCRINOLOGY, V143, P3884, DOI 10.1210/en.2002-220259
   Laliberte JP, 2009, P NATL ACAD SCI USA, V106, P17517, DOI 10.1073/pnas.0909376106
   Law M, 2006, P NATL ACAD SCI USA, V103, P5989, DOI 10.1073/pnas.0601025103
   Law M, 2001, VIROLOGY, V280, P132, DOI 10.1006/viro.2000.0750
   Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497
   Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007
   Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107
   Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510
   Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954
   Moss B, 2006, VIROLOGY, V344, P48, DOI 10.1016/j.virol.2005.09.037
   MOSS B, 2007, FIELDS VIROLOGY, V74, P2906
   Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121
   Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x
   Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141
   PAYNE L, 1978, J VIROL, V27, P28, DOI 10.1128/JVI.27.1.28-37.1978
   PAYNE LG, 1979, J VIROL, V31, P147, DOI 10.1128/JVI.31.1.147-155.1979
   PAYNE LG, 1980, J GEN VIROL, V50, P89, DOI 10.1099/0022-1317-50-1-89
   Pedersen K, 2000, J VIROL, V74, P3525, DOI 10.1128/JVI.74.8.3525-3536.2000
   Perdiguero B, 2008, J VIROL, V82, P2150, DOI 10.1128/JVI.01969-07
   Raghu H, 2009, J VIROL, V83, P4895, DOI 10.1128/JVI.02498-08
   Roberts KL, 2009, J GEN VIROL, V90, P1582, DOI 10.1099/vir.0.009092-0
   Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866
   Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002
   SCHLIWA M, 1981, P NATL ACAD SCI-BIOL, V78, P1037, DOI 10.1073/pnas.78.2.1037
   Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102
   Senkevich TG, 2004, J VIROL, V78, P2357, DOI 10.1128/JVI.78.5.2357-2366.2004
   Senkevich TG, 2004, J VIROL, V78, P2348, DOI 10.1128/JVI.78.5.2348-2356.2004
   Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365
   Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037
   Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915
   Soltoff SP, 2001, J BIOL CHEM, V276, P37986
   Tillman DM, 2003, CANCER RES, V63, P5118
   TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551
   Townsley AC, 2007, J VIROL, V81, P8613, DOI 10.1128/JVI.00606-07
   Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06
   Ulaeto D, 1996, J VIROL, V70, P3372, DOI 10.1128/JVI.70.6.3372-3377.1996
   Vanderplasschen A, 1997, J VIROL, V71, P4032, DOI 10.1128/JVI.71.5.4032-4041.1997
   Vanderplasschen A, 1998, J GEN VIROL, V79, P877, DOI 10.1099/0022-1317-79-4-877
   Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544
   Wolffe EJ, 1997, J VIROL, V71, P3904, DOI 10.1128/JVI.71.5.3904-3915.1997
   WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378
   ZWARTOUW HT, 1964, J GEN MICROBIOL, V34, P115, DOI 10.1099/00221287-34-1-115
NR 66
TC 59
Z9 59
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD AUG 31
PY 2011
VL 30
IS 17
BP 3647
EP 3661
DI 10.1038/emboj.2011.245
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 814MR
UT WOS:000294460000017
PM 21792173
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Schroder, G
   Schuelein, R
   Quebatte, M
   Dehio, C
AF Schroeder, Gunnar
   Schuelein, Ralf
   Quebatte, Maxime
   Dehio, Christoph
TI Conjugative DNA transfer into human cells by the VirB/VirD4 type IV
   secretion system of the bacterial pathogen Bartonella henselae
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE bacterial conjugation; transformation; bacterial infection; relaxase;
   oriT
ID AGROBACTERIUM-TUMEFACIENS; NUCLEAR-LOCALIZATION; ESCHERICHIA-COLI;
   ILLEGITIMATE RECOMBINATION; LEGIONELLA-PNEUMOPHILA; ENDOTHELIAL-CELLS;
   VIRULENCE SYSTEM; TUMOR-FORMATION; VIRE2 PROTEIN; VIRD2 PROTEIN
AB Bacterial type IV secretion systems (T4SS) mediate interbacterial conjugative DNA transfer and transkingdom protein transfer into eukaryotic host cells in bacterial pathogenesis. The sole bacterium known to naturally transfer DNA into eukaryotic host cells via a T4SS is the plant pathogen Agrobacterium tumefaciens. Here we demonstrate T4SS-mediated DNA transfer from a human bacterial pathogen into human cells. We show that the zoonotic pathogen Bartonella henselae can transfer a cryptic plasmid occurring in the bartonellae into the human endothelial cell line EA.hy926 via its T4SS VirB/VirD4. DNA transfer into EA.hy926 cells was demonstrated by using a reporter derivative of this Bartonella-specific mobilizable plasmid generated by insertion of a eukaryotic egfp-expression cassette. Fusion of the C-terminal secretion signal of the endogenous VirB/VirD4 protein substrate BepD with the plasmid-encoded DNA-transport protein Mob resulted in a 100-fold increased DNA transfer rate. Expression of the delivered egfp gene in EA.hy926 cells required cell division, suggesting that nuclear envelope breakdown may facilitate passive entry of the transferred ssDNA into the nucleus as prerequisite for complementary strand synthesis and transcription of the egfp gene. Addition of an eukaryotic neomycin phosphotransferase expression cassette to the reporter plasmid facilitated selection of stable transgenic EA.hy926 cell lines that display chromosomal integration of the transferred plasmid DNA. Our data suggest that T4SS-dependent DNA transfer into host cells may occur naturally during human infection with Bartonella and that these chronically infecting pathogens have potential for the engineering of in vivo gene-delivery vectors with applications in DNA vaccination and therapeutic gene therapy.
C1 [Schroeder, Gunnar; Schuelein, Ralf; Quebatte, Maxime; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Quebatte, Maxime/0000-0002-3733-1511
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [SCHR988/1-1]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [31003A-132979]; SystemsX.ch (Swiss Initiative for
   Systems Biology) [51RT-0-126008 (InfectX)]
FX We thank A. Pulliainen for critical reading of the manuscript and N.
   Balmelle-Devaux and Y. Ellner for excellent technical assistance. This
   work was supported by Deutsche Forschungsgemeinschaft Grant SCHR988/1-1
   (to G.S.), Swiss National Science Foundation Grant 31003A-132979 (to
   C.D.), and SystemsX.ch (Swiss Initiative for Systems Biology) Grant
   51RT-0-126008 (InfectX) (to C.D.).
CR Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09
   Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x
   Bates S, 1998, J BACTERIOL, V180, P6538, DOI 10.1128/JB.180.24.6538-6543.1998
   BEIJERSBERGEN A, 1992, SCIENCE, V256, P1324, DOI 10.1126/science.256.5061.1324
   BUCHANANWOLLASTON V, 1987, NATURE, V328, P172, DOI 10.1038/328172a0
   Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630
   Christie PJ, 1997, J BACTERIOL, V179, P3085, DOI 10.1128/jb.179.10.3085-3094.1997
   CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Duckely M, 2003, FEMS MICROBIOL LETT, V223, P1, DOI 10.1016/S0378-1097(03)00246-5
   Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124
   GHEYSEN G, 1991, GENE DEV, V5, P287, DOI 10.1101/gad.5.2.287
   HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0
   HOWARD EA, 1992, CELL, V68, P109, DOI 10.1016/0092-8674(92)90210-4
   Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034
   Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x
   Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598
   Lacroix B, 2006, CAN J PHYSIOL PHARM, V84, P333, DOI 10.1139/Y05-108
   LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x
   Loessner H, 2004, EXPERT OPIN BIOL TH, V4, P157, DOI 10.1517/14712598.4.2.157
   Loessner H, 2008, INT J MED MICROBIOL, V298, P21, DOI 10.1016/j.ijmm.2007.07.005
   MAYERHOFER R, 1991, EMBO J, V10, P697, DOI 10.1002/j.1460-2075.1991.tb07999.x
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Seubert A, 2003, PLASMID, V49, P44, DOI 10.1016/S0147-619X(02)00103-8
   TINLAND B, 1992, P NATL ACAD SCI USA, V89, P7442, DOI 10.1073/pnas.89.16.7442
   van Kregten M, 2009, MOL PLANT MICROBE IN, V22, P1356, DOI 10.1094/MPMI-22-11-1356
   Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873
   Waters VL, 2001, NAT GENET, V29, P375, DOI 10.1038/ng779
NR 40
TC 58
Z9 58
U1 0
U2 15
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 30
PY 2011
VL 108
IS 35
BP 14643
EP 14648
DI 10.1073/pnas.1019074108
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 814DH
UT WOS:000294425900056
PM 21844337
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Chan, JC
   Hannan, KM
   Riddell, K
   Ng, PY
   Peck, A
   Lee, RS
   Hung, S
   Astle, MV
   Bywater, M
   Wall, M
   Poortinga, G
   Jastrzebski, K
   Sheppard, KE
   Hemmings, BA
   Hall, MN
   Johnstone, RW
   McArthur, GA
   Hannan, RD
   Pearson, RB
AF Chan, Joanna C.
   Hannan, Katherine M.
   Riddell, Kim
   Pui Yee Ng
   Peck, Abigail
   Lee, Rachel S.
   Hung, Sandy
   Astle, Megan V.
   Bywater, Megan
   Wall, Meaghan
   Poortinga, Gretchen
   Jastrzebski, Katarzyna
   Sheppard, Karen E.
   Hemmings, Brian A.
   Hall, Michael N.
   Johnstone, Ricky W.
   McArthur, Grant A.
   Hannan, Ross D.
   Pearson, Richard B.
TI AKT Promotes rRNA Synthesis and Cooperates with c-MYC to Stimulate
   Ribosome Biogenesis in Cancer
SO SCIENCE SIGNALING
LA English
DT Article
ID POLYMERASE-I TRANSCRIPTION; CELL LUNG-CANCER; DEPENDENT REGULATION;
   PROTEIN-SYNTHESIS; OVARIAN-CANCER; PATHWAY; ACTIVATION; SURVIVAL; GENE;
   UBF
AB Precise regulation of ribosome biogenesis is fundamental to maintain normal cell growth and proliferation, and accelerated ribosome biogenesis is associated with malignant transformation. Here, we show that the kinase AKT regulates ribosome biogenesis at multiple levels to promote ribosomal RNA (rRNA) synthesis. Transcription elongation by RNA polymerase I, which synthesizes rRNA, required continuous AKT-dependent signaling, an effect independent of AKT's role in activating the translation-promoting complex mTORC1 (mammalian target of rapamycin complex 1). Sustained inhibition of AKT and mTORC1 cooperated to reduce rRNA synthesis and ribosome biogenesis by additionally limiting RNA polymerase I loading and pre-rRNA processing. In the absence of growth factors, constitutively active AKT increased synthesis of rRNA, ribosome biogenesis, and cell growth. Furthermore, AKT cooperated with the transcription factor c-MYC to synergistically activate rRNA synthesis and ribosome biogenesis, defining a network involving AKT, mTORC1, and c-MYC as a master controller of cell growth. Maximal activation of c-MYC-dependent rRNA synthesis in lymphoma cells required AKT activity. Moreover, inhibition of AKT-dependent rRNA transcription was associated with increased lymphoma cell death by apoptosis. These data indicate that decreased ribosome biogenesis is likely to be a fundamental component of the therapeutic response to AKT inhibitors in cancer.
C1 [Chan, Joanna C.; Hannan, Katherine M.; Riddell, Kim; Pui Yee Ng; Peck, Abigail; Lee, Rachel S.; Hung, Sandy; Astle, Megan V.; Bywater, Megan; Wall, Meaghan; Poortinga, Gretchen; Jastrzebski, Katarzyna; Sheppard, Karen E.; Johnstone, Ricky W.; McArthur, Grant A.; Hannan, Ross D.; Pearson, Richard B.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 8006, Australia.
   [Wall, Meaghan; Poortinga, Gretchen; McArthur, Grant A.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.
   [Wall, Meaghan] St Vincents Hosp, Victorian Canc Cytogenet Serv, Melbourne, Vic 8006, Australia.
   [Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [McArthur, Grant A.; Hannan, Ross D.; Pearson, Richard B.] St Vincents Hosp, Dept Med, Melbourne, Vic 8006, Australia.
   [Hannan, Ross D.; Pearson, Richard B.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.
   [Pearson, Richard B.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia.
RP Hannan, RD (corresponding author), Peter MacCallum Canc Ctr, Div Res, St Andrews Pl, Melbourne, Vic 8006, Australia.
EM ross.hannan@petermac.org; rick.pearson@petermac.org
RI Sheppard, Karen/P-5947-2019; Bywater, Megan/X-5606-2018; Johnstone,
   Ricky w/H-3748-2014; Pearson, Richard Bruce/I-1451-2013
OI Sheppard, Karen/0000-0002-2798-4703; Bywater, Megan/0000-0002-7466-6927;
   Johnstone, Ricky w/0000-0001-7053-9237; Pearson, Richard
   Bruce/0000-0001-5919-5090; Hung, Sandy/0000-0002-7496-7092; Hannan,
   Ross/0000-0002-2166-4493; McArthur, Grant/0000-0001-8908-6071; Hannan,
   Katherine/0000-0003-4186-8167
FU National Health and Medical Research Council (NHMRC) of
   AustraliaNational Health and Medical Research Council of Australia
   [166908, 400120, 509088, 509087, 400116]; Cancer Council
   VictoriaCanadian Institutes of Health Research (CIHR)Cancer Council
   Victoria; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Victorian Cancer Agency; Australian Rotary Health
FX This work was supported by grants and fellowships from the National
   Health and Medical Research Council (NHMRC) of Australia to R. D. H.
   (NHMRC #166908, #400120, and #509088) and to R. B. P. (NHMRC # 509087
   and # 400116), Cancer Council Victoria to R. B. P., and Swiss National
   Science Foundation to M.N.H. R.W.J. is an NHMRC Principal Research
   Fellow. M. W. is funded by a Clinical Research Fellowship from the
   Victorian Cancer Agency. This work is supported by NHMRC program and
   project grants plus grants from the Victorian Cancer Agency and
   Australian Rotary Health.
CR ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0
   Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085
   Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515
   Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225
   Arora B, 2003, PATHOLOGY, V35, P106, DOI 10.1080/0031302031000082188
   Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797
   Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449
   Bellmann K, 2006, APOPTOSIS, V11, P1311, DOI 10.1007/s10495-006-8205-1
   Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032
   Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184
   Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279
   Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024
   BUSCH H, 1963, CANCER RES, V23, P313
   Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933
   Campbell IG, 2005, CLIN CANCER RES, V11, P7042, DOI 10.1158/1078-0432.CCR-05-1024
   CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6
   Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968
   Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895
   Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189
   Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844
   Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494
   Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375
   Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858
   Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224
   Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223
   Guijarro MV, 2007, CARCINOGENESIS, V28, P2443, DOI 10.1093/carcin/bgm154
   Hagner PR, 2011, ONCOGENE, V30, P1531, DOI 10.1038/onc.2010.533
   Hagner PR, 2010, BLOOD, V115, P2127, DOI 10.1182/blood-2009-09-220020
   Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002
   Hannan K. M., 1998, FRONT BIOSCI, V3, P282, DOI [10.2741/A282, DOI 10.2741/A282]
   Hannan KM, 2011, IUBMB LIFE, V63, P79, DOI 10.1002/iub.428
   Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003
   JEFFERIES HBJ, 1994, J BIOL CHEM, V269, P4367
   Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8
   Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009
   Kumar A, 2006, MOL CELL BIOL, V26, P9116, DOI 10.1128/MCB.00783-06
   Lindemann RK, 2007, P NATL ACAD SCI USA, V104, P8071, DOI 10.1073/pnas.0702294104
   Lister K, 2006, CARDIOVASC RES, V70, P555, DOI 10.1016/j.cardiores.2006.02.010
   Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007
   Matheny RW, 2009, EXP BIOL MED, V234, P1264, DOI 10.3181/0904-MR-138
   Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883
   McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259
   Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752
   Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1
   Pahuja Sangeeta, 2003, Indian J Pathol Microbiol, V46, P573
   Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335
   Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015
   Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970
   Russell J, 2006, BIOCHEM SOC SYMP, V73, P203
   Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449
   Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146
   Schild C, 2009, MOL CARCINOGEN, V48, P1149, DOI 10.1002/mc.20569
   Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869
   Solomon B, 2009, J THORAC ONCOL, V4, P787, DOI 10.1097/JTO.0b013e3181a74dba
   Song MJ, 2010, PEDIATR BLOOD CANCER, V54, P629, DOI 10.1002/pbc.22316
   Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023
   Stefanovsky VY, 2008, NUCLEIC ACIDS RES, V36, P5093, DOI 10.1093/nar/gkn484
   Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907
   VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0
   Walkley CR, 2004, BLOOD, V103, P1286, DOI 10.1182/blood-2003-07-2391
   Wall M, 2008, BLOOD, V112, P2305, DOI 10.1182/blood-2007-09-111856
   Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006
   Wei YH, 2009, CELL CYCLE, V8, P4085, DOI 10.4161/cc.8.24.10170
   Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179
   Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369
   White RJ, 2010, TRENDS GENET, V26, P214, DOI 10.1016/j.tig.2010.02.004
   White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003
   Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986
NR 68
TC 95
Z9 95
U1 0
U2 10
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD AUG 30
PY 2011
VL 4
IS 188
AR ra56
DI 10.1126/scisignal.2001754
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 814FX
UT WOS:000294434500001
PM 21878679
DA 2021-01-25
ER

PT J
AU Gubaev, A
   Klostermeier, D
AF Gubaev, Airat
   Klostermeier, Dagmar
TI DNA-induced narrowing of the gyrase N-gate coordinates T-segment capture
   and strand passage
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE gyrase dynamics; nucleotide-induced conformational changes;
   topoisomerase mechanism; DNA wrapping; negative supercoiling
ID BACILLUS-SUBTILIS DNA; ATP-OPERATED CLAMP; TOPOISOMERASE-II; 2-GATE
   MECHANISM; FLUORIDE COMPLEXES; CRYSTAL-STRUCTURE; DOUBLE HELIX; DOMAIN;
   TRANSPORT; ENERGY
AB DNA gyrase introduces negative supercoils into DNA in an ATP-dependent reaction. DNA supercoiling is catalyzed by a strand-passage mechanism, in which a T-segment of DNA is passed through the gap in a transiently cleaved G-segment. Strand passage requires the coordinated closing and opening of three protein interfaces in gyrase, the N-gate, DNA-gate, and C-gate. We show here that DNA binding to the DNA-gate of gyrase and wrapping of DNA around the C-terminal domains of GyrA induces a narrowing of the N-gate. This half-closed state prepares capture of a T-segment in the upper cavity of gyrase. Subsequent N-gate closure upon binding of ATP then poises the reaction toward strand passage. The N-gate reopens after ATP hydrolysis, allowing for further catalytic cycles. DNA binding, cleavage, and wrapping and N-gate narrowing are intimately linked events that coordinate conformational changes at the DNA and the N-gate.
C1 [Gubaev, Airat; Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany.
   [Gubaev, Airat; Klostermeier, Dagmar] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany.
EM dagmar.klostermeier@uni-muenster.de
FU VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); National Center of Competence in
   Research (NCCR) Nanoscale SciencesSwiss National Science Foundation
   (SNSF)
FX We thank Martin Lanz and Markus Rudolph for comments on the manuscript,
   and Diana Blank, Ines Hertel, and Andreas Schmidt for excellent
   technical assistance. This work was supported by the VolkswagenStiftung,
   the Swiss National Science Foundation, and the National Center of
   Competence in Research (NCCR) Nanoscale Sciences.
CR Ahmad Z, 2006, FEBS LETT, V580, P517, DOI 10.1016/j.febslet.2005.12.057
   ANTONNY B, 1990, FEBS LETT, V268, P277, DOI 10.1016/0014-5793(90)81027-L
   BASHKIROV VI, 1991, GENETICA, V85, P3, DOI 10.1007/BF00056101
   Bates AD, 1996, BIOCHEMISTRY-US, V35, P1408, DOI 10.1021/bi952433y
   Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0
   BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x
   Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294
   CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T
   Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029
   Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101
   FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004
   GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872
   Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055
   Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6
   Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106
   Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414
   Kampranis SC, 1998, J BIOL CHEM, V273, P26305, DOI 10.1074/jbc.273.41.26305
   LIU LF, 1978, CELL, V15, P979, DOI 10.1016/0092-8674(78)90281-7
   MAXWELL A, 1984, J BIOL CHEM, V259, P4472
   ODea MH, 1996, J BIOL CHEM, V271, P9723, DOI 10.1074/jbc.271.16.9723
   ORPHANIDES G, 1994, NUCLEIC ACIDS RES, V22, P1567, DOI 10.1093/nar/22.9.1567
   Park S, 1999, BBA-PROTEIN STRUCT M, V1430, P127, DOI 10.1016/S0167-4838(98)00262-3
   Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057
   Roca J, 2004, J BIOL CHEM, V279, P25783, DOI 10.1074/jbc.M402555200
   ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4
   ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T
   Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994
   Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465
   Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X
   Schoeffler AJ, 2010, NUCLEIC ACIDS RES, V38, P7830, DOI 10.1093/nar/gkq665
   SUGINO A, 1980, J BIOL CHEM, V255, P6299
   SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838
   Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868
   Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424
   WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0
   Williams NL, 2001, J MOL BIOL, V306, P969, DOI 10.1006/jmbi.2001.4468
   Williams NL, 1999, BIOCHEMISTRY-US, V38, P14157, DOI 10.1021/bi991478m
   Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488
NR 38
TC 33
Z9 33
U1 0
U2 14
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 23
PY 2011
VL 108
IS 34
BP 14085
EP 14090
DI 10.1073/pnas.1102100108
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 810XO
UT WOS:000294163500048
PM 21817063
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Abel, S
   Chien, P
   Wassmann, P
   Schirmer, T
   Kaever, V
   Laub, MT
   Baker, TA
   Jenal, U
AF Abel, Soeren
   Chien, Peter
   Wassmann, Paul
   Schirmer, Tilman
   Kaever, Volkhard
   Laub, Michael T.
   Baker, Tania A.
   Jenal, Urs
TI Regulatory Cohesion of Cell Cycle and Cell Differentiation through Inter
   linked Phosphorylation and Second Messenger Networks
SO MOLECULAR CELL
LA English
DT Article
ID C-DI-GMP; CAULOBACTER-CRESCENTUS; POLAR LOCALIZATION; RESPONSE
   REGULATOR; ESCHERICHIA-COLI; MASTER REGULATOR; PROTEASE COMPLEX;
   DEGRADATION; PROTEOLYSIS; PROTEINS
AB In Caulobacter crescentus, phosphorylation of key regulators is coordinated with the second messenger cyclic di-GMP to drive cell-cycle progression and differentiation. The diguanylate cyclase PleD directs pole morphogenesis, while the c-di-GMP effector PopA initiates degradation of the replication inhibitor CtrA by the AAA+ protease CIpXP to license S phase entry. Here, we establish a direct link between PleD and PopA reliant on the phosphodiesterase PdeA and the diguanylate cyclase DgcB. PdeA antagonizes DgcB activity until the G1-S transition, when PdeA is degraded by the CIpXP protease. The unopposed DgcB activity, together with PleD activation, upshifts c-di-GMP to drive PopA-dependent CtrA degradation and S phase entry. PdeA degradation requires CpdR, a response regulator that delivers PdeA to the CIpXP protease in a phosphorylation-dependent manner. Thus, CpdR serves as a crucial link between phosphorylation pathways and c-di-GMP metabolism to mediate protein degradation events that irreversibly and coordinately drive bacterial cell-cycle progression and development.
C1 [Abel, Soeren; Wassmann, Paul; Schirmer, Tilman; Jenal, Urs] Univ Basel, Biozentrum, CH-4054 Basel, Switzerland.
   [Laub, Michael T.; Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.
   [Chien, Peter; Laub, Michael T.; Baker, Tania A.] MIT, Dept Biol, Cambridge, MA 02139 USA.
   [Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4054 Basel, Switzerland.
EM urs.jenal@unibas.ch
RI Kaever, Volkhard/G-3280-2013
OI Wassmann, Paul/0000-0001-7391-1065; Laub, Michael/0000-0002-8288-7607;
   Abel, Soren/0000-0002-4041-6989
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-108186, 31003A_130469]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [GM-082899, GM-049224, GM-084157]; NATIONAL INSTITUTE
   OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM082899, R01GM049224,
   R01GM049224, R01GM049224, K99GM084157, R01GM049224, R01GM082899,
   R01GM082899, R01GM082899, R01GM049224, R01GM049224, R01GM049224,
   K99GM084157, R00GM084157, R01GM049224, R01GM049224, R01GM082899,
   R01GM082899, R01GM049224, R01GM049224, R00GM084157, R01GM049224,
   R01GM082899, R01GM082899, R01GM049224, R01GM049224, R01GM049224,
   R01GM049224, R01GM049224, R01GM082899, R01GM049224, R01GM049224,
   R01GM049224, R01GM082899, R00GM084157, R01GM049224, R01GM082899,
   R01GM082899] Funding Source: NIH RePORTER
FX We thank Anna Duerig and Fabienne Hamburger for strains and plasmids,
   Samuel Steiner for strain E. coil MG1655 Delta cyaA::frt, and Pia Abel
   zur Wiesch for help with data analysis and for critical reading of the
   manuscript. This work was supported by Swiss National Science Foundation
   grants 31-108186 and 31003A_130469 to U.J., National Institutes of
   Health grants GM-082899 to M.T.L., GM-049224 to T.A.B., and GM-084157 to
   P.C.; T.A.B. and M.T.L. are employees of the Howard Hughes Medical
   Institute.
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028
   Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x
   Burton GJ, 1997, J BACTERIOL, V179, P5849, DOI 10.1128/jb.179.18.5849-5853.1997
   Caro E, 2007, NATURE, V447, P213, DOI 10.1038/nature05763
   Chen YE, 2009, J BACTERIOL, V191, P7417, DOI 10.1128/JB.00992-09
   Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658
   Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006
   Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09
   Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648
   Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750
   Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968
   Grunenfelder B, 2004, J BACTERIOL, V186, P4960, DOI 10.1128/JB.186.15.4960-4971.2004
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Iniesta AA, 2008, P NATL ACAD SCI USA, V105, P16602, DOI 10.1073/pnas.0808807105
   Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103
   Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658
   Kaiser D, 2008, ANNU REV GENET, V42, P109, DOI 10.1146/annurev.genet.42.110807.091615
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042
   Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185
   Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144
   Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699
   McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694
   McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033
   Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045
   Potocka I, 2002, J BACTERIOL, V184, P6635, DOI 10.1128/JB.184.23.6635-6642.2002
   Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120
   Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007
   Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907
   Yadirgi G, 2009, J PATHOL, V217, P242, DOI 10.1002/path.2480
NR 39
TC 110
Z9 113
U1 1
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1097-2765
J9 MOL CELL
JI Mol. Cell
PD AUG 19
PY 2011
VL 43
IS 4
BP 550
EP 560
DI 10.1016/j.molcel.2011.07.018
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 810TW
UT WOS:000294151000008
PM 21855795
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Fava, LL
   Kaulich, M
   Nigg, EA
   Santamaria, A
AF Fava, Luca L.
   Kaulich, Manuel
   Nigg, Erich A.
   Santamaria, Anna
TI Probing the in vivo function of Mad1:C-Mad2 in the spindle assembly
   checkpoint
SO EMBO JOURNAL
LA English
DT Article
DE closed-Mad2; Mad2 template model; mitotic timing; p31comet; spindle
   assembly checkpoint
ID ANAPHASE-PROMOTING COMPLEX; UNATTACHED KINETOCHORES; MAD2 ACTIVATION;
   CONFORMATIONAL DIMERIZATION; MONOCLONAL-ANTIBODY; PROTEIN BUBR1; CORE
   COMPLEX; CDC20; BINDING; MITOSIS
AB The spindle assembly checkpoint (SAC) restrains anaphase until all chromosomes become bi-oriented on the mitotic spindle. The SAC protein Mad2 can fold into two distinct conformers, open (O) and closed (C), and can asymmetrically dimerize. Here, we describe a monoclonal antibody that specifically recognizes the dimerization interface of C-Mad2. This antibody revealed several conformation-specific features of Mad2 in human cells. Notably, we show that Mad2 requires association with Mad1 to adopt the closed conformation and that the activity of the Mad1: C-Mad2 complex undergoes regulation by p31comet-dependent 'capping'. Furthermore, C-Mad2 antibody microinjection caused an abrupt termination of the SAC and accelerated mitotic progression. Remarkably, microinjection of a Mad1-neutralizing antibody triggered a comparable mitotic acceleration. Our study provides direct in vivo evidence for the model that a kinetochore complex of Mad1: C-Mad2 acts as a template to sustain the SAC and it challenges the distinction between SAC and mitotic timer. The EMBO Journal (2011) 30, 3322-3336. doi:10.1038/emboj.2011.239; Published online 19 July 2011
C1 [Fava, Luca L.; Kaulich, Manuel; Nigg, Erich A.; Santamaria, Anna] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Fava, Luca L.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erich.nigg@unibas.ch; anna.santamaria@unibas.ch
RI Fava, Luca/E-2876-2017; Kaulich, Manuel/U-4523-2017
OI Fava, Luca/0000-0002-6741-1723; Kaulich, Manuel/0000-0002-9528-8822;
   nigg, erich/0000-0003-4835-5719
FU Max Planck SocietyMax Planck SocietyFoundation CELLEX; University of
   Basel; European CommissionEuropean CommissionEuropean Commission Joint
   Research Centre [LSHG-CT-2005-518254]; International Max Planck Research
   School for Molecular and Cellular Life Sciences
FX We are especially grateful to A Musacchio for reagents, insight on the
   project and comments on the manuscript. We also thank J Ellenberg, AA
   Hyman, I Poser, NS Gray, A Uldschmid and YW Chan for reagents and A
   Wehner and E Nigg for technical help. We thank all past and present
   members of our laboratory for insightful discussion. This work was
   supported by the Max Planck Society, the University of Basel and the
   Experimental Network for Functional Integration (ENFIN) Contract
   LSHG-CT-2005-518254 funded by the European Commission within its FP6
   Programme. LLF was partly supported by the International Max Planck
   Research School for Molecular and Cellular Life Sciences.
CR Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570
   Burke DJ, 2008, DEV CELL, V14, P474, DOI 10.1016/j.devcel.2008.03.015
   Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107
   Campbell MS, 2001, J CELL SCI, V114, P953
   Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167
   Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283
   De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038
   Emre D, 2011, J CELL SCI, V124, P1664, DOI 10.1242/jcs.081216
   Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437
   Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871
   Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648
   GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x
   Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810
   Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193
   Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062
   Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659
   Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871
   Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133
   Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3
   Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093
   Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053
   Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2
   Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041
   King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342
   Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337
   Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005
   Lad L, 2009, BIOCHEMISTRY-US, V48, P9503, DOI 10.1021/bi900718e
   Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246
   Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748
   Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X
   Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002
   Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050
   Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033
   Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011
   Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049
   Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596
   Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006
   Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869
   Nezi L, 2006, J CELL BIOL, V174, P39, DOI 10.1083/jcb.200602109
   Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799
   Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988
   Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199
   Rahmani Z, 2009, J CELL BIOL, V187, P597, DOI 10.1083/jcb.200905026
   RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941
   Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036
   Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
   Simonetta M, 2009, PLOS BIOL, V7, P175, DOI 10.1371/journal.pbio.1000010
   Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496
   Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251
   Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093
   Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3
   Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028
   Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103
   Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057
   Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322
   Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050
   Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048
NR 60
TC 60
Z9 61
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD AUG 17
PY 2011
VL 30
IS 16
BP 3322
EP 3336
DI 10.1038/emboj.2011.239
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 808IL
UT WOS:000293971300011
PM 21772247
OA Green Published
DA 2021-01-25
ER

PT J
AU Loew, C
   Riske, KA
   Lamy, MT
   Seelig, J
AF Loew, Caroline
   Riske, Karin A.
   Teresa Lamy, M.
   Seelig, Joachim
TI Thermal Phase Behavior of DMPG Bilayers in Aqueous Dispersions as
   Revealed by H-2- and P-31-NMR
SO LANGMUIR
LA English
DT Article
ID NUCLEAR-MAGNETIC-RESONANCE; THERMOTROPIC BEHAVIOR; PHOSPHOLIPID-BILAYER;
   PHOSPHATIDYLGLYCEROL BILAYERS; ELECTRIC CHARGE; HEAD GROUP; DEUTERIUM;
   TRANSITION; MIXTURES; PHOSPHATIDYLCHOLINE
AB The synthetic lipid 1,2-dimyristoyl-sn-3-phosphoglycerol (DMPG), when dispersed in water/NaCl exhibits a complex phase behavior caused by its almost unlimited swelling in excess water. Using deuterium (H-2)- and phosphorus (P-31)-NMR we have studied the molecular properties of DMPG/water/NaCl dispersions as a function of lipid and NaCl concentration. We have measured the order profile of the hydrophobic part of the lipid bilayer with deuterated DMPG while the orientation of the phosphoglycerol headgroup was deduced from the P-31 NMR chemical shielding anisotropy. At temperatures > 30 degrees C we observe well-resolved H-2- and P-31 NMR spectra not much different from other liquid crystalline bilayers. From the order profiles it is possible to deduce the average length of the flexible fatty acyl chain. Unusual spectra are obtained in the temperature interval of 20-25 degrees C, indicating one or several phase transitions. The most dramatic changes are seen at low lipid concentration and low ionic strength. Under these conditions and at 25 degrees C, the phosphoglycerol headgroup rotates into the hydrocarbon layer and the hydrocarbon chains show larger flexing motions than at higher temperatures. The orientation of the phosphoglycerol headgroup depends on the bilayer surface charge and correlates with the degree of dissociation of DMPG-Na+. The larger the negative surface charge, the more the headgroup rotates toward the nonpolar region.
C1 [Loew, Caroline; Seelig, Joachim] Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   [Riske, Karin A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil.
   [Teresa Lamy, M.] Univ Sao Paulo, Inst Fis, BR-05314970 Sao Paulo, Brazil.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
RI Lamy, Maria Teresa/P-5305-2014; Complexos, INCT Fluidos/H-9172-2013;
   Riske, Karin A/F-2314-2014
OI Lamy, Maria Teresa/0000-0001-6616-6546; 
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-129701]
FX This research was supported by the Swiss National Science Foundation
   Grant # 31003A-129701.
CR Alakoskela JMI, 2007, LANGMUIR, V23, P4203, DOI 10.1021/la062875i
   Barroso RP, 2010, LANGMUIR, V26, P13805, DOI 10.1021/la101784w
   BORLE F, 1983, BIOCHIM BIOPHYS ACTA, V735, P131, DOI 10.1016/0005-2736(83)90268-7
   BORLE F, 1985, CHEM PHYS LIPIDS, V36, P263, DOI 10.1016/0009-3084(85)90007-6
   CHAPMAN D., 1967, CHEM PHYS LIPIDS, V1, P445, DOI 10.1016/0009-3084(67)90023-0
   EPAND RM, 1986, FEBS LETT, V209, P257, DOI 10.1016/0014-5793(86)81123-1
   EPAND RM, 1992, BIOPHYS J, V63, P327, DOI 10.1016/S0006-3495(92)81618-1
   FINDLAY EJ, 1978, BIOCHEMISTRY-US, V17, P2400, DOI 10.1021/bi00605a023
   GALLY HU, 1981, BIOCHEMISTRY-US, V20, P1826, DOI 10.1021/bi00510a017
   GERSHFELD NL, 1986, FARADAY DISCUSS, V81, P19, DOI 10.1039/dc9868100019
   GERSHFELD NL, 1989, BIOCHEMISTRY-US, V28, P4229, DOI 10.1021/bi00436a016
   HEIMBURG T, 1994, BIOCHEMISTRY-US, V33, P9477, DOI 10.1021/bi00198a013
   Lamy-Freund MT, 2003, CHEM PHYS LIPIDS, V122, P19, DOI 10.1016/S0009-3084(02)00175-5
   LOOSLEYMILLMAN ME, 1982, BIOPHYS J, V40, P221, DOI 10.1016/S0006-3495(82)84477-9
   McMullen TPW, 2009, BBA-BIOMEMBRANES, V1788, P345, DOI 10.1016/j.bbamem.2008.11.012
   MISCHEL M, 1987, CHEM PHYS LIPIDS, V43, P237, DOI 10.1016/0009-3084(87)90020-X
   NIEDERBERGER W, 1976, J AM CHEM SOC, V98, P3704, DOI 10.1021/ja00428a053
   Pabst G, 2007, BIOPHYS J, V93, P513, DOI 10.1529/biophysj.106.101592
   PASCHER I, 1987, BIOCHIM BIOPHYS ACTA, V896, P77, DOI 10.1016/0005-2736(87)90358-0
   PEARSON RH, 1979, NATURE, V281, P499, DOI 10.1038/281499a0
   Riske KA, 2004, BIOPHYS J, V86, P3722, DOI 10.1529/biophysj.103.033803
   Riske KA, 2003, CHEM PHYS LIPIDS, V124, P69, DOI 10.1016/S0009-3084(03)00046-X
   Riske KA, 2002, J PHYS CHEM B, V106, P239, DOI 10.1021/jp011584+
   Riske KA, 2001, BBA-BIOMEMBRANES, V1511, P297, DOI 10.1016/S0005-2736(01)00287-5
   Riske KA, 1997, CHEM PHYS LIPIDS, V89, P31, DOI 10.1016/S0009-3084(97)00058-3
   Riske KA, 2009, LANGMUIR, V25, P10083, DOI 10.1021/la9012137
   SACRE MM, 1977, CHEM PHYS LIPIDS, V18, P334, DOI 10.1016/0009-3084(77)90019-6
   SALONEN IS, 1989, BIOCHIM BIOPHYS ACTA, V982, P205, DOI 10.1016/0005-2736(89)90056-4
   SCHERER PG, 1989, BIOCHEMISTRY-US, V28, P7720, DOI 10.1021/bi00445a030
   SCHINDLER H, 1975, BIOCHEMISTRY-US, V14, P2283, DOI 10.1021/bi00682a001
   Schneider MF, 1999, P NATL ACAD SCI USA, V96, P14312, DOI 10.1073/pnas.96.25.14312
   SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024
   SEELIG J, 1985, BIOCHIM BIOPHYS ACTA, V814, P195, DOI 10.1016/0005-2736(85)90437-7
   SEELIG J, 1977, BIOCHIM BIOPHYS ACTA, V467, P109, DOI 10.1016/0005-2736(77)90188-2
   SEELIG J, 1987, BIOCHEMISTRY-US, V26, P7535, DOI 10.1021/bi00398a001
   SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1
   SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948
   SMALL DM, 1986, HDB LIPID RES, V4, P475
   SPEYER JB, 1987, BIOPHYS J, V51, P687, DOI 10.1016/S0006-3495(87)83394-5
   SUNDARAL, 1972, ANN NY ACAD SCI, V195, P324
   VANDIJCK PWM, 1975, BIOCHIM BIOPHYS ACTA, V406, P465, DOI 10.1016/0005-2736(75)90025-5
   WATTS A, 1978, BIOCHIM BIOPHYS ACTA, V510, P63, DOI 10.1016/0005-2736(78)90130-X
   WOHLGEMUTH R, 1980, BIOCHEMISTRY-US, V19, P3315, DOI 10.1021/bi00555a033
   Zhang YP, 1997, BIOPHYS J, V72, P779, DOI 10.1016/S0006-3495(97)78712-5
NR 44
TC 16
Z9 16
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 16
PY 2011
VL 27
IS 16
BP 10041
EP 10049
DI 10.1021/la201027p
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 804OI
UT WOS:000293662800050
PM 21732628
DA 2021-01-25
ER

PT J
AU Zygmunt, T
   Gay, CM
   Blondelle, J
   Singh, MK
   Flaherty, KM
   Means, PC
   Herwig, L
   Krudewig, A
   Belting, HG
   Affolter, M
   Epstein, JA
   Torres-Vazquez, J
AF Zygmunt, Tomasz
   Gay, Carl Michael
   Blondelle, Jordan
   Singh, Manvendra K.
   Flaherty, Kathleen McCrone
   Means, Paula Casey
   Herwig, Lukas
   Krudewig, Alice
   Belting, Heinz-Georg
   Affolter, Markus
   Epstein, Jonathan A.
   Torres-Vazquez, Jesus
TI Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF
   Decoy Receptor sFlt1
SO DEVELOPMENTAL CELL
LA English
DT Article
ID GROWTH-FACTOR RECEPTOR; TIP CELL-FORMATION; DEVELOPING ZEBRAFISH;
   VASCULAR MORPHOGENESIS; NEGATIVE REGULATOR; ENDOTHELIAL-CELLS; NETWORK
   FORMATION; NOTCH; LIGAND; EXPRESSION
AB Sprouting angiogenesis expands the embryonic vasculature enabling survival and homeostasis. Yet how the angiogenic capacity to form sprouts is allocated among endothelial cells (ECs) to guarantee the reproducible anatomy of stereotypical vascular beds remains unclear. Here we show that Sema-PlxnD1 signaling, previously implicated in sprout guidance, represses angiogenic potential to ensure the proper abundance and stereotypical distribution of the trunk's segmental arteries (SeAs). We find that Sema-PlxnD1 signaling exerts this effect by antagonizing the proangiogenic activity of vascular endothelial growth factor (VEGF). Specifically, Sema-PlxnD1 signaling ensures the proper endothelial abundance of soluble flt1 (sflt1), an alternatively spliced form of the VEGF receptor Flt1 encoding a potent secreted decoy. Hence, Sema-PlxnD1 signaling regulates distinct but related aspects of angiogenesis: the spatial allocation of angiogenic capacity within a primary vessel and sprout guidance.
C1 [Zygmunt, Tomasz; Gay, Carl Michael; Flaherty, Kathleen McCrone; Means, Paula Casey; Torres-Vazquez, Jesus] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Dept Cell Biol,Skirball Inst, New York, NY 10016 USA.
   [Blondelle, Jordan] Univ Paris 07, Paris, France.
   [Singh, Manvendra K.; Epstein, Jonathan A.] Univ Penn, Cardiovasc Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
   [Herwig, Lukas; Krudewig, Alice; Belting, Heinz-Georg; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Singh, Manvendra K.; Epstein, Jonathan A.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA.
RP Torres-Vazquez, J (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Dept Cell Biol,Skirball Inst, New York, NY 10016 USA.
EM jesus.torres-vazquez@med.nyu.edu
OI Torres-Vazquez, Jesus/0000-0002-3808-3978; Belting,
   Heinz-Georg/0000-0002-1538-4364; Singh, Manvendra/0000-0002-2884-0074;
   Affolter, Markus/0000-0002-5171-0016; Epstein,
   Jonathan/0000-0001-8637-4465
FU Werner Siemens-Foundation, Switzerland; NICHDUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [5T32HD007520-05]; David Himelberg Foundation;
   NHLBIUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD
   HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [T32HD007520, T32HD007520, T32HD007520, T32HD007520, T32HD007520,
   T32HD007520, T32HD007520, T32HD007520, T32HD007520] Funding Source: NIH
   RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH
   &HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [T32HD007520, T32HD007520, T32HD007520, T32HD007520, T32HD007520,
   T32HD007520, T32HD007520, T32HD007520, T32HD007520, T32HD007520,
   T32HD007520, T32HD007520, T32HD007520] Funding Source: NIH RePORTER;
   NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL092263, R01HL092263,
   R01HL092263, R01HL092263, R01HL092263, R01HL092263, R01HL092263] Funding
   Source: NIH RePORTER
FX We thank N.C. Chi, C-B. Chien, S. Childs, A. Chitnis, S.L. Johnson, K.
   Kawakami, N.D. Lawson, M. Parsons, S. Schulte-Merker, D. Stainier, B.M.
   Weinstein, and the Zebrafish International Resource Center for reagents;
   G. Fishell, E.J.A. Hubbard, H. Knaut, J.F. Nance, D.B. Rifkin, K.L.
   Targoff, J.E. Treisman, S.R. Schwab, F. Ulrich, K.A. Yaniv, and D. Ye
   Ion for discussions; J. Zavadil (NYU Cancer Institute Genomics
   Facility), D. Dalfo, and J.-Y. Roignant for qPCR advice; and D. Chan for
   administrative help. We were supported by Werner Siemens-Foundation,
   Switzerland (A.K.), NICHD Training Program grant 5T32HD007520-05
   (C.M.G.), and The David Himelberg Foundation and NHLBI (J.T.-V.). Author
   breakdown is as follows: T.Z., C.M.G., J.T.-V. (ideas, experiments, data
   analysis, fish lines, plasmids, writing); J.B., P.C.M. (experiments,
   data analysis); K.M.F. (experiments, fish lines, husbandry support,
   writing); M.K.S. (ideas, cell culture experiments, data analysis,
   writing); L.H., A.K., H.-G.B., M.A. (Tg(fliep:gal4ff)<SUP>ubs4</SUP>
   line); J.A.E. (ideas, data analysis). All authors commented on the
   manuscript.
CR Acevedo LM, 2008, CANCER CELL, V14, P429, DOI 10.1016/j.ccr.2008.11.009
   Ahn D, 2000, MECH DEVELOP, V95, P253, DOI 10.1016/S0925-4773(00)00346-4
   Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249
   Aref S, 2005, HEMATOLOGY, V10, P131, DOI 10.1080/10245330500065797
   Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje
   Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970
   Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006
   Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140
   Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881
   Bussmann J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000064
   Carmany-Rampey A, 2006, METHODS, V39, P228, DOI 10.1016/j.ymeth.2006.02.002
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011
   Childs S, 2002, DEVELOPMENT, V129, P973
   Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031
   Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103
   da Silva RG, 2010, AM J PATHOL, V177, P1534, DOI 10.2353/ajpath.2010.100043
   De Bock K, 2009, J MOL MED, V87, P561, DOI 10.1007/s00109-009-0482-z
   del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819
   Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900
   Funahashi Yasuhiro, 2010, J Angiogenes Res, V2, P3, DOI 10.1186/2040-2384-2-3
   Gay CM, 2011, DEV BIOL, V349, P1, DOI 10.1016/j.ydbio.2010.09.008
   Geudens I, 2010, ARTERIOSCL THROM VAS, V30, P1695, DOI 10.1161/ATVBAHA.110.203034
   Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795
   Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892
   Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8
   Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006
   Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577
   Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990
   Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321
   Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733
   Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995
   Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4
   Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103
   Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233
   James JM, 2009, DEVELOPMENT, V136, P833, DOI 10.1242/dev.028845
   Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114
   Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315
   KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705
   Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355
   Krueger J, 2011, DEVELOPMENT, V138, P2111, DOI 10.1242/dev.063933
   Kutschera S, 2011, ARTERIOSCL THROM VAS, V31, P151, DOI 10.1161/ATVBAHA.110.215871
   Lamont RE, 2009, DEV BIOL, V331, P199, DOI 10.1016/j.ydbio.2009.04.037
   Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102
   Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3
   Lawson ND, 2001, DEVELOPMENT, V128, P3675
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054
   Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186
   Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244
   Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104
   Moens Cecilia, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5038
   Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172
   Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889
   Orecchia A, 2003, J CELL SCI, V116, P3479, DOI 10.1242/jcs.00673
   Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002
   Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015
   Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009
   Raab S, 2007, ACTA NEUROPATHOL, V113, P607, DOI 10.1007/s00401-007-0228-3
   Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818
   Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207
   Roos M, 1999, MECH DEVELOP, V87, P103, DOI 10.1016/S0925-4773(99)00153-7
   Rottbauer W, 2005, GENE DEV, V19, P1624, DOI 10.1101/gad.1319405
   Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09
   Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784
   Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736
   Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577
   Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104
   Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370
   Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083
   Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008
   Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589
   Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200
   Wilkinson RN, 2009, DEV CELL, V16, P909, DOI 10.1016/j.devcel.2009.04.014
   Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000
   Yee CS, 1999, BRAIN RES BULL, V48, P581, DOI 10.1016/S0361-9230(99)00038-6
NR 76
TC 96
Z9 98
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD AUG 16
PY 2011
VL 21
IS 2
BP 301
EP 314
DI 10.1016/j.devcel.2011.06.033
PG 14
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 813RW
UT WOS:000294387300011
PM 21802375
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Viktorin, G
   Riebli, N
   Popkova, A
   Giangrande, A
   Reichert, H
AF Viktorin, Gudrun
   Riebli, Nadia
   Popkova, Anna
   Giangrande, Angela
   Reichert, Heinrich
TI Multipotent neural stem cells generate glial cells of the central
   complex through transit amplifying intermediate progenitors in
   Drosophila brain development
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Drosophila; Larval brain; Neuroblast lineages; Intermediate progenitor
   cells; Neuroglioblast; Gliogenesis
ID CENTRAL-NERVOUS-SYSTEM; NEUROBLAST LINEAGES; LARVAL BRAIN; POSTEMBRYONIC
   DEVELOPMENT; NEURONS ARISE; PROLIFERATION; MORPHOGENESIS; DIVISION;
   PATTERN; SWITCH
AB The neural stem cells that give rise to the neural lineages of the brain can generate their progeny directly or through transit amplifying intermediate neural progenitor cells (INPs). The INP-producing neural stem cells in Drosophila are called type II neuroblasts, and their neural progeny innervate the central complex, a prominent integrative brain center. Here we use genetic lineage tracing and clonal analysis to show that the INPs of these type II neuroblast lineages give rise to glial cells as well as neurons during postembryonic brain development. Our data indicate that two main types of INP lineages are generated, namely mixed neuronal/glial lineages and neuronal lineages. Genetic loss-of-function and gain-of-function experiments show that the gcm gene is necessary and sufficient for gliogenesis in these lineages. The INP-derived glial cells, like the INP-derived neuronal cells, make major contributions to the central complex. In postembryonic development, these INP-derived glial cells surround the entire developing central complex neuropile, and once the major compartments of the central complex are formed, they also delimit each of these compartments. During this process, the number of these glial cells in the central complex is increased markedly through local proliferation based on glial cell mitosis. Taken together, these findings uncover a novel and complex form of neurogliogenesis in Drosophila involving transit amplifying intermediate progenitors. Moreover, they indicate that type II neuroblasts are remarkably multipotent neural stem cells that can generate both the neuronal and the glial progeny that make major contributions to one and the same complex brain structure. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Viktorin, Gudrun; Riebli, Nadia; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Popkova, Anna; Giangrande, Angela] CU Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM,ULP, Strasbourg, France.
RP Viktorin, G (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM gudrunviktorin@gmail.com
OI , POPKOVA/0000-0001-6842-3243
FU SNSFSwiss National Science Foundation (SNSF) [31003A12488/1, SNSF/NFP63,
   406340128006/1]; INSERMInstitut National de la Sante et de la Recherche
   Medicale (Inserm); CNRSCentre National de la Recherche Scientifique
   (CNRS); UDS; Hopital de Strasbourg; ARCAustralian Research Council;
   INCAInstitut National du Cancer (INCA) France; ANRFrench National
   Research Agency (ANR); FRMFondation pour la Recherche Medicale
FX We thank Utpal Banerjee, Bruno Bello, Cory Evans, Cheng-Yu Lee, Barrett
   Pfeiffer, Veronica Rodrigues, Jerry Rubin, the Bloomington Stock Center
   and the DSHB for strains and antibodies, Volker Hartenstein for
   assistance in matching type II lineages with current nomenclature, and
   Susanne Flister for excellent technical help. This work was supported by
   SNSF grant 31003A12488/1 and SNSF/NFP63 "Neural stem cells and
   regenerative medicine" grant 406340128006/1 to HR. Work in the
   laboratory of AG was supported by INSERM, CNRS, UDS, Hopital de
   Strasbourg, ARC, INCA and ANR; AP was supported by FRM.
CR Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008
   Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26
   Beckervordersandforth RM, 2008, MECH DEVELOP, V125, P542, DOI 10.1016/j.mod.2007.12.004
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372
   Bernardoni R, 1998, DEVELOPMENT, V125, P3189
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Dumstrei K, 2003, J NEUROSCI, V23, P3325
   Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Hartenstein V, 1998, J COMP NEUROL, V402, P32
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100
   HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3
   Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9
   Izergina N, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-44
   JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5
   Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019
   Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173
   Miyata T, 2010, CURR OPIN NEUROBIOL, V20, P22, DOI 10.1016/j.conb.2010.01.001
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639
   Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Pereanu W, 2011, J COMP NEUROL, V519, P661, DOI 10.1002/cne.22542
   Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105
   Pignoni F, 1997, DEVELOPMENT, V124, P271
   Rasband W., 1997, IMAGEJ
   Schindelin J., 2008, FIJI IS JUST IMAGEJ
   Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660
   Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Soustelle L, 2007, DEVELOPMENT, V134, P625, DOI 10.1242/dev.02750
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   Van de Bor V, 2002, CURR OPIN GENET DEV, V12, P465, DOI 10.1016/S0959-437X(02)00327-1
   Vincent S, 1996, DEVELOPMENT, V122, P131
   WENG M, 2010, CURR OPIN NEUROBIOL, V21, P1
   Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007
   Young JM, 2010, J COMP NEUROL, V518, P1525, DOI 10.1002/cne.22285
NR 50
TC 35
Z9 36
U1 2
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD AUG 15
PY 2011
VL 356
IS 2
BP 553
EP 565
DI 10.1016/j.ydbio.2011.06.013
PG 13
WC Developmental Biology
SC Developmental Biology
GA 806JO
UT WOS:000293803900023
PM 21708145
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Alves, M
   Moes, S
   Jeno, P
   Pinheiro, C
   Passarinho, J
   Ricardo, CP
AF Alves, M.
   Moes, S.
   Jenoe, P.
   Pinheiro, C.
   Passarinho, J.
   Ricardo, C. P.
TI The analysis of Lupinus albus root proteome revealed cytoskeleton
   altered features due to long-term boron deficiency
SO JOURNAL OF PROTEOMICS
LA English
DT Article
DE Boron deficiency; Cytoskeleton; Lupinus albus; Proteomics; Root
ID PYRUVATE-DEHYDROGENASE COMPLEX; PATHOGENESIS-RELATED PROTEINS;
   RHAMNOGALACTURONAN-II; PLANT-CELL; ARABIDOPSIS; EXPRESSION; STRESS;
   IDENTIFICATION; RESPONSES; TRANSCRIPTS
AB Boron (B) deficiency greatly limits plants' growth and development. Since the root is the organ that first senses the deficiency, we have analyzed the adaptive responses of Lupinus albus roots to long-term B deficiency. Large morphological differences were observed between plants grown with or without B, and 265 polypeptides were found to be responsive to B deficiency out of a total of 406 polypeptides detected by two-dimensional electrophoresis in the L. albus root proteome. By using mass spectrometry techniques we were able to securely identify 128 of the responsive polypeptides that are related to cell wall metabolism, cell structure, defense, energy pathways and protein metabolism. The detection of multiple peptide isoforms is striking, suggesting that protein modification may have an important contribution during the plant response to long-term B deficiency. Furthermore, detected changes in cytoskeletal associated proteins indicate altered cytoskeletal biosynthesis and suggest that B may have an important contribution in this process. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Alves, M.; Pinheiro, C.; Ricardo, C. P.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal.
   [Moes, S.; Jenoe, P.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Passarinho, J.] Inst Nacl Recursos Biol L INIA, P-2784505 Oeiras, Portugal.
RP Ricardo, CP (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ, P-2780157 Oeiras, Portugal.
EM ricardo@itqb.unl.pt
RI Alves, Marta/E-9716-2015; Pinheiro, Carla/A-4053-2008
OI Alves, Marta/0000-0002-9679-4022; Pinheiro, Carla/0000-0002-7799-0183;
   Ricardo, Candido/0000-0003-4905-1274
FU Fundacao para a Ciencia e a Tecnologia (FCT)Portuguese Foundation for
   Science and Technology [SFRH/BD/18273/2004]
FX We are grateful to Dr. Phil Jackson (Instituto de Tecnologia Quimica e
   Biologica) for revising the manuscript and we thank the financial
   support from "Fundacao para a Ciencia e a Tecnologia" (FCT grant no.
   SFRH/BD/18273/2004). The Pacific Northwest National Laboratory
   (Richland, WA) is acknowledged concerning the utilization of Protein
   Coverage Summarizer software.
CR Ahsan N, 2009, PROTEOMICS, V9, P2602, DOI 10.1002/pmic.200800935
   Alves M, 2006, PLANT SOIL, V279, P1, DOI 10.1007/s11104-005-3154-y
   ALVES M, PHYSL PLANT IN PRESS
   Arnon DI, 1938, AM J BOT, V25, P322, DOI 10.2307/2436754
   Behrendt U, 1996, PHYSIOL PLANTARUM, V97, P321, DOI 10.1034/j.1399-3054.1996.970215.x
   Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2
   Blevins DG, 1998, ANNU REV PLANT PHYS, V49, P481, DOI 10.1146/annurev.arplant.49.1.481
   BOLANOS L, 1994, PLANT PHYSIOL, V104, P85, DOI 10.1104/pp.104.1.85
   Bonilla I., 2009, PLANT PHYSL
   Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740
   Cakmak I, 1997, PLANT SOIL, V193, P71, DOI 10.1023/A:1004259808322
   DELL B, 1994, CAN J FOREST RES, V24, P2409, DOI 10.1139/x94-311
   FERROL N, 1992, PLANT SCI, V86, P41, DOI 10.1016/0168-9452(92)90177-N
   FITTER A, 2002, PLANT ROOTS HIDDEN H, P3
   GATENBY AA, 1994, ANNU REV PLANT PHYS, V45, P469
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Gladstones J.S., 1998, LUPINS CROP PLANTS B
   Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w
   GUNNING BES, 1982, ANNU REV PLANT PHYS, V33, P651, DOI 10.1146/annurev.pp.33.060182.003251
   Haizel T, 1997, PLANT J, V11, P93, DOI 10.1046/j.1365-313X.1997.11010093.x
   Han S, 2008, J PLANT PHYSIOL, V165, P1331, DOI 10.1016/j.jplph.2007.11.002
   HIGUCHI T, 1990, WOOD SCI TECHNOL, V24, P23, DOI 10.1007/BF00225306
   Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0
   Kasajima I, 2010, PHYSIOL PLANTARUM, V139, P80, DOI 10.1111/j.1399-3054.2010.01349.x
   Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809
   Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017
   Kobayashi M, 2004, J EXP BOT, V55, P1441, DOI 10.1093/jxb/erh142
   Koshiba T, 2009, PLANT CELL PHYSIOL, V50, P26, DOI 10.1093/pcp/pcn184
   Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lim H, 2003, J AM SOC MASS SPECTR, V14, P957, DOI 10.1016/S1044-0305(03)00144-2
   Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004
   LOOMIS WD, 1992, BIOFACTORS, V3, P229
   Luethy MH, 2001, PHYSIOL PLANTARUM, V112, P559, DOI 10.1034/j.1399-3054.2001.1120414.x
   MARTINOIA E, 1994, ANNU REV PLANT PHYS, V45, P447, DOI 10.1146/annurev.pp.45.060194.002311
   Meunier B, 2005, ANAL BIOCHEM, V340, P226, DOI 10.1016/j.ab.2005.02.028
   Moeder W, 2007, PLANT MOL BIOL, V63, P273, DOI 10.1007/s11103-006-9087-x
   Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886
   NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905
   Nielsen FH, 1997, PLANT SOIL, V193, P199, DOI 10.1023/A:1004276311956
   Nuc K, 2001, MOL PLANT MICROBE IN, V14, P1384, DOI 10.1094/MPMI.2001.14.12.1384
   O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319
   ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923
   Park M, 2005, CELL CYCLE, V4, P24, DOI 10.4161/cc.4.1.1394
   Patterson J, 2007, PLANT PHYSIOL, V144, P1612, DOI 10.1104/pp.107.096388
   Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032
   RAMAGLI LS, 1999, METHODS MOL BIOL 2D, P95
   Rawson HM, 1996, AUST J PLANT PHYSIOL, V23, P709, DOI 10.1071/PP9960709
   Reguera M, 2010, J PLANT PHYSIOL, V167, P625, DOI 10.1016/j.jplph.2009.11.017
   Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490
   Salzer P, 2000, MOL PLANT MICROBE IN, V13, P763, DOI 10.1094/MPMI.2000.13.7.763
   Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069
   Stitt M, 1998, BOT ACTA, V111, P167, DOI 10.1111/j.1438-8677.1998.tb00692.x
   Thioulouse J, 2007, J STAT SOFTW, V22, P1
   Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005
   Tovar-Mendez A, 2003, EUR J BIOCHEM, V270, P1043, DOI 10.1046/j.1432-1033.2003.03469.x
   Unver T, 2008, PLANT CELL REP, V27, P1411, DOI 10.1007/s00299-008-0560-7
   VALE PR, 1995, PASTAGENS FORRAGENS, V16, P9
   Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213
   Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052
   Voigt G, 1997, PHYTOCHEMISTRY, V44, P389, DOI 10.1016/S0031-9422(96)00485-2
   Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200
   Wang ZF, 2010, PLANT MOL BIOL, V74, P265, DOI 10.1007/s11103-010-9671-y
   Warington K, 1923, ANN BOT-LONDON, V37, P629, DOI 10.1093/oxfordjournals.aob.a089871
   Watanabe A, 1999, BIOSCI BIOTECH BIOCH, V63, P251, DOI 10.1271/bbb.63.251
   Ytterberg AJ, 2010, J PROTEOMICS, V73, P2249, DOI 10.1016/j.jprot.2010.06.002
   Yu Q, 2003, PHYSIOL PLANTARUM, V117, P270, DOI 10.1034/j.1399-3054.2003.00029.x
   Yu Q, 2001, PLANT BIOLOGY, V3, P335, DOI 10.1055/s-2001-16452
   Zeng CY, 2008, PLANT CELL ENVIRON, V31, P112, DOI 10.1111/j.1365-3040.2007.01745.x
NR 69
TC 16
Z9 18
U1 1
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD AUG 12
PY 2011
VL 74
IS 8
SI SI
BP 1351
EP 1363
DI 10.1016/j.jprot.2011.03.002
PG 13
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 816II
UT WOS:000294591500016
PM 21406259
DA 2021-01-25
ER

PT J
AU Gillies, TE
   Cabernard, C
AF Gillies, Taryn E.
   Cabernard, Clemens
TI Cell Division Orientation in Animals
SO CURRENT BIOLOGY
LA English
DT Review
ID CENTRAL-NERVOUS-SYSTEM; REGULATES SPINDLE ORIENTATION; NEURAL
   STEM-CELLS; C-ELEGANS EMBRYOS; DROSOPHILA NEUROBLASTS;
   CAENORHABDITIS-ELEGANS; NEUROEPITHELIAL CELLS; ASYMMETRIC DIVISION;
   CYTOPLASMIC DYNEIN; CORTICAL POLARITY
AB Cell division orientation during animal development can serve to correctly organize and shape tissues, create cellular diversity or both. The underlying cellular mechanism is regulated spindle orientation. Depending on the developmental context, extrinsic signals or intrinsic cues control the correct orientation of the mitotic spindle. Cell geometry has been known to be another determinant of spindle orientation and recent results have shed new light on the link between cellular shape and cell division orientation. The importance of controlling spindle orientation is manifested in neurodevelopmental defects such as microcephaly, tumor initiation as well as defects in tissue architecture and cell fate misspecification. Here, we summarize the role of oriented cell division during animal development and also outline the cellular and molecular mechanisms in selected invertebrate and vertebrate systems.
C1 [Gillies, Taryn E.] Univ Oregon 1254, Inst Neurosci, Eugene, OR 97403 USA.
   [Cabernard, Clemens] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Gillies, TE (corresponding author), Univ Oregon 1254, Inst Neurosci, Eugene, OR 97403 USA.
EM clemens.cabernard@unibas.ch
OI Gillies, Taryn/0000-0001-6223-9357; Cabernard,
   Clemens/0000-0003-3706-6401
CR Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062
   Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025
   Bellaiche Y, 2001, NAT CELL BIOL, V3, P50
   Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005
   Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009
   Chalmers AD, 2003, DEVELOPMENT, V130, P2657, DOI 10.1242/dev.00490
   CHENG NN, 1995, GENETICS, V139, P549
   Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375
   Concha ML, 1998, DEVELOPMENT, V125, P983
   Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085
   da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008
   Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103
   Fleming ES, 2009, MOL CARCINOGEN, V48, P592, DOI 10.1002/mc.20506
   Furman DP, 2011, INT J DEV BIOL, V55, P133, DOI 10.1387/ijdb.103129df
   Galli M, 2008, ANNU REV GENET, V42, P389, DOI 10.1146/annurev.genet.40.110405.090523
   Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021
   Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603
   Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265
   Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014
   Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035
   Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388
   Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796
   Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031
   Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572
   Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560
   Hertwig O., 1884, JENA Z NATURW, V18, P276
   HONDA H, 1983, INT REV CYTOL, V81, P191, DOI 10.1016/S0074-7696(08)62339-6
   Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005
   Hyenne V, 2010, DEV DYNAM, V239, P1378, DOI 10.1002/dvdy.22237
   Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473
   Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409
   Januschke J, 2010, J CELL BIOL, V188, P693, DOI 10.1083/jcb.200905024
   Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041
   Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7
   KIMMEL CB, 1994, DEVELOPMENT, V120, P265
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010
   Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673
   Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0
   Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922
   Li W, 2009, CURR BIOL, V19, P1821, DOI 10.1016/j.cub.2009.09.023
   Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511
   Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254
   Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3
   Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016
   Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001
   Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984
   MUNRO E, 2009, PERSPECT BIOL, V1
   Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649
   Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104
   Park DH, 2008, DEV BIOL, V315, P42, DOI 10.1016/j.ydbio.2007.11.037
   Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406
   Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030
   Peyre E, 2011, J CELL BIOL, V193, P141, DOI 10.1083/jcb.201101039
   Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001
   Quesada-Hernandez E, 2010, CURR BIOL, V20, P1966, DOI 10.1016/j.cub.2010.10.009
   Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007
   Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021
   Rebollo E, 2009, DEVELOPMENT, V136, P3393, DOI 10.1242/dev.041822
   Roegiers F, 2001, P NATL ACAD SCI USA, V98, P14469, DOI 10.1073/pnas.261555598
   Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568
   Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003
   Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140
   Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523
   Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4
   Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004
   Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018
   SHIOI G, 2009, CEREB CORTEX S1, V19, P55
   Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043
   Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211
   Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018
   Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412
   Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365
   Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527
   Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550
   Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578
   Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722
   Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tsou MFB, 2002, DEVELOPMENT, V129, P4469
   van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834
   Wang HY, 2005, BIOL CELL, V97, P63
   Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793
   Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017
   Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795
   Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026
   Zigman M, 2011, CURR BIOL, V21, P79, DOI 10.1016/j.cub.2010.12.005
NR 92
TC 105
Z9 106
U1 1
U2 29
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD AUG 9
PY 2011
VL 21
IS 15
BP R599
EP R609
DI 10.1016/j.cub.2011.06.055
PG 11
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 806IP
UT WOS:000293801400015
PM 21820628
DA 2021-01-25
ER

PT J
AU Spang, A
AF Spang, Anne
TI Signalling gets sorted by retromer
SO EMBO JOURNAL
LA English
DT Editorial Material
ID ENDOSOME; COMPLEX
AB Wnt proteins are secreted glycoproteins required for intercellular communication and important for development and tissue homoeostasis. Wnts are secreted through association to the sorting receptor Wntless, which promotes transport of Wnt from the trans-Golgi network (TGN) to the plasma membrane. Harterink et al (2011) and Silhankova et al (2010) have investigated the intracellular recycling of the Wnt-sorting receptor and identified a novel retromer-dependent traffic route from early endosomes to the TGN that is dependent on the sorting nexin SNX3 and is regulated by PI3P levels on early endosomes.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
CR Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281
   Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011
   Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665
   Silhankova M, 2010, EMBO J, V29, P4094, DOI 10.1038/emboj.2010.278
   Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056
   Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296
   Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252
   Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051
NR 8
TC 1
Z9 1
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD AUG 3
PY 2011
VL 30
IS 15
BP 2988
EP 2989
DI 10.1038/emboj.2011.232
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 808IG
UT WOS:000293970800003
PM 21811301
OA Green Published
DA 2021-01-25
ER

PT J
AU Chami, M
   Franke, B
   Mayans, O
   Kreplak, L
AF Chami, Mohamed
   Franke, Barbara
   Mayans, Olga
   Kreplak, Laurent
TI Assembly of a protein "brush" by end-grafting titin fragments to
   liposomes
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Decorated liposomes; Titin; Cryo-electron microscopy; His-Tag; Nickel
   chelating lipid
ID IG TANDEMS; CONSTITUENTS; ARCHITECTURE; FLEXIBILITY; SYSTEM; LINE
AB Titin is a giant filamentous protein of striated muscle composed of >300 immunoglobulin-like domains linked in tandem. Here, we demonstrate that a six-immunoglobulin fragment of titin carrying a poly-histidine tag forms a protein "brush" on liposomes containing metallochelating lipids. These specimens might allow the direct visualization by cryo-EM of frozen hydrated and unstained titin chains with preserved architectural features. (C) 2011, The Society for Biotechnology, Japan. All rights reserved.
C1 [Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt C CINA, CH-4003 Basel, Switzerland.
   [Franke, Barbara; Mayans, Olga] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.
RP Kreplak, L (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada.
EM kreplak@dal.ca
OI Mayans, Olga/0000-0001-6876-8532; kreplak, laurent/0000-0001-9370-9809
CR Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994
   Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981
   Bucher RM, 2010, J MOL BIOL, V401, P843, DOI 10.1016/j.jmb.2010.06.011
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Improta S, 1998, J MOL BIOL, V284, P761, DOI 10.1006/jmbi.1998.2028
   Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009
   Marino M, 2005, J MUSCLE RES CELL M, V26, P355, DOI 10.1007/s10974-005-9017-6
   Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009
   Mrosek M, 2007, FASEB J, V21, P1383, DOI 10.1096/fj.06-7644com
   Tskhovrebova L, 2010, J MOL BIOL, V397, P1092, DOI 10.1016/j.jmb.2010.01.073
   Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105
   YAMADA H, 1978, J BACTERIOL, V135, P1024, DOI 10.1128/JB.135.3.1024-1031.1978
NR 12
TC 2
Z9 2
U1 0
U2 3
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD AUG
PY 2011
VL 112
IS 2
BP 178
EP 179
DI 10.1016/j.jbiosc.2011.04.014
PG 2
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 825AQ
UT WOS:000295243700013
PM 21616710
DA 2021-01-25
ER

PT J
AU Meinen, S
   Lin, S
   Thurnherr, R
   Erb, M
   Meier, T
   Ruegg, MA
AF Meinen, Sarina
   Lin, Shuo
   Thurnherr, Raphael
   Erb, Michael
   Meier, Thomas
   Rueegg, Markus A.
TI Apoptosis inhibitors and mini-agrin have additive benefits in congenital
   muscular dystrophy mice
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE cell death; extracellular matrix; laminin-211; merosin; muscle
   regeneration
ID SKELETAL-MUSCLES; LAMININ ALPHA-2; LAMA2 GENE; MEROSIN; SURVIVAL;
   DEFICIENT; DISEASE; MODEL; REGENERATION; DYSTROGLYCAN
AB Mutations in LAMA2 cause a severe form of congenital muscular dystrophy, called MDC1A. Studies in mouse models have shown that transgenic expression of a designed, miniaturized form of the extracellular matrix molecule agrin ('mini-agrin') or apoptosis inhibition by either overexpression of Bcl2 or application of the pharmacological substance omigapil can ameliorate the disease. Here, we tested whether mini-agrin and anti-apoptotic agents act on different pathways and thus exert additive benefits in MDC1A mouse models. By combining mini-agrin with either transgenic Bcl2 expression or oral omigapil application, we show that the ameliorating effect of mini-agrin, which acts by restoring the mechanical stability of muscle fibres and, thereby, reduces muscle fibre breakdown and concomitant fibrosis, is complemented by apoptosis inhibitors, which prevent the loss of muscle fibres. Treatment of mice with both agents results in improved muscle regeneration and increased force. Our results show that the combination of mini-agrin and anti-apoptosis treatment has beneficial effects that are significantly bigger than the individual treatments and suggest that such a strategy might also be applicable to MDC1A patients.
C1 [Meinen, Sarina; Lin, Shuo; Rueegg, Markus A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Thurnherr, Raphael] Univ Basel, Kantonsspital, Dept Anaesthesia, CH-4031 Basel, Switzerland.
   [Thurnherr, Raphael] Univ Basel, Kantonsspital, Dept Res, CH-4031 Basel, Switzerland.
   [Erb, Michael; Meier, Thomas] Santhera Pharmaceut, Liestal, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Muscular Dystrophy Association (MDA)Muscular Dystrophy Association [AZ
   85718]; Swiss Foundation for Research on Muscle Disease; Cantons of
   Basel-Stadt and Baselland
FX We thank Dr Janice Dominov for generously providing the mice expressing
   human Bcl2 in skeletal muscles. The in vitro force measurements on
   isolated muscles were performed in the laboratories of Dr Francesco
   Zorzato. We thank Teppo Huttunen for many helpful discussions. This work
   was supported by the 'Muscular Dystrophy Association (MDA)', 3300 East
   Sunrise Drive, Tucson, AZ 85718, the Swiss Foundation for Research on
   Muscle Disease and the Cantons of Basel-Stadt and Baselland.
CR Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008
   BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279
   Bulyakova NV, 2006, MINIM INVASIV THER, V15, P277, DOI 10.1080/13645700600803950
   Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279
   Charge SB, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-5
   Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8
   Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095
   Erb M, 2009, J PHARMACOL EXP THER, V331, P787, DOI 10.1124/jpet.109.160754
   Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928
   Girgenrath M, 2009, ANN NEUROL, V65, P47, DOI 10.1002/ana.21523
   Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0
   Kuang W, 1998, EXP CELL RES, V241, P117, DOI 10.1006/excr.1998.4025
   Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705
   Kuang W, 1999, LAB INVEST, V79, P1601
   Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258
   Laprise P, 2003, J CELL BIOCHEM, V89, P1115, DOI 10.1002/jcb.10581
   Laprise P, 2002, J CELL PHYSIOL, V191, P69, DOI 10.1002/jcp.10075
   Luna L., 1968, MANUAL HISTOLOGIC ST, P94
   Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152
   Miller R, 2007, NEUROLOGY, V69, P776, DOI 10.1212/01.wnl.0000269676.07319.09
   Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7
   Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0
   Olive M, 2000, MUSCLE NERVE, V23, P1862, DOI 10.1002/1097-4598(200012)23:12<1862::AID-MUS10>3.0.CO;2-Q
   Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102
   Shefer G, 2002, J CELL SCI, V115, P1461
   TAPSCOTT SJ, 1992, MOL CELL BIOL, V12, P4994, DOI 10.1128/MCB.12.11.4994
   Tome FMS, 1998, CURR OPIN NEUROL, V11, P453, DOI 10.1097/00019052-199810000-00007
   Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716
   Vachon PH, 1996, J CELL BIOL, V134, P1483, DOI 10.1083/jcb.134.6.1483
NR 38
TC 30
Z9 31
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1757-4676
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD AUG
PY 2011
VL 3
IS 8
BP 465
EP 479
DI 10.1002/emmm.201100151
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 813IG
UT WOS:000294359400005
PM 21674808
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Hochstetter, A
   Stellamanns, E
   Uppaluri, S
   Heddergott, N
   Engstler, M
   Pfohl, T
AF Hochstetter, Axel
   Stellamanns, Eric
   Uppaluri, Sravanti
   Heddergott, Niko
   Engstler, Markus
   Pfohl, Thomas
TI Tracing the microscopic motility of unicellular parasites
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Meeting Abstract
CT 8th EBSA European Biophysics Congress
CY AUG 23-27, 2011
CL Budapest, HUNGARY
SP Hungarian Biophys Soc, European Biophys Soc Assoc
C1 [Hochstetter, Axel; Pfohl, Thomas] Univ Basel, Dept Chem, Basel, Switzerland.
   [Stellamanns, Eric; Uppaluri, Sravanti; Pfohl, Thomas] Max Planck Inst Dynam & Selbstorg, Gottingen, Germany.
   [Heddergott, Niko; Engstler, Markus] Univ Wurzburg, Biozentrum, Wurzburg, Germany.
RI Pfohl, Thomas/D-7296-2016
OI Pfohl, Thomas/0000-0002-7879-5216
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD AUG
PY 2011
VL 40
SU 1
BP 149
EP 150
PG 2
WC Biophysics
SC Biophysics
GA 804EO
UT WOS:000293637300383
DA 2021-01-25
ER

PT J
AU Duveau, V
   Laustela, S
   Barth, L
   Gianolini, F
   Vogt, KE
   Keist, R
   Chandra, D
   Homanics, GE
   Rudolph, U
   Fritschy, JM
AF Duveau, Venceslas
   Laustela, Simon
   Barth, Lydia
   Gianolini, Francesca
   Vogt, Kaspar E.
   Keist, Ruth
   Chandra, Dev
   Homanics, Gregg E.
   Rudolph, Uwe
   Fritschy, Jean-Marc
TI Spatiotemporal specificity of GABA(A) receptor-mediated regulation of
   adult hippocampal neurogenesis
SO EUROPEAN JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE synaptic homeostasis; neural precursor cell; BrdU; retroviral vector;
   gabapentin
ID NEWLY GENERATED NEURONS; GRANULE CELLS; EXCITATORY ACTIONS; PRECURSOR
   CELLS; DENTATE GYRUS; SUBUNITS; EXPRESSION; SUBTYPES; RAT;
   DIFFERENTIATION
AB GABAergic transmission regulates adult neurogenesis by exerting negative feedback on cell proliferation and enabling dendrite formation and outgrowth. Further, GABAergic synapses target differentiating dentate gyrus granule cells prior to formation of glutamatergic connections. GABA(A) receptors (GABA(A)Rs) mediating tonic (extrasynaptic) and phasic (synaptic) transmission are molecularly and functionally distinct, but their specific role in regulating adult neurogenesis is unknown. Using global and single-cell targeted gene deletion of subunits contributing to the assembly of GABA(A)Rs mediating tonic (alpha 4, delta) or phasic (alpha 2) GABAergic transmission, we demonstrate here in the dentate gyrus of adult mice that GABA(A)Rs containing alpha 4, but not delta, subunits mediate GABAergic effects on cell proliferation, initial migration and early dendritic development. In contrast, alpha 2-GABA(A)Rs cell-autonomously signal to control positioning of newborn neurons and regulate late maturation of their dendritic tree. In particular, we observed pruning of distal dendrites in immature granule cells lacking the alpha 2 subunit. This alteration could be prevented by pharmacological inhibition of thrombospondin signaling with chronic gabapentin treatment, shown previously to reduce glutamatergic synaptogenesis. These observations point to homeostatic regulation of inhibitory and excitatory inputs onto newborn granule cells under the control of alpha 2-GABA(A)Rs. Taken together, the availability of distinct GABA(A)R subtypes provides a molecular mechanism endowing spatiotemporal specificity to GABAergic control of neuronal maturation in adult brain.
C1 [Duveau, Venceslas; Laustela, Simon; Gianolini, Francesca; Keist, Ruth; Fritschy, Jean-Marc] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland.
   [Barth, Lydia; Vogt, Kaspar E.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Chandra, Dev; Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol & Pharmacol & Chem Biol, Pittsburgh, PA USA.
   [Rudolph, Uwe] Harvard Univ, McLean Hosp, Sch Med, Lab Genet Neuropharmacol, Belmont, MA 02178 USA.
   [Rudolph, Uwe] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02178 USA.
RP Fritschy, JM (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM fritschy@pharma.uzh.ch
OI Fritschy, Jean-Marc/0000-0002-8552-3702; Vogt,
   Kaspar/0000-0002-0859-876X; Homanics, Gregg/0000-0003-3641-8153
FU Swiss National foundation (National Center of Competence in Research in
   Neuroscience, Neural Plasticity and Repair)Swiss National Science
   Foundation (SNSF); NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AA10422, DE14184];
   NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Dental & Craniofacial Research (NIDCR)
   [K08DE014184, K08DE014184, K08DE014184, K08DE014184, K08DE014184]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND
   ALCOHOLISMUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse
   & Alcoholism (NIAAA) [R01AA010422, R01AA010422, R01AA010422,
   R37AA010422, R01AA010422, R01AA010422, R37AA010422, R37AA010422,
   R37AA010422, R37AA010422, R37AA010422, R37AA010422, R37AA010422,
   R37AA010422, R01AA010422, R01AA010422, R01AA010422, R01AA010422,
   R01AA010422, R37AA010422, R01AA010422, R01AA010422, R01AA010422,
   R01AA010422] Funding Source: NIH RePORTER
FX This work was supported by the Swiss National foundation (National
   Center of Competence in Research in Neuroscience, Neural Plasticity and
   Repair) and NIH grants AA10422 and DE14184. We would like to thank Dr
   Sebastian Jessberger and Krishna Vadodaria (ETH Zurich) for providing
   retrovirus constructs and Dr Steven Brown and Ludmila Cuninkova
   (University of Zurich) for help with retrovirus production. The authors
   have no competing interests to declare.
CR Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003
   Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488
   Barnard EA, 1998, PHARMACOL REV, V50, P291
   Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899
   Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920
   Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102
   Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017
   Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103
   Dixon CI, 2008, PHARMACOL BIOCHEM BE, V90, P1, DOI 10.1016/j.pbb.2008.01.015
   Dixon CI, 2010, P NATL ACAD SCI USA, V107, P2289, DOI 10.1073/pnas.0910117107
   Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010
   Duveau V, 2010, EUR J NEUROSCI, V32, P89, DOI 10.1111/j.1460-9568.2010.07272.x
   Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025
   Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006
   Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005
   Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625
   Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8
   Frotscher M, 2000, CEREB CORTEX, V10, P946, DOI 10.1093/cercor/10.10.946
   Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5
   Gascon E, 2006, J NEUROSCI, V26, P12956, DOI 10.1523/JNEUROSCI.4508-06.2006
   Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404
   Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008
   Herd MB, 2008, J PHYSIOL-LONDON, V586, P989, DOI 10.1113/jphysiol.2007.146746
   Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009
   Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272
   Karten YJG, 2006, HIPPOCAMPUS, V16, P312, DOI 10.1002/hipo.20165
   Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x
   Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866
   Liang J, 2008, ALCOHOL CLIN EXP RES, V32, P19, DOI 10.1111/j.1530-0277.2007.00564.x
   Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522
   Luscher B, 1997, MOL BRAIN RES, V51, P197, DOI 10.1016/S0169-328X(97)00242-8
   Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672
   Manning EE, 2012, HIPPOCAMPUS, V22, P309, DOI 10.1002/hipo.20900
   Markwardt SJ, 2009, J NEUROSCI, V29, P15063, DOI 10.1523/JNEUROSCI.2727-09.2009
   Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489
   Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905
   Nguyen L, 2003, J NEUROSCI, V23, P3278
   Obrietan K, 2002, J NEUROPHYSIOL, V88, P1005, DOI 10.1152/jn.2002.88.2.1005
   Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919
   PANZANELLI P, 2010, NEUR M PLANN SAN DIE
   Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210
   Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006
   Schneider Gasser EM, 2007, EUR J NEUROSCI, V25, P3287, DOI 10.1111/j.1460-9568.2007.05558.x
   Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301
   Sernagor E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00011
   Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256
   Sun CS, 2004, BRAIN RES, V1029, P207, DOI 10.1016/j.brainres.2004.09.056
   Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028
   Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908
   Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023
   Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008
   Vollenweider I, 2011, BEHAV BRAIN RES, V217, P77, DOI 10.1016/j.bbr.2010.10.009
   Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005
   WISDEN W, 1992, J NEUROSCI, V12, P1040
   Witschi R, 2011, J NEUROSCI, V31, P8134, DOI 10.1523/JNEUROSCI.6328-10.2011
NR 55
TC 78
Z9 81
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0953-816X
EI 1460-9568
J9 EUR J NEUROSCI
JI Eur. J. Neurosci.
PD AUG
PY 2011
VL 34
IS 3
BP 362
EP 373
DI 10.1111/j.1460-9568.2011.07782.x
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 800HK
UT WOS:000293350200002
PM 21722213
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Manfredi, P
   Renzi, F
   Mally, M
   Sauteur, L
   Schmaler, M
   Moes, S
   Jeno, P
   Cornelis, GR
AF Manfredi, Pablo
   Renzi, Francesco
   Mally, Manuela
   Sauteur, Loic
   Schmaler, Mathias
   Moes, Suzette
   Jenoe, Paul
   Cornelis, Guy R.
TI The genome and surface proteome of Capnocytophaga canimorsus reveal a
   key role of glycan foraging systems in host glycoproteins
   deglycosylation
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID OUTER-MEMBRANE PROTEINS; BACTEROIDES-THETAIOTAOMICRON;
   STREPTOCOCCUS-PNEUMONIAE; STARCH UTILIZATION; GUT MICROBIOTA; DOG-BITE;
   SP-NOV; EXOGLYCOSIDASES; IDENTIFICATION; ADAPTATIONS
AB Capnocytophaga canimorsus are commensal Gram-negative bacteria from dog's mouth that cause rare but dramatic septicaemia in humans. C. canimorsus have the unusual property to feed on cultured mammalian cells, including phagocytes, by harvesting the glycan moiety of cellular glycoproteins. To understand the mechanism behind this unusual property, the genome of strain Cc5 was sequenced and analysed. In addition, Cc5 bacteria were cultivated onto HEK 293 cells and the surface proteome was determined. The genome was found to encode many lipoproteins encoded within 13 polysaccharide utilization loci (PULs) typical of the Flavobacteria-Bacteroides group. PULs encode surface exposed feeding complexes resembling the archetypal starch utilization system (Sus). The products of at least nine PULs were detected among the surface proteome and eight of them represented more than half of the total peptides detected from the surface proteome. Systematic deletions of the 13 PULs revealed that half of these Sus-like complexes contributed to growth on animal cells. The complex encoded by PUL5, one of the most abundant ones, was involved in foraging glycans from glycoproteins. It was essential for growth on cells and contributed to survival in mice. It thus represents a fitness factor during infection.
C1 [Manfredi, Pablo; Renzi, Francesco; Mally, Manuela; Sauteur, Loic; Moes, Suzette; Jenoe, Paul; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Schmaler, Mathias] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Renzi, Francesco/0000-0001-6940-1177
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-128659]
FX We thank Marlise Amstutz for a critical reading of this MS and Silvia
   Pietsch Luis for technical support. This work was supported by the Swiss
   National Science Foundation (grant 3100A0-128659).
CR Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x
   Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200
   BRENNER DJ, 1989, J CLIN MICROBIOL, V27, P231, DOI 10.1128/JCM.27.2.231-235.1989
   Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07
   Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469
   CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986
   Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Crump EM, 2001, APPL ENVIRON MICROB, V67, P750, DOI 10.1128/AEM.67.2.750-759.2001
   Doro F, 2009, MOL CELL PROTEOMICS, V8, P1728, DOI 10.1074/mcp.M800486-MCP200
   Frandsen EVG, 2008, INT J SYST EVOL MICR, V58, P324, DOI 10.1099/ijs.0.65373-0
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937
   King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x
   Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381
   Le Moal GL, 2003, CLIN INFECT DIS, V36, pE42, DOI 10.1086/345477
   Mally M, 2008, APPL ENVIRON MICROB, V74, P6369, DOI 10.1128/AEM.01218-08
   Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164
   Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007
   Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848
   McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09
   Meyer S, 2008, IMMUNOBIOLOGY, V213, P805, DOI 10.1016/j.imbio.2008.07.019
   Pers C, 1996, CLIN INFECT DIS, V23, P71, DOI 10.1093/clinids/23.1.71
   Reeves AR, 1996, J BACTERIOL, V178, P823, DOI 10.1128/jb.178.3.823-830.1996
   Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997
   Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012
   Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243
   Shin H, 2009, INFECT IMMUN, V77, P2262, DOI 10.1128/IAI.01324-08
   Shipman JA, 1999, J BACTERIOL, V181, P7206, DOI 10.1128/JB.181.23.7206-7211.1999
   Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000
   Walters MS, 2009, J MICROBIOL METH, V78, P131, DOI 10.1016/j.mimet.2009.04.013
   Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029
NR 32
TC 33
Z9 32
U1 0
U2 8
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD AUG
PY 2011
VL 81
IS 4
BP 1050
EP 1060
DI 10.1111/j.1365-2958.2011.07750.x
PG 11
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 805TS
UT WOS:000293752500016
PM 21762219
OA Bronze
DA 2021-01-25
ER

PT J
AU Punga, AR
   Lin, SO
   Oliveri, F
   Meinen, S
   Ruegg, MA
AF Punga, Anna Rostedt
   Lin, Shuo
   Oliveri, Filippo
   Meinen, Sarina
   Rueegg, Markus A.
TI Muscle-selective synaptic disassembly and reorganization in MuSK
   antibody positive MG mice
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Myasthenia Gravis; MG; MuSK; Neuromuscular junction; Masseter; Muscle
   atrophy; Denervation
ID EXPERIMENTAL MYASTHENIA-GRAVIS; RECEPTOR TYROSINE KINASE;
   SKELETAL-MUSCLE; ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION;
   HOUSEKEEPING GENES; BOTULINUM TOXIN; RAT MUSCLE; IN-VIVO; AGRIN
AB MuSK antibody seropositive (MuSK+) Myasthenia Gravis (MG) patients present a distinct selective fatigue, and sometimes atrophy, of bulbar, facial and neck muscles. Here, we study the mechanism underlying the focal muscle involvement in mice with MuSK+ experimental autoimmune MG (EAMG). 8 week-old female wildtype C57BL6 mice and transgenic mice, which express yellow fluorescence protein (YFP) in their motor neurons, were immunized with the extracellular domain of rat MuSK and compared with control mice. The soleus, EDL, sternomastoid, omohyoid, thoracic paraspinal and masseter muscles were examined for pre- and postsynaptic changes with whole mount immunostaining and confocal microscopy. Neuromuscular junction derangement was quantified and compared between muscles and correlated with transcript levels of MuSK and other postsynaptic genes. Correlating with the EAMG disease grade, the postsynaptic acetylcholine receptor (AChR) clusters were severely fragmented with a subsequent reduction also of the presynaptic nerve terminal area. Among the muscles analyzed, the thoracic paraspinal, sternomastoid and masseter muscles were more affected than the leg muscles. The masseter muscle was the most affected, leading to denervation and atrophy and this severity correlated with the lowest levels of MuSK mRNA. On the contrary, the soleus with high MuSK mRNA levels had less postsynaptic perturbation and more terminal nerve sprouting. We propose that low muscle-intrinsic MuSK levels render some muscles, such as the masseter, more vulnerable to the postsynaptic perturbation of MuSK antibodies with subsequent denervation and atrophy. These findings augment our understanding of the sometimes severe, facio-bulbar phenotype of MuSK+ MG. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Punga, Anna Rostedt; Lin, Shuo; Oliveri, Filippo; Meinen, Sarina; Rueegg, Markus A.] Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, Basel, Switzerland.
RP Punga, AR (corresponding author), Univ Uppsala Hosp, Dept Clin Neurophysiol, Inst Neurosci, S-75185 Uppsala, Sweden.
EM annarostedtpunga@gmail.com
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Punga, Anna/0000-0002-2178-9413
FU Swedish Society for Medical Research (SSMF); University of Basel;
   Cantons of Basel-Stadt and Baselland; Swiss Foundation for Research on
   Muscle Disease; FP7 "FIGHT-MG" [242210]
FX Professor Emeritus Erik Stalberg is acknowledged for his contribution to
   the scientific discussion. ARP was funded by a postdoctoral fellowship
   from the Swedish Society for Medical Research (SSMF) and funds from the
   University of Basel. The work in the laboratory of MAR is supported by
   the Cantons of Basel-Stadt and Baselland, the Swiss Foundation for
   Research on Muscle Disease and FP7 project number 242210 "FIGHT-MG".
CR ASHER O, 1993, J IMMUNOL, V151, P6442
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Benveniste O, 2005, J NEUROIMMUNOL, V170, P41, DOI 10.1016/j.jneuroim.2005.08.016
   BERMAN PW, 1980, J EXP MED, V151, P204, DOI 10.1084/jem.151.1.204
   Bezakova G, 2001, J CELL BIOL, V153, P1453, DOI 10.1083/jcb.153.7.1453
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874
   Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936
   Cartaud A, 2004, J CELL BIOL, V165, P505, DOI 10.1083/jcb.200307164
   Chevessier F, 2008, HUM MOL GENET, V17, P3577, DOI 10.1093/hmg/ddn251
   Cole RN, 2010, J PHYSIOL-LONDON, V588, P3217, DOI 10.1113/jphysiol.2010.190298
   Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371
   DRACHMAN DB, 1975, J PHYSIOL-LONDON, V252, P657, DOI 10.1113/jphysiol.1975.sp011163
   DUCHEN LW, 1970, J NEUROL NEUROSUR PS, V33, P40, DOI 10.1136/jnnp.33.1.40
   Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223
   Farrugia ME, 2006, BRAIN, V129, P1481, DOI 10.1093/brain/awl095
   Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2
   Hesser BA, 2006, MOL CELL NEUROSCI, V31, P470, DOI 10.1016/j.mcn.2005.10.020
   Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520
   Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016
   Jones G, 1999, J NEUROSCI, V19, P3376
   Kaminski HJ, 1996, INVEST OPHTH VIS SCI, V37, P345
   Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002
   Kong XC, 2004, EMBO REP, V5, P183, DOI 10.1038/sj.embor.7400065
   LASZEWSKI B, 1985, AM J PHYSIOL, V248, pE363
   Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105
   Losen M, 2005, BRAIN, V128, P2327, DOI 10.1093/brain/awh612
   Love FM, 1999, J NEUROSCI, V19, P10390
   MacLennan C, 1997, ANN NEUROL, V41, P423, DOI 10.1002/ana.410410404
   Murphy RM, 2003, PHYSIOL GENOMICS, V12, P163, DOI 10.1152/physiolgenomics.00060.2002
   Nakayashiki N, 2000, J NEUROIMMUNOL, V105, P131, DOI 10.1016/S0165-5728(00)00199-5
   Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142
   Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0
   Punga AR, 2011, EUR J NEUROSCI, V33, P890, DOI 10.1111/j.1460-9568.2010.07569.x
   Punga AR, 2006, MUSCLE NERVE, V34, P111, DOI 10.1002/mus.20515
   Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53
   Sanders DB, 2008, J NEUROIMMUNOL, V201, P85, DOI 10.1016/j.jneuroim.2008.05.032
   Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200
   Selcen D, 2004, NEUROLOGY, V62, P1945, DOI 10.1212/01.WNL.0000128048.23930.1D
   Shigemoto K, 2006, J CLIN INVEST, V116, P1016, DOI 10.1172/JCI21545
   Shigemoto K, 2008, ANN NY ACAD SCI, V1132, P93, DOI 10.1196/annals.1405.002
   Shiraishi H, 2005, ANN NEUROL, V57, P289, DOI 10.1002/ana.20341
   ter Beek WP, 2009, AM J PATHOL, V175, P1536, DOI 10.2353/ajpath.2009.090040
   Wang Q, 2006, J MOL NEUROSCI, V30, P223, DOI 10.1385/JMN:30:1:223
   WITZEMANN V, 1989, FEBS LETT, V242, P419, DOI 10.1016/0014-5793(89)80514-9
   Xu K, 2006, NEUROSCIENCE, V143, P655, DOI 10.1016/j.neuroscience.2006.09.022
   Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007
   Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006
   ZOUVELOU V, 2009, J NEUROIMAGING, V20, P1
NR 48
TC 56
Z9 60
U1 1
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
J9 EXP NEUROL
JI Exp. Neurol.
PD AUG
PY 2011
VL 230
IS 2
BP 207
EP 217
DI 10.1016/j.expneurol.2011.04.018
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 783CF
UT WOS:000292058400007
PM 21565192
DA 2021-01-25
ER

PT J
AU Gipson, BR
   Masiel, DJ
   Browning, ND
   Spence, J
   Mitsuoka, K
   Stahlberg, H
AF Gipson, Bryant R.
   Masiel, Daniel J.
   Browning, Nigel D.
   Spence, John
   Mitsuoka, Kaoru
   Stahlberg, Henning
TI Automatic recovery of missing amplitudes and phases in tilt-limited
   electron crystallography of two-dimensional crystals
SO PHYSICAL REVIEW E
LA English
DT Article
ID IMAGE; RECONSTRUCTION
AB Electron crystallography of 2D protein crystals provides a powerful tool for the determination of membrane protein structure. In this method, data is acquired in the Fourier domain as randomly sampled, uncoupled, amplitudes and phases. Due to physical constraints on specimen tilting, those Fourier data show a vast un-sampled "missing cone" of information, producing resolution loss in the direction perpendicular to the membrane plane. Based on the flexible language of projection onto sets, we provide a full solution for these problems with a projective constraint optimization algorithm that, for sufficiently oversampled data, produces complete recovery of unmeasured data in the missing cone. We apply this method to an experimental data set of Bacteriorhodopsin and show that, in addition to producing superior results compared to traditional reconstruction methods, full, reproducible, recovery of the missing cone from noisy data is possible. Finally, we present an automatic implementation of the refinement routine as open source, freely distributed, software that will be included in our 2dx software package.
C1 [Gipson, Bryant R.; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & Nano Analyt C CINA, Biozentrum, CH-4058 Basel, Switzerland.
   [Masiel, Daniel J.; Browning, Nigel D.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.
   [Spence, John] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA.
   [Mitsuoka, Kaoru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr BIRC, Koto Ku, Tokyo 1350064, Japan.
RP Gipson, BR (corresponding author), Rice Univ, Dept Comp Sci, Duncan Hall, Houston, TX 77030 USA.
EM bryant.gipson@rice.edu; henning.stahlberg@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Browning,
   Nigel/0000-0003-0491-251X
FU SNF [205321_12649]; Swiss initiative for Systems Biology; NSFNational
   Science Foundation (NSF) [MCB-0447860]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [U54-GM074929]; DOEUnited States Department of Energy (DOE)
   [DE-FG03-02ER45996, DE-FG52-06NA26213]; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U54GM074929, U54GM074929,
   U54GM074929, U54GM074929, U54GM074929, U54GM074929, U54GM074929,
   U54GM074929, U54GM074929, U54GM074929, U54GM074929, U54GM074929,
   U54GM074929, U54GM074929, U54GM074929, U54GM074929, U54GM074929,
   U54GM074929, U54GM074929, U54GM074929, U54GM074929, U54GM074929,
   U54GM074929, U54GM074929, U54GM074929, U54GM074929, U54GM074929,
   U54GM074929, U54GM074929, U54GM074929, U54GM074929, U54GM074929,
   U54GM074929, U54GM074929, U54GM074929] Funding Source: NIH RePORTER
FX The authors gratefully acknowledge Y. Fujiyoshi, Kyoto University, for
   the providing the Bacteriorhodopsin data set. We thank T. Schirmer,
   University Basel, and T. Strohmer, UC Davis, for fruitful discussions.
   This work was in part supported by SNF Grant 205321_12649, the Swiss
   initiative for Systems Biology (SystemsX.ch: CINA), and the NSF Grant
   MCB-0447860, NIH Grant U54-GM074929, DOE Award DE-FG03-02ER45996, and
   DOE Grant DE-FG52-06NA26213.
CR AGARD DA, 1983, J MOL BIOL, V167, P849, DOI 10.1016/S0022-2836(83)80114-4
   AGARD DA, 1982, BIOPHYS J, V37, P589
   BARTH M, 1988, SCANNING MICROSCOPY, P277
   BARTH M, 1989, ULTRAMICROSCOPY, V31, P365, DOI 10.1016/0304-3991(89)90335-5
   BAUSCHKE H, 2002, IEEE INT C IM PROC, V2, P841
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   Douglas J, 1956, T AM MATH SOC, V82, P421, DOI [10.1090/S0002-9947-1956-0084194-4, DOI 10.1090/S0002-9947-1956-0084194-4]
   EATON JW, 2002, GNU OCTAVE MANUAL
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673
   FIENUP JR, 1987, J OPT SOC AM A, V4, P118, DOI 10.1364/JOSAA.4.000118
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   HANSEN PC, 1987, BIT, V27, P534, DOI 10.1007/BF01937276
   Hernandez V, 2005, ACM T MATH SOFTWARE, V31, P351, DOI 10.1145/1089014.1089019
   JIN Y, ARXIV10030888V1
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   LEVI A, 1984, J OPT SOC AM A, V1, P932, DOI 10.1364/JOSAA.1.000932
   LIONS PL, 1979, SIAM J NUMER ANAL, V16, P964, DOI 10.1137/0716071
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Raines KS, 2010, NATURE, V463, P214, DOI 10.1038/nature08705
   Schenk AD, 2010, METHOD ENZYMOL, V482, P101, DOI 10.1016/S0076-6879(10)82004-X
   Spence J. C. H., 2007, SCI MICROSCOPY, VII, P1196
   Spence JCH, 2003, J STRUCT BIOL, V144, P209, DOI 10.1016/j.jsb.2003.09.019
   Spence JCH, 2002, PHILOS T R SOC A, V360, P875, DOI 10.1098/rsta.2001.0972
   STROUD RM, 1979, BIOPHYS J, V25, P495, DOI 10.1016/S0006-3495(79)85319-9
   Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684
   VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6
NR 29
TC 15
Z9 15
U1 0
U2 5
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 1539-3755
EI 1550-2376
J9 PHYS REV E
JI Phys. Rev. E
PD JUL 22
PY 2011
VL 84
IS 1
AR 011916
DI 10.1103/PhysRevE.84.011916
PN 1
PG 9
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA 801OT
UT WOS:000293450400006
PM 21867222
OA Bronze
DA 2021-01-25
ER

PT J
AU Papadopoulos, DK
   Resendez-Perez, D
   Cardenas-Chavez, DL
   Villanueva-Segura, K
   Canales-del-Castillo, R
   Felix, DA
   Funfschilling, R
   Gehring, WJ
AF Papadopoulos, Dimitrios K.
   Resendez-Perez, Diana
   Cardenas-Chavez, Diana L.
   Villanueva-Segura, Karina
   Canales-del-Castillo, Ricardo
   Felix, Daniel A.
   Fuenfschilling, Raphael
   Gehring, Walter J.
TI Functional synthetic Antennapedia genes and the dual roles of YPWM motif
   and linker size in transcriptional activation and repression
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Hox specificity; synthetic genes; homeotic transformations;
   antenna-to-tarsus transformation
ID DROSOPHILA-MELANOGASTER; HOX PROTEIN; ECTOPIC EXPRESSION; HOMEOTIC
   GENES; HOMEOBOX GENES; TARGET GENES; HOMEODOMAIN; DNA; SPECIFICITY;
   COMPLEX
AB Segmental identity along the anteroposterior axis of bilateral animals is specified by Hox genes. These genes encode transcription factors, harboring the conserved homeodomain and, generally, a YPWM motif, which binds Hox cofactors and increases Hox transcriptional specificity in vivo. Here we derive synthetic Drosophila Antennapedia genes, consisting only of the YPWM motif and homeodomain, and investigate their functional role throughout development. Synthetic peptides and full-length Antennapedia proteins cause head-to-thorax transformations in the embryo, as well as antenna-to-tarsus and eye-to-wing transformations in the adult, thus converting the entire head to a mesothorax. This conversion is achieved by repression of genes required for head and antennal development and ectopic activation of genes promoting thoracic and tarsal fates, respectively. Synthetic Antennapedia peptides bind DNA specifically and interact with Extradenticle and Bric-a-brac interacting protein 2 cofactors in vitro and ex vivo. Substitution of the YPWM motif by alanines abolishes Antennapedia homeotic function, whereas substitution of YPWM by the WRPW repressor motif, which binds the transcriptional corepressor Groucho, allows all proteins to act as repressors only. Finally, naturally occurring variations in the size of the linker between the homeodomain and YPWM motif enhance Antennapedia repressive or activating efficiency, emphasizing the importance of linker size, rather than sequence, for specificity. Our results clearly show that synthetic Antennapedia genes are functional in vivo and therefore provide powerful tools for synthetic biology. Moreover, the YPWM motif is necessary-whereas the entire N terminus of the protein is dispensable-for Antennapedia homeotic function, indicating its dual role in transcriptional activation and repression by recruiting either coactivators or corepressors.
C1 [Papadopoulos, Dimitrios K.; Felix, Daniel A.; Fuenfschilling, Raphael; Gehring, Walter J.] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Resendez-Perez, Diana; Cardenas-Chavez, Diana L.; Villanueva-Segura, Karina; Canales-del-Castillo, Ricardo] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Monterrey 66450, NL, Mexico.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
RI Villanueva-Segura, Olga Karina/AAF-2131-2020; Resendez-Perez,
   Diana/AAE-3352-2019; Felix, Daniel A/H-6108-2011
OI Resendez-Perez, Diana/0000-0002-4709-7677; Papadopoulos,
   Dimitrios/0000-0003-0914-3051; Cardenas-Chavez,
   Diana/0000-0003-2334-7018; Canales-del-Castillo,
   Ricardo/0000-0003-3902-9751
FU kantons of Basel-Stadt and Basel-Landschaft; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); European Network of
   Excellence "Cells into Organs"; Consejo Nacional de Ciencia y Tecnologia
   of MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT) [39479-Q,
   46659]; European Molecular Biology Organization short-term fellowship
   [ASTF 499-2010]
FX This work was supported by the kantons of Basel-Stadt and
   Basel-Landschaft, a grant from the Swiss National Science Foundation,
   the European Network of Excellence "Cells into Organs," and the Consejo
   Nacional de Ciencia y Tecnologia of Mexico, Project 39479-Q and
   Scholarship 46659. D. K. P. also was supported by a European Molecular
   Biology Organization short-term fellowship (ASTF 499-2010).
CR ANDREW DJ, 1994, EMBO J, V13, P1132, DOI 10.1002/j.1460-2075.1994.tb06362.x
   Bello B, 1998, DEVELOPMENT, V125, P2193
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945
   Emerald BS, 2003, DEVELOPMENT, V130, P1171, DOI 10.1242/dev.00323
   FURUKUBOTOKUNAGA K, 1992, GENE DEV, V6, P1082, DOI 10.1101/gad.6.6.1082
   FURUKUBOTOKUNAGA K, 1993, P NATL ACAD SCI USA, V90, P6360, DOI 10.1073/pnas.90.13.6360
   Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001
   Gehring WJ, 2009, CURR TOP DEV BIOL, V88, P35, DOI 10.1016/S0070-2153(09)88002-2
   GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726
   GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5
   GIBSON G, 1988, DEVELOPMENT, V102, P657
   GIBSON G, 1990, CELL, V62, P1087, DOI 10.1016/0092-8674(90)90386-S
   Grieder NC, 2009, DEV BIOL, V329, P315, DOI 10.1016/j.ydbio.2009.03.006
   Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823
   Janody F, 2001, DEVELOPMENT, V128, P2281
   Joshi R, 2010, GENE DEV, V24, P1533, DOI 10.1101/gad.1936910
   Kmita-Cunisse M, 1998, P NATL ACAD SCI USA, V95, P3030, DOI 10.1073/pnas.95.6.3030
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Liu Y, 2009, J MOL BIOL, V390, P760, DOI 10.1016/j.jmb.2009.05.059
   Lohr U, 2005, CURR BIOL, V15, P643, DOI 10.1016/j.cub.2005.02.048
   Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4
   MCCORMICK AM, 1995, DEVELOPMENT, V121, P2799
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0
   Merabet S, 2003, DEV CELL, V4, P761, DOI 10.1016/S1534-5807(03)00126-6
   OCONNOR MB, 1988, EMBO J, V7, P435, DOI 10.1002/j.1460-2075.1988.tb02831.x
   Papadopoulos DK, 2010, P NATL ACAD SCI USA, V107, P4087, DOI 10.1073/pnas.0914595107
   PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1
   Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833
   Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726
   Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5
   Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802
   Prince F, 2008, DEVELOPMENT, V135, P1669, DOI 10.1242/dev.018028
   QIAN YQ, 1994, P NATL ACAD SCI USA, V91, P4091, DOI 10.1073/pnas.91.9.4091
   Reed HC, 2010, GENETICS, V184, P745, DOI 10.1534/genetics.109.112086
   Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704
   SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115
   SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435
   STROEHER VL, 1988, MOL CELL BIOL, V8, P4143, DOI 10.1128/MCB.8.10.4143
   STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0
   Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804
   Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138
   Vukojevic V, 2010, P NATL ACAD SCI USA, V107, P4093, DOI 10.1073/pnas.0914612107
   WAGNERBERNHOLZ JT, 1991, GENE DEV, V5, P2467, DOI 10.1101/gad.5.12b.2467
   Yallowitz AR, 2009, DEV BIOL, V335, P156, DOI 10.1016/j.ydbio.2009.08.020
   Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851
   ZENG WL, 1993, DEVELOPMENT, V118, P339
   Zhao JJG, 1996, EMBO J, V15, P1313, DOI 10.1002/j.1460-2075.1996.tb00473.x
NR 49
TC 15
Z9 16
U1 0
U2 8
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 19
PY 2011
VL 108
IS 29
BP 11959
EP 11964
DI 10.1073/pnas.1108686108
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 794DY
UT WOS:000292876900052
PM 21712439
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Diefenbacher, M
   Thorsteinsdottir, H
   Spang, A
AF Diefenbacher, Melanie
   Thorsteinsdottir, Holmfridur
   Spang, Anne
TI The Dsl1 Tethering Complex Actively Participates in Soluble NSF
   (N-Ethylmaleimide-sensitive Factor) Attachment Protein Receptor (SNARE)
   Complex Assembly at the Endoplasmic Reticulum in Saccharomyces
   cerevisiae
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RETROGRADE TRANSPORT; MEMBRANE-FUSION; COPII VESICLES; GOLGI; YEAST; ER;
   RETRIEVAL; COAT; INTERACTS; COMPONENT
AB Intracellular transport is largely dependent on vesicles that bud off from one compartment and fuse with the target compartment. The first contact of an incoming vesicle with the target membrane is mediated by tethering factors. The tethering factor responsible for recruiting Golgi-derived vesicles to the ER is the Dsl1 tethering complex, which is comprised of the essential proteins Dsl1p, Dsl3p, and Tip20p. We investigated the role of the Tip20p subunit at the ER by analyzing two mutants, tip20-5 and tip20-8. Both mutants contained multiple mutations that were scattered throughout the TIP20 sequence. Individual mutations could not reproduce the temperature-sensitive phenotype of tip20-5 and tip20-8, indicating that the overall structure of Tip20p might be altered in the mutants. Using molecular dynamics simulations comparing Tip20p and Tip20-8p revealed that some regions, particularly the N-terminal domain and parts of the stalk region, were more flexible in the mutant protein, consistent with its increased susceptibility to proteolysis. Both Tip20-5p and Tip20-8p mutants prevented proper ER trans-SNARE complex assembly in vitro. Moreover, Tip20p mutant proteins disturbed the interaction between Dsl1p and the coatomer coat complex, indicating that the Dsl1p-coatomer interaction could be stabilized or regulated by Tip20p. We provide evidence for a direct role of the Dsl1 complex, in particular Tip20p, in the formation and stabilization of ER SNARE complexes.
C1 [Diefenbacher, Melanie; Thorsteinsdottir, Holmfridur; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel
FX This work was supported by the Swiss National Science Foundation and the
   University of Basel.
CR Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200
   Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200
   Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500
   BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696
   BRZOVIC PS, 1992, J BIOL CHEM, V267, P13028
   Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100
   Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005
   Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503
   Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55
   Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006
   Cosson P, 1997, EUR J CELL BIOL, V73, P93
   Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339
   Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440
   Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582
   Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117
   Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362
   Galiano L, 2009, J AM CHEM SOC, V131, P430, DOI 10.1021/ja807531v
   Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822
   Gotte M, 1997, FEBS LETT, V411, P48, DOI 10.1016/S0014-5793(97)00575-9
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0
   INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0
   Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002
   Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049
   Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6
   Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017
   Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204
   Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090
   Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327
   Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076
   Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8
   Perez-Victoria FJ, 2009, MOL CELL BIOL, V29, P5251, DOI 10.1128/MCB.00495-09
   Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799
   Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116
   Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783
   Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002
   REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755
   Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001
   SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Shestakova A, 2007, J CELL BIOL, V179, P1179, DOI 10.1083/jcb.200705145
   Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589
   Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003
   Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9
   Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077
   Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412
   SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x
   TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365
   Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548
   Tsui MMK, 2000, J CELL SCI, V113, P145
   Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719
   WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0
   Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x
   Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649
   Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015
   Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012
NR 64
TC 18
Z9 20
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 15
PY 2011
VL 286
IS 28
BP 25027
EP 25038
DI 10.1074/jbc.M110.215657
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 789WD
UT WOS:000292547900051
PM 21482823
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Wild, P
   Farhan, H
   McEwan, DG
   Wagner, S
   Rogov, VV
   Brady, NR
   Richter, B
   Korac, J
   Waidmann, O
   Choudhary, C
   Dotsch, V
   Bumann, D
   Dikic, I
AF Wild, Philipp
   Farhan, Hesso
   McEwan, David G.
   Wagner, Sebastian
   Rogov, Vladimir V.
   Brady, Nathan R.
   Richter, Benjamin
   Korac, Jelena
   Waidmann, Oliver
   Choudhary, Chunaram
   Doetsch, Volker
   Bumann, Dirk
   Dikic, Ivan
TI Phosphorylation of the Autophagy Receptor Optineurin Restricts
   Salmonella Growth
SO SCIENCE
LA English
DT Article
ID UBIQUITIN; TBK1; BINDING; DEGRADATION; P62/SQSTM1; INTEGRITY; BACTERIA;
   ADAPTER; NDP52
AB Selective autophagy can be mediated via receptor molecules that link specific cargoes to the autophagosomal membranes decorated by ubiquitin-like microtubule-associated protein light chain 3 (LC3) modifiers. Although several autophagy receptors have been identified, little is known about mechanisms controlling their functions in vivo. In this work, we found that phosphorylation of an autophagy receptor, optineurin, promoted selective autophagy of ubiquitin-coated cytosolic Salmonella enterica. The protein kinase TANK binding kinase 1 (TBK1) phosphorylated optineurin on serine-177, enhancing LC3 binding affinity and autophagic clearance of cytosolic Salmonella. Conversely, ubiquitin-or LC3-binding optineurin mutants and silencing of optineurin or TBK1 impaired Salmonella autophagy, resulting in increased intracellular bacterial proliferation. We propose that phosphorylation of autophagy receptors might be a general mechanism for regulation of cargo-selective autophagy.
C1 [Wild, Philipp; McEwan, David G.; Richter, Benjamin; Waidmann, Oliver; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Main, Germany.
   [Wild, Philipp; McEwan, David G.; Richter, Benjamin; Waidmann, Oliver; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Main, Germany.
   [Farhan, Hesso; Bumann, Dirk] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Wagner, Sebastian; Choudhary, Chunaram] Univ Copenhagen, Fac Hlth Sci, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark.
   [Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60439 Frankfurt, Main, Germany.
   [Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60439 Frankfurt, Main, Germany.
   [Rogov, Vladimir V.] Inst Prot Res, Pushchino 142290, Russia.
   [Brady, Nathan R.] German Canc Res Ctr, D-69120 Heidelberg, Germany.
   [Korac, Jelena; Dikic, Ivan] Univ Split, Sch Med, Dept Immunol & Med Genet, Split 21000, Croatia.
RP Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Main, Germany.
EM ivan.dikic@biochem2.de
RI choudhary, chunaram/ABE-6634-2020; Brady, Nathan/H-2452-2013; Wild,
   Philipp S./M-2106-2019; McEwan, David/A-3754-2015; McEwan,
   David/AAY-6264-2020; Prlic, Jelena Korac/I-7988-2012; Farhan,
   Hesso/C-7997-2012; Choudhary, Chunaram/E-9819-2011; Dikic,
   Ivan/O-4650-2015; Wagner, Sebastian/B-9056-2012
OI choudhary, chunaram/0000-0002-9863-433X; McEwan,
   David/0000-0003-0353-6532; Prlic, Jelena Korac/0000-0002-7840-9979;
   Farhan, Hesso/0000-0002-0889-8463; Choudhary,
   Chunaram/0000-0002-9863-433X; Dikic, Ivan/0000-0001-8156-9511; Dotsch,
   Volker/0000-0001-5720-212X; Brady, Nathan/0000-0002-1901-5996
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); Goethe
   University Frankfurt [EXC115]; Landes-Offensive zur Entwicklung
   Wissentschaftlich-okonomischer Exzellenz; European Research Council
   (ERC) under the European UnionEuropean Research Council (ERC)
   [250241-LineUb]; Swiss National FondsSwiss National Science Foundation
   (SNSF) [3100A0-121834/1]; Novo Nordisk FoundationNovo Nordisk
   Foundation; Split, Croatia, government; Danish Council for Independent
   ResearchDet Frie Forskningsrad (DFF) [FSS: 10-085134]; Helmholtz
   AssociationHelmholtz Association; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [31003A-121834]; Novo Nordisk
   Foundation Center for Protein Research [PI Chunaram Choudhary] Funding
   Source: researchfish
FX We thank P. Cohen, S. Mueller, K. Rajalingam, C. Behrends, and the
   members of Dikic laboratory for constructive comments and critical
   reading of the manuscript; P. Cohen for OPTN and TBK1 reagents; and V.
   Kirkin for the initial yeast two-hybrid screens. This work was supported
   by grants from Deutsche Forschungsgemeinschaft, the Cluster of
   Excellence "Macromolecular Complexes" of the Goethe University Frankfurt
   (EXC115), the Landes-Offensive zur Entwicklung
   Wissentschaftlich-okonomischer Exzellenz-funded Onkogene
   Signaltransduktion Frankfurt network, and the European Research Council
   (ERC) under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant agreement no. (250241-LineUb) to I. D. and
   partly by Swiss National Fonds (3100A0-121834/1) to D. B. The Center for
   Protein Research is funded by a generous grant from the Novo Nordisk
   Foundation. J.K. is supported by a scholarship from the Split, Croatia,
   government, S. W. by a postdoctoral fellowship from the Danish Council
   for Independent Research (FSS: 10-085134), N.R.B. by the Initiative and
   Networking Fund of the Helmholtz Association, and H. F. by Swiss
   National Science Foundation (31003A-121834).
CR Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204
   Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235
   Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046
   Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108
   Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414
   Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009
   Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026
   Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030
   Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026
   Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020
   Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107
   Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   McEwan DG, 2011, TRENDS CELL BIOL, V21, P195, DOI 10.1016/j.tcb.2010.12.006
   Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047
   Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033
   Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029
   Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013
   Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800
   Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042
   Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014
   Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441
NR 25
TC 758
Z9 778
U1 3
U2 119
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 8
PY 2011
VL 333
IS 6039
BP 228
EP 233
DI 10.1126/science.1205405
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 789GG
UT WOS:000292502700052
PM 21617041
OA Green Accepted
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Duany, YD
   Klostermeier, D
   Rudolph, MG
AF Duany, Yoandris del Toro
   Klostermeier, Dagmar
   Rudolph, Markus G.
TI The Conformational Flexibility of the Helicase-like Domain from
   Thermotoga maritima Reverse Gyrase Is Restricted by the Topoisomerase
   Domain
SO BIOCHEMISTRY
LA English
DT Article
ID DEAD-BOX PROTEIN; CRYSTAL-STRUCTURE; CLOSED CONFORMATION; STRUCTURAL
   BASIS; DNA; NUCLEOTIDE; ATP; COMPLEX; BINDING; MECHANISM
AB Reverse gyrase is the only enzyme known to introduce positive supercoils into DNA. Positive supercoiling is achieved by the functional cooperation of a helicase-like and a topoisomerase domain. The isolated helicase-like domain is a DNA-stimulated ATPase, and the isolated topoisomerase domain can relax supercoiled DNA. In the context of reverse gyrase, these individual activities are suppressed or attenuated. The helicase-like domain of Thermotoga maritima reverse gyrase is a nucleotide-dependent conformational switch that binds DNA and ATP cooperatively. It provides a nucleotide-dependent DNA-binding site to reverse gyrase and thus serves as a valuable model for the investigation of the effect of nucleotides on DNA processing by reverse gyrase that is key to its supercoiling activity. To improve our understanding of the structural basis for the functional cooperation of a helicase domain with a DNA topoisomerase, we have determined the structures of the isolated helicase-like domain of T. maritima reverse gyrase in five different conformations. Comparison of these structures reveals extensive domain flexibility in the absence of conformational restrictions by the topoisomerase that is consistent with single-molecule Forster resonance energy transfer experiments presented here. The structure of the first ADP-bound form provides novel details about nucleotide binding to reverse gyrase. It demonstrates that reverse gyrases use the canonical nucleotide binding mode common to superfamily 2 helicases despite large deviations in the conserved motifs. A characteristic insert region adopts drastically different structures in different reverse gyrases. Counterparts of this insert region are located at very different positions in other DNA-processing enzymes but may point toward a general role in DNA strand separation.
C1 [Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany.
   [Duany, Yoandris del Toro; Klostermeier, Dagmar] Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
   [Rudolph, Markus G.] Hoffrnann La Roche AG, CH-4070 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany.
EM dagmar.klostermeier@uni-muenster.de
OI Rudolph, Markus/0000-0003-0447-1101
FU VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF)
FX This work was supported by the VolkswagenStiftung (D.K.) and the Swiss
   National Science Foundation (D.K).
CR Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246
   Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080
   Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753
   de la Tour CB, 2008, J BIOL CHEM, V283, P27395, DOI 10.1074/jbc.M800867200
   Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199
   Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587
   Duany YD, 2011, PHYS CHEM CHEM PHYS, V13, P10009, DOI 10.1039/c0cp02859b
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1
   Ganguly A, 2011, NUCLEIC ACIDS RES, V39, P1789, DOI 10.1093/nar/gkq1048
   GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106
   Hilbert M, 2011, NUCLEIC ACIDS RES, V39, P2260, DOI 10.1093/nar/gkq1127
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200
   Jungblut SP, 2007, J MOL BIOL, V371, P197, DOI 10.1016/j.jmb.2007.05.031
   KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903
   Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683
   Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396
   Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109
   Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200
   Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418
   Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X
   Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296
   Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6
   Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28
NR 42
TC 10
Z9 10
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUL 5
PY 2011
VL 50
IS 26
BP 5816
EP 5823
DI 10.1021/bi200236a
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 783DC
UT WOS:000292060700002
PM 21627332
DA 2021-01-25
ER

PT J
AU Vuilleumier, R
   Affolter, M
   Pyrowolakis, G
AF Vuilleumier, Robin
   Affolter, Markus
   Pyrowolakis, George
TI Pentagone Patrolling BMP morphogen signaling
SO FLY
LA English
DT Article
DE Drosophila melanogaster; morphogen; BMP; Dpp; Pentagone; glypicans;
   Drosophila wing development; feed-back regulation
ID HEPARAN-SULFATE PROTEOGLYCANS; WING IMAGINAL DISC; GRADIENT FORMATION;
   PATTERN-FORMATION; DROSOPHILA EMBRYO; FEEDBACK-CONTROL; CELL-SURFACE;
   HOX CONTROL; DPP; BRINKER
AB Orchestration of spatial organization by signaling gradients-morphogen gradients-is a fundamental principle in animal development. Despite their importance in tissue patterning and growth, the exact mechanisms underlying the establishment and maintenance of morphogen gradients are poorly understood. Our recent work on BMP (bone morphogenetic protein) morphogen signaling during wing development identified a novel protein, Pentagone (Pent), as a critical regulator of morphogen activity. In the following, we discuss the properties of Pent and its role as a feedback loop in morphogen gradient formation.
C1 [Vuilleumier, Robin; Pyrowolakis, George] Univ Freiburg, Inst Biol, D-79106 Freiburg, Germany.
   [Pyrowolakis, George] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany.
   [Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
RP Pyrowolakis, G (corresponding author), Univ Freiburg, Inst Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM g.pyrowolakis@biologie.uni-freiburg.de
OI Affolter, Markus/0000-0002-5171-0016
FU DFG collaborative research centerGerman Research Foundation (DFG)
   [SFB592]; Excellence Initiative of the German Federal and State
   Governments [EXC 294]
FX Work in the lab of G. Pyrowolakis was supported by a grant of DFG
   collaborative research center SFB592 and by the Excellence Initiative of
   the German Federal and State Governments (EXC 294).
CR Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166
   Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035
   Ashe HL, 2008, FLY, V2, P313, DOI 10.4161/fly.7463
   Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031
   Ben-Zvi D, 2010, P NATL ACAD SCI USA, V107, P6924, DOI 10.1073/pnas.0912734107
   Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729
   Bornemann DJ, 2008, DEVELOPMENT, V135, P1039, DOI 10.1242/dev.017061
   Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5
   CRICKMORE M, NAT CELL BIOL, V12, P528
   Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650
   Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737
   de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609
   Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2
   Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500
   Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379
   Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200
   Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052
   Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681
   Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636
   Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   Khalsa O, 1998, DEVELOPMENT, V125, P2723
   Kicheva A, 2008, CURR OPIN CELL BIOL, V20, P137, DOI 10.1016/j.ceb.2008.01.008
   Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432
   Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010
   Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004
   Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0
   Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0
   Lecuit T, 1998, DEVELOPMENT, V125, P4901
   Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522
   Lin XH, 1999, NATURE, V400, P281
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9
   O'Connor MB, 2006, DEVELOPMENT, V133, P183
   Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2
   Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008
   Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669
   Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043
   Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7
   Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9
   Thomas JT, 2009, J BIOL CHEM, V284, P18994, DOI 10.1074/jbc.M807759200
   Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534
   Vincent JP, 2002, DEV CELL, V3, P615, DOI 10.1016/S1534-5807(02)00323-4
   Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064
   Wolpert L, 2011, J THEOR BIOL, V269, P359, DOI 10.1016/j.jtbi.2010.10.034
   Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493
   Yao LC, 2008, DEVELOPMENT, V135, P2183, DOI 10.1242/dev.015826
NR 48
TC 4
Z9 4
U1 1
U2 7
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1933-6934
J9 FLY
JI Fly
PD JUL-SEP
PY 2011
VL 5
IS 3
BP 210
EP 214
DI 10.4161/fly.5.3.15311
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 863QX
UT WOS:000298183400007
PM 21406970
OA Bronze
DA 2021-01-25
ER

PT J
AU Schwank, G
   Dalessi, S
   Yang, SF
   Yagi, R
   de Lachapelle, AM
   Affolter, M
   Bergmann, S
   Basler, K
AF Schwank, Gerald
   Dalessi, Sascha
   Yang, Schu-Fee
   Yagi, Ryohei
   de Lachapelle, Aitana Morton
   Affolter, Markus
   Bergmann, Sven
   Basler, Konrad
TI Formation of the Long Range Dpp Morphogen Gradient
SO PLOS BIOLOGY
LA English
DT Article
ID HEPARAN-SULFATE PROTEOGLYCANS; WING IMAGINAL DISC;
   DROSOPHILA-MELANOGASTER; POSITIONAL INFORMATION; THICK VEINS; I
   RECEPTORS; HOX CONTROL; BRINKER; TRAFFICKING; HEDGEHOG
AB The TGF-beta homolog Decapentaplegic (Dpp) acts as a secreted morphogen in the Drosophila wing disc, and spreads through the target tissue in order to form a long range concentration gradient. Despite extensive studies, the mechanism by which the Dpp gradient is formed remains controversial. Two opposing mechanisms have been proposed: receptor-mediated transcytosis (RMT) and restricted extracellular diffusion (RED). In these scenarios the receptor for Dpp plays different roles. In the RMT model it is essential for endocytosis, re-secretion, and thus transport of Dpp, whereas in the RED model it merely modulates Dpp distribution by binding it at the cell surface for internalization and subsequent degradation. Here we analyzed the effect of receptor mutant clones on the Dpp profile in quantitative mathematical models representing transport by either RMT or RED. We then, using novel genetic tools, experimentally monitored the actual Dpp gradient in wing discs containing receptor gain-of-function and loss-of-function clones. Gain-of-function clones reveal that Dpp binds in vivo strongly to the type I receptor Thick veins, but not to the type II receptor Punt. Importantly, results with the loss-of-function clones then refute the RMT model for Dpp gradient formation, while supporting the RED model in which the majority of Dpp is not bound to Thick veins. Together our results show that receptor-mediated transcytosis cannot account for Dpp gradient formation, and support restricted extracellular diffusion as the main mechanism for Dpp dispersal. The properties of this mechanism, in which only a minority of Dpp is receptor-bound, may facilitate long-range distribution.
C1 [Schwank, Gerald; Yang, Schu-Fee; Yagi, Ryohei; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.
   [Dalessi, Sascha; de Lachapelle, Aitana Morton; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.
   [Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
RP Schwank, G (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.
EM basler@imls.uzh.ch
RI Schwank, Gerald/A-8586-2018; Schwank, Gerald/AAE-6640-2020
OI Schwank, Gerald/0000-0003-0767-2953; Schwank,
   Gerald/0000-0003-0767-2953; Lebrand Neves, Aitana/0000-0002-3984-6842;
   Bergmann, Sven/0000-0002-6785-9034; Affolter,
   Markus/0000-0002-5171-0016; Basler, Konrad/0000-0003-3534-1529
FU SystemsX.ch initiative; European Research Council under European
   UnionEuropean Research Council (ERC); Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Kanton of Zurich
FX This work was supported by the SystemsX.ch initiative within the
   framework of the WingX Project, the European Research Council under the
   European Union's Seventh Framework Programme, the Swiss National Science
   Foundation, and the Kanton of Zurich. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821
   Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112
   Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035
   Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   Bollenbach T, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011901
   BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X
   Burke R, 1996, DEVELOPMENT, V122, P2261
   Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5
   Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4
   Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650
   Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737
   Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2
   Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379
   Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001
   Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751
   Gonzalez-Gaitan M, 2003, MECH DEVELOP, V120, P1265, DOI 10.1016/j.mod.2003.06.002
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   Haerry TE, 1998, DEVELOPMENT, V125, P3977
   Haerry TE, 2010, MECH DEVELOP, V127, P358, DOI 10.1016/j.mod.2010.04.001
   Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774
   Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906
   Kruse K, 2004, DEVELOPMENT, V131, P4843, DOI 10.1242/dev.01335
   Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X
   Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0
   LAWRENCE PA, 1972, J CELL SCI, V11, P815
   Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0
   LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7
   Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438
   Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003
   Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9
   NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3
   PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1
   Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000
   Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008
   Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0
   RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9
   Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669
   Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635
   SEKELSKY JJ, 1995, GENETICS, V139, P1347
   Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602
   Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784
   Strigini M, 1997, DEVELOPMENT, V124, P4697
   Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7
   Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9
   Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426
   Vincent JP, 2002, DEV CELL, V3, P615, DOI 10.1016/S1534-5807(02)00323-4
   Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064
   Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035
   WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0
   Yagi R, 2010, P NATL ACAD SCI USA, V107, P16166, DOI 10.1073/pnas.1005957107
   YAMASHITA H, 1994, J BIOL CHEM, V269, P20172
   Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493
   Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104
NR 59
TC 52
Z9 52
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1544-9173
J9 PLOS BIOL
JI PLoS. Biol.
PD JUL
PY 2011
VL 9
IS 7
AR e1001111
DI 10.1371/journal.pbio.1001111
PG 13
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 798OQ
UT WOS:000293219800015
PM 21814489
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Kouyianou, K
   De Bock, PJ
   Muller, SA
   Nikolaki, A
   Rizos, A
   Krzyzanek, V
   Aktoudianaki, A
   Vandekerckhove, J
   Engel, A
   Gevaert, K
   Tsiotis, G
AF Kouyianou, Kalliopi
   De Bock, Pieter-Jan
   Mueller, Shirley A.
   Nikolaki, Antigoni
   Rizos, Apostolos
   Krzyzanek, Vladislav
   Aktoudianaki, Aikaterini
   Vandekerckhove, Joel
   Engel, Andreas
   Gevaert, Kris
   Tsiotis, Georgios
TI The chlorosome of Chlorobaculum tepidum: Size, mass and protein
   composition revealed by electron microscopy, dynamic light scattering
   and mass spectrometry-driven proteomics
SO PROTEOMICS
LA English
DT Article
DE Chlorosome; Electron microscopy; Green sulfur bacteria; Light
   scattering; MS; Microbiology
ID CHLOROBIUM-TEPIDUM; SULFUR BACTERIUM; BACTERIOCHLOROPHYLL; ENVELOPE;
   GENES; CSMA; MS
AB Chlorosomes, the antenna complexes of green bacteria, are unique antenna systems in which pigments are organized in aggregates. Studies on isolated chlorosomes from Chlorobaculum tepidum based on SDS-PAGE, immunoblotting and molecular biology have revealed that they contain ten chlorosomal proteins, but no comprehensive information is available about the protein composition of the entire organelle. To extend these studies, chlorosomes were isolated from C. tepidum using three related and one independent isolation protocol and characterized by absorption spectroscopy, tricine SDS-PAGE, dynamic light scattering (DLS) and electron microscopy. Tricine SDS-PAGE showed the presence of more than 20 proteins with molecular weights ranging between 6 and 70 kDa. The chlorosomes varied in size. Their hydrodynamic radius (R-h) ranged from 51 to 75 nm and electron microscopy indicated that they were on average 140nm wide and 170nm long. Furthermore, the mass of 184 whole chlorosome organelles determined by scanning transmission electron microscopy ranged from 27 to 237MDa being on average 88 (+/- 28) MDa. In contrast their mass-per-area was independent of their size, indicating that there is a strict limit to chlorosome thickness. The average protein composition of the C. tepidum chlorosome organelles was obtained by MS/MS-driven proteomics and for the first time a detailed protein catalogue of the isolated chlorosomal proteome is presented. Based on the proteomics results for chlorosomes isolated by different protocols, four proteins that are involved in the electron or ion transport are proposed to be tightly associated with or incorporated into C. tepidum chlorosomes as well as the ten Csm proteins known to date.
C1 [Kouyianou, Kalliopi; Nikolaki, Antigoni; Aktoudianaki, Aikaterini; Tsiotis, Georgios] Univ Crete, Div Biochem, Dept Chem, Iraklion, Greece.
   [De Bock, Pieter-Jan; Vandekerckhove, Joel; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium.
   [De Bock, Pieter-Jan; Vandekerckhove, Joel; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium.
   [Mueller, Shirley A.; Engel, Andreas] Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, Basel, Switzerland.
   [Mueller, Shirley A.; Engel, Andreas] Univ Basel, Ctr Cellular Imaging & Nanoanalyt C CINA, Biozentrum, Basel, Switzerland.
   [Rizos, Apostolos] Univ Crete, Div Phys Chem, Dept Chem, Iraklion, Greece.
   [Rizos, Apostolos] Fdn Res & Technol Hellas FORTH, Iraklion, Greece.
   [Krzyzanek, Vladislav] Univ Munster, Inst Med Phys & Biophys, Univ Klinikum Munster, Munster, Germany.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
RP Tsiotis, G (corresponding author), Univ Crete, Div Biochem, Dept Chem, POB 2208, GR-71003 Voutes, Greece.
EM tsiotis@chemistry.uoc.gr
RI Krzyzanek, Vladislav/C-6275-2008; Gevaert, Kris/D-6489-2017; Gevaert,
   Kris/AAE-4212-2019; Rizos, Apostolos K/F-6807-2011; Gevaert,
   Kris/H-3637-2013
OI Krzyzanek, Vladislav/0000-0002-7996-2979; Gevaert,
   Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Gevaert,
   Kris/0000-0002-4237-0283
FU University of Crete; General Secretariat for Research and
   TechnologyGreek Ministry of Development-GSRT [PENED-03ED863]; Fund for
   Scientific Research - Flanders (Belgium)FWO [G.0042.07]; Concerted
   Research Actions, Ghent UniversityGhent University [BOF07/GOA/012];
   Inter University Attraction PolesBelgian Federal Science Policy Office
   [IUAP06]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [3100A0-108299]; Maurice E. Muller Institute of
   Switzerland; DFGGerman Research Foundation (DFG) [RE 782/11]
FX The authors thank Francoise Erne-Brand (C-CINA, Biozentrum, Basel) for
   the STEM and Eva Papadogiorgaki (EM Lab "V. Galanopoulos" University of
   Crete) and Philippe Ringler (C-CINA, Biozentrum, Basel) for the TEM
   microscopy. The authors also thank Thomas Braun for providing the IGOR
   Pro binary erosion/dilation procedure used in some STEM analyses. This
   research program was supported by the University of Crete and the
   General Secretariat for Research and Technology PENED-03ED863. The VIB
   lab acknowledges support from research grants from the Fund for
   Scientific Research - Flanders (Belgium) (project number G.0042.07), the
   Concerted Research Actions (project BOF07/GOA/012) from the Ghent
   University and the Inter University Attraction Poles (IUAP06). The STEM
   microscopy was supported by Swiss National Science Foundation (Grant
   3100A0-108299 to A.E.) and the Maurice E. Muller Institute of
   Switzerland. V.K. was supported by DFG Grant RE 782/11.
CR Aivaliotis M, 2003, BBA-BIOMEMBRANES, V1615, P69, DOI 10.1016/S0005-2736(03)00208-6
   ANSORGE W, 1985, J BIOCHEM BIOPH METH, V11, P13, DOI 10.1016/0165-022X(85)90037-5
   Bayer M. E., 1979, BACTERIAL OUTER MEMB, P167
   Berne B. J., 1976, DYNAMIC LIGHT SCATTE
   BLANKENSHIP RE, 2003, LIGHT HARVESTING ANT, P195
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102
   CHUNG S, 1994, PHOTOSYNTH RES, V41, P261, DOI 10.1007/BF02184167
   Chung SH, 1996, ARCH MICROBIOL, V166, P234, DOI 10.1007/s002030050379
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   FEICK RG, 1982, J BACTERIOL, V150, P905, DOI 10.1128/JB.150.2.905-915.1982
   Frigaard N-U, 2006, COMPLEX INTRACELLULA, P79, DOI DOI 10.1007/7171_021
   Frigaard NU, 2004, J BACTERIOL, V186, P646, DOI 10.1128/JB.186.3.646-653.2004
   Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4
   GEROLA PD, BIOCH BIOPHYS ACTA, V848, P69
   Ghesquiere B, 2006, J PROTEOME RES, V5, P2438, DOI 10.1021/pr060186m
   GOKCE E, 2011, J CHROMATOGR B, DOI DOI 10.1016/J.JCHROMB.2011.1001.1032
   GOLECKI JR, 1987, ARCH MICROBIOL, V148, P236, DOI 10.1007/BF00414818
   Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6
   Helsens K, 2010, PROTEOMICS, V10, P1261, DOI 10.1002/pmic.200900409
   Hohmann-Marriott MF, 2005, PHOTOSYNTH RES, V86, P145, DOI 10.1007/s11120-005-3647-9
   Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n
   Krzyzanek V., 2003, MICROSC MICROANAL S3, V9, P110
   Krzyzanek V, 2009, J STRUCT BIOL, V165, P78, DOI 10.1016/j.jsb.2008.10.006
   Li H, 2006, BIOCHEMISTRY-US, V45, P9095, DOI 10.1021/bi060776y
   Loo JA, 2005, J AM SOC MASS SPECTR, V16, P998, DOI 10.1016/j.jasms.2005.02.017
   Martinez-Planells A, 2002, PHOTOSYNTH RES, V71, P83, DOI 10.1023/A:1014955614757
   Milks KJ, 2005, PHOTOSYNTH RES, V86, P113, DOI 10.1007/s11120-005-3757-4
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603
   Olson JM, 2004, PHOTOSYNTH RES, V80, P181, DOI 10.1023/B:PRES.0000030428.36950.43
   Oostergetel GT, 2007, FEBS LETT, V581, P5435, DOI 10.1016/j.febslet.2007.10.045
   OVERMANN J, 1992, LIMNOL OCEANOGR, V37, P150, DOI 10.4319/lo.1992.37.1.0150
   Pedersen MO, 2008, FEBS LETT, V582, P2869, DOI 10.1016/j.febslet.2008.07.020
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Psencik J, 2006, BIOPHYS J, V91, P1433, DOI 10.1529/biophysj.106.084228
   Psencik J, 2009, J BACTERIOL, V191, P6701, DOI 10.1128/JB.00690-09
   Remigy HW, 1999, J MOL BIOL, V290, P851, DOI 10.1006/jmbi.1999.2925
   Rizos AK, 1998, POLYMER, V39, P4729, DOI 10.1016/S0032-3861(97)10325-1
   Saga Y, 2006, J BIOSCI BIOENG, V102, P118, DOI 10.1263/jbb.102.118
   STOLZ JF, 1990, ARCH MICROBIOL, V154, P422, DOI 10.1007/BF00245221
   Vassilieva EV, 2002, BIOCHEMISTRY-US, V41, P4358, DOI 10.1021/bi012051u
   Vassilieva EV, 2000, SPECTRUM-J STATE GOV, V13, P7
   Wang ZY, 1995, BBA-BIOENERGETICS, V1232, P187, DOI 10.1016/0005-2728(95)00113-1
   Wenzel RJ, 2005, ANAL CHEM, V77, P4329, DOI 10.1021/ac0482054
NR 46
TC 6
Z9 6
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD JUL
PY 2011
VL 11
IS 14
BP 2867
EP 2880
DI 10.1002/pmic.201000494
PG 14
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 799EV
UT WOS:000293268100010
PM 21681991
DA 2021-01-25
ER

PT J
AU Roth, J
   Guhl, B
   Kloter, U
   Gehring, WJ
AF Roth, Juergen
   Guhl, Bruno
   Kloter, Urs
   Gehring, Walter J.
TI The ommatidia of Arca noae: a three-tier structure with a central
   light-guiding element for the receptor cell
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE Arca noae; Ommatidium; Pigment cell; Receptor cell; Brush border;
   Electron microscopy
ID ULTRASTRUCTURAL-LOCALIZATION; EYE DEVELOPMENT; PAX GENES; EVOLUTION
AB The compound eyes of ark clams appear to function as an optical system to trigger shell closure against predators. We have analyzed the structure of the ommatidia of Arca noae by thin section electron microscopy and serial sectioning, Concanavalin A-gold labeling and acid phosphatase cytochemistry. Our results demonstrate that the ommatidia are a three-tier structure composed of a central single receptor cell, surrounded and covered by proximal pigment cells followed by rows of distal pigment cells. The receptor cells of Arca noae have no lens and the disks of their receptive segment are derived from sensory cilia. The distal mitochondrial segment in the cytoplasm between the nucleus and the receptive segment is surrounded by a mass of Concanavalin A-reactive glycogen particles. Although both, proximal and distal pigment cells have numerous microvilli, only those of the proximal pigment cells form a well-aligned brush border. The microvilli of the latter are a parts per thousand 9-11 mu m long and have a diameter of a parts per thousand 70-80 nm. Numerous microlamellar bodies cover them. The microlamellar bodies are stored in acid phosphatase-negative secretory granules of the pigment granule-free apical cytoplasm of proximal pigment cells before their secretion. Observation of living compound eyes indicated that the apex of proximal pigment cells transmitted significantly more light than the surrounding distal pigment cells. Hence, the regular geometry of the brush border seems to be a light-guiding structure for receptor cells similar to an optical fiber.
C1 [Roth, Juergen] Yonsei Univ, Grad Sch, WCU Program, Dept Integrated OMICs Biomed Sci, Seoul 120749, South Korea.
   [Roth, Juergen; Guhl, Bruno] Univ Zurich, Dept Pathol, Div Cell & Mol Pathol, CH-8091 Zurich, Switzerland.
   [Guhl, Bruno] Univ Zurich Irchel, Ctr Microscopy & Image Anal, CH-8057 Zurich, Switzerland.
   [Kloter, Urs; Gehring, Walter J.] Univ Basel, Biozentrum, Dept Cell & Dev Biol, CH-4056 Basel, Switzerland.
RP Roth, J (corresponding author), Yonsei Univ, Grad Sch, WCU Program, Dept Integrated OMICs Biomed Sci, 134 Shinchon Dong, Seoul 120749, South Korea.
EM jurgen.roth@yonsei.ac.kr
FU Ministry of Education, Science and Technology (MEST)Ministry of
   Education, Science and Technology, Republic of Korea [R31-10086];
   Kantons of Zurich; Basel and Basel-Landschaft, Switzerland; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
FX We thank Mrs. Annette Roulier for excellent artwork. This work was
   supported by World Class University (WCU) program through the National
   Research Foundation (NRF) of Korea funded by the Ministry of Education,
   Science and Technology (MEST) (Grant no. R31-10086), the Kantons of
   Zurich, Basel and Basel-Landschaft, Switzerland and the Swiss National
   Science Foundation.
CR Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553
   EAKIN RM, 1975, AM ZOOL, V15, P851
   ELIAS PM, 1991, ADV LIPID RES, V24, P1
   Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104
   Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   Goldstein I.J., 1986, LECTINS PROPERTIES F, P35
   Graziussi D, 2011, J EXP ZOOL IN PRESS
   Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1
   Karnovsky M, 1971, AM SOC CELL BIOL, V114
   KATAGIRI N, 1984, J ELECTRON MICROSC, V33, P142
   Kerneis A, 1973, J ULTRASTRUCT RES, V53, P164
   Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3
   Lee M, 2011, NATURE IN PRESS
   Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x
   Maunsbach A.B., 1999, BIOMEDICAL ELECT MIC
   NILSSON DE, 1994, PHILOS T ROY SOC B, V346, P195, DOI 10.1098/rstb.1994.0141
   OHASHI M, 1973, ACTA DERM-VENEREOL, V53, P47
   Orgeig S, 2004, LUNG DEV AGING ENV, P149, DOI DOI 10.1016/B978-012324751-3/50044-9
   Pavelka M, 2010, FUNCTIONAL ULTRASTRUCTURE: ATLAS OF TISSUE BIOLOGY AND PATHOLOGY, SECOND EDITION, P2, DOI 10.1007/978-3-211-99390-3
   ROBINSON JM, 1983, J HISTOCHEM CYTOCHEM, V31, P1197, DOI 10.1177/31.10.6309949
   ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014
   ROTH J, 1983, J HISTOCHEM CYTOCHEM, V31, P987, DOI 10.1177/31.8.6190857
   Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107
   TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x
   TOKUYASU KT, 1978, J ULTRA MOL STRUCT R, V63, P287, DOI 10.1016/S0022-5320(78)80053-7
   Vanhecke D, 2010, HISTOCHEM CELL BIOL, V134, P319, DOI 10.1007/s00418-010-0736-4
   WILLIAMS TJ, 1981, ARCH BIOCHEM BIOPHYS, V209, P555, DOI 10.1016/0003-9861(81)90313-1
NR 28
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD JUL
PY 2011
VL 136
IS 1
BP 11
EP 23
DI 10.1007/s00418-011-0828-9
PG 13
WC Cell Biology; Microscopy
SC Cell Biology; Microscopy
GA 789YH
UT WOS:000292555000002
PM 21706292
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Lenz, M
   Kolvenbach, B
   Gygax, B
   Moes, S
   Corvini, PFX
AF Lenz, Markus
   Kolvenbach, Boris
   Gygax, Benjamin
   Moes, Suzette
   Corvini, Philippe F. X.
TI Shedding Light on Selenium Biomineralization: Proteins Associated with
   Bionanominerals
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID RHODOSPIRILLUM-RUBRUM; RESPIRING BACTERIA; NANOPARTICLES; REDUCTION;
   HYDROGENASE; TOLERANCE; FEATURES
AB Selenium-reducing microorganisms produce elemental selenium nanoparticles with particular physicochemical properties due to an associated organic fraction. This study identified high-affinity proteins associated with such bionanominerals and with nonbiogenic elemental selenium. Proteins with an anticipated functional role in selenium reduction, such as a metalloid reductase, were found to be associated with nanoparticles formed by one selenium respirer, Sulfurospirillum barnesii.
C1 [Lenz, Markus; Kolvenbach, Boris; Corvini, Philippe F. X.] Univ Appl Sci NW Switzerland FHNW, Sch Life Sci, Inst Ecopreneurship, CH-4132 Muttenz, Switzerland.
   [Lenz, Markus] Wageningen Univ, Sub Dept Environm Technol, NL-6700 EV Wageningen, Netherlands.
   [Gygax, Benjamin] Univ Appl Sci NW Switzerland FHNW, Sch Life Sci, Inst Chem & Bioanalyt, CH-4132 Muttenz, Switzerland.
   [Moes, Suzette] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Corvini, Philippe F. X.] Nanjing Univ, Sch Environm, Nanjing 210093, Peoples R China.
RP Lenz, M (corresponding author), Univ Appl Sci NW Switzerland FHNW, Sch Life Sci, Inst Ecopreneurship, Grundenstr 40, CH-4132 Muttenz, Switzerland.
EM Markus.Lenz@fhnw.ch
RI corvini, philippe/H-9074-2013; Lenz, Markus/AAN-7142-2020
OI Lenz, Markus/0000-0001-6832-3218; Kolvenbach, Boris/0000-0003-3491-9026
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [200021_126899]
FX The work was supported by the Swiss National Science Foundation (SNF
   200021_126899).
CR De Luca G, 2001, APPL ENVIRON MICROB, V67, P4583, DOI 10.1128/AEM.67.10.4583-4587.2001
   Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976
   Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774
   Kessi J, 2004, J BIOL CHEM, V279, P50662, DOI 10.1074/jbc.M405887200
   Kessi J, 1999, APPL ENVIRON MICROB, V65, P4734
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lenz M, 2009, ADV MATER RES-SWITZ, V71-73, P721, DOI 10.4028/www.scientific.net/AMR.71-73.721
   Lenz M, 2008, J ENVIRON QUAL, V37, P1691, DOI 10.2134/jeq2007.0630
   Marteyn B, 2009, MOL MICROBIOL, V71, P520, DOI 10.1111/j.1365-2958.2008.06550.x
   Moreau JW, 2007, SCIENCE, V316, P1600, DOI 10.1126/science.1141064
   Narasingarao P, 2007, APPL ENVIRON MICROB, V73, P3519, DOI 10.1128/AEM.02737-06
   Oremland RS, 2004, APPL ENVIRON MICROB, V70, P52, DOI 10.1128/AEM.70.1.52-60.2004
   Pearce CI, 2009, ENVIRON TECHNOL, V30, P1313, DOI 10.1080/09593330902984751
   Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006
   Schroder I, 1997, J BIOL CHEM, V272, P23765, DOI 10.1074/jbc.272.38.23765
   Shiba K, 2010, CURR OPIN BIOTECH, V21, P412, DOI 10.1016/j.copbio.2010.07.008
   Vaupotic T, 2008, FUNGAL GENET BIOL, V45, P994, DOI 10.1016/j.fgb.2008.01.006
   Wigginton NS, 2010, ENVIRON SCI TECHNOL, V44, P2163, DOI 10.1021/es903187s
   YANKE LJ, 1995, ANAEROBE, V1, P61, DOI 10.1016/S1075-9964(95)80457-9
NR 19
TC 47
Z9 50
U1 2
U2 32
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JUL
PY 2011
VL 77
IS 13
BP 4676
EP 4680
DI 10.1128/AEM.01713-10
PG 5
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 782CR
UT WOS:000291985700048
PM 21602371
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Grava, S
   Keller, M
   Voegeli, S
   Seger, S
   Lang, C
   Philippsen, P
AF Grava, Sandrine
   Keller, Miyako
   Voegeli, Sylvia
   Seger, Shanon
   Lang, Claudia
   Philippsen, Peter
TI Clustering of Nuclei in Multinucleated Hyphae Is Prevented by
   Dynein-Driven Bidirectional Nuclear Movements and Microtubule Growth
   Control in Ashbya gossypii
SO EUKARYOTIC CELL
LA English
DT Article
ID CYTOPLASMIC DYNEIN; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE;
   ASPERGILLUS-NIDULANS; SPINDLE ORIENTATION; DEPENDENT INTERACTIONS;
   MITOTIC SPINDLE; CELL CORTEX; PLUS-ENDS; MIGRATION
AB During filamentous fungus development, multinucleated hyphae employ a system for long-range nuclear migration to maintain an equal nuclear density. A decade ago the microtubule motor dynein was shown to play a central role in this process. Previous studies with Ashbya gossypii revealed extensive bidirectional movements and bypassings of nuclei, an autonomous cytoplasmic microtubule (cMT) cytoskeleton emanating from each nucleus, and pulling of nuclei by sliding of cMTs along the cortex. Here, we show that dynein is the sole motor for bidirectional movements and bypassing because these movements are concomitantly decreased in mutants carrying truncations of the dynein heavy-chain DYN1 promoter. The dynactin component Jnm1, the accessory proteins Dyn2 and Ndl1, and the potential dynein cortical anchor Num1 are also involved in the dynamic distribution of nuclei. In their absence, nuclei aggregate to different degrees, whereby the mutants with dense nuclear clusters grow extremely long cMTs. As in budding yeast, we found that dynein is delivered to cMT plus ends, and its activity or processivity is probably controlled by dynactin and Num1. Together with its role in powering nuclear movements, we propose that dynein also plays (directly or indirectly) a role in the control of cMT length. Those combined dynein actions prevent nuclear clustering in A. gossypii and thus reveal a novel cellular role for dynein.
C1 [Grava, Sandrine; Keller, Miyako; Voegeli, Sylvia; Seger, Shanon; Lang, Claudia; Philippsen, Peter] Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-112688]
FX This work was supported by a grant from the Swiss National Science
   Foundation (grant 31003A-112688).
CR Alberti-Segui C, 2001, J CELL SCI, V114, P975
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   FARKASOVSKY M, 1995, J CELL BIOL, V131, P1003, DOI 10.1083/jcb.131.4.1003
   Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Grava S, 2006, DEV CELL, V10, P425, DOI 10.1016/j.devcel.2006.02.018
   Grava S, 2010, MOL BIOL CELL, V21, P3680, DOI 10.1091/mbc.E10-06-0527
   Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7
   Heil-Chapdelaine RA, 2000, J CELL BIOL, V151, P1337, DOI 10.1083/jcb.151.6.1337
   Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030
   Inoue S, 1998, J CELL SCI, V111, P1555
   Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804
   Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   Lang C, 2010, MOL BIOL CELL, V21, P753, DOI 10.1091/mbc.E09-07-0555
   Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063
   Lee WL, 2005, J CELL BIOL, V168, P201, DOI 10.1083/jcb.200407036
   Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022
   Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119
   Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273
   Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3
   Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047
   MCMILLAN JN, 1994, J CELL BIOL, V125, P143, DOI 10.1083/jcb.125.1.143
   Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x
   Moore JK, 2010, SEMIN CELL DEV BIOL, V21, P283, DOI 10.1016/j.semcdb.2010.01.020
   Moore JK, 2009, CELL MOTIL CYTOSKEL, V66, P546, DOI 10.1002/cm.20364
   Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097
   Ramos-Garcia SL, 2009, EUKARYOT CELL, V8, P1880, DOI 10.1128/EC.00062-09
   Requena N, 2001, MOL MICROBIOL, V42, P121, DOI 10.1046/j.1365-2958.2001.02609.x
   Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108
   Schuster M, 2011, EMBO J, V30, P652, DOI 10.1038/emboj.2010.360
   Seiler S, 1999, CURR BIOL, V9, P779, DOI 10.1016/S0960-9822(99)80360-1
   Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7
   Straube A, 2001, EMBO J, V20, P5091, DOI 10.1093/emboj/20.18.5091
   Tang XY, 2009, CELL CYCLE, V8, P3182, DOI 10.4161/cc.8.19.9731
   Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087
   Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Xiang X, 2004, FUNGAL GENET BIOL, V41, P411, DOI 10.1016/j.fgb.2003.11.010
   XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100
   Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949
   Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516
   Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036
NR 46
TC 14
Z9 15
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1535-9778
EI 1535-9786
J9 EUKARYOT CELL
JI Eukaryot. Cell
PD JUL
PY 2011
VL 10
IS 7
BP 902
EP 915
DI 10.1128/EC.05095-11
PG 14
WC Microbiology; Mycology
SC Microbiology; Mycology
GA 787KV
UT WOS:000292375900005
PM 21642510
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU McPhee, JS
   Williams, AG
   Perez-Schindler, J
   Degens, H
   Baar, K
   Jones, DA
AF McPhee, J. S.
   Williams, A. G.
   Perez-Schindler, J.
   Degens, H.
   Baar, K.
   Jones, D. A.
TI Variability in the magnitude of response of metabolic enzymes reveals
   patterns of co-ordinated expression following endurance training in
   women
SO EXPERIMENTAL PHYSIOLOGY
LA English
DT Article
ID HUMAN SKELETAL-MUSCLE; PHYSICAL-ACTIVITY; AEROBIC CAPACITY; HERITAGE
   FAMILY; SUCCINATE-DEHYDROGENASE; INDIVIDUAL-DIFFERENCES;
   GLUCOSE-HOMEOSTASIS; LEG MUSCLES; EXERCISE; HUMANS
AB Skeletal muscles improve their oxidative fatty acid and glucose metabolism following endurance training, but the magnitude of response varies considerably from person to person. In 20 untrained young women we examined inter individual variability in training responses of metabolic enzymes following 6 weeks of endurance training, sufficient to increase maximal oxygen uptake by 10 +/- 8% (mean +/- SD). Training led to increases in mitochondrial enzymes [ succinate dehydrogenase (SDH; 47 +/- 78%), cytochrome c oxidase (52 +/- 70%) and ATP synthase (63 +/- 69%)] and proteins involved in fatty acid metabolism [3-hydroxyacyl CoA dehydrogenase (69 +/- 92%) and fatty acid transporter CD36 (86 +/- 31%)]. Increases in enzymes of glucose metabolism [ phosphofructokinase (29 +/- 94%) and glucose transporter 4 (18 +/- 65%)] were not significant. There was no relationship between changes in maximal oxygen uptake and the changes in the metabolic proteins. Considerable inter individual variability was seen in the magnitude of responses. The response of each enzyme was proportional to the change in SDH; individuals with a large increase in SDH also showed high gains in all other enzymes, and vice versa. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protein content increased after training, but was not correlated with changes in the metabolic proteins. In conclusion, the results revealed co-ordinated adaptation of several metabolic enzymes following endurance training, despite differences between people in the magnitude of response. Differences between individuals in the magnitude of response might reflect the influence of environmental and genetic factors that govern training adaptations.
C1 [McPhee, J. S.; Degens, H.; Jones, D. A.] Manchester Metropolitan Univ, Inst Biomed Res Human Movement & Hlth, Manchester M1 5GD, Lancs, England.
   [Williams, A. G.] Manchester Metropolitan Univ, Inst Performance Res, Manchester M1 5GD, Lancs, England.
   [Perez-Schindler, J.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Baar, K.] Univ Calif Davis, Funct Mol Biol Lab, Davis, CA 95616 USA.
RP McPhee, JS (corresponding author), Manchester Metropolitan Univ, Inst Biomed Res Human Movement & Hlth, John Dalton Bldg,Room 216,Oxford Rd, Manchester M1 5GD, Lancs, England.
EM j.s.mcphee@mmu.ac.uk
RI Williams, Alun G/B-6817-2008
OI Williams, Alun G/0000-0002-8052-8184; Perez-Schindler,
   Joaquin/0000-0003-3141-8859; McPhee, Jamie/0000-0002-3659-0773; Baar,
   Keith/0000-0001-9337-6186
CR Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334
   BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
   Bekedam MA, 2003, CLIN PHYSIOL FUNCT I, V23, P337, DOI 10.1046/j.1475-0961.2003.00517.x
   BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093
   Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013
   Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010
   Boule NG, 2005, DIABETES CARE, V28, P108, DOI 10.2337/diacare.28.1.108
   Degens H, 1998, ACTA PHYSIOL SCAND, V163, P33, DOI 10.1046/j.1365-201x.1998.00329.x
   Dietrichson P, 1980, J Oslo City Hosp, V30, P73
   Gaskill SE, 2001, INT J SPORTS MED, V22, P586, DOI 10.1055/s-2001-18522
   HAMEL P, 1986, MED SCI SPORT EXER, V18, P690
   Haskell WL, 2007, CIRCULATION, V116, P1081, DOI 10.1161/CIRCULATIONAHA.107.185649
   Hautala AJ, 2006, EUR J APPL PHYSIOL, V96, P535, DOI 10.1007/s00421-005-0116-2
   HENRIKSSON J, 1977, ACTA PHYSIOL SCAND, V99, P91, DOI 10.1111/j.1748-1716.1977.tb10356.x
   HOPPELER H, 1985, J APPL PHYSIOL, V59, P320
   Huang YC, 2006, AM J PHYSIOL-CELL PH, V291, pC11, DOI 10.1152/ajpcell.00366.2005
   Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010
   Leon AS, 2002, INT J SPORTS MED, V23, P1, DOI 10.1055/s-2002-19270
   Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009
   LORTIE G, 1984, INT J SPORTS MED, V5, P232, DOI 10.1055/s-2008-1025911
   McPhee JS, 2010, EUR J APPL PHYSIOL, V109, P1111, DOI 10.1007/s00421-010-1454-2
   McPhee JS, 2009, EXP PHYSIOL, V94, P684, DOI 10.1113/expphysiol.2008.045658
   MCPHEE JS, EUR J APPL IN PRESS, DOI DOI 10.1007/S00421-00011-01869-00424
   REICHMANN H, 1991, PFLUG ARCH EUR J PHY, V418, P572, DOI 10.1007/BF00370573
   RICHARDSON RS, 1995, AM J PHYSIOL-HEART C, V268, pH1453
   Rico-Sanz J, 2003, MED SCI SPORT EXER, V35, P1360, DOI 10.1249/01.MSS.0000079031.22755.63
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567
   SIMONEAU JA, 1986, INT J SPORTS MED, V7, P167, DOI 10.1055/s-2008-1025756
   Timmons JA, 2006, GENOMICS, V87, P165, DOI 10.1016/j.ygeno.2005.09.007
   Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009
   Vollaard NBJ, 2009, J APPL PHYSIOL, V106, P1479, DOI 10.1152/japplphysiol.91453.2008
   Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887
   Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818
NR 35
TC 9
Z9 10
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0958-0670
J9 EXP PHYSIOL
JI Exp. Physiol.
PD JUL
PY 2011
VL 96
IS 7
BP 699
EP 707
DI 10.1113/expphysiol.2011.057729
PG 9
WC Physiology
SC Physiology
GA 783SV
UT WOS:000292105200009
PM 21571817
OA Bronze
DA 2021-01-25
ER

PT J
AU Johnson, MD
   Burton, NA
   Gutierrez, B
   Painter, K
   Lund, PA
AF Johnson, Matthew D.
   Burton, Neil A.
   Gutierrez, Bernardo
   Painter, Kimberley
   Lund, Peter A.
TI RcsB Is Required for Inducible Acid Resistance in Escherichia coli and
   Acts at gadE-Dependent and -Independent Promoters
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID 2-COMPONENT SYSTEMS; STRESS; CASCADE; PH; TRANSCRIPTION; PHOSPHORELAY;
   REPRESSION; REGULATOR; EVGS/EVGA; MECHANISM
AB RcsB interacts with GadE to mediate acid resistance in stationary-phase Escherichia coli K-12. We show here that RcsB is also required for inducible acid resistance in exponential phase and that it acts on promoters that are not GadE regulated. It is also required for acid resistance in E. coli O157:H7.
C1 [Johnson, Matthew D.; Burton, Neil A.; Gutierrez, Bernardo; Painter, Kimberley; Lund, Peter A.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
   [Burton, Neil A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Gutierrez, Bernardo] Univ San Francisco Quito, Quito, Ecuador.
RP Lund, PA (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
EM lundpa@gmail.com
RI johnson, matthew/L-7626-2017
OI johnson, matthew/0000-0002-0808-3336
FU Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC)
FX We gratefully acknowledge the award of Biotechnology and Biological
   Sciences Research Council studentships to M.D.J. and N.A.B.
CR Burton NA, 2010, J MOL BIOL, V401, P726, DOI 10.1016/j.jmb.2010.06.054
   Castanie-Cornet MP, 2007, MICROBIOL-SGM, V153, P238, DOI 10.1099/mic.0.29278-0
   Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097
   Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999
   Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83
   Coldewey SM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-21
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x
   Eguchi Y, 2004, J BACTERIOL, V186, P3006, DOI 10.1128/JB.186.10.3006-3014.2004
   Eguchi Y, 2007, P NATL ACAD SCI USA, V104, P18712, DOI 10.1073/pnas.0705768104
   Eguchi Y, 2011, J BACTERIOL, V193, P1222, DOI 10.1128/JB.01124-10
   Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0
   Itou J, 2009, BIOSCI BIOTECH BIOCH, V73, P870, DOI 10.1271/bbb.80795
   Kato A, 2000, BIOSCI BIOTECH BIOCH, V64, P1203, DOI 10.1271/bbb.64.1203
   Krin E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-273
   Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002
   Ma Z, 2004, J BACTERIOL, V186, P7378, DOI 10.1128/JB.186.21.7378-7389.2004
   Ma Z, 2003, J BACTERIOL, V185, P6852, DOI 10.1128/JB.185.23.6852-6859.2003
   Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x
   Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002
   Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06
   Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4
   Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x
   SHI JP, 1995, GENE, V164, P55, DOI 10.1016/0378-1119(95)00419-7
   Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002
   Venkatesh GR, 2010, J BACTERIOL, V192, P6456, DOI 10.1128/JB.00807-10
   Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013
   Winter SE, 2009, MOL MICROBIOL, V74, P175, DOI 10.1111/j.1365-2958.2009.06859.x
NR 28
TC 26
Z9 26
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JUL
PY 2011
VL 193
IS 14
BP 3653
EP 3656
DI 10.1128/JB.05040-11
PG 4
WC Microbiology
SC Microbiology
GA 784DQ
UT WOS:000292134900025
PM 21571995
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Maier, T
   Schmidt, A
   Guell, M
   Kuhner, S
   Gavin, AC
   Aebersold, R
   Serrano, L
AF Maier, Tobias
   Schmidt, Alexander
   Gueell, Marc
   Kuehner, Sebastian
   Gavin, Anne-Claude
   Aebersold, Ruedi
   Serrano, Luis
TI Quantification of mRNA and protein and integration with protein turnover
   in a bacterium
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE mRNA-protein; Mycoplasma pneumoniae; protein homeostasis; protein
   turnover; quantitative proteomics
ID ESCHERICHIA-COLI PROTEOME; STATISTICAL-MODEL; CRYSTAL-STRUCTURE;
   EXPRESSION; GENOME; ABUNDANCE; TRANSCRIPTOME; ORGANIZATION; SIMULATION;
   SYSTEMS
AB Biological function and cellular responses to environmental perturbations are regulated by a complex interplay of DNA, RNA, proteins and metabolites inside cells. To understand these central processes in living systems at the molecular level, we integrated experimentally determined abundance data for mRNA, proteins, as well as individual protein half-lives from the genome-reduced bacterium Mycoplasma pneumoniae. We provide a fine-grained, quantitative analysis of basic intracellular processes under various external conditions. Proteome composition changes in response to cellular perturbations reveal specific stress response strategies. The regulation of gene expression is largely decoupled from protein dynamics and translation efficiency has a higher regulatory impact on protein abundance than protein turnover. Stochastic simulations using in vivo data show how low translation efficiency and long protein half-lives effectively reduce biological noise in gene expression. Protein abundances are regulated in functional units, such as complexes or pathways, and reflect cellular lifestyles. Our study provides a detailed integrative analysis of average cellular protein abundances and the dynamic interplay of mRNA and proteins, the central biomolecules of a cell. Molecular Systems Biology 7: 511; published online 19 July 2011; doi:10.1038/msb.2011.38
C1 [Maier, Tobias; Gueell, Marc; Serrano, Luis] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona 08003, Spain.
   [Maier, Tobias; Gueell, Marc; Serrano, Luis] UPF, Barcelona 08003, Spain.
   [Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, Basel, Switzerland.
   [Kuehner, Sebastian; Gavin, Anne-Claude] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.
   [Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland.
RP Maier, T (corresponding author), Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Dr Aiguader 88, Barcelona 08003, Spain.
EM tobias.maier@crg.es; luis.serrano@crg.es
RI Serrano, Luis/B-3355-2013; Guell, Marc/AAB-3054-2021; Schmidt,
   Alexander/D-6426-2011; Guell, Marc/J-2970-2017
OI Serrano, Luis/0000-0002-5276-1392; Gavin,
   Anne-Claude/0000-0003-4917-2340; Guell, Marc/0000-0003-4000-7912
FU European Research council (ERC)European Research Council (ERC)
   [ERC-2008-AdG 233226]; Fundacion Marcelino Botin; Spanish Ministry of
   Research and InnovationSpanish Government; EUEuropean Union (EU);
   SystemsX.ch
FX We thank Ben Lehner (CRG Barcelona, Spain) for comments on the
   manuscript; JA Wodke (CRG Barcelona, Spain) for pBLAST and essentiality
   analysis; A Leitner (ETH Zurich, Switzerland) for help with protein
   turnover sample processing; I Vonkova and V Rybin (EMBL Heidelberg,
   Germany) for help with size exclusion chromatography; H Molina (CRG
   Barcelona, Spain) for additional mass spectrometry experiments; E Yus
   (CRG Barcelona) for minimal medium mRNA data. This work was supported by
   the European Research council (ERC) advanced grant, the Fundacion
   Marcelino Botin, the Spanish Ministry of Research and Innovation to the
   ICREA researcher LS; by the EU grants Prospect and Trireme, by the
   European Research Council (grant #ERC-2008-AdG 233226) to RA and by
   SystemsX.ch.
CR Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d
   Ander M., 2004, Systems Biology, V1, P129, DOI 10.1049/sb:20045017
   Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077
   Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]
   Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103
   Beynon RJ, 2005, MOL CELL PROTEOMICS, V4, P857, DOI 10.1074/mcp.R400010-MCP200
   Chen SF, 2004, PROTEINS, V55, P785, DOI 10.1002/prot.10593
   Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v
   Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q
   Giuliodori AM, 2007, RNA, V13, P1355, DOI 10.1261/rna.455607
   Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103
   Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951
   Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05
   Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a
   Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102
   Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511
   Jayapal KP, 2010, J PROTEOME RES, V9, P2087, DOI 10.1021/pr9007738
   Jordan JL, 2007, INFECT IMMUN, V75, P518, DOI 10.1128/IAI.01344-06
   Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857
   Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343
   Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270
   Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Mouw KW, 2007, MOL MICROBIOL, V63, P1319, DOI 10.1111/j.1365-2958.2007.05586.x
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736
   Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869
   Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Saengjaruk P, 2002, J CLIN MICROBIOL, V40, P480, DOI 10.1128/JCM.40.3.480-489.2002
   Sauer U, 2007, SCIENCE, V316, P550, DOI 10.1126/science.1142502
   Schmidl SR, 2010, INFECT IMMUN, V78, P184, DOI 10.1128/IAI.00958-09
   Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200
   Schmidt A, 2009, CURR OPIN CHEM BIOL, V13, P510, DOI 10.1016/j.cbpa.2009.08.016
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200
   Su HC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-63
   Szurmak B, 2008, ACTA BIOCHIM POL, V55, P151, DOI 10.18388/abp.2008_3173
   t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705
   Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308
   TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196
   Tolonen AC, 2011, MOL SYST BIOL, V7, DOI [10.1038/MSB.2010.116, 10.1038/msb.2010.116]
   Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59
   Weiner J, 2003, NUCLEIC ACIDS RES, V31, P6306, DOI 10.1093/nar/gkg841
   YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020
   Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263
   Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1
NR 53
TC 183
Z9 189
U1 0
U2 49
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD JUL
PY 2011
VL 7
AR 511
DI 10.1038/msb.2011.38
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 800IB
UT WOS:000293351900003
PM 21772259
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Schmidt, A
   Beck, M
   Malmstrom, J
   Lam, H
   Claassen, M
   Campbell, D
   Aebersold, R
AF Schmidt, Alexander
   Beck, Martin
   Malmstroem, Johan
   Lam, Henry
   Claassen, Manfred
   Campbell, David
   Aebersold, Ruedi
TI Absolute quantification of microbial proteomes at different states by
   directed mass spectrometry
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE absolute quantification; directed mass spectrometry; Leptospira
   interrogans; microbiology; proteomics
ID LEPTOSPIRA-INTERROGANS; GENE-EXPRESSION; QUANTITATIVE PROTEOMICS;
   STATISTICAL-MODEL; ESCHERICHIA-COLI; PROTEIN; DISCOVERY; IDENTIFICATION;
   TRANSCRIPTOME; PEPTIDEATLAS
AB Over the past decade, liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) has evolved into the main proteome discovery technology. Up to several thousand proteins can now be reliably identified from a sample and the relative abundance of the identified proteins can be determined across samples. However, the remeasurement of substantially similar proteomes, for example those generated by perturbation experiments in systems biology, at high reproducibility and throughput remains challenging. Here, we apply a directed MS strategy to detect and quantify sets of pre-determined peptides in tryptic digests of cells of the human pathogen Leptospira interrogans at 25 different states. We show that in a single LC-MS/MS experiment around 5000 peptides, covering 1680 L. interrogans proteins, can be consistently detected and their absolute expression levels estimated, revealing new insights about the proteome changes involved in pathogenic progression and antibiotic defense of L. interrogans. This is the first study that describes the absolute quantitative behavior of any proteome over multiple states, and represents the most comprehensive proteome abundance pattern comparison for any organism to date. Molecular Systems Biology 7: 510; published online 19 July 2011; doi:10.1038/msb.2011.37
C1 [Schmidt, Alexander] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schmidt, Alexander; Beck, Martin; Malmstroem, Johan; Claassen, Manfred; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Schmidt, Alexander; Aebersold, Ruedi] Ctr Syst Physiol & Metab Dis, Zurich, Switzerland.
   [Beck, Martin] European Mol Biol Lab, Dept Struct & Computat Biol, Heidelberg, Germany.
   [Malmstroem, Johan] IMSB ETH Zurich, BiognoSYS AG, Zurich, Switzerland.
   [Lam, Henry] Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Hong Kong, Hong Kong, Peoples R China.
   [Claassen, Manfred] ETH, Dept Comp Sci, CH-8093 Zurich, Switzerland.
   [Campbell, David] Inst Syst Biol, Seattle, WA USA.
   [Aebersold, Ruedi] Univ Zurich, Dept Sci, Zurich, Switzerland.
RP Schmidt, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM alex.schmidt@unibas.ch; aebersold@imsb.biol.ethz.ch
RI Beck, Martin/B-5589-2011; Schmidt, Alexander/D-6426-2011; Malmstrom,
   Johan A/B-7660-2009; Lam, Henry/D-8629-2011
OI Beck, Martin/0000-0002-7397-1321; Malmstrom, Johan
   A/0000-0002-2889-7169; Lam, Henry/0000-0001-7928-0364; Claassen,
   Manfred/0000-0002-4583-9083
FU ETH ZurichETH Zurich; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [31000-10767]; National Heart, Lung and Blood
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI); National Institutions of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [N01-HV-28179]; SystemsX.ch; Swiss initiative for systems biology;
   European Research CouncilEuropean Research Council (ERC) [ERC-2008-AdG
   233226]; Swedish Society of Medical Research (SSMF); European Molecular
   Biology OrganizationEuropean Molecular Biology Organization (EMBO);
   European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre; Competence Center for Systems Physiology and Metabolic Diseases;
   DIVISION OF HEART AND VASCULAR DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [N01HV028179] Funding
   Source: NIH RePORTER
FX This project was funded in part by ETH Zurich, the Swiss National
   Science Foundation (Grant 31000-10767), federal funds from the National
   Heart, Lung and Blood Institute, the National Institutions of Health
   (contract no. N01-HV-28179), SystemsX.ch and the Swiss initiative for
   systems biology. RA is supported by the European Research Council (Grant
   # ERC-2008-AdG 233226). JM was supported by a fellowship from the
   Swedish Society of Medical Research (SSMF), MB was supported by a
   long-term fellowship of the European Molecular Biology Organization and
   a Marie Curie fellowship of the European Commission, AS were supported
   by the Competence Center for Systems Physiology and Metabolic Diseases.
CR Ahrens CH, 2010, J PROTEOMICS, V73, P2051, DOI 10.1016/j.jprot.2010.09.001
   Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999
   Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999
   Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Benders GA, 2005, J BACTERIOL, V187, P4542, DOI 10.1128/JB.187.13.4542-4551.2005
   Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300
   Brusniak MY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-542
   Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06
   Claassen M, 2011, J COMPUT BIOL, V18, P283, DOI 10.1089/cmb.2010.0261
   de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341
   Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919
   Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI 10.1093/nar/gkj040
   Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56
   Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661
   Eshghi A, 2009, J PROTEOME RES, V8, P4564, DOI 10.1021/pr9004597
   Fonville NC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000865
   Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768
   Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200
   Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720
   HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991
   Heller M, 2005, J PROTEOME RES, V4, P2273, DOI 10.1021/pr050193v
   Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183
   Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109
   Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929
   Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067
   Jaffe JD, 2008, MOL CELL PROTEOMICS, V7, P1952, DOI 10.1074/mcp.M800218-MCP200
   Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044
   Lam H, 2008, NAT METHODS, V5, P873, DOI 10.1038/NMETH.1254
   Lam H, 2010, J PROTEOME RES, V9, P605, DOI 10.1021/pr900947u
   Lo M, 2010, INFECT IMMUN, V78, P4850, DOI 10.1128/IAI.00435-10
   Lopez E, 2007, MOL MICROBIOL, V64, P83, DOI 10.1111/j.1365-2958.2007.05642.x
   Lux R, 2000, J MOL MICROB BIOTECH, V2, P355
   MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200
   Makarov A, 2009, J AM SOC MASS SPECTR, V20, P1391, DOI 10.1016/j.jasms.2009.01.005
   Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275
   Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255
   Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n
   Patarakul K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-31
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Picotti P, 2007, MOL CELL PROTEOMICS, V6, P1589, DOI 10.1074/mcp.M700029-MCP200
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001
   Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200
   Schmidt A, 2009, CURR OPIN CHEM BIOL, V13, P510, DOI 10.1016/j.cbpa.2009.08.016
   Serizawa M, 2010, ANTIMICROB AGENTS CH, V54, P2787, DOI 10.1128/AAC.01405-09
   Spicer V, 2007, ANAL CHEM, V79, P8762, DOI 10.1021/ac071474k
   Stahl-Zeng J, 2007, MOL CELL PROTEOMICS, V6, P1809, DOI 10.1074/mcp.M700132-MCP200
   Van La M, 2007, J ANTIMICROB CHEMOTH, V59, P370, DOI 10.1093/jac/dkl507
   van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a
   Vlasic I, 2008, BIOCHIMIE, V90, P1347, DOI 10.1016/j.biochi.2008.04.002
   YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020
NR 63
TC 72
Z9 73
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD JUL
PY 2011
VL 7
AR 510
DI 10.1038/msb.2011.37
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 800IB
UT WOS:000293351900002
PM 21772258
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Kishore, S
   Jaskiewicz, L
   Burger, L
   Hausser, J
   Khorshid, M
   Zavolan, M
AF Kishore, Shivendra
   Jaskiewicz, Lukasz
   Burger, Lukas
   Hausser, Jean
   Khorshid, Mohsen
   Zavolan, Mihaela
TI A quantitative analysis of CLIP methods for identifying binding sites of
   RNA-binding proteins
SO NATURE METHODS
LA English
DT Article
ID T-CELL-ACTIVATION; MESSENGER-RNAS; NUCLEIC-ACIDS; CROSS-LINKING;
   IDENTIFICATION; BRAIN; HUR; RECOGNITION; SPECIFICITY; POPULATION
AB Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
C1 [Kishore, Shivendra; Jaskiewicz, Lukasz; Hausser, Jean; Khorshid, Mohsen; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
   [Kishore, Shivendra; Jaskiewicz, Lukasz; Hausser, Jean; Khorshid, Mohsen; Zavolan, Mihaela] Swiss Inst Bioinformat, Basel, Switzerland.
   [Burger, Lukas] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; Hausser, Jean/0000-0002-3321-7199
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_127307, PDAM_3_127218, PDFMP3_123123]; Swiss Initiative
   in Systems Biology (Cell Plasticity); Swiss Cancer League [KFS
   02477-08-2009]; European Molecular Biology OrganizationEuropean
   Molecular Biology Organization (EMBO) [184-2009]
FX We thank G. Meister (University of Regensburg) for Ago2 antibody, C.
   Rammelt for initial help with PAR-CLIP, I. Nissen and C. Beisel for
   support with deep sequencing, J. Krol for help with miRNA
   quantification, B. Dimitriades for help with cell culture, and W. Keller
   and W. Filipowicz for critical comments and suggestions. We also thank
   the members of the Zavolan laboratory for valuable discussions. This
   work was supported by grants from the Swiss National Science Foundation
   (#31003A_127307, PDAM_3_127218 and PDFMP3_123123), the Swiss Initiative
   in Systems Biology (Cell Plasticity) and the Swiss Cancer League (#KFS
   02477-08-2009) and by the European Molecular Biology Organization
   long-term fellowship 184-2009 to S. K.
CR Atasoy U, 1998, J CELL SCI, V111, P3145
   Berninger P, 2008, METHODS, V44, P13, DOI 10.1016/j.ymeth.2007.10.002
   Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031
   Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   DINGWALL C, 1981, NUCLEIC ACIDS RES, V9, P2659, DOI 10.1093/nar/9.12.2659
   Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210
   Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544
   Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448
   Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131
   Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   HOCKENSMITH JW, 1986, J BIOL CHEM, V261, P3512
   Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034
   Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105
   Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2
   Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940
   Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039
   Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608
   LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488
   Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44
   Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550
   Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808
   SMITH KC, 1968, BIOCHEMISTRY-US, V7, P1033, DOI 10.1021/bi00843a023
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Takahashi K, 1970, Adv Biophys, V1, P53
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
   Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018
   Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131
   Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021
   Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745
NR 35
TC 306
Z9 311
U1 1
U2 41
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
J9 NAT METHODS
JI Nat. Methods
PD JUL
PY 2011
VL 8
IS 7
BP 559
EP U61
DI 10.1038/NMETH.1608
PG 9
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 784YL
UT WOS:000292194500017
PM 21572407
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Kowalczyk, SW
   Kapinos, L
   Blosser, TR
   Magalhaes, T
   van Nies, P
   Lim, RYH
   Dekker, C
AF Kowalczyk, Stefan W.
   Kapinos, Larisa
   Blosser, Timothy R.
   Magalhaes, Tomas
   van Nies, Pauline
   Lim, Roderick Y. H.
   Dekker, Cees
TI Single-molecule transport across an individual biomimetic nuclear pore
   complex
SO NATURE NANOTECHNOLOGY
LA English
DT Article
ID NANOTUBE MEMBRANES; DNA; TRANSLOCATION; ARCHITECTURE; SELECTIVITY;
   FABRICATION; HYDROGEL
AB Nuclear pore complexes regulate the selective exchange of RNA and proteins across the nuclear envelope in eukaryotic cells(1). Biomimetic strategies offer new opportunities to investigate this remarkable transport phenomenon(2). Here, we show selective transport of proteins across individual biomimetic nuclear pore complexes at the single-molecule level. Each biomimetic complex is constructed by covalently tethering either Nup98 or Nup153 (phenylalanine-glycine (FG) nucleoporins) to a solid-state nanopore(3). Individual translocation events are monitored using ionic current measurements with sub-millisecond temporal resolution. Transport receptors (Imp beta) proceed with a dwell time of similar to 2.5 ms for both Nup98- and Nup153-coated pores, whereas the passage of non-specific proteins is strongly inhibited with different degrees of selectivity. For pores up to similar to 25 nm in diameter, Nups form a dense and low-conducting barrier, whereas they adopt a more open structure in larger pores. Our biomimetic nuclear pore complex provides a quantitative platform for studying nucleocytoplasmic transport phenomena at the single-molecule level in vitro.
C1 [Kapinos, Larisa; Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kapinos, Larisa; Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
   [Kowalczyk, Stefan W.; Blosser, Timothy R.; Magalhaes, Tomas; van Nies, Pauline; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch; c.dekker@tudelft.nl
OI Dekker, Cees/0000-0001-6273-071X; Lim, Roderick/0000-0001-5015-6087
FU Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)Netherlands
   Organization for Scientific Research (NWO); European CommissionEuropean
   CommissionEuropean Commission Joint Research Centre; National Center of
   Competence in Research 'Nanoscale Science' (NCCR-Nano)Swiss National
   Science Foundation (SNSF); Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Biozentrum; Swiss Nanoscience
   Institute
FX The authors thank K.A. Williams for suggestions on the chemistry, A.R.
   Hall, M. van den Hout and X. Janssen for membrane fabrication and
   discussions, D. Grunwald and G.V. Soni for help with TIRF measurements,
   Y. Rabin and A.Y. Grosberg for help with theoretical work, and T. Dange,
   N.H. Dekker, D. Grunwald, P.L. Hagedoorn, G.F. Schneider and G.M.
   Skinner for discussions. This research was funded by the 'Nederlandse
   Organisatie voor Wetenschappelijk Onderzoek (NWO)', programme NanoSci E+
   of the European Commission, and the READNA (REvolutionary Approaches and
   Devices for Nucleic Acid analysis) project of the European Commission.
   L.K. and R.Y.H.L. are supported by the National Center of Competence in
   Research 'Nanoscale Science' (NCCR-Nano), the Swiss National Science
   Foundation, the Biozentrum and the Swiss Nanoscience Institute.
CR Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   Alberts B., 2008, MOL BIOL CELL
   BUSTAMANTE JO, 1995, J MEMBRANE BIOL, V146, P263
   Caspi Y, 2008, NANO LETT, V8, P3728, DOI 10.1021/nl801975q
   Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173
   Danker T, 1999, P NATL ACAD SCI USA, V96, P13530, DOI 10.1073/pnas.96.23.13530
   Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Fologea D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767206
   Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024
   Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516
   HALL JE, 1975, J GEN PHYSIOL, V66, P531, DOI 10.1085/jgp.66.4.531
   Jin L, 2003, LANGMUIR, V19, P6968, DOI 10.1021/la034461k
   Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600
   Keyser UF, 2006, NAT PHYS, V2, P473, DOI 10.1038/nphys344
   Kohli P, 2004, SCIENCE, V305, P984, DOI 10.1126/science.1100024
   Kowalczyk SW, 2010, NANO LETT, V10, P324, DOI 10.1021/nl903631m
   Krapf D, 2006, NANO LETT, V6, P105, DOI 10.1021/nl052163x
   Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005
   Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978
   Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2006, CHROMOSOMA, V115, P15, DOI 10.1007/s00412-005-0037-1
   Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285
   Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107
   Moussavi-Baygi R, 2011, BIOPHYS J, V100, P1410, DOI 10.1016/j.bpj.2011.01.061
   Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007
   Siwy Z, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.198103
   Smeets RMM, 2008, P NATL ACAD SCI USA, V105, P417, DOI 10.1073/pnas.0705349105
   Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903
   Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Strelkov SV, 2004, METHOD CELL BIOL, V78, P25
   Wanunu M, 2007, NANO LETT, V7, P1580, DOI 10.1021/nl070462b
   Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374
   Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201
   Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101
   Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053
   Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125
   Zilman A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000804
NR 42
TC 176
Z9 179
U1 3
U2 123
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
EI 1748-3395
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD JUL
PY 2011
VL 6
IS 7
BP 433
EP 438
DI 10.1038/NNANO.2011.88
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 788RV
UT WOS:000292463000013
PM 21685911
DA 2021-01-25
ER

PT J
AU Piraino, S
   Zega, G
   Di Benedetto, C
   Leone, A
   Dell'Anna, A
   Pennati, R
   Carnevali, DC
   Schmid, V
   Reichert, H
AF Piraino, Stefano
   Zega, Giuliana
   Di Benedetto, Cristiano
   Leone, Antonella
   Dell'Anna, Alessandro
   Pennati, Roberta
   Carnevali, Daniela Candia
   Schmid, Volker
   Reichert, Heinrich
TI Complex Neural Architecture in the Diploblastic Larva of Clava
   multicornis (Hydrozoa, Cnidaria)
SO JOURNAL OF COMPARATIVE NEUROLOGY
LA English
DT Article
DE Cnidaria; Hydrozoa; neuroanatomy; planula; CNS; cephalization; early
   central nervous system evolution
ID CENTRAL-NERVOUS-SYSTEM; JELLYFISH TRIPEDALIA-CYSTOPHORA; CORAL
   BALANOPHYLLIA-ELEGANS; HYDRACTINIA-ECHINATA; BOX JELLYFISH; METAZOAN
   EVOLUTION; SEA-ANEMONE; MONOCLONAL-ANTIBODIES; MOLECULAR EVIDENCE;
   PENNARIA-TIARELLA
AB The organization of the cnidarian nervous system has been widely documented in polyps and medusae, but little is known about the nervous system of planula larvae, which give rise to adult forms after settling and metamorphosis. We describe histological and cytological features of the nervous system in planulae of the hydrozoan Clava multicornis. These planulae do not swim freely in the water column but rather crawl on the substrate by means of directional, coordinated ciliary movement coupled to lateral muscular bending movements associated with positive phototaxis. Histological analysis shows pronounced anteroposterior regionalization of the planula's nervous system, with different neural cell types highly concentrated at the anterior pole. Transmission electron microscopy of planulae shows the nervous system to be unusually complex, with a large, orderly array of sensory cells at the anterior pole. In the anterior half of the planula, the basiectodermal plexus of neurites forms an extensive orthogonal network, whereas more posteriorly neurites extend longitudinally along the body axis. Additional levels of nervous system complexity are uncovered by neuropeptide-specific immunocytochemistry, which reveals distinct neural subsets having specific molecular phenotypes. Together these observations imply that the nervous system of the planula of Clava multicornis manifests a remarkable level of histological, cytological, and functional organization, the features of which may be reminiscent of those present in early bilaterian animals. J. Comp. Neurol. 519:1931-1951, 2011. (C) 2011 Wiley-Liss, Inc.
C1 [Piraino, Stefano; Leone, Antonella; Dell'Anna, Alessandro] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, I-73100 Lecce, Italy.
   [Zega, Giuliana; Dell'Anna, Alessandro; Pennati, Roberta] Univ Milan, Dipartimento Biol Funct & Reprod Biol, I-20133 Milan, Italy.
   [Di Benedetto, Cristiano; Carnevali, Daniela Candia] Univ Milan, Dipartimento Biol Zool & Citol, I-20133 Milan, Italy.
   [Leone, Antonella] CNR ISPA, I-73100 Lecce, Italy.
   [Schmid, Volker; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Piraino, S (corresponding author), Univ Salento, Dipartimento Sci Tecnol Biol Ambientali, I-73100 Lecce, Italy.
EM stefano.piraino@unisalento.it
RI Leone, Antonella/J-4770-2012; Piraino, Stefano/J-5234-2012; Candia
   Carnevali, M.Daniela/I-8048-2015
OI Leone, Antonella/0000-0002-5610-4031; Piraino,
   Stefano/0000-0002-8752-9390; Candia Carnevali,
   M.Daniela/0000-0002-0215-8843
FU Italian Ministry for Research and EducationMinistry of Education,
   Universities and Research (MIUR) [2007-5WCPWM]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF)
FX Italian Ministry for Research and Education; Grant number: 2007-5WCPWM
   (to S. P.); Grant sponsor: Swiss National Science Foundation (to H. R.).
CR Arendt D, 2008, PHILOS T R SOC B, V363, P1523, DOI 10.1098/rstb.2007.2242
   Boero F, 1998, ITAL J ZOOL, V65, P5, DOI 10.1080/11250009809386722
   Boero F, 2007, INTEGR COMP BIOL, V47, P693, DOI 10.1093/icb/icm041
   Bouillon J, 1993, TRAITE ZOOL, VIII, P29
   Bouillon Jean, 2006, Memoires du Museum National d'Histoire Naturelle, V194, P1
   CHIA FS, 1979, J MORPHOL, V160, P275, DOI 10.1002/jmor.1051600303
   CHIA FS, 1978, SETTLEMENT METAMORPH, P1
   Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458
   De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003
   Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040
   DONINI SD, 1998, CELL TISSUE RES, V294, P81
   Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614
   Finnerty JR, 2003, INT J DEV BIOL, V47, P523
   Finnerty JR, 2003, EVOL DEV, V5, P331, DOI 10.1046/j.1525-142X.2003.03041.x
   Gaerber CW, 2007, ZOOMORPHOLOGY, V126, P73, DOI 10.1007/s00435-007-0039-z
   Gajewski M, 1996, ROUX ARCH DEV BIOL, V205, P232, DOI 10.1007/BF00365801
   Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563
   Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044
   Garm A, 2007, CELL TISSUE RES, V329, P147, DOI 10.1007/s00441-007-0393-7
   Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8
   GERRODETTE T, 1981, ECOLOGY, V62, P611, DOI 10.2307/1937728
   GRIMMELIKHUIJZEN CJP, 1985, CELL TISSUE RES, V241, P171, DOI 10.1007/BF00214639
   Groger H, 2001, GENESIS, V29, P110, DOI 10.1002/gene.1013
   Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052
   Hamaguchi-Hamada K, 2009, CELL TISSUE RES, V337, P15, DOI 10.1007/s00441-009-0808-8
   Hartnoll R. G., 1977, BIOL BENTHIC ORGANIS, P321, DOI DOI 10.1016/B978-0-08-021378-1.50036-1
   Hayward DC, 2001, DEV GENES EVOL, V211, P10
   HELLBERG ME, 1995, MAR BIOL, V123, P573, DOI 10.1007/BF00349236
   Heltzel PS, 2002, MAR BIOL, V140, P659, DOI 10.1007/s00227-001-0745-x
   Holland ND, 2003, NAT REV NEUROSCI, V4, P617, DOI 10.1038/nrn1175
   HYMAN LH, 1951, INVERTEBRATES PLATYH, V2, P1
   Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8
   Jacobs DK, 2007, INTEGR COMP BIOL, V47, P712, DOI 10.1093/icb/icm094
   Jellies J, 1996, J COMP NEUROL, V373, P1, DOI 10.1002/(SICI)1096-9861(19960909)373:1<1::AID-CNE1>3.0.CO;2-8
   Katsukura Y, 2004, J EXP BIOL, V207, P1803, DOI 10.1242/jeb.00974
   Korn H., 1966, Zeitschrift fuer Morphologie und Oekologie der Tiere, V57, P1, DOI 10.1007/BF00578361
   Kotikova EA, 2008, J EVOL BIOCHEM PHYS+, V44, P95, DOI 10.1134/S002209300801012X
   KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x
   Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158
   LEITZ T, 1994, DEV BIOL, V163, P440, DOI 10.1006/dbio.1994.1160
   LEITZ T, 1993, MAR BIOL, V116, P559, DOI 10.1007/BF00355474
   LEITZ T, 1995, ROUX ARCH DEV BIOL, V204, P276, DOI 10.1007/BF00208495
   Leitz T, 1998, ANN NY ACAD SCI, V839, P105, DOI 10.1111/j.1749-6632.1998.tb10740.x
   Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664
   Lichtneckert R, 2008, ADV EXP MED BIOL, V628, P32, DOI 10.1007/978-0-387-78261-4_2
   Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0
   Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155
   Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698
   MARTIN V, 1983, J MORPHOL, V176, P261, DOI 10.1002/jmor.1051760303
   MARTIN VJ, 1992, CELL TISSUE RES, V269, P431, DOI 10.1007/BF00353898
   MARTIN VJ, 1988, BIOL BULL, V174, P319, DOI 10.2307/1541957
   Martin VJ, 2000, INVERTEBR BIOL, V119, P243
   MARTIN VJ, 1981, J EXP ZOOL, V217, P303, DOI 10.1002/jez.1402170302
   MARTIN VJ, 1980, J MORPHOL, V166, P27, DOI 10.1002/jmor.1051660103
   Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103
   MAUNNSBACH AB, 1999, BIOMEDICAL ELECT MIC
   Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998
   Meinertzhagen IA, 2010, ACTA ZOOL-STOCKHOLM, V91, P64, DOI 10.1111/j.1463-6395.2009.00425.x
   Miller DJ, 2000, BIOESSAYS, V22, P291, DOI 10.1002/(SICI)1521-1878(200003)22:3<291::AID-BIES11>3.0.CO;2-2
   Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543
   Moroz LL, 2009, BRAIN BEHAV EVOLUT, V74, P177, DOI 10.1159/000258665
   Muller WA, 2002, CAN J ZOOL, V80, P1755, DOI 10.1139/Z02-130
   Nakanishi N, 2008, DEV GENES EVOL, V218, P511, DOI 10.1007/s00427-008-0239-7
   Nakanishi N, 2010, EVOL DEV, V12, P404, DOI 10.1111/j.1525-142X.2010.00427.x
   Nakanishi N, 2009, DEV GENES EVOL, V219, P301, DOI 10.1007/s00427-009-0291-y
   NIELSEN C, 1994, AM ZOOL, V34, P492
   Orlov DV, 1997, J EXP MAR BIOL ECOL, V208, P73, DOI 10.1016/S0022-0981(96)02673-1
   Otto J. J, 1976, COELENTERATE ECOLOGY, P319, DOI 10.1007/978-1-4757-9724-4_34.
   Parkefelt L, 2009, J COMP NEUROL, V516, P157, DOI 10.1002/cne.22072
   PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085
   PLICKERT G, 1989, CELL DIFFER DEV, V26, P19, DOI 10.1016/0922-3371(89)90780-6
   Plickert G, 2004, HYDROBIOLOGIA, V530, P49, DOI 10.1007/s10750-004-2689-x
   Plickert G, 2003, INT J DEV BIOL, V47, P439
   PLICKERT G, 1988, DEVELOPMENT, V103, P795
   Raikova OI, 1998, ZOOMORPHOLOGY, V118, P69, DOI 10.1007/s004350050058
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   ROOSENRUNGE EC, 1967, SCIENCE, V156, P74, DOI 10.1126/science.156.3771.74
   Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64
   Schmich J, 1998, DEV GENES EVOL, V208, P267, DOI 10.1007/s004270050181
   Schmich J, 1998, CELL TISSUE RES, V294, P169, DOI 10.1007/s004410051167
   Schmidt-Rhaesa A, 2009, ZOOMORPHOLOGY, V128, P199, DOI 10.1007/s00435-009-0096-6
   SCHWOERERBOHNIN.B, 1990, DEV BIOL, V198, P245
   Seipel K, 2005, DEV BIOL, V282, P14, DOI 10.1016/j.ydbio.2005.03.032
   SIDDIQUI SS, 1989, J NEUROSCI, V9, P2963
   Sommer Christian, 1992, Scientia Marina, V56, P205
   Spring J, 2002, DEV BIOL, V244, P372, DOI 10.1006/dbio.2002.0616
   THOMAS MB, 1987, INT J INVER REP DEV, V11, P265, DOI 10.1080/01688170.1987.10510286
   THOMAS MB, 1991, MICROSCOPIC ANATOMY, V2, P91
   Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x
   WERNER B, 1984, WIRBELLOSE TIERE, P10
   WIDERSTEN B, 1968, Zoologiska Bidrag fran Uppsala, V37, P139
   Yanze N, 2001, DEV BIOL, V236, P89, DOI 10.1006/dbio.2001.0299
   Yuan D, 2008, DEV GENES EVOL, V218, P525, DOI 10.1007/s00427-008-0254-8
NR 93
TC 26
Z9 26
U1 0
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9967
EI 1096-9861
J9 J COMP NEUROL
JI J. Comp. Neurol.
PD JUL 1
PY 2011
VL 519
IS 10
BP 1931
EP 1951
DI 10.1002/cne.22614
PG 21
WC Neurosciences; Zoology
SC Neurosciences & Neurology; Zoology
GA 770TK
UT WOS:000291111200006
PM 21452245
DA 2021-01-25
ER

PT J
AU Reiterer, V
   Grossniklaus, L
   Tschon, T
   Kasper, CA
   Sorg, I
   Arrieumerlou, C
AF Reiterer, Veronika
   Grossniklaus, Lars
   Tschon, Therese
   Kasper, Christoph Alexander
   Sorg, Isabel
   Arrieumerlou, Cecile
TI Shigella flexneri type III secreted effector OspF reveals new crosstalks
   of proinflammatory signaling pathways during bacterial infection
SO CELLULAR SIGNALLING
LA English
DT Article
DE OspF; Signaling; Crosstalks; NF-kappa B; MAPK; Shigella flexneri
ID NF-KAPPA-B; C-JUN; TRANSCRIPTION FACTOR; INNATE IMMUNITY; KINASE TAK1;
   PHOSPHORYLATION; ACTIVATION; STABILITY; TRANSIENT; RESPONSES
AB Shigella flexneri type III secreted effector OspF harbors a phosphothreonine lyase activity that irreversibly dephosphorylates MAP kinases (MAPKs) p38 and ERK in infected epithelial cells and thereby, dampens innate immunity. Whereas this activity has been well characterized, the impact of OspF on other host signaling pathways that control inflammation was unknown. Here we report that OspF potentiates the activation of the MAPK JNK and the transcription factor NF-kappa B during S. flexneri infection. This unexpected effect of OspF was dependent on the phosphothreonine lyase activity of OspF on p38, and resulted from the disruption of a negative feedback loop regulation between p38 and TGF-beta activated kinase 1 (TAK1), mediated via the phosphorylation of TAK1-binding protein 1. Interestingly, potentiated JNK activation was not associated with enhanced c-Jun signaling as OspF also inhibits c-Jun expression at the transcriptional level. Altogether, our data reveal the impact of OspF on the activation of NF-kappa B, JNK and c-Jun, and demonstrate the existence of a negative feedback loop regulation between p38 and TAK1 during S. flexneri infection. Furthermore, this study validates the use of bacterial effectors as molecular tools to identify the crosstalks that connect important host signaling pathways induced upon bacterial infection. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Arrieumerlou, Cecile] Univ Basel, Focal Area Infect Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Arrieumerlou, C (corresponding author), Univ Basel, Focal Area Infect Biol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM cecile.arrieumerlou@unibas.ch
OI ARRIEUMERLOU, Cecile/0000-0002-6463-2897
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-113561, 310030_1273361]; Werner-Siemens Foundation
FX We thank Prof. A.R. Nebreda (CNIO, Madrid, Spain) for the generous gift
   of wt and p38<SUP>-/-</SUP> MEFs. We thank Dr. Hesso Farhan for comments
   on the manuscript. This work was funded by the Swiss National Science
   Foundation (grants 3100A0-113561 and 310030_1273361 to CA.). C. Kasper
   was supported by the Werner-Siemens Foundation.
CR Ambrosino C, 2003, MOL CELL BIOL, V23, P370, DOI 10.1128/MCB.23.1.370-381.2003
   Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423
   ASHIDA H, 2010, CURR OPIN MICROBIOL
   Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006
   Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5
   Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552
   Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714
   Correia JD, 2007, CELL DEATH DIFFER, V14, P830, DOI 10.1038/sj.cdd.4402070
   Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295
   Faherty CS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-272
   Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008
   Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155
   Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677
   Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962
   Hazzalin CA, 1996, CURR BIOL, V6, P1028, DOI 10.1016/S0960-9822(02)00649-8
   Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033
   Kasper CA, 2010, IMMUNITY, V33, P804, DOI 10.1016/j.immuni.2010.10.015
   Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102
   Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006
   Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692
   Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x
   Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062
   Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457
   Le Bourhis L, 2007, MICROBES INFECT, V9, P629, DOI 10.1016/j.micinf.2007.01.014
   Lee J, 2000, J LEUKOCYTE BIOL, V68, P909
   Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960
   MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9
   Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336
   Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400
   Nembrini C, 2009, J BIOL CHEM, V284, P19183, DOI 10.1074/jbc.M109.006353
   Nemoto S, 1998, MOL CELL BIOL, V18, P3518, DOI 10.1128/MCB.18.6.3518
   Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876
   Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898
   Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255
   Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07
   Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200
   Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018
   Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597
   YASUMOTO K, 1992, J BIOL CHEM, V267, P22506
NR 41
TC 26
Z9 27
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0898-6568
EI 1873-3913
J9 CELL SIGNAL
JI Cell. Signal.
PD JUL
PY 2011
VL 23
IS 7
BP 1188
EP 1196
DI 10.1016/j.cellsig.2011.03.006
PG 9
WC Cell Biology
SC Cell Biology
GA 766KH
UT WOS:000290780500015
PM 21402152
DA 2021-01-25
ER

PT J
AU Trajkovski, M
   Hausser, J
   Soutschek, J
   Bhat, B
   Akin, A
   Zavolan, M
   Heim, MH
   Stoffel, M
AF Trajkovski, Mirko
   Hausser, Jean
   Soutschek, Juergen
   Bhat, Bal
   Akin, Akinc
   Zavolan, Mihaela
   Heim, Markus H.
   Stoffel, Markus
TI MicroRNAs 103 and 107 regulate insulin sensitivity
SO NATURE
LA English
DT Article
ID RESISTANCE; ADIPOSE; EXPRESSION; CAVEOLIN; RECEPTOR; MECHANISMS;
   STEATOSIS; HORMONE; OBESITY
AB Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes(1-3). MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism(4,5). However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.
C1 [Trajkovski, Mirko; Hausser, Jean; Heim, Markus H.; Stoffel, Markus] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland.
   [Trajkovski, Mirko; Stoffel, Markus] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum Basel, CH-4056 Basel, Switzerland.
   [Soutschek, Juergen; Bhat, Bal] Regulus Therapeut Inc, San Diego, CA 92121 USA.
   [Akin, Akinc] Alnylam Pharmaceut, Cambridge, MA 02142 USA.
   [Heim, Markus H.] Univ Basel Hosp, CH-4031 Basel, Switzerland.
RP Stoffel, M (corresponding author), ETH, Competence Ctr Syst Physiol & Metab Dis, Schafmattstr 18,HPM F 39-1, CH-8093 Zurich, Switzerland.
EM stoffel@imsb.biol.ethz.ch
RI Zavolan, Mihaela/S-3888-2016; Heim, Markus/A-7526-2008; Xie,
   Huangming/B-2260-2012
OI Heim, Markus/0000-0002-7523-4894; Hausser, Jean/0000-0002-3321-7199;
   Trajkovski, Mirko/0000-0002-3152-9551; Zavolan,
   Mihaela/0000-0002-8832-2041
FU Juvenile Diabetes Research Foundation InternationalJuvenile Diabetes
   Research Foundation; Swiss National Science Foundation (SNF)Swiss
   National Science Foundation (SNSF); European CommunityEuropean Community
   (EC); Leducq FoundationLeducq Foundation
FX We would like to thank F. Preitner and B. Thorens for the
   hyperinsulinaemic euglycaemic clamp studies. M. T. was supported by a
   fellowship from the Juvenile Diabetes Research Foundation International.
   The work was supported in part by the Swiss National Science Foundation
   (SNF, LiverX), the European Community (SIROCCO, ERC and MetaboloMirs)
   and the Leducq Foundation.
CR Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003
   Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003
   Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200
   Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010
   Hansen LH, 1998, MOL ENDOCRINOL, V12, P1140, DOI 10.1210/me.12.8.1140
   Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2
   Kahn C Ronald, 2003, Exp Diabesity Res, V4, P169, DOI 10.1155/EDR.2003.169
   Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009
   Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200
   Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327
   Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013
   Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022
   Otsu K, 2010, AM J PHYSIOL-CELL PH, V298, pC450, DOI 10.1152/ajpcell.00077.2009
   Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122
   Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009
   ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z
   Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602
   Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   TOZZO E, 1995, AM J PHYSIOL-ENDOC M, V268, pE956
   Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299
   Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
NR 27
TC 629
Z9 670
U1 2
U2 93
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 30
PY 2011
VL 474
IS 7353
BP 649
EP U127
DI 10.1038/nature10112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 785CF
UT WOS:000292204300041
PM 21654750
OA Green Published
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Alexander, J
   Lim, D
   Joughin, BA
   Hegemann, B
   Hutchins, JRA
   Ehrenberger, T
   Ivins, F
   Sessa, F
   Hudecz, O
   Nigg, EA
   Fry, AM
   Musacchio, A
   Stukenberg, PT
   Mechtler, K
   Peters, JM
   Smerdon, SJ
   Yaffe, MB
AF Alexander, Jes
   Lim, Daniel
   Joughin, Brian A.
   Hegemann, Bjoern
   Hutchins, James R. A.
   Ehrenberger, Tobias
   Ivins, Frank
   Sessa, Fabio
   Hudecz, Otto
   Nigg, Erich A.
   Fry, Andrew M.
   Musacchio, Andrea
   Stukenberg, P. Todd
   Mechtler, Karl
   Peters, Jan-Michael
   Smerdon, Stephen J.
   Yaffe, Michael B.
TI Spatial Exclusivity Combined with Positive and Negative Selection of
   Phosphorylation Motifs Is the Basis for Context-Dependent Mitotic
   Signaling
SO SCIENCE SIGNALING
LA English
DT Article
ID POLO-LIKE KINASE-1; AURORA-A KINASE; ANAPHASE-PROMOTING COMPLEX;
   PHASE-SPECIFIC PHOSPHORYLATION; SPINDLE-CHECKPOINT PROTEINS; HUMAN
   CYCLINS B1; CHROMOSOME SEGREGATION; MICROTUBULE DYNAMICS;
   MONOCLONAL-ANTIBODIES; SUBSTRATE-SPECIFICITY
AB The timing and localization of events during mitosis are controlled by the regulated phosphorylation of proteins by the mitotic kinases, which include Aurora A, Aurora B, Nek2 (never in mitosis kinase 2), Plk1 (Polo-like kinase 1), and the cyclin-dependent kinase complex Cdk1/cyclin B. Although mitotic kinases can have overlapping subcellular localizations, each kinase appears to phosphorylate its substrates on distinct sites. To gain insight into the relative importance of local sequence context in kinase selectivity, identify previously unknown substrates of these five mitotic kinases, and explore potential mechanisms for substrate discrimination, we determined the optimal substrate motifs of these major mitotic kinases by positional scanning oriented peptide library screening (PS-OPLS). We verified individual motifs with in vitro peptide kinetic studies and used structural modeling to rationalize the kinase-specific selection of key motif-determining residues at the molecular level. Cross comparisons among the phosphorylation site selectivity motifs of these kinases revealed an evolutionarily conserved mutual exclusion mechanism in which the positively and negatively selected portions of the phosphorylation motifs of mitotic kinases, together with their subcellular localizations, result in proper substrate targeting in a coordinated manner during mitosis.
C1 [Alexander, Jes; Lim, Daniel; Joughin, Brian A.; Ehrenberger, Tobias; Yaffe, Michael B.] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Hegemann, Bjoern; Hutchins, James R. A.; Hudecz, Otto; Mechtler, Karl; Peters, Jan-Michael] Res Inst Mol Pathol, A-1030 Vienna, Austria.
   [Ivins, Frank; Smerdon, Stephen J.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England.
   [Sessa, Fabio; Musacchio, Andrea] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.
   [Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.
   [Yaffe, Michael B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
RP Yaffe, MB (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM myaffe@mit.edu
RI Mechtler, Karl/AAF-2717-2019; Hegemann, Bjorn/A-8761-2015
OI Mechtler, Karl/0000-0002-3392-9946; Hegemann, Bjorn/0000-0002-1009-2952;
   Joughin, Brian/0000-0003-1022-9450; Smerdon,
   Stephen/0000-0001-5688-8465; nigg, erich/0000-0003-4835-5719; Musacchio,
   Andrea/0000-0003-2362-8784; Stukenberg, Todd/0000-0002-6788-2111
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GM-60594, GM-68762, ES-015339,
   CA-112967]; Ludwig Institute for Cancer Research; European
   CommissionEuropean CommissionEuropean Commission Joint Research Centre
   [LSHG-CT-2004-503464]; Canadian Institutes of Health ResearchCanadian
   Institutes of Health Research (CIHR); Tobacco Research Foundation of
   Virginia; Medical Research CouncilMedical Research Council UK (MRC)
   [MC_U117584228] Funding Source: researchfish; NATIONAL CANCER
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967, U54CA112967, U54CA112967, U54CA112967,
   U54CA112967, U54CA112967] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Environmental Health Sciences (NIEHS)
   [R01ES015339, R01ES015339, R01ES015339, R01ES015339, R01ES015339,
   R01ES015339, R01ES015339, R01ES015339, R01ES015339, R01ES015339] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, R01GM060594,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, R01GM060594,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, R01GM060594, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, R01GM060594, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   R01GM060594, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   R01GM060594, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, R01GM060594, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, R01GM060594,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, R01GM060594, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762] Funding
   Source: NIH RePORTER
FX This work was supported by NIH grants GM-60594, GM-68762, ES-015339, and
   CA-112967 to M.B.Y.; a Ludwig Institute for Cancer Research Graduate
   Fellowship to J.A.; the European Commission as part of the Sixth
   Framework Programme Integrated Project grant "MitoCheck"
   (LSHG-CT-2004-503464) to B. H., J.R.A.H., and J.-M.P.; Jane Coffin
   Childs Fund, Canadian Institutes of Health Research to D. L.; and the
   Tobacco Research Foundation of Virginia to P.T.S.
CR Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026
   ALBERTS B, 2002, MOL BIOL CELL, P1027
   Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2
   Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166
   Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200
   Bentley AM, 2007, MOL BIOL CELL, V18, P4847, DOI 10.1091/mbc.E06-06-0539
   BERETTA L, 1993, J BIOL CHEM, V268, P20076
   Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200
   Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105
   Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794
   Bregman DB, 2000, FRONT BIOSCI, V5, pD244, DOI 10.2741/Bregman
   Brown NR, 1999, NAT CELL BIOL, V1, P438
   Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245
   Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039
   Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X
   Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200
   Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002
   Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339
   DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408
   Draviam VM, 2001, J CELL BIOL, V152, P945, DOI 10.1083/jcb.152.5.945
   Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108
   Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079
   Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871
   Ferrari G, 2003, J BIOL CHEM, V278, P37761, DOI 10.1074/jbc.M304462200
   Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343
   Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563
   Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470
   Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101
   GOSS VL, 1994, J BIOL CHEM, V269, P19074
   Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x
   Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598
   Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069
   HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y
   HIGASHI H, 1995, BIOCHEM BIOPH RES CO, V216, P520, DOI 10.1006/bbrc.1995.2653
   Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240
   Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867
   Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769
   Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200
   Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348
   Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708
   Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918
   JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x
   Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065
   Kawajiri A, 2003, MOL BIOL CELL, V14, P1489, DOI 10.1091/mbc.E02-09-0612
   Keryer G, 2003, MOL BIOL CELL, V14, P2436, DOI 10.1091/mbc.E02-09-0614
   Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x
   Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011
   Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057
   Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714
   Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4
   Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627
   Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155
   LAMB NJC, 1990, CELL, V60, P151, DOI 10.1016/0092-8674(90)90725-T
   Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701
   Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530
   Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046
   Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200
   Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052
   Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200
   Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7
   Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683
   Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185
   Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762
   Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200
   Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200
   Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3
   Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06
   Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487
   Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101
   Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200
   Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009
   NICHOLLS A, 1993, BIOPHYS J, V64, pA166
   Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096
   Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952
   Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754
   Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082
   OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849
   Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P
   Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070
   Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006
   Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676
   Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199
   Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240
   Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200
   Roghi C, 1998, J CELL SCI, V111, P557
   Sakai H, 2002, J BIOL CHEM, V277, P48714, DOI 10.1074/jbc.M208461200
   Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049
   Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457
   Satinover DL, 2004, P NATL ACAD SCI USA, V101, P8625, DOI 10.1073/pnas.0402966101
   Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104
   Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425
   Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031
   Sillibourne JE, 2002, J MOL BIOL, V322, P785, DOI 10.1016/S0022-2836(02)00857-4
   Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432
   SUNKEL CE, 1988, J CELL SCI, V89, P25
   Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x
   Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069
   Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203
   Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077
   van Leuken R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005282
   van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617
   van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200
   WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U
   Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102
   Wong OK, 2005, J CELL BIOL, V170, P709, DOI 10.1083/jcb.200502163
   Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200
   Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322
   Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737
   Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048
   Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200
   Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002
   Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200
   Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005
   Zarkowska T, 1997, ONCOGENE, V14, P249, DOI 10.1038/sj.onc.1200824
   Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125
   Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200
   Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747
   ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9
   Zhu GZ, 2005, J BIOL CHEM, V280, P10743, DOI 10.1074/jbc.M413159200
NR 125
TC 113
Z9 113
U1 0
U2 9
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD JUN 28
PY 2011
VL 4
IS 179
AR ra42
DI 10.1126/scisignal.2001796
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 784FM
UT WOS:000292141300004
PM 21712545
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Plasilova, M
   Chattopadhyay, C
   Ghosh, A
   Wenzel, F
   Demougin, P
   Noppen, C
   Schaub, N
   Szinnai, G
   Terracciano, L
   Heinimann, K
AF Plasilova, Martina
   Chattopadhyay, Chandon
   Ghosh, Apurba
   Wenzel, Friedel
   Demougin, Philippe
   Noppen, Christoph
   Schaub, Nathalie
   Szinnai, Gabor
   Terracciano, Luigi
   Heinimann, Karl
TI Discordant Gene Expression Signatures and Related Phenotypic Differences
   in Lamin A- and A/C-Related Hutchinson-Gilford Progeria Syndrome (HGPS)
SO PLOS ONE
LA English
DT Article
ID MEMBRANE GLYCOPROTEIN PC-1; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE;
   IDIOPATHIC HYPERPHOSPHATASIA; INTERMEDIATE-FILAMENTS; DIABETES-MELLITUS;
   NUCLEAR LAMINS; BETA-CELL; A-TYPE; OSTEOPROTEGERIN
AB Hutchinson-Gilford progeria syndrome (HGPS) is a genetic disorder displaying features reminiscent of premature senescence caused by germline mutations in the LMNA gene encoding lamin A and C, essential components of the nuclear lamina. By studying a family with homozygous LMNA mutation (K542N), we showed that HGPS can also be caused by mutations affecting both isoforms, lamin A and C. Here, we aimed to elucidate the molecular mechanisms underlying the pathogenesis in both, lamin A- (sporadic) and lamin A and C-related (hereditary) HGPS. For this, we performed detailed molecular studies on primary fibroblasts of hetero- and homozygous LMNA K542N mutation carriers, accompanied with clinical examinations related to the molecular findings. By assessing global gene expression we found substantial overlap in altered transcription profiles (13.7%; 90/657) in sporadic and hereditary HGPS, with 83.3% (75/90) concordant and 16.7% (15/90) discordant transcriptional changes. Among the concordant ones we observed down-regulation of TWIST2, whose inactivation in mice and humans leads to loss of subcutaneous fat and dermal appendages, and loss of expression in dermal fibroblasts and periadnexial cells from a LMNA K542N/K542N patient further confirming its pivotal role in skin development. Among the discordant transcriptional profiles we identified two key mediators of vascular calcification and bone metabolism, ENPP1 and OPG, which offer a molecular explanation for the major phenotypic differences in vascular and bone disease in sporadic and hereditary HGPS. Finally, this study correlates reduced TWIST2 and OPG expression with increased osteocalcin levels, thereby linking altered bone remodeling to energy homeostasis in hereditary HGPS.
C1 [Plasilova, Martina; Wenzel, Friedel; Schaub, Nathalie; Heinimann, Karl] Univ Basel, Dept Biomed, Res Grp Human Genet, Basel, Switzerland.
   [Plasilova, Martina; Wenzel, Friedel; Schaub, Nathalie; Heinimann, Karl] Univ Childrens Hosp, Div Med Genet, Basel, Switzerland.
   [Chattopadhyay, Chandon; Ghosh, Apurba] Inst Child Hlth, Kolkata, India.
   [Chattopadhyay, Chandon] SB Devi Char Home, Kolkata, India.
   [Demougin, Philippe] Univ Basel, Life Sci Training Facil, Basel, Switzerland.
   [Demougin, Philippe] Univ Basel, Biozentrum, Div Mol Psychol, Basel, Switzerland.
   [Demougin, Philippe] Univ Basel, Pharmazentrum, Basel, Switzerland.
   [Noppen, Christoph] Viollier AG, Basel, Switzerland.
   [Szinnai, Gabor] Univ Childrens Hosp Basel, Div Pediat Endocrinol Diabetol, Basel, Switzerland.
   [Terracciano, Luigi] Univ Basel, Inst Pathol, Basel, Switzerland.
RP Plasilova, M (corresponding author), Univ Basel, Dept Biomed, Res Grp Human Genet, Basel, Switzerland.
EM martina.plasilova@unibas.ch; karl.heinimann@unibas.ch
OI Szinnai, Gabor/0000-0003-0559-2597
FU Novartis FoundationNovartis [06B33]; University Children's Hospital of
   Basel
FX This work was supported by the Novartis Foundation (Grant No. 06B33) to
   M.P. and K.H., and in part by the grant (Intramurale
   Forschungsfoerderung) from the University Children's Hospital of Basel
   to M.P. and K.H. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR BAKER PB, 1981, ARCH PATHOL LAB MED, V105, P384
   Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9
   Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138
   Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3
   Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102
   CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z
   Chong B, 2003, J BONE MINER RES, V18, P2095, DOI 10.1359/jbmr.2003.18.12.2095
   Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6
   Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2
   Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x
   Cundy T, 2002, HUM MOL GENET, V11, P2119, DOI 10.1093/hmg/11.18.2119
   Cundy T, 2005, NEW ENGL J MED, V353, P918, DOI 10.1056/NEJMoa050893
   De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125
   Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708
   Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629
   Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   FREIDENBERG GR, 1992, AM J DIS CHILD, V146, P93, DOI 10.1001/archpedi.1992.02160130095028
   Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002
   Gastaldelli A, 2010, DIGEST LIVER DIS, V42, P310, DOI 10.1016/j.dld.2010.01.013
   Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101
   Golledge J, 2004, STROKE, V35, P1636, DOI 10.1161/01.STR.0000129790.00318.a3
   Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214
   Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045
   Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440
   Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994
   Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455
   Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726
   Lang C, 2003, EUR J CELL BIOL, V82, P143, DOI 10.1078/0171-9335-00305
   Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010
   Liang LL, 2009, ACTA PAEDIATR, V98, P1365, DOI 10.1111/j.1651-2227.2009.01324.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006
   MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0
   Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13
   Marji J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011132
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004
   Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898
   Minoo P, 2009, HUM PATHOL
   Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030
   Nicodemus KK, 2001, DIABETES CARE, V24, P1192, DOI 10.2337/diacare.24.7.1192
   Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908
   Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x
   OLIVE M, 2010, ARTERIOSCLER THROMB
   Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27
   Pereira S, 2008, MECH AGEING DEV, V129, P449, DOI 10.1016/j.mad.2008.04.003
   Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156
   Piche ME, 2004, DIABETES CARE, V27, P2470, DOI 10.2337/diacare.27.10.2470
   Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422
   Plasilova M, 2004, J MED GENET, V41, P609, DOI 10.1136/jmg.2004.019661
   POLLOCK NK, 2010, J BONE MINER RES
   Psarros M, 2005, NUCLEIC ACIDS RES, V33, pW638, DOI 10.1093/nar/gki490
   ROBER RA, 1990, J CELL SCI, V95, P587
   ROBER RA, 1989, DEVELOPMENT, V105, P365
   Rosen CJ, 2010, CELL, V142, P198, DOI 10.1016/j.cell.2010.07.001
   ROSENBLOOM AL, 1983, J PEDIATR-US, V102, P400, DOI 10.1016/S0022-3476(83)80660-X
   Rusinol AE, 2006, J CELL SCI, V119, P3265, DOI 10.1242/jcs.03156
   Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221
   Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204
   Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807
   Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3
   Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647
   Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122
   Terracciano LM, 2000, AM J CLIN PATHOL, V114, P754
   Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009
   Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033
   Verstraeten VLRM, 2006, HUM MOL GENET, V15, P2509, DOI 10.1093/hmg/ddl172
   Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wang J, 2006, J HUM GENET, V51, P934, DOI 10.1007/s10038-006-0042-0
   Wang Y, 2008, HUM MOL GENET, V17, P2357, DOI 10.1093/hmg/ddn136
   Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028
   Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211
NR 86
TC 10
Z9 10
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 27
PY 2011
VL 6
IS 6
AR e21433
DI 10.1371/journal.pone.0021433
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 783OD
UT WOS:000292092600041
PM 21738662
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Mittal, N
   Scherrer, T
   Gerber, AP
   Janga, SC
AF Mittal, Nitish
   Scherrer, Tanja
   Gerber, Andre P.
   Janga, Sarath Chandra
TI Interplay between Posttranscriptional and Posttranslational Interactions
   of RNA-Binding Proteins
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE RNA-binding proteins; posttranscriptional networks; regulation; network
   interplay; protein interactions
ID GENOME-WIDE ANALYSIS; GENE-EXPRESSION; NETWORK MOTIFS; GLOBAL ANALYSIS;
   TRANSCRIPTIONAL REGULATION; REGULATORY NETWORKS; ESCHERICHIA-COLI; SR
   PROTEINS; NRD1; IDENTIFICATION
AB RNA-binding proteins (RBPs) play important roles in the posttranscriptional control of gene expression. However, our understanding of how RBPs interact with each other at different regulatory levels to coordinate the RNA metabolism of the cell is rather limited. Here, we construct the posttranscriptional regulatory network among 69 experimentally studied RBPs in yeast to show that more than one-third of the RBPs autoregulate their expression at the posttranscriptional level and demonstrate that autoregulatory RBPs show reduced protein noise with a tendency to encode for hubs in this network. We note that in- and outdegrees in the posttranscriptional RBP-RBP regulatory network exhibit gaussian and scale-free distributions, respectively. This network was also densely interconnected with extensive cross-talk between RBPs belonging to different posttranscriptional steps, regulating varying numbers of cellular RNA targets. We show that feed-forward loops and superposed feed-forward/feedback loops are the most significant three-node subgraphs in this network. Analysis of the corresponding protein-protein interaction (posttranslational) network revealed that it is more modular than the posttranscriptional regulatory network. There is significant overlap between the regulatory and protein-protein interaction networks, with RBPs that potentially control each other at the posttranscriptional level tending to physically interact and being part of the same ribonucleoprotein (RNP) complex. Our observations put forward a model wherein RBPs could be classified into those that can stably interact with a limited number of protein partners, forming stable RNP complexes, and others that form transient hubs, having the ability to interact with multiple RBPs forming many RNPs in the cell. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Janga, Sarath Chandra] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
   [Scherrer, Tanja; Gerber, Andre P.] ETH, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.
   [Mittal, Nitish] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Janga, SC (corresponding author), Univ Illinois, Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA.
EM sarath@igb.uiuc.edu
OI Janga, Sarath Chandra/0000-0001-7351-6268
FU UNIBAS; Institute for Genomic Biology at the University of Illinois at
   Urbana-Champaign; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [3100A0-112235]; Bonizzi-Theler Foundation
FX This work was supported by UNIBAS (to N.M.) and a Fellowship from the
   Institute for Genomic Biology at the University of Illinois at
   Urbana-Champaign (to S.C.J.). This work was supported by grants from the
   Swiss National Science Foundation (3100A0-112235) and the Bonizzi-Theler
   Foundation (to A.P.G.).
CR Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102
   Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38
   ANDERSON JT, 1993, MOL CELL BIOL, V13, P6102, DOI 10.1128/MCB.13.10.6102
   Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694
   Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100
   Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103
   Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249
   Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004
   Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11
   Collins LJ, 2009, J HERED, V100, P597, DOI 10.1093/jhered/esp064
   Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200
   Entelis N, 2006, GENE DEV, V20, P1609, DOI 10.1101/gad.385706
   Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532
   Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004
   Gross T, 1998, NUCLEIC ACIDS RES, V26, P505, DOI 10.1093/nar/26.2.505
   Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9
   Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873
   Gutierrez-Rios RM, 2003, GENOME RES, V13, P2435, DOI 10.1101/gr.1387003
   Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6
   Hobor F, 2011, J BIOL CHEM, V286, P3645, DOI 10.1074/jbc.M110.158774
   Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Hunt ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011517
   Janga SC, 2007, RES MICROBIOL, V158, P787, DOI 10.1016/j.resmic.2007.09.001
   Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615
   Kanitz A, 2010, WIRES SYST BIOL MED, V2, P245, DOI 10.1002/wsbm.55
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2
   Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125
   Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670
   Lang BD, 2001, NUCLEIC ACIDS RES, V29, P2567, DOI 10.1093/nar/29.12.2567
   Lee M.-H., 2006, C ELEGANS RES COMMUN
   Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090
   Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004
   Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4
   Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818
   Martinez-Antonio A, 2008, J MOL BIOL, V381, P238, DOI 10.1016/j.jmb.2008.05.054
   Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005
   Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824
   Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8
   Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106
   Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44
   Musunuru K, 2003, TRENDS CARDIOVAS MED, V13, P188, DOI 10.1016/S1050-1738(03)00075-6
   Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785
   Pascale A, 2008, CELL MOL LIFE SCI, V65, P128, DOI 10.1007/s00018-007-7017-y
   Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050
   Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891
   Ratti A, 2006, J CELL SCI, V119, P1442, DOI 10.1242/jcs.02852
   Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112
   Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374
   Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404
   Scherrer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r3
   Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884
   Sette C, 2010, ADV EXP MED BIOL, V693, P54
   Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881
   Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993
   Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090
   Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2
   Thomsen S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r93
   Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671
   Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028
   Wang E, 2005, TRENDS GENET, V21, P492, DOI 10.1016/j.tig.2005.06.013
   Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799
   Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5
   Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016
NR 69
TC 27
Z9 28
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUN 10
PY 2011
VL 409
IS 3
BP 466
EP 479
DI 10.1016/j.jmb.2011.03.064
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 774FS
UT WOS:000291371200014
PM 21501624
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Stelter, C
   Kappeli, R
   Konig, C
   Krah, A
   Hardt, WD
   Stecher, B
   Bumann, D
AF Stelter, Christian
   Kaeppeli, Rina
   Koenig, Claudia
   Krah, Alexander
   Hardt, Wolf-Dietrich
   Stecher, Baerbel
   Bumann, Dirk
TI Salmonella-Induced Mucosal Lectin RegIII beta Kills Competing Gut
   Microbiota
SO PLOS ONE
LA English
DT Article
ID ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; PEPTIDOGLYCAN
   RECOGNITION; INTESTINAL COLONIZATION; PATHOGENICITY ISLAND-1;
   DIGESTIVE-TRACT; GENE-EXPRESSION; MOUSE MODEL; MICE; LACTOBACILLUS
AB Intestinal inflammation induces alterations of the gut microbiota and promotes overgrowth of the enteric pathogen Salmonella enterica by largely unknown mechanisms. Here, we identified a host factor involved in this process. Specifically, the C-type lectin RegIII beta is strongly upregulated during mucosal infection and released into the gut lumen. In vitro, RegIII beta kills diverse commensal gut bacteria but not Salmonella enterica subspecies I serovar Typhimurium (S. Typhimurium). Protection of the pathogen was attributable to its specific cell envelope structure. Co-infection experiments with an avirulent S. Typhimurium mutant and a RegIII beta-sensitive commensal E. coli strain demonstrated that feeding of RegIII beta was sufficient for suppressing commensals in the absence of all other changes inflicted by mucosal disease. These data suggest that RegIII beta production by the host can promote S. Typhimurium infection by eliminating inhibitory gut microbiota.
C1 [Stelter, Christian; Bumann, Dirk] Hannover Med Sch, Inst Immunol, Jr Grp, D-3000 Hannover, Germany.
   [Kaeppeli, Rina; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.
   [Koenig, Claudia; Krah, Alexander; Bumann, Dirk] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany.
   [Stecher, Baerbel] Max von Pettenkofer Inst, Arbeitsgrp Mikrobiota & Infektionen, Munich, Germany.
   [Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland.
RP Stelter, C (corresponding author), Hannover Med Sch, Inst Immunol, Jr Grp, D-3000 Hannover, Germany.
EM Dirk.Bumann@unibas.ch
RI Stecher, Barbel/A-2911-2015; Stecher, Barbel/B-9940-2019
OI Stecher, Barbel/0000-0002-7445-5193; Hardt,
   Wolf-Dietrich/0000-0002-9892-6420
FU DFGGerman Research Foundation (DFG) [SFB621-A9]; ETH Zurich Research
   foundationETH Zurich [ETH-08 08-3]
FX This work was supported by DFG grants SFB621-A9 (DB), and the ETH Zurich
   Research foundation (ETH-08 08-3; WDH). The funders had no role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8
   Altmeyer M, 2010, INFECT IMMUN, V78, P3420, DOI 10.1128/IAI.00211-10
   Ashbolt NJ, 2004, TOXICOLOGY, V198, P229, DOI 10.1016/j.tox.2004.01.030
   Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07
   Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071
   BOHNHOFF M, 1964, J EXP MED, V120, P805, DOI 10.1084/jem.120.5.805
   Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563
   Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012
   Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014
   Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119
   Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005
   COLLINS FM, 1978, INFECT IMMUN, V21, P41, DOI 10.1128/IAI.21.1.41-47.1978
   Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005
   Cursino L, 2006, J APPL MICROBIOL, V100, P821, DOI 10.1111/j.1365-2672.2006.02834.x
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Dessein R, 2009, GUT, V58, P771, DOI 10.1136/gut.2008.168443
   ENDT K, 2010, PLOS PATHOG, P6
   Filho-Lima JVM, 2000, J APPL MICROBIOL, V88, P365, DOI 10.1046/j.1365-2672.2000.00973.x
   Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103
   GORDON MA, 2009, NONTYPHOID SALMONE S, V3, P2
   Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06
   Hantke K, 2003, P NATL ACAD SCI USA, V100, P3677, DOI 10.1073/pnas.0737682100
   Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008
   Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675
   Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004
   Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788
   HEMME D, 1980, ANN INST PASTEUR MIC, VA131, P297
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   HONE D, 1987, J INFECT DIS, V156, P167, DOI 10.1093/infdis/156.1.167
   Ilg K, 2009, INFECT IMMUN, V77, P2568, DOI 10.1128/IAI.01537-08
   KANDLER O, 1968, J BACTERIOL, V96, P1935, DOI 10.1128/JB.96.6.1935-1939.1968
   KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x
   Keilbaugh SA, 2005, GUT, V54, P623, DOI 10.1136/gut.2004.056028
   Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07
   Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09
   Layton Abigail N., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000373
   Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107
   Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200
   Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010
   Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107
   Millette M, 2008, APPL ENVIRON MICROB, V74, P1997, DOI 10.1128/AEM.02150-07
   Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011
   Rodenburg W, 2007, PHYSIOL GENOMICS, V30, P123, DOI 10.1152/physiolgenomics.00190.2006
   Rodenburg W, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-84
   Sansonetti PJ, 2008, CURR OPIN GASTROEN, V24, P435, DOI 10.1097/MOG.0b013e32830007f7
   SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972
   Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377
   Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08
   Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008
   Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x
   Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244
   Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003
   Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711
   Stoycheva Mariana V, 2006, Folia Med (Plovdiv), V48, P5
   Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02
   Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103
   Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200
   Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103
   Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105
   VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653
   Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799
   Whitfield C, 2003, J ENDOTOXIN RES, V9, P244, DOI 10.1179/096805103225001440
   Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415
NR 65
TC 79
Z9 82
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 9
PY 2011
VL 6
IS 6
AR e20749
DI 10.1371/journal.pone.0020749
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 777JX
UT WOS:000291612900022
PM 21694778
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Hall, MN
AF Hall, M. N.
TI TOR signaling, from yeast to human
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 36th FEBS Congress of the Biochemistry for Tomorrows Medicine
CY JUN 25-30, 2011
CL Torino, ITALY
SP Federat Soc Biochem & Mol Biol
C1 [Hall, M. N.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUN
PY 2011
VL 278
SU 1
SI SI
BP 44
EP 44
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 786UJ
UT WOS:000292333100126
DA 2021-01-25
ER

PT J
AU Schmitz, HP
   Philippsen, P
AF Schmitz, Hans-Peter
   Philippsen, Peter
TI Evolution of multinucleated Ashbya gossypii hyphae from a budding
   yeast-like ancestor
SO FUNGAL BIOLOGY
LA English
DT Article
DE Ashbya gossypii; Hypha; Polarity; Tip growth
ID SACCHAROMYCES-CEREVISIAE GENOME; ASPERGILLUS-NIDULANS; ACTIN
   CYTOSKELETON; CELL POLARITY; KINASE CLA4; RAC-HOMOLOG; G-PROTEINS;
   FORMIN; GROWTH; FUNGUS
AB In the filamentous ascomycete Ashbya gossypii polarity establishment at sites of germ tube and lateral branch emergence depends on homologues of Saccharomyces cerevisiae factors controlling bud site selection and bud emergence. Maintenance of polar growth involves homologues of well-known polarity factors of budding yeast. To achieve the much higher rates of sustained polar surface expansion of hyphae compared to mainly non-polarly growing yeast buds five important alterations had to evolve. Permanent presence of the polarity machinery at a confined area in the rapidly expanding hyphal tip, increased cytoplasmic space with a much enlarged ER surface for generating secretory vesicles, efficient directed transport of secretory vesicles to and accumulation at the tip, increased capacity of the exocytosis system to process these vesicles, and an efficient endocytosis system for membrane and polarity factor recycling adjacent to the zone of exocytosis. Morphological, cell biological, and molecular aspects of this evolution are discussed based on experiments performed within the past 10 y. (C) 2011 The British Mycological Society. Published by Elsevier Ltd. All rights reserved.
C1 [Schmitz, Hans-Peter] Univ Osnabruck, Inst Genet, D-49076 Osnabruck, Germany.
   [Philippsen, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schmitz, HP (corresponding author), Univ Osnabruck, Inst Genet, Barbarastr 11, D-49076 Osnabruck, Germany.
EM Hans-Peter.Schmitz@uos.de
OI Schmitz, Hans-Peter/0000-0001-5449-4593
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-55941.98]; DFGGerman Research Foundation (DFG)
   [Graduiertenkolleg 612]
FX We thank all present and former coworkers of our labs for their
   contributions. We specially thank Michael Kohli, Yasmina Bauer, Philipp
   Knechtle, Riccarda Rischatsch, Jeannine Winckler, Sylvia Voegeli, Kamila
   Wojnowska-Boudier, Lars Molzahn, Deborah Ley, Philippe Laissue,
   Hanspeter Helfer, Michael Kemper, Manuela Lickfeld, Doris Albers and
   Sabrina Wahlisch for providing unpublished data. The reported work has
   been supported by the Swiss National Science Foundation Grants
   31-55941.98 to PP and Grants by DFG, Graduiertenkolleg 612 to HPS.
CR Alberti-Segui C, 2001, J CELL SCI, V114, P975
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029
   Bauer Y, 2004, MOL BIOL CELL, V15, P4622, DOI 10.1091/mbc.E04-02-0104
   BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976
   Brachat S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r45
   Ruiz-Roldan MC, 2010, EUKARYOT CELL, V9, P1216, DOI 10.1128/EC.00040-10
   Chang F, 1999, CURR BIOL, V9, P849, DOI 10.1016/S0960-9822(99)80372-8
   Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975
   COLLINGE AJ, 1974, ARCH MICROBIOL, V99, P353, DOI 10.1007/BF00696249
   Crampin H, 2005, J CELL SCI, V118, P2935, DOI 10.1242/jcs.02414
   Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004
   Delgehyr N, 2008, J CELL SCI, V121, P3803, DOI 10.1242/jcs.036269
   Demay BS, 2009, MOL BIOL CELL, V20, P2311, DOI 10.1091/mbc.E08-12-1169
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118
   Feierbach B, 2004, J CELL BIOL, V165, P697, DOI 10.1083/jcb.200403090
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485
   Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1
   Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200
   Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474
   Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005
   Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565
   Hurtado CAR, 2000, J BACTERIOL, V182, P2376, DOI 10.1128/JB.182.9.2376-2386.2000
   Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745
   Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341
   Karpova TS, 2000, MOL BIOL CELL, V11, P1727, DOI 10.1091/mbc.11.5.1727
   Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08
   Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Knechtle P, 2008, FUNGAL GENET BIOL, V45, P829, DOI 10.1016/j.fgb.2008.03.010
   Knechtle P, 2006, EUKARYOT CELL, V5, P1635, DOI 10.1128/EC.00210-06
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063
   Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05
   LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305
   Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x
   Martin R, 2005, EUKARYOT CELL, V4, P1712, DOI 10.1128/EC.4.10.1712-1724.2005
   MONEY NP, 1990, EXP MYCOL, V14, P416, DOI 10.1016/0147-5975(90)90064-Z
   Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621
   Nern A, 2000, MOL CELL, V5, P853, DOI 10.1016/S1097-2765(00)80325-1
   Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217
   Petersen J, 1998, J CELL SCI, V111, P867
   Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309
   Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296
   Riquelme M, 2004, FUNGAL GENET BIOL, V41, P842, DOI 10.1016/j.fgb.2004.04.006
   Rolke Y, 2008, MOL MICROBIOL, V68, P405, DOI 10.1111/j.1365-2958.2008.06159.x
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   SEGER S, 2011, J CELL SCI IN PRESS
   Sharpless KE, 2002, MOL BIOL CELL, V13, P469, DOI 10.1091/mbc.01-07-0356
   Stahmann KP, 2001, ENVIRON MICROBIOL, V3, P545, DOI 10.1046/j.1462-2920.2001.00225.x
   STEINER S, 1995, GENETICS, V140, P973
   Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464
   Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x
   Vallim MA, 2005, EUKARYOT CELL, V4, P1066, DOI 10.1128/EC.4.6.1066-1078.2005
   Walther A, 2005, CURR GENET, V48, P247, DOI 10.1007/s00294-005-0017-2
   Walther A, 2003, FUNGAL GENET BIOL, V40, P187, DOI 10.1016/j.fgb.2003.08.005
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2003, EMBO REP, V4, P200, DOI 10.1038/sj.embor.embor727
   Wendland J, 2002, FUNGAL GENET BIOL, V37, P81, DOI 10.1016/S1087-1845(02)00034-8
   Wendland J, 2001, GENETICS, V157, P601
   Wendland J, 2000, J CELL SCI, V113, P1611
   Zahner JE, 1996, MOL CELL BIOL, V16, P1857
   Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057
NR 67
TC 21
Z9 21
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1878-6146
EI 1878-6162
J9 FUNGAL BIOL-UK
JI Fungal Biol.
PD JUN
PY 2011
VL 115
IS 6
SI SI
BP 557
EP 568
DI 10.1016/j.funbio.2011.02.015
PG 12
WC Mycology
SC Mycology
GA 789CQ
UT WOS:000292491300010
PM 21640319
DA 2021-01-25
ER

PT J
AU Kemper, M
   Mohlzahn, L
   Lickfeld, M
   Lang, C
   Wahlisch, S
   Schmitz, HP
AF Kemper, Michael
   Mohlzahn, Lars
   Lickfeld, Manuela
   Lang, Claudia
   Waehlisch, Sabrina
   Schmitz, Hans-Peter
TI A Bnr-like formin links actin to the spindle pole body during
   sporulation in the filamentous fungus Ashbya gossypii
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; FORESPORE MEMBRANE;
   PROSPORE MEMBRANE; GENE-EXPRESSION; MEIOTIC SPINDLE; CORE PROTEINS;
   YEAST; TRANSFORMATION; NUCLEATION
AB P>Formin proteins are nucleators of actin filaments and regulators of the microtubule cytoskeleton. As such, they play important roles in the development of yeast and other fungi. We show here that AgBnr2, a homologue of the ScBnr1 formin from the filamentous fungus Ashbya gossypii, localizes to the spindle pole body (SPB), the fungal analogue of the centrosome of metazoans. This protein plays an important role in the development of the typical needle-shaped spores of A. gossypii, as suggested by several findings. First, downregulation of AgBNR2 causes defects in sporangium formation and a decrease in the total spore number. Second, a fusion of AgBNR2 to GFP that is driven by the native AgBNR2 promoter is only visible in sporangia. Third, AgBnr2 interacts with a AgSpo21, a sporulation-specific component of the SPB. Furthermore, we provide evidence that AgBnr2 might nucleate actin cables, which are connected to SPBs during sporulation. Our findings add to our understanding of fungal sporulation, particularly the formation of spores with a complex, elongated morphology, and provide novel insights into formin function.
C1 [Kemper, Michael; Mohlzahn, Lars; Lickfeld, Manuela; Waehlisch, Sabrina; Schmitz, Hans-Peter] Univ Osnabruck, Dept Genet, D-49076 Osnabruck, Germany.
   [Mohlzahn, Lars; Lang, Claudia] Biozentrum Univ Basel, CH-4056 Basel, Switzerland.
RP Schmitz, HP (corresponding author), Univ Osnabruck, Dept Genet, Barbarastr 11, D-49076 Osnabruck, Germany.
EM hans-peter.schmitz@biologie.uni-osnabrueck.de
OI Schmitz, Hans-Peter/0000-0001-5449-4593
CR AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Ang SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013064
   ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911
   Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018
   Bajgier BK, 2001, MOL BIOL CELL, V12, P1611, DOI 10.1091/mbc.12.6.1611
   Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029
   Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761
   Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578
   Coluccio A, 2004, EUKARYOT CELL, V3, P1464, DOI 10.1128/EC.3.6.1464-1475.2004
   Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047
   DAVIDOW LS, 1980, GENETICS, V94, P581
   DEACON J. W., 2006, FUNGAL BIOL
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Dunkler A, 2007, CURR GENET, V52, P1, DOI 10.1007/s00294-007-0134-1
   EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482
   Pablo-Hernando ME, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-55
   GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565
   HOVLAND P, 1989, GENE, V83, P57, DOI 10.1016/0378-1119(89)90403-4
   James P, 1996, GENETICS, V144, P1425
   Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106
   Jasperson SL, 2002, J CELL BIOL, V159, P945, DOI 10.1083/jcb.200208169
   Kaiser Chris, 1994
   Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Knop M, 2000, EMBO J, V19, P3657, DOI 10.1093/emboj/19.14.3657
   Kupelic M., 1997, MOL CELLULAR BIOL YE, P889
   Lang C, 2010, MOL BIOL CELL, V21, P753, DOI 10.1091/mbc.E09-07-0555
   Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063
   Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880
   Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094
   Mathieson EM, 2010, MOL BIOL CELL, V21, P3693, DOI 10.1091/mbc.E10-07-0563
   Mathieson EM, 2010, J CELL SCI, V123, P2481, DOI 10.1242/jcs.062794
   Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200
   Muller EGD, 2005, MOL BIOL CELL, V16, P3341, DOI 10.1091/mbc.E05-03-0214
   Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955
   Neiman AM, 2000, GENETICS, V155, P1643
   Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005
   Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29
   Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002
   Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217
   Prillinger H, 1997, YEAST, V13, P945, DOI 10.1002/(SICI)1097-0061(199708)13:10<945::AID-YEA150>3.0.CO;2-5
   Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309
   Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296
   Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604
   Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834
   Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schlosser T, 2007, APPL MICROBIOL BIOT, V76, P569, DOI 10.1007/s00253-007-1075-9
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130
   Shimoda C, 2004, J CELL SCI, V117, P389, DOI 10.1242/jcs.00980
   Stahmann KP, 2001, ENVIRON MICROBIOL, V3, P545, DOI 10.1046/j.1462-2920.2001.00225.x
   TANAKA K, 1982, J CELL SCI, V56, P263
   Taxis C, 2006, TRAFFIC, V7, P1628, DOI 10.1111/j.1600-0854.2006.00496.x
   THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233
   Wanat JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000188
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z
   Zizlsperger N, 2008, BIOCHEMISTRY-US, V47, P11858, DOI 10.1021/bi801378z
NR 64
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JUN
PY 2011
VL 80
IS 5
BP 1276
EP 1295
DI 10.1111/j.1365-2958.2011.07644.x
PG 20
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 768UD
UT WOS:000290963000011
PM 21615551
OA Bronze
DA 2021-01-25
ER

PT J
AU Plodinec, M
   Loparic, M
   Suetterlin, R
   Herrmann, H
   Aebi, U
   Schoenenberger, CA
AF Plodinec, Marija
   Loparic, Marko
   Suetterlin, Rosmarie
   Herrmann, Harald
   Aebi, Ueli
   Schoenenberger, Cora-Ann
TI The nanomechanical properties of rat fibroblasts are modulated by
   interfering with the vimentin intermediate filament system
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Cytoskeleton; Intermediate filaments; Vimentin; Atomic force microscopy;
   Nanomechanics; Stiffness; Dynamic elastic modulus
ID VISCOELASTIC PROPERTIES; ARTICULAR-CARTILAGE; ELASTIC-MODULUS; DESMIN;
   MUTATIONS; INDENTATION; MECHANICS; PROTEINS; MYOPATHY; DISEASE
AB The contribution of the intermediate filament (IF) network to the mechanical response of cells has so far received little attention, possibly because the assembly and regulation of IFs are not as well understood as that of the actin cytoskeleton or of microtubules. The mechanical role of IFs has been mostly inferred from measurements performed on individual filaments or gels in vitro. In this study we employ atomic force microscopy (AFM) to examine the contribution of vimentin IFs to the nanomechanical properties of living cells under native conditions. To specifically target and modulate the vimentin network, Rat-2 fibroblasts were transfected with GFP-desmin variants. Cells expressing desmin variants were identified by the fluorescence microscopy extension of the AFM instrument. This allowed us to directly compare the nanomechanical response of transfected and untransfected cells at high spatial resolution by means of AFM. Depending on the variant desmin, transfectants were either softer or stiffer than untransfected fibroblasts. Expression of the non-filament forming GFP-DesL345P mutant led to a collapse of the endogenous vimentin network in the perinuclear region that was accompanied by localized stiffening. Correlative confocal microscopy indicates that the expression of desmin variants specifically targets the endogenous vimentin IF network without major rearrangements of other cytoskeletal components. By measuring functional changes caused by IF rearrangements in intact cells, we show that IFs play a crucial role in mechanical behavior not only at large deformations but also in the nanomechanical response of individual cells. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Plodinec, Marija; Loparic, Marko; Suetterlin, Rosmarie; Aebi, Ueli; Schoenenberger, Cora-Ann] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Herrmann, Harald] German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
RP Schoenenberger, CA (corresponding author), Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM cora-ann.schoenenberger@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); M.E. Muller Foundation of Switzerland; Canton Basel-Stadt;
   German Research Foundation (DFG)German Research Foundation (DFG) [HE
   1853, BA 2186/3-1]
FX This work was supported by an NCCR program grant on "Nanoscale Science"
   awarded by the Swiss National Science Foundation to CAS, the M.E. Muller
   Foundation of Switzerland and the Canton Basel-Stadt. H.H. was supported
   by the German Research Foundation (DFG; HE 1853 and BA 2186/3-1). We
   gratefully acknowledge Lydia Lussi for the drawing in Fig. 6, Sandra
   Mitrovic for advice on transfections. We are thankful to Martin Stolz,
   Janne Hyotyla and Roderick Lim for their help with data analysis.
CR Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   Bar H, 2006, EXP CELL RES, V312, P1554, DOI 10.1016/j.yexcr.2006.01.021
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   Bar H, 2007, HUM MUTAT, V28, P374, DOI 10.1002/humu.20459
   Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640
   Carlsson L, 2002, ACTA NEUROPATHOL, V104, P493, DOI 10.1007/s00401-002-0583-z
   Colakoglu G, 2009, J CELL BIOL, V185, P769, DOI 10.1083/jcb.200809166
   Coulombe PA, 1998, MOL BIOL CELL, V9, p164A
   Eckes B, 1998, J CELL SCI, V111, P1897
   Eckes B, 1998, J INVEST DERMATOL, V110, P592
   Evans RM, 1998, EXP CELL RES, V245, P69, DOI 10.1006/excr.1998.4250
   Faigle W, 2000, MOL BIOL CELL, V11, P3485, DOI 10.1091/mbc.11.10.3485
   GARD DL, 1980, CELL, V19, P263, DOI 10.1016/0092-8674(80)90408-0
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086
   Kreplak L, 2009, J MOL BIOL, V385, P1043, DOI 10.1016/j.jmb.2008.10.095
   Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826
   Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514
   Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797
   Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P430, DOI 10.1115/1.2720924
   Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013
   Ofek G, 2009, BIOPHYS J, V97, P1873, DOI 10.1016/j.bpj.2009.07.050
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Peeters EAG, 2004, ANN BIOMED ENG, V32, P1443, DOI 10.1114/B:ABME.0000042231.59230.72
   Pelling AE, 2007, NANOMED-NANOTECHNOL, V3, P43, DOI 10.1016/j.nano.2006.11.006
   Prasad S, 1999, INT J ONCOL, V14, P563
   Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101
   Radmacher M, 2007, METHOD CELL BIOL, V83, P347, DOI 10.1016/S0091-679X(07)83015-9
   Roduit C, 2009, BIOPHYS J, V97, P674, DOI 10.1016/j.bpj.2009.05.010
   Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8
   SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439
   SAGER PR, 1989, TOXICOL APPL PHARM, V97, P141, DOI 10.1016/0041-008X(89)90063-X
   Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206
   Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005
   Sjoberg G, 1999, HUM MOL GENET, V8, P2191, DOI 10.1093/hmg/8.12.2191
   Steinbock FA, 2000, J CELL SCI, V113, P483
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188
   Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004
NR 44
TC 42
Z9 43
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUN
PY 2011
VL 174
IS 3
BP 476
EP 484
DI 10.1016/j.jsb.2011.03.011
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 766ZY
UT WOS:000290826300007
PM 21426942
DA 2021-01-25
ER

PT J
AU Hyotyla, JT
   Deng, J
   Lim, RYH
AF Hyotyla, Janne T.
   Deng, Jie
   Lim, Roderick Y. H.
TI Synthetic Protein Targeting by the Intrinsic Biorecognition
   Functionality of Poly(ethylene glycol) Using PEG Antibodies as Biohybrid
   Molecular Adaptors
SO ACS NANO
LA English
DT Article
DE biointerface; biomimetics; biomaterials; biosensing; protein microarray;
   PEGylation; polymer brush; antibody; protein targeting; nuclear pore
   complex
ID POLYMER BRUSHES; SURFACES; BIOMATERIALS; MEMBRANES
AB Biointerfaces capable of biological recognition and specificity are sought after for conferring bioinspired functionality onto synthetic biomaterials systems. This is important for biosensing, bioseparations, and biomedical materials. Here, we demonstrate how intrinsic polymer protein interactions between highly localized polyethylene glycol (PEG) brushes and PEG-binding antibodies can be used for sorting specific biomolecules from complex bulk biological fluids to synthetic nanoscale targets. A principal feature lies with the antifouling property of PEG that prevents unspecific binding. Exclusive access is provided by anti-PEG, which acts as a biohybrid molecular adaptor that sifts out and targets specific IgG "cargo" from solution to the PEG. The PEG can be reversibly washed and targeted in blood serum, which suggests potential benefits in technological applications. Moreover, anti-PEG binding triggers a stimuli-responsive conformational collapse in the PEG brush, thereby imparting an intrinsic "smart" biorecognition functionality to the PEG that can considerably impact its use as an antifouling biomaterial.
C1 [Hyotyla, Janne T.; Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Hyotyla, Janne T.; Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
   [Deng, Jie] A STAR Agency Sci Technol & Res, Inst Mat Res & Engn, Singapore 117602, Singapore.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
RI Hyotyla, Janne/C-5640-2008
OI Hyotyla, Janne/0000-0002-4323-5817; Lim, Roderick/0000-0001-5015-6087
FU National Centre of Competence in Research "Nanoscale Science"
   (NCCR-Nano); Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Canton Basel-Stadt
FX We especially thank S. R. Roffler for the kind gift of E11. Thanks also
   to L. Kreplak, P. Rigler, U. Silvan, and E. K. Sinner for helpful
   comments and suggestions. Further acknowledgements go to R. Schoch for
   the SPR measurements and the SERC Nanofabrication and Characterisation
   Facility (SNFC) at the Institute of Materials Research and Engineering
   (Singapore) for the usage of equipment and facilities. This work is
   supported by the National Centre of Competence in Research "Nanoscale
   Science" (NCCR-Nano), the Swiss National Science Foundation, and the
   Canton Basel-Stadt.
CR Asatekin A, 2007, J MEMBRANE SCI, V298, P136, DOI 10.1016/j.memsci.2007.04.011
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Blobel G, 2000, CHEMBIOCHEM, V1, P87
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761
   Cheng TL, 2005, BIOCONJUGATE CHEM, V16, P1225, DOI 10.1021/bc050133f
   Cheng TL, 1999, BIOCONJUGATE CHEM, V10, P520, DOI 10.1021/bc980143z
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Falconnet D, 2004, NANO LETT, V4, P1909, DOI 10.1021/nl0489438
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Granick S, 2003, J POLYM SCI POL PHYS, V41, P2755, DOI 10.1002/polb.10669
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Halperin A, 2009, LANGMUIR, V25, P11621, DOI 10.1021/la9008569
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2009, ACS NANO, V3, P2911, DOI 10.1021/nn900152m
   Mitchell P, 2002, NAT BIOTECHNOL, V20, P225, DOI 10.1038/nbt0302-225
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
   Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Ruiz-Taylor LA, 2001, P NATL ACAD SCI USA, V98, P852, DOI 10.1073/pnas.98.3.852
   Su YC, 2010, BIOCONJUGATE CHEM, V21, P1264, DOI 10.1021/bc100067t
   Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204
   Tompa P., 2010, STRUCTURE FUNCTION I
   Tugulu S, 2005, BIOMACROMOLECULES, V6, P1602, DOI 10.1021/bm050016n
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   Wu P, 2008, J BIOMAT SCI-POLYM E, V19, P725, DOI 10.1163/156856208784522092
   Yoshimoto K, 2010, J AM CHEM SOC, V132, P7982, DOI 10.1021/ja910372e
NR 35
TC 9
Z9 9
U1 2
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD JUN
PY 2011
VL 5
IS 6
BP 5180
EP 5187
DI 10.1021/nn201327y
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 783AZ
UT WOS:000292055200109
PM 21627081
DA 2021-01-25
ER

PT J
AU Inoki, K
   Mori, H
   Wang, JY
   Suzuki, T
   Hong, SK
   Yoshida, S
   Blattner, SM
   Ikenoue, T
   Ruegg, MA
   Hall, MN
   Kwiatkowski, DJ
   Rastaldi, MP
   Huber, TB
   Kretzler, M
   Holzman, LB
   Wiggins, RC
   Guan, KL
AF Inoki, Ken
   Mori, Hiroyuki
   Wang, Junying
   Suzuki, Tsukasa
   Hong, SungKi
   Yoshida, Sei
   Blattner, Simone M.
   Ikenoue, Tsuneo
   Rueegg, Markus A.
   Hall, Michael N.
   Kwiatkowski, David J.
   Rastaldi, Maria P.
   Huber, Tobias B.
   Kretzler, Matthias
   Holzman, Lawrence B.
   Wiggins, Roger C.
   Guan, Kun-Liang
TI mTORC1 activation in podocytes is a critical step in the development of
   diabetic nephropathy in mice
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID EPITHELIAL-MESENCHYMAL TRANSITION; TUBEROUS-SCLEROSIS; NEPHRIN
   EXPRESSION; GLOMERULAR PROTEIN; MAMMALIAN TARGET; KIDNEY-DISEASE; SLIT
   DIAPHRAGM; ANGIOTENSIN-II; NOTCH PATHWAY; ER STRESS
AB Diabetic nephropathy (DN) is among the most lethal complications that occur in type 1 and type 2 diabetics. Podocyte dysfunction is postulated to be a critical event associated with proteinuria and glomerulosclerosis in glomerular diseases including DN. However, molecular mechanisms of podocyte dysfunction in the development of DN are not well understood. Here we have shown that activity of mTOR complex 1 (mTORC1), a kinase that senses nutrient availability, was enhanced in the podocytes of diabetic animals. Further, podocyte-specific mTORC1 activation induced by ablation of an upstream negative regulator (PcKOTsc1) recapitulated many DN features, including podocyte loss, glomerular basement membrane thickening, mesangial expansion, and proteinuria in nondiabetic young and adult mice. Abnormal mTORC1 activation caused mislocalizadon of slit diaphragm proteins and induced an epithelial-mesenchymal transition-like phenotypic switch with enhanced ER stress in podocytes. Conversely, reduction of ER stress with a chemical chaperone significantly protected against both the podocyte phenotypic switch and podocyte loss in PcKOTsc1 mice. Finally, genetic reduction of podocyte-specific mTORC1 in diabetic animals suppressed the development of DN. These results indicate that mTORC1 activation in podocytes is a critical event in inducing DN and suggest that reduction of podocyte mTORC1 activity is a potential therapeutic strategy to prevent DN.
C1 [Inoki, Ken; Wang, Junying; Suzuki, Tsukasa; Hong, SungKi; Yoshida, Sei; Ikenoue, Tsuneo] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.
   [Inoki, Ken; Mori, Hiroyuki] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.
   [Inoki, Ken; Blattner, Simone M.; Kretzler, Matthias; Wiggins, Roger C.] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA.
   [Rueegg, Markus A.; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Kwiatkowski, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA.
   [Rastaldi, Maria P.] Fdn IRCCS Policlin, Renal Res Lab, Milan, Italy.
   [Rastaldi, Maria P.] Fdn Amico, Milan, Italy.
   [Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, Freiburg, Germany.
   [Huber, Tobias B.] Univ Freiburg, Ctr Biol Signalling Studies Bioss, Freiburg, Germany.
   [Holzman, Lawrence B.] Univ Penn, Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.
   [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, Dept Pharmacol, San Diego, CA USA.
RP Inoki, K (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.
EM inokik@umich.edu; kuguan@ucsd.edu
RI Ruegg, Markus/X-7256-2019; MORI, HIROYUKI/D-3343-2013
OI Ruegg, Markus/0000-0002-4974-9384; Yoshida, Sei/0000-0002-4771-3900;
   Wiggins, Roger/0000-0002-1166-2849; Huber, Tobias B./0000-0001-7175-5062
FU George M. O'Brien Renal Center Developmental Research (DR)/Pilot and
   Feasibility (PF); Juvenile Diabetes Research FoundationJuvenile Diabetes
   Research Foundation; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [DK083491, GM051586];
   Excellence Initiative of the German Federal and State Governments [EXC
   294 5o]; NATIONAL CANCER INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [R01CA108941, R01CA108941, R01CA108941,
   R01CA108941, R01CA108941, R01CA108941, R01CA108941, R01CA108941,
   R01CA108941, R01CA108941, R01CA108941, R01CA108941, R01CA108941] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND
   KIDNEY DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK083491,
   R01DK083491, R01DK083491, R01DK083491, R01DK083491, R01DK083491,
   R01DK083491, R01DK083491, R01DK083491] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM051586,
   R01GM051586, R01GM051586, R01GM051586, R01GM051586, R01GM051586,
   R01GM051586, R01GM051586, R01GM051586, R01GM051586, R01GM051586,
   R01GM051586, R01GM051586, R01GM051586, R01GM051586, R01GM051586,
   R01GM051586, R01GM051586, R01GM051586, R01GM051586, R01GM051586,
   R01GM051586, R01GM051586, R01GM051586, R01GM051586, R01GM051586] Funding
   Source: NIH RePORTER
FX We thank A. Saltiel and F. Brosius (University of Michigan, Ann Arbor)
   for discussion and C. Tsui, R. Verma, and M. Uhm (University of
   Michigan, Ann Arbor) for technical assistance. We thank C. Edwards, S.
   Meshinchi, and D. Sorenson (Microscopy and Image Analysis Laboratory,
   University of Michigan, Ann Arbor) for EM analyses. This work was
   supported by a George M. O'Brien Renal Center Developmental Research
   (DR)/Pilot and Feasibility (P&F) grant (to K. Inoki), a Juvenile
   Diabetes Research Foundation Award (to K. Inoki), NIH grants DK083491
   (to K. Inoki) and GM051586 (to K.-L. Guan), and the Excellence
   Initiative of the German Federal and State Governments (EXC 294 5o T.B.
   Huber).
CR Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200
   Benndorf RA, 2009, KIDNEY INT, V75, P1039, DOI 10.1038/ki.2009.2
   Bonnet F, 2001, DIABETOLOGIA, V44, P874
   Boute N, 2000, NAT GENET, V24, P349
   Braissant O, 2010, MOL GENET METAB, V100, pS3, DOI 10.1016/j.ymgme.2010.02.010
   Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323
   Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031
   Diekmann F, 2006, NEPHROL DIAL TRANSPL, V21, P562, DOI 10.1093/ndt/gfi336
   Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023
   Fountain KJ, 2007, J CHROMATOGR B, V846, P245, DOI 10.1016/j.jchromb.2006.09.003
   Franz S, 2010, AM J KIDNEY DIS, V55, P335, DOI 10.1053/j.ajkd.2009.09.004
   Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1
   Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x
   Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]
   Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003
   Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101
   Karbowniczek M, 2010, J CLIN INVEST, V120, P93, DOI 10.1172/JCI40221
   Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X
   Kobayashi N, 2002, MICROSC RES TECHNIQ, V57, P217, DOI 10.1002/jemt.10077
   Kouraklis G, 2006, ONCOL REP, V15, P489
   Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x
   Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y
   Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x
   Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384
   Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057
   Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313
   Liu XL, 2004, J AM SOC NEPHROL, V15, P1731, DOI 10.1097/01.ASN.0000129826.28932.FD
   Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549
   Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053
   Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964
   Mazzucco G, 2002, AM J KIDNEY DIS, V39, P713, DOI 10.1053/ajkd.2002.31988
   Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164
   Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005
   Mori H, 2009, BIOCHEM BIOPH RES CO, V384, P471, DOI 10.1016/j.bbrc.2009.04.136
   Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172
   Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x
   Naito T, 2010, AM J PHYSIOL-RENAL, V298, pF683, DOI 10.1152/ajprenal.00503.2009
   Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731
   Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550
   Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339
   Reidy K, 2009, AM J KIDNEY DIS, V54, P590, DOI 10.1053/j.ajkd.2009.07.003
   Rincon-Choles H, 2006, DIABETES, V55, P894, DOI 10.2337/diabetes.55.04.06.db05-0355
   ROSENSTOCK J, 1986, DIABETES CARE, V9, P529, DOI 10.2337/diacare.9.5.529
   Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412
   Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410
   Sharma K, 1997, DIABETES, V46, P854, DOI 10.2337/diabetes.46.5.854
   Siragy HM, 1999, P NATL ACAD SCI USA, V96, P6506, DOI 10.1073/pnas.96.11.6506
   Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.00725.x
   Sung SH, 2006, J AM SOC NEPHROL, V17, P3093, DOI 10.1681/ASN.2006010064
   Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225
   Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566
   Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304
   Torras J, 2009, NEPHROL DIAL TRANSPL, V24, P3632, DOI 10.1093/ndt/gfp367
   Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019
   Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202
   Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015
   White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083
   Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009
   YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814
   Yang Y, 2007, AM J NEPHROL, V27, P495, DOI 10.1159/000106782
   Zhong Q, 2011, AM J RESP CELL MOL, V45, P498, DOI 10.1165/rcmb.2010-0347OC
   Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370
NR 74
TC 346
Z9 367
U1 0
U2 53
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JUN
PY 2011
VL 121
IS 6
BP 2181
EP 2196
DI 10.1172/JCI44771
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 772LB
UT WOS:000291234300020
PM 21606597
OA Green Accepted, Green Published, Bronze
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Godel, M
   Hartleben, B
   Herbach, N
   Liu, SY
   Zschiedrich, S
   Lu, S
   Debreczeni-Mor, A
   Lindenmeyer, MT
   Rastaldi, MP
   Hartleben, G
   Wiech, T
   Fornoni, A
   Nelson, RG
   Kretzler, M
   Wanke, R
   Pavenstadt, H
   Kerjaschki, D
   Cohen, CD
   Hall, MN
   Ruegg, MA
   Inoki, K
   Walz, G
   Huber, TB
AF Goedel, Markus
   Hartleben, Bjoern
   Herbach, Nadja
   Liu, Shuya
   Zschiedrich, Stefan
   Lu, Shun
   Debreczeni-Mor, Andrea
   Lindenmeyer, Maja T.
   Rastaldi, Maria-Pia
   Hartleben, Goetz
   Wiech, Thorsten
   Fornoni, Alessia
   Nelson, Robert G.
   Kretzler, Matthias
   Wanke, Ruediger
   Pavenstaedt, Hermann
   Kerjaschki, Dontscho
   Cohen, Clemens D.
   Hall, Michael N.
   Rueegg, Markus A.
   Inoki, Ken
   Walz, Gerd
   Huber, Tobias B.
TI Role of mTOR in podocyte function and diabetic nephropathy in humans and
   mice
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID FOCAL SEGMENTAL GLOMERULOSCLEROSIS; DE-NOVO; GLOMERULAR-FILTRATION;
   RENAL HYPERTROPHY; TRANSGENIC MICE; KIDNEY-DISEASE; GROWTH-HORMONE;
   IN-VIVO; RAPAMYCIN; PATHWAY
AB Chronic glomerular diseases, associated with renal failure and cardiovascular morbidity, represent a major health issue. However, they remain poorly understood. Here we have reported that tightly controlled mTOR activity was crucial to maintaining glomerular podocyte function, while dysregulation of mTOR facilitated glomerular diseases. Genetic deletion of mTOR complex 1 (mTORC1) in mouse podocytes induced proteinuria and progressive glomerulosclerosis. Furthermore, simultaneous deletion of both mTORC1 and mTORC2 from mouse podocytes aggravated the glomerular lesions, revealing the importance of both mTOR complexes for podocyte homeostasis. In contrast, increased mTOR activity accompanied human diabetic nephropathy, characterized by early glomerular hypertrophy and hyperfiltration. Curtailing mTORC1 signaling in mice by genetically reducing mTORC1 copy number in podocytes prevented glomerulosclerosis and significantly ameliorated the progression of glomerular disease in diabetic nephropathy. These results demonstrate the requirement for tightly balanced mTOR activity in podocyte homeostasis and suggest that mTOR inhibition can protect podocytes and prevent progressive diabetic nephropathy.
C1 [Goedel, Markus; Hartleben, Bjoern; Liu, Shuya; Zschiedrich, Stefan; Lu, Shun; Debreczeni-Mor, Andrea; Walz, Gerd; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany.
   [Herbach, Nadja; Wanke, Ruediger] Univ Munich, Ctr Clin Vet Med, Inst Vet Pathol, Munich, Germany.
   [Liu, Shuya; Huber, Tobias B.] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany.
   [Lindenmeyer, Maja T.; Cohen, Clemens D.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.
   [Lindenmeyer, Maja T.; Cohen, Clemens D.] Univ Zurich Hosp, Inst Physiol, CH-8091 Zurich, Switzerland.
   [Lindenmeyer, Maja T.; Cohen, Clemens D.] Univ Zurich, Zurich, Switzerland.
   [Rastaldi, Maria-Pia] Fdn IRCCS Osped Maggiore Policlin, Renal Res Lab, Milan, Italy.
   [Rastaldi, Maria-Pia] Fdn Amico, Milan, Italy.
   [Hartleben, Goetz] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany.
   [Wiech, Thorsten] Univ Hosp Freiburg, Dept Pathol, Freiburg, Germany.
   [Fornoni, Alessia] Univ Miami, L Miller Sch Med, Diabet Res Inst, Miami, FL USA.
   [Nelson, Robert G.] NIDDK, NIH, Phoenix, AZ USA.
   [Kretzler, Matthias] Univ Michigan, Div Nephrol, Ann Arbor, MI 48109 USA.
   [Pavenstaedt, Hermann] Univ Hosp Munster, Dept Med D, Munster, Germany.
   [Kerjaschki, Dontscho] Med Univ Vienna, Dept Pathol, Vienna, Austria.
   [Hall, Michael N.; Rueegg, Markus A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Inoki, Ken] Univ Michigan, Inst Life Sci, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.
   [Inoki, Ken] Univ Michigan, Div Nephol, Ann Arbor, MI 48109 USA.
   [Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.
RP Huber, TB (corresponding author), Univ Hosp Freiburg, Div Renal, Breisacher Str 66, D-79106 Freiburg, Germany.
EM tobias.huber@uniklinik-freiburg.de
RI Fornoni, Alessia/F-8350-2013; Liu, Shuya/S-8402-2018; Zschiedrich,
   Stefan/ABE-9871-2020; Nelson, Robert G/B-1470-2012; Wiech,
   Thorsten/ABA-3632-2020; Ruegg, Markus/X-7256-2019
OI Wiech, Thorsten/0000-0003-4053-1474; Ruegg, Markus/0000-0002-4974-9384;
   Herbach, Nadja/0000-0001-5893-0356; Huber, Tobias
   B./0000-0001-7175-5062; Lu, Shun/0000-0003-4501-2008; Lindenmeyer,
   Maja/0000-0003-4162-9107; fornoni, Alessia/0000-0002-1313-7773; Wanke,
   Rudiger/0000-0002-0153-224X
FU National Institute of Diabetes and Digestive and Kidney Diseases
   (NIDDK)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [NIDDK P30 DK081943]; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF)
   [32-122439/1]; Else Kroner-Fresenius-Stiftung [A62/04]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [DK083491]; Deutsche Forschungsgemeinschaft (DFG)German Research
   Foundation (DFG) [HU 1016/2-1, SFB 592 B10, P7-KFO 201]; Excellence
   Initiative of the German Federal and State Governments [EXC 294]; BMBF
   Gerontosys; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [P30DK081943, P30DK081943,
   P30DK081943, R01DK083491, P30DK081943, P30DK081943, ZIADK069062,
   ZIADK069062, P30DK081943, P30DK081943, P30DK081943, P30DK081943,
   P30DK081943, ZIADK069062, P30DK081943, R01DK083491, P30DK081943,
   P30DK081943, P30DK081943, P30DK081943, ZIADK069062, ZIADK069062,
   P30DK081943, P30DK081943, P30DK081943, P30DK081943, P30DK081943,
   ZIADK069063, R01DK083491, P30DK081943, R01DK083491, P30DK081943,
   R01DK083491, P30DK081943, P30DK081943, P30DK081943, P30DK081943,
   P30DK081943, P30DK081943, ZIADK069063, P30DK081943, ZIADK069063,
   R01DK083491, ZIADK069062, P30DK081943, P30DK081943, ZIADK069062,
   P30DK081943, P30DK081943, P30DK081943, P30DK081943, P30DK081943,
   ZIADK069062, P30DK081943, ZIADK069062, P30DK081943, P30DK081943,
   P30DK081943, R01DK083491, R01DK083491, P30DK081943, P30DK081943,
   P30DK081943, P30DK081943, ZIADK069062, R01DK083491] Funding Source: NIH
   RePORTER
FX We thank Dorte Thiel, Charlotte Meyer, (Renal Division, University
   Hospital Freiburg), Elisabeth Wieser, Brigitte Langer (Pathology,
   Medical University Vienna), Angela Siebert, Heike Sperling (Veterinary
   Pathology, Munich), and Evelyn Watzig (Pathology, University Hospital
   Freiburg) for excellent technical assistance. We thank Michael Kottgen
   and Sebastian Arnold for carefully reading the manuscript. We thank all
   participating centers of the European Renal cDNA Bank - Kroner-Fresenius
   biopsy bank and their patients for their cooperation. Active members at
   the time of the study are listed in ref. 58 and at
   http://www.forschungsportal.ch/unizh/p9291.htm. This study was supported
   by the Intramural Research Program of the National Institute of Diabetes
   and Digestive and Kidney Diseases (NIDDK) (to A.G. Nelson; NIDDK P30
   DK081943 to M. Kretzler), the Swiss National Science Foundation
   (32-122439/1 to C.D. Cohen) and the Else Kroner-Fresenius-Stiftung
   (A62/04 to C.D. Cohen), the NIH (DK083491 to K. Inoki), Deutsche
   Forschungsgemeinschaft (DFG) grants (HU 1016/2-1, SFB 592 B10, and
   P7-KFO 201 to T.B. Huber), the Excellence Initiative of the German
   Federal and State Governments (EXC 294), and BMBF Gerontosys-Project
   NephAge.
CR Amer H, 2009, J AM SOC NEPHROL, V20, P2490, DOI 10.1681/ASN.2008091005
   ARTACHOPERULA E, 1993, LAB INVEST, V68, P56
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328
   Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025
   Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008
   Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103
   Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x
   Cohen CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002937
   ELNAHAS AM, 1991, KIDNEY INT, V40, P29, DOI 10.1038/ki.1991.175
   Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330
   Estacio R O, 2001, Adv Intern Med, V46, P359
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069
   Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492
   Herbach N, 2009, AM J PHYSIOL-RENAL, V296, pF819, DOI 10.1152/ajprenal.90665.2008
   Hoeflich A, 2002, FASEB J, V16, P1721, DOI 10.1096/fj.02-0349com
   Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024
   Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771
   Inoki K, 2008, DIABETES RES CLIN PR, V82, pS59, DOI 10.1016/j.diabres.2008.09.028
   Izzedine H, 2005, NEW ENGL J MED, V353, P2088, DOI 10.1056/NEJM200511103531922
   Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056
   Kretzler M, 2005, J AM SOC NEPHROL, V16, P2830, DOI 10.1681/ASN.2005080841
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Letavernier E, 2007, CLIN J AM SOC NEPHRO, V2, P326, DOI 10.2215/CJN.03751106
   Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186
   Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549
   Meier M, 2007, DIABETES, V56, P346, DOI 10.2337/db06-0891
   Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164
   Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126
   Mori H, 2009, BIOCHEM BIOPH RES CO, V384, P471, DOI 10.1016/j.bbrc.2009.04.136
   Morita H, 2005, J AM SOC NEPHROL, V16, P1703, DOI 10.1681/ASN.2004050387
   Munivenkatappa R, 2010, HISTOL HISTOPATHOL, V25, P189, DOI 10.14670/HH-25.189
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335
   Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731
   OSTERBY R, 1975, DIABETOLOGIA, V11, P225, DOI 10.1007/BF00422326
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Rangan GK, 2007, NEPHROL DIAL TRANSPL, V22, P2175, DOI 10.1093/ndt/gfm191
   Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012
   Samuel T, 2005, J AM SOC NEPHROL, V16, P3102, DOI 10.1681/ASN.2005010123
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166
   Sharma S, 2011, CURR OPIN NEPHROL HY, V20, P56, DOI 10.1097/MNH.0b013e3283414c88
   Skov K, 1999, KIDNEY INT, V55, P1462, DOI 10.1046/j.1523-1755.1999.00398.x
   SOUSTER LP, 1980, J ANAT, V130, P595
   STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x
   Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3
   Torras J, 2009, NEPHROL DIAL TRANSPL, V24, P3632, DOI 10.1093/ndt/gfp367
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   WEENING JJ, 1987, AM J PATHOL, V129, P64
   WEIBEL ER, 1962, J APPL PHYSIOL, V17, P343
   Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015
   Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000
NR 58
TC 326
Z9 343
U1 3
U2 45
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA
SN 0021-9738
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JUN
PY 2011
VL 121
IS 6
BP 2197
EP 2209
DI 10.1172/JCI44774
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 772LB
UT WOS:000291234300021
PM 21606591
OA Green Accepted, Bronze, Green Published
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Uppaluri, S
   Nagler, J
   Stellamanns, E
   Heddergott, N
   Herminghaus, S
   Engstler, M
   Pfohl, T
AF Uppaluri, Sravanti
   Nagler, Jan
   Stellamanns, Eric
   Heddergott, Niko
   Herminghaus, Stephan
   Engstler, Markus
   Pfohl, Thomas
TI Impact of Microscopic Motility on the Swimming Behavior of Parasites:
   Straighter Trypanosomes are More Directional
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID AFRICAN TRYPANOSOMES; CELL MOTILITY; RANDOM-WALK; BRUCEI; COMPONENTS;
   FLAGELLUM; BIOLOGY; MOTION; CHEMOTAXIS; MOVEMENT
AB Microorganisms, particularly parasites, have developed sophisticated swimming mechanisms to cope with a varied range of environments. African Trypanosomes, causative agents of fatal illness in humans and animals, use an insect vector (the Tsetse fly) to infect mammals, involving many developmental changes in which cell motility is of prime importance. Our studies reveal that differences in cell body shape are correlated with a diverse range of cell behaviors contributing to the directional motion of the cell. Straighter cells swim more directionally while cells that exhibit little net displacement appear to be more bent. Initiation of cell division, beginning with the emergence of a second flagellum at the base, correlates to directional persistence. Cell trajectory and rapid body fluctuation correlation analysis uncovers two characteristic relaxation times: a short relaxation time due to strong body distortions in the range of 20 to 80 ms and a longer time associated with the persistence in average swimming direction in the order of 15 seconds. Different motility modes, possibly resulting from varying body stiffness, could be of consequence for host invasion during distinct infective stages.
C1 [Uppaluri, Sravanti; Nagler, Jan; Stellamanns, Eric; Herminghaus, Stephan; Pfohl, Thomas] Max Planck Inst Dynam & Self Org, Gottingen, Germany.
   [Nagler, Jan] Univ Gottingen, Inst Nonlinear Dynam, Fac Phys, Gottingen, Germany.
   [Heddergott, Niko; Engstler, Markus] Univ Wurzburg, Biozentrum, Dept Cell & Dev Biol, Wurzburg, Germany.
   [Pfohl, Thomas] Univ Basel, Dept Chem, Basel, Switzerland.
RP Uppaluri, S (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.
EM thomas.pfohl@unibas.ch
RI Pfohl, Thomas/D-7296-2016
OI Pfohl, Thomas/0000-0002-7879-5216
FU DFGGerman Research Foundation (DFG) [SPP1207, EN305/4, PF375/5]
FX We gratefully acknowledge funding from the DFG within the priority
   program SPP1207 (EN305/4, PF375/5). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352
   Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6
   Berg H. C., 1993, RANDOM WALKS BIOL
   Berg HC, 2000, PHYS TODAY, V53, P24, DOI 10.1063/1.882934
   Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078
   Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541
   Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014
   Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046
   Gadelha C, 2007, CELL MOTIL CYTOSKEL, V64, P629, DOI 10.1002/cm.20210
   Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009
   Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017
   Hill KL, 2010, CURR OPIN MICROBIOL, V13, P459, DOI 10.1016/j.mib.2010.05.015
   Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003
   Howard J., 2001, MECH MOTOR PROTEINS
   KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695
   Koster S, 2009, CELL MOTIL CYTOSKEL, V66, P771, DOI 10.1002/cm.20336
   Koster S, 2005, J PHYS-CONDENS MAT, V17, pS4091, DOI 10.1088/0953-8984/17/49/006
   Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601
   Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093
   LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6
   Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045
   Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649
   Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051
   Oberholzer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000739
   Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005
   PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903
   Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101
   Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353
   Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106
   Rubinstein M., 2003, POLYM PHYS
   Selmeczi D, 2008, EUR PHYS J-SPEC TOP, V157, P1, DOI 10.1140/epjst/e2008-00626-x
   Shaevitz JW, 2005, CELL, V122, P941, DOI 10.1016/j.cell.2005.07.004
   Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228
   Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648
   Takano Y, 2003, JSME INT J C-MECH SY, V46, P1241, DOI 10.1299/jsmec.46.1241
   Wada H, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021921
NR 36
TC 35
Z9 35
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD JUN
PY 2011
VL 7
IS 6
AR e1002058
DI 10.1371/journal.pcbi.1002058
PG 8
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA 787MW
UT WOS:000292381900008
PM 21698122
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Renzi, F
   Manfredi, P
   Mally, M
   Moes, S
   Jeno, P
   Cornelis, GR
AF Renzi, Francesco
   Manfredi, Pablo
   Mally, Manuela
   Moes, Suzette
   Jenoe, Paul
   Cornelis, Guy R.
TI The N-glycan Glycoprotein Deglycosylation Complex (Gpd) from
   Capnocytophaga canimorsus Deglycosylates Human IgG
SO PLOS PATHOGENS
LA English
DT Article
ID OUTER-MEMBRANE PROTEINS; STARCH; GROWTH; ENDOGLYCOSIDASE; SEPTICEMIA;
   CATABOLISM; FLORA; DOGS
AB C. canimorsus 5 has the capacity to grow at the expenses of glycan moieties from host cells N-glycoproteins. Here, we show that C. canimorsus 5 also has the capacity to deglycosylate human IgG and we analyze the deglycosylation mechanism. We show that deglycosylation is achieved by a large complex spanning the outer membrane and consisting of the Gpd proteins and sialidase SiaC. GpdD, -G, -E and -F are surface-exposed outer membrane lipoproteins. GpdDEF could contribute to the binding of glycoproteins at the bacterial surface while GpdG is a endo-beta-N-acetylglucosaminidase cleaving the N-linked oligosaccharide after the first N- linked GlcNAc residue. GpdC, resembling a TonB-dependent OM transporter is presumed to import the oligosaccharide into the periplasm after its cleavage from the glycoprotein. The terminal sialic acid residue of the oligosaccharide is then removed by SiaC, a periplasm-exposed lipoprotein in direct contact with GpdC. Finally, most likely degradation of the oligosaccharide proceeds sequentially from the desialylated non reducing end by the action of periplasmic exoglycosidases, including beta-galactosidases, beta-N-Acetylhexosaminidases and alpha-mannosidases.
C1 [Renzi, Francesco; Manfredi, Pablo; Mally, Manuela; Moes, Suzette; Jenoe, Paul; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Renzi, F (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Renzi, Francesco/0000-0001-6940-1177
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-128659/1]
FX This work was supported by Swiss National Science Foundation
   (www.snf.ch) through grant 3100A0-128659/1 to GRC. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR BAILIE WE, 1978, J CLIN MICROBIOL, V7, P223
   Blanche P, 1998, J INFECTION, V36, P134, DOI 10.1016/S0163-4453(98)93918-4
   BOBO RA, 1976, AM J CLIN PATHOL, V65, P564
   Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245
   Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07
   Byers HL, 1999, J DENT RES, V78, P1370, DOI 10.1177/00220345990780071201
   Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469
   Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001
   Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046
   DElla JN, 1996, J BACTERIOL, V178, P7173
   ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540
   Frandsen EVG, 2008, INT J SYST EVOL MICR, V58, P324, DOI 10.1099/ijs.0.65373-0
   GREEN ED, 1988, J BIOL CHEM, V263, P18253
   King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x
   Kitamura M, 2008, J BIOL CHEM, V283, P36328, DOI 10.1074/jbc.M806115200
   Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381
   Koropatkin N, 2009, BIOCHEMISTRY-US, V48, P1532, DOI 10.1021/bi801942a
   Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017
   Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10
   Le Moal GL, 2003, CLIN INFECT DIS, V36, pE42, DOI 10.1086/345477
   Mally M, 2008, APPL ENVIRON MICROB, V74, P6369, DOI 10.1128/AEM.01218-08
   Mally M, 2009, MICROBES INFECT, V11, P509, DOI 10.1016/j.micinf.2009.02.005
   Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164
   Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007
   Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848
   Meyer S, 2008, IMMUNOBIOLOGY, V213, P805, DOI 10.1016/j.imbio.2008.07.019
   Pers C, 1996, CLIN INFECT DIS, V23, P71, DOI 10.1093/clinids/23.1.71
   Reeves AR, 1996, J BACTERIOL, V178, P823, DOI 10.1128/jb.178.3.823-830.1996
   Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997
   Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243
   Shin H, 2009, INFECT IMMUN, V77, P2262, DOI 10.1128/IAI.01324-08
   Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   WESTWELL AJ, 1989, BRIT MED J, V298, P116, DOI 10.1136/bmj.298.6666.116-c
NR 34
TC 55
Z9 55
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUN
PY 2011
VL 7
IS 6
AR e1002118
DI 10.1371/journal.ppat.1002118
PG 17
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 787MC
UT WOS:000292379600045
PM 21738475
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Handschin, C
AF Handschin, C.
TI Peroxisome proliferator-activated receptor gamma coactivator 1 beta
   (PGC-1 beta) improves skeletal muscle mitochondrial function and insulin
   sensitivity
SO DIABETOLOGIA
LA English
DT Editorial Material
DE Insulin resistance; Long-chain acyl-CoA; PGC-1 beta; Reactive oxygen
   species; Skeletal muscle
ID PGC-1-ALPHA; METABOLISM; RESISTANCE; GENES
AB Proteins belonging to the peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) family are key regulators of cellular energy homeostasis in a number of oxidative tissues, including skeletal muscle. While the regulation and function of PGC-1 alpha seems central to muscle fibre plasticity in endurance exercise, the role of PGC-1 beta in this tissue is less clear. Wright et al. (Diabetologia, DOI: 10.1007/s00125-011-2068-x) provide evidence for a protective effect of moderately elevated PGC-1 beta in electroporated rat skeletal muscle against high-fat-diet-induced insulin resistance, at least in part by promoting the oxidation of long chain acyl-CoA entities and the elimination of reactive oxygen species. These data provide important insights into the biological role of PGC-1 beta in skeletal muscle and imply novel therapeutic avenues for improving peripheral insulin sensitivity.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003
   Benton CR, 2010, DIABETOLOGIA, V53, P2008, DOI 10.1007/s00125-010-1773-1
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2010, J RECEPT SIG TRANSD, V30, P376, DOI 10.3109/10799891003641074
   Handschin C, 2009, CLIN EXP PHARMACOL P, V36, P1139, DOI 10.1111/j.1440-1681.2009.05275.x
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4
   Wright LE, 2011, DIABETOLOGIA, V54, P1417, DOI 10.1007/s00125-011-2068-x
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
NR 13
TC 2
Z9 2
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
J9 DIABETOLOGIA
JI Diabetologia
PD JUN
PY 2011
VL 54
IS 6
BP 1270
EP 1272
DI 10.1007/s00125-011-2135-3
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 760ML
UT WOS:000290328300002
PM 21461634
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Ziegler, A
   Seelig, J
AF Ziegler, Andre
   Seelig, Joachim
TI Contributions of Glycosaminoglycan Binding and Clustering to the
   Biological Uptake of the Nonamphipathic Cell-Penetrating Peptide WR9
SO BIOCHEMISTRY
LA English
DT Article
ID PROTEIN TRANSDUCTION DOMAINS; ARGININE-RICH PEPTIDES; NONVIRAL GENE
   DELIVERY; DNA COMPLEXES; HIGH-AFFINITY; ENTERS CELLS; MEMBRANE; TAT;
   SURFACE; PROTEOGLYCANS
AB Many cell-penetrating peptides (CPPs) bind to glycosaminoglycans (GAG) located on the extracellular side of biological tissues. CPP binding to the cell surface is intimately associated with clustering of surface molecules and is usually followed by uptake into the cell interior. We have investigated the uptake mechanism by comparing CPPs which bind, but cannot induce, GAG clustering with those which do induce GAG clustering. We have synthesized the tryptophan-labeled CPP nona-L-arginine (WR9) and its monodispersely PEGylated derivate (PEG(27)-WR9) and have compared them with respect to glycan binding, glycan clustering, and their uptake into living cells. Both CPPs bind to the GAG heparin with high affinity (K-D similar to 100 nM), but the PEGylation prevents the GAG clustering. Thus, it is possible to uncouple and analyze the contributions of GAG binding and GAG clustering to the biological CPP uptake. The uptake of PEG-WR9 into CH-K1 cells is confined to intracellular vesicles, where colocalization with transferrin attests to an endocytic uptake. Transfection experiments with plasmid DNA for GFP revealed poor GFP expression, suggesting that endocytic uptake of PEG-WR9 is compromised by insufficient release from endocytic vesicles. In contrast, WR9 shows two uptake routes. At low concentration (<5 mu M), WR9 uptake occurs mainly through endocytosis. At higher concentration, WR9 uptake is greatly enhanced, showing a diffuse spreading over the entire cytoplasm and nucleus-a phenomenon termed "transduction". Transduction of WR9 leads to a higher GFP expression as compared to PEG-WR9 endocytosis but also damages the plasma membrane as evidenced by SYTOX Green staining. The results suggest that GAG binding without and with GAG clustering induce two different pathways of CPP uptake.
C1 [Ziegler, Andre; Seelig, Joachim] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Ziegler, A (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM andre.ziegler@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100-107793/1]
FX This work was supported by the Swiss National Science Foundation under
   Grant No. 3100-107793/1.
CR Akinc A, 2003, BIOCONJUGATE CHEM, V14, P979, DOI 10.1021/bc034067y
   Belting M, 1999, BIOCHEM J, V338, P317, DOI 10.1042/0264-6021:3380317
   BRETSCHER MS, 1981, COLD SPRING HARB SYM, V46, P707
   Burak Y, 2003, BIOPHYS J, V85, P2100, DOI 10.1016/S0006-3495(03)74638-4
   CHEN SY, 1994, HUM GENE THER, V5, P595, DOI 10.1089/hum.1994.5.5-595
   Chen XY, 2004, J NUCL MED, V45, P1776
   COAKLEY WT, 1985, EUR BIOPHYS J BIOPHY, V13, P123
   Deshayes S, 2006, BBA-BIOMEMBRANES, V1758, P1846, DOI 10.1016/j.bbamem.2006.08.010
   Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x
   Edsall J.T., 1943, PROTEINS AMINO ACIDS, P75
   FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2
   Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808
   GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964
   Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100
   Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009
   Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   KING AC, 1982, J BIOL CHEM, V257, P3053
   KOMGUTH SE, 1961, EXP CELL RES, V24, P484
   Kopatz I, 2004, J GENE MED, V6, P769, DOI 10.1002/jgm.558
   Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w
   KURNAGAI AK, 1987, J BIOL CHEM, V262, P15214
   LAMAZE C, 1995, CURR OPIN CELL BIOL, V7, P573, DOI 10.1016/0955-0674(95)80015-8
   Lebleu B, 2008, ADV DRUG DELIVER REV, V60, P517, DOI 10.1016/j.addr.2007.09.002
   Leifert JA, 2003, MOL THER, V8, P13, DOI 10.1016/S1525-0016(03)00151-5
   Lentz BR, 2007, EUR BIOPHYS J BIOPHY, V36, P315, DOI 10.1007/s00249-006-0097-z
   Levin C., 2003, Journal of Investigative Dermatology, V121, P1201
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Lundback T, 1996, P NATL ACAD SCI USA, V93, P4754, DOI 10.1073/pnas.93.10.4754
   Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450
   Magal LG, 2009, MOL BIOL CELL, V20, P3751, DOI 10.1091/mbc.E09-02-0142
   MATSUYA Y, 1985, J CELL SCI, V78, P273
   MAYHEW E, 1973, J MEMBRANE BIOL, V14, P213, DOI 10.1007/BF01868079
   McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100
   MILLER K, 1991, CELL, V65, P621, DOI 10.1016/0092-8674(91)90094-F
   Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349
   Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x
   Moulton HM, 2007, BIOCHEM SOC T, V35, P826, DOI 10.1042/BST0350826
   NADEL MK, 1957, J INFECT DIS, V100, P88, DOI 10.1093/infdis/100.1.88
   Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   PARSEGIAN A, 1969, NATURE, V221, P844, DOI 10.1038/221844a0
   Pellegrin P, 2002, MOL BIOL CELL, V13, P570, DOI 10.1091/mbc.01-06-0280
   Pouton CW, 1998, J CONTROL RELEASE, V53, P289, DOI 10.1016/S0168-3659(98)00015-7
   RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683
   Regina A, 2008, BRIT J PHARMACOL, V155, P185, DOI 10.1038/bjp.2008.260
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Rejman J, 2006, J LIPOSOME RES, V16, P237, DOI 10.1080/08982100600848819
   Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167
   Ross PC, 1999, GENE THER, V6, P651, DOI 10.1038/sj.gt.3300863
   Ruponen M, 2004, J GENE MED, V6, P405, DOI 10.1002/jgm.522
   RYSER HJP, 1965, SCIENCE, V150, P501, DOI 10.1126/science.150.3695.501
   Saar K, 2005, ANAL BIOCHEM, V345, P55, DOI 10.1016/j.ab.2005.07.033
   SANDERS EJ, 1970, J CELL SCI, V7, P739
   SARHAN S, 1989, BIOL CHEM H-S, V370, P1279, DOI 10.1515/bchm3.1989.370.2.1279
   Sauder R, 2011, METHODS MOL BIOL, V683, P129, DOI 10.1007/978-1-60761-919-2_10
   Scherrmann JM, 2005, INT CONGR SER, V1277, P199, DOI 10.1016/j.ics.2005.02.023
   Schuck P, 2004, BIOPHYS CHEM, V108, P187, DOI 10.1016/j.bpc.2003.10.016
   Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569
   Silhol M, 2002, EUR J BIOCHEM, V269, P494, DOI 10.1046/j.0014-2956.2001.02671.x
   SUBBARAO NK, 1987, BIOCHEMISTRY-US, V26, P2964, DOI 10.1021/bi00385a002
   TAKEUCHI Y, 1990, J BIOL CHEM, V265, P13661
   Ter-Avetisyan G, 2009, J BIOL CHEM, V284, P3370, DOI 10.1074/jbc.M805550200
   TRIGUERO D, 1991, J PHARMACOL EXP THER, V258, P186
   Truzzolillo D, 2009, EUR PHYS J E, V29, P229, DOI 10.1140/epje/i2009-10471-1
   Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968
   Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com
   Van den Berg B, 2006, AM J PHYSIOL-HEART C, V290, pH2174, DOI 10.1152/ajpheart.00197.2006
   VANHOLDE KE, 1998, PRINCIPLES PHYS BIOC, P604
   Verdurmen WPR, 2010, J CONTROL RELEASE, V147, P171, DOI 10.1016/j.jconrel.2010.06.030
   Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   Wiethoff CM, 2001, J BIOL CHEM, V276, P32806, DOI 10.1074/jbc.M007940200
   Williams SA, 2000, METHOD ENZYMOL, V313, P388
   Won YY, 2009, J CONTROL RELEASE, V139, P88, DOI 10.1016/j.jconrel.2009.06.031
   WOODLE MC, 1992, BIOPHYS J, V61, P902, DOI 10.1016/S0006-3495(92)81897-0
   Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338
   Zaro JL, 2005, EXP CELL RES, V307, P164, DOI 10.1016/j.yexcr.2005.02.024
   Zhou JY, 2007, PHARM RES, V24, P1079, DOI 10.1007/s11095-006-9229-5
   Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604
   Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805
   Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005
   Ziegler A, 2008, BIOPHYS J, V94, P2142, DOI 10.1529/biophysj.107.113472
   Ziegler A, 2007, BIOCHEMISTRY-US, V46, P8138, DOI 10.1021/bi700416h
   Zschornig O, 2000, GEN PHYSIOL BIOPHYS, V19, P85
NR 89
TC 61
Z9 61
U1 0
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAY 31
PY 2011
VL 50
IS 21
BP 4650
EP 4664
DI 10.1021/bi1019429
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 767EF
UT WOS:000290837400026
PM 21491915
DA 2021-01-25
ER

PT J
AU Mustafi, D
   Avishai, A
   Avishai, N
   Engel, A
   Heuer, A
   Palczewski, K
AF Mustafi, Debarshi
   Avishai, Amir
   Avishai, Nanthawan
   Engel, Andreas
   Heuer, Arthur
   Palczewski, Krzysztof
TI Serial sectioning for examination of photoreceptor cell architecture by
   focused ion beam technology
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Cone photoreceptor; Enhanced S-cone syndrome; Focused ion beam; Nrl;
   Retina; Rod photoreceptor; Serial ion ablation; Vision
ID SCANNING-ELECTRON-MICROSCOPY; BIOLOGICAL SAMPLES; ORGANIZATION;
   RECONSTRUCT; MORPHOLOGY; RHODOPSIN; SEM; NRL
AB Structurally deciphering complex neural networks requires technology with sufficient resolution to allow visualization of single cells and their intimate surrounding connections. Scanning electron microscopy (SEM), coupled with serial ion ablation (SIA) technology, presents a new avenue to study these networks. SIA allows ion ablation to remove nanometer sections of tissue for SEM imaging, resulting in serial section data collection for three-dimensional reconstruction. Here we highlight a method for preparing retinal tissues for imaging of photoreceptors by SIA-SEM technology. We show that this technique can be used to visualize whole rod photoreceptors and the internal disc elements from wild-type (wt) mice. The distance parameters of the discs and photoreceptors are in good agreement with previous work with other methods. Moreover, we show that large planes of retinal tissue can be imaged at high resolution to display the packing of normal rods. Finally, SIA-SEM imaging of retinal tissue from a mouse model (NrI(-/-)) with phenotypic changes akin to the human disease enhanced S-cone syndrome (ESCS) revealed a structural profile of overall photoreceptor ultrastructure and internal elements that accompany this disease. Overall, this work presents a new method to study photoreceptor cells at high structural resolution that has a broad applicability to the visual neuroscience field. Published by Elsevier B.V.
C1 [Mustafi, Debarshi; Engel, Andreas; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.
   [Avishai, Amir; Avishai, Nanthawan; Heuer, Arthur] Case Western Reserve Univ, Dept Mat Sci & Engn, Cleveland, OH 44106 USA.
   [Engel, Andreas] Univ Basel, ME Muller Inst, Ctr Cellular Imaging & Nanoanalyt, Biozentrum,WRO 1058, CH-4058 Basel, Switzerland.
RP Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM kxp65@case.edu
OI Mustafi, Debarshi/0000-0002-9164-7488; Avishai, Amir/0000-0002-6919-8516
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [EY009339, GM079191,
   EY019478, T32GM007250, T32EY007157]; Amgen Inc.Amgen; Maurice E. Muller
   Foundation of Switzerland; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [T32EY007157, R01EY009339,
   R01EY009339, T32EY007157, T32EY007157, R01EY009339, R01EY009339,
   R01EY009339, R01EY009339, T32EY007157, T32EY007157, T32EY007157,
   R01EY019478, T32EY007157, T32EY007157, T32EY007157, R01EY019478,
   R01EY009339, R01EY009339, T32EY007157, R01EY009339, T32EY007157,
   R01EY009339, R01EY019478, R01EY019478, R01EY009339, R01EY009339,
   R01EY009339, R01EY009339, R01EY009339, R01EY009339, T32EY007157,
   R01EY009339, R01EY009339, R01EY009339, T32EY007157, R01EY009339,
   T32EY007157, R01EY009339, R01EY009339, R01EY009339, T32EY007157,
   T32EY007157, T32EY007157, R01EY009339, R01EY009339, R01EY009339,
   R01EY009339, R01EY009339, R01EY009339, R01EY009339, T32EY007157,
   R01EY009339, R01EY009339, R01EY019478, R01EY009339, R01EY009339] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, R01GM079191, T32GM007250, T32GM007250, R01GM079191,
   T32GM007250, T32GM007250, R01GM079191, T32GM007250, T32GM007250,
   R01GM079191, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250, R01GM079191,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250] Funding Source: NIH
   RePORTER
FX This research was supported by NIH grants EY009339, GM079191, EY019478,
   and by an unrestricted grant from Amgen Inc.. D.M. was supported in part
   by the CWRU Medical Scientist Training Program grant T32GM007250 from
   the National Institutes of Health, the Visual Sciences Training grant
   T32EY007157 from the National Institutes of Health, and the Maurice E.
   Muller Foundation of Switzerland.
CR Bittermann AG, 2009, ADV ENG MATER, V11, pB182, DOI 10.1002/adem.200900080
   BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603
   Brugger J, 1997, MICROELECTRON ENG, V35, P401, DOI 10.1016/S0167-9317(96)00210-9
   Danelon C, 2006, LANGMUIR, V22, P22, DOI 10.1021/la052387v
   Daniele LL, 2005, INVEST OPHTH VIS SCI, V46
   den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258
   Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329
   Drobne D, 2007, MICROSC RES TECHNIQ, V70, P895, DOI 10.1002/jemt.20494
   Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x
   GLANVILLE J, 1989, SOLID STATE TECHNOL, V32, P270
   Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006
   Hekking LHP, 2009, J MICROSC-OXFORD, V235, P336, DOI 10.1111/j.1365-2818.2009.03274.x
   Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005
   Hennig P, 2007, J APPL PHYS, V102, DOI 10.1063/1.2817591
   Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006
   Heymann JAW, 2009, J STRUCT BIOL, V166, P1, DOI 10.1016/j.jsb.2008.11.005
   HOOD DC, 1995, VISION RES, V35, P1473, DOI 10.1016/0042-6989(95)98727-Q
   JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827
   JACOBSON SG, 1991, AM J OPHTHALMOL, V111, P446, DOI 10.1016/S0002-9394(14)72379-7
   Kamino T, 2004, J ELECTRON MICROSC, V53, P563, DOI 10.1093/jmicro/dfh063
   Kidd Grahame, 2010, MICROSC TODAY, V18, P18
   KIETZMANN GE, 1991, T AM MICROSC SOC, V110, P172, DOI 10.2307/3226753
   Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008
   Leser V, 2009, J MICROSC-OXFORD, V233, P309, DOI 10.1111/j.1365-2818.2009.03121.x
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200
   Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293
   Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105
   Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774
   Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099
   Moghadama SH, 2006, INT J PHARMACEUT, V321, P50, DOI 10.1016/j.ijpharm.2006.05.006
   Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003
   Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010
   Reyntjens S, 2001, J MICROMECH MICROENG, V11, P287, DOI 10.1088/0960-1317/11/4/301
   Rodieck R. W., 1998, 1 STEPS SEEING
   ROSENKRA J, 1970, CELL TISSUE RES, V111, P228
   Sugiyama M, 2004, J ELECTRON MICROSC, V53, P527, DOI 10.1093/jmicro/dfh071
   Urban KW, 2008, SCIENCE, V321, P506, DOI 10.1126/science.1152800
   Walker JF, 1996, MICROELECTRON ENG, V30, P517, DOI 10.1016/0167-9317(95)00299-5
   YOUNG RJ, 1993, VACUUM, V44, P353, DOI 10.1016/0042-207X(93)90182-A
   YOUNG RJ, 1993, J MICROSC-OXFORD, V172, P81, DOI 10.1111/j.1365-2818.1993.tb03396.x
NR 41
TC 10
Z9 10
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 1872-678X
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD MAY 15
PY 2011
VL 198
IS 1
BP 70
EP 76
DI 10.1016/j.jneumeth.2011.03.013
PG 7
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 771FM
UT WOS:000291142600010
PM 21439323
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Seger, S
   Rischatsch, R
   Philippsen, P
AF Seger, Shanon
   Rischatsch, Riccarda
   Philippsen, Peter
TI Formation and stability of eisosomes in the filamentous fungus Ashbya
   gossypii
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Hyphae; Polar growth; Eisosome; Endocytosis
ID PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; ACTIN
   CYTOSKELETON; PROTEIN-KINASE; YEAST; CELLS; ORGANIZATION; MICRODOMAINS;
   TURNOVER
AB One hallmark of the rapid expansion of the polar surface of fungal hyphae is the spatial separation of regions of exocytosis and endocytosis at hyphal tips, as recently shown for Ashbya gossypii and Aspergillus nidulans. To determine where cortex-associated eisosomes form with respect to these two regions, we monitored fluorescently marked eisosomes in A. gossypii. Each minute, 1.6+/-0.5 eisosomes form within the first 30 mu m of each hypha and are exclusively subapical of the endocytosis region. This spatial separation of the processes of eisosome formation and endocytosis, and the much lower frequency of eisosome formation compared with that of endocytic vesicle production do not support a recently proposed role for eisosomes in endocytosis. Levels of mRNA encoding eisosome components are tenfold higher in spores than in hyphae, explaining the observed higher eisosome density at the cortex of germ bubbles. As in Saccharomyces cerevisiae, eisosomes in A. gossypii are very stable. In contrast to S. cerevisiae, however, the A. gossypii homologue of Pil1, one of the main eisosome subunits, is very important for polar growth, whereas the homologue of Nce102, which colocalizes with eisosomes, is not needed for eisosome stability. By testing partial deletions of the A. gossypii homologue of Ymr086w, another component of the eisosome, we identified a novel protein domain essential for eisosome stability. We also compare our results with recent findings about eisosomes in A. nidulans.
C1 [Seger, Shanon; Rischatsch, Riccarda; Philippsen, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
FU University of Basel
FX We are grateful to Kumiko Masai for suggesting the ABP1 experiment and
   discussions. We also thank Jeremy Thorner for helpful suggestions and
   Markus Duerrenberger for advice on performing FRAP experiments. This
   work was supported by grants from the University of Basel.
CR AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x
   ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8
   Deng CH, 2009, MOL CELL PROTEOMICS, V8, P1413, DOI 10.1074/mcp.M800397-MCP200
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.E04-07-0564
   Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081
   Gattiker A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-9
   Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035
   Helfer H, 2006, MOL BIOL CELL, V17, P4494, DOI 10.1091/mbc.E06-03-0215
   Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   Loibl M, 2010, EUKARYOT CELL, V9, P1184, DOI 10.1128/EC.00006-10
   Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200
   Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493
   Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221
   Moreira KE, 2009, MOL BIOL CELL, V20, P809, DOI 10.1091/mbc.E08-03-0313
   Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227
   Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Vangelatos I, 2010, EUKARYOT CELL, V9, P1441, DOI 10.1128/EC.00087-10
   Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472
   Walther TC, 2007, EMBO J, V26, P4946, DOI 10.1038/sj.emboj.7601933
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002
   Zhang XP, 2004, J BIOL CHEM, V279, P22030, DOI 10.1074/jbc.M400299200
NR 29
TC 32
Z9 33
U1 0
U2 0
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD MAY 15
PY 2011
VL 124
IS 10
BP 1629
EP 1634
DI 10.1242/jcs.082487
PG 6
WC Cell Biology
SC Cell Biology
GA 757QD
UT WOS:000290101900005
PM 21525038
OA Bronze
DA 2021-01-25
ER

PT J
AU Perez-Schindler, J
   Philp, A
   Baar, K
   Hernandez-Cascales, J
AF Perez-Schindler, Joaquin
   Philp, Andrew
   Baar, Keith
   Hernandez-Cascales, Jesus
TI Regulation of contractility and metabolic signaling by the
   beta(2)-adrenergic receptor in rat ventricular muscle
SO LIFE SCIENCES
LA English
DT Article
DE beta(2)-adrenergic receptor; Cardiac contractility; Cardiac metabolism;
   AMPK; PI3K
ID ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; HEART-FAILURE; MULTISITE
   PHOSPHORYLATION; MITOCHONDRIAL BIOGENESIS; MYOCARDIAL-INFARCTION;
   CARDIAC MYOCYTES; FAILING HEART; BETA-AGONIST; CAMP SIGNALS
AB Aims: Cardiac function is modulated by the sympathetic nervous system through beta-adrenergic receptor (beta-AR) activity and this represents the main regulatory mechanism for cardiac performance. To date, however, the metabolic and molecular responses to beta(2)-agonists are not well characterized. Therefore, we studied the inotropic effect and signaling response to selective beta(2)-AR activation by tulobuterol.
   Main methods: Strips of rat right ventricle were electrically stimulated (1 Hz) in standard Tyrode solution (95% O-2. 5% CO2) in the presence of the beta(1)-antagonist CGP-20712A (1 mu M). A cumulative dose-response curve for tulobuterol (0.1-10 mu M), in the presence or absence of the phosphodiesterase (PDE) inhibitor IBMX (30 mu M), or 10 min incubation (1 mu M) with the beta(2)-agonist tulobuterol was performed.
   Key findings: beta(2)-AR stimulation induced a positive inotropic effect (maximal effect = 33 +/- 3.3%) and a decrease in the time required for half relaxation (from 45 +/- 0.6 to 31 +/- 1.8 ms, -30%, p < 0.001) after the inhibition of PDEs. After 10 min of beta(2)-AR stimulation, p-AMPK alpha(T172) (54%), p-PKBT308 (38%), p-AS160(T642) (46%) and p-CREBS133 (63%) increased, without any change in p-pKA(T197).
   Significance: These results suggest that the regulation of ventricular contractility is not the primary function of the beta(2)-AR. Rather, beta(2)-AR could function to activate PKB and AMPK signaling, thereby modulating muscle mass and energetic metabolism of rat ventricular muscle. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Perez-Schindler, Joaquin; Hernandez-Cascales, Jesus] Univ Murcia, Fac Med, Dept Pharmacol, Murcia, Spain.
   [Philp, Andrew; Baar, Keith] Univ Dundee, Div Mol Physiol, Dundee, Scotland.
RP Perez-Schindler, J (corresponding author), Univ Basel, Focal Area Growth & Dev, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM j.perezschindler@unibas.ch
OI Perez-Schindler, Joaquin/0000-0003-3141-8859; Baar,
   Keith/0000-0001-9337-6186; Philp, Andrew/0000-0003-3860-4136
CR Ahmet I, 2008, J PHARMACOL EXP THER, V325, P491, DOI 10.1124/jpet.107.135335
   Bernstein D, 2005, AM J PHYSIOL-HEART C, V289, pH2441, DOI 10.1152/ajpheart.00005.2005
   Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093
   Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063
   Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210
   Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377
   Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649
   Gonzalez-Munoz C, 2009, EUR J PHARMACOL, V607, P151, DOI 10.1016/j.ejphar.2009.02.029
   GONZALEZSICILIA L, 1988, GEN PHARMACOL, V19, P103, DOI 10.1016/0306-3623(88)90013-4
   Gregg CJ, 2010, ANESTH ANALG, V111, P870, DOI 10.1213/ANE.0b013e3181ee8312
   Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200
   Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1
   Jo SH, 2002, CIRC RES, V91, P46, DOI 10.1161/01.RES.0000024115.67561.54
   Kerfant BG, 2007, CIRC RES, V101, P400, DOI 10.1161/CIRCRESAHA.107.156422
   Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150
   Kume H., 2005, ALLERGOL INT, V54, P89
   LAORDEN ML, 1985, GEN PHARMACOL, V16, P65, DOI 10.1016/0306-3623(85)90272-1
   Latronico MVG, 2004, ANN NY ACAD SCI, V1015, P250, DOI 10.1196/annals.1302.021
   Leblais V, 2004, CIRC RES, V95, P1183, DOI 10.1161/01.RES.0000150049.74539.8a
   Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817
   Li J, 2010, J PHYSIOL-LONDON, V588, P2987, DOI 10.1113/jphysiol.2010.190900
   Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007
   MacNee W, 2010, SEMIN RESP CRIT CARE, V31, P295, DOI 10.1055/s-0030-1254070
   Marcantoni A, 2006, J CELL PHYSIOL, V206, P329, DOI 10.1002/jcp.20467
   McConville P, 2005, AM J PHYSIOL-ENDOC M, V289, pE412, DOI 10.1152/ajpendo.00049.2004
   Mokni W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014227
   Morin D, 2000, PHARMACOL RES, V41, P435, DOI 10.1006/phrs.1999.0609
   Nevzorova J, 2006, BRIT J PHARMACOL, V147, P446, DOI 10.1038/sj.bjp.0706626
   Ngala RA, 2008, BRIT J PHARMACOL, V155, P395, DOI 10.1038/bjp.2008.244
   PATEL KR, 1985, CLIN THER, V7, P452
   Persson H, 1996, EUR HEART J, V17, P741
   Ponicke K, 2003, N-S ARCH PHARMACOL, V367, P592, DOI 10.1007/s00210-003-0754-z
   Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e
   RUFF F, 1988, J PHARMACOL EXP THER, V244, P173
   RYDEN L, 1990, LANCET, V336, P1
   Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008
   Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010
   Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005
   SCHAFERS RF, 1994, J AM COLL CARDIOL, V23, P1224, DOI 10.1016/0735-1097(94)90615-7
   Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806
   Siedlecka U, 2008, AM J PHYSIOL-HEART C, V295, pH1917, DOI 10.1152/ajpheart.00258.2008
   Soppa GKR, 2005, AM J PHYSIOL-HEART C, V288, pH1468, DOI 10.1152/ajpheart.00624.2004
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   TERPSTRA GK, 1990, LUNG, V168, P179, DOI 10.1007/BF02718130
   Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007
   van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282
   Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103
   Xiao RP, 2004, TRENDS PHARMACOL SCI, V25, P358, DOI 10.1016/j.tips.2004.05.007
   XIAO RP, 1995, MOL PHARMACOL, V47, P322
   Yamamoto DL, 2007, DIABETOLOGIA, V50, P158, DOI 10.1007/s00125-006-0484-0
   Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009
   Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607
NR 54
TC 17
Z9 17
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
J9 LIFE SCI
JI Life Sci.
PD MAY 9
PY 2011
VL 88
IS 19-20
BP 892
EP 897
DI 10.1016/j.lfs.2011.03.020
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 762GI
UT WOS:000290462600010
PM 21466811
DA 2021-01-25
ER

PT J
AU Kuhfahl, S
   Hauburger, A
   Thieme, T
   Groppe, J
   Ihling, C
   Tomic, S
   Schutkowski, M
   Sinz, A
   Schwarz, E
AF Kuhfahl, Silke
   Hauburger, Anja
   Thieme, Tino
   Groppe, Jay
   Ihling, Christian
   Tomic, Sladjana
   Schutkowski, Mike
   Sinz, Andrea
   Schwarz, Elisabeth
TI Identification of a core domain within the proregion of bone
   morphogenetic proteins that interacts with the dimeric, mature domain
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Bone morphogenetic protein; Proregion; Core domain; Folding; Ligand
   binding
ID GROWTH-FACTOR-BETA; MOLECULAR-WEIGHT COMPLEX; HUMAN-PLATELETS;
   FACTOR-BETA-1; PRECURSOR; BMP-2
AB Proregions of bone morphogenetic proteins (BMPs) fulfill important biological functions as intramolecular chaperones and for extracellular targeting of the mature signal ligand. Knowledge of the structures of the proregions would contribute to a more comprehensive picture of the biological activities of the proforms of BMP growth factors. In this study, a protease resistant core domain of the proregions of three BMPs was identified. For a more detailed analysis, the core domain of the BMP-2 proregion was recombinantly produced. Unfolding/refolding experiments and spectroscopic analyses proved that the core domain can be obtained as a folded entity. Binding of the core domain to the mature growth factor was demonstrated by SPR. Via peptide microarray analysis, residues within the core fragment could be identified that engage in binding to the dimeric, mature domain. Our study reveals that diverse members of the BMP family share a common, independently folding core domain within the large proregions peculiar to TGF-beta superfamily members that may serve as a scaffold for folding and assembly of the dimeric proprotein complexes. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Tomic, Sladjana; Schwarz, Elisabeth] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Jr Res Grp Artificial Binding Prot, D-06120 Halle, Germany.
   [Groppe, Jay] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Ihling, Christian; Sinz, Andrea] Univ Halle Wittenberg, Dept Pharmaceut Chem & Bioanalyt, D-06120 Halle, Germany.
   [Schutkowski, Mike] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Dept Enzymol, D-06120 Halle, Germany.
RP Schwarz, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Jr Res Grp Artificial Binding Prot, D-06120 Halle, Germany.
EM elisabeth.schwarz@biochemtech.uni-halle.de
OI Schutkowski, MIke/0000-0003-0919-7076
FU BMBF within the ProNet-T<SUP>3</SUP>-Protein-Kompetenznetzwerk-Halle
FX This work was funded by the BMBF within the
   ProNet-T<SUP>3</SUP>-Protein-Kompetenznetzwerk-Halle: tools, targets,
   therapeutics, subproject Th04 to E. S. We thank David Rauh for assisting
   with the peptide microarray.
CR Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172
   BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8
   De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200
   DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618
   EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x
   GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700
   Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052
   HAMMONDS RG, 1991, MOL ENDOCRINOL, V5, P149, DOI 10.1210/mend-5-1-149
   Hauburger A, 2009, FEBS J, V276, P6386, DOI 10.1111/j.1742-4658.2009.07361.x
   Hillger F, 2005, J BIOL CHEM, V280, P14974, DOI 10.1074/jbc.M414413200
   Hoffmann A, 2010, PROTEIN EXPRES PURIF, V72, P238, DOI 10.1016/j.pep.2010.03.022
   ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2
   Kalkhof S, 2010, BIOCHEMISTRY-US, V49, P8359, DOI 10.1021/bi101187f
   MIYAZONO K, 1988, J BIOL CHEM, V263, P6407
   RUDOLPH R, 1997, PROTEIN FUNCTION PRA, P57
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Schmid F.-X., 1997, PROTEIN STRUCTURE PR, P251
   SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827
   Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200
   Thies RS, 2001, GROWTH FACTORS, V18, P251
   Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681
   WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646
   Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288
   Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200
NR 24
TC 12
Z9 12
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 6
PY 2011
VL 408
IS 2
BP 300
EP 305
DI 10.1016/j.bbrc.2011.04.021
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 764CO
UT WOS:000290606200019
PM 21510924
DA 2021-01-25
ER

PT J
AU Boyan, GS
   Reichert, H
AF Boyan, George S.
   Reichert, Heinrich
TI Mechanisms for complexity in the brain: generating the insect central
   complex
SO TRENDS IN NEUROSCIENCES
LA English
DT Review
ID GRASSHOPPER SCHISTOCERCA-GREGARIA; AMPLIFYING NEUROBLAST LINEAGES;
   INTERMEDIATE PROGENITOR CELLS; REGULATES SELF-RENEWAL;
   CENTRAL-NERVOUS-SYSTEM; ASYMMETRIC DIVISION; ELLIPSOID BODY; EARLY
   NEUROGENESIS; TUMOR-SUPPRESSOR; DROSOPHILA BRAIN
AB The central complex of the insect brain is a remarkably miniaturized but highly complex multimodal information-processing network. Recent work on central complex development in Drosophila and grasshopper reveals that the cells comprising its complex circuitry are generated by a surprisingly small number of primary progenitors. Of these, four identified neural stem cells generate a large number of neurons through a novel mode of neurogenesis that involves self-renewing intermediate progenitor cells. Interestingly, a comparable mode of amplification of proliferation also operates in the developing mammalian cortex; this could be a general strategy for increasing brain size and complexity. Although this type of proliferation generates a large number of progeny, it is also prone to dysregulation, resulting in brain tumors. Thus, furthering our knowledge of the development of the central complex is likely to be valuable not only for understanding brain complexity but could also have important implications for identifying developmental pathways that go awry during tumor formation.
C1 [Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Boyan, George S.] Univ Munich, Bioctr, D-82152 Martinsried, Germany.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BO
   1434/3-5]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [31003A124888/1]; National Research Program 63
   [406340128006/1]
FX This work was supported by Deutsche Forschungsgemeinschaft grant BO
   1434/3-5 to G.S.B. and by Swiss National Science Foundation grant
   31003A124888/1 and National Research Program 63 (Stem cells and
   regenerative medicine) grant 406340128006/1 to H.R.
CR Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26
   Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Boyan GS, 2008, ARTHROPOD STRUCT DEV, V37, P480, DOI 10.1016/j.asd.2008.04.002
   Boyan G, 2010, CELL TISSUE RES, V341, P259, DOI 10.1007/s00441-010-0992-6
   Boyan GS, 1997, DEV GENES EVOL, V207, P317, DOI 10.1007/s004270050119
   BULLOCK TH, 1965, STRUCTURE FUNCTION N, V2
   BULLOCK TH, 1965, STRUCTURE FUNCTION N, V1
   Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632
   CAYRE M, 1994, NATURE, V368, P57, DOI 10.1038/368057a0
   Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   el Jundi B, 2010, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.021.2009
   Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103
   GOODMAN CS, 1994, DEV DROSOPHILA, V1, P1131
   HALTER DA, 1995, DEVELOPMENT, V121, P317
   HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Heinze S, 2008, J COMP NEUROL, V511, P454, DOI 10.1002/cne.21842
   Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531
   Homberg U., 1987, P347
   HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597, DOI 10.1007/BF00199481
   ILIUS M, 1994, J NEUROGENET, V9, P189, DOI 10.3109/01677069409167279
   ITO K, 2008, BRAIN DEV DROSOPHILA, P137
   Izergina N, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-44
   JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700
   Januschke J, 2008, ONCOGENE, V27, P6994, DOI 10.1038/onc.2008.349
   Kao CF, 2010, CURR OPIN NEUROBIOL, V20, P14, DOI 10.1016/j.conb.2009.10.017
   KARLSTROM RO, 1993, DEVELOPMENT, V118, P509
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kurylas AE, 2008, CELL TISSUE RES, V333, P125, DOI 10.1007/s00441-008-0620-x
   Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381
   Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8
   Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4
   Miyata T, 2010, CURR OPIN NEUROBIOL, V20, P22, DOI 10.1016/j.conb.2010.01.001
   NASSEL DR, 1993, CELL TISSUE RES, V273, P1, DOI 10.1007/BF00304608
   Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809
   Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003
   Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639
   Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809
   Pereanu W, 2011, J COMP NEUROL, V519, P661, DOI 10.1002/cne.22542
   Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010
   Reichert H, 1997, TRENDS NEUROSCI, V20, P258, DOI 10.1016/S0166-2236(96)01034-X
   Renn SCP, 1999, J NEUROBIOL, V41, P189
   SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Strausfeld N. J., 1976, ATLAS INSECT BRAIN
   Strausfeld NJ, 2009, P ROY SOC B-BIOL SCI, V276, P1929, DOI 10.1098/rspb.2008.1471
   Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563
   STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993
   Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9
   Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528
   Urbach R, 2003, ARTHROPOD STRUCT DEV, V32, P103, DOI 10.1016/S1467-8039(03)00042-2
   Urbach R, 2003, ARTHROPOD STRUCT DEV, V32, P125, DOI 10.1016/S1467-8039(03)00043-4
   Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506
   Wegerhoff R, 1996, J COMP NEUROL, V375, P157
   Weinrich A, 2008, J COMP PHYSIOL A, V194, P763, DOI 10.1007/s00359-008-0347-x
   Weng M, 2011, CURR OPIN NEUROBIOL, V21, P36, DOI 10.1016/j.conb.2010.09.005
   Williams JLD, 2008, ARTHROPOD STRUCT DEV, V37, P129, DOI 10.1016/j.asd.2007.05.005
   Williams JLD, 2005, ARTHROPOD STRUCT DEV, V34, P97, DOI 10.1016/j.asd.2004.11.001
   WILLIAMS JLD, 1975, J ZOOL, V176, P67
   Young JM, 2010, J COMP NEUROL, V518, P1525, DOI 10.1002/cne.22285
   Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475
   Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016
   ZACHARIAS D, 1993, DEVELOPMENT, V118, P941
   Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002
NR 78
TC 41
Z9 41
U1 0
U2 12
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0166-2236
EI 1878-108X
J9 TRENDS NEUROSCI
JI Trends Neurosci.
PD MAY
PY 2011
VL 34
IS 5
BP 247
EP 257
DI 10.1016/j.tins.2011.02.002
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 771CV
UT WOS:000291135700003
PM 21397959
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Mariani, V
   Schenk, AD
   Philippsen, A
   Engel, A
AF Mariani, Valerio
   Schenk, Andreas D.
   Philippsen, Ansgar
   Engel, Andreas
TI Simulation and correction of electron images of tilted planar weak-phase
   samples
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Contrast Transfer Function; Tilted plane imaging; Image processing;
   Transmission electron microscopy; Electron tomography; Electron
   crystallography
AB The phase contrast theory describes the transfer of information from a weak-phase object to the image plane of a transmission electron microscope. For a tilted sample where the distance from the focal plane varies continuously across the field of view, the recently introduced Tilted Contrast Imaging Function (TCIF) model provides the mathematical description of this information transfer. Here we expand the TCIF model to account for astigmatism, and present several methods to generate simulated images of tilted samples and compare them to experimental results. We analyze in depth the differences between TCIF and the classical Contrast Transfer Function (CTF) model, which assumes invariant defocus, and discuss how they can affect the interpretation of experimental data. In addition, we apply the TCIF model to simulated test objects in order to explore the performance of techniques that aim to correct the artifacts introduced by the imaging function, and evaluate how well they recover the original information after optimizing the parameters. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Engel, Andreas] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, Basel, Switzerland.
   [Mariani, Valerio] Univ Basel, Swiss Inst Bioinformat, Basel, Switzerland.
   [Schenk, Andreas D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, Mattenstr 26, Basel, Switzerland.
EM andreas.engel@unibas.ch
OI Schenk, Andreas/0000-0001-9214-2505
FU EUEuropean Union (EU); National Center of Competence in Research
   Structural Biology; Swiss National FoundationSwiss National Science
   Foundation (SNSF); Maurice E. Muller Foundation
FX The work described in this manuscript was supported by the EU 6th
   framework (3DEM-NoE), the National Center of Competence in Research
   Structural Biology, the Swiss National Foundation and the Maurice E.
   Muller Foundation. The authors thank Prof. Salvatore Lanzavecchia from
   the University of Milano and Hans-Andreas Engel for inspiring
   discussions.
CR [Anonymous], 2010, INT TABLES CRYSTALLO
   Boothroyd CB, 2000, ULTRAMICROSCOPY, V83, P159, DOI 10.1016/S0304-3991(00)00012-7
   CHEVALIER JP, 1993, ULTRAMICROSCOPY, V52, P253, DOI 10.1016/0304-3991(93)90033-T
   DeRosier DJ, 2000, ULTRAMICROSCOPY, V81, P83, DOI 10.1016/S0304-3991(99)00120-5
   Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004
   FRANK J, 1973, OPTIK, V38, P519
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Goodman J. W., 2005, INTRO FOURIER OPTICS
   GOODMAN JW, 1981, OPTICAL INFORM PROCE
   Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933
   LANZAVECCHIA S, 1997, SCANNING MICROSCOPY, V11, P155
   LENZ F, 1971, ELECT MICROSCOPY MAT
   PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A
   Philippsen A, 2007, ULTRAMICROSCOPY, V107, P202, DOI 10.1016/j.ultramic.2006.07.010
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   Reimer L., 1997, TRANSMISSION ELECT M
   ROBBINS GM, 1972, PR INST ELECTR ELECT, V60, P862, DOI 10.1109/PROC.1972.8785
   SCHERZER O, 1949, J APPL PHYS, V20, P20, DOI 10.1063/1.1698233
   van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644
   WADE RH, 1977, OPTIK, V49, P81
   Wan Y, 2004, 2004 INTERNATIONAL CONFERENCE ON COMMUNICATION, CIRCUITS, AND SYSTEMS, VOLS 1 AND 2, P960, DOI 10.1109/ICCCAS.2004.1346339
   Winkler H, 2003, J STRUCT BIOL, V143, P24, DOI 10.1016/S1047-8477(03)00120-5
NR 24
TC 8
Z9 8
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAY
PY 2011
VL 174
IS 2
BP 259
EP 268
DI 10.1016/j.jsb.2011.02.008
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 754CL
UT WOS:000289829600001
PM 21362479
DA 2021-01-25
ER

PT J
AU Dezi, M
   Fribourg, PF
   Di Cicco, A
   Jault, JM
   Chami, M
   Levy, D
AF Dezi, Manuela
   Fribourg, Pierre-Frederic
   Di Cicco, Aurelie
   Jault, Jean-Michel
   Chami, Mohamed
   Levy, Daniel
TI Binding, reconstitution and 2D crystallization of membrane or soluble
   proteins onto functionalised lipid layer observed in situ by reflected
   light microscopy
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Functionalized lipid layer; 2D crystallization; BmrA; Reflective light
   microscopy; Electron microscopy
ID AIR-WATER-INTERFACE; TOXIN B-SUBUNIT; 2-DIMENSIONAL CRYSTALLIZATION;
   ELECTRON-MICROSCOPY; MONOLAYER PURIFICATION; STRUCTURAL-ANALYSIS;
   P-GLYCOPROTEIN; CRYSTALS; COMPLEXES; ARRAYS
AB Monolayer of functionalized lipid spread at the air/water interface is used for the structural analysis of soluble and membrane proteins by electron crystallography and single particle analysis. This powerful approach lacks of a method for the screening of the binding of proteins to the surface of the lipid layer. Here, we described an optical method based on the use of reflected light microscopy to image, without the use of any labeling, the lipid layer at the surface of buffers in the Teflon wells used for 2D crystallization. Images revealed that the lipid layer was made of a monolayer coexisting with liposomes or aggregates of lipids floating at the surface. Protein binding led to an increase of the contrast and the decrease of the fluidity of the lipid surface, as demonstrated with the binding of soluble Shiga toxin B subunit, of purple membrane and of solubilized His-BmrA, a bacterial ABC transporter. Moreover the reconstitution of membrane proteins bound to the lipidic surface upon detergent removal can be followed through the appearance of large recognizable domains at the surface. Proteins binding and reconstitution were further confirmed by electron microcopy. Overall, this method provides a quick evaluation of the monolayer trials, a significant reduction in screening by transmission electron microscopy and new insights in the proteins binding and 2D crystallogenesis at the lipid surface. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Dezi, Manuela; Fribourg, Pierre-Frederic; Di Cicco, Aurelie; Levy, Daniel] Ctr Rech, Inst Curie, F-75231 Paris, France.
   [Dezi, Manuela; Fribourg, Pierre-Frederic; Di Cicco, Aurelie; Levy, Daniel] CNRS, UMR 168, F-75231 Paris, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
   [Jault, Jean-Michel] Univ Lyon 1, Inst Biol & Chim Prot, CNRS, UMR 5086, F-69367 Lyon 07, France.
   [Jault, Jean-Michel] IFR 128, F-69367 Lyon 07, France.
RP Levy, D (corresponding author), Ctr Rech, Inst Curie, F-75231 Paris, France.
EM daniel.levy@curie.fr
RI jault, jean-michel/G-2086-2012
OI jault, jean-michel/0000-0003-1743-2777; levy, daniel/0000-0002-8949-4072
CR Arechaga I, 2007, J STRUCT BIOL, V160, P287, DOI 10.1016/j.jsb.2007.09.007
   ASTURIAS FJ, 1995, J STRUCT BIOL, V114, P60, DOI 10.1006/jsbi.1995.1005
   Barklis E, 1998, J BIOL CHEM, V273, P7177, DOI 10.1074/jbc.273.13.7177
   Brisson A, 1999, J CRYST GROWTH, V196, P456, DOI 10.1016/S0022-0248(98)00834-3
   Clemente-Leon M, 2006, LANGMUIR, V22, P6993, DOI 10.1021/la061284p
   DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N
   Dezi M, 2010, BBA-BIOMEMBRANES, V1798, P2094, DOI 10.1016/j.bbamem.2010.07.034
   Dietrich J, 2005, STRATEGIES FOR TWO-DIMENSIONAL CRYSTALLIZATION OF PROTEINS USING LIPID MONOLAYERS, P1
   Ellis MJ, 1997, J STRUCT BIOL, V118, P178, DOI 10.1006/jsbi.1997.3849
   Fezoua-Boubegtiten Z, 2010, BBA-BIOMEMBRANES, V1798, P1204, DOI 10.1016/j.bbamem.2010.03.014
   Fontaine P, 2007, LANGMUIR, V23, P12959, DOI 10.1021/la701293n
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Hagnerelle X, 2002, J STRUCT BIOL, V139, P113, DOI 10.1016/S1047-8477(02)00504-X
   Kelly DF, 2008, P NATL ACAD SCI USA, V105, P4703, DOI 10.1073/pnas.0800867105
   Kelly DF, 2010, METHOD ENZYMOL, V481, P83, DOI 10.1016/S0076-6879(10)81004-3
   Kita-Tokarczyk K, 2009, LANGMUIR, V25, P9847, DOI 10.1021/la900948a
   Lebeau L, 2001, J MOL BIOL, V308, P639, DOI 10.1006/jmbi.2001.4629
   Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200
   Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200
   Lenne PF, 2000, BIOPHYS J, V79, P496, DOI 10.1016/S0006-3495(00)76311-9
   Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X
   Levy D, 1999, J STRUCT BIOL, V127, P44, DOI 10.1006/jsbi.1999.4155
   MOSSER G, 1991, J ELECTRON MICR TECH, V18, P387, DOI 10.1002/jemt.1060180407
   MOSSER G, 1991, J STRUCT BIOL, V106, P191, DOI 10.1016/1047-8477(91)90068-8
   MOSSER G, 1992, J MOL BIOL, V226, P23, DOI 10.1016/0022-2836(92)90120-9
   Orelle C, 2008, BIOCHEMISTRY-US, V47, P2404, DOI 10.1021/bi702303s
   RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V
   Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018
   Taylor KA, 1999, J STRUCT BIOL, V128, P75, DOI 10.1006/jsbi.1999.4167
   Venien-Bryan C, 1998, BIOPHYS J, V74, P2649, DOI 10.1016/S0006-3495(98)77970-6
NR 30
TC 6
Z9 6
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAY
PY 2011
VL 174
IS 2
BP 307
EP 314
DI 10.1016/j.jsb.2010.12.001
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 754CL
UT WOS:000289829600006
PM 21163357
DA 2021-01-25
ER

PT J
AU Roux, B
   Berneche, S
   Egwolf, B
   Lev, B
   Noskov, SY
   Rowley, CN
   Yu, HB
AF Roux, Benoit
   Berneche, Simon
   Egwolf, Bernhard
   Lev, Bogdan
   Noskov, Sergei Y.
   Rowley, Christopher N.
   Yu, Haibo
TI Ion selectivity in channels and transporters
SO JOURNAL OF GENERAL PHYSIOLOGY
LA English
DT Editorial Material
ID KCSA POTASSIUM CHANNEL; MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY; K+
   CHANNEL; ALPHA-HEMOLYSIN; BINDING-SITES; FOLDING THERMODYNAMICS;
   TOPOLOGICAL CONTROL; RYANODINE RECEPTOR; BROWNIAN DYNAMICS
C1 [Roux, Benoit; Rowley, Christopher N.] Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA.
   [Berneche, Simon] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Egwolf, Bernhard] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany.
   [Lev, Bogdan; Noskov, Sergei Y.] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada.
   [Lev, Bogdan; Noskov, Sergei Y.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada.
   [Yu, Haibo] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia.
RP Roux, B (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, 920 E 58Th St, Chicago, IL 60637 USA.
EM roux@uchicago.edu
RI Berneche, Simon/L-6389-2013; Lev, Bogdan/A-8273-2018; Rowley,
   Christopher/A-1067-2009; Yu, Haibo/B-9750-2008
OI Berneche, Simon/0000-0002-6274-4094; Rowley,
   Christopher/0000-0002-0205-952X; Yu, Haibo/0000-0002-1099-2803; Noskov,
   Sergei/0000-0001-7769-335X; Lev, Bogdan/0000-0002-7631-9400
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [200804MOP-186232] Funding Source: Medline; NIGMS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM-062342, R01 GM062342] Funding Source:
   Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM062342, R01GM062342, R01GM062342, R01GM062342, R01GM062342,
   R01GM062342, R01GM062342, R01GM062342, R01GM062342, R01GM062342,
   R01GM062342, R01GM062342, R01GM062342, R01GM062342, R01GM062342,
   R01GM062342, R01GM062342, R01GM062342, R01GM062342, R01GM062342] Funding
   Source: NIH RePORTER
CR Alam A, 2011, J GEN PHYSIOL, V137, P397, DOI 10.1085/jgp.201010546
   Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531
   Allen TW, 2006, BIOPHYS CHEM, V124, P251, DOI 10.1016/j.bpc.2006.04.015
   Allen TW, 2004, J GEN PHYSIOL, V124, P679, DOI 10.1085/jgp.200409111
   AQVIST J, 1990, J PHYS CHEM-US, V94, P8021
   AQVIST J, 1992, J PHYS CHEM-US, V96, P10019
   Asthagiri D, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2205853
   BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098
   Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7
   Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019
   Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067
   Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100
   BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588
   Biggin PC, 2001, BBA-BIOMEMBRANES, V1510, P1, DOI 10.1016/S0005-2736(00)00345-X
   Boiteux C, 2011, STRUCTURE, V19, P70, DOI 10.1016/j.str.2010.10.008
   Bostick DL, 2007, P NATL ACAD SCI USA, V104, P9260, DOI 10.1073/pnas.0700554104
   Bostick DL, 2010, J AM CHEM SOC, V132, P13185, DOI 10.1021/ja106197e
   Bostick DL, 2009, BIOPHYS J, V96, P4470, DOI 10.1016/j.bpj.2009.03.001
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Bucher D, 2007, BIOPHYS J, V93, P2315, DOI 10.1529/biophysj.106.102509
   Bucher D, 2010, J GEN PHYSIOL, V135, P549, DOI 10.1085/jgp.201010404
   Bucher D, 2010, BIOPHYS J, V98, pL47, DOI 10.1016/j.bpj.2010.01.064
   CASPAR DLD, 1988, NATURE, V332, P659, DOI 10.1038/332659a0
   Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069
   Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136
   Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h
   DIETRICH B, 1985, J CHEM EDUC, V62, P954, DOI 10.1021/ed062p954
   Dixit PD, 2011, BIOPHYS J, V100, P1542, DOI 10.1016/j.bpj.2011.01.044
   Dixit PD, 2009, BIOPHYS J, V96, P2138, DOI 10.1016/j.bpj.2008.12.3917
   Domene C, 2008, J AM CHEM SOC, V130, P9474, DOI 10.1021/ja801792g
   Domene C, 2009, J MOL BIOL, V389, P637, DOI 10.1016/j.jmb.2009.04.038
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Dudev T, 2009, J AM CHEM SOC, V131, P8092, DOI 10.1021/ja900168k
   Egwolf B, 2010, J MOL BIOL, V401, P831, DOI 10.1016/j.jmb.2010.07.006
   Egwolf B, 2010, J PHYS CHEM B, V114, P2901, DOI 10.1021/jp906791b
   Furini S, 2009, P NATL ACAD SCI USA, V106, P16074, DOI 10.1073/pnas.0903226106
   Gillespie D, 2005, J PHYS CHEM B, V109, P15598, DOI 10.1021/jp052471j
   Gillespie D, 2008, BIOPHYS J, V94, P1169, DOI 10.1529/biophysj.107.113084
   Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495
   GROOTENHUIS PDJ, 1989, J AM CHEM SOC, V111, P2152, DOI 10.1021/ja00188a032
   Grossfield A, 2003, J AM CHEM SOC, V125, P15671, DOI 10.1021/ja037005r
   Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c
   Hille B, 1999, NAT MED, V5, P1105, DOI 10.1038/13415
   Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7
   Jang H, 2002, BIOPHYS J, V82, P646, DOI 10.1016/S0006-3495(02)75428-3
   Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107
   KNELLER GR, 1994, J MOL BIOL, V242, P181, DOI 10.1006/jmbi.1994.1570
   Lamoureux G, 2006, J PHYS CHEM B, V110, P3308, DOI 10.1021/jp056043p
   Lamoureux G, 2006, CHEM PHYS LETT, V418, P245, DOI 10.1016/j.cplett.2005.10.135
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lev B, 2010, J COMPUT CHEM, V31, P1015, DOI 10.1002/jcc.21387
   Lindemann FA, 1910, PHYS Z, V11, P609
   Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199
   Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121
   Luo Y, 2010, J PHYS CHEM B, V114, P952, DOI 10.1021/jp906790f
   Luzhkov VB, 2001, BBA-PROTEIN STRUCT M, V1548, P194, DOI 10.1016/S0167-4838(01)00213-8
   LYBRAND TP, 1986, P NATL ACAD SCI USA, V83, P833, DOI 10.1073/pnas.83.4.833
   MacKerell Jr AD, 1998, ENCY COMPUTATIONAL C, P271
   Maragliano L, 2009, J CHEM THEORY COMPUT, V5, P2589, DOI 10.1021/ct900279z
   MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0
   NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569
   NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549
   Nimigean CM, 2002, J GEN PHYSIOL, V120, P323, DOI 10.1085/jgp.20028614
   Nimigean CM, 2011, J GEN PHYSIOL, V137, P405, DOI 10.1085/jgp.201010551
   Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015
   Noskov SY, 2007, J GEN PHYSIOL, V129, P135, DOI 10.1085/jgp.200609633
   Noskov SY, 2006, BIOPHYS CHEM, V124, P279, DOI 10.1016/j.bpc.2006.05.033
   Noskov SY, 2004, BIOPHYS J, V87, P2299, DOI 10.1529/biophysj.104.044008
   Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943
   Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006
   Pan AC, 2008, J PHYS CHEM B, V112, P3432, DOI 10.1021/jp0777059
   Pan AC, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2959573
   Patel S, 2004, J COMPUT CHEM, V25, P1504, DOI 10.1002/jcc.20077
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Ratheal IM, 2010, P NATL ACAD SCI USA, V107, P18718, DOI 10.1073/pnas.1004214107
   Roux B, 1996, BIOPHYS J, V71, P3177, DOI 10.1016/S0006-3495(96)79511-5
   Roux B, 2004, Q REV BIOPHYS, V37, P15, DOI 10.1017/S0033583504003968
   Roux B, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3436632
   Roux B, 2010, BIOPHYS J, V98, P2877, DOI 10.1016/j.bpj.2010.03.038
   Roux B, 2010, J GEN PHYSIOL, V135, P547, DOI 10.1085/jgp.201010456
   Sheinerman FB, 1998, P NATL ACAD SCI USA, V95, P1562, DOI 10.1073/pnas.95.4.1562
   Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508
   Soper AK, 2006, BIOPHYS CHEM, V124, P180, DOI 10.1016/j.bpc.2006.04.009
   STRAATSMA TP, 1988, J CHEM PHYS, V89, P5876, DOI 10.1063/1.455539
   Thomas M, 2007, BIOPHYS J, V93, P2635, DOI 10.1529/biophysj.107.108167
   Thomas M, 2011, BIOPHYS J, V100, P60, DOI 10.1016/j.bpj.2010.11.022
   Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703
   TROULLIER N, 1991, PHYS REV B, V43, P8861, DOI 10.1103/PhysRevB.43.8861
   Valiyaveetil FI, 2006, SCIENCE, V314, P1004, DOI 10.1126/science.1133415
   VARMA S, 2011, J GEN PHYSL IN PRESS
   Varma S, 2007, BIOPHYS J, V93, P1093, DOI 10.1529/biophysj.107.107482
   Varma S, 2008, J AM CHEM SOC, V130, P15405, DOI 10.1021/ja803575y
   Whitfield TW, 2007, J CHEM THEORY COMPUT, V3, P2068, DOI 10.1021/ct700172b
   Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865
   Yu HB, 2010, P NATL ACAD SCI USA, V107, P20329, DOI 10.1073/pnas.1007150107
   Yu H, 2010, J AM CHEM SOC, V132, P10847, DOI 10.1021/ja103270w
   Yu HB, 2010, J CHEM THEORY COMPUT, V6, P774, DOI 10.1021/ct900576a
   Yu HB, 2009, BIOPHYS J, V97, pL15, DOI 10.1016/j.bpj.2009.08.005
   Yu HB, 2009, J PHYS CHEM B, V113, P8725, DOI 10.1021/jp901233v
   Zagotta WN, 2006, NATURE, V440, P427, DOI 10.1038/440427a
   Zhang R, 2010, ADV QUANTUM CHEM, V59, P353, DOI 10.1016/S0065-3276(10)59010-5
   Zhou YQ, 1999, J MOL BIOL, V293, P917, DOI 10.1006/jmbi.1999.2936
   Zhou YQ, 1997, P NATL ACAD SCI USA, V94, P14429, DOI 10.1073/pnas.94.26.14429
NR 105
TC 108
Z9 109
U1 0
U2 28
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1295
EI 1540-7748
J9 J GEN PHYSIOL
JI J. Gen. Physiol.
PD MAY
PY 2011
VL 137
IS 5
BP 415
EP 426
DI 10.1085/jgp.201010577
PG 12
WC Physiology
SC Physiology
GA 754VG
UT WOS:000289885200004
PM 21518830
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Summermatter, S
   Troxler, H
   Santos, G
   Handschin, C
AF Summermatter, Serge
   Troxler, Heinz
   Santos, Gesa
   Handschin, Christoph
TI Coordinated balancing of muscle oxidative metabolism through PGC-1 alpha
   increases metabolic flexibility and preserves insulin sensitivity
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Metabolic flexibility; Exercise mimetics; Insulin resistance; Glucose
   homeostasis; PGC-1 alpha
ID TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; SKELETAL-MUSCLE; EXERCISE
   MIMETICS; CHRONIC DISEASE; RESISTANCE; EXPRESSION; 1-ALPHA; RISK
AB The peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) enhances oxidative metabolism in skeletal muscle. Excessive lipid oxidation and electron transport chain activity can, however, lead to the accumulation of harmful metabolites and impair glucose homeostasis. Here, we investigated the effect of over-expression of PGC-1 alpha on metabolic control and generation of insulin desensitizing agents in extensor digitorum longus (EDL), a muscle that exhibits low levels of PGC-1 alpha in the untrained state and minimally relies on oxidative metabolism. We demonstrate that PGC-1 alpha induces a strictly balanced substrate oxidation in EDL by concomitantly promoting the transcription of activators and inhibitors of lipid oxidation. Moreover, we show that PGC-1 alpha enhances the potential to uncouple oxidative phosphorylation. Thereby, PGC-1 alpha boosts elevated, yet tightly regulated oxidative metabolism devoid of side products that are detrimental for glucose homeostasis. Accordingly, PI3K activity, an early phase marker for insulin resistance, is preserved in EDL muscle. Our findings suggest that PGC-1 alpha coordinately coactivates the simultaneous transcription of gene clusters implicated in the positive and negative regulation of oxidative metabolism and thereby increases metabolic flexibility. Thus, in mice fed a normal chow diet, overexpression of PGC-1 alpha does not alter insulin sensitivity and the metabolic adaptations elicited by PGC-1 alpha mimic the beneficial effects of endurance training on muscle metabolism in this context. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Summermatter, Serge; Santos, Gesa; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   [Troxler, Heinz] Univ Zurich, Univ Childrens Hosp, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Muscular Dystrophy Association USA (MDA)Muscular Dystrophy
   Association; SwissLife 'Jubilaumsstiftung fur Volksgesundheit und
   medizinische Forschung'; Swiss Society for Research on Muscle Diseases
   (SSEM); Swiss Diabetes Association; Roche Research Foundation; United
   Mitochondrial Disease Foundation (UMDF); Association Francaise contre
   les Myopathies (AFM)Association Francaise contre les Myopathies;
   Gebert-Ruf Stiftung (GRS); University of Basel
FX We thank Urs A. Meyer (Biozentrum, Basel) and our colleagues in the
   laboratory for discussions and comments on the manuscript. This project
   was funded by the Swiss National Science Foundation, the Muscular
   Dystrophy Association USA (MDA), the SwissLife 'Jubilaumsstiftung fur
   Volksgesundheit und medizinische Forschung', the Swiss Society for
   Research on Muscle Diseases (SSEM), the Swiss Diabetes Association, the
   Roche Research Foundation, the United Mitochondrial Disease Foundation
   (UMDF), the Association Francaise contre les Myopathies (AFM), the
   Gebert-Ruf Stiftung (GRS) and the University of Basel.
CR Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754
   An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Booth FW, 2008, EUR J APPL PHYSIOL, V102, P381, DOI 10.1007/s00421-007-0606-5
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Carey AL, 2009, DIABETOLOGIA, V52, P2015, DOI 10.1007/s00125-009-1420-x
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Civitarese AE, 2008, ENDOCRINOLOGY, V149, P950, DOI 10.1210/en.2007-1444
   Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249
   Dyck DJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE340
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   MIHALIK SJ, 2010, OBESITY SILVER SPRIN, P1695
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Russell AP, 2005, CURR DIABETES REV, V1, P175, DOI 10.2174/1573399054022811
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Summermatter S, 2008, FASEB J, V22, P774, DOI 10.1096/fj.07-8972com
   Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995
   Summermatter S, 2009, DIABETES, V58, P2228, DOI 10.2337/db08-1793
NR 26
TC 23
Z9 25
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 29
PY 2011
VL 408
IS 1
BP 180
EP 185
DI 10.1016/j.bbrc.2011.04.012
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 766KM
UT WOS:000290781000031
PM 21501593
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Colonques, J
   Ceron, J
   Reichert, H
   Tejedor, FJ
AF Colonques, Jordi
   Ceron, Julian
   Reichert, Heinrich
   Tejedor, Francisco J.
TI A Transient Expression of Prospero Promotes Cell Cycle Exit of
   Drosophila Postembryonic Neurons through the Regulation of Dacapo
SO PLOS ONE
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; DEPENDENT KINASE INHIBITOR;
   NEUROBLAST LINEAGES; SELF-RENEWAL; ASYMMETRIC LOCALIZATION;
   PROLIFERATION PATTERN; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MOSAIC
   ANALYSIS
AB Cell proliferation, specification and terminal differentiation must be precisely coordinated during brain development to ensure the correct production of different neuronal populations. Most Drosophila neuroblasts (NBs) divide asymmetrically to generate a new NB and an intermediate progenitor called ganglion mother cell (GMC) which divides only once to generate two postmitotic cells called ganglion cells (GCs) that subsequently differentiate into neurons. During the asymmetric division of NBs, the homeodomain transcription factor PROSPERO is segregated into the GMC where it plays a key role as cell fate determinant. Previous work on embryonic neurogenesis has shown that PROSPERO is not expressed in postmitotic neuronal progeny. Thus, PROSPERO is thought to function in the GMC by repressing genes required for cell-cycle progression and activating genes involved in terminal differentiation. Here we focus on postembryonic neurogenesis and show that the expression of PROSPERO is transiently upregulated in the newly born neuronal progeny generated by most of the larval NBs of the OL and CB. Moreover, we provide evidence that this expression of PROSPERO in GCs inhibits their cell cycle progression by activating the expression of the cyclin-dependent kinase inhibitor (CKI) DACAPO. These findings imply that PROSPERO, in addition to its known role as cell fate determinant in GMCs, provides a transient signal to ensure a precise timing for cell cycle exit of prospective neurons, and hence may link the mechanisms that regulate neurogenesis and those that control cell cycle progression in postembryonic brain development.
C1 [Colonques, Jordi; Ceron, Julian; Tejedor, Francisco J.] CSIC UMH, Inst Neurosci, Alicante, Spain.
   [Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland.
RP Colonques, J (corresponding author), CSIC UMH, Inst Neurosci, Alicante, Spain.
EM f.tejedor@umh.es
RI ceron, julian/AAA-8008-2019
OI Ceron, Julian/0000-0003-4739-2243; Tejedor, Francisco
   J/0000-0003-1942-2580
FU Ministry of Science and InnovationSpanish Government; Generalitat
   ValencianaGeneralitat Valenciana; Fundacioen Inocente Inocente; Ministry
   of Education and ScienceMinistry of Education, Culture, Sports, Science
   and Technology, Japan (MEXT)
FX This work was supported by grants from the Ministry of Science and
   Innovation, the Generalitat Valenciana, and the Fundacioen Inocente
   Inocente to FJT. J. Ceron and J. Colonques were recipients of PhD
   fellowships from the Ministry of Education and Science. The funders of
   this work had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004
   Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26
   Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Broadus J, 1998, NATURE, V391, P792
   Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110
   Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015
   Colonques J, 2007, MECH DEVELOP, V124, P327, DOI 10.1016/j.mod.2007.01.004
   DATTA S, 1995, DEVELOPMENT, V121, P1173
   deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X
   DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9
   Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144
   Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1
   Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103
   Grosjean Y, 2003, J NEUROBIOL, V55, P1, DOI 10.1002/neu.10208
   Hassan B, 1997, P NATL ACAD SCI USA, V94, P10991, DOI 10.1073/pnas.94.20.10991
   HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393
   IkeshimaKataoka H, 1997, NATURE, V390, P625
   Ito K, 1997, DEVELOPMENT, V124, P761
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854
   Kurusu M, 2009, DEV BIOL, V326, P224, DOI 10.1016/j.ydbio.2008.11.013
   Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8
   Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Li L, 2000, GENE DEV, V14, P147
   Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8
   Liu TH, 2002, MECH DEVELOP, V112, P25, DOI 10.1016/S0925-4773(01)00626-8
   Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.3.CO;2-O
   Matsuzaki F, 1998, DEVELOPMENT, V125, P4089
   Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009
   Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034
   Meinertzhagen Ian A., 1993, P1363
   OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M
   Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000
   Reddy GV, 1999, DEVELOPMENT, V126, P2083
   ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503
   Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847
   Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005
   Torii MA, 1999, DEVELOPMENT, V126, P443
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528
   VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8
   Wallace K, 2000, GENESIS, V26, P77, DOI 10.1002/(SICI)1526-968X(200001)26:1<77::AID-GENE10>3.0.CO;2-R
   WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5
   Wigle JT, 1999, NAT GENET, V21, P318
NR 53
TC 14
Z9 14
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 28
PY 2011
VL 6
IS 4
AR e19342
DI 10.1371/journal.pone.0019342
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 756NX
UT WOS:000290020700049
PM 21552484
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Kapinos, LE
   Burkhard, P
   Herrmann, H
   Aebi, U
   Strelkov, SV
AF Kapinos, Larisa E.
   Burkhard, Peter
   Herrmann, Harald
   Aebi, Ueli
   Strelkov, Sergei V.
TI Simultaneous Formation of Right- and Left-handed Anti-parallel
   Coiled-coil Interfaces by a Coil2 Fragment of Human Lamin A
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE intermediate filaments; nuclear lamins; left-handed coiled coil;
   right-handed coiled coil; filament assembly
ID INTERMEDIATE-FILAMENTS; ATOMIC-STRUCTURE; PROTEINS; DOMAIN;
   ARCHITECTURE; VIMENTIN; TAIL; 2B; LAMINOPATHIES; EXPRESSION
AB The elementary building block of all intermediate filaments (IFs) is a dimer featuring a central a-helical rod domain flanked by the N- and C-terminal end domains. In nuclear IF proteins (lamins), the rod domain consists of two coiled-coil segments, coil1 and coil2, that are connected by a short non-helical linker. Coil and the C-terminal part of coil2 contain the two highly conserved IF consensus motifs involved in the longitudinal assembly of dimers. The previously solved crystal structure of a lamin A fragment (residues 305-387) corresponding to the second half of coil2 has yielded a parallel left-handed coiled coil. Here, we present the crystal structure and solution properties of another human lamin A fragment (residues 328-398), which is largely overlapping with fragment 305-387 but harbors a short segment of the tail domain. Unexpectedly, no parallel coiled coil forms within the crystal. Instead, the a-helices are arranged such that two anti-parallel coiled-coil interfaces are formed. The most significant interface has a right-handed geometry, which is accounted for by a characteristic 15-residue repeat pattern that overlays with the canonical heptad repeat pattern. The second interface is a left-handed anti-parallel coiled coil based on the predicted heptad repeat pattern. In solution, the fragment reveals only a weak dimerization propensity. We speculate that the C-terminus of coil2 might unzip, thereby allowing for a right-handed coiled-coil interface to form between two laterally aligned dimers. Such an interface might co-exist with a heterotetrameric left-handed coiled-coil assembly, which is expected to be responsible for the longitudinal A(CN) contact. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kapinos, Larisa E.; Aebi, Ueli] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4003 Basel, Switzerland.
   [Burkhard, Peter] Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.
   [Burkhard, Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.
   [Herrmann, Harald] German Canc Res Ctr, D-6900 Heidelberg, Germany.
   [Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut Sci, Louvain, Belgium.
RP Kapinos, LE (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4003 Basel, Switzerland.
EM larisa.kapinos@unibas.ch; sergei.strelkov@pharm.kuleuven.be
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
FU SNF; EUEuropean Union (EU); Katholieke Universiteit LeuvenKU Leuven; M.
   E. Muller Foundation
FX We thank Professor Tilman Schirmer for help with crystallographic data
   processing and Ariel Lustig and Norbert Mucke for analytical
   ultracentrifugation measurements. Diffraction data collection facilities
   were provided by the SLS synchrotron (Switzerland), beamline PXI. This
   work was supported by the Marie Heim-Vogtlin Programme of the SNF (to
   L.E.K.), EU FP6 project EURO Laminopathies (to H.H. and U.A.), the OT
   grant from the Katholieke Universiteit Leuven (to S.V.S.) and the M. E.
   Muller Foundation.
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Ben-Harush K, 2009, J MOL BIOL, V386, P1392, DOI 10.1016/j.jmb.2008.12.024
   Bonne G., 2010, GENEREVIEWS
   Bosshard HR, 2001, BIOCHEMISTRY-US, V40, P3544, DOI 10.1021/bi002161l
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906
   Cowtan K, 1994, JOINT CCP4 ESF EACBM, V31, P34
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0
   Dragan AI, 2002, J MOL BIOL, V321, P891, DOI 10.1016/S0022-2836(02)00699-X
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Erber A, 1999, J MOL EVOL, V49, P260, DOI 10.1007/PL00006548
   GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x
   Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   HEITLINGER E, 1992, J STRUCT BIOL, V108, P74, DOI 10.1016/1047-8477(92)90009-Y
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214
   Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200
   Kapinos LE, 2010, J MOL BIOL, V396, P719, DOI 10.1016/j.jmb.2009.12.001
   Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101
   Leslie A.G.W., 1992, JOINT CCP4 ESF EAMCB, V26
   Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012
   Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4
   Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Taimen P, 2009, P NATL ACAD SCI USA, V106, P20788, DOI 10.1073/pnas.0911895106
   Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101
   Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679
   Zwerger M, 2010, MOL BIOL CELL, V21, P354, DOI 10.1091/mbc.E09-08-0739
NR 47
TC 21
Z9 22
U1 1
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 22
PY 2011
VL 408
IS 1
BP 135
EP 146
DI 10.1016/j.jmb.2011.02.037
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 753XL
UT WOS:000289813700011
PM 21354179
DA 2021-01-25
ER

PT J
AU Habazettl, J
   Allan, MG
   Jenal, U
   Grzesiek, S
AF Habazettl, Judith
   Allan, Martin G.
   Jenal, Urs
   Grzesiek, Stephan
TI Solution Structure of the PilZ Domain Protein PA4608 Complex with Cyclic
   di-GMP Identifies Charge Clustering as Molecular Readout
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; ALLOSTERIC CONTROL; BIOFILM FORMATION;
   DIGUANYLATE CYCLASE; BINDING-PROTEIN; VIRULENCE; NMR; BIOSYNTHESIS;
   MODULATION; SYSTEM
AB Cyclic diguanosine monophosphate (c-di-GMP) is a ubiquitous bacterial second messenger that controls the switch from a single-cell lifestyle to surface-attached, multicellular communities called biofilms. PilZ domain proteins are a family of bacterial c-di-GMP receptors, which control various cellular processes. We have solved the solution structure of the Pseudomonas aeruginosa single-domain PilZ protein PA4608 in complex with c-di-GMP by NMR spectroscopy. Isotope labeling by C-13 and N-15 of both the ligand and the protein made it possible to define the structure of c-di-GMP in the complex at high precision by a large number of intermolecular and intraligand NOEs and by two intermolecular hydrogen bond scalar couplings. Complex formation induces significant rearrangements of the C-and N-terminal parts of PA4608. c-di-GMP binds as an intercalated, symmetric dimer to one side of the beta-barrel, thereby displacing the C-terminal helix of the apo state. The N-terminal RXXXR PilZ domain motif, which is flexible in the apo state, wraps around the ligand and in turn ties the displaced C terminus in a loose manner by a number of hydrophobic contacts. The recognition of the dimeric ligand is achieved by numerous H-bonds and stacking interactions involving residues Arg(8), Arg(9), Arg(10), and Arg(13) of the PilZ motif, as well as beta-barrel residues Asp(35) and Trp(77). As a result of the rearrangement of the N and C termini, a highly negative surface is created on one side of the protein complex. We propose that the movement of the termini and the resulting negative surface form the basis for downstream signaling.
C1 [Habazettl, Judith; Allan, Martin G.; Jenal, Urs; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch; stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-109712, 31-132857, 31-108186]
FX This work was supported by Swiss National Science Foundation Grants
   31-109712 and 31-132857 (to S. G.) and 31-108186 (to U.J.).
CR Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881
   Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dingley AJ, 2008, NAT PROTOC, V3, P242, DOI 10.1038/nprot.2007.497
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163
   Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Fineran PC, 2007, J BACTERIOL, V189, P7653, DOI 10.1128/JB.00671-07
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Goddard T. D., 2007, SPARKY 3 114
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007
   Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x
   Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860
   Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804
   Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x
   NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7
   Plevin MJ, 2010, NAT CHEM, V2, P466, DOI [10.1038/NCHEM.650, 10.1038/nchem.650]
   Ramelot TA, 2007, PROTEINS, V66, P266, DOI 10.1002/prot.21199
   Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Shin JS, 2011, PROTEIN SCI, V20, P270, DOI 10.1002/pro.557
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Yan HB, 2010, CHEM SOC REV, V39, P2914, DOI 10.1039/b914942m
NR 43
TC 54
Z9 55
U1 0
U2 14
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 22
PY 2011
VL 286
IS 16
BP 14304
EP 14314
DI 10.1074/jbc.M110.209007
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 750NW
UT WOS:000289556200053
PM 21310957
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Hanisch, J
   Kolm, R
   Wozniczka, M
   Bumann, D
   Rottner, K
   Stradal, TEB
AF Haenisch, Jan
   Koelm, Robert
   Wozniczka, Milena
   Bumann, Dirk
   Rottner, Klemens
   Stradal, Theresia E. B.
TI Activation of a RhoA/Myosin II-Dependent but Arp2/3 Complex-Independent
   Pathway Facilitates Salmonella Invasion
SO CELL HOST & MICROBE
LA English
DT Article
ID ENTERICA SEROVAR TYPHIMURIUM; DIAPHANOUS-RELATED FORMINS;
   EPITHELIAL-CELLS; MYOSIN-II; RHO GTPASES; ACTIN; PROTEIN; MEMBRANE;
   KINASE; SOPE2
AB Salmonella stimulates host cell invasion using virulence effectors translocated by the pathogen's type-three secretion system (T3SS). These factors manipulate host signaling pathways, primarily driven by Rho family GTPases, which culminates in Arp2/3 complex-dependent activation of host actin nucleation to mediate the uptake of Salmonella into host cells. However, recent data argue for the existence of additional mechanisms that cooperate in T3SS-dependent Salmonella invasion. We identify a myosin II-mediated mechanism, operating independent of but complementary to the Arp2/3-dependent pathway, as contributing to Salmonella invasion into nonphagocytic cells. We also establish that the T3SS effector SopB constitutes an important regulator of this Rho/Rho kinase and myosin II-dependent invasion pathway. Thus, Salmonella enters nonphagocytic cells by manipulating the two core machineries of actin-based motility in the host: Arp2/3 complex-driven actin polymerization and actomyosin-mediated contractility.
C1 [Wozniczka, Milena; Rottner, Klemens] Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, D-38124 Braunschweig, Germany.
   [Haenisch, Jan; Koelm, Robert; Stradal, Theresia E. B.] Helmholtz Ctr Infect Res, Signaling & Motil Grp, D-38124 Braunschweig, Germany.
   [Bumann, Dirk] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Rottner, Klemens] Univ Bonn, Inst Genet, D-53117 Bonn, Germany.
   [Stradal, Theresia E. B.] Univ Munster, Inst Mol Cell Biol, D-48149 Munster, Germany.
RP Rottner, K (corresponding author), Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, Inhoffenstr 7, D-38124 Braunschweig, Germany.
EM klemens.rottner@uni-bonn.de; theresia.stradal@uni-muenster.de
OI Stradal, Theresia/0000-0002-0352-9474; Rottner,
   Klemens/0000-0003-4244-4198
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [SPP1150]
FX We are grateful to Mary-Anne Conti and Robert S. Adelstein (Bethesda,
   MD) for providing myosin IIA and myosin IIB knockout and control cells
   and to Wolf-Dietrich Hardt (Zurich, Switzerland) for providing the S.
   Typhimurium Delta sopB mutant and plasmids encoding SopE, SopE2 and
   SopB, as well as for continuous fruitful discussions. Moreover, we thank
   Patrick Duwe for excellent technical assistance and Brigitte Denker and
   Uwe Karst for continuous support. This project was funded in part by the
   Deutsche Forschungsgemeinschaft (SPP1150 to T.E.B.S. and K.R.).
CR Aiastui A, 2010, INFECT IMMUN, V78, P2700, DOI 10.1128/IAI.01389-09
   Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031
   Cain RJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000037
   Chang JH, 2005, MOL MICROBIOL, V55, P1379, DOI 10.1111/j.1365-2958.2004.04480.x
   Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x
   Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051
   Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112
   Criss AK, 2003, INFECT IMMUN, V71, P2885, DOI 10.1128/IAI.71.5.2885-2891.2003
   Criss AK, 2001, J CELL SCI, V114, P1331
   ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405
   Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200
   Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026
   Hachani A, 2008, MICROBES INFECT, V10, P260, DOI 10.1016/j.micinf.2007.11.011
   Hanisch J, 2010, CELL MICROBIOL, V12, P84, DOI 10.1111/j.1462-5822.2009.01380.x
   Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526
   Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788
   Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7
   Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093
   Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780
   Jiang J, 2010, CYTOSKELETON, V67, P32, DOI 10.1002/cm.20419
   Klink BU, 2010, J BIOL CHEM, V285, P17197, DOI 10.1074/jbc.M110.107953
   Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200
   Matsuzawa T, 2004, EMBO J, V23, P3570, DOI 10.1038/sj.emboj.7600359
   McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001
   Munter Sylvia, 2006, Sci STKE, V2006, pre5, DOI 10.1126/stke.3352006re5
   Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057
   OCALLAGHAN D, 1990, MOL GEN GENET, V223, P156, DOI 10.1007/BF00315809
   Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2
   Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144
   Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001
   Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473
   Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005
   ROTTNER K, 2010, ANN NY ACAD SCI, V1072, P307
   Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006
   Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200
   Sousa S, 2004, J CELL SCI, V117, P2121, DOI 10.1242/jcs.01066
   Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200
   Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x
   Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088
   Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x
   Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003
   Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447
   Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854
   Wasylnka JA, 2008, INFECT IMMUN, V76, P2722, DOI 10.1128/IAI.00152-08
   Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043
NR 47
TC 53
Z9 56
U1 1
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD APR 21
PY 2011
VL 9
IS 4
BP 273
EP 285
DI 10.1016/j.chom.2011.03.009
PG 13
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 756HO
UT WOS:000290002500006
PM 21501827
DA 2021-01-25
ER

PT J
AU Jakobsen, L
   Vanselow, K
   Skogs, M
   Toyoda, Y
   Lundberg, E
   Poser, I
   Falkenby, LG
   Bennetzen, M
   Westendorf, J
   Nigg, EA
   Uhlen, M
   Hyman, AA
   Andersen, JS
AF Jakobsen, Lis
   Vanselow, Katja
   Skogs, Marie
   Toyoda, Yusuke
   Lundberg, Emma
   Poser, Ina
   Falkenby, Lasse G.
   Bennetzen, Martin
   Westendorf, Jens
   Nigg, Erich A.
   Uhlen, Mathias
   Hyman, Anthony A.
   Andersen, Jens S.
TI Novel asymmetrically localizing components of human centrosomes
   identified by complementary proteomics methods
SO EMBO JOURNAL
LA English
DT Article
DE centrosome; mass spectrometry-based proteomics; mother and daughter
   centriole; protein turnover; SILAC
ID DAUGHTER CENTRIOLE; CELL-DIVISION; CHROMOSOME SEGREGATION; PEPTIDE
   IDENTIFICATION; MASS-SPECTROMETRY; JOUBERT-SYNDROME; PROTEIN; CILIA;
   REVEALS; DISEASE
AB Centrosomes in animal cells are dynamic organelles with a proteinaceous matrix of pericentriolar material assembled around a pair of centrioles. They organize the microtubule cytoskeleton and the mitotic spindle apparatus. Mature centrioles are essential for biogenesis of primary cilia that mediate key signalling events. Despite recent advances, the molecular basis for the plethora of processes coordinated by centrosomes is not fully understood. We have combined protein identification and localization, using PCP-SILAC mass spectrometry, BAC transgeneOmics, and antibodies to define the constituents of human centrosomes. From a background of non-specific proteins, we distinguished 126 known and 40 candidate centrosomal proteins, of which 22 were confirmed as novel components. An antibody screen covering 4000 genes revealed an additional 113 candidates. We illustrate the power of our methods by identifying a novel set of five proteins preferentially associated with mother or daughter centrioles, comprising genes implicated in cell polarity. Pulsed labelling demonstrates a remarkable variation in the stability of centrosomal protein complexes. These spatiotemporal proteomics data provide leads to the further functional characterization of centrosomal proteins. The EMBO Journal (2011) 30, 1520-1535. doi:10.1038/emboj.2011.63; Published online 11 March 2011 Subject Categories: cell & tissue architecture; cell cycle; genomic & computational biology
C1 [Jakobsen, Lis; Vanselow, Katja; Falkenby, Lasse G.; Bennetzen, Martin; Andersen, Jens S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark.
   [Skogs, Marie; Lundberg, Emma; Uhlen, Mathias] Royal Inst Technol KTH, AlbaNova Univ Ctr, Sch Biotechnol, Stockholm, Sweden.
   [Toyoda, Yusuke; Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.
   [Westendorf, Jens] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Nigg, Erich A.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Andersen, JS (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.
EM jens.andersen@bmb.sdu.dk
RI Lundberg, Emma S K/F-3891-2010; Hyman, Anthony A/B-3917-2017; Hyman,
   Tony/F-1923-2011; Uhlen, Mathias/B-3262-2016; Andersen, Jens
   S/L-2100-2015
OI Hyman, Anthony A/0000-0003-3664-154X; Uhlen,
   Mathias/0000-0002-4858-8056; Andersen, Jens S/0000-0002-6091-140X;
   Toyoda, Yusuke/0000-0003-0534-6898; nigg, erich/0000-0003-4835-5719
FU Lundbeck FoundationLundbeckfonden; Danish Agency for Science, Technology
   and Innovation; European CommissionEuropean CommissionEuropean
   Commission Joint Research Centre [HEALTH-F4-2008-201648/PROSPECTS]; Max
   Planck SocietyMax Planck SocietyFoundation CELLEX; BMBFFederal Ministry
   of Education & Research (BMBF) [01GS0859]; Knut and Alice Wallenberg
   foundationKnut & Alice Wallenberg Foundation; HPA project
FX We thank members of the Center for Experimental BioInformatics (CEBI),
   the Hyman, the Uhlen, and the Nigg group for fruitful collaboration,
   discussions, and critical reading of the manuscript; Rikke Jakobsen,
   Mogens M Nielsen, and Peter Mortensen for excellent technical
   assistance; Proxeon A/S for the use of ProteinCenter; Mark Payne,
   Technical University of Denmark for statistical data analysis; and
   Mikael Le Clech for initial bioinformatics exploration. The research
   leading to these results has received funding from The Lundbeck
   Foundation, The Danish Agency for Science, Technology and Innovation,
   and the European Commission's 7th Framework Programme (grant agreement
   HEALTH-F4-2008-201648/PROSPECTS. AAH acknowledges funding by the Max
   Planck Society, and the BMBF grant DiGtoP (01GS0859). EAN acknowledges
   support from the Max-Planck society; EL, MS, and MU acknowledge the
   staff working in the HPA project and the Knut and Alice Wallenberg
   foundation for funding.
CR Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780
   Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166
   Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034
   Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341
   Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200
   Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352
   Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180
   Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3
   Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164
   Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541
   Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107
   Chang P, 2000, NAT CELL BIOL, V2, P30
   Chen NS, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r126
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Debec A, 2010, CELL MOL LIFE SCI, V67, P2173, DOI 10.1007/s00018-010-0323-9
   Dekomien G, 2010, NEUROGENETICS, V11, P163, DOI 10.1007/s10048-009-0223-z
   den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318
   Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008
   Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575
   Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200
   Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278
   Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022
   Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248
   Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181
   Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939
   Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348
   Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619
   Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024
   Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659
   Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064
   LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919
   Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033
   Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7
   Lilley Kathryn S., 2008, V432, P373, DOI 10.1007/978-1-59745-028-7_25
   Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813
   Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200
   Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939
   Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349
   Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009
   Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067
   Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6
   MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455
   Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609
   MOUDJOU M, 1994, CELL BIOL LAB HDB, P595
   Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869
   Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924
   NIGG EA, 1982, P NATL ACAD SCI-BIOL, V79, P5939, DOI 10.1073/pnas.79.19.5939
   Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101
   Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200
   Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662
   Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008
   Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317
   Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330
   Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199
   Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094
   Reinders Y, 2006, J PROTEOME RES, V5, P589, DOI 10.1021/pr050350q
   Sadowski PG, 2006, NAT PROTOC, V1, P1778, DOI 10.1038/nprot.2006.254
   Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236
   Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200
   Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786
   Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3
   Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931
   Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027
   Sugimoto M, 2008, J CELL BIOL, V183, P19, DOI 10.1083/jcb.200803133
   Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985
   Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805
   Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435
   Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967
   Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910
   Yan Wei, 2008, V432, P389, DOI 10.1007/978-1-59745-028-7_26
   Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711
   Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185
NR 74
TC 200
Z9 216
U1 2
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD APR 20
PY 2011
VL 30
IS 8
BP 1520
EP 1535
DI 10.1038/emboj.2011.63
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 760EG
UT WOS:000290306300013
PM 21399614
OA Green Published
DA 2021-01-25
ER

PT J
AU Vogt, KE
AF Vogt, Kaspar E.
TI Dousing the flames of fear
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Editorial Material
ID AMYGDALA
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Vogt, KE (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM kaspar.vogt@unibas.ch
OI Vogt, Kaspar/0000-0002-0859-876X
CR Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499
   Chhatwal JP, 2005, J NEUROSCI, V25, P502, DOI 10.1523/JNEUROSCI.3301-04.2005
   Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559
   Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026
   Harris JA, 1998, BEHAV NEUROSCI, V112, P183, DOI 10.1037/0735-7044.112.1.183
   Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553
   Heidi SA, 2007, EUR J NEUROSCI, V26, P3631, DOI 10.1111/j.1460-9568.2007.05970.x
   Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167
   Manko M, 2011, J PHYSIOL-LONDON, V589, P1911, DOI 10.1113/jphysiol.2010.201475
   Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029
NR 10
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD APR 15
PY 2011
VL 589
IS 8
BP 1865
EP 1865
DI 10.1113/jphysiol.2011.206920
PG 1
WC Neurosciences; Physiology
SC Neurosciences & Neurology; Physiology
GA 750EH
UT WOS:000289527200003
PM 21498379
OA Green Published
DA 2021-01-25
ER

PT J
AU Affolter, M
   Basler, K
AF Affolter, Markus
   Basler, Konrad
TI Cytonemes Show Their Colors
SO SCIENCE
LA English
DT Editorial Material
ID DROSOPHILA
C1 [Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Basler, Konrad] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM affolter@unibas.ch; konrad.basler@imls.uzh.ch
OI Affolter, Markus/0000-0002-5171-0016; Basler, Konrad/0000-0003-3534-1529
CR Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008
   Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006
   Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951
   Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140
   Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0
   Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
NR 7
TC 7
Z9 7
U1 0
U2 5
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 15
PY 2011
VL 332
IS 6027
BP 312
EP 313
DI 10.1126/science.1205971
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 750AT
UT WOS:000289516600031
PM 21493848
DA 2021-01-25
ER

PT J
AU Piscuoglio, S
   Kovac, M
   Kishore, S
   Mele, V
   Zavolan, M
   Muller, H
   Terracciano, LM
   Heinimann, K
AF Piscuoglio, Salvatore
   Kovac, Michal
   Kishore, Shivendra
   Mele, Valentina
   Zavolan, Mihaela
   Muller, Hansjakob
   Terracciano, Luigi M.
   Heinimann, Karl
TI EWSR1: Identification and functional characterization of a novel target
   gene locus in Lynch syndrome
SO CANCER RESEARCH
LA English
DT Meeting Abstract
C1 [Piscuoglio, Salvatore; Kovac, Michal; Muller, Hansjakob; Heinimann, Karl] Univ Basel, Dept Biomed, Res Grp Human Genet, Basel, Switzerland.
   [Piscuoglio, Salvatore; Kovac, Michal; Muller, Hansjakob; Heinimann, Karl] Univ Childrens Hosp, Basel, Switzerland.
   [Kishore, Shivendra; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
   [Mele, Valentina] Univ Basel, Inst Surg Res & Hosp Management, Basel, Switzerland.
   [Terracciano, Luigi M.] Univ Basel, Inst Pathol, Basel, Switzerland.
RI Zavolan, Mihaela/S-3888-2016
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD APR 15
PY 2011
VL 71
SU 8
MA 3802
DI 10.1158/1538-7445.AM2011-3802
PG 2
WC Oncology
SC Oncology
GA V43SP
UT WOS:000209701400032
DA 2021-01-25
ER

PT J
AU Helfand, BT
   Mendez, MG
   Murthy, SNP
   Shumaker, DK
   Grin, B
   Mahammad, S
   Aebi, U
   Wedig, T
   Wu, YI
   Hahn, KM
   Inagaki, M
   Herrmann, H
   Goldman, RD
AF Helfand, Brian T.
   Mendez, Melissa G.
   Murthy, S. N. Prasanna
   Shumaker, Dale K.
   Grin, Boris
   Mahammad, Saleemulla
   Aebi, Ueli
   Wedig, Tatjana
   Wu, Yi I.
   Hahn, Klaus M.
   Inagaki, Masaki
   Herrmann, Harald
   Goldman, Robert D.
TI Vimentin organization modulates the formation of lamellipodia
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID INTERMEDIATE-FILAMENT REORGANIZATION; FIBRILLARY ACIDIC PROTEIN;
   PHOSPHORYLATION SITES; ASSEMBLY PROPERTIES; DYNAMIC PROPERTIES; CLEAVAGE
   FURROW; TAIL DOMAINS; IN-VITRO; LAMIN-A; CELL
AB Vimentin intermediate filaments (VIF) extend throughout the rear and perinuclear regions of migrating fibroblasts, but only nonfilamentous vimentin particles are present in lamellipodial regions. In contrast, VIF networks extend to the entire cell periphery in serum-starved or nonmotile fibroblasts. Upon serum addition or activation of Rac1, VIF are rapidly phosphorylated at Ser-38, a p21-activated kinase phosphorylation site. This phosphorylation of vimentin is coincident with VIF disassembly at and retraction from the cell surface where lamellipodia form. Furthermore, local induction of photoactivatable Rac1 or the microinjection of a vimentin mimetic peptide (2B2) disassemble VIF at sites where lamellipodia subsequently form. When vimentin organization is disrupted by a dominant-negative mutant or by silencing, there is a loss of polarity, as evidenced by the formation of lamellipodia encircling the entire cell, as well as reduced cell motility. These findings demonstrate an antagonistic relationship between VIF and the formation of lamellipodia.
C1 [Mendez, Melissa G.; Murthy, S. N. Prasanna; Grin, Boris; Mahammad, Saleemulla; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.
   [Helfand, Brian T.; Shumaker, Dale K.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.
   [Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Wedig, Tatjana; Herrmann, Harald] German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
   [Wu, Yi I.] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA.
   [Hahn, Klaus M.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.
   [Inagaki, Masaki] Aichi Canc Ctr Res Inst, Div Biochem, Chikusa Ku, Aichi 4648681, Japan.
RP Goldman, RD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.
EM r-goldman@northwestern.edu
RI Mendez, Melissa G/B-1357-2014; Inagaki, Masaki/B-9920-2016
OI Mendez, Melissa G/0000-0002-3995-2469; Hahn, Klaus/0000-0002-1970-7562
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM-036806, NS-071216,
   GM-057464]; American Urological Association Foundation; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R37GM036806, R01GM057464,
   R01GM036806, R01GM036806, R37GM036806, R01GM036806, R01GM057464,
   R01GM057464, R01GM036806, R37GM036806, R01GM036806, R01GM036806,
   R01GM057464, R37GM036806, R01GM036806, R01GM036806, R01GM057464,
   R01GM036806, R37GM036806, R01GM057464, R01GM036806, R01GM036806,
   R01GM036806, R37GM036806, R01GM057464, R01GM057464, R55GM057464,
   R37GM036806, R37GM036806, R01GM057464, R01GM057464, R01GM036806,
   R37GM036806, R01GM036806, R01GM036806, R37GM036806, R37GM036806,
   R01GM057464, R01GM057464, R37GM036806, R01GM057464, R37GM036806] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R21NS071216, R21NS071216, R21NS071216]
   Funding Source: NIH RePORTER; Grants-in-Aid for Scientific
   ResearchMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [20370082, 19057010] Funding Source: KAKEN
FX We thank Michael Davidson (Florida State University, Tallahassee) for
   the Emerald-vimentin construct and Karen Ridge (Northwestern University,
   Chicago, IL) for fibroblasts isolated from the vim<SUP>-/-</SUP> mouse.
   Thank you also to Lynne Chang and Satya Khuon for assistance with 2B2
   experiments and Anne Goldman, Kyung Hee Myung, and Yuan yuan Wang for
   technical assistance. This study was supported by the National
   Institutes of Health (grant GM-036806 to R. D. G., NS-071216 to Y.I.W.,
   and GM-057464 to K.M.G.) and the American Urological Association
   Foundation Research Scholar Program (B.T.H.).
CR ABERCROMBIE M, 1961, EXP CELL RES S, V8, P1188
   Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019
   ANDO S, 1989, BIOCHEMISTRY-US, V28, P2974, DOI 10.1021/bi00433a035
   Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846
   Barberis L, 2009, EUR J IMMUNOL, V39, P1136, DOI 10.1002/eji.200838884
   Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042
   CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574
   Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033
   Chang L, 2009, J CELL SCI, V122, P2914, DOI 10.1242/jcs.046789
   CHOU YH, 1991, J BIOL CHEM, V266, P7325
   Chou YH, 1996, J CELL SCI, V109, P817
   CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q
   COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3
   Eckes B, 1998, J CELL SCI, V111, P1897
   Eckes B, 2000, J CELL SCI, V113, P2455
   Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906
   Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8
   Gilles C, 1999, J CELL SCI, V112, P4615
   GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725
   Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971
   Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x
   Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891
   Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027
   Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376
   Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745
   Hendrix MJC, 1997, AM J PATHOL, V150, P483
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   HERRMANN H, 1993, J MOL BIOL, V234, P99, DOI 10.1006/jmbi.1993.1566
   Ho CL, 1998, J CELL SCI, V111, P1767
   HOLLENBECK PJ, 1989, J CELL SCI, V92, P621
   Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005
   Hyder CL, 2008, FEBS LETT, V582, P2140, DOI 10.1016/j.febslet.2008.04.064
   INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0
   Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   Janosch P, 2000, FASEB J, V14, P2008, DOI 10.1096/fj.99-0883com
   Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007
   Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200
   Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633
   Kosako H, 1997, J BIOL CHEM, V272, P10333
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826
   Kural C, 2007, P NATL ACAD SCI USA, V104, P5378, DOI 10.1073/pnas.0700145104
   LAMB NJC, 1989, J CELL BIOL, V108, P2409, DOI 10.1083/jcb.108.6.2409
   LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0
   Li J, 2002, NATURE, V420, P716, DOI 10.1038/nature01307
   Lin YC, 2010, J MOL BIOL, V399, P637, DOI 10.1016/j.jmb.2010.04.054
   Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021
   Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067
   Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639
   Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053
   MOIR RD, 1991, J CELL SCI, V99, P363
   Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023
   Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159
   Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113
   Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010
   Sin WC, 1998, MOL CELL BIOL, V18, P6325, DOI 10.1128/MCB.18.11.6325
   Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105
   Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004
   Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054
   Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069
   Vora HH, 2009, INT J BIOL MARKER, V24, P38
   WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205
   Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124
   Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241
   Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105
   Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503
   Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147
   Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656
   Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421
NR 73
TC 149
Z9 152
U1 0
U2 2
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD APR 15
PY 2011
VL 22
IS 8
BP 1274
EP 1289
DI 10.1091/mbc.E10-08-0699
PG 16
WC Cell Biology
SC Cell Biology
GA 750OU
UT WOS:000289558600013
PM 21346197
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Dou, Z
   von Schubert, C
   Korner, R
   Santamaria, A
   Elowe, S
   Nigg, EA
AF Dou, Zhen
   von Schubert, Conrad
   Koerner, Roman
   Santamaria, Anna
   Elowe, Sabine
   Nigg, Erich A.
TI Quantitative Mass Spectrometry Analysis Reveals Similar Substrate
   Consensus Motif for Human Mps1 Kinase and Plk1
SO PLOS ONE
LA English
DT Article
ID SPINDLE-ASSEMBLY CHECKPOINT; CENP-E; CHROMOSOMAL INSTABILITY; MITOTIC
   ARREST; PROTEIN-KINASE; PHOSPHORYLATION; ACTIVATION; LOCALIZATION;
   SPECIFICITY; EXPRESSION
AB Background: Members of the Mps1 kinase family play an essential and evolutionarily conserved role in the spindle assembly checkpoint (SAC), a surveillance mechanism that ensures accurate chromosome segregation during mitosis. Human Mps1 (hMps1) is highly phosphorylated during mitosis and many phosphorylation sites have been identified. However, the upstream kinases responsible for these phosphorylations are not presently known.
   Methodology/Principal Findings: Here, we identify 29 in vivo phosphorylation sites in hMps1. While in vivo analyses indicate that Aurora B and hMps1 activity are required for mitotic hyper-phosphorylation of hMps1, in vitro kinase assays show that Cdk1, MAPK, Plk1 and hMps1 itself can directly phosphorylate hMps1. Although Aurora B poorly phosphorylates hMps1 in vitro, it positively regulates the localization of Mps1 to kinetochores in vivo. Most importantly, quantitative mass spectrometry analysis demonstrates that at least 12 sites within hMps1 can be attributed to autophosphorylation. Remarkably, these hMps1 autophosphorylation sites closely resemble the consensus motif of Plk1, demonstrating that these two mitotic kinases share a similar substrate consensus.
   Conclusions/Significance: hMps1 kinase is regulated by Aurora B kinase and its autophosphorylation. Analysis on hMps1 autophosphorylation sites demonstrates that hMps1 has a substrate preference similar to Plk1 kinase.
C1 [Dou, Zhen; Koerner, Roman; Santamaria, Anna; Elowe, Sabine; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [von Schubert, Conrad; Santamaria, Anna; Nigg, Erich A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Dou, Zhen] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.
RP Dou, Z (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
EM douzhen@ustc.edu.cn; erich.nigg@unibas.ch
RI DOU, ZHEN/N-2022-2013; Korner, Roman/G-8565-2011
OI Korner, Roman/0000-0001-9285-9290; nigg, erich/0000-0003-4835-5719; DOU,
   ZHEN/0000-0003-3303-9393
FU Max Planck SocietyMax Planck Society; Chinese Academy of Sciences/Max
   Planck SocietyMax Planck SocietyChinese Academy of Sciences
FX This work was supported by the Max Planck Society and Z.D. acknowledges
   support through a post-doctoral fellowship from the Chinese Academy of
   Sciences/Max Planck Society. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X
   Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5
   Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027
   Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310
   Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091
   Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007
   Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008
   Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466
   Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953
   He XW, 1998, J CELL SCI, V111, P1635
   Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133
   HOGG D, 1994, ONCOGENE, V9, P89
   Holinger EP, 2009, J BIOL CHEM, V284, P12949, DOI 10.1074/jbc.M900088200
   Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718
   Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046
   Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415
   Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254
   Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105
   Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62
   Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345
   Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055
   Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074
   Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050
   Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596
   Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200
   Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200
   Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032
   MILLS GB, 1992, J BIOL CHEM, V267, P16000
   Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200
   Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009
   Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036
   Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173
   Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517
   Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457
   Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483
   Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063
   Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251
   Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723
   Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5
   Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029
   Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310
   Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203
   Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051
   Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111
   Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011
   WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745
   Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324
   Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435
   Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009
   Zich J, 2010, TRENDS BIOCHEM SCI, V35, P18, DOI 10.1016/j.tibs.2009.09.002
NR 58
TC 54
Z9 55
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 13
PY 2011
VL 6
IS 4
AR e18793
DI 10.1371/journal.pone.0018793
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 749IP
UT WOS:000289458800044
PM 21533207
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Handschin, C
   Spiegelman, BM
AF Handschin, Christoph
   Spiegelman, Bruce M.
TI PGC-1 Coactivators and the Regulation of Skeletal Muscle Fiber-Type
   Determination
SO CELL METABOLISM
LA English
DT Letter
C1 [Handschin, Christoph] Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   [Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.
RP Handschin, C (corresponding author), Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
EM handschin@unibas.ch; bruce_spiegelman@dfci.harvard.edu
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
NR 5
TC 27
Z9 29
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD APR 6
PY 2011
VL 13
IS 4
BP 351
EP 351
DI 10.1016/j.cmet.2011.03.008
PG 1
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 748HM
UT WOS:000289381300001
PM 21459315
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Cocas, LA
   Georgala, PA
   Mangin, JM
   Clegg, JM
   Kessaris, N
   Haydar, TF
   Gallo, V
   Price, DJ
   Corbin, JG
AF Cocas, Laura A.
   Georgala, Petrina A.
   Mangin, Jean-Marie
   Clegg, James M.
   Kessaris, Nicoletta
   Haydar, Tarik F.
   Gallo, Vittorio
   Price, David J.
   Corbin, Joshua G.
TI Pax6 Is Required at the Telencephalic Pallial-Subpallial Boundary for
   the Generation of Neuronal Diversity in the Postnatal Limbic System
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID LATERAL GANGLIONIC EMINENCE; FEAR; EXPRESSION; FOREBRAIN; MIGRATION;
   GSH2; IDENTIFICATION; SPECIFICATION; INTERNEURONS; PROGENITORS
AB During embryogenesis, the pallial-subpallial boundary (PSB) divides the two main progenitor domains in the telencephalon: the pallium, the major source of excitatory neurons, and the subpallium, the major source of inhibitory neurons. The PSB is formed at the molecular interface between the pallial (high Pax6+) and subpallial (high Gsx2+) ventricular zone (VZ) compartments. Initially, the PSB contains cells that express both Pax6 and Gsx2, but during later stages of development this boundary is largely refined into two separate compartments. In this study we examined the developmental mechanisms underlying PSB boundary formation and the postnatal consequences of conditional loss of Pax6 function at the PSB on neuronal fate in the amygdala and olfactory bulb, two targets of PSB-derived migratory populations. Our cell fate and time-lapse imaging analyses reveal that the sorting of Pax6+ and Gsx2+ progenitors during embryogenesis is the result of a combination of changes in gene expression and cell movements. Interestingly, we find that in addition to giving rise to inhibitory neurons in the amygdala and olfactory bulb, Gsx2+ progenitors generate a subpopulation of amygdala excitatory neurons. Consistent with this finding, targeted conditional ablation of Pax6 in Gsx2+ progenitors results in discrete local embryonic patterning defects that are linked to changes in the generation of subsets of postnatal excitatory and inhibitory neurons in the amygdala and inhibitory neurons in the olfactory bulb. Thus, in PSB progenitors, Pax6 plays an important role in the generation of multiple subtypes of neurons that contribute to the amygdala and olfactory bulb.
C1 [Cocas, Laura A.; Mangin, Jean-Marie; Haydar, Tarik F.; Gallo, Vittorio; Corbin, Joshua G.] Childrens Natl Med Ctr, Ctr Neurosci Res, Childrens Res Inst, Washington, DC 20010 USA.
   [Cocas, Laura A.] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Cocas, Laura A.] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.
   [Georgala, Petrina A.; Clegg, James M.; Price, David J.] Univ Edinburgh, Sch Biomed Sci, Genes & Dev Grp, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.
   [Kessaris, Nicoletta] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England.
   [Kessaris, Nicoletta] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.
   [Haydar, Tarik F.] Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA.
RP Corbin, JG (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Childrens Res Inst, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM jcorbin@cnmcresearch.org
RI ; Kessaris, Nicoletta/C-7249-2008
OI Haydar, Tarik/0000-0001-6772-3076; Kessaris,
   Nicoletta/0000-0003-1191-6009; Price, David/0000-0002-5318-307X
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 NIDA020140,
   NS564662]; National Research Service Award predoctoral fellowshipUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA; Cellular Imaging Core of Mental Retardation and
   Developmental Disabilities Research Center [P30HD40677]; Wellcome
   TrustWellcome Trust [08420]; Medical Research CouncilMedical Research
   Council UK (MRC) [0800429, 75618]; European Research CouncilEuropean
   Research Council (ERC) [207807]; Medical Research CouncilMedical
   Research Council UK (MRC) [G0501173, G0800429] Funding Source:
   researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH
   & HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677] Funding Source: NIH RePORTER;
   EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677, P30HD040677, P30HD040677, P30HD040677,
   P30HD040677, P30HD040677] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Drug Abuse (NIDA) [R01DA020140, R01DA020140, R01DA020140,
   R01DA020140, R01DA020140, R01DA020140, R01DA020140, R01DA020140,
   R01DA020140, R01DA020140, R01DA020140, R01DA020140, R01DA020140,
   R01DA020140, R01DA020140, R01DA020140, R01DA020140, R01DA020140,
   R01DA020140, R01DA020140, R01DA020140, R01DA020140, R01DA020140,
   R01DA020140, R01DA020140] Funding Source: NIH RePORTER
FX This work was supported by the following: National Institutes of Health
   (NIH) Grant R01 NIDA020140 (J.G.C.), National Research Service Award
   predoctoral fellowship and NIH Grant NS564662 (L.A.C.), the Cellular
   Imaging Core of Mental Retardation and Developmental Disabilities
   Research Center (P30HD40677), The Wellcome Trust 08420 (D.J.P.), The
   Medical Research Council Grants 0800429 (D.J.P.) and 75618 (N.K.), and
   the European Research Council Grant 207807 (N.K.). L.A.C. and J.G.C.
   designed, planned, and interpreted the experiments and wrote the
   manuscript. Conceptual input was also provided by D.J.P. L.A.C.
   performed all of the experiments, analyses, and figure preparation
   except as follows: P.A.G., under the direction of D.J.P., completed the
   Ngn2 immunostaining and, in coordination with L.A.C, embryonic in situ
   experiments as well as provided genotyped conditional knock-out tissues.
   J.-M.M., under the direction of V.G., and L.A.C. performed the
   patch-clamp experiments and analysis. J.M.C., under the direction of
   D.J.P., performed the embryonic Pax6 DAB immunostaining and Dbx1 in situ
   hybridization. N.K. provided genotyped Gsx2<SUP>Cre</SUP> embryonic
   brains and Gsx2<SUP>Cre</SUP> mice. L.A.C. performed the time-lapse
   experiments with training and guidance from T.F.H. We thank the
   following people for sharing of reagents: K. Campbell for the Gsx2
   antibody, R. Hevner for the Tbr1 antibody, V. van Heyningen for the Pax6
   antibody, and K. Yoshikawa for the pan-Dlx antibody. We thank R. Carney
   for contribution of select in situ hybridization probes and Martine
   Manuel for perfusing several Pax6<SUP>cKO</SUP> mice. We also thank the
   following people for their critical comments and reading of the
   manuscript: Jose Luis Olmos-Serrano, Judy Liu, Molly Huntsman, and Irene
   Zohn.
CR Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005
   Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008
   Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008
   Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006
   Carney RSE, 2009, CEREB CORTEX, V19, P745, DOI 10.1093/cercor/bhn123
   Cocas LA, 2009, J NEUROSCI, V29, P15933, DOI 10.1523/JNEUROSCI.2525-09.2009
   Corbin JG, 2003, DEVELOPMENT, V130, P4895, DOI 10.1242/dev.00717
   Corbin JG, 2000, DEVELOPMENT, V127, P5007
   Dellovade TL, 1998, J COMP NEUROL, V402, P402
   Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006
   Garcia-Moreno F, 2010, NAT NEUROSCI, V13, P680, DOI 10.1038/nn.2556
   Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033
   Haba H, 2009, NEUROSCI RES, V65, P116, DOI 10.1016/j.neures.2009.05.011
   Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166
   Hirata T, 2009, NAT NEUROSCI, V12, P141, DOI 10.1038/nn.2241
   Jimenez D, 2002, J NEUROCYTOL, V31, P719, DOI 10.1023/A:1025751914372
   Kaoru T, 2010, NEUROSCIENCE, V166, P220, DOI 10.1016/j.neuroscience.2009.12.004
   Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620
   Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005
   Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102
   Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167
   Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006
   Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453
   Mastick GS, 1997, DEVELOPMENT, V124, P1985
   Monk CS, 2008, DEV PSYCHOPATHOL, V20, P1231, DOI 10.1017/S095457940800059X
   Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971
   Nomura T, 2006, DEVELOPMENT, V133, P1335, DOI 10.1242/dev.02290
   Nomura T, 2007, DEV GROWTH DIFFER, V49, P683, DOI 10.1111/j.1440-169x.2007.00965.x
   Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014
   Roy K, 2002, PHYSIOL BEHAV, V77, P595, DOI 10.1016/S0031-9384(02)00902-2
   Sah P, 2003, ANN NY ACAD SCI, V985, P67
   Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003
   Simpson TI, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-19
   Stenman J, 2003, DEVELOPMENT, V130, P1113, DOI 10.1242/dev.00328
   Stenman J, 2003, J NEUROSCI, V23, P167
   Stoykova A, 1997, DEVELOPMENT, V124, P3765
   Stoykova A, 1996, DEVELOPMENT, V122, P3453
   Talamillo A, 2003, DEV BIOL, V255, P151, DOI 10.1016/S0012-1606(02)00046-5
   Tole S, 2005, J NEUROSCI, V25, P2753, DOI 10.1523/JNEUROSCI.3014-04.2005
   Toresson H, 2000, DEVELOPMENT, V127, P4361
   Umeda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015500
   Waclaw RR, 2010, J NEUROSCI, V30, P6944, DOI 10.1523/JNEUROSCI.5772-09.2010
   Waclaw RR, 2009, NEURON, V63, P451, DOI 10.1016/j.neuron.2009.07.015
   Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018
   Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007
   Yun K, 2001, DEVELOPMENT, V128, P193
NR 46
TC 31
Z9 31
U1 0
U2 3
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 1529-2401
J9 J NEUROSCI
JI J. Neurosci.
PD APR 6
PY 2011
VL 31
IS 14
BP 5313
EP 5324
DI 10.1523/JNEUROSCI.3867-10.2011
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 746AO
UT WOS:000289213500016
PM 21471366
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Hermes, JP
   Sander, F
   Peterle, T
   Cioffi, C
   Ringler, P
   Pfohl, T
   Mayor, M
AF Hermes, Jens P.
   Sander, Fabian
   Peterle, Torsten
   Cioffi, Carla
   Ringler, Philippe
   Pfohl, Thomas
   Mayor, Marcel
TI Direct Control of the Spatial Arrangement of Gold Nanoparticles in
   Organic-Inorganic Hybrid Superstructures
SO SMALL
LA English
DT Article
ID SUPRAMOLECULAR CHEMISTRY; MOLECULAR RECOGNITION; BUILDING-BLOCKS; DNA;
   FUNCTIONALIZATION; SIZE; ORGANIZATION; SUPERLATTICE; PARTICLES; NETWORKS
AB The directed assembly of gold nanoparticles is essential for their use in many kinds of applications, such as electronic devices, biological labels, and sensors. Herein an atomic alteration in the molecular structure of ligand-stabilized gold nanoparticles that can shift the interparticle distance up to 1 nm upon covalent coupling to organic-inorganic superstructures is presented. Gold nanoparticles are stabilized by two octadentate thioether ligands and have a mean diameter of 1.1 nm. The ligands contain a central rigid rod varying in length and terminally functionalized with a protected acetylene. The two peripheral functional groups on each particle enable the directed assembly of nanoparticles to dimers, trimers, and tetramers by oxidative acetylene coupling. This is a wet chemical protocol resulting in covalently bound nanoparticles. These organic-inorganic hybrid superstructures are analyzed by transmission electron microscopy, small angle X-ray scattering, and UV/vis spectroscopy. The focus of the comparison here is the subunit, which is anchoring the bridgehead, either a pyridine or benzene moiety. The pyridine-based ligands reflect the calculated length of the rigid-rod spacer in their interparticle distances in the obtained hybrid structures. This suggests a perpendicular arrangement that results from the coordination of the pyridine's lone pair to the gold surface. An atomic variation in the ligand's center leads to smaller interparticle distances in the case of hybrid structures obtained from benzene ligands. This large difference in the spatial arrangement suggests a tangential arrangement of the interparticle bridging structure in the latter case. Consequently a rather flat arrangement parallel to the particle surface must be assumed for the central benzene unit of the benzene-based ligand.
C1 [Hermes, Jens P.; Sander, Fabian; Peterle, Torsten; Cioffi, Carla; Pfohl, Thomas; Mayor, Marcel] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Peterle, Torsten] Evon Degussa GmbH, Creavis Technol & Innovat, D-45772 Marl, Germany.
   [Ringler, Philippe] Univ Basel, C CINA Biozentrum, CH-4002 Basel, Switzerland.
   [Mayor, Marcel] KIT, Inst Nanotechnol, D-76021 Karlsruhe, Germany.
RP Mayor, M (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.
EM marcel.mayor@unibas.ch
RI Pfohl, Thomas/D-7296-2016
OI Pfohl, Thomas/0000-0002-7879-5216
FU EUEuropean Union (EU) [213382]; Gebert Ruf Foundation; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF) [SNF
   200020-116033, SNF 200020-122096, SNF R'EQUIP 206021_128747]; National
   Research Smart Materials [62]
FX We are grateful for financial support from the EU through the project
   FUNMOL (number 213382) of the call FP7-NMP-2007-SMALL-1, the Gebert Ruf
   Foundation, the Swiss National Science Foundation (SNF 200020-116033,
   SNF 200020-122096 and SNF R'EQUIP 206021_128747) and the National
   Research Project No. 62 Smart Materials.
CR Abramoff D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Aldaye FA, 2006, ANGEW CHEM INT EDIT, V45, P2204, DOI 10.1002/anie.200502481
   Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   Alvarez MM, 1997, J PHYS CHEM B, V101, P3706, DOI 10.1021/jp962922n
   Andres RP, 1996, SCIENCE, V273, P1690, DOI 10.1126/science.273.5282.1690
   Bernard L, 2007, J PHYS CHEM C, V111, P18445, DOI 10.1021/jp077095c
   Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358
   Boal AK, 2000, NATURE, V404, P746
   Boettcher SW, 2007, NAT MATER, V6, P592, DOI 10.1038/nmat1943
   BROM CRV, 2007, CHEM COMMUN, P4922
   Brousseau LC, 1999, ADV MATER, V11, P447, DOI 10.1002/(SICI)1521-4095(199904)11:6<447::AID-ADMA447>3.0.CO;2-I
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   BRUST M, 1995, ADV MATER, V7, P795, DOI 10.1002/adma.19950070907
   Choi CL, 2010, ANNU REV PHYS CHEM, V61, P369, DOI 10.1146/annurev.physchem.012809.103311
   Dadosh T, 2005, NATURE, V436, P677, DOI 10.1038/nature03898
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Deng ZX, 2005, ANGEW CHEM INT EDIT, V44, P3582, DOI 10.1002/anie.200463096
   Descalzo AB, 2006, ANGEW CHEM INT EDIT, V45, P5924, DOI 10.1002/anie.200600734
   DeVries GA, 2007, SCIENCE, V315, P358, DOI 10.1126/science.1133162
   Evans SD, 2000, J MATER CHEM, V10, P183, DOI 10.1039/a903951a
   Fischler M, 2008, CHEM COMMUN, P169, DOI 10.1039/b715602b
   Fullam S, 2002, CHEM MATER, V14, P3643, DOI 10.1021/cm011182e
   Grunder S, 2007, J ORG CHEM, V72, P8337, DOI 10.1021/jo7013998
   Grunder S, 2010, EUR J ORG CHEM, V2010, P833, DOI 10.1002/ejoc.200901150
   Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404
   HAY AS, 1962, J ORG CHEM, V27, P3320, DOI 10.1021/jo01056a511
   Huo FW, 2006, ADV MATER, V18, P2304, DOI 10.1002/adma.200601178
   Jain PK, 2010, CHEM PHYS LETT, V487, P153, DOI 10.1016/j.cplett.2010.01.062
   Jorgensen JM, 2005, LANGMUIR, V21, P10320, DOI 10.1021/la051770x
   Kamenetska M, 2010, J AM CHEM SOC, V132, P6817, DOI 10.1021/ja1015348
   Kanehara M, 2006, J AM CHEM SOC, V128, P13084, DOI 10.1021/ja064510q
   Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651
   KESSLER P, 1994, BIOCONJUGATE CHEM, V5, P199, DOI 10.1021/bc00027a004
   Kim YJ, 2001, NANO LETT, V1, P165, DOI 10.1021/nl0100116
   Klajn R, 2008, ADV FUNCT MATER, V18, P2763, DOI 10.1002/adfm.200800293
   Klajn R, 2009, NAT CHEM, V1, P733, DOI [10.1038/nchem.432, 10.1038/NCHEM.432]
   Kruger C, 2008, J AM CHEM SOC, V130, P2710, DOI 10.1021/ja0763495
   Lee J, 2007, HEPATOLOGY, V46, p506A
   Leroux Y, 2009, NANO LETT, V9, P2144, DOI 10.1021/nl900695j
   Levy R, 2006, CHEMBIOCHEM, V7, P592, DOI 10.1002/cbic.200500457
   Liao J, 2006, ADV MATER, V18, P2444, DOI 10.1002/adma.200601001
   Liao JH, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/065019
   Lin XM, 1999, CHEM MATER, V11, P198, DOI 10.1021/cm980665o
   Liu J, 1999, J AM CHEM SOC, V121, P4304, DOI 10.1021/ja990330n
   Liu XF, 2010, LANGMUIR, V26, P3179, DOI 10.1021/la903838w
   Liz-Marzan LM, 2006, LANGMUIR, V22, P32, DOI 10.1021/la0513353
   Maier SA, 2001, APPL PHYS LETT, V78, P16, DOI 10.1063/1.1337637
   Mathew-Fenn RS, 2008, SCIENCE, V322, P446, DOI 10.1126/science.1158881
   Maye MM, 2002, J AM CHEM SOC, V124, P4958, DOI 10.1021/ja025724k
   Mayer D, 2002, J ELECTROANAL CHEM, V524, P20, DOI 10.1016/S0022-0728(01)00754-9
   Micheel CM, 2008, LANGMUIR, V24, P10084, DOI 10.1021/la801101k
   Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Naka K, 2003, LANGMUIR, V19, P5496, DOI 10.1021/la026898i
   Nakano Y, 2004, ORG LETT, V6, P2373, DOI 10.1021/ol049277k
   Niemeyer CM, 2003, ANGEW CHEM INT EDIT, V42, P5796, DOI 10.1002/anie.200301703
   Olson MA, 2009, NANO LETT, V9, P3185, DOI 10.1021/nl901385c
   Ozawa H, 2007, LANGMUIR, V23, P6365, DOI 10.1021/la0634544
   Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508
   Dmitrii F, 2007, ANGEW CHEM INT EDIT, V46, P6006, DOI 10.1002/anie.200701554
   Peterle T, 2008, CHEM COMMUN, P3438, DOI 10.1039/b802460j
   Peterle T, 2009, ADV FUNCT MATER, V19, P3497, DOI 10.1002/adfm.200901410
   Quinn AJ, 2007, SURF SCI, V601, P2740, DOI 10.1016/j.susc.2006.12.069
   Riskin M, 2008, J AM CHEM SOC, V130, P9726, DOI 10.1021/ja711278c
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Sanchez C, 2001, CHEM MATER, V13, P3061, DOI [10.1021/cm011061e, 10.1021/cm01106le]
   Sander F, 2010, J PHYS CHEM C, V114, P4118, DOI 10.1021/jp911879x
   Sardar R, 2009, LANGMUIR, V25, P13840, DOI 10.1021/la9019475
   Schmid G, 2005, CHEM COMMUN, P697, DOI 10.1039/b411696h
   Schmid G, 2001, ADV ENG MATER, V3, P737, DOI 10.1002/1527-2648(200110)3:10<737::AID-ADEM737>3.0.CO;2-8
   Schmid G, 1999, CHEM SOC REV, V28, P179, DOI 10.1039/a801153b
   Schultz DA, 2003, CURR OPIN BIOTECH, V14, P13, DOI 10.1016/S0958-1669(02)00015-0
   Shyr MHS, 2008, J AM CHEM SOC, V130, P8234, DOI 10.1021/ja711026r
   SONOGASHIRA K, 1975, TETRAHEDRON LETT, P4467, DOI 10.1016/s0040-4039(00)91094-3
   Srivastava S, 2009, SOFT MATTER, V5, P1146, DOI 10.1039/b812115j
   Stanca SE, 2006, FARADAY DISCUSS, V131, P155, DOI 10.1039/b508471g
   Stemmler MP, 2009, LANGMUIR, V25, P11917, DOI 10.1021/la901587e
   Sung KM, 2004, J AM CHEM SOC, V126, P5064, DOI 10.1021/ja049578p
   TAKALO H, 1988, ACTA CHEM SCAND B, V42, P373, DOI 10.3891/acta.chem.scand.42b-0373
   TAKALO H, 1987, ACTA CHEM SCAND B, P291
   Taubert A, 2003, J MATER CHEM, V13, P1090, DOI 10.1039/b207895c
   Torma V, 2003, EUR J INORG CHEM, P1121
   Wandlowski T, 2002, LANGMUIR, V18, P4331, DOI 10.1021/la025585k
   WELLER H, 1993, ANGEW CHEM INT EDIT, V32, P41, DOI 10.1002/anie.199300411
   Westerlund F, 2009, CURR OPIN COLLOID IN, V14, P126, DOI 10.1016/j.cocis.2008.07.002
   Worden JG, 2004, CHEM COMMUN, P518, DOI 10.1039/b312819a
   Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481
   Yan H, 2010, CHEM COMMUN, V46, P2218, DOI 10.1039/b927496k
   Yuan JY, 2010, POLYMER, V51, P4015, DOI 10.1016/j.polymer.2010.06.064
   Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e
   Zeng Q, 2010, LANGMUIR, V26, P1325, DOI 10.1021/la902258s
   Zhang HL, 2002, NANOTECHNOLOGY, V13, P439, DOI 10.1088/0957-4484/13/3/339
   Zhou Y, 2008, ANGEW CHEM INT EDIT, V47, P7454, DOI 10.1002/anie.200802317
   Zotti G, 2008, CHEM MATER, V20, P397, DOI 10.1021/cm071701z
NR 94
TC 20
Z9 20
U1 0
U2 38
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1613-6810
EI 1613-6829
J9 SMALL
JI Small
PD APR 4
PY 2011
VL 7
IS 7
BP 920
EP 929
DI 10.1002/smll.201002101
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 748GM
UT WOS:000289378000010
PM 21394907
DA 2021-01-25
ER

PT J
AU Klostermeier, D
AF Klostermeier, Dagmar
TI Single-molecule FRET reveals nucleotide-driven conformational changes in
   molecular machines and their link to RNA unwinding and DNA supercoiling
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 8th International Meeting on Recognition Studies in Nucleic Acids
CY SEP 12-16, 2010
CL Univ Sheffield, Sheffield, ENGLAND
HO Univ Sheffield
DE ATP hydrolysis; C-terminal domain; DEAD-box; fluorescence resonance
   energy transfer (FRET); RNA-binding domain; RNA-recognition motif
ID DEAD-BOX PROTEIN; C-TERMINAL DOMAIN; ATP-OPERATED CLAMP; 23S
   RIBOSOMAL-RNA; CRYSTAL-STRUCTURE; CLOSED CONFORMATION; STRAND-PASSAGE;
   HELICASE YXIN; GYRASE; MECHANISM
AB Many complex cellular processes in the cell are catalysed at the expense of ATP hydrolysis. The enzymes involved bind and hydrolyse ATP and couple ATP hydrolysis to the catalysed process via cycles of nucleotide-driven conformational changes. In this review, I illustrate how smFRET (single-molecule fluorescence resonance energy transfer) can define the underlying conformational changes that drive ATP-dependent molecular machines. The first example is a DEAD-box helicase that alternates between two different conformations in its catalytic cycle during RNA unwinding, and the second is DNA gyrase, a topoisomerase that undergoes a set of concerted conformational changes during negative supercoiling of DNA.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@uni-muenster.de
CR Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   Aregger R, 2009, BIOCHEMISTRY-US, V48, P10679, DOI 10.1021/bi901278p
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032
   Diges CM, 2005, BIOCHEMISTRY-US, V44, P7903, DOI 10.1021/bi050033x
   Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123
   GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872
   Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472
   Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106
   Hardin JW, 2010, J MOL BIOL, V402, P412, DOI 10.1016/j.jmb.2010.07.040
   Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414
   Karow AR, 2010, J MOL BIOL, V402, P629, DOI 10.1016/j.jmb.2010.07.049
   Karow AR, 2009, NUCLEIC ACIDS RES, V37, P4464, DOI 10.1093/nar/gkp397
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Kossen K, 1999, NUCLEIC ACIDS RES, V27, P3811, DOI 10.1093/nar/27.19.3811
   Linden MH, 2008, NUCLEIC ACIDS RES, V36, P5800, DOI 10.1093/nar/gkn581
   Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106
   MIZUUCHI K, 1978, P NATL ACAD SCI USA, V75, P5960, DOI 10.1073/pnas.75.12.5960
   Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041
   Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109
   Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X
   Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   Talavera MA, 2006, J MOL BIOL, V355, P697, DOI 10.1016/j.jmb.2005.10.058
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868
   Tsu CA, 2001, RNA, V7, P702, DOI 10.1017/S1355838201010135
   von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561
   Wang S, 2008, BIOPHYS J, V94, pL1, DOI 10.1529/biophysj.107.120709
   Wang SY, 2006, RNA, V12, P959, DOI 10.1261/rna.5906
   WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0
   Williams NL, 2001, J MOL BIOL, V306, P969, DOI 10.1006/jmbi.2001.4468
   Williams NL, 1999, BIOCHEMISTRY-US, V38, P14157, DOI 10.1021/bi991478m
   Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488
   Wilstermann AM, 2003, CURR TOP MED CHEM, V3, P321, DOI 10.2174/1568026033452519
NR 42
TC 7
Z9 7
U1 0
U2 8
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0300-5127
EI 1470-8752
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD APR
PY 2011
VL 39
BP 611
EP 616
DI 10.1042/BST0390611
PN 2
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 755SY
UT WOS:000289958200038
PM 21428949
DA 2021-01-25
ER

PT J
AU Sengupta, S
   Ganguly, A
   Roy, A
   BoseDasgupta, S
   D'Annessa, I
   Desideri, A
   Majumder, HK
AF Sengupta, Souvik
   Ganguly, Agneyo
   Roy, Amit
   BoseDasgupta, Somdeb
   D'Annessa, Ilda
   Desideri, Alessandro
   Majumder, Hemanta K.
TI ATP independent type IB topoisomerase of Leishmania donovani is
   stimulated by ATP: an insight into the functional mechanism
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID VIRUS-DNA TOPOISOMERASE; C-TERMINAL DOMAIN; LARGE SUBUNIT; BINDING;
   CLEAVAGE; FLUORESCENT; INHIBITION; PROTEIN; RELAXATION; MAGNESIUM
AB Most type IB topoisomerases do not require ATP and Mg2+ for activity. However, as shown previously for vaccinia topoisomerase I, we demonstrate that ATP stimulates the relaxation activity of the unusual heterodimeric type IB topoisomerase from Leishmania donovani (LdTOP1L/S) in the absence of Mg2+. The stimulation is independent of ATP hydrolysis but requires salt as a co-activator. ATP binds to LdTOP1L/S and increases its rate of strand rotation. Docking studies indicate that the amino acid residues His93, Tyr95, Arg188 and Arg190 of the large subunit may be involved in ATP binding. Site directed mutagenesis of these four residues individually to alanine and subsequent relaxation assays reveal that the R190A mutant topoisomerase is unable to exhibit ATP-mediated stimulation in the absence of Mg2+. However, the ATP-independent relaxation activities of all the four mutant enzymes remain unaffected. Additionally, we provide evidence that ATP binds LdTOP1L/S and modulates the activity of the otherwise ATP-independent enzyme. This study establishes ATP as an activator of LdTOP1L/S in the absence of Mg2+.
C1 [Sengupta, Souvik; Roy, Amit; Majumder, Hemanta K.] Indian Inst Chem Biol, Mol Parasitol Lab, Kolkata 700032, India.
   [BoseDasgupta, Somdeb] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [D'Annessa, Ilda; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy.
RP Majumder, HK (corresponding author), Indian Inst Chem Biol, Mol Parasitol Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India.
EM hkmajumder@iicb.res.in
RI Gupta, Souvik Sen/X-9547-2019
OI Gupta, Souvik Sen/0000-0001-7452-979X; desideri,
   alessandro/0000-0003-1541-4217
FU Department of Biotechnology, Government of IndiaDepartment of
   Biotechnology (DBT) India [NWP-38, BT/PR6399/BRB/10/434/2005]; CSIR,
   Government of IndiaCouncil of Scientific & Industrial Research (CSIR) -
   India; AIRCAssociazione Italiana per la Ricerca sul Cancro (AIRC)
   [10121]; Indian Institute of Chemical Biology, Kolkata, India
FX Network Project NWP-38 of the Council of Scientific and Industrial
   Research (CSIR), Government of India and BT/PR6399/BRB/10/434/2005 from
   the Department of Biotechnology, Government of India (to H. K. M.);
   Senior Research Fellowship from the CSIR, Government of India (to S.S.);
   grant no. 10121 from AIRC (to A.D.). Funding for open access charge:
   Indian Institute of Chemical Biology, Kolkata, India.
CR Bosedasgupta S, 2008, BIOCHEM J, V409, P481, DOI 10.1042/BJ20071358
   BoseDasgupta S, 2008, MOL MICROBIOL, V67, P31, DOI 10.1111/j.1365-2958.2007.06002.x
   Broccoli S, 1999, NUCLEIC ACIDS RES, V27, P2745, DOI 10.1093/nar/27.13.2745
   Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369
   CHEN BF, 1988, BIOCHEMISTRY-US, V27, P4386, DOI 10.1021/bi00412a027
   Chen HJ, 1999, EUR J BIOCHEM, V265, P367, DOI 10.1046/j.1432-1327.1999.00741.x
   Das BB, 2004, FEBS LETT, V565, P81, DOI 10.1016/j.febslet.2004.03.078
   Das BB, 2005, J BIOL CHEM, V280, P16335, DOI 10.1074/jbc.M412417200
   Das BB, 2007, FEBS J, V274, P150, DOI 10.1111/j.1742-4658.2006.05572.x
   Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022
   DEPEW RE, 1978, J BIOL CHEM, V253, P511
   Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l
   FOGLESONG PD, 1984, J VIROL, V49, P1
   Ganguly A, 2006, NUCLEIC ACIDS RES, V34, P6286, DOI 10.1093/nar/gkl829
   Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9
   Hiratsuka T, 2003, EUR J BIOCHEM, V270, P3479, DOI 10.1046/j.1432-1033.2003.03748.x
   Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   LOW RL, 1985, NUCLEIC ACIDS RES, V13, P6999, DOI 10.1093/nar/13.19.6999
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Osheroff N, 1998, BBA-GENE STRUCT EXPR, V1400, P1, DOI 10.1016/S0167-4781(98)00123-7
   OSHEROFF N, 1983, J BIOL CHEM, V258, P9536
   Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8
   Rossi F, 1998, NUCLEIC ACIDS RES, V26, P2963, DOI 10.1093/nar/26.12.2963
   Roy A, 2008, BIOCHEM J, V409, P611, DOI 10.1042/BJ20071286
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   SEKIGUCHI J, 1994, J BIOL CHEM, V269, P29760
   SHUMAN S, 1988, J BIOL CHEM, V263, P16401
   Shuman S, 1998, BBA-GENE STRUCT EXPR, V1400, P321, DOI 10.1016/S0167-4781(98)00144-4
   SHUMAN S, 1990, J BIOL CHEM, V265, P17826
   Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024
   Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534
   Stewart L, 1996, J BIOL CHEM, V271, P7593, DOI 10.1074/jbc.271.13.7593
   STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P327, DOI 10.1021/bi00167a043
   Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831
   WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665
   Wolf Federica I., 1999, Frontiers in Bioscience, V4, pd607, DOI 10.2741/Wolf
   Yang Z, 2001, J BIOL CHEM, V276, P677, DOI 10.1074/jbc.M007593200
   Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011
NR 41
TC 6
Z9 6
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR
PY 2011
VL 39
IS 8
BP 3295
EP 3309
DI 10.1093/nar/gkq1284
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 757AD
UT WOS:000290055200030
PM 21186185
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Kirchhofer, C
   Vargas, M
   Braissant, O
   Dong, YX
   Wang, XF
   Vennerstrom, JL
   Keiser, J
AF Kirchhofer, Carla
   Vargas, Mireille
   Braissant, Olivier
   Dong, Yuxiang
   Wang, Xiaofang
   Vennerstrom, Jonathan L.
   Keiser, Jennifer
TI Activity of OZ78 analogues against Fasciola hepatica and Echinostoma
   caproni
SO ACTA TROPICA
LA English
DT Article
DE Fasciola hepatica; Echinostoma caproni; Synthetic peroxides; In vivo
   studies; In vitro studies; Microcalorimetry
ID DRUG-DEVELOPMENT CANDIDATE; IN-VITRO; TRICLABENDAZOLE; VIVO;
   IDENTIFICATION; TREMATODIASES; ARTEMISININS; RESISTANCE; LIVER
AB The rapid spread of triclabendazole resistance in veterinary medicine is an important motivation for the discovery and development of novel fasciocidal drugs. The aim of this study was to characterize the fasciocidal properties of 1,2,4,5-tetraoxane (MT04 and MT14) and 1,2,4-trioxane (ST16 and ST28) analogues of the fasciocidal drug candidate OZ78, a 1,2,4-trioxolane. Dose response relationships were determined against juvenile and adult Fasciola hepatica in rats and Echinostoma caproni in mice. The temporal effects of MT04, MT14, ST16, and ST28 compared to 0278 on the viability of F. hepatica were tested in vitro. The heat flow of OZ78 and MT04 treated flukes was studied with isothermal microcalorimetry. Finally, surface changes to adult flukes were monitored by scanning electron microscopy (SEM) 18, 24, and 48 h post-treatment of rats with 50 mg/kg MT04. Administration of 50-100 mg/kg of the synthetic peroxides resulted in complete elimination of adult F. hepatica from rats. SEM pictures revealed sloughing and blebbing already 18 h post-treatment with MT04. MT04 (100 mg/kg) cured infections with juvenile F. hepatica, whereas MT14, ST16, and ST28 showed only low to moderate worm burden reductions. At 300 mg/kg, MT14 was the only compound to completely eliminate worms from E. caproni infected mice. MT14 showed the highest activity against juvenile F. hepatica in vitro. MT04 was very active against adult F. hepatica in vitro, which was confirmed by heat flow measurements. In conclusion, we have identified MT04 as another lead compound with potential against F. hepatica, hence further preclinical studies are necessary to determine if MT04 can be considered a drug development candidate. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Kirchhofer, Carla; Vargas, Mireille; Keiser, Jennifer] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
   [Braissant, Olivier] Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum, CH-4003 Basel, Switzerland.
   [Dong, Yuxiang; Wang, Xiaofang; Vennerstrom, Jonathan L.] Univ Nebraska, Med Ctr, Coll Pharm, Omaha, NE 68198 USA.
RP Keiser, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Socinstr 57, CH-4002 Basel, Switzerland.
EM Jennifer.Keiser@unibas.ch
RI Braissant, Olivier/AAO-2371-2020; Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
FU National Science FoundationNational Science Foundation (NSF)
   [PPOOA-114941]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21AI076783];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI076783, R21AI076783] Funding Source: NIH RePORTER
FX This investigation received financial support from the Swiss National
   Science Foundation (project no. PPOOA-114941) and the NIH (Grant
   R21AI076783).
CR DAWES B, 1961, NATURE, V190, P646, DOI 10.1038/190646a0
   Dong YX, 2010, J MED CHEM, V53, P481, DOI 10.1021/jm901473s
   Duthaler U, 2010, ANTIMICROB AGENTS CH, V54, P4596, DOI 10.1128/AAC.00828-10
   Espinoza Jos R., 2010, Rev. per. med. exp. salud publica, V27, P604, DOI 10.1590/s1726-46342010000400018
   Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377
   Fairweather I, 2009, J HELMINTHOL, V83, P139, DOI 10.1017/S0022149X09321173
   Halferty L, 2009, PARASITOLOGY, V136, P1325, DOI 10.1017/S0031182009990643
   Keiser J, 2008, EXP PARASITOL, V119, P87, DOI 10.1016/j.exppara.2007.12.015
   Keiser J, 2007, TRENDS PARASITOL, V23, P555, DOI 10.1016/j.pt.2007.07.012
   Keiser J, 2006, J ANTIMICROB CHEMOTH, V58, P1193, DOI 10.1093/jac/dkl408
   Keiser J, 2009, CLIN MICROBIOL REV, V22, P466, DOI 10.1128/CMR.00012-09
   Manneck T, 2011, EXP PARASITOL, V127, P260, DOI 10.1016/j.exppara.2010.08.011
   Mas-Coma Santiago, 2007, V11, P293
   Moll L, 2000, VET PARASITOL, V91, P153, DOI 10.1016/S0304-4017(00)00267-3
   O'Neill PM, 2010, ANGEW CHEM INT EDIT, V49, P5693, DOI 10.1002/anie.201001026
   R Core Team, 2017, R LANG ENV STAT COMP
   Robinson MW, 2009, PHILOS T R SOC B, V364, P2763, DOI 10.1098/rstb.2009.0089
   Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188
   Tang YQ, 2005, J ORG CHEM, V70, P5103, DOI 10.1021/jo050385+
   Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779
   Zhao QJ, 2010, J MED CHEM, V53, P4223, DOI 10.1021/jm100226t
NR 21
TC 27
Z9 27
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD APR
PY 2011
VL 118
IS 1
BP 56
EP 62
DI 10.1016/j.actatropica.2011.02.003
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 748OF
UT WOS:000289399200009
PM 21316331
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Manneck, T
   Braissant, O
   Haggenmuller, Y
   Keiser, J
AF Manneck, Theresia
   Braissant, Olivier
   Haggenmueller, Yolanda
   Keiser, Jennifer
TI Isothermal Microcalorimetry To Study Drugs against Schistosoma mansoni
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID IN-VITRO; PRAZIQUANTEL; MEFLOQUINE; TRANSFORMATION
AB Alternative antischistosomal drugs are required since praziquantel is virtually the only drug available for treatment and morbidity control of schistosomiasis. Manual microscopic reading is the current "gold standard" to assess the in vitro antischistosomal properties of test drugs; however, it is labor-intensive, subjective, and difficult to standardize. Hence, there is a need to develop novel tools for antischistosomal drug discovery. The in vitro effects of praziquantel, oxamniquine, artesunate, and mefloquine on metabolic activity and parasite motility of Schistosoma mansoni (newly transformed schistosomula [NTS] and 49-day-old adult worms) were studied using isothermal microcalorimetry (IMC). Results were compared to morphological readouts of viability. Results obtained for the four drugs tested with phenotypic evaluation by microscopy and IMC showed a good correlation, but IMC also identified drug effects that were not visible by microscopic evaluation, and IMC precisely determined the onset of action of the test drugs. Similar sensitivities on NTS and adult schistosomes were observed for praziquantel and mefloquine, while slight differences in the drug susceptibilities of the two developmental stages were noted with oxamniquine and artesunate. IMC is a useful tool for antischistosomal drug discovery that should be further validated. In addition, our data support the use of NTS in in vitro antischistosomal drug assays.
C1 [Manneck, Theresia; Haggenmueller, Yolanda; Keiser, Jennifer] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
   [Manneck, Theresia; Haggenmueller, Yolanda; Keiser, Jennifer] Univ Basel, CH-4003 Basel, Switzerland.
   [Braissant, Olivier] Univ Basel, Biozentrum Pharmazentrum, Lab Biomech & Biocalorimetry, CH-4056 Basel, Switzerland.
RP Keiser, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
EM jennifer.keiser@unibas.ch
RI Braissant, Olivier/AAO-2371-2020; Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
FU 3R Research Foundation; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [110/08, PPOOA-114941]; Hardy & Otto Frey-Zund
   Foundation, Basel, Switzerland
FX T.M. and J.K. are thankful to the 3R Research Foundation and Swiss
   National Science Foundation for financial support (project no. 110/08
   and PPOOA-114941), and O.B. and his laboratory are grateful for the
   support of the Hardy & Otto Frey-Zund Foundation, Basel, Switzerland.
CR Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478
   Boissier J, 2009, ANTIMICROB AGENTS CH, V53, P4903, DOI 10.1128/AAC.00640-09
   Botros SS, 2007, EXPERT OPIN DRUG DIS, V2, pS35, DOI 10.1517/17460441.2.S1.S35
   Braissant O, 2010, TUBERCULOSIS, V90, P57, DOI 10.1016/j.tube.2009.11.001
   Braissant O, 2010, SENSORS-BASEL, V10, P9369, DOI 10.3390/s101009369
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   BRINK LH, 1977, PARASITOLOGY, V74, P73, DOI 10.1017/S0031182000047545
   Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031
   CIOLI D, 1995, PHARMACOL THERAPEUT, V68, P35, DOI 10.1016/0163-7258(95)00026-7
   Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z
   Doenhoff MJ, 2009, PARASITOLOGY, V136, P1825, DOI 10.1017/S0031182009000493
   Doenhoff MJ, 2002, T ROY SOC TROP MED H, V96, P465, DOI 10.1016/S0035-9203(02)90405-0
   Holtfreter MC, 2011, EXP PARASITOL, V127, P270, DOI 10.1016/j.exppara.2010.08.008
   Holtfreter MC, 2010, PARASITOLOGY, V137, P1645, DOI 10.1017/S0031182010000405
   Keiser J, 2010, PARASITOLOGY, V137, P589, DOI 10.1017/S0031182009991739
   Keiser J, 2010, J ANTIMICROB CHEMOTH, V65, P1991, DOI 10.1093/jac/dkq233
   Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6
   Lamberton PHL, 2010, AM J TROP MED HYG, V83, P1340, DOI 10.4269/ajtmh.2010.10-0413
   LAMPRECHT I, 1988, THERMOCHIM ACTA, V130, P87, DOI 10.1016/0040-6031(88)87053-9
   LAMPRECHT I, 1999, HDB THERMAL ANAL CAL, V4, P405
   Lerchner J, 2008, J MICROBIOL METH, V74, P74, DOI 10.1016/j.mimet.2008.04.004
   Manneck T, 2010, PARASITOLOGY, V137, P85, DOI 10.1017/S0031182009990965
   Manneck T, 2011, EXP PARASITOL, V127, P260, DOI 10.1016/j.exppara.2010.08.011
   Mansour NR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000795
   Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504
   Mitsui Y, 2009, J HELMINTHOL, V83, P7, DOI 10.1017/S0022149X08070235
   Morales-Montor J, 2001, J PARASITOL, V87, P1132, DOI 10.2307/3285246
   Peak E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000759
   R Core Team, 2017, R LANG ENV STAT COMP
   RAMALHOPINTO FJ, 1974, EXP PARASITOL, V36, P360, DOI 10.1016/0014-4894(74)90076-9
   Ramirez B, 2007, EXPERT OPIN DRUG DIS, V2, pS53, DOI 10.1517/17460441.2.S1.S53
   Ribeiro-dos-Santos G, 2006, PARASITOL RES, V99, P505, DOI 10.1007/s00436-006-0175-2
   Runge FE, 2000, J AGR FOOD CHEM, V48, P47, DOI 10.1021/jf981163y
   Skelly PJ, 2000, INT J PARASITOL, V30, P625, DOI 10.1016/S0020-7519(00)00031-X
   Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7
   Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/14656566.5.2.263
   von Ah U, 2008, J CLIN MICROBIOL, V46, P2083, DOI 10.1128/JCM.00611-08
   von Ah U, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-106
   Xiao SH, 2001, T ROY SOC TROP MED H, V95, P67, DOI 10.1016/S0035-9203(01)90336-0
   XIAO SH, 1985, J INFECT DIS, V151, P1130, DOI 10.1093/infdis/151.6.1130
NR 40
TC 51
Z9 52
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD APR
PY 2011
VL 49
IS 4
BP 1217
EP 1225
DI 10.1128/JCM.02382-10
PG 9
WC Microbiology
SC Microbiology
GA 744FP
UT WOS:000289080600006
PM 21270220
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Hauer, D
   Weis, F
   Papassotiropoulos, A
   Schmoeckel, M
   Beiras-Fernandez, A
   Lieke, J
   Kaufmann, I
   Kirchhoff, F
   Vogeser, M
   Roozendaal, B
   Briegel, J
   de Quervain, D
   Schelling, G
AF Hauer, Daniela
   Weis, Florian
   Papassotiropoulos, Andreas
   Schmoeckel, Michael
   Beiras-Fernandez, Andres
   Lieke, Julia
   Kaufmann, Ines
   Kirchhoff, Fabian
   Vogeser, Michael
   Roozendaal, Benno
   Briegel, Josef
   de Quervain, Dominique
   Schelling, Gustav
TI Relationship of a common polymorphism of the glucocorticoid receptor
   gene to traumatic memories and posttraumatic stress disorder in patients
   after intensive care therapy
SO CRITICAL CARE MEDICINE
LA English
DT Article
DE glucocorticoid receptor gene; genetic polymorphism; traumatic memories;
   stress; posttraumatic stress disorder; outcome
ID QUALITY-OF-LIFE; FRAGMENT-LENGTH-POLYMORPHISM; PSYCHOSOCIAL STRESS;
   CARDIAC-SURGERY; SEPTIC SHOCK; HPA AXIS; HYDROCORTISONE; SYMPTOMS;
   CORTISOL; ASSOCIATION
AB Objective: Glucocorticoids play a major role in the consolidation and retrieval of traumatic information. They act through the glucocorticoid receptor, for which, in humans, several polymorphisms have been described. In particular, the BclI single-nucleotide polymorphism is associated with hypersensitivity to glucocorticoids and with susceptibility to development of major depression. Furthermore, in patients with posttraumatic stress disorder carrying the BclI GG genotype, cortisol levels were lower and showed an inverse relationship to posttraumatic stress disorder symptom intensity. Here, we studied the association of the BclI polymorphism with plasma cortisol levels, traumatic memories, posttraumatic stress disorder symptoms, and health-related quality of life outcomes in 126 patients undergoing cardiac surgery and intensive care unit therapy.
   Design: Prospective observational study.
   Setting: Cardiovascular intensive care unit in a university hospital.
   Patients: A total of 126 patients undergoing cardiac surgery and intensive care unit treatment
   Interventions: No interventions were performed.
   Measurements and Main Results: Validated questionnaires were used to quantify end points. Measurements were taken 1 day before and 1 wk and 6 months after cardiac surgery. Homozygous carriers of the BclI G allele (n = 21) had significantly lower preoperative plasma cortisol levels and more long-term traumatic memories from intensive care unit therapy at 6 months after cardiac surgery than heterozygous carriers or noncarriers (1.9 +/- 1.4 vs. 1.0 +/- 1.2, p = .01). Anxiety was significantly more common as a long-term traumatic memory in homozygous BclI G allele carriers than in heterozygous carriers or noncarriers (57% vs. 35%, p = .03). Posttraumatic stress disorder symptom scores were significantly higher at discharge from the intensive care unit in homozygous BclI G allele carriers than in heterozygous carriers or noncarriers. Only heterozygous carriers or BclI G allele noncarriers had a significant gain in health-related quality of life physical function at 6 months after cardiac surgery (p < .01). Baseline values were not statistically different between carriers of the different BclI alleles.
   Conclusion: Homozygous BclI G allele carriers are at risk for traumatic memories, posttraumatic stress disorder symptoms, and lower health-related quality of life after cardiac surgery and intensive care unit therapy. The BclI single-nucleotide polymorphism may help to identify individuals at need for tailored medical care. (Crit Care Med 2011; 39: 643-650)
C1 [Hauer, Daniela; Weis, Florian; Lieke, Julia; Kaufmann, Ines; Briegel, Josef; Schelling, Gustav] Univ Munich, Dept Anaesthesiol, Munich, Germany.
   [Schmoeckel, Michael; Beiras-Fernandez, Andres] Univ Munich, Dept Cardiac Surg, Munich, Germany.
   [Kirchhoff, Fabian; Vogeser, Michael] Univ Munich, Dept Clin Chem, Munich, Germany.
   [Roozendaal, Benno] Univ Groningen, Dept Neurosci, Sect Anat, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands.
   [Papassotiropoulos, Andreas] Univ Basel, Div Mol Psychol, Biozentrum, CH-4003 Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil, Biozentrum, CH-4003 Basel, Switzerland.
   [de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, CH-4003 Basel, Switzerland.
RP Weis, F (corresponding author), Univ Munich, Dept Anaesthesiol, Munich, Germany.
EM florian.weis@med.uni-muenchen.de
RI Beiras, Andres/AAE-4864-2020; Roozendaal, Benno/B-8403-2013; Schelling,
   Gustav/U-2603-2018; Briegel, Josef/AAG-3774-2019; Beiras-Fernandez,
   Andres/E-9468-2010
OI Schelling, Gustav/0000-0002-6538-0652; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; de Quervain, Dominique/0000-0001-7131-2464
FU Else Kroner-Fresenius Stiftung, Bad Homburg, Germany; European Science
   Foundation (BALANCE), Strasbourg, FranceEuropean Science Foundation
   (ESF); Swiss National Science Foundation, Bern, SwitzerlandSwiss
   National Science Foundation (SNSF) [PP00B-106708, PP00B-68859,
   PP00B-114813]
FX This study was supported, in part, by the Else Kroner-Fresenius
   Stiftung, Bad Homburg, Germany; the European Science Foundation
   (BALANCE), Strasbourg, France; and the Swiss National Science
   Foundation, Bern, Switzerland (grants PP00B-106708, PP00B-68859, and
   PP00B-114813).
CR Aerni A, 2004, AM J PSYCHIAT, V161, P1488, DOI 10.1176/appi.ajp.161.8.1488
   Bachmann AW, 2005, PSYCHONEUROENDOCRINO, V30, P297, DOI 10.1016/j.psyneuen.2004.08.006
   Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021
   Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291
   Boer KR, 2008, INTENS CARE MED, V34, P664, DOI 10.1007/s00134-007-0941-3
   Buemann B, 1997, OBES RES, V5, P186, DOI 10.1002/j.1550-8528.1997.tb00292.x
   BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N
   Cohen H, 2006, BIOL PSYCHIAT, V59, P1208, DOI 10.1016/j.biopsych.2005.12.003
   de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542
   de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873
   de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002
   Deja M, 2006, CRIT CARE, V10, DOI 10.1186/cc5070
   DeRijk RH, 2008, EUR J PHARMACOL, V585, P492, DOI 10.1016/j.ejphar.2008.03.012
   Duval F, 2004, ANN NY ACAD SCI, V1032, P273, DOI 10.1196/annals.1314.036
   Eid J, 1999, SCAND J PSYCHOL, V40, P101, DOI 10.1111/1467-9450.00105
   Girard TD, 2007, CRIT CARE, V11, DOI 10.1186/cc5708
   Hauer D, 2009, BRAIN RES, V1293, P114, DOI 10.1016/j.brainres.2009.04.014
   Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144
   Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x
   Kilger E, 2003, CRIT CARE MED, V31, P1068, DOI 10.1097/01.CCM.0000059646.89546.98
   Kuhlmann S, 2006, BEHAV NEUROSCI, V120, P217, DOI 10.1037/0735-7044.120.1.217
   Kuhlmann S, 2005, J NEUROSCI, V25, P2977, DOI 10.1523/JNEUROSCI.5139-04.2005
   Kumsta R, 2008, BIOL PSYCHOL, V79, P179, DOI 10.1016/j.biopsycho.2008.04.007
   McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9
   Panarelli M, 1998, J CLIN ENDOCR METAB, V83, P1846, DOI 10.1210/jc.83.6.1846
   Roozendaal B, 1997, ANN NY ACAD SCI, V821, P247, DOI 10.1111/j.1749-6632.1997.tb48284.x
   Roozendaal B, 2002, EUR J NEUROSCI, V15, P553, DOI 10.1046/j.0953-816x.2001.01876.x
   Rosmond R, 2002, OBES RES, V10, P1078, DOI 10.1038/oby.2002.146
   Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011
   Schelling G, 2004, BIOL PSYCHIAT, V55, P627, DOI 10.1016/j.biopsych.2003.09.014
   Schelling G, 2003, CRIT CARE MED, V31, P1971, DOI 10.1097/01.CCM.0000069512.10544.40
   Schelling G, 2001, BIOL PSYCHIAT, V50, P978, DOI 10.1016/S0006-3223(01)01270-7
   Schelling G, 1999, CRIT CARE MED, V27, P2678, DOI 10.1097/00003246-199912000-00012
   Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932
   Tollenaar MS, 2009, NEUROBIOL LEARN MEM, V91, P23, DOI 10.1016/j.nlm.2008.08.002
   van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007
   van Rossum EFC, 2005, TRENDS ENDOCRIN MET, V16, P445, DOI 10.1016/j.tem.2005.10.009
   van Rossum EFC, 2004, RECENT PROG HORM RES, V59, P333, DOI 10.1210/rp.59.1.333
   van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x
   Vogeser M, 2001, CLIN CHEM LAB MED, V39, P944, DOI 10.1515/CCLM.2001.151
   WEAVER JU, 1992, J MOL ENDOCRINOL, V9, P295, DOI 10.1677/jme.0.0090295
   Weis F, 2006, J THORAC CARDIOV SUR, V131, P277, DOI 10.1016/j.jtcvs.2005.07.063
   Wolf OT, 2003, BEST PRACT RES CL EN, V17, P287, DOI 10.1016/S1521-690X(02)00101-X
   Wust S, 2004, J CLIN ENDOCR METAB, V89, P565, DOI 10.1210/jc.2003-031148
   Yehuda R, 2004, NEUROPSYCHOPHARMACOL, V29, P433, DOI 10.1038/sj.npp.1300331
   YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583
   Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034
NR 47
TC 71
Z9 72
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0090-3493
EI 1530-0293
J9 CRIT CARE MED
JI Crit. Care Med.
PD APR
PY 2011
VL 39
IS 4
BP 643
EP 650
DI 10.1097/CCM.0b013e318206bae6
PG 8
WC Critical Care Medicine
SC General & Internal Medicine
GA 736ZD
UT WOS:000288533000005
PM 21169818
DA 2021-01-25
ER

PT J
AU Mueller, P
   Liu, XL
   Pieters, J
AF Mueller, Philipp
   Liu, Xiaolong
   Pieters, Jean
TI Migration and Homeostasis of Naive T Cells Depends on Coronin 1-Mediated
   Prosurvival Signals and Not on Coronin 1-Dependent Filamentous Actin
   Modulation
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID CALCINEURIN-A-BETA; BINDING-PROTEIN; IN-VIVO; F-ACTIN; ARP2/3 COMPLEX;
   DEFICIENT MICE; SURVIVAL; APOPTOSIS; POLYMERIZATION; JASPLAKINOLIDE
AB Coronins are WD repeat-containing proteins highly conserved in the eukaryotic kingdom implicated in the regulation of F-actin. Mammalian coronin 1, one of the most conserved isoforms expressed in leukocytes, regulates survival of T cells, which has been suggested to be due to its role in preventing F-actin-induced apoptosis. In this study, we come to a different conclusion. We show that coronin 1 does not modulate F-actin and that induction of F-actin failed to induce apoptosis. Instead, coronin 1 was required for providing prosurvival signals, in the absence of which T cells rapidly underwent apoptosis. These results argue against a role for coronin 1 in F-actin-mediated T cell apoptosis and establish coronin 1 as an essential regulator of the balance between prosurvival and proapoptotic signals in naive T cells. The Journal of Immunology, 2011, 186: 4039-4050.
C1 [Mueller, Philipp; Liu, Xiaolong; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Kanton Basel-Stadt
FX This work was supported by grants from the Swiss National Science
   Foundation and the Kanton Basel-Stadt.
CR Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149
   BUBB MR, 1994, J BIOL CHEM, V269, P14869
   Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399
   Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641
   Clissi B, 2000, J IMMUNOL, V164, P3292, DOI 10.4049/jimmunol.164.6.3292
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Combaluzier B, 2009, J IMMUNOL, V182, P2745, DOI 10.4049/jimmunol.0801812
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2
   Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1
   DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x
   DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163
   FAULSTICH H, 1993, FEBS LETT, V318, P218, DOI 10.1016/0014-5793(93)80515-V
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007
   Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148
   Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023
   Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8
   Herndon TM, 2001, J IMMUNOL, V166, P5654, DOI 10.4049/jimmunol.166.9.5654
   Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703
   Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kerstan A, 2006, J IMMUNOL, V177, P7689, DOI 10.4049/jimmunol.177.11.7689
   Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269
   Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343
   Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027
   Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4
   MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763
   Machesky LM, 1997, BIOCHEM J, V328, P105
   Manicassamy S, 2008, J IMMUNOL, V180, P106, DOI 10.4049/jimmunol.180.1.106
   Minamide LS, 2000, NAT CELL BIOL, V2, P628
   MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mueller P, 2007, FEBS LETT, V581, P3557, DOI 10.1016/j.febslet.2007.06.068
   Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467
   Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000
   Oku T, 2003, BIOL PHARM BULL, V26, P409
   Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898
   Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259
   Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868
   Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662
   Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416
   Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002
   SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N
   Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9
   Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098
   von Boehmer H, 2000, CURR BIOL, V10, pR642, DOI 10.1016/S0960-9822(00)00665-5
   Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989
   Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004
NR 51
TC 42
Z9 42
U1 0
U2 2
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD APR 1
PY 2011
VL 186
IS 7
BP 4039
EP 4050
DI 10.4049/jimmunol.1003352
PG 12
WC Immunology
SC Immunology
GA 739WH
UT WOS:000288751200028
PM 21339362
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Pantelic, RS
   Suk, JW
   Magnuson, CW
   Meyer, JC
   Wachsmuth, P
   Kaiser, U
   Ruoff, RS
   Stahlberg, H
AF Pantelic, Radosav S.
   Suk, Ji Won
   Magnuson, Carl W.
   Meyer, Jannik C.
   Wachsmuth, Philipp
   Kaiser, Ute
   Ruoff, Rodney S.
   Stahlberg, Henning
TI Graphene: Substrate preparation and introduction
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Graphene; Graphene oxide; Cryo-EM; Electron microscopy; DNA;
   Transmission electron microscopy
ID ELECTRON-MICROSCOPY; FILMS; OXIDE; MOLECULES
AB This technical note describes the transfer of continuous, single-layer, pristine graphene to standard Quantifoil TEM grids. We compare the transmission properties of pristine graphene substrates to those of graphene oxide and thin amorphous carbon substrates. Positively stained DNA imaged across amorphous carbon is typically indiscernible and requires metal shadowing for sufficient contrast. However, in a practical illustration of the new substrates properties, positively stained DNA is imaged across pristine graphene in striking contrast without the need of metal shadowing. We go onto discuss technical considerations and the potential applications of pristine graphene substrates as well as their ongoing development. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Pantelic, Radosav S.; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, Basel, Switzerland.
   [Suk, Ji Won; Magnuson, Carl W.; Ruoff, Rodney S.] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.
   [Suk, Ji Won; Magnuson, Carl W.; Ruoff, Rodney S.] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA.
   [Meyer, Jannik C.; Wachsmuth, Philipp; Kaiser, Ute] Univ Ulm, Electron Microscopy Dept Mat Sci, Ulm, Germany.
RP Stahlberg, H (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, Basel, Switzerland.
EM Henning.Stahlberg@unibas.ch
RI Meyer, Jannik C/H-8541-2012; Ruoff, Rodney/ABE-6532-2020; Suk, Ji
   Won/D-6073-2013; Stahlberg, Henning/H-1868-2011
OI Meyer, Jannik C/0000-0003-4023-0778; Ruoff, Rodney/0000-0002-6599-6764;
   Suk, Ji Won/0000-0002-3953-6617; Stahlberg, Henning/0000-0002-1185-4592
FU Swiss National Science foundation (SystemsX.ch)Swiss National Science
   Foundation (SNSF); DARPA iMINT centre; DARPA CERA centre; Office of
   Naval ResearchOffice of Naval Research; Advanced Energy Consortium;
   German Research Foundation (DFG)German Research Foundation (DFG);
   Ministry of Science, Research and Arts (MWK) of Baden-Wurttemberg
FX We wish to acknowledge Prof. Dr. Wolfgang Baumeister and Dr. Jurgen
   Plitzko for their support during the preliminary stages of our research
   into graphene. We thank Drs. Shirley Muller, Phillipe Ringler, and
   Mohamed Chami for fruitful discussions, and Priyanka Abeyrathne and Paul
   Baumgartner for their help with preparation of DNA samples. Plasmid DNA
   of pSK-CIC-ec1 was a kind gift from the Joseph Mindell group (NIH). This
   work was in part supported by the Swiss National Science foundation
   (SystemsX.ch). The group of Prof. Rodney S. Ruoff appreciates support
   from the DARPA iMINT and DARPA CERA centres, the Office of Naval
   Research, and the Advanced Energy Consortium. The group of Prof. Ute
   Kaiser acknowledges the financial support provided by the German
   Research Foundation (DFG) and Ministry of Science, Research and Arts
   (MWK) of Baden-Wurttemberg state within the SALVE (Sub Angstrom
   Low-Voltage Electron Microscopy) project.
CR BENESCH LP, 2009, J STRUCT BIOL UNPUB
   BRATOSINGUTTMAN S, 1992, J STRUCT BIOL, V108, P162, DOI 10.1016/1047-8477(92)90015-3
   Chen JH, 2008, NAT PHYS, V4, P377, DOI 10.1038/nphys935
   DOBELLE WH, 1968, J CELL BIOL, V39, P733, DOI 10.1083/jcb.39.3.733
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   HAHN M, 1974, BIOCHIM BIOPHYS ACTA, V371, P267, DOI 10.1016/0005-2795(74)90176-7
   Heersche HB, 2007, NATURE, V446, P56, DOI 10.1038/nature05555
   Kelly DF, 2008, P NATL ACAD SCI USA, V105, P4703, DOI 10.1073/pnas.0800867105
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Li XS, 2009, NANO LETT, V9, P4359, DOI 10.1021/nl902623y
   Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245
   Meyer JC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2901147
   Meyer JC, 2008, NATURE, V454, P319, DOI 10.1038/nature07094
   Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545
   Pantelic RS, 2010, J STRUCT BIOL, V170, P152, DOI 10.1016/j.jsb.2009.12.020
   Paredes JI, 2008, LANGMUIR, V24, P10560, DOI 10.1021/la801744a
   Rhinow D, 2008, ULTRAMICROSCOPY, V108, P698, DOI 10.1016/j.ultramic.2007.11.005
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969
   Wang GX, 2009, CARBON, V47, P1359, DOI 10.1016/j.carbon.2009.01.027
   Wang GX, 2009, CARBON, V47, P68, DOI 10.1016/j.carbon.2008.09.002
   Yu QK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2982585
   Zakharchenko KV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046808
   Zhang XY, 2009, CARBON, V47, P334, DOI 10.1016/j.carbon.2008.10.018
   Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235
   Ziegler K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266802
   Zobelli A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245402
NR 27
TC 46
Z9 46
U1 1
U2 51
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD APR
PY 2011
VL 174
IS 1
BP 234
EP 238
DI 10.1016/j.jsb.2010.10.002
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 738LA
UT WOS:000288640100027
PM 20937392
DA 2021-01-25
ER

PT J
AU Strohmeier, J
   Hertel, I
   Diederichsen, U
   Rudolph, MG
   Klostermeier, D
AF Strohmeier, Julian
   Hertel, Ines
   Diederichsen, Ulf
   Rudolph, Markus G.
   Klostermeier, Dagmar
TI Changing nucleotide specificity of the DEAD-box helicase Hera abrogates
   communication between the Q-motif and the P-loop
SO BIOLOGICAL CHEMISTRY
LA English
DT Article
DE crystal structure; Hera; hydrogen bond network; nucleotide specificity;
   8-oxo-adenosine; ribosome biogenesis
ID INITIATION-FACTOR 4A; C-TERMINAL DOMAIN; ELONGATION FACTOR-TU;
   CRYSTAL-STRUCTURE; THERMUS-THERMOPHILUS; PACKAGING MOTOR; RNA; COMPLEX;
   BINDING; RECOGNITION
AB DEAD-box proteins disrupt or remodel RNA and protein/RNA complexes at the expense of ATP. The catalytic core is composed of two flexibly connected RecA-like domains. The N-terminal domain contains most of the motifs involved in nucleotide binding and serves as a minimalistic model for helicase/nucleotide interactions. A single conserved glutamine in the so-called Q-motif has been suggested as a conformational sensor for the nucleotide state. To reprogram the Thermus thermophilus RNA helicase Hera for use of oxo-ATP instead of ATP and to investigate the sensor function of the Q-motif, we analyzed helicase activity of Hera Q28E. Crystal structures of the Hera N-terminal domain Q28E mutant (TthDEAD_Q28E) in apo- and ligand-bound forms show that Q28E does change specificity from adenine to 8-oxoadenine. However, significant structural changes accompany the Q28E mutation, which prevent the P-loop from adopting its catalytically active conformation and explain the lack of helicase activity of Hera_Q28E with either ATP or 8-oxo-ATP as energy sources. 8-Oxo-adenosine, 8-oxo-AMP, and 8-oxo-ADP weakly bind to TthDEAD_Q28E but in non-canonical modes. These results indicate that the Q-motif not only senses the nucleotide state of the helicase but could also stabilize a catalytically competent conformation of the P-loop and other helicase signature motifs.
C1 [Hertel, Ines; Klostermeier, Dagmar] Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
   [Strohmeier, Julian; Diederichsen, Ulf] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany.
   [Rudolph, Markus G.] F Hoffmann La Roche & Co Ltd, CH-4070 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
OI Diederichsen, Ulf/0000-0002-2654-9160; Rudolph,
   Markus/0000-0003-0447-1101
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX We thank the staff at SLS beamlines PX-II and PX-III and Manuel Hilbert
   for support during data collection and Caroline Loew for help with the
   ITC measurement. This work was supported by grants from the Swiss
   National Science Foundation (to D.K.).
CR Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080
   Chatgilialoglu C, 2006, TETRAHEDRON LETT, V47, P711, DOI 10.1016/j.tetlet.2005.11.099
   CHO BP, 1991, NUCLEIC ACIDS RES, V19, P1041, DOI 10.1093/nar/19.5.1041
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272
   Del Campo M, 2009, J MOL BIOL, V389, P674, DOI 10.1016/j.jmb.2009.04.043
   Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472
   HILBERT M, 2010, NUCL ACIDS IN PRESS
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   HOFFENBERG S, 1995, BIOCHEM BIOPH RES CO, V215, P241, DOI 10.1006/bbrc.1995.2459
   Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050
   HWANG YW, 1987, J BIOL CHEM, V262, P13081
   Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828
   Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410
   JONES S, 1995, J CELL BIOL, V130, P1051, DOI 10.1083/jcb.130.5.1051
   KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903
   KANG C, 1994, J BIOL CHEM, V269, P24046
   Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0
   Klostermeier D, 2009, NUCLEIC ACIDS RES, V37, P421, DOI 10.1093/nar/gkn947
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Linden MH, 2008, NUCLEIC ACIDS RES, V36, P5800, DOI 10.1093/nar/gkn581
   McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617
   MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396
   Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041
   Morlang S, 1999, J MOL BIOL, V294, P795, DOI 10.1006/jmbi.1999.3282
   POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124
   Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065
   Rudolph MG, 2009, RNA, V15, P1993, DOI 10.1261/rna.1820009
   Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0
   Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105
   Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101
   STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0
   STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0
   Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296
   Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6
   Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106
   Tsu CA, 2001, RNA, V7, P702, DOI 10.1017/S1355838201010135
   von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561
   Warkentin Matthew, 2007, Journal of Structural and Functional Genomics, V8, P141, DOI 10.1007/s10969-007-9029-0
   WEIJLAND A, 1993, FEBS LETT, V330, P334, DOI 10.1016/0014-5793(93)80899-6
   Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463
   Yu B, 1997, J BIOL CHEM, V272, P18015, DOI 10.1074/jbc.272.29.18015
   ZHONG JM, 1995, J BIOL CHEM, V270, P10002, DOI 10.1074/jbc.270.17.10002
   Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28
NR 57
TC 7
Z9 7
U1 1
U2 6
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1431-6730
EI 1437-4315
J9 BIOL CHEM
JI Biol. Chem.
PD APR
PY 2011
VL 392
IS 4
BP 357
EP 369
DI 10.1515/BC.2011.034
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 734EU
UT WOS:000288317600010
PM 21391900
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Balanescu, S
   Kopp, P
   Gaskill, MB
   Morgenthaler, NG
   Schindler, C
   Rutishauser, J
AF Balanescu, Sandrina
   Kopp, Peter
   Gaskill, Mary Beth
   Morgenthaler, Nils G.
   Schindler, Christian
   Rutishauser, Jonas
TI Correlation of Plasma Copeptin and Vasopressin Concentrations in Hypo-,
   Iso-, and Hyperosmolar States
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID ACUTE MYOCARDIAL-INFARCTION; TERMINAL PROVASOPRESSIN COPEPTIN;
   ARGININE-VASOPRESSIN; STABLE PEPTIDE; HEART-FAILURE;
   ANTIDIURETIC-HORMONE; NATRIURETIC PEPTIDE; WATER-DEPRIVATION; PRECURSOR;
   PHYSIOLOGY
AB Background: Copeptin, the C-terminal moiety of provasopressin, is cosecreted with vasopressin. Copeptin may be a useful parameter to characterize disorders of water homeostasis and can be readily measured in plasma or serum. However, it is unknown to date how circulating copeptin and vasopressin levels correlate at different plasma osmolalites.
   Objective: To correlate plasma copeptin with plasma osmolality and vasopressin concentrations in healthy subjects during iso-, hypo-, and hyperosmolar states.
   Methods: Plasma osmolalities, copeptin, and vasopressin levels were measured in 20 volunteers at baseline, after an oral water load, and during and after iv infusion of 3% saline. Correlation coefficients were determined between plasma osmolalites and copeptin and vasopressin concentrations, as well as between vasopressin and copeptin concentrations.
   Results: Median plasma osmolalities decreased from 290 mOsm/kg (range, 284-302) at baseline to 281 (273-288) mOsm/kg after water load and rose to 301 (298-307) mOsm/kg after hypertonic saline. Median plasma copeptin concentrations decreased from 3.3 (1.1-36.4) pM at baseline to 2.0 (0.9-10.4) pM after water load and increased to 13.6 (3.7-43.3) pM after hypertonic saline. Vasopressin and copeptin concentrations correlated with plasma osmolality (Spearman's rank correlation coefficient 0.49 and 0.77, respectively). There was a close correlation of vasopressin and copeptin concentrations (Spearman's rank correlation coefficient 0.8).
   Conclusion: Plasma vasopressin and copeptin correlate strongly over a wide range of osmolalities in healthy individuals. Therefore, the measurement of copeptin, which remains stable for several days, is a useful alternative to vasopressin measurements and will likely facilitate the differential diagnosis of disorders of water metabolism. (J Clin Endocrinol Metab 96: 1046-1052, 2011)
C1 [Balanescu, Sandrina; Rutishauser, Jonas] Ctr Hosp, Clin Internal Med, CH-2501 Biel, Switzerland.
   [Kopp, Peter] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.
   [Kopp, Peter] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA.
   [Gaskill, Mary Beth] Northwestern Univ, Feinberg Sch Med, Clin Res Unit, Chicago, IL 60611 USA.
   [Morgenthaler, Nils G.] BRAHMS AG, Dept Res, D-16761 Hennigsdorf, Germany.
   [Schindler, Christian] Univ Basel, Inst Social & Prevent Med, CH-4051 Basel, Switzerland.
   [Rutishauser, Jonas] Univ Basel, Biozentrum, CH-4051 Basel, Switzerland.
RP Rutishauser, J (corresponding author), Ctr Hosp, Clin Internal Med, Vogelsang 84, CH-2501 Biel, Switzerland.
EM j.rutishauser@unibas.ch
RI Schindler, Christian/D-3472-2015
OI Kopp, Peter A/0000-0001-5980-0529
CR BAUMANN G, 1976, J CLIN INVEST, V57, P1109, DOI 10.1172/JCI108377
   BAYLIS PH, 1977, LANCET, V2, P428
   Fenske W, 2009, J CLIN ENDOCR METAB, V94, P123, DOI 10.1210/jc.2008-1426
   Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830
   Katan M, 2007, J CLIN ENDOCR METAB, V92, P2640, DOI 10.1210/jc.2006-2046
   Keller T, 2010, J AM COLL CARDIOL, V55, P2096, DOI 10.1016/j.jacc.2010.01.029
   Kelly D, 2008, J CARD FAIL, V14, P739, DOI 10.1016/j.cardfail.2008.07.231
   Khan SQ, 2007, CIRCULATION, V115, P2103, DOI 10.1161/CIRCULATIONAHA.106.685503
   Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41
   Kluge M, 1999, CLIN CHEM, V45, P98
   LAND H, 1982, NATURE, V295, P299, DOI 10.1038/295299a0
   Loh JA, 2008, ENDOCRIN METAB CLIN, V37, P213, DOI 10.1016/j.ecl.2007.10.008
   Masia M, 2007, CLIN CHEM, V53, P2193, DOI 10.1373/clinchem.2007.085688
   Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038
   Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001
   Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da
   Neuhold S, 2008, J AM COLL CARDIOL, V52, P266, DOI 10.1016/j.jacc.2008.03.050
   Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.076
   Robertson GL, 2006, AM J MED, V119, pS36, DOI 10.1016/j.amjmed.2006.05.006
   Robertson GL, 2001, ENDOCRIN METAB CLIN, V30, P671, DOI 10.1016/S0889-8529(05)70207-3
   ROBERTSON GL, 1973, J CLIN INVEST, V52, P2340, DOI 10.1172/JCI107423
   ROBERTSON GL, 1994, SEMIN NEPHROL, V14, P368
   SAUSVILLE E, 1985, J BIOL CHEM, V260, P236
   SCHRIER RW, 1979, AM J PHYSIOL, V236, pF321
   Stachenfeld NS, 2001, J APPL PHYSIOL, V91, P1893
   Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.x
   Stolz D, 2007, CHEST, V131, P1058, DOI 10.1378/chest.06-2336
   Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019
   Szinnai G, 2005, AM J PHYSIOL-REG I, V289, pR275, DOI 10.1152/ajpregu.00501.2004
   Szinnai G, 2007, J CLIN ENDOCR METAB, V92, P3973, DOI 10.1210/jc.2007-0232
   Westermann I, 2007, SHOCK, V28, P644, DOI 10.1097/shk.0b013e3180cab33f
   ZERBE RL, 1991, J LAB CLIN MED, V117, P51
NR 32
TC 124
Z9 129
U1 0
U2 4
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD APR
PY 2011
VL 96
IS 4
BP 1046
EP 1052
DI 10.1210/jc.2010-2499
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 746JO
UT WOS:000289242800047
PM 21289257
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Lussi, YC
   Hugia, I
   Laurell, E
   Kutay, U
   Fahrenkrog, B
AF Lussi, Yvonne C.
   Huegia, Ilona
   Laurell, Eva
   Kutay, Ulrike
   Fahrenkrog, Birthe
TI The nucleoporin Nup88 is interacting with nuclear lamin A
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID HUTCHINSON-GILFORD PROGERIA; CELL-CYCLE PROGRESSION; C-TERMINAL DOMAIN;
   PORE COMPLEX; A-TYPE; NUCLEOCYTOPLASMIC TRANSPORT; CRYOELECTRON
   TOMOGRAPHY; PROTEIN IMPORT; LIVING CELLS; ARCHITECTURE
AB Nuclear pore complexes (NPCs) are embedded in the nuclear envelope (NE) and mediate bidirectional nucleocytoplasmic transport. Their spatial distribution in the NE is organized by the nuclear lamina, a meshwork of nuclear intermediate filament proteins. Major constituents of the nuclear lamina are A-and B-type lamins. In this work we show that the nuclear pore protein Nup88 binds lamin A in vitro and in vivo. The interaction is mediated by the N-terminus of Nup88, and Nup88 specifically binds the tail domain of lamin A but not of lamins B1 and B2. Expression of green fluorescent protein-tagged lamin A in cells causes a masking of binding sites for Nup88 antibodies in immunofluorescence assays, supporting the interaction of lamin A with Nup88 in a cellular context. The epitope masking disappears in cells expressing mutants of lamin A that are associated with laminopathic diseases. Consistently, an interaction of Nup88 with these mutants is disrupted in vitro. Immunoelectron microscopy using Xenopus laevis oocyte nuclei further revealed that Nup88 localizes to the cytoplasmic and nuclear face of the NPC. Together our data suggest that a pool of Nup88 on the nuclear side of the NPC provides a novel, unexpected binding site for nuclear lamin A.
C1 [Lussi, Yvonne C.; Huegia, Ilona; Fahrenkrog, Birthe] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Laurell, Eva; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland.
   [Fahrenkrog, Birthe] Univ Libre Bruxelles, Inst Mol Biol & Med, B-6041 Charleroi, Belgium.
RP Fahrenkrog, B (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM bfahrenk@ulb.ac.be
RI Fahrenkrog, Birthe/D-5840-2011
OI Lussi, Yvonne/0000-0002-5753-0235; Fahrenkrog,
   Birthe/0000-0003-4080-9413
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [31003A-125488, 31003A-118053]; Fonds de la Recherche
   Scientifique BelgiumFonds de la Recherche Scientifique - FNRS; Kanton
   Basel Stadt; M.E. Muller Foundation of Switzerland
FX We thank Teiba Al-Haboubi, Robert D. Goldman, Harald Herrmann, and Dale
   K. Shumaker for plasmids and antibodies as well as Dale K. Shumaker and
   Larisa Kapinos for purified lamin proteins. This work is supported by
   research grants from the Swiss National Science Foundation (SNF grant
   31003A-125488 to BF and 31003A-118053 to UK), the Fonds de la Recherche
   Scientifique Belgium (to BF), as well as the Kanton Basel Stadt and the
   M.E. Muller Foundation of Switzerland (to BF).
CR Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200
   Agudo D, 2004, INT J CANCER, V109, P717, DOI 10.1002/ijc.20034
   AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124
   Bastos R, 1997, J CELL BIOL, V137, P989, DOI 10.1083/jcb.137.5.989
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004
   Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200
   Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005
   Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125
   Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708
   Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807
   Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046
   Furukawa K, 2009, EXP CELL RES, V315, P1181, DOI 10.1016/j.yexcr.2008.12.024
   Gould VE, 2002, HUM PATHOL, V33, P536, DOI 10.1053/hupa.2002.124785
   Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Harborth J, 2001, J CELL SCI, V114, P4557
   Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.E04-10-0857
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   Hutchison CJ, 2001, J CELL SCI, V114, P9
   Krimm I, 2002, J BIOMOL NMR, V22, P371, DOI 10.1023/A:1014943122068
   Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3
   Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165
   LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001
   Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x
   Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006
   Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937
   LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Martinez N, 1999, CANCER RES, V59, P5408
   Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155
   Muralikrishna B, 2004, J CELL BIOCHEM, V91, P730, DOI 10.1002/jcb.10765
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046
   Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168
   Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003
   Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030
   Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155
   Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913
   Takahashi N, 2008, BIOCHEM BIOPH RES CO, V374, P424, DOI 10.1016/j.bbrc.2008.06.128
   Tunnah D, 2005, J MOL HISTOL, V36, P337, DOI 10.1007/s10735-005-9004-7
   Uv AE, 2000, GENE DEV, V14, P1945
   Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028
   Zhang ZY, 2007, TUMOR BIOL, V28, P93, DOI 10.1159/000099154
NR 57
TC 24
Z9 26
U1 0
U2 2
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD APR 1
PY 2011
VL 22
IS 7
BP 1080
EP 1090
DI 10.1091/mbc.E10-05-0463
PG 11
WC Cell Biology
SC Cell Biology
GA 743CW
UT WOS:000288995800018
PM 21289091
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Sanudo, M
   Jacko, M
   Rammelt, C
   Vanacova, S
   Stefl, R
AF Sanudo, Maria
   Jacko, Martin
   Rammelt, Christiane
   Vanacova, Stepanka
   Stefl, Richard
TI H-1, C-13, and N-15 chemical shift assignments of ZCCHC9
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE ZCCHC9; Zinc knuckle; CCHC; RNA degradation
AB ZCCHC9 is a human nuclear protein with sequence homology to yeast Air1p/Air2p proteins which are RNA-binding subunits of the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex involved in nuclear RNA quality control and degradation in yeast. The ZCCHC9 protein contains four retroviral-type zinc knuckle motifs. Here, we report the NMR spectral assignment of the zinc knuckle region of ZCCHC9. These data will allow performing NMR structural and RNA-binding studies of ZCCHC9 with the aim to investigate its role in the RNA quality control in human.
C1 [Sanudo, Maria; Jacko, Martin; Vanacova, Stepanka; Stefl, Richard] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno 62500, Czech Republic.
   [Rammelt, Christiane] Univ Basel, Biozentrum, CH-4057 Basel, Switzerland.
RP Vanacova, S (corresponding author), Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno 62500, Czech Republic.
EM vanacova@chemi.muni.cz; stefl@chemi.muni.cz
RI Jacko, Martin/C-5563-2018; Stefl, Richard/D-7010-2012; Vanacova,
   Stepanka/D-6858-2012
OI Jacko, Martin/0000-0001-7378-7439; Vanacova,
   Stepanka/0000-0001-8807-0684; Stefl, Richard/0000-0003-0558-5952
FU Wellcome TrustWellcome Trust [084316/Z/07/Z]; EMBOEuropean Molecular
   Biology Organization (EMBO) [1642]; European Molecular Biology
   Organization/Howard Hughes Medical InstituteHoward Hughes Medical
   InstituteEuropean Molecular Biology Organization (EMBO) [1263]; Human
   Frontier Science ProgramHuman Frontier Science Program [0049/2006];
   Ministry of Education of the Czech RepublicMinistry of Education, Youth
   & Sports - Czech Republic [MSM0021622413, Ingo LA08008]; GACRGrant
   Agency of the Czech Republic [204/08/1212, 305/10/1490]; GAAVGrant
   Agency of the Czech Republic [IAA401630903]; ECEuropean
   CommissionEuropean Commission Joint Research CentreEuropean Community
   (EC) [205872]
FX This work was supported by Wellcome Trust International Senior
   Fellowship 084316/Z/07/Z (to S. V.), EMBO Installation Grant Project No.
   1642 (to S. V.), European Molecular Biology Organization/Howard Hughes
   Medical Institute Start-up Grant No. 1263 (to R. S.), and Human Frontier
   Science Program Career Development Award No. 0049/2006 (to R. S.),
   Ministry of Education of the Czech Republic (MSM0021622413, Ingo
   LA08008), GACR (204/08/1212 and 305/10/1490), GAAV (IAA401630903). MS is
   supported by the EC FP-7 (grant no. 205872).
CR D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210
   D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600
   Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555
   Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005
   Zhou AD, 2008, J GENET GENOMICS, V35, P467, DOI 10.1016/S1673-8527(08)60064-8
   Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244
NR 10
TC 5
Z9 5
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD APR
PY 2011
VL 5
IS 1
BP 19
EP 21
DI 10.1007/s12104-010-9257-2
PG 3
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA 730ZO
UT WOS:000288076300005
PM 20711761
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Zanolari, B
   Rockenbauch, U
   Trautwein, M
   Clay, L
   Barral, Y
   Spang, A
AF Zanolari, Bettina
   Rockenbauch, Uli
   Trautwein, Mark
   Clay, Lorena
   Barral, Yves
   Spang, Anne
TI Transport to the plasma membrane is regulated differently early and late
   in the cell cycle in Saccharomyces cerevisiae
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Small GTPases; Intracellular traffic; Cell cycle; Yeast; Exocytosis;
   Endocytosis
ID SECRETORY VESICLES; ENDOPLASMIC-RETICULUM; FLUORESCENT PROTEIN; GOLGI
   NETWORK; YEAST GENES; COMPLEX; CHITIN; BUD; LOCALIZATION; EXOCYTOSIS
AB Traffic from the trans-Golgi network to the plasma membrane is thought to occur through at least two different independent pathways. The chitin synthase Chs3p requires the exomer complex and Arf1p to reach the bud neck of yeast cells in a cell-cycle-dependent manner, whereas the hexose transporter Hxt2p localizes over the entire plasma membrane independently of the exomer complex. Here, we conducted a visual screen for communalities and differences between the exomer-dependent and exomer-independent transport to the plasma membrane in Saccharomyces cerevisiae. We found that most of the components that are required for the fusion of transport vesicles with the plasma membrane, are involved in localization of both Chs3p and Hxt2p. However, the lethal giant larva homologue Sro7p is required primarily for the targeting of Chs3p, and not Hxt2p or other cargoes such as Itr1p, Cwp2p and Pma1p. Interestingly, this transport defect was more pronounced in large-budded cells just before cytokinesis than in small-budded cells. In addition, we found that the yeast Rab11 homologue Ypt31p determines the residence time of Chs3p in the bud neck of small-budded, but not large-budded, cells. We propose that transport to and from the bud neck is regulated differently in small-and large-budded cells, and differs early and late in the cell cycle.
C1 [Zanolari, Bettina; Rockenbauch, Uli; Trautwein, Mark; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Clay, Lorena; Barral, Yves] ETH Zurich Honggerberg, CH-8049 Zurich, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203;
   Barral, Yves/0000-0002-0989-3373
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel; ETH ZurichETH Zurich
FX We thank A. Reyes, C. Roncero, J. A. Cooper, O. Deloche, W. Guo, A.
   Nieman, H. Riezman and R. Schekman for strains and plasmids. Present and
   past members of the Spang lab are acknowledged for thoughtful
   discussions and comments. This work was supported by Swiss National
   Science Foundation, the University of Basel and the ETH Zurich.
CR Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065
   Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799
   Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324
   Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597
   DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75
   Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23
   Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071
   Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602
   HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297
   Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077
   Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142
   Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563
   Kamena F, 2008, J CELL SCI, V121, P1293, DOI 10.1242/jcs.016998
   Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145
   Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W
   Kruckeberg AL, 1999, BIOCHEM J, V339, P299, DOI 10.1042/0264-6021:3390299
   Larsson K, 1998, J BIOL CHEM, V273, P33610, DOI 10.1074/jbc.273.50.33610
   Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9
   McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18
   Miyashita M, 2003, J BIOSCI BIOENG, V96, P291, DOI 10.1016/S1389-1723(03)80196-2
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147
   RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55
   Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720
   Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013
   Sanchatjate S, 2006, MOL BIOL CELL, V17, P4157, DOI 10.1091/mbc.E06-03-0210
   SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   SIKORSKI RS, 1989, GENETICS, V122, P19
   SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283
   Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199
   TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x
   TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299
   Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007
   Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724
   Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100
   Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2
   Waddle JA, 1996, J CELL BIOL, V132, P861, DOI 10.1083/jcb.132.5.861
   Wadskog I, 2006, MOL BIOL CELL, V17, P4988, DOI 10.1091/mbc.E05-08-0798
   Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106
   Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199
   Williams DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005449
   Ziman M, 1996, MOL BIOL CELL, V7, P1909
NR 44
TC 23
Z9 23
U1 0
U2 6
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD APR 1
PY 2011
VL 124
IS 7
BP 1055
EP 1066
DI 10.1242/jcs.072371
PG 12
WC Cell Biology
SC Cell Biology
GA 734FC
UT WOS:000288318400008
PM 21363887
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Haefeli, RH
   Erb, M
   Gemperli, AC
   Robay, D
   Fruh, IC
   Anklin, C
   Dallmann, R
   Gueven, N
AF Haefeli, Roman H.
   Erb, Michael
   Gemperli, Anja C.
   Robay, Dimitri
   Fruh, Isabelle Courdier
   Anklin, Corinne
   Dallmann, Robert
   Gueven, Nuri
TI NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox
   Potential and Energy Levels
SO PLOS ONE
LA English
DT Article
ID NAD(P)H QUINONE OXIDOREDUCTASE; BRAIN MITOCHONDRIA; LIPID-PEROXIDATION;
   FRIEDREICH ATAXIA; DT-DIAPHORASE; COENZYME-Q; RESPIRATORY-CHAIN;
   INHIBITION; CYTOTOXICITY; ANTIOXIDANT
AB Short-chain quinones are described as potent antioxidants and in the case of idebenone have already been under clinical investigation for the treatment of neuromuscular disorders. Due to their analogy to coenzyme Q(10) (CoQ(10)), a long-chain quinone, they are widely regarded as a substitute for CoQ(10). However, apart from their antioxidant function, this provides no clear rationale for their use in disorders with normal CoQ(10) levels. Using recombinant NAD(P)H:quinone oxidoreductase (NQO) enzymes, we observed that contrary to CoQ(10) short-chain quinones such as idebenone are good substrates for both NQO1 and NQO2. Furthermore, the reduction of short-chain quinones by NQOs enabled an antimycin A-sensitive transfer of electrons from cytosolic NAD(P) H to the mitochondrial respiratory chain in both human hepatoma cells (HepG2) and freshly isolated mouse hepatocytes. Consistent with the substrate selectivity of NQOs, both idebenone and CoQ(1), but not CoQ(10), partially restored cellular ATP levels under conditions of impaired complex I function. The observed cytosolic-mitochondrial shuttling of idebenone and CoQ(1) was also associated with reduced lactate production by cybrid cells from mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) patients. Thus, the observed activities separate the effectiveness of short-chain quinones from the related long-chain CoQ(10) and provide the rationale for the use of short-chain quinones such as idebenone for the treatment of mitochondrial disorders.
C1 [Haefeli, Roman H.; Erb, Michael; Robay, Dimitri; Anklin, Corinne; Gueven, Nuri] Santhera Pharmaceut, Liestal, Switzerland.
   [Haefeli, Roman H.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Gemperli, Anja C.] Inst Straumann AG, Basel, Switzerland.
   [Fruh, Isabelle Courdier] Novartis Pharma AG, Basel, Switzerland.
   [Dallmann, Robert] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.
RP Haefeli, RH (corresponding author), Santhera Pharmaceut, Liestal, Switzerland.
EM nuri.gueven@santhera.com
OI Guven, Nuri/0000-0003-3782-767X; Dallmann, Robert/0000-0002-7490-0218
FU Santhera Pharmaceuticals (Switzerland) Ltd.
FX Santhera Pharmaceuticals (Switzerland) Ltd. (www.santhera.com) funded
   and approved the publication of this work.
CR Adikesavan AK, 2007, CANCER RES, V67, P7966, DOI 10.1158/0008-5472.CAN-06-4480
   Audi SH, 2003, FREE RADICAL BIO MED, V34, P892, DOI 10.1016/S0891-5849(03)00025-X
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   Boutin JA, 2005, CHEM-BIOL INTERACT, V151, P213, DOI 10.1016/j.cbi.2005.01.002
   Briere JJ, 2004, BIOCHEM BIOPH RES CO, V316, P1138, DOI 10.1016/j.bbrc.2004.03.002
   Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270
   Chapela SP, 2008, CELL BIOL INT, V32, P146, DOI 10.1016/j.cellbi.2007.08.003
   CIVENNI G, 2009, EUR J PHARMACOL, V370, P161
   Colucci MA, 2008, ORG BIOMOL CHEM, V6, P637, DOI 10.1039/b715270a
   Degli Esposti Mauro, 1996, Archives of Biochemistry and Biophysics, V330, P395
   Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019
   Dragan M, 2006, BRAIN RES, V1078, P9, DOI 10.1016/j.brainres.2006.01.068
   ERNSTER L, 1962, BIOCHIM BIOPHYS ACTA, V58, P171, DOI 10.1016/0006-3002(62)90997-6
   Ernster L., 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1
   FATO R, 2008, BIOCHIM BIOPHYS ACTA, V1787, P384
   GASDASKA PY, 1995, CANCER RES, V55, P2542
   Haginoya K, 2009, J NEUROL SCI, V278, P112, DOI 10.1016/j.jns.2008.11.008
   HOUCHI H, 1991, JPN J PHARMACOL, V57, P553, DOI 10.1254/jjp.57.553
   Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200
   Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055
   Knox RJ, 2000, CANCER RES, V60, P4179
   Kutz K, 2009, J NEUROL, V256, P31, DOI 10.1007/s00415-009-1006-z
   Lenaz G, 2001, FEBS LETT, V509, P151, DOI 10.1016/S0014-5793(01)03172-6
   Long DJ, 2000, CHEM-BIOL INTERACT, V129, P99, DOI 10.1016/S0009-2797(00)00200-3
   Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897
   MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7
   MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U
   Myers L, 2008, J NEUROL SCI, V267, P174, DOI 10.1016/j.jns.2007.10.008
   Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015
   OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7
   OKAMOTO K, 1998, CHEM PHARM BULL, V36, P178
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Paolino D, 2004, J PHARM SCI-US, V93, P1815, DOI 10.1002/jps.20088
   Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Rauchova H, 2008, J BIOENERG BIOMEMBR, V40, P85, DOI 10.1007/s10863-008-9134-1
   Rauchova H, 2006, BIOCHEM BIOPH RES CO, V339, P362, DOI 10.1016/j.bbrc.2005.11.035
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   Siegel D, 1997, MOL PHARMACOL, V52, P300
   SUGIYAMA Y, 1985, J PHARMACOBIO-DYNAM, V8, P1006
   SUNO M, 1984, BIOCHEM BIOPH RES CO, V125, P1046, DOI 10.1016/0006-291X(84)91389-5
   SUNO M, 1989, ARCH GERONTOL GERIAT, V8, P291, DOI 10.1016/0167-4943(89)90010-1
   Takuma K, 2000, EUR J PHARMACOL, V406, P333, DOI 10.1016/S0014-2999(00)00701-9
   Tan AS, 2010, FREE RADICAL BIO MED, V48, P421, DOI 10.1016/j.freeradbiomed.2009.11.016
   Tonon C, 2008, EXPERT OPIN PHARMACO, V9, P2327, DOI 10.1517/14656566.9.13.2327 
   Villalba JM, 2010, EXPERT OPIN INV DRUG, V19, P535, DOI 10.1517/13543781003727495
   Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344
NR 49
TC 103
Z9 105
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 31
PY 2011
VL 6
IS 3
AR e17963
DI 10.1371/journal.pone.0017963
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 743YU
UT WOS:000289057200014
PM 21483849
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Egli, S
   Nussbaumer, MG
   Balasubramanian, V
   Chami, M
   Bruns, N
   Palivan, C
   Meier, W
AF Egli, Stefan
   Nussbaumer, Martin G.
   Balasubramanian, Vimalkumar
   Chami, Mohamed
   Bruns, Nico
   Palivan, Cornelia
   Meier, Wolfgang
TI Biocompatible Functionalization of Polymersome Surfaces: A New Approach
   to Surface Immobilization and Cell Targeting Using Polymersomes
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID FLUORESCENCE CORRELATION SPECTROSCOPY; COPOLYMER VESICLES;
   LIGHT-SCATTERING; GENE DELIVERY; IN-VITRO; DRUG; OLIGONUCLEOTIDES;
   INHIBITION; MEMBRANES; PARTICLE
AB Vesicles assembled from amphiphilic block copolymers represent promising nanomaterials for applications that include drug delivery and surface functionalization. One essential requirement to guide such polymersomes to a desired site in vivo is conjugation of active, targeting ligands to the surface of preformed self-assemblies. Such conjugation chemistry must fulfill criteria of efficiency and selectivity, stability of the resulting bond, and biocompatibility. We have here developed a new system that achieves these criteria by simple conjugation of 4-formylbenzoate (4FB) functionalized polymersomes with 6-hydrazinonicotinate acetone hydrazone (HyNic) functionalized antibodies in aqueous buffer. The number of available amino groups on the surface of polymersomes composed of poly-(dimethylsiloxane)-block-poly(2-methyloxazoline) diblock copolymers was investigated by reacting hydrophilic succinimidyl-activated fluorescent dye with polymersomes and evaluating the resulting emission intensity. To prove attachment of biomolecules to polymersomes, HyNic functionalized enhanced yellow fluorescent protein (eYFP) was attached to 4FB functionalized polymersomes, resulting in an average number of 5 eYFP molecules per polymersome. Two different polymersome antibody conjugates were produced using either antibiotin IgG or trastuzumab. They showed specific targeting toward biotin-patterned surfaces and breast cancer cells. Overall, the polymersome ligand platform appears promising for therapeutic and diagnostic use.
C1 [Egli, Stefan; Nussbaumer, Martin G.; Balasubramanian, Vimalkumar; Bruns, Nico; Palivan, Cornelia; Meier, Wolfgang] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, CH-4058 Basel, Switzerland.
RP Meier, W (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.
EM wolfgang.meier@unibas.ch
RI balasubramanian, vimalkumar/H-6638-2015; Bruns, Nico/C-6485-2009
OI balasubramanian, vimalkumar/0000-0002-9856-5143; Bruns,
   Nico/0000-0001-6199-9995
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); NCCR NanosciencesSwiss National Science Foundation (SNSF);
   University of Basel; Marie-Curie Intra-European Fellowhip
FX We thank the Swiss National Science Foundation, the NCCR Nanosciences,
   and the University of Basel for financial support. N.B. is grateful for
   a Marie-Curie Intra-European Fellowhip. We acknowledge N. E. Hynes and
   T. Stolzle from Friedrich Miescher Institute for providing SKBR3 cell
   lines, Ch. Bitter and N. Ott from University Hospital Pharmacy Basel for
   providing trastuzumab antibody, and the Zentrum fur Mikroskopie Basel
   (ZMB) for access to TEM. Experimental assistance from S. Kasper, D.
   Haussinger, K. Jaskiewicz, I. Lieberwirth, and G. Persy is gratefully
   acknowledged. W.M. is thankful to P. Vajkoczy. We thank M. Inglin for
   editing this manuscript and R. Pfalzberger for some of the artwork.
CR Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012
   Axthelm F, 2008, J PHYS CHEM B, V112, P8211, DOI 10.1021/jp803032w
   Balasubramanian V, 2010, EXPERT OPIN DRUG DEL, V7, P63, DOI 10.1517/17425240903394520
   Baselga J, 2001, EUR J CANCER, V37, pS18, DOI 10.1016/S0959-8049(00)00404-4
   Battaglia G, 2006, J PHYS CHEM B, V110, P10272, DOI 10.1021/jp060728n
   Ben-Haim N, 2008, NANO LETT, V8, P1368, DOI 10.1021/nl080105g
   Bonne TB, 2004, COLLOID POLYM SCI, V282, P833, DOI 10.1007/s00396-004-1131-2
   Broz P, 2005, J CONTROL RELEASE, V102, P475, DOI 10.1016/j.jconrel.2004.10.014
   Broz P, 2008, J CARDIOVASC PHARM, V51, P246, DOI 10.1097/FJC.0b013e3181624aed
   Bruns N, 2009, ANGEW CHEM INT EDIT, V48, P5666, DOI 10.1002/anie.200900554
   Chen Y, 2004, CHEM COMMUN, P2804, DOI 10.1039/b411181h
   Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/nmat2512, 10.1038/NMAT2512]
   CLINE GW, 1987, J AM CHEM SOC, V109, P3087, DOI 10.1021/ja00244a035
   Craggs TD, 2009, CHEM SOC REV, V38, P2865, DOI 10.1039/b903641p
   Delamarche E, 2007, CHIMIA, V61, P126, DOI 10.2533/chimia.2007.126
   Discher DE, 2002, BIOMEDICAL ASPECTS OF DRUG TARGETING, P459
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Duportail G, 2005, SPR S FLUOR, V3, P133
   EVANS CE, 2009, CHEM COMMUN, V2305
   Gruber HJ, 2000, BIOCONJUGATE CHEM, V11, P161, DOI 10.1021/bc990107f
   Hartmann DM, 2002, J MATER RES, V17, P473, DOI 10.1557/JMR.2002.0066
   Hughes B, 2010, NAT REV DRUG DISCOV, V9, P665, DOI 10.1038/nrd3270
   Jin AJ, 1999, EUR BIOPHYS J BIOPHY, V28, P187, DOI 10.1007/s002490050199
   Kita-Tokarczyk K, 2005, POLYMER, V46, P3540, DOI 10.1016/j.polymer.2005.02.083
   Kita-Tokarczyk K, 2009, LANGMUIR, V25, P9847, DOI 10.1021/la900948a
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Kozlov IA, 2004, BIOPOLYMERS, V73, P621, DOI 10.1002/bip.20009
   Kumar M, 2007, P NATL ACAD SCI USA, V104, P20719, DOI 10.1073/pnas.0708762104
   Levine DH, 2008, METHODS, V46, P25, DOI 10.1016/j.ymeth.2008.05.006
   Lin JJ, 2006, LANGMUIR, V22, P3975, DOI 10.1021/la052445c
   Litvinchuk S, 2009, PHARM RES-DORDR, V26, P1711, DOI 10.1007/s11095-009-9881-7
   Longva KE, 2005, INT J CANCER, V116, P359, DOI 10.1002/ijc.21015
   Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0
   Martin AL, 2009, J AM CHEM SOC, V131, P734, DOI 10.1021/ja807220u
   Nardin C, 2000, LANGMUIR, V16, P7708, DOI 10.1021/la000204t
   Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u
   Nojima Y, 2009, BIOL PHARM BULL, V32, P523, DOI 10.1248/bpb.32.523
   Onaca O, 2009, MACROMOL BIOSCI, V9, P129, DOI 10.1002/mabi.200800248
   Opsteen JA, 2007, CHEM COMMUN, P3136, DOI 10.1039/b704568a
   PATEL RP, 2008, PHARMA REV, V6, P144
   Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811
   Rigler P, 2006, J AM CHEM SOC, V128, P367, DOI 10.1021/ja056719u
   Robbins GP, 2010, LANGMUIR, V26, P14089, DOI 10.1021/la1017032
   Stahn R, 2000, TUMOR BIOL, V21, P176, DOI 10.1159/000030124
   Starchev K, 1998, J COLLOID INTERF SCI, V203, P189, DOI 10.1006/jcis.1998.5470
   Stauch O, 2002, BIOMACROMOLECULES, V3, P565, DOI 10.1021/bm0200074
   Steinberg-Tatman G, 2006, BIOCONJUGATE CHEM, V17, P841, DOI 10.1021/bc060012v
   Uchegbu Ijeoma F, 2006, Expert Opin Drug Deliv, V3, P629, DOI 10.1517/17425247.3.5.629
   van Dongen SFM, 2009, CHEM-EUR J, V15, P1107, DOI 10.1002/chem.200802114
   Vira S, 2010, ANAL BIOCHEM, V402, P146, DOI 10.1016/j.ab.2010.03.036
   Wakankar AA, 2010, BIOCONJUGATE CHEM, V21, P1588, DOI 10.1021/bc900434c
   Walker GF, 2005, MOL THER, V11, P418, DOI 10.1016/j.ymthe.2004.11.006
   Wuang SC, 2008, BIOMATERIALS, V29, P2270, DOI 10.1016/j.biomaterials.2008.01.028
   Yuan QA, 2010, BIOMACROMOLECULES, V11, P1940, DOI 10.1021/bm100589g
   Zhong XB, 2003, P NATL ACAD SCI USA, V100, P11559, DOI 10.1073/pnas.1934783100
NR 55
TC 141
Z9 141
U1 1
U2 143
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAR 30
PY 2011
VL 133
IS 12
BP 4476
EP 4483
DI 10.1021/ja110275f
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 778OZ
UT WOS:000291715300054
PM 21370858
DA 2021-01-25
ER

PT J
AU Mietze, A
   Morick, D
   Kohler, H
   Harrus, S
   Dehio, C
   Nolte, I
   Goethe, R
AF Mietze, A.
   Morick, D.
   Koehler, H.
   Harrus, S.
   Dehio, C.
   Nolte, I.
   Goethe, R.
TI Combined MLST and AFLP typing of Bartonella henselae isolated from cats
   reveals new sequence types and suggests clonal evolution
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Cat-scratch disease; PCR-REA; MLST; AFLP; ELISA
ID FRAGMENT-LENGTH-POLYMORPHISM; DOMESTIC CATS; SYNTHASE GENE;
   IDENTIFICATION; RESTRICTION; HUMANS; PCR; INFECTIONS; PREVALENCE;
   CULTURE
AB Bartonella species are Gram-negative, fastidious bacteria. Bartonella henselae is found in cats and transmitted to humans via cat scratches or bites causing cat-scratch disease, characterized by clinical symptoms with varying severity. The prevalence of bartonellosis among humans in Germany appears to be high, and severe clinical cases have been described. However, epidemiological data of B. henselae in cats are rare. In this study we determined the detection rates of Bartonella ssp. in cats by culture and real-time PCR. Furthermore, B. henselae isolates were genetically characterized by highly discriminatory amplified fragment length polymorphism (AFLP) and multilocus sequence typing (MIST). Bartonella spp. were isolated by culture from 11(2.2%) of 507 blood samples. Out of 169 blood samples additionally analyzed by PCR, 28 (16.6%) were found positive for Bartonella spp., illustrating the advantage of PCR in Bartonella spp. detection. PCR-REA identified B. henselae in 27 cats and Bartonella clarridgeiae in one cat. B. henselae isolates from different geographical regions in Germany were genetically characterized by AFLP and MIST. Both methods confirmed genetic diversity of B. henselae on the strain level. MIST identified 11 new sequence types, all of them assigned to three clonal complexes as determined by eBURST. AFLP typing revealed genetic relation among the B. henselae isolates from the same geographical region. Combining AFLP typing and MLST/eBURST analyses revealed that B. henselae of the same AFLP subcluster belonged to the same clonal complex. Altogether these results indicate that B. henselae may evolve clonally. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Goethe, R.] Stiftung Tieraerztliche Hsch Hannover, Zentrum Infekt Med, Inst Mikrobiol, D-30173 Hannover, Germany.
   [Nolte, I.] Stiftung Tieraerztliche Hsch Hannover, Klin Kleintiere, D-30173 Hannover, Germany.
   [Koehler, H.] FLI Jena, Inst Mol Pathogenese, Jena, Germany.
   [Morick, D.; Harrus, S.] Hebrew Univ Jerusalem, Koret Sch Vet Med, IL-76100 Rehovot, Israel.
   [Dehio, C.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Goethe, R (corresponding author), Stiftung Tieraerztliche Hsch Hannover, Zentrum Infekt Med, Inst Mikrobiol, Bischofsholer Damm 15, D-30173 Hannover, Germany.
EM ralph.goethe@tiho-hannover.de
RI Dehio, Christoph/R-8277-2016; Harrus, Shimon/H-5175-2016; Dehio,
   Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Harrus,
   Shimon/0000-0003-0542-207X; Dehio, Christoph/0000-0001-7288-1052
FU Niedersachsen-Israel cooperation fund [VWZN2176]
FX We gratefully acknowledge Stefanie Kunz (Institut fur Medizinische
   Mikrobiologie und Hygiene, Freiburg, Germany) for providing the B.
   henselae isolates from Freiburg as well as Dr. Stefan Rist (Dortmund,
   Germany), Dr. Maren Gruetter (Hamburg-Finkenwerder, Germany) and the
   Tierarztliche Klinik auf Boyenstein (Beckum, Germany) for collecting cat
   blood samples. We thank Martin Beyerbach, IBEI (Tierarztliche Hochschule
   Hannover, Germany) for the help in the statistical analysis. This work
   was supported by the Niedersachsen-Israel cooperation fund (# VWZN2176).
CR Arvand M, 2001, J CLIN MICROBIOL, V39, P743, DOI 10.1128/JCM.39.2.743-746.2001
   Arvand M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001346
   Bergh K, 2002, APMIS, V110, P309, DOI 10.1034/j.1600-0463.2002.100405.x
   Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009
   Chomel BB, 1999, AM J TROP MED HYG, V60, P593, DOI 10.4269/ajtmh.1999.60.593
   Chomel BB, 2003, ANN NY ACAD SCI, V990, P267, DOI 10.1111/j.1749-6632.2003.tb07376.x
   Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dillon B, 2002, J CLIN MICROBIOL, V40, P4691, DOI 10.1128/JCM.40.12.4691-4699.2002
   Ehrenborg C, 2000, J CLIN MICROBIOL, V38, P682, DOI 10.1128/JCM.38.2.682-687.2000
   Goethe R, 2000, VACCINE, V19, P966, DOI 10.1016/S0264-410X(00)00212-7
   Guptill L, 1997, J INFECT DIS, V176, P206, DOI 10.1086/514026
   Houpikian P, 2001, J CLIN MICROBIOL, V39, P2768, DOI 10.1128/JCM.39.8.2768-2778.2001
   Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003
   Janssen P, 1996, MICROBIOL-UK, V142, P1881, DOI 10.1099/13500872-142-7-1881
   Johnson G, 2003, J CLIN MICROBIOL, V41, P1069, DOI 10.1128/JCM.41.3.1069-1072.2003
   La Scola B, 2003, TRENDS MICROBIOL, V11, P318, DOI 10.1016/S0966-842X(03)00143-4
   La Scola B, 1999, J CLIN MICROBIOL, V37, P1899, DOI 10.1128/JCM.37.6.1899-1905.1999
   La Scola B, 2002, J CLIN MICROBIOL, V40, P2002, DOI 10.1128/JCM.40.6.2002-2008.2002
   Li WJ, 2006, J CLIN MICROBIOL, V44, P2499, DOI 10.1128/JCM.00498-06
   MATAR GM, 1993, J CLIN MICROBIOL, V31, P1730, DOI 10.1128/JCM.31.7.1730-1734.1993
   NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995
   Raoult D, 1996, ANN INTERN MED, V125, P646, DOI 10.7326/0003-4819-125-8-199610150-00004
   Rehm T, 2007, J MED MICROBIOL, V56, P102, DOI 10.1099/jmm.0.46616-0
   Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001
   Riess T, 2008, APPL ENVIRON MICROB, V74, P5224, DOI 10.1128/AEM.00621-08
   RODRIGUEZBARRADAS MC, 1995, J CLIN MICROBIOL, V33, P1089, DOI 10.1128/JCM.33.5.1089-1093.1995
   Sander A, 1997, J CLIN MICROBIOL, V35, P584, DOI 10.1128/JCM.35.3.584-587.1997
   Sander A, 1998, J CLIN MICROBIOL, V36, P2973, DOI 10.1128/JCM.36.10.2973-2981.1998
   Savelkoul PHM, 1999, J CLIN MICROBIOL, V37, P3083, DOI 10.1128/JCM.37.10.3083-3091.1999
   YANAGIHARA M, 2010, FEMS IMMUNOL MED MIC
   Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P1023, DOI 10.1128/JCM.40.3.1023-1030.2002
NR 32
TC 22
Z9 23
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD MAR 24
PY 2011
VL 148
IS 2-4
BP 238
EP 245
DI 10.1016/j.vetmic.2010.08.012
PG 8
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA 739PM
UT WOS:000288730200016
PM 20863631
DA 2021-01-25
ER

PT J
AU Shende, P
   Plaisance, I
   Morandi, C
   Pellieux, C
   Berthonneche, C
   Zorzato, F
   Krishnan, J
   Lerch, R
   Hall, MN
   Ruegg, MA
   Pedrazzini, T
   Brink, M
AF Shende, Pankaj
   Plaisance, Isabelle
   Morandi, Christian
   Pellieux, Corinne
   Berthonneche, Corinne
   Zorzato, Francesco
   Krishnan, Jaya
   Lerch, Rene
   Hall, Michael N.
   Ruegg, Markus A.
   Pedrazzini, Thierry
   Brink, Marijke
TI Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic
   Gene Expression, and Causes Heart Failure in Mice
SO CIRCULATION
LA English
DT Article
DE heart failure; hypertrophy; myocardial metabolism; signal transduction
ID PROLIFERATOR-ACTIVATED RECEPTOR; PRESSURE-OVERLOAD; OXYGEN-CONSUMPTION;
   MAMMALIAN TARGET; SKELETAL-MUSCLE; DOWN-REGULATION; DIABETIC MICE;
   FAILING HEART; PPAR-ALPHA; S6 KINASE
AB Background-Cardiac hypertrophy involves growth responses to a variety of stimuli triggered by increased workload. It is an independent risk factor for heart failure and sudden death. Mammalian target of rapamycin (mTOR) plays a key role in cellular growth responses by integrating growth factor and energy status signals. It is found in 2 structurally and functionally distinct multiprotein complexes called mTOR complex (mTORC) 1 and mTORC2. The role of each of these branches of mTOR signaling in the adult heart is currently unknown.
   Methods and Results-We generated mice with deficient myocardial mTORC1 activity by targeted ablation of raptor, which encodes an essential component of mTORC1, during adulthood. At 3 weeks after the deletion, atrial and brain natriuretic peptides and beta-myosin heavy chain were strongly induced, multiple genes involved in the regulation of energy metabolism were altered, but cardiac function was normal. Function deteriorated rapidly afterward, resulting in dilated cardiomyopathy and high mortality within 6 weeks. Aortic banding-induced pathological overload resulted in severe dilated cardiomyopathy already at 1 week without a prior phase of adaptive hypertrophy. The mechanism involved a lack of adaptive cardiomyocyte growth via blunted protein synthesis capacity, as supported by reduced phosphorylation of ribosomal S6 kinase 1 and 4E-binding protein 1. In addition, reduced mitochondrial content, a shift in metabolic substrate use, and increased apoptosis and autophagy were observed.
   Conclusions-Our results demonstrate an essential function for mTORC1 in the heart under physiological and pathological conditions and are relevant for the understanding of disease states in which the insulin/insulin-like growth factor signaling axis is affected such as diabetes mellitus and heart failure or after cancer therapy. (Circulation. 2011;123:1073-1082.)
C1 [Shende, Pankaj; Plaisance, Isabelle; Morandi, Christian; Zorzato, Francesco; Brink, Marijke] Univ Basel, Dept Biomed, CH-4031 Basel, Switzerland.
   [Shende, Pankaj; Plaisance, Isabelle; Morandi, Christian; Zorzato, Francesco; Brink, Marijke] Univ Basel Hosp, CH-4031 Basel, Switzerland.
   [Pellieux, Corinne; Lerch, Rene] Univ Geneva, Med Res Fdn, Geneva, Switzerland.
   [Pellieux, Corinne; Lerch, Rene] Univ Geneva, Div Cardiol, Geneva, Switzerland.
   [Pellieux, Corinne; Lerch, Rene] Univ Hosp Geneva, Geneva, Switzerland.
   [Berthonneche, Corinne] Univ Lausanne, Sch Med, Cardiovasc Assessment Facil, Lausanne, Switzerland.
   [Pedrazzini, Thierry] Univ Lausanne, Sch Med, Dept Med, Lausanne, Switzerland.
   [Krishnan, Jaya] Swiss Fed Inst Technol, Zurich, Switzerland.
   [Hall, Michael N.; Ruegg, Markus A.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Brink, M (corresponding author), Univ Basel, Dept Biomed, Hebelstra 20, CH-4031 Basel, Switzerland.
EM marijke.brink@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Krishnan, Jaya/0000-0002-5698-7671;
   Brink, Marijke/0000-0002-1790-0190
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-116483]; Stiftung fur Kardiovaskulare Forschung Basel
FX This work was supported by the Swiss National Science Foundation (grant
   31-116483) and the Stiftung fur Kardiovaskulare Forschung Basel.
CR Aasum E, 2005, CAN J PHYSIOL PHARM, V83, P183, DOI 10.1139/Y04-139
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x
   Blyszczuk P, 2009, CIRC RES, V105, P912, DOI 10.1161/CIRCRESAHA.109.199802
   Boluyt MO, 2004, CARDIOVASC DRUG THER, V18, P257, DOI 10.1023/B:CARD.0000041245.61136.56
   Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176
   Campbell FM, 2002, J BIOL CHEM, V277, P4098, DOI 10.1074/jbc.M106054200
   Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105
   Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827
   Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243
   Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83
   Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009
   How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164
   Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004
   Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416
   Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044
   Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161
   Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200
   McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45
   McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004
   Pellieux C, 2006, J MOL CELL CARDIOL, V41, P459, DOI 10.1016/j.yjmcc.2006.06.004
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   ROCKMAN HA, 1994, AM J PHYSIOL, V266, pH2468
   Rosenblatt-Velin N, 2001, CARDIOVASC RES, V52, P407, DOI 10.1016/S0008-6363(01)00393-5
   Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837
   SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200
   Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88
   Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682
   Soesanto W, 2009, HYPERTENSION, V54, P1321, DOI 10.1161/HYPERTENSIONAHA.109.138818
   Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Taegtmeyer H, 1994, Curr Probl Cardiol, V19, P59
   Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008
NR 43
TC 150
Z9 155
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD MAR 15
PY 2011
VL 123
IS 10
BP 1073
EP U173
DI 10.1161/CIRCULATIONAHA.110.977066
PG 16
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 734VZ
UT WOS:000288369900012
PM 21357822
OA Bronze
DA 2021-01-25
ER

PT J
AU Siegmund, K
   Zeis, T
   Kunz, G
   Rolink, T
   Schaeren-Wiemers, N
   Pieters, J
AF Siegmund, Kerstin
   Zeis, Thomas
   Kunz, Gabriele
   Rolink, Ton
   Schaeren-Wiemers, Nicole
   Pieters, Jean
TI Coronin 1-Mediated Naive T Cell Survival Is Essential for the
   Development of Autoimmune Encephalomyelitis
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE
   GLYCOPROTEIN; MONOCLONAL-ANTIBODY; MULTIPLE-SCLEROSIS; REGULATORY CELLS;
   IMMUNE-RESPONSES; CNS; CYTOKINE; RECEPTOR; DISEASE
AB Autoimmune encephalomyelitis is a disease of the CNS that can develop when an initial peripheral inflammatory stimulus is followed by infiltration and reactivation of T lymphocytes in the CNS. We report a crucial role for coronin 1, which is essential for maintenance of the naive T cell pool, for the development of murine experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis. In the absence of coronin 1, immunization with myelin oligoglycoprotein (MOG(35-55)) peptide largely failed to induce EAE symptoms, despite normal mobilization of leukocyte subsets in the blood, as well as effector cytokine expression comparable with wild-type T cells on polyclonal stimulation. Susceptibility of coronin 1-deficient mice to EAE induction was restored by transfer of wild-type CD4(+) T cells, suggesting that the observed resistance of coronin 1-deficient mice to EAE development is T cell intrinsic. Importantly, although coronin 1-deficient regulatory T cells (Tregs) showed a suppressor activity comparable with wild-type Tregs, Treg depletion failed to restore EAE development in coronin 1-deficient animals. These results suggest a hitherto unrecognized role of naive T cells in the development of autoimmune encephalomyelitis and reveal coronin 1 as a crucial modulator of EAE induction. The Journal of Immunology, 2011, 186: 3452-3461.
C1 [Siegmund, Kerstin; Kunz, Gabriele; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Zeis, Thomas; Rolink, Ton; Schaeren-Wiemers, Nicole] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
RI Bellaire-Siegmund, Kerstin/AAA-9702-2021; Bellaire-Siegmund,
   Kerstin/D-4774-2018
OI Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Bellaire-Siegmund,
   Kerstin/0000-0002-3654-1170; Pieters, Jean/0000-0002-5284-9757
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Freiwillige Akademische Geselschaft Basel; National Multiple
   Sclerosis Societies of Switzerland; Fondation pour l'Aide a la Recherche
   sur la Sclerose en Plaques, France; Gemeinnutzige Hertie-Stiftung,
   Germany
FX This work was supported by grants from the Swiss National Science
   Foundation Sinergia Program "T cells in Health and Disease" (to J.P. and
   T.R.), the Freiwillige Akademische Geselschaft Basel (to J.P.), the
   National Multiple Sclerosis Societies of Switzerland (to T.Z. and
   N.S.-W.), the Fondation pour l'Aide a la Recherche sur la Sclerose en
   Plaques, France (to T.Z. and N.S.-W.), and the Gemeinnutzige
   Hertie-Stiftung, Germany (to T.Z. and N.S.-W.).
CR AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967
   Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444
   BROSTOFF SW, 1984, J IMMUNOL, V133, P1938
   Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X
   Cua DJ, 1997, J IMMUNOL, V159, P5834
   Davalos-Misslitz ACM, 2007, EUR J IMMUNOL, V37, P613, DOI 10.1002/eji.200636656
   Falcone M, 1997, J EXP MED, V185, P901, DOI 10.1084/jem.185.5.901
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075
   Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550
   Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197
   Greter M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000109
   Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023
   Harlow EL., 1989, ANTIBODIES LAB MANUA
   Hogquist KA, 2008, NAT IMMUNOL, V9, P1207, DOI 10.1038/ni1108-1207
   Iglesias A, 2001, GLIA, V36, P220, DOI 10.1002/glia.1111
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269
   Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379
   Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712
   Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159
   Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620
   Martin B, 2006, BLOOD, V108, P270, DOI 10.1182/blood-2006-01-0017
   McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467
   O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016
   Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898
   Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716
   Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101
   Seamons A, 2003, IMMUNOL RES, V28, P201, DOI 10.1385/IR:28:3:201
   Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489
   Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662
   Stephens LA, 2009, EUR J IMMUNOL, V39, P1108, DOI 10.1002/eji.200839073
   Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x
   Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715
   Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057
   Uboldi C, 2008, EUR J IMMUNOL, V38, P2156, DOI 10.1002/eji.200838209
   WALDOR MK, 1987, J IMMUNOL, V139, P3660
   WALDOR MK, 1985, SCIENCE, V227, P415, DOI 10.1126/science.3155574
   Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022
NR 46
TC 19
Z9 19
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAR 15
PY 2011
VL 186
IS 6
BP 3452
EP 3461
DI 10.4049/jimmunol.1003491
PG 10
WC Immunology
SC Immunology
GA 729BU
UT WOS:000287923500021
PM 21289301
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Zinzalla, V
   Stracka, D
   Oppliger, W
   Hall, MN
AF Zinzalla, Vittoria
   Stracka, Daniele
   Oppliger, Wolfgang
   Hall, Michael N.
TI Activation of mTORC2 by Association with the Ribosome
SO CELL
LA English
DT Article
ID ENDOPLASMIC-RETICULUM; MAMMALIAN TARGET; CELL-GROWTH; COMPLEX 2;
   TRANSLATION INITIATION; MOTIF PHOSPHORYLATION; AKT PHOSPHORYLATION;
   BINDING PARTNER; KINASE-B; RAPAMYCIN
AB The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of growth. Mammalian TOR complex 2 (mTORC2) regulates AGC kinase family members and is implicated in various disorders, including cancer and diabetes. Here, we investigated the upstream regulation of mTORC2. A genetic screen in yeast and subsequent studies in mammalian cells revealed that ribosomes, but not protein synthesis, are required for mTORC2 signaling. Active mTORC2 was physically associated with the ribosome, and insulin-stimulated PI3K signaling promoted mTORC2-ribosome binding, suggesting that ribosomes activate mTORC2 directly. Findings with melanoma and colon cancer cells suggest that mTORC2-ribosome association is important in oncogenic PI3K signaling. Thus, TORC2-ribosome interaction is a likely conserved mechanism of TORC2 activation that is physiologically relevant in both normal and cancer cells. As ribosome content determines growth capacity of a cell, this mechanism of TORC2 regulation ensures that TORC2 is active only in growing cells.
C1 [Zinzalla, Vittoria; Stracka, Daniele; Oppliger, Wolfgang; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
FU Swiss National Science Foundation, SystemsX.chSwiss National Science
   Foundation (SNSF); Swiss Cancer League; Louis Jeantet Foundation; Canton
   of Basel
FX We thank Rachel Idol and Stefano Grosso for valuable discussions and
   technical assistance and Giulio Spagnoli for the melanoma cell lines. We
   acknowledge support from the Swiss National Science Foundation,
   SystemsX.ch, the Swiss Cancer League, the Louis Jeantet Foundation, and
   the Canton of Basel. We declare that no competing interests exist.
CR Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015
   Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008
   Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449
   Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688
   Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902
   Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006
   Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8
   Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160
   Certa U, 2001, BRIT J CANCER, V85, P107, DOI 10.1054/bjoc.2001.1865
   Chiocchetti A, 2005, HAEMATOLOGICA, V90, P1453
   Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5
   DESCHODTLANCKMAN M, 1990, INT J CANCER, V46, P1124, DOI 10.1002/ijc.2910460629
   Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200
   Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120
   Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Gervois N, 1996, J EXP MED, V183, P2403, DOI 10.1084/jem.183.5.2403
   Grosso S, 2008, BIOCHEM J, V415, P77, DOI 10.1042/BJ20080463
   Grossso S, 2008, BIOCHEM BIOPH RES CO, V376, P65, DOI 10.1016/j.bbrc.2008.08.118
   Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017
   Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   He HN, 2010, CANCER LETT, V295, P38, DOI 10.1016/j.canlet.2010.02.011
   Helliwell SB, 1998, GENETICS, V148, P99
   Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200
   Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021
   Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001
   Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005
   Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083
   Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x
   Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003
   Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223
   Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200
   Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271
   Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540
   Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9
   Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015
   Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013
   Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200
   Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042
   Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007
   Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139
   Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399
   Stahl JM, 2003, CANCER RES, V63, P2881
   Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08
   Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217
   Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624
   Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
   Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
   Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001
NR 71
TC 417
Z9 438
U1 3
U2 58
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAR 4
PY 2011
VL 144
IS 5
BP 757
EP 768
DI 10.1016/j.cell.2011.02.014
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 730CE
UT WOS:000288007100014
PM 21376236
DA 2021-01-25
ER

PT J
AU Metz, P
   Dazert, E
   Mazur, J
   Frese, M
   Kaderali, L
   Lohmann, V
   Bartenschlager, R
AF Metz, P.
   Dazert, E.
   Mazur, J.
   Frese, M.
   Kaderali, L.
   Lohmann, V.
   Bartenschlager, R.
TI IDENTIFICATION OF EFFECTORS OF THE INTERFERON-INDUCED ANTIVIRAL RESPONSE
   AGAINST HEPATITIS C VIRUS
SO JOURNAL OF HEPATOLOGY
LA English
DT Meeting Abstract
CT 46th Annual Meeting of the
   European-Association-for-the-Study-of-the-Liver (EASL)
CY 2011
CL Berlin, GERMANY
SP European Assoc Study Liver (EASL)
C1 [Mazur, J.; Kaderali, L.] Univ Heidelberg, Viroquant Res Grp Modeling, Heidelberg, Germany.
   [Dazert, E.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Frese, M.] Univ Canberra, Fac Sci Appl, Canberra, ACT 2601, Australia.
EM philippe_metz@med.uni-heidelberg.de
RI Bartenschlager, Ralf/L-2582-2015
OI Bartenschlager, Ralf/0000-0001-5601-9307
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
J9 J HEPATOL
JI J. Hepatol.
PD MAR
PY 2011
VL 54
SU 1
MA 45
BP S20
EP S20
DI 10.1016/S0168-8278(11)60047-0
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 856GC
UT WOS:000297625600046
DA 2021-01-25
ER

PT J
AU Hilbert, M
   Kebbel, F
   Gubaev, A
   Klostermeier, D
AF Hilbert, Manuel
   Kebbel, Fabian
   Gubaev, Airat
   Klostermeier, Dagmar
TI eIF4G stimulates the activity of the DEAD box protein eIF4A by a
   conformational guidance mechanism
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID INITIATION-FACTOR 4A; EUKARYOTIC TRANSLATION INITIATION; RNA-HELICASE;
   CRYSTAL-STRUCTURE; MESSENGER-RNA; CLOSED CONFORMATION; STRUCTURAL BASIS;
   ATP HYDROLYSIS; COMPLEX; BINDING
AB The activity of eIF4A, a key player in translation initiation, is regulated by other translation factors through currently unknown mechanisms. Here, we provide the necessary framework to understand the mechanism of eIF4A's regulation by eIF4G. In solution, eIF4A adopts a defined conformation that is different from the crystal structure. Binding of eIF4G induces a 'half-open' conformation by interactions with both domains, such that the helicase motifs are pre-aligned for activation. A primary interface acts as an anchor for complex formation. We show here that formation of the secondary interface is essential for imposing the 'half-open' conformation on eIF4A, and it is critical for the functional interaction of eIF4G with eIF4A. Via this bipartite interaction, eIF4G guides the transition of eIF4A between the 'half-open' and closed conformations, and stimulates its activity by accelerating the rate-limiting step of phosphate release. Subtle changes induced by eIF4G may be amplified by input signals from other translation factors, leading to an efficient regulation of translation initiation.
C1 [Hilbert, Manuel; Kebbel, Fabian; Gubaev, Airat; Klostermeier, Dagmar] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
FU VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Roche Research Foundation
FX VolkswagenStiftung (to D.K.); Swiss National Science Foundation (to
   D.K.); Roche Research Foundation (to M.H.). The open access publication
   charge for this paper has been waived by Oxford University Press-NAR
   Editorial Board members are entitled to one free paper per year in
   recognition of their work on behalf of the journal.
CR Adam H., 1962, METHODEN ENZYMATISCH, P573
   Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   Aregger R, 2009, BIOCHEMISTRY-US, V48, P10679, DOI 10.1021/bi901278p
   Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013
   Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080
   Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106
   Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4
   Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838
   Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410
   JOHNSON KA, 1986, METHOD ENZYMOL, V134, P677
   Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419
   Karow AR, 2009, NUCLEIC ACIDS RES, V37, P4464, DOI 10.1093/nar/gkp397
   Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200
   Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106
   Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g
   Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319
   Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014
   Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109
   Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305
   Oguro A, 2003, RNA, V9, P394, DOI 10.1261/rna.2161303
   PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789
   PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x
   Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236
   Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4
   Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200
   Rozovsky N, 2008, RNA, V14, P2136, DOI 10.1261/rna.1049608
   Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Svitkin YV, 2001, RNA, V7, P1743
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561
   Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003
NR 40
TC 59
Z9 61
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD MAR
PY 2011
VL 39
IS 6
BP 2260
EP 2270
DI 10.1093/nar/gkq1127
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 745LH
UT WOS:000289166400031
PM 21062831
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Ganguly, A
   Duany, YD
   Rudolph, MG
   Klostermeier, D
AF Ganguly, Agneyo
   Duany, Yoandris del Toro
   Rudolph, Markus G.
   Klostermeier, Dagmar
TI The latch modulates nucleotide and DNA binding to the helicase-like
   domain of Thermotoga maritima reverse gyrase and is required for
   positive DNA supercoiling
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID TOPOISOMERASE; MECHANISM; RHO
AB Reverse gyrase is the only topoisomerase that can introduce positive supercoils into DNA in an ATP-dependent process. It has a modular structure and harnesses a helicase-like domain to support a topoisomerase activity, thereby creating the unique function of positive DNA supercoiling. The isolated topoisomerase domain can relax negatively supercoiled DNA, an activity that is suppressed in reverse gyrase. The isolated helicase-like domain is a nucleotide-dependent switch that is attenuated by the topoisomerase domain. Inter-domain communication thus appears central for the functional cooperation of the two domains. The latch, an insertion into the helicase-like domain, has been suggested as an important element in coordinating their activities. Here, we have dissected the influence of the latch on nucleotide and DNA binding to the helicase-like domain, and on DNA supercoiling by reverse gyrase. We find that the latch is required for positive DNA supercoiling. It is crucial for the cooperativity of DNA and nucleotide binding to the helicase-like domain. The latch contributes to DNA binding, and affects the preference of reverse gyrase for ssDNA. Thus, the latch coordinates the individual domain activities by modulating the helicase-like domain, and by communicating changes in the nucleotide state to the topoisomerase domain.
C1 [Ganguly, Agneyo; Duany, Yoandris del Toro; Klostermeier, Dagmar] Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
   [Rudolph, Markus G.] Hoffmann La Roche AG, CH-4070 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Dept Biophys Chem, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
OI Rudolph, Markus/0000-0003-0447-1101
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Marie Curie postdoctoral fellowshipEuropean Union (EU);
   University of Basel; VolkswagenStiftungVolkswagen
FX VolkswagenStiftung (to D. K.); Swiss National Science Foundation (to D.
   K.); Marie Curie postdoctoral fellowship (to A. G.). Funding for open
   access charge: University of Basel.
CR Adam H., 1962, METHODEN ENZYMATISCH, P573
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427
   CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753
   de la Tour CB, 2008, J BIOL CHEM, V283, P27395, DOI 10.1074/jbc.M800867200
   Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199
   DOLAN JW, 1990, J BIOL CHEM, V265, P5747
   DOMBROSKI AJ, 1988, P NATL ACAD SCI USA, V85, P2538, DOI 10.1073/pnas.85.8.2538
   Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4
   Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200
   Jungblut SP, 2007, J MOL BIOL, V371, P197, DOI 10.1016/j.jmb.2007.05.031
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683
   KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0
   LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0
   Rodriguez AC, 2003, BIOCHEMISTRY-US, V42, P5993, DOI 10.1021/bi034188l
   Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200
   Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418
   Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28
NR 24
TC 12
Z9 12
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD MAR
PY 2011
VL 39
IS 5
BP 1789
EP 1800
DI 10.1093/nar/gkq1048
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 740NE
UT WOS:000288800700020
PM 21051354
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Corioni, M
   Antih, N
   Tanackovic, G
   Zavolan, M
   Kramer, A
AF Corioni, Margherita
   Antih, Nicolas
   Tanackovic, Goranka
   Zavolan, Mihaela
   Kraemer, Angela
TI Analysis of in situ pre-mRNA targets of human splicing factor SF1
   reveals a function in alternative splicing
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID POLYPYRIMIDINE TRACT RECOGNITION; PROTEIN-PROTEIN INTERACTIONS;
   POINT-BINDING-PROTEIN; STRUCTURAL BASIS; BRANCH POINT;
   MYOTONIC-DYSTROPHY; U2 SNRNP; INTERACTS; U2AF(65); COMPLEX
AB The conserved pre-mRNA splicing factor SF1 is implicated in 3' splice site recognition by binding directly to the intron branch site. However, because SF1 is not essential for constitutive splicing, its role in pre-mRNA processing has remained mysterious. Here, we used crosslinking and immunoprecipitation (CLIP) to analyze short RNAs directly bound by human SF1 in vivo. SF1 bound mainly pre-mRNAs, with 77% of target sites in introns. Binding to target RNAs in vitro was dependent on the newly defined SF1 binding motif ACUNAC, strongly resembling human branch sites. Surprisingly, the majority of SF1 binding sites did not map to the expected position near 3' splice sites. Instead, target sites were distributed throughout introns, and a smaller but significant fraction occurred in exons within coding and untranslated regions. These data suggest a more complex role for SF1 in splicing regulation. Indeed, SF1 silencing affected alternative splicing of endogenous transcripts, establishing a previously unexpected role for SF1 and branch site-like sequences in splice site selection.
C1 [Corioni, Margherita; Antih, Nicolas; Tanackovic, Goranka; Kraemer, Angela] Univ Geneva, Dept Cell Biol, Fac Sci, CH-1211 Geneva 4, Switzerland.
   [Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Kramer, A (corresponding author), Univ Geneva, Dept Cell Biol, Fac Sci, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.
EM angela.kraemer@unige.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100-068239]; European Science FoundationEuropean Science
   Foundation (ESF) [ERAS-CT-2003-980409]; European CommissionEuropean
   CommissionEuropean Commission Joint Research Centre
   [EURASNET-LSHG-CT-2005-518238]; Fondation MEDIC; Canton of Geneva;
   University of Geneva
FX Swiss National Science Foundation (3100-068239 to A. K.); the European
   Science Foundation, EUROCORES Programme EuroDYNA (ERAS-CT-2003-980409 to
   A. K.); the European Commission (EURASNET-LSHG-CT-2005-518238 to A. K.
   and M.Z.); the Fondation MEDIC and the Canton of Geneva (to A. K.).
   Funding for open access charge: University of Geneva.
CR Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4
   Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2
   Banerjee H, 2003, RNA, V9, P88, DOI 10.1261/rna.2131603
   Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5
   Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858
   Berninger P, 2008, METHODS, V44, P13, DOI 10.1016/j.ymeth.2007.10.002
   Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777
   Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260
   Corsini L, 2009, J BIOL CHEM, V284, P630, DOI 10.1074/jbc.M805395200
   Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004
   Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4
   Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3
   Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2
   Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113
   Garrey SM, 2006, J BIOL CHEM, V281, P27443, DOI 10.1074/jbc.M603137200
   Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001
   Guth S, 2000, J BIOL CHEM, V275, P38059, DOI 10.1074/jbc.M001483200
   Haraguchi N, 2007, J BIOL CHEM, V282, P2221, DOI 10.1074/jbc.M609430200
   Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538
   Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015
   Kralovicova J, 2004, HUM MOL GENET, V13, P3189, DOI 10.1093/hmg/ddh334
   Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281
   Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488
   Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719
   Mazroui R, 1999, RNA, V5, P1615, DOI 10.1017/S1355838299991872
   McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001
   Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807
   Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331
   Moore MJ, 2000, NAT STRUCT BIOL, V7, P14, DOI 10.1038/71207
   Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101
   Peled-Zehavi H, 2001, MOL CELL BIOL, V21, P5232, DOI 10.1128/MCB.21.15.5232-5241.2001
   Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x
   Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335
   Rino J, 2008, MOL CELL BIOL, V28, P3045, DOI 10.1128/MCB.02015-07
   Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873
   Rutz B, 1999, RNA, V5, P819, DOI 10.1017/S1355838299982286
   Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108
   Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369
   Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025
   Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908
   Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1
   Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106
   Shen HH, 2004, MOL CELL, V16, P363, DOI 10.1016/j.molcel.2004.10.021
   Shitashige M, 2007, CANCER SCI, V98, P1862, DOI 10.1111/j.1349-7006.2007.00629.x
   Shitashige M, 2007, GASTROENTEROLOGY, V132, P1039, DOI 10.1053/j.gastro.2007.01.007
   Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025
   SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834
   Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004
   Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034
   Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
   Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018
   Vagner S, 2000, GENE DEV, V14, P403
   Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706
   Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009
   Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607
   Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536
   Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310
   Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003
   Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545
   ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0
   Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086
   Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016
NR 65
TC 36
Z9 36
U1 1
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD MAR
PY 2011
VL 39
IS 5
BP 1868
EP 1879
DI 10.1093/nar/gkq1042
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 740NE
UT WOS:000288800700027
PM 21062807
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Colombi, M
   Molle, KD
   Benjamin, D
   Rattenbacher-Kiser, K
   Schaefer, C
   Betz, C
   Thiemeyer, A
   Regenass, U
   Hall, MN
   Moroni, C
AF Colombi, M.
   Molle, K. D.
   Benjamin, D.
   Rattenbacher-Kiser, K.
   Schaefer, C.
   Betz, C.
   Thiemeyer, A.
   Regenass, U.
   Hall, M. N.
   Moroni, C.
TI Genome-wide shRNA screen reveals increased mitochondrial dependence upon
   mTORC2 addiction
SO ONCOGENE
LA English
DT Article
DE shRNA screen; mTOR addiction; IL-3 dependence; mitochondria; drug
   targets
ID LENTIVIRAL RNAI LIBRARY; CANCER-CELLS; GLUT4 TRANSLOCATION; PROTEIN;
   KINASE; EXPRESSION; METABOLISM; GENE; IDENTIFICATION; INHIBITION
AB Release from growth factor dependence and acquisition of signalling pathway addiction are critical steps in oncogenesis. To identify genes required on mammalian target of rapamycin (mTOR) addiction, we performed a genome-wide short hairpin RNA screen on a v-H-ras-transformed Pten-deficient cell line that displayed two alternative growth modes, interleukin (IL)-3-independent/mTOR-addicted proliferation (transformed growth mode) and IL-3-dependent/mTOR-non-addicted proliferation (normal growth mode). We screened for genes required only in the absence of IL-3 and thus specifically for the transformed growth mode. The top 800 hits from this conditional lethal screen were analyzed in silico and 235 hits were subsequently rescreened in two additional Pten-deficient cell lines to generate a core set of 47 genes. Hits included genes encoding mTOR and the mTOR complex 2 (mTORC2) component rictor and several genes encoding mitochondrial functions including components of the respiratory chain, adenosine triphosphate synthase, the mitochondrial ribosome and mitochondrial fission factor. Small interfering RNA knockdown against a sizeable fraction of these genes triggered apoptosis in human cancer cell lines but not in normal fibroblasts. We conclude that mTORC2-addicted cells require mitochondrial functions that may be novel drug targets in human cancer. Oncogene (2011) 30, 1551-1565; doi: 10.1038/onc.2010.539; published online 20 December 2010
C1 [Colombi, M.; Molle, K. D.; Benjamin, D.; Betz, C.; Thiemeyer, A.; Hall, M. N.; Moroni, C.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Rattenbacher-Kiser, K.; Schaefer, C.] Univ Basel, Inst Med Microbiol, CH-4056 Basel, Switzerland.
   [Regenass, U.] Actel Pharmaceut Ltd, Allschwil, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch; christoph.moroni@unibas.ch
RI Betz, Charles/B-7444-2008
OI Betz, Charles/0000-0002-9837-6916
FU Commission of Technology and Innovation (CTI); Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Swiss Cancer League;
   Louis-Jeantet Foundation
FX We thank TW Sturgill for comments and Dr F Wenzel for providing normal
   human fibroblasts. We acknowledge support from the Commission of
   Technology and Innovation (CTI) (CM, MNH and UR), the Swiss National
   Science Foundation (CM and MNH) and the Swiss Cancer League and the
   Louis-Jeantet Foundation (MNH).
CR Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081
   Bandyopadhyay G, 2001, J BIOL CHEM, V276, P35537, DOI 10.1074/jbc.M106042200
   Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dang CV, 2010, MOL CELL BIOL, V30, P1300, DOI 10.1128/MCB.01661-09
   Fan YJ, 2010, J BIOL CHEM, V285, P7324, DOI 10.1074/jbc.M109.035584
   Fantin VR, 2006, ONCOGENE, V25, P4787, DOI 10.1038/sj.onc.1209599
   Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016
   Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287
   Gonez LJ, 2008, MOL MED, V14, P697, DOI 10.2119/2008-00072.Gonez
   Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Heyward CA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-25
   Hill MM, 1999, MOL CELL BIOL, V19, P7771
   Jung HC, 2005, LIFE SCI, V77, P1249, DOI 10.1016/j.lfs.2005.02.009
   Kiser KF, 2006, ONCOGENE, V25, P6595, DOI 10.1038/sj.onc.1209673
   Lipscomb EA, 2001, J BIOL CHEM, V276, P5085, DOI 10.1074/jbc.M008407200
   Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105
   Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006
   Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052
   Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040
   Mueller BA, 2009, CURR PHARM DESIGN, V15, P120
   Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057
   NAIR APK, 1992, ONCOGENE, V7, P1963
   Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Pytel D, 2009, ANTI-CANCER AGENT ME, V9, P66, DOI 10.2174/187152009787047752
   Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106
   Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924
   Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200
   Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017
   Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007
   Soria JC, 2002, CLIN CANCER RES, V8, P1178
   Thaimattam R, 2007, CURR PHARM DESIGN, V13, P2751, DOI 10.2174/138161207781757042
   van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865
   Wang QH, 1999, MOL CELL BIOL, V19, P4008
   Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107
   Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x
   Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105
   WITTWER AJ, 1980, P NATL ACAD SCI-BIOL, V77, P4484, DOI 10.1073/pnas.77.8.4484
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 46
TC 28
Z9 28
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD MAR
PY 2011
VL 30
IS 13
BP 1551
EP 1565
DI 10.1038/onc.2010.539
PG 15
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 743DU
UT WOS:000288998300006
PM 21170086
OA Bronze
DA 2021-01-25
ER

PT J
AU Punga, AR
   Maj, M
   Lin, S
   Meinen, S
   Ruegg, MA
AF Punga, Anna R.
   Maj, Marcin
   Lin, Shuo
   Meinen, Sarina
   Rueegg, Markus A.
TI MuSK levels differ between adult skeletal muscles and influence
   postsynaptic plasticity
SO EUROPEAN JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE acetylcholine receptors; agrin; mice; muscle; MuSK; neuromuscular
   junction
ID RECEPTOR TYROSINE KINASE; CONGENITAL MYASTHENIC SYNDROMES; REAL-TIME
   PCR; NEUROMUSCULAR-JUNCTION; RAT MUSCLE; MUSCULAR-DYSTROPHY;
   HOUSEKEEPING GENES; INNERVATED MUSCLE; MUTANT MICE; MOUSE MODEL
AB Muscle-specific tyrosine kinase (MuSK) is involved in the formation and maintenance of the neuromuscular junction (NMJ), and is necessary for NMJ integrity. As muscle involvement is strikingly selective in pathological conditions in which MuSK is targeted, including congenital myasthenic syndrome with MuSK mutation and MuSK antibody-seropositive myasthenia gravis, we hypothesized that the postsynaptic response to MuSK-agrin signalling differs between adult muscles. Transcript levels of postsynaptic proteins were compared between different muscles in wild-type adult mice. MuSK expression was high in the soleus and sternomastoid muscles and low in the extensor digitorum longus (EDL) and omohyoid muscles. The acetylcholine receptor (AChR) alpha subunit followed a similar expression pattern, whereas expression of Dok-7, Lrp4 and rapsyn was comparable between the muscles. We subsequently examined muscles in mice that overexpressed a miniaturized form of neural agrin or MuSK. In these transgenic mice, the soleus and sternomastoid muscles responded with formation of ectopic AChR clusters, whereas such clusters were almost absent in the EDL and omohyoid muscles. Electroporation of Dok-7 revealed its important role as an activator of MuSK in AChR cluster formation in adult muscles. Together, our findings indicate for the first time that adult skeletal muscles harbour different endogenous levels of MuSK and that these levels determine the ability to form ectopic AChR clusters upon overexpression of agrin or MuSK. We believe that these findings are important for our understanding of adult muscle plasticity and the selective muscle involvement in neuromuscular disorders in which MuSK is diminished.
C1 [Punga, Anna R.; Maj, Marcin; Lin, Shuo; Meinen, Sarina; Rueegg, Markus A.] Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, Basel, Switzerland.
RP Punga, AR (corresponding author), Univ Uppsala Hosp, Dept Clin Neurophysiol, Inst Neurosci, S-75185 Uppsala, Sweden.
EM annarostedtpunga@gmail.com
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Punga, Anna/0000-0002-2178-9413
FU Swedish Society for Medical Research (SSMF); Cantons of Basel-Stadt and
   Baselland; Swiss Foundation for Research on Muscle Disease; FP7 project
   [242210]
FX A.R.P. was funded by a postdoctoral fellowship from the Swedish Society
   for Medical Research (SSMF). Work in the laboratory of M.A.R. is
   supported by the Cantons of Basel-Stadt and Baselland, the Swiss
   Foundation for Research on Muscle Disease and FP7 project no. 242210
   'FIGHT-MG'. Professor emeritus Erik V Stalberg is acknowledged for his
   contribution to the scientific discussion.
CR Beeson D, 2008, ANN NY ACAD SCI, V1132, P99, DOI 10.1196/annals.1405.049
   Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936
   Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333
   Chevessier F, 2008, HUM MOL GENET, V17, P3577, DOI 10.1093/hmg/ddn251
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   DULHUNTY AF, 1979, AM J ANAT, V156, P51, DOI 10.1002/aja.1001560105
   Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007
   Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223
   Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2
   GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0
   GOLDMAN D, 1989, NEURON, V3, P219, DOI 10.1016/0896-6273(89)90035-4
   Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112
   Hesser BA, 2006, MOL CELL NEUROSCI, V31, P470, DOI 10.1016/j.mcn.2005.10.020
   Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520
   Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113
   Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016
   Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654
   Jones G, 1999, J NEUROSCI, V19, P3376
   Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002
   Kong XC, 2004, EMBO REP, V5, P183, DOI 10.1038/sj.embor.7400065
   Krejci E, 1999, J NEUROSCI, V19, P10672
   KUES WA, 1995, EUR J NEUROSCI, V7, P1376, DOI 10.1111/j.1460-9568.1995.tb01129.x
   Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105
   Meier T, 1997, J NEUROSCI, V17, P6534
   Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152
   Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   MUNTENER M, 1980, ANAT EMBRYOL, V159, P49, DOI 10.1007/BF00299254
   Murphy RM, 2003, PHYSIOL GENOMICS, V12, P163, DOI 10.1152/physiolgenomics.00060.2002
   Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142
   Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0
   Punga AR, 2006, CLIN NEUROPHYSIOL, V117, P1434, DOI 10.1016/j.clinph.2006.03.028
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200
   Slater CR, 2008, ANN NY ACAD SCI, V1132, P1, DOI 10.1196/annals.1405.003
   Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6
   VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9
   Wang Q, 2006, J MOL NEUROSCI, V30, P223, DOI 10.1385/JMN:30:1:223
   WITZEMANN V, 1989, FEBS LETT, V242, P419, DOI 10.1016/0014-5793(89)80514-9
   Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007
   Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006
NR 43
TC 33
Z9 34
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0953-816X
EI 1460-9568
J9 EUR J NEUROSCI
JI Eur. J. Neurosci.
PD MAR
PY 2011
VL 33
IS 5
BP 890
EP 898
DI 10.1111/j.1460-9568.2010.07569.x
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA 727MN
UT WOS:000287804500009
PM 21255125
DA 2021-01-25
ER

PT J
AU Reder-Christ, K
   Falkenstein-Paul, H
   Klocek, G
   Al-Kaddah, S
   Bakowsky, U
   Bendas, G
AF Reder-Christ, Katrin
   Falkenstein-Paul, Hildegard
   Klocek, Gabriela
   Al-Kaddah, Saad
   Bakowsky, Udo
   Bendas, Gerd
TI Model membrane approaches to determine the role of calcium for the
   antimicrobial activity of friulimicin
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Antibiotic cyclic lipopeptides; Atomic force microscopy; Biosensor;
   C(55)-P; Friulimicin
ID LIPOPEPTIDE ANTIBIOTICS; BIOSENSOR TECHNIQUES; DAPTOMYCIN
AB Friulimicin is a cyclic lipopeptide antibiotic, currently in clinical development, that possesses excellent activity against Gram-positive bacteria, including multiresistant strains. A recent study on the mode of action of friulimicin reported on the interference with bacterial cell wall biosynthesis via a calcium-dependent complexing of the bactoprenol phosphate carrier C(55)-P. The calcium dependency of this non-common targeted activity remains to be elucidated. In the present model membrane approach, the role of calcium for friulimicin targeting to C(55)-P was investigated by biosensor-based detection of binding affinities. The findings were supplemented by atomic force microscopy (AFM) and circular dichroism (CD) spectroscopy. Comparing the calcium salt of friulimicin with the calcium-free peptide, calcium appeared to be essential for friulimicin interaction with DOPC model membranes. The binding affinity was even higher in the presence of 0.1 mol% C(55)-P (0.21 mu M vs. 1.22 mu M), confirming the targeted mode of action. Binding experiments with supplemented calcium salts suggest (i) the phosphate group as the essential moiety of C(55)-P, referring to a bridging function of calcium between the negatively charged friulimicin and C(55)-P, and (ii) a structural effect of calcium shifting the peptide into a suitable binding conformation (CD spectra). AFM images confirmed that calcium has no, or only a minor, effect on the aggregate formation of friulimicin. These data shed new light on the mechanisms of antibacterial activity of friulimicin. (C) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
C1 [Reder-Christ, Katrin; Falkenstein-Paul, Hildegard; Al-Kaddah, Saad; Bendas, Gerd] Univ Bonn, Dept Pharm, D-53121 Bonn, Germany.
   [Klocek, Gabriela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Bakowsky, Udo] Univ Marburg, Dept Pharm, D-35032 Marburg, Germany.
RP Reder-Christ, K (corresponding author), Univ Bonn, Dept Pharm, Immenburg 4, D-53121 Bonn, Germany.
EM kchrist@uni-bonn.de
OI Bakowsky, Udo/0000-0002-3895-0453; Quebatte,
   Gabriela/0000-0002-2530-5527
FU German Research FoundationGerman Research Foundation (DFG) [FOR 854, Be
   2242/3-1]
FX This work was supported by the German Research Foundation (FOR 854, Be
   2242/3-1).
CR Baltz RH, 2005, NAT PROD REP, V22, P717, DOI 10.1039/b416648p
   Bemer P, 2003, ANTIMICROB AGENTS CH, V47, P3025, DOI 10.1128/AAC.47.9.3025-3029.2003
   Christ K, 2005, PHOTOCHEM PHOTOBIOL, V81, P1417, DOI 10.1562/2005-04-19-RA-493
   Christ K, 2007, BBA-BIOMEMBRANES, V1768, P694, DOI 10.1016/j.bbamem.2006.12.003
   Ho SW, 2008, EUR BIOPHYS J BIOPHY, V37, P421, DOI 10.1007/s00249-007-0227-2
   Jung D, 2004, CHEM BIOL, V11, P949, DOI 10.1016/j.chembiol.2004.04.020
   Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08
   Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003
   SMITH L, 1994, J BIOL CHEM, V269, P9857
   Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009
   Vertesy L, 2000, J ANTIBIOT, V53, P816, DOI 10.7164/antibiotics.53.816
   Wecke T, 2009, ANTIMICROB AGENTS CH, V53, P1619, DOI 10.1128/AAC.01046-08
NR 12
TC 4
Z9 4
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD MAR
PY 2011
VL 37
IS 3
BP 256
EP 260
DI 10.1016/j.ijantimicag.2010.11.024
PG 5
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 723AF
UT WOS:000287476900013
PM 21306875
DA 2021-01-25
ER

PT J
AU Chen, YY
   Peng, B
   Yang, QH
   Glew, MD
   Veith, PD
   Cross, KJ
   Goldie, KN
   Chen, DN
   O'Brien-Simpson, N
   Dashper, SG
   Reynolds, EC
AF Chen, Yu-Yen
   Peng, Benjamin
   Yang, Qiaohui
   Glew, Michelle D.
   Veith, Paul D.
   Cross, Keith J.
   Goldie, Kenneth N.
   Chen, Dina
   O'Brien-Simpson, Neil
   Dashper, Stuart G.
   Reynolds, Eric C.
TI The outer membrane protein LptO is essential for the O-deacylation of
   LPS and the co-ordinated secretion and attachment of A-LPS and CTD
   proteins in Porphyromonas gingivalis
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID GRAM-NEGATIVE BACTERIA; C-TERMINAL-DOMAIN; SUBCELLULAR-LOCALIZATION;
   CYSTEINE PROTEINASE; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE;
   KGP-PROTEINASE; ARG-GINGIPAIN; LIPOPOLYSACCHARIDE; RGPA
AB P>Protein substrates of a novel secretion system of Porphyromonas gingivalis contain a conserved C-terminal domain (CTD) essential for secretion and attachment to the cell surface. Inactivation of lptO (PG0027) or porT produced mutants that lacked surface protease activity and an electron-dense surface layer. Both mutants showed co-accumulation of A-LPS and unmodified CTD proteins in the periplasm. Lipid profiling by mass spectrometry showed the presence of both tetra- and penta-acylated forms of mono-phosphorylated lipid A in the wild-type and porT mutant, while only the penta-acylated forms of mono-phosphorylated lipid A were found in the lptO mutant, indicating a specific role of LptO in the O-deacylation of mono-phosphorylated lipid A. Increased levels of non-phosphorylated lipid A and the presence of novel phospholipids in the lptO mutant were also observed that may compensate for the missing mono-phosphorylated tetra-acylated lipid A in the outer membrane (OM). Molecular modelling predicted LptO to adopt a beta-barrel structure characteristic of an OM protein, supported by the enrichment of LptO in OM vesicles. The results suggest that LPS deacylation by LptO is linked to the co-ordinated secretion of A-LPS and CTD proteins by a novel secretion and attachment system to form a structured surface layer.
C1 [Chen, Yu-Yen; Peng, Benjamin; Yang, Qiaohui; Glew, Michelle D.; Veith, Paul D.; Cross, Keith J.; Chen, Dina; O'Brien-Simpson, Neil; Dashper, Stuart G.; Reynolds, Eric C.] Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Melbourne, Vic 3010, Australia.
   [Chen, Yu-Yen; Peng, Benjamin; Yang, Qiaohui; Glew, Michelle D.; Veith, Paul D.; Cross, Keith J.; Chen, Dina; O'Brien-Simpson, Neil; Dashper, Stuart G.; Reynolds, Eric C.] Univ Melbourne, Bio21 Inst, Melbourne, Vic 3010, Australia.
   [Goldie, Kenneth N.] Univ Basel, Ctr Cellular Imaging & Nano Analyt, Biozentrum, CH-4003 Basel, Switzerland.
RP Reynolds, EC (corresponding author), Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Melbourne, Vic 3010, Australia.
EM e.reynolds@unimelb.edu.au
RI Cross, Keith J/N-4602-2013; Glew, Michelle/AAW-9955-2020; Cross,
   Keith/F-4566-2012
OI Cross, Keith/0000-0002-4079-2132; Reynolds, Eric/0000-0002-6618-4856;
   Glew, Michelle/0000-0002-0690-6079; Dashper, Stuart/0000-0003-0106-8691;
   Veith, Paul/0000-0002-7344-1662; O'Brien-Simpson,
   Neil/0000-0001-8462-5603
FU Australian National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia [509326]
FX Siow Teng Chan, Bee Cin Tan and Rita A. Paolini are acknowledged for
   their technical assistance. The support of the Australian National
   Health and Medical Research Council project 509326 is acknowledged.
CR Aduse-Opoku J, 2006, INFECT IMMUN, V74, P449, DOI 10.1128/IAI.74.1.449-460.2006
   Al-Qutub MN, 2006, INFECT IMMUN, V74, P4474, DOI 10.1128/IAI.01924-05
   Bainbridge BW, 2006, CELL MICROBIOL, V8, P120, DOI 10.1111/j.1462-5822.2005.00605.x
   Bhogal PS, 1997, MICROBIOL-SGM, V143, P2485, DOI 10.1099/00221287-143-7-2485
   Cascales E, 2004, MOL MICROBIOL, V51, P873, DOI 10.1046/j.1365-2958.2003.03881.x
   Chen YY, 2002, J BIOL CHEM, V277, P23433, DOI 10.1074/jbc.M200811200
   Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x
   Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999
   Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453
   Ford PJ, 2007, J DENT RES, V86, P35, DOI 10.1177/154405910708600105
   Frazer LT, 2006, VACCINE, V24, P6542, DOI 10.1016/j.vaccine.2006.06.013
   Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057
   Genco CA, 1999, CLIN INFECT DIS, V28, P456, DOI 10.1086/515156
   HARLOW E, 1988, ANTIBIOTICS LAB MANU
   Ishiguro I, 2009, FEMS MICROBIOL LETT, V292, P261, DOI 10.1111/j.1574-6968.2009.01489.x
   Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998
   Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x
   Mikolajczyk J, 2003, J BIOL CHEM, V278, P10458, DOI 10.1074/jbc.M210564200
   Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126
   Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003
   Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06
   Nguyen KA, 2009, MICROBIOL-SGM, V155, P328, DOI 10.1099/mic.0.024323-0
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   Noble JM, 2009, J NEUROL NEUROSUR PS, V80, P1206, DOI 10.1136/jnnp.2009.174029
   O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980
   O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009
   Okamoto K, 1998, J BIOL CHEM, V273, P21225, DOI 10.1074/jbc.273.33.21225
   Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x
   Paramonov NA, 2009, J BACTERIOL, V191, P5272, DOI 10.1128/JB.00019-09
   Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027
   Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803
   Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200
   Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07
   Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184
   Rutten L, 2009, P NATL ACAD SCI USA, V106, P1960, DOI 10.1073/pnas.0813064106
   Saiki K, 2007, MICROBIOL IMMUNOL, V51, P483, DOI 10.1111/j.1348-0421.2007.tb03936.x
   Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200
   Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107
   Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06
   Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762
   Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955
   Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10
   Takii R, 2005, INFECT IMMUN, V73, P883, DOI 10.1128/IAI.73.2.883-893.2005
   van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524
   Veith PD, 2004, INFECT IMMUN, V72, P3655, DOI 10.1128/IAI.72.6.3655-3657.2004
   Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105
   Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018
   Zhou P, 2009, J LIPID RES, V50, P1936, DOI 10.1194/jlr.D900013-JLR200
NR 48
TC 81
Z9 81
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD MAR
PY 2011
VL 79
IS 5
BP 1380
EP 1401
DI 10.1111/j.1365-2958.2010.07530.x
PG 22
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 724PP
UT WOS:000287589000022
PM 21244528
OA Bronze
DA 2021-01-25
ER

PT J
AU Scheidegger, F
   Quebatte, M
   Mistl, C
   Dehio, C
AF Scheidegger, Florine
   Quebatte, Maxime
   Mistl, Claudia
   Dehio, Christoph
TI The Bartonella henselae VirB/Bep system interferes with vascular
   endothelial growth factor (VEGF) signalling in human vascular
   endothelial cells
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID IV SECRETION SYSTEMS; FACTOR RECEPTOR-2; DNA-SYNTHESIS; PROLIFERATION;
   ACTIVATION; PROTEIN; BLOOD; VASCULOGENESIS; ANGIOGENESIS; MIGRATION
AB P>The vasculotropic pathogen Bartonella henselae (Bh) intimately interacts with human endothelial cells (ECs) and subverts multiple cellular functions. Here we report that Bh specifically interferes with vascular endothelial growth factor (VEGF) signalling in ECs. Bh infection abrogated VEGF-induced proliferation and wound closure of EC monolayers as well as the capillary-like sprouting of EC spheroids. On the molecular level, Bh infection did not alter VEGF receptor 2 (VEGFR2) expression or cell surface localization, but impeded VEGF-stimulated phosphorylation of VEGFR2 at tyrosine(1175). Consistently, we observed that Bh infection diminished downstream events of the tyrosine(1175)-dependent VEGFR2-signalling pathway leading to EC proliferation, i.e. phospholipase-C gamma activation, cytosolic calcium fluxes and mitogen-activated protein kinase ERK1/2 phosphorylation. Pervanadate treatment neutralized the inhibitory activity of Bh on VEGF signalling, suggesting that Bh infection may activate a phosphatase that alleviates VEGFR2 phosphorylation. Inhibition of VEGFR2 signalling by Bh infection was strictly dependent on a functional VirB type IV secretion system and thereby translocated Bep effector proteins. The data presented in this study underscore the role of the VirB/Bep system as important factor controlling EC proliferation in response to Bh infection; not only as previously reported by counter-acting an intrinsic bacterial mitogenic stimulus, but also by restricting the exogenous angiogenic stimulation by Bh-induced VEGF.
C1 [Scheidegger, Florine; Quebatte, Maxime; Mistl, Claudia; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Quebatte, Maxime/0000-0002-3733-1511
FU Misrock Foundation; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [31003A-109925]; Howard Hughes Medical
   InstituteHoward Hughes Medical Institute [55005501]; SystemsX.ch, the
   Swiss Initiative for Systems Biology [51RT-0-126008 (InfectX)]
FX We are grateful to Dr R. Jayachandran and P. Muller for technical
   assistance. We thank A. Pulliainen for critically reading of the
   manuscript and acknowledge the donation of human umbilical cords from
   the University Women's Hospital Basel. This work was supported by a PhD
   fellowship from the Misrock Foundation, Grant 31003A-109925 from the
   Swiss National Science Foundation, Grant 55005501 from the Howard Hughes
   Medical Institute and Grant 51RT-0-126008 (InfectX) from SystemsX.ch,
   the Swiss Initiative for Systems Biology.
CR Augustin HG, 2004, SPRING LAB MAN, P145
   BROCK TA, 1991, AM J PATHOL, V138, P213
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Chian CA, 2002, INT J DERMATOL, V41, P461, DOI 10.1046/j.1365-4362.2002.01489.x
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   CONLEY T, 1994, J LAB CLIN MED, V124, P521
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8
   Drancourt M, 1996, LANCET, V347, P441, DOI 10.1016/S0140-6736(96)90012-4
   Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897
   Fong GH, 1999, DEVELOPMENT, V126, P3015
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   GARCIA FU, 1990, AM J PATHOL, V136, P1125
   Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349
   Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013
   HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   KOEHLER JE, 1993, CLIN INFECT DIS, V17, P612, DOI 10.1093/clinids/17.4.612
   Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341
   Korff T, 1999, J CELL SCI, V112, P3249
   Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Riess T, 2007, INFECT IMMUN, V75, P35, DOI 10.1128/IAI.00963-06
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469
   Sobke ACS, 2006, FASEB J, V20, P2621, DOI 10.1096/fj.06-5764fje
   Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370
   Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527
   Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768
   WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988
   Weber H, 2008, TOXICOL IN VITRO, V22, P531, DOI 10.1016/j.tiv.2007.09.014
   Yashima R, 2001, J CELL PHYSIOL, V188, P201, DOI 10.1002/jcp.1107
   Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200
NR 48
TC 9
Z9 10
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD MAR
PY 2011
VL 13
IS 3
BP 419
EP 431
DI 10.1111/j.1462-5822.2010.01545.x
PG 13
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 720XX
UT WOS:000287317100009
PM 21044238
OA Bronze
DA 2021-01-25
ER

PT J
AU Lauer, ME
   Grassmann, O
   Siam, M
   Tardio, J
   Jacob, L
   Page, S
   Kindt, JH
   Engel, A
   Alsenz, J
AF Lauer, Matthias Eckhard
   Grassmann, Olaf
   Siam, Monira
   Tardio, Joseph
   Jacob, Laurence
   Page, Susanne
   Kindt, Johannes Heinrich
   Engel, Andreas
   Alsenz, Jochem
TI Atomic Force Microscopy-Based Screening of Drug-Excipient Miscibility
   and Stability of Solid Dispersions
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE amorphous formulation; raman microscopy; solid dispersion; stability
   prediction; AFM
ID DIRECTED SPINODAL DECOMPOSITION; HIGH-THROUGHPUT; PHASE-SEPARATION;
   MECHANICAL-PROPERTIES; CRYSTALLIZATION; SOLUBILITY; MIXTURES; LACTOSE;
   MICROSTRUCTURE; PARTICLES
AB Development of a method to assess the drug/polymer miscibility and stability of solid dispersions using a melt-based mixing method.
   Amorphous fractured films are prepared and characterized with Raman Microscopy in combination with Atomic Force Microscopy to discriminate between homogenously and heterogeneously mixed drug/polymer combinations. The homogenous combinations are analyzed further for physical stability under stress conditions, such as increased humidity or temperature.
   Combinations that have the potential to form a molecular disperse mixture are identified. Their potential to phase separate is determined through imaging at molecular length scales, which results in short observation time. De-mixing is quantified by phase separation analysis, and the drug/polymer combinations are ranked to identify the most stable combinations.
   The presented results demonstrate that drug/polymer miscibility and stability of solid dispersions, with many mechanistic details, can be analyzed with Atomic Force Microscopy. The assay allows to identify well-miscible and stable combinations within hours or a few days.
C1 [Lauer, Matthias Eckhard; Engel, Andreas] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4006 Basel, Switzerland.
   [Lauer, Matthias Eckhard; Grassmann, Olaf; Siam, Monira] F Hoffmann La Roche & Co Ltd, Discovery Technol, CH-4070 Basel, Switzerland.
   [Tardio, Joseph; Jacob, Laurence; Page, Susanne; Alsenz, Jochem] F Hoffmann La Roche & Co Ltd, Formulat Res, CH-4070 Basel, Switzerland.
   [Kindt, Johannes Heinrich] Bruker Nano GmbH, D-68165 Mannheim, Germany.
RP Lauer, ME (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, Mattenstr 26, CH-4006 Basel, Switzerland.
EM Matthias.Lauer@roche.com
OI Lauer, Matthias/0000-0003-3252-8718
FU F. Hoffmann-La Roche Ltd.Hoffmann-La Roche; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R01EY019478,
   R01EY019478, R01EY019478, R01EY019478, R01EY019478] Funding Source: NIH
   RePORTER
FX The authors would like to thank Natalia Erina, and Chanmin Su for
   discussions. We would like to thank F. Hoffmann-La Roche Ltd. for the
   financial support.
CR AVRAAM I, 2010, ENCY POLYM BLENDS, V1, P314
   Barillaro V, 2008, J COMB CHEM, V10, P637, DOI 10.1021/cc8000585
   Bhattacharya S, 2009, J PHARM SCI-US, V98, P2935, DOI 10.1002/jps.21728
   Cabral JT, 2002, MACROMOLECULES, V35, P1941, DOI 10.1021/ma0114990
   Cabral JT, 2001, MACROMOLECULES, V34, P3748, DOI 10.1021/ma0017743
   Conte-Mayweg A, 2007, United States patent, Patent No. 7259183
   Danesh A, 2000, LANGMUIR, V16, P866, DOI 10.1021/la990470a
   Flory PJ, 1941, J CHEM PHYS, V9, P660, DOI 10.1063/1.1750971
   Forster A, 2001, INT J PHARM, V226, P147, DOI 10.1016/S0378-5173(01)00801-8
   Henderson IC, 2005, MACROMOL THEOR SIMUL, V14, P435, DOI 10.1002/mats.200500027
   Hoffmann-Emery F, 2006, J ORG CHEM, V71, P2000, DOI 10.1021/jo0523666
   Huggins M. M, 1941, ANN NY ACAD SCI, V43, P1
   Ivanisevic I, 2009, J PHARM SCI-US, V98, P3373, DOI 10.1002/jps.21717
   Janssens S, 2009, J PHARM PHARMACOL, V61, P1571, DOI 10.1211/jpp/61.12.0001
   JONES RAL, 1991, PHYS REV LETT, V66, P1326, DOI 10.1103/PhysRevLett.66.1326
   JOSEPH T, 1997, ANTEC 97 PLAST SAV P, V13, P3371
   Koyama T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.065701
   Mahlin D, 2004, J PHARM SCI-US, V93, P29, DOI 10.1002/jps.10503
   Mahlin D, 2006, J PHARM PHARMACOL, V58, pA74
   Marsac P, 2009, PHARM RES-DORDR, V26, P139, DOI 10.1007/s11095-008-9721-1
   Mecholsky JJ, 2009, KEY ENG MATER, V409, P145, DOI 10.4028/www.scientific.net/KEM.409.145
   Meredith JC, 2000, MACROMOLECULES, V33, P5760, DOI 10.1021/ma0004662
   Meredith JC, 2001, ABSTR PAP AM CHEM S, V222, pU327
   Pajula K, 2010, MOL PHARMACEUT, V7, P795, DOI 10.1021/mp900304p
   Price R, 2004, J PHARM SCI-US, V93, P155, DOI 10.1002/jps.10513
   Puri SJ, 2005, J PHYS-CONDENS MAT, V17, pR101, DOI 10.1088/0953-8984/17/3/R01
   Qi S, 2010, PHARM RES-DORDR, V27, P1869, DOI 10.1007/s11095-010-0185-8
   Qian F, 2010, J PHARM SCI-US, V99, P2941, DOI 10.1002/jps.22074
   Quiroga CC, 2007, FOOD BIOPHYS, V2, P172, DOI 10.1007/s11483-007-9041-8
   Raghavan D, 2001, MACROMOL SYMP, V167, P297, DOI 10.1002/1521-3900(200103)167:1<297::AID-MASY297>3.0.CO;2-2
   Rumondor ACF, 2009, PHARM RES-DORDR, V26, P2599, DOI 10.1007/s11095-009-9974-3
   Rumondor ACF, 2009, PHARM RES-DORDR, V26, P2523, DOI 10.1007/s11095-009-9970-7
   Rumondor ACF, 2009, MOL PHARMACEUT, V6, P1492, DOI 10.1021/mp900050c
   Sagui C, 1998, MATER RES SOC SYMP P, V481, P125
   Sakai T, 2002, LANGMUIR, V18, P1985, DOI 10.1021/la0111248
   Sawyer L., 2008, POLYM MICROSCOPY
   Sitterberg J, 2010, EUR J PHARM BIOPHARM, V74, P2, DOI 10.1016/j.ejpb.2009.09.005
   Six K, 2003, PHARM RES-DORDR, V20, P135, DOI 10.1023/A:1022219429708
   Sormana JL, 2003, MACROMOL RAPID COMM, V24, P118, DOI 10.1002/marc.200390007
   Tumer YTA, 2007, ADV DRUG DELIVER REV, V59, P1453, DOI 10.1016/j.addr.2007.08.020
   Van Eerdenbrugh B, 2010, MOL PHARMACEUT, V7, P1328, DOI 10.1021/mp1001153
   Ward S, 2005, J PHARM PHARMACOL, V57, pS98
   Ward S, 2005, PHARM RES-DORDR, V22, P1195, DOI 10.1007/s11095-005-6027-4
   Weuts I, 2011, J PHARM SCI-US, V100, P260, DOI 10.1002/jps.22242
   Wheaton BR, 2007, J NON-CRYST SOLIDS, V353, P4767, DOI 10.1016/j.jnoncrysol.2007.06.073
   Zhang JX, 2009, INT J PHARMACEUT, V380, P170, DOI 10.1016/j.ijpharm.2009.07.003
NR 46
TC 52
Z9 54
U1 1
U2 20
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
J9 PHARM RES-DORDR
JI Pharm. Res.
PD MAR
PY 2011
VL 28
IS 3
BP 572
EP 584
DI 10.1007/s11095-010-0306-4
PG 13
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 722RZ
UT WOS:000287453300015
PM 21046435
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Palanivelu, DV
   Goepfert, A
   Meury, M
   Guye, P
   Dehio, C
   Schirmer, T
AF Palanivelu, Dinesh V.
   Goepfert, Arnaud
   Meury, Marcel
   Guye, Patrick
   Dehio, Christoph
   Schirmer, Tilman
TI Fic domain-catalyzed adenylylation: Insight provided by the structural
   analysis of the type IV secretion system effector BepA
SO PROTEIN SCIENCE
LA English
DT Article
DE FIC domain; AMPylation; adenylylation; AMP transfer; type IV secretion
   system
ID BARTONELLA-HENSELAE; ENDOTHELIAL-CELLS; PROTEIN; REFINEMENT; ACTIVATION;
   AMPYLATION; BINDING; SITE
AB Numerous bacterial pathogens subvert cellular functions of eukaryotic host cells by the injection of effector proteins via dedicated secretion systems. The type IV secretion system (T4SS) effector protein BepA from Bartonella henselae is composed of an N-terminal Fic domain and a C-terminal Bartonella intracellular delivery domain, the latter being responsible for T4SS-mediated translocation into host cells. A proteolysis resistant fragment (residues 10-302) that includes the Fic domain shows autoadenylylation activity and adenylyl transfer onto Hela cell extract proteins as demonstrated by autoradiography on incubation with alpha-[P-32]-ATP. Its crystal structure, determined to 2.9-angstrom resolution by the SeMet-SAD method, exhibits the canonical Fic fold including the HPFxxGNGRxxR signature motif with several elaborations in loop regions and an additional beta-rich domain at the C-terminus. On crystal soaking with ATP/Mg2+, additional electron density indicated the presence of a PPi/Mg2+ moiety, the side product of the adenylylation reaction, in the anion binding nest of the signature motif. On the basis of this information and that of the recent structure of IbpA(Fic2) in complex with the eukaryotic target protein Cdc42, we present a detailed model for the ternary complex of Fic with the two substrates, ATP/Mg2+ and target tyrosine. The model is consistent with an in-line nucleophilic attack of the deprotonated side-chain hydroxyl group onto the alpha-phosphorus of the nucleotide to accomplish AMP transfer. Furthermore, a general, sequence-independent mechanism of target positioning through antiparallel beta-strand interactions between enzyme and target is suggested.
C1 [Palanivelu, Dinesh V.; Goepfert, Arnaud; Meury, Marcel; Schirmer, Tilman] Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, CH-4056 Basel, Switzerland.
   [Goepfert, Arnaud; Guye, Patrick; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100a0-109925]; Howard Hughes Medical InstituteHoward Hughes
   Medical Institute [55005501]; SystemsX.ch Swiss Initiative for Systems
   Biology [51RT 0_126008 (InfectX)]
FX Grant sponsor: Swiss National Science Foundation; Grant number:
   3100a0-109925; Grant sponsor: Howard Hughes Medical Institute; Grant
   number: 55005501; Grant sponsor: SystemsX.ch Swiss Initiative for
   Systems Biology; Grant number: 51RT 0_126008 (InfectX)
CR AGW Leslie, 1992, JOINT CCP4 ESF EACBM, V27, P30
   Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5
   Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   Desogus G, 2000, BIOCHEMISTRY-US, V39, P8418, DOI 10.1021/bi0006722
   Desveaux D, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030048
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200
   Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366
   Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818
   Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884
   Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276
   Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200
   VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012
   Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227
   Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456
   Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008
   Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867
   Xu YB, 2010, J MOL BIOL, V396, P773, DOI 10.1016/j.jmb.2009.12.011
   Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382
NR 28
TC 40
Z9 41
U1 2
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD MAR
PY 2011
VL 20
IS 3
BP 492
EP 499
DI 10.1002/pro.581
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 731VG
UT WOS:000288136900003
PM 21213248
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Kim, ML
   Sorg, I
   Arrieumerlou, C
AF Kim, Man Lyang
   Sorg, Isabel
   Arrieumerlou, Cecile
TI Endocytosis-Independent Function of Clathrin Heavy Chain in the Control
   of Basal NF-kappa B Activation
SO PLOS ONE
LA English
DT Article
ID RECEPTOR TRAFFICKING; PROTEINS; CELLS; TRANSCRIPTION; INHIBITOR;
   PATHWAYS; MICE
AB Background: Nuclear factor-kappa B (NF-kappa B) is a transcription factor that regulates the transcription of genes involved in a variety of biological processes, including innate and adaptive immunity, stress responses and cell proliferation. Constitutive or excessive NF-kappa B activity has been associated with inflammatory disorders and higher risk of cancer. In contrast to the mechanisms controlling inducible activation, the regulation of basal NF-kappa B activation is not well understood. Here we test whether clathrin heavy chain (CHC) contributes to the regulation of basal NF-kappa B activity in epithelial cells.
   Methodology: Using RNA interference to reduce endogenous CHC expression, we found that CHC is required to prevent constitutive activation of NF-kappa B and gene expression. Immunofluorescence staining showed constitutive nuclear localization of the NF-kappa B subunit p65 in absence of stimulation after CHC knockdown. Elevated basal p65 nuclear localization is caused by constitutive phosphorylation and degradation of inhibitor of NF-kappa B alpha (I kappa B alpha) through an I kappa B kinase alpha (IKK alpha)-dependent mechanism. The role of CHC in NF-kappa B signaling is functionally relevant as constitutive expression of the proinflammatory chemokine interleukin-8 (IL-8), whose expression is regulated by NF-kappa B, was found after CHC knockdown. Disruption of clathrin-mediated endocytosis by chemical inhibition or depletion of the mu 2-subunit of the endocytosis adaptor protein AP-2, and knockdown of clathrin light chain a (CHLa), failed to induce constitutive NF-kappa B activation and IL-8 expression, showing that CHC acts on NF-kappa B independently of endocytosis and CLCa.
   Conclusions: We conclude that CHC functions as a built-in molecular brake that ensures a tight control of basal NF-kappa B activation and gene expression in unstimulated cells. Furthermore, our data suggest a potential link between a defect in CHC expression and chronic inflammation disorder and cancer.
C1 [Kim, Man Lyang; Sorg, Isabel; Arrieumerlou, Cecile] Univ Basel, Biozentrum, Basel, Switzerland.
RP Kim, ML (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM cecile.arrieumerlou@unibas.ch
OI ARRIEUMERLOU, Cecile/0000-0002-6463-2897
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-113561]; University of Basel
FX This work was funded by the Swiss National Science Foundation (grant
   3100A0-113561 to CA; www.snf.ch) and the University of Basel
   (www.unibas.ch). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428
   BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942
   BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064
   BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032
   Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906
   Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142
   GIBSON AE, 1989, AM J PHYSIOL, V257, pC182
   Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954
   Hayden Matthew S, 2006, Cell, V127, P1286
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200
   Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914
   Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543
   Kim ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015371
   Liberatore RA, 2009, P NATL ACAD SCI USA, V106, P17823, DOI 10.1073/pnas.0905935106
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073
   Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145
   Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876
   Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937
   Pilecka I, 2007, EUR J CELL BIOL, V86, P533, DOI 10.1016/j.ejcb.2007.04.004
   Poupon V, 2008, P NATL ACAD SCI USA, V105, P168, DOI 10.1073/pnas.0707269105
   Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2
   Prescott JL, 1998, ENDOCRINOLOGY, V139, P2111, DOI 10.1210/en.139.4.2111
   Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0
   Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502
   Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292
   Weil R, 2003, IMMUNITY, V18, P13, DOI 10.1016/S1074-7613(02)00506-X
   Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x
NR 33
TC 8
Z9 8
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 25
PY 2011
VL 6
IS 2
AR e17158
DI 10.1371/journal.pone.0017158
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 726YS
UT WOS:000287764100032
PM 21364927
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Baud, O
   Etter, S
   Spreafico, M
   Bordoli, L
   Schwede, T
   Vogel, H
   Pick, H
AF Baud, Olivia
   Etter, Sylvain
   Spreafico, Morena
   Bordoli, Lorenza
   Schwede, Torsten
   Vogel, Horst
   Pick, Horst
TI The Mouse Eugenol Odorant Receptor: Structural and Functional Plasticity
   of a Broadly Tuned Odorant Binding Pocket
SO BIOCHEMISTRY
LA English
DT Article
ID PROTEIN-COUPLED RECEPTORS; OLFACTORY RECEPTOR; CRYSTAL-STRUCTURE;
   MOLECULAR-BASIS; LIGAND SPECIFICITY; EXPRESSION; CELLS; SENSE;
   IDENTIFICATION; RECOGNITION
AB Molecular interactions of odorants with their olfactory receptors (ORs) are of central importance for the ability of the mammalian olfactory system to detect and discriminate a vast variety of odors with a limited set of receptors. How a particular OR binds and distinguishes different odorant molecules remains largely unknown on a structural basis. Here we investigated this question for the mouse eugenol receptor (mOR-EG). By screening a large odorant library, we discovered a wide range of chemical structures activating the receptor in heterologous mammalian cells. Potent agonists comprise (i) benzene, (ii) cyclohexane, or (iii) polycyclic structures substituted with alcohol, aldehyde, keto, ether, or esterified carboxylic groups. To detect those amino acids within the receptor that are in contact with a particular bound odorant molecule, we investigated how distinct mOR-EG point mutants were activated by the different odorant agonists found for the wild-type receptor. We identified 11 amino acids as a part of the receptor's ligand binding pocket. Molecular modeling predicted 10 of these residues in transmembrane helices TM3-TM6 and one in the extracellular loop between TM2 and TM3. These amino acids participate in odorant binding with variable importance depending on the type of odorant, revealing functional "fingerprints" of ligand-receptor interactions.
C1 [Baud, Olivia; Etter, Sylvain; Vogel, Horst; Pick, Horst] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland.
   [Spreafico, Morena; Bordoli, Lorenza; Schwede, Torsten] Univ Basel, Biozentrum, SIB Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland.
EM Horst.Vogel@epfl.ch; Horst.Pick@epfl.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
FU SystemsX program
FX We thank Sayako Katada and Kazushige Touhara for kindly providing their
   model of the mouse eugenol receptor based on the rhodopsin template and
   for a set of point mutations introduced into mOR-EG cDNA. We are
   grateful to Luigino Grasso for his assistance in flow cytometry analysis
   and to Joachim Piguet for his support in informatics. Financial support
   from SystemsX program is acknowledged.
CR Abaffy T, 2007, J BIOL CHEM, V282, P1216, DOI 10.1074/jbc.M609355200
   Araneda RC, 2000, NAT NEUROSCI, V3, P1248
   Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092
   Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a
   Borysik AJ, 2010, J MOL BIOL, V404, P372, DOI 10.1016/j.jmb.2010.09.019
   Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002
   Breer H, 2008, ANN NY ACAD SCI, V1126, P1, DOI 10.1196/annals.1433.010
   Breer H, 2003, ANAL BIOANAL CHEM, V377, P427, DOI 10.1007/s00216-003-2113-9
   BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X
   Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203
   Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577
   Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410
   Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106
   Doszczak L, 2007, ANGEW CHEM INT EDIT, V46, P3367, DOI 10.1002/anie.200605002
   Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039
   Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026
   Floriano WB, 2004, CHEM SENSES, V29, P269, DOI 10.1093/chemse/bjh030
   Floriano WB, 2000, P NATL ACAD SCI USA, V97, P10712, DOI 10.1073/pnas.97.20.10712
   Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444
   Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100
   Grosmaitre X, 2009, J NEUROSCI, V29, P14545, DOI 10.1523/JNEUROSCI.2752-09.2009
   Hall SE, 2004, CHEM SENSES, V29, P595, DOI 10.1093/chemse/bjh063
   Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005
   Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772
   Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103
   Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x
   Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005
   Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6
   Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789
   Khafizov K, 2007, J MOL MODEL, V13, P401, DOI 10.1007/s00894-006-0160-9
   Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X
   Lundstrom K, 2005, IDRUGS, V8, P909
   Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100
   Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4
   Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404
   Menini A, 2004, NEWS PHYSIOL SCI, V19, P101, DOI 10.1152/nips.1507.2003
   Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103
   Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915
   Murrell JR, 1999, J NEUROSCI, V19, P8260
   Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032
   Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063
   Pick H, 2009, J BIOL CHEM, V284, P30547, DOI 10.1074/jbc.M109.040964
   Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325
   Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021
   Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774
   Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330
   Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200
   SINGER MS, 1995, RECEPTOR CHANNEL, V3, P89
   Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262
   Taylor AJ, 2008, CHEMOSENS PERCEPT, V1, P153, DOI 10.1007/s12078-008-9016-2
   Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870
   Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050
   Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101
   Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011
   Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396
   Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120
   Zozulya S, 2001, GENOME BIOL, V2
NR 63
TC 63
Z9 64
U1 0
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 8
PY 2011
VL 50
IS 5
BP 843
EP 853
DI 10.1021/bi1017396
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 712UD
UT WOS:000286690800026
PM 21142015
DA 2021-01-25
ER

PT J
AU Teoh, CL
   Pham, CLL
   Todorova, N
   Hung, A
   Lincoln, CN
   Lees, E
   Lam, YH
   Binger, KJ
   Thomson, NH
   Radford, SE
   Smith, TA
   Muller, SA
   Engel, A
   Griffin, MDW
   Yarovsky, I
   Gooley, PR
   Howlett, GJ
AF Teoh, Chai Lean
   Pham, Chi L. L.
   Todorova, Nevena
   Hung, Andrew
   Lincoln, Craig N.
   Lees, Emma
   Lam, Yuen Han
   Binger, Katrina J.
   Thomson, Neil H.
   Radford, Sheena E.
   Smith, Trevor A.
   Mueller, Shirley A.
   Engel, Andreas
   Griffin, Michael D. W.
   Yarovsky, Irene
   Gooley, Paul R.
   Howlett, Geoffrey J.
TI A Structural Model for Apolipoprotein C-II Amyloid Fibrils: Experimental
   Characterization and Molecular Dynamics Simulations
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE X-ray diffraction; atomic force microscopy; scanning transmission
   electron microscopy; fluorescence resonance energy transfer;
   cross-beta-structure
ID SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; X-RAY-DIFFRACTION; PROBING
   SOLVENT ACCESSIBILITY; ALPHA-SYNUCLEIN FIBRILS; PARALLEL BETA-SHEET;
   SECONDARY STRUCTURE; HYDROGEN-EXCHANGE; SUPRAMOLECULAR STRUCTURE;
   ELECTRON-MICROSCOPY
AB The self-assembly of specific proteins to form insoluble amyloid fibrils is a characteristic feature of a number of age-related and debilitating diseases. Lipid-free human apolipoprotein C-II (apoC-H) forms characteristic amyloid fibrils and is one of several apolipoproteins that accumulate in amyloid deposits located within atherosclerotic plaques. X-ray diffraction analysis of aligned apoC-II fibrils indicated a simple cross-beta-structure composed of two parallel beta-sheets. Examination of apoC-II fibrils using transmission electron microscopy, scanning transmission electron microscopy, and atomic force microscopy indicated that the fibrils are flat ribbons composed of one apoC-II molecule per 4.7-angstrom rise of the cross-beta-structure. Cross-linking results using single-cysteine substitution mutants are consistent with a parallel in-register structural model for apoC-H fibrils. Fluorescence resonance energy transfer analysis of apoC-H fibrils labeled with specific fluorophores provided distance constraints for selected donor acceptor pairs located within the fibrils. These findings were used to develop a simple 'letter-G-like' beta-strand-loop-beta-strand model for apoC-II fibrils. Fully solvated all-atom molecular dynamics (MD) simulations showed that the model contained a stable cross-beta-core with a flexible connecting loop devoid of persistent secondary structure. The time course of the MD simulations revealed that charge clusters in the fibril rearrange to minimize the effects of same-charge interactions inherent in parallel in-register models. Our structural model for apoC-II fibrils suggests that apoC-II monomers fold and self-assemble to form a stable cross-beta-scaffold containing relatively unstructured connecting loops. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Teoh, Chai Lean; Pham, Chi L. L.; Lees, Emma; Lam, Yuen Han; Binger, Katrina J.; Griffin, Michael D. W.; Gooley, Paul R.; Howlett, Geoffrey J.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.
   [Teoh, Chai Lean; Pham, Chi L. L.; Lees, Emma; Lam, Yuen Han; Binger, Katrina J.; Griffin, Michael D. W.; Gooley, Paul R.; Howlett, Geoffrey J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.
   [Todorova, Nevena; Hung, Andrew; Yarovsky, Irene] RMIT Univ, Sch Appl Sci, Hlth Innovat Res Inst, Melbourne, Vic 3001, Australia.
   [Lincoln, Craig N.; Smith, Trevor A.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia.
   [Lincoln, Craig N.; Smith, Trevor A.] Univ Melbourne, ARC Ctr Excellence Coherent Xray Sci, Parkville, Vic 3010, Australia.
   [Thomson, Neil H.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
   [Thomson, Neil H.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England.
   [Radford, Sheena E.] Univ Leeds, Inst Struct & Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
   [Mueller, Shirley A.; Engel, Andreas] Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4058 Basel, Switzerland.
   [Mueller, Shirley A.; Engel, Andreas] Univ Basel, C CINA, CH-4058 Basel, Switzerland.
RP Howlett, GJ (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.
EM ghowlett@unimelb.edu.au
RI Binger, Katrina/G-6640-2018; Todorova, Nevena/L-5190-2016; Lincoln,
   Craig N/L-8858-2013; Thomson, Neil. H/O-4198-2016
OI Binger, Katrina/0000-0003-1139-3308; Todorova,
   Nevena/0000-0001-6358-2974; Lincoln, Craig N/0000-0003-3239-0114;
   Thomson, Neil. H/0000-0001-7332-790X; Griffin,
   Michael/0000-0001-9845-7735; Radford, Sheena/0000-0002-3079-8039;
   Yarovsky, Irene/0000-0002-4033-5150; Gooley, Paul/0000-0002-0323-449X;
   Smith, Trevor/0000-0003-4453-9713; Hung, Andrew/0000-0003-3569-2951
FU Australian Research CouncilAustralian Research Council [DP0877800,
   DP0984565]; ARC Center of Excellence in Coherent X-ray ScienceAustralian
   Research Council [CE0561787]; Swiss National FoundationSwiss National
   Science Foundation (SNSF) [3100A0-108299]; Maurice E. Muller Foundation
   of Switzerland; Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/D011191/1] Funding Source: researchfish
FX We thank Drs. Terry Mulhern, Danny Hatters, and Michael Bailey for
   discussions and advice throughout the preparation of this work. This
   work was funded by grants from the Australian Research Council
   (DP0877800 and DP0984565) and the ARC Center of Excellence in Coherent
   X-ray Science (CE0561787). We thank Philippe Ringler for STEM. The STEM
   experiments were supported by the Swiss National Foundation (grant
   3100A0-108299 to A.E.) and by the Maurice E. Muller Foundation of
   Switzerland. Part of this research was undertaken on beamline MX-2 of
   the Australian Synchrotron.
CR Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097
   Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185
   ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351
   Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2
   Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106
   Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072
   Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055
   Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9
   Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484
   Cherny I, 2005, J MOL BIOL, V352, P245, DOI 10.1016/j.jmb.2005.07.028
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   COHEN AS, 1982, ELECT MICROSCOPY PRO
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443
   Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200
   EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673
   Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x
   ESSMANN U, 1995, LANGMUIR, V11, P4519, DOI 10.1021/la00011a056
   FOJO SS, 1984, P NATL ACAD SCI-BIOL, V81, P6354, DOI 10.1073/pnas.81.20.6354
   Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003
   Griffin MDW, 2008, J MOL BIOL, V375, P240, DOI 10.1016/j.jmb.2007.10.038
   Gunzburg MJ, 2007, J BIOL CHEM, V282, P35831, DOI 10.1074/jbc.M706425200
   GVANGUNSTEREN WF, 1996, BIOMOLECULAR SIMULAT
   Hamada D, 2004, TRENDS BIOTECHNOL, V22, P93, DOI 10.1016/j.tibtech.2003.12.003
   Hatters DM, 2006, J MOL BIOL, V361, P932, DOI 10.1016/j.jmb.2006.06.080
   Hatters DM, 2003, BIOPHYS J, V85, P3979, DOI 10.1016/S0006-3495(03)74812-7
   Hatters DM, 2002, EUR BIOPHYS J BIOPHY, V31, P2, DOI 10.1007/s002490100172
   Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w
   Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792
   HOSPATTANKAR AV, 1984, J BIOL CHEM, V259, P318
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hung A, 2008, EUR BIOPHYS J BIOPHY, V38, P99, DOI 10.1007/s00249-008-0363-3
   Hung A, 2009, J PHYS CHEM B, V113, P9447, DOI 10.1021/jp901051n
   Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999
   Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103
   Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200
   KATZ BA, 1986, J BIOL CHEM, V261, P5480
   Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z
   Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897
   KINNUNEN PKJ, 1977, P NATL ACAD SCI USA, V74, P4848, DOI 10.1073/pnas.74.11.4848
   Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679
   Krzyzanek V, 2009, J STRUCT BIOL, V165, P78, DOI 10.1016/j.jsb.2008.10.006
   Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100
   Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE
   LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990
   Legge ES, 2007, BIOPHYS CHEM, V130, P102, DOI 10.1016/j.bpc.2007.08.002
   Legge FS, 2009, J PHYS CHEM B, V113, P14006, DOI 10.1021/jp903842u
   LI WH, 1988, J LIPID RES, V29, P245
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q
   Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102
   MacPhee CE, 1999, BIOCHEMISTRY-US, V38, P10878, DOI 10.1021/bi990726b
   MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l
   MacRaild CA, 2001, BIOCHEMISTRY-US, V40, P5414, DOI 10.1021/bi002821m
   Makin OS, 2007, J APPL CRYSTALLOGR, V40, P966, DOI 10.1107/S0021889807034681
   Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102
   Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101
   Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733
   Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200
   Monti M, 2002, PROTEIN SCI, V11, P2362, DOI 10.1110/ps.0206902
   Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200
   Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200
   Myers SL, 2006, RAPID COMMUN MASS SP, V20, P1628, DOI 10.1002/rcm.2482
   MYKLEBOST O, 1984, J BIOL CHEM, V259, P4401
   Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680
   Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200
   Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499
   Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044
   Pham CLL, 2002, BIOCHEMISTRY-US, V41, P14313, DOI 10.1021/bi026070v
   Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793
   Ryan TM, 2010, J MOL BIOL, V399, P731, DOI 10.1016/j.jmb.2010.04.042
   Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200
   Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695
   Serpell LC, 1999, METHOD ENZYMOL, V309, P526
   Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589
   Shivaprasad S, 2006, J BIOL CHEM, V281, P993, DOI 10.1074/jbc.M505091200
   Steinmetz MO, 2008, J MOL BIOL, V376, P898, DOI 10.1016/j.jmb.2007.11.100
   Stewart CR, 2007, J LIPID RES, V48, P2162, DOI 10.1194/jlr.M700098-JLR200
   STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4
   Todorova N, 2010, PHYS CHEM CHEM PHYS, V12, P14762, DOI 10.1039/c0cp00299b
   Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200
   Tycko R, 2003, J AM CHEM SOC, V125, P6606, DOI 10.1021/ja0342042
   Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105
   Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839
   Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196
   Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u
   Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040
   Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107
   WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003
   WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134
NR 97
TC 38
Z9 38
U1 0
U2 13
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD FEB 4
PY 2011
VL 405
IS 5
BP 1246
EP 1266
DI 10.1016/j.jmb.2010.12.006
PG 21
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 721FY
UT WOS:000287340200010
PM 21146539
DA 2021-01-25
ER

PT J
AU Hensen, U
   Meyer, T
   Haas, J
   Rex, R
   Grubmuller, H
AF Hensen, Ulf
   Meyer, Tim
   Haas, Juergen
   Rex, Rene
   Grubmueller, Helmut
TI Dynasome: How Does Protein Structure and Function Relate to Dynamics?
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 55th Annual Meeting of the Biophysical-Society
CY MAR 05-09, 2011
CL Baltimore, MD
SP Biophys Soc
C1 [Hensen, Ulf; Meyer, Tim; Rex, Rene; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Gottingen, Germany.
   [Haas, Juergen] Univ Basel, Biozentrum, Basel, Switzerland.
RI Meyer, Tim/ABC-1340-2020
NR 0
TC 0
Z9 0
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB 2
PY 2011
VL 100
IS 3
SU 1
BP 171
EP 172
PG 2
WC Biophysics
SC Biophysics
GA 972PF
UT WOS:000306288601324
DA 2021-01-25
ER

PT J
AU Boiteux, C
   Berneche, S
AF Boiteux, Celine
   Berneche, Simon
TI Inactivation and Voltage-Dependent Rectification Mechanisms in the KcsA
   Potassium Channel
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 55th Annual Meeting of the Biophysical-Society
CY MAR 05-09, 2011
CL Baltimore, MD
SP Biophys Soc
C1 [Boiteux, Celine; Berneche, Simon] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB 2
PY 2011
VL 100
IS 3
SU 1
BP 366
EP 366
PG 1
WC Biophysics
SC Biophysics
GA 972PF
UT WOS:000306288603119
DA 2021-01-25
ER

PT J
AU Brachet, C
   Birk, J
   Christophe, C
   Tenoutasse, S
   Velkeniers, B
   Heinrichs, C
   Rutishauser, J
AF Brachet, Cecile
   Birk, Julia
   Christophe, Catherine
   Tenoutasse, Sylvie
   Velkeniers, Brigitte
   Heinrichs, Claudine
   Rutishauser, Jonas
TI Growth retardation in untreated autosomal dominant familial
   neurohypophyseal diabetes insipidus caused by one recurring and two
   novel mutations in the vasopressin-neurophysin II gene
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID ARGININE-VASOPRESSIN; SIGNAL; PRECURSORS; EXPRESSION; CHILDREN
AB Objective: Autosomal dominant familial neurohypophyseal diabetes insipidus (adFNDI), a disorder caused by mutations in the vasopressin (AVP)-neurophysin II (NPII) gene, manifests gradually during early childhood with progressive polyuria and polydipsia. Patients are usually treated with synthetic AVP analog. If unlimited access to water is provided, prognosis is usually good even in the absence of specific treatment.
   In this study, we describe three families with adFNDI, in which growth failure was a prominent complaint, on the clinical and molecular level.
   Design/methods: Histories from affected and unaffected family members were taken. Height and weight of index patients were recorded longitudinally. Patients underwent water deprivation tests, magnetic resonance imaging, and genetic analysis. One mutant was studied by heterologous expression in cell culture.
   Results: A total of ten affected individuals were studied. In two of the three pedigrees, a novel mutation in the AVP-NPII gene was found. The index children in each pedigree showed growth retardation, which was the reason for referral in two. In these cases, water intake was tightly restricted by the parents in an attempt to overcome suspected psychogenic polydipsia and to improve appetite. Once the children were treated by hormone replacement, they rapidly caught up to normal weight and height.
   Conclusions: Genetic testing and appropriate parent counseling should be enforced in adFNDI families to ensure adequate treatment and avoid chronic water deprivation, which causes failure to thrive. European Journal of Endocrinology 164 179-187
C1 [Birk, Julia; Rutishauser, Jonas] Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
   [Brachet, Cecile; Christophe, Catherine; Tenoutasse, Sylvie; Heinrichs, Claudine] Hop Univ Enfants Reine Fabiola ULB, B-1020 Brussels, Belgium.
   [Velkeniers, Brigitte] Univ Ziekenhuis Brussel, B-1020 Brussels, Belgium.
RP Rutishauser, J (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM j.rutishauser@unibas.ch
RI Brachet, Cecile/AAL-2105-2020
OI Brachet, Cecile/0000-0001-7955-2534
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-113319]
FX This work was supported by grant 31003A-113319 from the Swiss National
   Science Foundation to J Rutishauser.
CR Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965
   Birk J, 2009, J CELL SCI, V122, P3994, DOI 10.1242/jcs.051136
   BROOKS BS, 1989, AM J NEURORADIOL, V10, P943
   Christensen JH, 2006, SEMIN NEPHROL, V26, P209, DOI 10.1016/j.semnephrol.2006.03.003
   Christensen JH, 2004, J CLIN ENDOCR METAB, V89, P4521, DOI 10.1210/jc.2003-031813
   de Melo ME, 2008, ARQ BRAS ENDOCRINOL, V52, P1272, DOI 10.1590/S0004-27302008000800011
   Elias LLK, 1997, J CLIN ENDOCR METAB, V82, P1243, DOI 10.1210/jc.82.4.1243
   Elias PCL, 2003, CLIN ENDOCRINOL, V59, P511, DOI 10.1046/j.1365-2265.2003.01834.x
   Friberg MA, 2004, J BIOL CHEM, V279, P19441, DOI 10.1074/jbc.M310249200
   Grant FD, 1998, J CLIN ENDOCR METAB, V83, P3958, DOI 10.1210/jc.83.11.3958
   HILLMAN DA, 1958, PEDIATRICS, V21, P430
   ITO M, 1991, J CLIN INVEST, V87, P725, DOI 10.1172/JCI115052
   Ito M, 1997, J CLIN INVEST, V99, P1897, DOI 10.1172/JCI119357
   Maghnie M, 2000, NEW ENGL J MED, V343, P998, DOI 10.1056/NEJM200010053431403
   Mahoney CP, 2002, J CLIN ENDOCR METAB, V87, P870, DOI 10.1210/jc.87.2.870
   MCLEOD JF, 1993, J CLIN ENDOCR METAB, V77, pA599, DOI 10.1210/jcem.77.3.8370682
   Miyakoshi M, 2004, ENDOCR J, V51, P551, DOI 10.1507/endocrj.51.551
   Nijenhuis M, 1999, J BIOL CHEM, V274, P21200, DOI 10.1074/jbc.274.30.21200
   Nijenhuis M, 2001, J CLIN ENDOCR METAB, V86, P3410, DOI 10.1210/jc.86.7.3410
   Nijenhuis M, 2000, MOL CELL ENDOCRINOL, V167, P55, DOI 10.1016/S0303-7207(00)00288-4
   Olias G, 1996, DNA CELL BIOL, V15, P929, DOI 10.1089/dna.1996.15.929
   Russell TA, 2003, J CLIN INVEST, V112, P1697, DOI 10.1172/JCI200318616
   Rutishauser J, 1996, J CLIN ENDOCR METAB, V81, P192, DOI 10.1210/jc.81.1.192
   Rutishauser J, 2002, EUR J ENDOCRINOL, V146, P649, DOI 10.1530/eje.0.1460649
   SAUSVILLE E, 1985, J BIOL CHEM, V260, P236
   Siggaard C, 2005, CLIN ENDOCRINOL, V63, P207, DOI 10.1111/j.1365-2265.2005.02327.x
   Siggaard C, 1999, J CLIN ENDOCR METAB, V84, P2933, DOI 10.1210/jc.84.8.2933
   van Lieburg AF, 1999, J AM SOC NEPHROL, V10, P1958
   YUASA H, 1993, J CLIN ENDOCR METAB, V77, P600, DOI 10.1210/jc.77.3.600
NR 29
TC 14
Z9 15
U1 0
U2 5
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD FEB
PY 2011
VL 164
IS 2
BP 179
EP 187
DI 10.1530/EJE-10-0823
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 707UY
UT WOS:000286315500004
PM 21088058
OA Bronze
DA 2021-01-25
ER

PT J
AU Benkert, P
   Biasini, M
   Schwede, T
AF Benkert, Pascal
   Biasini, Marco
   Schwede, Torsten
TI Toward the estimation of the absolute quality of individual protein
   structure models
SO BIOINFORMATICS
LA English
DT Article
ID STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; SWISS-MODEL; 3-DIMENSIONAL
   STRUCTURES; THERMOTOGA-MARITIMA; SECONDARY STRUCTURE; SERVER; SEQUENCE;
   RECOGNITION; GENOMICS
AB Motivation: Quality assessment of protein structures is an important part of experimental structure validation and plays a crucial role in protein structure prediction, where the predicted models may contain substantial errors. Most current scoring functions are primarily designed to rank alternative models of the same sequence supporting model selection, whereas the prediction of the absolute quality of an individual protein model has received little attention in the field. However, reliable absolute quality estimates are crucial to assess the suitability of a model for specific biomedical applications.
   Results: In this work, we present a new absolute measure for the quality of protein models, which provides an estimate of the 'degree of nativeness' of the structural features observed in a model and describes the likelihood that a given model is of comparable quality to experimental structures. Model quality estimates based on the QMEAN scoring function were normalized with respect to the number of interactions. The resulting scoring function is independent of the size of the protein and may therefore be used to assess both monomers and entire oligomeric assemblies. Model quality scores for individual models are then expressed as 'Z-scores' in comparison to scores obtained for high-resolution crystal structures. We demonstrate the ability of the newly introduced QMEAN Z-score to detect experimentally solved protein structures containing significant errors, as well as to evaluate theoretical protein models.
   In a comprehensive QMEAN Z-score analysis of all experimental structures in the PDB, membrane proteins accumulate on one side of the score spectrum and thermostable proteins on the other. Proteins from the thermophilic organism Thermatoga maritima received significantly higher QMEAN Z-scores in a pairwise comparison with their homologous mesophilic counterparts, underlining the significance of the QMEAN Z-score as an estimate of protein stability.
C1 [Benkert, Pascal; Biasini, Marco; Schwede, Torsten] Univ Basel, Biozentrum, Basel, Switzerland.
   [Benkert, Pascal; Biasini, Marco; Schwede, Torsten] SIB Swiss Inst Bioinformat, Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008; Benkert, Pascal/C-3895-2009; Syed,
   Khajamohiddin/L-8774-2013
OI Schwede, Torsten/0000-0003-2715-335X; Syed,
   Khajamohiddin/0000-0002-1497-3570
FU SIB Swiss Institute of Bioinformatics; Biozentrum der Universitat Basel,
   Switzerland
FX The development of QMEAN Z-score has been supported by the SIB Swiss
   Institute of Bioinformatics; Biozentrum der Universitat Basel,
   Switzerland.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   [Anonymous], 2009, J BIOL CHEM, V284, P34468
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322
   Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Biasini M, 2010, BIOINFORMATICS, V26, P2626, DOI 10.1093/bioinformatics/btq481
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   Cozzetto D, 2009, PROTEINS, V77, P157, DOI 10.1002/prot.22534
   Dunbrack RL, 2006, CURR OPIN STRUC BIOL, V16, P374, DOI 10.1016/j.sbi.2006.05.006
   EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9
   Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108
   JANES RW, 1994, NAT STRUCT BIOL, V1, P311, DOI 10.1038/nsb0594-311
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200
   Lee SH, 2007, P NATL ACAD SCI USA, V104, P16122, DOI 10.1073/pnas.0705794104
   Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291
   McGuffin LJ, 2008, BIOINFORMATICS, V24, P586, DOI 10.1093/bioinformatics/btn014
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767
   Murthy HMK, 1999, J BIOL CHEM, V274, P5573, DOI 10.1074/jbc.274.9.5573
   Pettitt CS, 2005, BIOINFORMATICS, V21, P3509, DOI 10.1093/bioinformatics/bti540
   Randall A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-52
   Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065
   Robinson-Rechavi M, 2005, STRUCTURE, V13, P857, DOI 10.1016/j.str.2005.03.011
   Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85
   Rykunov D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-128
   Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014
   Siebold C, 2004, P NATL ACAD SCI USA, V101, P1999, DOI 10.1073/pnas.0308458100
   SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   Thomas A, 2010, BBA-PROTEINS PROTEOM, V1804, P1265, DOI 10.1016/j.bbapap.2010.02.008
   Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316
   Tramontano A, 2003, BIOTECHNOL BIOENG, V84, P756, DOI 10.1002/bit.10850
   Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803
   Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224
   Wang Z, 2009, PROTEINS, V75, P638, DOI 10.1002/prot.22275
   WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X
   White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002
NR 55
TC 1003
Z9 1075
U1 7
U2 93
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
J9 BIOINFORMATICS
JI Bioinformatics
PD FEB 1
PY 2011
VL 27
IS 3
BP 343
EP 350
DI 10.1093/bioinformatics/btq662
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 716RN
UT WOS:000286991300007
PM 21134891
OA Bronze, Green Published
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Truttmann, MC
   Rhomberg, TA
   Dehio, C
AF Truttmann, Matthias C.
   Rhomberg, Thomas A.
   Dehio, Christoph
TI Combined action of the type IV secretion effector proteins BepC and BepF
   promotes invasome formation of Bartonella henselae on endothelial and
   epithelial cells
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID LIM-KINASE; INFECTION; SYSTEMS; INVASION; COFILIN; DISEASE
AB P>Bartonella henselae (Bhe) can invade human endothelial cells (ECs) by two distinguishable entry routes: either individually by endocytosis or as large bacterial aggregates by invasome-mediated internalization. Only the latter process is dependent on a functional VirB/VirD4 type IV secretion system (T4SS) and the thereby translocated Bep effector proteins. Here, we introduce HeLa cells as a new cell system suitable to study invasome formation. We describe a novel route to trigger invasome formation by the combined action of the effectors BepC and BepF. Co-infections of either HUVEC or HeLa cells with the Bep-deficient Delta bepA-G mutant expressing either BepC or BepF restores invasome formation. Likewise, ectopic expression of a combination of BepC and BepF in HeLa cells enables invasome-mediated uptake of the Bhe Delta bepA-G mutant strain. Further, eGFP-BepC and eGFP-BepF fusion proteins localize to the cell membrane and, upon invasome formation, to the invasome. Furthermore, the combined action of BepC and BepF inhibits endocytic uptake of inert microspheres. Finally, we show that BepC and BepF-triggered invasome formation differs from BepG-triggered invasome formation in its requirement for cofilin1, while the Rac1/Scar1/WAVE/Arp2/3 and Cdc42/WASP/Arp2/3 signalling pathways are required in both cases.
C1 [Truttmann, Matthias C.; Rhomberg, Thomas A.; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; truttmann, matthias/0000-0002-0536-7923
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-109925]; Howard Hughes Medical InstituteHoward Hughes
   Medical Institute [55005501]; SystemsX.ch, the Swiss Initiative for
   Systems Biology [51RT-0-126008 (InfectX)]
FX We would like to thank Dr A. Pulliainen for critical reading of the
   manuscript and Y. Ellner as well as C. Mistl for technical assistance.
   We are grateful to M. Duggelin and M. Durrenberger for their excellent
   SEM service. The University Women's Hospital Basel is acknowledged for
   providing human umbilical cords. This work was supported by grant
   31003A-109925 from the Swiss National Science Foundation, grant 55005501
   from the Howard Hughes Medical Institute and grant 51RT-0-126008
   (InfectX) from SystemsX.ch, the Swiss Initiative for Systems Biology.
CR Arber S, 1998, NATURE, V393, P805
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037
   Boyd JM, 2008, J BACTERIOL, V190, P4596, DOI 10.1128/JB.00262-08
   BROWN SS, 1979, J CELL BIOL, V83, P657, DOI 10.1083/jcb.83.3.657
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897
   GEY GO, 1952, CANCER RES, V12, P264
   Goodwin EC, 2009, J VIROL, V83, P5630, DOI 10.1128/JVI.00203-09
   GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59
   JONES GW, 1981, J GEN MICROBIOL, V127, P351
   Kaiser PO, 2008, CELL MICROBIOL, V10, P2223, DOI 10.1111/j.1462-5822.2008.01201.x
   Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818
   Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x
   Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001
   Mirold S, 2001, J BACTERIOL, V183, P2348, DOI 10.1128/JB.183.7.2348-2358.2001
   Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schroder G, 2005, TRENDS MICROBIOL, V13, P336, DOI 10.1016/j.tim.2005.05.008
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6
   Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004
   Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282
   Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001
   Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7
NR 36
TC 29
Z9 31
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD FEB
PY 2011
VL 13
IS 2
BP 284
EP 299
DI 10.1111/j.1462-5822.2010.01535.x
PG 16
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 706GN
UT WOS:000286206100010
PM 20964799
OA Bronze
DA 2021-01-25
ER

PT J
AU Arber, S
   Davis, G
AF Arber, Silvia
   Davis, Graeme
TI Developmental neuroscience
SO CURRENT OPINION IN NEUROBIOLOGY
LA English
DT Editorial Material
C1 [Arber, Silvia] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Arber, Silvia] Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   [Davis, Graeme] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94941 USA.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch; Graeme.davis@ucsf.edu
OI Arber, Silvia/0000-0002-6261-250X
FU NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01 NS059867-04, R01 NS059867, R01 NS047342,
   R01 NS047342-08] Funding Source: Medline; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [R01NS047342,
   R01NS059867, R01NS059867, R01NS047342, R01NS047342, R01NS059867,
   R01NS047342, R01NS047342, R01NS059867, R01NS047342, R01NS059867,
   R01NS047342, R01NS047342, R01NS059867, R01NS059867, R01NS047342,
   R01NS047342, R01NS059867] Funding Source: NIH RePORTER
NR 0
TC 1
Z9 1
U1 0
U2 1
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-4388
J9 CURR OPIN NEUROBIOL
JI Curr. Opin. Neurobiol.
PD FEB
PY 2011
VL 21
IS 1
BP 1
EP 4
DI 10.1016/j.conb.2010.12.001
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA 741PN
UT WOS:000288876100001
PM 21208796
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Stetak, A
   Hajnal, A
AF Stetak, Attila
   Hajnal, Alex
TI The C. elegans MAGI-1 protein is a novel component of cell junctions
   that is required for junctional compartmentalization
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Adhesion; C. elegans; Junction; Epithelia; Cadherin
ID CAENORHABDITIS-ELEGANS; GUANYLATE KINASE; EPITHELIAL-CELLS;
   MORPHOGENESIS; ADHESION; CATENIN; EMBRYO; MAINTENANCE; EXPRESSION;
   MOLECULE
AB Cell junctions are essential to maintain polarity and tissue integrity. Epithelial cell junctions are composed of distinct sub-compartments that together ensure the strong adhesion between neighboring cells. In Caenorhabditis elegans epithelia, the apical junction (CeAJ) forms a single electron-dense structure, but at the molecular level it is composed of two sub-compartments that function redundantly and localize independently as two distinct but adjacent circumferential rings on the lateral plasma membrane. While investigating the role of the multi PDZ-domain containing protein MAGI-1 during C elegans epidermal morphogenesis, we found that MAGI-1 localizes apical to both the Cadherin/Catenin (CCC) and AJM-1/DLG-1 (DAC) containing sub-domains. Removal of MAGI-1 function causes a loss of junctional compartmentalization along the lateral membrane and reduces the overall robustness of cell-cell adhesion mediated by either type of cell junctions. Our results suggest that MAGI-1 functions as an "organizer" that ensures the correct segregation of different cell adhesion complexes into distinct domains along the lateral plasma membrane. Thus, the formation of stable junctions requires the proper distribution of the CCC and DAC adhesion protein complexes along the lateral plasma membrane. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Stetak, Attila] Univ Basel, Inst Mol Psychol, CH-4056 Basel, Switzerland.
   [Stetak, Attila] Univ Basel, Life Sci Training Facil, Biozentrum, CH-4056 Basel, Switzerland.
   [Hajnal, Alex] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
RP Stetak, A (corresponding author), Univ Basel, Inst Mol Psychol, Klingelbergstr 60-70, CH-4056 Basel, Switzerland.
EM a.stetak@unibas.ch
OI Hajnal, Alex/0000-0002-4098-3721
FU SNF
FX We wish to thank Jeff Hardin for providing the hmp-1::gfp, dlg-1::dsred
   strain prior to publication, to Christopher Rongo for the MAGI-1
   antibody, and the CGC for providing strains. We are also grateful to
   Ursula Sauder for her help in electron microscopy. This work was
   supported by grant from the SNF to A.H.
CR Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029
   BRENNER S, 1974, GENETICS, V77, P71
   Chastre E, 2009, FASEB J, V23, P916, DOI 10.1096/fj.08-106344
   Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297
   Cox EA, 2004, J CELL SCI, V117, P1867, DOI 10.1242/jcs.01177
   Cox EA, 2004, J CELL SCI, V117, P1885, DOI 10.1242/jcs.01176
   Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074
   Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589
   Dobrosotskaya IY, 2001, BIOCHEM BIOPH RES CO, V283, P969, DOI 10.1006/bbrc.2001.4880
   Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471
   Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613
   Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161
   Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003
   Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01
   Hoier EF, 2000, GENE DEV, V14, P874
   Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153
   Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278
   Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161
   Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983
   Labouesse M, 1997, DEV DYNAM, V210, P19, DOI 10.1002/(SICI)1097-0177(199709)210:1<19::AID-AJA3>3.0.CO;2-4
   Legouis R, 2000, NAT CELL BIOL, V2, P415
   Lockwood C, 2008, CURR BIOL, V18, P1333, DOI 10.1016/j.cub.2008.07.086
   Lynch AM, 2009, FRONT BIOSCI-LANDMRK, V14, P1414, DOI 10.2741/3316
   McMahon L, 2001, J CELL SCI, V114, P2265
   MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x
   Michaux G, 2001, GENE, V277, P83, DOI 10.1016/S0378-1119(01)00700-4
   Muller HAJ, 2003, MECH DEVELOP, V120, P1231, DOI 10.1016/j.mod.2003.06.001
   Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136
   Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9
   Simske JS, 2003, NAT CELL BIOL, V5, P619, DOI 10.1038/ncb1002
   Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019
NR 31
TC 12
Z9 13
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD FEB 1
PY 2011
VL 350
IS 1
BP 24
EP 31
DI 10.1016/j.ydbio.2010.10.026
PG 8
WC Developmental Biology
SC Developmental Biology
GA 710WL
UT WOS:000286547600003
PM 21034729
DA 2021-01-25
ER

PT J
AU Xia, Y
   Cortez-Retamozo, V
   Niederkofler, V
   Salie, R
   Chen, SZ
   Samad, TA
   Hong, CC
   Arber, S
   Vyas, JM
   Weissleder, R
   Pittet, MJ
   Lin, HY
AF Xia, Yin
   Cortez-Retamozo, Virna
   Niederkofler, Vera
   Salie, Rishard
   Chen, Shanzhuo
   Samad, Tarek A.
   Hong, Charles C.
   Arber, Silvia
   Vyas, Jatin M.
   Weissleder, Ralph
   Pittet, Mikael J.
   Lin, Herbert Y.
TI Dragon (Repulsive Guidance Molecule b) Inhibits IL-6 Expression in
   Macrophages
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID MORPHOGENETIC PROTEIN CORECEPTOR; REGULATES HEPCIDIN EXPRESSION; GROWTH
   IMPAIRMENT; MESSENGER-RNA; SMOOTH-MUSCLE; BONE; CELLS; RECEPTORS;
   PATHWAY; DISEASE
AB Repulsive guidance molecule (RGM) family members RGMa, RGMb/Dragon, and RGMc/hemojuvelin were found recently to act as bone morphogenetic protein (BMP) coreceptors that enhance BMP signaling activity. Although our previous studies have shown that hemojuvelin regulates hepcidin expression and iron metabolism through the BMP pathway, the role of the BMP signaling mediated by Dragon remains largely unknown. We have shown previously that Dragon is expressed in neural cells, germ cells, and renal epithelial cells. In this study, we demonstrate that Dragon is highly expressed in macrophages. Studies with RAW264.7 and J774 macrophage cell lines reveal that Dragon negatively regulates IL-6 expression in a BMP ligand-dependent manner via the p38 MAPK and Erk1/2 pathways but not the Smad1/5/8 pathway. We also generated Dragon knockout mice and found that IL-6 is upregulated in macrophages and dendritic cells derived from whole lung tissue of these mice compared with that in respective cells derived from wild-type littermates. These results indicate that Dragon is an important negative regulator of IL-6 expression in immune cells and that Dragon-deficient mice may be a useful model for studying immune and inflammatory disorders. The Journal of Immunology, 2011, 186: 1369-1376.
C1 [Xia, Yin; Cortez-Retamozo, Virna; Chen, Shanzhuo; Weissleder, Ralph; Pittet, Mikael J.; Lin, Herbert Y.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA.
   [Xia, Yin; Chen, Shanzhuo; Lin, Herbert Y.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Membrane Biol, Boston, MA 02114 USA.
   [Xia, Yin; Chen, Shanzhuo; Lin, Herbert Y.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Nephrol,Dept Med, Boston, MA 02114 USA.
   [Niederkofler, Vera; Salie, Rishard; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
   [Niederkofler, Vera; Salie, Rishard; Arber, Silvia] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
   [Samad, Tarek A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neural Plast Res Unit,Dept Anesthesia, Boston, MA 02114 USA.
   [Hong, Charles C.] Vet Affairs Tennessee Valley Healthcare Syst, Res Med, Nashville, TN 37212 USA.
   [Hong, Charles C.] Vanderbilt Univ, Div Cardiovasc Med, Sch Med, Nashville, TN 37232 USA.
   [Vyas, Jatin M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis,Dept Med, Boston, MA 02114 USA.
   [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.
RP Xia, Y (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, CPZN 8150,185 Cambridge St, Boston, MA 02114 USA.
EM Xia.Yin@mgh.harvard.edu; Lin.Herbert@mgh.harvard.edu
RI Xia, Yin/M-5440-2018; Vyas, Jatin/Q-1627-2016
OI Xia, Yin/0000-0003-0315-7532; Vyas, Jatin/0000-0002-9985-9565; Arber,
   Silvia/0000-0002-6261-250X; /0000-0003-0828-4143
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 DK-071837, R01
   DK-069533, R03 HD60641, K01 DK084081, U01 HL080731, P50 CA86355, U54
   CA126515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH
   &HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [R03HD060641, R03HD060641] Funding Source: NIH RePORTER; NATIONAL CANCER
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, U54CA126515, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, U54CA126515,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, U54CA126515,
   P50CA086355, P50CA086355, P50CA086355, U54CA126515, P50CA086355,
   P50CA086355, P50CA086355, U54CA126515, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, U54CA126515, P50CA086355, P50CA086355, P50CA086355,
   U54CA126515, P50CA086355, P50CA086355, P50CA086355, U54CA126515,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, U54CA126515, P50CA086355, U54CA126515, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   U54CA126515, P50CA086355, P50CA086355, P50CA086355, U54CA126515,
   U54CA126515, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, U54CA126515, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   U54CA126515, P50CA086355, U54CA126515, P50CA086355, P50CA086355,
   P50CA086355, U54CA126515, U54CA126515, U54CA126515, U54CA126515,
   P50CA086355, U54CA126515, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   U54CA126515, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355, P50CA086355, P50CA086355, P50CA086355,
   P50CA086355, P50CA086355] Funding Source: NIH RePORTER; NATIONAL HEART,
   LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R01HL104040, U01HL080731, R01HL104040,
   U01HL080731, U01HL080731, R01HL104040, R01HL104040, U01HL080731,
   R01HL104040, U01HL080731, R01HL104040] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI092084, R01AI084880, R01AI084880, R01AI084880, R01AI092084,
   R01AI084880, R01AI084880, R01AI092084, R01AI092084, R01AI092084,
   R01AI084880, R01AI084880, R01AI084880, R01AI084880, R01AI084880,
   R01AI084880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R01DK071837, P30DK043351, R01DK071837, R01DK069533, P30DK043351,
   R01DK069533, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, R01DK069533, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, R01DK071837,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   K01DK084081, P30DK043351, P30DK043351, R01DK071837, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, R01DK069533, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, R01DK071837, P30DK043351,
   R01DK069533, P30DK043351, P30DK043351, P30DK043351, R01DK069533,
   P30DK043351, P30DK043351, R01DK069533, P30DK043351, P30DK043351,
   R01DK071837, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, R01DK071837, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, R01DK069533, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, R01DK071837, P30DK043351, P30DK043351,
   R01DK071837, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, R01DK069533,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351, P30DK043351,
   P30DK043351, P30DK043351, P30DK043351, P30DK043351] Funding Source: NIH
   RePORTER
FX This work was supported by National Institutes of Health Grants R01
   DK-071837 and R01 DK-069533 (to H.Y.L.), R03 HD60641 and K01 DK084081
   (to Y.X.), and U01 HL080731, P50 CA86355, and U54 CA126515 (to V.C.R.,
   M.J.P., and R.W.).
CR Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335
   Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777
   Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200
   Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052
   Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x
   Hagen M, 2007, AM J PHYSIOL-LUNG C, V292, pL1473, DOI 10.1152/ajplung.00197.2006
   Heinke J, 2007, CARDIOVASC RES, V76, P390, DOI 10.1016/j.cardiores.2007.08.003
   Hong JH, 2009, IMMUNOLOGY, V128, pe442, DOI 10.1111/j.1365-2567.2008.02998.x
   Hori M, 2006, CONNECT TISSUE RES, V47, P124, DOI 10.1080/03008200600685350
   Kwon SJ, 2009, IMMUNOLOGY, V128, pe758, DOI 10.1111/j.1365-2567.2009.03079.x
   LaPensee CR, 2008, ENDOCRINOLOGY, V149, P5415, DOI 10.1210/en.2008-0549
   Lee MJ, 2003, J IMMUNOL, V170, P2557, DOI 10.4049/jimmunol.170.5.2557
   Lieskovska J, 2003, GROWTH HORM IGF RES, V13, P26, DOI 10.1016/S1096-6374(02)00135-1
   Lieskovska J, 2002, GROWTH HORM IGF RES, V12, P388, DOI 10.1016/S1096-6374(02)00079-5
   Maric I, 2003, J CELL PHYSIOL, V196, P258, DOI 10.1002/jcp.10275
   Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004
   Nojima J, 2010, J BIOL CHEM, V285, P15577, DOI 10.1074/jbc.M109.028019
   Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200
   Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0
   Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007
   Takahashi M, 2008, J ENDOCRINOL, V199, P445, DOI 10.1677/JOE-08-0226
   Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107
   Wang P, 2002, WORLD J GASTROENTERO, V8, P531, DOI 10.3748/wjg.v8.i3.531
   Xia Y, 2005, ENDOCRINOLOGY, V146, P3614, DOI 10.1210/en.2004-1676
   Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567
   Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200
   Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511
   Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549
   Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179
   Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200
NR 32
TC 36
Z9 38
U1 0
U2 6
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD FEB 1
PY 2011
VL 186
IS 3
BP 1369
EP 1376
DI 10.4049/jimmunol.1002047
PG 8
WC Immunology
SC Immunology
GA 708RE
UT WOS:000286381200014
PM 21187450
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Vogt, KE
   Gerharz, S
   Graham, J
   Canepari, M
AF Vogt, Kaspar E.
   Gerharz, Stephan
   Graham, Jeremy
   Canepari, Marco
TI High-resolution simultaneous voltage and Ca2+imaging
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
ID CALCIUM; TRANSIENTS; DENDRITES; CORTEX
AB Combining voltage and Ca2+ imaging allows the correlation of electrical and chemical activity at sub-cellular level. Here we describe a novel apparatus designed to obtain simultaneous voltage and Ca2+ measurements with single-trial resolution from sites as small as a few microns. These measurements can be obtained with negligible optical cross-talk between the two signals and negligible photo-damage of the preparation. The capability of the technique was assessed recording either from individual neurons in brain slices or from networks of cultured neurons. The present achievements open the gate to many novel physiological investigations requiring simultaneous measurement of voltage and Ca2+ signals.
C1 [Vogt, Kaspar E.; Gerharz, Stephan] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, CH-4003 Basel, Switzerland.
   [Graham, Jeremy] CAIRN Res Ltd, Faversham, England.
   [Canepari, Marco] INSERM, Team 3, U836, F-38042 Grenoble 09, France.
   [Canepari, Marco] Univ Grenoble 1, Inst Neurosci, F-38042 Grenoble 09, France.
RP Canepari, M (corresponding author), Grenoble Inst Neurosci, INSERM, U836, Batiment Edmond Safra,Chemin Fortune Ferrini,Site, F-38042 Grenoble 9, France.
EM marco.canepari@ujf-grenoble.fr
RI Canepari, Marco/H-6772-2012
OI Canepari, Marco/0000-0001-9759-2388; Vogt, Kaspar/0000-0002-0859-876X
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [3100A0_122000]
FX We thank Dr Alexander Kriz for preparing the cultures. We thank Dr Dejan
   Zecevic for helping us in setting up laser illumination at the early
   stage of the project and for comments on the manuscript. This work was
   supported by the Swiss National Science Foundation (SNSF) grant
   3100A0_122000 (M.C.).
CR Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006
   Bullen A, 1998, PFLUG ARCH EUR J PHY, V436, P788, DOI 10.1007/s004240050703
   Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005
   Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024
   Canepari M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004011
   Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y
   Holthoff H, 2010, J PHYSL, V588, P1085
   Milojkovic BA, 2007, J PHYSIOL-LONDON, V585, P447, DOI 10.1113/jphysiol.2007.142315
   Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008
   Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0
   SINHA SR, 1995, J NEUROSCI METH, V60, P49, DOI 10.1016/0165-0270(94)00219-7
NR 11
TC 25
Z9 25
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD FEB 1
PY 2011
VL 589
IS 3
BP 489
EP 494
DI 10.1113/jphysiol.2010.200220
PG 6
WC Neurosciences; Physiology
SC Neurosciences & Neurology; Physiology
GA 713NG
UT WOS:000286744100009
PM 21115640
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Coudray, N
   Hermann, G
   Caujolle-Bert, D
   Karathanou, A
   Erne-Brand, F
   Buessler, JL
   Daum, P
   Plitzko, JM
   Chami, M
   Mueller, U
   Kihl, H
   Urban, JP
   Engel, A
   Remigy, HW
AF Coudray, Nicolas
   Hermann, Gilles
   Caujolle-Bert, Daniel
   Karathanou, Argyro
   Erne-Brand, Francoise
   Buessler, Jean-Luc
   Daum, Pamela
   Plitzko, Juergen M.
   Chami, Mohamed
   Mueller, Urs
   Kihl, Hubert
   Urban, Jean-Philippe
   Engel, Andreas
   Remigy, Herve-W.
TI Automated screening of 2D crystallization trials using transmission
   electron microscopy: A high-throughput tool-chain for sample preparation
   and microscopic analysis
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Automation; 2D crystallization; Electron crystallography; Grid
   preparation; High throughput; Image processing; Membrane protein;
   Negative staining
ID MEMBRANE-PROTEINS; 2-DIMENSIONAL CRYSTALLIZATION; HEME UPTAKE;
   BIO-BEADS; CRYSTALS; SYSTEM; ACQUISITION; CRYSTALLOGRAPHY; RESOLUTION;
   STRATEGY
AB We have built and extensively tested a tool-chain to prepare and screen two-dimensional crystals of membrane proteins by transmission electron microscopy (TEM) at room temperature. This automated process is an extension of a new procedure described recently that allows membrane protein 2D crystallization in parallel (Iacovache et al., 2010). The system includes a gantry robot that transfers and prepares the crystalline solutions on grids suitable for TEM analysis and an entirely automated microscope that can analyze 96 grids at once without human interference. The operation of the system at the user level is solely controlled within the MATLAB environment: the commands to perform sample handling (loading/unloading in the microscope), microscope steering (magnification, focus, image acquisition, etc.) as well as automatic crystal detection have been implemented. Different types of thin samples can efficiently be screened provided that the particular detection algorithm is adapted to the specific task. Hence, operating time can be shared between multiple users. This is a major step towards the integration of transmission electron microscopy into a high throughput work-flow. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Caujolle-Bert, Daniel; Erne-Brand, Francoise; Chami, Mohamed; Mueller, Urs; Engel, Andreas; Remigy, Herve-W.] Univ Basel, C CINA, ME Mueller Inst Struct Biol, Biozentrum, CH-4003 Basel, Switzerland.
   [Coudray, Nicolas; Hermann, Gilles; Karathanou, Argyro; Buessler, Jean-Luc; Daum, Pamela; Kihl, Hubert; Urban, Jean-Philippe] Univ Haute Alsace, MIPS Lab, F-68093 Mulhouse, France.
   [Plitzko, Juergen M.] Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Remigy, Herve-W.] FEI Elect Opt BV, Eindhoven, Netherlands.
RP Remigy, HW (corresponding author), Univ Basel, C CINA, ME Mueller Inst Struct Biol, Biozentrum, CH-4003 Basel, Switzerland.
EM hrernigy@fei.com
RI Coudray, Nicolas/O-5935-2015; Plitzko, Juergen M/H-9576-2014
OI Coudray, Nicolas/0000-0002-6050-2219; Plitzko, Juergen
   M/0000-0002-6402-8315
FU European UnionEuropean Union (EU) [LSHG-CT-2005-018811]; University of
   Basel; Maurice E. Muller Foundation of Switzerland
FX We are grateful to Jeroen van der Water, Roland Jonkers, Robert Wyss,
   Robert Haering and Raymond Strittmater for the Autoloader and the
   Carousel design, building and implementation, and Bart van der Schoot
   and Marcos Sancho for their technical support for the pipettors. Laurent
   Naris, Yoan Meret, Ibrahim Mansour and Sebastien Lehmann are
   acknowledged for their support during software development. We are
   grateful to Frederic Huche and Philippe Delepelaire (Institut Pasteur,
   Paris) for providing HasA-HasR-heme complex and Kitaru Suda for OmpF
   purification. This work was supported by the HT3DEM project granted by
   European Union (Project No. LSHG-CT-2005-018811; http://ht3dem.org), the
   University of Basel and the Maurice E. Muller Foundation of Switzerland.
CR AEBI U, 1987, J ELECTRON MICR TECH, V7, P29, DOI 10.1002/jemt.1060070104
   Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366
   Benevides-Matos N, 2010, MICROBIOL-SGM, V156, P1749, DOI 10.1099/mic.0.034405-0
   Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314
   Cheng A, 2007, J STRUCT BIOL, V160, P324, DOI 10.1016/j.jsb.2007.09.012
   Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107
   COUDRAY N, 2007, 15 EUROPEAN SIGNAL P, P120
   DUBOCHET J, 1981, J MICROSC-OXFORD, V124, pRP3
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   Fellmann D, 2002, J STRUCT BIOL, V137, P273, DOI 10.1016/S1047-8477(02)00002-3
   Fujiyoshi Y, 2008, CURR OPIN STRUC BIOL, V18, P587, DOI 10.1016/j.sbi.2008.07.005
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   HARRIS JR, 1997, NEGATIVE STAINING CR
   Hasler L, 1998, J STRUCT BIOL, V121, P162, DOI 10.1006/jsbi.1998.3960
   Hayat MA, 1990, NEGATIVE STAINING
   Hite RK, 2007, CURR OPIN STRUC BIOL, V17, P389, DOI 10.1016/j.sbi.2007.06.006
   Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056
   HOLZENBURG A, 1989, BIOCHEMISTRY-US, V28, P4187, DOI 10.1021/bi00436a010
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Karathanou A, 2010, ADV EXP MED BIOL, V680, P327, DOI 10.1007/978-1-4419-5913-3_37
   Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193
   Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106
   LACOVACHE I, 2010, J STRUCT BIOL, V169, P370
   Lefman J, 2007, J STRUCT BIOL, V158, P318, DOI 10.1016/j.jsb.2006.11.007
   Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004
   Morgenstern R, 2005, METHOD ENZYMOL, V401, P136, DOI 10.1016/S0076-6879(05)01008-6
   Nakazato K, 1998, J APPL CRYSTALLOGR, V31, P644, DOI 10.1107/S0021889898002507
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   Potter CS, 2004, J STRUCT BIOL, V146, P431, DOI 10.1016/j.jsb.2004.02.002
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   Rigaud JL, 2000, BBA-BIOMEMBRANES, V1508, P112, DOI 10.1016/S0005-2736(00)00307-2
   Ringler P, 2000, PRACT APPROACH SER, P229
   ROSENBUSCH JP, 1990, EXPERIENTIA, V46, P167
   Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011
   Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010
   Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049
   Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031
   Vink M, 2007, J STRUCT BIOL, V160, P295, DOI 10.1016/j.jsb.2007.09.003
NR 42
TC 25
Z9 25
U1 0
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD FEB
PY 2011
VL 173
IS 2
BP 365
EP 374
DI 10.1016/j.jsb.2010.09.019
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 714YD
UT WOS:000286846700019
PM 20868753
DA 2021-01-25
ER

PT J
AU Bischoff, V
   Nikoletopoulou, V
   Barde, YA
AF Bischoff, Vincent
   Nikoletopoulou, Vassiliki
   Barde, Yves-Alain
TI Save or kill: the ambivalence of neurotrophin receptors
SO M S-MEDECINE SCIENCES
LA French
DT News Item
ID DEPENDENCE RECEPTOR; PARADIGM; BRAIN; DEATH
C1 [Bischoff, Vincent; Nikoletopoulou, Vassiliki; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bischoff, V (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM vincent.bischoff@unibas.ch
OI Nikoletopoulou, Vassiliki/0000-0003-3646-992X; Barde,
   Yves/0000-0002-7627-461X
CR BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13
   JOHNSON J, 1994, CURR BIOL, V4, P662, DOI 10.1016/S0960-9822(00)00149-4
   LEVIMONTALCINI R, 1954, CANCER RES, V14, P49
   Mehlen P, 2003, M S-MED SCI, V19, P1062, DOI 10.1051/medsci/200319111062
   Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X
   Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336
   Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010
   Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104
NR 11
TC 1
Z9 1
U1 0
U2 0
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 0767-0974
J9 M S-MED SCI
JI M S-Med. Sci.
PD FEB
PY 2011
VL 27
IS 2
BP 119
EP 121
DI 10.1051/medsci/2011272119
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 783CB
UT WOS:000292058000003
PM 21382315
OA Bronze
DA 2021-01-25
ER

PT J
AU Muller, SA
   Muller, DJ
   Engel, A
AF Mueller, Shirley A.
   Mueller, Daniel J.
   Engel, Andreas
TI Assessing the structure and function of single biomolecules with
   scanning transmission electron and atomic force microscopes
SO MICRON
LA English
DT Review
DE Atomic force microscopy; Force spectroscopy; High-resolution imaging;
   Intermolecular interactions; Mass-mapping; Scanning transmission
   electron microscopy
ID NATIVE MEMBRANE-PROTEINS; ESCHERICHIA-COLI; CELL-ENVELOPE; MASS
   ANALYSIS; COMPLEXES; RECONSTRUCTION; SPECTROSCOPY; RADIODURANS;
   CANTILEVERS; ANTIPORTER
AB The scanning transmission electron microscope (STEM) and the atomic force microscope (AFM) have provided a wealth of useful information on a wide variety of biological structures. These instruments have in common that they raster-scan a probe over a sample and are able to address single molecules. In the STEM the probe is a focused electron beam that is deflected by the scan-coils. Detectors collecting the scattered electrons provide quantitative information for each sub-nanometer sized sample volume irradiated. These electron scattering data can be reconstituted to images of single macromolecules or can be integrated to provide the mass of the macromolecules. Samples need to be dehydrated for such quantitative STEM imaging. In contrast, the AFM raster-scans a sharp tip over a sample surface submerged in a buffer solution to acquire information on the sample's surface topography at sub-nanometer resolution. Direct observation of function-related structural changes induced by variation of temperature, pH, ionic strength, and applied force provides insight into the structure-function relationship of macromolecules. Further, the AFM allows single molecules to be addressed and quantitatively unfolded using the tip as nano-tweezers. The performance of these two scanning probe approaches is illustrated by several examples including the chaperonin GroEL, bacterial surface layers, protein crystals, and bacterial appendices. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Mueller, Shirley A.; Engel, Andreas] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4058 Basel, Switzerland.
   [Mueller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.
RP Engel, A (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM andreas.engel@case.edu
RI Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [3100A0-108299]; National Center of Competence in Research in
   Structural Biology; EUEuropean Union (EU) [211800-2]; University of
   Basel; Maurice E. Muller Foundation of Switzerland
FX The authors are indebted to Patrick Frederix, who provided AFM
   topographs of GroEL, to Kenny Goldie for dark-field images of GroEL
   GroES complexes, to Philippe Ringler for dark-field images of type-1
   pili of Streptococcus pneumoniae all recorded by STEM, and to Wolfgang
   Baumeister for a long-lasting most fruitful collaboration. The GroEL
   single ring sample was a kind gift of Manajit Hayer-Hartl. This work was
   supported by the Swiss National Science Foundation (SNF grant No.
   3100A0-108299), the National Center of Competence in Research in
   Structural Biology, EU Training Network grant No. 211800-2, the
   University of Basel, and the Maurice E. Muller Foundation of
   Switzerland. The AFM-facility used was built up with contributions from
   the Swiss University Conference and JPK-Instruments AG (Berlin,
   Germany).
CR BAUMEISTER W, 1981, J ULTRA MOL STRUCT R, V75, P60, DOI 10.1016/S0022-5320(81)80100-1
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNIG G, 1983, PHYS REV LETT, V50, P120, DOI 10.1103/PhysRevLett.50.120
   BINNIG G, 1982, HELV PHYS ACTA, V55, P726
   BRAUN T, 2005, 2 DIMENSIONAL ELECT
   BUTT HJ, 1993, J MICROSC-OXFORD, V169, P75, DOI 10.1111/j.1365-2818.1993.tb03280.x
   COLE MD, 1977, J MOL BIOL, V117, P387, DOI 10.1016/0022-2836(77)90134-6
   CREWE AV, 1970, SCIENCE, V168, P1338, DOI 10.1126/science.168.3937.1338
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   ENGEL A, 1982, P NATL ACAD SCI-BIOL, V79, P4050, DOI 10.1073/pnas.79.13.4050
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   ENGEL A, 1995, SCIENCE, V269, P832, DOI 10.1126/science.7638600
   Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450
   Engel A, 2009, ADV IMAG ELECT PHYS, V159, P357, DOI 10.1016/S1076-5670(09)59009-X
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   FREDERIX PLT, 2004, MRS B            JUL, P449
   HAMMEL M, 1995, ULTRAMICROSCOPY, V58, P403, DOI 10.1016/0304-3991(95)00007-N
   HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795
   Heymann JB, 1999, J STRUCT BIOL, V128, P243, DOI 10.1006/jsbi.1999.4180
   Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360
   KARRASCH S, 1994, P NATL ACAD SCI USA, V91, P836, DOI 10.1073/pnas.91.3.836
   Kedrov A, 2006, J MOL BIOL, V355, P2, DOI 10.1016/j.jmb.2005.10.028
   Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Khan A, 2004, J APPL PHYS, V95, P1667, DOI 10.1063/1.1638886
   Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879
   Mou JX, 1996, FEBS LETT, V381, P161, DOI 10.1016/0014-5793(96)00112-3
   Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309
   Muller SA, 2006, CHIMIA, V60, pA749, DOI 10.2533/chimia.2006.749
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1996, J BACTERIOL, V178, P3025
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Muller SA, 1998, J STRUCT BIOL, V121, P219, DOI 10.1006/jsbi.1997.3953
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879
   Scheuring S, 2007, J STRUCT BIOL, V160, P385, DOI 10.1016/j.jsb.2007.07.009
   Schiener J, 2005, BIOCHEM BIOPH RES CO, V328, P477, DOI 10.1016/j.bbrc.2005.01.005
   Sousa AA, 2009, ULTRAMICROSCOPY, V109, P213, DOI 10.1016/j.ultramic.2008.10.005
   Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027
   Tchelidze Pavel, 2008, V463, P137, DOI 10.1007/978-1-59745-406-3_10
   THOMAS D, 1994, BIOL CELL, V80, P181, DOI 10.1016/0248-4900(94)90041-8
   Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936
   von Ardenne M, 1938, Z PHYS, V109, P553, DOI 10.1007/BF01341584
   WALL J, 2009, ADV IMAG ELECT PHYS, P101
   Wall JS, 2008, METHOD ENZYMOL, V436, P487, DOI 10.1016/S0076-6879(08)36027-3
   WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355
   WALZTHONY D, 1984, EMBO J, V3, P2621, DOI 10.1002/j.1460-2075.1984.tb02183.x
   Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786
NR 56
TC 18
Z9 18
U1 0
U2 58
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD FEB
PY 2011
VL 42
IS 2
SI SI
BP 186
EP 195
DI 10.1016/j.micron.2010.10.002
PG 10
WC Microscopy
SC Microscopy
GA 707QN
UT WOS:000286301200010
PM 21087869
DA 2021-01-25
ER

PT J
AU Li, HB
   Muller, M
   Bahechar, IA
   Kyrchanova, O
   Ohno, K
   Georgiev, P
   Pirrotta, V
AF Li, Hua-Bing
   Mueller, Martin
   Bahechar, Ilham Anne
   Kyrchanova, Olga
   Ohno, Katsuhito
   Georgiev, Pavel
   Pirrotta, Vincenzo
TI Insulators, Not Polycomb Response Elements, Are Required for Long-Range
   Interactions between Polycomb Targets in Drosophila melanogaster
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID ENHANCER-PROMOTER COMMUNICATION; BITHORAX COMPLEX; NUCLEAR-ORGANIZATION;
   CHROMATIN INSULATOR; MCP ELEMENT; GAGA-FACTOR; CHROMOSOME CONFORMATION;
   RNA INTERFERENCE; GYPSY INSULATOR; BOUNDARY
AB The genomic binding sites of Polycomb group (PcG) complexes have been found to cluster, forming Polycomb "bodies" or foci in mammalian or fly nuclei. These associations are thought to be driven by interactions between PcG complexes and result in enhanced repression. Here, we show that a Polycomb response element (PRE) with strong PcG binding and repressive activity cannot mediate trans interactions. In the case of the two best-studied interacting PcG targets in Drosophila, the Mcp and the Fab-7 regulatory elements, we find that these associations are not dependent on or caused by the Polycomb response elements they contain. Using functional assays and physical colocalization by in vivo fluorescence imaging or chromosome conformation capture (3C) methods, we show that the interactions between remote copies of Mcp or Fab-7 elements are dependent on the insulator activities present in these elements and not on their PREs. We conclude that insulator binding proteins rather than PcG complexes are likely to be the major determinants of the long-range higher-order organization of PcG targets in the nucleus.
C1 [Li, Hua-Bing; Ohno, Katsuhito; Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.
   [Mueller, Martin; Bahechar, Ilham Anne; Pirrotta, Vincenzo] Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland.
   [Mueller, Martin] Univ Basel, Dept Cell Biol, Biozentrum, Basel, Switzerland.
   [Kyrchanova, Olga; Georgiev, Pavel] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia.
RP Pirrotta, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, 604 Allison Rd, Piscataway, NJ 08854 USA.
EM pirrotta@biology.rutgers.edu
RI Li, Huabing/M-5390-2013; Kyrchanova, Olga/C-1163-2014
OI Li, Huabing/0000-0003-3573-6803; Georgiev, Pavel/0000-0002-6509-3194;
   Kyrchanova, Olga/0000-0002-6249-0418
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Rutgers University; Russian Foundation for Basic ResearchRussian
   Foundation for Basic Research (RFBR) [10-04-00474-a]; Ministry of
   Science and Education of the Russian FederationMinistry of Education and
   Science, Russian Federation [02.740.11.0289]; Russian Academy of
   SciencesRussian Academy of Sciences
FX This work was supported in part by funds to V.P. from the Swiss National
   Science Foundation and from Rutgers University, to P.G. from the Russian
   Foundation for Basic Research (project 10-04-00474-a) and the Ministry
   of Science and Education of the Russian Federation (project
   02.740.11.0289), and to O.K. from the Molecular and Cell Biology Program
   of the Russian Academy of Sciences.
CR Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503
   Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209
   Busturia A, 2001, DEVELOPMENT, V128, P2163
   Byrd K, 2003, J CELL BIOL, V162, P565, DOI 10.1083/jcb.200305013
   Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004
   COOK PR, 1994, BIOESSAYS, V16, P425, DOI 10.1002/bies.950160611
   Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799
   Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024
   Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518
   Gohl D, 2008, GENETICS, V178, P127, DOI 10.1534/genetics.107.077768
   Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914
   Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036
   Gruzdeva N, 2005, MOL CELL BIOL, V25, P3682, DOI 10.1128/MCB.25.9.3682-3689.2005
   Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243
   Hagstrom K, 1996, GENE DEV, V10, P3202, DOI 10.1101/gad.10.24.3202
   Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112
   Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000
   Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200
   Kassis JA, 2002, ADV GENET, V46, P421
   Kravchenko E, 2005, MOL CELL BIOL, V25, P9283, DOI 10.1128/MCB.25.21.9283-9291.2005
   Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103
   Kyrchanova O, 2007, MOL CELL BIOL, V27, P3035, DOI 10.1128/MCB.02203-06
   Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850
   Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001
   Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851
   Muller M, 1999, GENETICS, V153, P1333
   Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814
   Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423
   Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004
   Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817
   Schweinsberg S, 2004, GENETICS, V168, P1371, DOI 10.1534/genetics.104.029561
   Siegal ML, 1996, GENETICS, V144, P715
   Sigrist CJA, 1997, GENETICS, V147, P209
   SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435
   Thakar R, 2005, J CELL SCI, V118, P951, DOI 10.1242/jcs.01684
   Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5
   Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049
   Zhou JM, 1996, GENE DEV, V10, P3195, DOI 10.1101/gad.10.24.3195
NR 38
TC 85
Z9 87
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD FEB
PY 2011
VL 31
IS 4
BP 616
EP 625
DI 10.1128/MCB.00849-10
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 711MV
UT WOS:000286596600002
PM 21135119
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Papassotiropoulos, A
   Henke, K
   Stefanova, E
   Aerni, A
   Muller, A
   Demougin, P
   Vogler, C
   Sigmund, JC
   Gschwind, L
   Huynh, KD
   Coluccia, D
   Mondadori, CR
   Hanggi, J
   Buchmann, A
   Kostic, V
   Novakovic, I
   van den Bussche, H
   Kaduszkiewicz, H
   Weyerer, S
   Bickel, H
   Riedel-Heller, S
   Pentzek, M
   Wiese, B
   Dichgans, M
   Wagner, M
   Jessen, F
   Maier, W
   de Quervain, DJF
AF Papassotiropoulos, A.
   Henke, K.
   Stefanova, E.
   Aerni, A.
   Mueller, A.
   Demougin, P.
   Vogler, C.
   Sigmund, J. C.
   Gschwind, L.
   Huynh, K-D
   Coluccia, D.
   Mondadori, C. R.
   Haenggi, J.
   Buchmann, A.
   Kostic, V.
   Novakovic, I.
   van den Bussche, H.
   Kaduszkiewicz, H.
   Weyerer, S.
   Bickel, H.
   Riedel-Heller, S.
   Pentzek, M.
   Wiese, B.
   Dichgans, M.
   Wagner, M.
   Jessen, F.
   Maier, W.
   de Quervain, D. J-F
TI A genome-wide survey of human short-term memory
SO MOLECULAR PSYCHIATRY
LA English
DT Article
DE SCN1A; sodium channel; memory; functional brain imaging; fMRI; GWAS
ID SEVERE MYOCLONIC EPILEPSY; NEURONAL SODIUM-CHANNEL; WORKING-MEMORY;
   BRAIN ACTIVATION; SCN1A; POLYMORPHISM; LAMOTRIGINE; MUTATIONS;
   CARBAMAZEPINE; METAANALYSIS
AB Recent advances in the development of high-throughput genotyping platforms allow for the unbiased identification of genes and genomic sequences related to heritable traits. In this study, we analyzed human short-term memory, which refers to the ability to remember information over a brief period of time and which has been found disturbed in many neuropsychiatric conditions, including schizophrenia and depression. We performed a genome-wide survey at 909 622 polymorphic loci and report six genetic variations significantly associated with human short-term memory performance after genome-wide correction for multiple comparisons. A polymorphism within SCN1A (encoding the alpha subunit of the type I voltage-gated sodium channel) was replicated in three independent populations of 1699 individuals. Functional magnetic resonance imaging during an n-back working memory task detected SCN1A allele-dependent activation differences in brain regions typically involved in working memory processes. These results suggest an important role for SCN1A in human short-term memory. Molecular Psychiatry (2011) 16, 184-192; doi:10.1038/mp.2009.133; published online 29 December 2009
C1 [Papassotiropoulos, A.; Mueller, A.; Demougin, P.; Vogler, C.; Sigmund, J. C.; Gschwind, L.; Huynh, K-D] Univ Basel, Div Mol Psychol, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, A.; Mueller, A.; Demougin, P.; Vogler, C.; Sigmund, J. C.; Gschwind, L.; Huynh, K-D] Univ Basel, Life Sci Training Facil, Biozentrum, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA.
   [Henke, K.] Univ Bern, Dept Psychol, Bern, Switzerland.
   [Stefanova, E.; Kostic, V.] Univ Belgrade, Inst Neurol, CCS, Sch Med, Belgrade, Serbia.
   [Aerni, A.; de Quervain, D. J-F] Univ Basel, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Coluccia, D.; Buchmann, A.] Univ Zurich, Div Psychiat Res, Zurich, Switzerland.
   [Mondadori, C. R.] Univ Zurich Hosp, Dept Neurol, Div Neuropsychol, CH-8091 Zurich, Switzerland.
   [Haenggi, J.] Univ Zurich, Div Neuropsychol, Inst Psychol, Zurich, Switzerland.
   [Novakovic, I.] Univ Belgrade, Inst Biol, Sch Med, Belgrade, Serbia.
   [van den Bussche, H.; Kaduszkiewicz, H.] Univ Med Ctr, Inst Primary Med Care, Hamburg, Germany.
   [Weyerer, S.] Cent Inst Mental Hlth, D-6800 Mannheim, Germany.
   [Bickel, H.] Tech Univ Munich, Dept Psychiat, Munich, Germany.
   [Riedel-Heller, S.] Univ Leipzig, Dept Psychiat, Publ Mental Hlth Res Unit, Leipzig, Germany.
   [Pentzek, M.] Univ Dusseldorf, Med Ctr, Dept Gen Practice, Dusseldorf, Germany.
   [Wiese, B.] Hannover Med Sch, Inst Biometr, D-3000 Hannover, Germany.
   [Dichgans, M.] Univ Munich, Klinikum Grosshadern, Dept Neurol, D-8000 Munich, Germany.
   [Wagner, M.; Jessen, F.; Maier, W.] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany.
   [de Quervain, D. J-F] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland.
RP Papassotiropoulos, A (corresponding author), Univ Basel, Div Mol Psychol, Missionsstr 60-62, CH-4055 Basel, Switzerland.
EM andreas.papas@unibas.ch; Dominique.dequervain@unibas.ch
RI Jessen, Frank/E-7655-2012; Wagner, Michael/E-2325-2011; Kostic, Vladimir
   S/Q-6998-2018; Jessen, Frank/AAK-6170-2020
OI Wagner, Michael/0000-0003-2589-6440; de Quervain,
   Dominique/0000-0001-7131-2464; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; Hanggi, Jurgen/0000-0001-8124-6018
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00B-106708, PP00B-68859, PP00B-114813, 3100-067114]; German
   Research Network on Dementia (KND); German Research Network on
   Degenerative Dementia (KNDD); German Federal Ministry of Education and
   ResearchFederal Ministry of Education & Research (BMBF) [01GI0420,
   01GI0711]; Ministry of Science, Republic of SerbiaMinistry of Science,
   Serbia [145057D]
FX We thank Dr Heike Kolsch for expert support. This work was funded by the
   Swiss National Science Foundation (grants PP00B-106708, PP00B-68859,
   PP00B-114813, Sinergia, 3100-067114 to DQ, AP, and KH), by the German
   Research Network on Dementia (KND) and the German Research Network on
   Degenerative Dementia (KNDD), German Federal Ministry of Education and
   Research grants 01GI0420 and 01GI0711, and by the Ministry of Science,
   Republic of Serbia (project no. 145057D).
CR Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582
   Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201
   Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014
   Bowden CL, 2003, ARCH GEN PSYCHIAT, V60, P392, DOI 10.1001/archpsyc.60.4.392
   Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247
   Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2
   Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609
   Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0
   de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103
   de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146
   Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4
   Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Escayg A, 2000, NAT GENET, V24, P343
   FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007
   Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786
   Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461
   Haldane M, 2008, EUR NEUROPSYCHOPHARM, V18, P48, DOI 10.1016/j.euroneuro.2007.05.009
   Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005
   Hautzel H, 2002, NEUROSCI LETT, V323, P156, DOI 10.1016/S0304-3940(02)00125-8
   Heinzen EL, 2007, AM J HUM GENET, V80, P876, DOI 10.1086/516650
   Jaeggi SM, 2007, COGN AFFECT BEHAV NE, V7, P75, DOI 10.3758/CABN.7.2.75
   Jessen F, 2007, PSYCHOL MED, V37, P1753, DOI 10.1017/S0033291707001122
   Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462
   Kuo CC, 1998, MOL PHARMACOL, V54, P712
   Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011
   Luck T, 2007, DEMENT GERIATR COGN, V24, P307, DOI 10.1159/000108099
   Mattay VS, 2008, BIOL PSYCHOL, V79, P9, DOI 10.1016/j.biopsycho.2008.03.015
   Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103
   Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16
   Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735
   Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016
   Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627
   Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558
   Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001
   Schmidt CF, 2005, NEUROIMAGE, V25, P625, DOI 10.1016/j.neuroimage.2004.12.002
   Schumacher EH, 1996, NEUROIMAGE, V3, P79, DOI 10.1006/nimg.1996.0009
   Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114
   Tate SK, 2006, PHARMACOGENET GENOM, V16, P721, DOI 10.1097/01.fpc.0000230114.41828.73
   Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102
   Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255
   Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516
   Wechsler D., 1987, WECHSLER MEMORY SCAL
   WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609
   Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754
NR 47
TC 23
Z9 24
U1 0
U2 26
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
EI 1476-5578
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD FEB
PY 2011
VL 16
IS 2
BP 184
EP 192
DI 10.1038/mp.2009.133
PG 9
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA 711HZ
UT WOS:000286581400008
PM 20038948
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Dufrene, YF
   Evans, E
   Engel, A
   Helenius, J
   Gaub, HE
   Muller, DJ
AF Dufrene, Yves F.
   Evans, Evan
   Engel, Andreas
   Helenius, Jonne
   Gaub, Hermann E.
   Mueller, Daniel J.
TI Five challenges to bringing single-molecule force spectroscopy into
   living cells
SO NATURE METHODS
LA English
DT Article
ID TOOLBOX
C1 [Dufrene, Yves F.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium.
   [Evans, Evan] Boston Univ, Boston, MA 02215 USA.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Engel, Andreas] Univ Basel, Biozentrum, Basel, Switzerland.
   [Helenius, Jonne; Mueller, Daniel J.] Tech Hsch Zurich, Dept Biosyst Sci & Engn, Basel, Switzerland.
   [Gaub, Hermann E.] Univ Munich, Munich, Germany.
RP Dufrene, YF (corresponding author), Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium.
EM daniel.mueller@bsse.ethz.ch
RI Cai, Mingjun/F-1844-2011; Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665; Dufrene, Yves/0000-0002-7289-4248
CR Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542
   Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072
   Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592
   Gerber C, 2006, NAT NANOTECHNOL, V1, P3, DOI 10.1038/nnano.2006.70
   Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618
   Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198
   Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871
   Horber JKH, 2003, SCIENCE, V302, P1002, DOI 10.1126/science.1067410
   Iwai S, 2008, P NATL ACAD SCI USA, V105, P16882, DOI 10.1073/pnas.0805513105
   Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621
   Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100
   Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181
   Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218
   Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523
   Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208
   Schwaiger I, 2004, NAT STRUCT MOL BIOL, V11, P81, DOI 10.1038/nsmb705
   Shroff H, 2008, BIOPHYS J, V94, P2179, DOI 10.1529/biophysj.107.114413
   Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021
   Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591
   Struckmeier J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384020
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
NR 25
TC 117
Z9 124
U1 2
U2 96
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
EI 1548-7105
J9 NAT METHODS
JI Nat. Methods
PD FEB
PY 2011
VL 8
IS 2
BP 123
EP 127
DI 10.1038/nmeth0211-123
PG 5
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 712GQ
UT WOS:000286654600005
PM 21278722
DA 2021-01-25
ER

PT J
AU Kalinovsky, A
   Boukhtouche, F
   Blazeski, R
   Bornmann, C
   Suzuki, N
   Mason, CA
   Scheiffele, P
AF Kalinovsky, Anna
   Boukhtouche, Fatiha
   Blazeski, Richard
   Bornmann, Caroline
   Suzuki, Noboru
   Mason, Carol A.
   Scheiffele, Peter
TI Development of Axon-Target Specificity of Ponto-Cerebellar Afferents
SO PLOS BIOLOGY
LA English
DT Article
ID REGULATES SYNAPTIC GROWTH; TGF-BETA; NERVOUS-SYSTEM; SUBPLATE NEURONS;
   GRANULE NEURONS; II RECEPTOR; DENDRITIC GROWTH; CLIMBING FIBERS;
   GENE-EXPRESSION; MOSSY FIBERS
AB The function of neuronal networks relies on selective assembly of synaptic connections during development. We examined how synaptic specificity emerges in the pontocerebellar projection. Analysis of axon-target interactions with correlated light-electron microscopy revealed that developing pontine mossy fibers elaborate extensive cell-cell contacts and synaptic connections with Purkinje cells, an inappropriate target. Subsequently, mossy fiber-Purkinje cell connections are eliminated resulting in granule cell-specific mossy fiber connectivity as observed in mature cerebellar circuits. Formation of mossy fiber-Purkinje cell contacts is negatively regulated by Purkinje cell-derived BMP4. BMP4 limits mossy fiber growth in vitro and Purkinje cell-specific ablation of BMP4 in mice results in exuberant mossy fiber-Purkinje cell interactions. These findings demonstrate that synaptic specificity in the pontocerebellar projection is achieved through a stepwise mechanism that entails transient innervation of Purkinje cells, followed by synapse elimination. Moreover, this work establishes BMP4 as a retrograde signal that regulates the axon-target interactions during development.
C1 [Kalinovsky, Anna; Scheiffele, Peter] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.
   [Kalinovsky, Anna; Scheiffele, Peter] Columbia Univ, Dept Neurosci, New York, NY USA.
   [Boukhtouche, Fatiha; Bornmann, Caroline; Scheiffele, Peter] Univ Basel, Biozentrum, Basel, Switzerland.
   [Blazeski, Richard; Mason, Carol A.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA.
   [Blazeski, Richard; Mason, Carol A.] Columbia Univ, Dept Neurosci & Ophthalmol, New York, NY USA.
   [Suzuki, Noboru] Mie Univ, Life Sci Res Ctr Anim Genom, Funct Genom Inst, Tsu, Mie, Japan.
RP Kalinovsky, A (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.
EM peter.scheiffele@unibas.ch
OI Kalinovsky, Anna/0000-0003-3793-052X
FU Patterson Trust; Biozentrum of the University of Basel; DANA Foundation
   [R01 DA020844]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF);  [NS 16951];  [EY 015290]; NATIONAL EYE
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R01EY015290, R01EY015290, R01EY015290, R01EY015290, R01EY015290,
   R01EY015290, R01EY015290, R01EY015290, R01EY015290, R01EY015290,
   R01EY015290, R01EY015290, R01EY015290, R01EY015290, R01EY015290] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS016951, R01NS016951, R01NS016951,
   R01NS016951, R01NS016951, R01NS016951, R01NS016951, R01NS016951,
   R01NS016951, R01NS016951, R01NS016951, R01NS016951, R01NS016951,
   R01NS016951, R01NS016951, R01NS016951, R01NS016951] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute on Drug Abuse (NIDA) [R01DA020844, R01DA020844,
   R01DA020844, R01DA020844, R01DA020844] Funding Source: NIH RePORTER;
   Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [20590276] Funding Source: KAKEN
FX F.B. is the recipient of a Postdoctoral Fellowship from the Patterson
   Trust. This work was supported by grants NS 16951 and EY 015290 to C. A.
   M., and by the Biozentrum of the University of Basel, a DANA Foundation
   Brain Imaging Award, R01 DA020844, and an award from the Swiss National
   Science Foundation to P. S. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5
   Alder J, 1999, NAT NEUROSCI, V2, P535
   Altman J, 1997, DEV CEREBELLAR SYSTE
   Angley C, 2003, J NEUROSCI, V23, P260
   Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004
   Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2
   Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027
   Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026
   Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X
   Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050
   DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0
   Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4
   Dipietrantonio HJ, 2009, NEUROSCIENCE, V162, P560, DOI 10.1016/j.neuroscience.2009.02.082
   Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010
   ECCLES EC, CEREBELLUM NEURONAL
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2
   Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060
   GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795
   GHOSH A, 1992, J NEUROSCI, V12, P39
   GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0
   Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033
   Goold CP, 2007, NEURON, V56, P109, DOI 10.1016/j.neuron.2007.08.006
   Guo X, 2001, J NEUROBIOL, V48, P120, DOI 10.1002/neu.1046.abs
   Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3
   Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008
   Hawkes R, 1997, PERSPECT DEV NEUROBI, V5, P95
   Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25
   Hodge LK, 2007, NEURON, V55, P572, DOI 10.1016/j.neuron.2007.07.010
   Ito S, 2009, P NATL ACAD SCI USA, V106, P12782, DOI 10.1073/pnas.0906653106
   Kalinovsky A, 2004, CURR OPIN NEUROBIOL, V14, P272, DOI 10.1016/j.conb.2004.05.011
   Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152
   Kawauchi D, 2006, DEVELOPMENT, V133, P1113, DOI 10.1242/dev.02283
   Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555
   Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004
   Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046
   Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418
   Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805
   Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632
   Manzini MC, 2006, J NEUROSCI, V26, P6040, DOI 10.1523/JNEUROSCI.4815-05.2006
   MARCUS RC, 1995, J NEUROSCI, V15, P3716
   Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0
   MASON C, 1987, NEW CONCEPTS CEREBEL
   Mason CA, 1997, PERSPECT DEV NEUROBI, V5, P69
   MASON CA, 1984, J NEUROSCI, V4, P1715
   McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X
   McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4
   Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022
   Moon JI, 2008, DEV BIOL, V315, P404, DOI 10.1016/j.ydbio.2007.12.041
   Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022
   Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209
   O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007
   Odeh F, 2005, J NEUROSCI, V25, P5680, DOI 10.1523/JNEUROSCI.0558-05.2005
   Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036
   PALAY SL, 1974, CEREBELLAR CORTEX CY, pR12
   Patzke H, 2001, MECH DEVELOP, V108, P149, DOI 10.1016/S0925-4773(01)00503-2
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   Perron JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008198
   Pijpers A, 2006, J NEUROSCI, V26, P12067, DOI 10.1523/JNEUROSCI.2905-06.2006
   Qin LH, 2006, J NEUROSCI, V26, P1896, DOI 10.1523/JNEUROSCI.3202-05.2006
   Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189
   Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188
   Saito H, 2005, BIOCHEM BIOPH RES CO, V331, P1216, DOI 10.1016/j.bbrc.2005.04.043
   Salie R, 2005, NEURON, V45, P189, DOI 10.1016/j.neuron.2005.01.002
   Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063
   Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6
   Shen K, 2010, ANN REV NEUROSCI
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237
   SOTELO C, 1982, EXP BRAIN RES S, V6, P50
   Sotelo C, 2008, CEREBELLUM, V7, P517, DOI 10.1007/s12311-008-0078-0
   Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4
   Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006
   Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9
   TAKEDA T, 1989, NEUROSCIENCE, V32, P99, DOI 10.1016/0306-4522(89)90110-3
   Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007
   Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041
   Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025
   Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055
   Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x
   Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8
   Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469
   Yamauchi K, 2008, DEVELOPMENT, V135, P1119, DOI 10.1242/dev.012989
   Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010
   Zhang Q, 1998, DEV BIOL, V195, P75, DOI 10.1006/dbio.1997.8837
   Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2
   Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009
NR 87
TC 42
Z9 42
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1544-9173
J9 PLOS BIOL
JI PLoS. Biol.
PD FEB
PY 2011
VL 9
IS 2
AR e1001013
DI 10.1371/journal.pbio.1001013
PG 16
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 725OB
UT WOS:000287653800011
PM 21346800
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Engel, P
   Salzburger, W
   Liesch, M
   Chang, CC
   Maruyama, S
   Lanz, C
   Calteau, A
   Lajus, A
   Medigue, C
   Schuster, SC
   Dehio, C
AF Engel, Philipp
   Salzburger, Walter
   Liesch, Marius
   Chang, Chao-Chin
   Maruyama, Soichi
   Lanz, Christa
   Calteau, Alexandra
   Lajus, Aurelie
   Medigue, Claudine
   Schuster, Stephan C.
   Dehio, Christoph
TI Parallel Evolution of a Type IV Secretion System in Radiating Lineages
   of the Host-Restricted Bacterial Pathogen Bartonella
SO PLOS GENETICS
LA English
DT Article
ID SMALL MAMMALS; SP-NOV.; PHOSPHORYLATION SITES; PHYLOGENETIC ANALYSIS;
   ADAPTIVE RADIATIONS; RATTUS-NORVEGICUS; GENETIC DIVERSITY; WILD RODENTS;
   HENSELAE; PREVALENCE
AB Adaptive radiation is the rapid origination of multiple species from a single ancestor as the result of concurrent adaptation to disparate environments. This fundamental evolutionary process is considered to be responsible for the genesis of a great portion of the diversity of life. Bacteria have evolved enormous biological diversity by exploiting an exceptional range of environments, yet diversification of bacteria via adaptive radiation has been documented in a few cases only and the underlying molecular mechanisms are largely unknown. Here we show a compelling example of adaptive radiation in pathogenic bacteria and reveal their genetic basis. Our evolutionary genomic analyses of the alpha-proteobacterial genus Bartonella uncover two parallel adaptive radiations within these host-restricted mammalian pathogens. We identify a horizontally-acquired protein secretion system, which has evolved to target specific bacterial effector proteins into host cells as the evolutionary key innovation triggering these parallel adaptive radiations. We show that the functional versatility and adaptive potential of the VirB type IV secretion system (T4SS), and thereby translocated Bartonella effector proteins (Beps), evolved in parallel in the two lineages prior to their radiations. Independent chromosomal fixation of the virB operon and consecutive rounds of lineage-specific bep gene duplications followed by their functional diversification characterize these parallel evolutionary trajectories. Whereas most Beps maintained their ancestral domain constitution, strikingly, a novel type of effector protein emerged convergently in both lineages. This resulted in similar arrays of host cell-targeted effector proteins in the two lineages of Bartonella as the basis of their independent radiation. The parallel molecular evolution of the VirB/Bep system displays a striking example of a key innovation involved in independent adaptive processes and the emergence of bacterial pathogens. Furthermore, our study highlights the remarkable evolvability of T4SSs and their effector proteins, explaining their broad application in bacterial interactions with the environment.
C1 [Engel, Philipp; Liesch, Marius; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Salzburger, Walter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland.
   [Chang, Chao-Chin] Natl Chung Hsing Univ, Coll Vet Med, Taichung 40227, Taiwan.
   [Maruyama, Soichi] Nihon Univ, Kanagawa, Japan.
   [Lanz, Christa] Max Planck Inst Dev Biol, Tubingen, Germany.
   [Calteau, Alexandra; Lajus, Aurelie; Medigue, Claudine] CEA, Direct Sci Vivant, Inst Genom, Evry, France.
   [Calteau, Alexandra; Lajus, Aurelie; Medigue, Claudine] CNRS, Lab Anal Bioinformat Genom & Metab, UMR 8030, Evry, France.
   [Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA.
RP Engel, P (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Salzburger, Walter/G-1598-2011; Engel, Philipp/N-1788-2015; Dehio,
   Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Salzburger, Walter/0000-0002-9988-1674; Engel,
   Philipp/0000-0002-4678-6200; Dehio, Christoph/0000-0001-7288-1052;
   Dehio, Christoph/0000-0001-7288-1052; Chang,
   Chao-chin/0000-0002-6299-9214; CALTEAU, Alexandra/0000-0002-5871-9347
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-132979]; Howard Hughes Medical InstituteHoward Hughes
   Medical Institute [55005501]; SystemsX.ch Swiss Initiative for Systems
   Biology [51RT 0_126008]
FX This work was supported by grant 31003A-132979 from the Swiss National
   Science Foundation (to CD), grant 55005501 from the Howard Hughes
   Medical Institute (to CD), and grant 51RT 0_126008 (InfectX) in the
   frame of the SystemsX.ch Swiss Initiative for Systems Biology (to CD).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Arvand M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009765
   Bai Y, 2007, FEMS MICROBIOL ECOL, V61, P438, DOI 10.1111/j.1574-6941.2007.00364.x
   Bai Y, 2009, AM J TROP MED HYG, V81, P811, DOI 10.4269/ajtmh.2009.09-0294
   Bemis DA, 2007, EMERG INFECT DIS, V13, P1565, DOI 10.3201/eid1310.070570
   Berglund EC, 2010, MOL ECOL, V19, P2241, DOI 10.1111/j.1365-294X.2010.04646.x
   Berglund EC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-152
   Berglund EC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000546
   Bermond D, 2002, INT J SYST EVOL MICR, V52, P383, DOI 10.1099/00207713-52-2-383
   Bermond D, 2000, INT J SYST EVOL MICR, V50, P1973, DOI 10.1099/00207713-50-6-1973
   Bininda-Emonds ORP, 2005, METHOD ENZYMOL, V395, P745, DOI 10.1016/S0076-6879(05)95038-6
   Birtles RJ, 1996, INT J SYST BACTERIOL, V46, P891, DOI 10.1099/00207713-46-4-891
   BIRTLES RJ, 1995, INT J SYST BACTERIOL, V45, P1, DOI 10.1099/00207713-45-1-1
   Birtles RJ, 2001, EPIDEMIOL INFECT, V126, P323, DOI 10.1017/S095026880100526X
   Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310
   Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590
   Brakefield PM, 2006, AM NAT, V168, pS4, DOI 10.1086/509049
   Carroll JA, 2000, INFECT IMMUN, V68, P6750, DOI 10.1128/IAI.68.12.6750-6757.2000
   Celebi B, 2010, J VET MED SCI, V72, P969, DOI 10.1292/jvms.09-0466
   Chamberlin J, 2002, J INFECT DIS, V186, P983, DOI 10.1086/344054
   Chang CC, 2000, EMERG INFECT DIS, V6, P306, DOI 10.3201/eid0603.000313
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009010
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011
   CLARRIDGE JE, 1995, J CLIN MICROBIOL, V33, P2107, DOI 10.1128/JCM.33.8.2107-2113.1995
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 2001, INT J SYST EVOL MICR, V51, P1557, DOI 10.1099/00207713-51-4-1557
   Dillon B, 2002, J CLIN MICROBIOL, V40, P4691, DOI 10.1128/JCM.40.12.4691-4699.2002
   Duponchelle F, 2008, P NATL ACAD SCI USA, V105, P15475, DOI 10.1073/pnas.0802343105
   Ellis BA, 1999, J INFECT DIS, V180, P220, DOI 10.1086/314824
   Engel P, 2009, GENOME DYNAM, V6, P158, DOI 10.1159/000235769
   Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987
   Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124
   GRANT PR, 2008, WHY SPECIES MULTIPLY, pR19
   Gundi VAKB, 2004, J CLIN MICROBIOL, V42, P3816, DOI 10.1128/JCM.42.8.3816-3818.2004
   Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2
   Harrus S, 2009, AM J TROP MED HYG, V81, P55, DOI 10.4269/ajtmh.2009.81.55
   Harvey P. H., 1991, COMP METHOD EVOLUTIO
   Heller R, 1997, J CLIN MICROBIOL, V35, P1327, DOI 10.1128/JCM.35.6.1327-1331.1997
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Henn JB, 2009, EMERG INFECT DIS, V15, P1984, DOI 10.3201/eid1512.081692
   Henn JB, 2009, J CLIN MICROBIOL, V47, P787, DOI 10.1128/JCM.01351-08
   Hofmeister EK, 1998, J INFECT DIS, V177, P409, DOI 10.1086/514201
   Holmberg M, 2003, EPIDEMIOL INFECT, V130, P149, DOI 10.1017/S0950268802008075
   Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]
   Inoue K, 2008, APPL ENVIRON MICROB, V74, P5086, DOI 10.1128/AEM.00071-08
   Inoue K, 2009, EMERG INFECT DIS, V15, P526, DOI 10.3201/eid1504.081223
   Inoue K, 2009, MICROB ECOL, V57, P534, DOI 10.1007/s00248-009-9488-x
   Jardine C, 2005, VECTOR-BORNE ZOONOT, V5, P402, DOI 10.1089/vbz.2005.5.402
   Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052
   Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818
   Kordick DL, 1997, J CLIN MICROBIOL, V35, P1813, DOI 10.1128/JCM.35.7.1813-1818.1997
   Kosoy M, 2003, J CLIN MICROBIOL, V41, P645, DOI 10.1128/JCM.41.2.645-650.2003
   Kosoy MY, 2000, COMP IMMUNOL MICROB, V23, P221, DOI 10.1016/S0147-9571(99)00075-2
   Kosoy MY, 1997, AM J TROP MED HYG, V57, P578, DOI 10.4269/ajtmh.1997.57.578
   Kronforst MR, 2006, GENETICS, V174, P535, DOI 10.1534/genetics.106.059527
   Li Dong-mei, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P333
   Lin JW, 2008, J MED MICROBIOL, V57, P1496, DOI 10.1099/jmm.0.2008/004671-0
   Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893
   Lydy SL, 2008, J CLIN MICROBIOL, V46, P627, DOI 10.1128/JCM.01207-07
   Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209
   Maillard R, 2004, INT J SYST EVOL MICR, V54, P215, DOI 10.1099/ijs.0.02770-0
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Marignac G, 2010, COMP IMMUNOL MICROB, V33, P95, DOI 10.1016/j.cimid.2008.07.011
   Marquez FJ, 2010, VECTOR-BORNE ZOONOT, V10, P731, DOI 10.1089/vbz.2009.0135
   Marston EL, 1999, CLIN DIAGN LAB IMMUN, V6, P41, DOI 10.1128/CDLI.6.1.41-44.1999
   McCann HC, 2008, NEW PHYTOL, V177, P33, DOI 10.1111/j.1469-8137.2007.02293.x
   Minnick MF, 2003, INFECT IMMUN, V71, P814, DOI 10.1128/IAI.71.2.814-821.2003
   Nylander J. A. A., 2004, MRMODELTEST V2 PROGR
   Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252
   Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584
   Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106
   Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada David, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0605s00
   Pretorius AM, 2004, INT J SYST EVOL MICR, V54, P1959, DOI 10.1099/ijs.0.03033-0
   Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Rolain JM, 2003, J CLIN MICROBIOL, V41, P4001, DOI 10.1128/JCM.41.8.4001-4002.2003
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x
   Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   SCHLUTER D, 2000, ECOLOGY ADAPTIVE RAD, pR8
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Sikorski J, 2005, P NATL ACAD SCI USA, V102, P15924, DOI 10.1073/pnas.0507944102
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tea A, 2004, EMERG INFECT DIS, V10, P963, DOI 10.3201/eid1005.030430
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00
   Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Yarbrough ML, 2009, NAT CHEM BIOL, V5, P378, DOI 10.1038/nchembio0609-378
   Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382
   Ying B, 2002, AM J TROP MED HYG, V66, P622, DOI 10.4269/ajtmh.2002.66.622
   Zeaiter Z, 2002, INT J SYST EVOL MICR, V52, P165, DOI 10.1099/00207713-52-1-165
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
NR 105
TC 64
Z9 68
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD FEB
PY 2011
VL 7
IS 2
AR e1001296
DI 10.1371/journal.pgen.1001296
PG 16
WC Genetics & Heredity
SC Genetics & Heredity
GA 726CV
UT WOS:000287697300011
PM 21347280
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Guilvout, I
   Nickerson, NN
   Chami, M
   Pugsley, AP
AF Guilvout, Ingrid
   Nickerson, Nicholas N.
   Chami, Mohamed
   Pugsley, Anthony P.
TI Multimerization-defective variants of dodecameric secretin PulD
SO RESEARCH IN MICROBIOLOGY
LA English
DT Article
DE In vitro synthesis; Mutations; Outer membrane protein; Oligomerization;
   Secretion
ID OUTER-MEMBRANE PROTEIN; CHAPERONE-LIKE PROTEIN; ESCHERICHIA-COLI;
   TERMINAL DOMAIN; PHAGE EXPORT; INSERTION; PATHWAY; PIV; IDENTIFICATION;
   ASSOCIATION
AB The C-terminal core domain of the secretin PulD from Klebsiella oxytoca forms heat-resistant dodecameric complexes within less than 10 min in an Escherichia coli in vitro transcription-translation system containing liposomes, and is toxic when made in the cytoplasm without a signal peptide. Random mutagenesis of DNA encoding this region of PulD revealed that amino acid changes throughout almost its entire length abolished toxicity. Most of the amino acid substitutions engendered by the mutations retarded or abolished assembly of the dodecameric secretin complex in vitro and/or in the periplasm. Only one of the tested multimerization-defective variants could be rescued by co-production and mixed multimer formation with wild-type secretin in vitro. A three amino acid insertion specifically generated in a region of PulD that was not affected by the spontaneous mutations formed functional multimers that, unlike the wild-type protein, were dissociated by heating in SDS. (C) 2011 Published by Elsevier Masson SAS on behalf of the Institut Pasteur.
C1 [Guilvout, Ingrid; Nickerson, Nicholas N.; Pugsley, Anthony P.] Inst Pasteur, Mol Genet Unit, F-75724 Paris 15, France.
   [Guilvout, Ingrid; Nickerson, Nicholas N.; Pugsley, Anthony P.] CNRS, URA2172, F-75015 Paris, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4058 Basel, Switzerland.
RP Pugsley, AP (corresponding author), Inst Pasteur, Mol Genet Unit, 28 Rue Dr Roux, F-75724 Paris 15, France.
EM max@pasteur.fr
FU la Fondation canadienne Louis Pasteur;  [ANR-05-0307-01]; 
   [ANR-09-BLAN-0291]
FX We are grateful to Severine Collin and Nicolas Bayan for their
   contributions to these studies, and to Henning Stahlberg and MGU members
   for their help and support. This work was supported in part by grants
   ANR-05-0307-01 and ANR-09-BLAN-0291. NNN was supported by a grant from
   la Fondation canadienne Louis Pasteur.
CR Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588
   Chen LY, 1996, J BIOL CHEM, V271, P2703, DOI 10.1074/jbc.271.5.2703
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x
   Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x
   Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267
   Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999
   Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Helm RA, 2007, J BACTERIOL, V189, P3198, DOI 10.1128/JB.01833-06
   Hu NT, 1998, MICROBIOL-SGM, V144, P1479, DOI 10.1099/00221287-144-6-1479
   Jansen C, 2000, EUR J BIOCHEM, V267, P3792, DOI 10.1046/j.1432-1327.2000.01417.x
   KAZMIERCZAK BI, 1994, J MOL BIOL, V238, P187, DOI 10.1006/jmbi.1994.1280
   Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011
   KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367
   Marciano DK, 1999, SCIENCE, V284, P1516, DOI 10.1126/science.284.5419.1516
   Marciano DK, 2001, P NATL ACAD SCI USA, V98, P9359, DOI 10.1073/pnas.161170398
   MEERMAN HJ, 1994, BIO-TECHNOL, V12, P1107, DOI 10.1038/nbt1194-1107
   MICHAELIS S, 1985, J BACTERIOL, V164, P633, DOI 10.1128/JB.164.2.633-638.1985
   Miller JH, 1972, EXPT MOL GENETICS
   Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   REID J, 1988, J BIOL CHEM, V263, P7753
   Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322
   RUSSEL M, 1994, MOL MICROBIOL, V14, P357, DOI 10.1111/j.1365-2958.1994.tb01296.x
   Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007
   Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007
   Spagnuolo J, 2010, MOL MICROBIOL, V76, P133, DOI 10.1111/j.1365-2958.2010.07085.x
   Tokuda H, 2004, BIOCHIM BIOPHYS ACTA, V1694, pIN1
NR 32
TC 22
Z9 22
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0923-2508
EI 1769-7123
J9 RES MICROBIOL
JI Res. Microbiol.
PD FEB-MAR
PY 2011
VL 162
IS 2
BP 180
EP 190
DI 10.1016/j.resmic.2011.01.006
PG 11
WC Microbiology
SC Microbiology
GA 741QZ
UT WOS:000288880500011
PM 21256212
DA 2021-01-25
ER

PT J
AU Gossert, AD
   Hiller, S
   Fernandez, C
AF Gossert, Alvar D.
   Hiller, Sebastian
   Fernandez, Cesar
TI Automated NMR Resonance Assignment of Large Proteins for Protein-Ligand
   Interaction Studies
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID PROJECTION SPECTROSCOPY APSY; BACKBONE ASSIGNMENT; ESCHERICHIA-COLI;
   SPECTRA
AB The detection and structural characterization of protein-ligand interactions by solution NMR is central to functional biology research as well as to drug discovery. Here we present a robust and highly automated procedure for obtaining the resonance assignments necessary for studies of such interactions. The procedure relies on a combination of three automated projection spectroscopy (APSY) experiments, including the new 4D APSY-HNCACB, and the use of fractionally deuterated protein samples. This labeling pattern increases the experimental sensitivity on the one hand, but it leads to peak multiplets on the other hand. The latter complications are however overcome by the geometric APSY analysis of the projection spectra. The three APSY experiments thus provide high precision chemical shift correlations of the backbone and side chain methyl groups, allowing a reliable and robust assignment of the protein by suitable algorithms. The present approach doubles the molecular size limit of APSY-based assignments to 25 kDa, thus providing the basis for efficient characterization of protein-ligand interactions at atomic resolution by NMR, such as structure-based drug design. We show the application to two human proteins with molecular weights of 15 and 22 kDa, respectively, at concentrations of 0.4 mM and discuss the general applicability to studies of protein-protein and protein-nucleic acid complexes.
C1 [Gossert, Alvar D.; Fernandez, Cesar] Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.
   [Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Fernandez, C (corresponding author), Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.
EM cesar.fernandez@novartis.com
RI Hiller, Sebastian/B-3573-2008
OI Hiller, Sebastian/0000-0002-6709-4684; Gossert,
   Alvar/0000-0001-7732-495X
CR Fiorito F, 2006, J BIOMOL NMR, V35, P27, DOI 10.1007/s10858-006-0030-x
   Gossert AD, 2007, J BIOMOL NMR, V38, P195, DOI 10.1007/s10858-006-9123-9
   Gossert AD, 2009, J BIOMOL NMR, V43, P211, DOI 10.1007/s10858-009-9303-5
   Hajduk PJ, 1997, J AM CHEM SOC, V119, P12257, DOI 10.1021/ja9715962
   Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102
   Hiller S, 2008, J BIOMOL NMR, V42, P179, DOI 10.1007/s10858-008-9266-y
   Hiller S, 2008, J AM CHEM SOC, V130, P12073, DOI 10.1021/ja803161d
   Hiller S, 2007, J AM CHEM SOC, V129, P10823, DOI 10.1021/ja072564+
   Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u
   Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o
   Jaravine VA, 2006, J AM CHEM SOC, V128, P13421, DOI 10.1021/ja062146p
   Leiting B, 1998, ANAL BIOCHEM, V265, P351, DOI 10.1006/abio.1998.2904
   Lescop E, 2009, J BIOMOL NMR, V44, P43, DOI 10.1007/s10858-009-9314-2
   Liu GH, 2005, P NATL ACAD SCI USA, V102, P10487, DOI 10.1073/pnas.0504338102
   Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l
   Moseley HNB, 2001, METHOD ENZYMOL, V339, P91, DOI 10.1016/S0076-6879(01)39311-4
   Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f
   Otten R, 2010, J AM CHEM SOC, V132, P2952, DOI 10.1021/ja907706a
   Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603
   Staykova DK, 2008, J BIOMOL NMR, V42, P87, DOI 10.1007/s10858-008-9265-z
   Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005
   Yee A, 2006, CURR OPIN STRUC BIOL, V16, P611, DOI 10.1016/j.sbi.2006.08.002
NR 24
TC 25
Z9 25
U1 0
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JAN 19
PY 2011
VL 133
IS 2
BP 210
EP 213
DI 10.1021/ja108383x
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 710VK
UT WOS:000286544900014
PM 21162534
DA 2021-01-25
ER

PT J
AU Thiele, I
   Hyduke, DR
   Steeb, B
   Fankam, G
   Allen, DK
   Bazzani, S
   Charusanti, P
   Chen, FC
   Fleming, RMT
   Hsiung, CA
   De Keersmaecker, SCJ
   Liao, YC
   Marchal, K
   Mo, ML
   Ozdemir, E
   Raghunathan, A
   Reed, JL
   Shin, SI
   Sigurbjornsdottir, S
   Steinmann, J
   Sudarsan, S
   Swainston, N
   Thijs, IM
   Zengler, K
   Palsson, BO
   Adkins, JN
   Bumann, D
AF Thiele, Ines
   Hyduke, Daniel R.
   Steeb, Benjamin
   Fankam, Guy
   Allen, Douglas K.
   Bazzani, Susanna
   Charusanti, Pep
   Chen, Feng-Chi
   Fleming, Ronan M. T.
   Hsiung, Chao A.
   De Keersmaecker, Sigrid C. J.
   Liao, Yu-Chieh
   Marchal, Kathleen
   Mo, Monica L.
   Oezdemir, Emre
   Raghunathan, Anu
   Reed, Jennifer L.
   Shin, Sook-Il
   Sigurbjornsdottir, Sara
   Steinmann, Jonas
   Sudarsan, Suresh
   Swainston, Neil
   Thijs, Inge M.
   Zengler, Karsten
   Palsson, Bernhard O.
   Adkins, Joshua N.
   Bumann, Dirk
TI A community effort towards a knowledge-base and mathematical model of
   the human pathogen Salmonella Typhimurium LT2
SO BMC SYSTEMS BIOLOGY
LA English
DT Article
ID ESCHERICHIA-COLI; RECONSTRUCTION; ANNOTATION; METABOLISM; NETWORKS;
   GENOMES; PROTEIN
AB Background: Metabolic reconstructions (MRs) are common denominators in systems biology and represent biochemical, genetic, and genomic (BiGG) knowledge-bases for target organisms by capturing currently available information in a consistent, structured manner. Salmonella enterica subspecies I serovar Typhimurium is a human pathogen, causes various diseases and its increasing antibiotic resistance poses a public health problem.
   Results: Here, we describe a community-driven effort, in which more than 20 experts in S. Typhimurium biology and systems biology collaborated to reconcile and expand the S. Typhimurium BiGG knowledge-base. The consensus MR was obtained starting from two independently developed MRs for S. Typhimurium. Key results of this reconstruction jamboree include i) development and implementation of a community-based workflow for MR annotation and reconciliation; ii) incorporation of thermodynamic information; and iii) use of the consensus MR to identify potential multi-target drug therapy approaches.
   Conclusion: Taken together, with the growing number of parallel MRs a structured, community-driven approach will be necessary to maximize quality while increasing adoption of MRs in experimental design and interpretation.
C1 [Steeb, Benjamin; Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland.
   [Thiele, Ines; Fleming, Ronan M. T.] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland.
   [Thiele, Ines] Univ Iceland, Fac Ind Engn Mech Engn & Comp Sci, Reykjavik, Iceland.
   [Hyduke, Daniel R.; Fankam, Guy; Charusanti, Pep; Mo, Monica L.; Zengler, Karsten; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Allen, Douglas K.] USDA ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO USA.
   [Bazzani, Susanna] Tech Univ Carolo Wilhelmina Braunschweig, Inst Bioinformat & Biochem, Braunschweig, Germany.
   [Chen, Feng-Chi; Hsiung, Chao A.; Liao, Yu-Chieh] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Zhunan, Taiwan.
   [Fleming, Ronan M. T.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland.
   [De Keersmaecker, Sigrid C. J.; Marchal, Kathleen; Thijs, Inge M.] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Microbial & Mol Syst, Leuven, Belgium.
   [Oezdemir, Emre] Ecole Polytech Fed Lausanne, Lab Computat Syst Biotechnol, Swiss Inst Bioinformat, Lausanne, Switzerland.
   [Raghunathan, Anu; Shin, Sook-Il] Mt Sinai Sch Med, Dept Infect Dis, New York, NY USA.
   [Reed, Jennifer L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA.
   [Sigurbjornsdottir, Sara; Steinmann, Jonas] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland.
   [Sudarsan, Suresh] Tech Univ Dortmund, Dept Biochem & Chem Engn, Dortmund, Germany.
   [Swainston, Neil] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England.
   [Swainston, Neil] Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.
   [Adkins, Joshua N.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.
RP Bumann, D (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM dirk.bumann@unibas.ch
RI Thiele, Ines/A-7629-2014; Marchal, Kathleen/O-7936-2017; Liao,
   Yu-Chieh/L-5113-2019; Reed, Jennifer L/E-5137-2011; Hsiung, Chao
   Agnes/E-3994-2010; Thiele, Ines/AAZ-3717-2020; Allen, Doug
   K/M-2836-2013; Marchal, Kathleen/B-5001-2013; Adkins,
   Joshua/B-9881-2013; Chen, Feng-Chi/E-3841-2010; Liao,
   Yu-Chieh/E-5031-2011
OI Thiele, Ines/0000-0002-8071-7110; Marchal, Kathleen/0000-0002-2169-4588;
   Liao, Yu-Chieh/0000-0002-4360-7932; Reed, Jennifer
   L/0000-0001-7854-6220; Thiele, Ines/0000-0002-8071-7110; Allen, Doug
   K/0000-0001-8599-8946; Marchal, Kathleen/0000-0002-2169-4588; Adkins,
   Joshua/0000-0003-0399-0700; De Keersmaecker, Sigrid
   C.J./0000-0003-4198-4133; Zengler, Karsten/0000-0002-8062-3296;
   Charusanti, Pep/0000-0003-0009-6615; Sigurbjornsdottir,
   Sara/0000-0002-3030-8888; Ozdemir, Emre/0000-0001-5548-6720; Fleming,
   Ronan MT/0000-0001-5346-9812
FU National Institute of Allergy and Infectious Diseases NIH/DHHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [Y1-AI-8401-01]; European CommunityEuropean Community
   (EC) [PIRG05-GA-2009-249261]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R22AI008401, R01AI008401,
   R22AI008401, R22AI008401, R22AI008401, R22AI008401] Funding Source: NIH
   RePORTER
FX The authors would like to thank R. Archila and K.C. Soh for
   participation at the opening day of the reconstruction jamboree. I.T.
   would like to thank M. Herrgard for the valuable discussions. This work
   was supported in part by the National Institute of Allergy and
   Infectious Diseases NIH/DHHS through interagency agreement
   Y1-AI-8401-01. I.T. was supported in part by a Marie Curie International
   Reintegration Grant within the 7th European Community Framework Program
   (PIRG05-GA-2009-249261).
CR AbuOun M, 2009, J BIOL CHEM, V284, P29480, DOI 10.1074/jbc.M109.005868
   Barthelmes J, 2007, NUCLEIC ACIDS RES, V35, pD511, DOI 10.1093/nar/gkl972
   BAYNE HG, 1961, J BACTERIOL, V81, P126, DOI 10.1128/JB.81.1.126-129.1961
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89
   Bjorkman J, 1998, P NATL ACAD SCI USA, V95, P3949, DOI 10.1073/pnas.95.7.3949
   Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104
   Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401
   Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155
   Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949
   Fleming RMT, 2009, BIOPHYS CHEM, V145, P47, DOI 10.1016/j.bpc.2009.08.007
   Gianchandani EP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000403
   GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969
   Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492
   Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104
   Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750
   Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26
   Jarboe LR, 2008, J BIOL CHEM, V283, P5148, DOI 10.1074/jbc.M706018200
   Justino MC, 2006, FEMS MICROBIOL LETT, V257, P278, DOI 10.1111/j.1574-6968.2006.00179.x
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212
   Kumar VS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000308
   Li F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000292
   Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177
   McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614
   Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1
   Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77
   Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259
   OIKAWA T, 2007, AMINO ACID BIOSYNTHE, V5, P273, DOI DOI 10.1007/7171_2006_062
   Palsson B, 2004, NAT BIOTECHNOL, V22, P1218, DOI 10.1038/nbt1004-1218
   Palsson BO, 2006, SYSTEMS BIOL PROPERT
   Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001
   Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38
   Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54
   Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769
   SCHELLENBERGER J, NAT PROT
   Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200
   Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56
   Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285
   Thiele I, 2010, BIOPHYS J, V98, P2072, DOI 10.1016/j.bpj.2010.01.060
   Thiele I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.15
   Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203
   Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312
   VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994
   Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415
   Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008
NR 46
TC 91
Z9 93
U1 1
U2 20
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1752-0509
J9 BMC SYST BIOL
JI BMC Syst. Biol.
PD JAN 18
PY 2011
VL 5
AR 8
DI 10.1186/1752-0509-5-8
PG 9
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA 714PS
UT WOS:000286822100001
PM 21244678
OA Green Published, Other Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Farhan, H
   Rabouille, C
AF Farhan, Hesso
   Rabouille, Catherine
TI Signalling to and from the secretory pathway
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Endoplasmic reticulum exit sites; Golgi; Signal transduction
ID ER-EXIT SITES; GOLGI INTERMEDIATE COMPARTMENT; ENDOPLASMIC-RETICULUM;
   VESICULAR TRANSPORT; PROTEIN-TRANSPORT; LIPID PHOSPHATASE; MAMMALIAN
   TARGET; TRANSITIONAL ER; CELL POLARITY; COPII
AB For growth, survival, communication and homeostasis, cells transport a large number of proteins to the plasma membrane and the extracellular medium by using the secretory pathway. Consequently, to adapt to the surrounding environment and the different intracellular contexts, the secretory pathway needs to accommodate and respond to a plethora of endogenous and exogenous stimuli. It is now well established that several kinases, known to be activated by environmental stimuli, signal from the plasma membrane to the secretory pathway in order to remodel its architecture and modulate the cellular secretion capacity. By contrast, membranes of the early secretory pathway, similar to the endosomal system, can also initiate and modulate signalling cascades, thereby spatially organising cellular signalling and eliciting a different cellular outcome than when signalling is localised to the plasma membrane. This Commentary highlights recent contributions to our understanding of the mutual regulation of the secretory pathway and cellular signalling.
C1 [Farhan, Hesso] Univ Basel, Biozentrum, Basel, Switzerland.
   [Farhan, Hesso] Univ Constance, Biotechnol Inst Thurgau, Kreuzlingen, Switzerland.
   [Rabouille, Catherine] UMC Utrecht, Dept Cell Biol, Cell Microscopy Ctr, Utrecht, Netherlands.
RP Farhan, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, Basel, Switzerland.
EM hesso.farhan@bitg.ch; c.rabouille@hybrecht.eu
RI Farhan, Hesso/C-7997-2012
OI Farhan, Hesso/0000-0002-0889-8463
FU Thurgauische Stiftung fur Wissenschaft und Forschung; University of
   Basel
FX We thank Fulvio Reggiori (UMC Utrecht, The Netherlands), Jesse Hay
   (University of Montana, MT) Anne Spang (Biozentrum, Basel, Switzerland)
   and our reviewers for critically reading the manuscript and helpful
   comments, and the Rabouille group past and present for discussion. H. F.
   is supported by the Thurgauische Stiftung fur Wissenschaft und Forschung
   and by the University of Basel.
CR Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   ARIDO RM, 2000, J BIOL CHEM, V275, P35673
   Arozarena I, 2004, MOL CELL BIOL, V24, P1516, DOI 10.1128/MCB.24.4.1516-1530.2004
   Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377
   BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4
   Bejarano E, 2006, J CELL SCI, V119, P3764, DOI 10.1242/jcs.03146
   Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045
   Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806
   Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109
   Blumental-Perry A, 2006, DEV CELL, V11, P671, DOI 10.1016/j.devcel.2006.09.001
   Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166
   Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200
   Cabrera M, 2003, MOL BIOL CELL, V14, P4114, DOI 10.1091/mbc.E03-04-0194
   Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165
   Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08
   Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783
   Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019
   Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8
   Colanzi A, 2007, CURR OPIN CELL BIOL, V19, P386, DOI 10.1016/j.ceb.2007.06.002
   Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779
   Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065
   Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020
   DEMATTEIS MA, 1993, NATURE, V364, P818, DOI 10.1038/364818a0
   Di Fiore PP, 2003, NATURE, V424, P624, DOI 10.1038/424624a
   Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052
   Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200
   Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7
   Dunne JC, 2002, DEV BIOL, V245, P172, DOI 10.1006/dbio.2002.0632
   Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115
   Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136
   Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082
   Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x
   Feng L, 2007, P NATL ACAD SCI USA, V104, P14348, DOI 10.1073/pnas.0701298104
   Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341
   Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076
   Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119
   Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058
   Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105
   Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289
   Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032
   Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020
   Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246
   Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907
   Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581
   Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1
   Jiang YH, 2010, MOL CELL BIOL, V30, P78, DOI 10.1128/MCB.01038-09
   Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105
   Kano F, 2004, MOL BIOL CELL, V15, P4289, DOI 10.1091/mbc.E03-11-0822
   Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901
   Kodani A, 2009, MOL BIOL CELL, V20, P1192, DOI 10.1091/mbc.E08-08-0834
   Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743
   Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008
   Kondylis V, 2009, FEBS LETT, V583, P3827, DOI 10.1016/j.febslet.2009.09.048
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483
   Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8
   Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406
   Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006
   Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9
   Mavillard F, 2010, TRAFFIC, V11, P90, DOI 10.1111/j.1600-0854.2009.01007.x
   Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6
   Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010
   Muniz M, 1997, P NATL ACAD SCI USA, V94, P14461, DOI 10.1073/pnas.94.26.14461
   Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106
   Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496
   Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061
   Pryde JG, 1998, MOL CELL BIOL, V18, P1125, DOI 10.1128/MCB.18.2.1125
   Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751
   Quatela SE, 2006, CURR OPIN CELL BIOL, V18, P162, DOI 10.1016/j.ceb.2006.02.004
   Rabouille C, 2007, CELL CYCLE, V6, P2723, DOI 10.4161/cc.6.22.4896
   Rismanchi N, 2009, TRAFFIC, V10, P201, DOI 10.1111/j.1600-0854.2008.00856.x
   Salama NR, 1997, MOL BIOL CELL, V8, P205
   San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194
   Schotman H, 2009, J CELL SCI, V122, P2662, DOI 10.1242/jcs.039347
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109
   SHARPE LJ, 2010, TRAFFIC
   Shindiapina P, 2010, MOL BIOL CELL, V21, P1530, DOI 10.1091/mbc.E09-07-0605
   Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003
   Stephens DJ, 2003, EMBO REP, V4, P210, DOI 10.1038/sj.embor.embor736
   Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018
   Supek F, 2002, J CELL BIOL, V158, P1029, DOI 10.1083/jcb.200207053
   Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107
   Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019
   Tseng YT, 2001, FASEB J, V15, pA476
   Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411
   Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317
   Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x
   Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107
   Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350
   Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063
   Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135
   Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077
   Yi P, 2010, J CELL SCI, V123, P1060, DOI 10.1242/jcs.059717
NR 97
TC 75
Z9 76
U1 1
U2 21
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD JAN 15
PY 2011
VL 124
IS 2
BP 171
EP 180
DI 10.1242/jcs.076455
PG 10
WC Cell Biology
SC Cell Biology
GA 698ZP
UT WOS:000285634000005
PM 21187344
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Boiteux, C
   Berneche, S
AF Boiteux, Celine
   Berneche, Simon
TI Absence of Ion-Binding Affinity in the Putatively Inactivated Low-[K+]
   Structure of the KcsA Potassium Channel
SO STRUCTURE
LA English
DT Article
ID C-TYPE INACTIVATION; MOLECULAR-DYNAMICS SIMULATIONS; K+ CHANNEL;
   SELECTIVITY FILTER; POTENTIAL FUNCTIONS; SLOW INACTIVATION; SHAKER
   CHANNELS; CONDUCTION; RECOVERY; ENERGETICS
AB Potassium channels are membrane proteins that selectively conduct K+ across cellular membranes. The narrowest part of their pore, the selectivity filter, is responsible for distinguishing K+ from Na+, and can also act as a gate through a mechanism known as C-type inactivation. It has been proposed that a conformation of the KcsA channel obtained by crystallization in presence of low concentration of K+ (PDB 1K4D) could correspond to the C-type inactivated state. Here, we show using molecular mechanics simulations that such conformation has little ion-binding affinity and that ions do not contribute to its stability. The simulations suggest that, in this conformation, the selectivity filter is mostly occupied by water molecules. Whether such ion-free state of the KcsA channel is physiologically accessible and representative of the inactivated state of eukaryotic channels remains unclear.
C1 [Boiteux, Celine; Berneche, Simon] Univ Basel, Biozentrum, Swiss Inst Bioinformat Computat & Syst Biol, CH-4056 Basel, Switzerland.
RP Berneche, S (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat Computat & Syst Biol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM simon.berneche@unibas.ch
RI Berneche, Simon/L-6389-2013
OI Berneche, Simon/0000-0002-6274-4094
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [118928]
FX We are grateful to C. Deutsch for helpful comments on a previous version
   of the manuscript. This work has been supported by a grant from the
   Swiss National Science Foundation to S. B. (SNF-Professorship No.
   118928).
CR Ader C, 2008, NAT STRUCT MOL BIOL, V15, P605, DOI 10.1038/nsmb.1430
   Ambriz-Rivas M, 2005, PFLUG ARCH EUR J PHY, V450, P255, DOI 10.1007/s00424-005-1411-9
   Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653
   Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148
   Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019
   Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843
   Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069
   Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309
   COX BG, 1974, AUST J CHEM, V27, P477, DOI 10.1071/CH9740477
   Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153
   Domene C, 2008, J AM CHEM SOC, V130, P9474, DOI 10.1021/ja801792g
   Domene C, 2009, J MOL BIOL, V389, P637, DOI 10.1016/j.jmb.2009.04.038
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   Furini S, 2009, PROTEINS, V74, P437, DOI 10.1002/prot.22163
   Gao LZ, 2005, P NATL ACAD SCI USA, V102, P17630, DOI 10.1073/pnas.0505158102
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107
   Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929
   Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4
   Levy DI, 1996, BIOPHYS J, V71, P3157, DOI 10.1016/S0006-3495(96)79509-7
   Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3
   Loboda A, 2001, BIOPHYS J, V80, P2704, DOI 10.1016/S0006-3495(01)76239-X
   Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334
   Rasmusson RL, 1995, J PHYSIOL-LONDON, V489, P709, DOI 10.1113/jphysiol.1995.sp021085
   Ray EC, 2006, J GEN PHYSIOL, V128, P203, DOI 10.1085/jgp.200609561
   Roux B, 2002, BIOPHYS J, V82, P1681, DOI 10.1016/S0006-3495(02)75520-3
   Saparov SM, 2004, P NATL ACAD SCI USA, V101, P4805, DOI 10.1073/pnas.0308309101
   Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0
   Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539
   WOOLF TB, 1994, P NATL ACAD SCI USA, V91, P11631, DOI 10.1073/pnas.91.24.11631
   Yellen G, 2001, NAT STRUCT BIOL, V8, P1011, DOI 10.1038/nsb1201-1011
   Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448
   Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022
   Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009
NR 43
TC 12
Z9 12
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD JAN 12
PY 2011
VL 19
IS 1
BP 70
EP 79
DI 10.1016/j.str.2010.10.008
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 708FP
UT WOS:000286348000010
PM 21220117
OA Bronze
DA 2021-01-25
ER

PT J
AU Palacios-Chaves, L
   Conde-Alvarez, R
   Gil-Ramirez, Y
   Zuniga-Ripa, A
   Barquero-Calvo, E
   Chacon-Diaz, C
   Chaves-Olarte, E
   Arce-Gorvel, V
   Gorvel, JP
   Moreno, E
   de Miguel, MJ
   Grillo, MJ
   Moriyon, I
   Iriarte, M
AF Palacios-Chaves, Leyre
   Conde-Alvarez, Raquel
   Gil-Ramirez, Yolanda
   Zuniga-Ripa, Amaia
   Barquero-Calvo, Elias
   Chacon-Diaz, Carlos
   Chaves-Olarte, Esteban
   Arce-Gorvel, Vilma
   Gorvel, Jean-Pierre
   Moreno, Edgardo
   de Miguel, Maria-Jesus
   Grillo, Maria-Jesus
   Moriyon, Ignacio
   Iriarte, Maite
TI Brucella abortus Ornithine Lipids Are Dispensable Outer Membrane
   Components Devoid of a Marked Pathogen-Associated Molecular Pattern
SO PLOS ONE
LA English
DT Article
ID BACTERICIDAL CATIONIC PEPTIDES; PSEUDOMONAS-FLUORESCENS;
   LIPOPOLYSACCHARIDE; RESISTANCE; MUTANTS; CELLS; MICE;
   PHOSPHATIDYLCHOLINE; FLAVOBACTERIUM; IDENTIFICATION
AB The brucellae are alpha-Proteobacteria facultative intracellular parasites that cause an important zoonosis. These bacteria escape early detection by innate immunity, an ability associated to the absence of marked pathogen-associated molecular patterns in the cell envelope lipopolysaccharide, lipoproteins and flagellin. We show here that, in contrast to the outer membrane ornithine lipids (OL) of other Gram negative bacteria, Brucella abortus OL lack a marked pathogen-associated molecular pattern activity. We identified two OL genes (olsB and olsA) and by generating the corresponding mutants found that olsB deficient B. abortus did not synthesize OL or their lyso-OL precursors. Liposomes constructed with B. abortus OL did not trigger IL-6 or TNF-alpha release by macrophages whereas those constructed with Bordetella pertussis OL and the olsB mutant lipids as carriers were highly active. The OL deficiency in the olsB mutant did not promote proinflammatory responses or generated attenuation in mice. In addition, OL deficiency did not increase sensitivity to polymyxins, normal serum or complement consumption, or alter the permeability to antibiotics and dyes. Taken together, these observations indicate that OL have become dispensable in the extant brucellae and are consistent within the trend observed in alpha-Proteobacteria animal pathogens to reduce and eventually eliminate the envelope components susceptible of recognition by innate immunity.
C1 [Palacios-Chaves, Leyre; Conde-Alvarez, Raquel; Gil-Ramirez, Yolanda; Zuniga-Ripa, Amaia; Moriyon, Ignacio; Iriarte, Maite] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain.
   [Conde-Alvarez, Raquel] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Chacon-Diaz, Carlos; Chaves-Olarte, Esteban; Moreno, Edgardo] Univ Costa Rica, Fac Microbiol, Ctr Invest Enfermedades Trop, San Jose, Costa Rica.
   [Barquero-Calvo, Elias; Chacon-Diaz, Carlos; Chaves-Olarte, Esteban] Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Trop, Heredia, Costa Rica.
   [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Fac Sci Luminy, INSERM,CNRS,U631,UMR6102, Marseille, France.
   [Moreno, Edgardo] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Pedro, Costa Rica.
   [de Miguel, Maria-Jesus] CITA, Unidad Sanidad Anim, Zaragoza, Spain.
   [Grillo, Maria-Jesus] CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Pamplona, Spain.
RP Palacios-Chaves, L (corresponding author), Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain.
EM miriart@unav.es
RI De Miguel, Maria Jesus/K-5860-2014; Zuniga-Ripa, Amaia/ABB-4859-2020;
   ZUNIGA-RIPA, AMAIA/F-5117-2017; IRIARTE, MAITE/L-9460-2014;
   Conde-Alvarez, Raquel/K-5854-2014; Moriyon, Ignacio/N-4764-2016; Grillo,
   Maria-Jesus/F-9621-2011; Gorvel, Jean-Pierre/O-1332-2018
OI De Miguel, Maria Jesus/0000-0002-5037-3687; Zuniga-Ripa,
   Amaia/0000-0001-7865-8994; ZUNIGA-RIPA, AMAIA/0000-0001-7865-8994;
   IRIARTE, MAITE/0000-0002-6726-8920; Conde-Alvarez,
   Raquel/0000-0003-0046-3577; Moriyon, Ignacio/0000-0002-4288-0195;
   Grillo, Maria-Jesus/0000-0002-1819-0186; Gorvel,
   Jean-Pierre/0000-0002-2829-9804; Arce-Gorvel, Vilma/0000-0003-0090-837X
FU Ministerio de Ciencia y Tecnologia of SpainSpanish Government
   [AGL2008-04514-C03]; Universidad Nacional de Costa Rica; S-Conare
   UNA/UCR, Costa Rica [IFEG29]; NeTropica [P00059, F00013-02];
   MICIT/CONICIT [IFDG12]; Fundacion CRUSA-CSIC [CR2008-0006]; Centre
   National de la Recherche ScientifiqueCentre National de la Recherche
   Scientifique (CNRS); Institut National de la Sante et de la Recherche
   Medicale and the Ministry of Education in France; Ministerio de Ciencia
   y Tecnologia of SpainSpanish Government; University of Navarra
FX Research at the laboratories of the authors is supported by the
   Ministerio de Ciencia y Tecnologia of Spain (AGL2008-04514-C03); FIDA,
   Universidad Nacional de Costa Rica; FS-Conare UNA/UCR IFEG29 Costa Rica;
   NeTropica P00059 and F00013-02; MICIT/CONICIT IFDG12; Fundacion
   CRUSA-CSIC (CR2008-0006); Centre National de la Recherche Scientifique,
   Institut National de la Sante et de la Recherche Medicale and the
   Ministry of Education in France. Fellowship support for L.P.-C., Y.G.-R.
   and A.Z.-R from the Ministerio de Ciencia y Tecnologia of Spain,
   Gobierno de Navarra and Friends of the University of Navarra is also
   acknowledged. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Alton G., 1988, TECHNIQUES BRUCELLOS
   Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102
   Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006
   Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631
   Barquero-Calvo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005893
   Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x
   Comerci DJ, 2006, J BACTERIOL, V188, P1929, DOI 10.1128/JB.188.5.1929-1934.2006
   Conde-Alvarez R, 2006, CELL MICROBIOL, V8, P1322, DOI 10.1111/j.1462-5822.2006.00712.x
   DECHASTELLIER C, 1993, INFECT IMMUN, V61, P3775, DOI 10.1128/IAI.61.9.3775-3784.1993
   DETEJADA GM, 1995, INFECT IMMUN, V63, P3054
   DETEJADA GM, 1993, J BACTERIOL, V175, P5273
   DORRER E, 1977, ARCH MICROBIOL, V114, P87, DOI 10.1007/BF00429636
   Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204
   Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050
   Freer E, 1996, J BACTERIOL, V178, P5867, DOI 10.1128/jb.178.20.5867-5876.1996
   GAMAZO C, 1987, INFECT IMMUN, V55, P609, DOI 10.1128/IAI.55.3.609-615.1987
   Gao JL, 2004, MOL MICROBIOL, V53, P1757, DOI 10.1111/j.1365-2958.2004.04240.x
   Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002
   GERHARDT P, 1958, BACTERIOL REV, V22, P81, DOI 10.1128/MMBR.22.2.81-98.1958
   Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760
   Grillo MJ, 2006, VACCINE, V24, P2910, DOI 10.1016/j.vaccine.2005.12.038
   Hallez R, 2007, APPL ENVIRON MICROB, V73, P1375, DOI 10.1128/AEM.01873-06
   Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998
   IRIARTE M, 2004, MOL CELL BIOL, P159
   Kato H, 1997, MICROBIOL IMMUNOL, V41, P101, DOI 10.1111/j.1348-0421.1997.tb01175.x
   KAWAI Y, 1985, EUR J BIOCHEM, V147, P367, DOI 10.1111/j.1432-1033.1985.tb08759.x
   Kawai Y, 1985, Dev Biol Stand, V61, P249
   Kawai Y, 1999, FEMS IMMUNOL MED MIC, V23, P67, DOI 10.1016/S0928-8244(98)00122-9
   KAWAI Y, 1991, INFECT IMMUN, V59, P2560, DOI 10.1128/IAI.59.8.2560-2566.1991
   KAWAI Y, 1991, FEMS MICROBIOL LETT, V83, P127
   Kawai Y, 2000, FEMS IMMUNOL MED MIC, V28, P205
   KAWAI Y, 1989, INFECT IMMUN, V57, P2086, DOI 10.1128/IAI.57.7.2086-2091.1989
   Kawai Y, 2000, FEMS IMMUNOL MED MIC, V28, P197, DOI 10.1016/S0928-8244(00)00156-5
   Kong WM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-12
   KUPFER D, 1984, J BACTERIOL, V159, P776, DOI 10.1128/JB.159.2.776-779.1984
   Lapaque N, 2009, MICROB PATHOGENESIS, V47, P299, DOI 10.1016/j.micpath.2009.09.005
   Lin MQ, 2003, CELL MICROBIOL, V5, P809, DOI 10.1046/j.1462-5822.2003.00322.x
   Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567
   Manterola L, 2005, J BACTERIOL, V187, P5631, DOI 10.1128/JB.187.16.5631-5639.2005
   MINNIKIN DE, 1974, FEBS LETT, V43, P257, DOI 10.1016/0014-5793(74)80655-1
   Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003
   MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990
   MORIYON I, 1982, J BACTERIOL, V152, P822
   NIKAIDO H, 1985, MICROBIOL REV, V49, P1
   Rikihisa Y, 2006, CURR OPIN MICROBIOL, V9, P95, DOI 10.1016/j.mib.2005.12.003
   Rojas-Jimenez K, 2005, MOL PLANT MICROBE IN, V18, P1175, DOI 10.1094/MPMI-18-1175
   Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017
   THIELE O W, 1973, European Journal of Biochemistry, V34, P333, DOI 10.1111/j.1432-1033.1973.tb02764.x
   Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000
   Weissenmayer B, 2002, MOL MICROBIOL, V45, P721, DOI 10.1046/j.1365-2958.2002.03043.x
   West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200
NR 55
TC 24
Z9 24
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 7
PY 2011
VL 6
IS 1
AR e16030
DI 10.1371/journal.pone.0016030
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 710LJ
UT WOS:000286512900019
PM 21249206
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Matsumoto, T
   Dieni, S
   Dekkers, M
   Rauskolb, S
   Ionescu, M
   Deogracias, R
   Gundelfinger, ED
   Kojima, M
   Nestel, S
   Frotscher, M
   Barde, YA
AF Matsumoto, Tomoya
   Dieni, Sandra
   Dekkers, Martijn
   Rauskolb, Stefanie
   Ionescu, Mihai
   Deogracias, Ruben
   Gundelfinger, Eckart D.
   Kojima, Masami
   Nestel, Sigrun
   Frotscher, Michael
   Barde, Yves-Alain
TI Localization and secretion of BDNF in the hippocampus
SO NEUROSCIENCE RESEARCH
LA English
DT Meeting Abstract
C1 [Matsumoto, Tomoya] Hiroshima Univ, Grad Sch Med Sci, Dept Psychiat & Neurosci, Hiroshima, Japan.
   [Dieni, Sandra; Nestel, Sigrun; Frotscher, Michael] Univ Freiburg, Inst Anat & Cell Biol, D-79106 Freiburg, Germany.
   [Matsumoto, Tomoya; Dekkers, Martijn; Rauskolb, Stefanie; Ionescu, Mihai; Deogracias, Ruben; Barde, Yves-Alain] Univ Basel, Biozentrum, Basel, Switzerland.
   [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany.
   [Kojima, Masami] AIST, Biointerface Res Grp, Ikeda, Osaka, Japan.
   [Kojima, Masami] JST, CREST, Kawaguchi, Saitama, Japan.
RI Deogracias, Ruben/I-5751-2015
OI Deogracias, Ruben/0000-0002-9279-7867
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
J9 NEUROSCI RES
JI Neurosci. Res.
PY 2011
VL 71
SU S
BP E138
EP E138
DI 10.1016/j.neures.2011.07.594
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA 998DT
UT WOS:000308218100588
DA 2021-01-25
ER

PT J
AU Herrmann, H
   Moller, D
   Mauermann, M
   Noske, K
   Hergt, M
   Aebi, U
AF Herrmann, H.
   Moeller, D.
   Mauermann, M.
   Noeske, K.
   Hergt, M.
   Aebi, U.
TI Assembly properties and cellular distribution of human lamin A progeria
   mutants
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Cell-Biology (ASCB)
CY DEC 03-07, 2011
CL Denver, CO
SP Amer Soc Cell Biol (ASCB)
C1 [Herrmann, H.; Moeller, D.; Mauermann, M.; Noeske, K.; Hergt, M.] German Canc Res Ctr, Heidelberg, Germany.
   [Aebi, U.] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2011
VL 22
MA 291
PG 2
WC Cell Biology
SC Cell Biology
GA 961YM
UT WOS:000305505500290
DA 2021-01-25
ER

PT J
AU Kilchert, C
   Spang, A
AF Kilchert, C.
   Spang, A.
TI Cotranslational transport of ABP140 mRNA to the distal pole of S.
   cerevisiae
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Cell-Biology (ASCB)
CY DEC 03-07, 2011
CL Denver, CO
SP Amer Soc Cell Biol (ASCB)
C1 [Kilchert, C.; Spang, A.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2011
VL 22
MA 1707
PG 1
WC Cell Biology
SC Cell Biology
GA 961YM
UT WOS:000305505503289
DA 2021-01-25
ER

PT J
AU Mihov, D
   Spiess, M
AF Mihov, D.
   Spiess, M.
TI Glycosaminoglycan attachment affects the intracellular transport of the
   amyloid precursor protein.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Cell-Biology (ASCB)
CY DEC 03-07, 2011
CL Denver, CO
SP Amer Soc Cell Biol (ASCB)
C1 [Mihov, D.; Spiess, M.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2011
VL 22
MA 1986
PG 2
WC Cell Biology
SC Cell Biology
GA 961YM
UT WOS:000305505504017
DA 2021-01-25
ER

PT J
AU Silvan, U
   Boiteux, C
   Suetterlin, R
   Mannherz, HG
   Jockusch, BM
   Berneche, S
   Aebi, U
   Schoenenberger, CA
AF Silvan, U.
   Boiteux, C.
   Suetterlin, R.
   Mannherz, H. G.
   Jockusch, B. M.
   Berneche, S.
   Aebi, U.
   Schoenenberger, C-A.
TI Antiparallel subunit contacts are present in supramolecular actin
   structures related to the endocytic compartment.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Cell-Biology (ASCB)
CY DEC 03-07, 2011
CL Denver, CO
SP Amer Soc Cell Biol (ASCB)
C1 [Silvan, U.; Aebi, U.; Schoenenberger, C-A.] Univ Basel, Biozentrum, MIH, Basel, Switzerland.
   [Mannherz, H. G.] Ruhr Univ Bochum, Bochum, Germany.
   [Jockusch, B. M.] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig, Germany.
RI Silvan, Unai/J-7376-2013
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2011
VL 22
MA 1407
PG 1
WC Cell Biology
SC Cell Biology
GA 961YM
UT WOS:000305505502520
DA 2021-01-25
ER

PT J
AU Hadziselimovic, F
   Hadziselimovic, NO
   Demougin, P
   Krey, G
   Oakeley, EJ
AF Hadziselimovic, F.
   Hadziselimovic, N. O.
   Demougin, P.
   Krey, G.
   Oakeley, E. J.
TI Deficient Expression of Genes Involved in the Endogenous Defense System
   against Transposons in Cryptorchid Boys with Impaired Mini-Puberty
SO SEXUAL DEVELOPMENT
LA English
DT Article
DE Adult/dark spermatogonia; Azoospermia; Cryptorchidism; Germ cell;
   Transposon
ID TESTICULAR DEVELOPMENT; KALLMANN-SYNDROME; GERM; FERTILITY;
   RETROTRANSPOSONS
AB Mini-puberty is the period between 30 and 80 days after birth when testosterone and gonadotropin surges occur in male infants to induce the transformation of gonocytes into adult/dark spermatogonia. Cryptorchid boys with impaired mini-puberty develop infertility despite timely and successful surgical treatment. The decreased germ cell count found in this group of boys could be the result of uncontrolled transposon activity inducing genomic instability and germ cell death. A genome-wide analysis of 18 cryptorchid and 4 control testes was performed with Affymetrix chips. We found that 5 of 8 genes that are important for transposon silencing were not expressed in the high azoospermia risk group of cryptorchid boys but were expressed in the low azoospermia risk and control groups. Two genes, CBX3 and DNMT1, were equally expressed in all 3 groups. Impaired expression of the DDX4, MAEL, MOV10L1, PIWIL2, PIWIL4, and TDRD9 genes in the group of cryptorchid boys at high risk of infertility indicates that gene instability induced by impaired expression of transposon silencing genes contribute to the development of azoospermia. Intact mini-puberty appears to be essential for the development of the endogenous defense system mediated by transposon silencing. Copyright (C) 2012 S. Karger AG, Basel
C1 [Hadziselimovic, F.] Kindertagesklin Liestal, CH-4410 Liestal, Switzerland.
   [Hadziselimovic, F.; Hadziselimovic, N. O.; Krey, G.] Inst Androl, Liestal, Switzerland.
   [Demougin, P.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Oakeley, E. J.] Novartis Inst Biomed Res, Basel, Switzerland.
RP Hadziselimovic, F (corresponding author), Kindertagesklin Liestal, Oristalstr 87A, CH-4410 Liestal, Switzerland.
EM praxis@kindertagesklinik.ch
CR Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058
   Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408
   Beyer U, 2011, P NATL ACAD SCI USA, V108, P3624, DOI 10.1073/pnas.1016201108
   Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848
   Brown JP, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-9
   Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001
   Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640
   Deutsch EW, 2008, NAT BIOTECHNOL, V26, P305, DOI 10.1038/nbt1391
   Fedder J, 2004, FERTIL STERIL, V82, P1463, DOI 10.1016/j.fertnstert.2004.06.035
   Frost RJA, 2010, P NATL ACAD SCI USA, V107, P11847, DOI 10.1073/pnas.1007158107
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   HADZISELIMOVIC F, 1986, J UROLOGY, V136, P274, DOI 10.1016/S0022-5347(17)44839-7
   Hadziselimovic F, 2008, KLIN PADIATR, V220, P302, DOI 10.1055/s-2007-993194
   Hadziselimovic F, 2008, J UROLOGY, V180, P1116, DOI 10.1016/j.juro.2008.05.063
   HADZISELIMOVIC F, 1975, J PEDIATR SURG, V10, P19, DOI 10.1016/S0022-3468(75)80004-2
   Hadziselimovic F, 2005, J UROLOGY, V174, P1536, DOI 10.1097/01.ju.0000181506.97839.b0
   Hadziselimovic F, 2011, SEX DEV, V5, P49, DOI 10.1159/000323955
   Hadziselimovic F, 2009, SEX DEV, V3, P253, DOI 10.1159/000249147
   Hadziselimovic F, 2001, LANCET, V358, P1156, DOI 10.1016/S0140-6736(01)06274-2
   Hadziselimovic F, 2007, HORM RES, V68, P46, DOI 10.1159/000100874
   Hadziselimovic NO, 2010, UROL INT, V84, P353, DOI 10.1159/000288242
   HUFF DS, 1991, J UROLOGY, V146, P630, DOI 10.1016/S0022-5347(17)37876-X
   Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973
   Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110
   Laitinen EM, 2011, MOL CELL ENDOCRINOL, V341, P35, DOI 10.1016/j.mce.2011.05.015
   Mitchell AL, 2011, TRENDS ENDOCRIN MET, V22, P249, DOI 10.1016/j.tem.2011.03.002
   Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995
   Pierik FH, 2009, INT J ANDROL, V32, P249
   Sato N, 2006, J CLIN ENDOCR METAB, V91, P1415, DOI 10.1210/jc.2005-2266
   Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012
   Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015
   van der Heijden GW, 2009, EPIGENETICS-US, V4, P76, DOI 10.4161/epi.4.2.7783
   Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449
   Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031
   Zivkovic D, 2007, BJU INT, V100, P1147, DOI 10.1111/j.1464-410X.2007.07034.x
NR 35
TC 20
Z9 22
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1661-5425
EI 1661-5433
J9 SEX DEV
JI Sex. Dev.
PY 2011
VL 5
IS 6
BP 287
EP 293
DI 10.1159/000335188
PG 7
WC Developmental Biology
SC Developmental Biology
GA 889UP
UT WOS:000300100100004
PM 22223142
DA 2021-01-25
ER

PT J
AU Duany, YD
   Klostermeier, D
AF Duany, Yoandris del Toro
   Klostermeier, Dagmar
TI Nucleotide-driven conformational changes in the reverse gyrase
   helicase-like domain couple the nucleotide cycle to DNA processing
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID TOPOISOMERASE; ATP; BINDING; RHO
AB Reverse gyrase introduces positive supercoils into DNA in an ATP-dependent process. It has a modular structure comprising a helicase-like and a topoisomerase domain. The helicase-like domain consists of two RecA-like subdomains and thus structurally resembles members of the helicase superfamily 2. It is a nucleotide-dependent switch that alters between an ATP state with a slight preference for dsDNA, and an ADP state with a high preference for ssDNA. Inter-domain communication between the helicase-like and the topoisomerase domain is central for their functional cooperation in reverse gyrase. The latch, an insertion into the helicase-like domain, has been suggested as an important element in coordinating their activities. Here, we have dissected the nucleotide cycle of the reverse gyrase helicase-like domain in the absence and presence of different DNA substrates. With this comprehensive thermodynamic characterization of the nucleotide cycle of the helicase-like domain, in combination with single molecule FRET data on the conformation of the helicase-like domain at all stages of the catalytic cycle, a picture emerges as to how the helicase-like domain may guide ATP-dependent positive supercoiling by reverse gyrase.
C1 [Duany, Yoandris del Toro; Klostermeier, Dagmar] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany.
EM dagmar.klostermeier@uni-muenster.de
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX This work was supported by the Swiss National Science Foundation.
CR Aregger R, 2009, BIOCHEMISTRY-US, V48, P10679, DOI 10.1021/bi901278p
   CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753
   de la Tour CB, 2008, J BIOL CHEM, V283, P27395, DOI 10.1074/jbc.M800867200
   Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199
   DOLAN JW, 1990, J BIOL CHEM, V265, P5747
   DOMBROSKI AJ, 1988, P NATL ACAD SCI USA, V85, P2538, DOI 10.1073/pnas.85.8.2538
   DUANY YD, UNPUB
   Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587
   Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1
   Ganguly A, 2011, NUCLEIC ACIDS RES, V39, P1789, DOI 10.1093/nar/gkq1048
   Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4
   Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200
   Hsieh TS, 2005, J BIOL CHEM, V280, P20467, DOI 10.1074/jbc.M502739200
   Jungblut SP, 2007, J MOL BIOL, V371, P197, DOI 10.1016/j.jmb.2007.05.031
   Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683
   Karow AR, 2009, NUCLEIC ACIDS RES, V37, P4464, DOI 10.1093/nar/gkp397
   KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0
   Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125
   Plank J, 2009, J BIOL CHEM, V284, P30737, DOI 10.1074/jbc.R109.051268
   RECORD MT, 1981, ANNU REV BIOCHEM, V50, P997, DOI 10.1146/annurev.bi.50.070181.005025
   Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
NR 24
TC 14
Z9 14
U1 0
U2 5
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2011
VL 13
IS 21
BP 10009
EP 10019
DI 10.1039/c0cp02859b
PG 11
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 765TR
UT WOS:000290732000012
PM 21350762
DA 2021-01-25
ER

PT J
AU Nowak, C
   Schach, D
   Gebert, J
   Grosserueschkamp, M
   Gennis, RB
   Ferguson-Miller, S
   Knoll, W
   Walz, D
   Naumann, RLC
AF Nowak, Christoph
   Schach, Denise
   Gebert, Jens
   Grosserueschkamp, Marc
   Gennis, Robert B.
   Ferguson-Miller, Shelagh
   Knoll, Wolfgang
   Walz, Dieter
   Naumann, Renate L. C.
TI Oriented immobilization and electron transfer to the cytochrome c
   oxidase
SO JOURNAL OF SOLID STATE ELECTROCHEMISTRY
LA English
DT Article
ID PROTEIN; SURFACE; VOLTAMMETRY; MECHANISMS; BILAYER
AB Direct electron transfer to cytochrome c oxidase (CcO) is investigated as a function of packing density of the surface layer. This is varied by the surface concentration of chelator molecules when the enzyme is immobilized on the electrode using the his-tag technology. Chelator molecules with a terminal nitrilotriacetic acid group are synthesized ex situ in contrast to in situ synthesis used in a previous work. Self-assembled monolayers of the chelator mixed at different mole fractions with a dilution molecule are prepared to bind the CcO after complex formation with Ni2+ ions. The CcO, which is immobilized in the solubilized form, is then reconstituted into a protein-tethered bilayer lipid membrane (ptBLM). Varying the mixing ratio of chelator to dilution molecules enabled us to control the packing density of CcO residing in the ptBLM. Subtle differences in the architecture of the protein/lipid layers revealed by surface-enhanced IR absorption spectroscopy are considered to be essential for an effective electron transfer. Cyclic voltammograms are measured under anaerobic conditions at different scan rates and analyzed by means of a model which describes the transfer of four electrons to CcO in the ptBLM. The rate constants thus obtained show a marked dependence on the packing density.
C1 [Nowak, Christoph; Schach, Denise; Gebert, Jens; Grosserueschkamp, Marc; Naumann, Renate L. C.] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
   [Ferguson-Miller, Shelagh] Michigan State Univ Biochem & Mol Biol, E Lansing, MI USA.
   [Nowak, Christoph; Schach, Denise; Gebert, Jens; Grosserueschkamp, Marc; Knoll, Wolfgang; Naumann, Renate L. C.] Austrian Inst Technol GmbH AIT, A-1220 Vienna, Austria.
   [Walz, Dieter] Univ Basel, Biozentrum, Basel, Switzerland.
RP Naumann, RLC (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM naumannr@mpip-mainz.mpg.de
CR Armstrong FA, 2002, RUSS J ELECTROCHEM+, V38, P49, DOI 10.1023/A:1013786328075
   Armstrong FA, 2002, J CHEM SOC DALTON, P661, DOI 10.1039/b108359g
   Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h
   Baymann F, 2003, FEBS LETT, V539, P91, DOI 10.1016/S0014-5793(03)00206-0
   Friedrich MG, 2008, BIOPHYS J, V95, P1500, DOI 10.1529/biophysj.107.122747
   Friedrich MG, 2008, BIOPHYS J, V94, P3698, DOI 10.1529/biophysj.107.117846
   FRIEDRICH MG, 2004, CHEM COMM CAMB, V21, P2376
   Giess F, 2004, BIOPHYS J, V87, P3213, DOI 10.1529/biophysj.104.046169
   Hesse M., 2005, SPEKTROSKOPISCHE MET
   Hrabakova J, 2006, PHYS CHEM CHEM PHYS, V8, P759, DOI 10.1039/b513379n
   Jeuken LJC, 2002, J AM CHEM SOC, V124, P5702, DOI 10.1021/ja012638w
   Kroger D, 1999, BIOSENS BIOELECTRON, V14, P155, DOI 10.1016/S0956-5663(98)00116-X
   MCINTOSH JEA, 1980, MATH MODELLING COMPU
   MITCHELL DM, 1995, FEBS LETT, V368, P148, DOI 10.1016/0014-5793(95)00626-K
   Nowak C, 2009, APPL SPECTROSC, V63, P1068, DOI 10.1366/000370209789379330
   NOWAK C, 2010, LANGMUIR IN PRESS
   Nowak C, 2009, J PHYS CHEM C, V113, P2256, DOI 10.1021/jp8071052
   Robertson JWF, 2008, J PHYS CHEM B, V112, P10475, DOI 10.1021/jp800162d
   SCHACH D, 2009, J SOLID ELE IN PRESS
   Stuart B.H., 1997, BIOL APPL INFRARED S
   WALZ D, 1995, BIOELECTROCHEMISTRY, P1
NR 21
TC 28
Z9 29
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1432-8488
EI 1433-0768
J9 J SOLID STATE ELECTR
JI J. Solid State Electrochem.
PD JAN
PY 2011
VL 15
IS 1
BP 105
EP 114
DI 10.1007/s10008-010-1032-x
PG 10
WC Electrochemistry
SC Electrochemistry
GA 722TH
UT WOS:000287457300012
OA Other Gold
DA 2021-01-25
ER

PT J
AU Grimm, M
   Jeney, S
   Franosch, T
AF Grimm, Matthias
   Jeney, Sylvia
   Franosch, Thomas
TI Brownian motion in a Maxwell fluid
SO SOFT MATTER
LA English
DT Article
ID MICRORHEOLOGY; MODULI
AB The equilibrium dynamics of a spherical particle immersed in a complex Maxwell fluid is analyzed in terms of velocity autocorrelation function (VACF), mean-square displacement (MSD), and power spectral density (PSD). We elucidate the role of hydrodynamic memory and its interplay with medium viscoelasticity for a free and a harmonically confined particle. The elastic response at high frequencies introduces oscillations in the VACF, which are found to be strongly damped by the coupling to the fluid. We show that in all Maxwell fluids hydrodynamic memory eventually leads to a power-law decay in the VACF as is already known for Newtonian fluids. The MSD displays asymptotically an intermediate plateau reflecting the elastic restoring forces of the medium. In the frequency domain, the PSD exhibits at high frequencies a step due to the trapping, whereas the low-frequency decay reflects the viscoelastic relaxation. Our results suggest that high-frequency microrheology is well-suited to infer the elastic modulus, which is sensitive over a wide range of Maxwell times.
C1 [Grimm, Matthias; Franosch, Thomas] Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Fak Phys, D-80333 Munich, Germany.
   [Franosch, Thomas] Univ Erlangen Nurnberg, Inst Theoret Phys, D-91058 Erlangen, Germany.
   [Grimm, Matthias; Jeney, Sylvia] Ecole Polytech Fed Lausanne, Inst Phys Matiere Condensee, CH-1015 Lausanne, Switzerland.
   [Grimm, Matthias; Jeney, Sylvia] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Franosch, T (corresponding author), Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Fak Phys, Theresienstr 37, D-80333 Munich, Germany.
EM franosch@physik.uni-erlangen.de
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); German Academic Exchange Service (DAAD)Deutscher Akademischer
   Austausch Dienst (DAAD); German Excellence Initiative;  [200021-113529]
FX We acknowledge helpful discussions with B. U. Felderhof and thank A.
   Doyon for drawing the illustration of Fig. 1. This work was supported by
   grants from the Swiss National Science Foundation through the NCCR-Nano
   module 1 and the project no. 200021-113529 to SJ and MG. MG is also
   supported by a scholarship of the German Academic Exchange Service
   (DAAD). TF acknowledges support by the German Excellence Initiative via
   the program 'Nanosystems Initiative Munich (NIM)'.
CR ALDER BJ, 1967, PHYS REV LETT, V18, P988, DOI 10.1103/PhysRevLett.18.988
   Atakhorrami M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061508
   Atakhorrami M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208302
   Barnes H.A., 1989, INTRO RHEOLOGY
   Basset III A. B., 1888, PHILOS T ROY SOC LON, V179, P43, DOI DOI 10.1098/RSTA.1888.0003
   Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654
   Boon J. P., 1991, MOL HYDRODYNAMICS
   Buchanan M, 2005, MACROMOLECULES, V38, P8840, DOI 10.1021/ma0500990
   Cardinaux F, 2002, EUROPHYS LETT, V57, P738, DOI 10.1209/epl/i2002-00525-0
   Cicuta P, 2007, SOFT MATTER, V3, P1449, DOI 10.1039/b706004c
   CLERCX HJH, 1992, PHYS REV A, V46, P1942, DOI 10.1103/PhysRevA.46.1942
   Derkach SR, 2009, ADV COLLOID INTERFAC, V151, P1, DOI 10.1016/j.cis.2009.07.001
   Felderhof BU, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3258343
   Feller W., 1991, INTRO PROBABILITY TH
   Ferry J.D., 1980, VISCOELASTIC PROPERT
   Franosch T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031402
   Frey E, 2005, ANN PHYS-BERLIN, V14, P20, DOI 10.1002/andp.200410132
   Fu HC, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061503
   Furst EM, 2005, CURR OPIN COLLOID IN, V10, P79, DOI 10.1016/j.cocis.2005.04.001
   Gagliano J, 2010, EUR BIOPHYS J BIOPHY, V39, P801, DOI 10.1007/s00249-009-0560-8
   Galvan-Miyoshi J, 2008, EUR PHYS J E, V26, P369, DOI 10.1140/epje/i2007-10335-8
   Gisler T, 1999, PHYS REV LETT, V82, P1606, DOI 10.1103/PhysRevLett.82.1606
   Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007
   Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286
   Gotze W., 2009, COMPLEX DYNAMICS GLA
   Guzman C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020713
   HINCH EJ, 1975, J FLUID MECH, V72, P499, DOI 10.1017/S0022112075003102
   J. Boussinesq, 1885, CR HEBD ACAD SCI, V100, P935
   Jeney S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240604
   Kimura Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.041005
   Kubo R., 1991, STAT PHYS
   Landau L.D., 1987, COURSE THEORETICAL P, V6
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Lisy V., ARXIVCONDMAT0410222
   Lukic B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160601
   Lukic B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011112
   Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094
   Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282
   Schmiedeberg M, 2005, EUROPHYS LETT, V69, P629, DOI 10.1209/epl/i2004-10397-8
   Sprakel J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208301
   Sprakel J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061502
   Squires TM, 2010, ANNU REV FLUID MECH, V42, P413, DOI 10.1146/annurev-fluid-121108-145608
   TUCK EO, 1967, MATH COMPUT, V21, P239, DOI 10.2307/2004168
   van der Gucht J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051106
   van Zanten JH, 2000, PHYS REV E, V62, P5389, DOI 10.1103/PhysRevE.62.5389
   Vladimirsky V., 1945, ZH EKSP TEOR FIZ, V15, P258
   WEITZ DA, 1989, PHYS REV LETT, V63, P1747, DOI 10.1103/PhysRevLett.63.1747
   WITZ D, 2009, ANNU REV BIOPHYS, V38, P301
   Yao A, 2009, LAB CHIP, V9, P2568, DOI 10.1039/b907992k
   ZWANZIG R, 1970, PHYS REV A, V2, P2005, DOI 10.1103/PhysRevA.2.2005
NR 50
TC 53
Z9 53
U1 2
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 5
BP 2076
EP 2084
DI 10.1039/c0sm00636j
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 724PN
UT WOS:000287588800066
DA 2021-01-25
ER

PT J
AU Mayans, O
   Basle, A
   Bucher, R
AF Mayans, Olga
   Basle, Arnaud
   Bucher, Rainer
TI TrpS - evolutionary paths to catalytic efficiency
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE tryptophan synthase; enzyme evolution; indels
C1 [Mayans, Olga; Basle, Arnaud] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
   [Bucher, Rainer] Univ Basel, Biozentrum, Basel, Switzerland.
EM Olga.Mayans@liv.ac.uk
CR Dunn MF, 2008, TRENDS BIOCHEM SCI, V33, P254, DOI 10.1016/j.tibs.2008.04.008
   Leopoldseder S, 2006, BIOCHEMISTRY-US, V45, P14111, DOI 10.1021/bi061684b
NR 2
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2011
VL 67
SU S
MA MS93.P22
BP C776
EP C776
DI 10.1107/S010876731108038X
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI4FT
UT WOS:000484219403430
OA Bronze
DA 2021-01-25
ER

PT J
AU Wiegels, T
   Biasini, M
   Lamzin, V
AF Wiegels, Tim
   Biasini, Marco
   Lamzin, Victor
TI Towards more complete models in macromolecular crystal structure
   determination
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE model building; automation; macromolecular crystallography
C1 [Wiegels, Tim; Lamzin, Victor] EMBL, Hamburg Unit, Hamburg, Germany.
   [Biasini, Marco] Univ Basel, Swiss Inst Bioinformat, Biozentrum, Basel, Switzerland.
EM wiegels@embl-hamburg.de
CR Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91
   Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021
NR 2
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2011
VL 67
SU S
MA MS58.P04
BP C592
EP C592
DI 10.1107/S0108767311085023
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI4FT
UT WOS:000484219402484
OA Bronze
DA 2021-01-25
ER

PT J
AU Kohler, V
   Mao, JC
   Heinisch, T
   Pordea, A
   Sardo, A
   Wilson, YM
   Knorr, L
   Creus, M
   Prost, JC
   Schirmer, T
   Ward, TR
AF Koehler, Valentin
   Mao, Jincheng
   Heinisch, Tillmann
   Pordea, Anca
   Sardo, Alessia
   Wilson, Yvonne M.
   Knoerr, Livia
   Creus, Marc
   Prost, Jean-Christophe
   Schirmer, Tilman
   Ward, Thomas R.
TI OsO4 center dot Streptavidin: A Tunable Hybrid Catalyst for the
   Enantioselective cis-Dihydroxylation of Olefins
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE dihydroxylation; metalloenzymes; mutagenesis; osmium
ID ASYMMETRIC DIHYDROXYLATION; ARTIFICIAL METALLOENZYMES; DISUBSTITUTED
   OLEFINS; BIOTIN-BINDING; STREPTAVIDIN; LIGANDS; SITE; METALLOPROTEINS;
   DIOXYGENASE; PROTEINS
C1 [Heinisch, Tillmann; Schirmer, Tilman] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Koehler, Valentin; Mao, Jincheng; Heinisch, Tillmann; Pordea, Anca; Sardo, Alessia; Wilson, Yvonne M.; Knoerr, Livia; Creus, Marc; Prost, Jean-Christophe; Ward, Thomas R.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch; thomas.ward@unibas.ch
RI Pordea, Anca/I-1003-2013; Ward, Thomas R/K-6419-2012; Creus,
   Marc/E-8397-2012
OI Pordea, Anca/0000-0001-8453-0743; Ward, Thomas R/0000-0001-8602-5468;
   Prost, Jean-Christophe/0000-0002-8820-706X; Di Spiezio Sardo,
   Attilio/0000-0001-6485-5735
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [200020-126366]; Cantons of Basel; Marie Curie Training
   NetworkEuropean Union (EU) [FP7-ITN-238434]
FX We thank Prof. C. R. Cantor for the SAV gene, Chiral Technologies Europe
   for help with the method development for chiral-phase HPLC analysis,
   Beat Amrein for preliminary experiments, and Maurus Schmid for his
   contribution to the artwork. This research was funded by the Swiss
   National Science Foundation (Grant 200020-126366), the Cantons of Basel,
   and the Marie Curie Training Network (FP7-ITN-238434).
CR Abe S, 2009, TOP ORGANOMETAL CHEM, V25, P25, DOI 10.1007/3418_2008_4
   Andersson MA, 2002, ANGEW CHEM INT EDIT, V41, P472, DOI 10.1002/1521-3773(20020201)41:3<472::AID-ANIE472>3.0.CO;2-7
   ANDERSSON MA, 2002, ANGEW CHEM, V114, P490
   BECKER H, 1995, J ORG CHEM, V60, P3940, DOI 10.1021/jo00118a005
   Bergstad K, 1999, J AM CHEM SOC, V121, P10424, DOI 10.1021/ja991710b
   Boyd DR, 1998, NAT PROD REP, V15, P309
   Colussi P. A., 2007, [No title captured], Patent No. 2007123689
   DeChancie J, 2007, J AM CHEM SOC, V129, P5419, DOI 10.1021/ja066950n
   Deuss P. J., 2010, ANGEW CHEM, V122, P5443
   Deuss PJ, 2010, ANGEW CHEM INT EDIT, V49, P5315, DOI 10.1002/anie.201002174
   FOURNIER P, 2009, ANGEW CHEM, V121, P4490
   Fournier P, 2009, ANGEW CHEM INT EDIT, V48, P4426, DOI 10.1002/anie.200900713
   Freitag S, 1999, P NATL ACAD SCI USA, V96, P8384, DOI 10.1073/pnas.96.15.8384
   Heinisch T, 2010, CURR OPIN CHEM BIOL, V14, P184, DOI 10.1016/j.cbpa.2009.11.026
   Hudlicky T, 1999, ALDRICHIM ACTA, V32, P35
   Hudlicky T, 2009, SYNLETT, P685, DOI 10.1055/s-0028-1087946
   Humbert N, 2005, ELECTROPHORESIS, V26, P47, DOI 10.1002/elps.200406148
   IMADA Y, 1992, TETRAHEDRON LETT, V33, P5081, DOI 10.1016/S0040-4039(00)61195-4
   Jing Q, 2010, CHEMCATCHEM, V2, P953, DOI 10.1002/cctc.201000159
   Jonsson SY, 2001, J AM CHEM SOC, V123, P1365, DOI 10.1021/ja0035809
   Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020
   KOKUBO T, 1983, J CHEM SOC CHEM COMM, P769, DOI 10.1039/c39830000769
   KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009
   KOLB HC, 1994, J AM CHEM SOC, V116, P1278, DOI 10.1021/ja00083a014
   Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304
   OISHI T, 1992, TETRAHEDRON LETT, V33, P639, DOI 10.1016/S0040-4039(00)92331-1
   PODTETENIEFF J, 2010, ANGEW CHEM, V122, P5277, DOI DOI 10.1002/ANGE.201002106
   Podtetenieff J, 2010, ANGEW CHEM INT EDIT, V49, P5151, DOI 10.1002/anie.201002106
   Pordea A, 2008, J AM CHEM SOC, V130, P8085, DOI 10.1021/ja8017219
   Reetz MT, 2009, TOP ORGANOMETAL CHEM, V25, P63, DOI 10.1007/3418_2008_12
   Rosati F, 2010, CHEMCATCHEM, V2, P916, DOI 10.1002/cctc.201000011
   Sharpless K. B., 2002, ANGEW CHEM, V114, P2126
   Sharpless KB, 2002, ANGEW CHEM INT EDIT, V41, P2024, DOI 10.1002/1521-3773(20020617)41:12<2024::AID-ANIE2024>3.0.CO;2-O
   WALSH PJ, 1994, TETRAHEDRON LETT, V35, P5129, DOI 10.1016/S0040-4039(00)77045-6
   WANG L, 1992, J AM CHEM SOC, V114, P7568, DOI 10.1021/ja00045a042
   WANG ZM, 1993, TETRAHEDRON LETT, V34, P2267, DOI 10.1016/S0040-4039(00)77590-3
   WANG ZM, 1994, J ORG CHEM, V59, P6895, DOI 10.1021/jo00102a008
   WEBER PC, 1992, J AM CHEM SOC, V114, P3197, DOI 10.1021/ja00035a004
   WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722
   Zaitsev AB, 2006, SYNTHESIS-STUTTGART, P1725, DOI 10.1055/s-2006-942378
NR 40
TC 54
Z9 54
U1 1
U2 44
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2011
VL 50
IS 46
BP 10863
EP 10866
DI 10.1002/anie.201103632
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 851ZY
UT WOS:000297312600018
PM 21948623
DA 2021-01-25
ER

PT S
AU Ruegg, MA
   Glass, DJ
AF Rueegg, Markus A.
   Glass, David J.
BE Cho, AK
TI Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases
SO ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011
SE Annual Review of Pharmacology and Toxicology
LA English
DT Review; Book Chapter
DE atrophy; muscular dystrophy; proteasome; dystrophin glycoprotein
   complex; exon skipping; protein synthesis; insulin-like growth factor;
   nonsense suppression
ID GROWTH-FACTOR-I; DUCHENNE MUSCULAR-DYSTROPHY; SCF UBIQUITIN LIGASE;
   DEPENDENT CARDIAC-HYPERTROPHY; SKELETAL MYOTUBE HYPERTROPHY; FOXO
   TRANSCRIPTION FACTORS; CELL-CYCLE ARREST; PROTEIN-KINASE-B; P70 S6
   KINASE; NF-KAPPA-B
AB Loss of muscle mass can be the consequence of pathological changes, as observed in muscular dystrophies; or it can be secondary to cachexia-inducing diseases that cause muscle atrophy, such as cancer, heart disease, or chronic obstructive pulmonary disease; or it can be a consequence of aging or simple disuse. Although muscular dystrophies are rare, muscle loss affects millions of people worldwide. We discuss the molecular mechanisms involved in muscular dystrophy and in muscle atrophy and present current strategies aimed at ameliorating these diseases. Finally, we discuss whether lessons learned from studying muscular dystrophies will also be helpful for halting muscle loss secondary to nondystrophic diseases and whether strategies to halt muscle atrophy have potential for the treatment of muscular dystrophies.
C1 [Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Glass, David J.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch; david.glass@novartis.com
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
CR Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607
   Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918
   Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004
   Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345
   ANIANSSON A, 1980, AGE AGEING, V9, P186, DOI 10.1093/ageing/9.3.186
   Arechavala-Gomeza V, 2010, NEUROPATH APPL NEURO, V36, P265, DOI 10.1111/j.1365-2990.2009.01056.x
   Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106
   Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012
   Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071
   Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866
   Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264
   Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874
   Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154
   Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0
   Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1
   Bosone I, 2001, CLIN NEUROPATHOL, V20, P196
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   Brussee V, 1997, NEUROMUSCULAR DISORD, V7, P487, DOI 10.1016/S0960-8966(97)00115-6
   Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432
   Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6
   Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448
   Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200
   Clancy JP, 2007, AM J RESP CELL MOL, V37, P57, DOI 10.1165/rcmb.2006-0173OC
   Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009
   Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052
   Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8
   COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109
   CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0
   de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870
   Dehoux MJM, 2003, FEBS LETT, V544, P214, DOI 10.1016/S0014-5793(03)00505-2
   DeRuisseau KC, 2005, J APPL PHYSIOL, V98, P1314, DOI 10.1152/japplphysiol.00993.2004
   DEVOL DL, 1990, AM J PHYSIOL, V259, pE89
   Du J, 2000, J BIOL CHEM, V275, P19661, DOI 10.1074/jbc.M907258199
   Dunant P, 2003, MUSCLE NERVE, V27, P624, DOI 10.1002/mus.10341
   Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7
   Escher C, 2010, NEUROMUSCULAR DISORD, V20, P302, DOI 10.1016/j.nmd.2010.02.017
   Escolar DM, 2005, ANN NEUROL, V58, P151, DOI 10.1002/ana.20523
   Gehrig SM, 2008, EXP PHYSIOL, V93, P1190, DOI 10.1113/expphysiol.2008.042838
   Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df
   Glass DJ, 2005, CANCER CELL, V8, P351, DOI 10.1016/j.ccr.2005.10.016
   Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198
   Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297
   Gregorevic P, 2002, AM J PATHOL, V161, P2263, DOI 10.1016/S0002-9440(10)64502-6
   Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71
   Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547
   Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Helderman-van den Enden ATJM, 2010, NEUROMUSCULAR DISORD, V20, P251, DOI 10.1016/j.nmd.2010.01.013
   Heslop L, 2000, J CELL SCI, V113, P2299
   HONG DH, 1995, MOL CELL ENDOCRINOL, V108, P199, DOI 10.1016/0303-7207(95)03476-N
   Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5
   Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910
   Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200
   Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657
   Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X
   KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6
   Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52
   Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004
   Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200
   Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200
   Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789
   Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1
   Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x
   Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220
   Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757
   Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003
   Li ZF, 2005, AM J PATHOL, V166, P491, DOI 10.1016/S0002-9440(10)62271-7
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3
   McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089
   McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457
   Mendell JR, 2009, MOL THER, V17, pS140
   Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837
   Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002
   Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126
   Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176
   Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079
   Murphy KT, 2010, AM J PATHOL, V176, P2425, DOI 10.2353/ajpath.2010.090932
   Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839
   Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005
   Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599
   Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822
   PELLEGRINO C, 1963, J CELL BIOL, V17, P327, DOI 10.1083/jcb.17.2.327
   Peter AK, 2009, HUM MOL GENET, V18, P318, DOI 10.1093/hmg/ddn358
   Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131
   Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015
   Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016
   Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003
   Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007
   Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140
   Rios R, 2004, ENDOCRINOLOGY, V145, P2795, DOI 10.1210/en.2003-1166
   Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131
   Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009
   Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738
   Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004
   Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009
   Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/0968-0004(96)10036-0
   Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4
   Schumperli D, 2004, CELL MOL LIFE SCI, V61, P2560, DOI 10.1007/s00018-004-4190-0
   Sermet-Gaudelus I, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-5
   Shavlakadze T, 2005, GROWTH HORM IGF RES, V15, P4, DOI 10.1016/j.ghir.2004.11.001
   Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x
   Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4
   Straub V, 2008, NEUROTHERAPEUTICS, V5, P619, DOI 10.1016/j.nurt.2008.08.003
   Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004
   Tang Y, 2010, EXPERT OPIN BIOL TH, V10, P395, DOI 10.1517/14712591003604690
   Tarnopolsky MA, 2004, NEUROLOGY, V62, P1771, DOI 10.1212/01.WNL.0000125178.18862.9D
   Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373
   Thirion C, 2007, DRUG NEWS PERSPECT, V20, P357, DOI 10.1358/dnp.2007.20.6.1138159
   Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0
   Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200
   Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008
   Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009
   Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110
   van der Velden JLJ, 2008, J BIOL CHEM, V283, P358, DOI 10.1074/jbc.M707812200
   van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108
   VANDENBURGH HH, 1991, AM J PHYSIOL, V260, pC475
   Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002
   Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338
   Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297
   Wang L, 1998, SHOCK, V10, P298, DOI 10.1097/00024382-199810000-00011
   WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1
   Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200
   Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627
   Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512
   Yoshimura M, 2004, MOL THER, V10, P821, DOI 10.1016/j.ymthe.2004.07.025
   ZENOBI PD, 1992, J CLIN INVEST, V89, P1908, DOI 10.1172/JCI115796
   ZHEN Y, 1993, J APPL PHYSIOL, V74, P410, DOI 10.1152/jappl.1993.74.1.410
NR 150
TC 70
Z9 72
U1 0
U2 18
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0362-1642
BN 978-0-8243-0451-5
J9 ANNU REV PHARMACOL
JI Annu. Rev. Pharmacol. Toxicol.
PY 2011
VL 51
BP 373
EP 395
DI 10.1146/annurev-pharmtox-010510-100537
PG 23
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA BTS31
UT WOS:000287956600017
PM 20936944
DA 2021-01-25
ER

PT J
AU Zahringer, F
   Massa, C
   Schirmer, T
AF Zaehringer, Franziska
   Massa, Claudia
   Schirmer, Tilman
TI Efficient Enzymatic Production of the Bacterial Second Messenger
   c-di-GMP by the Diguanylate Cyclase YdeH from E. coli
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE c-di-GMP; Diguanylate cyclase; GGDEF domain; Enzymatic synthesis; E.
   coli
ID CYCLIC DIGUANYLATE; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; SIGNALING
   MOLECULE; ALLOSTERIC CONTROL; STRUCTURAL BASIS; PILZ DOMAIN;
   PHOSPHODIESTERASE; EAL; IDENTIFICATION
AB Cyclic di-GMP (c-di-GMP) is an almost universal bacterial second messenger involved in the regulation of cell surface-associated traits and the persistence of infections. GGDEF and EAL domain-containing proteins catalyse c-di-GMP synthesis and degradation, respectively. We report the enzymatic large-scale synthesis of c-di-GMP, making use of the GGDEF domain-containing protein YdeH from Escherichia coli. Overexpression and purification of YdeH have been established, and the conditions for c-di-GMP synthesis were optimised. In contrast to the chemical synthesis of c-di-GMP, enzymatic c-di-GMP production is a one-step reaction that can easily be performed with the equipment of a standard biochemical lab. The protocol allows the production of milligram amounts of c-di-GMP within 1 day and paves the way for extensive biochemical and biophysical studies on c-di-GMP-mediated processes.
C1 [Zaehringer, Franziska; Massa, Claudia; Schirmer, Tilman] Univ Basel, Core Program Struct Biol & Biophys, Biozentrum, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Core Program Struct Biol & Biophys, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-105587]
FX We thank Dr. Alexander Bohm, Biozentrum Basel, for the gift of the
   plasmid, Dr. Martin Allan, Biozentrum Basel, for help with
   <SUP>1</SUP>H-NMR spectroscopy and Dietrich Samoray for suggesting to
   test the effect of osmolytes on YdeH solubility. The work was supported
   by Swiss National Science Foundation grant 3100A0-105587.
CR Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   Amiot N, 2006, SYNTHESIS-STUTTGART, P4230, DOI 10.1055/s-2006-950361
   Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x
   Brouillette E, 2005, ANTIMICROB AGENTS CH, V49, P3109, DOI 10.1128/AAC.49.8.3109-3113.2005
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05
   Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h
   Hayakawa Y, 2003, TETRAHEDRON, V59, P6465, DOI 10.1016/S0040-4020(03)01045-7
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06
   Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171
   Karaolis DKR, 2005, BIOCHEM BIOPH RES CO, V329, P40, DOI 10.1016/j.bbrc.2005.01.093
   Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005
   KAWAI R, 2003, NUCL ACIDS RES S, V3, P103
   Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x
   Kiburu I, 2008, MOL BIOSYST, V4, P518, DOI 10.1039/b719423d
   Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x
   Ogunniyi AD, 2008, VACCINE, V26, P4676, DOI 10.1016/j.vaccine.2008.06.099
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007
   Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08
   Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSS P, 1990, J BIOL CHEM, V265, P18933
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005
   Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702
   Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519
   Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998
   Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200
   Tamayo R, 2008, INFECT IMMUN, V76, P1617, DOI 10.1128/IAI.01337-07
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409
   Yan HB, 2007, NUCLEOS NUCLEOT NUCL, V26, P189, DOI 10.1080/15257770601112762
   Zhang ZY, 2004, J AM CHEM SOC, V126, P16700, DOI 10.1021/ja0449832
NR 40
TC 30
Z9 30
U1 2
U2 25
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD JAN
PY 2011
VL 163
IS 1
BP 71
EP 79
DI 10.1007/s12010-010-9017-x
PG 9
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 708TS
UT WOS:000286387800007
PM 20582742
DA 2021-01-25
ER

PT S
AU Engel, A
AF Engel, Andreas
BE Braga, PC
   Ricci, D
TI Imaging and Interrogating Native Membrane Proteins Using the Atomic
   Force Microscope
SO ATOMIC FORCE MICROSCOPY IN BIOMEDICAL RESEARCH: METHODS AND PROTOCOLS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE Atomic force microscope; High-resolution imaging; Single-molecule force
   spectroscopy; Bacterial porin; pH gating; Voltage gating;
   Voltage-dependent anion channel
ID ESCHERICHIA-COLI; OUTER-MEMBRANE; LIPID-BILAYERS; SUBNANOMETER
   RESOLUTION; PORIN CHANNELS; GAP-JUNCTIONS; VOLTAGE; MODULATION; LIQUID;
   AFM
AB Membrane proteins exist in a lipid bilayer and provide for cell-cell communication, transport solutes, and convert energies. Detergents are used to extract membrane proteins and keep them in solution for purification and subsequent analyses. The atomic force microscope (AFM) is a powerful tool for imaging and manipulating membrane proteins in their native state without the necessity to solubilize them. It allows membranes that are adsorbed to flat solid supports to be raster-scanned in physiological solutions with an atomically sharp tip. Therefore, AFM is capable of observing biological molecular machines at work. Superb images of native membranes have been recorded, and a quantitative interpretation of the data acquired using the AFM tip has become possible. In addition, multifunctional probes to simultaneously acquire information on the topography and electrical properties of membrane proteins have been produced. This progress is discussed here and fosters expectations for future developments and applications of AFM and single-molecule force spectroscopy.
C1 Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Basel, Switzerland.
CR Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BRUNEN M, 1993, EUR J BIOCHEM, V212, P129, DOI 10.1111/j.1432-1033.1993.tb17642.x
   Buzhynskyy N, 2007, J MOL BIOL, V374, P162, DOI 10.1016/j.jmb.2007.09.022
   Cisneros DA, 2006, ANGEW CHEM INT EDIT, V45, P3252, DOI 10.1002/anie.200504506
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350
   Delcour AH, 1997, FEMS MICROBIOL LETT, V151, P115, DOI 10.1016/S0378-1097(97)00166-3
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Frederix P. L., 2008, NANOTECHNOLOGY, V19
   Frederix PLTM, 2009, BIOPHYS J, V96, P329, DOI 10.1016/j.bpj.2008.09.046
   Fukuma T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999856
   Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063
   Goncalves RP, 2006, NAT METHODS, V3, P1007, DOI 10.1038/nmeth965
   Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013
   HOH JH, 1991, SCIENCE, V253, P1405, DOI 10.1126/science.1910206
   Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073
   Hoogenboom BW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202638
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   KARSHIKOFF A, 1994, J MOL BIOL, V240, P372, DOI 10.1006/jmbi.1994.1451
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Kienberger F, 2004, EMBO REP, V5, P579, DOI 10.1038/sj.embor.7400149
   MANNELLA CA, 1986, METHOD ENZYMOL, V125, P595
   Mari SA, 2010, J MOL BIOL, V396, P610, DOI 10.1016/j.jmb.2009.12.034
   Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309
   Muller DJ, 2008, CURR OPIN COLLOID IN, V13, P338, DOI 10.1016/j.cocis.2007.09.002
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 2003, J MOL BIOL, V327, P925, DOI 10.1016/S0022-2836(03)00206-7
   Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   NIKAIDO H, 1985, MICROBIOL REV, V49, P1
   PHALE RS, 1997, P NATL ACAD SCI USA, V94, P6741
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   SCHCURING S, 1999, J MICROSC-OXFORD, V193, P28
   SCHINDLER H, 1978, P NATL ACAD SCI USA, V75, P3751, DOI 10.1073/pnas.75.8.3751
   Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946
   Schulz GE, 1993, CURR OPIN CELL BIOL, V5, P701, DOI 10.1016/0955-0674(93)90143-E
   SEN K, 1988, J BIOL CHEM, V263, P1182
   Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164
   TODT JC, 1992, BIOCHEMISTRY-US, V31, P10471, DOI 10.1021/bi00158a009
   Uchihashi T, 2004, APPL PHYS LETT, V85, P3575, DOI 10.1063/1.1803932
   Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2
   Yildiz O, 2006, EMBO J, V25, P3702, DOI 10.1038/sj.emboj.7601237
NR 47
TC 2
Z9 2
U1 0
U2 4
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
BN 978-1-61779-104-8
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2011
VL 736
BP 153
EP 167
DI 10.1007/978-1-61779-105-5_11
D2 10.1007/978-1-61779-105-5
PG 15
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Microscopy
SC Biochemistry & Molecular Biology; Microscopy
GA BVR29
UT WOS:000292530700011
PM 21660727
DA 2021-01-25
ER

PT J
AU Cailleau, G
   Braissant, O
   Verrecchia, EP
AF Cailleau, G.
   Braissant, O.
   Verrecchia, E. P.
TI Turning sunlight into stone: the oxalate-carbonate pathway in a tropical
   tree ecosystem
SO BIOGEOSCIENCES
LA English
DT Article
ID CALCIUM-OXALATE; XYLEM SAP; CRYSTALS; PLANTS; SOILS
AB An African oxalogenic tree, the iroko tree (Milicia excelsa), has the property to enhance carbonate precipitation in tropical oxisols, where such accumulations are not expected due to the acidic conditions in these types of soils. This uncommon process is linked to the oxalate-carbonate pathway, which increases soil pH through oxalate oxidation. In order to investigate the oxalate-carbonate pathway in the iroko system, fluxes of matter have been identified, described, and evaluated from field to microscopic scales. In the first centimeters of the soil profile, decaying of the organic matter allows the release of whewellite crystals, mainly due to the action of termites and saprophytic fungi. In addition, a concomitant flux of carbonate formed in wood tissues contributes to the carbonate flux and is identified as a direct consequence of wood feeding by termites. Nevertheless, calcite biomineralization of the tree is not a consequence of in situ oxalate consumption, but rather related to the oxalate oxidation inside the upper part of the soil. The consequence of this oxidation is the presence of carbonate ions in the soil solution pumped through the roots, leading to preferential mineralization of the roots and the trunk base. An ideal scenario for the iroko biomineralization and soil carbonate accumulation starts with oxalatization: as the iroko tree grows, the organic matter flux to the soil constitutes the litter, and an oxalate pool is formed on the forest ground. Then, wood rotting agents (mainly termites, saprophytic fungi, and bacteria) release significant amounts of oxalate crystals from decaying plant tissues. In addition, some of these agents are themselves producers of oxalate (e. g. fungi). Both processes contribute to a soil pool of "available" oxalate crystals. Oxalate consumption by oxalotrophic bacteria can then start. Carbonate and calcium ions present in the soil solution represent the end products of the oxalate-carbonate pathway. The solution is pumped through the roots, leading to carbonate precipitation. The main pools of carbon are clearly identified as the organic matter (the tree and its organic products), the oxalate crystals, and the various carbonate features. A functional model based on field observations and diagenetic investigations with delta C-13 signatures of the various compartments involved in the local carbon cycle is proposed. It suggests that the iroko ecosystem can act as a long-term carbon sink, as long as the calcium source is related to non-carbonate rocks. Consequently, this carbon sink, driven by the oxalate carbonate pathway around an iroko tree, constitutes a true carbon trapping ecosystem as defined by ecological theory.
C1 [Cailleau, G.; Verrecchia, E. P.] Univ Lausanne, Inst Geol & Palaeontol, Lausanne, Switzerland.
   [Braissant, O.] Univ Basel, Biozentrum, Lab Biomech & Biocalorimetry, Pharmazentrum, Basel, Switzerland.
RP Cailleau, G (corresponding author), Univ Lausanne, Inst Geol & Palaeontol, Lausanne, Switzerland.
EM guillaume.cailleau@unil.ch
RI Braissant, Olivier/AAO-2371-2020; Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [2153-065174, 205320-101564, K-23K1-118130]; EC CO2SolStock
   research consortium
FX The authors wish to thank the CSRS (Swiss Science Research Centre,
   Abidjan, Ivory Coast), Mr. E. Bomisso, Universite de Cocody, Abidjan,
   Ivory Coast, and Mr. J. M. Gargouille and Societe d'Exploitation
   Forestiere du Noun, Massangam, Cameroon. Sample preparations,
   <SUP>14</SUP>C dating and organic matter carbon isotope signature were
   performed at the Institute of Physics, University of Bern. Many thanks
   to M. Andre Villard who prepared all the thin sections used in this
   study, Thierry Adatte for XRD analysis, and Massoud Dadras for his help
   during electron microscopy imaging. Many thanks to K. Verrecchia for her
   help improving the manuscript and suggesting the title. This work has
   been supported by the Swiss National Science Foundation, grants no
   2153-065174, 205320-101564, and K-23K1-118130, and partly funded by the
   EC FP7 CO2SolStock research consortium. We kindly acknowledge Alexander
   Brasier, three anonymous reviewers, and Steven Bouillon for their very
   helpful improvement to the first version of this manuscript.
CR Beazley MJ, 2002, RADIOCARBON, V44, P675, DOI 10.1017/S0033822200032124
   BONSEN KJM, 1991, IAWA BULL, V12, P67, DOI 10.1163/22941932-90001205
   Braissant O, 2002, NATURWISSENSCHAFTEN, V89, P366, DOI 10.1007/s00114-002-0340-0
   BRAISSANT O, 2005, THESIS U NEUCHATEL S
   Braissant O, 2004, GEOBIOLOGY, V2, P59, DOI 10.1111/j.1472-4677.2004.00019.x
   Cailleau G, 2005, CATENA, V59, P1, DOI 10.1016/j.catena.2004.06.002
   Cailleau G, 2004, NATURWISSENSCHAFTEN, V91, P191, DOI 10.1007/s00114-004-0512-1
   Cailleau G., 2006, FUNGI BIOGEOCHEMICAL
   Cailleau G, 2009, SEDIMENTOLOGY, V56, P1858, DOI 10.1111/j.1365-3091.2009.01060.x
   Campbell WG, 1932, EMPIRE FORESTRY J, V11, P244
   Canti MG, 2003, CATENA, V54, P339, DOI 10.1016/S0341-8162(03)00127-9
   CAROZZI AV, 1967, J SEDIMENT PETROL, V37, P597
   Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229
   Clausen CA, 2008, INT BIODETER BIODEGR, V62, P372, DOI 10.1016/j.ibiod.2008.04.001
   CLEMENT A, 1973, Annales des Sciences Forestieres (Paris), V30, P63, DOI 10.1051/forest/19730103
   Cromack Jr K, 1977, ECOL B STOCKHOLM, V25, P246
   Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107
   Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106
   FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532
   Gadd GM, 1999, ADV MICROB PHYSIOL, V41, P47, DOI 10.1016/S0065-2911(08)60165-4
   GLAVAC V, 1990, NEW PHYTOL, V116, P47, DOI 10.1111/j.1469-8137.1990.tb00509.x
   Glavac V, 1990, TREES-STRUCT FUNCT, V4, P75, DOI 10.1007/BF00226069
   GRAUSTEIN WC, 1977, SCIENCE, V198, P1252, DOI 10.1126/science.198.4323.1252
   HARRIS CM, 1933, EMPIRE FORESTRY J, V12, P229
   Hofmann BA, 1998, CHEM GEOL, V149, P127, DOI 10.1016/S0009-2541(98)00043-6
   JANIN G, 1972, Annales des Sciences Forestieres (Paris), V29, P67, DOI 10.1051/forest/19720104
   JAYASURIYA GCN, 1955, J GEN MICROBIOL, V12, P419, DOI 10.1099/00221287-12-3-419
   JOHNSON FB, 1962, ARCH PATHOL, V74, P347
   Leidy J, 1883, Science, V2, P707, DOI 10.1126/science.ns-2.43.707
   Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126
   MENSAH K O A, 1968, Preslia (Prague), V40, P21
   Pobeguin T., 1954, ANN SCI NATURE, V15, P32
   POBEGUIN T., 1943, ANN SCI NATURELLES B, V4, P1
   RECORD SAMUEL J., 1927, TROPICAL WOODS, V12, P22
   Richter H. G., COMMERCIAL TIMBERS D
   ROBERT D, 1989, BIOL VEGETALE
   Schneider A, 1901, BOT GAZ, V32, P142, DOI 10.1086/328143
   Tansley AG, 1935, ECOLOGY, V16, P284, DOI 10.2307/1930070
   VERRECCHIA EP, 1990, GEOMICROBIOL J, V8, P87, DOI 10.1080/01490459009377882
   VERRECCHIA EP, 1991, NATURWISSENSCHAFTEN, V78, P505, DOI 10.1007/BF01131398
   Walton RC, 2003, J STRUCT BIOL, V143, P14, DOI 10.1016/S1047-8477(03)00117-5
   WOLMAN M, 1962, J HISTOCHEM CYTOCHEM, V10, P505, DOI 10.1177/10.4.505
NR 42
TC 33
Z9 35
U1 2
U2 47
PU COPERNICUS GESELLSCHAFT MBH
PI GOTTINGEN
PA BAHNHOFSALLEE 1E, GOTTINGEN, 37081, GERMANY
SN 1726-4170
EI 1726-4189
J9 BIOGEOSCIENCES
JI Biogeosciences
PY 2011
VL 8
IS 7
BP 1755
EP 1767
DI 10.5194/bg-8-1755-2011
PG 13
WC Ecology; Geosciences, Multidisciplinary
SC Environmental Sciences & Ecology; Geology
GA 810UT
UT WOS:000294153700001
OA DOAJ Gold
DA 2021-01-25
ER

PT S
AU Reichert, H
AF Reichert, Heinrich
BE Kubiak, JZ
TI Drosophila Neural Stem Cells: Cell Cycle Control of Self-Renewal,
   Differentiation, and Termination in Brain Development
SO CELL CYCLE IN DEVELOPMENT
SE Results and Problems in Cell Differentiation
LA English
DT Article; Book Chapter
ID PRONEURAL GENE-EXPRESSION; CENTRAL-NERVOUS-SYSTEM; AMPLIFYING NEUROBLAST
   LINEAGES; REGULATES SPINDLE ORIENTATION; ASYMMETRIC DIVISION; TEMPORAL
   IDENTITY; POSTEMBRYONIC NEUROBLASTS; TRANSCRIPTION FACTORS;
   TUMOR-SUPPRESSOR; G-PROTEIN
AB The wealth of neurons that make up the brain are generated through the proliferative activity of neural stem cells during development. This neurogenesis activity involves complex cell cycle control of proliferative self-renewal, differentiation, and termination processes in these cells. Considerable progress has been made in understanding these processes in the neural stem cell-like neuroblasts which generate the brain in the genetic model system Drosophila. Neuroblasts in the developing fly brain generate neurons through repeated series of asymmetrical cell divisions, which balance self-renewal of the neuroblast with generation of differentiated progeny through the segregation of cell fate determinants such as Numb, Prospero, and Brat to the neural progeny. A number of classical cell cycle regulators such as cdc2/CDK 1, Polo, Aurora A, and cyclin E are implicated in the control of asymmetric divisions in neuroblasts linking the cell cycle to the asymmetrical division machinery. The cellular and molecular identity of the postmitotic neurons produced by proliferating neuroblasts is influenced by the timing of their exit from the cell cycle through the action of a temporal expression series of transcription factors, which include Hunchback, Kruppel, Pdm, and Castor. This temporal series is also implicated in the control of termination of neuroblast proliferation which is effected by two different cell cycle exit strategies, terminal differentiative division or programmed cell death of the neuroblast. Defects in the asymmetric division machinery which interfere with the termination of proliferation can result in uncontrolled tumorigenic overgrowth. These findings in Drosophila brain development are likely to have general relevance in neural stem cell biology and may apply to cell cycle control in mammalian brain development as well.
C1 [Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch
CR Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004
   Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582
   Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706
   ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Berger C, 2005, NAT CELL BIOL, V7, P56, DOI 10.1038/ncb1203
   Berger C, 2010, DEV BIOL, V337, P415, DOI 10.1016/j.ydbio.2009.11.012
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Bhat KM, 2004, DEVELOPMENT, V131, P1123, DOI 10.1242/dev.01014
   Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005
   Britton JS, 1998, DEVELOPMENT, V125, P2149
   Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829
   Budirahardja Y, 2009, DEVELOPMENT, V136, P2861, DOI 10.1242/dev.021931
   Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029
   Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632
   Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932
   Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110
   Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015
   Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206
   Das A, 2010, J NEUROGENET, V24, P42, DOI 10.3109/01677060903582202
   DATTA S, 1995, DEVELOPMENT, V121, P1173
   Dirks PB, 2008, PHILOS T R SOC B, V363, P139, DOI 10.1098/rstb.2006.2017
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9
   DOE CQ, 1992, DEVELOPMENT, V116, P855
   Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144
   EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1
   Frank DJ, 2002, DEVELOPMENT, V129, P399
   Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019
   Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306
   HARTENSTEIN V, 2008, BRAIN DEV DROSOPHILA, P1
   HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0
   HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393
   IkeshimaKataoka H, 1997, NATURE, V390, P625
   Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2
   Ito K, 1997, DEVELOPMENT, V124, P761
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   Izergina N, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-44
   Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162
   Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409
   Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931
   Januschke J, 2008, ONCOGENE, V27, P6994, DOI 10.1038/onc.2008.349
   Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246
   Kanai MI, 2005, DEV CELL, V8, P203, DOI 10.1016/j.devcel.2004.12.014
   Kao CF, 2010, CURR OPIN NEUROBIOL, V20, P14, DOI 10.1016/j.conb.2009.10.017
   KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5
   Kumar A, 2009, DEVELOPMENT, V136, P3433, DOI 10.1242/dev.037226
   Kurusu M, 2009, DEV BIOL, V326, P224, DOI 10.1016/j.ydbio.2008.11.013
   KURZIKDUMKE U, 1992, DIFFERENTIATION, V51, P91, DOI 10.1111/j.1432-0436.1992.tb00685.x
   Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017
   Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299
   Lee T, 1999, DEVELOPMENT, V126, P4065
   Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4
   Li L, 2000, GENE DEV, V14, P147
   Lichtneckert R, 2008, ADV EXP MED BIOL, V628, P32, DOI 10.1007/978-0-387-78261-4_2
   Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699
   Liu TH, 2002, MECH DEVELOP, V112, P25, DOI 10.1016/S0925-4773(01)00626-8
   MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T
   Matsuzaki F, 1998, DEVELOPMENT, V125, P4089
   Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009
   Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034
   Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008
   Mettler U, 2006, DEVELOPMENT, V133, P429, DOI 10.1242/dev.02229
   Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956
   Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9
   Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000
   Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910
   Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124
   Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Prokop A, 1998, MECH DEVELOP, V74, P99, DOI 10.1016/S0925-4773(98)00068-9
   Read TA, 2006, ANN NEUROL, V60, P3, DOI 10.1002/ana.20912
   RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0
   Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9
   Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135
   Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024
   Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X
   Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060
   Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412
   SKEATH JB, 1992, DEVELOPMENT, V114, P939
   SKEATH JB, 1994, FASEB J, V8, P714
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Slack C, 2007, DEVELOPMENT, V134, P3781, DOI 10.1242/dev.010900
   Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801
   Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005
   SPANA EP, 1995, DEVELOPMENT, V121, P3187
   TECHNAU GM, 2009, DEV DYNAM, V235, P861
   Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124
   Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349
   Truman James W., 1993, P1245
   TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189
   UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0
   Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532
   URBACH R, 2008, BRAIN DEV DROSOPHILA, P43
   VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8
   Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120
   Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506
   Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056
   Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007
   WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319
   Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128
   Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003
   Wu PS, 2008, SEMIN CELL DEV BIOL, V19, P283, DOI 10.1016/j.semcdb.2008.01.007
   Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505
   Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5
   Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174
   Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002
   Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844
NR 131
TC 34
Z9 38
U1 0
U2 6
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0080-1844
EI 1861-0412
BN 978-3-642-19064-3
J9 RESULTS PROBL CELL D
JI Results Probl. Cell Differ.
PY 2011
VL 53
BP 529
EP 546
DI 10.1007/978-3-642-19065-0_21
D2 10.1007/978-3-642-19065-0
PG 18
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA BVP45
UT WOS:000292219600021
PM 21630158
DA 2021-01-25
ER

PT S
AU Dulla, K
   Santamaria, A
AF Dulla, Kalyan
   Santamaria, Anna
BE Banfalvi, G
TI Large-Scale Mitotic Cell Synchronization
SO CELL CYCLE SYNCHRONIZATION: METHODS AND PROTOCOLS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE Mitosis; large-scale synchronization; HeLa S3; HeLa S; spinner cultures;
   triple flasks; prometaphase; metaphase; anaphase/telophase
ID QUANTITATIVE PHOSPHOPROTEOMICS; PHOSPHORYLATION; CYCLE; CDK1
AB Understanding cell growth and cell division involves the study of regulatory events that occur in a cell cycle phase-dependent manner. Studies analyzing cell cycle regulatory mechanisms and cell cycle progression invariably require synchronization of cell populations at specific cell cycle stages. Several methods have been established to synchronize cells, including serum deprivation, contact inhibition, centrifugal elutriation, and drug-dependent synchronization. Despite potential adverse cellular consequences of synchronizing cells by pharmacological agents, drug-dependent methods can be advantageous when studying later cell cycle events to ensure specific enrichment at selected mitotic stages. This chapter describes protocols used in our laboratory for isolating mitotic mammalian cells in a large-scale manner. In particular, we discuss the technical aspects of adherent or suspension cell isolation, the methods necessary to enrich cells at different mitotic stages and the optimized culture conditions.
C1 [Dulla, Kalyan] Philips Res, Dept Mol Diagnost, Eindhoven, Netherlands.
   [Santamaria, Anna] Univ Basel, Biozentrum, Basel, Switzerland.
RP Dulla, K (corresponding author), Philips Res, Dept Mol Diagnost, Eindhoven, Netherlands.
CR Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34
   Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900
   Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Dulla K, 2010, MOL CELL PROTEOMICS, V9, P1167, DOI 10.1074/mcp.M900335-MCP200
   Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867
   IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0
   Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773
   Morgan D. O., 2007, CELL CYCLE PRINCIPLE
   Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103
   Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   REICHARD P, 1983, SCIENCE, V221, P514, DOI 10.1126/science.6306767
   Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457
   Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104
   TERASIMA T, 1963, EXP CELL RES, V30, P344, DOI 10.1016/0014-4827(63)90306-9
   Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103
   Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601
   ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7
NR 19
TC 1
Z9 1
U1 0
U2 3
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
BN 978-1-61779-181-9
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2011
VL 761
BP 65
EP 74
DI 10.1007/978-1-61779-182-6_4
D2 10.1007/978-1-61779-182-6
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Cell
   Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA BWE73
UT WOS:000293772400004
PM 21755441
DA 2021-01-25
ER

PT S
AU Sauder, R
   Seelig, J
   Ziegler, A
AF Sauder, Reto
   Seelig, Joachim
   Ziegler, Andre
BE Langel, U
TI Thermodynamics of Lipid Interactions with Cell-Penetrating Peptides
SO CELL-PENETRATING PEPTIDES: METHODS AND PROTOCOLS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE Cell membrane; Drug delivery; Liposomes; Membrane anchor; Protein
   transport
ID NUCLEAR-MAGNETIC-RESONANCE; POLYELECTROLYTE-INDUCED DOMAINS; NEGATIVELY
   CHARGED LIPOSOMES; PROTEIN TRANSDUCTION DOMAINS; HUMAN IMMUNODEFICIENCY
   VIRUS; PARTICLE-SIZE DISTRIBUTION; RAPID EXTRUSION PROCEDURE;
   PLASMA-MEMBRANE; BILAYER-MEMBRANES; MODEL MEMBRANES
AB Cationic peptides are efficiently taken up by biological cells through different pathways, which can be exploited for delivery of intracellular drugs. For example, their endocytosis is known since 1967, and this typically produces entrapment of the peptides in endocytotic vesicles. The resulting peptide (and cargo) degradation in lysosomes is of little therapeutic interest. Beside endocytosis (and various subtypes thereof), cationic cell-penetrating peptides (CPPs) may also gain access to cytosol and nucleus of livings cells. This process is known since 1988, but it is poorly understood whether the cytosolic CPP appearance requires an active cellular machinery with membrane proteins and signaling molecules, or whether this translocation occurs by passive diffusion and thus can be mimicked with model membranes devoid of proteins or glycans. In the present chapter, protocols arc presented that allow for testing the membrane binding and disturbance of CPPs on model membranes with special focus on particular CPP properties. Protocols include vesicle preparation, lipid quantification, and analysis of membrane leakage, lipid polymorphism (P-31 NMR), and membrane binding (isothermal titration calorimetry). Using these protocols, a major difference among CPPs is observed: At low micromolar concentration, nonamphipathic CPPs, such as nona-arginine (WR9) and penetratin, have only a poor affinity for model membranes with a lipid composition typical of eukaryotic membranes. No membrane leakage is induced by these compounds at low micromolar concentration. In contrast, their amphipathic derivatives, such as acylated WR9 (C-14, C-16, C-18) or amphipathic penetratin mutant p2AL (Drill et al., Biochemistry 40:1824-1834, 2001), bind and disturb lipid model membranes already at low micromolar peptide concentration. This suggests that the mechanism for cytosolic CPP delivery (and potential toxicity) differs among CPPs despite their common name.
C1 [Sauder, Reto; Seelig, Joachim; Ziegler, Andre] Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
RP Sauder, R (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
CR Afonin S, 2006, CHEMPHYSCHEM, V7, P2134, DOI 10.1002/cphc.200600306
   Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817
   ALTENBACH C, 1984, BIOCHEMISTRY-US, V23, P3913, DOI 10.1021/bi00312a019
   ANDREWS SB, 1975, BIOCHEM BIOPH RES CO, V65, P913, DOI 10.1016/S0006-291X(75)80472-4
   Aschi M, 2008, J ORG CHEM, V73, P3411, DOI 10.1021/jo800036z
   Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1
   BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8
   Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001
   BEINING PR, 1975, J BACTERIOL, V121, P137, DOI 10.1128/JB.121.1.137-143.1975
   Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200
   BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P10995, DOI 10.1021/bi00501a018
   BLIXT Y, 1990, IN VITRO CELL DEV B, V26, P691
   CHEN RF, 1988, ANAL BIOCHEM, V172, P61, DOI 10.1016/0003-2697(88)90412-5
   Cho YW, 2003, J PHARM PHARMACOL, V55, P721, DOI 10.1211/002235703765951311
   Constan AA, 2002, TOXICOL SCI, V66, P201, DOI 10.1093/toxsci/66.2.201
   CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8
   Dennison SR, 2007, BIOCHEM BIOPH RES CO, V363, P178, DOI 10.1016/j.bbrc.2007.08.162
   Deshayes S, 2004, BIOCHEMISTRY-US, V43, P7698, DOI 10.1021/bi049298m
   DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001
   Drin G, 2001, BIOCHEMISTRY-US, V40, P1824, DOI 10.1021/bi002019k
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   ELORZA B, 1993, J PHARM SCI-US, V82, P1160, DOI 10.1002/jps.2600821119
   Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023
   Esbjorner EK, 2007, BBA-BIOMEMBRANES, V1768, P1550, DOI 10.1016/j.bbamem.2007.03.004
   FABRIE CHJP, 1990, BIOCHIM BIOPHYS ACTA, V1024, P380, DOI 10.1016/0005-2736(90)90368-X
   FELGNER JH, 1994, J BIOL CHEM, V269, P2550
   Fischer A, 2000, BBA-BIOMEMBRANES, V1467, P177, DOI 10.1016/S0005-2736(00)00217-0
   Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044
   FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2
   Franzin CM, 2001, BIOPHYS J, V81, P3346, DOI 10.1016/S0006-3495(01)75968-1
   Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808
   Frimer AA, 1996, FREE RADICAL BIO MED, V20, P843, DOI 10.1016/0891-5849(95)02148-5
   Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x
   Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l
   Garbuzenko O, 2005, CHEM PHYS LIPIDS, V135, P117, DOI 10.1016/j.chemphyslip.2005.02.003
   Garcia MA, 2002, APPL PHYS A-MATER, V74, P83, DOI 10.1007/s003390100852
   GAVINO VC, 1981, J LIPID RES, V22, P57
   Geueke B, 2005, CHEMBIOCHEM, V6, P982, DOI 10.1002/cbic.200400394
   GLAESER RM, 1984, BIOPHYS J, V45, P95, DOI 10.1016/S0006-3495(84)84122-3
   GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0
   GRIT M, 1992, CHEM PHYS LIPIDS, V62, P113, DOI 10.1016/0009-3084(92)90089-8
   HAUSER HO, 1971, BIOCHEM BIOPH RES CO, V45, P1049, DOI 10.1016/0006-291X(71)90443-8
   Henriques ST, 2005, BIOCHEMISTRY-US, V44, P10189, DOI 10.1021/bi0502644
   Herbig ME, 2005, BBA-BIOMEMBRANES, V1712, P197, DOI 10.1016/j.bbamem.2005.04.006
   Holm T, 2005, FEBS LETT, V579, P5217, DOI 10.1016/j.febslet.2005.07.099
   HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8
   HRISTOVA K, 1994, J COLLOID INTERF SCI, V168, P302, DOI 10.1006/jcis.1994.1424
   HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048
   IRITANI N, 1973, JPN ANALYST, V22, P174
   ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8
   Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279
   Kaasgaard T, 2003, BBA-BIOMEMBRANES, V1615, P77, DOI 10.1016/S0005-2736(03)00194-9
   Kaasgaard T, 2001, INT J PHARM, V214, P63, DOI 10.1016/S0378-5173(00)00633-5
   Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018
   Kopatz I, 2004, J GENE MED, V6, P769, DOI 10.1002/jgm.558
   Kramer SD, 2003, BBA-BIOMEMBRANES, V1609, P161, DOI 10.1016/S0005-2736(02)00683-1
   Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201
   LANGNER M, 1993, CHEM PHYS LIPIDS, V65, P23, DOI 10.1016/0009-3084(93)90078-H
   LARRABEE AL, 1979, BIOCHEMISTRY-US, V18, P3321, DOI 10.1021/bi00582a019
   LASIC DD, 1988, BIOCHEM J, V256, P1
   LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2
   LICHTENBERG D, 1981, BIOCHEMISTRY-US, V20, P3462, DOI 10.1021/bi00515a024
   Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7
   Macdonald PM, 2000, SOLID STATE NUCL MAG, V16, P21, DOI 10.1016/S0926-2040(00)00051-5
   Macdonald PM, 1998, BIOCHEM CELL BIOL, V76, P452, DOI 10.1139/bcb-76-2-3-452
   Mano M, 2006, BBA-BIOMEMBRANES, V1758, P336, DOI 10.1016/j.bbamem.2006.01.014
   Marinova Z, 2005, J BIOL CHEM, V280, P26360, DOI 10.1074/jbc.M412494200
   Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4
   MARTIN FJ, 1976, BIOCHEMISTRY-US, V15, P321, DOI 10.1021/bi00647a013
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   Maulucci G, 2005, BIOPHYS J, V88, P3545, DOI 10.1529/biophysj.104.048876
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   McCulloch A, 2003, CHEMOSPHERE, V50, P1291, DOI 10.1016/S0045-6535(02)00697-5
   MICHAELSON DM, 1973, BIOCHEMISTRY-US, V12, P2637, DOI 10.1021/bi00738a014
   Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x
   MORAD N, 1984, BIOCHIM BIOPHYS ACTA, V801, P117, DOI 10.1016/0304-4165(84)90219-8
   Nekhotiaeva N, 2003, FASEB J, V17, P394, DOI 10.1096/fj.03-0449fje
   NEWMAN GC, 1975, BIOCHEMISTRY-US, V14, P3363, DOI 10.1021/bi00686a012
   NIESMAN MR, 1992, INVEST OPHTH VIS SCI, V33, P2113
   Nishihara M, 2005, ORG BIOMOL CHEM, V3, P1659, DOI 10.1039/b501472g
   Pereira-Lachataignerais J, 2006, CHEM PHYS LIPIDS, V140, P88, DOI 10.1016/j.chemphyslip.2006.01.008
   Persson D, 2003, BIOCHEMISTRY-US, V42, P421, DOI 10.1021/bi026453t
   Persson D, 2004, BIOCHEMISTRY-US, V43, P11045, DOI 10.1021/bi036054d
   PETERSEN NO, 1978, BIOCHIM BIOPHYS ACTA, V509, P111, DOI 10.1016/0005-2736(78)90012-3
   Prochiantz A, 1996, CURR OPIN NEUROBIOL, V6, P629, DOI 10.1016/S0959-4388(96)80095-X
   QIU RZ, 1994, BBA-BIOMEMBRANES, V1191, P343, DOI 10.1016/0005-2736(94)90185-6
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536
   ROUX M, 1988, EUR BIOPHYS J BIOPHY, V16, P267
   RUOCCO MJ, 1982, BIOCHIM BIOPHYS ACTA, V691, P309, DOI 10.1016/0005-2736(82)90420-5
   RYSER HJP, 1967, NATURE, V215, P934, DOI 10.1038/215934a0
   Saar K, 2005, ANAL BIOCHEM, V345, P55, DOI 10.1016/j.ab.2005.07.033
   Sakai N, 2005, CHEMBIOCHEM, V6, P114, DOI 10.1002/cbic.200400256
   SANTAREN JF, 1982, BIOCHIM BIOPHYS ACTA, V687, P231, DOI 10.1016/0005-2736(82)90551-X
   Scheller A, 1999, J PEPT SCI, V5, P185, DOI 10.1002/(SICI)1099-1387(199904)5:4<185::AID-PSC184>3.0.CO;2-9
   SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2
   SCHINDLER H, 1979, BIOCHIM BIOPHYS ACTA, V555, P316, DOI 10.1016/0005-2736(79)90171-8
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004
   SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   SMITH R, 1972, J MOL BIOL, V67, P75, DOI 10.1016/0022-2836(72)90387-7
   Soubias Olivier, 2007, V400, P77
   SUBBARAO NK, 1987, BIOCHEMISTRY-US, V26, P2964, DOI 10.1021/bi00385a002
   SUURKUUSK J, 1976, BIOCHEMISTRY-US, V15, P1393, DOI 10.1021/bi00652a007
   SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343
   Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200
   Ter-Avetisyan G, 2009, J BIOL CHEM, V284, P3370, DOI 10.1074/jbc.M805550200
   Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X
   Thoren PEG, 2005, BIOPHYS CHEM, V114, P169, DOI 10.1016/j.bpc.2004.11.016
   Thoren PEG, 2004, BIOCHEMISTRY-US, V43, P3471, DOI 10.1021/bi0360049
   Thoren PEG, 2003, BIOCHEM BIOPH RES CO, V307, P100, DOI 10.1016/S0006-291X(03)01135-5
   Tiriveedhi V, 2007, BIOCHEMISTRY-US, V46, P3888, DOI 10.1021/bi602527t
   Tirosh O, 1998, BIOPHYS J, V74, P1371, DOI 10.1016/S0006-3495(98)77849-X
   Traikia M, 2000, EUR BIOPHYS J BIOPHY, V29, P184, DOI 10.1007/s002490000077
   Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968
   Vemuri S, 2005, J PEPT RES, V65, P433, DOI 10.1111/j.1399-3011.2005.00225.x
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   Volodkin D, 2007, J CONTROL RELEASE, V117, P111, DOI 10.1016/j.jconrel.2006.10.021
   Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996
   WALLACH DFH, 1959, ANAL CHEM, V31, P456, DOI 10.1021/ac60147a041
   White DA, 1973, FORM FUNCTION PHOSPH, P441
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k
   WINTERHALTER M, 1993, CHEM PHYS LIPIDS, V64, P35, DOI 10.1016/0009-3084(93)90056-9
   Woodbury DJ, 2006, J LIPOSOME RES, V16, P57, DOI 10.1080/08982100500528842
   Yamaguchi T, 2009, CHEM PHYS LIPIDS, V160, P58, DOI 10.1016/j.chemphyslip.2009.04.002
   Yi DD, 2007, BIOCHEM BIOPH RES CO, V359, P1024, DOI 10.1016/j.bbrc.2007.06.015
   Zaro JL, 2006, MOL PHARMACEUT, V3, P181, DOI 10.1021/mp0500869
   ZENKE M, 1990, P NATL ACAD SCI USA, V87, P3655, DOI 10.1073/pnas.87.10.3655
   Zhou Z, 1999, BIOPHYS J, V76, P387, DOI 10.1016/S0006-3495(99)77205-X
   Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604
   Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805
   Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005
   Ziegler A, 2008, BIOPHYS J, V94, P2142, DOI 10.1529/biophysj.107.113472
NR 135
TC 10
Z9 10
U1 2
U2 18
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 1940-6029
BN 978-1-60761-918-5
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2011
VL 683
BP 129
EP 155
DI 10.1007/978-1-60761-919-2_10
D2 10.1007/978-1-60761-919-2
PG 27
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BSJ65
UT WOS:000284725100011
PM 21053127
DA 2021-01-25
ER

PT J
AU Monnard, FW
   Heinisch, T
   Nogueira, ES
   Schirmer, T
   Ward, TR
AF Monnard, Fabien W.
   Heinisch, Tillmann
   Nogueira, Elisa S.
   Schirmer, Tilman
   Ward, Thomas R.
TI Human Carbonic Anhydrase II as a host for piano-stool complexes bearing
   a sulfonamide anchor
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID ARTIFICIAL METALLOENZYMES; ENANTIOSELECTIVE CATALYSIS; COMPUTATIONAL
   DESIGN; SERUM-ALBUMIN; PROTEIN; ENZYMES; HYDROGENATION; AFFINITY;
   LIGANDS; INHIBITORS
AB d(6)-piano-stool complexes bearing an arylsulfonamide anchor display sub-micromolar affinity towards human Carbonic Anhydrase II (hCA II). The 1.3 angstrom resolution X-ray crystal structure of [(eta(6)-C6Me6)Ru(bispy 3)Cl](+) subset of hCA II highlights the nature of the host-guest interactions.
C1 [Monnard, Fabien W.; Heinisch, Tillmann; Nogueira, Elisa S.; Ward, Thomas R.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Heinisch, Tillmann; Schirmer, Tilman] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ward, TR (corresponding author), Univ Basel, Dept Chem, Spitalstr 51, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch; thomas.ward@unibas.ch
RI Ward, Thomas R/K-6419-2012
OI Ward, Thomas R/0000-0001-8602-5468
FU SNF [FN 200020_126366]; Marie Curie Training Networks [238434];
   NovartisNovartis; University of Basel
FX Financial support for this project comes from the SNF (Grants FN
   200020_126366), Marie Curie Training Networks (FP7-ITN-238531, and
   FP7/2007-2013 grant agreement n<SUP>o</SUP> 238434), Novartis and the
   University of Basel. We thank Prof. C. A. Fierke (U of Michigan) for
   providing us the hCA II construct as well as Dr Lu Zheng for help in
   setting up the expression of hCA II and Dr Daniel Haussinger for NMR
   measurement.
CR Ang WH, 2009, ANGEW CHEM INT EDIT, V48, P3854, DOI 10.1002/anie.200900185
   Banerjee AL, 2004, J AM CHEM SOC, V126, P10875, DOI 10.1021/ja047557p
   Beasley NJP, 2001, CANCER RES, V61, P5262
   Briesewitz R, 1999, P NATL ACAD SCI USA, V96, P1953, DOI 10.1073/pnas.96.5.1953
   Carey JR, 2004, J AM CHEM SOC, V126, P10812, DOI 10.1021/ja046908x
   Collot J, 2003, J AM CHEM SOC, V125, P9030, DOI 10.1021/ja035545i
   Davies CL, 2009, DALTON T, P10141, DOI 10.1039/b915776j
   Deuss PJ, 2010, ANGEW CHEM INT EDIT, V49, P5315, DOI 10.1002/anie.201002174
   Faiella M, 2009, NAT CHEM BIOL, V5, P882, DOI 10.1038/nchembio.257
   Fernandez-Gacio A, 2006, CHEMBIOCHEM, V7, P1013, DOI 10.1002/cbic.200600127
   Grzybowski BA, 2002, P NATL ACAD SCI USA, V99, P1270, DOI 10.1073/pnas.032673399
   Haquette P, 2008, TETRAHEDRON LETT, V49, P4670, DOI 10.1016/j.tetlet.2008.05.043
   Heinisch T, 2010, CURR OPIN CHEM BIOL, V14, P184, DOI 10.1016/j.cbpa.2009.11.026
   Jing Q, 2010, CHEMCATCHEM, V2, P953, DOI 10.1002/cctc.201000159
   Jing Q, 2009, CHEM-EUR J, V15, P1370, DOI 10.1002/chem.200801673
   Jude KM, 2006, J AM CHEM SOC, V128, P3011, DOI 10.1021/ja057257n
   KIEFER LL, 1994, BIOCHEMISTRY-US, V33, P15233, DOI 10.1021/bi00255a003
   Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p
   Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997
   Letondor C, 2006, CHEMBIOCHEM, V7, P1845, DOI 10.1002/cbic.200600264
   Lin CC, 1999, TETRAHEDRON-ASYMMETR, V10, P1887, DOI 10.1016/S0957-4166(99)00193-7
   Liu MM, 2010, ANGEW CHEM INT EDIT, V49, P1661, DOI 10.1002/anie.200906079
   Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304
   McNae IW, 2004, CHEM COMMUN, P1786, DOI 10.1039/b408141b
   Meggers E, 2009, CHEM COMMUN, P1001, DOI 10.1039/b813568a
   NAIR SK, 1991, J BIOL CHEM, V266, P17320
   Neault JF, 1998, BBA-PROTEIN STRUCT M, V1384, P153, DOI 10.1016/S0167-4838(98)00011-9
   Okrasa K, 2006, CHEM-EUR J, V12, P1587, DOI 10.1002/chem.200501413
   Qi DF, 2001, CHEM REV, V101, P3081, DOI 10.1021/cr000059o
   Rami M, 2008, BIOORG MED CHEM LETT, V18, P836, DOI 10.1016/j.bmcl.2007.11.025
   Reetz MT, 2008, CHEMBIOCHEM, V9, P552, DOI 10.1002/cbic.200700413
   Reetz MT, 2006, CHEM COMMUN, P4318, DOI 10.1039/b610461d
   Rutten L, 2009, CHEM-EUR J, V15, P4270, DOI 10.1002/chem.200801995
   Salmain M, 2006, BIOORGANOMETALLICS: BIOMOLECULES, LABELING, MEDICINE, P181
   Schatzschneider U, 2006, ANGEW CHEM INT EDIT, V45, P1504, DOI 10.1002/anie.200504604
   Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239
   Timerbaev AR, 2006, CHEM REV, V106, P2224, DOI 10.1021/cr040704h
   Ueno T, 2007, COORDIN CHEM REV, V251, P2717, DOI 10.1016/j.ccr.2007.04.007
   Ueno T, 2007, J ORGANOMET CHEM, V692, P142, DOI 10.1016/j.jorganchem.2006.08.043
   Ward TR, 2008, ANGEW CHEM INT EDIT, V47, P7802, DOI 10.1002/anie.200802865
   WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064
   Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620
   Zhang XY, 2005, ACCOUNTS CHEM RES, V38, P379, DOI 10.1021/ar040257s
NR 43
TC 50
Z9 50
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2011
VL 47
IS 29
BP 8238
EP 8240
DI 10.1039/c1cc10345h
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 795NM
UT WOS:000292980900008
PM 21706094
DA 2021-01-25
ER

PT J
AU Manneck, T
   Braissant, O
   Ellis, W
   Keiser, J
AF Manneck, Theresia
   Braissant, Olivier
   Ellis, William
   Keiser, Jennifer
TI Schistosoma mansoni: Antischistosomal activity of the four optical
   isomers and the two racemates of mefloquine on schistosomula and adult
   worms in vitro and in vivo
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE Mefloquine; Schistosoma mansoni; Isomer; Racemate; In vitro; In vivo;
   Microcalorimetry
ID CHIRAL INVERSION; ABSOLUTE STEREOCHEMISTRY; PLASMODIUM-FALCIPARUM;
   ANTIMALARIAL AGENTS; TENEBRIO-MOLITOR; PRAZIQUANTEL; IBUPROFEN; INVITRO;
   DRUGS; CHEMOTHERAPY
AB Recent studies have shown that mefloquine (MQ) reveals interesting antischistosomal properties. We examined the antischistosomal activities of the erythro and threo isomers and racemates of MQ on newly transformed schistosomula (NTS) and adult Schistosoma mansoni in vitro and in mice harbouring adult S. mansoni. The in vitro effects in the presence and absence of haemin were monitored by means of microcalorimetry, scanning electron microscopy and phenotypic evaluation. Incubation of NTS with the erythro derivatives at concentrations of 3 mu g/ml and above resulted in convulsions, granularity, decrease in heat flow, and death while NTS incubated with the threo derivatives were only affected at high concentrations (100 mu g/ml). Extensive tegumental alterations, decrease in metabolic activity, viability, and death were observed when adult schistosomes had been exposed to 10 mu g/ml of the erythro compounds. Moderate tegumental and viability changes but reduced heat production rates were observed with the threo derivatives at 10 mu g/ml. In the presence of haemin, all MQ derivatives showed pronounced antischistosomal properties against adult S. mansoni in vitro. In vivo, MQ derivatives achieved statistically significant total and female worm burden reductions ranging between 65.4% and 100%. The highest total worm burden reductions of 93.4% and 90.2% were observed following treatment with the erythro and threo racemates, respectively. In conclusion, the optical isomers and racemates of MQ show only moderate stereoselectivity, in particular in vivo. Our results may enhance our understanding of the mechanism of action and therapeutic profile of MQ derivates on schistosomes. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Manneck, Theresia; Keiser, Jennifer] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
   [Braissant, Olivier] Univ Basel, Pharmazentrum, Biozentrum, Lab Biomech & Biocalorimetry, CH-4003 Basel, Switzerland.
   [Ellis, William] Walter Reed Army Inst Res, Dept Chem Informat, Washington, DC 20314 USA.
RP Keiser, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, POB, CH-4002 Basel, Switzerland.
EM jennifer.keiser@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PPOOA-114941]
FX This investigation received financial support from the Swiss National
   Science Foundation to T. M. and J. K. (project no. PPOOA-114941). We are
   grateful to Mireille Vargas for excellent technical assistance. The
   authors thank Dr. Dieter Wirz for helpful discussions on the
   microcalorimetric data analysis. We also thank Mr. Daniel Mathys, Mrs.
   Evi Bieler and Mr. Marcel Duggelin at the Centre for Microscopy at the
   University of Basel for expert help with the SEM studies.
CR ADAMS SS, 1976, J PHARM PHARMACOL, V28, P256, DOI 10.1111/j.2042-7158.1976.tb04144.x
   BASCO LK, 1992, BRIT J CLIN PHARMACO, V33, P517, DOI 10.1111/j.1365-2125.1992.tb04081.x
   Botros SS, 2007, EXPERT OPIN DRUG DIS, V2, pS35, DOI 10.1517/17460441.2.S1.S35
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   BROCKS DR, 1995, PHARMACOTHERAPY, V15, P551, DOI 10.1002/j.1875-9114.1995.tb02863.x
   Brocks DR, 2003, CLIN PHARMACOKINET, V42, P1359, DOI 10.2165/00003088-200342150-00004
   Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031
   CARROLL FI, 1974, J MED CHEM, V17, P210, DOI 10.1021/jm00248a015
   DALTON JP, 1995, PARASITOL TODAY, V11, P299, DOI 10.1016/0169-4758(95)80045-X
   Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f
   Dorn A, 1998, BIOCHEM PHARMACOL, V55, P727, DOI 10.1016/S0006-2952(97)00510-8
   GEISSLINGER G, 1989, AGENTS ACTIONS, V28, P256
   Harak M, 1996, THERMOCHIM ACTA, V276, P41, DOI 10.1016/0040-6031(95)02750-5
   KARLE JM, 1993, EXP PARASITOL, V76, P345, DOI 10.1006/expr.1993.1042
   Keiser J, 2010, PARASITOLOGY, V137, P589, DOI 10.1017/S0031182009991739
   Keiser J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000350
   Keiser J, 2010, CLIN INFECT DIS, V50, P1205, DOI 10.1086/651682
   King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407
   KNIHINICKI RD, 1989, BIOCHEM PHARMACOL, V38, P4389, DOI 10.1016/0006-2952(89)90647-3
   KOENIGBAUER MJ, 1994, PHARMACEUT RES, V11, P777, DOI 10.1023/A:1018957103417
   KUUSIK A, 1995, THERMOCHIM ACTA, V251, P247, DOI 10.1016/0040-6031(94)02048-S
   LAMPRECHT I, 1988, THERMOCHIM ACTA, V130, P87, DOI 10.1016/0040-6031(88)87053-9
   LIU YH, 1993, CHINESE MED J-PEKING, V106, P593
   Manneck T, 2010, PARASITOLOGY, V137, P85, DOI 10.1017/S0031182009990965
   Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504
   MULLER S, 1990, CHIRALITY, V2, P74, DOI 10.1002/chir.530020203
   Oliveira MF, 2000, MOL BIOCHEM PARASIT, V111, P217, DOI 10.1016/S0166-6851(00)00299-1
   RAMALHOPINTO FJ, 1974, EXP PARASITOL, V36, P360, DOI 10.1016/0014-4894(74)90076-9
   Reddy A, 2007, INT J PHARMACEUT, V335, P63, DOI 10.1016/j.ijpharm.2006.11.006
   Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7
   SWEENEY TR, 1981, MED RES REV, V1, P281, DOI 10.1002/med.2610010304
   TRENHOLME GM, 1975, SCIENCE, V190, P792
   Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/14656566.5.2.263
   Van Nassauw Luc, 2008, Travel Med Infect Dis, V6, P253, DOI 10.1016/j.tmaid.2008.06.006
   Xie ZX, 2008, CHINESE J CHEM, V26, P1272, DOI 10.1002/cjoc.200890231
NR 35
TC 33
Z9 37
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
EI 1090-2449
J9 EXP PARASITOL
JI Exp. Parasitol.
PD JAN
PY 2011
VL 127
IS 1
BP 260
EP 269
DI 10.1016/j.exppara.2010.08.011
PG 10
WC Parasitology
SC Parasitology
GA 710BV
UT WOS:000286486800040
PM 20732321
DA 2021-01-25
ER

PT J
AU Gehring, WJ
AF Gehring, Walter J.
TI Chance and Necessity in Eye Evolution
SO GENOME BIOLOGY AND EVOLUTION
LA English
DT Article
DE eye evolution; Jacques Monod; chance; necessity
ID DROSOPHILA-MELANOGASTER; GENE-COMPLEX; TRIPEDALIA-CYSTOPHORA;
   VISUAL-SYSTEM; EYELESS GENE; PAX GENES; JELLYFISH; ELEMENTS; ARTHROPODS;
   EXPRESSION
AB Charles Darwin has proposed the theory that evolution of live organisms is based on random variation and natural selection. Jacques Monod in his classic book Chance and Necessity, published 40 years ago, presented his thesis "that the biosphere does not contain a predictable class of objects or events, but constitutes a particular occurrence, compatible indeed with the first principles, but not deducible from those principals and therefore, essentially unpredictable." Recent discoveries in eye evolution are in agreement with both of these theses. They confirm Darwin's assumption of a simple eye prototype and lend strong support for the notion of a monophyletic origin of the various eye types. Considering the complexity of the underlying gene regulatory networks the unpredictability is obvious. The evolution of the Hox gene cluster and the specification of the body plan starting from an evolutionary prototype segment is discussed. In the course of evolution, a series of similar prototypic segments gradually undergoes cephalization anteriorly and caudalization posteriorly through diversification of the Hox genes.
C1 Univ Basel, Biozentrum, Dept Growth & Dev, CH-4003 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Dept Growth & Dev, CH-4003 Basel, Switzerland.
EM walter.gehring@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Kantons of Basel-Stadt; Basel-Landschaft
FX This work was supported by a grant from the Swiss National Science
   Foundation and the Kantons of Basel-Stadt and Basel-Landschaft, for
   which we are grateful.
CR Arnheiter H, 1998, NATURE, V391, P632, DOI 10.1038/35487
   Blanco J, 2005, DEVELOPMENT, V132, P1895, DOI 10.1242/dev.01738
   Blanco J, 2008, GENE EXPR PATTERNS, V8, P523, DOI 10.1016/j.gep.2008.06.002
   Clarkson ENK., 1998, INVERTEBRATE PALAEON
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Darwin C. R., 1872, ORIGIN SPECIES MEANS
   Dzik J, 2003, PALAEONTOLOGY, V46, P93, DOI 10.1111/1475-4983.00289
   Gehring WJ, 2009, CURR TOP DEV BIOL, V88, P35, DOI 10.1016/S0070-2153(09)88002-2
   Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   GOLDBERG ML, 1983, P NATL ACAD SCI-BIOL, V80, P5017, DOI 10.1073/pnas.80.16.5017
   Graziussi DF, 2011, EYES ABSENT EY UNPUB
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Hertwig P., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P220, DOI 10.1007/BF01741984
   Hesse R., 1897, Z WISS ZOOL, V62, P527
   HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0
   HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T
   Hou X. G., 2007, CAMBRIAN FOSSILS CHE
   HUGHES MJ, 1993, J BIOL CHEM, V268, P20687
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Jacobs David K., 1998, P323
   KAUFMAN TC, 1980, GENETICS, V94, P115
   Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3
   Lee MSY, 2011, NATURE, V474, P631, DOI 10.1038/nature10097
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-255
   Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100
   Missarzhevsky V.V., 1981, T GEOLOGICHESKOGO I, V326, P1
   Monod J, 1970, HAZARD NECESSITE
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504
   OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123
   Parkefelt L, 2005, J COMP NEUROL, V492, P251, DOI 10.1002/cne.20658
   Planque N, 1999, CELL GROWTH DIFFER, V10, P525
   Plate L, 1924, ALLGEMEINE ZOOLOGIE, P444
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   Reichert H, 1999, CURR OPIN NEUROBIOL, V9, P589, DOI 10.1016/S0959-4388(99)00002-1
   SALVINIPLAWEN LV, 1977, EVOLUTION PHOTORECEP
   Skogh C, 2006, J MORPHOL, V267, P1391, DOI 10.1002/jmor.10472
   Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107
   TACHIBANA M, 1992, MOL CELL NEUROSCI, V3, P433, DOI 10.1016/1044-7431(92)90055-7
   Takeda H, 2009, ZOOL SCI, V26, P805, DOI 10.2108/zsj.26.805
   Tomarev SI, 1997, P NATL ACAD SCI USA, V94, P2421, DOI 10.1073/pnas.94.6.2421
   WALTHER C, 1991, DEVELOPMENT, V113, P1435
NR 44
TC 30
Z9 31
U1 1
U2 58
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1759-6653
J9 GENOME BIOL EVOL
JI Genome Biol. Evol.
PY 2011
VL 3
BP 1053
EP 1066
DI 10.1093/gbe/evr061
PG 14
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA 830XR
UT WOS:000295693200053
PM 21979158
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI Molecular Darwinism: The Contingency of Spontaneous Genetic Variation
SO GENOME BIOLOGY AND EVOLUTION
LA English
DT Article
DE evolution genes; molecular mechanisms of variation; natural strategies
   of variation; variation generator; modulator of rates of variation;
   systemic aspects of evolution
AB The availability of spontaneously occurring genetic variants is an important driving force of biological evolution. Largely thanks to experimental investigations by microbial geneticists, we know today that several different molecular mechanisms contribute to the overall genetic variations. These mechanisms can be assigned to three natural strategies to generate genetic variants: 1) local sequence changes, 2) intragenomic reshuffling of DNA segments, and 3) acquisition of a segment of foreign DNA. In these processes, specific gene products are involved in cooperation with different nongenetic elements. Some genetic variations occur fully at random along the DNA filaments, others rather with a statistical reproducibility, although at many possible sites. We have to be aware that evolution in natural ecosystems is of higher complexity than under most laboratory conditions, not at least in view of symbiotic associations and the occurrence of horizontal gene transfer. The encountered contingency of genetic variation can possibly best ensure a long-term persistence of life under steadily changing living conditions.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM werner.arber@unibas.ch
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   Arber W, 2007, GENOMICS GENETICS, V1, P385
NR 2
TC 4
Z9 5
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1759-6653
J9 GENOME BIOL EVOL
JI Genome Biol. Evol.
PY 2011
VL 3
BP 1090
EP 1092
DI 10.1093/gbe/evr035
PG 3
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA 830XR
UT WOS:000295693200056
PM 21979160
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, Gottfried
TI Science in Time of Crisis
SO GERONTOLOGY
LA English
DT Editorial Material
DE Financial crisis; Basic research; Program grants; Short-term thinking
AB A crisis usually poses novel challenges that cannot be met with existing knowledge. To confront the unexpected, we need scientific inquisitiveness and long-term basic research. Narrowly focused research programs cater to short-term thinking and are rarely an effective way to spend precious public funds. Copyright (C) 2010 S. Karger AG, Basel
C1 [Schatz, Gottfried] Univ Basel, Biozentrum, Basel, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, Unterer Rebbergweg 33, CH-4153 Reinach, Switzerland.
EM gottfried.schatz@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PY 2011
VL 57
IS 1
BP 1
EP 2
DI 10.1159/000322088
PG 2
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 698GB
UT WOS:000285580900001
PM 20962516
OA Bronze
DA 2021-01-25
ER

PT J
AU Arnold, AS
   Egger, A
   Handschin, C
AF Arnold, Anne-Sophie
   Egger, Anna
   Handschin, Christoph
TI PGC-1 alpha and Myokines in the Aging Muscle - A Mini-Review
SO GERONTOLOGY
LA English
DT Review
DE Sarcopenia; Skeletal muscle; Peroxisome proliferator-activated receptor
   gamma coactivator-1 alpha; Myokines; Transcriptional regulation
ID SKELETAL-MUSCLE; ENERGY-METABOLISM; SARCOPENIA; EXERCISE; EXPRESSION;
   ACTIVATION; MECHANISMS; GENE; INFLAMMATION; CONSEQUENCES
AB Aging is associated with far-reaching changes in physiological functions resulting in morbidity and ultimately death. Age-related frailty, insecurity and reduced physical activity contribute to a progressive loss of muscle mass and function, commonly referred to as sarcopenia. Due to the increase in life expectancy in many countries, loss of muscle mass and its consequences gain in relevance for public health. At the same time, the molecular mechanisms that underlie sarcopenia are poorly understood and therefore, therapeutic approaches are limited. Interestingly though, endurance, strength and stretching exercise is significantly superior to all known pharmacological, nutritional and hormonal interventions for stabilizing, alleviating and reversing sarcopenia. Thus, increased knowledge about the plastic changes of skeletal muscle after physical activity and the signaling factors that mediate the beneficial effects of exercise on other organs might yield a better understanding of the disease and open new avenues for treatment. Here, we discuss how current discoveries about the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha), a key exercise factor in muscle, and myokines, factors produced and secreted by active muscle fibers, expand our view of the pathological changes and the therapeutic options for sarcopenia. Copyright (C) 2010 S. Karger AG, Basel
C1 [Arnold, Anne-Sophie; Egger, Anna; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Arnold, Anne-Sophie/A-9234-2014; Handschin, Christoph/E-6886-2015
OI Arnold, Anne-Sophie/0000-0002-2435-0297; Handschin,
   Christoph/0000-0003-0603-1097
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [PP00A-110746]; Muscular Dystrophy Association USA (MDA)Muscular
   Dystrophy Association; SwissLife 'Jubilaumsstiftung fur Volksgesundheit
   und medizinische Forschung'; Swiss Society for Research on Muscle
   Diseases (SSEM); Swiss Diabetes Association; Roche Research Foundation;
   United Mitochondrial Disease Foundation (UMDF); Association Francaise
   contre les Myopathies (AFM)Association Francaise contre les Myopathies;
   University of Basel
FX We thank our colleagues for discussions, ideas and suggestions during
   the writing of this manuscript. Work in the authors' laboratory related
   to this review is supported by the Swiss National Science Foundation
   (SNF PP00A-110746), the Muscular Dystrophy Association USA (MDA), the
   SwissLife 'Jubilaumsstiftung fur Volksgesundheit und medizinische
   Forschung', the Swiss Society for Research on Muscle Diseases (SSEM),
   the Swiss Diabetes Association, the Roche Research Foundation, the
   United Mitochondrial Disease Foundation (UMDF), the Association
   Francaise contre les Myopathies (AFM), and the University of Basel.
CR Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675
   Betik AC, 2009, AM J PHYSIOL-REG I, V297, pR744, DOI 10.1152/ajpregu.90959.2008
   Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004
   Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011
   Cox LS, 2009, REJUV RES, V12, P283, DOI 10.1089/rej.2009.0894
   Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003
   Febbraio MA, 2005, EXERC SPORT SCI REV, V33, P114, DOI 10.1097/00003677-200507000-00003
   Febbraio MA, 2007, J APPL PHYSIOL, V103, P376, DOI 10.1152/japplphysiol.00414.2007
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   Giovannini S, 2008, MECH AGEING DEV, V129, P593, DOI 10.1016/j.mad.2008.08.001
   Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007
   Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3
   Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Handschin C, 2009, CLIN EXP PHARMACOL P, V36, P1139, DOI 10.1111/j.1440-1681.2009.05275.x
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Hepple Russell T, 2003, Sci Aging Knowledge Environ, V2003, ppe31
   Johnston APW, 2008, APPL PHYSIOL NUTR ME, V33, P191, DOI 10.1139/H07-141
   Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a
   Koopman R, 2009, J APPL PHYSIOL, V106, P2040, DOI 10.1152/japplphysiol.91551.2008
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   LOTTE L, 2010, EXP GERONTOL
   Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   Marzetti E, 2009, BIOFACTORS, V35, P28, DOI 10.1002/biof.5
   Mehta LH, 2009, ANN NY ACAD SCI, V1172, P28, DOI 10.1111/j.1749-6632.2009.04409.x
   Michel RN, 2004, P NUTR SOC, V63, P341, DOI 10.1079/PNS2004362
   Paddon-Jones D, 2008, AM J CLIN NUTR, V87, p1558S
   Pedersen BK, 2009, J APPL PHYSIOL, V107, P1006, DOI 10.1152/japplphysiol.00734.2009
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Prokopchuk O, 2007, EXERC IMMUNOL REV, V13, P67
   Roubenoff R, 2003, J GERONTOL A-BIOL, V58, P1012
   Roubenoff R, 2003, AM J MED, V115, P429, DOI 10.1016/j.amjmed.2003.05.001
   Roubenoff R, 2007, NUTR REV, V65, pS208, DOI 10.1301/nr.2007.dec.S208-S212
   Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0
   Saini A, 2009, AGEING RES REV, V8, P251, DOI 10.1016/j.arr.2009.02.001
   Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Short K, 2003, DIABETES, V52, pA346
   Snijders T, 2009, AGEING RES REV, V8, P328, DOI 10.1016/j.arr.2009.05.003
   Walsh K, 2009, CIRC J, V73, P13, DOI 10.1253/circj.CJ-08-0961
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
NR 59
TC 38
Z9 39
U1 0
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PY 2011
VL 57
IS 1
BP 37
EP 43
DI 10.1159/000281883
PG 7
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 698GB
UT WOS:000285580900007
PM 20134150
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Goldsbury, C
   Baxa, U
   Simon, MN
   Steven, AC
   Engel, A
   Wall, JS
   Aebi, U
   Muller, SA
AF Goldsbury, Claire
   Baxa, Ulrich
   Simon, Martha N.
   Steven, Alasdair C.
   Engel, Andreas
   Wall, Joseph S.
   Aebi, Ueli
   Mueller, Shirley A.
TI Amyloid structure and assembly: Insights from scanning transmission
   electron microscopy
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Review
DE Amyloid; Mass measurement; Fibril; Filament; Oligomer; Protein
   aggregation; Electron microscopy; Scanning transmission electron
   microscopy; STEM; Alzheimer Disease; Type 2 Diabetes Mellitus; Prion;
   Scrapie; Yeast; Fungi
ID PAIRED HELICAL FILAMENTS; URE2P PRION FILAMENTS; IN-VITRO; MOLECULAR
   ARCHITECTURE; PROTEIN AGGREGATION; FIBRIL FORMATION; MASS ANALYSIS;
   BETA; MODEL; POLYMORPHISM
AB Amyloid fibrils are filamentous protein aggregates implicated in several common diseases such as Alzheimer's disease and type II diabetes. Similar structures are also the molecular principle of the infectious spongiform encephalopathies such as Creutzfeldt-Jakob disease in humans, scrapie in sheep, and of the so-called yeast prions, inherited non-chromosomal elements found in yeast and fungi. Scanning transmission electron microscopy (STEM) is often used to delineate the assembly mechanism and structural properties of amyloid aggregates. In this review we consider specifically contributions and limitations of STEM for the investigation of amyloid assembly pathways, fibril polymorphisms and structural models of amyloid fibrils. This type of microscopy provides the only method to directly measure the mass-per-length (MPL) of individual filaments. Made on both in vitro assembled and ex vivo samples, STEM mass measurements have illuminated the hierarchical relationships between amyloid fibrils and revealed that polymorphic fibrils and various globular oligomers can assemble simultaneously from a single polypeptide. The MPLs also impose strong constraints on possible packing schemes, assisting in molecular model building when combined with high-resolution methods like solid-state nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR). (C) 2010 Elsevier Inc. All rights reserved.
C1 [Simon, Martha N.; Wall, Joseph S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.
   [Goldsbury, Claire] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.
   [Baxa, Ulrich; Steven, Alasdair C.] NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.
   [Engel, Andreas; Mueller, Shirley A.] Univ Basel, Ctr Cellular Imaging & Nanoanalyt, Biozentrum, CH-4058 Basel, Switzerland.
   [Engel, Andreas; Aebi, Ueli; Mueller, Shirley A.] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Wall, JS (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.
EM wall@bnl.gov; shirley.mueller@unibas.ch
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [3100A0-108299]; Maurice E Muller Foundation of Switzerland; NIAMS,
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); USDOE-OHER
   (Department of Energy, Office of Health and Environmental
   Research)United States Department of Energy (DOE); NATIONAL INSTITUTE OF
   ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Arthritis & Musculoskeletal & Skin Diseases
   (NIAMS) [ZIAAR041157, ZIAAR041157, ZIAAR041157, ZIAAR041157,
   ZIAAR041157, ZIAAR041157, ZIAAR041157, ZIAAR041157, ZIAAR041157,
   ZIAAR041157] Funding Source: NIH RePORTER
FX We thank all current and past operators of the Basel STEM for their
   contributions to the cited work and Robert Haring, Robert Wyss and
   Roland Burki for maintenance of the instrument and its computer system.
   We thank Robert Tycko, Beat Meier and David Eisenberg for data and
   images adapted in Figs. 2 and 4. The Basel STEM has been continuously
   supported by Swiss National Foundation grants (present Grant:
   3100A0-108299 to A.E.) and by the Maurice E Muller Foundation of
   Switzerland. This work was supported in part by the Intramural Research
   Program of NIAMS, National Institutes of Health. The BNL STEM is
   supported by USDOE-OHER (Department of Energy, Office of Health and
   Environmental Research).
CR Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185
   Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x
   BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024
   Baxa U, 2005, J STRUCT BIOL, V150, P170, DOI 10.1016/j.jsb.2005.02.007
   Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200
   Baxa U, 2008, CURR ALZHEIMER RES, V5, P308, DOI 10.2174/156720508784533367
   Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b
   Baxa U, 2006, ADV PROTEIN CHEM, V73, P125, DOI 10.1016/S0065-3233(06)73005-4
   Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958
   Bitan G, 2006, METHOD ENZYMOL, V413, P217, DOI 10.1016/S0076-6879(06)13012-8
   Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772
   Cardoso I, 2002, J MOL BIOL, V317, P683, DOI 10.1006/jmbi.2002.5441
   Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986
   Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106
   Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200
   Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104
   Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718
   DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786
   Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106
   Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102
   EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673
   Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437
   Engel A, 2009, ADV IMAG ELECT PHYS, V159, P357, DOI 10.1016/S1076-5670(09)59009-X
   Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2
   Feja B, 1997, J STRUCT BIOL, V119, P72, DOI 10.1006/jsbi.1997.3861
   FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8
   FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3
   Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010
   Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200
   Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0
   Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268
   Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259
   Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858
   Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040
   Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7
   Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Holmes DF, 2006, P NATL ACAD SCI USA, V103, P17249, DOI 10.1073/pnas.0608417103
   Kajava A.V., 2009, FASEB J IN PRESS
   Kajava AV, 2004, J PEPT SCI, V10, P291, DOI 10.1002/psc.520
   Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029
   Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   Kendall A, 2008, J VIROL, V82, P9546, DOI 10.1128/JVI.00895-08
   King ME, 2001, AM J PATHOL, V158, P1481, DOI 10.1016/S0002-9440(10)64099-0
   Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007
   Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x
   Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x
   Krzyzanek V, 2009, J STRUCT BIOL, V165, P78, DOI 10.1016/j.jsb.2008.10.006
   Ksiezak-Reding H, 2005, MICROSC RES TECHNIQ, V67, P126, DOI 10.1002/jemt.20188
   Ksiezak-Reding H, 1998, BRAIN RES, V814, P86, DOI 10.1016/S0006-8993(98)01052-X
   KsiezakReding H, 1996, AM J PATHOL, V149, P639
   KSIEZAKREDING H, 1994, NEUROBIOL AGING, V15, P11, DOI 10.1016/0197-4580(94)90140-6
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290
   Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6
   Lashuel Hilal A., 2004, V299, P81
   Leapman RD, 1997, P NATL ACAD SCI USA, V94, P7820, DOI 10.1073/pnas.94.15.7820
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q
   Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x
   Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008
   Muller SA, 2006, CHIMIA, V60, pA749, DOI 10.2533/chimia.2006.749
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200
   Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200
   Nybo M, 1999, SCAND J IMMUNOL, V49, P219
   Padrick SB, 2001, J MOL BIOL, V308, P783, DOI 10.1006/jmbi.2001.4608
   Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106
   Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793
   Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066
   Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106
   Sen A, 2007, J BIOL CHEM, V282, P5545, DOI 10.1074/jbc.M611464200
   Sherratt Michael J., 2009, V522, P151, DOI 10.1007/978-1-59745-413-1_9
   Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103
   Steinmetz MO, 2008, J MOL BIOL, V376, P898, DOI 10.1016/j.jmb.2007.11.100
   Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392
   Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922
   von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j
   Wall JS, 2008, METHOD ENZYMOL, V436, P487, DOI 10.1016/S0076-6879(08)36027-3
   WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355
   Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364
   Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839
   White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066
   WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170
   Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105
   Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108
   WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884
   Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005
   Yun SJ, 2007, BIOPHYS J, V92, P4064, DOI 10.1529/biophysj.106.097766
NR 98
TC 64
Z9 66
U1 1
U2 54
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN
PY 2011
VL 173
IS 1
BP 1
EP 13
DI 10.1016/j.jsb.2010.09.018
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 705JB
UT WOS:000286123600001
PM 20868754
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Levi, A
   Folcher, M
   Jenal, U
   Shuman, HA
AF Levi, Assaf
   Folcher, Marc
   Jenal, Urs
   Shuman, Howard A.
TI Cyclic Diguanylate Signaling Proteins Control Intracellular Growth of
   Legionella pneumophila
SO MBIO
LA English
DT Article
ID C-DI-GMP; BIOFILM FORMATION; PILZ DOMAIN; BACTERIAL 2ND-MESSENGER;
   PSEUDOMONAS-AERUGINOSA; RESPONSE REGULATOR; ALLOSTERIC CONTROL;
   ESCHERICHIA-COLI; STRUCTURAL BASIS; GENE-EXPRESSION
AB Proteins that metabolize or bind the nucleotide second messenger cyclic diguanylate regulate a wide variety of important processes in bacteria. These processes include motility, biofilm formation, cell division, differentiation, and virulence. The role of cyclic diguanylate signaling in the lifestyle of Legionella pneumophila, the causative agent of Legionnaires' disease, has not previously been examined. The L. pneumophila genome encodes 22 predicted proteins containing domains related to cyclic diguanylate synthesis, hydrolysis, and recognition. We refer to these genes as cdgS (cyclic diguanylate signaling) genes. Strains of L. pneumophila containing deletions of all individual cdgS genes were created and did not exhibit any observable growth defect in growth medium or inside host cells. However, when overexpressed, several cdgS genes strongly decreased the ability of L. pneumophila to grow inside host cells. Expression of these cdgS genes did not affect the Dot/Icm type IVB secretion system, the major determinant of intracellular growth in L. pneumophila. L. pneumophila strains overexpressing these cdgS genes were less cytotoxic to THP-1 macrophages than wild-type L. pneumophila but retained the ability to resist grazing by amoebae. In many cases, the intracellular-growth inhibition caused by cdgS gene overexpression was independent of diguanylate cyclase or phosphodiesterase activities. Expression of the cdgS genes in a Salmonella enterica serovar Enteritidis strain that lacks all diguanylate cyclase activity indicated that several cdgS genes encode potential cyclases. These results indicate that components of the cyclic diguanylate signaling pathway play an important role in regulating the ability of L. pneumophila to grow in host cells.
   IMPORTANCE All bacteria must sense and respond to environmental cues. Intracellular bacterial pathogens must detect and respond to host functions that limit their ability to carry out a successful infection. Small-molecule second messengers play key roles in transmitting signals from environmental receptors to the proteins and other components that respond to signals. Cyclic diguanylate is a ubiquitous bacterial second messenger known to play an important role in many sensing and signaling systems in bacteria. The causative agent of Legionnaires' disease, Legionella pneumophila, is an intracellular pathogen that grows inside environmental protists and human macrophages by subverting the normal processes that these cells use to capture and destroy bacteria. We show that the several cyclic diguanylate signaling components in Legionella play a role in the ability to grow inside both kinds of host cells. This work highlights the role of cyclic diguanylate signaling during intracellular growth.
C1 [Levi, Assaf; Shuman, Howard A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA.
   [Folcher, Marc] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn D BSSE, Basel, Switzerland.
   [Jenal, Urs] Univ Basel, Biozentrum, Basel, Switzerland.
RP Shuman, HA (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.
EM hshuman@bsd.uchicago.edu
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [PBBSA-116884];  [AI23549];  [AI064481]; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI023549, R01AI023549,
   R01AI023549, R01AI064481, R01AI064481, R01AI023549, R01AI023549,
   R01AI023549, R01AI064481, R01AI023549, R01AI023549, R01AI023549,
   R01AI023549, R01AI023549, R01AI023549, R01AI023549, R01AI023549,
   R01AI023549, R01AI023549, R01AI023549, R01AI023549, R01AI064481,
   R01AI064481, R01AI023549, R01AI023549, R01AI023549, R01AI023549,
   R01AI023549, R01AI023549, R01AI023549, R01AI023549, R01AI023549,
   R01AI023549] Funding Source: NIH RePORTER
FX This work was supported by grants AI23549 and AI064481 (to H. A. S.). A.
   L. was partially supported by grant PBBSA-116884 from the Swiss National
   Foundation.
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966
   Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918
   BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x
   Carlson HK, 2010, MOL MICROBIOL, V77, P930, DOI 10.1111/j.1365-2958.2010.07259.x
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226
   Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104
   de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x
   Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07
   Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X
   Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x
   Hales LM, 1999, J BACTERIOL, V181, P4879, DOI 10.1128/JB.181.16.4879-4889.1999
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   HEUNER K, 1995, INFECT IMMUN, V63, P2499, DOI 10.1128/IAI.63.7.2499-2507.1995
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x
   Holland LM, 2008, J BACTERIOL, V190, P5178, DOI 10.1128/JB.00375-08
   HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874
   Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10
   Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08
   Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034
   Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019
   Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x
   Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007
   Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713
   Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x
   MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607
   McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x
   Mikkelsen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006018
   Muder R R, 1989, Semin Respir Infect, V4, P32
   Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006
   O'Shea TM, 2006, J BACTERIOL, V188, P8196, DOI 10.1128/JB.00728-06
   Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001
   Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010
   Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06
   Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200
   Saga G, 1998, TRENDS MICROBIOL, V6, P253, DOI 10.1016/S0966-842X(98)01308-0
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669
   Segal G, 1997, INFECT IMMUN, V65, P5057, DOI 10.1128/IAI.65.12.5057-5066.1997
   Sexton JA, 2004, J BACTERIOL, V186, P3814, DOI 10.1128/JB.186.12.3814-3825.2004
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Simm R, 2007, J BACTERIOL, V189, P3613, DOI 10.1128/JB.01719-06
   Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106
   Steinert M, 2002, FEMS MICROBIOL REV, V26, P149, DOI 10.1111/j.1574-6976.2002.tb00607.x
   Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519
   Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x
   Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005
   Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x
   Wiater LA, 1998, INFECT IMMUN, V66, P4450
   Wolfe A. J., 2010, 2 MESSENGER CYCLIC D
   Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07
NR 70
TC 29
Z9 29
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JAN-FEB
PY 2011
VL 2
IS 1
AR e00316-10
DI 10.1128/mBio.00316-10
PG 12
WC Microbiology
SC Microbiology
GA 734XK
UT WOS:000288375400013
PM 21249170
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Santamaria, A
   Bin, W
   Elowe, S
   Malik, R
   Zhang, F
   Bauer, M
   Schmidt, A
   Sillje, HHW
   Koorner, R
   Nigg, EA
AF Santamaria, Anna
   Wang, Bin
   Elowe, Sabine
   Malik, Rainer
   Zhang, Feng
   Bauer, Manuel
   Schmidt, Alexander
   Sillje, Herman H. W.
   Koerner, Roman
   Nigg, Erich A.
TI The Plk1-dependent Phosphoproteome of the Early Mitotic Spindle
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID POLO-BOX DOMAIN; SPECTROMETRY-BASED PROTEOMICS; SMALL-MOLECULE
   INHIBITOR; AURORA-A; MASS-SPECTROMETRY; ASSEMBLY CHECKPOINT; PLK1
   SUBSTRATE; CELL-DIVISION; IN-VIVO; PHOSPHORYLATION
AB Polo-like kinases regulate many aspects of mitotic and meiotic progression from yeast to man. In early mitosis, mammalian Polo-like kinase 1 (Plk1) controls centrosome maturation, spindle assembly, and microtubule attachment to kinetochores. However, despite the essential and diverse functions of Plk1, the full range of Plk1 substrates remains to be explored. To investigate the Plk1-dependent phosphoproteome of the human mitotic spindle, we combined stable isotope labeling by amino acids in cell culture with Plk1 inactivation or depletion followed by spindle isolation and mass spectrometry. Our study identified 358 unique Plk1-dependent phosphorylation sites on spindle proteins, including novel substrates, illustrating the complexity of the Plk1-dependent signaling network. Over 100 sites were validated by in vitro phosphorylation of peptide arrays, resulting in a broadening of the Plk1 consensus motif. Collectively, our data provide a rich source of information on Plk1-dependent phosphorylation, Plk1 docking to substrates, the influence of phosphorylation on protein localization, and the functional interaction between Plk1 and Aurora A on the early mitotic spindle. Molecular & Cellular Proteomics 10: 10.1074/mcp.M110.004457, 1-18, 2011.
C1 [Santamaria, Anna; Bauer, Manuel; Schmidt, Alexander; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Santamaria, Anna; Wang, Bin; Elowe, Sabine; Malik, Rainer; Zhang, Feng; Sillje, Herman H. W.; Koerner, Roman; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
RP Santamaria, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM anna.santamaria@unibas.ch
RI Korner, Roman/G-8565-2011; Schmidt, Alexander/D-6426-2011
OI Korner, Roman/0000-0001-9285-9290; nigg, erich/0000-0003-4835-5719
FU European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [LSHG-CT-2005-518254]; Spanish Education and Science
   MinistrySpanish Government; Max Planck SocietyMax Planck
   SocietyFoundation CELLEX; Chinese Academy of SciencesChinese Academy of
   Sciences; Canadian Institutes of Health ResearchCanadian Institutes of
   Health Research (CIHR)
FX This work was supported by the Max Planck Society as well as by
   Experimental Network for Functional Integration Contract
   LSHG-CT-2005-518254 funded by the European Commission within its FP6
   Program.; Supported by a grant from the Spanish Education and Science
   Ministry.; Supported by a grant from a joint Ph.D. promotion program of
   the Max Planck Society and the Chinese Academy of Sciences.; Supported
   by a grant from the Canadian Institutes of Health Research.
CR Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026
   Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653
   Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739
   Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401
   Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505
   Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6
   Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163
   Bonaldi T, 2008, MOL CELL, V31, P762, DOI 10.1016/j.molcel.2008.07.018
   Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103
   Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794
   Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111
   Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5
   Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310
   Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   De Luca M, 2006, CELL CYCLE, V5, P296
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086
   Eckerdt F, 2008, TRENDS BIOCHEM SCI, V33, P511, DOI 10.1016/j.tibs.2008.08.004
   Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6
   Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007
   Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343
   Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350
   Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633
   Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641
   Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801
   Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976
   Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867
   Jang CY, 2009, J CELL SCI, V122, P1334, DOI 10.1242/jcs.044321
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254
   Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016
   Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069
   Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627
   Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155
   Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701
   Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208
   Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046
   Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200
   LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153
   Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683
   Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185
   Macurek L, 2009, CANCER RES, V69, P4555, DOI 10.1158/0008-5472.CAN-09-0142
   Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200
   Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971
   Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433
   Mishra RK, 2010, NAT CELL BIOL, V12, P164, DOI 10.1038/ncb2016
   Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200
   Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009
   Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100
   Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475
   Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826
   Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014
   Plyte S, 2007, CURR BIOL, V17, pR280, DOI 10.1016/j.cub.2007.02.018
   Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201
   Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240
   Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013
   Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517
   Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200
   Schreiber TB, 2008, PROTEOMICS, V8, P4416, DOI 10.1002/pmic.200800132
   Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146
   Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Sillje HHW, 2006, METHODS, V38, P25, DOI 10.1016/j.ymeth.2005.07.006
   Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011
   Tang LY, 2007, MOL CELL PROTEOMICS, V6, P1952, DOI 10.1074/mcp.M700120-MCP200
   Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008
   Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0
   Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739
   ZHU XL, 1995, J BIOL CHEM, V270, P19545, DOI 10.1074/jbc.270.33.19545
NR 79
TC 155
Z9 155
U1 0
U2 12
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD JAN
PY 2011
VL 10
IS 1
AR M110.004457
DI 10.1074/mcp.M110.004457
PG 18
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 715XL
UT WOS:000286928400022
PM 20860994
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kawaji, H
   Severin, J
   Lizio, M
   Forrest, ARR
   van Nimwegen, E
   Rehli, M
   Schroder, K
   Irvine, K
   Suzuki, H
   Carninci, P
   Hayashizaki, Y
   Daub, CO
AF Kawaji, Hideya
   Severin, Jessica
   Lizio, Marina
   Forrest, Alistair R. R.
   van Nimwegen, Erik
   Rehli, Michael
   Schroder, Kate
   Irvine, Katharine
   Suzuki, Harukazu
   Carninci, Piero
   Hayashizaki, Yoshihide
   Daub, Carsten O.
TI Update of the FANTOM web resource: from mammalian transcriptional
   landscape to its dynamic regulation
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID FUNCTIONAL ANNOTATION; ATLAS; MOUSE; IDENTIFICATION; EXPRESSION; SITES
AB The international Functional Annotation Of the Mammalian Genomes 4 (FANTOM4) research collaboration set out to better understand the transcriptional network that regulates macrophage differentiation and to uncover novel components of the transcriptome employing a series of high-throughput experiments. The primary and unique technique is cap analysis of gene expression (CAGE), sequencing mRNA 5'-ends with a second-generation sequencer to quantify promoter activities even in the absence of gene annotation. Additional genome-wide experiments complement the setup including short RNA sequencing, microarray gene expression profiling on large-scale perturbation experiments and ChIP-chip for epigenetic marks and transcription factors. All the experiments are performed in a differentiation time course of the THP-1 human leukemic cell line. Furthermore, we performed a large-scale mammalian two-hybrid (M2H) assay between transcription factors and monitored their expression profile across human and mouse tissues with qRT-PCR to address combinatorial effects of regulation by transcription factors. These interdependent data have been analyzed individually and in combination with each other and are published in related but distinct papers. We provide all data together with systematic annotation in an integrated view as resource for the scientific community (http://fantom.gsc.riken.jp/4/). Additionally, we assembled a rich set of derived analysis results including published predicted and validated regulatory interactions. Here we introduce the resource and its update after the initial release.
C1 [Kawaji, Hideya; Severin, Jessica; Lizio, Marina; Forrest, Alistair R. R.; Suzuki, Harukazu; Carninci, Piero; Hayashizaki, Yoshihide; Daub, Carsten O.] RIKEN Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
   [van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Rehli, Michael] Univ Hosp Regensburg, Dept Hematol, D-93053 Regensburg, Germany.
   [Schroder, Kate] Univ Lausanne, Dept Biochem, CH-1056 Epalinges, Switzerland.
   [Irvine, Katharine] Univ Queensland, Inst Mol Biosci, Brisbane St Lucia, Qld 4072, Australia.
RP Kawaji, H (corresponding author), RIKEN Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.
EM kawaji@gsc.riken.jp
RI Schroder, Kate/L-9415-2019; Kawaji, Hideya/N-5116-2015; Daub, Carsten
   O/A-7436-2010; Forrest, Alistair/A-6597-2008; Irvine, Katharine
   M/A-5559-2011; Rehli, Michael/E-9093-2011; Schroder, Kate/C-6132-2008;
   Severin, Jessica/AAQ-2723-2020; Carninci, Piero/K-1568-2014; Suzuki,
   Harukazu/N-9553-2015
OI Schroder, Kate/0000-0001-9261-3805; Kawaji, Hideya/0000-0002-0575-0308;
   Daub, Carsten O/0000-0002-3295-8729; Forrest,
   Alistair/0000-0003-4543-1675; Irvine, Katharine M/0000-0002-6716-1605;
   Rehli, Michael/0000-0003-3992-932X; Schroder, Kate/0000-0001-9261-3805;
   Severin, Jessica/0000-0003-1274-208X; Carninci,
   Piero/0000-0001-7202-7243; Suzuki, Harukazu/0000-0002-8087-0836; van
   Nimwegen, Erik/0000-0001-6338-1312
FU Ministry of Education, Culture, Sports, Science and Technology, Japan,
   Genome Network Project; MEXT, JapanMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT); RIKEN Omics Science Center
   from MEXT
FX Ministry of Education, Culture, Sports, Science and Technology, Japan,
   Genome Network Project (to Y.H.); Innovative Cell Biology by Innovative
   Technology (Cell Innovation Program) from the MEXT, Japan (to Y.H.);
   RIKEN Omics Science Center from MEXT, Research Grant (to Y.H.). Funding
   for open access charge: RIKEN Omics Science Center from MEXT, Research
   Grant (to Y.H.).
CR Adati Naoki, 2009, BMC Res Notes, V2, P153, DOI 10.1186/1756-0500-2-153
   Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   BERNERS-LEE T., 2001, SCI AM, P29
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789
   de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109
   Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368
   Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Harbers M, 2005, NAT METHODS, V2, P495, DOI 10.1038/NMETH768
   Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412
   Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009
   Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500
   Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034
   Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40
   Kawaji H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-133
   Kratz A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-257
   Kubosaki A, 2010, MOL IMMUNOL, V47, P2295, DOI 10.1016/j.molimm.2010.05.289
   Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41
   Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110
   Masuya H., 2010, NUCL ACIDS IN PRESS
   Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266
   Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857
   Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889
   Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/NMETH.1470, 10.1038/nmeth.1470]
   Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044
   Rayner TF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-489
   Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961
   Sansone SA, 2008, OMICS, V12, P143, DOI 10.1089/omi.2008.0019
   Severin J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r39
   Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100
   Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108
NR 36
TC 40
Z9 40
U1 1
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN
PY 2011
VL 39
SU 1
BP D856
EP D860
DI 10.1093/nar/gkq1112
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 701PA
UT WOS:000285831700134
PM 21075797
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Khorshid, M
   Rodak, C
   Zavolan, M
AF Khorshid, Mohsen
   Rodak, Christoph
   Zavolan, Mihaela
TI CLIPZ: a database and analysis environment for experimentally determined
   binding sites of RNA-binding proteins
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID BURROWS-WHEELER TRANSFORM; READ ALIGNMENT; MESSENGER-RNA; EXPRESSION;
   CODE
AB The stability, localization and translation rate of mRNAs are regulated by a multitude of RNA-binding proteins (RBPs) that find their targets directly or with the help of guide RNAs. Among the experimental methods for mapping RBP binding sites, cross-linking and immunoprecipitation (CLIP) coupled with deep sequencing provides transcriptome-wide coverage as well as high resolution. However, partly due to their vast volume, the data that were so far generated in CLIP experiments have not been put in a form that enables fast and interactive exploration of binding sites. To address this need, we have developed the CLIPZ database and analysis environment. Binding site data for RBPs such as Argonaute 1-4, Insulin-like growth factor II mRNA-binding protein 1-3, TNRC6 proteins A-C, Pumilio 2, Quaking and Polypyrimidine tract binding protein can be visualized at the level of the genome and of individual transcripts. Individual users can upload their own sequence data sets while being able to limit the access to these data to specific users, and analyses of the public and private data sets can be performed interactively. CLIPZ, available at http://www.clipz.unibas.ch,, aims to provide an open access repository of information for post-transcriptional regulatory elements.
C1 [Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PDAMP3_127218, PDFMP3_123123]; Swiss Institute of
   Bioinformatics; University of Basel
FX ProDoc program of the Swiss National Science Foundation [Grants
   PDAMP3_127218 and PDFMP3_123123]; Swiss Institute of Bioinformatics.
   Funding for open access charge: University of Basel.
CR Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620
   Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433
   Berninger P, 2008, METHODS, V44, P13, DOI 10.1016/j.ymeth.2007.10.002
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412
   Holmes I, 1998, J COMPUT BIOL, V5, P493, DOI 10.1089/cmb.1998.5.493
   Izquierdo JM, 2007, J BIOL CHEM, V282, P19410, DOI 10.1074/jbc.M700688200
   Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
   Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
   Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545
   Zheng S, 2007, FEBS J, V274, P6378, DOI 10.1111/j.1742-4658.2007.06155.x
NR 22
TC 99
Z9 101
U1 0
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN
PY 2011
VL 39
SU 1
BP D245
EP D252
DI 10.1093/nar/gkq940
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 701PA
UT WOS:000285831700042
PM 21087992
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT B
AU Vuister, GW
   Tjandra, N
   Shen, Y
   Grishaev, A
   Grzesiek, S
AF Vuister, Geerten W.
   Tjandra, Nico
   Shen, Yang
   Grishaev, Alex
   Grzesiek, Stephan
BE Lian, LY
   Roberts, G
TI Measurement of Structural Restraints
SO PROTEIN NMR SPECTROSCOPY: PRACTICAL TECHNIQUES AND APPLICATIONS
LA English
DT Article; Book Chapter
ID RESIDUAL DIPOLAR COUPLINGS; PROTEIN-STRUCTURE DETERMINATION;
   X-RAY-SCATTERING; NMR CHEMICAL-SHIFTS; SMALL-ANGLE SCATTERING;
   HIGH-RESOLUTION NMR; MOLECULAR FRAGMENT REPLACEMENT; LIQUID-CRYSTALLINE
   MEDIUM; HYDROGEN-BOND LENGTH; BIOLOGICAL MACROMOLECULES
C1 [Vuister, Geerten W.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6500 HB Nijmegen, Netherlands.
   [Vuister, Geerten W.] Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England.
   [Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA.
   [Shen, Yang; Grishaev, Alex] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.
   [Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Vuister, GW (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
OI Grzesiek, Stephan/0000-0003-1998-4225
CR Andersson P, 1998, J BIOMOL NMR, V12, P435, DOI 10.1023/A:1008239027287
   Annila A, 1999, J BIOMOL NMR, V14, P223, DOI 10.1023/A:1008330519680
   Avbelj F, 2004, P NATL ACAD SCI USA, V101, P17394, DOI 10.1073/pnas.0407969101
   Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818
   Barbieri R, 2002, J BIOMOL NMR, V22, P365, DOI 10.1023/A:1014980101965
   Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v
   Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006
   BAX A, 1992, J AM CHEM SOC, V114, P6923, DOI 10.1021/ja00043a052
   BAX A, 1991, J MAGN RESON, V91, P174, DOI 10.1016/0022-2364(91)90422-P
   BAX A, 1994, METHOD ENZYMOL, V239, P79
   Becker E.D., 1996, ENCY NUCL MAGNETIC R, V4, P2409
   Beraud S, 2002, J AM CHEM SOC, V124, P13709, DOI 10.1021/ja0268783
   Bergmann A, 2000, J APPL CRYSTALLOGR, V33, P1212, DOI 10.1107/S0021889800008372
   Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bertini I, 2002, CONCEPT MAGNETIC RES, V14, P259, DOI 10.1002/cmr.10027
   Billeter M, 2008, J BIOMOL NMR, V42, P155, DOI 10.1007/s10858-008-9277-8
   Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002
   BOELENS R, 1988, J MOL STRUCT, V173, P299, DOI 10.1016/0022-2860(88)80062-0
   Bolon PJ, 1999, J MOL BIOL, V293, P107, DOI 10.1006/jmbi.1999.3133
   BONVIN AMJJ, 1994, J MOL BIOL, V236, P328, DOI 10.1006/jmbi.1994.1138
   BORGIAS BA, 1990, J MAGN RESON, V87, P475, DOI 10.1016/0022-2364(90)90305-S
   BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069
   BOTHNERBY AA, 1981, J AM CHEM SOC, V103, P5602, DOI 10.1021/ja00408a069
   Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102
   Bouvignies G, 2006, ANGEW CHEM INT EDIT, V45, P8166, DOI 10.1002/anie.200603627
   Bowers PM, 2000, J BIOMOL NMR, V18, P311, DOI 10.1023/A:1026744431105
   Braddock DT, 2001, J AM CHEM SOC, V123, P8634, DOI 10.1021/ja016234f
   BRAUN D, 1994, J AM CHEM SOC, V116, P8466, DOI 10.1021/ja00098a005
   BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206
   Bystrov V. F., 1976, Progress in Nuclear Magnetic Resonance Spectroscopy, P41
   Case DA, 1995, J BIOMOL NMR, V6, P341
   Cavagnero S, 1999, J BIOMOL NMR, V13, P387, DOI 10.1023/A:1008360022444
   Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104
   Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594
   Choy WY, 2001, J BIOMOL NMR, V21, P31, DOI 10.1023/A:1011933020122
   Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419
   Clore GM, 2006, J MOL BIOL, V355, P879, DOI 10.1016/j.jmb.2005.11.042
   Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f
   Clore GM, 1999, J AM CHEM SOC, V121, P6513, DOI 10.1021/ja991143s
   Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010
   Cordier F, 1999, J MAGN RESON, V140, P510, DOI 10.1006/jmre.1999.1899
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cordier F, 2008, NAT PROTOC, V3, P235, DOI 10.1038/nprot.2007.498
   Cornilescu G, 2000, J AM CHEM SOC, V122, P2168, DOI 10.1021/ja993609c
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106
   de Alba E, 1999, J AM CHEM SOC, V121, P4282, DOI 10.1021/ja990062t
   DEDIOS AC, 1993, SCIENCE, V260, P1491, DOI 10.1126/science.8502992
   Delaglio F, 2000, J AM CHEM SOC, V122, P2142, DOI 10.1021/ja993603n
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DELAGLIO F, 1991, Journal of Biomolecular NMR, V1, P439, DOI 10.1007/BF02192865
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   Doreleijers JF, 2005, J BIOMOL NMR, V32, P1, DOI 10.1007/s10858-005-2195-0
   Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104
   Englaender S.W., 1996, ENCY NUCL MAGNETIC R, V4, P2415
   Fischer MWF, 1999, BIOCHEMISTRY-US, V38, P9013, DOI 10.1021/bi9905213
   Fleming K, 2000, J AM CHEM SOC, V122, P5224, DOI 10.1021/ja000764e
   Freyssingeas E, 1996, LANGMUIR, V12, P6028, DOI 10.1021/la9605246
   Gaponenko V, 2004, J BIOMOL NMR, V28, P205, DOI 10.1023/B:JNMR.0000013706.09264.36
   GARRETT DS, 1994, J MAGN RESON SER B, V104, P99, DOI 10.1006/jmrb.1994.1061
   Gong HP, 2007, PROTEIN SCI, V16, P1515, DOI 10.1110/ps.072988407
   GRIESINGER C, 1985, J AM CHEM SOC, V107, P6394, DOI 10.1021/ja00308a042
   Griesinger C., 1999, BIOL MAGN RESON, V16, P259
   Grishaev A, 2005, J AM CHEM SOC, V127, P16621, DOI 10.1021/ja054342m
   Grishaev A, 2008, J BIOMOL NMR, V42, P99, DOI 10.1007/s10858-008-9267-x
   Grishaev A, 2008, J BIOMOL NMR, V40, P95, DOI 10.1007/s10858-007-9211-5
   Gryk MR, 2008, P NATL ACAD SCI USA, V105, P4533, DOI 10.1073/pnas.0801069105
   Grzesiek S, 2004, PROG NUCL MAG RES SP, V45, P275, DOI 10.1016/j.pnmrs.2004.08.001
   GRZESIEK S, 1995, J AM CHEM SOC, V117, P5312, DOI 10.1021/ja00124a014
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052
   GRZESIEK S, 1995, J AM CHEM SOC, V117, P9594, DOI 10.1021/ja00142a040
   Grzesiek S, 1997, J BIOMOL NMR, V9, P207, DOI 10.1023/A:1018614505948
   Grzesiek S, 2009, CURR OPIN STRUC BIOL, V19, P585, DOI 10.1016/j.sbi.2009.07.015
   Guntert Peter, 2004, Methods Mol Biol, V278, P353
   Habeck Michael, 2004, Methods Mol Biol, V278, P379
   HAIGH CW, 1979, PROG NUCL MAG RES SP, V13, P303, DOI 10.1016/0079-6565(79)80010-2
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3
   Haussinger D, 2009, J AM CHEM SOC, V131, P14761, DOI 10.1021/ja903233w
   Heller WT, 2005, ACTA CRYSTALLOGR D, V61, P33, DOI 10.1107/S0907444904025855
   HOCH JC, 1985, BIOCHEMISTRY-US, V24, P3831, DOI 10.1021/bi00336a003
   Huang JR, 2010, J AM CHEM SOC, V132, P694, DOI 10.1021/ja907974m
   Hus JC, 2001, J AM CHEM SOC, V123, P1541, DOI 10.1021/ja005590f
   Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351
   Jain NU, 2003, J MOL BIOL, V328, P451, DOI 10.1016/S0022-2836(03)00268-7
   Jaravine V, 2006, NAT METHODS, V3, P605, DOI 10.1038/NMETH900
   Jeffrey G.A., 1991, HYDROGEN BONDING BIO
   Jensen MR, 2009, STRUCTURE, V17, P1169, DOI 10.1016/j.str.2009.08.001
   Juranic N, 2008, PROTEIN SCI, V17, P768, DOI 10.1110/ps.073331608
   KARPLUS M, 1959, J CHEM PHYS, V30, P11, DOI 10.1063/1.1729860
   KARPLUS M, 1963, J AM CHEM SOC, V85, P2870, DOI 10.1021/ja00901a059
   KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411
   Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871
   Koenig BW, 2000, J BIOMOL NMR, V16, P121, DOI 10.1023/A:1008378523816
   Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3
   Koenig BW, 1999, J AM CHEM SOC, V121, P1385, DOI 10.1021/ja9837856
   Kontaxis G, 2005, METHOD ENZYMOL, V394, P42, DOI 10.1016/S0076-6879(05)94003-2
   Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723
   Kung HC, 1995, J MAGN RESON SER B, V109, P323, DOI 10.1006/jmrb.1995.9987
   Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092
   Le HB, 1996, J PHYS CHEM-US, V100, P16423, DOI 10.1021/jp9606164
   LEMASTER DM, 1990, Q REV BIOPHYS, V23, P133, DOI 10.1017/S0033583500005527
   Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010
   Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655
   Lipsitz RS, 2003, J MAGN RESON, V164, P171, DOI 10.1016/S1090-7807(03)00176-9
   Lipsitz RS, 2001, J AM CHEM SOC, V123, P11065, DOI 10.1021/ja016854g
   Lorieau J, 2008, J AM CHEM SOC, V130, P7536, DOI 10.1021/ja801729f
   Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754
   Losonczi JA, 1998, J BIOMOL NMR, V12, P447, DOI 10.1023/A:1008302110884
   Ma JH, 2008, J AM CHEM SOC, V130, P16148, DOI 10.1021/ja807064k
   Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449
   Meier S, 2002, J BIOMOL NMR, V24, P351, DOI 10.1023/A:1021609207024
   Meier S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2838167
   Meiler J, 2003, P NATL ACAD SCI USA, V100, P15404, DOI 10.1073/pnas.2434121100
   MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466
   MIERKE DF, 1992, BIOPOLYMERS, V32, P1277, DOI 10.1002/bip.360321003
   Moltke S, 1999, J BIOMOL NMR, V15, P77, DOI 10.1023/A:1008309630377
   Montalvao RW, 2008, J AM CHEM SOC, V130, P15990, DOI 10.1021/ja805258z
   Mueller GA, 2000, J MOL BIOL, V300, P197, DOI 10.1006/jmbi.2000.3842
   Mylonas E., 2003, J APPL CRYSTALLOGR, V40, ps245
   Nabuurs SB, 2006, PLOS COMPUT BIOL, V2, P71, DOI 10.1371/journal.pcbi.0020009
   Nabuurs SB, 2003, J AM CHEM SOC, V125, P12026, DOI 10.1021/ja035440f
   Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288
   Neuhaus D., 2000, NUCL OVERHAUSER EFFE
   Neylon C, 2008, EUR BIOPHYS J BIOPHY, V37, P531, DOI 10.1007/s00249-008-0259-2
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546
   Ottiger M, 1999, J BIOMOL NMR, V13, P187, DOI 10.1023/A:1008395916985
   Otting G, 2008, J BIOMOL NMR, V42, P1, DOI 10.1007/s10858-008-9256-0
   Parsons LM, 2008, BIOCHEMISTRY-US, V47, P3131, DOI 10.1021/bi702283x
   Perez C, 2001, J AM CHEM SOC, V123, P7081, DOI 10.1021/ja003724j
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   Petoukhov MV, 2003, J APPL CRYSTALLOGR, V36, P540, DOI 10.1107/S0021889803000591
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   PLANTENGA TM, 1982, CHEM PHYS, V66, P1, DOI 10.1016/0301-0104(82)88001-4
   Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i
   Prosser RS, 1998, J AM CHEM SOC, V120, P11010, DOI 10.1021/ja982671r
   Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649
   Ramirez BE, 1998, J AM CHEM SOC, V120, P9106, DOI 10.1021/ja982310b
   RICHARZ R, 1978, BIOPOLYMERS, V17, P2133, DOI 10.1002/bip.1978.360170908
   Robustelli P, 2008, STRUCTURE, V16, P1764, DOI 10.1016/j.str.2008.10.016
   Rohl CA, 2004, METHOD ENZYMOL, V383, P66
   Rohl CA, 2002, J AM CHEM SOC, V124, P2723, DOI 10.1021/ja016880e
   Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603
   Ruan K, 2005, J AM CHEM SOC, V127, P15032, DOI 10.1021/ja055520e
   Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h
   SAITO H, 1986, MAGN RESON CHEM, V24, P835, DOI 10.1002/mrc.1260241002
   Sass HJ, 2007, J AM CHEM SOC, V129, P5898, DOI 10.1021/ja068336h
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   SAUPE A, 1963, PHYS REV LETT, V11, P462, DOI 10.1103/PhysRevLett.11.462
   Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Schwieters CD, 2007, BIOCHEMISTRY-US, V46, P1152, DOI 10.1021/bi061943x
   Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105
   Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5
   Showalter SA, 2007, J AM CHEM SOC, V129, P4158, DOI 10.1021/ja070658d
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1
   SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559
   Sorensen MD, 1999, J MAGN RESON, V137, P237, DOI 10.1006/jmre.1998.1635
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675
   Suzuki M, 2008, J BIOL CHEM, V283, P25936, DOI 10.1074/jbc.M803773200
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05
   Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267
   Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1
   Tjandra N, 1996, J AM CHEM SOC, V118, P6264, DOI 10.1021/ja960106n
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732
   TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279
   TORDA AE, 1993, J BIOMOL NMR, V3, P55, DOI 10.1007/BF00242475
   Tsui V, 2000, J BIOMOL NMR, V16, P9, DOI 10.1023/A:1008302430561
   Tugarinov V, 2005, J AM CHEM SOC, V127, P2767, DOI 10.1021/ja044032o
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684
   Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105
   van Lune F, 2002, J BIOMOL NMR, V23, P169, DOI 10.1023/A:1019877830921
   VANZIJL PCM, 1984, ACCOUNTS CHEM RES, V17, P172, DOI 10.1021/ar00101a004
   Vogeli B, 2007, J AM CHEM SOC, V129, P9377, DOI 10.1021/ja070324o
   Vuister G. W., 1999, BIOL MAGN RESON, P195
   VUISTER GW, 1992, J AM CHEM SOC, V114, P9674, DOI 10.1021/ja00050a066
   VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024
   VUISTER GW, 1994, J BIOMOL NMR, V4, P193
   WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056
   WANG AC, 1995, J AM CHEM SOC, V117, P1810, DOI 10.1021/ja00111a021
   Wang JB, 2009, J AM CHEM SOC, V131, P10507, DOI 10.1021/ja902528f
   Wang LY, 2005, J BIOMOL NMR, V32, P13, DOI 10.1007/s10858-005-1717-0
   Wang YJ, 2002, J AM CHEM SOC, V124, P14075, DOI 10.1021/ja026811f
   Wang YJ, 2004, J BIOMOL NMR, V28, P327, DOI 10.1023/B:JNMR.0000015397.82032.2a
   Wang Y, 2008, J MOL BIOL, V377, P1576, DOI 10.1016/j.jmb.2008.02.009
   Wang YX, 1999, J BIOMOL NMR, V14, P181, DOI 10.1023/A:1008346517302
   Warren JJ, 2001, J BIOMOL NMR, V20, P311, DOI 10.1023/A:1011214214552
   Warren JJ, 2001, J MAGN RESON, V149, P271, DOI 10.1006/jmre.2001.2307
   Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136
   WILLIAMSON MP, 1995, J MOL BIOL, V247, P541, DOI 10.1006/jmbi.1995.0160
   Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305
   Wishart DS, 1997, J BIOMOL NMR, V10, P329, DOI 10.1023/A:1018373822088
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   Wishart DS, 2001, METHOD ENZYMOL, V338, P3
   WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   Wuthrich K, 2003, J BIOMOL NMR, V27, P13, DOI 10.1023/A:1024733922459
   XU RX, 1992, FEBS LETT, V305, P137, DOI 10.1016/0014-5793(92)80881-G
   Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681
   Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055
   ZHU G, 1993, J MAGN RESON SER A, V105, P219, DOI 10.1006/jmra.1993.1274
   ZHU G, 1993, J MAGN RESON SER A, V104, P353, DOI 10.1006/jmra.1993.1235
   Zuo XB, 2008, J AM CHEM SOC, V130, P3292, DOI 10.1021/ja7114508
   Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908
   Zweckstetter M, 2004, BIOPHYS J, V86, P3444, DOI 10.1529/biophysj.103.035790
   Zweckstetter M, 2001, J BIOMOL NMR, V20, P365, DOI 10.1023/A:1011263920003
NR 223
TC 4
Z9 4
U1 0
U2 5
PU BLACKWELL SCIENCE PUBL
PI OXFORD
PA OSNEY MEAD, OXFORD OX2 0EL, ENGLAND
BN 978-1-119-97201-3; 978-0-470-72193-3
PY 2011
BP 83
EP 157
D2 10.1002/9781119972006
PG 75
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA BA6BS
UT WOS:000337090900005
DA 2021-01-25
ER

PT J
AU Kryshtafovych, A
   Moult, J
   Bartual, SG
   Bazan, JF
   Berman, H
   Casteel, DE
   Christodoulou, E
   Everett, JK
   Hausmann, J
   Heidebrecht, T
   Hills, T
   Hui, R
   Hunt, JF
   Seetharaman, J
   Joachimiak, A
   Kennedy, MA
   Kim, C
   Lingel, A
   Michalska, K
   Montelione, GT
   Otero, JM
   Perrakis, A
   Pizarro, JC
   van Raaij, MJ
   Ramelot, TA
   Rousseau, F
   Tong, L
   Wernimont, AK
   Young, J
   Schwede, T
AF Kryshtafovych, Andriy
   Moult, John
   Bartual, Sergio G.
   Bazan, J. Fernando
   Berman, Helen
   Casteel, Darren E.
   Christodoulou, Evangelos
   Everett, John K.
   Hausmann, Jens
   Heidebrecht, Tatjana
   Hills, Tanya
   Hui, Raymond
   Hunt, John F.
   Seetharaman, Jayaraman
   Joachimiak, Andrzej
   Kennedy, Michael A.
   Kim, Choel
   Lingel, Andreas
   Michalska, Karolina
   Montelione, Gaetano T.
   Otero, Jose M.
   Perrakis, Anastassis
   Pizarro, Juan C.
   van Raaij, Mark J.
   Ramelot, Theresa A.
   Rousseau, Francois
   Tong, Liang
   Wernimont, Amy K.
   Young, Jasmine
   Schwede, Torsten
TI Target highlights in CASP9: Experimental target structures for the
   critical assessment of techniques for protein structure prediction
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE CASP; protein structure; X-ray crystal-lography; NMR; structure
   prediction
ID LONG TAIL-FIBER; KINASE-I-BETA; LYSOPHOSPHATIDIC ACID;
   LYSOPHOSPHOLIPASE-D; CRYSTAL-STRUCTURE; BINDING DOMAIN; BASE J;
   BACTERIOPHAGE-T4; AUTOTAXIN; REVEALS
AB One goal of the CASP community wide experiment on the critical assessment of techniques for protein structure prediction is to identify the current state of the art in protein structure prediction and modeling. A fundamental principle of CASP is blind prediction on a set of relevant protein targets, that is, the participating computational methods are tested on a common set of experimental target proteins, for which the experimental structures are not known at the time of modeling. Therefore, the CASP experiment would not have been possible without broad support of the experimental protein structural biology community. In this article, several experimental groups discuss the structures of the proteins which they provided as prediction targets for CASP9, highlighting structural and functional peculiarities of these structures: the long tail fiber protein gp37 from bacteriophage T4, the cyclic GMP-dependent protein kinase I beta dimerization/docking domain, the ectodomain of the JTB (jumping translocation breakpoint) transmembrane receptor, Autotaxin in complex with an inhibitor, the DNA-binding J-binding protein 1 domain essential for biosynthesis and maintenance of DNA base-J (beta-D-glucosyl-hydroxymethyluracil) in Trypanosoma and Leishmania, an so far uncharacterized 73 residue domain from Ruminococcus gnavus with a fold typical for PDZ-like domains, a domain from the phycobilisome core-membrane linker phycobiliprotein ApcE from Synechocystis, the heat shock protein 90 activators PFC0360w and PFC0270w from Plasmodium falciparum, and 2-oxo-3-deoxygalactonate kinase from Klebsiella pneumoniae. Proteins 2011; 79(Suppl 10):6-20. (C) 2011 Wiley-Liss, Inc.
C1 [Schwede, Torsten] Univ Basel, Biozentrum, SIB Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Kryshtafovych, Andriy] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.
   [Moult, John] Univ Maryland, Inst Biosci & Biotechnol Res, Dept Cell Biol & Mol Genet, Rockville, MD 20850 USA.
   [Bartual, Sergio G.] CSIC, Dept Cristalog & Biol Estruct, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain.
   [Bartual, Sergio G.; Otero, Jose M.; van Raaij, Mark J.] Univ Santiago de Compostela, Dept Bioquim & Biol Mol, Fac Farm, E-15782 Santiago De Compostela, Spain.
   [Bazan, J. Fernando; Lingel, Andreas; Rousseau, Francois] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA.
   [Berman, Helen; Young, Jasmine] Rutgers State Univ, RCSB PDB, Piscataway, NJ 08854 USA.
   [Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Christodoulou, Evangelos; Hausmann, Jens; Heidebrecht, Tatjana; Perrakis, Anastassis] NKI, Dept Biochem, NL-1066 CX Amsterdam, Netherlands.
   [Everett, John K.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.
   [Everett, John K.] Rutgers State Univ, NE Struct Genom Consortium NESG, Piscataway, NJ 08854 USA.
   [Hills, Tanya; Hui, Raymond; Pizarro, Juan C.; Wernimont, Amy K.] MaRS Ctr, SGC, Toronto, ON M5G 1L7, Canada.
   [Hunt, John F.; Seetharaman, Jayaraman; Tong, Liang] Columbia Univ, Dept Biol Sci, NE Struct Genom Consortium NESG, New York, NY 10027 USA.
   [Joachimiak, Andrzej; Michalska, Karolina] Argonne Natl Lab, MCSG, Biosci Div, Argonne, IL 60439 USA.
   [Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA.
   [Joachimiak, Andrzej] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA.
   [Kennedy, Michael A.; Ramelot, Theresa A.] Miami Univ, Dept Chem & Biochem, NE Struct Genom Consortium NESG, Oxford, OH 45056 USA.
   [Kim, Choel] Baylor Coll Med, Dept Pharmacol, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.
   [Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA.
   [Montelione, Gaetano T.] Rutgers State Univ, NE Struct Genom Consortium NESG, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.
   [Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.
   [van Raaij, Mark J.] CSIC, Dept Estructura Macromol, Ctr Nacl Biotecnol, E-28049 Madrid, Spain.
   [Bazan, J. Fernando; Lingel, Andreas; Rousseau, Francois] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, SIB Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Bartual, Sergio/S-8244-2016; Kennedy, Michael/M-2578-2019; Schwede,
   Torsten/A-4650-2008; Ramelot, Theresa A/V-1413-2017; van Raaij, Mark
   J/B-3678-2009; Perrakis, Anastassis/E-8704-2013; Otero, Jose/C-2626-2008
OI Bartual, Sergio/0000-0002-9755-8152; Schwede,
   Torsten/0000-0003-2715-335X; Ramelot, Theresa A/0000-0002-0335-1573; van
   Raaij, Mark J/0000-0002-4781-1375; Perrakis,
   Anastassis/0000-0002-1151-6227; Otero, Jose/0000-0001-5543-4859; Tong,
   Liang/0000-0002-0563-6468; Young, Jasmine/0000-0001-8896-6878; Berman,
   Helen/0000-0002-3337-0660; Kryshtafoych, Andriy/0000-0001-5066-7178;
   Christodoulou, Evangelos/0000-0001-8464-1558; Moult,
   John/0000-0002-3012-2282
FU National Library of Medicine (NIH/NLM)United States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Library of Medicine (NLM) [LM007085]; Spanish Ministry of Education and
   ScienceSpanish Government [BFU2008-01588]; European CommissionEuropean
   CommissionEuropean Commission Joint Research Centre
   [NMP4-CT-2006-033256]; Spanish Ministry of Education and ScienceSpanish
   Government; Xunta de GaliciaXunta de Galicia; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [K22-CA124517, R01-GM090161, GM074942,
   GM094585]; U.S. Department of Energy, Office of Biological and
   Environmental ResearchUnited States Department of Energy (DOE)
   [DE-AC02-06CH11357]; Foundation for Polish ScienceFoundation for Polish
   Science; NSFNational Science Foundation (NSF) [DBI 0829586]; Div Of
   Biological InfrastructureNational Science Foundation (NSF)NSF -
   Directorate for Biological Sciences (BIO) [0829586] Funding Source:
   National Science Foundation; NATIONAL CANCER INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [K22CA124517, K22CA124517,
   K22CA124517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U54GM074942, U54GM094585,
   U54GM094585, U54GM094585, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM094585, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM094585, U54GM094585,
   U54GM094585, U54GM074942, U54GM074942, U54GM094585, U54GM094585,
   U54GM074942, R01GM100482, U54GM094585, U54GM074942, U54GM094585,
   U54GM074942, R01GM100482, U54GM074942, U54GM074942, U54GM074942,
   U54GM094585, R01GM100482, U54GM074942, U54GM074942, U54GM094585,
   U54GM094585, U54GM094585, U54GM074942, U54GM074942, U54GM074942,
   U54GM094585, U54GM074942, U54GM094585, R01GM100482, U54GM074942,
   U54GM074942, U54GM074942, U54GM094585, U54GM094585, U54GM074942,
   U54GM074942, R01GM090161, R01GM100482, U54GM074942, R01GM100482,
   U54GM094585, U54GM094585, U54GM094585, R01GM090161, U54GM074942,
   U54GM074942, U54GM074942, R01GM090161, U54GM094585, U54GM094585,
   U54GM094585, R01GM090161, U54GM094585, U54GM074942, R01GM090161,
   R01GM100482, U54GM094585, R01GM090161, U54GM074942, U54GM094585,
   U54GM094585, U54GM094585, U54GM074942, U54GM094585, U54GM074942,
   R01GM090161, U54GM074942, U54GM094585, U54GM094585, U54GM074942,
   U54GM094585, U54GM094585, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM094585, U54GM094585, R01GM100482, R01GM090161,
   U54GM074942, U54GM074942, U54GM094585, U54GM074942, U54GM074942,
   U54GM094585, R01GM100482, U54GM094585, U54GM074942, U54GM094585,
   U54GM094585, U54GM094585, U54GM074942, U54GM074942, U54GM074942,
   U54GM094585, R01GM090161, U54GM094585, U54GM074942] Funding Source: NIH
   RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Library of Medicine (NLM) [P41LM007085, P41LM007085, P41LM007085,
   P41LM007085, P41LM007085, P41LM007085, P41LM007085, P41LM007085,
   P41LM007085, P41LM007085, P41LM007085, P41LM007085, P41LM007085,
   P41LM007085, P41LM007085, P41LM007085] Funding Source: NIH RePORTER
FX Grant sponsor: National Library of Medicine (NIH/NLM); Grant number:
   LM007085 (A. K.); Grant sponsor: Spanish Ministry of Education and
   Science; Grant number: BFU2008-01588; Grant sponsor: European
   Commission; Grant number: NMP4-CT-2006-033256; Grant sponsor: Spanish
   Ministry of Education and Science (Jose Castillejo fellowship); Grant
   sponsor: Xunta de Galicia (Angeles Alvarino fellowship); Grant sponsor:
   National Institutes of Health; Grant numbers: K22-CA124517 (D. E. C.);
   R01-GM090161 (C. K.) GM074942; GM094585; Grant sponsor: U.S. Department
   of Energy, Office of Biological and Environmental Research; Grant
   number: DE-AC02-06CH11357 (to A.J.); Grant sponsor: Foundation for
   Polish Science (to K. M.); Grant sponsor: NSF; Grant number: DBI
   0829586.
CR Ackermann HW, 1999, ADV VIRUS RES, V51, P135
   Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107
   Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   Bartual SG, 2010, P NATL ACAD SCI USA, V107, P20287, DOI 10.1073/pnas.1011218107
   Bartual SG, 2010, PROTEIN EXPRES PURIF, V70, P116, DOI 10.1016/j.pep.2009.11.005
   Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750
   Buss KA, 2001, J BACTERIOL, V183, P680, DOI 10.1128/JB.183.2.680-686.2001
   Casteel DE, 2010, J BIOL CHEM, V285, P32684, DOI 10.1074/jbc.C110.161430
   Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200
   Cerritelli ME, 1996, J MOL BIOL, V260, P767, DOI 10.1006/jmbi.1996.0436
   DELEY J, 1957, J BIOL CHEM, V227, P745
   Dessailly BH, 2009, STRUCTURE, V17, P869, DOI 10.1016/j.str.2009.03.015
   Diao J, 2009, PROTEINS IN PRESS
   Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907
   GOMMERSAMPT JH, 1993, CELL, V75, P1129, DOI 10.1016/0092-8674(93)90322-H
   Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008
   Grishin N, 2011, PROTEINS S10, V79, P59
   Hatakeyama S, 1999, ONCOGENE, V18, P2085, DOI 10.1038/sj.onc.1202510
   Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980
   Heidebrecht T, 2011, NUCLEIC ACIDS RES, V39, P5715, DOI 10.1093/nar/gkr125
   Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366
   Iwasaki W, 1997, EMBO J, V16, P6936, DOI 10.1093/emboj/16.23.6936
   Karam G, 1994, MOL BIOL BACTERIOPHA
   Kinch LN, 2011, PROTEINS, V79, P21, DOI 10.1002/prot.23190
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Kryshtafovych A, 2005, PROTEINS, V61, P225, DOI 10.1002/prot.20740
   Kryshtafovych A, 2011, PROTEINS, V79, P196, DOI 10.1002/prot.23182
   Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860
   Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355
   Leiman PG, 2000, J MOL BIOL, V301, P975, DOI 10.1006/jmbi.2000.3989
   Leiman PG, 2006, J MOL BIOL, V358, P912, DOI 10.1016/j.jmb.2006.02.058
   Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001
   Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177
   Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781
   McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404
   Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141
   Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105
   Michalska K, 2011, ACTA CRYSTALLOGR D, V67, P678, DOI 10.1107/S0907444911021834
   Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915
   Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998
   Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010
   OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T
   Platica O, 2000, INT J ONCOL, V16, P1055
   Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006
   Richie-Jannetta R, 2003, J BIOL CHEM, V278, P50070, DOI 10.1074/jbc.M306796200
   Rossmann MG, 2004, CURR OPIN STRUC BIOL, V14, P171, DOI 10.1016/j.sbi.2004.02.001
   Schmidt T, 2011, PROTEINS, V79, P126, DOI 10.1002/prot.23174
   Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1
   Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI DOI 10.1007/978-94-011-0227-8_7
   Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005
   Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19
   Thomassen E, 2003, J MOL BIOL, V331, P361, DOI 10.1016/s0022-2836(03)00755-1
   Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200
   Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026
   van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200
   Yu YB, 2002, ADV DRUG DELIVER REV, V54, P1113, DOI 10.1016/S0169-409X(02)00058-3
   Zalatan JG, 2006, BIOCHEMISTRY-US, V45, P9788, DOI 10.1021/bi060847t
   Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008
NR 61
TC 14
Z9 14
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PY 2011
VL 79
SU 10
BP 6
EP 20
DI 10.1002/prot.23196
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 860UD
UT WOS:000297972300002
PM 22020785
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Kinch, LN
   Shi, S
   Cheng, H
   Cong, Q
   Pei, JM
   Mariani, V
   Schwede, T
   Grishin, NV
AF Kinch, Lisa N.
   Shi, Shuoyong
   Cheng, Hua
   Cong, Qian
   Pei, Jimin
   Mariani, Valerio
   Schwede, Torsten
   Grishin, Nick V.
TI CASP9 target classification
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE protein structure; CASP9; classification; fold space; sequence homologs;
   structure analogs; free modeling; template based modeling; structure
   prediction
ID PROTEIN STRUCTURES; STRUCTURAL BASIS; DOMAIN; DATABASE; SERVER;
   SIMILARITIES; HOMOLOGY; PROSMOS
AB The Critical assessment of protein structure prediction round 9 (CASP9) aimed to evaluate predictions for 129 experimentally determined protein structures. To assess tertiary structure predictions, these target structures were divided into domain-based evaluation units that were then classified into two assessment categories: template based modeling (TBM) and template free modeling (FM). CASP9 targets were split into domains of structurally compact evolutionary modules. For the targets with more than one defined domain, the decision to split structures into domains for evaluation was based on server performance. Target domains were categorized based on their evolutionary relatedness to existing templates as well as their difficulty levels indicated by server performance. Those target domains with sequence-related templates and high server prediction performance were classified as TMB, whereas those targets without identifiable templates and low server performance were classified as FM. However, using these generalizations for classification resulted in a blurred boundary between CASP9 assessment categories. Thus, the FM category included those domains without sequence detectable templates (25 target domains) as well as some domains with difficult to detect templates whose predictions were as poor as those without templates (five target domains). Several interesting examples are discussed, including targets with sequence related templates that exhibit unusual structural differences, targets with homologous or analogous structure templates that are not detectable by sequence, and targets with new folds. Proteins 2011; 79(Suppl 10):21-36. (C) 2011 Wiley-Liss, Inc.
C1 [Kinch, Lisa N.; Pei, Jimin; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.
   [Shi, Shuoyong; Cheng, Hua; Cong, Qian; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.
   [Mariani, Valerio; Schwede, Torsten] Univ Basel, Swiss Inst Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
RP Kinch, LN (corresponding author), UT Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
EM lkinch@chop.swmed.edu
RI shi, shuoyong/D-9925-2013; Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Kinch, Lisa/0000-0003-3041-2615
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM094575]; Welch
   FoundationThe Welch Foundation [I-1505]; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM094575, R01GM094575,
   R01GM067165, R01GM094575, R01GM067165, R01GM094575, R01GM094575,
   R01GM067165, R01GM094575, R01GM067165, R01GM094575, R01GM094575] Funding
   Source: NIH RePORTER
FX This work was supported in part by the National Institutes of Health
   (GM094575 to NVG) and the Welch Foundation (I-1505 to NVG).
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BABU M, MOL MICROBIOL, V79, P484
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3
   Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335
   Heidebrecht T, 2011, NUCLEIC ACIDS RES, V39, P5715, DOI 10.1093/nar/gkr125
   Hemond M, 2009, J MOL BIOL, V386, P1024, DOI 10.1016/j.jmb.2009.01.004
   Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507
   Kim BH, 2009, NUCLEIC ACIDS RES, V37, pW532, DOI 10.1093/nar/gkp328
   Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402
   Majumdar I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005084
   Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011
   MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159
   Shi SY, 2007, BIOINFORMATICS, V23, P1331, DOI 10.1093/bioinformatics/btm121
   Shi SY, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap003
   Shi SY, 2009, NUCLEIC ACIDS RES, V37, pW526, DOI 10.1093/nar/gkp316
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Wang Y, 2009, NUCLEIC ACIDS RES, V37, P3522, DOI 10.1093/nar/gkp212
   Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103
NR 21
TC 45
Z9 45
U1 1
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0887-3585
J9 PROTEINS
JI Proteins
PY 2011
VL 79
SU 10
BP 21
EP 36
DI 10.1002/prot.23190
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 860UD
UT WOS:000297972300003
PM 21997778
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Mariani, V
   Kiefer, F
   Schmidt, T
   Haas, J
   Schwede, T
AF Mariani, Valerio
   Kiefer, Florian
   Schmidt, Tobias
   Haas, Juergen
   Schwede, Torsten
TI Assessment of template based protein structure predictions in CASP9
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE protein structure; evaluation; structure prediction; CASP
ID DOMAIN DEFINITION; MODELS; CLASSIFICATION; ALIGNMENTS; ACCURACY
AB In the Ninth Edition of the Critical Assessment of Techniques for Protein Structure Prediction (CASP9), 61,665 models submitted by 176 groups were assessed for their accuracy in the template based modeling category. The models were evaluated numerically in comparison to their experimental control structures using two global measures (GDT and GDC), and a novel local score evaluating the correct modeling of local interactions (IDDT). Overall, the state of the art of template based modeling in CASP9 is high, with many groups performing well. Among the methods registered as prediction "servers", six independent groups are performing on average better than the rest. The submissions by "human" groups are dominated by meta-predictors, with one group performing noticeably better than the others. Most of the participating groups failed to assign realistic confidence estimates to their predictions, and only a very small fraction of the assessed methods have provided highly accurate models and realistic error estimates at the same time. Also, the accuracy of predictions for homo-oligomeric assemblies was overall poor, and only one group performed better than a naive control predictor. Here, we present the results of our assessment of the CASP9 predictions in the category of template based modeling, documenting the state of the art and highlighting areas for future developments. Proteins 2011; 79(Suppl 10): 37-58. (C) 2011 Wiley-Liss, Inc.
C1 [Schwede, Torsten] Univ Basel, Biozentrum, SIB, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Mariani, Valerio; Kiefer, Florian; Schmidt, Tobias; Haas, Juergen; Schwede, Torsten] SIB Swiss Inst Bioinformat, Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, SIB, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
FU SIB Swiss Institute of Bioinformatics
FX We thank all experimental groups and participating predictors, without
   whom CASP would not be possible. We wish to thank our fellow assessor
   Nick Grishin and his team for the constructive collaboration, and the
   Prediction Center, especially Andriy Krystafovych, for handling the
   submission procedures and providing data for the analysis. Last but not
   least, we thank John Moult and Anna Tramontano for continuous
   encouragement and valuable discussions. We gratefully acknowledge
   support of our group by the SIB Swiss Institute of Bioinformatics.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761
   Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971
   Biasini M, 2010, BIOINFORMATICS, V26, P2626, DOI 10.1093/bioinformatics/btq481
   Clarke ND, 2007, PROTEINS, V69, P10, DOI 10.1002/prot.21686
   Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304
   Cozzetto D, 2009, PROTEINS, V77, P18, DOI 10.1002/prot.22561
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964
   Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617
   Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105
   Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431
   Kalyanaraman C, 2008, STRUCTURE, V16, P1668, DOI 10.1016/j.str.2008.08.015
   Keedy DA, 2009, PROTEINS, V77, P29, DOI 10.1002/prot.22551
   Kinch LN, 2011, PROTEINS, V79, P21, DOI 10.1002/prot.23190
   Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753
   Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kryshtafovych A, 2007, PROTEINS, V69, P194, DOI 10.1002/prot.21769
   Kryshtafovych A, 2011, PROTEINS, V79, P6, DOI 10.1002/prot.23196
   Kryshtafovych A, 2011, PROTEINS, V79, P196, DOI 10.1002/prot.23182
   Kryshtafovych A, 2011, PROTEINS, V79, P91, DOI 10.1002/prot.23180
   Kryshtafovych A, 2009, PROTEINS, V77, P217, DOI 10.1002/prot.22562
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lees J, 2010, NUCLEIC ACIDS RES, V38, pD296, DOI 10.1093/nar/gkp987
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189
   Margelevicius M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-89
   Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006
   McGuffin LJ, 2011, PROTEINS, V79, P137, DOI 10.1002/prot.23120
   Morais DADL, 2011, NUCLEIC ACIDS RES, V39, pD427, DOI 10.1093/nar/gkq1130
   Peng J, 2011, PROTEINS, V79, P161, DOI 10.1002/prot.23175
   POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993
   Poupon A, 2010, METHODS MOL BIOL, V609, P349, DOI 10.1007/978-1-60327-241-4_20
   Scheeff ED, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-410
   Schmidt T, 2011, PROTEINS, V79, P126, DOI 10.1002/prot.23174
   Schwarzenbacher R, 2008, ACTA CRYSTALLOGR D, V64, P133, DOI 10.1107/S0907444907050111
   Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014
   Shang Y, 2011, PROTEINS S10, V79, P185
   Shi SY, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap003
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   Tramontano A, 2003, PROTEINS, V53, P352, DOI 10.1002/prot.10543
   Tress ML, 2009, PROTEINS, V77, P10, DOI 10.1002/prot.22497
   Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224
   Xu D, 2011, PROTEINS S10, V79, P172
   Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264
NR 49
TC 114
Z9 116
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PY 2011
VL 79
SU 10
BP 37
EP 58
DI 10.1002/prot.23177
PG 22
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 860UD
UT WOS:000297972300004
PM 22002823
DA 2021-01-25
ER

PT J
AU Schmidt, T
   Haas, J
   Cassarino, TG
   Schwede, T
AF Schmidt, Tobias
   Haas, Juergen
   Cassarino, Tiziano Gallo
   Schwede, Torsten
TI Assessment of ligand-binding residue predictions in CASP9
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE protein function; protein structure; evaluation; assessment; binding
   site; active site; cofactor; ligand; CASP
ID FUNCTIONAL RESIDUES; PROTEIN STRUCTURES; SITE PREDICTION;
   IDENTIFICATION; CONSERVATION; DOCKING; WEB
AB Interactions between proteins and their ligands play central roles in many physiological processes. The structural details for most of these interactions, however, have not yet been characterized experientially. Therefore, various computational tools have been developed to predict the location of binding sites and the amino acid residues interacting with ligands. In this manuscript, we assess the performance of 33 methods participating in the ligand-binding site prediction category in CASP9. The overall accuracy of ligand-binding site predictions in CASP9 appears rather high (average Matthews correlation coefficient of 0.62 for the 10 top performing groups) and compared to previous experiments more groups performed equally well. However, this should be seen in context of a strong bias in the test data toward easy template-based models. Overall, the top performing methods have converged to a similar approach using ligand-binding site inference from related homologous structures, which limits their applicability for difficult de novo prediction targets. Here, we present the results of the CASP9 assessment of the ligand-binding site category, discuss examples for successful and challenging prediction targets in CASP9, and finally suggest changes in the format of the experiment to overcome the current limitations of the assessment. Proteins 2011; 79(Suppl 10): 126-136. (C) 2011 Wiley-Liss, Inc.
C1 [Schwede, Torsten] Univ Basel, Biozentrum, SIB Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, SIB Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008; Cassarino, Tiziano Gallo/AAM-2845-2020
OI Schwede, Torsten/0000-0003-2715-335X; Cassarino, Tiziano
   Gallo/0000-0001-9220-2360
FU SIB Swiss Institute of Bioinformatics; National Institute of General
   Medical SciencesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U01 GM093324-01]; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324] Funding Source: NIH RePORTER
FX Grant sponsor: SIB Swiss Institute of Bioinformatics; Grant sponsor:
   National Institute of General Medical Sciences; Grant number: U01
   GM093324-01.
CR Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020
   Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5
   Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070
   Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971
   Biasini M, 2010, BIOINFORMATICS, V26, P2626, DOI 10.1093/bioinformatics/btq481
   Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105
   CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171
   Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626
   Gherardini Pier Federico, 2008, Briefings in Functional Genomics & Proteomics, V7, P291, DOI 10.1093/bfgp/eln030
   Glaser F, 2006, PROTEINS, V62, P479, DOI 10.1002/prot.20769
   Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3
   Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281
   Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19
   Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356
   Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a
   Innis CA, 2007, NUCLEIC ACIDS RES, V35, pW489, DOI 10.1093/nar/gkm422
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9
   LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P307
   Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m
   Lopez G, 2007, NUCLEIC ACIDS RES, V35, pW573, DOI 10.1093/nar/gkm297
   Lopez G, 2007, PROTEINS, V69, P165, DOI 10.1002/prot.21651
   Lopez G, 2009, PROTEINS, V77, P138, DOI 10.1002/prot.22557
   MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9
   Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1
   Oh M, 2009, PROTEINS, V77, P152, DOI 10.1002/prot.22572
   Pandit SB, 2010, BIOINFORMATICS, V26, P687, DOI 10.1093/bioinformatics/btq006
   Pazos F, 2006, BIOINFORMATICS, V22, P1440, DOI 10.1093/bioinformatics/btl104
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Roche DB, 2010, BIOINFORMATICS, V26, P2920, DOI 10.1093/bioinformatics/btq543
   Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197
   Soro S, 2005, PROTEINS, V61, P201, DOI 10.1002/prot.20738
   Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n
   Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406
   Wass MN, 2009, PROTEINS, V77, P147, DOI 10.1002/prot.22513
   WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.2307/3001968
NR 36
TC 49
Z9 52
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PY 2011
VL 79
SU 10
BP 126
EP 136
DI 10.1002/prot.23174
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 860UD
UT WOS:000297972300010
PM 21987472
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Knechtle, P
   Kohler, G
AF Knechtle, Beat
   Knechtle, Patrizia
   Kohler, Goetz
TI The Effect of 1,000 Km Nonstop Cycling on Fat Mass and Skeletal Muscle
   Mass
SO RESEARCH IN SPORTS MEDICINE
LA English
DT Article
DE ultra-endurance; energy deficit; muscle mass; fat mass; H-1-NMR
   spectroscopy
ID NUCLEAR-MAGNETIC-RESONANCE; BODY-COMPOSITION; LACTATE SHUTTLES;
   ENERGY-BALANCE; URINE; SPECTROSCOPY; EXERCISE; METABOLITES; TRIATHLON;
   RUNNERS
AB We evaluated the change in body mass including fat mass and skeletal muscle mass in one ultracyclist whilst cycling 1,000 km in 48 hours at a constant intensity of similar to 48% VO(2)max, corresponding to a heart rate frequency of similar to 105 +/- 5 bpm. A 1 kg fat mass decrease resulted, with the largest decrease occurring between the 12th and the 24th hour. No steady state in metabolism was observed and no regular decrease of subcutaneous adipose tissue resulted. This result is backed up by the nuclear magnetic resonance (NMR) urine analysis. Body water increase with simultaneous dehydration is possibly due to endocrine-induced renal water retention, in order to maintain metabolism processes that are required for energy supply and blood flow during very prolonged exercise. Both applied methods, the anthropometric and the bioelectrical impedance analysis, analyse fluid accumulation-especially in the skinfolds of the lower extremities-apparently incorrectly as an increase in body mass and not as an increase in fluids.
C1 [Knechtle, Beat] Gesundheitszentrum, Facharzt FMH Allgemeinmed, CH-9001 St Gallen, Switzerland.
   [Knechtle, Beat] Univ Zurich, Dept Gen Practice & Hlth Serv Res, Zurich, Switzerland.
   [Kohler, Goetz] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
RP Knechtle, B (corresponding author), Gesundheitszentrum, Facharzt FMH Allgemeinmed, Vadianstr 26, CH-9001 St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
CR BALES JR, 1984, CLIN CHEM, V30, P426
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Bircher S, 2006, J SPORT SCI MED, V5, P154
   Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/BST0300258
   Brooks GA, 2000, MED SCI SPORT EXER, V32, P790, DOI 10.1097/00005768-200004000-00011
   Brooks GA, 2007, SPORTS MED, V37, P341, DOI 10.2165/00007256-200737040-00017
   Gastmann U, 1998, J SPORT MED PHYS FIT, V38, P18
   Hiilloskorpi HK, 2003, INT J SPORTS MED, V24, P332
   Klever-Schubert K., 2007, GROSSE KLEVER KALORI
   Knechtle B, 2008, BRIT J SPORT MED, V42, P121, DOI 10.1136/bjsm.2007.038034
   Knechtle B, 2005, Praxis (Bern 1994), V94, P371
   KNECHTLE B, 2003, SCHWEIZERISCHE Z SPO, V51, P174
   KNECHTLE B, 2003, SCHWEIZERISCHE Z SPO, V51, P180
   Knechtle B, 2007, J SPORT SCI MED, V6, P401
   Knechtle B, 2011, RES SPORTS MED, V19, P14, DOI 10.1080/15438627.2010.510039
   Knechtle B, 2009, RES SPORTS MED, V17, P104, DOI 10.1080/15438620902900260
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   MELIN B, 1980, EUR J APPL PHYSIOL O, V44, P141, DOI 10.1007/BF00421092
   Messana I, 1998, CLIN CHEM, V44, P1529
   NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1
   NICHOLSON JK, 1984, BIOCHEM J, V217, P365, DOI 10.1042/bj2170365
   POORTMANS JR, 1984, SPORTS MED, V1, P125, DOI 10.2165/00007256-198401020-00003
   Rogers G, 1997, MED SCI SPORT EXER, V29, P1477, DOI 10.1097/00005768-199711000-00014
   Segal Karen R., 1996, American Journal of Clinical Nutrition, V64, p469S, DOI 10.1093/ajcn/64.3.469S
   Speedy DB, 1999, MED SCI SPORT EXER, V31, P809, DOI 10.1097/00005768-199906000-00008
   Stewart IB, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-15
   Tatara T, 1999, CLIN CHIM ACTA, V279, P117, DOI 10.1016/S0009-8981(98)00174-0
   VANBEAUMONT W, 1972, J APPL PHYSIOL, V32, P712
   Weibel J, 2007, J SPORT MED PHYS FIT, V47, P491
   Zuppi C, 1997, CLIN CHIM ACTA, V265, P85, DOI 10.1016/S0009-8981(97)00110-1
NR 30
TC 11
Z9 11
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1543-8627
J9 RES SPORTS MED
JI Res. Sports Med.
PY 2011
VL 19
IS 3
BP 170
EP 185
DI 10.1080/15438627.2011.582827
PG 16
WC Sport Sciences
SC Sport Sciences
GA 884SO
UT WOS:000299729100003
PM 21722005
DA 2021-01-25
ER

PT J
AU Hadziselimovic, F
   Hadziselimovic, NO
   Demougin, P
   Oakeley, EJ
AF Hadziselimovic, F.
   Hadziselimovic, N. O.
   Demougin, P.
   Oakeley, E. J.
TI Testicular Gene Expression in Cryptorchid Boys at Risk of Azoospermia
SO SEXUAL DEVELOPMENT
LA English
DT Article
DE Ad spermatogonia; Affymetrix; Azoospermia; Cryptorchidism; Gene
   expression; Testis
ID UNILATERAL CRYPTORCHIDISM; CHROMOSOMAL-ABNORMALITIES; HAD ORCHIDOPEXY;
   SEMEN ANALYSIS; Y-CHROMOSOME; FERTILITY; TESTIS; MEN; SPERMATOGENESIS;
   DIFFERENTIATION
AB Despite timely and successful surgery, 32% of patients with bilateral and 10% with unilateral cryptorchidism will develop azoospermia. Cryptorchid boys at risk of azoospermia display a typical testicular histology of impaired mini-puberty at the time of the orchidopexy. During mini-puberty increased gonadotropin and testosterone secretion stimulate transformation of gonocytes into Ad spermatogonia. In the azoospermia risk group this transformation is to a great extent impaired. This study aimed to analyze data on whole genome expression signatures of undescended testes at risk of developing azoospermia. Twenty-three testicular biopsies from 22 boys were analyzed (19 testes from 18 boys with cryptorchidism and 4 contralateral descended testes from patients with testicular agenesis). Expression profiling identified 483 genes not or under-expressed in the azoospermia risk group compared with the control and low risk for azoospermia (LAZR) groups. Annotated loci were associated with spermatogenesis. Other significant genes were cellular defense response genes and hormone-controlled loci involved in spermatogenesis. Some genes transcribed in normal adult meiotic and post-meiotic germ cells are activated in healthy juvenile Ad spermatogonia. Thus, molecular events initiating the testicular expression program at the onset of puberty and maintaining it during adulthood occur very early in prepubertal testes. This molecular event is to a great extent impaired in the high risk for azoospermia (HAZR) group lacking Ad spermatogonia (stem cells for spermatozoa) indicating impaired mini-puberty. Copyright (C) 2011 S. Karger AG, Basel
C1 [Hadziselimovic, F.] Childrens Day Care Clin Liestal, Liestal, Switzerland.
   [Hadziselimovic, F.; Hadziselimovic, N. O.] Inst Androl, Liestal, Switzerland.
   [Hadziselimovic, N. O.; Demougin, P.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Oakeley, E. J.] Novartis Inst Biomed Res, Basel, Switzerland.
RP Hadziselimovic, F (corresponding author), Kindertagesklin Liestal, Oristalstr 87A, CH-4410 Liestal, Switzerland.
EM praxis@kindertagesklinik.ch
CR Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333
   Barsoum I, 2006, TRENDS ENDOCRIN MET, V17, P223, DOI 10.1016/j.tem.2006.06.009
   BRAMBLE FJ, 1974, LANCET, V2, P311
   Canlorbe P, 1966, Ann Pediatr (Paris), V13, P270
   Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950
   Chaudhary J, 2001, ENDOCRINOLOGY, V142, P1727, DOI 10.1210/en.142.5.1727
   Cortes D, 1996, J UROLOGY, V155, P1061, DOI 10.1016/S0022-5347(01)66392-4
   CZAPLICKI M, 1974, International Urology and Nephrology, V6, P259, DOI 10.1007/BF02089274
   Deutsch EW, 2008, NAT BIOTECHNOL, V26, P305, DOI 10.1038/nbt1391
   DUVIE SOA, 1984, ARCH ANDROLOGY, V12, P231, DOI 10.3109/01485018409161181
   EISENHUT L, 1964, ANN PAEDIATR-BASEL, V203, P157
   Fagerli J, 1999, FERTIL STERIL, V71, P697, DOI 10.1016/S0015-0282(98)00535-4
   Fedder J, 2004, FERTIL STERIL, V82, P1463, DOI 10.1016/j.fertnstert.2004.06.035
   Gatta V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-401
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   GIAROLA A, 1979, CRYPTORCHIDISM, P533
   Gracia J, 2000, BJU INT, V85, P1100, DOI 10.1046/j.1464-410x.2000.00662.x
   GUILLON G, 1979, CRYPTORCHIDISM, P505
   HADZISELIMOVIC F, 1986, J UROLOGY, V136, P274, DOI 10.1016/S0022-5347(17)44839-7
   Hadziselimovic F, 2005, J UROLOGY, V174, P1536, DOI 10.1097/01.ju.0000181506.97839.b0
   Hadziselimovic F, 2004, SWISS MED WKLY, V134, P381
   Hadziselimovic F, 2009, SEX DEV, V3, P253, DOI 10.1159/000249147
   Hadziselimovic F, 2001, LANCET, V358, P1156, DOI 10.1016/S0140-6736(01)06274-2
   Hadziselimovic F, 1979, CRYPTORCHIDISM, P129
   Hadziselimovic F., 2008, KLIN PADIATR, V219, P1
   Hadziselimovic Faruk, 2006, Int. braz j urol., V32, P570, DOI 10.1590/S1677-55382006000500012
   Hadziselimovic F, 2007, ACTA PAEDIATR, V96, P1368, DOI 10.1111/j.1651-2227.2007.00417.x
   Hadziselimovic F, 2007, HORM RES, V68, P46, DOI 10.1159/000100874
   Hamza AF, 2001, EUR J PEDIATR SURG, V11, P173, DOI 10.1055/s-2001-15484
   HANSEN TS, 1949, P ROY SOC MED, V42, P645, DOI 10.1177/003591574904200902
   HUFF DS, 1991, J UROLOGY, V146, P630, DOI 10.1016/S0022-5347(17)37876-X
   HUTANHEMI I, 2003, ENDOCR DEV, V5, P81
   Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462
   Inoue N, 1999, HUM MOL GENET, V8, P1201, DOI 10.1093/hmg/8.7.1201
   Itoh N, 2001, J ANDROL, V22, P40
   Jeong DG, 2007, PROTEINS, V66, P253, DOI 10.1002/prot.21224
   JOB JC, 1987, EUR PEDIAT S, V2, P2
   Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757
   Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958
   Kleinteich B, 1976, Arztl Jugendkd, V67, P173
   Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200
   MADERSBACHER H, 1972, UROLOGE, V11, P210
   MANDAT KM, 1994, EUR J PEDIATR SURG, V4, P94, DOI 10.1055/s-2008-1066076
   Moretti E, 2007, J ANDROL, V28, P194, DOI 10.2164/jandrol.106.000828
   NISTAL M, 1984, ANDROLOGIA, V16, P532
   Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5
   OKUYAMA A, 1989, J UROLOGY, V142, P749, DOI 10.1016/S0022-5347(17)38876-6
   Paasch U, 2004, UROL INT, V72, P154, DOI 10.1159/000075971
   PANIAGUA R, 1984, J ANAT, V139, P535
   Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995
   PONCHIETTI R, 1986, Acta Europaea Fertilitatis, V17, P277
   PURI P, 1988, LANCET, V2, P1051
   Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100
   Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507
   RICHTER W, 1976, KLIN WOCHENSCHR, V54, P467, DOI 10.1007/BF01469047
   SCOTT LS, 1961, J REPROD FERTIL, V2, P54
   SEGUCHI H, 1974, Verhandlungen der Anatomischen Gesellschaft, V68, P133
   Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669
   Siomi MC, 2010, GENE DEV, V24, P636, DOI 10.1101/gad.1899210
   Smith JM, 2004, GENE EXPR PATTERNS, V4, P701, DOI 10.1016/j.modgep.2004.04.002
   Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109
   Stuppia L, 1998, HUM GENET, V102, P566, DOI 10.1007/s004390050741
   Taskinen S, 1996, J UROLOGY, V156, P82, DOI 10.1016/S0022-5347(01)65946-9
   Toppari J, 2007, MOL CELL ENDOCRINOL, V269, P34, DOI 10.1016/j.mce.2006.10.021
   Trsinar B, 2009, WORLD J UROL, V27, P513, DOI 10.1007/s00345-009-0406-0
   Virtanen HE, 2007, ACTA PAEDIATR, V96, P622, DOI 10.1111/j.1651-2227.2007.00244.x
   Vogt PH, 2005, REPROD BIOMED ONLINE, V10, P81, DOI 10.1016/S1472-6483(10)60807-3
   von Kopylow K, 2010, HUM REPROD, V25, P1104, DOI 10.1093/humrep/deq053
   Vutyavanich T, 2007, ASIAN J ANDROL, V9, P68, DOI 10.1111/j.1745-7262.2007.00239.x
   Watson ML, 1998, P NATL ACAD SCI USA, V95, P14361, DOI 10.1073/pnas.95.24.14361
   WERDER EA, 1976, BRIT MED J, V2, P1357, DOI 10.1136/bmj.2.6048.1357
   Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449
   Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031
   WOJCIECHOWSKI K, 1979, CRYPTORCHIDISM, P557
   Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106
   Yang Bo, 2009, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V25, P393
   Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x
NR 77
TC 34
Z9 36
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1661-5425
EI 1661-5433
J9 SEX DEV
JI Sex. Dev.
PY 2011
VL 5
IS 2
BP 49
EP 59
DI 10.1159/000323955
PG 11
WC Developmental Biology
SC Developmental Biology
GA 739BN
UT WOS:000288687400001
PM 21412036
OA Other Gold
DA 2021-01-25
ER

PT J
AU Oggier, DM
   Lenard, A
   Kury, M
   Hoeger, B
   Affolter, M
   Fent, K
AF Oggier, Daniela M.
   Lenard, Anna
   Kuery, Michael
   Hoeger, Birgit
   Affolter, Markus
   Fent, Karl
TI Effects of the Protein Kinase Inhibitor PKC412 on Gene Expression and
   Link to Physiological Effects in Zebrafish Danio rerio Eleuthero-Embryos
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE PKC412; Danio rerio; transgenic zebrafish; microarray; angiogenesis;
   apoptosis
ID MYELOID-LEUKEMIA CELLS; HUMAN PHARMACEUTICALS; VASCULAR DEVELOPMENT;
   CIRCADIAN CLOCK; ANGIOGENESIS; RECEPTOR; ACTIVATION; ORGANISMS; REPAIR;
   TIE2
AB To identify molecular effects of the antineoplastic agent protein kinase C inhibitor 412 (PKC412) (midostaurin), we applied gene expression profiling in zebrafish using whole-genome microarrays. Behavioral, developmental, and physiological effects were investigated in order to analyze for correlations between altered gene expression profiles with effects on development and physiology. Zebrafish blastula-stage embryos were exposed for 6 days postfertilization to nominal levels of 2 and 40 mu g/l PKC412. Among the 259 and 511 altered transcripts at both concentrations, respectively, the expressions of genes involved in the circadian rhythm were further investigated. Alteration of swimming behavior was not observed. Pathways of interest affected by PKC412 were angiogenesis, apoptosis, DNA damage response, and response to oxidative stress. Angiogenesis was analyzed in double-transgenic zebrafish embryos Tg(fli1a:EGFP)y1;Tg(gata1:dsRed)sd2; no major defects were induced by PKC412 treatment at both concentrations. Apoptosis occurred in olfactory placodes of embryos exposed to 40 mu g/l, and DNA damage was induced at both PKC412 concentrations. However, there were no significant effects on reactive oxygen species formation. This study leads to the conclusion that PKC412-induced alterations of gene transcripts are partly paralleled by physiological effects at high, but not at low PKC412 concentrations expected to be of environmental relevance.
C1 [Oggier, Daniela M.; Kuery, Michael; Fent, Karl] Univ Appl Sci NW Switzerland, Sch Life Sci, CH-4132 Muttenz, Switzerland.
   [Oggier, Daniela M.] Univ Zurich, Div Limnol, Inst Plant Biol, CH-8802 Kilchberg, Switzerland.
   [Lenard, Anna; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Hoeger, Birgit] Novartis Pharma AG, CH-4058 Basel, Switzerland.
   [Fent, Karl] Swiss Fed Inst Technol ETHZ, Dept Environm Sci, CH-8092 Zurich, Switzerland.
RP Fent, K (corresponding author), Univ Appl Sci NW Switzerland, Sch Life Sci, Grundenstr 40, CH-4132 Muttenz, Switzerland.
EM karl.fent@fhnw.ch
OI Affolter, Markus/0000-0002-5171-0016
FU Novartis Pharma AG; Novartis International AGNovartis; F. Hoffmann-La
   Roche Ltd.Hoffmann-La Roche
FX Novartis Pharma AG; Novartis International AG; F. Hoffmann-La Roche Ltd.
   to K.F.
CR Campochiaro PA, 2004, INVEST OPHTH VIS SCI, V45, P922, DOI 10.1167/iovs.03-0955
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Chabner B. A., 2006, GOODMAN GILMANS PHAR, P1396
   Chan J, 2002, CANCER CELL, V1, P257, DOI 10.1016/S1535-6108(02)00042-9
   Christen V, 2010, AQUAT TOXICOL, V96, P167, DOI 10.1016/j.aquatox.2009.11.021
   Clark JI, 2004, EXP EYE RES, V78, P427, DOI 10.1016/j.exer.2003.10.008
   Comolli AC, 1999, J BIOL RHYTHM, V14, P11, DOI 10.1177/074873099129000399
   Deng J, 2009, AQUAT TOXICOL, V93, P29, DOI 10.1016/j.aquatox.2009.03.001
   DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897
   Duong FHT, 2010, HEPATOLOGY, V51, P741, DOI 10.1002/hep.23388
   EMEA, 2006, GUID ENV RISK ASS ME
   Fabbro D, 2000, ANTI-CANCER DRUG DES, V15, P17
   Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009
   GERHARDT A, 1994, ENVIRON INT, V20, P209, DOI 10.1016/0160-4120(94)90138-4
   Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173
   Hastings MH, 1997, TRENDS NEUROSCI, V20, P459, DOI 10.1016/S0166-2236(97)01087-4
   Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200
   Jakubcakova V, 2007, NEURON, V54, P831, DOI 10.1016/j.neuron.2007.04.031
   Jones OAH, 2007, COMP ANAL C, V50, P387, DOI 10.1016/S0166-526X(07)50012-7
   Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kling PG, 2000, FREE RADICAL BIO MED, V28, P1628, DOI 10.1016/S0891-5849(00)00277-X
   Kubota Y, 2005, P NATL ACAD SCI USA, V102, P13502, DOI 10.1073/pnas.0501902102
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   Mimeault C, 2006, TOXICOLOGY, V228, P140, DOI 10.1016/j.tox.2006.08.025
   Monteiro SC, 2010, REV ENVIRON CONTAM T, V202, P53, DOI 10.1007/978-1-4419-1157-5_2
   Oggier DM, 2010, ENVIRON SCI TECHNOL, V44, P7685, DOI 10.1021/es100980r
   Patten SA, 2007, INT J DEV NEUROSCI, V25, P155, DOI 10.1016/j.ijdevneu.2007.02.003
   Pham V, 2001, DEV DYNAM, V221, P470, DOI 10.1002/dvdy.1157
   Robbens J, 2007, TRENDS BIOTECHNOL, V25, P460, DOI 10.1016/j.tibtech.2007.08.005
   Runnalls TJ, 2007, AQUAT TOXICOL, V84, P111, DOI 10.1016/j.aquatox.2007.06.005
   Saishin Y, 2003, INVEST OPHTH VIS SCI, V44, P3656, DOI 10.1167/iovs.02-1143
   Schak KM, 1999, BRAIN RES, V840, P158, DOI 10.1016/S0006-8993(99)01787-4
   Seedhouse CH, 2006, LEUKEMIA, V20, P2130, DOI 10.1038/sj.leu.2404439
   Si MS, 2005, INT IMMUNOPHARMACOL, V5, P1141, DOI 10.1016/j.intimp.2005.02.012
   Slatter CAB, 2005, J NEUROBIOL, V62, P425, DOI 10.1002/neu.20110
   Stolzel F, 2010, ANN HEMATOL, V89, P653, DOI 10.1007/s00277-009-0889-1
   Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9
   TAKAHASHI I, 1989, J ANTIBIOT, V42, P571, DOI 10.7164/antibiotics.42.571
   Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532
   Tenzer A, 2001, CANCER RES, V61, P8203
   Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2
   Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007
   VANDERZEE EA, 1995, BRAIN RES, V701, P99, DOI 10.1016/0006-8993(95)00968-1
NR 45
TC 9
Z9 9
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD JAN
PY 2011
VL 119
IS 1
BP 104
EP 115
DI 10.1093/toxsci/kfq330
PG 12
WC Toxicology
SC Toxicology
GA 701TD
UT WOS:000285845400010
PM 20980353
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Lardenois, A
   Chalmel, F
   Barrionuevo, F
   Demougin, P
   Scherer, G
   Primig, M
AF Lardenois, Aurelie
   Chalmel, Frederic
   Barrionuevo, Francisco
   Demougin, Philippe
   Scherer, Gerd
   Primig, Michael
TI Profiling spermatogenic failure in adult testes bearing Sox9-deficient
   Sertoli cells identifies genes involved in feminization, inflammation
   and stress
SO REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
LA English
DT Article
ID AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA;
   GERM-CELLS; SERINE PROTEASES; NERVOUS-SYSTEM; MOUSE TESTIS; FACTOR SOX9;
   EXPRESSION; MICE
AB Background: Sox9 (Sry box containing gene 9) is a DNA-binding transcription factor involved in chondrocyte development and sex determination. The protein's absence in testicular Sertoli nurse cells has been shown to disrupt testicular function in adults but little is known at the genome-wide level about molecular events concomitant with testicular break-down.
   Methods: To determine the genome-wide effect on mRNA concentrations triggered by the absence of Sox9 in Sertoli cells we analysed adult testicular tissue from wild-type versus mutant mice with high-density oligonucleotide microarrays and integrated the output of this experiment with regulatory motif predictions and protein-protein network data.
   Results: We report the genome-wide mRNA signature of adult testes lacking Sox9 in Sertoli cells before and after the onset of late spermatogenic failure as compared to fertile controls. The GeneChip data integrated with evolutionarily conserved Sox9 DNA binding motifs and regulatory network data identified genes involved in feminization, stress response and inflammation.
   Conclusions: Our results extend previous observations that genes required for female gonadogenesis are up-regulated in the absence of Sox9 in fetal Sertoli cells to the adult stage. Importantly, we identify gene networks involved in immunological processes and stress response which is reminiscent of a phenomenon occurring in a sub-group of infertile men. This suggests mice lacking Sox9 in their Sertoli cells to be a potentially useful model for adult human testicular failure.
C1 [Lardenois, Aurelie; Chalmel, Frederic; Primig, Michael] Univ Rennes 1, INSERM, U625, IFR140, F-35042 Rennes, France.
   [Barrionuevo, Francisco; Scherer, Gerd] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany.
   [Demougin, Philippe] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Barrionuevo, Francisco] Univ Granada, Dept Genet, Granada, Spain.
   [Barrionuevo, Francisco] Univ Granada, Inst Biotechnol, Granada, Spain.
RP Primig, M (corresponding author), Univ Rennes 1, INSERM, U625, IFR140, F-35042 Rennes, France.
EM michael.primig@inserm.fr
RI Chalmel, Frederic/L-5360-2018; Lardenois, Aurelie/AAA-8961-2020; Primig,
   Michael/G-3175-2013; Barrionuevo, Francisco/AAA-7639-2019; Chalmel,
   Frederic/M-1297-2016
OI Chalmel, Frederic/0000-0002-0535-3628; Primig,
   Michael/0000-0002-2061-0119; Barrionuevo, Francisco/0000-0003-2651-1530;
   
FU Inserm Young Investigator fellowship; INERIS; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [Sche 195/15];
   Inserm AvenirInstitut National de la Sante et de la Recherche Medicale
   (Inserm) [R07216NS]
FX We thank B. Jegou for critical reading of the manuscript, H. Scherthan
   and J. Moore for stimulating discussions and O. Collin (IRISA, GenOuest
   bioinformatics platform) for MIMAS and GermOnline system administration.
   A. Lardenois was supported by an Inserm Young Investigator fellowship
   and INERIS. This work was supported by Deutsche Forschungsgemeinschaft
   grant Sche 195/15 awarded to G. Scherer and by Inserm Avenir grant
   R07216NS awarded to M. Primig.
CR Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102
   AKIYAMA H, 2007, GENE DEV, V16, P2813
   Auer Herbert, 2009, V509, P35, DOI 10.1007/978-1-59745-372-1_3
   BARRETT T, 2010, NUCL ACIDS RES
   Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930
   Barrionuevo F, 2010, INT J BIOCHEM CELL B, V42, P433, DOI 10.1016/j.biocel.2009.07.015
   Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011
   Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007
   Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876
   Bi WM, 1999, NAT GENET, V22, P85
   Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139
   Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627
   Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789
   Campagnoni A, 2001, BRAIN PATHOL, V11, P74
   Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087
   Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86
   Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104
   Charron Y, 2006, MOL REPROD DEV, V73, P9, DOI 10.1002/mrd.20385
   Chu TM, 2004, ENVIRON HEALTH PERSP, V112, P449, DOI 10.1289/ehp.6787
   CONNOR F, 1995, NUCLEIC ACIDS RES, V23, P3365, DOI 10.1093/nar/23.17.3365
   daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62
   Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723
   Faro A, 2009, ZEBRAFISH, V6, P59, DOI 10.1089/zeb.2009.0580
   FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0
   Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099
   Gattiker A, 2007, NUCLEIC ACIDS RES, V35, pD457, DOI 10.1093/nar/gkl957
   Gordon CT, 2009, J MED GENET, V46, P649, DOI 10.1136/jmg.2009.068361
   Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203
   Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08
   Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025
   Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020
   Hu L, 2007, REPRODUCTION, V134, P585, DOI 10.1530/REP-07-0133
   Ikeda T, 2007, BIOCHEM BIOPH RES CO, V357, P383, DOI 10.1016/j.bbrc.2007.03.133
   Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169
   Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585
   Kent J, 1996, DEVELOPMENT, V122, P2813
   Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050
   Kostic TS, 2010, INT J ANDROL, V33, P717, DOI 10.1111/j.1365-2605.2009.01018.x
   Lardenois A, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq030
   Laurich VM, 2002, ENDOCRINOLOGY, V143, P3351, DOI 10.1210/en.2001-211352
   Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100
   LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0
   MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X
   Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660
   Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143
   Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335
   Odet F, 2006, ENDOCRINOLOGY, V147, P4374, DOI 10.1210/en.2006-0484
   Ohashi R, 2004, TRENDS CARDIOVAS MED, V14, P187, DOI 10.1016/j.tcm.2004.04.002
   Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235
   Pappas DJ, 2009, PHYSIOL GENOMICS, V38, P362, DOI 10.1152/physiolgenomics.00058.2009
   Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889
   Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142
   Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627
   Qin J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003285
   Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939
   Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762
   Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305
   Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011
   Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008
   Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Sipione S, 2006, J IMMUNOL, V177, P5051, DOI 10.4049/jimmunol.177.8.5051
   Spiess AN, 2007, HUM REPROD, V22, P2936, DOI 10.1093/humrep/dem292
   Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335
   Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200
   TOPPI L, 2009, BIOL CHEM, V284, P3323
   Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021
   Uhrin P, 2000, J CLIN INVEST, V106, P1531, DOI 10.1172/JCI10768
   Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068
   Veitia RA, 2010, BIOESSAYS, V32, P375, DOI 10.1002/bies.200900193
   WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8
   Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965
   Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197
   Wohlfahrt-Veje C, 2009, CLIN ENDOCRINOL, V71, P459, DOI 10.1111/j.1365-2265.2009.03545.x
   Wrobel G, 2005, REPRODUCTION, V129, P1, DOI 10.1530/rep.1.00408
NR 75
TC 9
Z9 9
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-7827
J9 REPROD BIOL ENDOCRIN
JI Reprod. Biol. Endocrinol.
PD DEC 23
PY 2010
VL 8
AR 154
DI 10.1186/1477-7827-8-154
PG 12
WC Endocrinology & Metabolism; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA 711JC
UT WOS:000286585900001
PM 21182756
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Scheiffele, P
   Beg, AA
AF Scheiffele, Peter
   Beg, Asim A.
TI NEUROSCIENCE Angelman syndrome connections
SO NATURE
LA English
DT Editorial Material
ID MOUSE MODEL; DEFICITS
C1 [Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Beg, Asim A.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.
RP Scheiffele, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM peter.scheiffele@unibas.ch; asimbeg@umich.edu
CR Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033
   Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026
   Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6
   Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038
   Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024
   Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153
   van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845
   Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074
NR 8
TC 13
Z9 13
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD DEC 16
PY 2010
VL 468
IS 7326
BP 907
EP 908
DI 10.1038/468907a
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 695BC
UT WOS:000285344600035
PM 21164477
DA 2021-01-25
ER

PT J
AU Vogler, C
   Gschwind, L
   Rothlisberger, B
   Huber, A
   Filges, I
   Miny, P
   Auschra, B
   Stetak, A
   Demougin, P
   Vukojevic, V
   Kolassa, IT
   Elbert, T
   de Quervain, DJF
   Papassotiropoulos, A
AF Vogler, Christian
   Gschwind, Leo
   Roethlisberger, Benno
   Huber, Andreas
   Filges, Isabel
   Miny, Peter
   Auschra, Bianca
   Stetak, Attila
   Demougin, Philippe
   Vukojevic, Vanja
   Kolassa, Iris-Tatjana
   Elbert, Thomas
   de Quervain, Dominique J. -F.
   Papassotiropoulos, Andreas
TI Microarray-Based Maps of Copy-Number Variant Regions in European and
   Sub-Saharan Populations
SO PLOS ONE
LA English
DT Article
ID HUMAN GENOME; SEGMENTAL DUPLICATIONS; EVOLUTIONARY HISTORY; STRUCTURAL
   VARIATION; ARRAY-CGH; DISEASE; HAPLOTYPE; GENE; SUSCEPTIBILITY
AB The genetic basis of phenotypic variation can be partially explained by the presence of copy-number variations (CNVs). Currently available methods for CNV assessment include high-density single-nucleotide polymorphism (SNP) microarrays that have become an indispensable tool in genome-wide association studies (GWAS). However, insufficient concordance rates between different CNV assessment methods call for cautious interpretation of results from CNV-based genetic association studies. Here we provide a cross-population, microarray-based map of copy-number variant regions (CNVRs) to enable reliable interpretation of CNV association findings. We used the Affymetrix Genome-Wide Human SNP Array 6.0 to scan the genomes of 1167 individuals from two ethnically distinct populations (Europe, N = 717; Rwanda, N = 450). Three different CNV-finding algorithms were tested and compared for sensitivity, specificity, and feasibility. Two algorithms were subsequently used to construct CNVR maps, which were also validated by processing subsamples with additional microarray platforms (Illumina 1M-Duo BeadChip, Nimblegen 385K aCGH array) and by comparing our data with publicly available information. Both algorithms detected a total of 42669 CNVs, 74% of which clustered in 385 CNVRs of a cross-population map. These CNVRs overlap with 862 annotated genes and account for approximately 3.3% of the haploid human genome. We created comprehensive cross-populational CNVR-maps. They represent an extendable framework that can leverage the detection of common CNVs and additionally assist in interpreting CNV-based association studies.
C1 [Vogler, Christian; Gschwind, Leo; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Basel, Switzerland.
   [Vogler, Christian; Gschwind, Leo; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Basel, Switzerland.
   [Vogler, Christian; Gschwind, Leo; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Basel, Dept Med, Basel, Switzerland.
   [Roethlisberger, Benno; Huber, Andreas] Cantonal Hosp, Ctr Lab Med, Aarau, Switzerland.
   [Filges, Isabel; Miny, Peter] Univ Childrens Hosp, Dept Biomed, Basel, Switzerland.
   [Kolassa, Iris-Tatjana; Elbert, Thomas] Univ Konstanz, Dept Psychol, Constance, Germany.
RP Vogler, C (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.
EM christian.vogler@unibas.ch
RI Kolassa, Iris Tatjana/Y-3032-2018; Elbert, Thomas/C-8556-2009
OI Elbert, Thomas/0000-0003-1332-4939; de Quervain,
   Dominique/0000-0001-7131-2464; Vukojevic, Vanja/0000-0001-5303-9492;
   Papassotiropoulos, Andreas/0000-0002-2210-9651; Vogler,
   Christian/0000-0003-3922-109X
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [PP00B-106708]; Sinergia [CRSIKO_122691]; National
   Centre of Competence in Research (NCCR) Swiss Etiological Study of
   Adjustment and Mental Health (sesam)Swiss National Science Foundation
   (SNSF); Swiss National Science Foundation (SNF)Swiss National Science
   Foundation (SNSF) [51A240-104890]; University of Basel; F. Hoffmann-La
   Roche Corp.Hoffmann-La Roche; European UnionEuropean Union (EU)
   [242257]; European Science FoundationEuropean Science Foundation (ESF)
FX This work was supported in part by the Swiss National Science Foundation
   (SNSF) grants PP00B-106708 (D. Q.) and Sinergia CRSIKO_122691 (D. Q. and
   A. P.). This work is part of the National Centre of Competence in
   Research (NCCR) Swiss Etiological Study of Adjustment and Mental Health
   (sesam), The Swiss National Science Foundation (SNF) (project no.
   51A240-104890); the University of Basel, the F. Hoffmann-La Roche Corp.
   and the Freie Akademische Gesellschaft provided core support for the
   NCCR sesam. This work is also part of the 7th framework programme of the
   European Union (ADAMS, project number 242257, FP7-HEALTH-2009) and of
   the European Science Foundation grant, EUROStress (D. Q. and A. P.). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895
   Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110
   Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767
   Filges I, 2009, AM J MED GENET A, V149A, P237, DOI 10.1002/ajmg.a.32622
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Goidts V, 2006, HUM GENET, V120, P270, DOI 10.1007/s00439-006-0217-y
   Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160
   Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002
   HASTINGS PJ, 2009, NAT REV GENET
   *INC BOZ, GOLD HEL CNAM SOFTW
   Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742
   Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108
   Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237
   LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4
   McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238
   Onyut Lamaro P, 2009, Confl Health, V3, P6, DOI 10.1186/1752-1505-3-6
   *R DEV COR TEAM, 2009, COMP RFFS
   Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329
   Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311
   Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718
   Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918
   Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652
   Solomon NM, 2004, J MED GENET, V41, P669, DOI 10.1136/jmg.2003.016949
   Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678
   Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731
   Tishkoff SA, 2003, CURR OPIN GENET DEV, V13, P569, DOI 10.1016/j.gde.2003.10.010
   Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646
   Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124
   Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907
   Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017
   Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80
   Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006
NR 32
TC 20
Z9 20
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 16
PY 2010
VL 5
IS 12
AR e15246
DI 10.1371/journal.pone.0015246
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 695OI
UT WOS:000285381200019
PM 21179565
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Beck, A
   Li-Blatter, X
   Seelig, A
   Seelig, J
AF Beck, Andreas
   Li-Blatter, Xiaochun
   Seelig, Anna
   Seelig, Joachim
TI On the Interaction of Ionic Detergents with Lipid Membranes
   Thermodynamic Comparison of n-Alkyl-N+(CH3)(3) and n-Alkyl-SO4-
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID MICELLE FORMATION; BINDING; SURFACTANT; CHARGE; TEMPERATURE; PRESSURE;
   VESICLES
AB Ionic detergents find widespread commercial applications as disinfectants fungicides or excipients in drug formulations and cosmetics One mode of action is their ease of insertion into biological membranes Very little quantitative information on this membrane-binding process is available to date Using isothermal titration calorimetry (ITC) and dynamic light scattering (DLS) we have made a systematic comparison of the binding of cationic and anionic detergents to neutral and negatively charged lipid membranes The detergents investigated were n-alkyl chains carrying either the trimethylammonium chloride (-N+(CH3)(3)Cl-) or the sodium sulfate (-SO4-Na+) headgroup with chain lengths of n = 10-16 The titration of lipid vesicles into detergent solutions provided the binding enthalpy and the binding isotherm in a model-independent manner At 25 degrees C the membrane binding enthalpies Delta H-mem(0) were small (-0 4 to -4 2 kcal/mol) and showed little correlation with the length of the alkyl chains The ITC binding Isotherms were analyzed in terms of a surface partition model To this purpose, the surface concentration, c(M), of detergent immediately above the plane of binding was calculated with the Gouy-Chapman theory The surface concentration corrects for electrostatic attraction or repulsion and can be larger or smaller than the bulk detergent concentration c(eq) at equilibrium The analysis provides the chemical or hydrophobic binding constant K-D(0) of the detergent and the corresponding free energy The free energies of binding, Delta G(mem)(0), vary between -4 and -10 kcal/mol They show a linear dependence on the chain length which can be used to separate the contributions of the polar group and the hydrocarbon tail in membrane binding The neutral maltose and the cationic N+(CH3)(3) headgroup show stenc repulsion energies of about 2 5 kcal/mol counteracting the hydrophobic binding of the alkyl tail whereas the anionic SO4- headgroup makes almost no contribution to membrane binding The chemical nature of the headgroup influences the packing density of the hydrocarbon chains in the lipid bilayer with N+(CH3)(3) eliciting the weakest chain-chain interaction The minimum repulsive interaction of the SO4- polar group makes the sodium n-alkyl-sulfates much stronger detergents than the nonionic or cationic counterparts, the binding constants K-D(0) being 10-50 times larger than those of the corresponding n-alkyl-trimethylammonium chlorides The membrane insertion was further compared with micelle formation of the same detergent A cooperative aggregation model which includes all possible aggregation states is proposed to analyze micelle formation The partition function can be defined in closed form and it is straightforward to predict the thermodynamic properties of the micellar system When aggregated in micelles the detergent polar groups are in direct interaction and are not separated by lipid molecules Under these conditions the SO4- group exhibits a strong electrostatic repulsive effect of 3 2 kcal/mol while the contributions of the maltose and N+(CH3)(3) headgroups are very similar to those in the lipid bilayer
C1 [Beck, Andreas; Li-Blatter, Xiaochun; Seelig, Anna; Seelig, Joachim] Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A 129701/1]
FX This work was supported by the Swiss National Science Foundation Grant
   No 31003A 129701/1
CR Aveyard Robert, 1973, INTRO PRINCIPLES SUR
   Beyer K, 2006, COLLOID SURFACE B, V49, P31, DOI 10.1016/j.colsurfb.2006.02.003
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   CANTOR CR, 1980, BIOPHYSICAL CHEM, V1
   Chakraborty I, 2007, J PHYS CHEM B, V111, P3658, DOI 10.1021/jp066500h
   delaMaza A, 1997, BIOPHYS J, V72, P1668, DOI 10.1016/S0006-3495(97)78812-X
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   Hanakam F, 1996, BIOCHEMISTRY-US, V35, P11036, DOI 10.1021/bi960789j
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 2001, BIOPHYS J, V81, P1547, DOI 10.1016/S0006-3495(01)75808-0
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   HEYN MP, 1975, BIOPHYS CHEM, V3, P35, DOI 10.1016/0301-4622(75)80035-4
   HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8
   LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71
   Meier M, 2010, BIOPHYS J, V98, P1529, DOI 10.1016/j.bpj.2009.12.4286
   PAULA S, 1995, J PHYS CHEM-US, V99, P11742, DOI 10.1021/j100030a019
   Perger TM, 2007, J COLLOID INTERF SCI, V313, P288, DOI 10.1016/j.jcis.2007.04.043
   Ranganathan R, 2000, J PHYS CHEM B, V104, P2260, DOI 10.1021/jp993917x
   ROBINSON BH, 1973, J CHEM SOC FARAD T 1, V69, P56, DOI 10.1039/f19736900056
   Sarac B, 2009, J COLLOID INTERF SCI, V338, P216, DOI 10.1016/j.jcis.2009.06.027
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   SEELIG J, 1987, BIOCHEMISTRY-US, V26, P7535, DOI 10.1021/bi00398a001
   Tan AM, 2002, BIOPHYS J, V83, P1547, DOI 10.1016/S0006-3495(02)73924-6
   Tanford C., 1980, HYDROPHOBIC EFFECT F
   Zielinski R, 2001, J COLLOID INTERF SCI, V235, P201, DOI 10.1006/jcis.2000.7364
   ANATRACE CATALOGUE 2
NR 29
TC 18
Z9 18
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
EI 1520-5207
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD DEC 9
PY 2010
VL 114
IS 48
BP 15862
EP 15871
DI 10.1021/jp107088d
PG 10
WC Chemistry, Physical
SC Chemistry
GA 686YR
UT WOS:000284738800017
PM 21067191
DA 2021-01-25
ER

PT J
AU Casutt-Meyer, S
   Renzi, F
   Schmaler, M
   Jann, NJ
   Amstutz, M
   Cornelis, GR
AF Casutt-Meyer, Salome
   Renzi, Francesco
   Schmaler, Mathias
   Jann, Naja J.
   Amstutz, Marlise
   Cornelis, Guy R.
TI Oligomeric Coiled-Coil Adhesin YadA Is a Double-Edged Sword
SO PLOS ONE
LA English
DT Article
ID OUTER-MEMBRANE PROTEIN; NEUTROPHIL EXTRACELLULAR TRAPS; MEDIATES
   SPECIFIC BINDING; YERSINIA-ENTEROCOLITICA; COLLAGEN-BINDING;
   ENTEROPATHOGENIC YERSINIAE; TRANSCRIPTIONAL ACTIVATOR;
   HUMAN-GRANULOCYTES; ESCHERICHIA-COLI; INVASIN PROTEIN
AB Yersinia adhesin A (YadA) is an essential virulence factor for the food-borne pathogens Yersinia enterocolitica and Yersinia pseudotuberculosis. Suprisingly, it is a pseudogene in Yersinia pestis. Even more intriguing, the introduction of a functional yadA gene in Y. pestis EV76 was shown to correlate with a decrease in virulence in a mouse model. Here, we report that wild type (wt) Y. enterocolitica E40, as well as YadA-deprived E40 induced the synthesis of neutrophil extracellular traps (NETs) upon contact with neutrophils, but only YadA-expressing Y. enterocolitica adhered to NETs and were killed. As binding seemed to be a prerequisite for killing, we searched for YadA-binding substrates and detected the presence of collagen within NETs. E40 bacteria expressing V98D,N99A mutant YadA with a severely reduced ability to bind collagen were found to be more resistant to killing, suggesting that collagen binding contributes significantly to sensitivity to NETs. Wt Y. pestis EV76 were resistant to killing by NETs, while recombinant EV76 expressing YadA from either Y. pseudotuberculosis or Y. enterocolitica were sensitive to killing by NETs, outlining the importance of YadA for susceptibility to NET-dependent killing. Recombinant EV76 endowed with YadA from Y. enterocolitica were also less virulent for the mouse than wt EV76, as shown before. In addition, EV76 carrying wt YadA were less virulent for the mouse than EV76 expressing YadA(V98D,N99A). The observation that YadA makes Yersinia sensitive to NETs provides an explanation as for why evolution selected for the inactivation of yadA in the flea-borne Y. pestis and clarifies an old enigma. Since YadA imposes the same cost to the food-borne Yersinia but was nevertheless conserved by evolution, this observation also illustrates the duality of some virulence functions.
C1 [Casutt-Meyer, Salome; Renzi, Francesco; Amstutz, Marlise; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Schmaler, Mathias; Jann, Naja J.] Univ Basel, Dept Biomed, Basel, Switzerland.
RP Casutt-Meyer, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Renzi, Francesco/0000-0001-6940-1177
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-128659/1]
FX This work was supported by the Swiss National Science Foundation
   (www.snf.ch)(grant 3100A0-128659/1). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043
   BALLIGAND G, 1985, INFECT IMMUN, V48, P782, DOI 10.1128/IAI.48.3.782-786.1985
   Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07
   BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993
   BOLIN I, 1984, INFECT IMMUN, V43, P72
   Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039
   CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978
   CHINA B, 1993, INFECT IMMUN, V61, P3129, DOI 10.1128/IAI.61.8.3129-3136.1993
   CHINA B, 1994, INFECT IMMUN, V62, P1275, DOI 10.1128/IAI.62.4.1275-1281.1994
   CORNELIS G, 1975, J GEN MICROBIOL, V87, P285, DOI 10.1099/00221287-87-2-285
   CORNELIS G, 1989, J BACTERIOL, V171, P254, DOI 10.1128/jb.171.1.254-262.1989
   Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077
   Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004
   DEROUVROIT CL, 1992, MOL MICROBIOL, V6, P395, DOI 10.1111/j.1365-2958.1992.tb01483.x
   Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002
   El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119
   El Tahir Y, 2000, MOL MICROBIOL, V37, P192, DOI 10.1046/j.1365-2958.2000.01992.x
   EMODY L, 1989, J BACTERIOL, V171, P6674
   FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x
   Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002
   Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003
   Han YW, 1997, INFECT IMMUN, V65, P327, DOI 10.1128/IAI.65.1.327-330.1997
   Heesemann J, 1987, Contrib Microbiol Immunol, V9, P312
   Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103
   Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004
   Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989
   ISBERG RR, 1988, P NATL ACAD SCI USA, V85, P6682, DOI 10.1073/pnas.85.18.6682
   JEPSEN LV, 1982, SCAND J CLIN LAB INV, V42, P235
   KAPPERUD G, 1987, INFECT IMMUN, V55, P2247, DOI 10.1128/IAI.55.9.2247-2254.1987
   Koretke KK, 2006, J STRUCT BIOL, V155, P154, DOI 10.1016/j.jsb.2006.03.012
   Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580
   Mayer-Scholl A, 2004, CURR OPIN MICROBIOL, V7, P62, DOI 10.1016/j.mib.2003.12.004
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100
   Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011
   PEPE JC, 1990, J BACTERIOL, V172, P3780, DOI 10.1128/jb.172.7.3780-3789.1990
   Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231
   Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003
   ROSQVIST R, 1988, NATURE, V334, P522, DOI 10.1038/334522a0
   SCHULZEKOOPS H, 1992, INFECT IMMUN, V60, P2153, DOI 10.1128/IAI.60.6.2153-2159.1992
   SCHULZEKOOPS H, 1993, INFECT IMMUN, V61, P2513, DOI 10.1128/IAI.61.6.2513-2519.1993
   SKURNIK M, 1989, MOL MICROBIOL, V3, P517, DOI 10.1111/j.1365-2958.1989.tb00198.x
   SKURNIK M, 1992, J BACTERIOL, V174, P2047, DOI 10.1128/jb.174.6.2047-2051.1992
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   TAMM A, 1993, MOL MICROBIOL, V10, P995, DOI 10.1111/j.1365-2958.1993.tb00971.x
   Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x
   Visser LG, 1996, INFECT IMMUN, V64, P1653, DOI 10.1128/IAI.64.5.1653-1658.1996
   Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x
   Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a
   Wong KW, 2005, CURR OPIN MICROBIOL, V8, P4, DOI 10.1016/j.mib.2004.12.009
   YANG YX, 1993, INFECT IMMUN, V61, P3907, DOI 10.1128/IAI.61.9.3907-3913.1993
   YOUNG VB, 1990, MOL MICROBIOL, V4, P1119, DOI 10.1111/j.1365-2958.1990.tb00686.x
NR 56
TC 20
Z9 22
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 8
PY 2010
VL 5
IS 12
AR e15159
DI 10.1371/journal.pone.0015159
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 691MJ
UT WOS:000285084100024
PM 21170337
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Bensimon, A
   Schmidt, A
   Ziv, Y
   Elkon, R
   Wang, SY
   Chen, DJ
   Aebersold, R
   Shiloh, Y
AF Bensimon, Ariel
   Schmidt, Alexander
   Ziv, Yael
   Elkon, Ran
   Wang, Shih-Ya
   Chen, David J.
   Aebersold, Ruedi
   Shiloh, Yosef
TI ATM-Dependent and -Independent Dynamics of the Nuclear Phosphoproteome
   After DNA Damage
SO SCIENCE SIGNALING
LA English
DT Article
ID DOUBLE-STRAND BREAKS; PROTEIN PHOSPHATASE 2A; ACTIVATION IN-VIVO;
   ATAXIA-TELANGIECTASIA; WIP1 PHOSPHATASE; KINASE-ACTIVITY; CELL-CYCLE;
   QUANTITATIVE PHOSPHOPROTEOMICS; INTERACTION NETWORKS; IONIZING-RADIATION
AB The double-strand break (DSB) is a cytotoxic DNA lesion caused by oxygen radicals, ionizing radiation, and radiomimetic chemicals. Cells cope with DNA damage by activating the DNA damage response (DDR), which leads either to damage repair and cellular survival or to programmed cell death. The main transducer of the DSB response is the nuclear protein kinase ataxia telangiectasia mutated (ATM). We applied label-free quantitative mass spectrometry to follow the dynamics of DSB-induced phosphoproteome in nuclear fractions of the human melanoma G361 cells after radiomimetic treatment. We found that these dynamics are complex, including both phosphorylation and dephosphorylation events. In addition to identifying previously unknown ATM-dependent phosphorylation and dephosphorylation events, we found that about 40% of DSB-induced phosphorylations were ATM-independent and that several other kinases are potentially involved. Sustained activity of ATM was required to maintain many ATM-dependent phosphorylations. We identified an ATM-dependent phosphorylation site on ATM itself that played a role in its retention on damaged chromatin. By connecting many of the phosphorylated and dephosphorylated proteins into functional networks, we highlight putative cross talks between proteins pertaining to several cellular biological processes. Our study expands the DDR phosphorylation landscape and identifies previously unknown ATM-dependent and -independent branches. It reveals insights into the breadth and complexity of the cellular responses involved in the coordination of many DDR pathways, which is in line with the critical importance of genomic stability in maintenance of cellular homeostasis.
C1 [Schmidt, Alexander; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Bensimon, Ariel; Ziv, Yael; Shiloh, Yosef] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, David & Inez Myers Lab Canc Genet, IL-69978 Tel Aviv, Israel.
   [Schmidt, Alexander] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Elkon, Ran] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands.
   [Wang, Shih-Ya; Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA.
   [Aebersold, Ruedi] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland.
RP Aebersold, R (corresponding author), ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
EM rudolf.aebersold@imsb.biol.ethz.ch; yossih@post.tau.ac.il
RI Schmidt, Alexander/D-6426-2011
FU European CommunityEuropean Community (EC) [HEALTH-F4-2009-223575]; A-T
   Medical Research Foundation; Israel Cancer Research Fund; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [CA050519, CA13499]; NATIONAL CANCER INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) [R37CA050519,
   R01CA050519, R37CA050519, R01CA050519, R01CA050519, R37CA050519,
   R37CA050519, R01CA050519, R37CA050519, R01CA050519, R01CA050519,
   R01CA050519, R37CA050519, R37CA050519, R01CA050519, R37CA050519,
   R01CA050519, R01CA050519, R01CA050519, R37CA050519, R01CA050519,
   R37CA050519, R37CA050519, R01CA050519, R01CA050519] Funding Source: NIH
   RePORTER
FX This work was supported by research grants from the European Community's
   Seventh Framework Programme (HEALTH-F4-2009-223575, the TRIREME
   Project), the A-T Medical Research Foundation, and the Israel Cancer
   Research Fund to Y.S., and the NIH (CA050519 and CA13499) to D.J.C. Y.S.
   is a Research Professor of the Israel Cancer Research Fund.
CR Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004
   Andegeko Y, 2001, J BIOL CHEM, V276, P38224
   Antonov AV, 2009, PROTEOMICS, V9, P2740, DOI 10.1002/pmic.200800612
   Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875
   Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368
   Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894
   Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001
   Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016
   Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240
   Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130
   Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09
   Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200
   Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g
   Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005
   Bonnette PC, 2010, J PROTEOMICS, V73, P1306, DOI 10.1016/j.jprot.2010.01.011
   Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231
   Briers S, 2009, J CELL SCI, V122, P937, DOI 10.1242/jcs.034793
   Britton S, 2009, CELL CYCLE, V8, P3717, DOI 10.4161/cc.8.22.10025
   Brusniak MY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-542
   Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025
   Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677
   Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003
   Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010
   Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450
   Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154
   Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007
   Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059
   Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772
   Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801
   Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508
   Gerard A, 2006, EMBO REP, V7, P817, DOI 10.1038/sj.embor.7400750
   Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455
   Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017
   Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200
   Guo CY, 2002, J BIOL CHEM, V277, P41756, DOI 10.1074/jbc.M207519200
   Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015
   Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2
   Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727
   Hilger M, 2009, MOL CELL PROTEOMICS, V8, P1908, DOI 10.1074/mcp.M800559-MCP200
   Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772
   Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109
   Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Jowsey P, 2007, DNA REPAIR, V6, P1536, DOI 10.1016/j.dnarep.2007.04.011
   Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601
   Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024
   Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602
   Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656
   Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231
   Larive RM, 2009, ONCOGENE, V28, P2337, DOI 10.1038/onc.2009.99
   Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514
   Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180
   Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060
   Lee H, 2009, BIOCHEM BIOPH RES CO, V378, P32, DOI 10.1016/j.bbrc.2008.10.150
   Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06
   Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052
   Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006
   Lu XB, 2005, CELL CYCLE, V4, P1060
   Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033
   Luo H, 2008, J BIOL CHEM, V283, P19176, DOI 10.1074/jbc.M802299200
   Maclean KH, 2007, MOL CANCER RES, V5, P705, DOI 10.1158/1541-7786.MCR-07-0058
   Macurek L, 2010, ONCOGENE, V29, P2281, DOI 10.1038/onc.2009.501
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321
   Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007
   Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev
   Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210
   Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000
   Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696
   Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204
   Morris JR, 2010, BIOCHEM SOC T, V38, P92, DOI 10.1042/BST0380092
   Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200
   Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057
   Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200
   Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116
   Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291
   Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021
   Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112
   Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020
   Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06
   Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006
   Pieroni E, 2008, PROTEOMICS, V8, P799, DOI 10.1002/pmic.200700767
   Pinkse MWH, 2008, J PROTEOME RES, V7, P687, DOI 10.1021/pr700605z
   Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617
   Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196
   Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103
   Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470
   Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018
   Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029
   Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936
   Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298
   SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600
   Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517
   Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146
   Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004
   Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010
   So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064
   Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008
   St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2
   Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428
   Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07
   Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931
   Tang X, 2008, MOL CELL BIOL, V28, P2559, DOI 10.1128/MCB.01711-07
   Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829
   Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077
   Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230
   Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6
   White JS, 2008, CELL CYCLE, V7, P1277, DOI 10.4161/cc.7.9.5961
   Wu F, 2010, MOL CELL PROTEOMICS, V9, P1616, DOI 10.1074/mcp.M000153-MCP201
   Wu YB, 2009, MOL CELL PROTEOMICS, V8, P2809, DOI 10.1074/mcp.M900293-MCP200
   Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668
   Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200
   Yamaguchi H, 2007, BIOCHEMISTRY-US, V46, P12594, DOI 10.1021/bi701096s
   YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020
   Yoda A, 2006, J BIOL CHEM, V281, P24847, DOI 10.1074/jbc.M600403200
   Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200
   Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636
   Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122
   Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200
   Zhang XN, 2009, CANCER RES, V69, P7960, DOI 10.1158/0008-5472.CAN-09-0634
   Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319
   Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446
NR 130
TC 179
Z9 183
U1 0
U2 25
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD DEC 7
PY 2010
VL 3
IS 151
AR rs3
DI 10.1126/scisignal.2001034
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 690ZS
UT WOS:000285050100006
PM 21139141
DA 2021-01-25
ER

PT J
AU Mysore, K
   Baragur, S
   Reichert, H
   Rodrigues, V
AF Mysore, Keshava
   Baragur, Shyamala
   Reichert, Heinrich
   Rodrigues, Veronica
TI Comparative Analysis of Olfactory System Organization in Flies and
   Social Hymenopterans
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Mysore, Keshava; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Mysore, Keshava; Rodrigues, Veronica] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Rodrigues, Veronica] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India.
   [Mysore, Keshava; Baragur, Shyamala] Univ Mysore, Dept Zool, Mysore 570006, Karnataka, India.
RI Mysore, Keshava/P-6248-2019
OI Mysore, Keshava/0000-0003-2794-7029
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2010
VL 24
SU 1
BP 31
EP 31
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 684GD
UT WOS:000284537500080
DA 2021-01-25
ER

PT J
AU Marrosu, D
   Hartmann, B
   Reichert, H
AF Marrosu, Delia
   Hartmann, Beate
   Reichert, Heinrich
TI Gal4-lines as a genetic tool to investigate antennal disc development in
   Drosophila melanogaster
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Marrosu, Delia; Hartmann, Beate; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM Delia.marrosu@stud.unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2010
VL 24
SU 1
BP 32
EP 32
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 684GD
UT WOS:000284537500083
DA 2021-01-25
ER

PT J
AU Sen, S
   Hartmann, B
   Reichert, H
   Rodrigues, V
AF Sen, Sonia
   Hartmann, Beate
   Reichert, Heinrich
   Rodrigues, Veronica
TI Expression and function of empty spiracles gene in olfactory sense organ
   development of Drosophila melanogaster
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Sen, Sonia; Rodrigues, Veronica] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Hartmann, Beate; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM veronica@ncbs.res.in
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2010
VL 24
SU 1
BP 75
EP 75
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 684GD
UT WOS:000284537500199
DA 2021-01-25
ER

PT J
AU Das, A
   Chiang, A
   Davla, S
   Priya, R
   Reichert, H
   VijayRaghavan, K
   Rodrigues, V
AF Das, Abhijit
   Chiang, Albert
   Davla, Sejal
   Priya, Rashi
   Reichert, Heinrich
   VijayRaghavan, K.
   Rodrigues, Veronica
TI Lineage and specification of diversity of olfactory interneurons in
   Drosophila
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Das, Abhijit; Rodrigues, Veronica] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India.
   [Chiang, Albert; Davla, Sejal; Priya, Rashi; VijayRaghavan, K.; Rodrigues, Veronica] UAS, TIFR, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2010
VL 24
SU 1
BP 79
EP 79
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 684GD
UT WOS:000284537500209
DA 2021-01-25
ER

PT J
AU Viktorin, G
   Riebli, N
   Popkova, A
   Giangrande, A
   Reichert, H
AF Viktorin, Gudrun
   Riebli, Nadia
   Popkova, Anna
   Giangrande, Angela
   Reichert, Heinrich
TI Origin of glia from neuroglioblast lineages in the central brain
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Viktorin, Gudrun; Riebli, Nadia; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Popkova, Anna; Giangrande, Angela] IGBMC, F-67404 Illkirch Graffenstaden, France.
EM gudrunviktorin@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2010
VL 24
SU 1
BP 81
EP 82
PG 2
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 684GD
UT WOS:000284537500216
DA 2021-01-25
ER

PT J
AU Jiang, YR
   Reichert, H
AF Jiang, Yanrui
   Reichert, Heinrich
TI Programmed Cell Death in the Postembryonic Development of Type II
   Neuroblast Lineages of the Drosophila Brain
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Jiang, Yanrui; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2010
VL 24
SU 1
BP 82
EP 82
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 684GD
UT WOS:000284537500217
DA 2021-01-25
ER

PT J
AU Kuert, PA
   Bello, BC
   Reichert, H
AF Kuert, Philipp A.
   Bello, Bruno C.
   Reichert, Heinrich
TI The Hox protein Labial terminates neuroblast lineages in the larval
   central brain of Drosophila
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Kuert, Philipp A.; Bello, Bruno C.; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM philipp.kuert@stud.unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2010
VL 24
SU 1
BP 89
EP 89
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 684GD
UT WOS:000284537500235
DA 2021-01-25
ER

PT J
AU Mazumder, S
   Ganguly, A
   Ali, N
AF Mazumder, Saumyabrata
   Ganguly, Agneyo
   Ali, Nahid
TI The effect of C-terminal domain deletion on the catalytic activity of
   Leishmania donovani surface proteinase GP63: Role of Ser446 in
   proteolysis
SO BIOCHIMIE
LA English
DT Article
DE Leishmania donovani; Major surface glycoprotein; Leishmanolysin;
   C-terminal domain; C-terminal end; Proteinase activity
ID SUBSTRATE-SPECIFICITY; PEPTIDE SUBSTRATE; GLYCOPROTEIN GP63; PROTEASE
   ACTIVITY; BALB/C MICE; PROMASTIGOTES; METALLOPROTEASE; SITE;
   MACROPHAGES; EXPRESSION
AB The kinetoplastid protozoan Leishmania encodes major surface glycoprotein GP63, a zinc metallopeptidase (EC.3.4.24.36) expressed both in promastigote and amastigote life stages. In the present study, we explored for the first time the role of C-terminal domain (CTD) in proteinase activity by serial truncation of Leishmania donovani GP63 (LdGP63) from carboxyl terminal end (CTend). Deletion of 180-211 amino acids from CTend (Delta 420 and Delta 389) resulted in almost 50% loss of catalytic activity against azocasein, casein and gelatin. Moreover, all the truncated constructs showed reduced activity towards immunoglobulin (IgG). Upon homology modeling, we identified two residues, S446, and F448 in CTD, conserved in different Leishmania species, which were positioned 6.8-11 angstrom apart from the active site. To ascertain the role of S446 and F448 in catalysis, we replaced S446 with Ala and Thr, and F448 with Val and Tyr by site-directed mutagenesis. The variant enzymes (S446T, F448V, and F448Y) maintained near wild-type activity, whereas S446A demonstrated 50% loss of catalytic activity towards the cleavage of various biological substrates. Kinetic analysis of S446A resulted in a 2.6-fold decrease in the affinity, 10-fold decrease in turn-over rates, and large increase in transition-state binding energy (1.4 kcal/mol) for the quenched peptide substrates. These results emphasize the relevance of CUD in the proteolytic activity of LdGP63. Fluorescence spectroscopy, and CD analysis however, indicated that the reduced activities showed by Delta 389 and S446A were not due to global changes in the enzyme structures. Indeed, identification of S446 and its possible role in the stabilization of transition-state binding between enzyme and substrate can be exploited towards understanding of structure function relationship of GP63. (C) 2010 Elsevier Masson SAS. All rights reserved.
C1 [Mazumder, Saumyabrata; Ali, Nahid] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata 700032, India.
   [Ganguly, Agneyo] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ali, N (corresponding author), Indian Inst Chem Biol, Infect Dis & Immunol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.
EM nali@iicb.res.in
RI bhattacharyya, Anirban/F-6067-2015
FU Council of Scientific and Industrial Research, Government of
   IndiaCouncil of Scientific & Industrial Research (CSIR) - India;
   Department of Science and Technology, Government of IndiaDepartment of
   Science & Technology (India)
FX We gratefully acknowledge Professor S. Roy, Director of Indian Institute
   of Chemical Biology (IICB), Kolkata, for supporting this work. We would
   like to express our gratitude to Dr. H.K. Majumder (our Divisional Head)
   for his kind support and help to carry out the experiments. We are
   thankful to Bioinformatics Division of IICB for the homology-modeling
   study. The authors would like to express their gratitude to Dr. Aparna
   Gomes of IICB and Prof Dipak Dasgupta of Saha Institute of Nuclear
   Physics for their kind permission in performing HPLC and CD spectroscopy
   work. We thank Dr. Krishnanda Chattopadhyay, Dr. Amit Roy, and Sandip
   Paul for helpful suggestions and discussions. S.M was financially
   supported by a Senior Research Fellowship from the Council of Scientific
   and Industrial Research, Government of India. This work was financially
   supported by research grant from the Department of Science and
   Technology, Government of India.
CR Abramoff D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Afrin F, 1997, INFECT IMMUN, V65, P2371, DOI 10.1128/IAI.65.6.2371-2377.1997
   Alexander J, 1999, J CELL SCI, V112, P2993
   Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07
   BOUVIER J, 1990, BIOCHEMISTRY-US, V29, P10113, DOI 10.1021/bi00495a015
   BOUVIER J, 1993, EXP PARASITOL, V76, P146, DOI 10.1006/expr.1993.1017
   BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102
   BUTTON LL, 1988, J EXP MED, V167, P724, DOI 10.1084/jem.167.2.724
   BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5
   Cao P, 2005, PROTEIN EXPRES PURIF, V41, P199, DOI 10.1016/j.pep.2005.01.001
   CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0
   CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483
   Chen DQ, 2000, INFECT IMMUN, V68, P80, DOI 10.1128/IAI.68.1.80-86.2000
   Corradin S, 2002, BIOCHEM J, V367, P761, DOI 10.1042/BJ20020386
   Fersht A., 1998, STRUCTURE MECH PROTE
   Halle M, 2009, J BIOL CHEM, V284, P6893, DOI 10.1074/jbc.M805861200
   KORNELYUK AI, 1995, BIOPOLYM CELL KIEV, V11, P56
   Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x
   MACDONALD MH, 1995, BBA-PROTEIN STRUCT M, V1253, P199, DOI 10.1016/0167-4838(95)00155-5
   McGwire BS, 1996, J BIOL CHEM, V271, P7903, DOI 10.1074/jbc.271.14.7903
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V57, P31, DOI 10.1016/0166-6851(93)90241-O
   Mel SF, 2000, INFECT IMMUN, V68, P6487, DOI 10.1128/IAI.68.11.6487-6492.2000
   Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005
   Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5
   MURRAY PJ, 1990, EXP PARASITOL, V71, P294, DOI 10.1016/0014-4894(90)90034-A
   Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   RAMAMOORTHY R, 1992, J BIOL CHEM, V267, P1888
   RUSSELL DG, 1986, J IMMUNOL, V136, P2613
   SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5
   Schlagenhauf E, 1998, STRUCTURE, V6, P1035, DOI 10.1016/S0969-2126(98)00104-X
   Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242
   Thiakaki M, 2006, MICROBES INFECT, V8, P1455, DOI 10.1016/j.micinf.2006.01.006
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   TZINIA AK, 1991, MOL BIOCHEM PARASIT, V47, P83, DOI 10.1016/0166-6851(91)90150-5
   WEBB JR, 1991, MOL BIOCHEM PARASIT, V48, P173, DOI 10.1016/0166-6851(91)90113-K
   WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
NR 38
TC 3
Z9 4
U1 0
U2 22
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD DEC
PY 2010
VL 92
IS 12
BP 1876
EP 1885
DI 10.1016/j.biochi.2010.07.014
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 707OM
UT WOS:000286295900022
PM 20678540
DA 2021-01-25
ER

PT J
AU Blatter, XL
   Seelig, A
AF Blatter, Xiaochun Li
   Seelig, Anna
TI Exploring the P-Glycoprotein Binding Cavity with Polyoxyethylene Alkyl
   Ethers
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID BRAIN-BARRIER PERMEATION; SUBSTRATE RECOGNITION; MULTIDRUG TRANSPORTER;
   PLASMA-MEMBRANE; DRUGS; DETERGENTS; MODELS; BLOOD
AB P glycoprotein (ABCB1) moves allocrits from the cytosolic to the extracellular membrane leaflet preventing their intrusion into the cytosol It is generally accepted that allocrit binding from water to the cavity lined by the transmembrane domains occurs in two steps a lipid water partitioning step and a cavity binding step in the lipid membrane whereby hydrogen bond (i e weak electrostatic) interactions play a crucial role The remaining key question was whether hydrophobic interactions also play a role for allocrit binding to the cavity To answer this question we chose polyoxyethylene alkyl ethers CmEOn varying in the number of methylene and ethoxyl residues as model allocrits Using isothermal titration calorimetry we showed that the lipid water partitioning step was purely hydrophobic increasing linearly with the number of methylene and decreasing with the number of ethoxyl residues respectively Using in addition ATPase activity measurements we demon strated that allocrit binding to the cavity required minimally two ethoxyl residues and increased linearly with the number of ethoxyl residues The analysis provides the first direct evidence to our knowledge that allocrit binding to the cavity is purely electrostatic apparently without any hydrophobic contribution While the polar part of allocrits forms weak electrostatic interactions with the cavity the hydrophobic part seems to remain associated with the lipid membrane The interplay between the two types of interactions is most likely essential for allocrit flipping
C1 [Blatter, Xiaochun Li; Seelig, Anna] Univ Basel, Biozentrum, Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100AO 107793]
FX This work was supported by the Swiss National Science Found titan (grant
   No 3100AO 107793)
CR Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   Astumian RD, 1998, EUR BIOPHYS J BIOPHY, V27, P474, DOI 10.1007/s002490050158
   Berthod A, 2001, TALANTA, V55, P69, DOI 10.1016/S0039-9140(01)00395-2
   CATLIK L, 2006, BIOCHEMISTRY-US, V45, P3020
   Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155
   Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594
   Ekins S, 2007, XENOBIOTICA, V37, P1152, DOI 10.1080/00498250701646341
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   Gerebtzoff G, 2006, J CHEM INF MODEL, V46, P2638, DOI 10.1021/ci0600814
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 1997, J PHYS CHEM B, V101, P639, DOI 10.1021/jp962342q
   HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A
   Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993
   Kol MA, 2003, J BIOL CHEM, V278, P24586, DOI 10.1074/jbc.M301875200
   LABLATTER X, 2009, BIOCHIM BIOPHYS ACTA, V1788, P2335
   LING V, 1978, SOMAT CELL GENET, V4, P193, DOI 10.1007/BF01538984
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Meier M, 2010, BIOPHYS J, V98, P1529, DOI 10.1016/j.bpj.2009.12.4286
   Nervi P, 2010, BBA-BIOMEMBRANES, V1798, P515, DOI 10.1016/j.bbamem.2009.11.022
   O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069
   Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200
   Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743
   PEARCE HL, 1989, P NATL ACAD SCI USA, V86, P5128, DOI 10.1073/pnas.86.13.5128
   Plevin MJ, 2010, NAT CHEM, V2, P466, DOI [10.1038/NCHEM.650, 10.1038/nchem.650]
   RAVIV Y, 1990, J BIOL CHEM, V265, P3975
   Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733
   Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q
   Seelig A, 2000, INT J CLIN PHARM TH, V38, P111
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   SEELIG A, 2003, DRUG BIOAVAILABILITY, P461
   SEELIG A, 2009, UNDERSTANDING P GLYC
   Seelig A, 2006, EXPERT OPIN DRUG MET, V2, P733, DOI 10.1517/17425255.2.5.733
   Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x
   Shilling RA, 2006, TRENDS PHARMACOL SCI, V27, P195, DOI 10.1016/j.tips.2006.02.008
   TANFORD C, 1980, HYDROPHOBIC FIFEET
   Toth G, 2007, CURR PHARM DESIGN, V13, P3476, DOI 10.2174/138161207782794284
NR 41
TC 22
Z9 22
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD DEC 1
PY 2010
VL 99
IS 11
BP 3589
EP 3598
DI 10.1016/j.bpj.2010.10.033
PG 10
WC Biophysics
SC Biophysics
GA 690UL
UT WOS:000285033800011
PM 21112283
OA Green Published
DA 2021-01-25
ER

PT J
AU Kishore, S
   Luber, S
   Zavolan, M
AF Kishore, Shivendra
   Luber, Sandra
   Zavolan, Mihaela
TI Deciphering the role of RNA-binding proteins in the post-transcriptional
   control of gene expression
SO BRIEFINGS IN FUNCTIONAL GENOMICS
LA English
DT Article
DE RNA-binding proteins; RNA-binding domains; RBP-RNA interaction; RBP
   regulatory networks; RBP target identification
ID INDUCED CROSS-LINKS; AU-RICH ELEMENTS; MESSENGER-RNA; CRYSTAL-STRUCTURE;
   ZINC-FINGER; STRANDED-RNA; ESCHERICHIA-COLI; SPLICING FACTOR; SR
   PROTEINS; STRESS GRANULES
AB Eukaryotic cells express a large variety of ribonucleic acid-(RNA)-binding proteins (RBPs) with diverse affinity and specificity towards target RNAs that play a crucial role in almost every aspect of RNA metabolism. In addition, specific domains in RBPs impart catalytic activity or mediate protein-protein interactions, making RBPs versatile regulators of gene expression. In this review, we elaborate on recent experimental and computational approaches that have increased our understanding of RNA-protein interactions and their role in cellular function. We review aspects of gene expression that are modulated post-transcriptionally by RBPs, namely the stability of polymerase II-derived mRNA transcripts and their rate of translation into proteins. We further highlight the extensive regulatory networks of RBPs that implement a combinatorial control of gene expression. Taking cues from the recent development in the field, we argue that understanding spatio-temporal RNA-protein association on a transcriptome level will provide invaluable and unexpected insights into the regulatory codes that define growth, differentiation and disease.
C1 [Luber, Sandra; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016; Luber, Sandra/M-6475-2016
OI Luber, Sandra/0000-0002-6203-9379
FU EMBOEuropean Molecular Biology Organization (EMBO); Swiss National
   FoundationSwiss National Science Foundation (SNSF) [CRSII3_127454/1]
FX We thank Lukasz Jaskiewicz for critical reading of the article and for
   useful suggestions. S. K. is supported by an EMBO LTF-fellowship and S.
   L. by a Swiss National Foundation grant (number CRSII3_127454/1) to M.Z.
CR Anantharaman V, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-45
   Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916
   Ashiya M, 1997, RNA, V3, P996
   Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   BAILEY TL, 1995, MACH LEARN, V21, P51, DOI 10.1023/A:1022617714621
   Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000
   Baroni Timothy E., 2008, V419, P93, DOI 10.1007/978-1-59745-033-1_6
   Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031
   Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039
   Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707
   Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6
   Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020
   BYCROFT M, 1995, EMBO J, V14, P3563, DOI 10.1002/j.1460-2075.1995.tb07362.x
   Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55
   Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292
   Calaluce R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-126
   Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x
   Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909
   CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002
   CUATRECA.P, 1967, J BIOL CHEM, V242, P1541
   Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9
   De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017
   de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005
   de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101
   Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200
   DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527
   Doyle M, 2002, J STRUCT BIOL, V140, P147, DOI 10.1016/S1047-8477(02)00544-0
   Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760
   Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200
   Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Forties RA, 2010, BIOINFORMATICS, V26, P61, DOI 10.1093/bioinformatics/btp627
   FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505
   Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071
   GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047
   Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396
   GHISOLFI L, 1992, J BIOL CHEM, V267, P2955
   Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028
   Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638
   Grosjean H, 1996, BIOCHIMIE, V78, P488, DOI 10.1016/0300-9084(96)84755-9
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720
   Hackermuller J, 2005, GENE, V345, P3, DOI 10.1016/j.gene.2004.11.043
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004
   Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043
   Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109
   Heiss NS, 1999, HUM MOL GENET, V8, P2515, DOI 10.1093/hmg/8.13.2515
   Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244
   Hiller M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl544
   Jenkins HT, 2009, J STRUCT BIOL, V167, P271, DOI 10.1016/j.jsb.2009.06.007
   Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038
   Kalsotra A, 2010, GENE DEV, V24, P653, DOI 10.1101/gad.1894310
   Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938
   Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034
   Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47
   Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2
   KHARRAT A, 1995, EMBO J, V14, P3572, DOI 10.1002/j.1460-2075.1995.tb07363.x
   Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9
   KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x
   Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509
   Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039
   Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676
   Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164
   LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871
   Leontis NB, 2003, CURR OPIN STRUC BIOL, V13, P300, DOI 10.1016/S0959-440X(03)00076-9
   Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210
   Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488
   Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088
   Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178
   Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015
   Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929
   MELVIN WT, 1978, EUR J BIOCHEM, V92, P373, DOI 10.1111/j.1432-1033.1978.tb12756.x
   Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013
   MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x
   Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297
   Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0
   Monshausen M, 2001, J NEUROCHEM, V76, P155, DOI 10.1046/j.1471-4159.2001.00061.x
   Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44
   NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0
   NIKPOUR P, 2010, J CELL MOL MED  0514
   Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251
   Noah JW, 2000, NUCLEIC ACIDS RES, V28, P3785, DOI 10.1093/nar/28.19.3785
   Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001
   PARRAGA G, 1988, SCIENCE, V241, P1489, DOI 10.1126/science.3047872
   PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256
   Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07
   Rabani M, 2008, P NATL ACAD SCI USA, V105, P14885, DOI 10.1073/pnas.0803169105
   Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h
   Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550
   Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992
   Samson ML, 1998, GENETICS, V150, P723
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369
   Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404
   Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Siddharthan Rahul, 2007, V395, P381
   SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193
   Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2
   Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051
   Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785
   Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031
   Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404
   Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904
   Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200
   Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528
   Timothy B, 1994, P 2 INT C INT SYST M, V2, P28
   Toba G, 2008, NUCLEIC ACIDS RES, V36, P1390, DOI 10.1093/nar/gkm1168
   Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
   Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018
   Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304
   Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x
   VANNIMWEGEN E, 2007, BMC BIOINFORMATIC S6, V8, pNIL16
   Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018
   Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460
   Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038
   WAGENMAKERS AJM, 1980, EUR J BIOCHEM, V112, P323, DOI 10.1111/j.1432-1033.1980.tb07207.x
   Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009
   Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5
   Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315
   Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012
   Wilms C, 1997, RNA, V3, P602
   Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1
   Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711
   Zheng S, 2007, FEBS J, V274, P6378, DOI 10.1111/j.1742-4658.2007.06155.x
NR 142
TC 89
Z9 91
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2041-2649
EI 2041-2657
J9 BRIEF FUNCT GENOMICS
JI Brief. Funct. Genomics
PD DEC
PY 2010
VL 9
IS 5-6
SI SI
BP 391
EP 404
DI 10.1093/bfgp/elq028
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 712OC
UT WOS:000286675100005
PM 21127008
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Asante, CO
   Chu, A
   Fisher, M
   Benson, L
   Beg, A
   Scheiffele, P
   Martin, J
AF Asante, Curtis Oware
   Chu, Amy
   Fisher, Mark
   Benson, Leora
   Beg, Asim
   Scheiffele, Peter
   Martin, John
TI Cortical Control of Adaptive Locomotion in Wild-Type Mice and Mutant
   Mice Lacking the Ephrin-Eph Effector Protein alpha 2-Chimaerin
SO JOURNAL OF NEUROPHYSIOLOGY
LA English
DT Article
ID HEMIPLEGIC CEREBRAL-PALSY; MOTOR CORTEX; CORTICOSPINAL PROJECTIONS;
   VISUOMOTOR COORDINATION; MIRROR MOVEMENTS; RED NUCLEUS; SPINAL-CORD;
   WALKING; TRACT; CAT
AB Asante CO, Chu A, Fisher M, Benson L, Beg A, Scheiffele P, Martin J. Cortical control of adaptive locomotion in wild-type mice and mutant mice lacking the ephrin-Eph effector protein alpha 2-chimaerin. J Neurophysiol 104: 3189 -3202, 2010. First published September 29, 2010; doi: 10.1152/jn.00671.2010. In voluntary control, supraspinal motor systems select the appropriate response and plan movement mechanics to match task constraints. Spinal circuits translate supraspinal drive into action. We studied the interplay between motor cortex (M1) and spinal circuits during voluntary movements in wild-type (WT) mice and mice lacking the alpha 2-chimaerin gene (Chn1(-/-)),necessary for ephrinB3-EphA4 signaling. Chn1(-/-) mice have aberrant bilateral corticospinal systems, aberrant bilateral-projecting spinal interneurons, and disordered voluntary control because they express a hopping gait, which may be akin to mirror movements. We addressed three issues. First, we determined the role of the corticospinal system in adaptive control. We trained mice to step over obstacles during treadmill locomotion. We compared performance before and after bilateral M1 ablation. WT mice adaptively modified their trajectory to step over obstacles, and M1 ablation increased substantially the incidence of errant steps over the obstacle. Chn1(-/-) mice randomly stepped or hopped during unobstructed locomotion but hopped over the obstacle. Bilateral M1 ablation eliminated this obstacle-dependent hop selection and increased forelimb obstacle contact errors. Second, we characterized the laterality of corticospinal action in Chn1(-/-) mice using pseudorabies virus retrograde transneuronal transport and intracortical microstimulation. We showed bilateral connections between M1 and forelimb muscles in Chn1(-/-) and unilateral connections in WT mice. Third, in Chn1(-/-) mice, we studied adaptive responses before and after unilateral M1 ablation. We identified a more important role for contralateral than ipsilateral M1 in hopping over the obstacle. Our findings suggest an important role for M1 in the mouse in moment-to-moment adaptive control, and further, using Chn1(-/-) mice, a role in mediating task-dependent selection of mirror-like hopping movements over the obstacle. Our findings also stress the importance of subcortical control during adaptive locomotion because key features of the trajectory remained largely intact after M1 ablation.
C1 [Asante, Curtis Oware; Martin, John] CUNY, City Coll, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA.
   [Asante, Curtis Oware; Chu, Amy; Fisher, Mark; Benson, Leora; Beg, Asim; Scheiffele, Peter; Martin, John] Columbia Univ, Dept Neurosci, New York, NY USA.
   [Martin, John] Columbia Univ, Dept Neurol Surg & Psychiat, New York, NY USA.
   [Beg, Asim] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.
   [Scheiffele, Peter] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
   [Martin, John] New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
RP Martin, J (corresponding author), CUNY, City Coll, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA.
EM jmartin@ccny.cuny.edu
OI Fisher, Mark/0000-0001-8737-7393
FU National Institute of Neurological Disorders and StrokeUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [NS-36835]; Motor Neuron Center of Columbia University; NATIONAL
   INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS036835, R01NS036835, R01NS036835, R01NS036835, R01NS036835,
   R01NS036835, R01NS036835, R01NS036835, R01NS036835, R01NS036835,
   R01NS036835, R56NS036835, R01NS036835, R01NS036835, R01NS036835,
   R01NS036835] Funding Source: NIH RePORTER
FX This work was supported by National Institute of Neurological Disorders
   and Stroke Grant NS-36835 to J. Martin and grants from the Motor Neuron
   Center of Columbia University to. P. Scheiffele and J. Martin.
CR Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006
   ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319
   Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003
   Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331
   Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036
   Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102
   BROUWER B, 1991, BRAIN, V114, P1395, DOI 10.1093/brain/114.3.1395
   Brown TG, 1914, J PHYSL, V48, P1
   Brus-Ramer M, 2009, J NEUROSCI, V29, P6196, DOI 10.1523/JNEUROSCI.5852-08.2009
   CARR LJ, 1993, BRAIN, V116, P1223, DOI 10.1093/brain/116.5.1223
   CHENEY PD, 1991, PROG BRAIN RES, V87, P213
   Coonan JR, 2001, J COMP NEUROL, V436, P248
   Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2
   DREW T, 1988, BRAIN RES, V457, P181, DOI 10.1016/0006-8993(88)90073-X
   Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017
   Eyre JA, 2007, ANN NEUROL, V62, P493, DOI 10.1002/ana.21108
   Fanardjian VV, 1997, NEUROSCIENCE, V77, P965, DOI 10.1016/S0306-4522(96)00493-9
   FARMER SF, 1991, NEUROLOGY, V41, P1505, DOI 10.1212/WNL.41.9.1505
   Friel KM, 2007, J NEUROPHYSIOL, V97, P3396, DOI 10.1152/jn.00750.2006
   Friel KM, 2007, J NEUROSCI, V27, P11083, DOI 10.1523/JNEUROSCI.2814-07.2007
   GEORGOPOULOS AP, 1986, ANNU REV NEUROSCI, V9, P147, DOI 10.1146/annurev.ne.09.030186.001051
   GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307
   Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608
   Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022
   Jiang W, 1996, J NEUROPHYSIOL, V76, P849
   Karayannidou A, 2009, J PHYSIOL-LONDON, V587, P3795, DOI 10.1113/jphysiol.2009.170183
   Krouchev N, 2006, J NEUROPHYSIOL, V96, P1991, DOI 10.1152/jn.00241.2006
   Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641
   Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901
   Kuypers H, 1981, HDB PHYSL, P597
   Lavoie S, 2002, J NEUROPHYSIOL, V88, P1791, DOI 10.1152/jn.2002.88.4.1791
   LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267
   MARTIN JH, 1988, BEHAV BRAIN RES, V28, P217, DOI 10.1016/0166-4328(88)90099-X
   Mayston MJ, 1997, BRAIN, V120, P1199, DOI 10.1093/brain/120.7.1199
   McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3
   Mcvea DA, 2007, CURR BIOL, V17, pR621, DOI 10.1016/j.cub.2007.06.026
   Muller K, 1997, ANN NEUROL, V42, P705, DOI 10.1002/ana.410420506
   Patla AE, 1996, J MOTOR BEHAV, V28, P35, DOI 10.1080/00222895.1996.9941731
   Pearson K, 2010, ANN NY ACAD SCI, V1198, P1, DOI 10.1111/j.1749-6632.2009.05422.x
   Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103
   Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106
   Rho MJ, 1997, J COMP NEUROL, V388, P228, DOI 10.1002/(SICI)1096-9861(19971117)388:2<228::AID-CNE4>3.0.CO;2-3
   Salimi I, 2008, J NEUROSCI, V28, P7426, DOI 10.1523/JNEUROSCI.1078-08.2008
   Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104
   Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264
   Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463
   Vulliemoz S, 2005, LANCET NEUROL, V4, P87, DOI 10.1016/S1474-4422(05)00990-7
   Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038
   Z'Graggen WJ, 2000, J NEUROSCI, V20, P6561, DOI 10.1523/JNEUROSCI.20-17-06561.2000
NR 49
TC 20
Z9 20
U1 0
U2 7
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-3077
EI 1522-1598
J9 J NEUROPHYSIOL
JI J. Neurophysiol.
PD DEC
PY 2010
VL 104
IS 6
BP 3189
EP 3202
DI 10.1152/jn.00671.2010
PG 14
WC Neurosciences; Physiology
SC Neurosciences & Neurology; Physiology
GA 695SK
UT WOS:000285392700025
PM 20881205
OA Green Published
DA 2021-01-25
ER

PT J
AU Handschin, C
AF Handschin, Christoph
TI Regulation of skeletal muscle cell plasticity by the peroxisome
   proliferator-activated receptor gamma coactivator 1 alpha
SO JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
LA English
DT Review
DE Exercise; PGC-1 alpha; signal transduction; skeletal muscle;
   transcriptional regulation
ID PGC-1-ALPHA MESSENGER-RNA; FATTY-ACID OXIDATION; TRANSCRIPTIONAL
   COACTIVATOR; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION;
   ENERGY-METABOLISM; ADAPTIVE THERMOGENESIS; INDUCED ANGIOGENESIS;
   GLUCOSE-HOMEOSTASIS; HEME-BIOSYNTHESIS
AB Exercise triggers a pleiotropic response in skeletal muscle, which results in a profound remodeling of this tissue. Physical activity-dependent muscle fiber plasticity is regulated by a number of distinct signaling pathways. Even though most of these pathways are activated by different stimuli and in a temporally and spatially separated manner during exercise, many of the major signal transduction events converge on the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) by post-translationally modifying the PGC-1 alpha protein, modulating PGC-1 alpha gene expression or both. In turn, depending on the cellular context, PGC-1 alpha regulates specific gene programs. Ultimately, PGC-1 alpha modulates most of the transcriptional adaptations of skeletal muscle to exercise. In this review, the regulation and function of this pivotal transcriptional coactivator in muscle are discussed.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [PP00A-110746]; Muscular Dystrophy Association USAMuscular
   Dystrophy Association [MDA68442]; SwissLife "Jubilaumsstiftung fur
   Volksgesundheit und medizinische Forschung"; Swiss Society for Research
   on Muscle Diseases (SSEM); United Mitochondrial Disease Foundation
   (UMDF); Association Francaise contre les myopathies (AFM)Association
   Francaise contre les Myopathies; Roche Research Foundation; SystemsX.ch
   (the Swiss initiative in systems biology); University of Basel
FX The author declares no conflict of interest. Our research is supported
   by grants from the Swiss National Science Foundation (SNF PP00A-110746),
   the Muscular Dystrophy Association USA (MDA68442), the SwissLife
   "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung", the
   Swiss Society for Research on Muscle Diseases (SSEM), the United
   Mitochondrial Disease Foundation (UMDF), the Association Francaise
   contre les myopathies (AFM), the Roche Research Foundation, SystemsX.ch
   (the Swiss initiative in systems biology), and the University of Basel.
   The funders had no role in the preparation of the manuscript.
CR Akimoto T, 2008, AM J PHYSIOL-CELL PH, V295, pC288, DOI 10.1152/ajpcell.00104.2008
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com
   Berchtold MW, 2000, PHYSIOL REV, V80, P1215
   Booth FW, 2009, J PHYSIOL-LONDON, V587, P5527, DOI 10.1113/jphysiol.2009.179507
   Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106
   Choi S, 2005, J APPL PHYSIOL, V99, P2406, DOI 10.1152/japplphysiol.00545.2005
   Colley SM, 2009, CRIT REV BIOCHEM MOL, V44, P25, DOI [10.1080/10409230802661719, 10.1080/10409230802661719 ]
   Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100
   Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9
   Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7
   GENG T, 2010, AM J PHYSL IN PRESS
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Handschin C, 2009, CLIN EXP PHARMACOL P, V36, P1139, DOI 10.1111/j.1440-1681.2009.05275.x
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015
   Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200
   Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004
   Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002
   Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X
   Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   LEICK L, 2010, EXP GERONTO IN PRESS
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013
   Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013
   Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861
   Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767
   Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012
   Lowell BB, 2000, NATURE, V404, P652
   Mahajan Muktar A, 2008, Nucl Recept Signal, V6, pe002, DOI 10.1621/nrs.06002
   McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466
   Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646
   Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7
   Pette D, 2001, J APPL PHYSIOL, V90, P1119
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2
   Rangwala SM, 2007, BIOCHEM BIOPH RES CO, V357, P231, DOI 10.1016/j.bbrc.2007.03.126
   Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874
   Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200
   Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387
   Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wernbom M, 2008, SCAND J MED SCI SPOR, V18, P401, DOI 10.1111/j.1600-0838.2008.00788.x
   Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Zhang XP, 2009, J APPL PHYSIOL, V107, P1647, DOI 10.1152/japplphysiol.00725.2009
   Zorzano A, 2009, APPL PHYSIOL NUTR ME, V34, P433, DOI 10.1139/H09-049
NR 93
TC 35
Z9 37
U1 0
U2 5
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1079-9893
J9 J RECEPT SIG TRANSD
JI J. Recept. Signal Transduct.
PD DEC
PY 2010
VL 30
IS 6
SI SI
BP 376
EP 384
DI 10.3109/10799891003641074
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 685DX
UT WOS:000284609700003
PM 20178454
DA 2021-01-25
ER

PT J
AU Peter, JC
   Zipfel, G
   Lecourt, AC
   Bekel, A
   Hofbauer, KG
AF Peter, Jean-Christophe
   Zipfel, Geraldine
   Lecourt, Anne-Catherine
   Bekel, Akkiz
   Hofbauer, Karl G.
TI Antibodies raised against different extracellular loops of the
   melanocortin-3 receptor affect energy balance and autonomic function in
   rats
SO JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
LA English
DT Article
DE MC3R; antibodies; appetite; blood pressure; body temperature; locomotor
   activity
ID MONOCLONAL-ANTIBODY; 5-HT4 RECEPTOR; FOOD-INTAKE; OBESITY; MOUSE;
   SYSTEM; MICE; AUTOANTIBODIES; STIMULATION; DISRUPTION
AB Melanocortin receptors (MCR) play an important role in the regulation of energy balance and autonomic function. In the present studies, we used active immunization against peptide sequences from the first and the third extracellular loop (EL1 and EL3) of the MC3R to generate selective antibodies (Abs) against this MCR subtype in rats. Immunization with the EL1 peptide resulted in Abs that enhanced the effects of the endogenous ligand alpha-melanocyte-stimulating hormone (alpha-MSH), whereas immunization with the EL3 peptide resulted in Abs acting as non-competitive antagonists. The phenotype of immunized rats chronically instrumented with telemetry transducers was studied under four different conditions: a high-fat diet was followed by standard lab chow, by fasting, and finally by an intraperitoneal injection of lipopolysaccharide (LPS). Under high-fat diet, food intake and body weight were higher in the EL3 than in the EL1 or the control group. Blood pressure was increased in EL3 rats and locomotor activity was reduced. Plasma concentrations of triglycerides, insulin, and leptin tended to rise in the EL3 group. After switching to standard lab chow, the EL1 group showed a small significant increase in blood pressure that was more pronounced and associated with an increase in heart rate during food restriction. No differences between the EL1 or the EL3 group were observed after LPS injection. These results show that immunization against the MC3R resulted in the production of Abs with positive or negative allosteric properties. The presence of such Abs induced small changes in metabolic and cardiovascular parameters.
C1 [Hofbauer, Karl G.] Univ Basel, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, 50-70 Klingelbergstr, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929
   Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518
   Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029
   Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254
   Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455
   Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085
   Cummings DE, 2000, NAT GENET, V26, P8, DOI 10.1038/79223
   Escobar AL, 2006, J MOL CELL CARDIOL, V40, P829, DOI 10.1016/j.yjmcc.2006.03.430
   Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050
   Feng NP, 2005, DIABETES, V54, P2663, DOI 10.2337/diabetes.54.9.2663
   GANTZ I, 1993, J BIOL CHEM, V268, P15174
   GUILLET JG, 1992, CLIN EXP IMMUNOL, V89, P461
   Hao XJ, 2002, CHINESE MED J-PEKING, V115, P170
   Hofbauer KG, 2008, NUTRITION, V24, P791, DOI 10.1016/j.nut.2008.06.001
   Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6
   Kamel R, 2005, BIOCHEM PHARMACOL, V70, P1009, DOI 10.1016/j.bcp.2005.07.005
   Kamel R, 2005, J AUTOIMMUN, V25, P72, DOI 10.1016/j.jaut.2005.04.005
   Kamel R, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-34
   Kawabe T, 2006, BRAIN RES, V1102, P117, DOI 10.1016/j.brainres.2006.05.002
   Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875
   KEOV P, 2010, NEUROPHARMA IN PRESS
   Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002
   Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8
   Lee M, 2008, PEPTIDES, V29, P440, DOI 10.1016/j.peptides.2007.11.005
   Marks DL, 2006, PEPTIDES, V27, P259, DOI 10.1016/j.peptides.2005.01.025
   Marks DL, 2003, ANN NY ACAD SCI, V994, P258, DOI 10.1111/j.1749-6632.2003.tb03188.x
   NEIMARK J, 1993, PEPTIDE RES, V6, P219
   Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa
   Ni XP, 2003, J CLIN INVEST, V111, P1251, DOI 10.1172/JCI200316993
   Nordheim U, 2006, PEPTIDES, V27, P438, DOI 10.1016/j.peptides.2005.01.026
   Peter JC, 2005, FASEB J, V19, P943, DOI 10.1096/fj.04-3042com
   Peter JC, 2004, J BIOL CHEM, V279, P55697, DOI 10.1074/jbc.M407213200
   Peter JC, 2003, J BIOL CHEM, V278, P36740, DOI 10.1074/jbc.M306877200
   Peter JC, 2007, AM J PHYSIOL-REG I, V292, pR2151, DOI 10.1152/ajpregu.00878.2006
   ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856
   Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209
   WALLUKAT G, 1991, J ALLERGY CLIN IMMUN, V88, P581, DOI 10.1016/0091-6749(91)90151-D
NR 37
TC 9
Z9 13
U1 0
U2 1
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1079-9893
J9 J RECEPT SIG TRANSD
JI J. Recept. Signal Transduct.
PD DEC
PY 2010
VL 30
IS 6
SI SI
BP 444
EP 453
DI 10.3109/10799893.2010.534485
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 685DX
UT WOS:000284609700009
PM 21091037
DA 2021-01-25
ER

PT J
AU Ben-Tekaya, H
   Kahn, RA
   Hauri, HP
AF Ben-Tekaya, Houchaima
   Kahn, Richard A.
   Hauri, Hans-Peter
TI ADP Ribosylation Factors 1 and 4 and Group VIA Phospholipase A(2)
   Regulate Morphology and Intraorganellar Traffic in the Endoplasmic
   Reticulum-Golgi Intermediate Compartment
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID BREFELDIN-A; BROMOENOL LACTONE; PROTEIN ERGIC-53; ER; IDENTIFICATION;
   MEMBRANES; CELLS; INHIBITION; TRANSPORT; ARF
AB Organelle morphology of the endomembrane system is critical for optimal organelle function. ADP ribosylation factors (Arfs), a family of small GTPases, are required for maintaining the structure of the Golgi and endosomes. What determines the discontinuous nature of the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) as tubulovesicular clusters is unknown. In search of morphological determinants for the ERGIC, we found that a double knockdown of Arf1 + Arf4 induced dynamic ERGIC tubules that connect ERGIC clusters, indicating that the tubules mediated lateral intraERGIC traffic. Tubule formation was inhibited by an antagonist of group VI calcium-independent phospholipase A(2) (PLA2G6) and by silencing the A isoform of PLA2G6 (PLA2G6-A). Arf1 + Arf4 depletion altered the expression of PLA2G6-A splice variants and relocalized PLA2G6-A from the cytosol to ERGIC clusters and tubules, suggesting that the enzyme became locally active. We show that changes in Arf1 can modulate the activity of PLA2G6-A. We propose that a concerted action of Arf1, Arf4, and PLA2G6-A controls the architecture of the ERGIC in a way that is predicted to impact the rate and possibly the destination of cargos. Our findings have identified key components in the molecular mechanism underlying the regulation of tubules in the ERGIC and uncover tubular carriers as tightly controlled machinery.
C1 [Ben-Tekaya, Houchaima; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
RI Kahn, Richard/ABD-2666-2020
OI Kahn, Richard/0000-0002-0259-0601
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [GM-67226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [R01GM067226, R01GM067226, R01GM067226, R01GM067226,
   R01GM067226, R01GM067226, R01GM067226, R01GM067226] Funding Source: NIH
   RePORTER
FX We thank Franck Gorelick (Yale University School of Medicine) for
   anti-Sec 31 antibodies; Laura Volpicelli-Daley for knockdown protocols;
   Pascal Escher (Biozentrum, University of Basel) for nucEGFP; Brian P.
   Kennedy (Merck Frosst Centre for Therapeutic Research) for
   L-iPLA<INF>2</INF> cDNA; Benjamin S. Glick (University of Chicago) for
   pDsRedT1 vector; Jean Pieters (Biozentrum, University of Basel) for
   PLA2G6-A antibody; Eva Kogler, Kathy Bucher, Sandra Mitrovic, and Carine
   Bonnon for technical advice; Shamshad Cockroft (University College
   London) for valuable input and for reagents; and members of the Hauri
   group for suggestions. We also thank Christoph Dehio and his group
   members for support during the revision of this manuscript. The study
   was supported by the Swiss National Science Foundation and the
   University of Basel (to H.B.-T. and H.-P.H.) and by the National
   Institutes of Health grant GM-67226 (to R.A.K.).
CR ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445
   ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   Blum R, 2000, J CELL SCI, V113, P3151
   Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200
   Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x
   Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767
   Choukroun GJ, 2000, J CLIN INVEST, V106, P983, DOI 10.1172/JCI8914
   Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373
   de Figueiredo P, 2000, TRAFFIC, V1, P504, DOI 10.1034/j.1600-0854.2000.010608.x
   DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295
   Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200
   Fensome-Green A, 2007, CELL CALCIUM, V41, P145, DOI 10.1016/j.ceca.2006.06.002
   Fullekrug J, 1997, FEBS LETT, V404, P75, DOI 10.1016/S0014-5793(97)00097-5
   Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2
   Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003
   Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421
   Grewal S, 2005, FEBS J, V272, P1278, DOI 10.1111/j.1742-4658.2005.04565.x
   Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025
   ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57
   Jones DH, 1999, BIOCHEM J, V341, P185, DOI 10.1042/0264-6021:3410185
   Jones G, 1999, J NEUROSCI, V19, P3376
   Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006
   Klumperman J, 1998, J CELL SCI, V111, P3411
   KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x
   KUISMANEN E, 1989, METHOD CELL BIOL, V32, P257
   Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207
   Linstedt AD, 1997, MOL BIOL CELL, V8, P1073
   LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W
   LOTTI LV, 1992, J CELL BIOL, V118, P43, DOI 10.1083/jcb.118.1.43
   Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200
   Marie M, 2009, MOL BIOL CELL, V20, P4458, DOI 10.1091/mbc.E08-12-1229
   Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101
   Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6
   Morikawa RK, 2009, J BIOL CHEM, V284, P26620, DOI 10.1074/jbc.M109.038869
   Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280
   PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303
   Poulsen KA, 2007, AM J PHYSIOL-CELL PH, V293, pC1605, DOI 10.1152/ajpcell.00012.2007
   Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197
   San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194
   Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792
   Saraste J, 2009, FEBS LETT, V583, P3804, DOI 10.1016/j.febslet.2009.10.084
   Scheel J, 1997, J CELL BIOL, V137, P319, DOI 10.1083/jcb.137.2.319
   Schmidt JA, 2009, J CELL BIOL, V186, P211, DOI 10.1083/jcb.200904147
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185
   Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155
   Shugrue CA, 1999, J CELL SCI, V112, P4547
   Simpson JC, 2006, MOL BIOL CELL, V17, P723, DOI 10.1091/mbc.E05-06-0580
   Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200
   Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769
   Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.E04-07-0554
   Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042
   Yang JY, 2003, FEBS LETT, V546, P247, DOI 10.1016/S0014-5793(03)00581-7
   Zeghouf M, 2005, BIOCHEM SOC T, V33, P1265, DOI 10.1042/BST0331265
NR 57
TC 30
Z9 30
U1 0
U2 3
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD DEC 1
PY 2010
VL 21
IS 23
BP 4130
EP 4140
DI 10.1091/mbc.E10-01-0022
PG 11
WC Cell Biology
SC Cell Biology
GA 686HL
UT WOS:000284687300008
PM 20881058
OA Green Published
DA 2021-01-25
ER

PT J
AU Sharma, SK
   De Los Rios, P
   Christen, P
   Lustig, A
   Goloubinoff, P
AF Sharma, Sandeep K.
   De Los Rios, Paolo
   Christen, Philipp
   Lustig, Ariel
   Goloubinoff, Pierre
TI The kinetic parameters and energy cost of the Hsp70 chaperone as a
   polypeptide unfoldase
SO NATURE CHEMICAL BIOLOGY
LA English
DT Article
ID HEAT-SHOCK PROTEINS; DNAK CHAPERONE; ESCHERICHIA-COLI; MOLECULAR
   CHAPERONES; SUBSTRATE-SPECIFICITY; MANGANESE IONS; GRPE; MECHANISM;
   SYSTEM; ATP
AB Hsp70-Hsp40-NEF and possibly Hsp100 are the only known molecular chaperones that can use the energy of ATP to convert stably pre-aggregated polypeptides into natively refolded proteins. However, the kinetic parameters and ATP costs have remained elusive because refolding reactions have only been successful with a molar excess of chaperones over their polypeptide substrates. Here we describe a stable, misfolded luciferase species that can be efficiently renatured by substoichiometric amounts of bacterial Hsp70-Hsp40-NEF. The reactivation rates increased with substrate concentration and followed saturation kinetics, thus allowing the determination of apparent V(max)' and K(m)' values for a chaperone-mediated renaturation reaction for the first time. Under the in vitro conditions used, one Hsp70 molecule consumed five ATPs to effectively unfold a single misfolded protein into an intermediate that, upon chaperone dissociation, spontaneously refolded to the native state, a process with an ATP cost a thousand times lower than expected for protein degradation and resynthesis.
C1 [Sharma, Sandeep K.; Goloubinoff, Pierre] Univ Lausanne, Dept Biol Mol Vegetale, Lausanne, Switzerland.
   [De Los Rios, Paolo] Ecole Polytech Fed Lausanne, Sch Basic Sci, Lab Biophys Stat, Lausanne, Switzerland.
   [Christen, Philipp] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland.
   [Lustig, Ariel] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Sharma, SK (corresponding author), Univ Lausanne, Dept Biol Mol Vegetale, Lausanne, Switzerland.
EM pierre.goloubinoff@unil.ch
RI Sharma, Sandeep/F-7420-2010; De Los Rios, Paolo/B-2456-2010
OI Sharma, Sandeep/0000-0002-0039-7883; De Los Rios,
   Paolo/0000-0002-5394-5062; Goloubinoff, Pierre/0000-0002-4802-0807
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-109290]; Faculty of Biology and Medicine, University of
   Lausanne
FX We thank A. S. Spirin (Institute of Protein Research, Russian Academy of
   Sciences) for the luciferase plasmid, H. J. SchOnfeld (F. Hoffmann-La
   Roche) for DnaK, DnaJ and GrpE, A. Azem (Tel Aviv University) for
   discussions and AUC analyses, M. Muriset and R. U. H. Mattoo for
   discussions and technical assistance, G. Lorimer and J. Buchner for
   suggesting, respectively, the experiments in Figures 5b and 2b, and A.
   Finka and S. Priya for discussions and manuscript correction. This
   research was financed by grant 3100A0-109290 from the Swiss National
   Science Foundation and in part by the Zwahlen Grant from the Faculty of
   Biology and Medicine, University of Lausanne.
CR ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223
   Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021
   Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z
   Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200
   Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106
   Bischofberger P, 2003, J BIOL CHEM, V278, P19044, DOI 10.1074/jbc.M300922200
   Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200
   CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0
   Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0
   De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103
   Diamant S, 1998, BIOCHEMISTRY-US, V37, P9688, DOI 10.1021/bi980338u
   DIAMANT S, 1995, J BIOL CHEM, V270, P28387
   DIAMANT S, 1995, BIOCHEMISTRY-US, V34, P273, DOI 10.1021/bi00001a033
   Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Feifel B, 1996, EUR J BIOCHEM, V237, P318, DOI 10.1111/j.1432-1033.1996.0318n.x
   FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0
   FISHBEIN WN, 1979, PROTEINS LOW TEMPERA, V180, P55
   GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M
   Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4
   GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0
   Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732
   Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008
   Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200
   Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408
   HELLEBUST H, 1990, J BACTERIOL, V172, P5030, DOI 10.1128/jb.172.9.5030-5034.1990
   Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249
   Hu B, 2006, BIOPHYS J, V91, P496, DOI 10.1529/biophysj.106.083394
   JAKOB U, 1993, J BIOL CHEM, V268, P1517
   Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452
   Mally A, 2001, NAT STRUCT BIOL, V8, P254, DOI 10.1038/85002
   MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0
   Mayer MP, 2000, NAT STRUCT BIOL, V7, P586
   Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587
   PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0
   Popp S, 2005, J MOL BIOL, V347, P1039, DOI 10.1016/j.jmb.2005.02.026
   Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016
   Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501
   Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042
   SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183
   SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x
   Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006
   Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930
   SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J
   Svetlov MS, 2007, MOL BIOL+, V41, P86, DOI 10.1134/S0026893307010128
   SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345
   Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032
   WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0
NR 48
TC 129
Z9 131
U1 1
U2 38
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1552-4450
J9 NAT CHEM BIOL
JI Nat. Chem. Biol.
PD DEC
PY 2010
VL 6
IS 12
BP 914
EP 920
DI 10.1038/NCHEMBIO.455
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 680EH
UT WOS:000284214700021
PM 20953191
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI PROCEEDINGS OF A STUDY WEEK OF THE PONTIFICAL ACADEMY OF SCIENCES
SO NEW BIOTECHNOLOGY
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM werner.arber@unibas.ch
NR 0
TC 0
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
J9 NEW BIOTECHNOL
JI New Biotech.
PD NOV 30
PY 2010
VL 27
IS 5
SI SI
BP 445
EP 446
DI 10.1016/j.nbt.2010.09.013
PG 2
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 701ZI
UT WOS:000285863300001
PM 20933623
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI Genetic engineering compared to natural genetic variations
SO NEW BIOTECHNOLOGY
LA English
DT Review
ID EVOLUTION; ELEMENTS; DNA
AB By comparing strategies of genetic alterations introduced in genetic engineering with spontaneously occurring genetic variation, we have come to conclude that both processes depend on several distinct and specific molecular mechanisms. These mechanisms can be attributed, with regard to their evolutionary impact, to three different strategies of genetic variation. These are local nucleotide sequence changes, intragenomic rearrangement of DNA segments and the acquisition of a foreign DNA segment by horizontal gene transfer. Both the strategies followed in genetic engineering and the amounts of DNA sequences thereby involved are identical to, or at least very comparable with, those involved in natural genetic variation. Therefore, conjectural risks of genetic engineering must be of the same order as those for natural biological evolution and for conventional breeding methods. These risks are known to be quite low. There is no scientific reason to assume special long-term risks for GM crops. For future agricultural developments, a road map is designed that can be expected to lead, by a combination of genetic engineering and conventional plant breeding, to crops that can insure food security and eliminate malnutrition and hunger for the entire human population on our planet. Public-private partnerships should be formed with the mission to reach the set goals in the coming decades.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM w.arber@unibas.ch
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   ARBER W, 1991, J MOL EVOL, V33, P4, DOI 10.1007/BF02100190
   Arber W, 2007, GENOMICS GENETICS, V1, P385
   Arber W., 2006, PONTIFICAL ACAD SCI, V18, P219
   Arber W., 2002, PONTIFICAL ACAD SCI, V103, P90
   Arber W., 2008, PREDICTABILITY SCI A, V19, P126
   Arber W, 2009, BIOTECHNOL ADV, V27, P940, DOI 10.1016/j.biotechadv.2009.05.014
   Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137
   DUSSOIX D, 1962, J MOL BIOL, V5, P37, DOI 10.1016/S0022-2836(62)80059-X
   LEDERBERG J, 1947, GENETICS, V32, P505
   Mayr E., 1982, GROWTH BIOLOGICAL TH
   WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Weber M, 1996, BIOL PHILOS, V11, P67, DOI 10.1007/BF00127472
   Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303
   ZINDER ND, 1952, J BACTERIOL, V64, P679, DOI 10.1002/path.1700640402
NR 16
TC 17
Z9 17
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
EI 1876-4347
J9 NEW BIOTECHNOL
JI New Biotech.
PD NOV 30
PY 2010
VL 27
IS 5
SI SI
BP 517
EP 521
DI 10.1016/j.nbt.2010.05.007
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 701ZI
UT WOS:000285863300012
PM 20472106
DA 2021-01-25
ER

PT J
AU Kasper, CA
   Sorg, I
   Schmutz, C
   Tschon, T
   Wischnewski, H
   Kim, ML
   Arrieumerlou, C
AF Kasper, Christoph Alexander
   Sorg, Isabel
   Schmutz, Christoph
   Tschon, Therese
   Wischnewski, Harry
   Kim, Man Lyang
   Arrieumerlou, Cecile
TI Cell-Cell Propagation of NF-kappa B Transcription Factor and MAP Kinase
   Activation Amplifies Innate Immunity against Bacterial Infection
SO IMMUNITY
LA English
DT Article
ID SHIGELLA-FLEXNERI; SIGNALING PATHWAYS; INTERLEUKIN-8; RESPONSES; TAK1;
   IDENTIFICATION; INVASION; PLASMID; SYSTEM; DOMAIN
AB The enteroinvasive bacterium Shigella flexneri uses multiple secreted effector proteins to downregulate interleukin-8 (IL-8) expression in infected epithelial cells. Yet, massive IL-8 secretion is observed in Shigellosis. Here we report a host mechanism of cell-cell communication that circumvents the effector proteins and strongly amplifies IL-8 expression during bacterial infection. By monitoring proinflammatory signals at the single-cell level, we found that the activation of the transcription factor NF-kappa B and the MAP kinases JNK, ERK, and p38 rapidly propagated from infected to uninfected adjacent cells, leading to IL-8 production by uninfected bystander cells. Bystander IL-8 production was also observed during Listeria monocyto genes and Salmonella typhimurium infection. This response could be triggered by recognition of peptidoglycan and is mediated by gap junctions. Thus, we have identified a mechanism of cell-cell communication that amplifies innate immunity against bacterial infection by rapidly spreading proinflammatory signals via gap junctions to yet uninfected cells.
C1 [Kasper, Christoph Alexander; Sorg, Isabel; Schmutz, Christoph; Tschon, Therese; Wischnewski, Harry; Kim, Man Lyang; Arrieumerlou, Cecile] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arrieumerlou, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM cecile.arrieumerlou@unibas.ch
OI ARRIEUMERLOU, Cecile/0000-0002-6463-2897
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-113561]; SystemsX.ch.; Werner-Siemens Foundation
FX We thank J. Neefjes (NKI, Amsterdam, Netherlands) and M. Kelliher
   (Massachusetts Medical School, Worcester, USA) for the generous gift of
   A431-Cx43 cells and Tnfr1<SUP>-/-</SUP> MEFs, respectively. We also
   thank G. Cornelis, U. Jenal, and C. Dehio for comments on the manuscript
   and M. Podvinec for help with research IT. This work was funded by the
   Swiss National Science Foundation (grant 3100A0-113561 to C.A.) and the
   InfectX project from SystemsX.ch. C.A.K. was supported by the
   Werner-Siemens Foundation.
CR Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423
   BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   DAVIDSON JS, 1986, BIOCHEM BIOPH RES CO, V134, P29, DOI 10.1016/0006-291X(86)90522-X
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133
   ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993
   Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677
   Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084
   Holtmann H, 1999, MOL CELL BIOL, V19, P6742
   Islam D, 1997, INFECT IMMUN, V65, P739, DOI 10.1128/IAI.65.2.739-749.1997
   Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043
   Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102
   Kohler H, 2002, INFECT IMMUN, V70, P1150, DOI 10.1128/IAI.70.3.1150-1158.2002
   Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020
   Lee J, 2000, J LEUKOCYTE BIOL, V68, P909
   Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960
   MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9
   MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z
   Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290
   Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465
   Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145
   Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002
   Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106
   Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200
   Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025
   Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748
   Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999
   Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07
   Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747
   TROYANOVSKY SM, 1994, J CELL BIOL, V127, P151, DOI 10.1083/jcb.127.1.151
   Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597
   Zurawski DV, 2009, MOL MICROBIOL, V71, P350, DOI 10.1111/j.1365-2958.2008.06524.x
NR 34
TC 72
Z9 76
U1 0
U2 16
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD NOV 24
PY 2010
VL 33
IS 5
BP 804
EP 816
DI 10.1016/j.immuni.2010.10.015
PG 13
WC Immunology
SC Immunology
GA 704VB
UT WOS:000286082600017
PM 21093316
DA 2021-01-25
ER

PT J
AU Backmann, N
   Kappeler, N
   Braun, T
   Huber, F
   Lang, HP
   Gerber, C
   Lim, RYH
AF Backmann, Natalija
   Kappeler, Natascha
   Braun, Thomas
   Huber, Francois
   Lang, Hans-Peter
   Gerber, Christoph
   Lim, Roderick Y. H.
TI Sensing surface PEGylation with microcantilevers
SO BEILSTEIN JOURNAL OF NANOTECHNOLOGY
LA English
DT Article
DE AFM; cantilever sensor; polyethylene glycol; polymer brush; reversible
   collapse; static mode
AB Polymers are often used to modify surface properties to control interfacial processes. Their sensitivity to solvent conditions and ability to undergo conformational transitions makes polymers attractive in tailoring surface properties with specific functionalities leading to applications in diverse areas ranging from tribology to colloidal stability and medicine. A key example is polyethylene glycol (PEG), which is widely used as a protein-resistant coating given its low toxicity and biocompatibility. We report here a microcantilever-based sensor for the in situ characterization of PEG monolayer formation on Au using the "grafting to" approach. Moreover, we demonstrate how microcantilevers can be used to monitor conformational changes in the grafted PEG layer in different solvent conditions. This is supported by atomic force microscope (AFM) images and force-distance curve measurements of the microcantilever chip surface, which show that the grafted PEG undergoes a reversible collapse when switching between good and poor solvent conditions, respectively.
C1 [Backmann, Natalija; Kappeler, Natascha; Huber, Francois; Lang, Hans-Peter; Gerber, Christoph] Univ Basel, Natl Ctr Competence Res Nanoscale Sci, Dept Phys, CH-4056 Basel, Switzerland.
   [Braun, Thomas] Univ Basel, Ctr Cellular Imaging & Nanoanalyt, Biozentrum, CH-4058 Basel, Switzerland.
   [Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
RP Backmann, N (corresponding author), Univ Basel, Natl Ctr Competence Res Nanoscale Sci, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.
EM natalija.backmann@unibas.ch; natascha.kappeler@stud.unibas.ch;
   thomas.braun@unibas.ch; francois.huber@unibas.ch;
   hans-peter.lang@unibas.ch; christoph.gerber@unibas.ch;
   roderick.lim@unibas.ch
OI Lang, Hans Peter/0000-0002-0012-2564; Lim, Roderick/0000-0001-5015-6087;
   Gerber, Christoph/0000-0001-7035-3838
FU Swiss National Center of Competence in Research in Nanoscale Science
   (NCCR-Nano); Swiss National Science FoundationSwiss National Science
   Foundation (SNSF)
FX This work was funded by the Swiss National Center of Competence in
   Research in Nanoscale Science (NCCR-Nano) and the Swiss National Science
   Foundation. We would like to gratefully acknowledge the Cleven Becker
   Foundation. We also express our thanks to IBM Research (IBM Zurich
   Research GmbH) for microfabrication support.
CR Anne A, 2002, MACROMOLECULES, V35, P5578, DOI 10.1021/ma020071d
   Asatekin A, 2007, J MEMBRANE SCI, V298, P136, DOI 10.1016/j.memsci.2007.04.011
   Backmann N, 2005, P NATL ACAD SCI USA, V102, P14587, DOI 10.1073/pnas.0504917102
   Berglin M, 2009, LANGMUIR, V25, P5602, DOI 10.1021/la803686m
   Biswal SL, 2006, ANAL CHEM, V78, P7104, DOI 10.1021/ac052171y
   Braun T, 2007, J PHYS CONF SER, V61, P341, DOI 10.1088/1742-6596/61/1/069
   Braun T, 2006, BIOPHYS J, V90, P2970, DOI 10.1529/biophysj.105.072934
   Braun T, 2007, SENSOR ACTUAT B-CHEM, V128, P75, DOI 10.1016/j.snb.2007.05.031
   Braun T, 2009, NAT NANOTECHNOL, V4, P179, DOI [10.1038/NNANO.2008.398, 10.1038/nnano.2008.398]
   Brown HG, 1997, BIOCHEMISTRY-US, V36, P15035, DOI 10.1021/bi9721748
   Bumbu GG, 2007, LANGMUIR, V23, P2203, DOI 10.1021/la062137u
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   Cherian S, 2003, BIOSENS BIOELECTRON, V19, P411, DOI 10.1016/S0956-5663(03)00226-4
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Fritz J, 2008, ANALYST, V133, P855, DOI 10.1039/b718174d
   Godin M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/7/075501
   Gupta A, 2004, APPL PHYS LETT, V84, P1976, DOI 10.1063/1.1667011
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Huang HQ, 2004, J POLYM SCI POL CHEM, V42, P5530, DOI 10.1002/pola.20407
   Huber F, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2969912
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Koutsos V, 1999, MACROMOLECULES, V32, P1233, DOI 10.1021/ma971702k
   Koutsos V, 1997, MACROMOLECULES, V30, P4719, DOI 10.1021/ma961625d
   KUHL TL, 1994, BIOPHYS J, V66, P1479, DOI 10.1016/S0006-3495(94)80938-5
   Lang HP, 2005, MATER TODAY, V8, P30, DOI 10.1016/S1369-7021(05)00792-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lavrik NV, 2004, REV SCI INSTRUM, V75, P2229, DOI 10.1063/1.1763252
   Lee HS, 2008, MACROMOLECULES, V41, P8124, DOI 10.1021/ma8009307
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Lim RYH, 2009, ACS NANO, V3, P2911, DOI 10.1021/nn900152m
   Liu L, 2006, J AM CHEM SOC, V128, P14067, DOI 10.1021/ja062802l
   McKendry R, 2002, P NATL ACAD SCI USA, V99, P9783, DOI 10.1073/pnas.152330199
   Mertens J, 2008, NAT NANOTECHNOL, V3, P301, DOI 10.1038/nnano.2008.91
   Mukhopadhyay R, 2005, LANGMUIR, V21, P8400, DOI 10.1021/la0511687
   Mukhopadhyay R, 2001, FEBS LETT, V505, P374, DOI 10.1016/S0014-5793(01)02844-7
   Ndieyira JW, 2008, NAT NANOTECHNOL, V3, P691, DOI 10.1038/nnano.2008.275
   Nugaeva N, 2007, MICROSC MICROANAL, V13, P13, DOI 10.1017/S1431927607070067
   OSHEA SJ, 1993, LANGMUIR, V9, P1826, DOI 10.1021/la00031a034
   Pera I, 2007, LANGMUIR, V23, P1543, DOI 10.1021/la0624337
   Shu WM, 2007, BIOSENS BIOELECTRON, V22, P2003, DOI 10.1016/j.bios.2006.08.047
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Tokumitsu S, 2002, LANGMUIR, V18, P8862, DOI 10.1021/la0258953
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350
   Yeh PYJ, 2008, LANGMUIR, V24, P4907, DOI 10.1021/la702867t
   Yoshikawa G, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/1/015501
   Zhang GZ, 2009, MACROMOL RAPID COMM, V30, P328, DOI 10.1002/marc.200800611
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 51
TC 25
Z9 25
U1 3
U2 23
PU BEILSTEIN-INSTITUT
PI FRANKFURT AM MAIN
PA TRAKEHNER STRASSE 7-9, FRANKFURT AM MAIN, 60487, GERMANY
SN 2190-4286
J9 BEILSTEIN J NANOTECH
JI Beilstein J. Nanotechnol.
PD NOV 22
PY 2010
VL 1
BP 3
EP 13
DI 10.3762/bjnano.1.2
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA V21NJ
UT WOS:000208214000002
PM 21977390
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Schach, D
   Nowak, C
   Gennis, RB
   Ferguson-Miller, S
   Knoll, W
   Walz, D
   Naumann, RLC
AF Schach, D.
   Nowak, Ch
   Gennis, R. B.
   Ferguson-Miller, Sh
   Knoll, W.
   Walz, D.
   Naumann, R. L. C.
TI Modeling direct electron transfer to a multi-redox center protein
   Cytochrome c oxidase
SO JOURNAL OF ELECTROANALYTICAL CHEMISTRY
LA English
DT Article
DE Multi redox center proteins; Cyclic voltammetry; Modeling of electron
   transfer; Kinetic coefficients; Four electron transfer model; Sequential
   and independent mechanism
ID FILM VOLTAMMETRY; MECHANISMS; SITE; ELECTROCHEMISTRY; MEMBRANE; ENZYMES;
   CHAINS
AB Direct electron transfer to Cytochrome c Oxidase (CcO) was investigated using fast scan cyclic voltamme try The enzyme was tethered to the electrode in a strict orientation by means of a histidine tag with Cu-A the first electron acceptor directed towards the electrode A lipid bilayer was then reconstituted in situ around the bound proteins forming a protein tethered bilayer lipid membrane Cyclic voltammograms were measured under anaerobic conditions at different scan rates with CcO in the non-activated and the activated state The activated state was attained after catalytic turnover of the enzyme in the presence of oxygen A four-electron transfer model was developed to analyze the data This enables us to discriminate between the mechanisms of sequential and Independent electron transfer to the four redox centers Cu-A heme a heme a(3) and Cu-B Moreover values of parameters such as standard redox potentials and kinetic coefficients of electron transfer could be obtained Based on these results we conclude that direct electron transfer to CcO most likely follows the sequential mechanism thus mimicking the electron transfer form cytochrome c the genuine electron donor of CcO (C) 2010 Elsevier B V All rights reserved
C1 [Schach, D.; Nowak, Ch; Naumann, R. L. C.] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Gennis, R. B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
   [Ferguson-Miller, Sh] Michigan State Univ, E Lansing, MI 48824 USA.
   [Schach, D.; Nowak, Ch; Knoll, W.; Naumann, R. L. C.] Austrian Inst Technol GmbH, AIT, A-1220 Vienna, Austria.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Naumann, RLC (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
CR Armstrong FA, 2008, SCIENCE, V322, P529, DOI 10.1126/science.1161326
   Armstrong FA, 2002, RUSS J ELECTROCHEM+, V38, P49, DOI 10.1023/A:1013786328075
   Armstrong FA, 2002, J CHEM SOC DALTON, P661, DOI 10.1039/b108359g
   ARMSTRONG FA, 2000, FARADAY DISCUSSIONS, V191
   Baymann F, 2003, FEBS LETT, V539, P91, DOI 10.1016/S0014-5793(03)00206-0
   BUTT JA, 2008, VOLTAMMETRY ADSORBED
   Fourmond V, 2009, BIOELECTROCHEMISTRY, V76, P141, DOI 10.1016/j.bioelechem.2009.02.010
   Friedrich MG, 2008, BIOPHYS J, V94, P3698, DOI 10.1529/biophysj.107.117846
   Friedrich MG, 2004, CHEM COMMUN, P2376, DOI 10.1039/b410998h
   Gorbikova EA, 2006, BIOCHEMISTRY-US, V45, P5641, DOI 10.1021/bi060257v
   Haas AS, 2001, J PHYS CHEM B, V105, P11351, DOI 10.1021/jp011834m
   Hill T., 1977, FREE ENERGY TRANSDUC
   Hiser C, 2001, BIOCHEMISTRY-US, V40, P1606, DOI 10.1021/bi0018988
   Jeuken LJC, 2002, J AM CHEM SOC, V124, P5702, DOI 10.1021/ja012638w
   LAVIRON E, 1982, ELECTROANAL CHEM, V12, P53
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Leger C, 2003, BIOCHEMISTRY-US, V42, P8653, DOI 10.1021/bi034789c
   Lisdat F, 2009, CHEM COMMUN, P274, DOI 10.1039/b813559b
   MCINTOSH JEA, 1980, MATH MODELLING COMPU
   Naumann R, 2003, LANGMUIR, V19, P5435, DOI 10.1021/la0342060
   NOWAK C, 2010, J SOLID STATE ELECTR
   NOWAK C, SOFT MATTER IN PRESS
   NOWAK C, BIOCHEMISTRY UNPUB
   Robertson JWF, 2008, J PHYS CHEM B, V112, P10475, DOI 10.1021/jp800162d
   Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8
   Udit AK, 2006, J AM CHEM SOC, V128, P10320, DOI 10.1021/ja061896w
   Udit AK, 2006, LANGMUIR, V22, P10854, DOI 10.1021/la061162x
   Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u
   WALZ D, 1995, BIOELECTROCHEMISTRY
   Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013
   Willner I, 2009, FUEL CELLS, V9, P7, DOI 10.1002/fuce.200800115
   Zheng Z, 2009, PROTEINS, V75, P719, DOI 10.1002/prot.22282
NR 32
TC 15
Z9 15
U1 1
U2 18
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1572-6657
J9 J ELECTROANAL CHEM
JI J. Electroanal. Chem.
PD NOV 15
PY 2010
VL 649
IS 1-2
SI SI
BP 268
EP 276
DI 10.1016/j.jelechem.2010.07.009
PG 9
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 687BZ
UT WOS:000284750200036
DA 2021-01-25
ER

PT J
AU Rasch, B
   Papassotiropoulos, A
   de Quervain, DF
AF Rasch, B.
   Papassotiropoulos, A.
   de Quervain, D-F
TI Imaging genetics of cognitive functions: Focus on episodic memory
SO NEUROIMAGE
LA English
DT Review
ID MEDIAL TEMPORAL-LOBE; ALZHEIMERS-DISEASE; VAL66MET POLYMORPHISM;
   HIPPOCAMPAL ACTIVITY; SAMPLE-SIZE; FMRI; PERFORMANCE; ACTIVATION;
   SYSTEM; POWER
AB Human cognitive functions are highly variable across individuals and are both genetically and environmentally influenced. Recent behavioral genetics studies have identified several common genetic polymorphisms, which are related to individual differences in memory performance. In addition, imaging genetics studies are starting to explore the neural correlates of genetic differences in memory functions on the level of brain circuits. In this review we will describe how functional magnetic resonance imaging (fMRI) can be used to validate and extend findings of behavioral genetics studies of episodic memory and give examples of recent advances in this new and exciting research field. In addition, we will present advantages and problems related to the different sensitivity of behavioral- vs. imaging genetics studies and discuss possible methodological approaches for an appropriate evaluation and integration of the results. Although the field of imaging genetics of episodic memory is still young, it already became clear that imaging methods have a large potential to enhance our understanding of the neural mechanisms that underlie genetic differences in memory. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Rasch, B.; de Quervain, D-F] Univ Basel, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Rasch, B.; Papassotiropoulos, A.] Univ Basel, Div Mol Psychol, CH-4055 Basel, Switzerland.
   [Rasch, B.; Papassotiropoulos, A.] Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland.
   [Rasch, B.; de Quervain, D-F] Univ Basel, Psychiat Univ Clin, CH-4055 Basel, Switzerland.
   [Rasch, B.; de Quervain, D-F] Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland.
RP Rasch, B (corresponding author), Univ Basel, Div Cognit Neurosci, Birmannsgasse 8, CH-4055 Basel, Switzerland.
EM Bjoern.Rasch@unibas.ch; Dominique.Dequervain@unibas.ch
RI Rasch, Bjorn/A-3119-2015
OI Rasch, Bjorn/0000-0001-7607-3415; de Quervain,
   Dominique/0000-0001-7131-2464; Papassotiropoulos,
   Andreas/0000-0002-2210-9651
CR Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79
   Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078
   Buchmann A, 2008, NEUROPSYCHOLOGIA, V46, P2389, DOI 10.1016/j.neuropsychologia.2008.03.002
   Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459
   Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008
   Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9
   Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed.
   Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7
   de Frias CM, 2004, BEHAV GENET, V34, P533, DOI 10.1023/B:BEGE.0000038491.06972.8c
   de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103
   de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146
   de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150
   Dempster EL, 2006, AM J PSYCHIAT, V163, P1832, DOI 10.1176/appi.ajp.163.10.1832
   Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8
   Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328
   Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849
   Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3
   Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011
   Han SD, 2009, DEMENT GERIATR COGN, V27, P1, DOI 10.1159/000182420
   Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005
   Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003
   Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003
   Hayasaka S, 2007, NEUROIMAGE, V37, P721, DOI 10.1016/j.neuroimage.2007.06.009
   Hedden T, 2005, CURR OPIN NEUROL, V18, P740, DOI 10.1097/01.wco.0000189875.29852.48
   Huentelman MJ, 2007, HUM MOL GENET, V16, P1469, DOI 10.1093/hmg/ddm097
   Jung MW, 2008, REV NEUROSCIENCE, V19, P29
   Kolsch H, 2009, J NEURAL TRANSM, V116, P897, DOI 10.1007/s00702-009-0238-5
   LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825
   Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007
   Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612
   Liberzon I, 2006, ANN NY ACAD SCI, V1071, P87, DOI 10.1196/annals.1364.009
   Mattay VS, 2008, BIOL PSYCHOL, V79, P9, DOI 10.1016/j.biopsycho.2008.03.015
   McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560
   Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993
   Milner B, 1972, Clin Neurosurg, V19, P421
   Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x
   Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013
   Murphy K, 2004, NEUROIMAGE, V22, P879, DOI 10.1016/j.neuroimage.2004.02.005
   Murphy K, 2004, NEUROIMAGE, V21, P219, DOI 10.1016/j.neuroimage.2003.09.016
   Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4
   Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228
   Papassotiropoulos A, 2005, NEUROREPORT, V16, P839, DOI 10.1097/00001756-200505310-00012
   Papassotiropoulos A, 2005, J CLIN PSYCHIAT, V66, P940, DOI 10.4088/JCP.v66n0720
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015
   Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004
   Potkin Steven G, 2009, Cogn Neuropsychiatry, V14, P391, DOI 10.1080/13546800903059829
   Prvulovic D, 2005, PSYCHIAT RES-NEUROIM, V140, P97, DOI 10.1016/j.pscychresns.2005.06.006
   Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608
   Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106
   Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102
   Reiman EM, 2007, ANN NY ACAD SCI, V1097, P94, DOI 10.1196/annals.1379.011
   Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102
   Samanez-Larkin GR, 2008, SOC COGN AFFECT NEUR, V3, P290, DOI 10.1093/scan/nsn029
   Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K
   Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006
   Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028
   Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515
   Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130
   SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195
   Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011
   Vogler C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.004.2009
   Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939
NR 69
TC 37
Z9 37
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1053-8119
EI 1095-9572
J9 NEUROIMAGE
JI Neuroimage
PD NOV 15
PY 2010
VL 53
IS 3
BP 870
EP 877
DI 10.1016/j.neuroimage.2010.01.001
PG 8
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 652VQ
UT WOS:000282039300009
PM 20060913
DA 2021-01-25
ER

PT J
AU Stepien, AE
   Tripodi, M
   Arber, S
AF Stepien, Anna E.
   Tripodi, Marco
   Arber, Silvia
TI Monosynaptic Rabies Virus Reveals Premotor Network Organization and
   Synaptic Specificity of Cholinergic Partition Cells
SO NEURON
LA English
DT Article
ID SPINAL-CORD; COMMISSURAL INTERNEURONS; HORSERADISH-PEROXIDASE;
   GENE-EXPRESSION; MOTOR-NEURONS; GROUP-I; MOTONEURONS; AFFERENTS;
   PROJECTIONS; CIRCUITS
AB Movement is the behavioral output of neuronal activity in the spinal cord. Motor neurons are grouped into motor neuron pools, the functional units innervating individual muscles. Here we establish an anatomical rabies virus-based connectivity assay in early postnatal mice. We employ it to study the connectivity scheme of premotor neurons, the neuronal cohorts monosynaptically connected to motor neurons, unveiling three aspects of organization. First, motor neuron pools are connected to segmentally widely distributed yet stereotypic interneuron populations, differing for pools innervating functionally distinct muscles. Second, depending on subpopulation identity, interneurons take on local or segmentally distributed positions. Third, cholinergic partition cells involved in the regulation of motor neuron excitability segregate into ipsilaterally and bilaterally projecting populations, the latter exhibiting preferential connections to functionally equivalent motor neuron pools bilaterally. Our study visualizes the widespread yet precise nature of the connectivity matrix for premotor interneurons and reveals exquisite synaptic specificity for bilaterally projecting cholinergic partition cells.
C1 [Stepien, Anna E.; Tripodi, Marco; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Stepien, Anna E.; Tripodi, Marco; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Tripodi, Marco/0000-0002-6827-6690; Arber, Silvia/0000-0002-6261-250X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); EUEuropean Union (EU); ERCEuropean Research Council (ERC);
   Kanton of Basel-Stadt; Novartis Research Foundation; EMBOEuropean
   Molecular Biology Organization (EMBO)
FX We are very grateful to all other members of the lab, for help and
   fruitful discussions; to Ian Wickerham, Ed Callaway, and Klaus
   Conzelmann, for helpful advice, sharing information prior to
   publication, and supplying us with an initial set of reagents; to
   Laurent Gelman, Aaron Ponti, and Patrick Schwarb, for help and advice
   with image acquisition and analysis; to Dimosthenis Gaidatzis, for help
   with statistical analysis; to Ole Kiehn, for providing
   vGlut2<SUP>Cre</SUP> mice; and to Pico Caroni, Andreas Luethi, and
   Botond Roska, for helpful comments on the manuscript and discussions.
   A.E.S., M.T., and S.A. were supported by grants from the Swiss National
   Science Foundation, EU Framework 7 program, and ERC Advanced Grant
   program; by the Kanton of Basel-Stadt; and by the Novartis Research
   Foundation. M.T. was supported by an EMBO long-term fellowship.
CR Al-Mosawie A, 2007, EUR J NEUROSCI, V26, P3003, DOI 10.1111/j.1460-9568.2007.05907.x
   Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711
   Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200
   Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   Bannatyne BA, 2009, J PHYSIOL-LONDON, V587, P379, DOI 10.1113/jphysiol.2008.159129
   Bannatyne BA, 2003, EUR J NEUROSCI, V18, P2273, DOI 10.1046/j.1460-9568.2003.02973.x
   Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016
   Burke RE, 1996, J COMP NEUROL, V372, P465
   Conradi S, 1969, Acta Physiol Scand Suppl, V333, P5
   Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009
   Dougherty KJ, 2010, J NEUROSCI, V30, P24, DOI 10.1523/JNEUROSCI.4821-09.2010
   ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794
   Ekstrand MI, 2008, TRENDS MOL MED, V14, P134, DOI 10.1016/j.molmed.2007.12.008
   Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608
   Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008
   Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   HOLSTEGE G, 1987, EXP BRAIN RES, V67, P179, DOI 10.1007/BF00269465
   HOLSTEGE JC, 1987, NEUROSCIENCE, V23, P809, DOI 10.1016/0306-4522(87)90160-6
   HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P637, DOI 10.1113/jphysiol.1971.sp009489
   JANKOWSKA E, 1986, NEUROSCI LETT, V71, P163, DOI 10.1016/0304-3940(86)90552-5
   Jankowska E, 2003, J NEUROSCI, V23, P1867
   Jankowska E, 2009, J PHYSIOL-LONDON, V587, P401, DOI 10.1113/jphysiol.2008.159236
   JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910
   Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381
   Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026
   Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5
   Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2
   Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003
   Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001
   McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006
   MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082
   Mears SC, 1997, J NEUROSCI, V17, P3128
   Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104
   Nishimaru H, 2006, J NEUROSCI, V26, P5320, DOI 10.1523/JNEUROSCI.5127-05.2006
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007
   Renshaw B, 1941, J NEUROPHYSIOL, V4, P167
   ROMANES G. J., 1964, PROGR BRAIN RES, V11, P93
   Sakmann B, 2006, PFLUG ARCH EUR J PHY, V453, P249, DOI 10.1007/s00424-006-0172-4
   Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3
   Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4
   Stepien AE, 2008, NEURON, V60, P1, DOI 10.1016/j.neuron.2008.09.030
   Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905
   THERIAULT E, 1988, J NEUROPHYSIOL, V60, P463
   THERIAULT E, 1988, J NEUROPHYSIOL, V60, P446
   Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119
   Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001
   Venables W.N., 2002, MODERN APPL STAT S, V4th edition
   von Engelhardt J, 2007, J NEUROSCI, V27, P5633, DOI 10.1523/JNEUROSCI.4647-06.2007
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wang Z, 2008, J NEUROPHYSIOL, V100, P185, DOI 10.1152/jn.90354.2008
   Wang Z, 2007, J NEUROSCI, V27, P3686, DOI 10.1523/JNEUROSCI.0197-07.2007
   Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033
   Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999
   Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248
   Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010
   WINDHORST U, 1990, PROG NEUROBIOL, V35, P135, DOI 10.1016/0301-0082(90)90020-H
   Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017
NR 61
TC 145
Z9 148
U1 0
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD NOV 4
PY 2010
VL 68
IS 3
BP 456
EP 472
DI 10.1016/j.neuron.2010.10.019
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA 680SX
UT WOS:000284255800014
PM 21040847
DA 2021-01-25
ER

PT J
AU Bruemmer, A
   Salazar, C
   Zinzalla, V
   Alberghina, L
   Hoefer, T
AF Bruemmer, Anneke
   Salazar, Carlos
   Zinzalla, Vittoria
   Alberghina, Lilia
   Hoefer, Thomas
TI Mathematical modeling of DNA replication
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Meeting Abstract
CT 14th International Biotechnology Symposium and Exhibition (IBS-2008)
CY SEP 14-18, 2010
CL Rimini, ITALY
DE mathematical model; DNA replication; cyclin-dependent kinase (CDK);
   replication origins
C1 [Bruemmer, Anneke; Salazar, Carlos; Hoefer, Thomas] German Canc Res Ctr, Heidelberg, Germany.
   [Zinzalla, Vittoria] Univ Basel, Biozentrum Basel, CH-4003 Basel, Switzerland.
   [Alberghina, Lilia] Univ Milano Bicocca, Milan, Italy.
RI Hofer, Thomas/G-5665-2013
OI Hofer, Thomas/0000-0003-3560-8780
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD NOV
PY 2010
VL 150
SU 1
BP S544
EP S544
DI 10.1016/j.jbiotec.2010.09.899
PG 1
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 741OQ
UT WOS:000288873402216
DA 2021-01-25
ER

PT J
AU Brando, C
   McCoy, ME
   Kaba, SA
   Guo, Q
   Dasgupta, D
   Golden, H
   Mittelholzer, C
   Pimentel, TA
   Yang, YK
   Burkhard, P
   Lanar, DE
AF Brando, Clara
   McCoy, Margaret E.
   Kaba, Stephen A.
   Guo, Qin
   Dasgupta, Debleena
   Golden, Hannah
   Mittelholzer, Christian
   Pimentel, Tais A.
   Yang, Yongkun
   Burkhard, Peter
   Lanar, David E.
TI POLYPEPTIDE NANOPARTICLES GENERATE CD8(+) T-CELL RESPONSES IN THE
   ABSENCE OF ADJUVANT
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Brando, Clara; McCoy, Margaret E.; Kaba, Stephen A.; Guo, Qin; Dasgupta, Debleena; Golden, Hannah; Lanar, David E.] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Mittelholzer, Christian] Univ Basel, Biozentrum, ME Muller Inst, Basel, Switzerland.
   [Lanar, David E.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.
   [Pimentel, Tais A.; Yang, Yongkun; Burkhard, Peter] Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 1175
BP 349
EP 349
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701542
DA 2021-01-25
ER

PT J
AU Wilmshurst, JM
   Lillis, S
   Zhou, H
   Pillay, K
   Henderson, H
   Kress, W
   Muller, CR
   Ndondo, A
   Cloke, V
   Cullup, T
   Bertini, E
   Boennemann, C
   Straub, V
   Quinlivan, R
   Dowling, JJ
   Al-Sarraj, S
   Treves, S
   Abbs, S
   Manzur, AY
   Sewry, CA
   Muntoni, F
   Jungbluth, H
AF Wilmshurst, J. M.
   Lillis, S.
   Zhou, H.
   Pillay, K.
   Henderson, H.
   Kress, W.
   Mueller, C. R.
   Ndondo, A.
   Cloke, V.
   Cullup, T.
   Bertini, E.
   Boennemann, C.
   Straub, V.
   Quinlivan, R.
   Dowling, J. J.
   Al-Sarraj, S.
   Treves, S.
   Abbs, S.
   Manzur, A. Y.
   Sewry, C. A.
   Muntoni, F.
   Jungbluth, H.
TI RYR1 Mutations Are a Common Cause of Congenital Myopathies with Central
   Nuclei
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID LINKED MYOTUBULAR MYOPATHY; RYANODINE RECEPTOR RYR1; CENTRAL CORE
   DISEASE; MALIGNANT HYPERTHERMIA; CENTRONUCLEAR MYOPATHY; AMPHIPHYSIN-2
   BIN1; MUSCLE; FIBERS; FAMILY; DYNAMIN-2
AB Objective: Centronuclear myopathy (CNM) is a rare congenital myopathy characterized by prominence of central nuclei on muscle biopsy. CNM has been associated with mutations in MTM1, DNM2, and BIN1 but many cases remain genetically unresolved. RYR1 encodes the principal sarcoplasmic reticulum calcium release channel and has been implicated in various congenital myopathies. We investigated whether RYR1 mutations cause CNM.
   Methods: We sequenced the entire RYR1 coding sequence in 24 patients with a diagnosis of CNM from South Africa (n = 14) and Europe (n = 10) and identified mutations in 17 patients. The most common genotypes featured compound heterozygosity for RYR1 missense mutations and mutations resulting in reduced protein expression, including intronic splice site and frameshift mutations.
   Results: The high incidence in South African patients (n = 12/14) in conjunction with recurrent RYR1 mutations associated with common haplotypes suggested the presence of founder effects. In addition to central nuclei, prominent histopathological findings included (often multiple) internalized nuclei and type 1 fiber predominance and hypotrophy with relative type 2 hypertrophy. Although cores were not typically seen on oxidative stains, electron microscopy revealed subtle abnormalities in most cases. External ophthalmoplegia, proximal weakness, and bulbar involvement were prominent clinical findings.
   Interpretation: Our findings expand the range of RYR1-related phenotypes and suggest RYR1 mutations as a common cause of congenital myopathies with central nuclei. Corresponding to recent observations in X-linked CNM, these findings indicate disturbed assembly and/or malfunction of the excitation-contraction machinery as a key mechanism in CNM and related myopathies. ANN NEUROL 2010;68:717-726
C1 [Jungbluth, H.] Kings Coll London, IOP, Dept Clin Neurosci, Clin Neurosci Div, London SE1 7EH, England.
   [Wilmshurst, J. M.; Ndondo, A.] Univ Cape Town, Red Cross Childrens Hosp, Sch Child & Adolescent Hlth, Dept Paediat Neurol, ZA-7925 Cape Town, South Africa.
   [Lillis, S.; Cloke, V.; Cullup, T.; Abbs, S.] Guys Hosp, GSTS Pathol, Diagnost Genet Lab, London SE1 9RT, England.
   [Zhou, H.; Manzur, A. Y.; Sewry, C. A.; Muntoni, F.] Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.
   [Pillay, K.] Univ Cape Town, Red Cross Childrens Hosp, Sch Child & Adolescent Hlth, Dept Paediat Pathol, ZA-7925 Cape Town, South Africa.
   [Henderson, H.] Univ Cape Town, Dept Mol Genet, ZA-7925 Cape Town, South Africa.
   [Kress, W.; Mueller, C. R.] Univ Wurzburg, Inst Human Genet, Biozentrum, Wurzburg, Germany.
   [Bertini, E.] Bambino Gesu Pediat Hosp, Mol Med Unit, Rome, Italy.
   [Boennemann, C.] Childrens Hosp Philadelphia, Dept Paediat Neurol, Philadelphia, PA 19104 USA.
   [Straub, V.] Newcastle Univ, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Quinlivan, R.; Sewry, C. A.] Robert Jones & Agnes Hunt Orthopaed Hosp, Ctr Inherited Neuromuscular Disorders, Oswestry SY10 7AG, Shrops, England.
   [Dowling, J. J.] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA.
   [Al-Sarraj, S.] Kings Coll Hosp London, Dept Clin Neuropathol, London, England.
   [Treves, S.] Univ Basel Hosp, Dept Anaesthesia, CH-4031 Basel, Switzerland.
   [Treves, S.] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.
   [Jungbluth, H.] St Thomas Hosp, Evelina Childrens Hosp, Neuromuscular Serv, Dept Paediat Neurol, London, England.
RP Jungbluth, H (corresponding author), Kings Coll London, IOP, Dept Clin Neurosci, Clin Neurosci Div, Lambeth Palace Rd, London SE1 7EH, England.
EM Heinz.Jungbluth@gstt.nhs.uk
RI pillay, komala/AAB-1964-2019; Jungbluth, Heinz/B-8893-2012; Bertini,
   Enrico/ABG-1278-2020; Bertini, Enrico/A-2284-2014
OI pillay, komala/0000-0003-1971-900X; Bertini, Enrico/0000-0001-9276-4590;
   Wilmshurst, Jo/0000-0001-7328-1796; Jungbluth,
   Heinz/0000-0002-7159-3427; Straub, Volker/0000-0001-9046-3540
FU Guy's and St Thomas' Charitable Foundation [070404]; Muscular Dystrophy
   Association (MDA), USAMuscular Dystrophy Association [68762]; National
   Commissioning Group (NCG) of the United Kingdom; Medical Research
   CouncilMedical Research Council UK (MRC) [G0601943] Funding Source:
   researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND
   SKIN DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Arthritis &
   Musculoskeletal & Skin Diseases (NIAMS) [K08AR054835, K08AR054835,
   K08AR054835, K08AR054835, K08AR054835] Funding Source: NIH RePORTER
FX Part of this work was supported by a grant from the Guy's and St Thomas'
   Charitable Foundation to H.J. (Grant number 070404) and of the Muscular
   Dystrophy Association (MDA) of the USA to EM. (Grant number 68762).
   Supported also by the National Commissioning Group (NCG) of the United
   Kingdom to the Dubowitz Neuromuscular Centre and Guy's Hospital.
CR Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106
   Bevilacqua JA, 2009, ACTA NEUROPATHOL, V117, P283, DOI 10.1007/s00401-008-0472-1
   Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657
   Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235
   Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399
   Buj-Bello A, 2008, HUM MOL GENET, V17, P2132, DOI 10.1093/hmg/ddn112
   Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355
   Clarke NF, 2003, J NEUROPATH EXP NEUR, V62, P977, DOI 10.1093/jnen/62.10.977
   Clarke NF, 2008, ANN NEUROL, V63, P329, DOI 10.1002/ana.21308
   Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372
   Dubowitz V., 2007, MUSCLE BIOPSY PRACTI
   Goldman A, 2001, CLIN GENET, V59, P37, DOI 10.1034/j.1399-0004.2001.590106.x
   Henderson Howard, 2002, BMC Pediatr, V2, P7, DOI 10.1186/1471-2431-2-7
   ISAACS H, 1975, J NEUROL NEUROSUR PS, V38, P1177, DOI 10.1136/jnnp.38.12.1177
   ISAACS H, 1975, S AFR MED J, V49, P1923
   ISAACS H, 1992, MUSCLE NERVE, V15, P740, DOI 10.1002/mus.880150619
   ISAACS H, 1980, S AFR MED J, V57, P543
   ISAACS H, 1991, S AFR MED J, V80, P247
   Jeannet PY, 2004, NEUROLOGY, V62, P1484, DOI 10.1212/01.WNL.0000124388.67003.56
   Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2
   Jungbluth H, 2003, NEUROMUSCULAR DISORD, V13, P55, DOI 10.1016/S0960-8966(02)00194-3
   Jungbluth H, 2007, NEUROMUSCULAR DISORD, V17, P338, DOI 10.1016/j.nmd.2007.01.016
   Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26
   Laing NG, 2004, ANN NEUROL, V56, P689, DOI 10.1002/ana.20260
   Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273
   Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175
   Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362
   Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121
   Monnier N, 2008, HUM MUTAT, V29, P670, DOI 10.1002/humu.20696
   Monnier N, 2009, NEUROMUSCULAR DISORD, V19, P680, DOI 10.1016/j.nmd.2009.07.007
   Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086
   Quinlivan RM, 2003, ARCH DIS CHILD, V88, P1051, DOI 10.1136/adc.88.12.1051
   QUINN RD, 1992, ANN THORAC SURG, V53, P1114, DOI 10.1016/0003-4975(92)90403-Q
   Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801
   Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356
   Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014
   Schara U, 2003, NEUROLOGY, V60, P1363, DOI 10.1212/01.WNL.0000058763.90924.FA
   Schessl J, 2007, NEUROMUSCULAR DISORD, V17, P28, DOI 10.1016/j.nmd.2006.09.013
   Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884
   SPIRO AJ, 1966, ARCH NEUROL-CHICAGO, V14, P1, DOI 10.1001/archneur.1966.00470070005001
   Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008
   Zhou H, 2007, BRAIN, V130, P2024, DOI 10.1093/brain/awm096
   Zhou HY, 2006, AM J HUM GENET, V79, P859, DOI 10.1086/508500
   Zhou HY, 2010, NEUROMUSCULAR DISORD, V20, P166, DOI 10.1016/j.nmd.2009.12.005
NR 44
TC 157
Z9 160
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD NOV
PY 2010
VL 68
IS 5
BP 717
EP 726
DI 10.1002/ana.22119
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 675HR
UT WOS:000283819000019
PM 20839240
OA Green Published
DA 2021-01-25
ER

PT J
AU Al-Kaddah, S
   Reder-Christ, K
   Klocek, G
   Wiedemann, I
   Brunschweiger, M
   Bendas, G
AF Al-Kaddah, Saad
   Reder-Christ, Katrin
   Klocek, Gabriela
   Wiedemann, Imke
   Brunschweiger, Manuela
   Bendas, Gerc
TI Analysis of membrane interactions of antibiotic peptides using ITC and
   biosensor measurements
SO BIOPHYSICAL CHEMISTRY
LA English
DT Article
DE Antibiotics; Gallidermin; Isothermal titration calorimetry (ITC); Lipid
   II; Surface acoustic wave (SAW) biosensor; Vancomycin
ID LIPID-II; CELL-WALL; PEPTIDOGLYCAN BIOSYNTHESIS; ANTIMICROBIAL PEPTIDES;
   TITRATION CALORIMETRY; PORE FORMATION; NISIN; BINDING; VANCOMYCIN; MODE
AB The interaction of the lantibiotic gallidermin and the glycopeptide antibiotic vancomycin with bacterial membranes was simulated using mass sensitive biosensors and isothermal titration calorimetry (ITC). Both peptides interfere with cell wall biosynthesis by targeting the cell wall precursor lipid II, but differ clearly in their antibiotic activity against individual bacterial strains. We determined the binding affinities of vancomycin and gallidermin to model membranes +/- lipid II in detail. Both peptides bind to DOPC/lipid II membranes with high affinity (K-D 0.30 mu M and 0.27 mu M). Gallidermin displayed also strong affinity to pure DOPC membranes (0.53 mu M)an effect that was supported by ITC measurements. A surface acoustic wave (SAW) sensor allowed measurements in the picomolar concentration range and revealed that gallidermin targets lipid II at an equimolar ratio and simultaneously inserts into the bilayer. These results indicate that gallidermin, in contrast to vancomycin, combines cell wall inhibition and interference with the bacterial membrane integrity for potent antimicrobial activity. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Al-Kaddah, Saad; Reder-Christ, Katrin; Brunschweiger, Manuela; Bendas, Gerc] Univ Bonn, Dept Pharm, D-53121 Bonn, Germany.
   [Klocek, Gabriela] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   [Wiedemann, Imke] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Unit, D-53115 Bonn, Germany.
RP Bendas, G (corresponding author), Univ Bonn, Dept Pharm, Immenburg 4, D-53121 Bonn, Germany.
EM gbendas@uni-bonn.de
OI Quebatte, Gabriela/0000-0002-2530-5527
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [BE2242/2-1, FOR 854, GRK 677]
FX This work was supported by the Deutsche Forschungsgemeinschaft,
   BE2242/2-1, FOR 854, and GRK 677. The authors are thankful to Prof.
   Joachim Seelig for helpful discussions concerning the ITC data, Dr.
   Thomas Gronewold for help in interpretation of the SAW data, and Prof.
   Hans-Georg Sahl for providing the lipid II. We thank H. Falkenstein-Paul
   for excellent technical assistance, and M. Josten for mass determination
   of the peptides.
CR AMES BN, 1960, J BIOL CHEM, V235, P769
   Andra J, 2008, LANGMUIR, V24, P9148, DOI 10.1021/la801252t
   Arnusch CJ, 2007, BIOCHEMISTRY-US, V46, P13437, DOI 10.1021/bi7015553
   BEAUREGARD DA, 1995, ANTIMICROB AGENTS CH, V39, P781, DOI 10.1128/AAC.39.3.781
   Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8
   Bottiger T, 2009, APPL ENVIRON MICROB, V75, P4427, DOI 10.1128/AEM.00262-09
   Bonelli RR, 2006, ANTIMICROB AGENTS CH, V50, P1449, DOI 10.1128/AAC.50.4.1449-1457.2006
   Breukink E, 2000, BIOCHEMISTRY-US, V39, P10247, DOI 10.1021/bi000915q
   Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200
   Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004
   Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x
   Brotz H, 1997, EUR J BIOCHEM, V246, P193, DOI 10.1111/j.1432-1033.1997.t01-1-00193.x
   CHATTERJEE AN, 1966, BIOCHEM BIOPH RES CO, V24, P489, DOI 10.1016/0006-291X(66)90188-4
   Christ K, 2005, PHOTOCHEM PHOTOBIOL, V81, P1417, DOI 10.1562/2005-04-19-RA-493
   Christ K, 2007, BBA-BIOMEMBRANES, V1768, P694, DOI 10.1016/j.bbamem.2006.12.003
   Christ K, 2008, J MEMBRANE BIOL, V226, P9, DOI 10.1007/s00232-008-9134-4
   Cooper A, 1998, METH MOL B, V88, P11
   Domenech O, 2009, BBA-BIOMEMBRANES, V1788, P1832, DOI 10.1016/j.bbamem.2009.05.003
   Ghalit N, 2007, CHEMBIOCHEM, V8, P1540, DOI 10.1002/cbic.200700244
   Gilbert Y, 2007, NANO LETT, V7, P796, DOI 10.1021/nl0700853
   Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b
   Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818
   Holdgate GA, 2001, BIOTECHNIQUES, V31, P164
   Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830
   KELLNER R, 1988, EUR J BIOCHEM, V177, P53, DOI 10.1111/j.1432-1033.1988.tb14344.x
   Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576
   Martinez B, 2008, APPL ENVIRON MICROB, V74, P4666, DOI 10.1128/AEM.00092-08
   Rekharsky M, 2006, J AM CHEM SOC, V128, P7736, DOI 10.1021/ja061828+
   Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k
   RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841
   Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   SHELDRICK GM, 1978, NATURE, V271, P223, DOI 10.1038/271223a0
   van Heusden HE, 2002, BIOCHEMISTRY-US, V41, P12171, DOI 10.1021/bi026090x
   Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n
   Wiedemann I, 2006, APPL ENVIRON MICROB, V72, P2809, DOI 10.1128/AEM.72.4.2809-2814.2006
   WILLIAMSON P, 1983, BIOCHIM BIOPHYS ACTA, V732, P387, DOI 10.1016/0005-2736(83)90055-X
   Wong KK, 1998, ADV EXP MED BIOL, V456, P197
NR 39
TC 18
Z9 18
U1 1
U2 33
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0301-4622
EI 1873-4200
J9 BIOPHYS CHEM
JI Biophys. Chem.
PD NOV
PY 2010
VL 152
IS 1-3
BP 145
EP 152
DI 10.1016/j.bpc.2010.09.002
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA 684RS
UT WOS:000284567600017
PM 20934241
DA 2021-01-25
ER

PT J
AU Sen, S
   Hartmann, B
   Reichert, H
   Rodrigues, V
AF Sen, Sonia
   Hartmann, Beate
   Reichert, Heinrich
   Rodrigues, Veronica
TI Expression and function of the empty spiracles gene in olfactory sense
   organ development of Drosophila melanogaster
SO DEVELOPMENT
LA English
DT Article
DE Olfactory sense organs; empty spiracles; amos; lozenge; Axonal targeting
ID NERVE CORD DEVELOPMENT; BRAIN-DEVELOPMENT; HOMEOBOX GENES; TRANSCRIPTION
   FACTOR; WIRING SPECIFICITY; RECEPTOR NEURONS; HEAD DEVELOPMENT; EMX2
   COOPERATE; ANTENNAL LOBE; MOUSE-BRAIN
AB In Drosophila, the cephalic gap gene empty spiracles plays key roles in embryonic patterning of the peripheral and central nervous system. During postembryonic development, it is involved in the development of central olfactory circuitry in the antennal lobe of the adult. However, its possible role in the postembryonic development of peripheral olfactory sense organs has not been investigated. Here, we show that empty spiracles acts in a subset of precursors that generate the olfactory sense organs of the adult antenna. All empty spiracles-expressing precursor cells co-express the proneural gene amos and the early patterning gene lozenge. Moreover, the expression of empty spiracles in these precursor cells is dependent on both amos and lozenge. Functional analysis reveals two distinct roles of empty spiracles in the development of olfactory sense organs. Genetic interaction studies in a lozenge-sensitized background uncover a requirement of empty spiracles in the formation of trichoid and basiconic olfactory sensilla. MARCM-based clonal mutant analysis reveals an additional role during axonal targeting of olfactory sensory neurons to glomeruli within the antennal lobe. Our findings on empty spiracles action in olfactory sense organ development complement previous studies that demonstrate its requirement in olfactory interneurons and, taken together with studies on the murine homologs of empty spiracles, suggest that conserved molecular genetic programs might be responsible for the formation of both peripheral and central olfactory circuitry in insects and mammals.
C1 [Hartmann, Beate; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Sen, Sonia; Rodrigues, Veronica] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch; veronica@ncbs.res.in
RI Sen, Sonia/H-6681-2019
OI Sen, Sonia/0000-0003-4693-3378
FU EMBOEuropean Molecular Biology Organization (EMBO)
FX This work was supported by grants from TIFR, SNSF and the Indo-Swiss
   Joint Research Program. We are grateful to Hugo Bellen, Andrew Jarman
   and Uwe Walldorf; the Bloomington Drosophila Stock Centre DSHB for fly
   stocks and reagents; and K. VijayRaghavan, Abhijit Das and Ajeet Pratap
   Singh for many useful discussions and comments on the manuscript. We
   thank the Department of Science and Technology, Government of India
   (Centre for Nanotechnology No. SR/S5/NM-36/2005) for the Olympus FV1000
   confocal microscopes in the Central Imaging and Flow Cytometry Facility
   (CIFF) and NOMIC, NCBS. We acknowledge Tripti Gupta, Melanie Gentner,
   Mario Metzler, Susanne Flister and Bruno Bello for technical help. S.S.
   was funded by a short term fellowship from EMBO.
CR Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356
   AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154
   Bai L, 2009, J NEUROSCI, V29, P12940, DOI 10.1523/JNEUROSCI.3525-09.2009
   Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550
   Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8
   Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0
   COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0
   DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940
   Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33
   Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066
   Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7
   Gupta BP, 1998, DEV BIOL, V203, P400, DOI 10.1006/dbio.1998.9064
   Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006
   Hartmann B, 2000, MECH DEVELOP, V90, P143, DOI 10.1016/S0925-4773(99)00237-3
   HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302
   Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8
   Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2
   Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002
   Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083
   Jhaveri D, 2002, DEVELOPMENT, V129, P1251
   JRGENS G, 1984, DEV GENES EVOL, V193, P283
   Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284
   Komiyama T, 2006, CURR OPIN NEUROBIOL, V16, P67, DOI 10.1016/j.conb.2005.12.002
   Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028
   Lage PIZ, 2003, DEVELOPMENT, V130, P4683, DOI 10.1242/dev.00680
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lichtneckert R, 2008, DEVELOPMENT, V135, P2415, DOI 10.1242/dev.022210
   Lichtneckert R, 2008, ADV EXP MED BIOL, V628, P32, DOI 10.1007/978-0-387-78261-4_2
   Lichtneckert R, 2007, DEVELOPMENT, V134, P1291, DOI 10.1242/dev.02814
   Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5
   Matsuo I, 1997, COLD SPRING HARB SYM, V62, P545
   McIntyre JC, 2008, CHEM SENSES, V33, P825, DOI 10.1093/chemse/bjn061
   Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135
   Nedelec S, 2004, P NATL ACAD SCI USA, V101, P10815, DOI 10.1073/pnas.0403824101
   Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4
   RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0
   Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6
   Sakurai M, 2009, J NEUROSCI, V29, P4972, DOI 10.1523/JNEUROSCI.2821-08.2009
   SCHMIDTOTT U, 1994, P NATL ACAD SCI USA, V91, P8363, DOI 10.1073/pnas.91.18.8363
   Shanbhag SR, 2000, ARTHROPOD STRUCT DEV, V29, P211, DOI 10.1016/S1467-8039(00)00028-1
   Shinozaki K, 2004, MECH DEVELOP, V121, P475, DOI 10.1016/j.mod.2004.03.013
   Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916
   SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x
   SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Stocker RF, 2008, ADV EXP MED BIOL, V628, P69, DOI 10.1007/978-0-387-78261-4_5
   Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022
   Tichy AL, 2008, J NEUROSCI, V28, P7121, DOI 10.1523/JNEUROSCI.2063-08.2008
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336
   Yao Y, 2007, NAT NEUROSCI, V10, P1423, DOI 10.1038/nn1993
   YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475
NR 55
TC 8
Z9 9
U1 0
U2 10
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD NOV 1
PY 2010
VL 137
IS 21
BP 3687
EP 3695
DI 10.1242/dev.052407
PG 9
WC Developmental Biology
SC Developmental Biology
GA 673ND
UT WOS:000283669300016
PM 20940227
OA Bronze
DA 2021-01-25
ER

PT J
AU Summers, KM
   Raza, S
   van Nimwegen, E
   Freeman, TC
   Hume, DA
AF Summers, Kim M.
   Raza, Sobia
   van Nimwegen, Erik
   Freeman, Thomas C.
   Hume, David A.
TI Co-expression of FBN1 with mesenchyme-specific genes in mouse cell
   lines: implications for phenotypic variability in Marfan syndrome
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE Fibrillin-1; Marfan syndrome; mesenchyme; connective tissue;
   extracellular matrix
ID TRANSCRIPTION FACTORS; CONNECTIVE-TISSUE; TIGHT-SKIN; EXPRESSION;
   GROWTH; FAMILY; FIBRILLIN-1; MUTATION; DIFFERENTIATION; IDENTIFICATION
AB Mutations in the human FBN1 gene cause Marfan syndrome, a complex disease affecting connective tissues but with a highly variable phenotype. To identify genes that might participate in epistatic interactions with FBN1, and could therefore explain the observed phenotypic variability, we have looked for genes that are co-expressed with Fbn1 in the mouse. Microarray expression data derived from a range of primary mouse cells and cell lines were analysed using the network analysis tool BioLayout Express(3D). A cluster of 205 genes, including Fbn1, were selectively expressed by mouse cell lines of different mesenchymal lineages and by mouse primary mesenchymal cells (preadipocytes, myoblasts, fibroblasts, osteoblasts). Promoter analysis of this gene set identified several candidate transcriptional regulators. Genes within this co-expressed cluster are candidate genetic modifiers for Marfan syndrome and for other connective tissue diseases. European Journal of Human Genetics (2010) 18, 1209-1215; doi: 10.1038/ejhg.2010.91; published online 16 June 2010
C1 [Summers, Kim M.; Raza, Sobia; Freeman, Thomas C.; Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.
   [van Nimwegen, Erik] Univ Basel, Div Bioinformat, Biozentrum, Basel, Switzerland.
RP Summers, KM (corresponding author), Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.
EM kim.summers@roslin.ed.ac.uk
RI Hume, David A/C-7695-2013; Summers, Kim M/M-4086-2015
OI Summers, Kim M/0000-0002-7084-4386; Freeman, Thomas/0000-0001-5235-8483;
   Hume, David/0000-0002-2615-1478; van Nimwegen, Erik/0000-0001-6338-1312
FU National Heart Foundation of AustraliaNational Heart Foundation of
   Australia [G06B2527]; Biotechnology and Biological Sciences Council of
   the United Kingdom; Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/I001107/1] Funding Source: researchfish; Medical Research
   CouncilMedical Research Council UK (MRC) [G9900991B] Funding Source:
   researchfish
FX This work was supported by a grant-in-aid from the National Heart
   Foundation of Australia (G06B2527) and by the Biotechnology and
   Biological Sciences Council of the United Kingdom (Institutional
   Strategic Programme Grant to The Roslin Institute).
CR Ahmed S, 2007, CELLS TISSUES ORGANS, V185, P131, DOI 10.1159/000101314
   Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280
   Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200
   Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167
   Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034
   Chrousos GP, 2005, J CLIN INVEST, V115, P844, DOI 10.1172/JCI200524886
   DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R
   Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068
   DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766
   DONGEN SV, 2000, THESIS U UTRECHT UTR
   Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695
   Ezzat S, 2005, MOL ENDOCRINOL, V19, P1004, DOI 10.1210/me.2004-0432
   Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206
   GREEN MC, 1976, AM J PATHOL, V82, P493
   Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345
   Hayata T, 2008, BIOCHEM BIOPH RES CO, V368, P205, DOI 10.1016/j.bbrc.2008.01.040
   Himeda CL, 2008, MOL CELL BIOL, V28, P6521, DOI 10.1128/MCB.00306-08
   Hume DA, 2010, GENOMICS, V95, P328, DOI 10.1016/j.ygeno.2010.03.002
   James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084
   Jordan C. D., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P366
   Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641
   Kaneko KJ, 1998, DEV GENET, V22, P43, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;43::AID-DVG5&gt;3.0.CO;2-7
   Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5
   Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006
   Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434
   Mercado-Pimentel ME, 2007, CELLS TISSUES ORGANS, V185, P146, DOI 10.1159/000101315
   Nataatmadja M, 2006, CIRCULATION, V114, pI371, DOI 10.1161/CIRCULATIONAHA.105.000927
   PENG L, 2008, STEM CELLS DEV
   Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481
   Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006
   Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669
   Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6
   Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127
   Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009
   Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300
   Song J, 1999, EUR J BIOCHEM, V259, P676, DOI 10.1046/j.1432-1327.1999.00081.x
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Summers KM, 2006, MED J AUSTRALIA, V184, P627, DOI 10.5694/j.1326-5377.2006.tb00419.x
   Summers KM, 2009, GENOMICS, V94, P233, DOI 10.1016/j.ygeno.2009.06.005
   Summers KM, 2004, CLIN GENET, V65, P66, DOI 10.1111/j..2004.00186.x
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Thunyakitpisal P, 2001, J BONE MINER RES, V16, P10, DOI 10.1359/jbmr.2001.16.1.10
   Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111
   Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5
   Xu TS, 1998, NAT GENET, V20, P78
   Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011
NR 50
TC 22
Z9 22
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD NOV
PY 2010
VL 18
IS 11
BP 1209
EP 1215
DI 10.1038/ejhg.2010.91
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 668ZE
UT WOS:000283314700008
PM 20551991
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Avalos, J
   Estrada, AF
AF Avalos, Javier
   Estrada, Alejandro F.
TI Regulation by light in Fusarium
SO FUNGAL GENETICS AND BIOLOGY
LA English
DT Review
DE Fusarium; Gibberella; Secondary metabolism; Carotenoids; Sporulation;
   Photoreceptors; White Collar; Opsins
ID DEPENDENT CAROTENOID SYNTHESIS; GIBBERELLIN BIOSYNTHETIC-PATHWAY;
   BLUE-LIGHT; NEUROSPORA-CRASSA; SYNTHASE GENE; ALPHA-TOMATINE; WHITE
   COLLAR-1; ALBINO-3 GENE; FUJIKUROI; PROTEIN
AB The genus Fusarium stands out as research model for pathogenesis and secondary metabolism. Light stimulates the production of some Fusarium metabolites, such as the carotenoids, and in many species it influences the production of asexual spores and sexual fruiting bodies. As found in other fungi with well-known photoresponses, the Fusarium genomes contain several genes for photoreceptors, among them a set of White Collar (WC) proteins, a cryptochrome, a photolyase, a phytochrome and two presumably photoactive opsins. The mutation of the opsin genes produced no apparent phenotypic alterations, but the loss of the only WC-1 orthologous protein eliminated the photoinduced expression of the photolyase and opsin genes. In contrast to other carotenogenic species, lack of the WC photoreceptor did not impede the light-induced accumulation of carotenoids, but produced alterations in conidiation, animal pathogenicity and nitrogen-regulated secondary metabolism. The regulation and functional role of other Fusarium photoreceptors is currently under investigation. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Avalos, Javier] Univ Seville, Dept Genet, Fac Biol, E-41080 Seville, Spain.
   [Estrada, Alejandro F.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Avalos, J (corresponding author), Univ Seville, Dept Genet, Fac Biol, Apartado 1095, E-41080 Seville, Spain.
EM avalos@us.es
RI Avalos, Javier/B-4218-2011
OI Avalos, Javier/0000-0001-5484-2893
FU Spanish GovernmentSpanish Government [BIO2006-01323, BIO2009-11131];
   Junta de AndaluciaJunta de Andalucia [P07-CVI-02813]
FX We thank the Spanish Government (projects BIO2006-01323 and
   BIO2009-11131) and Junta de Andalucia (project P07-CVI-02813) for their
   financial support during the preparation of this review. We are grateful
   to Julie Weidner for grammar revision.
CR AASEN AJ, 1965, ACTA CHEM SCAND, V19, P1843, DOI 10.3891/acta.chem.scand.19-1843
   Alejandre-Duran E, 2003, FUNGAL GENET BIOL, V40, P159, DOI 10.1016/S1087-1845(03)00089-6
   ALEJANDREDURAN E, 2002, RECENT RES DEV DNA R, P1
   AUDHYA TK, 1974, J GEN MICROBIOL, V82, P181, DOI 10.1099/00221287-82-1-181
   Avalos J, 2007, CURR ORG CHEM, V11, P721, DOI 10.2174/138527207780598729
   AVALOS J, 1985, APPL ENVIRON MICROB, V49, P187, DOI 10.1128/AEM.49.1.187-191.1985
   Avalos J., 2004, Handbook of fungal biotechnology, P367
   AVALOS J, 1990, FEMS MICROBIOL LETT, V66, P295
   Avalos J., 1987, CURR GENET, V25, P1837
   BAIMA S, 1991, J PHOTOCH PHOTOBIO B, V11, P107, DOI 10.1016/1011-1344(91)80253-E
   BAIMA S, 1992, J PHOTOCH PHOTOBIO B, V15, P233, DOI 10.1016/1011-1344(92)85127-G
   Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x
   Berrocal-Tito G, 1999, J BIOL CHEM, V274, P14288, DOI 10.1074/jbc.274.20.14288
   Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034
   Bieszke JA, 1999, BIOCHEMISTRY-US, V38, P14138, DOI 10.1021/bi9916170
   Bomke C, 2009, PHYTOCHEMISTRY, V70, P1876, DOI 10.1016/j.phytochem.2009.05.020
   Brown DW, 2004, FUNGAL GENET BIOL, V41, P454, DOI 10.1016/j.fgb.2003.12.002
   Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g
   Brown LS, 2001, J BIOL CHEM, V276, P32495, DOI 10.1074/jbc.M102652200
   Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014
   CANDAU R, 1991, APPL ENVIRON MICROB, V57, P3378, DOI 10.1128/AEM.57.11.3378-3382.1991
   CARLILE MJ, 1956, J GEN MICROBIOL, V14, P643, DOI 10.1099/00221287-14-3-643
   Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0
   CHAUDHARY SK, 1975, J PHYTOPATHOL, V82, P287
   Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k
   DAS J, 1990, International Journal of Developmental Biology, V34, P319
   Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024
   Desjardins A.E., 2006, FUSARIUM MYCOTOXINS
   Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]
   Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116
   Estrada AF, 2008, MOL MICROBIOL, V69, P1207, DOI 10.1111/j.1365-2958.2008.06349.x
   Estrada AF, 2008, FUNGAL GENET BIOL, V45, P705, DOI 10.1016/j.fgb.2007.12.003
   Estrada AF, 2009, J MOL BIOL, V387, P59, DOI 10.1016/j.jmb.2009.01.057
   Estrada AF, 2008, FUNGAL GENET BIOL, V45, P1497, DOI 10.1016/j.fgb.2008.09.001
   Fernandez-Martin R, 2000, MOL GEN GENET, V263, P838, DOI 10.1007/s004380000249
   Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005
   GRIFFIN GJ, 1976, CAN J MICROBIOL, V22, P1381, DOI 10.1139/m76-202
   Harter LL, 1939, AM J BOT, V26, P234, DOI 10.2307/2436496
   He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795
   Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2
   Herrera-Estrella A, 2007, MOL MICROBIOL, V64, P5, DOI 10.1111/j.1365-2958.2007.05632.x
   Homann V, 1996, CURR GENET, V30, P232, DOI 10.1007/s002940050126
   HUANG J-W, 1983, Annals of the Phytopathological Society of Japan, V49, P704, DOI 10.3186/jjphytopath.49.704
   Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103
   Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095
   Ito S, 2007, FEBS LETT, V581, P3217, DOI 10.1016/j.febslet.2007.06.010
   Jestoi M, 2008, CRIT REV FOOD SCI, V48, P21, DOI 10.1080/10408390601062021
   JOHNSON SW, 1990, PLANT PHYSIOL, V94, P1696, DOI 10.1104/pp.94.4.1696
   Kershaw MJ, 1998, FUNGAL GENET BIOL, V23, P18, DOI 10.1006/fgbi.1997.1022
   LANGFEULNER J, 1975, PHOTOCHEM PHOTOBIOL, V21, P179, DOI 10.1111/j.1751-1097.1975.tb06649.x
   LAUTER FR, 1991, NUCLEIC ACIDS RES, V19, P6883, DOI 10.1093/nar/19.24.6883
   LEACH CHARLES M., 1962, CANADIAN JOUR BOT, V40, P151, DOI 10.1139/b62-016
   LEACH CM, 1972, ANN APPL BIOL, V72, P155, DOI 10.1111/j.1744-7348.1972.tb01280.x
   Leslie J.F., 2006, FUSARIUM LAB MANUAL
   Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x
   Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98
   Linden H, 2002, MYCOLOGY S, V15, P165
   Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7
   Linnemannstons P, 2002, MOL GENET GENOMICS, V267, P593, DOI 10.1007/s00438-002-0690-5
   Mende K, 1997, MOL GEN GENET, V255, P96, DOI 10.1007/s004380050477
   MERTZ D, 1970, PLANT CELL PHYSIOL, V11, P273, DOI 10.1093/oxfordjournals.pcp.a074508
   MERTZ D, 1967, NATURE, V214, P844, DOI 10.1038/214844a0
   Mihlan M, 2003, MOL MICROBIOL, V47, P975, DOI 10.1046/j.1365-2958.2003.03326.x
   MITANI H, 1995, PHOTOCHEM PHOTOBIOL, V61, P373, DOI 10.1111/j.1751-1097.1995.tb08625.x
   NELSON MA, 1989, MOL CELL BIOL, V9, P1271, DOI 10.1128/MCB.9.3.1271
   O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407
   Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004
   Prado MM, 2004, CURR GENET, V46, P47, DOI 10.1007/s00294-004-0508-6
   Prado-Cabrero A, 2007, MOL MICROBIOL, V64, P448, DOI 10.1111/j.1365-2958.2007.05665.x
   Prado-Cabrero A, 2009, FEBS J, V276, P4582, DOI 10.1111/j.1742-4658.2009.07164.x
   Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X
   Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061
   Ramisey CB, 1930, BOT GAZ, V89, P113
   RAU W, 1967, PLANTA, V72, P14
   RAU W, 1969, PLANTA, V84, P30
   RAU W, 1967, BIOCHIM BIOPHYS ACTA, V136, P589, DOI 10.1016/0304-4165(67)90026-8
   RAU W, 1980, BLUE LIGHT SYNDROME, P283
   Rodriguez-Ortiz R, 2009, APPL ENVIRON MICROB, V75, P405, DOI 10.1128/AEM.01089-08
   Rodriguez-Romero J, 2004, CURR GENET, V46, P295, DOI 10.1007/s00294-004-0534-4
   Ruiz-Roldan MC, 2008, EUKARYOT CELL, V7, P1227, DOI 10.1128/EC.00072-08
   Saelices L, 2007, MOL GENET GENOMICS, V278, P527, DOI 10.1007/s00438-007-0269-2
   SALICHOS L, 2009, DIVERSITY EVOLUTION
   Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348
   Sandmann G, 2002, MYCOTA, V10, P247
   SCHMIDHAUSER TJ, 1994, J BIOL CHEM, V269, P12060
   SCHMIDHAUSER TJ, 1990, MOL CELL BIOL, V10, P5064, DOI 10.1128/MCB.10.10.5064
   SCHROTT EL, 1982, PHOTOCHEM PHOTOBIOL, V35, P213, DOI 10.1111/j.1751-1097.1982.tb03834.x
   SCHROTT EL, 1980, PLANTA, V150, P174, DOI 10.1007/BF00582363
   Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006
   Silva F, 2006, MOL MICROBIOL, V61, P1023, DOI 10.1111/j.1365-2958.2006.05291.x
   SNYDER W. C, 1941, MYCOLOGIA, V33, P580, DOI 10.2307/3754775
   Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005
   THEIMER RR, 1972, PLANTA, V106, P331, DOI 10.1007/BF00384770
   THEIMER RR, 1969, BIOCHIM BIOPHYS ACTA, V177, P180, DOI 10.1016/0304-4165(69)90087-7
   THEIMER RR, 1970, PLANTA, V92, P129, DOI 10.1007/BF00385205
   Thewes S, 2005, MOL GENET GENOMICS, V274, P217, DOI 10.1007/s00438-005-0015-6
   Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794
   TSCHANZ AT, 1976, MYCOLOGIA, V68, P327, DOI 10.2307/3759003
   Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1
   Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950
   Tudzynski B, 1998, FUNGAL GENET BIOL, V25, P157, DOI 10.1006/fgbi.1998.1095
   Velayos A, 2003, CURR GENET, V43, P112, DOI 10.1007/s00294-003-0376-5
   Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x
   YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x
   ZACHARIAH AT, 1956, MYCOLOGIA, V48, P459, DOI 10.2307/3755327
   ZALOKAR M, 1955, ARCH BIOCHEM BIOPHYS, V56, P318, DOI 10.1016/0003-9861(55)90252-6
   ZALOKAR M, 1954, ARCH BIOCHEM BIOPHYS, V50, P71, DOI 10.1016/0003-9861(54)90010-7
   ZALOKAR M, 1957, ARCH BIOCHEM BIOPHYS, V70, P568, DOI 10.1016/0003-9861(57)90144-3
NR 108
TC 56
Z9 60
U1 1
U2 41
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1087-1845
EI 1096-0937
J9 FUNGAL GENET BIOL
JI Fungal Genet. Biol.
PD NOV
PY 2010
VL 47
IS 11
SI SI
BP 930
EP 938
DI 10.1016/j.fgb.2010.05.001
PG 9
WC Genetics & Heredity; Mycology
SC Genetics & Heredity; Mycology
GA 665AY
UT WOS:000283007700008
PM 20460165
DA 2021-01-25
ER

PT J
AU Grava, S
   Philippsen, P
AF Grava, Sandrine
   Philippsen, Peter
TI Dynamics of Multiple Nuclei in Ashbya gossypii Hyphae Depend on the
   Control of Cytoplasmic Microtubules Length by Bik1, Kip2, Kip3, and Not
   on a Capture/Shrinkage Mechanism
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; BUDDING YEAST; PLUS ENDS;
   PROTEIN; MIGRATION; CLIP-170; TUBULIN; DYNEIN; CELLS
AB Ashbya gossypii has a budding yeast-like genome but grows exclusively as multinucleated hyphae. In contrast to budding yeast where positioning of nuclei at the bud neck is a major function of cytoplasmic microtubules (cMTs), A. gossypii nuclei are constantly in motion and positioning is not an issue. To investigate the role of cMTs in nuclear oscillation and bypassing, we constructed mutants potentially affecting cMT lengths. Hyphae lacking the plus (+)end marker Bik1 or the kinesin Kip2 cannot polymerize long cMTs and lose wild-type nuclear movements. Interestingly, hyphae lacking the kinesin Kip3 display longer cMTs concomitant with increased nuclear oscillation and bypassing. Polymerization and depolymerization rates of cMTs are 3 times higher in A. gossypii than in budding yeast and cMT catastrophes are rare. Growing cMTs slide along the hyphal cortex and exert pulling forces on nuclei. Surprisingly, a capture/shrinkage mechanism seems to be absent in A. gossypii. cMTs reaching a hyphal tip do not shrink, and cMT +ends accumulate in hyphal tips. Thus, differences in cMT dynamics and length control between budding yeast and A. gossypii are key elements in the adaptation of the cMT cytoskeleton to much longer cells and much higher degrees of nuclear mobilities.
C1 [Grava, Sandrine; Philippsen, Peter] Univ Basel, Dept Mol Microbiol Biozentrum, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Dept Mol Microbiol Biozentrum, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-112688]
FX We thank Shanon Seger, Eloise Kremer, and Clara Metz for help in strain
   construction. We acknowledge the advice and suggestions of Sue Jaspersen
   and Claudia Lang. We also thank Christine Alberti-Segui for providing
   unpublished data. This work was supported by the Swiss National Science
   Foundation grant 3100A0-112688 (to P.P.).
CR Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863
   Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2
   Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369
   Alberti-Segui C, 2001, J CELL SCI, V114, P975
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573
   Bode CJ, 2003, EMBO REP, V4, P94, DOI 10.1038/sj.embor.embor716
   Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X
   Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001
   Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6
   Caudron F, 2008, J CELL SCI, V121, P1506, DOI 10.1242/jcs.023374
   Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002
   Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83
   DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Efimov VP, 2006, MOL BIOL CELL, V17, P2021, DOI 10.1091/mbc.E05-11-1084
   Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8
   Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010
   Helfer H, 2006, MOL BIOL CELL, V17, P4494, DOI 10.1091/mbc.E06-03-0215
   Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713
   Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058
   Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602
   Lang C, 2010, MOL BIOL CELL, V21, P753, DOI 10.1091/mbc.E09-07-0555
   Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063
   Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260
   Lee L, 1999, J CELL BIOL, V144, P947, DOI 10.1083/jcb.144.5.947
   Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022
   Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119
   Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051
   Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985
   Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7
   Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009
   Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066
   Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993
   van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007
   Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462
   Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148
   Wolyniak MJ, 2006, MOL BIOL CELL, V17, P2789, DOI 10.1091/mbc.E05-09-0892
NR 44
TC 15
Z9 15
U1 0
U2 3
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV 1
PY 2010
VL 21
IS 21
BP 3680
EP 3692
DI 10.1091/mbc.E10-06-0527
PG 13
WC Cell Biology
SC Cell Biology
GA 672KR
UT WOS:000283582400006
PM 20844079
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Bruning, M
   Kreplak, L
   Leopoldseder, S
   Muller, SA
   Ringler, P
   Duchesne, L
   Fernig, DG
   Engel, A
   Ucurum-Fotiadis, Z
   Mayans, O
AF Bruning, Marc
   Kreplak, Laurent
   Leopoldseder, Sonja
   Mueller, Shirley A.
   Ringler, Philippe
   Duchesne, Laurence
   Fernig, David G.
   Engel, Andreas
   Ucurum-Fotiadis, Zoehre
   Mayans, Olga
TI Bipartite Design of a Self-Fibrillating Protein Copolymer with
   Nanopatterned Peptide Display Capabilities
SO NANO LETTERS
LA English
DT Article
DE Nanofiber; protein polymer; protein engineering; self-assembly;
   biomaterial; peptide display system; gold nanoparticles; 1D array
ID BIOMATERIALS; TITIN; Z1Z2
AB The development of biomatrices for technological and biomedical applications employs self-assembled scaffolds built from short peptidic motifs. However, biopolymers composed of protein domains would offer more varied molecular frames to introduce finer and more complex functionalities in bioreactive scaffolds using bottom-up approaches. Yet, the rules governing the three-dimensional organization of protein architectures in nature are complex and poorly understood. As a result, the synthetic fabrication of ordered protein association into polymers poses major challenges to bioengineering. We have now fabricated a self-assembling protein nanofiber with predictable morphologies and amenable to bottom-up customization, where features supporting function and assembly are spatially segregated. The design was inspired by the cross-linking of titin filaments by telethonin in the muscle sarcomere. The resulting fiber is a two-protein system that has nanopatterned peptide display capabilities as shown by the recruitment of functionalized gold nanoparticles at regular intervals of similar to 5 nm, yielding a semiregular linear array over micrometers. This polymer promises the uncomplicated display of biologically active motifs to selectively bind and organize matter in the fine nanoscale. Further, its conceptual design has high potential for controlled plurifunctionalization.
C1 [Bruning, Marc; Leopoldseder, Sonja; Ucurum-Fotiadis, Zoehre; Mayans, Olga] Univ Basel, Div Struct Biol, CH-4056 Basel, Switzerland.
   [Kreplak, Laurent; Mueller, Shirley A.; Ringler, Philippe; Engel, Andreas] Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland.
   [Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada.
   [Bruning, Marc; Duchesne, Laurence; Fernig, David G.; Mayans, Olga] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.
   [Bruning, Marc; Duchesne, Laurence; Fernig, David G.; Mayans, Olga] Univ Liverpool, Liverpool Inst Nanoscale Sci Engn & Technol, Liverpool L69 7ZB, Merseyside, England.
RP Mayans, O (corresponding author), Univ Basel, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Olga.Mayans@liv.ac.uk
RI Fernig, David G/A-3590-2008
OI Fernig, David G/0000-0003-4875-4293; Mayans, Olga/0000-0001-6876-8532;
   kreplak, laurent/0000-0001-9370-9809
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [3100A0-112595, 3100A0-108299]; Maurice E. Muller Foundation; Human
   Frontiers Science ProgrammeHuman Frontier Science Program; North West
   Cancer Research Fund
FX This work was supported by the Swiss National Foundation (Grants
   3100A0-112595 to O.M. and I.K. and 3100A0-108299 to All.) and by the
   Maurice E. Muller Foundation. D.G.F. and thank the Human Frontiers
   Science Programme and the North West Cancer Research Fund.
CR Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673
   Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105
   Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   DOMINGO GJ, 2001, R N J MEL, V305, P259
   Duchesne L, 2008, LANGMUIR, V24, P13572, DOI 10.1021/la802876u
   Ghirlanda G, 2002, J MOL BIOL, V319, P243, DOI 10.1016/S0022-2836(02)00233-4
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421
   Kasotakis E, 2009, BIOPOLYMERS, V92, P164, DOI 10.1002/bip.21163
   Kheterpal I, 2006, ACCOUNTS CHEM RES, V39, P584, DOI 10.1021/ar050057w
   Kodama H, 2004, CHEM COMMUN, P2876, DOI 10.1039/b409641j
   Lee EH, 2007, BIOPHYS J, V93, P1719, DOI 10.1529/biophysj.107.105528
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009
   Moll D, 2002, P NATL ACAD SCI USA, V99, P14646, DOI 10.1073/pnas.232299399
   Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404
   Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998
   Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007
   Ryadnov MG, 2004, J AM CHEM SOC, V126, P7454, DOI 10.1021/ja048144r
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Villard V, 2006, J PEPT SCI, V12, P206, DOI 10.1002/psc.707
   WILLIAMS AD, 2006, N J BLOT, V357, P1283
   Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343
NR 26
TC 11
Z9 11
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
EI 1530-6992
J9 NANO LETT
JI Nano Lett.
PD NOV
PY 2010
VL 10
IS 11
BP 4533
EP 4537
DI 10.1021/nl1024886
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 676JQ
UT WOS:000283907600040
PM 20954695
DA 2021-01-25
ER

PT J
AU Schneider, A
   Falkai, P
   Papassotiropoulos, A
AF Schneider, A.
   Falkai, P.
   Papassotiropoulos, A.
TI Molecular principles of tau-induced toxicity. New experimental therapy
   strategies for treatment of Alzheimer's disease
SO NERVENARZT
LA German
DT Article
DE Alzheimer's disease; Tau proteins; Phosphorylation; Animal models;
   Clinical trials
ID CYCLIN-DEPENDENT KINASE-5; PHOSPHORYLATION; AGGREGATION; PROTEIN; BETA;
   HYPERPHOSPHORYLATION; TAUOPATHY; LITHIUM; INHIBITORS; GSK-3-BETA
AB Neurofibrillary tangles are the hallmark of Alzheimer's disease together with amyloid plaques. They are composed of hyperphosphorylated and aggregated Tau proteins. Consequently, experimental disease modifying approaches include kinase and aggregation inhibitors as well as substances which increase degradation of Tau proteins.
C1 [Schneider, A.; Falkai, P.] Univ Med Gottingen, Klin Psychiat & Psychotherapie, D-37075 Gottingen, Germany.
   [Papassotiropoulos, A.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Schneider, A (corresponding author), Univ Med Gottingen, Klin Psychiat & Psychotherapie, Von Siebold Str 5, D-37075 Gottingen, Germany.
EM aschnei8@gwdg.de
RI Schneider, Anja/F-5293-2010; Falkai, Peter/E-3273-2017
OI Falkai, Peter/0000-0003-2873-8667; Papassotiropoulos,
   Andreas/0000-0002-2210-9651
CR Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x
   Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423
   Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458
   Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200
   Brunden KR, 2010, EXP NEUROL, V223, P304, DOI 10.1016/j.expneurol.2009.08.031
   Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621
   Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901
   Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715
   Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje
   Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1
   Engel T, 2006, NEUROBIOL AGING, V27, P1258, DOI 10.1016/j.neurobiolaging.2005.06.010
   Feuillette S, 2010, J NEUROCHEM, V113, P895, DOI 10.1111/j.1471-4159.2010.06663.x
   Ghittoni R, 2006, EUR J IMMUNOL, V36, P2885, DOI 10.1002/eji.200636567
   Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0
   Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0
   Hajieva P, 2009, J NEUROCHEM, V110, P118, DOI 10.1111/j.1471-4159.2009.06114.x
   Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x
   Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606
   Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003
   Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x
   Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7
   Kesavapany S, 2004, BBA-PROTEINS PROTEOM, V1697, P143, DOI 10.1016/j.bbapap.2003.11.020
   Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798
   Langhorst MF, 2006, FASEB J, V20, P711, DOI 10.1096/fj.05-4760fje
   Li GB, 2003, J NEUROCHEM, V84, P347, DOI 10.1046/j.1471-4159.2003.01526.x
   Liu F, 2002, FEBS LETT, V530, P209, DOI 10.1016/S0014-5793(02)03487-7
   Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x
   MATSUOKA Y, 2008, J PHARM EXP THER
   Matsuoka Y, 2007, J MOL NEUROSCI, V31, P165, DOI 10.1385/JMN/31:02:165
   MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C
   MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823
   Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200
   Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6
   Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0
   Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035
   Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p
   Schulte T, 1997, DEVELOPMENT, V124, P577
   Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025
   Sigurdsson EM, 2009, CURR ALZHEIMER RES, V6, P446, DOI 10.2174/156720509789207930
   Thal DR, 2000, EXP NEUROL, V163, P98, DOI 10.1006/exnr.2000.7380
   Uno Y, 2009, BRAIN RES, V1296, P148, DOI 10.1016/j.brainres.2009.08.034
   VANBEBBER F, 2010, NEUROBIOL DIS
   Wang Y, 2010, NEURODEGENER DIS, V7, P103, DOI 10.1159/000285516
   Wimo A, 2007, ALZHEIMERS DEMENT, V3, P81, DOI 10.1016/j.jalz.2007.02.001
   Wischik CM, 2008, ALZHEIMERS DEMENT, V4, pT167, DOI DOI 10.1016/J.JALZ.2008.05.438
   Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042
   Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102
   Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0
NR 52
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0028-2804
EI 1433-0407
J9 NERVENARZT
JI Nervenarzt
PD NOV
PY 2010
VL 81
IS 11
BP 1289
EP +
DI 10.1007/s00115-010-3052-2
PG 6
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 681DF
UT WOS:000284289600003
PM 20842339
DA 2021-01-25
ER

PT J
AU Summermatter, S
   Baum, O
   Santos, G
   Hoppeler, H
   Handschin, C
AF Summermatter, Serge
   Baum, Oliver
   Santos, Gesa
   Hoppeler, Hans
   Handschin, Christoph
TI Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha
   (PGC-1 alpha) Promotes Skeletal Muscle Lipid Refueling in Vivo by
   Activating de Novo Lipogenesis and the Pentose Phosphate Pathway
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FATTY-ACID SYNTHESIS; INSULIN SENSITIVITY; MITOCHONDRIAL-FUNCTION;
   GLUCOSE-TOLERANCE; CHRONIC DISEASE; ADIPOSE-TISSUE; EXERCISE;
   RESISTANCE; HUMANS; PGC-1
AB Exercise induces a pleiotropic adaptive response in skeletal muscle, largely through peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha). PGC-1 alpha enhances lipid oxidation and thereby provides energy for sustained muscle contraction. Its potential implication in promoting muscle refueling remains unresolved, however. Here, we investigated a possible role of elevated PGC-1 alpha levels in skeletal muscle lipogenesis in vivo and the molecular mechanisms that underlie PGC-1 alpha-mediated de novo lipogenesis. To this end, we studied transgenic mice with physiological overexpression of PGC-1 alpha and human muscle biopsies pre-and post-exercise. We demonstrate that PGC-1 alpha enhances lipogenesis in skeletal muscle through liver X receptor alpha-dependent activation of the fatty acid synthase (FAS) promoter and by increasing FAS activity. Using chromatin immunoprecipitation, we establish a direct interaction between PGC-1 alpha and the liver X receptor-responsive element in the FAS promoter. Moreover, we show for the first time that increased glucose uptake and activation of the pentose phosphate pathway provide substrates for RNA synthesis and cofactors for de novo lipogenesis. Similarly, we observed increased lipogenesis and lipid levels in human muscle biopsies that were obtained post-exercise. Our findings suggest that PGC-1 alpha coordinates lipogenesis, intramyocellular lipid accumulation, and substrate oxidation in exercised skeletal muscle in vivo.
C1 [Summermatter, Serge; Santos, Gesa; Handschin, Christoph] Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   [Summermatter, Serge; Handschin, Christoph] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland.
   [Summermatter, Serge; Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8057 Zurich, Switzerland.
   [Baum, Oliver; Hoppeler, Hans] Univ Bern, Inst Anat, CH-3009 Bern, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Div Pharmacol Neurobiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015; Baum, Oliver/E-6367-2012
OI Handschin, Christoph/0000-0003-0603-1097; Baum,
   Oliver/0000-0001-5706-0942
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF PP00A-110746]; Muscular Dystrophy AssociationMuscular
   Dystrophy Association; SwissLife "Jubilaumsstiftung fur Volksgesundheit
   und Medizinische Forschung"; Swiss Society for Research on Muscle
   Diseases; Swiss Diabetes Association; Roche Research Foundation; United
   Mitochondrial Disease Foundation; Association Francaise contre les
   MyopathiesAssociation Francaise contre les Myopathies; University of
   Basel
FX This work was supported by Swiss National Science Foundation Grant SNF
   PP00A-110746, the Muscular Dystrophy Association, the SwissLife
   "Jubilaumsstiftung fur Volksgesundheit und Medizinische Forschung," the
   Swiss Society for Research on Muscle Diseases, the Swiss Diabetes
   Association, the Roche Research Foundation, the United Mitochondrial
   Disease Foundation, the Association Francaise contre les Myopathies, and
   the University of Basel.
CR Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com
   Bergman BC, 2010, J APPL PHYSIOL, V108, P1134, DOI 10.1152/japplphysiol.00684.2009
   BERK PD, 1990, P NATL ACAD SCI USA, V87, P3484, DOI 10.1073/pnas.87.9.3484
   Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005
   Booth FW, 2008, EUR J APPL PHYSIOL, V102, P381, DOI 10.1007/s00421-007-0606-5
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Chen SY, 2006, INT J OBESITY, V30, P40, DOI 10.1038/sj.ijo.0803073
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Espinoza DO, 2010, FASEB J, V24, P1003, DOI 10.1096/fj.09-133728
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7
   FUNGWE TV, 1994, J LIPID RES, V35, P311
   Geiser J, 2001, INT J SPORTS MED, V22, P579, DOI 10.1055/s-2001-18521
   GLAZER RI, 1971, J NEUROCHEM, V18, P1569, DOI 10.1111/j.1471-4159.1971.tb00018.x
   Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755
   Goodyear LJ, 2008, NEW ENGL J MED, V359, P1842, DOI 10.1056/NEJMcibr0806723
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   HANSEN PA, 1994, J APPL PHYSIOL, V76, P979
   Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005
   HOPPELER H, 1985, J APPL PHYSIOL, V59, P320
   Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Liu TC, 2008, J SPORT SCI, V26, P919, DOI 10.1080/02640410801885925
   Morifuji M, 2005, NUTRITION, V21, P1052, DOI 10.1016/j.nut.2005.01.010
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Ninfali P, 1997, BRAIN RES PROTOC, V1, P357, DOI 10.1016/S1385-299X(97)00011-1
   PENICAUD L, 1991, BIOCHEM J, V279, P303, DOI 10.1042/bj2790303
   Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600
   RANDLE PJ, 1963, LANCET, V1, P785
   Richter EA, 2008, CELL METAB, V8, P96, DOI 10.1016/j.cmet.2008.07.004
   Rico-Sanz J, 2000, LIPIDS, V35, P1313, DOI 10.1007/s11745-000-0647-2
   Rimbert V, 2009, FEBS LETT, V583, P2927, DOI 10.1016/j.febslet.2009.07.059
   ROGERS MA, 1990, J APPL PHYSIOL, V68, P1833
   Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874
   Russell AP, 2004, INT J OBESITY, V28, pS66, DOI 10.1038/sj.ijo.0802859
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413
   Stellingwerff T, 2007, AM J PHYSIOL-ENDOC M, V292, pE1715, DOI 10.1152/ajpendo.00678.2006
   Sugden MC, 2007, BRIT J NUTR, V97, P809, DOI 10.1017/S0007114507659054
   van Loon LJC, 2004, AM J PHYSIOL-ENDOC M, V287, pE558, DOI 10.1152/ajpendo.00464.2003
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
NR 47
TC 72
Z9 78
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 22
PY 2010
VL 285
IS 43
BP 32793
EP 32800
DI 10.1074/jbc.M110.145995
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 665PP
UT WOS:000283048200015
PM 20716531
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Stein, S
   Lohmann, C
   Handschin, C
   Stenfeldt, E
   Boren, J
   Luscher, TF
   Matter, CM
AF Stein, Sokrates
   Lohmann, Christine
   Handschin, Christoph
   Stenfeldt, Elin
   Boren, Jan
   Luescher, Thomas F.
   Matter, Christian M.
TI ApoE-/- PGC-1 alpha-/- Mice Display Reduced IL-18 Levels and Do Not
   Develop Enhanced Atherosclerosis
SO PLOS ONE
LA English
DT Article
ID TRANSMEMBRANE CXC-CHEMOKINE; CORONARY-ARTERY-DISEASE; C-REACTIVE
   PROTEIN; E-DEFICIENT MICE; ADIPOSE-TISSUE; ACCELERATES ATHEROSCLEROSIS;
   TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; SCAVENGER
   RECEPTOR; CHOLESTEROL EFFLUX
AB Background: Atherosclerosis is a chronic inflammatory disease that evolves from the interaction of activated endothelial cells, macrophages, lymphocytes and modified lipoproteins (LDLs). In the last years many molecules with crucial metabolic functions have been shown to prevent important steps in the progression of atherogenesis, including peroxisome proliferator activated receptors (PPARs) and the class III histone deacetylase (HDAC) SIRT1. The PPAR gamma coactivator 1 alpha (Ppargc1a or PGC-1 alpha) was identified as an important transcriptional cofactor of PPAR gamma and is activated by SIRT1. The aim of this study was to analyze total PGC-1 alpha deficiency in an atherosclerotic mouse model.
   Methodology/Principal Findings: To investigate if total PGC-1 alpha deficiency affects atherosclerosis, we compared ApoE(-/-) PGC-1 alpha(-/-) and ApoE(-/-) PGC-1 alpha(+/+) mice kept on a high cholesterol diet. Despite having more macrophages and a higher ICAM-1 expression in plaques, ApoE(-/-) PGC-1 alpha(-/-) did not display more or larger atherosclerotic plaques than their ApoE(-/-) PGC-1 alpha(+/+) littermates. In line with the previously published phenotype of PGC-1 alpha(-/-) mice, ApoE(-/-) PGC-1 alpha(-/-) mice had marked reduced body, liver and epididymal white adipose tissue (WAT) weight. VLDL/LDL-cholesterol and triglyceride contents were also reduced. Aortic expression of PPAR alpha and PPAR gamma, two crucial regulators for adipocyte differentitation and glucose and lipid metabolism, as well as the expression of some PPAR target genes was significantly reduced in ApoE(-/-) PGC-1 alpha(-/-) mice. Importantly, the epididymal WAT and aortic expression of IL-18 and IL-18 plasma levels, a pro-atherosclerotic cytokine, was markedly reduced in ApoE(-/-) PGC-1 alpha(-/-) mice.
   Conclusions/Significance: ApoE(-/-) PGC-1 alpha(-/-) mice, similar as PGC-1 alpha(-/-) mice exhibit markedly reduced total body and visceral fat weight. Since inflammation of visceral fat is a crucial trigger of atherogenesis, decreased visceral fat in PGC-1 alpha-deficient mice may explain why these mice do not develop enhanced atherosclerosis.
C1 [Stein, Sokrates; Lohmann, Christine; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich, Inst Physiol, Zurich, Switzerland.
   [Stein, Sokrates; Lohmann, Christine; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.
   [Stein, Sokrates; Lohmann, Christine; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland.
   [Handschin, Christoph] Univ Basel, Biozentrum, Basel, Switzerland.
   [Stenfeldt, Elin; Boren, Jan] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden.
RP Stein, S (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.
EM christian.matter@access.uzh.ch
RI Stein, Sokrates/D-4661-2009; Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097; Stein,
   Sokrates/0000-0001-6984-6934
FU University of Zurich; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [31-114094/1, 310030-130626/1, 3100-068118]
FX This work was funded by the University Research Priority Program
   'Integrative Human Physiology' at the University of Zurich and the Swiss
   National Science Foundation (#31-114094/1, #310030-130626/1, and
   #3100-068118). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362
   Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002
   Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2
   COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2
   FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706
   Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0
   Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Hulthe J, 2006, ATHEROSCLEROSIS, V188, P450, DOI 10.1016/j.atherosclerosis.2005.11.013
   Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456
   Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200
   Lakka HM, 2002, EUR HEART J, V23, P706, DOI 10.1053/euhj.2001.2889
   Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380
   Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lutgens E, 1999, NAT MED, V5, P1313, DOI 10.1038/15271
   Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735
   Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738
   MIN HY, 1986, NUCLEIC ACIDS RES, V14, P8879
   Mitsuoka H, 2009, J ATHEROSCLER THROMB, V16, P586, DOI 10.5551/jat.1081
   Mussig K, 2009, METABOLISM, V58, P519, DOI 10.1016/j.metabol.2008.11.011
   Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665
   Ohman MK, 2008, CIRCULATION, V117, P798, DOI 10.1161/CIRCULATIONAHA.107.717595
   Ploplis VA, 2001, ANN NY ACAD SCI, V936, P466
   PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915
   Qian H, 2008, GENE THER, V15, P224, DOI 10.1038/sj.gt.3303069
   Recinos A, 2004, PHYSIOL GENOMICS, V19, P131, DOI 10.1152/physiolgenomics.00146.2003
   See R, 2007, J AM COLL CARDIOL, V50, P752, DOI 10.1016/j.jacc.2007.04.066
   Shimaoka T, 2004, J BIOL CHEM, V279, P26807, DOI 10.1074/jbc.C400163200
   Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200
   Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465
   Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107
   Suchanek H, 2005, EUR CYTOKINE NETW, V16, P177
   Tenger C, 2005, ARTERIOSCL THROM VAS, V25, P791, DOI 10.1161/01.ATV.0000153516.02782.65
   Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829
   Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1
   WHITE RT, 1992, J BIOL CHEM, V267, P9210
   Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292
   Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382
   Won JC, 2010, ARTERIOSCL THROM VAS, V30, P290, DOI 10.1161/ATVBAHA.109.198721
   Xie Gaoqiang, 2007, BMC Cardiovasc Disord, V7, P33, DOI 10.1186/1471-2261-7-33
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Zhang YG, 2008, CLIN EXP PHARM PHYSL
NR 52
TC 23
Z9 24
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 22
PY 2010
VL 5
IS 10
AR e13539
DI 10.1371/journal.pone.0013539
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 670KA
UT WOS:000283419100005
PM 21042583
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Kim, ML
   Jeong, HG
   Kasper, CA
   Arrieumerlou, C
AF Kim, Man Lyang
   Jeong, Hyun Gyeong
   Kasper, Christoph Alexander
   Arrieumerlou, Cecile
TI IKK alpha Contributes to Canonical NF-kappa B Activation Downstream of
   Nod1-Mediated Peptidoglycan Recognition
SO PLOS ONE
LA English
DT Article
ID SHIGELLA-FLEXNERI; SIGNALING PATHWAY; ESCHERICHIA-COLI; INNATE IMMUNITY;
   REGULATOR; NOD1; PATHOGENESIS; INFLAMMATION; EXPRESSION; INHIBITOR
AB Background: During pathogen infection, innate immunity is initiated via the recognition of microbial products by pattern recognition receptors and the subsequent activation of transcription factors that upregulate proinflammatory genes. By controlling the expression of cytokines, chemokines, anti-bacterial peptides and adhesion molecules, the transcription factor nuclear factor-kappa B (NF-kappa B) has a central function in this process. In a typical model of NF-kappa B activation, the recognition of pathogen associated molecules triggers the canonical NF-kappa B pathway that depends on the phosphorylation of Inhibitor of NF-kappa B (I kappa B) by the catalytic subunit IkB kinase beta (IKK beta), its degradation and the nuclear translocation of NF-kappa B dimers.
   Methodology: Here, we performed an RNA interference (RNAi) screen on Shigella flexneri-induced NF-kappa B activation to identify new factors involved in the regulation of NF-kappa B following infection of epithelial cells by invasive bacteria. By targeting a subset of the human signaling proteome, we found that the catalytic subunit IKK alpha is also required for complete NF-kappa B activation during infection. Depletion of IKK alpha by RNAi strongly reduces the nuclear translocation of NF-kappa B p65 during S. flexneri infection as well as the expression of the proinflammatory chemokine interleukin-8. Similar to IKK beta, IKK alpha contributes to the phosphorylation of IkBa on serines 32 and 36, and to its degradation. Experiments performed with the synthetic Nod1 ligand L-Ala-D-gamma-Glu-meso-diaminopimelic acid confirmed that IKK alpha is involved in NF-kappa B activation triggered downstream of Nod1-mediated peptidoglycan recognition.
   Conclusions: Taken together, these results demonstrate the unexpected role of IKK alpha in the canonical NF-kappa B pathway triggered by peptidoglycan recognition during bacterial infection. In addition, they suggest that IKK alpha may be an important drug target for the development of treatments that aim at limiting inflammation in bacterial infection.
C1 [Kim, Man Lyang; Jeong, Hyun Gyeong; Kasper, Christoph Alexander; Arrieumerlou, Cecile] Univ Basel, Biozentrum, Basel, Switzerland.
RP Kim, ML (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM cecile.arrieumerlou@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-113561]; University of Basel; Werner-Siemens Foundation;
   SystemsX.ch
FX This work was supported by Swiss National Science Foundation (grant
   3100A0-113561, www.snf.ch), the University of Basel (www.unibas.ch) and
   the InfectX grant from SystemsX.ch (www.systemsx.ch). C. Kasper was
   supported by the Werner-Siemens Foundation
   (www.wernersiemens-stiftung.ch). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ADLI M, PLOS ONE, V5, pE9428
   Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423
   Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x
   BLASIUS AL, IMMUNITY, V32, P305
   Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039
   Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x
   Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x
   Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142
   Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954
   Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155
   Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704
   Inohara N, 2000, J BIOL CHEM, V275, P27823
   Islam D, 1997, INFECT IMMUN, V65, P739, DOI 10.1128/IAI.65.2.739-749.1997
   Izmailova ES, 2007, ARTHRITIS RHEUM-US, V56, P117, DOI 10.1002/art.22303
   Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020
   Le Bourhis L, 2007, BIOCHEM SOC T, V35, P1479, DOI 10.1042/BST0351479
   Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960
   Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055
   Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246
   Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11
   OGAWA H, CLIN EXP ALLERGY
   Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814
   Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200
   Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571
   Rasmussen SB, 2009, APMIS, V117, P323, DOI 10.1111/j.1600-0463.2009.02456.x
   REIJMERINK NE, ALLERGY, V65, P199
   Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999
   Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07
   Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200
   Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034
   Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031
   Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176
NR 38
TC 8
Z9 8
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 15
PY 2010
VL 5
IS 10
AR e15371
DI 10.1371/journal.pone.0015371
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 665NX
UT WOS:000283043700033
PM 20976174
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU McGlincy, NJ
   Tan, LY
   Paul, N
   Zavolan, M
   Lilley, KS
   Smith, CWJ
AF McGlincy, Nicholas J.
   Tan, Lit-Yeen
   Paul, Nicodeme
   Zavolan, Mihaela
   Lilley, Kathryn S.
   Smith, Christopher W. J.
TI Expression proteomics of UPF1 knockdown in HeLa cells reveals
   autoregulation of hnRNP A2/B1 mediated by alternative splicing resulting
   in nonsense-mediated mRNA decay
SO BMC GENOMICS
LA English
DT Article
ID 2-DIMENSIONAL DIFFERENCE GEL; OPEN READING FRAMES; BINDING-PROTEIN;
   ULTRACONSERVED ELEMENTS; EXPERIMENTAL-DESIGN; REPORTER SYSTEM; DIVERSE
   CLASSES; TRANSLATION; TRANSCRIPTS; GENE
AB Background: In addition to acting as an RNA quality control pathway, nonsense-mediated mRNA decay (NMD) plays roles in regulating normal gene expression. In particular, the extent to which alternative splicing is coupled to NMD and the roles of NMD in regulating uORF containing transcripts have been a matter of debate.
   Results: In order to achieve a greater understanding of NMD regulated gene expression we used 2D-DiGE proteomics technology to examine the changes in protein expression induced in HeLa cells by UPF1 knockdown. QPCR based validation of the corresponding mRNAs, in response to both UPF1 knockdown and cycloheximide treatment, identified 17 bona fide NMD targets. Most of these were associated with bioinformatically predicted NMD activating features, predominantly upstream open reading frames (uORFs). Strikingly, however, the majority of transcripts up-regulated by UPF1 knockdown were either insensitive to, or even down-regulated by, cycloheximide treatment. Furthermore, the mRNA abundance of several down-regulated proteins failed to change upon UPF1 knockdown, indicating that UPF1's role in regulating mRNA and protein abundance is more complex than previously appreciated. Among the bona fide NMD targets, we identified a highly conserved AS-NMD event within the 3' UTR of the HNRNPA2B1 gene. Overexpression of GFP tagged hnRNP A2 resulted in a decrease in endogenous hnRNP A2 and B1 mRNA with a concurrent increase in the NMD sensitive isoforms.
   Conclusions: Despite the large number of changes in protein expression upon UPF1 knockdown, a relatively small fraction of them can be directly attributed to the action of NMD on the corresponding mRNA. From amongst these we have identified a conserved AS-NMD event within HNRNPA2B1 that appears to mediate autoregulation of HNRNPA2B1 expression levels.
C1 [McGlincy, Nicholas J.; Tan, Lit-Yeen; Lilley, Kathryn S.; Smith, Christopher W. J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England.
   [Paul, Nicodeme; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Smith, CWJ (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.
EM cwjs1@cam.ac.uk
RI Lilley, Kathryn/ABF-5787-2020; McGlincy, Nicholas/G-2635-2010; Zavolan,
   Mihaela/S-3888-2016
OI Lilley, Kathryn/0000-0003-0594-6543; Zavolan,
   Mihaela/0000-0002-8832-2041; McGlincy, Nicholas/0000-0003-1412-2298
FU Wellcome TrustWellcome Trust [077877]; ECEuropean CommissionEuropean
   Commission Joint Research CentreEuropean Community (EC)
   [EURASNET-LSHG-CT-2005-518238]; EURASNET; MRCMedical Research Council UK
   (MRC); Cambridge Australia Trust
FX We would like to thank members of the Cambridge Centre for Proteomics
   for their invaluable help and advice in the execution of this study. We
   thank P. Berninger for his help with programming in Perl, J. Mendell for
   the kind gift of antibodies against UPF1. Work in CWJS' laboratory is
   funded by the Wellcome Trust (077877) and in part by the EC grant
   EURASNET-LSHG-CT-2005-518238. Collaboration with MZ's group was also
   supported by EURASNET. NJM was supported by a studentship from the MRC.
   LYT was supported by a studentship from the Cambridge Australia Trust.
CR Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006
   Barberan-Soler S, 2009, RNA, V15, P1652, DOI 10.1261/rna.1711109
   Barnes CA, 1998, NUCLEIC ACIDS RES, V26, P2433, DOI 10.1093/nar/26.10.2433
   Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588
   Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119
   Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720
   Boelz S, 2006, BIOCHEM BIOPH RES CO, V349, P186, DOI 10.1016/j.bbrc.2006.08.017
   Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550
   Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005
   Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106
   Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628
   Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909
   Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107
   CONTRERAS RM, 2006, PLOS BIOL, V4, pE21
   CULBERTSON MR, 1980, GENETICS, V95, P833
   David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697
   Donnadieu E, 2003, IMMUNITY, V18, P665, DOI 10.1016/S1074-7613(03)00115-8
   Dreumont N, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-1
   Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092
   Fahling M, 2006, J BIOL CHEM, V281, P9279, DOI 10.1074/jbc.M510925200
   Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310
   Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012
   Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07
   Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015
   Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609
   Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203
   Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770
   Hansen KD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000525
   Heikkinen HL, 2003, NUCLEIC ACIDS RES, V31, P4006, DOI 10.1093/nar/gkg474
   Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515
   Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8
   HODGKIN J, 1989, GENETICS, V123, P301
   Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403
   ISKEN O, 2008, NAT REV GENET
   Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17
   Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129
   Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083
   Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881
   Karp NA, 2004, PROTEOMICS, V4, P1421, DOI 10.1002/pmic.200300681
   Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972
   Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]
   Kim SH, 2001, J NEURAL TRANSM-SUPP, P273
   Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050
   Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712
   Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9
   Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125
   Kumar S, 2005, EMBO J, V24, P2646, DOI 10.1038/sj.emboj.7600723
   Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676
   Lee HC, 2010, FEBS LETT, V584, P795, DOI 10.1016/j.febslet.2010.01.003
   Lejeune F, 2001, J BIOL CHEM, V276, P7850, DOI 10.1074/jbc.M009510200
   Lenth RV, 2006, JAVA APPLETS POWER S
   Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015
   Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645
   MCGLINCY NJ, 2008, TRENDS BIOCH SCI
   Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99
   Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428
   Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429
   Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004
   Moran-Jones K, 2009, CANCER RES, V69, P9219, DOI 10.1158/0008-5472.CAN-09-1852
   Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000
   Morrison M, 1997, P NATL ACAD SCI USA, V94, P9782, DOI 10.1073/pnas.94.18.9782
   Neu-Yilik G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-218
   Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507
   Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1
   Pacheco TR, 2004, J BIOL CHEM, V279, P27039, DOI 10.1074/jbc.M402136200
   Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052
   Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806
   Patry C, 2003, CANCER RES, V63, P7679
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Pontius J. U., 2003, NCBI HDB
   POPIELARZ M, 1995, J BIOL CHEM, V270, P17830, DOI 10.1074/jbc.270.30.17830
   Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504
   Ramani AK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r101
   Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007
   Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905
   Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005
   Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916
   Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08
   Roy B, 2010, RNA, V16, P748, DOI 10.1261/rna.2056010
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7
   Sachs MS, 2006, GENE DEV, V20, P915, DOI 10.1101/gad.1427006
   SALTZMAN A, 2008, MOL CELL BIOL
   SCADDEN ADJ, 1995, EMBO J, V14, P3236
   Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108
   Silva AL, 2006, RNA, V12, P2160, DOI 10.1261/rna.201406
   Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111
   SOERGEL DAW, 2006, NONSENSE MEDIATED MR
   Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016
   Staiger D, 2003, PLANT J, V33, P361, DOI 10.1046/j.1365-313X.2003.01629.x
   Stockklausner C, 2006, NUCLEIC ACIDS RES, V34, P2355, DOI 10.1093/nar/gkl277
   Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051
   SUN S, 2010, NAT STRUCT MOL BIOL
   Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785
   Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122
   van Nimwegen E, 2006, PLOS GENET, V2, P587, DOI 10.1371/journal.pgen.0020024
   VANDEN B, 2004, CURR OPIN BIOTECH, V15, P38
   Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08
   VIEGAS MH, 2007, NUCL ACIDS RES
   Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7
   Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154
   Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09
   Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006
   Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1
   Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002
   Yan-Sanders Y, 2002, CANCER LETT, V183, P215, DOI 10.1016/S0304-3835(02)00168-4
   You KT, 2007, PLOS BIOL, V5, P1098, DOI 10.1371/journal.pbio.0050109
   Zavolan M, 2002, GENOME RES, V12, P1377, DOI 10.1101/gr.191702
   Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303
   Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826
   Zhou J, 2001, BREAST CANCER RES TR, V66, P217, DOI 10.1023/A:1010631915831
NR 115
TC 46
Z9 47
U1 0
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD OCT 14
PY 2010
VL 11
AR 565
DI 10.1186/1471-2164-11-565
PG 19
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 673KU
UT WOS:000283661000001
PM 20946641
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Bumann, D
AF Bumann, Dirk
TI Pathogen proteomes during infection: A basis for infection research and
   novel control strategies
SO JOURNAL OF PROTEOMICS
LA English
DT Review
DE Bacterial infection; Pathogen metabolism; Vaccine antigen identification
ID SALMONELLA GENE-EXPRESSION; ESCHERICHIA-COLI; PERSISTENT INFECTION;
   SEROVAR TYPHIMURIUM; PROTEIN; IDENTIFICATION; PHOSPHOPEPTIDES;
   RESISTANCE; RESPONSES; SELECTION
AB Infectious diseases cause tremendous mortality and morbidity worldwide. Rising antimicrobial resistance and the lack of new drugs cause an increasingly alarming crisis in infectious disease control. New system-level approaches are likely to help understand complex host/pathogen interactions as a basis for rational development of novel antibiotics and vaccines. Proteome analysis of pathogens in infected tissues comprehensively reveals functionally relevant pathogen activities during infection. It also highlights potential targets for antimicrobial chemotherapy as well as promising antigens for vaccination. Integration of these data with complementary large-scale data helps to further prioritize candidates for in-depth experimental analysis. Here, I discuss some of these approaches with a special emphasis on the model pathogen Salmonella. (C) 2010 Elsevier B.V. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bumann, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM dirk.bumann@unibas.ch
FU Deutsche Forschungsgemeinschaft und Schweizerischer Nationalfonds
FX I thank past and present members of my lab for stimulating discussions
   and Deutsche Forschungsgemeinschaft und Schweizerischer Nationalfonds
   for funding.
CR Ahmed D, 2006, ANTIMICROB AGENTS CH, V50, P3516, DOI 10.1128/AAC.00667-06
   Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999
   Alcaine SD, 2007, J FOOD PROTECT, V70, P780, DOI 10.4315/0362-028X-70.3.780
   Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x
   BALEMANS W, NATURE, V463, pE4
   Balemans W, 2010, NATURE, V463, pE3, DOI 10.1038/nature08667
   Bambini S, 2009, DRUG DISCOV TODAY, V14, P252, DOI 10.1016/j.drudis.2008.12.007
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4
   Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011
   Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998
   Boyce JD, 2006, PROTEOMICS, V6, P870, DOI 10.1002/pmic.200401342
   Brinster S, 2010, NATURE, V463, pE4, DOI 10.1038/nature08668
   Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772
   Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x
   Bumann D, 2009, CURR OPIN MICROBIOL, V12, P559, DOI 10.1016/j.mib.2009.08.004
   Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Depontieu FR, 2009, P NATL ACAD SCI USA, V106, P12073, DOI 10.1073/pnas.0903852106
   FAUBARESCHBERNA.HJ, IDENTIFICATION IN VI
   FAUCONG YHY, IDENTIFICATION IN VI
   FAUHALLINGBROWN PF, IMMUNOGRID INTEGRATI
   FAUSHABAN RHB, PROTEINS ACCESSIBLE
   Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994
   Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797
   Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717
   Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Kang HY, 2003, FEMS IMMUNOL MED MIC, V37, P99, DOI 10.1016/S0928-8244(03)00063-4
   Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09
   Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751
   Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027
   Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111
   Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195
   Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200
   Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Mattow J, 2006, PROTEOMICS, V6, P2485, DOI 10.1002/pmic.200500547
   Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984
   Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104
   Molestina RE, 2002, INFECT IMMUN, V70, P2976, DOI 10.1128/IAI.70.6.2976-2981.2002
   NANNINI E, 2010, CURR OPIN PHARM, V30
   Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200
   Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1
   Paape D, 2008, MOL CELL PROTEOMICS, V7, P1688, DOI 10.1074/mcp.M700343-MCP200
   Paape D, 2010, MOL BIOCHEM PARASIT, V169, P108, DOI 10.1016/j.molbiopara.2009.10.009
   Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0
   Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006
   Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101
   Sabarth N, 2002, INFECT IMMUN, V70, P6499, DOI 10.1128/IAI.70.11.6499-6503.2002
   Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477
   Schmidt F, 2010, PROTEOMICS, V10, P2801, DOI 10.1002/pmic.201000045
   Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x
   Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200
   Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104
   THONE F, 2007, J MICROBIOL METH
   Toomey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006195
   Twine SM, 2006, BIOCHEM BIOPH RES CO, V345, P1621, DOI 10.1016/j.bbrc.2006.05.070
   Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687
   Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x
   Wendland M, 2002, FEBS LETT, V521, P105, DOI 10.1016/S0014-5793(02)02834-X
   Xia QW, 2007, PROTEOMICS, V7, P4323, DOI 10.1002/pmic.200700543
   Yamamoto T, 2001, INFECT IMMUN, V69, P3164, DOI 10.1128/IAI.69.5.3164-3174.2001
   Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306
   Zarling AL, 2006, P NATL ACAD SCI USA, V103, P14889, DOI 10.1073/pnas.0604045103
NR 65
TC 31
Z9 31
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD OCT 10
PY 2010
VL 73
IS 11
SI SI
BP 2267
EP 2276
DI 10.1016/j.jprot.2010.08.004
PG 10
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 676IA
UT WOS:000283903000018
PM 20797457
DA 2021-01-25
ER

PT J
AU Bellemare, A
   Vernoux, N
   Morin, S
   Gagne, SM
   Bourbonnais, Y
AF Bellemare, Audrey
   Vernoux, Nathalie
   Morin, Sebastien
   Gagne, Stephane M.
   Bourbonnais, Yves
TI Structural and antimicrobial properties of human pre-elafin/trappin-2
   and derived peptides against Pseudomonas aeruginosa
SO BMC MICROBIOLOGY
LA English
DT Article
ID ELASTASE-SPECIFIC INHIBITOR; HUMAN PRE-ELAFIN; CYSTIC-FIBROSIS; FOLDING
   PROBLEM; EMPIRICAL PARAMETERS; CATIONIC PEPTIDES; BUFORIN II; MEMBRANE;
   AZITHROMYCIN; ANTIBIOTICS
AB Background: Pre-elafin/trappin-2 is a human innate defense molecule initially described as a potent inhibitor of neutrophil elastase. The full-length protein as well as the N-terminal "cementoin" and C-terminal "elafin" domains were also shown to possess broad antimicrobial activity, namely against the opportunistic pathogen P. aeruginosa. The mode of action of these peptides has, however, yet to be fully elucidated. Both domains of pre-elafin/trappin-2 are polycationic, but only the structure of the elafin domain is currently known. The aim of the present study was to determine the secondary structures of the cementoin domain and to characterize the antibacterial properties of these peptides against P. aeruginosa.
   Results: We show here that the cementoin domain adopts an a-helical conformation both by circular dichroism and nuclear magnetic resonance analyses in the presence of membrane mimetics, a characteristic shared with a large number of linear polycationic antimicrobial peptides. However, pre-elafin/trappin-2 and its domains display only weak lytic properties, as assessed by scanning electron micrography, outer and inner membrane depolarization studies with P. aeruginosa and leakage of liposome-entrapped calcein. Confocal microscopy of fluorescein-labeled pre-elafin/trappin-2 suggests that this protein possesses the ability to translocate across membranes. This correlates with the finding that pre-elafin/trappin-2 and elafin bind to DNA in vitro and attenuate the expression of some P. aeruginosa virulence factors, namely the biofilm formation and the secretion of pyoverdine.
   Conclusions: The N-terminal cementoin domain adopts a-helical secondary structures in a membrane mimetic environment, which is common in antimicrobial peptides. However, unlike numerous linear polycationic antimicrobial peptides, membrane disruption does not appear to be the main function of either cementoin, elafin or full-length pre-elafin/trappin-2 against P. aeruginosa. Our results rather suggest that pre-elafin/trappin-2 and elafin, but not cementoin, possess the ability to modulate the expression of some P. aeruginosa virulence factors, possibly through acting on intracellular targets.
C1 [Bellemare, Audrey; Vernoux, Nathalie; Morin, Sebastien; Gagne, Stephane M.; Bourbonnais, Yves] Univ Laval, Inst Biol Integrat & Syst & Regrp PROTEO, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.
   [Vernoux, Nathalie] Univ Laval, INAF, Dept Sci Aliments & Nutr, Fac Sci Agr & Alimentat, Quebec City, PQ, Canada.
   [Morin, Sebastien] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Bourbonnais, Y (corresponding author), Univ Laval, Inst Biol Integrat & Syst & Regrp PROTEO, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.
EM Yves.Bourbonnais@bcm.ulaval.ca
OI Morin, Sebastien/0000-0003-4426-326X
FU Fonds quebecois de la recherche sur la nature et les technologiesFQRNT;
   Regroupement quebecois 'PROTEO'; Fonds de la recherche en sante du
   QuebecFonds de la Recherche en Sante du Quebec; Natural Sciences and
   Engineering Research Council of CanadaNatural Sciences and Engineering
   Research Council of CanadaCGIAR
FX We would like to thank Richard Janvier for his valuable expertise in
   scanning electron micrography and confocal microscopy and Steve Charette
   for critical reading of the manuscript. We also acknowledge the Fonds
   quebecois de la recherche sur la nature et les technologies for a
   studentship to A.B., the Regroupement quebecois 'PROTEO' for a
   fellowship to N.V. and the Fonds de la recherche en sante du Quebec for
   a studentship to S.M. This work was supported by grants from the Natural
   Sciences and Engineering Research Council of Canada to S.M.G. and Y.B.
CR Ambrosi C, 2005, J BACTERIOL, V187, P5097, DOI 10.1128/JB.187.15.5097-5107.2005
   Baranger K, 2008, FEBS J, V275, P2008, DOI 10.1111/j.1742-4658.2008.06355.x
   Bellemare A, 2008, ANTIMICROB AGENTS CH, V52, P483, DOI 10.1128/AAC.00585-07
   BOURBONNAIS Y, 1993, EMBO J, V12, P285, DOI 10.1002/j.1460-2075.1993.tb05655.x
   Bourbonnais Y, 2000, PROTEIN EXPRES PURIF, V20, P485, DOI 10.1006/prep.2000.1338
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Devine DA, 2003, MOL IMMUNOL, V40, P431, DOI 10.1016/S0161-5890(03)00162-7
   Doring Gerd, 2004, J Cyst Fibros, V3, P67, DOI 10.1016/j.jcf.2004.03.008
   Doucet A, 2007, BIOCHEM J, V405, P455, DOI 10.1042/BJ20070020
   Doucet N, 2007, J BIOL CHEM, V282, P21448, DOI 10.1074/jbc.M609777200
   Elkin Sarah, 2003, Expert Rev Anti Infect Ther, V1, P609, DOI 10.1586/14787210.1.4.609
   Erwin AL, 2002, CURR OPIN PULM MED, V8, P547, DOI 10.1097/00063198-200211000-00011
   Favre-Bonte S, 2003, J ANTIMICROB CHEMOTH, V52, P598, DOI 10.1093/jac/dkg397
   Francart C, 1997, J MOL BIOL, V268, P666, DOI 10.1006/jmbi.1997.0983
   Giacometti A, 1999, J ANTIMICROB CHEMOTH, V44, P641, DOI 10.1093/jac/44.5.641
   Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951
   Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6
   Haney EF, 2009, BBA-BIOMEMBRANES, V1788, P1639, DOI 10.1016/j.bbamem.2009.01.002
   Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001
   Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06
   Hoiby N, 2005, J Cyst Fibros, V4 Suppl 2, P49, DOI 10.1016/j.jcf.2005.05.018
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   KAISER C, 1994, LAB COURSE MANUAL ME
   Katsu T, 2007, ANAL SCI, V23, P517, DOI 10.2116/analsci.23.517
   Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007
   Kobayashi S, 2004, BIOCHEMISTRY-US, V43, P15610, DOI 10.1021/bi048206q
   Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145
   Li Q, 2010, RESPIRATION, V79, P68, DOI 10.1159/000218154
   Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875
   LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546
   Marcotte I, 2004, BIOPHYS J, V86, P1587, DOI 10.1016/S0006-3495(04)74226-5
   Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306
   Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8
   McMichael JW, 2005, AM J RESP CELL MOL, V32, P443, DOI 10.1165/rcmb.2004-0250OC
   Meyer-Hoffert U, 2003, EXP DERMATOL, V12, P418, DOI 10.1034/j.1600-0625.2002.120409.x
   MOLINARI G, 1993, J ANTIMICROB CHEMOTH, V31, P681, DOI 10.1093/jac/31.5.681
   Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.0.CO;2-H
   MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024
   MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399
   MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023
   Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d
   Nalca Y, 2006, ANTIMICROB AGENTS CH, V50, P1680, DOI 10.1128/AAC.50.5.1680-1688.2006
   Nan YH, 2009, PEPTIDES, V30, P832, DOI 10.1016/j.peptides.2009.01.015
   Otvos L, 2005, J PEPT SCI, V11, P697, DOI 10.1002/psc.698
   Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097
   Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159
   PEDERSEN SS, 1989, J CLIN MICROBIOL, V27, P691, DOI 10.1128/JCM.27.4.691-699.1989
   Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010
   Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020
   Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569
   Schwab U, 1999, ANTIMICROB AGENTS CH, V43, P1435, DOI 10.1128/AAC.43.6.1435
   Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5
   Simpson AJ, 2001, J IMMUNOL, V167, P1778, DOI 10.4049/jimmunol.167.3.1778
   Singh PK, 2000, AM J PHYSIOL-LUNG C, V279, pL799
   Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182
   Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286
   Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l
   WIEDOW O, 1991, BIOCHEM BIOPH RES CO, V174, P6, DOI 10.1016/0006-291X(91)90476-N
   WIEDOW O, 1990, J BIOL CHEM, V265, P14791
   Wilkinson TS, 2009, AM J PATHOL, V174, P1338, DOI 10.2353/ajpath.2009.080746
   Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29
   Zhang LJ, 2004, EXPERT OPIN INV DRUG, V13, P97
   Zhang LJ, 2005, ANTIMICROB AGENTS CH, V49, P2921, DOI 10.1128/AAC.49.7.2921-2927.2005
   Zhang LJ, 2006, EXPERT OPIN PHARMACO, V7, P653, DOI 10.1517/14656566.7.6.653
NR 68
TC 13
Z9 13
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD OCT 8
PY 2010
VL 10
AR 253
DI 10.1186/1471-2180-10-253
PG 13
WC Microbiology
SC Microbiology
GA 667WF
UT WOS:000283226300001
PM 20932308
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Appenzeller-Herzog, C
   Riemer, J
   Zito, E
   Chin, KT
   Ron, D
   Spiess, M
   Ellgaard, L
AF Appenzeller-Herzog, Christian
   Riemer, Jan
   Zito, Ester
   Chin, King-Tung
   Ron, David
   Spiess, Martin
   Ellgaard, Lars
TI Disulphide production by Ero1 alpha-PDI relay is rapid and effectively
   regulated
SO EMBO JOURNAL
LA English
DT Article
DE disulphide-bond formation; endoplasmic reticulum; Ero1; glutathione;
   protein disulphide isomerase
ID ENDOPLASMIC-RETICULUM STRESS; BOND FORMATION; THIOL OXIDASE; PROTEIN;
   GLUTATHIONE; ISOMERASE; OXIDOREDUCTASE; OXIDATION; COMPLEX; PDI
AB The molecular networks that control endoplasmic reticulum (ER) redox conditions in mammalian cells are incompletely understood. Here, we show that after reductive challenge the ER steady-state disulphide content is restored on a time scale of seconds. Both the oxidase Ero1 alpha and the oxidoreductase protein disulphide isomerase (PDI) strongly contribute to the rapid recovery kinetics, but experiments in ERO1-deficient cells indicate the existence of parallel pathways for disulphide generation. We find PDI to be the main substrate of Ero1 alpha, and mixed-disulphide complexes of Ero1 primarily form with PDI, to a lesser extent with the PDI-family members ERp57 and ERp72, but are not detectable with another homologue TMX3. We also show for the first time that the oxidation level of PDIs and glutathione is precisely regulated. Apparently, this is achieved neither through ER import of thiols nor by transport of disulphides to the Golgi apparatus. Instead, our data suggest that a dynamic equilibrium between Ero1- and glutathione disulphide-mediated oxidation of PDIs constitutes an important element of ER redox homeostasis. The EMBO Journal (2010) 29, 3318-3329. doi:10.1038/emboj.2010.203; Published online 27 August 2010
C1 [Appenzeller-Herzog, Christian] Univ Basel, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland.
   [Appenzeller-Herzog, Christian; Riemer, Jan; Ellgaard, Lars] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark.
   [Appenzeller-Herzog, Christian; Spiess, Martin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Zito, Ester; Chin, King-Tung; Ron, David] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA.
   [Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge, England.
RP Appenzeller-Herzog, C (corresponding author), Univ Basel, Dept Pharmaceut Sci, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM christian.appenzeller@unibas.ch; lellgaard@bio.ku.dk
RI Riemer, Jan/AAC-1072-2021; Zito, Ester/AAA-7246-2020;
   Appenzeller-Herzog, Christian/A-2894-2014; Zito, Ester/ABB-9687-2020;
   Riemer, Jan/B-3340-2012; Ellgaard, Lars/I-9034-2014
OI Zito, Ester/0000-0001-7786-7698; Appenzeller-Herzog,
   Christian/0000-0001-7430-294X; Ellgaard, Lars/0000-0002-7018-0137;
   Spiess, Martin/0000-0001-7139-0550; Ron, David/0000-0002-3014-5636
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF); Bohringer Ingelheim Foundation; Novartis Stiftung;
   CarlsbergfondetCarlsberg Foundation; Novo Nordisk FondenNovo Nordisk
   Foundation; European Molecular Biology OrganizationEuropean Molecular
   Biology Organization (EMBO); National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA; Medical Research CouncilMedical Research Council UK (MRC)
   [G0600717B] Funding Source: researchfish
FX We thank Sandra Abel Nielsen and Nicole Beuret for excellent technical
   assistance, Mirko Lukic for the production of plastic cover-slips,
   Roberto Sitia, Ineke Braakman, Jonathan Silver, Gunter J Hammerling and
   An Helenius for providing reagents, Kazutaka Araki and Kazuhiro Nagata
   for sharing data before publication and the members of the Ellgaard
   laboratory and Jakob R Winther for helpful discussions and critical
   reading of the paper. Funding obtained from the Swiss National Science
   Foundation (SNSF), the Bohringer Ingelheim Foundation, the Novartis
   Stiftung, Carlsbergfondet, Novo Nordisk Fonden, the European Molecular
   Biology Organization and the National Institutes of Health is gratefully
   acknowledged. CA-H is an independent ambizione fellow of the SNSF.
CR Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202
   APPENZELLERHERZ.C, 2008, Signal, V10, P55
   Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010
   Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230
   Banhegyi G, 1999, J BIOL CHEM, V274, P12213, DOI 10.1074/jbc.274.18.12213
   Barzilay E, 2005, TRAFFIC, V6, P794, DOI 10.1111/j.1600-0854.2005.00317.x
   Bass R, 2004, J BIOL CHEM, V279, P5257, DOI 10.1074/jbc.M304951200
   Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493
   Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827
   Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645
   Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200
   Cuozzo JW, 1999, NAT CELL BIOL, V1, P130
   Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027
   Dias-Gunasekara S, 2005, J BIOL CHEM, V280, P33066, DOI 10.1074/jbc.M505023200
   Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105
   Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880
   Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7
   Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9
   Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200
   Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288
   Gilady SY, 2010, CELL STRESS CHAPERON, V15, P619, DOI 10.1007/s12192-010-0174-1
   Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103
   Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106
   Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]
   HAUGSTETTER J, 2005, J BIOL CHEM, V83, P71
   Haugstetter J, 2007, J BIOL CHEM, V282, P33859, DOI 10.1074/jbc.M706442200
   Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154
   Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200
   Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI [10.1089/ars.2008.2326, 10.1089/ARS.2008.2326]
   Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200
   Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060
   LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004
   Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782
   Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704
   Margittai E, 2010, FEBS LETT, V584, P2995, DOI 10.1016/j.febslet.2010.05.055
   Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011
   Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288
   Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200
   Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06
   Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274
   Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041
   Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200
   Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0
   Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064
   Saaranen MJ, 2010, ANTIOXID REDOX SIGN, V12, P15, DOI 10.1089/ars.2009.2674
   Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI [10.1089/ars.2009.2625, 10.1089/ARS.2009.2625]
   Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011
   Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039
   Singh AK, 2008, J BIOL CHEM, V283, P15762, DOI 10.1074/jbc.M800982200
   THORPE C, 2010, ANTIOXID REDOX SIGN, DOI DOI 10.1089/ARS.2010.3098
   Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001
   Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571
   Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200
   Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200
   Yang Y, 2007, P NATL ACAD SCI USA, V104, P10813, DOI 10.1073/pnas.0702027104
   Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009
   Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086
NR 57
TC 89
Z9 90
U1 1
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD OCT 6
PY 2010
VL 29
IS 19
BP 3318
EP 3329
DI 10.1038/emboj.2010.203
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 673YS
UT WOS:000283700700010
PM 20802462
OA Green Published
DA 2021-01-25
ER

PT J
AU Massa, C
   Guarnaccia, C
   Lamba, D
   Anselmi, C
AF Massa, Claudia
   Guarnaccia, Corrado
   Lamba, Doriano
   Anselmi, Claudio
TI Insight into the structure of an endopolygalacturonase from the
   phytopathogen Burkholderia cepacia: A biochemical and computational
   study
SO BIOCHIMIE
LA English
DT Article
DE Disulphide bridges mapping; MALDI mass spectrometry; Fold recognition;
   Low homology; Molecular dynamics
ID POLYGALACTURONASE-INHIBITING PROTEINS; PARALLEL BETA-HELIX;
   CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; ASPERGILLUS-NIGER; SEQUENCE;
   IDENTIFICATION; PROCESSIVITY; FEATURES; PROFILE
AB We have recently investigated and characterized the mode of action of BcPeh28A, an endopolygalacturonase (endoPG) from the phytopathogen Burkholderia cepacia. EndoPGs belong to glycoside hydrolase family 28 and are responsible for the hydrolysis of the non-esterified regions of pectins.
   Here we report a 3-D structural model of BcPeh28A by combining mass spectrometry (MS) analysis, aimed at disulphide bridges mapping, and computational modelling tools. MS analyses have revealed the complete pattern of disulphide bridges in BcPeh28A, pointing out the presence of three disulphide bonds, defined as Cys3-25, Cys216-244 and Cys309-421. A 3-D model of BcPeh28A was generated by computational methods based on profile-profile sequence alignments and fold recognition algorithms. The final model exhibits a right-handed beta-helix fold with eleven beta-helical coils and includes the disulphide bonds as additional spatial restraints. Molecular dynamics simulations have been performed to test the conformational stability of the model.
   Finally, the structural analysis of the BcPeh28A model allows defining the architecture and the amino acid topology of the subsites involved in the catalysis and in the substrate binding specificity. (C) 2010 Elsevier Masson SAS. All rights reserved.
C1 [Massa, Claudia] Sincrotrone Trieste SCpA, Struct Biol Lab, I-34149 Trieste, Italy.
   [Guarnaccia, Corrado] Int Ctr Genet Engn & Biotechnol, ICGEB, I-34012 Trieste, Italy.
   [Lamba, Doriano] CNR, Ist Cristallog, Unita Org Supporto, I-34149 Trieste, Italy.
   [Anselmi, Claudio] ISAS, Int Sch Adv Studies Stat & Biol Phys, I-34014 Trieste, Italy.
RP Massa, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM claudia.massa@unibas.ch; guarna@icgeb.org; doriano.lamba@ts.ic.cnr.it;
   claudio.anselmi@biophys.mpg.de
RI Lamba, Doriano/L-9808-2018; Lamba, Doriano/B-2961-2011; Anselmi,
   Claudio/D-6244-2012; Anselmi, Claudio/Q-6599-2019
OI Lamba, Doriano/0000-0001-6859-7868; Lamba, Doriano/0000-0001-6859-7868;
   Anselmi, Claudio/0000-0002-3017-5085; Anselmi,
   Claudio/0000-0002-3017-5085
CR Andre-Leroux G, 2009, BBA-PROTEINS PROTEOM, V1794, P5, DOI 10.1016/j.bbapap.2008.09.004
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bonivento D, 2008, PROTEINS, V70, P294, DOI 10.1002/prot.21610
   Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298
   BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115
   Cho SW, 2001, J MOL BIOL, V311, P863, DOI 10.1006/jmbi.2001.4919
   COLLMER A, 1986, ANNU REV PHYTOPATHOL, V24, P383, DOI 10.1146/annurev.py.24.090186.002123
   D'Ovidio R, 2004, BBA-PROTEINS PROTEOM, V1696, P237, DOI 10.1016/j.bbapap.2003.08.012
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005
   Federici L, 2001, P NATL ACAD SCI USA, V98, P13425, DOI 10.1073/pnas.231473698
   Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464
   Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556
   Heffron S, 1998, J STRUCT BIOL, V122, P223, DOI 10.1006/jsbi.1998.3978
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Huwiler Kristin G, 2003, J Biomol Tech, V14, P289
   Jacobs JL, 2008, APPL ENVIRON MICROB, V74, P3121, DOI 10.1128/AEM.01941-07
   Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418
   Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Markovic O, 2001, PROTEIN ENG, V14, P615, DOI 10.1093/protein/14.9.615
   Massa C, 2007, BIOCHEM J, V407, P207, DOI 10.1042/BJ20061833
   Massa C, 2007, PROTEIN EXPRES PURIF, V54, P300, DOI 10.1016/j.pep.2007.03.019
   Michel G, 2001, J BIOL CHEM, V276, P40202, DOI 10.1074/jbc.M100670200
   Pages S, 2001, J BIOL CHEM, V276, P33652, DOI 10.1074/jbc.M105770200
   Petersen TN, 1997, STRUCTURE, V5, P533, DOI 10.1016/S0969-2126(97)00209-8
   Pickersgill R, 1998, J BIOL CHEM, V273, P24660, DOI 10.1074/jbc.273.38.24660
   Pijning T, 2009, FEBS LETT, V583, P3665, DOI 10.1016/j.febslet.2009.10.047
   Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27
   Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200
   Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6
   Shimizu T, 2002, BIOCHEMISTRY-US, V41, P6651, DOI 10.1021/bi025541a
   Shimizu T, 2000, EUR J BIOCHEM, V267, P2380, DOI 10.1046/j.1432-1327.2000.01249.x
   Sorensen JF, 2004, BBA-PROTEINS PROTEOM, V1696, P275, DOI 10.1016/j.bbapap.2003.09.016
   van Pouderoyen G, 2003, FEBS LETT, V554, P462, DOI 10.1016/S0014-5793(03)01221-3
   van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474
   Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   Weichenberger CX, 2006, BIOINFORMATICS, V22, P1397, DOI 10.1093/bioinformatics/btl128
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314
   Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148
   YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994
NR 48
TC 2
Z9 2
U1 2
U2 15
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD OCT
PY 2010
VL 92
IS 10
BP 1445
EP 1453
DI 10.1016/j.biochi.2010.07.007
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 673DB
UT WOS:000283637800022
PM 20637827
DA 2021-01-25
ER

PT J
AU Biasini, M
   Mariani, V
   Haas, J
   Scheuber, S
   Schenk, AD
   Schwede, T
   Philippsen, A
AF Biasini, Marco
   Mariani, Valerio
   Haas, Juergen
   Scheuber, Stefan
   Schenk, Andreas D.
   Schwede, Torsten
   Philippsen, Ansgar
TI OpenStructure: a flexible software framework for computational
   structural biology
SO BIOINFORMATICS
LA English
DT Article
ID MODEL QUALITY ESTIMATION; SWISS-MODEL; PROTEIN; WORKSPACE
AB Motivation: Developers of new methods in computational structural biology are often hampered in their research by incompatible software tools and non-standardized data formats. To address this problem, we have developed OpenStructure as a modular open source platform to provide a powerful, yet flexible general working environment for structural bioinformatics. OpenStructure consists primarily of a set of libraries written in C++ with a cleanly designed application programmer interface. All functionality can be accessed directly in C++ or in a Python layer, meeting both the requirements for high efficiency and ease of use. Powerful selection queries and the notion of entity views to represent these selections greatly facilitate the development and implementation of algorithms on structural data. The modular integration of computational core methods with powerful visualization tools makes OpenStructure an ideal working and development environment. Several applications, such as the latest versions of IPLT and QMean, have been implemented based on OpenStructure-demonstrating its value for the development of next-generation structural biology algorithms.
C1 [Biasini, Marco; Mariani, Valerio; Haas, Juergen; Scheuber, Stefan; Schwede, Torsten; Philippsen, Ansgar] Univ Basel, Biozentrum, Basel, Switzerland.
   [Biasini, Marco; Mariani, Valerio; Haas, Juergen; Scheuber, Stefan; Schwede, Torsten] SIB Swiss Inst Bioinformat, Basel, Switzerland.
   [Schenk, Andreas D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Schenk,
   Andreas/0000-0001-9214-2505
FU SIB Swiss Institute of Bioinformatics; Biozentrum University of Basel;
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [3U54GM074958-05S2];
   Rutgers University [3U54GM074958-05S2]; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958] Funding Source: NIH
   RePORTER
FX Development of OpenStructure was funded by the SIB Swiss Institute of
   Bioinformatics and the Biozentrum University of Basel. Implementation of
   the structure comparison for the Nature PSI SBKB Protein Model Portal
   based on OpenStructure was supported by the National Institutes of
   Health as a sub-grant with Rutgers University, under Prime Agreement
   Award Number: (3U54GM074958-05S2).
CR Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5
   Benkert P, 2009, PROTEINS, V77, P173, DOI 10.1002/prot.22532
   Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438
   DeLorbe JE, 2009, J AM CHEM SOC, V131, P16758, DOI 10.1021/ja904698q
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8
   Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Hinsen K, 2000, J COMPUT CHEM, V21, P79, DOI 10.1002/(SICI)1096-987X(20000130)21:2<79::AID-JCC1>3.0.CO;2-B
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kohlbacher O, 2000, BIOINFORMATICS, V16, P815, DOI 10.1093/bioinformatics/16.9.815
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
NR 17
TC 28
Z9 28
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD OCT
PY 2010
VL 26
IS 20
BP 2626
EP 2628
DI 10.1093/bioinformatics/btq481
PG 3
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 661SZ
UT WOS:000282749700021
PM 20733063
OA Green Published
DA 2021-01-25
ER

PT J
AU Dill, MT
   Duong, FHT
   Vogt, JE
   Bibert, S
   Bochud, PY
   Terracciano, L
   Papassotiropoulos, A
   Roth, V
   Heim, MH
AF Dill, Michael T.
   Duong, Francois H. T.
   Vogt, Julia E.
   Bibert, Stephanie
   Bochud, Pierre-Yves
   Terracciano, Luigi
   Papassotiropoulos, Andreas
   Roth, Volker
   Heim, Markus H.
TI IFN stimulated gene expression in the liver is a better predictor of
   treatment response in chronic hepatitis C than the IL28B (IFN lambda 3)
   genotype
SO CYTOKINE
LA English
DT Meeting Abstract
CT 8th Joint Conference of the
   International-Cytokine-Society/International-Society-for-and-Cytokine-Re
   search
CY OCT 03-07, 2010
CL Chicago, IL
SP Int Cytokine Soc, Int Soc Interferon & Cytokine Res
C1 [Dill, Michael T.; Duong, Francois H. T.; Heim, Markus H.] Univ Basel, Dept Biomed, Hepatol Lab, Basel, Switzerland.
   [Dill, Michael T.] Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland.
   [Vogt, Julia E.; Roth, Volker] Univ Basel, Dept Comp Sci, Basel, Switzerland.
   [Bibert, Stephanie; Bochud, Pierre-Yves] Univ Lausanne Hosp, Dept Med, Infect Dis Serv, Lausanne, Switzerland.
   [Bibert, Stephanie; Bochud, Pierre-Yves] Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland.
   [Bibert, Stephanie; Bochud, Pierre-Yves] Univ Lausanne, Lausanne, Switzerland.
   [Terracciano, Luigi] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Biozentrum, Div Mol Psychol, Life Sci Training Facil, Basel, Switzerland.
RI Roth, Volker/Q-4025-2017; Bochud, Pierre-Yves/ABE-5979-2020
OI Roth, Volker/0000-0003-0991-0273; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
J9 CYTOKINE
JI Cytokine
PD OCT-NOV
PY 2010
VL 52
IS 1-2
SI SI
BP 41
EP 41
DI 10.1016/j.cyto.2010.07.173
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 657NC
UT WOS:000282418400152
DA 2021-01-25
ER

PT J
AU O'Keefe, KJ
   Silander, OK
   McCreery, H
   Weinreich, DM
   Wright, KM
   Chao, L
   Edwards, SV
   Remold, SK
   Turner, PE
AF O'Keefe, Kara J.
   Silander, Olin K.
   McCreery, Helen
   Weinreich, Daniel M.
   Wright, Kevin M.
   Chao, Lin
   Edwards, Scott V.
   Remold, Susanna K.
   Turner, Paul E.
TI GEOGRAPHIC DIFFERENCES IN SEXUAL REASSORTMENT IN RNA PHAGE
SO EVOLUTION
LA English
DT Article
DE Biogeography; genetic variation; hybridization; phylogenetics;
   population structure; sex
ID DOUBLE-STRANDED-RNA; VIRUS PHI 6; BACTERIOPHAGE PHI-6;
   POPULATION-DYNAMICS; EVOLUTION; GENOMES; SUBSTITUTIONS; COMMUNITIES;
   DIVERSITY
AB The genetic structure of natural bacteriophage populations is poorly understood. Recent metagenomic studies suggest that phage biogeography is characterized by frequent migration. Using virus samples mostly isolated in Southern California, we recently showed that very little population structure exists in segmented RNA phage of the Cystoviridae family due to frequent segment reassortment (sexual genetic mixis) between unrelated virus individuals. Here we use a larger genetic dataset to examine the structure of Cystoviridae phage isolated from three geographic locations in Southern New England. We document extensive natural variation in the physical sizes of RNA genome segments for these viruses. In addition, consistent with earlier findings, our phylogenetic analyses and calculations of linkage disequilibrium (LD) show no evidence of within-segment recombination in wild populations. However, in contrast to the prior study, our analysis finds that reassortment of segments between individual phage plays a lesser role among cystoviruses sampled in New England, suggesting that the evolutionary importance of genetic mixis in Cystoviridae phage may vary according to geography. We discuss possible explanations for these conflicting results across the studies, such as differing local ecology and its impact on phage growth, and geographic differences in selection against hybrid phage genotypes.
C1 [O'Keefe, Kara J.; Turner, Paul E.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
   [O'Keefe, Kara J.; Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.
   [Silander, Olin K.] Univ Basel, Biozentrum, Core Program Computat & Syst Biol, Basel, Switzerland.
   [McCreery, Helen] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.
   [Weinreich, Daniel M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
   [Wright, Kevin M.] Duke Univ, Dept Biol, Durham, NC 27708 USA.
   [Chao, Lin] Univ Calif San Diego, Sect Ecol Evolut & Behav, La Jolla, CA 92093 USA.
   [Remold, Susanna K.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA.
RP O'Keefe, KJ (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
EM paul.turner@yale.edu
RI McCreery, Helen/AAI-7654-2020; Edwards, Scott V./D-9071-2018
OI McCreery, Helen/0000-0003-3811-7960; Edwards, Scott
   V./0000-0003-2535-6217; Silander, Olin/0000-0003-4105-8316
FU National Science FoundationNational Science Foundation (NSF)
   [DBI-0400834, DEB-0452163]
FX We thank S. Abedon, R. Froissart, P. Lewis, J. Wertz, B. O'Meara (with
   his instructive website), E. Simms's laboratory group and the Turner
   laboratory group for helpful discussions and manuscript comments, M.B.
   Decker for assistance with some figure graphics, and C. Burch for
   providing PCR and sequencing primers. This work was supported by a
   National Science Foundation Microbial Biology Postdoctoral Fellowship
   DBI-0400834 to KJO, and a National Science Foundation grant DEB-0452163
   to PET.
CR Abedon ST, 2008, BACTERIOPHAGE ECOLOG
   Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358
   Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368
   Ashelford KE, 1999, APPL ENVIRON MICROB, V65, P169
   BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0
   Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003
   Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399
   Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477
   Chao L, 1997, GENETICS, V147, P953
   CHAO L, 1992, TRENDS ECOL EVOL, V7, P147, DOI 10.1016/0169-5347(92)90207-R
   CHAO L, 1988, J THEOR BIOL, V133, P99, DOI 10.1016/S0022-5193(88)80027-4
   Dennehy JJ, 2007, EVOLUTION, V61, P2516, DOI 10.1111/j.1558-5646.2007.00205.x
   Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735
   Duffy S, 2007, EVOLUTION, V61, P2614, DOI 10.1111/j.1558-5646.2007.00226.x
   Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119
   HALL TA, 2007, BIOEDIT USER FRIENDL
   Herbeck JT, 2007, AIDS RES HUM RETROV, V23, P755, DOI 10.1089/aid.2006.0237.A
   HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103
   Laurila MRL, 2002, J BIOL CHEM, V277, P17117, DOI 10.1074/jbc.M111220200
   Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407
   Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999
   Mindich L, 1999, J BACTERIOL, V181, P4505, DOI 10.1128/JB.181.15.4505-4508.1999
   Mindich L, 2004, VIRUS RES, V101, P83, DOI 10.1016/j.virusres.2003.12.008
   Mindich L, 1999, ADV VIRUS RES, V53, P341, DOI 10.1016/S0065-3527(08)60355-3
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Nei M., 1987, MOL EVOLUTIONARY GEN
   Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699
   OHTA T, 1995, J MOL EVOL, V40, P56, DOI 10.1007/BF00166595
   Page R.D.M., 1993, USERS MANUAL COMPONE
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   PRESSING J, 1984, J MOL EVOL, V20, P135, DOI 10.1007/BF02257374
   Raftery AE, 1996, MARKOV CHAIN MONTE C, P163
   Rizvanov AA, 2004, VIROLOGY, V327, P225, DOI 10.1016/j.virol.2004.07.012
   RODGER SM, 1979, J VIROL, V30, P839, DOI 10.1128/JVI.30.3.839-846.1979
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359
   Silander OK, 2005, P NATL ACAD SCI USA, V102, P19009, DOI 10.1073/pnas.0503074102
   Snyder JC, 2007, P NATL ACAD SCI USA, V104, P19102, DOI 10.1073/pnas.0709445104
   Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160
   Swofford DL., 2002, PAUP PHYLOGENETIC AN
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Turner PE, 2009, EXPERIMENTAL EVOLUTION: CONCEPTS, METHODS, AND APPLICATIONS OF SELECTION EXPERIMENTS, P479
   Turner PE, 2003, ORIGINS LIFE EVOL B, V33, P95, DOI 10.1023/A:1023973015054
   Turner PE, 1998, GENETICS, V150, P523
   Turner PE, 1999, J VIROL, V73, P2420, DOI 10.1128/JVI.73.3.2420-2424.1999
   VIDAVER AK, 1973, J VIROL, V11, P799, DOI 10.1128/JVI.11.5.799-805.1973
   Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000
   Xu XY, 2004, VIRUS RES, V103, P55, DOI 10.1016/j.virusres.2004.02.013
NR 48
TC 15
Z9 15
U1 0
U2 12
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0014-3820
J9 EVOLUTION
JI Evolution
PD OCT
PY 2010
VL 64
IS 10
BP 3010
EP 3023
DI 10.1111/j.1558-5646.2010.01040.x
PG 14
WC Ecology; Evolutionary Biology; Genetics & Heredity
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity
GA 659NN
UT WOS:000282573800015
PM 20500219
DA 2021-01-25
ER

PT J
AU Karow, AR
   Klostermeier, D
AF Karow, Anne R.
   Klostermeier, Dagmar
TI A Structural Model for the DEAD Box Helicase YxiN in Solution:
   Localization of the RNA Binding Domain
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE DEAD box helicase; smFRET; ribosome assembly; RNA recognition motif; RNA
   unwinding
ID C-TERMINAL DOMAIN; ESCHERICHIA-COLI DBPA; 23S RIBOSOMAL-RNA;
   BIOCHEMICAL-CHARACTERIZATION; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE;
   GENERAL RNA; GROUP-I; PROTEIN; COMPLEX
AB DEAD box proteins consist of a common helicase core formed by two globular RecA domains that are separated by a cleft. The helicase core acts as a nucleotide-dependent switch that alternates between open and closed conformations during the catalytic cycle of duplex separation, thereby providing basic helicase activity. Flanking domains can direct the helicase core to a specific RNA substrate by mediating high-affinity or high-specificity RNA binding. In addition, they may position RNA for the helicase core or may directly contribute to unwinding. While structures of different helicase cores have been determined previously, little is known about the orientation of flanking domains relative to the helicase core.
   YxiN is a DEAD box protein that consists of a helicase core and a C-terminal RNA binding domain (RBD) that mediates specific binding to hairpin 92 in 23S rRNA. To provide a framework for understanding the functional cooperation of the YxiN helicase core and the RBD, we mapped the orientation of the RBD in single-molecule fluorescence resonance energy transfer experiments. We present a model for the global conformation of YxiN in which the RBD lies above a slightly concave patch that is formed by flexible loops on the surface of the C-terminal RecA domain. The orientation of the RBD is different from the orientations of flanking domains in the Thermus thermophilus DEAD box protein Hera and in Saccharomyces cerevisiae Mss116p, in line with the different functions of these DEAD box proteins and of their RBDs. Interestingly, the corresponding patch on the C-terminal RecA domain that is covered by the YxiN RBD is also part of the interface between the translation factors eIF4A and eIF4G. Possibly, this region constitutes an adaptable interface that generally allows for the interaction of the helicase core with additional domains or interacting factors. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Karow, Anne R.; Klostermeier, Dagmar] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
FU Volkswagen-StiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF)
FX This work was supported by the Volkswagen-Stiftung and the Swiss
   National Science Foundation. We thank Ines Hertel for providing
   excellent technical assistance and Regula Aregger for performing control
   smFRET experiments.
CR Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   Aregger R, 2009, BIOCHEMISTRY-US, V48, P10679, DOI 10.1021/bi901278p
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032
   Diges CM, 2005, BIOCHEMISTRY-US, V44, P7903, DOI 10.1021/bi050033x
   Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503
   Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472
   Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083
   Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046
   HILBERT M, 2010, NUCL ACIDS RES UNPUB
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101
   Karginov FV, 2005, J BIOL CHEM, V280, P35499, DOI 10.1074/jbc.M506815200
   Karow AR, 2007, FEBS J, V274, P463, DOI 10.1111/j.1742-4658.2006.05593.x
   Karow AR, 2009, NUCLEIC ACIDS RES, V37, P4464, DOI 10.1093/nar/gkp397
   Klostermeier D, 2009, NUCLEIC ACIDS RES, V37, P421, DOI 10.1093/nar/gkn947
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Kossen K, 1999, NUCLEIC ACIDS RES, V27, P3811, DOI 10.1093/nar/27.19.3811
   Linden MH, 2008, NUCLEIC ACIDS RES, V36, P5800, DOI 10.1093/nar/gkn581
   Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106
   Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041
   Morlang S, 1999, J MOL BIOL, V294, P795, DOI 10.1006/jmbi.1999.3282
   Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109
   Rudolph MG, 2009, RNA, V15, P1993, DOI 10.1261/rna.1820009
   Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Talavera MA, 2006, J MOL BIOL, V355, P697, DOI 10.1016/j.jmb.2005.10.058
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Tsu CA, 2001, RNA, V7, P702, DOI 10.1017/S1355838201010135
   VONMOELLE, 2009, NAT STRUCT MOL BIOL, V16, P247
   WANG S, 2007, BIOPHYS J, V94
   Wang SY, 2006, RNA, V12, P959, DOI 10.1261/rna.5906
NR 35
TC 17
Z9 17
U1 0
U2 10
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD OCT 1
PY 2010
VL 402
IS 4
BP 629
EP 637
DI 10.1016/j.jmb.2010.07.049
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 666JU
UT WOS:000283111800002
PM 20691700
DA 2021-01-25
ER

PT J
AU Kuemin, M
   Engel, J
   Wennemers, H
AF Kuemin, Michael
   Engel, Juergen
   Wennemers, Helma
TI Temperature-induced transition between polyproline I and II helices:
   quantitative fitting of hysteresis effects
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Article
DE PPI and PPII helices; CD spectroscopy; hysteresis; oligoproline;
   peptides
ID POLY-L-PROLINE; COOPERATIVE CONFORMATIONAL TRANSITIONS; LINEAR
   BIOPOLYMERS; ISOMERIZATION; STABILITY; INTERCONVERSION; PEPTIDES;
   PROTEIN
AB The conformational properties of the polyproline I (PPI) helix of oligoprolines toward heating were examined. Oligoproline H-Pro(12)-NH2 served as a model which adopts in n-PrOH a pronounced PPI conformation with all cis amide bonds, whereas a polyproline II (PPII) conformation with all trans amide bonds is predominant in pure aqueous buffer. CD spectroscopic studies revealed that a conformational change from the PPI to the PPII helix takes place upon heating and back to the PPI helix upon cooling. This conformational transition cycle is characterized by a strong hysteresis. With a quantitative fitting of the experimentally observed hysteresis loops by a newly developed iterative integration with different starting conditions, kinetic and thermodynamic parameters for the transition from the PPI to the PPII helical conformation were determined. The transition is as expected for cis-trans isomerizations of amide bonds comparatively slow (k = 0.003 s(-1) at 80 degrees C) and characterized by an activation energy E-a of 81.1 +/- 3.6 kJ mol(-1). Thermodynamically, the transition from the PPI to the PPII helix is characterized by a positive standard enthalpy (Delta H degrees = 33.5 +/- 2.1 kJ min(-1)) and a positive standard entropy (Delta S degrees = 102 +/- 6.6 J mol(-1) K-1). Copyright (C) 2010 European Peptide Society and John Wiley & Sons, Ltd.
C1 [Kuemin, Michael; Wennemers, Helma] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Engel, Juergen] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Wennemers, H (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.
EM Helma.Wennemers@unibas.ch
CR Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710
   Bachinger HP, 2005, PROTEIN FOLDING HANDBOOK, P1059
   Beausoleil E, 2000, BIOPOLYMERS, V53, P249, DOI 10.1002/(SICI)1097-0282(200003)53:3<249::AID-BIP4>3.0.CO;2-J
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Chiang YC, 2009, PROTEIN SCI, V18, P1967, DOI 10.1002/pro.208
   COWAN PM, 1955, NATURE, V176, P501, DOI 10.1038/176501a0
   Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375
   Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946
   Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818
   ENGEL J, 1970, ANGEW CHEM INT EDIT, V9, P389, DOI 10.1002/anie.197003891
   Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8
   Erdmann RS, 2009, CHIMIA, V63, P197, DOI 10.2533/chimia.2009.197
   Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750
   Fischer G, 2000, CHEM SOC REV, V29, P119, DOI 10.1039/a803742f
   Franghanel J, 2006, ANAL CHEM, V78, P4517, DOI 10.1021/ac052040x
   Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806
   Kakinoki S, 2005, POLYM BULL, V53, P109, DOI 10.1007/s00289-004-0317-6
   Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a
   Kumin M, 2007, J AM CHEM SOC, V129, P466, DOI 10.1021/ja067148o
   Kuemin M, 2009, J AM CHEM SOC, V131, P15474, DOI 10.1021/ja906466q
   Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130
   MIZUNO K, 2010, BIOPHYS J IN PRESS
   Moroder L., 2006, CIS T ISOMERIZATION, P225, DOI DOI 10.1002/9783527609338.CH11
   Mutter M, 1999, BIOPOLYMERS, V51, P121, DOI 10.1002/(SICI)1097-0282(1999)51:2<121::AID-BIP2>3.0.CO;2-O
   RABANAL F, 1993, BIOPOLYMERS, V33, P1019, DOI 10.1002/bip.360330704
   Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227
   Rothe M, 1976, PEPTIDES 1976, P309
   Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004
   Schmid F, 2005, PROTEIN FOLDING HANDBOOK, P916, DOI 10.1002/9783527619498.ch25
   SCHWARZ G, 1972, ANGEW CHEM INT EDIT, V11, P568, DOI 10.1002/anie.197205681
   Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Sonntag LS, 2006, J AM CHEM SOC, V128, P14697, DOI 10.1021/ja0654938
   STEINBERG IZ, 1960, J AM CHEM SOC, V82, P5263, DOI 10.1021/ja01505a001
   TRAUB W, 1963, NATURE, V198, P1165, DOI 10.1038/1981165a0
   Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b
   Woody RW, 2009, J AM CHEM SOC, V131, P8234, DOI 10.1021/ja901218m
NR 37
TC 28
Z9 28
U1 1
U2 43
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD OCT
PY 2010
VL 16
IS 10
SI SI
BP 596
EP 600
DI 10.1002/psc.1245
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 658GN
UT WOS:000282478600014
PM 20862727
DA 2021-01-25
ER

PT J
AU Soulard, A
   Cremonesi, A
   Moes, S
   Schutz, F
   Jeno, P
   Hall, MN
AF Soulard, Alexandre
   Cremonesi, Alessio
   Moes, Suzette
   Schuetz, Frederic
   Jenoe, Paul
   Hall, Michael N.
TI The Rapamycin-sensitive Phosphoproteome Reveals That TOR Controls
   Protein Kinase A Toward Some But Not All Substrates
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID CELL-WALL INTEGRITY; POLYMERASE-III TRANSCRIPTION;
   SACCHAROMYCES-CEREVISIAE; REGULATORY SUBUNIT; SIGNALING PATHWAY;
   NUCLEAR-LOCALIZATION; GENE-EXPRESSION; GROWTH-CONTROL; QUANTITATIVE
   PROTEOMICS; CATALYTIC SUBUNITS
AB Regulation of cell growth requires extensive coordination of several processes including transcription, ribosome biogenesis, translation, nutrient metabolism, and autophagy. In yeast, the protein kinases Target of Rapamycin (TOR) and protein kinase A (PKA) regulate these processes and are thereby the main activators of cell growth in response to nutrients. How TOR, PKA, and their corresponding signaling pathways are coordinated to control the same cellular processes is not understood. Quantitative analysis of the rapamycin-sensitive phosphoproteome combined with targeted analysis of PKA substrates suggests that TOR complex 1 (TORC1) activates PKA but only toward a subset of substrates. Furthermore, we show that TORC1 signaling impinges on BCY1, the negative regulatory subunit of PKA. Inhibition of TORC1 with rapamycin leads to BCY1 phosphorylation on several sites including T129. Phosphorylation of BCY1 T129 results in BCY1 activation and inhibition of PKA. TORC1 inhibits BCY1 T129 phosphorylation by phosphorylating and activating the S6K homolog SCH9 that in turn inhibits the MAP kinase MPK1. MPK1 phosphorylates BCY1 T129 directly. Thus, TORC1 activates PKA toward some substrates by preventing MPK1-mediated activation of BCY1.
C1 [Soulard, Alexandre; Cremonesi, Alessio; Moes, Suzette; Schuetz, Frederic; Jenoe, Paul; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
OI Soulard, Alexandre/0000-0003-3556-1994
FU Canton of Basel, SystemsX.ch; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF)
FX We thank J. M. Thevelein (University of Leuven, Belgium) for plasmids,
   R. Loewith (University of Geneva, Switzerland) for yeast strains and
   discussions, and D. Schwartz for the kind advice on using Motif-X 1.2.
   This work was supported by grants from the Canton of Basel, SystemsX.ch
   and the Swiss National Science Foundation (M.N.H).
CR Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Bharucha N, 2008, MOL BIOL CELL, V19, P2708, DOI 10.1091/mbc.E07-11-1199
   Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102
   CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653
   Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884
   Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163
   Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586
   Griffioen G, 2003, J BIOL CHEM, V278, P23460, DOI 10.1074/jbc.M210691200
   Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449
   Griffioen G, 2001, MOL CELL BIOL, V21, P511, DOI 10.1128/MCB.21.2.511-523.2001
   Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200
   Guthrie C., 1991, GUIDE YEAST GENETICS
   Hilger M, 2009, MOL CELL PROTEOMICS, V8, P1908, DOI 10.1074/mcp.M800559-MCP200
   HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791
   Ho HL, 2005, CURR GENET, V47, P273, DOI 10.1007/s00294-005-0570-8
   Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   JOHNSON KE, 1987, J BIOL CHEM, V262, P8636
   Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kassir Y, 2006, CURR DRUG TARGETS, V7, P1455, DOI 10.2174/1389450110607011455
   Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1
   Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x
   KURET J, 1988, J BIOL CHEM, V263, P9149
   Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200
   Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005
   Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101
   Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047
   Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103
   NEIGEBORN L, 1991, GENE DEV, V5, P533, DOI 10.1101/gad.5.4.533
   Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Park JI, 2005, J BIOL CHEM, V280, P2529, DOI 10.1074/jbc.M407900200
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006
   Santhanam A, 2004, EUKARYOT CELL, V3, P1261, DOI 10.1128/EC.3.5.1261-1271.2004
   Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146
   Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l
   Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007
   Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106
   Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185
   TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371
   TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517
   TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6
   Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200
   Trott A, 2005, GENETICS, V170, P1009, DOI 10.1534/genetics.105.043109
   Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020
   VERMA R, 1988, J BIOL CHEM, V263, P8576
   Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175
   Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615
   Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179
   WERNERWASHBURNE M, 1991, J BIOL CHEM, V266, P19704
   Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102
   Zappacosta F, 2002, ANAL CHEM, V74, P3221, DOI 10.1021/ac025538x
   Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110
   Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005
NR 76
TC 153
Z9 161
U1 0
U2 19
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD OCT 1
PY 2010
VL 21
IS 19
BP 3475
EP 3486
DI 10.1091/mbc.E10-03-0182
PG 12
WC Cell Biology
SC Cell Biology
GA 655UJ
UT WOS:000282275600018
PM 20702584
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Rasch, B
   Spalek, K
   Buholzer, S
   Luechinger, R
   Boesiger, P
   de Quervain, DJF
   Papassotiropoulos, A
AF Rasch, B.
   Spalek, K.
   Buholzer, S.
   Luechinger, R.
   Boesiger, P.
   de Quervain, D. J. -F.
   Papassotiropoulos, A.
TI Aversive stimuli lead to differential amygdala activation and
   connectivity patterns depending on catechol-O-methyltransferase
   Val158Met genotype
SO NEUROIMAGE
LA English
DT Article
DE Amygdala; COMT; Polymorphism; fMRI; Affective processing
ID OBSESSIVE-COMPULSIVE DISORDER; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX;
   COMT VAL(158)MET; PANIC DISORDER; PERSONALITY-TRAIT; ADOLESCENT HEALTH;
   MESSENGER-RNA; POLYMORPHISM; ASSOCIATION
AB The functional Val158Met polymorphism in the gene coding for the catechol-O-methyltransferase (COMT), the major enzyme degrading the catecholaminergic neurotransmitters dopamine, norepinephrine, and epinephrine, has been associated with differential reactivity in limbic and prefrontal brain areas in response to aversive stimuli. However, studies on COMT-genotype effects on activity of the amygdala, a brain region centrally involved in affective processing, have yielded inconsistent results. Here we investigated the impact of the COMT Val158Met polymorphism on amygdala activity and connectivity during processing of emotional and neutral pictures using functional magnetic resonance imaging (fMRI) in 56 healthy participants. Homozygosity for the low-activity Met allele was positively correlated with increased activation in the right amygdala in response to unpleasant, but not pleasant pictures. In addition, the Met allele exerted an additive effect on the positive connectivity between the right amygdala and orbitofrontal regions. Our results support previous reports of a COMT-genotype-dependent difference in amygdala responsivity as well as connectivity, and highlight the importance of naturally occurring genetic variations in the catecholaminergic system for neural activity underlying affective processing. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Rasch, B.; Spalek, K.; Buholzer, S.; Papassotiropoulos, A.] Univ Basel, Div Mol Psychol, Dept Psychol, CH-4055 Basel, Switzerland.
   [Rasch, B.; Spalek, K.; de Quervain, D. J. -F.] Univ Basel, Div Cognit Neurosci, Dept Psychol, CH-4055 Basel, Switzerland.
   [Rasch, B.; Spalek, K.; Buholzer, S.; Papassotiropoulos, A.] Univ Basel, Dept Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland.
   [Rasch, B.; de Quervain, D. J. -F.] Univ Basel, Psychiat Univ Clin, CH-4055 Basel, Switzerland.
   [Rasch, B.; de Quervain, D. J. -F.] Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland.
   [Luechinger, R.; Boesiger, P.] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland.
   [Luechinger, R.; Boesiger, P.] Swiss Fed Inst Technol, Inst Biomed Engn, CH-8092 Zurich, Switzerland.
RP Rasch, B (corresponding author), Univ Basel, Div Mol Psychol, Dept Psychol, Birmannsgasse 8, CH-4055 Basel, Switzerland.
EM Bjoern.Rasch@unibas.ch; Andreas.Papas@unibas.ch
RI Rasch, Bjorn/A-3119-2015; Luechinger, Roger/AAD-5192-2019
OI Rasch, Bjorn/0000-0001-7607-3415; Luechinger, Roger/0000-0002-7365-0421;
   de Quervain, Dominique/0000-0001-7131-2464; Papassotiropoulos,
   Andreas/0000-0002-2210-9651
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00B-106708, CRSIK0_122691]; European Science
   FoundationEuropean Science Foundation (ESF); Center of Integrative Human
   Physiology
FX Supported by grants from the Swiss National Science Foundation to D.Q.
   (PP00B-106708; CRSIK0_122691) and A.P. (CRSIK0_122691), from the
   European Science Foundation to D.Q. and A.P. (EUROStress), and by a
   grant from the Center of Integrative Human Physiology to D.Q.
CR Aleman A, 2008, BIOL PSYCHOL, V79, P58, DOI 10.1016/j.biopsycho.2008.01.009
   Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005
   Bishop SJ, 2006, COGN AFFECT BEHAV NE, V6, P62, DOI 10.3758/CABN.6.1.62
   Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220
   Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589
   Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0
   Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013
   Domschke K, 2004, INT J NEUROPSYCHOPH, V7, P183, DOI 10.1017/s146114570400416X
   Domschke K, 2008, PSYCHIAT RES-NEUROIM, V163, P13, DOI 10.1016/j.pscychresns.2007.04.016
   Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396
   Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006
   Ettinger U, 2008, NEUROPSYCHOPHARMACOL, V33, P3046, DOI 10.1038/sj.npp.1301658
   Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291
   Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011
   GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K
   Heinz A, 2006, REV NEUROSCIENCE, V17, P359
   Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002
   Huey ED, 2008, J NEUROPSYCH CLIN N, V20, P390, DOI 10.1176/appi.neuropsych.20.4.390
   Kempton MJ, 2009, INT J NEUROPSYCHOPH, V12, P371, DOI 10.1017/S1461145708009395
   Kienast T, 2008, NAT NEUROSCI, V11, P1381, DOI 10.1038/nn.2222
   KOLASSA IT, 2009, BIOL PSYCHIAT
   Lachman HM, 2008, NEUROPSYCHOPHARMACOL, V33, P3027, DOI 10.1038/npp.2008.189
   Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007
   Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8
   Lang P.J., 2008, AFFECTIVE RATINGS PI
   Lang UE, 2007, NEUROPSYCHOPHARMACOL, V32, P1950, DOI 10.1038/sj.npp.1301335
   LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008
   Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1
   McGrath M, 2004, AM J PSYCHIAT, V161, P1703, DOI 10.1176/appi.ajp.161.9.1703
   Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993
   Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016
   Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262
   Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010
   Olsson CA, 2007, GENES BRAIN BEHAV, V6, P647, DOI 10.1111/j.1601-183X.2007.00313.x
   Olsson CA, 2005, PSYCHIAT GENET, V15, P109, DOI 10.1097/00041444-200506000-00007
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087
   Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196
   Pooley EC, 2007, MOL PSYCHIATR, V12, P556, DOI 10.1038/sj.mp.4001951
   Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S
   RASCH B, 2010, NEUROIMAGE ADV, DOI DOI 10.1016/J.NEUROIMAGE.2010.01.001
   Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020
   Reuter M, 2006, INT J NEUROPSYCHOPH, V9, P155, DOI 10.1017/S1461145705005419
   Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001
   Schoenbaum G, 2000, J NEUROSCI, V20, P5179
   Schoenbaum G, 2008, BIOL PSYCHIAT, V63, P256, DOI 10.1016/j.biopsych.2007.06.003
   Shin LM, 1999, AM J PSYCHIAT, V156, P575
   Smolka MN, 2007, MOL PSYCHIATR, V12, P307, DOI 10.1038/sj.mp.4001946
   Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005
   Stein MB, 2005, NEUROPSYCHOPHARMACOL, V30, P2092, DOI 10.1038/sj.npp.1300787
   Torregrossa MM, 2008, BIOL PSYCHIAT, V63, P253, DOI 10.1016/j.biopsych.2007.11.014
   Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004
   WILLIAMS LM, 2010, NEUROIMAGE ADV, DOI DOI 10.1016/J.NEUROIMAGE.2010.01.084
   Woo JM, 2004, J PSYCHIATR RES, V38, P365, DOI 10.1016/j.jpsychires.2004.01.001
NR 54
TC 38
Z9 40
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1053-8119
EI 1095-9572
J9 NEUROIMAGE
JI Neuroimage
PD OCT 1
PY 2010
VL 52
IS 4
BP 1712
EP 1719
DI 10.1016/j.neuroimage.2010.05.054
PG 8
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 635YY
UT WOS:000280695200059
PM 20510373
DA 2021-01-25
ER

PT J
AU Braissant, O
   Wirz, D
   Gopfert, B
   Daniels, AU
AF Braissant, Olivier
   Wirz, Dieter
   Goepfert, Beat
   Daniels, A. U.
TI Biomedical Use of Isothermal Microcalorimeters
SO SENSORS
LA English
DT Review
DE microcalorimeters; bacteria; human cell lines; antimicrobial agent
   testing; materials biocompatibility
ID HUMAN SKELETAL-MUSCLE; MIC DETERMINATIONS; MICROBIAL ACTIVITY;
   ESCHERICHIA-COLI; CALORIMETRY; GROWTH; HEAT; ENTHALPY; CHIP;
   THERMOGENESIS
AB Isothermal microcalorimetry is becoming widely used for monitoring biological activities in vitro. Microcalorimeters are now able to measure heat production rates of less than a microwatt. As a result, metabolism and growth of relatively small numbers of cultured bacteria, protozoans, human cells and even small animals can be monitored continuously and extremely accurately at any chosen temperature. Dynamic effects on these organisms of changes in the culture environment-or of additions to it-are easily assessed over periods from hours to days. In addition microcalorimetry is a non-destructive method that does not require much sample preparation. It is also completely passive and thus allows subsequent evaluations of any kind on the undisturbed sample. In this review, we present a basic description of current microcalorimetry instruments and an overview of their use for various biomedical applications. These include detecting infections, evaluating effects of pharmaceutical or antimicrobial agents on cells, monitoring growth of cells harvested for tissue eingineering, and assessing medical and surgical device material physico-chemical stability and cellular biocompatibility.
C1 [Braissant, Olivier; Wirz, Dieter; Goepfert, Beat; Daniels, A. U.] Univ Basel, Biozentrum Pharmazentrum, Lab Biomech & Biocalorimetry, CH-4056 Basel, Switzerland.
RP Braissant, O (corresponding author), Univ Basel, Biozentrum Pharmazentrum, Lab Biomech & Biocalorimetry, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM olivier.braissant@unibas.ch; dieter.wirz@unibas.ch;
   beat.goefpert@unibas.ch; au.daniels@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
FU Swiss foundations
FX The authors wish to gratefully thank the following Swiss foundations and
   individuals for financial support: ProMotio, HOFZ, H. Wyss and H.H.
   Zaeslin. Chondrocyte cultures and cells counts used in Figure 3 were
   kindly provided by R. Santoro and I. Martin, Tissue Engineering Research
   Group, University Hospital, Basel, Switzerland. Biopsies samples used in
   Figure 5 and confirmation of the tumorous nature of these biopsies were
   kindly provided by F. Hefti (Universitats-Kinderspital beider Basel) and
   the members of the Tumorgruppe.
CR Baldoni D, 2010, ANTIMICROB AGENTS CH, V54, P157, DOI 10.1128/AAC.00700-09
   Baldoni D, 2009, J CLIN MICROBIOL, V47, P774, DOI 10.1128/JCM.02374-08
   BARGMANN LS, 1999, CLIN ORTHOP RELAT R, V369, P49
   Bohner M, 2006, ACTA BIOMATER, V2, P343, DOI 10.1016/j.actbio.2006.01.003
   Braissant O, 2010, TUBERCULOSIS, V90, P57, DOI 10.1016/j.tube.2009.11.001
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Camire CL, 2005, BIOMATERIALS, V26, P2787, DOI 10.1016/j.biomaterials.2004.08.001
   Charlebois SJ, 2003, BIOMATERIALS, V24, P291, DOI 10.1016/S0142-9612(02)00317-4
   CURTIN NA, 1979, J PHYSIOL-LONDON, V288, P353
   DANIELS AU, 2005, WELL CEMENTED TOTAL, P381
   DANIELS AU, 2000, P 46 ANN M ORTH RES
   FAGHER B, 1986, CLIN SCI, V70, P435, DOI 10.1042/cs0700435
   FAGHER B, 1995, THERMOCHIM ACTA, V251, P183, DOI 10.1016/0040-6031(94)02010-L
   FAGHER B, 1993, BRIT J CLIN PHARMACO, V35, P629, DOI 10.1111/j.1365-2125.1993.tb04193.x
   Hauser-Gerspach I, 2008, J BIOMED MATER RES B, V85B, P42, DOI 10.1002/jbm.b.30914
   Heng Z, 2005, J THERM ANAL CALORIM, V79, P45, DOI 10.1007/s10973-004-0560-y
   Higuera-Guisset J, 2005, THERMOCHIM ACTA, V427, P187, DOI 10.1016/j.tca.2004.09.010
   Hill A. V., 1965, Trails and trials in physiology. A bibliography, 1909-1964; with reviews of certain topics and methods and a reconnaissance for further research.
   HILL AV, 1964, PROC R SOC SER B-BIO, V159, P297, DOI 10.1098/rspb.1964.0004
   Hofmann MP, 2006, J BIOMED MATER RES B, V79B, P360, DOI 10.1002/jbm.b.30550
   James M. A., 1987, THERMAL ENERGETIC ST, P221
   JESPERSEN ND, 1982, BIOCH CLIN APPL THER, P254
   Johannessen EA, 2002, IEEE T NANOBIOSCI, V1, P29, DOI 10.1109/TNB.2002.806935
   Kallerhoff M, 1996, UROL RES, V24, P83, DOI 10.1007/BF00431084
   KEMP R, 2000, HDB THERMAL ANAL CAL, P557
   Kemp RB, 2000, THERMOCHIM ACTA, V349, P23, DOI 10.1016/S0040-6031(99)00493-1
   LAVOISIER A, 1801, TRAITE CHIMIE, P410
   Lavoisier A., 1780, MEM ACAD SCI, V1780, P355
   Lerchner J, 2006, THERMOCHIM ACTA, V445, P144, DOI 10.1016/j.tca.2005.07.011
   Lerchner J, 2002, THERMOCHIM ACTA, V382, P65, DOI 10.1016/S0040-6031(01)00738-9
   Lerchner J, 2008, CHEM ENG PROCESS, V47, P991, DOI 10.1016/j.cep.2007.02.014
   Lewis G, 2003, J BIOMED MATER RES B, V66B, P487, DOI 10.1002/jbm.b.10044
   Li X, 2000, BIOL TRACE ELEM RES, V75, P167, DOI 10.1385/BTER:75:1-3:167
   Li X, 2002, THERMOCHIM ACTA, V387, P57
   LONNBRO P, 1991, J PHYSIOL-LONDON, V440, P385
   Ma J, 2007, J MICROBIOL METH, V68, P172, DOI 10.1016/j.mimet.2006.07.007
   MANNECK T, EXP PARASIT IN PRESS
   MARDH PA, 1976, ANTIMICROB AGENTS CH, V10, P604, DOI 10.1128/AAC.10.4.604
   MASKOW T, 2009, MICROBIAL BIOTECH, V10, P1
   MONTI M, 2000, HDB THERMAL ANAL CAL, P657
   Navrotsky A, 2007, P NATL ACAD SCI USA, V104, P9187, DOI 10.1073/pnas.0608165104
   Pelttari K, 2009, SWISS MED WKLY, V139, P602, DOI smw-12742
   Postollec F, 2003, J MICROBIOL METH, V55, P241, DOI 10.1016/S0167-7012(03)00145-3
   Recht MI, 2008, ANAL BIOCHEM, V377, P33, DOI 10.1016/j.ab.2008.03.007
   Rong XM, 2007, PEDOSPHERE, V17, P137, DOI 10.1016/S1002-0160(07)60019-8
   Russel M, 2009, J AM SCI, V5, P194, DOI DOI 10.7537/MARSJAS050409.29
   Scotti C, 2010, BIOMATERIALS, V31, P2252, DOI 10.1016/j.biomaterials.2009.11.110
   SEMENITZ E, 1978, J ANTIMICROB CHEMOTH, V4, P455, DOI 10.1093/jac/4.5.455
   Slenters TV, 2010, MATERIALS, V3, P3407, DOI 10.3390/ma3053407
   STEWART AW, 1991, BASIC APPL MYOL, V1, P163
   Torres FE, 2004, P NATL ACAD SCI USA, V101, P9517, DOI 10.1073/pnas.0403573101
   Trampuz A, 2007, TRANSFUSION, V47, P1643, DOI 10.1111/j.1537-2995.2007.01336.x
   VANHERWAARDEN S, 2000, MECH VARIABLES MEASU, P11
   von Ah U, 2008, J CLIN MICROBIOL, V46, P2083, DOI 10.1128/JCM.00611-08
   von Ah U, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-106
   von Rege H, 1998, J MICROBIOL METH, V33, P227, DOI 10.1016/S0167-7012(98)00055-4
   Wadso I, 2002, THERMOCHIM ACTA, V394, P305, DOI 10.1016/S0040-6031(02)00263-0
   Wadso I, 2001, PURE APPL CHEM, V73, P1625, DOI 10.1351/pac200173101625
   Wadso I, 2009, J THERM ANAL CALORIM, V95, P843, DOI 10.1007/s10973-008-9467-3
   Wadso L, 2001, J CHEM EDUC, V78, P1080
   Wadso L., 2005, CEMENT INT, V3, P94
   Wadso L, 2009, FOOD CONTROL, V20, P956, DOI 10.1016/j.foodcont.2008.11.008
   Wang L, 2008, SENSOR ACTUAT B-CHEM, V134, P953, DOI 10.1016/j.snb.2008.06.059
   Xu CP, 2007, COLLOID SURFACE B, V54, P193, DOI 10.1016/j.colsurfb.2006.10.016
   Yang JM, 1997, BIOMATERIALS, V18, P1293, DOI 10.1016/S0142-9612(97)00060-4
   Yang LN, 2008, J THERM ANAL CALORIM, V93, P417, DOI 10.1007/s10973-007-8680-9
   Yao J, 2008, CHINESE J CHEM, V26, P101, DOI 10.1002/cjoc.200890000
   Yoon SI, 2008, J MICROELECTROMECH S, V17, P590, DOI 10.1109/JMEMS.2008.924846
   Zhang YY, 2004, BIOSENS BIOELECTRON, V19, P1733, DOI 10.1016/j.bios.2004.01.009
NR 69
TC 49
Z9 52
U1 2
U2 24
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD OCT
PY 2010
VL 10
IS 10
BP 9369
EP 9383
DI 10.3390/s101009369
PG 15
WC Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments
   & Instrumentation
SC Chemistry; Engineering; Instruments & Instrumentation
GA 672KF
UT WOS:000283581100034
PM 22163413
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Dill, MT
   Duong, FHT
   Vogt, JE
   Bibert, S
   Bochud, PY
   Terracciano, L
   Papassotiropoulos, A
   Roth, V
   Heim, MH
AF Dill, Michael T.
   Duong, Francois H. T.
   Vogt, Julia E.
   Bibert, Stephanie
   Bochud, Pierre-Yves
   Terracciano, Luigi
   Papassotiropoulos, Andreas
   Roth, Volker
   Heim, Markus H.
TI IFN Stimulated Gene Expression in the Liver is a Better Predictor of
   Treatment Response in Chronic Hepatitis C than the IL28B (IFN lambda 3)
   Genotype
SO SWISS MEDICAL WEEKLY
LA English
DT Meeting Abstract
C1 [Dill, Michael T.; Duong, Francois H. T.; Heim, Markus H.] Univ Basel, Dept Biomed, Hepatol Lab, Basel, Switzerland.
   [Dill, Michael T.; Heim, Markus H.] Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland.
   [Vogt, Julia E.; Roth, Volker] Univ Basel, Dept Comp Sci, Basel, Switzerland.
   [Bibert, Stephanie; Bochud, Pierre-Yves] Univ Lausanne, Lausanne, Switzerland.
   [Bibert, Stephanie; Bochud, Pierre-Yves] Univ Lausanne Hosp, Infect Dis Serv, Dept Med, Lausanne, Switzerland.
   [Bibert, Stephanie; Bochud, Pierre-Yves] Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland.
   [Terracciano, Luigi] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Div Mol Psychol, Life Sci Training Facil, Biozentrum, Basel, Switzerland.
RI Bochud, Pierre-Yves/ABE-5979-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD SEP 18
PY 2010
VL 140
SU 183
BP 4S
EP 4S
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA 662WJ
UT WOS:000282844700007
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Chen, CL
   Gajewski, KM
   Hamaratoglu, F
   Bossuyt, W
   Sansores-Garcia, L
   Tao, CY
   Halder, G
AF Chen, Chiao-Lin
   Gajewski, Kathleen M.
   Hamaratoglu, Fisun
   Bossuyt, Wouter
   Sansores-Garcia, Leticia
   Tao, Chunyao
   Halder, Georg
TI The apical-basal cell polarity determinant Crumbs regulates Hippo
   signaling in Drosophila
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE organ size control; tumor suppressor; cell proliferation; imaginal discs
ID ORGAN SIZE CONTROL; TUMOR-SUPPRESSOR PATHWAY; TRANSMEMBRANE PROTEIN
   CRUMBS; TISSUE-GROWTH; EPITHELIAL POLARITY; EXPANDED ACT; DOMAIN SIZE;
   FAT; PROLIFERATION; MEMBRANE
AB Defects in apical-basal cell polarity and abnormal expression of cell polarity determinants are often associated with cancer in vertebrates. In Drosophila, abnormal expression of apical-basal determinants can cause neoplastic phenotypes, including loss of cell polarity and overproliferation. However, the pathways through which apical-basal polarity determinants affect growth are poorly understood. Here, we investigated the mechanism by which the apical determinant Crumbs (Crb) affects growth in Drosophila imaginal discs. Overexpression of Crb causes severe overproliferation, and we found that loss of Crb similarly results in overgrowth of imaginal discs. Crb gain and loss of function caused defects in Hippo signaling, a key signaling pathway that controls tissue growth in Drosophila and mammals. Manipulation of Crb levels caused the up-regulation of Hippo target genes, genetically interacted with known Hippo pathway components, and required Yorkie, a transcriptional coactivator that acts downstream in the Hippo pathway, for target gene induction and overgrowth. Interestingly, Crb regulates growth and cell polarity through different motifs in its intracellular domain. A juxtamembrane FERM domain-binding motif is responsible for growth regulation and induction of Hippo target gene expression, whereas Crb uses a PDZ-binding motif to form a complex with other polarity factors. The Hippo pathway component Expanded, an apically localized adaptor protein, is mislocalized in both crb mutant cells and Crb overexpressing tissues, whereas the other Hippo pathway components, Fat and Merlin, are unaffected. Taken together, our data show that Crb regulates growth through Hippo signaling, and thus identify Crb as a previously undescribed upstream input into the Hippo pathway.
C1 [Chen, Chiao-Lin; Hamaratoglu, Fisun; Bossuyt, Wouter; Sansores-Garcia, Leticia; Tao, Chunyao; Halder, Georg] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.
   [Chen, Chiao-Lin; Halder, Georg] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA.
   [Gajewski, Kathleen M.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.
   [Hamaratoglu, Fisun; Halder, Georg] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.
   [Hamaratoglu, Fisun] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Halder, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.
EM ghalder@mdanderson.org
RI Halder, Georg/F-2966-2015
OI Halder, Georg/0000-0001-7580-3236; Hamaratoglu,
   Fisun/0000-0002-1461-9248
FU National Cancer Institute Cancer Center CoreUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) [CA16672]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; NATIONAL CANCER INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672] Funding Source: NIH RePORTER
FX We thank Elisabeth Knust (Max Planck Institute of Molecular Cell
   Biology, Dresden, Germany), Hugo Bellen (Baylor College of Medicine,
   Houston, TX), Kwang-Wook Choi (Korea Advanced Institute of Science and
   Technology, Daejon, Korea), Duojia Pan (The Johns Hopkins University,
   Baltimore, MD), Richard G. Fehon (University of Chicago, Chicago, IL),
   Allen Laughon (University of Wisconsin, Madison, WI), Kenneth D. Irvine
   (Rutgers, The State University of New Jersey, Piscataway, NJ), Michael
   A. Simon (Stanford University, Stanford, CA), Tadashi Uemura (Kyoto
   University, Kyoto, Japan), the Bloomington Drosophila Stock Center, the
   Developmental Studies Hybridoma Bank (University of Iowa), the National
   Institute of Genetics Fly Stock Center, and the Vienna Drosophila RNAi
   Center for fly stocks and antibodies. We also thank Marlese Pisegna for
   technical help and members of the G. H. laboratory for discussions. We
   thank Kenneth Dunner, Jr., for technical help with the SEM analysis,
   which was done at M. D. Anderson core facilities supported by National
   Cancer Institute Cancer Center Core Grant CA16672. This work was
   supported by a National Institutes of Health grant (to G. H.), and F. H.
   is a fellow of the Human Frontier Science Program.
CR Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029
   Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a
   Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010
   Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010
   Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013
   Bazellieres E, 2009, FRONT BIOSCI-LANDMRK, V14, P2149, DOI 10.2741/3368
   Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887
   Dow LE, 2007, INT REV CYTOL, V262, P253, DOI 10.1016/S0074-7696(07)62006-3
   Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105
   Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011
   Genevet A, 2009, J CELL SCI, V122, P2360, DOI 10.1242/jcs.041806
   Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339
   Hamaratoglu F, 2009, J CELL SCI, V122, P2351, DOI 10.1242/jcs.046482
   Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738
   Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070
   Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617
   Ho LL, 2010, DEV BIOL, V337, P274, DOI 10.1016/j.ydbio.2009.10.042
   Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a
   Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341
   Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720
   Karp CM, 2008, CANCER RES, V68, P4105, DOI 10.1158/0008-5472.CAN-07-6814
   Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8
   Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001
   Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107
   Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324
   Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427
   Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080
   Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007
   Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721
   Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974
   Richardson ECN, 2010, DEVELOPMENT, V137, P641, DOI 10.1242/dev.041913
   Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019
   Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004
   Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031
   Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891
   Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415
   TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L
   Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050
   Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019
   Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005
   Willecke M, 2008, P NATL ACAD SCI USA, V105, P14897, DOI 10.1073/pnas.0805201105
   WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5
   Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012
   Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006
   Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210
NR 45
TC 213
Z9 218
U1 1
U2 33
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 7
PY 2010
VL 107
IS 36
BP 15810
EP 15815
DI 10.1073/pnas.1004060107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 647RY
UT WOS:000281637800035
PM 20798049
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Bucher, RM
   Svergun, DI
   Muhle-Goll, C
   Mayans, O
AF Bucher, Rainer M.
   Svergun, Dmitri I.
   Muhle-Goll, Claudia
   Mayans, Olga
TI The Structure of the FnIII Tandem A77-A78 Points to a Periodically
   Conserved Architecture in the Myosin-Binding Region of Titin
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE A-band titin; FnIII tandem; X-ray protein crystallography; small-angle
   X-ray scattering (SAXS); sequence motif conservation
ID SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; STRUCTURE ELASTICITY;
   IG TANDEMS; PROTEIN; MUSCLE; FIBRONECTIN; MODULES; FLEXIBILITY;
   RESOLUTION
AB Titin is a large intrasarcomeric protein that, among its many roles in muscle, is thought to modulate the in vivo assembly of the myosin motor filament. This is achieved through the molecular template properties of its A-band region, which is composed of fibronectin type III (FnIII) and immunoglobulin (Ig) domains organized into characteristic 7-domain (D-zone) and 11-domain (C-zone) superrepeats. Currently, there is little knowledge on the structural details of this region of titin. Here we report the conformational characterization of three FnIII tandems, A77-A78, A80-A82, and A84-A86, which are components of the representative fourth C-zone superrepeat. The structure of A77-A78 has been elucidated by X-ray crystallography to 1.65 angstrom resolution, while low-resolution models of A80-A82 and A84-A86 have been calculated using small-angle X-ray scattering. A77-A78 adopts an extended "up down" domain arrangement, where domains are connected by a hydrophilic three-residue linker sequence. The linker is embedded in a rich network of polar contacts at the domain interface that results in a stiff molecular conformation. The models of A80-A82 and A84-A86, which contain hydrophobic six-residue-long interdomain linkers, equally showed elongated molecular shapes, but with slightly coiled or zigzagged conformations. Small-angle X-ray scattering data further suggested that the long linkers do not result in a noticeable increase in molecular flexibility but lead to semibent domain arrangements. Our findings indicate that the structural characteristics of FnIII tandems from A-band titin contrast markedly with those of poly-Ig tandems from the elastic I-band, which exhibit domain interfaces depleted of interactions and compliant conformations. Furthermore, the analysis of sequence conservation in FnIII domains from A-band titin points to the existence of conformationally defined interfaces at specific superrepeat positions, possibly leading to a periodic and locally ordered architecture supporting the molecular scaffold properties of this region of titin. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.
C1 [Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany.
   [Bucher, Rainer M.; Mayans, Olga] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   [Muhle-Goll, Claudia] European Mol Biol Lab, D-69117 Heidelberg, Germany.
   [Mayans, Olga] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.
RP Svergun, DI (corresponding author), DESY, European Mol Biol Lab, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.
EM Svergun@EMBL-Hamburg.de; Olga.Mayans@liv.ac.uk
OI Svergun, Dmitri/0000-0003-0830-5696; Mayans, Olga/0000-0001-6876-8532
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-100852]; Human Frontier Science ProgramHuman Frontier
   Science Program [RGP0055/2006-C]; Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) [Mu1606/2]
FX O.M. acknowledges the support of the Swiss National Science Foundation
   (3100A0-100852), D.I.S. acknowledges the support of the Human Frontier
   Science Program (RGP0055/2006-C), and C.M.-G. acknowledges the support
   of Deutsche Forschungsgemeinschaft (Mu1606/2).
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Amodeo P, 2001, J MOL BIOL, V311, P283, DOI 10.1006/jmbi.2001.4797
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981
   CAMPBELL ID, 1994, STRUCTURE, V2, P333, DOI 10.1016/S0969-2126(00)00034-4
   de Pereda JM, 1999, EMBO J, V18, P4087, DOI 10.1093/emboj/18.15.4087
   Delano W., 2008, PYMOL MOL GRAPHICS S
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x
   FURST DO, 1992, J CELL SCI, V102, P769
   Guinier A., 1939, Annales de Physique, V12, P161
   Hamill SJ, 2000, J MOL BIOL, V295, P641, DOI 10.1006/jmbi.1999.3360
   Heller WT, 2005, ACTA CRYSTALLOGR D, V61, P33, DOI 10.1107/S0907444904025855
   HIGGINS DG, 1994, J MOL EVOL, V38, P395, DOI 10.1007/BF00163156
   HOUMEIDA A, 1995, J CELL BIOL, V131, P1471, DOI 10.1083/jcb.131.6.1471
   HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9
   HUXLEY HE, 1963, J MOL BIOL, V7, P281, DOI 10.1016/S0022-2836(63)80008-X
   Improta S, 1998, J MOL BIOL, V284, P761, DOI 10.1006/jmbi.1998.2028
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   LABEIT S, 1992, EMBO J, V11, P1711, DOI 10.1002/j.1460-2075.1992.tb05222.x
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Lee EH, 2007, BIOPHYS J, V93, P1719, DOI 10.1529/biophysj.107.105528
   Lee EH, 2010, BIOPHYS J, V98, P1085, DOI 10.1016/j.bpj.2009.12.4192
   MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H
   Marino M, 2005, J MUSCLE RES CELL M, V26, P355, DOI 10.1007/s10974-005-9017-6
   Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009
   McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617
   Mrosek M, 2007, FASEB J, V21, P1383, DOI 10.1096/fj.06-7644com
   Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017
   MUHLEGOLL C, 1998, STRUCTURE, V6, P1291
   Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263
   Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154
   Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   SCHULTHEISS T, 1990, J CELL BIOL, V110, P1159, DOI 10.1083/jcb.110.4.1159
   SOTERIOU A, 1993, J CELL SCI, V104, P119
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Tskhovrebova L, 2010, J MOL BIOL, V397, P1092, DOI 10.1016/j.jmb.2010.01.073
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105
   WHITING A, 1989, J MOL BIOL, V205, P263, DOI 10.1016/0022-2836(89)90381-1
   Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343
NR 48
TC 21
Z9 21
U1 1
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 3
PY 2010
VL 401
IS 5
BP 843
EP 853
DI 10.1016/j.jmb.2010.06.011
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 643NR
UT WOS:000281303900013
PM 20542041
DA 2021-01-25
ER

PT J
AU Nikoletopoulou, V
   Lickert, H
   Frade, JM
   Rencurel, C
   Giallonardo, P
   Zhang, LX
   Bibel, M
   Barde, YA
AF Nikoletopoulou, Vassiliki
   Lickert, Heiko
   Frade, Jose Maria
   Rencurel, Chantal
   Giallonardo, Patrizia
   Zhang, Lixin
   Bibel, Miriam
   Barde, Yves-Alain
TI Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB
   does not
SO NATURE
LA English
DT Article
ID NERVE GROWTH-FACTOR; EMBRYONIC STEM-CELLS; SYMPATHETIC NEURONS;
   GENETIC-EVIDENCE; MESSENGER-RNA; P75; EXPRESSION; DEPENDENCE; GANGLIA;
   MICE
AB Neurons of the peripheral nervous system have long been known to require survival factors to prevent their death during development. But why they selectively become dependent on secretory molecules has remained a mystery, as is the observation that in the central nervous system, most neurons do not show this dependency. Using engineered embryonic stem cells, we show here that the neurotrophin receptors TrkA and TrkC (tropomyosin receptor kinase A and C, also known as Ntrk1 and Ntrk3, respectively) instruct developing neurons to die, both in vitro and in vivo. By contrast, TrkB (also known as Ntrk2), a closely related receptor primarily expressed in the central nervous system, does not. These results indicate that TrkA and TrkC behave as dependence receptors, explaining why developing sympathetic and sensory neurons become trophic-factor-dependent for survival. We suggest that the expansion of the Trk gene family that accompanied the segregation of the peripheral from the central nervous system generated a novel mechanism of cell number control.
C1 [Nikoletopoulou, Vassiliki; Rencurel, Chantal; Zhang, Lixin; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Lickert, Heiko; Giallonardo, Patrizia] Helmholtz Zentrum Munchen, Inst Stem Cell Res, D-85764 Neuherberg, Germany.
   [Frade, Jose Maria] CSIC, Inst Cajal, E-28002 Madrid, Spain.
   [Bibel, Miriam] Novartis Inst BioMed Res, Neurodegenerat Dept, CH-4002 Basel, Switzerland.
RP Nikoletopoulou, V (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM n.vassiliki@unibas.ch; yves.barde@unibas.ch
RI Barde, Yves/F-6019-2011; Lickert, Heiko/K-9045-2013; Frade,
   Jose/E-7913-2013
OI Frade, Jose/0000-0001-7067-2505; Nikoletopoulou,
   Vassiliki/0000-0003-3646-992X; Barde, Yves/0000-0002-7627-461X
FU DFGGerman Research Foundation (DFG); consortium EuTRACC; Swiss National
   FoundationSwiss National Science Foundation (SNSF)
FX H.L. is supported by an Emmy-Nother fellowship of the DFG. V.N. and
   Y.-A.B. thank S. Arber, G. Dechant as well as members of our laboratory
   for discussions and suggestions.; Tetraploid embryos were generated by
   P. G. and H. L.; J.M.F. initiated the comparison of the Ngf and TrkA
   mutant embryos; C. R performed the cloning of the HA-tagged Trk cDNAs;
   ES lines expressing non-tagged Trk cDNAs from the Mapt locus were
   generated by M. B.; L.Z. made the first observations with the neuronal
   differentiation of Trk-expressing ES cells. V.N. and Y.-A.B designed and
   carried out all other experiments. This work was supported by the
   consortium EuTRACC and the Swiss National Foundation.
CR Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x
   Benito-Gutierrez E, 2005, DEVELOPMENT, V132, P2191, DOI 10.1242/dev.01803
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147
   Bredesen DE, 2005, CELL DEATH DIFFER, V12, P1031, DOI 10.1038/sj.cdd.4401680
   Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158
   Chao MV, 2010, DEV NEUROBIOL, V70, P269, DOI 10.1002/dneu.20779
   COUGHLIN MD, 1981, DEV BIOL, V82, P56, DOI 10.1016/0012-1606(81)90428-0
   Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254
   ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0
   ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4
   ESCANDON E, 1994, J NEUROSCI, V14, P2054
   Frade JM, 1999, DEVELOPMENT, V126, P683
   GAESE F, 1994, DEVELOPMENT, V120, P1613
   Gschwendtner A, 2003, MOL CELL NEUROSCI, V24, P307, DOI 10.1016/S1044-7431(03)00167-2
   HAMBURGER V, 1981, J NEUROSCI, V1, P60
   Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703
   KAHANE N, 1994, J NEUROBIOL, V25, P571, DOI 10.1002/neu.480250509
   Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1
   Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011
   Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x
   LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229
   LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0
   Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9
   Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6
   Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283
   NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424
   Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4
   Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897
   Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010
   Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894
   Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767
   Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307
   Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114
   Stenqvist A, 2005, EMBO REP, V6, P973, DOI 10.1038/sj.embor.7400512
   Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104
   Tucker KL, 2001, NAT NEUROSCI, V4, P29
   von Bartheld CS, 1998, HISTOL HISTOPATHOL, V13, P437, DOI 10.14670/HH-13.437
   von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730
   Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395
   White FA, 1996, J NEUROSCI, V16, P4662
   WYATT S, 1993, DEVELOPMENT, V119, P635
   WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435
   Yano H, 2001, J NEUROSCI, V21
NR 48
TC 135
Z9 140
U1 0
U2 25
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD SEP 2
PY 2010
VL 467
IS 7311
BP 59
EP U87
DI 10.1038/nature09336
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 645MB
UT WOS:000281461200034
PM 20811452
DA 2021-01-25
ER

PT J
AU Shende, P
   Plaisance, I
   Morandi, C
   Pellieux, C
   Berthonneche, C
   Lerch, R
   Hall, M
   Ruegg, M
   Pedrazzini, T
   Brink, M
AF Shende, P.
   Plaisance, I.
   Morandi, C.
   Pellieux, C.
   Berthonneche, C.
   Lerch, R.
   Hall, M.
   Ruegg, M.
   Pedrazzini, T.
   Brink, M.
TI Cardiac raptor deletion impairs adaptive hypertrophy, alters metabolic
   gene expression and causes heart failure in mice
SO EUROPEAN HEART JOURNAL
LA English
DT Meeting Abstract
CT ESC Congress
CY AUG 28-SEP 01, 2010
CL Stockholm, SWEDEN
C1 [Shende, P.; Plaisance, I.; Morandi, C.; Brink, M.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Pellieux, C.; Lerch, R.] Univ Hosp Geneva, Dept Cardiol, Geneva, Switzerland.
   [Berthonneche, C.; Pedrazzini, T.] Univ Lausanne, Sch Med, Dept Med, Lausanne, Switzerland.
   [Berthonneche, C.; Pedrazzini, T.] Univ Lausanne, Sch Med, Cardiovasc Assessment Facil, Lausanne, Switzerland.
   [Hall, M.; Ruegg, M.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
J9 EUR HEART J
JI Eur. Heart J.
PD SEP
PY 2010
VL 31
SU 1
BP 146
EP 146
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 646ID
UT WOS:000281531901064
DA 2021-01-25
ER

PT J
AU Biemans, B
   Aubert, L
   Jagasia, R
   Scheiffele, P
   Spooren, W
AF Biemans, B.
   Aubert, L.
   Jagasia, R.
   Scheiffele, P.
   Spooren, W.
TI THE EFFECTS OF PRENATAL VALPROIC ACID ON ADULT NEUROGENESIS IN A MOUSE
   MODEL FOR AUTISM
SO BEHAVIOURAL PHARMACOLOGY
LA English
DT Meeting Abstract
CT Meeting on Drugs, Psychiatric Disorders and Neurogenesis
CY SEP 03-05, 2010
CL Tours, FRANCE
C1 [Biemans, B.; Aubert, L.; Jagasia, R.; Spooren, W.] Univ Basel, CNS Discovery & Translat Area, Basel, Switzerland.
   [Scheiffele, P.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0955-8810
J9 BEHAV PHARMACOL
JI Behav. Pharmacol.
PD SEP
PY 2010
VL 21
IS 5-6
BP 587
EP 587
PG 1
WC Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy
SC Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy
GA 641IS
UT WOS:000281119000050
DA 2021-01-25
ER

PT J
AU Vogt, KE
   Canepari, M
AF Vogt, Kaspar E.
   Canepari, Marco
TI On the Induction of Postsynaptic Granule Cell-Purkinje Neuron LTP and
   LTD
SO CEREBELLUM
LA English
DT Article
DE Parallel fiber; Ascending fiber; Purkinje neuron; LTP; LTD
ID LONG-TERM DEPRESSION; PARALLEL FIBER STIMULATION; SYNAPTIC PLASTICITY;
   DENDRITIC SPINES; NITRIC-OXIDE; FUNCTIONAL SPECIALIZATION; COINCIDENCE
   DETECTION; GLUTAMATE RECEPTORS; SIGNAL-TRANSDUCTION; CEREBELLAR SLICES
AB In the last decade, several experimental studies have demonstrated that particular patterns of synaptic activity can induce postsynaptic parallel fiber (PF) long-term potentiation (LTP). This form of plasticity can reverse postsynaptic PF long-term depression (LTD), which has been traditionally considered as the principal form of plasticity underlying cerebellar learning. Postsynaptic PF-LTP requires a transient increase in intracellular Ca2+ concentration and, in contrast to PF-LTD, is induced without concomitant climbing fiber (CF) activation. Thus, it has been postulated that the polarity of long-term synaptic plasticity is determined by the amplitude of the Ca2+ transient during the induction protocol, with PF-LTP induced by smaller Ca2+ signals without concomitant CF activation. However, this hypothesis is contradicted by recent studies. A quantitative analysis of Ca2+ signals associated with induction of PF-LTP indicates that the bidirectional induction of long-term plasticity is regulated by more complex mechanisms. Here we review the state-of-the-art of research on postsynaptic PF-LTP and PF-LTD and discuss the principal open questions on this topic.
C1 [Canepari, Marco] Grenoble Inst Neurosci, Res Grp 3, Unite Inserm 836, F-38042 Grenoble 09, France.
   [Vogt, Kaspar E.; Canepari, Marco] Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
RP Canepari, M (corresponding author), Grenoble Inst Neurosci, Res Grp 3, Unite Inserm 836, Bat Edmond J Safra,Chemin Fortune Ferrini,Site Sa, F-38042 Grenoble 09, France.
EM marco.canepari@ujf-grenoble.fr
RI Canepari, Marco/H-6772-2012
OI Canepari, Marco/0000-0001-9759-2388; Vogt, Kaspar/0000-0002-0859-876X
FU University of Basel; SNSFSwiss National Science Foundation (SNSF)
   [3100A0_122000]
FX This work was supported by the University of Basel and by SNSF grant
   3100A0_122000 (M. C.). We thank Prof. Josef Kapfhammer for valuable
   comments on the manuscript.
CR ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U
   AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6
   Albus JS, 1971, MATH BIOSCI, V28, P167
   Belmeguenai A, 2005, J NEUROSCI, V25, P10768, DOI 10.1523/JNEUROSCI.2876-05.2005
   BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982
   Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045
   Canepari M, 2004, J NEUROSCI, V24, P3563, DOI 10.1523/JNEUROSCI.5374-03.2004
   Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770
   Canepari M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004011
   Chung HJ, 2000, J NEUROSCI, V20, P7258
   Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031
   CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0
   DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x
   Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X
   Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541
   Fisher JAN, 2008, J NEUROPHYSIOL, V99, P1545, DOI 10.1152/jn.00929.2007
   Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O
   Han VZ, 2007, J NEUROSCI, V27, P13499, DOI 10.1523/JNEUROSCI.2613-07.2007
   HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015
   Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3
   Hartell Nicholas A, 2002, Cerebellum, V1, P3, DOI 10.1080/147342202753203041
   Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009
   HEMART N, 1994, NEUROSCI RES, V19, P213, DOI 10.1016/0168-0102(94)90145-7
   ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103
   Ito M, 2001, PHYSIOL REV, V81, P1143
   Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032
   Kakegawa W, 2005, P NATL ACAD SCI USA, V102, P17846, DOI 10.1073/pnas.0508910102
   KARACHOT L, 1994, NEUROSCI RES, V21, P161, DOI 10.1016/0168-0102(94)90158-9
   KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051
   Kuruma A, 2003, EUR J NEUROSCI, V18, P2677, DOI 10.1111/j.1460-9568.2003.02977.x
   Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399
   LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243
   LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358
   Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458
   Marcaggi P, 2007, J PHYSIOL-LONDON, V578, P545, DOI 10.1113/jphysiol.2006.115014
   MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820
   Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765
   OKADA D, 1995, J NEUROCHEM, V64, P1298
   Rancz EA, 2006, J NEUROSCI, V26, P5428, DOI 10.1523/JNEUROSCI.5284-05.2006
   Renzi M, 2007, J PHYSIOL-LONDON, V585, P91, DOI 10.1113/jphysiol.2007.141531
   Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7
   Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X
   Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020
   Sarkisov DV, 2008, J NEUROSCI, V28, P133, DOI 10.1523/JNEUROSCI.1729-07.2008
   Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824
   Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005
   Sims RE, 2006, J NEUROSCI, V26, P5153, DOI 10.1523/JNEUROSCI.4121-05.2006
   Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547
   Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026
   Tanaka K, 2007, NEURON, V54, P787, DOI 10.1016/j.neuron.2007.05.014
   Wang SSH, 2000, NAT NEUROSCI, V3, P1266
   Wang X, 2009, NEUROSCIENCE, V162, P713, DOI 10.1016/j.neuroscience.2009.01.071
NR 52
TC 15
Z9 15
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1473-4222
EI 1473-4230
J9 CEREBELLUM
JI Cerebellum
PD SEP
PY 2010
VL 9
IS 3
BP 284
EP 290
DI 10.1007/s12311-010-0174-9
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 658SD
UT WOS:000282508800004
PM 20446074
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Azadi, S
   Moradian, R
   Shafaee, AM
AF Azadi, Sam
   Moradian, Rostam
   Shafaee, Atoosa Mousavi
TI The effect of Stone-Wales defect orientations on the electronic
   properties of single-walled carbon nanotubes
SO COMPUTATIONAL MATERIALS SCIENCE
LA English
DT Article
DE Carbon nanotubes; Stone-Wales defect; Density functional theory; Density
   of states
ID MECHANICAL RELAXATION; TRANSPORT-PROPERTIES; TOPOLOGICAL DEFECTS;
   NITRIDE NANOTUBES; OZONE ADSORPTION; BEHAVIOR; BORON
AB Density functional theory (DFT) calculations of the Stone-Wales defected (S-WD) single-walled carbon nanotube (CNT) (10,0) are carried out to understand the effect of S-WD orientations on the electronic properties of CNT. We have considered the influence of super-cell approximation on the defect formation energy and the electronic properties of both circumferential and axial S-W defects in CNT. We found that the probability of S-WD orientation depends on the defect concentration. Density of states of defected CNTs calculations have been applied to indicate the effect of S-WD concentration on the semiconducting energy gap. Utilizing the local density of states investigation, also, we explain the reasons for the adsorption of foreign atoms and molecules on S-WDs. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Azadi, Sam] SISSA, Int Sch Adv Studies, I-34014 Trieste, Italy.
   [Azadi, Sam; Moradian, Rostam] Razi Univ, Fac Sci, Dept Phys, Kermanshah, Iran.
   [Azadi, Sam; Moradian, Rostam] Razi Univ, Nano Sci & Nano Technol Res Ctr, Kermanshah, Iran.
   [Moradian, Rostam] Inst Res Fundamental Sci IPM, Dept Nanosci, Computat Phys Sci Lab, Tehran, Iran.
   [Shafaee, Atoosa Mousavi] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Azadi, S (corresponding author), SISSA, Int Sch Adv Studies, Via Bonomea 265, I-34136 Trieste, Italy.
EM azadi@sissa.it; rmoradian@razi.ac.ir; atoosa.mousavi@unibas.ch
RI azadi, sam/G-6342-2014
OI azadi, sam/0000-0002-1040-4645
FU Nano committee of Ministry of Science, Research and Technology of Iran
FX This research is supported by Nano committee of Ministry of Science,
   Research and Technology of Iran.
CR Akdim B, 2007, CHEM PHYS LETT, V445, P281, DOI 10.1016/j.cplett.2007.08.001
   Blaha P., WIEN2K
   BLOCHL PE, 1994, PHYS REV B, V49, P16223, DOI 10.1103/PhysRevB.49.16223
   Choi HJ, 2000, PHYS REV LETT, V84, P2917, DOI 10.1103/PhysRevLett.84.2917
   Crespi VH, 1997, PHYS REV LETT, V79, P2093, DOI 10.1103/PhysRevLett.79.2093
   Dai HJ, 2002, SURF SCI, V500, P218, DOI 10.1016/S0039-6028(01)01558-8
   Dinadayalane TC, 2007, CHEM PHYS LETT, V434, P86, DOI 10.1016/j.cplett.2006.11.099
   Grujicic M, 2003, APPL SURF SCI, V211, P166, DOI 10.1016/S0169-4332(03)00224-1
   HADDON RC, 1988, ACCOUNTS CHEM RES, V21, P243, DOI 10.1021/ar00150a005
   LIJIMA S, 1992, NATURE, V356, P776
   Lu Q, 2005, NANOTECHNOLOGY, V16, P555, DOI 10.1088/0957-4484/16/4/037
   Lu X, 2008, CHEM PHYS LETT, V454, P305, DOI 10.1016/j.cplett.2008.02.027
   Meng FY, 2003, CARBON, V41, P2023, DOI 10.1016/S0008-6223(03)00183-0
   Miyamoto Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121413
   Moradian R, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205425
   Moradian R, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/17007
   Moradian R, 2006, PHYSICA E, V35, P157, DOI 10.1016/j.physe.2006.07.020
   Moradian R, 2008, PHYS LETT A, V372, P6935, DOI 10.1016/j.physleta.2008.09.044
   Nardelli MB, 1998, PHYS REV LETT, V81, P4656, DOI 10.1103/PhysRevLett.81.4656
   Pan BC, 2000, PHYS REV B, V62, P12652, DOI 10.1103/PhysRevB.62.12652
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Picozzi S, 2004, J CHEM PHYS, V120, P7147, DOI 10.1063/1.1669381
   Rafii-Tabar H, 2004, PHYS REP, V390, P235, DOI 10.1016/j.physrep.2003.10.012
   Samsonidze GG, 2002, COMP MATER SCI, V23, P62, DOI 10.1016/S0927-0256(01)00220-8
   Tekleab D, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.035419
   Yakobson BI, 2000, CARBON, V38, P1675, DOI 10.1016/S0008-6223(00)00093-2
   Yakobson BI, 1998, APPL PHYS LETT, V72, P918, DOI 10.1063/1.120873
   Zhou LG, 2003, CARBON, V41, P613, DOI 10.1016/S0008-6223(02)00399-8
   ZHOU O, 1994, SCIENCE, V263, P1744, DOI 10.1126/science.263.5154.1744
   Zhou T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.193407
NR 30
TC 25
Z9 25
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0256
J9 COMP MATER SCI
JI Comput. Mater. Sci.
PD SEP
PY 2010
VL 49
IS 3
BP 699
EP 703
DI 10.1016/j.commatsci.2010.06.013
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 647LD
UT WOS:000281619100035
DA 2021-01-25
ER

PT J
AU Cathomas, F
   Vogler, C
   Euler-Sigmund, JC
   de Quervain, DJF
   Papassotiropoulos, A
AF Cathomas, Flurin
   Vogler, Christian
   Euler-Sigmund, Jessica C.
   de Quervain, Dominique J. -F.
   Papassotiropoulos, Andreas
TI Fine-mapping of the brain-derived neurotrophic factor (BDNF) gene
   supports an association of the Val66Met polymorphism with episodic
   memory
SO INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
LA English
DT Article
DE Brain-derived neurotrophic factor (BDNF); emotion; memory; polymorphism
ID HIPPOCAMPAL; GENOTYPE; PROBDNF; VOLUME
AB Brain-derived neurotrophic factor (BDNF) plays an important role in hippocampal synaptic plasticity and long-term potentiation. A valine (Val) to methionine (Met) substitution in the BDNF gene (Val66Met) has been associated with episodic memory performance. This study aimed at fine-mapping the genomic region harbouring BDNF and the adjacent gene, BDNFOS, in order to identify other possible memory-related gene variants. Healthy young Swiss adults (n= 333) underwent a verbal memory free-recall task which used words with both neutral and emotional content. Genetic variability of the BDNF and BDNFOS region was covered by analysing 55 single nucleotide polymorphisms (SNPs). Among all examined SNPs, the non-synonymous Val66Met SNP rs6265 showed the highest significant level of association with memory performance for words with emotional content. Recall performance for neutral words was unrelated to the analysed SNPs. Our results support a role for the Val66Met BDNF polymorphism in episodic memory and suggest a modulatory influence of emotional valence.
C1 [Cathomas, Flurin; Vogler, Christian; Euler-Sigmund, Jessica C.; Papassotiropoulos, Andreas] Univ Basel, Div Mol Psychol, Dept Psychol, CH-4055 Basel, Switzerland.
   [Cathomas, Flurin; Vogler, Christian; Euler-Sigmund, Jessica C.; Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, CH-4055 Basel, Switzerland.
   [de Quervain, Dominique J. -F.] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [de Quervain, Dominique J. -F.] Univ Basel, Psychiat Univ Clin, CH-4055 Basel, Switzerland.
RP Cathomas, F (corresponding author), Univ Basel, Div Mol Psychol, Dept Psychol, Missionsstr 60-62, CH-4055 Basel, Switzerland.
EM flurin.cathomas@stud.unibas.ch
OI Vogler, Christian/0000-0003-3922-109X; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; de Quervain, Dominique/0000-0001-7131-2464
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00B-106708, CRSIK0_122691]; European Science
   FoundationEuropean Science Foundation (ESF); European UnionEuropean
   Union (EU) [242257]
FX Supported by grants from the Swiss National Science Foundation to D.Q.
   (PP00B-106708; CRSIK0_122691) and A.P. (CRSIK0_122691), from the
   European Science Foundation to D.Q. and A.P. (EUROStress) and from the
   7th framework programme of the European Union (ADAMS, project no.
   242257, FP7-HEALTH-2009). We also thank Ms. Kim-Dung Huynh for expert
   technical assistance.
CR Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022
   Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663
   De La Vega Francisco M, 2007, Methods Mol Biol, V376, P177
   de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146
   Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Goldberg TE, 2008, BIOL PSYCHOL, V77, P20, DOI 10.1016/j.biopsycho.2007.08.009
   Hager W., 1994, HDB DEUTSCHSPRACHIGE
   Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003
   Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799
   Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020
   Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726
   Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971
   McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560
   Montag C, 2008, NEUROIMAGE, V42, P1554, DOI 10.1016/j.neuroimage.2008.06.008
   Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Pezawas L, 2008, MOL PSYCHIATR, V13, P709, DOI 10.1038/mp.2008.32
   Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004
   Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004
   Sabb FW, 2009, NEUROSCIENCE, V164, P88, DOI 10.1016/j.neuroscience.2009.05.013
   Stern AJ, 2008, BIOL PSYCHIAT, V64, P856, DOI 10.1016/j.biopsych.2008.07.009
   Strauss J, 2004, NEUROMOL MED, V5, P181, DOI 10.1385/NMM:5:3:181
   Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656
   Tan YL, 2005, SCHIZOPHR RES, V77, P355, DOI 10.1016/j.schres.2005.03.012
   Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510
NR 29
TC 24
Z9 25
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1461-1457
EI 1469-5111
J9 INT J NEUROPSYCHOPH
JI Int. J. Neuropsychopharmacol.
PD SEP
PY 2010
VL 13
IS 8
SI SI
BP 975
EP 980
DI 10.1017/S1461145710000519
PG 6
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 651HS
UT WOS:000281919200001
PM 20482942
OA Bronze
DA 2021-01-25
ER

PT J
AU Abgottspon, D
   Rolli, G
   Hosch, L
   Steinhuber, A
   Jiang, XH
   Schwardt, O
   Cutting, B
   Smiesko, M
   Jenal, U
   Ernst, B
   Trampuz, A
AF Abgottspon, Daniela
   Roelli, Gina
   Hosch, Lucie
   Steinhuber, Andrea
   Jiang, Xiaohua
   Schwardt, Oliver
   Cutting, Brian
   Smiesko, Martin
   Jenal, Urs
   Ernst, Beat
   Trampuz, Andrej
TI Development of an aggregation assay to screen FimH antagonists
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE Aggregation; E. coli; FimH antagonist; Type 1 pili; Urinary tract
   infection (UTI)
ID URINARY-TRACT-INFECTION; FIMBRIATED ESCHERICHIA-COLI; TYPE-1 PILI; MOUSE
   MODEL; MANNOSE; ADHESIN; ADHERENCE; RECEPTOR; INHIBITION; AFFINITY
AB alpha-D-Mannopyranosides are potent FimH antagonists, which inhibit the adhesion of Escherichia coli to highly mannosylated uroplakin la on the urothelium and therefore offer an efficient therapeutic opportunity for the treatment and prevention of urinary tract infection. For the evaluation of the therapeutic potential of FimH antagonists, their effect on the disaggregation of E. coli from Candida albicans and guinea pig erythrocytes (GPE) was studied.
   The mannose-specific binding of E. coli to yeast cells and erythrocytes is mediated by type 1 pili and can be monitored by aggregometry. Maximal aggregation of C. albicans or GPE to E. coli is reached after 600 s. Then the FimH antagonist was added and disaggregation determined by light transmission over a period of 1400 s. A FimH-deleted mutant of E coli. which does not induce any aggregation, was used in a control experiment. The activities of FimH antagonists are expressed as IC(50)s, the half maximal inhibitory concentration of the disaggregation potential. n-Heptyl alpha-D-mannopyranoside (1) was used as a reference compound and exhibits an IC50 of 77.14 mu M, whereas methyl alpha-D-mannopyranoside (2) does not lead to any disaggregation at concentrations up to 800 mu M. o-Chloro-p-[N-(2-ethoxy-3,4-dioxocyclobut-1-enyl)amino]phenyl alpha-D-mannopyranoside (3) shows a 90-fold and 2-chloro-4-nitrophenyl alpha-D-mannopyranoside (4) a 6-fold increased affinity compared to 1. Finally. 4-nitrophenyl alpha-D-mannopyranoside (5) exhibits an activity similar to 1. As negative control, D-galactose (6) was used.
   The standardized aggregation assay generates concentration-dependent, reproducible data allowing the evaluation of FimH antagonists according to their potency to inhibit E. coli adherence and can therefore be employed to select candidates for experimental and clinical studies for treatment and prevention of urinary tract infections. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Abgottspon, Daniela; Roelli, Gina; Steinhuber, Andrea; Jiang, Xiaohua; Schwardt, Oliver; Cutting, Brian; Smiesko, Martin; Ernst, Beat] Univ Basel, Inst Mol Pharm, Pharmactr, CH-4056 Basel, Switzerland.
   [Abgottspon, Daniela; Roelli, Gina; Trampuz, Andrej] Univ Basel Hosp, Infect Dis Res Lab, Dept Biomed, CH-4031 Basel, Switzerland.
   [Hosch, Lucie; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Trampuz, Andrej] Univ Lausanne Hosp, Infect Dis Serv, Dept Internal Med, CH-1011 Lausanne, Switzerland.
   [Trampuz, Andrej] Univ Lausanne, CH-1011 Lausanne, Switzerland.
RP Ernst, B (corresponding author), Univ Basel, Inst Mol Pharm, Pharmactr, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM beat.ernst@unibas.ch; andrej.trampuz@chuv.ch
RI Smiesko, Martin/K-8233-2019; Ernst, Beat/AAN-8420-2020; Smiesko,
   Martin/K-7571-2012
OI Smiesko, Martin/0000-0003-2758-2680; 
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [K-32 K1-120904]
FX This study was supported by the Swiss National Science Foundation (SNF
   interdisciplinary grant K-32 K1-120904). Part of the results were
   presented at the 49th Interscience Conference of Antimicrobial Agents
   and Chemotherapy, San Francisco, CA, September 12 to 15 2009 (B-040).
CR BAUMGARTNER HR, 1968, NATURE, V218, P137, DOI 10.1038/218137a0
   BLOOD RM, 1995, INT J FOOD MICROBIOL, V26, P93, DOI 10.1016/0168-1605(94)00040-D
   Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x
   Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x
   Capitani G, 2006, MICROBES INFECT, V8, P2284, DOI 10.1016/j.micinf.2006.03.013
   Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818
   Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061
   CLEGG H, 1984, INFECT IMMUN, V45, P299, DOI 10.1128/IAI.45.1.299-301.1984
   COLLIER W. A., 1955, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V21, P133, DOI 10.1007/BF02543807
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852
   Fihn SD, 2003, NEW ENGL J MED, V349, P259, DOI 10.1056/NEJMcp030027
   FIRON N, 1983, CARBOHYD RES, V120, P235, DOI 10.1016/0008-6215(83)88019-7
   FIRON N, 1982, BIOCHEM BIOPH RES CO, V105, P1426, DOI 10.1016/0006-291X(82)90947-0
   FIRON N, 1987, INFECT IMMUN, V55, P472, DOI 10.1128/IAI.55.2.472-476.1987
   GIAMPAPA CS, 1988, J BIOL CHEM, V263, P5362
   Gouin SG, 2009, CHEMMEDCHEM, V4, P749, DOI 10.1002/cmdc.200900034
   Hooton TM, 2001, INT J ANTIMICROB AG, V17, P259, DOI 10.1016/S0924-8579(00)00350-2
   HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986
   Hvidberg H, 2000, ANTIMICROB AGENTS CH, V44, P156, DOI 10.1128/AAC.44.1.156-163.2000
   Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258
   Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607
   Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x
   Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001
   Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11
   Nagahori N, 2002, CHEMBIOCHEM, V3, P836, DOI 10.1002/1439-7633(20020902)3:9<836::AID-CBIC836>3.0.CO;2-2
   OFEK I, 1978, INFECT IMMUN, V22, P247, DOI 10.1128/IAI.22.1.247-254.1978
   OLD DC, 1972, J GEN MICROBIOL, V71, P149, DOI 10.1099/00221287-71-1-149
   Rosen DA, 2008, INFECT IMMUN, V76, P4290, DOI 10.1128/IAI.00255-08
   Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008
   Sperling O, 2006, ORG BIOMOL CHEM, V4, P3913, DOI 10.1039/b610745a
   Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040
   Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007
NR 33
TC 27
Z9 27
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD SEP
PY 2010
VL 82
IS 3
BP 249
EP 255
DI 10.1016/j.mimet.2010.06.015
PG 7
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 653QY
UT WOS:000282113000010
PM 20620174
DA 2021-01-25
ER

PT J
AU Domingues, M
   Seelig, J
   Riske, K
   Miranda, A
AF Domingues, M.
   Seelig, J.
   Riske, K.
   Miranda, A.
TI Revealing the lytic mechanism of gomesin by optical microscopy of giant
   unilamellar vesicles and isothermal titration calorimetry
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Meeting Abstract
C1 [Domingues, M.; Riske, K.; Miranda, A.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.
   [Seelig, J.] Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
RI Miranda, Antonio/C-8855-2012
NR 0
TC 0
Z9 0
U1 0
U2 3
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1075-2617
J9 J PEPT SCI
JI J. Pept. Sci.
PD SEP
PY 2010
VL 16
SU 1
BP 144
EP 144
PG 1
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 647IC
UT WOS:000281610800380
DA 2021-01-25
ER

PT J
AU Lamoureux, G
   Javelle, A
   Baday, S
   Wang, S
   Berneche, S
AF Lamoureux, G.
   Javelle, A.
   Baday, S.
   Wang, S.
   Berneche, S.
TI Transport mechanisms in the ammonium transporter family
SO TRANSFUSION CLINIQUE ET BIOLOGIQUE
LA English
DT Article
DE AmtB; Rhesus proteins; Ammonia channels; Ammonium transporters; Proton
   cotransport; Proton wires; Grouhuss mechanism
ID ESCHERICHIA-COLI; DEPROTONATION MECHANISM; CRYSTAL-STRUCTURE;
   HYDROPHOBIC PORE; CHANNEL AMTB; SUBSTRATE; PROTEINS; BINDING; NH4+; RHCG
AB Ammonium transport is mediated by membrane proteins of the ubiquitous Amt/Rh family Despite the availability of different X-ray structures that provide many insights on the ammonium permeation process. the molecular details of its mechanism remain controversial The X-ray structures have revealed that the pore of the Amt and Rh proteins is characterized by a hydrophobic portion about 12 A long in which electronic density was observed in crystallographic study of AmtB from Escherichia coli. This electronic density was initially only observed when crystals were grown in presence of ammonium salt and was thus attributed to ammonia (NH3) molecules, and lead the authors to suggest that the conduction mechanism in the Amt/Rh proteins involves the single-file diffusion of NH3 molecules However, other X-ray crystallography results and molecular mechanics simulations suggest that the pore of AmtB could also he filled with water molecules The possible presence of water molecules in the pore lumen calls for a reassessment of the growing consensus that Amt/Rh proteins work as plain NH3 channels Indeed, functional experiments on plant ammonium transporters and rhesus proteins suggest a variety of permeation mechanisms including the passive diffusion of NH3 the ant port of NH4+/H+, the transport of NH4+, or the cotransport of NH3/H+ We discuss these mechanisms in light of some recent functional and simulation studies on the Ann B transporter and illustrate how they can be reconciled with the available high resolution X-ray data (C) 2010 Elsevier Masson SAS All rights reserved
C1 [Baday, S.; Berneche, S.] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Lamoureux, G.; Wang, S.] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H4B 1R6, Canada.
   [Javelle, A.] Univ Dundee, Coll Life Sci, Dept Mol Microbiol, Dundee DD1 5EH, Scotland.
RP Berneche, S (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Berneche, Simon/L-6389-2013; Lamoureux, Guillaume/K-4038-2013; baday,
   sefer/ABA-9111-2020
OI Berneche, Simon/0000-0002-6274-4094; baday, sefer/0000-0002-2913-6687
FU FQRNT Etablissement de nouveaux chercheursFQRNT [NC-125413]; Royal
   Society of Edinburgh; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [118928]
FX This work is supported in part by an FQRNT Etablissement de nouveaux
   chercheurs grant to G L. (NC-125413), a Royal Society of Edinburgh,
   personnal Research Fellowship to A J., and by a grant from the Swiss
   National Science Foundation to S.B. (SNF-Professorship #118928)
CR Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102
   Bakouh N, 2006, TRANSFUS CLIN BIOL, V13, P139, DOI 10.1016/j.tracli.2006.02.008
   BENNAIM A, 1984, J CHEM PHYS, V81, P2016, DOI 10.1063/1.447824
   Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518
   Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022
   Bruce LJ, 2009, BLOOD, V113, P1350, DOI 10.1182/blood-2008-07-171140
   Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001
   Cao Z, 2007, ANGEW CHEM INT EDIT, V46, P6811, DOI 10.1002/anie.200701348
   Conroy MJ, 2005, BRIT J HAEMATOL, V131, P543, DOI 10.1111/j.1365-2141.2005.05786.x
   DAYCOCK JT, 1968, NATURE, V218, P672, DOI 10.1038/218672a0
   Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104
   Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107
   Howitt SM, 2000, BBA-BIOMEMBRANES, V1465, P152, DOI 10.1016/S0005-2736(00)00136-X
   Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102
   Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n
   Javelle A, 2001, FEBS LETT, V505, P393, DOI 10.1016/S0014-5793(01)02802-2
   Javelle A, 1999, FEMS MICROBIOL ECOL, V30, P355, DOI 10.1111/j.1574-6941.1999.tb00663.x
   Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094
   Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200
   Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105
   Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004
   Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200
   KAWADA A, 1970, J CHEM PHYS, V52, P3121, DOI 10.1063/1.1673447
   Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952
   KLEINER D, 1985, FEBS LETT, V187, P237, DOI 10.1016/0014-5793(85)81249-7
   Lamoureux G, 2007, BIOPHYS J, V92, pL82, DOI 10.1529/biophysj.106.102756
   Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104
   Lin YC, 2009, J PHYS CHEM B, V113, P4922, DOI 10.1021/jp810651m
   Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549
   Liu YM, 2006, J PHYS CHEM A, V110, P1375, DOI 10.1021/jp054261c
   Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012
   Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200
   Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104
   Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799
   Manca C, 2005, INT REV PHYS CHEM, V24, P457, DOI 10.1080/01442350500390912
   MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x
   Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282
   Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5
   Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369
   Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135
   Mouro-Chanteloup I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008921
   NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x
   Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714
   Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101
   Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030
   Soupene E, 2002, P NATL ACAD SCI USA, V99, P3926, DOI 10.1073/pnas.062043799
   Thomas GH, 2000, MOL MICROBIOL, V37, P331, DOI 10.1046/j.1365-2958.2000.01994.x
   von Wiren N, 2000, CURR OPIN PLANT BIOL, V3, P254, DOI 10.1016/S1369-5266(00)00073-X
   von Wiren N, 2004, TOP CURR GENET, V9, P95
   Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6
   Yang HY, 2007, BIOPHYS J, V92, P877, DOI 10.1529/biophysj.106.090191
   Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
   Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657
NR 53
TC 25
Z9 28
U1 0
U2 24
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 1246-7820
J9 TRANSFUS CLIN BIOL
JI Transfu. Clin. Biol.
PD SEP
PY 2010
VL 17
IS 3
BP 168
EP 175
DI 10.1016/j.tracli.2010.06.004
PG 8
WC Hematology; Immunology
SC Hematology; Immunology
GA 646LY
UT WOS:000281543300014
PM 20674437
DA 2021-01-25
ER

PT J
AU Goc, A
   Chami, M
   Lodowski, DT
   Bosshart, P
   Moiseenkova-Bell, V
   Baehr, W
   Engel, A
   Palczewski, K
AF Goc, Anna
   Chami, Mohamed
   Lodowski, David T.
   Bosshart, Patrick
   Moiseenkova-Bell, Vera
   Baehr, Wolfgang
   Engel, Andreas
   Palczewski, Krzysztof
TI Structural Characterization of the Rod cGMP Phosphodiesterase 6
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE photoreceptor cells; phosphodiesterase 6; 3D electron microscopy;
   phototransduction; vision
ID CYCLIC-GMP PHOSPHODIESTERASE; INHIBITORY GAMMA-SUBUNIT; PRENYL-BINDING
   PROTEIN; GAF-A DOMAIN; CATALYTIC SUBUNITS; OUTER SEGMENTS; PHOTORECEPTOR
   PHOSPHODIESTERASE; DELTA-SUBUNIT; PDE-DELTA; DETERMINANTS
AB Rod cGMP phosphodiesterase 6 (PDE6) is a key enzyme of the phototransduction cascade, consisting of PDE6 alpha, PDE6 beta, and two regulatory PDE6 gamma subunits. PDE6 is membrane associated through isoprenyl membrane anchors attached to the C-termini of PDE6 alpha and PDE6 beta and can form a complex with prenyl-binding protein delta (PrBP/delta), an isoprenyl-binding protein that is highly expressed in photoreceptors. The stoichiometry of PDE6-PrBP/delta binding and the mechanism by which the PDE6-PrBP/delta complex assembles have not been fully characterized, and the location of regulatory PDE6 gamma subunits within the protein assembly has not been elucidated. To clarify these questions, we have developed a rapid purification method for PDE6-PrBP/delta from bovine rod outer segments utilizing recombinant PrBP/delta. Transmission electron microscopy of negatively stained samples revealed the location of PrBP/delta and, thus, where the carboxyl-termini of PDE6 alpha and PDE6 beta must be located. The three-dimensional structure of the PDE6 alpha beta gamma complex was determined up to 18 angstrom resolution from single-particle projections and was interpreted by model building to identify the probable location of isoprenylation, PDE6 gamma subunits, and catalytic sites. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Goc, Anna; Lodowski, David T.; Moiseenkova-Bell, Vera; Engel, Andreas; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Chami, Mohamed; Bosshart, Patrick; Engel, Andreas] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Baehr, Wolfgang] John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.
RP Engel, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM andreas.engel@case.edu; kxp65@case.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [EY008061, EY019478,
   EY019298, T32EY007157, GM079191, P30EY11373]; Foundation Fighting
   Blindness; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Swiss National Center of Competence in Structural
   Biology; Maurice E. Muller Foundation; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [P30EY011373,
   P30EY014800, R01EY008061, P30EY011373, T32EY007157, P30EY014800,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, R29EY008061,
   P30EY011373, P30EY011373, P30EY014800, P30EY014800, P30EY011373,
   P30EY011373, P30EY011373, P30EY014800, R01EY008061, P30EY011373,
   P30EY011373, P30EY011373, T32EY007157, R01EY008061, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY014800, P30EY011373,
   P30EY011373, P30EY014800, T32EY007157, P30EY011373, P30EY011373,
   T32EY007157, P30EY014800, P30EY011373, R01EY008061, R01EY008061,
   P30EY014800, P30EY014800, R29EY008061, P30EY011373, P30EY011373,
   T32EY007157, R29EY008061, P30EY014800, P30EY011373, P30EY011373,
   T32EY007157, P30EY011373, R01EY008061, P30EY014800, R01EY019298,
   R01EY019298, P30EY011373, P30EY011373, P30EY014800, P30EY011373,
   P30EY011373, R01EY008061, P30EY014800, P30EY011373, P30EY011373,
   R01EY008061, R01EY019298, P30EY011373, R01EY008061, P30EY014800,
   P30EY011373, R01EY019478, P30EY011373, T32EY007157, P30EY014800,
   P30EY014800, P30EY011373, T32EY007157, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, T32EY007157, P30EY011373, R01EY008061,
   R01EY008061, P30EY011373, P30EY014800, P30EY011373, R01EY008061,
   P30EY014800, P30EY011373, P30EY014800, P30EY011373, P30EY014800,
   T32EY007157, P30EY011373, P30EY014800, P30EY014800, P30EY011373,
   P30EY011373, P30EY011373, P30EY014800, P30EY011373, P30EY011373,
   P30EY011373, R01EY008061, R01EY019298, R01EY019298, R29EY008061,
   R01EY008061, R29EY008061, P30EY011373, P30EY014800, P30EY011373,
   P30EY011373, P30EY011373, P30EY014800, P30EY011373, P30EY014800,
   R01EY019298, P30EY011373, P30EY011373, R01EY008061, R01EY008061,
   P30EY011373, P30EY014800, P30EY011373, R01EY008061, P30EY014800,
   R01EY019298, T32EY007157, P30EY011373, P30EY011373, P30EY011373,
   P30EY014800, P30EY011373, T32EY007157, T32EY007157, P30EY011373,
   P30EY011373, P30EY011373, P30EY014800, P30EY011373, P30EY014800,
   P30EY011373, R01EY008061, P30EY011373, P30EY014800, P30EY014800,
   P30EY011373, P30EY014800, P30EY014800, P30EY011373, P30EY011373,
   P30EY014800, P30EY011373, P30EY011373, P30EY014800, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY014800, R01EY019478,
   P30EY011373, P30EY014800, P30EY014800, T32EY007157, R01EY019478,
   R01EY019478, P30EY011373, R01EY019298, P30EY014800, P30EY011373,
   R01EY019298, T32EY007157, R01EY008061, P30EY014800, P30EY011373,
   P30EY014800, P30EY014800, P30EY011373, R01EY008061, P30EY011373,
   P30EY011373, P30EY011373, P30EY014800, T32EY007157, T32EY007157,
   P30EY011373, P30EY011373, P30EY014800, T32EY007157, P30EY014800,
   P30EY014800, P30EY011373, P30EY011373, R01EY019478, R01EY019298,
   P30EY014800, P30EY011373, P30EY014800, R01EY008061, P30EY011373,
   P30EY011373, R29EY008061, P30EY011373, P30EY014800, P30EY011373,
   P30EY011373, P30EY011373, P30EY014800, P30EY011373, P30EY011373,
   P30EY011373, P30EY014800, P30EY014800, R01EY008061, P30EY011373,
   R01EY008061, P30EY011373, P30EY011373, P30EY014800, P30EY014800] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM079191, R01GM079191, R01GM079191,
   R01GM079191, R01GM079191] Funding Source: NIH RePORTER
FX This research was supported by National Institutes of Health grants
   EY008061, EY019478, EY019298, T32EY007157, GM079191, and P30EY11373; the
   Foundation Fighting Blindness; the Swiss National Science Foundation;
   the Swiss National Center of Competence in Structural Biology; and the
   Maurice E. Muller Foundation, Switzerland. K.P. is a Senior Fellow of
   the American Asthma and Sandler Program for Asthma Research.
CR ANANT JS, 1992, J BIOL CHEM, V267, P687
   Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1
   Artemyev NO, 1996, J BIOL CHEM, V271, P25382, DOI 10.1074/jbc.271.41.25382
   ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273
   ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067
   BAEHR W, 1979, J BIOL CHEM, V254, P1669
   Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444
   Cook TA, 2000, BIOCHEMISTRY-US, V39, P13516, DOI 10.1021/bi001070l
   DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424
   Frank J, 2002, J STRUCT BIOL, V138, P85, DOI 10.1016/S1047-8477(02)00019-9
   FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006
   GILLESPIE PG, 1989, J BIOL CHEM, V264, P12187
   Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444
   Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200
   Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095
   HURLEY JB, 1982, J BIOL CHEM, V257, P1094
   Kajimura N, 2002, J STRUCT BIOL, V139, P27, DOI 10.1016/S1047-8477(02)00502-6
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Li N, 1998, GENOMICS, V49, P76, DOI 10.1006/geno.1998.5210
   Li N, 1998, FEBS LETT, V440, P454, DOI 10.1016/S0014-5793(98)01501-4
   Liu YT, 2009, J BIOL CHEM, V284, P31541, DOI 10.1074/jbc.M109.018606
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003
   Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899
   Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200
   Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317
   Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200
   Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015
   Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013
   Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200
   OPPERT B, 1991, BIOCHEM BIOPH RES CO, V178, P474, DOI 10.1016/0006-291X(91)90131-P
   Paglia MJ, 2002, J BIOL CHEM, V277, P5017, DOI 10.1074/jbc.M106328200
   Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106
   PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48
   QIN N, 1994, J BIOL CHEM, V269, P3265
   Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138
   Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813
   Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010
   Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200
   Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406
NR 42
TC 17
Z9 17
U1 0
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 20
PY 2010
VL 401
IS 3
BP 363
EP 373
DI 10.1016/j.jmb.2010.06.044
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 641ZB
UT WOS:000281171000004
PM 20600113
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Blanco, J
   Pauli, T
   Seimiya, M
   Udolph, G
   Gehring, WJ
AF Blanco, Jorge
   Pauli, Tobias
   Seimiya, Makiko
   Udolph, Gerald
   Gehring, Walter J.
TI Genetic interactions of eyes absent, twin of eyeless and orthodenticle
   regulate sine oculis expression during ocellar development in Drosophila
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Drosophila; Eyes absent; Eye/ocellus enhancer; Ocelli development;
   Orthodenticle; Sine oculis; Twin of eyeless
ID PROTEIN-TYROSINE-PHOSPHATASE; HEAD DEVELOPMENT; TISSUE SPECIFICATION;
   HOMEOBOX GENE; ADULT HEAD; OTX GENES; WINGLESS; EVOLUTION; MELANOGASTER;
   MUTATIONS
AB The homeobox gene sine oculis (so) is required for the development of the entire visual system in Drosophila, which includes the compound eyes, the ocelli, the optic lobe of the brain and the Bolwig's organ. During ocelli development, so expression labels, together with eyes absent (eya), the emergence of the ocellar precursor cells in the third instar eye-antennal disc. Footprinting and misexpression studies have led to the proposal that the Pax6 homologue twin of eyeless (toy) directly regulates the initiation of so expression in ocellar precursor cells. However, so expression in a toy loss-of-function mutant background has not been yet analyzed due to the lack of eye-antennal disc development in strong toy mutant alleles. Using an embryonic eye primordium-specific enhancer of toy, we have rescued the developmental defect of a strong toy mutant allele and analyzed so expression in the ocelli primordium of toy loss-of-function eye-antennal discs during third instar larva. The results show that so expression is only marginally affected in the absence of Toy transcriptional activity and that the toy positive effect on so expression is largely eya-mediated. These results suggest that eya is the main factor controlling both initiation and maintenance of so expression in ocellar precursor cells. In addition, we present the characterization of a new minimal eye/ocellus-specific enhancer of the so gene. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Blanco, Jorge; Udolph, Gerald] Inst Med Biol, Singapore 138648, Singapore.
   [Blanco, Jorge; Pauli, Tobias; Gehring, Walter J.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Seimiya, Makiko] Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.
RP Blanco, J (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138648, Singapore.
EM jorge.blanco@imb.a-star.edu.sg
FU Kantons of Basel-Stadt and Basel-Land; Swiss National FondsSwiss
   National Science Foundation (SNSF)
FX We acknowledge N. Azpiazu, B. Bello, P. Callaerts, C. Desplan, F.
   Pignoni, I. Rebay, U. Walldorf, the Bloomington Stock Center and the
   Developmental Studies Hybridoma Bank for kindly providing fly strains
   and reagents. This work was supported by the Kantons of Basel-Stadt and
   Basel-Land and the Swiss National Fonds.
CR Acampora D, 2005, BRAIN RES BULL, V66, P410, DOI 10.1016/j.brainresbull.2005.02.005
   Aldaz S, 2003, DEVELOPMENT, V130, P4473, DOI 10.1242/dev.00643
   Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096
   Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027
   BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7
   Bonini NM, 1997, DEVELOPMENT, V124, P4819
   CHEYETTE BN, 1994, NEURON, V12, P996
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311
   FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516
   Furukubo-Tokunaga K, 2009, FLY, V3, P263, DOI 10.4161/fly.10385
   Gao Q, 1996, MECH DEVELOP, V56, P3, DOI 10.1016/0925-4773(96)00504-7
   Gehring W, 2010, ITAL J ZOOL, V77, P124, DOI 10.1080/11250001003795350
   Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027
   Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289
   GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Halder G, 1998, DEVELOPMENT, V125, P2181
   HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302
   Hazelett DJ, 1998, DEVELOPMENT, V125, P3741
   Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438
   Jacobsson L, 2009, MOL GENET GENOMICS, V282, P217, DOI 10.1007/s00438-009-0458-2
   Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522
   Jun S, 1998, P NATL ACAD SCI USA, V95, P13720, DOI 10.1073/pnas.95.23.13720
   Kenyon KL, 2003, DEV CELL, V5, P403, DOI 10.1016/S1534-5807(03)00243-0
   Kronhamn J, 2002, DEVELOPMENT, V129, P1015
   Kumar JP, 2009, BBA-GENE REGUL MECH, V1789, P306, DOI 10.1016/j.bbagrm.2008.10.001
   Lee JD, 2001, DEVELOPMENT, V128, P1519
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083
   Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019
   Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp
   Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Punzo C, 2002, DEVELOPMENT, V129, P625
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721
   ROYET J, 1995, DEVELOPMENT, V121, P3561
   Royet J, 1997, DEVELOPMENT, V124, P4793
   Royet J, 1996, DEVELOPMENT, V122, P1849
   Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539
   SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x
   STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219
   Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097
   Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005
   Yao JG, 2008, DEV BIOL, V315, P535, DOI 10.1016/j.ydbio.2007.12.037
   YOUNOSSIHARTENSTEIN A, 1993, ROUX ARCH DEV BIOL, V203, P60, DOI 10.1007/BF00539891
   Zimmerman JE, 2000, GENETICS, V154, P237
NR 52
TC 25
Z9 25
U1 4
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD AUG 15
PY 2010
VL 344
IS 2
BP 1088
EP 1099
DI 10.1016/j.ydbio.2010.05.494
PG 12
WC Developmental Biology
SC Developmental Biology
GA 637AR
UT WOS:000280787100048
PM 20580700
OA Bronze
DA 2021-01-25
ER

PT J
AU Suga, H
   Tschopp, P
   Graziussi, DF
   Stierwald, M
   Schmid, V
   Gehring, WJ
AF Suga, Hiroshi
   Tschopp, Patrick
   Graziussi, Daria F.
   Stierwald, Michael
   Schmid, Volker
   Gehring, Walter J.
TI Flexibly deployed Pax genes in eye development at the early evolution of
   animals demonstrated by studies on a hydrozoan jellyfish
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biodiversity; Cladonema radiatum; Cnidaria; evo-devo; gene duplication
ID EYELESS GENE; SINE-OCULIS; DNA-BINDING; DROSOPHILA; CNIDARIAN;
   EXPRESSION; SPONGE; FAMILY; ROLES; DIFFERENTIATION
AB Pax transcription factors are involved in a variety of developmental processes in bilaterians, including eye development, a role typically assigned to Pax-6. Although no true Pax-6 gene has been found in nonbilateral animals, some jellyfish have eyes with complex structures. In the cubozoan jellyfish Tripedalia, Pax-B, an ortholog of vertebrate Pax-2/5/8, had been proposed as a regulator of eye development. Here we have isolated three Pax genes (PaxA, Pax-B, and Pax-E) from Cladonema radiatum, a hydrozoan jellyfish with elaborate eyes. Cladonema Pax-A is strongly expressed in the retina, whereas Pax-B and Pax-E are highly expressed in the manubrium, the feeding and reproductive organ. Misexpression of Cladonema Pax-A induces ectopic eyes in Drosophila imaginal discs, whereas Pax-B and Pax-E do not. Furthermore, Cladonema Pax-A paired domain protein directly binds to the 5' upstream region of eye-specific Cladonema opsin genes, whereas Pax-B does not. Our data suggest that Pax-A, but not Pax-B or Pax-E, is involved in eye development and/or maintenance in Cladonema. Phylogenetic analysis indicates that Pax-6, Pax-B, and Pax-A belong to different Pax subfamilies, which diverged at the latest before the Cnidaria-Bilateria separation. We argue that our data, showing the involvement of Pax genes in hydrozoan eye development as in bilaterians, supports the monophyletic evolutionary origin of all animal eyes. We then propose that during the early evolution of animals, distinct classes of Pax genes, which may have played redundant roles at that time, were flexibly deployed for eye development in different animal lineages.
C1 [Suga, Hiroshi; Tschopp, Patrick; Graziussi, Daria F.; Gehring, Walter J.] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Stierwald, Michael; Schmid, Volker] Univ Basel, Pharmazentrum, Inst Zool, CH-4056 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
FU Yamada Science Foundation; Swiss National FoundationSwiss National
   Science Foundation (SNSF); Kantons of Basel-Stadt and Basel-Landschaft
FX We thank M. Noll (University of Zurich, Zurich) for fly strains; P.
   Callaerts (Katholieke Universiteit Leuven, Louvain, Belgium) and J.
   Blanco (Insitute of Medical Biology, Singapore, Singapore) for the PD
   control probe; and M. M. Burger (Friedrich Miescher Institute, Basel,
   Switzerland) for Microciona cDNA; J. Blanco and D. Papadopoulos for
   critically reading the manuscript; and D. Duboule for allowing P.T. to
   continue the project. H.S. was supported by Yamada Science Foundation
   for a long-term visit. This work was supported by the Swiss National
   Foundation and the Kantons of Basel-Stadt and Basel-Landschaft.
CR Bjorn LO, 2009, PHOTOCH PHOTOBIO SCI, V8, P755, DOI 10.1039/b904988f
   BOUILLON J, 1994, COMPENDIUM ZOOLOGY 2, V3, P165
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Campbell R.D., 1988, P123
   CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5
   Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   CZERNY T, 1995, MOL CELL BIOL, V15, P2858
   Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023
   Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066
   Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Hill A, 2010, DEV BIOL, V343, P106, DOI 10.1016/j.ydbio.2010.03.010
   HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0
   Hoshiyama D, 1998, J MOL EVOL, V47, P640, DOI 10.1007/PL00006421
   Hoshiyama D, 2007, FEBS LETT, V581, P1639, DOI 10.1016/j.febslet.2007.03.027
   Jiao RJ, 2001, DEVELOPMENT, V128, P3307
   Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I
   King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617
   Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3
   Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105
   Kozmik Z, 2008, BRAIN RES BULL, V75, P335, DOI 10.1016/j.brainresbull.2007.10.046
   Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024
   Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047
   Leys SP, 2002, J COMP PHYSIOL A, V188, P199, DOI 10.1007/s00359-002-0293-y
   Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611
   Maldonado M, 2003, MAR BIOL, V143, P427, DOI 10.1007/s00227-003-1100-1
   Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1
   Mansouri A, 1999, CANCER RES, V59, p1707S
   Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136
   Matus DQ, 2007, EVOL DEV, V9, P25, DOI 10.1111/j.1525-142X.2006.00135.x
   Miller DJ, 2000, P NATL ACAD SCI USA, V97, P4475, DOI 10.1073/pnas.97.9.4475
   Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999
   Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Pineda D, 2000, P NATL ACAD SCI USA, V97, P4525, DOI 10.1073/pnas.97.9.4525
   Punzo C, 2004, DEVELOPMENT, V131, P3943, DOI 10.1242/dev.01278
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8
   Sharp P, 1999, CANCER RES, V59, p1709S
   Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122
   Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539
   Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018
   Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059
   Sun HM, 2001, MOL BIOL EVOL, V18, P1905, DOI 10.1093/oxfordjournals.molbev.a003731
   WEBER C, 1981, J MORPHOL, V167, P313, DOI 10.1002/jmor.1051670306
   WISTOW G, 1993, TRENDS BIOCHEM SCI, V18, P301, DOI 10.1016/0968-0004(93)90041-K
NR 48
TC 31
Z9 33
U1 1
U2 23
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 10
PY 2010
VL 107
IS 32
BP 14263
EP 14268
DI 10.1073/pnas.1008389107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 636UD
UT WOS:000280767700053
PM 20660753
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Wagner, S
   Stenta, M
   Metzger, LC
   Dal Peraro, M
   Cornelis, GR
AF Wagner, Stefanie
   Stenta, Marco
   Metzger, Lisa C.
   Dal Peraro, Matteo
   Cornelis, Guy R.
TI Length control of the injectisome needle requires only one molecule of
   Yop secretion protein P (YscP)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE molecular ruler; nanomachine; type III secretion; Yersinia; stochastic
   modeling
ID FLAGELLAR HOOK-LENGTH; III SECRETION; SUBSTRATE-SPECIFICITY; YERSINIA
   INJECTISOME; SHIGELLA-FLEXNERI; SALMONELLA-ENTERICA; HOST MEMBRANES;
   SWITCH; FLIK; RULER
AB The needle length of the Yersinia spp. injectisome is determined by Yop secretion protein P (YscP), an early substrate of the injectisome itself. There is a linear correlation between the length of YscP and the length of the needle, suggesting that YscP acts as a molecular ruler. However, it is not known whether one single molecule of YscP suffices to control the length of one needle or whether several molecules of YscP are exported in alternation with the needle subunit YscF until the needle length matches the ruler length, which would stop needle growth. To address this question, three different strains expressing simultaneously a short and a long version of YscP were engineered. The experimentally obtained needle length distribution was compared with the distributions predicted by stochastic modeling of the various possible scenarios. The experimental data are compatible with the single ruler model and not with the scenarios involving more than one ruler per needle.
C1 [Wagner, Stefanie; Metzger, Lisa C.; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Stenta, Marco; Dal Peraro, Matteo] Ecole Polytech Fed Lausanne, Lab Biomol Modeling, Inst Bioengn, Sch Life Sci, CH-1015 Lausanne, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Stenta, Marco/A-3934-2011; Wagner, Stefanie/A-5756-2011
OI Metzger, Lisa Christina/0000-0001-7398-0941; Wagner,
   Stefanie/0000-0002-3873-7011
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310000-113333/1]; collaborative Sinergia Grant [CRSII3_125110/1]
FX We thank G. Morson for assistance in EM. This work was supported by the
   Swiss National Science Foundation through Grant 310000-113333/1 (to
   G.R.C.) and through the collaborative Sinergia Grant CRSII3_125110/1.
CR Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x
   Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Botteaux A, 2008, MOL MICROBIOL, V70, P1515, DOI 10.1111/j.1365-2958.2008.06499.x
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Ferris HU, 2006, TRENDS MICROBIOL, V14, P519, DOI 10.1016/j.tim.2006.10.006
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Georgi B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-9
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994
   Hirano T, 2009, J BACTERIOL, V191, P3938, DOI 10.1128/JB.01811-08
   Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Li CM, 2002, EMBO J, V21, P1909, DOI 10.1093/emboj/21.8.1909
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002
   Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822
   Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x
   Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012
   Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200
   Moriya N, 2006, J MOL BIOL, V359, P466, DOI 10.1016/j.jmb.2006.03.025
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Shibata S, 2007, MOL MICROBIOL, V64, P1404, DOI 10.1111/j.1365-2958.2007.05750.x
   Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731
   Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x
   Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001
   Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002
   Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x
   Wagner S, 2009, MOL MICROBIOL, V71, P692, DOI 10.1111/j.1365-2958.2008.06556.x
   Yip CK, 2006, TRENDS BIOCHEM SCI, V31, P223, DOI 10.1016/j.tibs.2006.02.005
NR 31
TC 27
Z9 27
U1 0
U2 6
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 3
PY 2010
VL 107
IS 31
BP 13860
EP 13865
DI 10.1073/pnas.1006985107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 634SP
UT WOS:000280605900056
PM 20643949
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Guetg, N
   Aziz, SA
   Holbro, N
   Turecek, R
   Rose, T
   Seddik, R
   Gassmann, M
   Moes, S
   Jenoe, P
   Oertner, TG
   Casanova, E
   Bettler, B
AF Guetg, Nicole
   Aziz, Said Abdel
   Holbro, Niklaus
   Turecek, Rostislav
   Rose, Tobias
   Seddik, Riad
   Gassmann, Martin
   Moes, Suzette
   Jenoe, Paul
   Oertner, Thomas G.
   Casanova, Emilio
   Bettler, Bernhard
TI NMDA receptor-dependent GABA(B) receptor internalization via CaMKII
   phosphorylation of serine 867 in GABA(B1)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE gamma-aminobutyric acid; spines; trafficking; synaptic plasticity; GABAB
ID LONG-TERM POTENTIATION; RECTIFYING POTASSIUM CHANNELS; PROTEIN-KINASE;
   MEDIATED INHIBITION; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; PYRAMIDAL
   CELLS; K+ CHANNELS; SYNAPSES; DEGRADATION
AB GABA(B) receptors are the G-protein-coupled receptors for GABA, the main inhibitory neurotransmitter in the brain. GABA(B) receptors are abundant on dendritic spines, where they dampen postsynaptic excitability and inhibit Ca2+ influx through NMDA receptors when activated by spillover of GABA from neighboring GABAergic terminals. Here, we show that an excitatory signaling cascade enables spines to counteract this GABA(B)-mediated inhibition. We found that NMDA application to cultured hippocampal neurons promotes dynamin-dependent endocytosis of GABA(B) receptors. NMDA-dependent internalization of GABA(B) receptors requires activation of Ca2+/Calmodulin-dependent protein kinase II (CaMKII), which associates with GABA(B) receptors in vivo and phosphorylates serine 867 (S867) in the intracellular C terminus of the GABA(B1) subunit. Blockade of either CaMKII or phosphorylation of S867 renders GABA(B) receptors refractory to NMDA-mediated internalization. Time-lapse two-photon imaging of organotypic hippocampal slices reveals that activation of NMDA receptors removes GABA(B) receptors within minutes from the surface of dendritic spines and shafts. NMDA-dependent S867 phosphorylation and internalization is predominantly detectable with the GABA(B1b) subunit isoform, which is the isoform that clusters with inhibitory effector K+ channels in the spines. Consistent with this, NMDA receptor activation in neurons impairs the ability of GABA(B) receptors to activate K+ channels. Thus, our data support that NMDA receptor activity endocytoses postsynaptic GABA(B) receptors through CaMKII-mediated phosphorylation of S867. This provides a means to spare NMDA receptors at individual glutamatergic synapses from reciprocal inhibition through GABA(B) receptors.
C1 [Guetg, Nicole; Aziz, Said Abdel; Turecek, Rostislav; Seddik, Riad; Gassmann, Martin; Casanova, Emilio; Bettler, Bernhard] Univ Basel, Pharmazentrum, Dept Biomed, Inst Physiol, CH-4056 Basel, Switzerland.
   [Holbro, Niklaus; Rose, Tobias; Oertner, Thomas G.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Turecek, Rostislav] Acad Sci Czech Republic, Inst Expt Med, Prague 14220, Czech Republic.
   [Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bettler, B (corresponding author), Univ Basel, Pharmazentrum, Dept Biomed, Inst Physiol, CH-4056 Basel, Switzerland.
EM bernhard.bettler@unibas.ch
RI Rose, Tobias/H-5388-2019; Turecek, Rostislav/H-2706-2014; Turecek,
   Rostislav/AAL-3523-2020; bettler, bernhard/AAO-8018-2020; Oertner,
   Thomas/F-2214-2010; Casanova, Emilio/Y-6553-2019
OI Rose, Tobias/0000-0002-7156-4714; Turecek,
   Rostislav/0000-0003-4978-7556; Oertner, Thomas/0000-0002-2312-7528;
   Casanova, Emilio/0000-0001-7992-5361; Gassmann,
   Martin/0000-0001-6201-3032; Bettler, Bernhard/0000-0003-0842-8207
FU Swiss Science FoundationSwiss National Science Foundation (SNSF)
   [3100A0-117816]; European CommunityEuropean Community (EC) [201714];
   Wellcome TrustWellcome Trust; EUEuropean Union (EU)
   [LSHM-CT-2005-019055]
FX We thank N. Hardel (Department of Biomedicine, Institute of Physiology,
   Pharmazentrum, University of Basel, Basel, Switzerland) for the
   Rab11-eGFP plasmid, K. Ivankova and A. Cremonesi for technical help, and
   F. Schatzmann for comments on the manuscript. B.B. was supported by the
   Swiss Science Foundation (3100A0-117816) and the European Community's
   Seventh Framework Programme FP7/2007-2013 under Grant Agreement 201714.
   R.T. was supported by the Wellcome Trust International Senior Research
   Fellowship and an EU Synapse grant (LSHM-CT-2005-019055).
CR Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003
   Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Butcher AJ, 2009, J BIOL CHEM, V284, P17147, DOI 10.1074/jbc.M901031200
   Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012
   Chung HJ, 2009, P NATL ACAD SCI USA, V106, P635, DOI 10.1073/pnas.0811685106
   Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106
   Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007
   Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908
   Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833
   Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200
   Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790
   Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004
   Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200
   Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004
   Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009
   Hardel N, 2008, CARDIOVASC RES, V79, P52, DOI 10.1093/cvr/cvn062
   Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106
   Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033
   Jarolimek W, 1997, J NEUROSCI, V17, P1025
   Kaupmann K, 1998, NATURE, V396, P683
   Kim CH, 2008, J NEUROSCI RES, V86, P1, DOI 10.1002/jnr.21437
   Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006
   Kornau HC, 2006, CELL TISSUE RES, V326, P517, DOI 10.1007/s00441-006-0264-7
   Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006
   Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015
   Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842
   Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753
   Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X
   Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8
   Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315
   MORRISETT RA, 1991, J NEUROSCI, V11, P203
   Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x
   Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004
   Pagano A, 2001, J NEUROSCI, V21, P1189
   PEARSON RB, 1985, J BIOL CHEM, V260, P4471
   SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8
   Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7
   Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2
   Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964
   STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M
   Straessle A, 2003, EUR J NEUROSCI, V18, P2213, DOI 10.1046/j.1460-9568.2003.02964.x
   TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063
   Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001
   Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200
   Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014
   Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200
   Zhang YP, 2008, P NATL ACAD SCI USA, V105, P12039, DOI 10.1073/pnas.0802940105
NR 50
TC 68
Z9 70
U1 0
U2 9
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 3
PY 2010
VL 107
IS 31
BP 13924
EP 13929
DI 10.1073/pnas.1000909107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 634SP
UT WOS:000280605900067
PM 20643921
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Ottaviani, S
   Tahiri, K
   Frazier, A
   Hassaine, ZN
   Dumontier, MF
   Baschong, W
   Rannou, F
   Corvol, MT
   Savouret, JF
   Richette, P
AF Ottaviani, Sebastien
   Tahiri, Khadija
   Frazier, Aline
   Hassaine, Zohra Nabila
   Dumontier, Marie-France
   Baschong, Werner
   Rannou, Francois
   Corvol, Marie-Therese
   Savouret, Jean-Francois
   Richette, Pascal
TI Hes1, a new target for interleukin 1 beta in chondrocytes
SO ANNALS OF THE RHEUMATIC DISEASES
LA English
DT Article
ID NOTCH SIGNALING PATHWAY; ARTICULAR CHONDROCYTES; DEVELOPMENTAL
   REGULATION; RHEUMATOID SYNOVIOCYTES; GROWTH-PLATE; CARTILAGE;
   OSTEOARTHRITIS; EXPRESSION; CELL; DIFFERENTIATION
AB Objectives To investigate the effects of interleukin 1 beta (IL1 beta) treatment on the Notch1/Hes1 pathway in chondrocytes in vitro.
   Methods Mouse articular chondrocytes in primary culture were challenged with IL1 beta, alone or combined with Notch1 and IL1 beta pathway inhibitors. Notch1 and Hes1 expressions were investigated by immunocytochemistry, western blot and real-time quantitative (q) PCR. IL1 beta-responsive genes were assessed by real-time qPCR and a specific siRNA against Hes1 was used to identify Hes1 target genes.
   Results Notch1 labelling remained nuclear and stable in intensity irrespective of treatment, suggesting a steady state activation of this pathway in our model. IL1 beta transiently increased Hes1 mRNA (2.5-fold) and protein expression in treated versus naive chondrocytes. Hes1 mRNA level then decreased below control and its cyclic pattern of expression was lost. This was associated with nuclear translocation of the cytoplasmic Hes1 protein. IL1 beta induced increase in Hes1 mRNA was transcriptional, occurred through nuclear factor (NF)kappa B activation and appeared to be associated with downregulation by its own protein. Hes1 induction was insensitive to the gamma-secretase inhibitor N-(N-(3,5-difluorophenacetyl)l-alanyl)-S-phenylglycine t-butyl ester (DAPT), which suggested its independence from novel Notch1 activation. Hes1 expression was efficiently silenced by a specific siRNA. This experiment revealed that Hes1 did not mediate IL1 beta-induced downregulation of Sox9, type II collagen and aggrecan transcription but mediated IL1 beta induction of matrix metalloproteinase (MMP) 13 and ADAM metallopeptidase with thrombospondin type 1 motif, 5 (ADAMTS5). The Hes1-related repressor Hey1 was expressed at a very low level and was not inducible by IL1 beta.
   Conclusion Hes1 is a novel IL1 beta target gene in chondrocytes which influences a discrete subset of genes linked to cartilage matrix remodelling and/or degradation.
C1 [Savouret, Jean-Francois] Univ Paris 05, INSERM, UMRS 747, UFR Biomed, F-75006 Paris, France.
   [Baschong, Werner] Univ Basel, Biozentrum, ME Muller Inst, Basel, Switzerland.
   [Richette, Pascal] Univ Paris Diderot, Hop Lariboisiere, Assistance Publ Hop Paris, Paris, France.
RP Savouret, JF (corresponding author), Univ Paris 05, INSERM, UMRS 747, UFR Biomed, 45 Rue St Peres, F-75006 Paris, France.
EM jean-francois.savouret@parisdescartes.fr
OI Frazier-Mironer, Aline/0000-0003-0499-2628
FU INSERMInstitut National de la Sante et de la Recherche Medicale
   (Inserm); Association Rhumatisme et travail; Fonds d'Etude et de
   Recherche du Corps Medical; Societe Francaise de Rhumatologie
FX This work was supported by INSERM (Programme National de Recherche sur
   les Maladies Osteo-Articulaires (PRO-A)) and grants from 'Association
   Rhumatisme et travail', 'Fonds d'Etude et de Recherche du Corps Medical'
   and 'Societe Francaise de Rhumatologie'.
CR Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655
   Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803
   Blaise R, 2009, ARTHRITIS RHEUM-US, V60, P428, DOI 10.1002/art.24250
   Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098
   Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091
   Crowe R, 1999, DEVELOPMENT, V126, P987
   Curry CL, 2006, LAB INVEST, V86, P842, DOI 10.1038/labinvest.3700442
   Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260
   Gelse K, 2003, OSTEOARTHR CARTILAGE, V11, P141, DOI 10.1053/joca.2002.0873
   Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592
   Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f
   Gosset M, 2008, ARTHRITIS RHEUM-US, V58, P1399, DOI 10.1002/art.23431
   Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052
   Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730
   Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560
   Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208
   Jacques C, 2006, VITAM HORM, V74, P371, DOI 10.1016/S0083-6729(06)74016-X
   Jin YH, 2009, BBA-MOL CELL RES, V1793, P290, DOI 10.1016/j.bbamcr.2008.10.002
   Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786
   Karlsson C, 2008, CELLS TISSUES ORGANS, V188, P287, DOI 10.1159/000121610
   Karlsson C, 2007, CELL TISSUE RES, V327, P539, DOI 10.1007/s00441-006-0307-0
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657
   Nakazawa M, 2001, ARTHRITIS RHEUM-US, V44, P1545, DOI 10.1002/1529-0131(200107)44:7<1545::AID-ART278>3.0.CO;2-Q
   Nakazawa M, 2001, INT J MOL MED, V7, P31
   Rodriguez-Gonzalez JG, 2007, J THEOR BIOL, V248, P37, DOI 10.1016/j.jtbi.2007.05.003
   Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008
   Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148
   Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011
   Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200
   Thirunavukkarasu K, 2007, MOL BIOL REP, V34, P225, DOI 10.1007/s11033-006-9037-3
   Watanabe N, 2003, J BONE MINER METAB, V21, P344, DOI 10.1007/s00774-003-0428-4
   William DA, 2007, DEV BIOL, V305, P172, DOI 10.1016/j.ydbio.2007.02.007
   Williams R, 2009, J ANAT, V215, P159, DOI 10.1111/j.1469-7580.2009.01089.x
   Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747
   Zheng YF, 2008, CELL BIOCHEM FUNCT, V26, P692, DOI 10.1002/cbf.1494
NR 36
TC 12
Z9 13
U1 0
U2 17
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-4967
EI 1468-2060
J9 ANN RHEUM DIS
JI Ann. Rheum. Dis.
PD AUG
PY 2010
VL 69
IS 8
BP 1488
EP 1494
DI 10.1136/ard.2009.120816
PG 7
WC Rheumatology
SC Rheumatology
GA 629CL
UT WOS:000280171700016
PM 19914905
DA 2021-01-25
ER

PT J
AU Ruiz-Roldan, MC
   Kohli, M
   Roncero, MIG
   Philippsen, P
   Di Pietro, A
   Espeso, EA
AF Carmen Ruiz-Roldan, M.
   Koehli, Michael
   Roncero, M. Isabel G.
   Philippsen, Peter
   Di Pietro, Antonio
   Espeso, Eduardo A.
TI Nuclear Dynamics during Germination, Conidiation, and Hyphal Fusion of
   Fusarium oxysporum
SO EUKARYOTIC CELL
LA English
DT Article
ID FUNGAL SPORE GERMINATION; RED FLUORESCENT PROTEIN; VASCULAR WILT FUNGUS;
   ASPERGILLUS-NIDULANS; NEUROSPORA-CRASSA; VEGETATIVE COMPATIBILITY;
   ANASTOMOSIS TUBES; FILAMENTOUS FUNGI; MONOMERIC RED; DIVISION
AB In many fungal pathogens, infection is initiated by conidial germination. Subsequent stages involve germ tube elongation, conidiation, and vegetative hyphal fusion (anastomosis). Here, we used live-cell fluorescence to study the dynamics of green fluorescent protein (GFP)- and cherry fluorescent protein (ChFP)-labeled nuclei in the plant pathogen Fusarium oxysporum. Hyphae of F. oxysporum have uninucleated cells and exhibit an acropetal nuclear pedigree, where only the nucleus in the apical compartment is mitotically active. In contrast, conidiation follows a basopetal pattern, whereby mononucleated microconidia are generated by repeated mitotic cycles of the subapical nucleus in the phialide, followed by septation and cell abscission. Vegetative hyphal fusion is preceded by directed growth of the fusion hypha toward the receptor hypha and followed by a series of postfusion nuclear events, including mitosis of the apical nucleus of the fusion hypha, migration of a daughter nucleus into the receptor hypha, and degradation of the resident nucleus. These previously unreported patterns of nuclear dynamics in F. oxysporum could be intimately related to its pathogenic lifestyle.
C1 [Carmen Ruiz-Roldan, M.; Roncero, M. Isabel G.; Di Pietro, Antonio] Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain.
   [Koehli, Michael; Philippsen, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Espeso, Eduardo A.] CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid 28040, Spain.
RP Ruiz-Roldan, MC (corresponding author), Univ Cordoba, Dept Genet, Edificio Gregor Mendel,Campus Rabanales, E-14071 Cordoba, Spain.
EM ge2rurom@uco.es
RI Espeso, Eduardo A/C-5259-2011; Di Pietro, Antonio/K-9220-2014; Roldan,
   Carmen Ruiz/AAB-2100-2019; Roncero, M. Isabel G./M-2496-2014
OI Espeso, Eduardo A/0000-0002-5873-6059; Di Pietro,
   Antonio/0000-0001-5930-5763; Roncero, M. Isabel G./0000-0002-5283-7836;
   Ruiz Roldan, M. Carmen/0000-0003-3427-2998
FU Junta de AndaluciaJunta de Andalucia; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [31003A-112688];
   Spanish Ministerio de Ciencia e InnovacionInstituto de Salud Carlos
   IIISpanish Government [BIO2007-62661, BFU2006-04185, BFU2009-08701]
FX This research was supported by Junta de Andalucia (AGR 209), the Swiss
   National Science Foundation (31003A-112688), and Spanish Ministerio de
   Ciencia e Innovacion grants BIO2007-62661 to A.D.P. and
   BFU2006-04185(BMC) and BFU2009-08701(BMC) to E.A.E.
CR AIST JR, 1969, J CELL BIOL, V40, P120, DOI 10.1083/jcb.40.1.120
   AIST JR, 1972, J CELL BIOL, V55, P368, DOI 10.1083/jcb.55.2.368
   AYLMORE RC, 1984, S BRIT MYCOLOGICAL S, P103
   Barhoom S, 2004, FUNGAL GENET BIOL, V41, P317, DOI 10.1016/j.fgb.2003.11.011
   BENSAUDE M, 1918, THESIS U PARIS NEMOU
   Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699
   CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133
   CORRELL JC, 1985, PHYTOPATHOLOGY, V75, P1347
   COUTEAUDIER Y, 1990, CAN J MICROBIOL, V36, P551, DOI 10.1139/m90-096
   dEnfert C, 1997, FUNGAL GENET BIOL, V21, P163, DOI 10.1006/fgbi.1997.0975
   Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]
   Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91
   Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1046/j.1365-2958.2001.02307.x
   Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106
   Gladfelter AS, 2006, CURR OPIN MICROBIOL, V9, P547, DOI 10.1016/j.mib.2006.09.002
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001
   Grant M, 1999, CURR OPIN PLANT BIOL, V2, P312, DOI 10.1016/S1369-5266(99)80055-7
   HARDHAM AR, 2001, BIOL FUNGAL CELL MYC, V13, P90
   Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880
   HARRIS SD, 1994, GENETICS, V136, P517
   Harris SD, 1999, MICROBIOL-SGM, V145, P2747, DOI 10.1099/00221287-145-10-2747
   Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X
   HICKEY PC, 2003, BIOL LIVING FUNGI
   JACOBSON DJ, 1988, PHYTOPATHOLOGY, V78, P668, DOI 10.1094/Phyto-78-668
   Katan T, 1997, PHYTOPATHOLOGY, V87, P712, DOI 10.1094/PHYTO.1997.87.7.712
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   KOHLER E, 1930, PLANTA, V10, P495
   LOO M, 1976, DEV BIOL, V54, P201, DOI 10.1016/0012-1606(76)90299-2
   Maheshwari R, 2005, FEMS MICROBIOL LETT, V249, P7, DOI 10.1016/j.femsle.2005.06.031
   Marek SM, 2003, FUNGAL GENET BIOL, V40, P126, DOI 10.1016/S1087-1845(03)00086-0
   MESTERHA.A, 1973, MYCOLOGIA, V65, P916, DOI 10.2307/3758525
   Minke PF, 1999, FUNGAL GENET BIOL, V28, P55, DOI 10.1006/fgbi.1999.1160
   Momany M, 2000, MICROBIOL-UK, V146, P3279, DOI 10.1099/00221287-146-12-3279
   Noble M, 1937, ANN BOT-LONDON, V1, P67, DOI 10.1093/oxfordjournals.aob.a083461
   Nucci M, 2002, CLIN INFECT DIS, V35, P909, DOI 10.1086/342328
   Olivain C, 1999, NEW PHYTOL, V141, P497, DOI 10.1046/j.1469-8137.1999.00365.x
   Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004
   Pareja-Jaime Y, 2010, MOL PLANT PATHOL, V11, P479, DOI [10.1111/j.1364-3703.2010.00624.x, 10.1111/J.1364-3703.2010.00624.X]
   Rosales RCP, 2008, EUKARYOT CELL, V7, P162, DOI 10.1128/EC.00258-07
   PUHALLA JE, 1985, CAN J BOT, V63, P179, DOI 10.1139/b85-020
   Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260
   Requena N, 2001, MOL MICROBIOL, V42, P121, DOI 10.1046/j.1365-2958.2001.02609.x
   Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09
   Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048
   Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005
   ROSENBERGER RF, 1967, J BACTERIOL, V94, P1464, DOI 10.1128/JB.94.5.1464-1469.1967
   Sanders IR, 2006, TRENDS ECOL EVOL, V21, P656, DOI 10.1016/j.tree.2006.10.006
   Seong KY, 2008, FUNGAL GENET BIOL, V45, P389, DOI 10.1016/j.fgb.2007.09.002
   SERNA L, 1978, J BACTERIOL, V136, P341, DOI 10.1128/JB.136.1.341-351.1978
   SEWALL TC, 1990, PLANT CELL, V2, P731, DOI 10.1105/tpc.2.8.731
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   TODD NK, 1985, DEV BIOL AGARICS, V10, P231
   Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385
   Wolkow TD, 1996, J CELL SCI, V109, P2179
   Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004
NR 56
TC 43
Z9 45
U1 1
U2 20
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1535-9778
EI 1535-9786
J9 EUKARYOT CELL
JI Eukaryot. Cell
PD AUG
PY 2010
VL 9
IS 8
BP 1216
EP 1224
DI 10.1128/EC.00040-10
PG 9
WC Microbiology; Mycology
SC Microbiology; Mycology
GA 634JO
UT WOS:000280577300008
PM 20543061
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Pereanu, W
   Kumar, A
   Jennett, A
   Reichert, H
   Hartenstein, V
AF Pereanu, Wayne
   Kumar, Abilasha
   Jennett, Arnim
   Reichert, Heinrich
   Hartenstein, Volker
TI Development-Based Compartmentalization of the Drosophila Central Brain
SO JOURNAL OF COMPARATIVE NEUROLOGY
LA English
DT Article
DE Drosophila; brain; lineages; connectivity; mapping
ID CENTRAL-NERVOUS-SYSTEM; KERATAN SULFATE PROTEOGLYCAN; GLIAL-CELLS;
   OLFACTORY GLOMERULI; MUSHROOM BODY; FLY BRAIN; IDENTIFIED NEUROBLASTS;
   EMBRYONIC-DEVELOPMENT; MOLECULAR MARKERS; CLONAL ANALYSIS
AB The neuropile of the Drosophila brain is subdivided into anatomically discrete compartments. Compartments are rich in terminal neurite branching and synapses; they are the neuropile domains in which signal processing takes place. Compartment boundaries are defined by more or less dense layers of glial cells as well as long neurite fascicles. These fascicles are formed during the larval period, when the approximately 100 neuronal lineages that constitute the Drosophila central brain differentiate. Each lineage forms an axon tract with a characteristic trajectory in the neuropile; groups of spatially related tracts congregate into the brain fascicles that can be followed from the larva throughout metamorphosis into the adult stage. Here we provide a map of the adult brain compartments and the relevant fascicles defining compartmental boundaries. We have identified the neuronal lineages contributing to each fascicle, which allowed us to compare compartments of the larval and adult brain directly. Most adult compartments can be recognized already in the early larval brain, where they form a "protomap" of the later adult compartments. Our analysis highlights the morphogenetic changes shaping the Drosophila brain; the data will be important for studies that link early-acting genetic mechanisms to the adult neuronal structures and circuits controlled by these mechanisms. J. Comp. Neurol. 518:2996-3023, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Pereanu, Wayne; Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.
   [Kumar, Abilasha; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pereanu, W (corresponding author), 19700 Helix Dr, Sterling, VA 20164 USA.
EM neromike@gmail.com
OI Jenett, Arnim/0000-0003-3039-2060
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 NS054814];
   NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS054814, R01NS054814, R01NS054814, R01NS054814, R01NS054814,
   R01NS054814, R01NS054814, R01NS054814, R01NS054814, R01NS054814,
   R01NS054814, R01NS054814, R01NS054814] Funding Source: NIH RePORTER
FX Grant sponsor: National Institutes of Health; Grant number: R01 NS054814
   (to V.H.).
CR Ashburner M., 1989, DROSOPHILA LAB MANUA, P214
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9
   Bullock TH, 1965, STRUCTURE FUNCTION N
   delaCruz RR, 1996, REV NEUROSCIENCE, V7, P115
   DELAESCALERA S, 1990, EMBO J, V9, P3593, DOI 10.1002/j.1460-2075.1990.tb07570.x
   DOE CQ, 1992, DEVELOPMENT, V116, P855
   Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484
   GEISERT EE, 1993, DEV BRAIN RES, V75, P163, DOI 10.1016/0165-3806(93)90020-B
   GONZALEZ MD, 1993, EXP NEUROL, V123, P91, DOI 10.1006/exnr.1993.1143
   HANSTROEM B, 1928, VERGLEICHENDE ANATOM, P498
   HARRIS WA, 2007, FUNDAMENTAL NEUROSCI
   HARTENSTEIN V, 2010, LINEAGE BASED UNPUB
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   HORTSCH M, 1990, DEVELOPMENT, V110, P1327
   Hsaki K, 2006, NEUROSCIENCE, V141, P1899, DOI 10.1016/j.neuroscience.2006.04.082
   Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257
   Ito K, 1997, DEVELOPMENT, V124, P761
   ITO K, 2010, COORDINATED NO UNPUB
   Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9
   Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9
   Jacobson M., 1991, DEV NEUROBIOLOGY
   Jenett A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-544
   KALB RG, 1990, NEUROSCIENCE, V34, P391, DOI 10.1016/0306-4522(90)90148-W
   Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2
   Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702
   KINTNER C, 2007, FUNDAMENTAL NEUROSCI
   Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308
   KUMAR A, 2009, J COMP NEUR IN PRESS
   Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380
   Laissue PP, 1999, J COMP NEUROL, V405, P543
   LARSEN C, 2009, PATTERNS GROWT UNPUB
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891
   Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235
   Malun D, 1998, LEARN MEMORY, V5, P90
   Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037
   MARTIN JH, 1985, PRINCIPLES NEUROSCIE
   Moon LDF, 2002, NEUROSCIENCE, V109, P101, DOI 10.1016/S0306-4522(01)00457-2
   Morris J, 2004, DEV GENES EVOL, V214, P220, DOI 10.1007/s00427-004-0406-4
   MURPHEY RK, 1980, J NEUROPHYSIOL, V43, P367
   Nassif C, 1998, J COMP NEUROL, V402, P10
   Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482
   Nieuwenhuys R, 1981, HUMAN CENTRAL NERVOU
   Noveen A, 2000, DEVELOPMENT, V127, P3475
   O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010
   OLAND LA, 1990, J NEUROSCI, V10, P2096
   Oland LA, 1996, J NEUROBIOL, V30, P92
   Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015
   PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9
   Pereanu W, 2007, DEV BIOL, V302, P169, DOI 10.1016/j.ydbio.2006.09.022
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Petersen CCH, 2000, J NEUROSCI, V20, P7579
   Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105
   RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116
   Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5
   Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445
   Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4
   Schmid A, 1999, DEVELOPMENT, V126, P4653
   SEO HY, 1995, NEUROSCI LETT, V197, P13, DOI 10.1016/0304-3940(95)11885-Z
   SNOW PM, 1987, J NEUROSCI, V7, P4137
   STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372
   Strausfeld N. J., 1976, ATLAS INSECT BRAIN
   Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438
   TABATA T, 1995, DEVELOPMENT, V121, P3359
   Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5
   TOLBERT LP, 1990, EXP NEUROL, V109, P19, DOI 10.1016/S0014-4886(05)80005-6
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395
   Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008
   Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7
   Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008
   Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035
   WELLER WL, 1993, J COMP NEUROL, V337, P471, DOI 10.1002/cne.903370310
   WOOLSEY TA, 1975, J COMP NEUROL, V164, P79, DOI 10.1002/cne.901640107
   Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483
   Younossi-Hartenstein A, 2006, J COMP NEUROL, V497, P981, DOI 10.1002/cne.20884
NR 77
TC 36
Z9 36
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9967
EI 1096-9861
J9 J COMP NEUROL
JI J. Comp. Neurol.
PD AUG 1
PY 2010
VL 518
IS 15
BP 2996
EP 3023
DI 10.1002/cne.22376
PG 28
WC Neurosciences; Zoology
SC Neurosciences & Neurology; Zoology
GA 615EO
UT WOS:000279116500006
PM 20533357
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Cheng, Y
   Pieters, J
AF Cheng, Yong
   Pieters, Jean
TI Novel Proteasome Inhibitors as Potential Drugs to Combat Tuberculosis
SO JOURNAL OF MOLECULAR CELL BIOLOGY
LA English
DT Editorial Material
ID MYCOBACTERIUM-TUBERCULOSIS
AB Mycobacterium tuberculosis is one of the most notorious killers worldwide. These pathogens have evolved to infect human beings in a so-called dormant form that is extremely difficult to treat. New work, however, suggests that mycobacterial proteasomes, multicomponent structures that protect the microbe from damaging effects of nitric oxide generated by the host, can be selectively and specifically blocked by small molecules.
C1 [Cheng, Yong; Pieters, Jean] Univ Basel, Biozentrum, CH-4156 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingenbergstr 50, CH-4156 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR Butler D, 2000, NATURE, V406, P670, DOI 10.1038/35021291
   Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033
   Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176
   Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683
   Huang L, 2009, CURR MED CHEM, V16, P931, DOI 10.2174/092986709787581860
   Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357
   Nguyen L, 2009, ANNU REV PHARMACOL, V49, P427, DOI 10.1146/annurev-pharmtox-061008-103123
   Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006
   Warner DF, 2007, NAT MED, V13, P282, DOI 10.1038/nm0307-282
   Zwickl P, 2002, ADV PROTEIN CHEM, V59, P187
NR 10
TC 8
Z9 9
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1674-2788
EI 1759-4685
J9 J MOL CELL BIOL
JI J. Mol. Cell Biol.
PD AUG
PY 2010
VL 2
IS 4
BP 173
EP 175
DI 10.1093/jmcb/mjp053
PG 3
WC Cell Biology
SC Cell Biology
GA 709HC
UT WOS:000286428100002
PM 20123700
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Huang, NP
   Stubenrauch, M
   Koser, J
   Taschner, N
   Aebi, U
   Stolz, M
AF Huang, Ning-Ping
   Stubenrauch, Mike
   Koeser, Joachim
   Taschner, Nicole
   Aebi, Ueli
   Stolz, Martin
TI Towards monitoring transport of single cargos across individual nuclear
   pore complexes by time-lapse atomic force microscopy
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Nanobiology; Cellular nanomachine; Nuclear pore complex (NPC);
   Nucleoporin; Nucleocytoplasmic transport; Time-lapse AFM; Immuno-gold
   labeling
ID CONFORMATIONAL-CHANGES; INFECTION PATHWAY; ARCHITECTURE; ELECTRON;
   VISUALIZATION; LOCALIZATION; MOLECULES; SURFACES; BINDING; VIRUS
AB A new preparation procedure was developed for the stable adsorption of either the cytoplasmic or the nuclear face of native (i.e. in physiological buffer without detergent extraction and in the absence of chemical fixatives) Xenopus oocyte nuclear envelopes (NEs) onto silicon (Si) surfaces. This yields optimal structural preservation of the nuclear pore complexes (NPCs) without compromising their functional properties. The functional viability of thus prepared NPCs was documented by time-lapse atomic force microscopy (AFM) of the reversible calcium-mediated opening (i.e. +Ca2+) and closing (i.e. -Ca2+) of the iris diaphragm-like distal ring topping the NPCs' nuclear baskets. Moreover, site-specific single colloidal gold particle detection was documented by AFM imaging one and the same NPC before and after immuno-gold labeling the sample with a nucleoporin-specific antibody. With this new preparation protocol at hand, we should eventually be able to follow by time-lapse AFM transport of single gold-conjugated cargos across individual NPCs. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Huang, Ning-Ping] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
   [Huang, Ning-Ping; Koeser, Joachim; Taschner, Nicole; Aebi, Ueli; Stolz, Martin] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Stubenrauch, Mike] Ilmenau Univ Technol, Inst Micro & Nanotechnol, D-98693 Ilmenau, Germany.
   [Stolz, Martin] Univ Southampton, nCATS, Sch Engn Sci, Southampton SO9 5NH, Hants, England.
RP Huang, NP (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
EM nphuang@seu.edu.cn; ueli.aebi@unibas.ch
OI Stolz, Martin/0000-0002-0732-0811
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); EU Network of Excellence [LSHG-CT-2004-502828]; M.E. Muller
   Foundation of Switzerland; Canton Basel-Stadt; Ministry of Science and
   Technology of ChinaMinistry of Science and Technology, China
   [2006CB933206]; National Science Foundation of ChinaNational Natural
   Science Foundation of China (NSFC) [30870626]
FX This work was supported by a NCCR program grant on 'Nanoscale Science'
   awarded by the Swiss National Science Foundation, the 'EU Network of
   Excellence 3D-EM' Project No. LSHG-CT-2004-502828, the M.E. Muller
   Foundation of Switzerland, and the Canton Basel-Stadt. N.-P. Huang
   acknowledges the financial support from the Ministry of Science and
   Technology of China on the National Program on Key Basic Research
   Project (973 Program on 'Nanoscience', 2006CB933206) and the National
   Science Foundation of China (No. 30870626). We acknowledge the expert
   proofreading of the manuscript by Drs. Birthe Fahrenkrog and Roderick
   Lim, and last but not least, we thank Dr. Theo Staehelin for critical
   discussion of the data and constructive review of the manuscript.
CR AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   Brauchle C, 2002, CHEMPHYSCHEM, V3, P299, DOI 10.1002/1439-7641(20020315)3:3<299::AID-CPHC299>3.0.CO;2-R
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350
   Danelon C, 2006, LANGMUIR, V22, P10711, DOI 10.1021/la061321c
   Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173
   Desai TA, 2000, BIOMOL ENG, V17, P23, DOI 10.1016/S1389-0344(00)00063-0
   Engel A, 1999, CURR BIOL, V9, pR133, DOI 10.1016/S0960-9822(99)80081-5
   Fahrenkrog B, 2000, J STRUCT BIOL, V129, P295, DOI 10.1006/jsbi.2000.4223
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010
   FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0
   Goldberg MW, 1996, J MOL BIOL, V257, P848, DOI 10.1006/jmbi.1996.0206
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   Hansma HG, 1999, P NATL ACAD SCI USA, V96, P14678, DOI 10.1073/pnas.96.26.14678
   HENDERSON E, 1992, NUCLEIC ACIDS RES, V20, P445, DOI 10.1093/nar/20.3.445
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   HUES SM, 1993, MRS BULL, V18, P41, DOI 10.1557/S088376940004344X
   Huwiler C, 2005, NANOTECHNOLOGY, V16, P3045, DOI 10.1088/0957-4484/16/12/053
   Jaggi RD, 2003, BIOPHYS J, V85, P4093, DOI 10.1016/S0006-3495(03)74821-8
   JARNIK M, 1991, J STRUCT BIOL, V107, P291, DOI 10.1016/1047-8477(91)90054-Z
   Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005
   Lill Y, 2006, BIOPHYS J, V91, P3123, DOI 10.1529/biophysj.106.087650
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Lim RYH, 2006, CHROMOSOMA, V115, P15, DOI 10.1007/s00412-005-0037-1
   Lyubchenko YL, 1997, P NATL ACAD SCI USA, V94, P496, DOI 10.1073/pnas.94.2.496
   Maco Bohumil, 2006, V322, P273
   Moore-Nichols D, 2002, BIOPHYS J, V83, P1421, DOI 10.1016/S0006-3495(02)73913-1
   Mooren OL, 2004, PHYS BIOL, V1, P125, DOI 10.1088/1478-3967/1/2/008
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002
   Pasche S, 2005, J PHYS CHEM B, V109, P17545, DOI 10.1021/jp050431+
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Sanner M. F., 2005, NANOBIOTECHNOLOGY, V1, P7
   SAXTON WO, 1979, ULTRAMICROSCOPY, V4, P343, DOI 10.1016/S0304-3991(79)80044-3
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   Schlune A, 2006, J CELL BIOCHEM, V98, P567, DOI 10.1002/jcb.20742
   Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6
   Stoffler D, 1999, FASEB J, V13, pS195
   Stolz M, 2000, J STRUCT BIOL, V131, P171, DOI 10.1006/jsbi.2000.4301
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stolz M, 2007, NANOMED-NANOTECHNOL, V3, P53, DOI 10.1016/j.nano.2007.01.001
   Thalhammer S, 1997, J STRUCT BIOL, V119, P232, DOI 10.1006/jsbi.1997.3869
   Tong HD, 2004, NANO LETT, V4, P283, DOI 10.1021/nl0350175
   Wang HW, 1999, BIOPHYS J, V77, P241, DOI 10.1016/S0006-3495(99)76885-2
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
NR 59
TC 4
Z9 5
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD AUG
PY 2010
VL 171
IS 2
BP 154
EP 162
DI 10.1016/j.jsb.2010.04.004
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 615QX
UT WOS:000279151900005
PM 20394822
DA 2021-01-25
ER

PT J
AU Michels, AA
   Robitaille, AM
   Buczynski-Ruchonnet, D
   Hodroj, W
   Reina, JH
   Hall, MN
   Hernandez, N
AF Michels, Annemieke A.
   Robitaille, Aaron M.
   Buczynski-Ruchonnet, Diane
   Hodroj, Wassim
   Reina, Jaime H.
   Hall, Michael N.
   Hernandez, Nouria
TI mTORC1 Directly Phosphorylates and Regulates Human MAF1
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID RNA-POLYMERASE-III; P70 S6 KINASE; SACCHAROMYCES-CEREVISIAE;
   NUCLEAR-LOCALIZATION; POLYACRYLAMIDE-GELS; TRANSCRIBED GENES;
   STATISTICAL-MODEL; MASS-SPECTROMETRY; MAMMALIAN TARGET; IN-VITRO
AB mTORC1 is a central regulator of growth in response to nutrient availability, but few direct targets have been identified. RNA polymerase (pol) III produces a number of essential RNA molecules involved in protein synthesis, RNA maturation, and other processes. Its activity is highly regulated, and deregulation can lead to cell transformation. The human phosphoprotein MAF1 becomes dephosphorylated and represses pol III transcription after various stresses, but neither the significance of the phosphorylations nor the kinase involved is known. We find that human MAF1 is absolutely required for pol III repression in response to serum starvation or TORC1 inhibition by rapamycin or Torin1. The protein is phosphorylated mainly on residues S60, S68, and S75, and this inhibits its pol III repression function. The responsible kinase is mTORC1, which phosphorylates MAF1 directly. Our results describe molecular mechanisms by which mTORC1 controls human MAF1, a key repressor of RNA polymerase III transcription, and add a new branch to the signal transduction cascade immediately downstream of TORC1.
C1 [Michels, Annemieke A.; Buczynski-Ruchonnet, Diane; Hodroj, Wassim; Reina, Jaime H.; Hernandez, Nouria] Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, CH-1015 Lausanne, Switzerland.
   [Robitaille, Aaron M.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hernandez, N (corresponding author), Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Genopode Bldg,Dorigny Campus, CH-1015 Lausanne, Switzerland.
EM Nouria.Hernandez@unil.ch
OI Robitaille, Aaron Mark/0000-0003-2774-2066; Michels,
   Annemieke/0000-0002-1735-1697; Hernandez, Nouria/0000-0003-1465-4585
FU University of Lausanne [3100A0-109941]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); European
   CommunityEuropean Community (EC); Roche Research Foundation
FX We thank Philippe l'Hote for invaluable help with tissue culture, Pascal
   Cousin for technical assistance, Viviane Praz for help with designing
   tRNA Leu primers, Marco Mehr for the GST-URI construct, and Manfredo
   Quadroni and Patrice Waridel of the Protein Analysis Facility, Center
   for Integrative Genomics, Faculty of Biology and Medicine, University of
   Lausanne, Switzerland, for the proteomic analysis. We thank Sara C.
   Kozma and Jongsun Park (University of Cincinnati) for the S6K1 S6K2
   double KO MEFs and Nathanael S. Gray (Dana Farber Cancer Institute,
   Harvard Medical School) for Torin1.; This work was funded by the
   University of Lausanne and by grant 3100A0-109941 from the Swiss
   National Science Foundation. A.A.M. was financed in part by a European
   Community Sixth Framework Marie Curie Intra-European Fellowship. J.H.R.
   was supported in part by the Roche Research Foundation.
CR Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07
   De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884
   Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010
   Geiduschek EP, 2006, CURR BIOL, V16, pR849, DOI 10.1016/j.cub.2006.08.071
   Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060
   Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Hu P, 2002, MOL CELL BIOL, V22, P8044, DOI 10.1128/MCB.22.22.8044-8055.2002
   Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109
   Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kinoshita E, 2004, DALTON T, P1189, DOI 10.1039/b400269e
   Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243
   Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200
   Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020
   Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321
   Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103
   Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008
   PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x
   Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004
   Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001
   Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134
   Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009
   Saitoh M, 1998, BIOCHEM BIOPH RES CO, V253, P470, DOI 10.1006/bbrc.1998.9784
   Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649
   Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639
   Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Towpik J, 2008, J BIOL CHEM, V283, P17168, DOI 10.1074/jbc.M709157200
   Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876
   Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6
   Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020
   Wei YH, 2009, CELL CYCLE, V8, P4085, DOI 10.4161/cc.8.24.10170
   Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179
   Willis IM, 2004, PROG NUCLEIC ACID RE, V77, P323, DOI 10.1016/S0079-6603(04)77009-9
   Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 44
TC 93
Z9 97
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD AUG
PY 2010
VL 30
IS 15
BP 3749
EP 3757
DI 10.1128/MCB.00319-10
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 623CF
UT WOS:000279714500003
PM 20516213
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kilchert, C
   Weidner, J
   Prescianotto-Baschong, C
   Spang, A
AF Kilchert, Cornelia
   Weidner, Julie
   Prescianotto-Baschong, Cristina
   Spang, Anne
TI Defects in the Secretory Pathway and High Ca2+ Induce Multiple P-bodies
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA;
   OSMOTIC-STRESS; BODY FORMATION; TRANSLATION INITIATION;
   ENDOPLASMIC-RETICULUM; PROCESSING BODIES; TRAILER HITCH; YEAST
AB mRNA is sequestered and turned over in cytoplasmic processing bodies (PBs), which are induced by various cellular stresses. Unexpectedly, in Saccharomyces cerevisiae, mutants of the small GTPase Arf1 and various secretory pathway mutants induced a significant increase in PB number, compared with PB induction by starvation or oxidative stress. Exposure of wild-type cells to osmotic stress or high extracellular Ca2+ mimicked this increase in PB number. Conversely, intracellular Ca2+-depletion strongly reduced PB formation in the secretory mutants. In contrast to PB induction through starvation or osmotic stress, PB formation in secretory mutants and by Ca2+ required the PB components Pat1 and Scd6, and calmodulin, indicating that different stressors act through distinct pathways. Consistent with this hypothesis, when stresses were combined, PB number did not correlate with the strength of the translational block, but rather with the type of stress encountered. Interestingly, independent of the stressor, PBs appear as spheres of similar to 40-100 nm connected to the endoplasmic reticulum (ER), consistent with the idea that translation and silencing/degradation occur in a spatially coordinated manner at the ER. We propose that PB assembly in response to stress occurs at the ER and depends on intracellular signals that regulate PB number.
C1 [Kilchert, Cornelia; Weidner, Julie; Prescianotto-Baschong, Cristina; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019; Weidner,
   Julie/AAS-6673-2020
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203;
   Weidner, Julie/0000-0002-7140-8666; Kilchert,
   Cornelia/0000-0001-6834-0704
FU Boehringer Ingelheim FondsBoehringer Ingelheim; Werner Siemens
   Foundation; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); University of Basel
FX We are grateful to E. Schiebel, A. Diepold and members of the Spang lab
   for discussions, and to E. Hartmann and I. G. Macara for critical
   comments on the manuscript. S. Michaelis is acknowledged for providing
   the Sec63-RFP plasmid, and we thank T. Davis (University of Washington,
   Seattle, WA), M. Hall (University of Basel, Basel, Switzerland), A.
   Nakano, R. Schekman, and E. Schiebel for reagents. This work was
   supported by the Boehringer Ingelheim Fonds (C. K.), the Werner Siemens
   Foundation (J.W.), the Swiss National Science Foundation, and the
   University of Basel.
CR Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513
   Anderson JR, 2006, RNA, V12, P1810, DOI 10.1261/rna.144606
   Aronov S, 2004, J BIOL CHEM, V279, P36962, DOI 10.1074/jbc.M402068200
   Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833
   Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357
   Bi J, 2007, P NATL ACAD SCI USA, V104, P13810, DOI 10.1073/pnas.0703805104
   Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661
   Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043
   Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507
   Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4
   De Filippi L, 2007, CURR GENET, V52, P171, DOI 10.1007/s00294-007-0151-0
   Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147
   Decker CJ, 2006, J CELL BIOL, V173, P159, DOI 10.1083/jcb.200601153
   delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201
   Deloche O, 2004, MOL CELL, V13, P357, DOI 10.1016/S1097-2765(04)00008-5
   Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411
   Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174
   Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07
   Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039
   Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001
   GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C
   Hayashi M, 2006, J BIOCHEM, V139, P797, DOI 10.1093/jb/mvj089
   Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004
   Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002
   Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010
   Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088
   Kimata Y, 2006, GENES CELLS, V11, P59, DOI 10.1111/j.1365-2443.2005.00921.x
   Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W
   LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067
   Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200
   NELSON KK, 1993, MOL CELL BIOL, V13, P521, DOI 10.1128/MCB.13.1.521
   OHYA Y, 1994, SCIENCE, V263, P963, DOI 10.1126/science.8310294
   Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011
   Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246
   Prescianotto-Baschong C, 2002, TRAFFIC, V3, P37, DOI 10.1034/j.1600-0854.2002.30106.x
   Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976
   Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709
   Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451
   Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002
   Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   SIDRAUSKI C, 1997, CELL, V90, P1
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Spang A, 1996, J CELL SCI, V109, P2229
   Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874
   Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006
   Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505
   Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199
   Tharun S, 2005, GENETICS, V170, P33, DOI 10.1534/genetics.104.034322
   Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676
   Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1
   Trautwein M, 2004, MOL BIOL CELL, V15, P5021, DOI 10.1091/mbc.E04-05-0411
   Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x
   Wilczynska Z, 2005, EUKARYOT CELL, V4, P1513, DOI 10.1128/EC.4.9.1513-1525.2005
   Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015
NR 55
TC 35
Z9 35
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD AUG 1
PY 2010
VL 21
IS 15
BP 2624
EP 2638
DI 10.1091/mbc.E10-02-0099
PG 15
WC Cell Biology
SC Cell Biology
GA 633UE
UT WOS:000280531400008
PM 20519435
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Martin, G
   Ostareck-Lederer, A
   Chari, A
   Neuenkirchen, N
   Dettwiler, S
   Blank, D
   Ruegsegger, U
   Fischer, U
   Keller, W
AF Martin, Georges
   Ostareck-Lederer, Antje
   Chari, Ashwin
   Neuenkirchen, Nils
   Dettwiler, Sabine
   Blank, Diana
   Rueegsegger, Ursula
   Fischer, Utz
   Keller, Walter
TI Arginine methylation in subunits of mammalian pre-mRNA cleavage factor I
SO RNA
LA English
DT Article
DE protein arginine methyltransferase; PRMT1; PRMT2; PRMT5; mammalian
   cleavage factor I; CF I-m
ID NUCLEAR POLY(A)-BINDING PROTEIN; N-METHYLTRANSFERASE; POLY(A)
   POLYMERASE; KDA SUBUNIT; BINDING; POLYADENYLATION; SPECIFICITY;
   MECHANISM; DYNAMICS; COMPLEX
AB Mammalian cleavage factor I (CF I-m) is composed of two polypeptides of 25 kDa and either a 59 or 68 kDa subunit (CF I(m)25, CF I(m)59, CF I(m)68). It is part of the cleavage and polyadenylation complex responsible for processing the 39 ends of messenger RNA precursors. To investigate post-translational modifications in factors of the 3' processing complex, we systematically searched for enzymes that modify arginines by the addition of methyl groups. Protein arginine methyltransferases (PRMTs) are such enzymes that transfer methyl groups from S-adenosyl methionine to arginine residues within polypeptide chains resulting in mono- or dimethylated arginines. We found that CF I(m)68 and the nuclear poly(A) binding protein 1 (PABPN1) were methylated by HeLa cell extracts in vitro. By fractionation of these extracts followed by mass spectral analysis, we could demonstrate that the catalytic subunit PRMT5, together with its cofactor WD45, could symmetrically dimethylate CF I(m)68, whereas pICln, the third polypeptide of the complex, was stimulatory. As sites of methylation in CF I(m)68 we could exclusively identify arginines in a GGRGRGRF or "GAR" motif that is conserved in vertebrates. Further in vitro assays revealed a second methyltransferase, PRMT1, which modifies CF I(m)68 by asymmetric dimethylation of the GAR motif and also weakly methylates the C-termini of both CF I(m)59 and CF I(m)68. The results suggest that native-as compared with recombinant-protein substrates may contain additional determinants for methylation by specific PRMTs. A possible involvement of CF I-m methylation in the context of RNA export is discussed.
C1 [Martin, Georges; Dettwiler, Sabine; Blank, Diana; Rueegsegger, Ursula; Keller, Walter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Chari, Ashwin; Neuenkirchen, Nils; Fischer, Utz] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany.
   [Ostareck-Lederer, Antje] Rhein Westfal TH Aachen, Univ Hosp, Expt Res Unit, Dept Intens Care, D-52074 Aachen, Germany.
RP Keller, W (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM walter.keller@unibas.ch
RI Chari, Ashwin/ABC-5304-2020; Fischer, Utz/AAT-8422-2020; Fischer,
   Utz/A-4090-2016
OI Chari, Ashwin/0000-0001-6220-9828; Fischer, Utz/0000-0002-1465-6591;
   Fischer, Utz/0000-0002-1465-6591
FU German Research CouncilGerman Research Foundation (DFG) [FOR855];
   DFGGerman Research Foundation (DFG) [OS290/2-1, OS290/2-2];
   Heisenberg-FellowshipGerman Research Foundation (DFG) [OS290/1-2];
   University of Basel; Swiss National Science FundSwiss National Science
   Foundation (SNSF) [3100A0-102132/2]
FX We thank Christiane Rammelt for help with RNAi, Suzette Moes and Paul
   Jeno for the mass spectral analysis, Isabelle Kaufmann for the purified
   CPSF, Henk de Vries for the purified CF I<INF>m</INF>/CF II<INF>m</INF>,
   Uwe Kuhn for the recombinant PABPN1 plasmid, and Elmar Wahle for the
   purified PABPN1. U.F. was supported by grant no. FOR855 from the German
   Research Council. A.O.-L. was supported by DFG grant nos. OS290/2-1 and
   OS290/2-2 and Heisenberg-Fellowship OS290/1-2. W. K. was supported by
   the University of Basel and the Swiss National Science Fund (Grant no.
   3100A0-102132/2).
CR Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003
   Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199
   Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036
   Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200
   Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200
   Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2
   Cardinale S, 2007, MOL BIOL CELL, V18, P1282, DOI 10.1091/mbc.E06-09-0846
   Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020
   Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174
   Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0
   Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167
   Coseno M, 2008, NUCLEIC ACIDS RES, V36, P3474, DOI 10.1093/nar/gkn079
   de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895
   Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200
   Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200
   Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200
   Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960
   Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X
   GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3
   Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200
   Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005
   JENNY A, 1995, NUCLEIC ACIDS RES, V23, P2629, DOI 10.1093/nar/23.14.2629
   Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070
   Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226
   Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200
   Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037
   Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268
   Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200
   Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200
   Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380
   Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034
   Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807
   Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9
   Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1
   Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200
   Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009
   Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200
   Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008
   Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000
   Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200
   Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209
   Ruegsegger U, 1996, J BIOL CHEM, V271, P6107
   Ruegsegger U, 1998, MOL CELL, V1, P243, DOI 10.1016/S1097-2765(00)80025-8
   Ruepp MD, 2009, MOL BIOL CELL, V20, P5211, DOI 10.1091/mbc.E09-05-0389
   Ryan K, 2008, INT J BIOCHEM CELL B, V40, P2384, DOI 10.1016/j.biocel.2008.03.016
   Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679
   Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028
   Shimazu T, 2007, J BIOL CHEM, V282, P4470, DOI 10.1074/jbc.M609745200
   Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229
   Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935
   Vagner S, 2000, GENE DEV, V14, P403
   Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605
   Vethantham V, 2008, GENE DEV, V22, P499, DOI 10.1101/gad.1628208
   Wahle E, 1996, TRENDS BIOCHEM SCI, V21, P247, DOI 10.1016/0968-0004(96)10030-X
   Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
NR 60
TC 20
Z9 22
U1 0
U2 4
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD AUG
PY 2010
VL 16
IS 8
BP 1646
EP 1659
DI 10.1261/rna.2164210
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 624XJ
UT WOS:000279855200018
PM 20562214
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Reiterer, V
   Nyfeler, B
   Hauri, HP
AF Reiterer, Veronika
   Nyfeler, Beat
   Hauri, Hans-Peter
TI Role of the Lectin VIP36 in Post-ER Quality Control of Human alpha
   1-Antitrypsin
SO TRAFFIC
LA English
DT Article
DE BiP; endoplasmic reticulum; Golgi; kifunensine; L-type lectins; membrane
   traffic; recycling; yellow fluorescent protein fragment complementation
ID ENDOPLASMIC-RETICULUM; PROTEIN INTERACTIONS; SECRETORY PATHWAY;
   MEMBRANE-PROTEIN; INTRACELLULAR-TRANSPORT; MOLECULAR-BASIS; ERGIC-53;
   GLYCOPROTEINS; COMPARTMENT; RECEPTOR
AB The leguminous-type (L-type) lectin VIP36 localizes to the Golgi apparatus and cycles early in the secretory pathway. In vitro, VIP36 binds high-mannose glycans with a pH optimum of 6.5, a value similar to the luminal pH of the Golgi apparatus. Although the sugar-binding properties of VIP36 in vitro have been characterized in detail, the function of VIP36 in the intact cell remains unclear as no convincing glycoprotein cargo has been identified. Here, we used yellow fluorescent protein (YFP) fragment complementation to identify luminal interaction partners of VIP36. By screening a human liver cDNA library, we identified the glycoprotein alpha 1-antitrypsin (alpha 1-AT) as a cargo of VIP36. The VIP36/alpha 1-AT complex localized to Golgi and endoplasmic reticulum (ER). In the living cell, VIP36 bound exclusively to the high-mannose form of alpha 1-AT. The binding was increased when complex glycosylation was prevented by kifunensine and abolished when the glycosylation sites of alpha 1-AT were inactivated by mutagenesis. Silencing VIP36 accelerated alpha 1-AT transport, arguing against a role of VIP36 in anterograde traffic. The complex formed by VIP36 and alpha 1-AT in the Golgi recycled back to the ER. The combined data are most consistent with a function of VIP36 in post-ER quality control of alpha 1-AT.
C1 [Reiterer, Veronika; Nyfeler, Beat; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Hans-Peter.Hauri@unibas.ch
FU University of Basel; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF)
FX We gratefully acknowledge Verena Jaggin (Department of Biomedicine,
   University of Basel) for the help in FACS sorting. We thank Annie-Claude
   Roche for providing mannosylated BSA and Karl Matter, Sreenivasan
   Ponnambalam and Kai Simons for gifts of antibodies. This work was
   supported by the University of Basel and the Swiss National Science
   Foundation.
CR Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200
   Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8
   Coleman R Edward, 1998, Clin Positron Imaging, V1, P15, DOI 10.1016/S1095-0397(97)00004-6
   Cortini M, 2010, TRAFFIC, V11, P651, DOI 10.1111/j.1600-0854.2010.01043.x
   Dahm T, 2001, MOL BIOL CELL, V12, P1481, DOI 10.1091/mbc.12.5.1481
   Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052
   FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x
   Fiedler K, 1996, J CELL SCI, V109, P271
   Fullekrug J, 1999, J CELL SCI, V112, P2813
   GROSS V, 1982, EUR J BIOCHEM, V129, P317, DOI 10.1111/j.1432-1033.1982.tb07054.x
   Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043
   HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687
   Hara-Kuge S, 1999, GLYCOBIOLOGY, V9, P833, DOI 10.1093/glycob/9.8.833
   Hara-Kuge S, 2004, GLYCOBIOLOGY, V14, P739, DOI 10.1093/glycob/cwh082
   Hara-Kuge S, 2002, J BIOL CHEM, V277, P16332, DOI 10.1074/jbc.M112188200
   Hauri HP, 2002, BIOCHEM SOC SYMP, V69, P73
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3
   Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006
   Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752
   Itin C, 1996, MOL BIOL CELL, V7, P483
   Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200
   Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Lackie PM, 2006, CLIN EXP ALLERGY, V36, P560, DOI 10.1111/j.1365-2222.2006.02482.x
   LE A, 1990, J BIOL CHEM, V265, P14001
   Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004
   Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540
   LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679
   Marcus NY, 2000, J BIOL CHEM, V275, P1987, DOI 10.1074/jbc.275.3.1987
   Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417
   MCCRACKEN AA, 1989, MOL CELL BIOL, V9, P1406, DOI 10.1128/MCB.9.4.1406
   Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331
   Morell M, 2007, PROTEOMICS, V7, P1023, DOI 10.1002/pmic.200600966
   Nawa D, 2007, GLYCOBIOLOGY, V17, P913, DOI 10.1093/glycob/cwm067
   Neve EPA, 2003, EXP CELL RES, V288, P70, DOI 10.1016/S0014-4827(03)00161-7
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200
   Nyfeler B, 2007, BIOCHEM SOC T, V35, P970, DOI 10.1042/BST0350970
   Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102
   Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100
   Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181
   Parfrey H, 2003, INT J BIOCHEM CELL B, V35, P1009, DOI 10.1016/S1357-2725(02)00250-9
   Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004
   Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185
   SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967
   Shimada O, 2003, J HISTOCHEM CYTOCHEM, V51, P1057, DOI 10.1177/002215540305100809
   TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255
   Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.E04-07-0554
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   WENG SA, 1993, J BIOL CHEM, V268, P25656
   WRIGHT A, 1994, J EXP MED, V180, P1087, DOI 10.1084/jem.180.3.1087
   Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200
NR 58
TC 27
Z9 27
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-9219
EI 1600-0854
J9 TRAFFIC
JI Traffic
PD AUG
PY 2010
VL 11
IS 8
BP 1044
EP 1055
DI 10.1111/j.1600-0854.2010.01078.x
PG 12
WC Cell Biology
SC Cell Biology
GA 621WE
UT WOS:000279615300003
PM 20477988
OA Bronze
DA 2021-01-25
ER

PT J
AU Boudko, SP
   Zientek, KD
   Vance, J
   Hacker, JL
   Engel, J
   Bachinger, HP
AF Boudko, Sergei P.
   Zientek, Keith D.
   Vance, Jesse
   Hacker, Jessica L.
   Engel, Juergen
   Baechinger, Hans Peter
TI The NC2 Domain of Collagen IX Provides Chain Selection and
   Heterotrimerization
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID OLIGOMERIC MATRIX PROTEIN; CARTILAGE FIBRILS; CRYSTAL-STRUCTURE;
   TRIPLE-HELIX; ALPHA-CHAINS; ARTHRITIS; SEQUENCE; GLYCOSAMINOGLYCANS;
   TRIMERIZATION; PROTEOGLYCAN
AB The mechanism of chain selection and trimerization of fibril-associated collagens with interrupted triple helices (FACITs) differs from that of fibrillar collagens that have special C-propeptides. We recently showed that the second carboxyl-terminal non-collagenous domain (NC2) of homotrimeric collagen XIX forms a stable trimer and substantially stabilizes a collagen triple helix attached to either end. We then hypothesized a general trimerizing role for the NC2 domain in other FACITs. Here we analyzed the NC2 domain of human heterotrimeric collagen IX, the only member of FACITs with all three chains encoded by distinct genes. Upon oxidative folding of equimolar amounts of the alpha 1, alpha 2, and alpha 3 chains of NC2, a stable heterotrimer with a disulfide bridge between alpha 1 and alpha 3 chains is formed. Our experiments show that this heterotrimerization domain can stabilize a short triple helix attached at the carboxyl-terminal end and allows for the proper oxidation of the cystine knot of type III collagen after the short triple helix.
C1 Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
   [Boudko, Sergei P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
   [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bachinger, HP (corresponding author), 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
EM hpb@shcc.org
FU Shriners Hospital for Children
FX This work was supported by a grant from the Shriners Hospital for
   Children.
CR Asamura K, 2005, NEUROSCIENCE, V132, P493, DOI 10.1016/j.neuroscience.2005.01.013
   Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200
   Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200
   Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054
   Boyd LM, 2008, ARTHRITIS RHEUM, V58, P164, DOI 10.1002/art.23231
   BRUCKNER P, 1988, J BIOL CHEM, V263, P16911
   Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817
   Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5
   Diab M, 1993, Orthop Rev, V22, P165
   DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6
   EYRE DR, 1995, J RHEUMATOL, V22, P82
   FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070
   Fresquet M, 2007, J BIOL CHEM, V282, P34634, DOI 10.1074/jbc.M705301200
   HEDBOM E, 1992, J BIOL CHEM, V267, P6132
   Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200
   Jaalinoja J, 2008, J RHEUMATOL, V35, P745
   Jaalinoja J, 2008, BIOCHEM J, V409, P545, DOI 10.1042/BJ20070984
   Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602
   LABOURDETTE L, 1993, FEBS LETT, V320, P211, DOI 10.1016/0014-5793(93)80588-L
   Leppanen VM, 2007, J BIOL CHEM, V282, P23219, DOI 10.1074/jbc.M702514200
   Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p
   MAZZORANA M, 1993, J BIOL CHEM, V268, P3029
   Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200
   McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200
   Mechling DE, 1996, J BIOL CHEM, V271, P13781, DOI 10.1074/jbc.271.23.13781
   MORGELIN M, 1994, BIOPHYS CHEM, V50, P113, DOI 10.1016/0301-4622(94)85024-0
   Munakata H, 1999, GLYCOBIOLOGY, V9, P1023, DOI 10.1093/glycob/9.10.1023
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   OKADA Y, 1989, FEBS LETT, V244, P473, DOI 10.1016/0014-5793(89)80586-1
   Paassilta P, 1999, J BIOL CHEM, V274, P22469, DOI 10.1074/jbc.274.32.22469
   Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200
   Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464
   Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024
   Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397
   Rowley MJ, 2008, MOD RHEUMATOL, V18, P429, DOI 10.1007/s10165-008-0080-x
   Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200
   VANDERREST M, 1988, J BIOL CHEM, V263, P1615
   VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991
   WU JJ, 1991, J BIOL CHEM, V266, P5625
NR 39
TC 12
Z9 12
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 30
PY 2010
VL 285
IS 31
BP 23721
EP 23731
DI 10.1074/jbc.M110.128405
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 630RT
UT WOS:000280291400022
PM 20507993
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Samad, OA
   Liu, Y
   Yang, FC
   Kramer, I
   Arber, S
   Ma, QF
AF Samad, Omar Abdel
   Liu, Yang
   Yang, Fu-Chia
   Kramer, Ina
   Arber, Silvia
   Ma, Qiufu
TI Characterization of two Runx1-dependent nociceptor differentiation
   programs necessary for inflammatory versus neuropathic pain
SO MOLECULAR PAIN
LA English
DT Article
ID SENSORY NEURONS; MOLECULAR-MECHANISMS; GENE DELETION; COLD; CHANNELS;
   CELL; SENSATION; SUBSETS; SYSTEM; MOUSE
AB Background: The cellular and molecular programs that control specific types of pain are poorly understood. We reported previously that the runt domain transcription factor Runx1 is initially expressed in most nociceptors and controls sensory neuron phenotypes necessary for inflammatory and neuropathic pain.
   Results: Here we show that expression of Runx1-dependent ion channels and receptors is distributed into two nociceptor populations that are distinguished by persistent or transient Runx1 expression. Conditional mutation of Runx1 at perinatal stages leads to preferential impairment of Runx1-persistent nociceptors and a selective defect in inflammatory pain. Conversely, constitutive Runx1 expression in Runx1-transient nociceptors leads to an impairment of Runx1-transient nociceptors and a selective deficit in neuropathic pain. Notably, the subdivision of Runx1-persistent and Runx1-transient nociceptors does not follow the classical nociceptor subdivision into IB4(+) nonpeptidergic and IB4(-) peptidergic populations.
   Conclusion: Altogether, we have uncovered two distinct Runx1-dependent nociceptor differentiation programs that are permissive for inflammatory versus neuropathic pain. These studies lend support to a transcription factor-based distinction of neuronal classes necessary for inflammatory versus neuropathic pain.
C1 [Samad, Omar Abdel; Liu, Yang; Yang, Fu-Chia; Ma, Qiufu] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Samad, Omar Abdel; Liu, Yang; Yang, Fu-Chia; Ma, Qiufu] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.
   [Kramer, Ina; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Kramer, Ina; Arber, Silvia] Friedrich Miescher Inst, CH-4002 Basel, Switzerland.
RP Ma, QF (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.
EM qiufu_ma@dfci.harvard.edu
RI samad, omar/K-1921-2012
OI Arber, Silvia/0000-0002-6261-250X; Liu, Yang/0000-0002-0396-3844
FU NIH (NINDS)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [5T32NS007473-09, 5P01NS047572]; NIH from
   NIDCRUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Dental &
   Craniofacial Research (NIDCR) [1R01DE018025]; NATIONAL INSTITUTE OF
   DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Dental & Craniofacial Research (NIDCR) [R01DE018025, R01DE018025,
   R01DE018025, R01DE018025, R01DE018025] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Dental & Craniofacial Research (NIDCR)
   [R01DE018025, R01DE013843, R01DE018025, R01DE018025, R01DE013843,
   R01DE013843, R01DE018025, R01DE018025, R01DE013843, R01DE013843] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [T32NS007473, P01NS047572, T32NS007473,
   P01NS047572, P01NS047572, P01NS047572, T32NS007473, P01NS047572,
   P01NS047572, P01NS047572, P01NS047572, P01NS047572, T32NS007473,
   P01NS047572, P01NS047572, P01NS047572, P01NS047572, P01NS047572,
   T32NS007473, P01NS047572, T32NS007473, P01NS047572, T32NS007473,
   P01NS047572, T32NS007473, P01NS047572, T32NS007473, P01NS047572,
   P01NS047572, T32NS007473, P01NS047572, P01NS047572, P01NS047572,
   P01NS047572, P01NS047572, T32NS007473, P01NS047572, T32NS007473,
   P01NS047572, P01NS047572, P01NS047572, P01NS047572, P01NS047572,
   P01NS047572, T32NS007473, T32NS007473, T32NS007473, P01NS047572,
   P01NS047572, P01NS047572, T32NS007473, T32NS007473, P01NS047572,
   P01NS047572, T32NS007473, P01NS047572, P01NS047572, P01NS047572,
   P01NS047572, P01NS047572, T32NS007473, T32NS007473, P01NS047572,
   P01NS047572, P01NS047572, P01NS047572, T32NS007473, P01NS047572,
   T32NS007473, T32NS007473, P01NS047572, P01NS047572, P01NS047572,
   P01NS047572, T32NS007473, P01NS047572, T32NS007473, P01NS047572,
   P01NS047572, P01NS047572, P01NS047572, P01NS047572, T32NS007473,
   P01NS047572, P01NS047572, P01NS047572, P01NS047572] Funding Source: NIH
   RePORTER
FX We thank Drs. Gary Gilliland and Nancy Speck for the Runx1 conditional
   knockout mice, Dr. Rohini Kuner for the Nav1.8<SUP>Cre</SUP> mice, and
   Dr. Tom Jessell for the Runx1 antibody. We thank Drs. Clifford Woolf,
   Tarek Samad, Ru-Rong Ji, and Gary J. Brenner for technical assistance in
   performing surgeries and measuring pain behaviors and for their critical
   reading of this manuscript. The work is supported by the NIH training
   grant to FY (NINDS: 5T32NS007473-09), and the NIH grants from NIDCR
   (1R01DE018025) and NINDS (5P01NS047572) to QM. QM is a Claudia Adams
   Barr Scholar.
CR Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916
   Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010
   Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028
   Bourane S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-97
   Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021
   Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006
   Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306
   Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106
   Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036
   Cheng JK, 2008, NEUROCHEM RES, V33, P1970, DOI 10.1007/s11064-008-9711-z
   Christianson JA, 2006, NEUROSCIENCE, V140, P247, DOI 10.1016/j.neuroscience.2006.02.015
   Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531
   Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076
   Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1
   Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008
   Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024
   Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4
   Foulkes T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000086
   Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280
   HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7
   Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008
   Jiang XB, 2000, DEVELOPMENT, V127, P1607
   Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019
   Kiasalari Z, 2010, J COMP NEUROL, V518, P137, DOI 10.1002/cne.22187
   Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008
   Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078
   Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937
   Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034
   Liu Y, 2008, J NEUROSCI, V28, P125, DOI 10.1523/JNEUROSCI.4472-07.2008
   Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700
   Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631
   Momin A, 2008, CURR OPIN NEUROBIOL, V18, P383, DOI 10.1016/j.conb.2008.08.017
   Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757
   Pezet S, 2006, ANNU REV NEUROSCI, V29, P507, DOI 10.1146/annurev.neuro.29.051605.112929
   Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009
   Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X
   STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1
   Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015
   Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007
   Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016
   Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007
   Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015
NR 42
TC 30
Z9 30
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
EI 1744-8069
J9 MOL PAIN
JI Mol. Pain
PD JUL 30
PY 2010
VL 6
AR 45
DI 10.1186/1744-8069-6-45
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 658JI
UT WOS:000282485900001
PM 20673362
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Boukhtouche, F
   Brugg, B
   Wehrle, R
   Bois-Joyeux, B
   Danan, JL
   Dusart, I
   Mariani, J
AF Boukhtouche, Fatiha
   Brugg, Bernard
   Wehrle, Rosine
   Bois-Joyeux, Brigitte
   Danan, Jean-Louis
   Dusart, Isabelle
   Mariani, Jean
TI Induction of early Purkinje cell dendritic differentiation by thyroid
   hormone requires ROR alpha
SO NEURAL DEVELOPMENT
LA English
DT Article
ID ORPHAN RECEPTOR-ALPHA; NUCLEAR RECEPTOR; RAT CEREBELLUM; MUTANT MICE;
   MOUSE CEREBELLUM; GENE-EXPRESSION; STAGGERER MICE; IN-VITRO; RT-PCR;
   SYNAPTOGENESIS
AB Background: The active form (T-3) of thyroid hormone (TH) controls critical aspects of cerebellar development, such as migration of postmitotic neurons and terminal dendritic differentiation of Purkinje cells. The effects of T-3 on early dendritic differentiation are poorly understood.
   Results: In this study, we have analyzed the influence of T-3 on the progression of the early steps of Purkinje cell dendritic differentiation in postnatal day 0 organotypic cerebellar cultures. These steps include, successively, regression of immature neuritic processes, a stellate cell stage, and the extension of several long and mature perisomatic protrusions before the growth of the ultimate dendritic tree. We also studied the involvement of ROR alpha, a nuclear receptor controlling early Purkinje cell dendritic differentiation. We show that T-3 treatment leads to an accelerated progression of the early steps of dendritic differentiation in culture, together with an increased expression of ROR alpha (mRNA and protein) in both Purkinje cells and interneurons. Finally, we show that T-3 failed to promote early dendritic differentiation in staggerer ROR alpha-deficient Purkinje cells.
   Conclusions: Our results demonstrate that T-3 action on the early Purkinje cell dendritic differentiation process is mediated by ROR alpha.
C1 [Boukhtouche, Fatiha; Brugg, Bernard; Wehrle, Rosine; Dusart, Isabelle; Mariani, Jean] Univ Paris 06, UPMC, UMR 7102 NPA, F-75005 Paris, France.
   [Boukhtouche, Fatiha; Brugg, Bernard; Wehrle, Rosine; Dusart, Isabelle; Mariani, Jean] CNRS, UMR 7102 NPA, F-75005 Paris, France.
   [Boukhtouche, Fatiha] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Bois-Joyeux, Brigitte; Danan, Jean-Louis] CNRS, Fac Med Paris Descartes, FRE 3210, F-75015 Paris, France.
   [Mariani, Jean] UEF, Hop Charles Foix, F-94205 Ivry, France.
RP Boukhtouche, F (corresponding author), Univ Paris 06, UPMC, UMR 7102 NPA, F-75005 Paris, France.
EM fatiha.boukhtouche@gmail.com
OI Mariani, Jean/0000-0002-2701-1581; Dusart, Isabelle/0000-0002-3211-4323
FU Fondation pour la Recherche MedicaleFondation pour la Recherche
   Medicale; Fondation Lejeune;  [ANR-07-NEURO-043-01]
FX This research was supported by grants from Fondation pour la Recherche
   Medicale (FB), Fondation Lejeune (FB) and ANR-07-NEURO-043-01 (ID). We
   thank Rachel Sherrard for helping us with the manuscript.
CR Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399
   Anderson GW, 2001, FRONT NEUROENDOCRIN, V22, P1, DOI 10.1006/frne.2000.0208
   ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3
   BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976
   Boukhtouche F, 2006, J NEUROCHEM, V96, P1778, DOI 10.1111/j.1471-4159.2006.03708.x
   Boukhtouche F, 2006, J NEUROSCI, V26, P1531, DOI 10.1523/JNEUROSCI.4636-05.2006
   Boukhtouche F, 2006, CEREBELLUM, V5, P97, DOI 10.1080/14734220600750184
   BRADLEY P, 1978, BRAIN RES, V142, P135, DOI 10.1016/0006-8993(78)90182-8
   CARLBERG C, 1994, MOL ENDOCRINOL, V8, P757, DOI 10.1210/me.8.6.757
   Chauvet C, 2004, BIOCHEM J, V384, P79, DOI 10.1042/BJ20040709
   CREPEL F, 1974, EXP BRAIN RES, V20, P403
   Doulazmi M, 2001, DEV BRAIN RES, V127, P165, DOI 10.1016/S0165-3806(01)00131-6
   Duplus E, 2008, J NEUROCHEM, V104, P1321, DOI 10.1111/j.1471-4159.2007.05074.x
   Ghoumari AM, 2002, J NEUROSCI, V22, P3531
   GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538
   Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4
   Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0
   Herrup K, 1983, Brain Res, V313, P267
   Heuer H, 2003, J NEUROSCI, V23, P10604
   Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000
   Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311, DOI 10.1177/002215540405200302
   Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003
   Kimura-Kuroda J, 2002, DEV BRAIN RES, V137, P55, DOI 10.1016/S0165-3806(02)00408-X
   Koibuchi N, 1999, ENDOCRINOLOGY, V140, P1356, DOI 10.1210/en.140.3.1356
   Koibuchi N, 1998, ENDOCRINOLOGY, V139, P2335, DOI 10.1210/en.139.5.2335
   Koibuchi N, 2001, THYROID, V11, P205, DOI 10.1089/105072501750159534
   Koibuchi N, 2008, CEREBELLUM, V7, P530, DOI 10.1007/s12311-008-0069-1
   LINDHOLM D, 1993, J CELL BIOL, V122, P443, DOI 10.1083/jcb.122.2.443
   Manzano J, 2007, ENDOCRINOLOGY, V148, P5746, DOI 10.1210/en.2007-0567
   MESSER A, 1984, Journal of Neurogenetics, V1, P239, DOI 10.3109/01677068409107089
   MESSER A, 1988, J NEUROCHEM, V51, P888, DOI 10.1111/j.1471-4159.1988.tb01825.x
   MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092
   NICHOLSO.JL, 1972, BRAIN RES, V44, P25, DOI 10.1016/0006-8993(72)90363-0
   NICHOLSO.JL, 1972, BRAIN RES, V44, P13, DOI 10.1016/0006-8993(72)90362-9
   NICHOLSON JL, 1972, SCIENCE, V176, P530, DOI 10.1126/science.176.4034.530
   Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94
   Poulain FE, 2008, J NEUROSCI, V28, P7387, DOI 10.1523/JNEUROSCI.1942-08.2008
   Qiu CH, 2007, ENDOCRINOLOGY, V148, P1745, DOI 10.1210/en.2006-1131
   RABIE A, 1973, BRAIN RES, V61, P267, DOI 10.1016/0006-8993(73)90532-5
   SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W
   SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610
   SOTELO C, 1990, J EXP BIOL, V153, P225
   SOTELO C, 1978, ACTA NEUROPATHOL, V43, P19
   Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035
   SOTELO C, 1974, BRAIN RES, V67, P519, DOI 10.1016/0006-8993(74)90499-5
   Swinny JD, 2004, EUR J NEUROSCI, V19, P1749, DOI 10.1111/j.1460-9568.2004.03279.x
   Thompson CC, 2000, CEREB CORTEX, V10, P939, DOI 10.1093/cercor/10.10.939
   VINCENT J, 1983, J PHYSIOL-PARIS, V78, P729
   Vogel MW, 2000, J NEUROBIOL, V42, P323, DOI 10.1002/(SICI)1097-4695(20000215)42:3<323::AID-NEU4>3.0.CO;2-2
NR 51
TC 23
Z9 23
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-8104
J9 NEURAL DEV
JI Neural Dev.
PD JUL 27
PY 2010
VL 5
AR 18
DI 10.1186/1749-8104-5-18
PG 11
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 658KN
UT WOS:000282489000001
PM 20663205
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Haas, P
   Then, P
   Wild, A
   Grange, W
   Zorman, S
   Hegner, M
   Calame, M
   Aebi, U
   Flammer, J
   Hecht, B
AF Haas, Philippe
   Then, Patrick
   Wild, Andreas
   Grange, Wilfried
   Zorman, Sylvain
   Hegner, Martin
   Calame, Michel
   Aebi, Ueli
   Flammer, Josef
   Hecht, Bert
TI Fast Quantitative Single-Molecule Detection at Ultra low Concentrations
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID PATTERNS
AB The applicability of single-molecule fluorescence assays in liquids is limited by diffusion to concentrations in the low picomolar range. Here, we demonstrate quantitative single-molecule detection at attomolar concentrations within 1 min by excitation and detection of fluorescence through a single-mode optical fiber in presence of turbulent flow. The combination of high detectability and short measurement times promises applications in ultrasensitive assays, sensors, and point-of-care medical diagnostics.
C1 [Hecht, Bert] Univ Basel, Inst Phys, Natl Ctr Competence Res Nanoscale Sci, CH-4056 Basel, Switzerland.
   Wilhelm Conrad Rontgen Ctr Complex Mat Syst RCCM, Nanoopt & Biophoton Grp, Inst Phys, D-97074 Wurzburg, Germany.
   Inst Jacques Monod, F-75013 Paris, France.
   Ctr Res Adapt Nanostruct & Nanodevices, Coll Green, CH-4056 Basel 2, Switzerland.
   Univ Basel, Dept Phys, CH-4056 Basel, Switzerland.
   Biozentrum, CH-4056 Basel, Switzerland.
   Univ Augenklin, CH-4031 Basel, Switzerland.
RP Hecht, B (corresponding author), Univ Basel, Inst Phys, Natl Ctr Competence Res Nanoscale Sci, Klingelbergstr 82, CH-4056 Basel, Switzerland.
EM hecht@physik.uni-wuerzburg.de
RI Hecht, Bert/B-4996-2010; Calame, Michel/A-5037-2008; Calame,
   Michel/O-8818-2019
OI Hecht, Bert/0000-0002-4883-8676; Calame, Michel/0000-0001-7467-9915;
   Calame, Michel/0000-0001-7467-9915; Hegner, Martin/0000-0003-1514-3437
CR Ferguson JA, 1996, NAT BIOTECHNOL, V14, P1681, DOI 10.1038/nbt1296-1681
   Grange W, 2008, J PHYS CHEM B, V112, P7140, DOI 10.1021/jp7114862
   HECHT B, 2010, Patent No. 7657133
   Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104
   Liu XJ, 1999, ANAL CHEM, V71, P5054, DOI 10.1021/ac990561c
   LUKOSZ W, 1977, J OPT SOC AM, V67, P1615, DOI 10.1364/JOSA.67.001615
   Munson BR, 2006, FUNDAMENTALS FLUID M
   NIE SM, 1995, ANAL CHEM, V67, P2849, DOI 10.1021/ac00113a019
   Novotny L., 2006, PRINCIPLES NANOOPTIC
   Sauer M, 1996, CHEM PHYS LETT, V254, P223, DOI 10.1016/0009-2614(96)00303-X
   Schaffer J, 1999, J PHYS CHEM A, V103, P331, DOI 10.1021/jp9833597
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   SOPER SA, 1993, ANAL CHEM, V65, P740, DOI 10.1021/ac00054a015
   Steemers FJ, 2000, NAT BIOTECHNOL, V18, P91
   Wolfbeis OS, 2004, ANAL CHEM, V76, P3269, DOI [10.1021/ac040049d, 10.1021/a1000013k]
   Zander C, 1996, APPL PHYS B-LASERS O, V63, P517
   Zander C., 2002, SINGLE MOL DETECTION
NR 17
TC 18
Z9 20
U1 1
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD JUL 15
PY 2010
VL 82
IS 14
BP 6299
EP 6302
DI 10.1021/ac100779c
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 623GU
UT WOS:000279727800052
PM 20568715
DA 2021-01-25
ER

PT J
AU Peleg, O
   Lim, RYH
AF Peleg, Orit
   Lim, Roderick Y. H.
TI Converging on the function of intrinsically disordered nucleoporins in
   the nuclear pore complex
SO BIOLOGICAL CHEMISTRY
LA English
DT Review
DE FG-domains; hydrogel; intrinsically unstructured proteins; nanopore;
   natively unfolded proteins; nucleocytoplasmic transport; polymer brush
ID PHENYLALANINE-GLYCINE NUCLEOPORINS; IMPORTIN-BETA; PROTEIN IMPORT;
   NUCLEOCYTOPLASMIC TRANSPORT; CRYOELECTRON TOMOGRAPHY; MOLECULAR
   ARCHITECTURE; PERMEABILITY BARRIER; BINDING-DYNAMICS; STRUCTURAL BASIS;
   POLYMER BRUSHES
AB Several biological mechanisms involve proteins or proteinaceous components that are intrinsically disordered. A case in point pertains to the nuclear pore complex (NPC), which regulates molecular transport between the nucleus and the cytoplasm. NPC functionality is dependent on unfolded domains rich in Phe-Gly (FG) repeats (i.e., FG-domains) that collectively act to promote or hinder cargo translocation. To a large extent, our understanding of FG-domain behavior is limited to in vitro investigations given the difficulty to resolve them directly in the NPC. Nevertheless, recent findings indicate a collective convergence towards rationalizing RI-domain function. This review aims to glean further insight into this fascinating problem by taking an objective look at the boundary conditions and contextual details underpinning FG-domain behavior in the NPC. Here, we treat the FG-domains as being commensurate with polymeric chains to address ambiguities such as for instance, how FG-domains tethered to the central channel of the NPC would behave differently as compared with their free-floating counterparts in solution. By bringing such fundamental questions to the fore, this review seeks to illuminate the importance of how such parameters can hold influence over the structure-function relation of intrinsically disordered proteins in the NPC and beyond.
C1 [Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
   [Peleg, Orit] ETH, Dept Mat, CH-8093 Zurich, Switzerland.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
OI Lim, Roderick/0000-0001-5015-6087; Peleg, Orit/0000-0001-9481-7967
CR Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107
   Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166
   Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200
   Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085
   BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022
   Bright JN, 2001, PROG BIOPHYS MOL BIO, V76, P131, DOI 10.1016/S0079-6107(01)00012-8
   Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713
   Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Cushman I, 2006, METHODS, V39, P329, DOI 10.1016/j.ymeth.2006.06.011
   D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103
   Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34
   Elad N, 2009, CURR OPIN STRUC BIOL, V19, P226, DOI 10.1016/j.sbi.2009.02.009
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010
   Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024
   Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516
   Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199
   Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607
   Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Herrmann M, 2009, NANO LETT, V9, P3330, DOI 10.1021/nl901598z
   Hong SK, 1997, J MEMBRANE SCI, V132, P159, DOI 10.1016/S0376-7388(97)00060-4
   Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007
   Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213
   Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600
   Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9
   Koehler JA, 1997, LANGMUIR, V13, P4162, DOI 10.1021/la970010m
   Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9
   Leksa NC, 2009, STRUCTURE, V17, P1082, DOI 10.1016/j.str.2009.06.003
   Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x
   Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Lim RYH, 2009, ACS NANO, V3, P2911, DOI 10.1021/nn900152m
   Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165
   Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107
   Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001
   Miao LL, 2009, STRUCTURE, V17, P449, DOI 10.1016/j.str.2008.12.021
   Minko S, 2006, POLYM REV, V46, P397, DOI 10.1080/15583720600945402
   Naim B, 2009, EMBO J, V28, P2697, DOI 10.1038/emboj.2009.225
   Nolting B., 2006, PROTEIN FOLDING KINE
   Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x
   Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x
   Peters R, 2009, BBA-MOL CELL RES, V1793, P1533, DOI 10.1016/j.bbamcr.2009.06.003
   Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159
   Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200
   RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771
   Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007
   Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09
   Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151
   Whittle JRR, 2009, J BIOL CHEM, V284, P28442, DOI 10.1074/jbc.M109.023580
   Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
   Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101
   Zhou F, 2006, PHYS CHEM CHEM PHYS, V8, P3815, DOI 10.1039/b606415a
   ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331
NR 80
TC 35
Z9 35
U1 3
U2 32
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1431-6730
EI 1437-4315
J9 BIOL CHEM
JI Biol. Chem.
PD JUL
PY 2010
VL 391
IS 7
BP 719
EP 730
DI 10.1515/BC.2010.092
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 621JR
UT WOS:000279573200002
PM 20482319
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Cornelis, GR
AF Cornelis, Guy R.
TI The type III secretion injectisome, a complex nanomachine for
   intracellular 'toxin' delivery
SO BIOLOGICAL CHEMISTRY
LA English
DT Review
DE microbial pathogenesis; protein secretion; virulence; Yersinia
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; FLAGELLAR HOOK-LENGTH; ENTERICA
   SEROVAR TYPHIMURIUM; PROTON MOTIVE FORCE; YERSINIA-ENTEROCOLITICA;
   SALMONELLA-TYPHIMURIUM; NEEDLE COMPLEX; SHIGELLA-FLEXNERI; PROTEIN
   SECRETION; SUBSTRATE-SPECIFICITY
AB The type III secretion injectisome is a nanomachine that delivers bacterial proteins into the cytosol of eukaryotic target cells. It consists of a cylindrical basal structure spanning the two bacterial membranes and the peptidoglycan, connected to a hollow needle, eventually followed by a filament (animal pathogens) or to a long pilus (plant pathogens). Export employs a type III pathway. During assembly, all the protein subunits of external elements are sequentially exported by the basal structure itself, implying that the export apparatus can switch its substrate specificity over time. The length of the needle is controlled by a protein that it also secreted during assembly and presumably acts as a molecular ruler.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
CR Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x
   Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992
   Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731
   ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994
   Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Bogdanove AJ, 1996, MOL MICROBIOL, V20, P681, DOI 10.1046/j.1365-2958.1996.5731077.x
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004
   Burr SE, 2003, DIS AQUAT ORGAN, V57, P167, DOI 10.3354/dao057167
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x
   Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x
   Crepin VF, 2005, MOL MICROBIOL, V55, P1658, DOI 10.1111/j.1365-2958.2005.04508.x
   Daefler S, 1998, MOL MICROBIOL, V28, P1367, DOI 10.1046/j.1365-2958.1998.00908.x
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103
   Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010
   DRIKS A, 1990, J MOL BIOL, V211, P669, DOI 10.1016/0022-2836(90)90063-R
   Erhardt M, 2010, MOL MICROBIOL, V75, P376, DOI 10.1111/j.1365-2958.2009.06973.x
   Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101
   Ferris HU, 2006, TRENDS MICROBIOL, V14, P519, DOI 10.1016/j.tim.2006.10.006
   FIELDS KA, 1994, J BACTERIOL, V176, P569, DOI 10.1128/jb.176.3.569-579.1994
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x
   Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7
   Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004
   Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251
   Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x
   HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994
   Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x
   Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397
   Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   KHAN IH, 1992, P NATL ACAD SCI USA, V89, P5956, DOI 10.1073/pnas.89.13.5956
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Kubori T, 1997, J BACTERIOL, V179, P813, DOI 10.1128/jb.179.3.813-817.1997
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   Li CM, 2002, EMBO J, V21, P1909, DOI 10.1093/emboj/21.8.1909
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822
   Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x
   Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012
   Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x
   Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449
   Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200
   Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806
   Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001
   Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497
   PLANO GV, 1993, J BACTERIOL, V175, P3536, DOI 10.1128/jb.175.11.3536-3545.1993
   Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200
   Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737
   RUSSEL M, 1994, SCIENCE, V265, P612, DOI 10.1126/science.8036510
   Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731
   Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579
   Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603
   Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003
   Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001
   Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876
   Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06
   Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005
   UENO T, 1994, J MOL BIOL, V236, P546, DOI 10.1006/jmbi.1994.1164
   VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x
   Wagner S, 2009, MOL MICROBIOL, V71, P692, DOI 10.1111/j.1365-2958.2008.06556.x
   Wiesand U, 2009, J MOL BIOL, V385, P854, DOI 10.1016/j.jmb.2008.10.034
   Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08
   Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554
   Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830
   Young HS, 2003, BIOPHYS J, V84, P571, DOI 10.1016/s0006-3495(03)74877-2
   Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832
   Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196
NR 91
TC 82
Z9 84
U1 0
U2 28
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1431-6730
J9 BIOL CHEM
JI Biol. Chem.
PD JUL
PY 2010
VL 391
IS 7
BP 745
EP 751
DI 10.1515/BC.2010.079
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 621JR
UT WOS:000279573200005
PM 20482311
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Scheiffele, P
   Yuzaki, M
AF Scheiffele, Peter
   Yuzaki, Michizuke
TI Recent excitements about excitatory synapses
SO EUROPEAN JOURNAL OF NEUROSCIENCE
LA English
DT Editorial Material
C1 [Scheiffele, Peter] Univ Basel, Biozentrum, Basel, Switzerland.
   [Yuzaki, Michizuke] Keio Univ, Sch Med, Tokyo, Japan.
RP Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
RI Yuzaki, Michisuke/K-5328-2013
OI Yuzaki, Michisuke/0000-0002-5750-3544
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0953-816X
J9 EUR J NEUROSCI
JI Eur. J. Neurosci.
PD JUL
PY 2010
VL 32
IS 2
SI SI
BP 179
EP 180
DI 10.1111/j.1460-9568.2010.07360.x
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA 635BV
UT WOS:000280631500001
PM 20646054
OA Bronze
DA 2021-01-25
ER

PT J
AU Prut, L
   Prenosil, G
   Willadt, S
   Vogt, K
   Fritschy, JM
   Crestani, F
AF Prut, L.
   Prenosil, G.
   Willadt, S.
   Vogt, K.
   Fritschy, J-M
   Crestani, F.
TI A reduction in hippocampal GABA(A) receptor alpha 5 subunits disrupts
   the memory for location of objects in mice
SO GENES BRAIN AND BEHAVIOR
LA English
DT Article
DE GABA(A) receptor; hippocampus; memory; mutant mice; object-location
   learning; 129X1; SvJ
ID MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY;
   RECOGNITION MEMORY; CAUDATE-NUCLEUS; DENTATE GYRUS; TASK; PERSPECTIVE;
   INHIBITION; EXPERIENCE
AB The memory for location of objects, which binds information about objects to discrete positions or spatial contexts of occurrence, is a form of episodic memory particularly sensitive to hippocampal damage. Its early decline is symptomatic for elderly dementia. Substances that selectively reduce alpha 5-GABA(A) receptor function are currently developed as potential cognition enhancers for Alzheimer's syndrome and other dementia, consistent with genetic studies implicating these receptors that are highly expressed in hippocampus in learning performance. Here we explored the consequences of reduced GABA(A) alpha 5-subunit contents, as occurring in alpha 5(H105R) knock-in mice, on the memory for location of objects. This required the behavioral characterization of alpha 5(H105R) and wild-type animals in various tasks examining learning and memory retrieval strategies for objects, locations, contexts and their combinations. In mutants, decreased amounts of alpha 5-subunits and retained long-term potentiation in hippocampus were confirmed. They exhibited hyperactivity with conserved circadian rhythm in familiar actimeters, and normal exploration and emotional reactivity in novel places, allocentric spatial guidance, and motor pattern learning acquisition, inhibition and flexibility in T- and eight-arm mazes. Processing of object, position and context memories and object-guided response learning were spared. Genotype difference in object-in-place memory retrieval and in encoding and response learning strategies for object-location combinations manifested as a bias favoring object-based recognition and guidance strategies over spatial processing of objects in the mutants. These findings identify in alpha 5(H105R) mice a behavioral-cognitive phenotype affecting basal locomotion and the memory for location of objects indicative of hippocampal dysfunction resulting from moderately decreased alpha 5-subunit contents.
C1 [Prut, L.; Fritschy, J-M; Crestani, F.] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland.
   [Prenosil, G.; Willadt, S.; Vogt, K.] Univ Basel, Neurobiol Biozentrum, CH-4003 Basel, Switzerland.
RP Crestani, F (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM crestani@pharma.uzh.ch
OI Fritschy, Jean-Marc/0000-0002-8552-3702; Vogt,
   Kaspar/0000-0002-0859-876X
CR Aalten P, 2008, DEMENT GERIATR COGN, V25, P1, DOI 10.1159/000111082
   Aggleton JP, 2006, TRENDS COGN SCI, V10, P455, DOI 10.1016/j.tics.2006.08.003
   Alescio-Lautier B, 2007, NEUROPSYCHOLOGIA, V45, P1948, DOI 10.1016/j.neuropsychologia.2006.04.033
   Atack JR, 2006, NEUROPHARMACOLOGY, V51, P1023, DOI 10.1016/j.neuropharm.2006.04.018
   Atack JR, 2010, PHARMACOL THERAPEUT, V125, P11, DOI 10.1016/j.pharmthera.2009.09.001
   Atack JR, 2009, J PHARMACOL EXP THER, V331, P470, DOI 10.1124/jpet.109.157636
   Bachevalier J, 2008, HIPPOCAMPUS, V18, P64, DOI 10.1002/hipo.20369
   Ballard TM, 2009, PSYCHOPHARMACOLOGY, V202, P207, DOI 10.1007/s00213-008-1357-7
   Bast T, 2007, REV NEUROSCIENCE, V18, P253
   Cheng VY, 2006, J NEUROSCI, V26, P3713, DOI 10.1523/JNEUROSCI.5024-05.2006
   Cipolotti L, 2006, CURR OPIN NEUROL, V19, P593, DOI 10.1097/01.wco.0000247608.42320.f9
   Collinson N, 2006, PSYCHOPHARMACOLOGY, V188, P619, DOI 10.1007/s00213-006-0361-z
   Collinson N, 2002, J NEUROSCI, V22, P5572
   Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207
   Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699
   Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x
   Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P112, DOI 10.1006/nlme.1997.3746
   ENNACEUR A, 2010, BEHAV BRAIN IN PRESS
   Fritschy JM, 1998, J COMP NEUROL, V390, P194
   Gallo DA, 2004, NEUROPSYCHOLOGY, V18, P556, DOI 10.1037/0894-4105.18.3.556
   Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999
   Howell O, 2000, NEUROSCIENCE, V98, P669, DOI 10.1016/S0306-4522(00)00163-9
   Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004
   Hwang TJ, 2004, ALZ DIS ASSOC DIS, V18, P17, DOI 10.1097/00002093-200401000-00004
   Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1
   Kesner RP, 2006, EUR J NEUROSCI, V23, P1888, DOI 10.1111/j.1460-9568.2006.04709.x
   Lee ACH, 2003, EUR J NEUROSCI, V18, P1660, DOI 10.1046/j.1460-9568.2003.02883.x
   Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x
   Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136
   Nelson AP, 2008, CNS SPECTRUMS, V13, P56, DOI 10.1017/S1092852900016163
   Ohm TG, 2007, PROG BRAIN RES, V163, P723, DOI 10.1016/S0079-6123(07)63039-8
   PARKINSON JK, 1988, J NEUROSCI, V8, P4159
   Piterkin P, 2008, LEARN MEMORY, V15, P785, DOI 10.1101/lm.1035508
   Postma A, 2008, NEUROSCI BIOBEHAV R, V32, P1339, DOI 10.1016/j.neubiorev.2008.05.001
   Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006
   Rauchs G, 2007, NEUROBIOL AGING, V28, P1410, DOI 10.1016/j.neurobiolaging.2006.06.005
   Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x
   Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005
   Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867
   SHORS TJ, 1992, PSYCHOBIOLOGY, V20, P247
   Troyer AK, 2008, NEUROPSYCHOLOGY, V22, P10, DOI 10.1037/0894-4105.22.1.10
   Vanderwolf CH, 2001, BEHAV BRAIN RES, V127, P25, DOI 10.1016/S0166-4328(01)00354-0
   Westerberg CE, 2006, NEUROPSYCHOLOGY, V20, P193, DOI 10.1037/0894-4105.20.2.193
   White NM, 2009, BEHAV BRAIN RES, V199, P3, DOI 10.1016/j.bbr.2008.12.003
   Zarnowska ED, 2009, J NEUROPHYSIOL, V101, P1179, DOI 10.1152/jn.91203.2008
NR 45
TC 40
Z9 43
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1601-1848
EI 1601-183X
J9 GENES BRAIN BEHAV
JI Genes Brain Behav.
PD JUL
PY 2010
VL 9
IS 5
BP 478
EP 488
DI 10.1111/j.1601-183X.2010.00575.x
PG 11
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA 619QC
UT WOS:000279443700005
PM 20180861
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Varela, E
   Schlecht, U
   Moina, A
   Fackenthal, JD
   Washburn, BK
   Niederhauser-Wiederkehr, C
   Tsai-Pflugfelder, M
   Primig, M
   Gasser, SM
   Esposito, RE
AF Varela, Elisa
   Schlecht, Ulrich
   Moina, Anca
   Fackenthal, James D.
   Washburn, Brian K.
   Niederhauser-Wiederkehr, Christa
   Tsai-Pflugfelder, Monika
   Primig, Michael
   Gasser, Susan M.
   Esposito, Rochelle E.
TI Mitotic Expression of Spo13 Alters M-Phase Progression and Nucleolar
   Localization of Cdc14 in Budding Yeast
SO GENETICS
LA English
DT Article
ID ANAPHASE-PROMOTING COMPLEX; SACCHAROMYCES-CEREVISIAE; MEIOSIS-I;
   CHROMOSOME SEGREGATION; DEPENDENT DEGRADATION; CENTROMERIC COHESION;
   PHOSPHATASE CDC14; GENE-EXPRESSION; CELL-CYCLE; EXIT
AB Spo13 is a key meiosis-specific regulator required for centromere cohesion and coorientation, and for progression through two nuclear divisions. We previously reported that it causes a G2/M arrest and may delay the transition from late anaphase to G1, when overexpressed in mitosis. Yet its mechanism of action has remained elusive. Here we show that Spo13, which is phosphorylated and stabilized at G2/M in a Cdk/Clb-dependent manner, acts at two stages during mitotic cell division. Spo13 provokes a G2/M arrest that is reversible and largely independent of the Mad2 spindle checkpoint. Since mRNAs whose induction requires Cdc14 activation are reduced, we propose that its anaphase delay results from inhibition of Cdc14 function. Indeed, the Spo13-induced anaphase delay correlates with Cdc14 phosphatase retention in the nucleolus and with cyclin B accumulation, which both impede anaphase exit. At the onset of arrest, Spo13 is primarily associated with the nucleolus, where Cdc14 accumulates. Significantly, overexpression of separase (Esp1), which promotes G2/M and anaphase progression, suppresses Spo13 effects in mitosis, arguing that Spo13 acts upstream or parallel to Esp1. Given that Spo13 overexpression reduces Pds1 and cyclin B degradation, our findings are consistent with a role for Spo13 in regulating APC, which controls both G2/M and anaphase. Similar effects of Spo13 during meiotic MI may prevent cell cycle exit and initiation of DNA replication prior to MII, thereby ensuring two successive chromosome segregation events without an intervening S phase.
C1 [Varela, Elisa; Tsai-Pflugfelder, Monika; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Schlecht, Ulrich; Moina, Anca; Niederhauser-Wiederkehr, Christa; Primig, Michael] Univ Basel, Biozentrum & Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Fackenthal, James D.; Washburn, Brian K.; Esposito, Rochelle E.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.
RP Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.
EM susan.gasser@fmi.ch
RI Primig, Michael/G-3175-2013
OI Primig, Michael/0000-0002-2061-0119; Gasser, Susan/0000-0003-3610-9123
FU Swiss Cancer League; Novartis Research Foundation; European Molecular
   Biology OrganizationEuropean Molecular Biology Organization (EMBO);
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM-29182]; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [3100A0-105861]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [R01GM029182, R01GM029182, R01GM029182, R01GM029182,
   R01GM029182, R01GM029182, R01GM029182, R01GM029182, R01GM029182,
   R01GM029182, R01GM029182, R01GM029182, R01GM029182, R01GM029182,
   R01GM029182, R01GM029182, R01GM029182, R01GM029182, R01GM029182,
   R01GM029182, R01GM029182] Funding Source: NIH RePORTER
FX We thank P. Demougin and M. Cartron for help with yeast array
   experiments, M. Rebhan for protein motif analysis and F. Uhlmann for
   kindly providing strains that were used to generate those used here.
   Finally, R.E.E. extends special thanks to S.M.G. and M.P. for graciously
   hosting her during several sabbatical stays in Basel. E.V. was supported
   by the Swiss Cancer League, the Novartis Research Foundation, and a
   short-term European Molecular Biology Organization fellowship. This work
   was further funded by National Institutes of Health GM-29182 (to R.E.E.)
   and Swiss National Science Foundation grant 3100A0-105861 (to M.P.).
CR Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402
   Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148
   Brown NR, 1999, NAT CELL BIOL, V1, P438
   BUCKINGHAM LE, 1990, P NATL ACAD SCI USA, V87, P9406, DOI 10.1073/pnas.87.23.9406
   Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1
   Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091
   Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032
   Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86
   Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8
   CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081
   D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1
   Gattiker A, 2007, NUCLEIC ACIDS RES, V35, pD457, DOI 10.1093/nar/gkl957
   Geymonat M, 2002, CURR BIOL, V12, pR482, DOI 10.1016/S0960-9822(02)00963-6
   Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349
   Granovskaia MV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r24
   Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750
   Hochwagen A, 2005, MOL CELL BIOL, V25, P4767, DOI 10.1128/MCB.25.11.4767-4781.2005
   Jolly ER, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-275
   Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020
   Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145
   KLAPHOLZ S, 1980, GENETICS, V96, P567
   KLAPHOLZ S, 1980, GENETICS, V96, P589
   Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1
   Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033
   Lee BH, 2002, GENE DEV, V16, P1672, DOI 10.1101/gad.989302
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8
   MCCARROLL RM, 1994, GENETICS, V138, P47
   McCord R, 2003, MOL CELL BIOL, V23, P2009, DOI 10.1128/MCB.23.6.2009-2016.2003
   O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084
   Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002
   Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038
   Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8
   Rutkowski LH, 2000, GENETICS, V155, P1607
   Schlecht U, 2008, MOL BIOL CELL, V19, P2193, DOI 10.1091/mbc.E07-12-1242
   Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300
   Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802
   Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3
   SHUSTER EO, 1989, GENETICS, V123, P29
   Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9
   Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051
   Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5
   Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940
   Sullivan M, 2007, J BIOL CHEM, V282, P19710, DOI 10.1074/jbc.M701507200
   SUROSKY RT, 1992, MOL CELL BIOL, V12, P3948, DOI 10.1128/MCB.12.9.3948
   Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2
   Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936
   Torres-Rosell J, 2005, CELL CYCLE, V4, P109, DOI 10.4161/cc.4.1.1356
   Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8
   Toth A, 2007, J THEOR BIOL, V248, P560, DOI 10.1016/j.jtbi.2007.06.014
   Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6
   Varela E, 2009, EMBO J, V28, P1562, DOI 10.1038/emboj.2009.111
   Visintin R, 1999, NATURE, V398, P818
   Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5
   WAGSTAFF JE, 1982, P NATL ACAD SCI-BIOL, V79, P2986, DOI 10.1073/pnas.79.9.2986
   WANG HT, 1987, MOL CELL BIOL, V7, P1425, DOI 10.1128/MCB.7.4.1425
   Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299
   Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448
NR 58
TC 4
Z9 4
U1 0
U2 0
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD JUL
PY 2010
VL 185
IS 3
BP 841
EP 854
DI 10.1534/genetics.109.113746
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA 651EE
UT WOS:000281906800012
PM 20407133
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Quebatte, M
   Dehio, M
   Tropel, D
   Basler, A
   Toller, I
   Raddatz, G
   Engel, P
   Huser, S
   Schein, H
   Lindroos, HL
   Andersson, SGE
   Dehio, C
AF Quebatte, Maxime
   Dehio, Michaela
   Tropel, David
   Basler, Andrea
   Toller, Isabella
   Raddatz, Guenter
   Engel, Philipp
   Huser, Sonja
   Schein, Hermine
   Lindroos, Hillevi L.
   Andersson, Siv G. E.
   Dehio, Christoph
TI The BatR/BatS Two-Component Regulatory System Controls the Adaptive
   Response of Bartonella henselae during Human Endothelial Cell Infection
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID IV SECRETION SYSTEMS; ESCHERICHIA-COLI; AGROBACTERIUM-TUMEFACIENS;
   SIGNAL-TRANSDUCTION; SINORHIZOBIUM-MELILOTI; CRYSTAL-STRUCTURE;
   GENE-EXPRESSION; VIRULENCE; PROTEIN; PHOSPHORYLATION
AB Here, we report the first comprehensive study of Bartonella henselae gene expression during infection of human endothelial cells. Expression of the main cluster of upregulated genes, comprising the VirB type IV secretion system and its secreted protein substrates, is shown to be under the positive control of the transcriptional regulator BatR. We demonstrate binding of BatR to the promoters of the virB operon and a substrate-encoding gene and provide biochemical evidence that BatR and BatS constitute a functional two-component regulatory system. Moreover, in contrast to the acid-inducible (pH 5.5) homologs ChvG/ChvI of Agrobacterium tumefaciens, BatR/BatS are optimally activated at the physiological pH of blood (pH 7.4). By conservation analysis of the BatR regulon, we show that BatR/BatS are uniquely adapted to upregulate a genus-specific virulence regulon during hemotropic infection in mammals. Thus, we propose that BatR/BatS two-component system homologs represent vertically inherited pH sensors that control the expression of horizontally transmitted gene sets critical for the diverse host-associated life styles of the alphaproteobacteria.
C1 [Quebatte, Maxime; Dehio, Michaela; Tropel, David; Basler, Andrea; Toller, Isabella; Raddatz, Guenter; Engel, Philipp; Huser, Sonja; Schein, Hermine; Dehio, Christoph] Univ Basel, Focal Area Infect Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Lindroos, Hillevi L.; Andersson, Siv G. E.] Uppsala Univ, Dept Mol Evolut, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden.
RP Dehio, C (corresponding author), Univ Basel, Focal Area Infect Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Engel, Philipp/N-1788-2015; Dehio, Christoph/AAD-5572-2019; Dehio,
   Christoph/R-8277-2016
OI Engel, Philipp/0000-0002-4678-6200; Dehio,
   Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052;
   Quebatte, Maxime/0000-0002-3733-1511
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100AO-109925]; Howard Hughes Medical InstituteHoward Hughes
   Medical Institute [55005501]; SystemsX.ch Swiss Iniative for Systems
   Biology [51RT-O_126008]; Swedish Research CouncilSwedish Research
   Council; Goran Gustafsson Foundation; Swedish Foundation for Strategic
   ResearchSwedish Foundation for Strategic Research
FX This work was supported by grant 3100AO-109925 from the Swiss National
   Science Foundation, grant 55005501 from the International Research
   Scholar program of the Howard Hughes Medical Institute, and grant
   51RT-O_126008 (InfectX) in the framework of the SystemsX.ch Swiss
   Iniative for Systems Biology (to C. D.), as well as by grants from the
   Swedish Research Council, the Goran Gustafsson Foundation, and the
   Swedish Foundation for Strategic Research (to S. G. E. A.).
CR Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263
   Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067
   Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143
   Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06
   Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005
   Birck C, 2003, J BACTERIOL, V185, P254, DOI 10.1128/JB.185.1.254-261.2003
   CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993
   Chen EJ, 2009, J BACTERIOL, V191, P6833, DOI 10.1128/JB.00734-09
   Chen YH, 2003, J BACTERIOL, V185, P262, DOI 10.1128/JB.185.1.262-273.2003
   Cheng HP, 1998, J BACTERIOL, V180, P20, DOI 10.1128/JB.180.1.20-26.1998
   Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996
   Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Dehio M, 2005, THROMB HAEMOSTASIS, V94, P347, DOI 10.1160/TH05-02-0106
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   Engel P, 2009, GENOME DYNAM, V6, P158, DOI 10.1159/000235769
   Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124
   Gillaspie D, 2009, APPL ENVIRON MICROB, V75, P5434, DOI 10.1128/AEM.00949-09
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399
   Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739
   Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x
   Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003
   Li LP, 2002, P NATL ACAD SCI USA, V99, P12369, DOI 10.1073/pnas.192439499
   Lindroos HL, 2005, J BACTERIOL, V187, P6155, DOI 10.1128/JB.187.17.6155-6165.2005
   Liu P, 2005, J BACTERIOL, V187, P6039, DOI 10.1128/JB.187.17.6039-6045.2005
   Lopez-Goni I, 2002, VET MICROBIOL, V90, P329, DOI 10.1016/S0378-1135(02)00218-3
   MANTIS NJ, 1993, J BACTERIOL, V175, P6626, DOI 10.1128/jb.175.20.6626-6636.1993
   MIZUNO T, 1990, MOL MICROBIOL, V4, P1077, DOI 10.1111/j.1365-2958.1990.tb00681.x
   O'Connell KP, 2000, APPL ENVIRON MICROB, V66, P392, DOI 10.1128/AEM.66.1.392-400.2000
   PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443
   Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002
   Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428
   Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125
   Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Sallstrom B, 2005, CURR OPIN MICROBIOL, V8, P579, DOI 10.1016/j.mib.2005.08.002
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schmiederer M, 2001, INFECT IMMUN, V69, P6495, DOI 10.1128/IAI.69.10.6495-6502.2001
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   TOKISHITA S, 1990, J BIOCHEM-TOKYO, V108, P488, DOI 10.1093/oxfordjournals.jbchem.a123226
   Tzeng YL, 2006, J BACTERIOL, V188, P5055, DOI 10.1128/JB.00264-06
   Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006
   Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06
   Wells DH, 2007, MOL MICROBIOL, V64, P647, DOI 10.1111/j.1365-2958.2007.05680.x
   Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07
   Wu QM, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-102
   Yao SY, 2004, J BACTERIOL, V186, P6042, DOI 10.1128/jb.186.18.6042-6049.2004
   Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07
NR 60
TC 38
Z9 39
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD JUL
PY 2010
VL 192
IS 13
BP 3352
EP 3367
DI 10.1128/JB.01676-09
PG 16
WC Microbiology
SC Microbiology
GA 611HX
UT WOS:000278806100015
PM 20418395
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Guderian, G
   Westendorf, J
   Uldschmid, A
   Nigg, EA
AF Guderian, Gernot
   Westendorf, Jens
   Uldschmid, Andreas
   Nigg, Erich A.
TI Plk4 trans-autophosphorylation regulates centriole number by controlling
   beta TrCP-mediated degradation
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Plk4; Autophosphorylation; beta TrCP; Centriole duplication
ID CENTROSOME DUPLICATION; DEPENDENT DEGRADATION; CYTOSTATIC FACTOR;
   PROTEIN; ELEGANS; CELLS; UBIQUITINATION; BIOGENESIS; MECHANISMS; KINASES
AB Centrioles are the main constituents of the mammalian centrosome and act as basal bodies for ciliogenesis. Centrosomes organize the cytoplasmic microtubule network during interphase and the mitotic spindle during mitosis, and aberrations in centrosome number have been implicated in chromosomal instability and tumor formation. The centriolar protein Polo-like kinase 4 (Plk4) is a key regulator of centriole biogenesis and is crucial for maintaining constant centriole number, but the mechanisms regulating its activity and expression are only beginning to emerge. Here, we show that human Plk4 is subject to beta TrCP-dependent proteasomal degradation, indicating that this pathway is conserved from Drosophila to human. Unexpectedly, we found that stable overexpression of kinase-dead Plk4 leads to centriole overduplication. This phenotype depends on the presence of endogenous wild-type Plk4. Our data indicate that centriole overduplication results from disruption of Plk4 trans-autophosphorylation by kinase-dead Plk4, which then shields endogenous Plk4 from recognition by beta TrCP. We conclude that active Plk4 promotes its own degradation by catalyzing beta TrCP binding through trans-autophosphorylation (phosphorylation by the other kinase in the dimer) within homodimers.
C1 [Guderian, Gernot; Westendorf, Jens; Uldschmid, Andreas; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Guderian, Gernot; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Nigg, EA (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.
EM erich.nigg@unibas.ch
OI nigg, erich/0000-0003-4835-5719
FU Max-Planck SocietyMax Planck Society; Boehringer Ingelheim
   FondsBoehringer Ingelheim
FX We are grateful to Stefan Muller (Max-Planck Institute of Biochemistry)
   for sharing reagents. We thank Elena Nigg and Claudia Szalma for
   excellent technical assistance. We also thank all members of our
   laboratory for helpful discussions. This work was supported by the
   Max-Planck Society. G. G. was funded by a PhD fellowship from the
   Boehringer Ingelheim Fonds.
CR Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042
   Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3
   Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5
   Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037
   Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102
   Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059
   Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610
   Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563
   Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136
   Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102
   Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102
   Kang BS, 2000, ONCOGENE, V19, P4263, DOI 10.1038/sj.onc.1203779
   Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109
   Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Korzeniewski N, 2009, CANCER RES, V69, P6668, DOI 10.1158/0008-5472.CAN-09-1284
   Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848
   Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2
   Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030
   Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711
   Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054
   Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881
   Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046
   Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318
   Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093
   Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950
   Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049
   Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016
   Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505
   Song MH, 2008, CURR OPIN CELL BIOL, V20, P688, DOI 10.1016/j.ceb.2008.09.001
   Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004
   Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101
   Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810
   Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001
NR 40
TC 123
Z9 124
U1 0
U2 7
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD JUL 1
PY 2010
VL 123
IS 13
BP 2163
EP 2169
DI 10.1242/jcs.068502
PG 7
WC Cell Biology
SC Cell Biology
GA 611WU
UT WOS:000278856400003
PM 20516151
OA Other Gold
DA 2021-01-25
ER

PT J
AU Jeney, S
   Mor, F
   Koszali, R
   Forro, L
   Moy, VT
AF Jeney, Sylvia
   Mor, Flavio
   Koszali, Roland
   Forro, Laszlo
   Moy, Vincent T.
TI Monitoring ligand-receptor interactions by photonic force microscopy
SO NANOTECHNOLOGY
LA English
DT Article
ID OPTICAL TWEEZERS; CATCH BONDS; STREPTAVIDIN; ADHESION; CELLS; MOLECULES;
   STRENGTH; DNA
AB We introduce a method for the acquisition of single molecule force measurements of ligand-receptor interactions using the photonic force microscope (PFM). Biotin-functionalized beads, manipulated with an optical trap, and a streptavidin-functionalized coverslip were used to measure the effect of different pulling forces on the lifetime of individual streptavidin-biotin complexes. By optimizing the design of the optical trap and selection of the appropriate bead size, pulling forces in excess of 50 pN were achieved. Based on the amplitude of three-dimensional (3D) thermal position fluctuations of the attached bead, we were able to select for a bead-coverslip interaction that was mediated by a single streptavidin-biotin complex. Moreover, the developed experimental system was greatly accelerated by automation of data acquisition and analysis. In force-dependent kinetic measurements carried out between streptavidin and biotin, we observed that the streptavidin-biotin complex exhibited properties of a catch bond, with the lifetime increasing tenfold when the pulling force increased from 10 to 20 pN. We also show that silica beads were more appropriate than polystyrene beads for the force measurements, as tethers, longer than 200 nm, could be extracted from polystyrene beads.
C1 [Jeney, Sylvia] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Jeney, Sylvia; Mor, Flavio; Forro, Laszlo] Ecole Polytech Fed Lausanne, LPMC, CH-1015 Lausanne, Switzerland.
   [Koszali, Roland] Univ Appl Sci Western Switzerland HEIG VD, IICT, CH-1401 Yverdon, Switzerland.
   [Moy, Vincent T.] Univ Miami, Dept Physiol & Biophys, Miller Sch Med, Miami, FL 33136 USA.
RP Jeney, S (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sylvia.jeney@unibas.ch; vmoy@miami.edu
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [206021_121396]; SNF-NCCR-Nano; M E Muller Foundation of
   Switzerland; NCCBI; University of Applied Sciences of Western
   Switzerland (HEIG-VD); NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM086808]; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM086808, R01GM086808,
   R01GM086808, R01GM086808, R01GM086808, R01GM086808] Funding Source: NIH
   RePORTER
FX This work was supported by grants from the Swiss National Science
   Foundation (SNF) through the R'Equip project No 206021_121396 for
   equipment, the SNF-NCCR-Nano and the M E Muller Foundation of
   Switzerland to SJ, the NCCBI to FM, the University of Applied Sciences
   of Western Switzerland (HEIG-VD) to RK, and the NIH (GM086808) to VTM.
CR ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653
   Bartsch TF, 2009, CHEMPHYSCHEM, V10, P1541, DOI 10.1002/cphc.200900211
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   Bianco P, 2007, BIOPHYS J, V93, P2102, DOI 10.1529/biophysj.l07.106153
   Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923
   Breisch S, 2005, BIOPHYS J, V89, pL19, DOI 10.1529/biophysj.105.066795
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   GHISLAIN LP, 1993, OPT LETT, V18, P1678, DOI 10.1364/OL.18.001678
   GREEN NM, 1990, METHOD ENZYMOL, V184, P51
   Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103
   Guzman C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020713
   Jeney S, 2004, CHEMPHYSCHEM, V5, P1150, DOI 10.1002/cphc.200301027
   Jeney S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240604
   Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002
   Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104
   KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975
   Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z
   Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0
   LECKBAND D, 1995, BIOPHYS J, V69, P1162, DOI 10.1016/S0006-3495(95)79990-8
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Lukic B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011112
   Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225
   MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0
   Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7
   Pierrat S, 2004, BIOPHYS J, V87, P2855, DOI 10.1529/biophysj.104.043695
   Pincet F, 2005, BIOPHYS J, V89, P4374, DOI 10.1529/biophysj.105.067769
   Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z
   Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997
   Reichle C, 2001, ELECTROPHORESIS, V22, P272, DOI 10.1002/1522-2683(200101)22:2<272::AID-ELPS272>3.0.CO;2-K
   Rico F, 2007, J MOL RECOGNIT, V20, P495, DOI 10.1002/jmr.841
   Rohrbach A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168102
   Schaffer E, 2007, LANGMUIR, V23, P3654, DOI 10.1021/la0622368
   Steinberg G, 2004, BIOPOLYMERS, V73, P597, DOI 10.1002/bip.20006
   Tees DFJ, 2001, BIOPHYS J, V80, P668, DOI 10.1016/S0006-3495(01)76047-X
   Tischer C, 2001, APPL PHYS LETT, V79, P3878, DOI 10.1063/1.1423404
   Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852
   Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200
NR 39
TC 17
Z9 17
U1 0
U2 15
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD JUN 25
PY 2010
VL 21
IS 25
AR 255102
DI 10.1088/0957-4484/21/25/255102
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 605AP
UT WOS:000278320000002
PM 20516583
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Lewandowski, JR
   Sein, J
   Sass, HJ
   Grzesiek, S
   Blackledge, M
   Emsley, L
AF Lewandowski, Jozef R.
   Sein, Julien
   Sass, Hans Juergen
   Grzesiek, Stephan
   Blackledge, Martin
   Emsley, Lyndon
TI Measurement of Site-Specific C-13 Spin-Lattice Relaxation in a
   Crystalline Protein
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SOLID-STATE NMR; 2-PULSE PHASE MODULATION; CONFORMATIONAL FLEXIBILITY;
   CORRELATION SPECTROSCOPY; BACKBONE DYNAMICS; RESIDUAL DIPOLAR;
   DIFFUSION; MOTIONS
AB We demonstrate that it is possible to record site-specific spin-lattice relaxation rates for the majority of C-13 sites in uniformly C-13 and N-15 labeled solid proteins as a result of the slowing down of proton-driven spin diffusion at sample spinning frequencies >= 60 kHz, thus providing a series of new experimental probes for characterizing molecular dynamics in solid proteins.
C1 [Lewandowski, Jozef R.; Sein, Julien; Emsley, Lyndon] Univ Lyon, CNRS, ENS Lyon, Ctr RMN Tres Hauts Champs,UCB Lyon 1, F-69100 Villeurbanne, France.
   [Blackledge, Martin] UJF, CEA, CNRS, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38027 Grenoble, France.
   [Sass, Hans Juergen; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Emsley, L (corresponding author), Univ Lyon, CNRS, ENS Lyon, Ctr RMN Tres Hauts Champs,UCB Lyon 1, F-69100 Villeurbanne, France.
EM lyndon.emsley@ens-lyon.fr
RI Emsley, Lyndon/AAS-6384-2020; Emsley, Lyndon/C-6108-2008; Lewandowski,
   Jozef/F-3480-2011
OI Emsley, Lyndon/0000-0003-1360-2572; Emsley, Lyndon/0000-0003-1360-2572;
   Lewandowski, Jozef/0000-0001-6525-7083; Grzesiek,
   Stephan/0000-0003-1998-4225
FU Agence Nationale de la Recherche (ANR)French National Research Agency
   (ANR); ECEuropean CommissionEuropean Commission Joint Research
   CentreEuropean Community (EC) [RII3-026145]; EUEuropean Union (EU)
   [PIRG03-GA-2008-231026]
FX We would like to thank Nicolas Giraud for helpful discussions. This work
   was supported in part by the Agence Nationale de la Recherche (ANR PCV
   2007 Protein Motion) and the Access to Research Infrastructures activity
   in the 6th Framework Program of the EC (RII3-026145, EU-NMR). J.R.L. was
   supported by EU IRG (PIRG03-GA-2008-231026). Molecular graphics images
   were produced with Chimera, UCSF.<SUP>20</SUP>
CR BENNETT AE, 1992, J CHEM PHYS, V96, P8624, DOI 10.1063/1.462267
   Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q
   Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102
   Chandran CV, 2008, MAGN RESON CHEM, V46, P943, DOI 10.1002/mrc.2285
   Chevelkov V, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2819311
   De Paepe G, 2006, J AM CHEM SOC, V128, P1776, DOI 10.1021/ja0550430
   DEPAEPE G, 2004, THESIS ECOLE NORMALE
   Franks WT, 2006, J AM CHEM SOC, V128, P3154, DOI 10.1021/ja058292x
   GERSTEIN M, 1992, ACTA CRYSTALLOGR A, V48, P271, DOI 10.1107/S0108767391012680
   Giraud N, 2005, J AM CHEM SOC, V127, P18190, DOI 10.1021/ja055182h
   Giraud N, 2004, J AM CHEM SOC, V126, P11422, DOI 10.1021/ja046578g
   Giraud N, 2007, J MAGN RESON, V184, P51, DOI 10.1016/j.jmr.2006.09.015
   Kotecha M, 2007, MAGN RESON CHEM, V45, pS221, DOI 10.1002/mrc.2151
   Krushelnitsky A, 2006, J MAGN RESON, V182, P339, DOI 10.1016/j.jmr.2006.06.028
   Laage S, 2008, J AM CHEM SOC, V130, P17216, DOI 10.1021/ja805926d
   Lakomek NA, 2008, J BIOMOL NMR, V41, P139, DOI 10.1007/s10858-008-9244-4
   Lewandowski JR, 2010, J AM CHEM SOC, V132, P1246, DOI 10.1021/ja907067j
   Lorieau JL, 2006, J AM CHEM SOC, V128, P11505, DOI 10.1021/ja062443u
   Markwick PRL, 2007, J AM CHEM SOC, V129, P4724, DOI 10.1021/ja0687668
   Markwick PRL, 2009, J AM CHEM SOC, V131, P16968, DOI 10.1021/ja907476w
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Salmon L, 2009, ANGEW CHEM INT EDIT, V48, P4154, DOI 10.1002/anie.200900476
   Sheppard D, 2009, J AM CHEM SOC, V131, P15853, DOI 10.1021/ja9063958
   Thakur RS, 2006, CHEM PHYS LETT, V426, P459, DOI 10.1016/j.cplett.2006.06.007
   Verel R, 2001, J MAGN RESON, V150, P81, DOI 10.1006/jmre.2001.2310
   Wang TZ, 2003, J AM CHEM SOC, V125, P8639, DOI 10.1021/ja034077+
NR 27
TC 67
Z9 67
U1 2
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUN 23
PY 2010
VL 132
IS 24
BP 8252
EP +
DI 10.1021/ja102744b
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 612NJ
UT WOS:000278905700013
PM 20507068
DA 2021-01-25
ER

PT J
AU Spang, A
   Shiba, Y
   Randazzo, PA
AF Spang, Anne
   Shiba, Yoko
   Randazzo, Paul A.
TI Arf GAPs: Gatekeepers of vesicle generation
SO FEBS LETTERS
LA English
DT Review
DE Arf GAP; Small GTPase; GTPase activating protein; Vesicle formation;
   Intracellular traffic
ID GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTOR; MEMBRANE CURVATURE;
   ARFGAP1; GOLGI; COAT; MOTIF; TRANSPORT; COMPLEX; HYDROLYSIS
AB Arf GAP proteins are a versatile and diverse group of proteins. They control the activity of the GTP-binding proteins of the ARF family by inducing the hydrolysis of GTP that is bound to Arf proteins. The best-studied role of Arf GAPs is in intracellular traffic. In this review, we will focus mainly on the Arf GAPs that play a role in vesicle formation, Arf GAP1, Arf GAP2 and Arf GAP3 and their yeast homologues, Gcs1p and Glo3p. We discuss the roles of Arf GAPs as regulators and effectors for Arf GTP-binding proteins. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 [Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Shiba, Yoko; Randazzo, Paul A.] NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Shiba, Yoko/AAX-3885-2020; Spang,
   Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU University of Basel; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); National Institutes of Health, USAUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA; NATIONAL CANCER INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) [ZIABC007365, ZIABC007365, ZIABC007365,
   ZIABC007365, ZIABC007365, ZIABC007365, ZIABC007365, ZIABC007365,
   ZIABC007365, ZIABC007365] Funding Source: NIH RePORTER
FX This work was supported by the University of Basel and the Swiss
   National Science Foundation (A.S.) and by the intramural program of the
   National Institutes of Health, USA (P.A.R.).
CR Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06
   Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714
   Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108
   Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6
   CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999
   DREBOT MA, 1987, P NATL ACAD SCI USA, V84, P7948, DOI 10.1073/pnas.84.22.7948
   Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194
   Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209
   Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5
   Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X
   Hashimoto S, 2004, J BIOL CHEM, V279, P37677, DOI 10.1074/jbc.M404196200
   Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x
   Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041
   Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008
   LEWIS SM, 2004, MOL BIOL CELL, V14, P14
   MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232
   Mandiyan V, 1999, EMBO J, V18, P6890, DOI 10.1093/emboj/18.24.6890
   Manneville JB, 2008, P NATL ACAD SCI USA, V105, P16946, DOI 10.1073/pnas.0807102105
   Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w
   Nickel W, 2002, J CELL SCI, V115, P3235
   Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924
   Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555
   Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075
   Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074
   RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758
   RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555
   RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809
   Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9
   Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0
   Weiss M, 2003, TRAFFIC, V4, P65, DOI 10.1034/j.1600-0854.2003.40202.x
   Yahara N, 2006, J CELL SCI, V119, P2604, DOI 10.1242/jcs.02997
   Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873
   Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015
NR 33
TC 52
Z9 54
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD JUN 18
PY 2010
VL 584
IS 12
SI SI
BP 2646
EP 2651
DI 10.1016/j.febslet.2010.04.005
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 601BA
UT WOS:000278031800019
PM 20394747
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Mizuno, K
   Boudko, SP
   Engel, J
   Bachinger, HP
AF Mizuno, Kazunori
   Boudko, Sergei P.
   Engel, Juergen
   Baechinger, Hans Peter
TI Kinetic Hysteresis in Collagen Folding
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID TRIPLE-HELIX FORMATION; STABILIZATION; TRANSITIONS; NUCLEATION;
   MECHANISM; PEPTIDES; CHAIN; STEP
AB The triple helix of collagen shows a steep unfolding transition upon heating, whereas less steep and more gradual refolding is observed upon cooling. The shape of the hysteresis loop depends on the rate of temperature change as well as the peptide concentration. Experimental heating and cooling rates are usually much faster than rates of unfolding and refolding. In this work, collagen model peptides were used to study hysteresis quantitatively. Their unfolding and refolding profiles were recorded at different heating and cooling rates, and at different peptide concentrations. Data were fitted assuming kinetic mechanisms in which three chains combine to a helix with or without an intermediate that acts as a nucleus. A quantitative fit was achieved with the same kinetic model for the forward and backward reactions. Transitions of exogenously trimerized collagen models were also analyzed with a simplified kinetic mechanism. It follows that true equilibrium transitions can only be measured at high concentrations of polypeptide chains with slow scanning rates, for example, 0.1 degrees C/h at 0.25 mM peptide concentration of (Gly-Pro-Pro)(10). (Gly-Pro-4(R)Hyp)(10) folds similar to 2000 times faster than (Gly-Pro-Pro)(10). This was explained by a more stable nucleus, whereas the rate of propagation was almost equal. The analysis presented here can be used to derive kinetic and thermodynamic data for collagenous and other systems with kinetically controlled hysteresis.
C1 [Mizuno, Kazunori; Boudko, Sergei P.; Baechinger, Hans Peter] Shriners Hosp Children, Portland, OR 97201 USA.
   [Boudko, Sergei P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.
   [Engel, Juergen] Univ Basel, Biozentrum, Basel, Switzerland.
RP Bachinger, HP (corresponding author), Shriners Hosp Children, Portland, OR 97201 USA.
EM hpb@shcc.org
OI Mizuno, Kazunori/0000-0003-3354-6264
FU Shriners Hospital for Children
FX This work was supported by a grant from Shriners Hospital for Children
   (to H.P.B.).
CR BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x
   Bachmann A, 2005, P NATL ACAD SCI USA, V102, P13897, DOI 10.1073/pnas.0505141102
   Bachinger HP, 2005, PROTEIN FOLDING HANDBOOK, P1059
   BARTSCH H.-J., 1982, TASCHENBUCH MATHEMAT, P66
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200
   DAVIS JM, 1993, J BIOL CHEM, V268, P25965
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818
   ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137
   Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8
   Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750
   Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Gursky O, 2002, BIOCHEMISTRY-US, V41, P7373, DOI 10.1021/bi025588w
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Lai ZH, 1997, BIOCHEMISTRY-US, V36, P10230, DOI 10.1021/bi963195p
   Mergny JL, 1998, NUCLEIC ACIDS RES, V26, P4797, DOI 10.1093/nar/26.21.4797
   Mizuno K, 2004, J BIOL CHEM, V279, P38072, DOI 10.1074/jbc.M402953200
   Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x
   Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704
   Singh S, 2003, J BIOL CHEM, V278, P18249, DOI 10.1074/jbc.M211408200
   Terao K, 2008, MACROMOLECULES, V41, P7203, DOI 10.1021/ma800790w
   Xu YJ, 2002, BIOCHEMISTRY-US, V41, P8143, DOI 10.1021/bi015952b
NR 24
TC 34
Z9 34
U1 1
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JUN 16
PY 2010
VL 98
IS 12
BP 3004
EP 3014
DI 10.1016/j.bpj.2010.03.019
PG 11
WC Biophysics
SC Biophysics
GA 612PR
UT WOS:000278913500029
PM 20550913
OA Green Published
DA 2021-01-25
ER

PT J
AU Farhan, H
   Wendeler, MW
   Mitrovic, S
   Fava, E
   Silberberg, Y
   Sharan, R
   Zerial, M
   Hauri, HP
AF Farhan, Hesso
   Wendeler, Markus W.
   Mitrovic, Sandra
   Fava, Eugenio
   Silberberg, Yael
   Sharan, Roded
   Zerial, Marino
   Hauri, Hans-Peter
TI MAPK signaling to the early secretory pathway revealed by
   kinase/phosphatase functional screening
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID RETICULUM EXIT SITES; GOLGI FRAGMENTATION; CELL-MIGRATION; HUMAN
   KINASES; CIS-SIDE; PROTEIN; ER; TRANSPORT; COMPLEX; EXPORT
AB To what extent the secretory pathway is regulated by cellular signaling is unknown. In this study, we used RNA interference to explore the function of human kinases and phosphatases in controlling the organization of and trafficking within the secretory pathway. We identified 122 kinases/phosphatases that affect endoplasmic reticulum (ER) export, ER exit sites (ERESs), and/or the Golgi apparatus. Numerous kinases/phosphatases regulate the number of ERESs and ER to Golgi protein trafficking. Among the pathways identified, the Raf-MEK (MAPK/ERK [extracellular signal-regulated kinase] kinase)-ERK cascade, including its regulatory proteins CNK1 (connector enhancer of the kinase suppressor of Ras-1) and neurofibromin, controls the number of ERESs via ERK2, which targets Sec16, a key regulator of ERESs and COPII (coat protein II) vesicle biogenesis. Our analysis reveals an unanticipated complexity of kinase/phosphatase-mediated regulation of the secretory pathway, uncovering a link between growth factor signaling and ER export.
C1 [Farhan, Hesso; Wendeler, Markus W.; Mitrovic, Sandra; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Fava, Eugenio] High Throughput Technol Dev Studio, D-01307 Dresden, Germany.
   [Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
   [Silberberg, Yael; Sharan, Roded] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM Hans-Peter.Hauri@unibas.ch
RI Farhan, Hesso/C-7997-2012
OI Farhan, Hesso/0000-0002-0889-8463
FU Austrian Science FoundationAustrian Science Fund (FWF); European
   Molecular Biology OrganizationEuropean Molecular Biology Organization
   (EMBO); Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Universitat Basel
FX H. Farhan was supported by a Schrodinger Fellowship of the Austrian
   Science Foundation and a European Molecular Biology Organization
   long-term fellowship. This work was supported by the Swiss National
   Science Foundation and the Universitat Basel.
CR Agrawal A, 2006, J IMMUNOL, V176, P5788, DOI 10.4049/jimmunol.176.10.5788
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377
   Bejarano E, 2006, J CELL SCI, V119, P3764, DOI 10.1242/jcs.03146
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   Bhattacharyya D, 2007, MOL BIOL CELL, V18, P839, DOI 10.1091/mbc.E06-08-0707
   Blumental-Perry A, 2006, DEV CELL, V11, P671, DOI 10.1016/j.devcel.2006.09.001
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200
   Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005
   Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564
   Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X
   Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136
   Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200
   Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036
   Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200
   Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Kapetanovich L, 2005, MOL BIOL CELL, V16, P835
   Karandikar M, 2000, J BIOL CHEM, V275, P40120, DOI 10.1074/jbc.M005926200
   Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6
   Li N, 2004, HUM MOL GENET, V13, P171, DOI 10.1093/hmg/ddh020
   MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258
   Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   ORCI L, 1991, P NATL ACAD SCI USA, V88, P8611, DOI 10.1073/pnas.88.19.8611
   Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496
   Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571
   Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061
   Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751
   Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615
   Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47
   Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227
   Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063
   Shaul YD, 2009, GENE DEV, V23, P1779, DOI 10.1101/gad.523909
   Shugrue CA, 1999, J CELL SCI, V112, P4547
   Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762
   Supek F, 2002, J CELL BIOL, V158, P1029, DOI 10.1083/jcb.200207053
   Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x
   Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893
   Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077
   Yosef N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.3
   Zeuschner D, 2006, NAT CELL BIOL, V8, P377, DOI 10.1038/ncb1371
NR 51
TC 114
Z9 116
U1 0
U2 12
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD JUN 14
PY 2010
VL 189
IS 6
BP 997
EP 1011
DI 10.1083/jcb.200912082
PG 15
WC Cell Biology
SC Cell Biology
GA 613UX
UT WOS:000279008700009
PM 20548102
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Burch, N
   Arnold, AS
   Item, F
   Summermatter, S
   Santos, GBS
   Christe, M
   Boutellier, U
   Toigo, M
   Handschin, C
AF Burch, Nathalie
   Arnold, Anne-Sophie
   Item, Flurin
   Summermatter, Serge
   Santos, Gesa Brochmann Santana
   Christe, Martine
   Boutellier, Urs
   Toigo, Marco
   Handschin, Christoph
TI Electric Pulse Stimulation of Cultured Murine Muscle Cells Reproduces
   Gene Expression Changes of Trained Mouse Muscle
SO PLOS ONE
LA English
DT Article
ID PROLIFERATOR-ACTIVATED RECEPTOR; MAMMALIAN SKELETAL-MUSCLE;
   MESSENGER-RNA EXPRESSION; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM;
   MYOSIN ISOFORMS; FIBER TYPES; ERR-ALPHA; EXERCISE; PGC-1-ALPHA
AB Adequate levels of physical activity are at the center of a healthy lifestyle. However, the molecular mechanisms that mediate the beneficial effects of exercise remain enigmatic. This gap in knowledge is caused by the lack of an amenable experimental model system. Therefore, we optimized electric pulse stimulation of muscle cells to closely recapitulate the plastic changes in gene expression observed in a trained skeletal muscle. The exact experimental conditions were established using the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) as a marker for an endurance-trained muscle fiber. We subsequently compared the changes in the relative expression of metabolic and myofibrillar genes in the muscle cell system with those observed in mouse muscle in vivo following either an acute or repeated bouts of treadmill exercise. Importantly, in electrically stimulated C2C12 mouse muscle cells, the qualitative transcriptional adaptations were almost identical to those in trained muscle, but differ from the acute effects of exercise on muscle gene expression. In addition, significant alterations in the expression of myofibrillar proteins indicate that this stimulation could be used to modulate the fiber-type of muscle cells in culture. Our data thus describe an experimental cell culture model for the study of at least some of the transcriptional aspects of skeletal muscle adaptation to physical activity. This system will be useful for the study of the molecular mechanisms that regulate exercise adaptation in muscle.
C1 [Burch, Nathalie; Arnold, Anne-Sophie; Item, Flurin; Summermatter, Serge; Boutellier, Urs; Toigo, Marco; Handschin, Christoph] Univ Zurich, Inst Physiol, Zurich, Switzerland.
   [Burch, Nathalie; Arnold, Anne-Sophie; Item, Flurin; Summermatter, Serge; Boutellier, Urs; Toigo, Marco; Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.
   [Burch, Nathalie; Item, Flurin; Boutellier, Urs; Toigo, Marco] ETH, Inst Human Movement Sci, Zurich, Switzerland.
   [Arnold, Anne-Sophie; Summermatter, Serge; Santos, Gesa Brochmann Santana; Christe, Martine; Handschin, Christoph] Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, Basel, Switzerland.
RP Burch, N (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015; Arnold, Anne-Sophie/A-9234-2014; Item,
   Flurin/H-9870-2012; Boutellier, Urs/A-8749-2011
OI Handschin, Christoph/0000-0003-0603-1097; Arnold,
   Anne-Sophie/0000-0002-2435-0297; 
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF PP00A-110746]; Muscular Dystrophy Association USAMuscular
   Dystrophy Association [MDA68442]; SwissLife "Jubilaumsstiftung fur
   Volksgesundheit und medizinische Forschung''; Swiss Society for Research
   on Muscle Diseases (SSEM); United Mitochondrial Disease Foundation
   (UMDF); Association Francaise contre les myopathies (AFM)Association
   Francaise contre les Myopathies; University Research Priority Program;
   Hartmann Muller-Stiftung fur medizinische Forschung; Universities of
   Basel, Zurich; ETH ZurichETH Zurich
FX The research described in this manuscript was supported by grants from
   the Swiss National Science Foundation (SNF PP00A-110746 to CH), the
   Muscular Dystrophy Association USA (MDA68442 to CH), the SwissLife
   "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung'' to
   CH, the Swiss Society for Research on Muscle Diseases (SSEM) to CH, the
   United Mitochondrial Disease Foundation (UMDF) to CH, the Association
   Francaise contre les myopathies (AFM) to CH, the University Research
   Priority Program "Integrative Human Physiology'' at the University of
   Zurich to UB, MT and CH, the "Hartmann Muller-Stiftung fur medizinische
   Forschung'' to MT, and the Universities of Basel, Zurich and the ETH
   Zurich. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006
   BOOTH FW, 1991, PHYSIOL REV, V71, P541
   Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002
   Cairns SP, 2007, J APPL PHYSIOL, V103, P359, DOI 10.1152/japplphysiol.01267.2006
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006
   Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001
   Coffey VG, 2006, INT J SPORT PHYSIOL, V1, P284, DOI 10.1123/ijspp.1.3.284
   Coffey VG, 2006, AM J PHYSIOL-ENDOC M, V290, pE849, DOI 10.1152/ajpendo.00299.2005
   Consitt LA, 2009, IUBMB LIFE, V61, P47, DOI 10.1002/iub.142
   Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x
   Ebeling P, 1998, FEBS LETT, V436, P301, DOI 10.1016/S0014-5793(98)01149-1
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149
   Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7
   Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002
   Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   HANDSCHIN C, 2010, J RECEPT SI IN PRESS
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   HOH JFY, 1991, NEWS PHYSIOL SCI, V6, P1
   Holloway GP, 2009, APPL PHYSIOL NUTR ME, V34, P440, DOI 10.1139/H09-028
   Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182
   HOWALD H, 1982, INT J SPORTS MED, V3, P1, DOI 10.1055/s-2008-1026053
   Huang YC, 2006, AM J PHYSIOL-CELL PH, V291, pC11, DOI 10.1152/ajpcell.00366.2005
   Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004
   IVY JL, 1991, SPORTS MED, V11, P6, DOI 10.2165/00007256-199111010-00002
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Marotta M, 2004, BIOTECHNIQUES, V36, P68, DOI 10.2144/04361ST01
   Matsuoka Y, 2008, CELL TISSUE RES, V332, P123, DOI 10.1007/s00441-008-0582-z
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   NAUMANN K, 1994, DIFFERENTIATION, V55, P203, DOI 10.1046/j.1432-0436.1994.5530203.x
   NEDACHI T, 2009, AM J PHYSL ENDOCRINO
   Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008
   Nielsen JN, 2003, ACTA PHYSIOL SCAND, V178, P309, DOI 10.1046/j.1365-201X.2003.01165.x
   Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003
   Park H, 2008, J TISSUE ENG REGEN M, V2, P279, DOI 10.1002/term.93
   Partridge T, 2005, J PHYSIOL-LONDON, V562, P646, DOI 10.1113/jphysiol.2004.080671
   Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, pH1620, DOI 10.1152/ajpheart.00610.2003
   Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7
   Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268
   Pilegaard H, 2005, METABOLISM, V54, P1048, DOI 10.1016/j.metabol.2005.03.008
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Putman CT, 2000, AM J PHYSIOL-CELL PH, V279, pC682
   Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874
   Santos JM, 2008, INT J SPORTS MED, V29, P785, DOI 10.1055/s-2008-1038404
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101
   Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200
   Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010
   Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   Staron RS, 1997, CAN J APPL PHYSIOL, V22, P307, DOI 10.1139/h97-020
   Stern-Straeter J, 2005, J CELL MOL MED, V9, P883, DOI 10.1111/j.1582-4934.2005.tb00386.x
   Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005
   Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1
   Thelen MHM, 1997, BIOCHEM J, V321, P845, DOI 10.1042/bj3210845
   THOMAS PE, 1993, MUSCLE NERVE, V16, P193, DOI 10.1002/mus.880160213
   Vissing K, 2004, FASEB J, V18, P94, DOI 10.1096/fj.04-2084fje
   Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   YAMAGUCHI T, 2009, AM J PHYSL CELL PHYS
NR 71
TC 46
Z9 49
U1 1
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 4
PY 2010
VL 5
IS 6
AR e10970
DI 10.1371/journal.pone.0010970
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 605XA
UT WOS:000278380500014
PM 20532042
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Loparic, M
   Wirz, D
   Daniels, AU
   Raiteri, R
   VanLandingham, MR
   Guex, G
   Martin, I
   Aebi, U
   Stolz, M
AF Loparic, Marko
   Wirz, Dieter
   Daniels, A. U.
   Raiteri, Roberto
   VanLandingham, Mark R.
   Guex, Geraldine
   Martin, Ivan
   Aebi, Ueli
   Stolz, Martin
TI Micro- and Nanomechanical Analysis of Articular Cartilage by
   Indentation-Type Atomic Force Microscopy: Validation with a
   Gel-Microfiber Composite
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID UNCONFINED COMPRESSION; MECHANICAL-PROPERTIES; ELASTIC-MODULUS;
   COLLAGEN; TISSUE; DEGENERATION; AGGREGATE; SAMPLES; MATRIX; PROBE
AB As documented previously, articular cartilage exhibits a scale-dependent dynamic stiffness when probed by indentation-type atomic force microscopy (IT-AFM). In this study, a micrometer-size spherical tip revealed an unimodal stiffness distribution (which we refer to as microstiffness), whereas probing articular cartilage with a nanometer-size pyramidal tip resulted in a bimodal nanostiffness distribution. We concluded that indentation of the cartilage's soft proteoglycan (PG) gel gave rise to the lower nanostiffness peak, whereas deformation of its collagen fibrils yielded the higher nanostiffness peak. To test our hypothesis, we produced a gel-microfiber composite consisting of a chondroitin sulfate-containing agarose gel and a fibrillar poly(ethylene glycol)-terephthalate/poly(butylene)-terephthalate block copolymer. In striking analogy to articular cartilage, the microstiffness distribution of the synthetic composite was unimodal, whereas its nanostiffness exhibited a bimodal distribution. Also, similar to the case with cartilage, addition of the negatively charged chondroitin sulfate rendered the gel-microfiber composite's water content responsive to salt. When the ionic strength of the surrounding buffer solution increased from 0.15 to 2 M NaCl, the cartilage's microstiffness increased by 21%, whereas that of the synthetic biomaterial went up by 31%. When the nanostiffness was measured after the ionic strength was raised by the same amount, the cartilage's lower peak increased by 28%, whereas that of the synthetic biomaterial went up by 34%. Of interest, the higher peak values remained unchanged for both materials. Taken together, these results demonstrate that the nanoscale lower peak is a measure of the soft PG gel, and the nanoscale higher peak measures collagen fibril stiffness. In contrast, the micrometer-scale measurements fail to resolve separate stiffness values for the PG and collagen fibril moieties. Therefore, we propose to use nanostiffness as a new biomarker to analyze structure-function relationships in normal, diseased, and engineered cartilage.
C1 [Loparic, Marko; Aebi, Ueli; Stolz, Martin] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
   [Wirz, Dieter; Daniels, A. U.] Univ Basel, Fac Med, Lab Biomech & Biocalometry, Basel, Switzerland.
   [Raiteri, Roberto] Univ Genoa, Dept Biophys & Elect Engn, Genoa, Italy.
   [VanLandingham, Mark R.] USA, Ballist Res Lab, Aberdeen Proving Ground, MD 21005 USA.
   [Guex, Geraldine; Martin, Ivan] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.
   [Loparic, Marko; Guex, Geraldine; Martin, Ivan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Stolz, Martin] Univ Southampton, Sch Engn Sci, Natl Ctr Adv Tribol Southampton, Southampton, Hants, England.
RP Stolz, M (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
EM mstolz@nanoinspec.com
RI Martin, Ivan/K-9286-2016
OI Martin, Ivan/0000-0001-6493-0432; Guex, Anne
   Geraldine/0000-0001-9374-0275; Stolz, Martin/0000-0002-0732-0811
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); EUEuropean Union (EU) [LSHG-CT-2004-502828]; Hardy und Otto
   Frey-Zund Stiftung; M.E. Muller Foundation of Switzerland
FX This work was supported by a National Center of Competence in Research
   program grant for Nanoscale Science awarded by the Swiss National
   Science Foundation, the EU Meshwork of Excellence 3D-EM project No.
   LSHG-CT-2004-502828, the M.E. Muller Foundation of Switzerland, and
   Canton Basel-Stadt. Part of the work was also supported by the Hardy und
   Otto Frey-Zund Stiftung and by private patients supporting the efforts
   of the University of Basel Laboratory for Orthopedic Biomechanics.
CR Appleyard RC, 2001, PHYS MED BIOL, V46, P541, DOI 10.1088/0031-9155/46/2/319
   ASPDEN RM, 1991, J BIOMED ENG, V13, P521, DOI 10.1016/0141-5425(91)90102-D
   Athanasiou KA, 2000, ANN BIOMED ENG, V28, P143, DOI 10.1114/1.238
   Benninghoff A., 1925, Z ZELLFORSCH, V2, P783, DOI DOI 10.1007/BF00583443
   Boudriot U, 2006, ARTIF ORGANS, V30, P785, DOI 10.1111/j.1525-1594.2006.00301.x
   Broom N, 2001, J ANAT, V199, P683, DOI 10.1046/j.1469-7580.2001.19960683.x
   Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465
   BUSCHMANN MD, 1995, J BIOMECH ENG-T ASME, V117, P179, DOI 10.1115/1.2796000
   Buschmann MD, 1996, J CELL SCI, V109, P499
   Chen SS, 2001, OSTEOARTHR CARTILAGE, V9, P561, DOI 10.1053/joca.2001.0424
   Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388
   CUSACK S, 1979, J MOL BIOL, V135, P39, DOI 10.1016/0022-2836(79)90339-5
   Duda GN, 2004, AM J SPORT MED, V32, P693, DOI 10.1177/0363546503261725
   EISENBERG SR, 1985, J ORTHOPAED RES, V3, P148, DOI 10.1002/jor.1100030204
   Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380
   Formalas A., 1934, U.S. Patent, Patent No. [1,975,504, 1975504, US 1975504]
   Garner D L, 1971, Ann Rheum Dis, V30, P3, DOI 10.1136/ard.30.1.3
   GRODZINSKY AJ, 1983, CRIT REV BIOMED ENG, V9, P133
   GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315
   HARDINGHAM TE, 1987, J ORTHOP RES, V5, P36, DOI 10.1002/jor.1100050107
   Hughes L C, 2005, Eur Cell Mater, V9, P68
   Hunziker EB, 1997, MICROSC RES TECHNIQ, V37, P271
   Imer R, 2006, JPN J APPL PHYS 1, V45, P2319, DOI 10.1143/JJAP.45.2319
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Laasanen MS, 2003, BIORHEOLOGY, V40, P133
   Mankin H., 2000, ARTICULAR CARTILAGE
   MANKIN HJ, 1994, ORTHOPAEDIC BASIC SC
   MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0
   MAROUDAS A, 1979, PHYSICOCHEMICAL PROP, P215
   Meechai N, 2001, BIOMACROMOLECULES, V2, P780, DOI 10.1021/bm015520g
   MORGELIN M, 1994, BIOPHYS CHEM, V50, P113, DOI 10.1016/0301-4622(94)85024-0
   MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1982, BIOMECHANICS PRINCIP, P63
   Ng L, 2003, J STRUCT BIOL, V143, P242, DOI 10.1016/j.jsb.2003.08.006
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Poole A. Robin, 1999, Frontiers in Bioscience, V4, pd662, DOI 10.2741/Poole
   Reichlin T, 2005, J STRUCT BIOL, V152, P52, DOI 10.1016/j.jsb.2005.07.009
   Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021
   Shepherd DET, 1997, P I MECH ENG H, V211, P155, DOI 10.1243/0954411971534278
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P267
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stolz M, 2007, NANOMED-NANOTECHNOL, V3, P53, DOI 10.1016/j.nano.2007.01.001
   Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]
   Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192
   WU JJ, 1984, BIOCHEM BIOPH RES CO, V123, P1033, DOI 10.1016/S0006-291X(84)80237-5
NR 47
TC 109
Z9 109
U1 0
U2 58
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JUN 2
PY 2010
VL 98
IS 11
BP 2731
EP 2740
DI 10.1016/j.bpj.2010.02.013
PG 10
WC Biophysics
SC Biophysics
GA 606LW
UT WOS:000278427500037
PM 20513418
OA Green Published
DA 2021-01-25
ER

PT J
AU Diepold, A
   Amstutz, M
   Abel, S
   Sorg, I
   Jenal, U
   Cornelis, GR
AF Diepold, Andreas
   Amstutz, Marlise
   Abel, Soeren
   Sorg, Isabel
   Jenal, Urs
   Cornelis, Guy R.
TI Deciphering the assembly of the Yersinia type III secretion injectisome
SO EMBO JOURNAL
LA English
DT Article
DE microbial pathogenesis; nanomachine; protein complex assembly; protein
   transport
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM;
   FLAGELLAR PROTEIN EXPORT; PROTON MOTIVE FORCE; SALMONELLA-TYPHIMURIUM;
   NEEDLE COMPLEX; SHIGELLA-FLEXNERI; OUTER-MEMBRANE; YOP SECRETION;
   SUPRAMOLECULAR STRUCTURE
AB The assembly of the Yersinia enterocolitica type III secretion injectisome was investigated by grafting fluorescent proteins onto several components, YscC (outer-membrane (OM) ring), YscD (forms the inner-membrane (IM) ring together with YscJ), YscN (ATPase), and YscQ (putative C ring). The recombinant injectisomes were functional and appeared as fluorescent spots at the cell periphery. Epistasis experiments with the hybrid alleles in an array of injectisome mutants revealed a novel outside-in assembly order: whereas YscC formed spots in the absence of any other structural protein, formation of YscD foci required YscC, but not YscJ. We therefore propose that the assembly starts with YscC and proceeds through the connector YscD to YscJ, which was further corroborated by co-immunoprecipitation experiments. Completion of the membrane rings allowed the subsequent assembly of cytosolic components. YscN and YscQ attached synchronously, requiring each other, the interacting proteins YscK and YscL, but no further injectisome component for their assembly. These results show that assembly is initiated by the formation of the OM ring and progresses inwards to the IM ring and, finally, to a large cytosolic complex. The EMBO Journal (2010) 29, 1928-1940. doi:10.1038/emboj.2010.84; Published online 7 May 2010
C1 [Diepold, Andreas; Amstutz, Marlise; Abel, Soeren; Sorg, Isabel; Jenal, Urs; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Diepold, Andreas/0000-0002-4475-3923; Abel, Soren/0000-0002-4041-6989
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310000-113333/1]
FX We thank K Maylandt and I Stainier for providing strains pKEM5,
   pKEM4001, pSI51, and pSI4006. This work was supported by the Swiss
   National Science Foundation (grant 310000-113333/1) to GC.
CR ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992
   Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731
   Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Buddelmeijer N, 2009, J BACTERIOL, V191, P161, DOI 10.1128/JB.01138-08
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   CORNELIS GR, 1989, MOL MICROBIOL, V3, P1455, DOI 10.1111/j.1365-2958.1989.tb00129.x
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Crepin VF, 2005, MOL MICROBIOL, V55, P1658, DOI 10.1111/j.1365-2958.2005.04508.x
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103
   DRIKS A, 1990, J MOL BIOL, V211, P669, DOI 10.1016/0022-2836(90)90063-R
   Erhardt M, 2010, MOL MICROBIOL, V75, P376, DOI 10.1111/j.1365-2958.2009.06973.x
   Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x
   Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599
   Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104
   Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x
   Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   KHAN IH, 1992, P NATL ACAD SCI USA, V89, P5956, DOI 10.1073/pnas.89.13.5956
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Kimbrough TG, 2002, MICROBES INFECT, V4, P75, DOI 10.1016/S1286-4579(01)01512-X
   Konishi M, 2009, J BACTERIOL, V191, P6186, DOI 10.1128/JB.00601-09
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   KUBORI T, 1992, J MOL BIOL, V226, P433, DOI 10.1016/0022-2836(92)90958-M
   Kubori T, 1997, J BACTERIOL, V179, P813, DOI 10.1128/jb.179.3.813-817.1997
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   Lux R, 2000, J MOL BIOL, V298, P577, DOI 10.1006/jmbi.2000.3703
   Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   McMurry JL, 2006, BIOCHEMISTRY-US, V45, P11790, DOI 10.1021/bi0605890
   Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x
   Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449
   Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011
   Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200
   Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x
   Nilles ML, 1997, J BACTERIOL, V179, P1307, DOI 10.1128/jb.179.4.1307-1316.1997
   Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806
   Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497
   Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200
   Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007
   Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824
   Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Silva-Herzog E, 2008, MICROBIOL-SGM, V154, P593, DOI 10.1099/mic.0.2007/013045-0
   Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731
   Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603
   Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001
   Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876
   Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818
   Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06
   Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x
   VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x
   Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554
   Young HS, 2003, BIOPHYS J, V84, P571, DOI 10.1016/s0006-3495(03)74877-2
   Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196
NR 73
TC 103
Z9 105
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD JUN 2
PY 2010
VL 29
IS 11
BP 1928
EP 1940
DI 10.1038/emboj.2010.84
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 603VB
UT WOS:000278235100014
PM 20453832
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Stein, S
   Schaefer, N
   Breitenstein, A
   Besler, C
   Winnik, S
   Lohmann, C
   Heinrich, K
   Brokopp, CE
   Handschin, C
   Landmesser, U
   Tanner, FC
   Luscher, TF
   Matter, CM
AF Stein, Sokrates
   Schaefer, Nicola
   Breitenstein, Alexander
   Besler, Christian
   Winnik, Stephan
   Lohmann, Christine
   Heinrich, Kathrin
   Brokopp, Chad E.
   Handschin, Christoph
   Landmesser, Ulf
   Tanner, Felix C.
   Luescher, Thomas F.
   Matter, Christian M.
TI SIRT1 reduces endothelial activation without affecting vascular function
   in ApoE-/- mice
SO AGING-US
LA English
DT Article
DE SIRT1; atherosclerosis; endothelium; inflammation
ID INTERCELLULAR-ADHESION MOLECULE-1; NITRIC-OXIDE SYNTHASE;
   FACTOR-KAPPA-B; E-SELECTIN; ATHEROSCLEROSIS; RESVERATROL; DYSFUNCTION;
   INFLAMMATION; RESTRICTION; MECHANISMS
AB Excessive production of reactive oxygen species (ROS) contributes to progression of atherosclerosis, at least in part by causing endothelial dysfunction and inflammatory activation. The class III histone deacetylase SIRT1 has been implicated in extension of lifespan. In the vasculature, SIRT1 gain-of-function using SIRT1 overexpression or activation has been shown to improve endothelial function in mice and rats via stimulation of endothelial nitric oxide (NO) synthase (eNOS). However, the effects of SIRT1 loss-of-function on the endothelium in atherosclerosis remain to be characterized. Thus, we have investigated the endothelial effects of decreased endogenous SIRT1 in hypercholesterolemic ApoE(-/-) mice. We observed no difference in endothelial relaxation and eNOS (Ser(1177)) phosphorylation between 20-week old male atherosclerotic ApoE(-/-) SIRT1(+/-) and ApoE(-/-) SIRT1(+/+) mice. However, SIRT1 prevented endothelial superoxide production, inhibited NF-kappa B signaling, and diminished expression of adhesion molecules. Treatment of young hypercholesterolemic ApoE(-/-) SIRT1(+/-) mice with lipopolysaccharide to boost NF-kappa B signaling led to a more pronounced endothelial expression of ICAM-1 and VCAM-1 as compared to ApoE(-/-) SIRT1(+/+) mice. In conclusion, endogenous SIRT1 diminishes endothelial activation in ApoE(-/-) mice, but does not affect endothelium-dependent vasodilatation.
C1 [Stein, Sokrates; Schaefer, Nicola; Breitenstein, Alexander; Besler, Christian; Winnik, Stephan; Lohmann, Christine; Heinrich, Kathrin; Brokopp, Chad E.; Landmesser, Ulf; Tanner, Felix C.; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Inst Physiol, CH-8057 Zurich, Switzerland.
   [Stein, Sokrates; Schaefer, Nicola; Breitenstein, Alexander; Besler, Christian; Winnik, Stephan; Lohmann, Christine; Heinrich, Kathrin; Brokopp, Chad E.; Landmesser, Ulf; Tanner, Felix C.; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8057 Zurich, Switzerland.
   [Handschin, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Stein, S (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Inst Physiol, CH-8057 Zurich, Switzerland.
EM sokrates@access.uzh.ch; christian.matter@access.uzh.ch
RI Handschin, Christoph/E-6886-2015; Stein, Sokrates/D-4661-2009
OI Handschin, Christoph/0000-0003-0603-1097; Winnik,
   Stephan/0000-0002-1277-5132; Stein, Sokrates/0000-0001-6984-6934
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-114094/1, 310030_130626/1, 3100-068118]; University of Zurich
FX This work was funded by grants from the Swiss National Science
   Foundation (#31-114094/1, #310030_130626/1, and #3100-068118) and the
   University Research Priority Program "Integrative Human Physiology" at
   the University of Zurich.
CR Alom-Ruiz SP, 2008, ANTIOXID REDOX SIGN, V10, P1089, DOI 10.1089/ars.2007.2007
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398
   Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224
   Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kawashima S, 2004, ARTERIOSCL THROM VAS, V24, P998, DOI 10.1161/01.ATV.0000125114.88079.96
   Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104
   Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb
   MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233
   Nichols T C, 2001, Ann Periodontol, V6, P20, DOI 10.1902/annals.2001.6.1.20
   OBrien KD, 1996, CIRCULATION, V93, P672
   Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694
   Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107
   Stokes KY, 2001, CIRC RES, V88, P499, DOI 10.1161/01.RES.88.5.499
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
   Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224
NR 32
TC 116
Z9 124
U1 0
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUN
PY 2010
VL 2
IS 6
BP 353
EP 360
DI 10.18632/aging.100162
PG 8
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA 636ID
UT WOS:000280724300011
PM 20606253
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Bumann, D
AF Bumann, D.
TI Salmonella metabolism during infection
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 35th Congress of the Federation-of-European-Biochemical-Societies
CY JUN 26-JUL 01, 2010
CL Gothenburg, SWEDEN
C1 [Bumann, D.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUN
PY 2010
VL 277
SU 1
BP 6
EP 6
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 608EI
UT WOS:000278565100020
DA 2021-01-25
ER

PT J
AU Poteryaev, D
   Datta, S
   Ackema, K
   Zerial, M
   Spang, A
AF Poteryaev, D.
   Datta, S.
   Ackema, K.
   Zerial, M.
   Spang, A.
TI Identification of the switch in early-to-late endosome transition
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 35th Congress of the Federation-of-European-Biochemical-Societies
CY JUN 26-JUL 01, 2010
CL Gothenburg, SWEDEN
C1 [Poteryaev, D.; Ackema, K.; Spang, A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Datta, S.; Zerial, M.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 11
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUN
PY 2010
VL 277
SU 1
BP 30
EP 30
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 608EI
UT WOS:000278565100119
DA 2021-01-25
ER

PT J
AU Ivkovic, A
   Pascher, A
   Hudetz, D
   Maticic, D
   Jelic, M
   Dickinson, S
   Loparic, M
   Haspl, M
   Windhager, R
   Pecina, M
AF Ivkovic, A.
   Pascher, A.
   Hudetz, D.
   Maticic, D.
   Jelic, M.
   Dickinson, S.
   Loparic, M.
   Haspl, M.
   Windhager, R.
   Pecina, M.
TI Articular cartilage repair by genetically modified bone marrow aspirate
   in sheep
SO GENE THERAPY
LA English
DT Article
DE adenovirus; articular cartilage defects; transforming growth factor-beta
   1; bone marrow; cell transplantation
ID GROWTH-FACTOR-BETA; ADULT STEM-CELLS; CHONDRAL DEFECTS; GENE-TRANSFER;
   KNEE; REGENERATION; EXPRESSION; SCAFFOLDS; PROTEIN-7; STIFFNESS
AB Bone marrow presents an attractive option for the treatment of articular cartilage defects as it is readily accessible, it contains mesenchymal progenitor cells that can undergo chondrogenic differentiation and, once coagulated, it provides a natural scaffold that contains the cells within the defect. This study was performed to test whether an abbreviated ex vivo protocol using vector-laden, coagulated bone marrow aspirates for gene delivery to cartilage defects may be feasible for clinical application. Ovine autologous bone marrow was transduced with adenoviral vectors containing cDNA for green fluorescent protein or transforming growth factor (TGF)-beta 1. The marrow was allowed to clot forming a gene plug and implanted into partial-thickness defects created on the medial condyle. At 6 months, the quality of articular cartilage repair was evaluated using histological, biochemical and biomechanical parameters. Assessment of repair showed that the groups treated with constructs transplantation contained more cartilage-like tissue than untreated controls. Improved cartilage repair was observed in groups treated with unmodified bone marrow plugs and Ad. TGF-beta 1-transduced plugs, but the repaired tissue from TGF-treated defects showed significantly higher amounts of collagen II (P<0.001). The results confirmed that the proposed method is fairly straightforward technique for application in clinical settings. Genetically modified bone marrow clots are sufficient to facilitate articular cartilage repair of partial-thickness defects in vivo. Further studies should focus on selection of transgene combinations that promote more natural healing. Gene Therapy (2010) 17, 779-789; doi: 10.1038/gt.2010.16; published online 11 March 2010
C1 [Ivkovic, A.] Univ Zagreb, Univ Hosp Ctr Zagreb, Clin Inst Orthopaed Aids & Rehabil, Sch Med, Zagreb 10000, Croatia.
   [Pascher, A.; Windhager, R.] Med Univ Graz, Dept Orthopaed Surg, Graz, Austria.
   [Hudetz, D.] Univ Zagreb, Sch Med, Univ Hosp Traumatol, Zagreb 10000, Croatia.
   [Maticic, D.] Univ Zagreb, Dept Surg Orthopaed & Ophthalmol, Sch Vet, Zagreb 10000, Croatia.
   [Jelic, M.] Univ Hosp Ctr Zagreb, Dept Orthopaed Surg, Zagreb, Croatia.
   [Dickinson, S.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England.
   [Loparic, M.] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.
   [Loparic, M.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Loparic, M.] Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, Basel, Switzerland.
   [Haspl, M.] Special Hosp Orthopaed Surg Akromion, Krapinske Toplice, Croatia.
   [Pecina, M.] Univ Zagreb, Dept Orthopaed Surg, Sch Med, Zagreb 10000, Croatia.
RP Ivkovic, A (corresponding author), Univ Zagreb, Univ Hosp Ctr Zagreb, Clin Inst Orthopaed Aids & Rehabil, Sch Med, Bozidareviceva 11, Zagreb 10000, Croatia.
EM aivkovic@inet.hr
RI Pecina, Marko/J-3959-2013; Pecina, Marko/S-3009-2019; Pecina,
   Marko/AAG-2664-2020; Ivkovic, Alan/V-8656-2019
OI Pecina, Marko/0000-0002-8537-1761; Ivkovic, Alan/0000-0003-0236-6244;
   Windhager, Reinhard/0000-0002-6321-1804
FU Croatian Ministry of ScienceMinistry of Science, Education and Sports,
   Republic of Croatia [108-0000000-3652, 108-1080327-0161]; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF)
FX We thank Pierre Mainil-Varlet, MD, PhD, Davor Jezek, MD, PhD, Andreja
   Vukasovic and Ivan Cerovecki for assistance in histological analysis;
   Snjezana Martinovic, MD, PhD for valuable insight in designing this
   study; Mario Kreszinger, DVM, PhD, Drazen Vnuk, DVM, PhD, and Norbert
   Kastner, MD, for assistance during animal surgeries; and Fran Borovecki,
   MD, PhD, for his work with PCR analysis. This study was supported by the
   Croatian Ministry of Science (projects No. 108-0000000-3652 and
   108-1080327-0161). Marko Loparic acknowledges an NCCR 'Nanoscale
   Science' grant, awarded by the Swiss National Science Foundation to Ueli
   Aebi and Ivan Martin.
CR Ahern BJ, 2009, OSTEOARTHR CARTILAGE, V17, P705, DOI 10.1016/j.joca.2008.11.008
   Appleyard RC, 2001, PHYS MED BIOL, V46, P541, DOI 10.1088/0031-9155/46/2/319
   Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de
   Caplan AI, 2000, CLIN ORTHOP RELAT R, pS67
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Cucchiarini M, 2005, MOL THER, V12, P229, DOI 10.1016/j.ymthe.2005.03.012
   Dickinson SC, 2005, TISSUE ENG, V11, P277, DOI 10.1089/ten.2005.11.277
   Evans CH, 2004, CLIN ORTHOP RELAT R, P316, DOI 10.1097/01.blo.0000148854.14399.ec
   Evans CH, 2000, CLIN ORTHOP RELAT R, pS214
   Evans CH, 2007, TISSUE ENG, V13, P1987, DOI 10.1089/ten.2006.0302
   Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Ghivizzani S C, 2000, Phys Med Rehabil Clin N Am, V11, P289
   Glansbeek HL, 1998, LAB INVEST, V78, P133
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Guo CA, 2007, J BIOSCI BIOENG, V103, P547, DOI 10.1263/jbb.103.547
   HANDLEY CJ, 1995, METHOD ENZYMOL, V248, P47
   Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997
   Jelic M, 2001, GROWTH FACTORS, V19, P101, DOI 10.3109/08977190109001079
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kang R, 1997, OSTEOARTHR CARTILAGE, V5, P139, DOI 10.1016/S1063-4584(97)80007-6
   Kaps C, 2002, ARTHRITIS RHEUM-US, V46, P149, DOI 10.1002/1529-0131(200201)46:1<149::AID-ART10058>3.0.CO;2-W
   Lee KH, 2001, HUM GENE THER, V12, P1805, DOI 10.1089/104303401750476294
   LYYRA T, 1995, MED ENG PHYS, V17, P395, DOI 10.1016/1350-4533(95)97322-G
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Mason JM, 1998, GENE THER, V5, P1098, DOI 10.1038/sj.gt.3300703
   McPhee SWJ, 2006, J GENE MED, V8, P577, DOI 10.1002/jgm.885
   Pagnotto MR, 2007, GENE THER, V14, P804, DOI 10.1038/sj.gt.3302938
   Palmer GD, 2005, MOL THER, V12, P219, DOI 10.1016/j.ymthe.2005.03.024
   Pascher A, 2004, GENE THER, V11, P133, DOI 10.1038/sj.gt.3302155
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Safran MR, 2008, J AM ACAD ORTHOP SUR, V16, P306, DOI 10.5435/00124635-200806000-00002
   Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Steinbock E, 2008, PARALLAX, V14, P1, DOI 10.1080/13534640701781297
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stolz M, 2007, NANOMED-NANOTECHNOL, V3, P53, DOI 10.1016/j.nano.2007.01.001
   Swanepoel M. W., 1994, Proceedings of the Institution of Mechanical Engineers, Part H (Journal of Engineering in Medicine), V208, P33
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
   Yeh P, 1997, FASEB J, V11, P615
NR 46
TC 65
Z9 68
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0969-7128
EI 1476-5462
J9 GENE THER
JI Gene Ther.
PD JUN
PY 2010
VL 17
IS 6
BP 779
EP 789
DI 10.1038/gt.2010.16
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Research & Experimental Medicine
GA 608GL
UT WOS:000278571400011
PM 20220780
OA Bronze
DA 2021-01-25
ER

PT J
AU Lenz, M
   Kolvenbach, B
   Gygax, B
   Moes, S
   Corvini, PFX
AF Lenz, M.
   Kolvenbach, B.
   Gygax, B.
   Moes, S.
   Corvini, P. F. X.
TI The ObioOin biominerals N Identification of proteins associated to
   microbially produced selenium particles
SO GEOCHIMICA ET COSMOCHIMICA ACTA
LA English
DT Meeting Abstract
CT Conference on Goldschmidt 2010 - Earth, Energy, and the Environment
CY JUN 13-18, 2010
CL Knoxville, TN
C1 [Lenz, M.; Kolvenbach, B.; Corvini, P. F. X.] Univ Appl Sci NW Switzerland FHNW, Inst Ecopreneurship, CH-4132 Muttenz, Switzerland.
   [Gygax, B.] Univ Appl Sci NW Switzerland FHNW, Inst Chem & Bioanalyt, CH-4132 Muttenz, Switzerland.
   [Moes, S.] Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
RI corvini, philippe/H-9074-2013
CR Lenz, 2008, JEQ, V37
   Moreau JW, 2007, SCIENCE, V316, P1600, DOI 10.1126/science.1141064
   Zhang, 2004, JEQ, V33
NR 3
TC 0
Z9 0
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0016-7037
EI 1872-9533
J9 GEOCHIM COSMOCHIM AC
JI Geochim. Cosmochim. Acta
PD JUN
PY 2010
VL 74
IS 12
SU 1
BP A581
EP A581
PG 1
WC Geochemistry & Geophysics
SC Geochemistry & Geophysics
GA 676TL
UT WOS:000283941401730
DA 2021-01-25
ER

PT J
AU Mittermann, I
   Zidarn, M
   Silar, M
   Markovic-Housley, Z
   Aberer, W
   Korosec, P
   Kosnik, M
   Valenta, R
AF Mittermann, Irene
   Zidarn, Mihaela
   Silar, Mira
   Markovic-Housley, Zora
   Aberer, Werner
   Korosec, Peter
   Kosnik, Mitja
   Valenta, Rudolf
TI Recombinant allergen-based IgE testing to distinguish bee and wasp
   allergy
SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
LA English
DT Article
DE Venom allergy; recombinant allergen; in vitro diagnosis; glycosylation
ID REACTIVE CARBOHYDRATE DETERMINANTS; YELLOW JACKET VENOM; HONEYBEE VENOM;
   IMMUNOLOGICAL CHARACTERIZATION; HYMENOPTERA VENOMS; DOUBLE POSITIVITY;
   IMMUNOGLOBULIN-E; INSECT CELLS; N-GLYCANS; DIAGNOSIS
AB Background: The identification of the disease-causing insect in venom allergy is often difficult.
   Objective: To establish recombinant allergen-based IgE tests to diagnose bee and yellow jacket wasp allergy.
   Methods: Sera from patients with bee and/or wasp allergy (n = 43) and patients with pollen allergy with false-positive IgE serology to venom extracts were tested for IgE reactivity in allergen extract-based tests or with purified allergens, including nonglycosylated Escherichia coli expressed recombinant (r) Api m 1, rApi m 2, rVes v 5, and insect cell expressed, glycosylated rApi m 2 as well as 2 natural plant glycoproteins (Phl p 4, bromelain).
   Results: The patients with venom allergy could be diagnosed with a combination of E coli expressed rApi m 1, rApi m 2, and rVes v 5 whereas patients with pollen allergy remained negative. For a group of 29 patients for whom the sensitizing venom could not be identified with natural allergen extracts, testing with nonglycosylated allergens allowed identification of the sensitizing venom. Recombinant nonglycosylated allergens also allowed definition of the sensitizing venom for those 14 patients who had reacted either with bee or wasp venom extracts. By IgE inhibition studies, it is shown that glycosylated Api m 2 contains carbohydrate epitopes that cross-react with natural Api m 1, Ves v 2, natural Phl p 4, and bromelain, thus identifying cross-reactive structures responsible for serologic false-positive test results or double-positivity to bee and wasp extracts.
   Conclusion: Nonglycosylated recombinant bee and wasp venom allergens allow the identification of patients with bee and wasp allergy and should facilitate accurate prescription of venom immunotherapy. (J Allergy Clin Immunol 2010;125:1300-7.)
C1 [Valenta, Rudolf] Med Univ Vienna, Div Immunopathol, Dept Pathophysiol, Ctr Physiol & Pathophysiol, A-1090 Vienna, Austria.
   [Mittermann, Irene] Med Univ Vienna, Christian Doppler Lab Dev Allergen Chips, A-1090 Vienna, Austria.
   [Markovic-Housley, Zora] Univ Basel, Biozentrum, Dept Biol Struct, CH-4003 Basel, Switzerland.
   [Aberer, Werner] Graz Univ, Dept Dermatol & Venereol, A-8010 Graz, Austria.
RP Valenta, R (corresponding author), Med Univ Vienna, Div Immunopathol, Dept Pathophysiol, Ctr Physiol & Pathophysiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM rudolf.valenta@meduniwien.ac.at
RI Kosnik, Mitja/AAI-2295-2019
OI Kosnik, Mitja/0000-0002-4701-7374; Mittermann,
   Irene/0000-0002-6240-6730; Korosec, Peter/0000-0002-0835-1599; Zidarn,
   Mihaela/0000-0003-0515-5207
FU Christian Doppler Research Association, Phadia, Uppsala, Sweden; Biomay,
   Vienna, Austria; Austrian Science FundAustrian Science Fund (FWF)
FX Supported by the Christian Doppler Research Association, Phadia,
   Uppsala, Sweden and Biomay, Vienna, Austria.; Disclosure of potential
   conflict of interest: R. Valenta receives research support from the
   Austrian Science Fund, the Christian Doppler Research Association,
   Phadia, and Biomay. The rest of the authors have declared that they have
   no conflict of interest.
CR ALTMANN F, 1991, INSECT BIOCHEM, V21, P467, DOI 10.1016/0020-1790(91)90099-Z
   Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114
   Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x
   FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9
   Golden DBK, 2006, ANN ALLERG ASTHMA IM, V96, pS16, DOI 10.1016/S1081-1206(10)60897-6
   Golden DBK, 2001, J ALLERGY CLIN IMMUN, V107, P897, DOI 10.1067/mai.2001.114706
   Grunwald T, 2006, J ALLERGY CLIN IMMUN, V117, P848, DOI 10.1016/j.jaci.2005.12.1331
   HAMILTON RG, 1993, J ALLERGY CLIN IMMUN, V92, P651, DOI 10.1016/0091-6749(93)90007-3
   Hemmer W, 2004, CLIN EXP ALLERGY, V34, P460, DOI 10.1111/j.1365-2222.2004.01897.x
   Hemmer W, 2001, J ALLERGY CLIN IMMUN, V108, P1045, DOI 10.1067/mai.2001.120013
   Jappe U, 2006, ALLERGY, V61, P1220, DOI 10.1111/j.1398-9995.2006.01232.x
   Kettner A, 2001, J ALLERGY CLIN IMMUN, V107, P914, DOI 10.1067/mai.2001.113867
   King TP, 1996, J ALLERGY CLIN IMMUN, V98, P588, DOI 10.1016/S0091-6749(96)70093-3
   King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440
   Kochuyt AM, 2005, CLIN EXP ALLERGY, V35, P441, DOI 10.1111/j.1365-2222.2005.02217.x
   Mahler V, 2006, CLIN EXP ALLERGY, V36, P1446, DOI 10.1111/j.1365-2222.2006.02587.x
   Mari A, 1999, J ALLERGY CLIN IMMUN, V103, P1005, DOI 10.1016/S0091-6749(99)70171-5
   MARKOVICHOUSLEY Z, 2000, STRUCTURE FOLD DES, V15, P1025
   Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x
   Muller U, 1997, CLIN EXP ALLERGY, V27, P915, DOI 10.1111/j.1365-2222.1997.tb01233.x
   MULLER UR, 1995, J ALLERGY CLIN IMMUN, V96, P395, DOI 10.1016/S0091-6749(95)70059-5
   Muller UR, 2001, INT ARCH ALLERGY IMM, V124, P447, DOI 10.1159/000053779
   Soldatova LN, 1998, J ALLERGY CLIN IMMUN, V101, P691, DOI 10.1016/S0091-6749(98)70179-4
   Stumvoll S, 2002, BIOL CHEM, V383, P1383, DOI 10.1515/BC.2002.157
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TRETTER V, 1993, INT ARCH ALLERGY IMM, V102, P259, DOI 10.1159/000236534
   VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377
   van Ree R, 2002, INT ARCH ALLERGY IMM, V129, P189, DOI 10.1159/000066770
   Vrtala S, 1996, J ALLERGY CLIN IMMUN, V97, P781, DOI 10.1016/S0091-6749(96)80156-4
NR 29
TC 88
Z9 90
U1 0
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0091-6749
EI 1097-6825
J9 J ALLERGY CLIN IMMUN
JI J. Allergy Clin. Immunol.
PD JUN
PY 2010
VL 125
IS 6
BP 1300
EP 1307
DI 10.1016/j.jaci.2010.03.017
PG 8
WC Allergy; Immunology
SC Allergy; Immunology
GA 611PH
UT WOS:000278831000018
PM 20466415
DA 2021-01-25
ER

PT J
AU de Paz, HD
   Larrea, D
   Zunzunegui, S
   Dehio, C
   de la Cruz, F
   Llosa, M
AF de Paz, Hector D.
   Larrea, Delfina
   Zunzunegui, Sandra
   Dehio, Christoph
   de la Cruz, Fernando
   Llosa, Matxalen
TI Functional Dissection of the Conjugative Coupling Protein TrwB
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID IV SECRETION SYSTEM; BACTERIAL CONJUGATION; DNA TRANSFER; TRANSMEMBRANE
   DOMAIN; INCW PLASMID-R388; BINDING; TRAD; SPECIFICITY; ATP; SUBSTRATE
AB The conjugative coupling protein TrwB is responsible for connecting the relaxosome to the type IV secretion system during conjugative DNA transfer of plasmid R388. It is directly involved in transport of the relaxase TrwC, and it displays an ATPase activity probably involved in DNA pumping. We designed a conjugation assay in which the frequency of DNA transfer is directly proportional to the amount of TrwB. A collection of point mutants was constructed in the TrwB cytoplasmic domain on the basis of the crystal structure of TrwB Delta N70, targeting the nucleotide triphosphate (NTP)-binding region, the cytoplasmic surface, or the internal channel in the hexamer. An additional set of transfer-deficient mutants was obtained by random mutagenesis. Most mutants were impaired in both DNA and protein transport. We found that the integrity of the nucleotide binding domain is absolutely required for TrwB function, which is also involved in monomer-monomer interactions. Polar residues surrounding the entrance and inside the internal channel were important for TrwB function and may be involved in interactions with the relaxosomal components. Finally, the N-terminal transmembrane domain of TrwB was subjected to random mutagenesis followed by a two-hybrid screen for mutants showing enhanced protein-protein interactions with the related TrwE protein of Bartonella tribocorum. Several point mutants were obtained with mutations in the transmembranal helices: specifically, one proline from each protein may be the key residue involved in the interaction of the coupling protein with the type IV secretion apparatus.
C1 [Llosa, Matxalen] Univ Cantabria, Dept Biol Mol, Fac Med, Santander 39011, Spain.
   [de Paz, Hector D.; Larrea, Delfina; Zunzunegui, Sandra; de la Cruz, Fernando; Llosa, Matxalen] Univ Cantabria, IBBTEC, IDICAN, CSIC, Santander 39011, Spain.
   [Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4003 Basel, Switzerland.
RP Llosa, M (corresponding author), Univ Cantabria, Dept Biol Mol, Fac Med, C Herrera Oria S-N, Santander 39011, Spain.
EM llosam@unican.es
RI , matxalen/ABG-5541-2020; de la Cruz, Fernando/L-2812-2014; Dehio,
   Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI , matxalen/0000-0002-4826-2240; de la Cruz,
   Fernando/0000-0003-4758-6857; Dehio, Christoph/0000-0001-7288-1052;
   Dehio, Christoph/0000-0001-7288-1052; de Paz Fernandez, Hector
   David/0000-0002-4190-5063
FU Spanish Ministry of Science and InnovationSpanish Government
   [BIO2008-00133, BFU2008-00995/BMC]; Fundacion Marques de
   ValdecillaInstituto de Salud Carlos III [API 07/01]; European
   CommissionEuropean CommissionEuropean Commission Joint Research Centre
   [LSHM-CT-2005_019023]; RETICS Research Network [RD06/0008/1012];
   Instituto de Salud Carlos IIIInstituto de Salud Carlos III; Spanish
   Ministry of HealthInstituto de Salud Carlos IIISpanish Government;
   University of Cantabria; JAE-predoc (CSIC)Consejo Superior de
   Investigaciones Cientificas (CSIC)
FX This work was supported by grants BIO2008-00133 from the Spanish
   Ministry of Science and Innovation and API 07/01 from the Fundacion
   Marques de Valdecilla to M. L. and grants LSHM-CT-2005_019023 from the
   European Commission, BFU2008-00995/BMC from the Spanish Ministry of
   Science and Innovation, and RETICS Research Network RD06/0008/1012,
   Instituto de Salud Carlos III, Spanish Ministry of Health, to F.C. H.P.
   and D.L. were the recipients of predoctoral fellowships from the
   University of Cantabria and JAE-predoc (CSIC), respectively. We are
   grateful to Gabriel Moncalian for providing TrwA and TrwB antisera and
   Elena Cabezon and Ignacio Arechaga for helpful discussions.
CR Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x
   Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x
   BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I
   Beranek A, 2004, J BACTERIOL, V186, P6999, DOI 10.1128/JB.186.20.6999-7006.2004
   Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432
   CABEZON E, 1994, J BACTERIOL, V176, P4455, DOI 10.1128/jb.176.14.4455-4458.1994
   Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002
   CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276
   Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101
   Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588
   Chen YQ, 2008, J BACTERIOL, V190, P3632, DOI 10.1128/JB.01999-07
   de Paz HD, 2005, MICROBIOL-SGM, V151, P3505, DOI 10.1099/mic.0.28410-0
   DELACRUZ F, 1982, J BACTERIOL, V151, P222, DOI 10.1128/JB.151.1.222-228.1982
   DisqueKochem C, 1997, J BACTERIOL, V179, P6133, DOI 10.1128/jb.179.19.6133-6137.1997
   Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102
   Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x
   Gilmour MW, 2003, MOL MICROBIOL, V49, P105, DOI 10.1046/j.1365-2958.2003.03551.x
   Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P7556, DOI 10.1074/jbc.M110462200
   Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586
   Grahn AM, 2000, J BACTERIOL, V182, P1564, DOI 10.1128/JB.182.6.1564-1574.2000
   GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645
   Gunton JE, 2005, MICROBIOL-SGM, V151, P3549, DOI 10.1099/mic.0.28255-0
   Haft RJF, 2007, J BACTERIOL, V189, P6626, DOI 10.1128/JB.00513-07
   Hamilton CM, 2000, J BACTERIOL, V182, P1541, DOI 10.1128/JB.182.6.1541-1548.2000
   Hormaeche I, 2004, J BIOL CHEM, V279, P10955, DOI 10.1074/jbc.M310422200
   Hormaeche I, 2002, J BIOL CHEM, V277, P46456, DOI 10.1074/jbc.M207250200
   Hormaeche I, 2006, FEBS LETT, V580, P3075, DOI 10.1016/j.febslet.2006.04.059
   Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73
   Kumar RB, 2002, MOL MICROBIOL, V43, P1523, DOI 10.1046/j.1365-2958.2002.02829.x
   Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451
   Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x
   Llosa M, 2005, RES MICROBIOL, V156, P1, DOI 10.1016/j.resmic.2004.07.008
   Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100
   LLOSA M, 1994, J BACTERIOL, V176, P3210, DOI 10.1128/jb.176.11.3210-3217.1994
   LLOSA M, 1991, MOL GEN GENET, V226, P473, DOI 10.1007/BF00260661
   Lu J, 2005, J BACTERIOL, V187, P4767, DOI 10.1128/JB.187.14.4767-4773.2005
   Lu J, 2008, MOL MICROBIOL, V70, P89, DOI 10.1111/j.1365-2958.2008.06391.x
   MARTINEZ E, 1988, MOL GEN GENET, V211, P320, DOI 10.1007/BF00330610
   Mihajlovic S, 2009, J BACTERIOL, V191, P6877, DOI 10.1128/JB.00918-09
   Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117
   Moncalian G, 1997, J MOL BIOL, V270, P188, DOI 10.1006/jmbi.1997.1082
   SADLER JR, 1980, GENE, V8, P279, DOI 10.1016/0378-1119(80)90005-0
   Sambrook J., 2001, MOL CLONING LAB MANU
   Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445
   SARKAR G, 1990, BIOTECHNIQUES, V8, P404
   Sastre JI, 1998, J BACTERIOL, V180, P6039, DOI 10.1128/JB.180.22.6039-6042.1998
   Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002
   Steen JA, 2009, J BACTERIOL, V191, P2926, DOI 10.1128/JB.00032-09
   Sut MV, 2009, J BACTERIOL, V191, P6888, DOI 10.1128/JB.00920-09
   Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102
   Tato I, 2007, J BIOL CHEM, V282, P25569, DOI 10.1074/jbc.M703464200
   WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x
NR 54
TC 33
Z9 33
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JUN
PY 2010
VL 192
IS 11
BP 2655
EP 2669
DI 10.1128/JB.01692-09
PG 15
WC Microbiology
SC Microbiology
GA 594PJ
UT WOS:000277549300001
PM 20363945
OA Green Accepted, Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Walter, D
   Matter, A
   Fahrenkrog, B
AF Walter, David
   Matter, Anja
   Fahrenkrog, Birthe
TI Bre1p-mediated histone H2B ubiquitylation regulates apoptosis in
   Saccharomyces cerevisiae
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Apoptosis; Histone H2B; S. cerevisiae; Ubiquitin; YCA1
ID PROGRAMMED CELL-DEATH; BUDDING YEAST; DNA-DAMAGE; TRANSCRIPTIONAL
   ACTIVATION; H3 METHYLATION; UBIQUITINATION; CASPASE; MONOUBIQUITINATION;
   DEUBIQUITYLATION; PHOSPHORYLATION
AB BRE1 encodes an E3 ubiquitin protein ligase that is required for the ubiquitylation of histone H2B at lysine 123 (K123). Ubiquitylation of this histone residue is involved in a variety of cellular processes including gene activation and gene silencing. Abolishing histone H2B ubiquitylation also confers X-ray sensitivity and abrogates checkpoint activation after DNA damage. Here we show that Saccharomyces cerevisiae Bre1p exhibits anti-apoptotic activity in yeast and that this is linked to histone H2B ubiquitylation. We found that enhanced levels of Bre1p protect from hydrogen-peroxide-induced cell death, whereas deletion of BRE1 enhances cell death. Moreover, cells lacking Bre1p show reduced lifespan during chronological ageing, a physiological apoptotic condition in yeast. Importantly, the resistance against apoptosis is conferred by histone H2B ubiquitylation mediated by the E3 ligase activity of Bre1p. Furthermore, we found that the death of Delta bre1 cells depends on the yeast caspase Yca1p, because Delta bre1 cells exhibit increased caspase activity when compared with wild-type cells, and deletion of YCA1 leads to reduced apoptosis sensitivity of cells lacking Bre1p.
C1 [Walter, David; Matter, Anja; Fahrenkrog, Birthe] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Fahrenkrog, B (corresponding author), Univ Libre Bruxelles, Inst Mol Biol & Med, B-6041 Gosselies, Belgium.
EM bfahrenk@ulb.ac.be
RI Fahrenkrog, Birthe/D-5840-2011
OI Walter, David/0000-0003-4363-0339; Fahrenkrog,
   Birthe/0000-0003-4080-9413
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Kanton Basel Stadt; M. E. Muller Foundation
FX We thank C. D. Allis for providing plasmids YZS276 and YZS277 and Yvonne
   Lussi for critically reading the manuscript. This work was supported by
   grants from the Swiss National Science Foundation (to B.F.) as well as
   by the Kanton Basel Stadt and the M. E. Muller Foundation.
CR Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016
   Ahn SH, 2006, MOL CELL, V24, P211, DOI 10.1016/j.molcel.2006.09.008
   Belanger KD, 2009, J CELL SCI, V122, P3931, DOI 10.1242/jcs.056887
   Bettiga M, 2004, FEMS YEAST RES, V5, P141, DOI 10.1016/j.femsyr.2004.07.005
   Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201
   Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021
   Burhans WC, 2003, MUTAT RES-FUND MOL M, V532, P227, DOI 10.1016/j.mrfmmm.2003.08.019
   Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6
   Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809
   Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200
   Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007
   Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x
   Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848
   Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904
   FINK GA, 1991, METHOD ENZYMOL, V194, P1
   Game JC, 2006, GENETICS, V173, P1951, DOI 10.1534/genetics.106.057794
   Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005
   Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200
   GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425
   Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148
   Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23
   Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374
   Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003
   Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014
   Huang HK, 2000, J BIOL CHEM, V275, P26661
   Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2
   Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604
   Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x
   Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124
   Lee JC, 2003, IMMUNOL REV, V193, P39, DOI 10.1034/j.1600-065X.2003.00043.x
   Lettre G, 2004, CELL DEATH DIFFER, V11, P1198, DOI 10.1038/sj.cdd.4401488
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335
   Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161
   Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4
   Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729
   Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757
   Madeo F, 2009, BIOCHEM BIOPH RES CO, V382, P227, DOI 10.1016/j.bbrc.2009.02.117
   Mimnaugh EG, 2001, CELL DEATH DIFFER, V8, P1182, DOI 10.1038/sj.cdd.4400924
   Mutiu AI, 2007, MOL GENET GENOMICS, V277, P491, DOI 10.1007/s00438-007-0212-6
   Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501
   Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5
   Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883
   Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902
   Weinberger M, 2005, J CELL SCI, V118, P3543, DOI 10.1242/jcs.02477
   Wilson JF, 2002, LANCET NEUROL, V1, P4, DOI 10.1016/S1474-4422(02)00025-X
   Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138
   Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200
   Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X
   Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035
   Wysocki R, 2004, J CELL BIOL, V166, P311, DOI 10.1083/jcb.200405016
   Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005
   Yamaki M, 2001, GENES CELLS, V6, P1043, DOI 10.1046/j.1365-2443.2001.00487.x
   Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584
NR 54
TC 27
Z9 27
U1 0
U2 2
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JUN 1
PY 2010
VL 123
IS 11
BP 1931
EP 1939
DI 10.1242/jcs.065938
PG 9
WC Cell Biology
SC Cell Biology
GA 598TR
UT WOS:000277862000012
PM 20460436
OA Bronze
DA 2021-01-25
ER

PT J
AU Spangler, C
   Bohm, A
   Jenal, U
   Seifert, R
   Kaever, V
AF Spangler, Christian
   Boehm, Alex
   Jenal, Urs
   Seifert, Roland
   Kaever, Volkhard
TI A liquid chromatography-coupled tandem mass spectrometry method for
   quantitation of cyclic di-guanosine monophosphate
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE HPLC-MS/MS; Quantitation; c-di-GMP; Di-guanylate cyclase
ID PSEUDOMONAS-AERUGINOSA; ALLOSTERIC CONTROL; BIOFILM FORMATION; GMP;
   DOMAIN; EAL; PHOSPHODIESTERASE; IDENTIFICATION; BACTERIA
AB Cyclic di-guanosine monophosphate (c-di-GMP) represents an important ubiquitous second messenger in bacteria. It controls the transition between a sessile and a motile lifestyle of bacteria and, hence, affects the formation of biofilms which are highly resistant to antimicrobial treatment. c-di-GMP is synthesized by diguanylate cyclases (DGCs) and degraded by specific phosphodiesterases (PDEs), two highly abundant protein families in bacteria. We have established a robust and highly sensitive high performance liquid chromatography-coupled tandem mass spectrometry (HPLC-MS/MS) based method for the quantitation of c-di-GMP and investigated various method performance parameters such as limit of detection (LOD), lower limit of quantitation (LLOQ), linearity, accuracy, recovery and analyte stability. As a proof of principle we used this method to accurately measure the activity of the prototype DGC PleD* from Caulobacter crescentus in vitro. In addition the methodology was successfully applied to determine in vivo levels of c-di-GMP in bacterial extracts of E. coli at different stages of bacterial growth. This demonstrates that our method is suitable for the sensitive and specific quantitation of c-di-GMP in bacterial cell extracts. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Spangler, Christian; Seifert, Roland; Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany.
   [Boehm, Alex; Jenal, Urs] Univ Basel, Biozentrum, Mol Microbiol Div, CH-4056 Basel, Switzerland.
RP Spangler, C (corresponding author), Hannover Med Sch, Inst Pharmacol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM spangler.christian@mh-hannover.de
RI Seifert, Roland/G-3189-2013; Kaever, Volkhard/G-3280-2013
CR Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0
   LIAW YC, 1990, FEBS LETT, V264, P223, DOI 10.1016/0014-5793(90)80253-F
   Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Simm R, 2009, ANAL BIOCHEM, V386, P53, DOI 10.1016/j.ab.2008.12.013
   Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519
   Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200
   Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006
   US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research and Center for Veterinary Medicine, 2001, GUID IND BIOAN METH
   Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07
   Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627
NR 25
TC 106
Z9 109
U1 4
U2 53
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD JUN
PY 2010
VL 81
IS 3
BP 226
EP 231
DI 10.1016/j.mimet.2010.03.020
PG 6
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 604RU
UT WOS:000278297000003
PM 20385176
DA 2021-01-25
ER

PT J
AU Dulla, K
   Daub, H
   Hornberger, R
   Nigg, EA
   Korner, R
AF Dulla, Kalyan
   Daub, Henrik
   Hornberger, Renate
   Nigg, Erich A.
   Koerner, Roman
TI Quantitative Site-specific Phosphorylation Dynamics of Human Protein
   Kinases during Mitotic Progression
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID CELL-CYCLE; MAP KINASE; P38 MAPK; IN-VIVO; PLK1; IDENTIFICATION;
   ACTIVATION; ENRICHMENT; DIVISION; MITOSIS
AB Reversible protein phosphorylation is a key regulatory mechanism of mitotic progression. Importantly, protein kinases themselves are also regulated by phosphorylation-dephosphorylation processes; hence, phosphorylation dynamics of kinases hold a wealth of information about phosphorylation networks. Here, we investigated the site-specific phosphorylation dynamics of human kinases during mitosis using synchronization of HeLa suspension cells, kinase enrichment, and high resolution mass spectrometry. In biological triplicate analyses, we identified 206 protein kinases and more than 900 protein kinase phosphorylation sites, including 61 phosphorylation sites on activation segments, and quantified their relative abundances across three specific mitotic stages. Around 25% of the kinase phosphorylation site ratios were found to be changed by at least 50% during mitotic progression. Further network analysis of jointly regulated kinase groups suggested that Cyclin-dependent kinase-and mitogen-activated kinase-centered interaction networks are coordinately down- and up-regulated in late mitosis, respectively. Importantly, our data cover most of the already known mitotic kinases and, moreover, identify attractive candidates for future studies of phosphorylation-based mitotic signaling. Thus, the results of this study provide a valuable resource for cell biologists and provide insight into the system properties of the mitotic phosphokinome. Molecular & Cellular Proteomics 9:1167-1181, 2010.
C1 [Dulla, Kalyan; Nigg, Erich A.; Koerner, Roman] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Daub, Henrik; Hornberger, Renate] Max Planck Inst Biochem, Dept Mol Biol, Cell Signaling Grp, D-82152 Martinsried, Germany.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Korner, R (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.
EM rkoerner@biochem.mpg.de
RI Korner, Roman/G-8565-2011
OI Korner, Roman/0000-0001-9285-9290; nigg, erich/0000-0003-4835-5719
FU Max Planck SocietyMax Planck SocietyFoundation CELLEX; European
   CommissionEuropean CommissionEuropean Commission Joint Research Centre
   [LSHG-CT-2005-518254]
FX This work was supported by the Max Planck Society as well as by
   Experimental Network for Functional Integration (ENFIN) Contract
   LSHG-CT-2005-518254 funded by the European Commission within its FP6
   Program under the thematic area "Life sciences, genomics and
   biotechnology for health."
CR Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328
   Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401
   Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437
   Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052
   Brehmer D, 2005, CANCER RES, V65, P379
   Campos CBL, 2002, NEUROSCIENCE, V112, P583, DOI 10.1016/S0306-4522(02)00096-9
   Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200
   Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q
   Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Draviam VM, 2001, J CELL BIOL, V152, P945, DOI 10.1083/jcb.152.5.945
   Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007
   Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001
   Godl K, 2005, CANCER RES, V65, P6919, DOI 10.1158/0008-5472.CAN-05-0574
   Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019
   Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731
   KAUFFMAN S, 1975, J THEOR BIOL, V55, P47, DOI 10.1016/S0022-5193(75)80108-1
   Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659
   KREK W, 1992, NEW BIOL, V4, P323
   KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x
   Li JJ, 2006, PHARMACOL THERAPEUT, V111, P974, DOI 10.1016/j.pharmthera.2006.02.006
   Ma W, 2008, DEV BIOL, V320, P414, DOI 10.1016/j.ydbio.2008.05.550
   Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067
   Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762
   Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526
   McNulty DE, 2008, MOL CELL PROTEOMICS, V7, P971, DOI 10.1074/mcp.M700543-MCP200
   Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006
   Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167
   Morgan D. O., 2007, CELL CYCLE PRINCIPLE
   Mundt KE, 1997, BIOCHEM BIOPH RES CO, V239, P377, DOI 10.1006/bbrc.1997.7378
   Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467
   MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557
   Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200
   Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096
   Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200
   Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240
   Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i
   Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749
   Schreiber TB, 2008, PROTEOMICS, V8, P4416, DOI 10.1002/pmic.200800132
   Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Shinohara M, 2006, MOL BIOL CELL, V17, P5227, DOI 10.1091/mbc.E06-04-0284
   Sturgill TW, 2008, BIOCHEM BIOPH RES CO, V371, P1, DOI 10.1016/j.bbrc.2008.04.002
   Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200
   Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262
   Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203
   Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150
   Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200
   Wang B, 2008, ANAL CHEM, V80, P9526, DOI 10.1021/ac801708p
   Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101
   Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584
   Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1
   Wissing J, 2007, MOL CELL PROTEOMICS, V6, P537, DOI 10.1074/mcp.T600062-MCP200
NR 70
TC 35
Z9 35
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD JUN
PY 2010
VL 9
IS 6
BP 1167
EP 1181
DI 10.1074/mcp.M900335-MCP200
PG 15
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 618ZZ
UT WOS:000279396900010
PM 20097925
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Vuilleumier, R
   Springhorn, A
   Patterson, L
   Koidl, S
   Hammerschmidt, M
   Affolter, M
   Pyrowolakis, G
AF Vuilleumier, Robin
   Springhorn, Alexander
   Patterson, Lucy
   Koidl, Stefanie
   Hammerschmidt, Matthias
   Affolter, Markus
   Pyrowolakis, George
TI Control of Dpp morphogen signalling by a secreted feedback regulator
SO NATURE CELL BIOLOGY
LA English
DT Article
ID HEPARAN-SULFATE PROTEOGLYCANS; CALCIUM-BINDING PROTEIN; WING IMAGINAL
   DISC; GRADIENT FORMATION; DROSOPHILA DEVELOPMENT; PATTERN-FORMATION;
   EXPRESSION; ZEBRAFISH; HEDGEHOG; BMP
AB In many instances during development, morphogens specify cell fates by forming concentration gradients. In the Drosophila melanogaster wing imaginal disc, Decapentaplegic (Dpp), a bone morphogenetic protein (BMP), functions as a long-range morphogen to control patterning and growth(1). Dpp is secreted from a stripe of cells at the anterior-posterior compartment boundary and spreads into both compartments to generate a characteristic BMP activity gradient(2-6). Ever since the identification of the morphogen activity of Dpp in the developing wing, the system has served as a paradigm to understand how long-range gradients are established and how cells respond to such gradients. Here we reveal the tight and direct connection of these two processes with the identification and characterization of pentagone (pent), a transcriptional target of BMP signalling encoding a secreted regulator of the pathway. Absence of pent in the wing disc causes a severe contraction of the BMP activity gradient resulting in patterning and growth defects. We show that Pent interacts with the glypican Dally to control Dpp distribution and provide evidence that proper establishment of the BMP morphogen gradient requires the inbuilt feedback loop embodied by Pent.
C1 [Pyrowolakis, George] Univ Freiburg, Inst Biol 1, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany.
   [Patterson, Lucy; Hammerschmidt, Matthias] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany.
   [Affolter, Markus] Biozentrum Univ Basel, CH-4056 Basel, Switzerland.
RP Pyrowolakis, G (corresponding author), Univ Freiburg, Inst Biol 1, Ctr Biol Signalling Studies BIOSS, Hauptstr 1, D-79104 Freiburg, Germany.
EM g.pyrowolakis@biologie.uni-freiburg.de
RI Patterson, Lucy/G-1803-2011
OI Patterson, Lucy/0000-0002-2578-381X; Affolter,
   Markus/0000-0002-5171-0016
CR Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166
   Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035
   Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6
   Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03
   Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606
   Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061
   Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5
   Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737
   Entchev EV, 2002, TRAFFIC, V3, P98, DOI 10.1034/j.1600-0854.2002.030203.x
   Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2
   Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018
   Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500
   Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379
   Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200
   Glise B, 2005, DEV CELL, V8, P255, DOI 10.1016/j.devcel.2005.01.003
   Gorfinkiel N, 2005, DEV CELL, V8, P241, DOI 10.1016/j.devcel.2004.12.018
   Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.0.CO;2-R
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   JOLY JS, 1993, DEVELOPMENT, V119, P1261
   KELLEY C, 1994, DEV BIOL, V165, P193, DOI 10.1006/dbio.1994.1246
   Khalsa O, 1998, DEVELOPMENT, V125, P2723
   Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432
   Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010
   Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247
   Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0
   Lecuit T, 1998, DEVELOPMENT, V125, P4901
   LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0
   Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522
   Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9
   Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899
   Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4
   Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312
   Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2
   Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008
   Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752
   Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X
   Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7
   Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9
   Thomas JT, 2009, J BIOL CHEM, V284, P18994, DOI 10.1074/jbc.M807759200
   Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362
   Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534
   Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532
   Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200
   Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715
   Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012
NR 51
TC 83
Z9 83
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD JUN
PY 2010
VL 12
IS 6
BP 611
EP U198
DI 10.1038/ncb2064
PG 17
WC Cell Biology
SC Cell Biology
GA 603MT
UT WOS:000278213400014
PM 20453847
DA 2021-01-25
ER

PT J
AU Christ, F
   Voet, A
   Marchand, A
   Nicolet, S
   Desimmie, BA
   Marchand, D
   Bardiot, D
   Van der Veken, NJ
   Van Remoortel, B
   Strelkov, SV
   De Maeyer, M
   Chaltin, P
   Debyser, Z
AF Christ, Frauke
   Voet, Arnout
   Marchand, Arnaud
   Nicolet, Stefan
   Desimmie, Belete A.
   Marchand, Damien
   Bardiot, Dorothee
   Van der Veken, Nam Joo
   Van Remoortel, Barbara
   Strelkov, Sergei V.
   De Maeyer, Marc
   Chaltin, Patrick
   Debyser, Zeger
TI Rational design of small-molecule inhibitors of the LEDGF/p75-integrase
   interaction and HIV replication
SO NATURE CHEMICAL BIOLOGY
LA English
DT Article
ID PROTEIN-PROTEIN INTERACTIONS; INTEGRASE INHIBITOR; CATALYTIC DOMAIN;
   SCORING FUNCTION; BINDING-SITE; HIGH-LEVEL; LEDGF/P75; IDENTIFICATION;
   RALTEGRAVIR; REVEALS
AB Lens epithelium-derived growth factor (LEDGF/p75) is a cellular cofactor of HIV-1 integrase that promotes viral integration by tethering the preintegration complex to the chromatin. By virtue of its crucial role in the early steps of HIV replication, the interaction between LEDGF/p75 and integrase represents an attractive target for antiviral therapy. We have rationally designed a series of 2-(quinolin-3-yl) acetic acid derivatives (LEDGINs) that act as potent inhibitors of the LEDGF/p75-integrase interaction and HIV-1 replication at submicromolar concentration by blocking the integration step. A 1.84-angstrom resolution crystal structure corroborates the binding of the inhibitor in the LEDGF/p75-binding pocket of integrase. Together with the lack of cross-resistance with two clinical integrase inhibitors, these findings define the 2-(quinolin-3-yl) acetic acid derivatives as the first genuine allosteric HIV-1 integrase inhibitors. Our work demonstrates the feasibility of rational design of small molecules inhibiting the protein-protein interaction between a viral protein and a cellular host factor.
C1 [Christ, Frauke; Desimmie, Belete A.; Van der Veken, Nam Joo; Van Remoortel, Barbara; Debyser, Zeger] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Div Mol Med, Louvain, Belgium.
   [Voet, Arnout; De Maeyer, Marc] Katholieke Univ Leuven, Lab Biomol Modelling, Dept Chem, Div Biochem Mol & Struct Biol, Louvain, Belgium.
   [Nicolet, Stefan; Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut Sci, Lab Biocrystallog, Louvain, Belgium.
   [Chaltin, Patrick] Katholieke Univ Leuven, Ctr Drug Design & Dev, Kuleuven R&D, Louvain, Belgium.
   [Marchand, Arnaud; Marchand, Damien; Bardiot, Dorothee; Chaltin, Patrick] Ctr Innovat & Stimulat Med Dev, Louvain, Belgium.
   [Nicolet, Stefan] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Christ, F (corresponding author), Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Div Mol Med, Louvain, Belgium.
EM zeger.debyser@med.kuleuven.be
RI Strelkov, Sergei V/G-7425-2014; voet, arnout/O-5248-2014; debyser,
   zeger/H-1310-2013
OI Strelkov, Sergei V/0000-0001-7189-4652; Desimmie,
   Belete/0000-0002-1157-4224; Christ, Frauke/0000-0001-9580-3874; voet,
   arnout/0000-0002-3329-2703; debyser, zeger/0000-0002-3982-1565
FU Flemish Agentschap voor Innovatie door Wetenschap en Technologie
   [60813]; FWOFWO [G.0530.08]; ECEuropean CommissionEuropean Commission
   Joint Research CentreEuropean Community (EC) [THINC
   (HEALTH-F3-2008-201032)]; Research Fund; K.U. LeuvenKU Leuven; Science
   and Technology in FlandersInstitute for the Promotion of Innovation by
   Science and Technology in Flanders (IWT); Industrieel Onderzoeksfonds
   mandate; Bijzonder Onderzoeksfonds-PhD scholarship
FX We acknowledge A. Calleja for performing analytical chemistry on the
   compounds, M. Michiels for macrophage and integrase assays and L.
   Desender for performing large-scale protein purifications. We thank A.
   Jonckheer for information and communication technology support. X-ray
   diffraction data collection was done at the X06DA beamline of the Swiss
   Light Source, Paul Scherrer Institut, Villigen, Switzerland. We thank R.
   Clayton of Tibotec for providing raltegravir and elvitegravir as well as
   HXB2D-IN<SUP>N155H</SUP> <SUP>E92Q</SUP> <SUP>Q148H</SUP>. Research was
   funded by the CellCoVir SBO grant (60813) of the Flemish Agentschap voor
   Innovatie door Wetenschap en Technologie, the FWO grant G.0530.08, the
   EC grant THINC (HEALTH-F3-2008-201032), the Research Fund and the
   Industrieel Onderzoeksfonds Program of the K.U. Leuven. A.V. is
   supported by a grant from the Institute for the Promotion of Innovation
   through Science and Technology in Flanders. F.C. is funded by an
   Industrieel Onderzoeksfonds mandate, and B.A.D. is funded by a Bijzonder
   Onderzoeksfonds-PhD scholarship for international cooperation with
   non-EEA countries outside the EEA.
CR Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090
   Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200
   Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094
   Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102
   Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200
   Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200
   Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329
   De Luca L, 2009, CHEMMEDCHEM, V4, P1311, DOI 10.1002/cmdc.200900070
   De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06
   Debyser Zeger, 2002, Antiviral Chemistry & Chemotherapy, V13, P1
   Delelis O, 2009, NUCLEIC ACIDS RES, V37, P1193, DOI 10.1093/nar/gkn1050
   DeVreese K, 1996, J VIROL, V70, P689, DOI 10.1128/JVI.70.2.689-696.1996
   Du L, 2008, BIOCHEM BIOPH RES CO, V375, P139, DOI 10.1016/j.bbrc.2008.07.139
   DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124
   Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545
   Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200
   Ganapathy V, 2003, AUTOIMMUN REV, V2, P290, DOI 10.1016/S1568-9972(03)00063-6
   Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723
   Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371
   Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003
   Hazuda DJ, 2006, CURR OPIN HIV AIDS, V1, P212, DOI 10.1097/01.COH.0000221594.57035.55
   Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646
   Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047
   Johnson NP, 2007, OPTO-ELECTRON REV, V15, P125, DOI 10.2478/s11772-007-0009-5
   Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897
   Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948
   LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983
   Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319
   Maertens G, 2004, J BIOL CHEM, V279, P33421, DOI 10.1074/jbc.M404700200
   Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995
   Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002
   Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07
   Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652
   Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377
   NUNBERG JH, 1991, J VIROL, V65, P4887, DOI 10.1128/JVI.65.9.4887-4892.1991
   Ryan DP, 2005, CURR OPIN STRUC BIOL, V15, P441, DOI 10.1016/j.sbi.2005.06.001
   Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139
   Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107
   Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06
   Singh DP, 2000, BIOCHEM BIOPH RES CO, V267, P373, DOI 10.1006/bbrc.1999.1979
   Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z
   Tsantrizos YS, 2007, PCT CA2007, Patent No. 2007
   Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002
   Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006
   Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002
   Yu F, 2007, BIOCHEMISTRY-US, V46, P2899, DOI 10.1021/bi602387u
NR 50
TC 326
Z9 336
U1 1
U2 53
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1552-4450
EI 1552-4469
J9 NAT CHEM BIOL
JI Nat. Chem. Biol.
PD JUN
PY 2010
VL 6
IS 6
BP 442
EP 448
DI 10.1038/nchembio.370
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 597HS
UT WOS:000277748100014
PM 20473303
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Vayssier-Taussat, M
   Le Rhun, D
   Deng, HK
   Biville, F
   Cescau, S
   Danchin, A
   Marignac, G
   Lenaour, E
   Boulouis, HJ
   Mavris, M
   Arnaud, L
   Yang, HM
   Wang, J
   Quebatte, M
   Engel, P
   Saenz, H
   Dehio, C
AF Vayssier-Taussat, Muriel
   Le Rhun, Danielle
   Deng, Hong Kuan
   Biville, Francis
   Cescau, Sandra
   Danchin, Antoine
   Marignac, Genevieve
   Lenaour, Evelyne
   Boulouis, Henri Jean
   Mavris, Maria
   Arnaud, Lionel
   Yang, Huanming
   Wang, Jing
   Quebatte, Maxime
   Engel, Philipp
   Saenz, Henri
   Dehio, Christoph
TI The Trw Type IV Secretion System of Bartonella Mediates Host-Specific
   Adhesion to Erythrocytes
SO PLOS PATHOGENS
LA English
DT Article
ID GREEN FLUORESCENT PROTEIN; LISTERIA-MONOCYTOGENES;
   EXPERIMENTAL-INFECTION; PHYLOGENETIC ANALYSIS; PATHOGEN BARTONELLA;
   MAXIMUM-LIKELIHOOD; SP. NOV.; HENSELAE; INVASION; QUINTANA
AB Bacterial pathogens typically infect only a limited range of hosts; however, the genetic mechanisms governing host-specificity are poorly understood. The alpha-proteobacterial genus Bartonella comprises 21 species that cause host-specific intraerythrocytic bacteremia as hallmark of infection in their respective mammalian reservoirs, including the human-specific pathogens Bartonella quintana and Bartonella bacilliformis that cause trench fever and Oroya fever, respectively. Here, we have identified bacterial factors that mediate host-specific erythrocyte colonization in the mammalian reservoirs. Using mouse-specific Bartonella birtlesii, human-specific Bartonella quintana, cat-specific Bartonella henselae and rat-specific Bartonella tribocorum, we established in vitro adhesion and invasion assays with isolated erythrocytes that fully reproduce the host-specificity of erythrocyte infection as observed in vivo. By signature-tagged mutagenesis of B. birtlesii and mutant selection in a mouse infection model we identified mutants impaired in establishing intraerythrocytic bacteremia. Among 45 abacteremic mutants, five failed to adhere to and invade mouse erythrocytes in vitro. The corresponding genes encode components of the type IV secretion system (T4SS) Trw, demonstrating that this virulence factor laterally acquired by the Bartonella lineage is directly involved in adherence to erythrocytes. Strikingly, ectopic expression of Trw of rat-specific B. tribocorum in cat-specific B. henselae or human-specific B. quintana expanded their host range for erythrocyte infection to rat, demonstrating that Trw mediates host-specific erythrocyte infection. A molecular evolutionary analysis of the trw locus further indicated that the variable, surface-located TrwL and TrwJ might represent the T4SS components that determine host-specificity of erythrocyte parasitism. In conclusion, we show that the laterally acquired Trw T4SS diversified in the Bartonella lineage to facilitate host-restricted adhesion to erythrocytes in a wide range of mammals.
C1 [Vayssier-Taussat, Muriel; Le Rhun, Danielle; Deng, Hong Kuan; Marignac, Genevieve; Lenaour, Evelyne; Mavris, Maria] INRA, Unite Contrat Bartonella, Maisons Alfort, France.
   [Vayssier-Taussat, Muriel; Quebatte, Maxime; Engel, Philipp; Saenz, Henri; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Biville, Francis; Boulouis, Henri Jean] ENVA AFSSA, Equipe Bacteries Zoonot Hemotropes, UMR BIPAR, Maisons Alfort, France.
   [Cescau, Sandra] Inst Pasteur, CNRS, URA 2171, Unite Genomes Bacteriens, Paris, France.
   [Danchin, Antoine] AMAbiotics, Evry, France.
   [Arnaud, Lionel] Inst Natl Transfus Sanguine, F-75015 Paris, France.
   [Yang, Huanming] Beijing Genom Inst, Shenzhen, Peoples R China.
   [Wang, Jing] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.
RP Vayssier-Taussat, M (corresponding author), INRA, Unite Contrat Bartonella, Maisons Alfort, France.
EM mvayssier@vet-alfort.f; christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Marignac, Genevieve/M-2984-2019; Danchin,
   Antoine/F-3745-2018; Dehio, Christoph/AAD-5572-2019; Engel,
   Philipp/N-1788-2015
OI Dehio, Christoph/0000-0001-7288-1052; Marignac,
   Genevieve/0000-0002-1014-3238; Danchin, Antoine/0000-0002-6350-5001;
   Dehio, Christoph/0000-0001-7288-1052; Engel,
   Philipp/0000-0002-4678-6200; Saenz, Henri/0000-0001-7536-7817; Quebatte,
   Maxime/0000-0002-3733-1511
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [Hem-Bart06-08]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [31003A-109925]; Howard Hughes Medical InstituteHoward
   Hughes Medical Institute [55005501]; SystemsX.ch Swiss Initiative for
   Systems Biology, InfectX [51RT-0_126008]
FX This work was supported by grant Hem-Bart06-08 from Agence Nationale de
   la Recherche (to M.V.-T.), grant 31003A-109925 from the Swiss National
   Science Foundation (to C.D.), grant 55005501 from the Howard Hughes
   Medical Institute (to C.D.), and grant 51RT-0_126008 (InfectX) in the
   frame of the SystemsX.ch Swiss Initiative for Systems Biology (to C.D.).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Bermond D, 2000, INT J SYST EVOL MICR, V50, P1973, DOI 10.1099/00207713-50-6-1973
   Boulouis HJ, 2001, INFECT IMMUN, V69, P5313, DOI 10.1128/IAI.69.9.5313-5317.2001
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009010
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011
   Coleman SA, 2001, INFECT IMMUN, V69, P4373, DOI 10.1128/IAI.69.7.4373-4381.2001
   de Paz HD, 2005, MICROBIOL-SGM, V151, P3505, DOI 10.1099/mic.0.28410-0
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303
   Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718
   Foucault C, 2004, J CLIN MICROBIOL, V42, P4904, DOI 10.1128/JCM.42.10.4904-4906.2004
   Fournier PE, 2001, INFECT IMMUN, V69, P1876, DOI 10.1128/IAI.69.3.1876-1879.2001
   Heller R, 1999, INT J SYST BACTERIOL, V49, P283, DOI 10.1099/00207713-49-1-283
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Kabeya H, 2003, J VET MED SCI, V65, P479, DOI 10.1292/jvms.65.479
   Khelef N, 2006, CELL MICROBIOL, V8, P457, DOI 10.1111/j.1462-5822.2005.00634.x
   Kosoy MY, 2000, COMP IMMUNOL MICROB, V23, P221, DOI 10.1016/S0147-9571(99)00075-2
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956
   Mavris M, 2005, ANN NY ACAD SCI, V1063, P312, DOI 10.1196/annals.1355.050
   Mehock JR, 1998, INFECT IMMUN, V66, P3462, DOI 10.1128/IAI.66.7.3462-3466.1998
   MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995
   Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Rolain JM, 2004, CLIN DIAGN LAB IMMUN, V11, P423, DOI 10.1128/CDLI.11.2.423-425.2003
   Rolain JM, 2002, LANCET, V360, P226, DOI 10.1016/S0140-6736(02)09462-X
   Rolain JM, 2001, J CLIN MICROBIOL, V39, P2978, DOI 10.1128/JCM.39.8.2978-2980.2001
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013
   SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Welch DF, 1999, J CLIN MICROBIOL, V37, P2598, DOI 10.1128/JCM.37.8.2598-2601.1999
   Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00
   Yamamoto K, 2002, VET RES, V33, P669, DOI 10.1051/vetres:2002048
   Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
NR 43
TC 77
Z9 78
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7366
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUN
PY 2010
VL 6
IS 6
AR e1000946
DI 10.1371/journal.ppat.1000946
PG 10
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 624GX
UT WOS:000279806300020
PM 20548954
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Cailleau, G
   Verrecchia, EP
   Braissant, O
   Emmanuel, L
AF Cailleau, Guillaume
   Verrecchia, Eric P.
   Braissant, Olivier
   Emmanuel, Laurent
TI Reply to the Discussion by Denis Lacelle on "The biogenic origin of
   needle fibre calcite" by Cailleau et al. (2009), Sedimentology, 56,
   1858-1875
SO SEDIMENTOLOGY
LA English
DT Editorial Material
C1 [Cailleau, Guillaume; Verrecchia, Eric P.] Univ Lausanne, Inst Geol & Paleontol, CH-1015 Lausanne, Switzerland.
   [Braissant, Olivier] Univ Basel, Biozentrum Pharmazentrum, CH-4012 Basel, Switzerland.
   [Emmanuel, Laurent] Univ Paris 06, Lab Biomineralisat & Paleoenvironm, F-75252 Paris 05, France.
RP Cailleau, G (corresponding author), Univ Lausanne, Inst Geol & Paleontol, CH-1015 Lausanne, Switzerland.
EM eric.verrecchia@unil.ch
RI EMMANUEL, Laurent/E-6145-2013; Braissant, Olivier/H-2284-2012;
   Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR Braissant O, 2004, GEOBIOLOGY, V2, P59, DOI 10.1111/j.1472-4677.2004.00019.x
   BUCKLEY HE, 1951, CRYSTAL GROWTH
   Cailleau G, 2005, CATENA, V59, P1, DOI 10.1016/j.catena.2004.06.002
   Cailleau G, 2009, SEDIMENTOLOGY, V56, P1858, DOI 10.1111/j.1365-3091.2009.01060.x
   LACELLE D, 2010, SEDIMENTOLO IN PRESS
NR 5
TC 1
Z9 1
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0037-0746
J9 SEDIMENTOLOGY
JI Sedimentology
PD JUN
PY 2010
VL 57
IS 4
BP 1150
EP 1151
DI 10.1111/j.1365-3091.2009.01135.x
PG 2
WC Geology
SC Geology
GA 596VN
UT WOS:000277713700010
DA 2021-01-25
ER

PT J
AU Luca, L
   Capelle, MAH
   Machaidze, G
   Arvinte, T
   Jordan, O
   Gurny, R
AF Luca, Ludmila
   Capelle, Martinus A. H.
   Machaidze, Gia
   Arvinte, Tudor
   Jordan, Olivier
   Gurny, Robert
TI Physical instability, aggregation and conformational changes of
   recombinant human bone morphogenetic protein-2 (rhBMP-2)
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE BMP-2; Aggregation; Physical stability; Fluorescence spectroscopy; Nile
   Red; 1,8-ANS; Light scattering; Electron microscopy
ID ABSORBABLE COLLAGEN SPONGES; REGENERATION; FORMULATION; STABILITY;
   MECHANISM; BMP-2; ACID
AB The influence of two different pH values on the physical stability of recombinant human bone morphogenetic protein-2 (rhBMP-2) in aqueous solution was evaluated in the present work. RhBMP-2 in solution at pH 4.5 or 6.5 was characterized by intrinsic and extrinsic (Nile Red and 1,8-ANS) fluorescence spectroscopy, 90 degrees light-scattering and transmission electron microscopy (TEM). Compared to the pH 4.5 solution, rhBMP-2 at pH 6.5 had (i) a stronger intrinsic fluorescence intensity, (ii) a longer fluorescence lifetime, (iii) a stronger 90 degrees light-scattering intensity, (iv) a stronger Nile Red fluorescence intensity, (v) a higher Nile Red fluorescence anisotropy, (vi) a lower 1,8-ANS fluorescence intensity, (vii) a higher 1,8-ANS fluorescence anisotropy and (viii) a longer 1,8-ANS fluorescence lifetime. Electron microscopy showed that rhBMP-2 at pH 4.5 contained aggregates of about 100 nm in diameter. More and larger protein aggregates (0.1-2 mu m) were observed in solution at pH 6.5. Taken together, these results indicate conformational changes and increased aggregation of rhBMP-2 at pH 6.5 compared to pH 4.5, demonstrating a strong influence of pH on rhBMP-2 physical stability. These observations must be considered when developing a delivery system for rhBMP-2. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Luca, Ludmila; Arvinte, Tudor; Jordan, Olivier; Gurny, Robert] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Dept Pharmaceut & Biopharmaceut, CH-1211 Geneva 4, Switzerland.
   [Capelle, Martinus A. H.; Arvinte, Tudor] Univ Geneva, Dept Pharmaceut & Biopharmaceut, Therapeomic Inc, CH-1211 Geneva 4, Switzerland.
   [Machaidze, Gia] Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, Basel, Switzerland.
RP Arvinte, T (corresponding author), Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Dept Pharmaceut & Biopharmaceut, CH-1211 Geneva 4, Switzerland.
EM Tudor.Arvinte@unige.ch
RI Jordan, Olivier/B-5590-2009
OI Jordan, Olivier/0000-0003-3752-2198
CR BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210
   Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Capelle MAH, 2005, VACCINE, V23, P1686, DOI 10.1016/j.vaccine.2004.09.031
   Capelle M, 2009, PHARM RES-DORDR, V26, P118, DOI 10.1007/s11095-008-9662-8
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906
   Demeule B, 2007, BBA-PROTEINS PROTEOM, V1774, P146, DOI 10.1016/j.bbapap.2006.10.010
   Demeule B, 2007, INT J PHARMACEUT, V329, P37, DOI 10.1016/j.ijpharm.2006.08.024
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Glatz C.E., 1992, STABILITY PROTEIN PH, P135
   Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9
   Hollinger J, 1996, ORAL SURG ORAL MED O, V82, P594, DOI 10.1016/S1079-2104(96)80431-8
   Hsu HP, 2006, J ORTHOP RES, V24, P1660, DOI 10.1002/jor.20204
   Jiskoot W, 2005, METHODS STRUCTURAL A
   KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961
   Lakowicz J.R., 2004, PRINCIPLES FLUORESCE
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   MANNING MC, 1989, PHARM RES-DORDR, V6, P903, DOI 10.1023/A:1015929109894
   Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9
   Maus U, 2008, ARCH ORTHOP TRAUM SU, V128, P1461, DOI 10.1007/s00402-008-0608-8
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   MIDDAUGH CR, 1992, STABILITY PROTEIN PH, P109
   Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016
   Pellaud J, 1999, J BIOL CHEM, V274, P7699, DOI 10.1074/jbc.274.12.7699
   Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P359, DOI 10.2174/138920109788488815
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6
   SCHWARTZ D, 2005, THESIS U MUNICH GERM
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   Vallejo LF, 2004, BIOTECHNOL BIOENG, V85, P601, DOI 10.1002/bit.10906
   Wei W, 1999, INT J PHARMACEUT, V185, P129, DOI 10.1016/S0378-5173(99)00152-0
NR 37
TC 24
Z9 24
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD MAY 31
PY 2010
VL 391
IS 1-2
BP 48
EP 54
DI 10.1016/j.ijpharm.2010.02.015
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 605JD
UT WOS:000278342900007
PM 20156542
DA 2021-01-25
ER

PT J
AU Berkemeier, C
   Hall, MN
   Ruegg, MA
   Hollander, GA
AF Berkemeier, C.
   Hall, M. N.
   Rueegg, M. A.
   Hollaender, G. A.
TI The role of the mTor pathway for the development of the mouse thymic
   epithelium and function
SO SWISS MEDICAL WEEKLY
LA English
DT Meeting Abstract
C1 [Berkemeier, C.; Hollaender, G. A.] Univ Basel, Dept Biomed, Basel, Switzerland.
   [Hall, M. N.; Rueegg, M. A.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD MAY 29
PY 2010
VL 140
IS 21-22
SU 180
BP 41S
EP 41S
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA 610NI
UT WOS:000278739300161
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Baudouin, S
   Scheiffele, P
AF Baudouin, Stephane
   Scheiffele, Peter
TI SnapShot: Neuroligin-Neurexin Complexes
SO CELL
LA English
DT Editorial Material
C1 [Baudouin, Stephane; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Baudouin, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
CR BOURGERON T, 2009, NEURON, V19, P231, DOI DOI 10.1016/J.CONB.2009.06.003
   Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011
   ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8
   Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023
   Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007
   USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094
NR 8
TC 39
Z9 39
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
J9 CELL
JI Cell
PD MAY 28
PY 2010
VL 141
IS 5
BP 908
EP U187
AR 908.e1
DI 10.1016/j.cell.2010.05.024
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 602IO
UT WOS:000278132900024
PM 20510934
OA Bronze
DA 2021-01-25
ER

PT J
AU Nikolaev, Y
   Deillon, C
   Hoffmann, SRK
   Bigler, L
   Friess, S
   Zenobi, R
   Pervushin, K
   Hunziker, P
   Gutte, B
AF Nikolaev, Yaroslav
   Deillon, Christine
   Hoffmann, Stefan R. K.
   Bigler, Laurent
   Friess, Sebastian
   Zenobi, Renato
   Pervushin, Konstantin
   Hunziker, Peter
   Gutte, Bernd
TI The Leucine Zipper Domains of the Transcription Factors GCN4 and c-Jun
   Have Ribonuclease Activity
SO PLOS ONE
LA English
DT Article
ID COILED-COIL; ARTIFICIAL RIBONUCLEASES; QUALITY-CONTROL; MESSENGER-RNA;
   PEPTIDE; HYDROLYSIS; REPRESSOR; PROTEINS; CLEAVAGE; OLIGONUCLEOTIDES
AB Basic-region leucine zipper (bZIP) proteins are one of the largest transcription factor families that regulate a wide range of cellular functions. Owing to the stability of their coiled coil structure leucine zipper (LZ) domains of bZIP factors are widely employed as dimerization motifs in protein engineering studies. In the course of one such study, the X-ray structure of the retro-version of the LZ moiety of yeast transcriptional activator GCN4 suggested that this retro-LZ may have ribonuclease activity. Here we show that not only the retro-LZ but also the authentic LZ of GCN4 has weak but distinct ribonuclease activity. The observed cleavage of RNA is unspecific, it is not suppressed by the ribonuclease A inhibitor RNasin and involves the breakage of 39,59-phosphodiester bonds with formation of 29,39-cyclic phosphates as the final products as demonstrated by HPLC/electrospray ionization mass spectrometry. Several mutants of the GCN4 leucine zipper are catalytically inactive, providing important negative controls and unequivocally associating the enzymatic activity with the peptide under study. The leucine zipper moiety of the human factor c-Jun as well as the entire c-Jun protein are also shown to catalyze degradation of RNA. The presented data, which was obtained in the test-tube experiments, adds GCN4 and c-Jun to the pool of proteins with multiple functions (also known as moonlighting proteins). If expressed in vivo, the endoribonuclease activity of these bZIP-containing factors may represent a direct coupling between transcription activation and controlled RNA turnover. As an additional result of this work, the retro-leucine zipper of GCN4 can be added to the list of functional retro-peptides.
C1 [Nikolaev, Yaroslav; Deillon, Christine; Hoffmann, Stefan R. K.; Gutte, Bernd] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland.
   [Nikolaev, Yaroslav; Pervushin, Konstantin] Univ Basel, Biozentrum, Basel, Switzerland.
   [Bigler, Laurent] Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland.
   [Friess, Sebastian; Zenobi, Renato] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland.
   [Hunziker, Peter] Funct Genom Ctr Zurich, Zurich, Switzerland.
RP Nikolaev, Y (corresponding author), Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland.
EM gutte@bioc.unizh.ch
RI Zenobi, Renato/F-1113-2010; Pervushin, Konstantin/AAJ-6580-2020; Bigler,
   Laurent/AAP-3799-2020; Nikolaev, Yaroslav/I-1976-2013
OI Pervushin, Konstantin/0000-0002-6393-4340; Bigler,
   Laurent/0000-0003-3548-3594; Nikolaev, Yaroslav/0000-0002-1479-7474
FU Kanton of Zurich; Mesta Foundation; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [3100A0-118381];
   Stiftung fur wissenschaftliche Forschung an der Universitat Zurich
FX This work was supported by the Kanton of Zurich, the Mesta Foundation,
   Swiss National Science Foundation (grant 3100A0-118381 to K. Pervushin)
   and the Stiftung fur wissenschaftliche Forschung an der Universitat
   Zurich. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002
   BARBIER B, 1992, J AM CHEM SOC, V114, P3511, DOI 10.1021/ja00035a053
   BASHKIN JK, 1994, J AM CHEM SOC, V116, P5981, DOI 10.1021/ja00092a064
   Bibillo A, 1999, NUCLEIC ACIDS RES, V27, P3931, DOI 10.1093/nar/27.19.3931
   BRESLOW R, 1978, J AM CHEM SOC, V100, P3227, DOI 10.1021/ja00478a052
   Brittain IJ, 1998, BIOCHEMISTRY-US, V37, P12113, DOI 10.1021/bi9806605
   Caderas G, 1999, EUR J BIOCHEM, V266, P599, DOI 10.1046/j.1432-1327.1999.00899.x
   CARPINO LA, 1970, J AM CHEM SOC, V92, P5748, DOI 10.1021/ja00722a043
   d'Avignon DA, 2006, BIOPOLYMERS, V83, P255, DOI 10.1002/bip.20555
   Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1
   Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041
   Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945
   Fouace S, 2004, NUCLEIC ACIDS RES, V32, P151, DOI 10.1093/nar/gkh157
   Gnaccarini C, 2006, J AM CHEM SOC, V128, P8063, DOI 10.1021/ja061036f
   HEHLGANS T, 1993, FEBS LETT, V315, P51, DOI 10.1016/0014-5793(93)81131-I
   Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037
   Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7
   Koroleva LS, 2007, PROTEIN PEPTIDE LETT, V14, P151, DOI 10.2174/092986607779816177
   LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117
   Landt O, 1997, BIOL CHEM, V378, P553, DOI 10.1515/bchm.1997.378.6.553
   Lei G, 1998, ARCH BIOCHEM BIOPHYS, V355, P160, DOI 10.1006/abbi.1998.0735
   Lima WF, 1999, P NATL ACAD SCI USA, V96, P10010, DOI 10.1073/pnas.96.18.10010
   Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103
   Liu N, 2001, CURR PROTEIN PEPT SC, V2, P107, DOI 10.2174/1389203013381161
   Liu NK, 1997, EUR BIOPHYS J BIOPHY, V25, P399, DOI 10.1007/s002490050052
   Liu NK, 1998, PROTEIN SCI, V7, P1214, DOI 10.1002/pro.5560070517
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005
   MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025
   MERRIFIELD RB, 1995, PEPTIDES SYNTHESIS S, P93
   MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028
   Mittl PRE, 2000, P NATL ACAD SCI USA, V97, P2562, DOI 10.1073/pnas.97.6.2562
   Moore MJ, 2002, CELL, V108, P431, DOI 10.1016/S0092-8674(02)00645-1
   Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017
   Niittymaki T, 2006, ORG BIOMOL CHEM, V4, P15, DOI 10.1039/b509022a
   Nikolaev Y, 2007, J AM CHEM SOC, V129, P6461, DOI 10.1021/ja0685295
   O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Perreault DM, 1997, BIOORGAN MED CHEM, V5, P1209, DOI 10.1016/S0968-0896(97)00051-5
   Pitsch S, 2003, HELV CHIM ACTA, V86, P3740, DOI 10.1002/hlca.200390316
   Richards F. M., 1971, ENZYMES, V4, P647
   Rieker JD, 2000, METHOD ENZYMOL, V328, P282, DOI 10.1016/S0076-6879(00)28403-6
   Scheffer U, 2005, J AM CHEM SOC, V127, P2211, DOI 10.1021/ja0443934
   Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804
   Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0
   STADLER K, 1995, INT J PEPT PROT RES, V46, P333
   STEYAERT J, 1990, BIOCHEMISTRY-US, V29, P9064, DOI 10.1021/bi00490a025
   Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103
   Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8
   Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011
   Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930
   Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642
   ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 54
TC 20
Z9 20
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2010
VL 5
IS 5
AR e10765
DI 10.1371/journal.pone.0010765
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 600VQ
UT WOS:000278017400019
PM 20505831
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Bonnon, C
   Wendeler, MW
   Paccaud, JP
   Hauri, HP
AF Bonnon, Carine
   Wendeler, Markus W.
   Paccaud, Jean-Pierre
   Hauri, Hans-Peter
TI Selective export of human GPI-anchored proteins from the endoplasmic
   reticulum
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Cargo receptor; CD59; COPII; ER export signal; ERGIC-53; Folate
   receptor; Glycosylphosphatidylinositol-anchored proteins; p23; p24;
   Sec24 isoforms; Lipid rafts
ID EARLY SECRETORY PATHWAY; COATED TRANSPORT VESICLES; CELL-SURFACE;
   MEMBRANE-PROTEINS; LIPID RAFTS; GOLGI-APPARATUS; P24 PROTEINS;
   INTRACELLULAR-TRANSPORT; TRANSMEMBRANE PROTEIN; FOLATE RECEPTOR
AB Selective export of transmembrane proteins from the endoplasmic reticulum (ER) relies on recognition of cytosolic-domain-localized transport signals by the Sec24 subunit of the COPII vesicle coat. Human cells express four Sec24 isoforms, termed Sec24A, Sec24B, Sec24C and Sec24D that are differentially required for selective, signal-mediated ER export of transmembrane proteins. By contrast, luminally exposed glycosylphosphatidylinositol (GPI)-anchored membrane proteins cannot bind directly to Sec24 and must either use membrane-spanning cargo receptors or alternative mechanisms for ER export. Little is known about the mechanism underlying export of GPI-anchored proteins from the ER in higher eukaryotes. Using siRNA-based silencing, we identified that ER-to-Golgi transport of the human GPI-anchored protein CD59 requires Sec24, with preference for the Sec24C and Sec24D isoforms, and the recycling transmembrane protein complex p24-p23 that exhibited the same Sec24C-Sec24D isoform preference for ER export. Co-immunoprecipitation indicated unprecedented physical interaction of CD59 as well as a GFP-folate-receptor-GPI-anchor hybrid with a p24-p23 complex. Density gradient centrifugation revealed co-partitioning of CD59 and p24-p23 into biosynthetically early lipid raft fractions, and CD59 transport to the Golgi was cholesterol dependent. The results suggest that the 24p-23p complex acts as a cargo receptor for GPI-anchored proteins by facilitating their export from the ER in a Sec24-isoform-selective manner involving lipid rafts as early sorting platforms.
C1 [Bonnon, Carine; Wendeler, Markus W.; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Paccaud, Jean-Pierre] Drugs Neglected Dis Initiat, CH-1200 Geneva, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel
FX We thank Jean Gruenberg, Anne Kenworthy, Karl Matter, Kai Simons, Felix
   Wieland, Gert Zimmer and Chiara Zurzolo for providing cDNAs and
   antibodies, Joachim Seelig for calculations of biophysical parameters of
   membrane proteins and lipids, and the members of the Hauri lab for their
   suggestions. This work was supported by the Swiss National Science
   Foundation and the University of Basel.
CR Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213
   Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697
   Baines AC, 2007, TRENDS BIOCHEM SCI, V32, P381, DOI 10.1016/j.tibs.2007.06.006
   Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5
   Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032
   Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7
   Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06
   Blum R, 1999, J CELL SCI, V112, P537
   Blum R, 2008, TRAFFIC, V9, P1530, DOI 10.1111/j.1600-0854.2008.00784.x
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060
   Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200
   Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111
   BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J
   Carney GE, 2004, BIOL CELL, V96, P271, DOI 10.1016/j.biolcel.2004.01.004
   Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831
   Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667
   Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3
   Doering TL, 1996, EMBO J, V15, P182, DOI 10.1002/j.1460-2075.1996.tb00346.x
   Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751
   Elortza F, 2006, J PROTEOME RES, V5, P935, DOI 10.1021/pr050419u
   Emery G, 2000, J CELL SCI, V113, P2507
   Emery G, 2003, J CELL SCI, V116, P4821, DOI 10.1242/jcs.00802
   ENNS CA, 1991, J BIOL CHEM, V266, P13272
   Fujita S, 2009, INT J INNOV COMPUT I, V5, P139
   Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X
   Hauri HP, 2000, J CELL SCI, V113, P587
   Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797
   Hoetzl S, 2007, J NEUROCHEM, V103, P3, DOI 10.1111/j.1471-4159.2007.04721.x
   ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57
   Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645
   Koegler E, 2010, TRAFFIC, V11, P70, DOI 10.1111/j.1600-0854.2009.01009.x
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   Linstedt AD, 1997, MOL BIOL CELL, V8, P1073
   London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1
   Magal LG, 2009, MOL BIOL CELL, V20, P3751, DOI 10.1091/mbc.E09-02-0142
   Mancias JD, 2005, TRAFFIC, V6, P278, DOI 10.1111/j.1600-0854.2005.00279.x
   Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208
   Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309
   Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605
   Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3
   Mitrovic S, 2008, MOL BIOL CELL, V19, P1976, DOI 10.1091/mbc.E07-10-0989
   Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Muniz M, 2000, EMBO J, V19, P10, DOI 10.1093/emboj/19.1.10
   Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529
   Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556
   Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759
   Nufer O, 2002, J CELL SCI, V115, P619
   Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x
   Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200
   Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833
   Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094
   Pielsticker LK, 2005, BIOCHEM BIOPH RES CO, V330, P163, DOI 10.1016/j.bbrc.2005.02.136
   Roberts SJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P227, DOI 10.1006/abbi.1997.0551
   Rojo M, 2000, J CELL SCI, V113, P1043
   Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229
   Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501
   SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x
   Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13
   Sevlever D, 1999, BIOCHEM J, V343, P627, DOI 10.1042/0264-6021:3430627
   Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239
   STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011
   Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233
   Sutterlin C, 1997, J CELL SCI, V110, P2703
   Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234
   van Meer G, 2002, J BIOL CHEM, V277, P25855, DOI 10.1074/jbc.R200010200
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893
   Zheng X, 2003, MOL CELL BIOL, V23, P2202, DOI 10.1128/MCB.23.6.2202-2212.2003
NR 78
TC 90
Z9 98
U1 0
U2 9
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD MAY 15
PY 2010
VL 123
IS 10
BP 1705
EP 1715
DI 10.1242/jcs.062950
PG 11
WC Cell Biology
SC Cell Biology
GA 592EB
UT WOS:000277357400011
PM 20427317
OA Bronze
DA 2021-01-25
ER

PT J
AU Junne, T
   Kocik, L
   Spiess, M
AF Junne, Tina
   Kocik, Lucyna
   Spiess, Martin
TI The Hydrophobic Core of the Sec61 Translocon Defines the Hydrophobicity
   Threshold for Membrane Integration
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID PROTEIN-CONDUCTING CHANNEL; ENDOPLASMIC-RETICULUM; SIGNAL SEQUENCE; PLUG
   DOMAIN; SACCHAROMYCES-CEREVISIAE; CHARGED RESIDUES; YEAST SEC61P;
   RECOGNITION; ORIENTATION; MUTATIONS
AB The Sec61 translocon mediates the translocation of proteins across the endoplasmic reticulum membrane and the lateral integration of transmembrane segments into the lipid bilayer. The structure of the idle translocon is closed by a lumenal plug domain and a hydrophobic constriction ring. To test the function of the apolar constriction, we have mutated all six ring residues of yeast Sec61p to more hydrophilic, bulky, or even charged amino acids (alanines, glycines, serines, tryptophans, lysines, or aspartates). The translocon was found to be surprisingly tolerant even to the charge mutations in the constriction ring, because growth and translocation efficiency were not drastically affected. Most interestingly, ring mutants were found to affect the integration of hydrophobic sequences into the lipid bilayer, indicating that the translocon does not simply catalyze the partitioning of potential transmembrane segments between an aqueous environment and the lipid bilayer but that it also plays an active role in setting the hydrophobicity threshold for membrane integration.
C1 [Junne, Tina; Kocik, Lucyna; Spiess, Martin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-125423]
FX We thank Drs. Simon Berneche, Lorenza Bordoli, and Torsten Schwede (all
   from Biozentrum) for valuable discussions. This work was supported by
   grant 31003A-125423 from the Swiss National Science Foundation.
CR BELTZER JP, 1991, J BIOL CHEM, V266, P973
   DAVIS NG, 1985, CELL, V41, P607, DOI 10.1016/S0092-8674(85)80033-7
   Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0
   EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5
   Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361
   Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999
   HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786
   Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3
   Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216
   Hessa T, 2009, J MOL BIOL, V386, P1222, DOI 10.1016/j.jmb.2009.01.027
   Ismail N, 2006, J CELL SCI, V119, P2826, DOI 10.1242/jcs.03018
   Junne T, 2007, J BIOL CHEM, V282, P33201, DOI 10.1074/jbc.M707219200
   Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200
   Kida Y, 2009, J BIOL CHEM, V284, P2861, DOI 10.1074/jbc.M808020200
   Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002
   Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200
   McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6
   Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269
   Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902
   Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126
   Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022
   Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005
   Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804
   van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218
   Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009
   von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063
   VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x
   Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521
   Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518
   Xie K, 2007, BIOCHEMISTRY-US, V46, P15153, DOI 10.1021/bi701398y
   Zhang B, 2010, P NATL ACAD SCI USA, V107, P5399, DOI 10.1073/pnas.0914752107
NR 31
TC 56
Z9 57
U1 0
U2 7
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAY 15
PY 2010
VL 21
IS 10
BP 1662
EP 1670
DI 10.1091/mbc.E10-01-0060
PG 9
WC Cell Biology
SC Cell Biology
GA 595PS
UT WOS:000277625200003
PM 20357000
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Canepari, M
   Willadt, S
   Zecevic, D
   Vogt, KE
AF Canepari, Marco
   Willadt, Silvia
   Zecevic, Dejan
   Vogt, Kaspar E.
TI Imaging Inhibitory Synaptic Potentials Using Voltage Sensitive Dyes
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID PATCH-CLAMP; NEURONS; CELLS; GABA; INTERNEURONS; DENDRITES; DIVERSITY;
   NETWORK
AB Studies of the spatio-temporal distribution of inhibitory postsynaptic potentials (IPSPs) in a neuron have been limited by the spatial information that can be obtained by electrode recordings. We describe a method that overcomes these limitations by imaging IPSPs with voltage-sensitive dyes. CA1 hippocampal pyramidal neurons from brain slices were loaded with the voltage-sensitive dye JPW-1114 from a somatic patch electrode in whole-cell configuration. After removal of the patch electrode, we found that neurons recover their physiological intracellular chloride concentration. Using an improved voltage-imaging technique, dendritic GABAergic IPSPs as small as 1 mV could be resolved optically from multiple sites with spatial averaging. We analyzed the sensitivity of the technique, in relation to its spatial resolution. We monitored the origin and the spread of IPSPs originating in different areas of the apical dendrite and reconstructed their spatial distribution. We achieved a clear discrimination of IPSPs from the dendrites and from the axon. This study indicates that voltage imaging is a uniquely suited approach for the investigation of several fundamental aspects of inhibitory synaptic transmission that require spatial information.
C1 [Canepari, Marco; Willadt, Silvia; Vogt, Kaspar E.] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland.
   [Zecevic, Dejan] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.
RP Canepari, M (corresponding author), Grenoble Inst Neurosci, Res Grp 3, U836, INSERM, Site Sante,BP 170, F-38042 Grenoble 09, France.
EM marco.canepari@unibas.ch; kaspar.vogt@unibas.ch
RI Canepari, Marco/H-6772-2012
OI Canepari, Marco/0000-0001-9759-2388; Zecevic, Dejan/0000-0002-8917-5784;
   Vogt, Kaspar/0000-0002-0859-876X
FU University of Basel; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [3100A0_122000, 3100A0-118352, IZKOBO-121641];
   NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS068407, R01NS068407, R01NS068407, R01NS068407] Funding Source: NIH
   RePORTER; Direct For Biological SciencesNational Science Foundation
   (NSF)NSF - Directorate for Biological Sciences (BIO) [0817969] Funding
   Source: National Science Foundation
FX This work was supported by the University of Basel, the Swiss National
   Science Foundation (3100A0_122000 to M.C. and 3100A0-118352 to K.V.),
   and by the Swiss National Science Foundation travel grant IZKOBO-121641
   to D.Z.
CR Antic S, 1999, J NEUROPHYSIOL, V82, P1615
   BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0
   BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0
   Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005
   Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y
   CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D
   Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004
   Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034
   Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230
   Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7
   Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008
   Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381
   KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X
   Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002
   Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006
   Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005
   RHEE JS, 1994, J NEUROPHYSIOL, V72, P1103
   Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495
   Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006
   Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915
   Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325
   Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x
NR 22
TC 50
Z9 50
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD MAY 5
PY 2010
VL 98
IS 9
BP 2032
EP 2040
DI 10.1016/j.bpj.2010.01.024
PG 9
WC Biophysics
SC Biophysics
GA 592KH
UT WOS:000277377300038
PM 20441768
OA Green Published
DA 2021-01-25
ER

PT J
AU Ellertsdottir, E
   Lenard, A
   Blum, Y
   Krudewig, A
   Herwig, L
   Affolter, M
   Belting, HG
AF Ellertsdottir, Elin
   Lenard, Anna
   Blum, Yannick
   Krudewig, Alice
   Herwig, Lukas
   Affolter, Markus
   Belting, Heinz-Georg
TI Vascular morphogenesis in the zebrafish embryo
SO DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE Angiogenesis; Vasculogenesis; Branching morphogenesis; Cell migration;
   Lumen formation; Development; Zebrafish
ID ENDOTHELIAL-GROWTH-FACTOR; VEGF RECEPTORS; BLOOD-VESSELS; IN-VIVO;
   NETWORK FORMATION; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION;
   CELL-MIGRATION; NOTCH PATHWAY; DE-CADHERIN
AB During embryonic development, the vertebrate vasculature is undergoing vast growth and remodeling. Blood vessels can be formed by a wide spectrum of different morphogenetic mechanisms, such as budding, cord hollowing, cell hollowing, cell wrapping and intussusception. Here, we describe the vascular morphogenesis that occurs in the early zebrafish embryo. We discuss the diversity of morphogenetic mechanisms that contribute to vessel assembly, angiogenic sprouting and tube formation in different blood vessels and how some of these complex cell behaviors are regulated by molecular pathways. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Ellertsdottir, Elin; Lenard, Anna; Blum, Yannick; Krudewig, Alice; Herwig, Lukas; Affolter, Markus; Belting, Heinz-Georg] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Belting, HG (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM heinz-georg.belting@unibas.ch
OI Belting, Heinz-Georg/0000-0002-1538-4364; Affolter,
   Markus/0000-0002-5171-0016
FU Basel-Land; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Werner Siemens-Foundation;  [Kantons Basel-Stadt]
FX The authors wish to thank Ralf Adams, Victoria Bautch, Holger Gerhardt,
   Eckhard Lammert, Stefan Schulte-Merker and Arndt Siekmann for
   interesting discussions and two anonymous referees for very helpful
   comments on the original manuscript. This work has been supported by the
   Kantons Basel-Stadt and Basel-Land, and by the Swiss National Science
   Foundation. A.L. and A.K. are supported by fellowships from the Werner
   Siemens-Foundation (Zug).
CR Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057
   Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295
   Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024
   Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7
   AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8
   Baer MM, 2009, CURR TOP DEV BIOL, V89, P137, DOI 10.1016/S0070-2153(09)89006-6
   Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378
   BAR T, 1984, CELL TISSUE RES, V235, P99
   Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970
   Beis D, 2006, TRENDS CELL BIOL, V16, P105, DOI 10.1016/j.tcb.2005.12.001
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3
   Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412
   CHAPPELL JC, 2009, DEV CELL, P1
   Childs S, 2002, DEVELOPMENT, V129, P973
   COFFIN JD, 1988, DEVELOPMENT, V102, P735
   COFFIN JD, 1991, ANAT REC, V231, P383
   Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031
   Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103
   Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244
   De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014
   De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049
   DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713
   Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004
   Eichmann A, 2005, INT J DEV BIOL, V49, P259, DOI 10.1387/ijdb.041941ae
   Eriksson J, 2000, J MORPHOL, V244, P167, DOI 10.1002/(SICI)1097-4687(200006)244:3<167::AID-JMOR2>3.3.CO;2-A
   FOLKMAN J, 1982, ANN NY ACAD SCI, V401, P212, DOI 10.1111/j.1749-6632.1982.tb25720.x
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029
   Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8
   Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577
   HIRAKOW R, 1981, ANAT EMBRYOL, V163, P299, DOI 10.1007/BF00315706
   Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990
   Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426
   Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733
   Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995
   Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   Kemp HA, 2009, DEV BIOL, V327, P313, DOI 10.1016/j.ydbio.2008.12.010
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kucera Tomas, 2007, Novartis Found Symp, V283, P46
   Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026
   Lamont RE, 2009, DEV BIOL, V331, P199, DOI 10.1016/j.ydbio.2009.04.037
   Lampugnani MG, 2007, THROMB RES, V120, pS1, DOI 10.1016/S0049-3848(07)70124-X
   Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144
   Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3
   Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203
   Lawson ND, 2001, DEVELOPMENT, V128, P3675
   Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244
   Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621
   Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Makanya AN, 2009, ANGIOGENESIS, V12, P113, DOI 10.1007/s10456-009-9129-5
   Matsumoto T, 2006, J ATHEROSCLER THROMB, V13, P130, DOI 10.5551/jat.13.130
   MEIER S, 1980, J EMBRYOL EXP MORPH, V55, P291
   Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907
   Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772
   Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2
   Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5
   Nguyen TH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061907
   Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533
   Nikolova G, 2003, CELL TISSUE RES, V314, P33, DOI 10.1007/s00441-003-0739-8
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131
   Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855
   Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087
   Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028
   Perryn ED, 2008, DEV BIOL, V313, P545, DOI 10.1016/j.ydbio.2007.10.036
   Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015
   POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210
   Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   RISAU W, 1988, DEVELOPMENT, V102, P471
   RISAU W, 1995, FASEB J, V9, P926
   Rocha SF, 2009, ANGIOGENESIS, V12, P139, DOI 10.1007/s10456-009-9132-x
   Roman BL, 2002, DEVELOPMENT, V129, P3009
   Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002
   Rupp PA, 2004, DEVELOPMENT, V131, P2887, DOI 10.1242/dev.01160
   Sakaguchi TF, 2008, CURR BIOL, V18, P1565, DOI 10.1016/j.cub.2008.08.065
   Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012
   Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736
   Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577
   Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509
   Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002
   STAINIER DYR, 1995, DEVELOPMENT, V121, P3141
   Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011
   Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104
   Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083
   Thisse C, 2002, SCIENCE, V295, P457, DOI 10.1126/science.1063654
   Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887
   Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008
   Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001
   Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853
   Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3
   Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427
   Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599
   ZON LI, 1991, P NATL ACAD SCI USA, V88, P10642, DOI 10.1073/pnas.88.23.10642
NR 106
TC 118
Z9 119
U1 0
U2 29
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD MAY 1
PY 2010
VL 341
IS 1
BP 56
EP 65
DI 10.1016/j.ydbio.2009.10.035
PG 10
WC Developmental Biology
SC Developmental Biology
GA 586VT
UT WOS:000276943100005
PM 19895803
DA 2021-01-25
ER

PT J
AU Kolassa, IT
   Ertl, V
   Eckart, C
   Glockner, F
   Kolassa, S
   Papassotiropoulos, A
   de Quervain, DJF
   Elbert, T
AF Kolassa, Iris-Tatjana
   Ertl, Verena
   Eckart, Cindy
   Gloeckner, Franka
   Kolassa, Stephan
   Papassotiropoulos, Andreas
   de Quervain, Dominique J.-F.
   Elbert, Thomas
TI Association Study of Trauma Load and SLC6A4 Promoter Polymorphism in
   Posttraumatic Stress Disorder: Evidence From Survivors of the Rwandan
   Genocide
SO JOURNAL OF CLINICAL PSYCHIATRY
LA English
DT Article
ID SEROTONIN TRANSPORTER; GENETIC-VARIATION; LIFE EVENTS; DEPRESSION;
   GENOTYPE; MODERATION; AFRICAN
AB Objective: As exposure to different types of traumatic stressors increases, the occurrence of posttraumatic stress disorder (PTSD) increases. However, because some people exhibit either surprising resilience or high vulnerability, further influencing factors have been conjectured, such as gene-environment interactions. The SLC6A4 gene, which encodes serotonin transporter, has been identified as predisposing toward differential emotional processing between genotypes of its promoter polymorphism.
   Method: We investigated 408 refugees from the Rwandan genocide and assessed lifetime exposure to traumatic events, PTSD (according to DSM-IV) status, and genotype of the SLC6A4 promoter polymorphism. The study was conducted from March 2006 to February 2007.
   Results: The prevalence of PTSD approached 100% when traumatic exposure reached extreme levels. However, persons homozygous for the short allele of the SLC6A4 promoter polymorphism showed no dose-response relationship but were at high risk for developing PTSD after very few traumatic events. This genotype influence vanished with increasing exposure to traumatic stressors.
   Conclusion: We find evidence for a gene-environment interplay for PTSD and show that genetic influences lose importance when environmental factors cause an extremely high trauma burden to an individual. In the future, it may be important to determine whether the effectiveness of therapeutic interventions in PTSD is also modulated by the SLC6A4 genotype. J Clin Psychiatry 2010;71(5):543-547 (C) Copyright 2010 Physicians Postgraduate Press, Inc.
C1 [Kolassa, Iris-Tatjana; Ertl, Verena; Eckart, Cindy; Gloeckner, Franka] Univ Konstanz, D-78457 Constance, Germany.
   [Kolassa, Stephan] SAF Simulat Anal & Forecasting AG, Res & Innovat, Tagerwilen, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Sci Training Facil, Biozentrum, CH-4003 Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Div Mol Psychol, CH-4003 Basel, Switzerland.
   [de Quervain, Dominique J.-F.] Univ Zurich, Div Psychiat Res, CH-8006 Zurich, Switzerland.
RP Kolassa, IT (corresponding author), Univ Konstanz, Univ Str 10, D-78457 Constance, Germany.
EM Iris.Kolassa@uni-konstanz.de
RI Elbert, Thomas/C-8556-2009; Kolassa, Iris Tatjana/Y-3032-2018
OI Elbert, Thomas/0000-0003-1332-4939; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; Thurm, Franka/0000-0001-9684-7705; de
   Quervain, Dominique/0000-0001-7131-2464; Kolassa,
   Stephan/0000-0001-9393-0765
FU German Research Foundation (DFG)German Research Foundation (DFG)
   [FOR751]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [PP00B-106708, PP00B-68859, PP00B-114813];
   Zukunftskolleg of the University of Konstanz
FX Funding/support: This study was funded by the German Research Foundation
   (DFG), research unit FOR751, by grants from the Swiss National Science
   Foundation to Drs de Quervain and Papassotiropoulos (PP00B-106708,
   PP00B-68859, PP00B-114813), and a stipend of the Zukunftskolleg of the
   University of Konstanz was awarded to Dr I.-T. Kolassa.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001
   Burnham KP., 2002, MODEL SELECTION MULT, V2
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   ERTL V, 2008, RELIABILITAT VALIDIT
   Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445
   Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358
   Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624
   Good P., 2005, PERMUTATION PARAMETR
   Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555
   Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0
   Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829
   Harrell F, 2001, REGRESSION MODELING
   HARRELL FE, 2007, HMISC HARRELL MISCEL
   HARRELL FE, 2007, DESIGN DESIGN R PACK
   HOLM S, 1979, SCAND J STAT, V6, P65
   Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529
   Kilpatrick DG, 2007, AM J PSYCHIAT, V164, P1693, DOI 10.1176/appi.ajp.2007.06122007
   Koenen KC, 2007, J TRAUMA STRESS, V20, P737, DOI 10.1002/jts.20205
   Kolassa IT, 2007, CURR DIR PSYCHOL SCI, V16, P321, DOI 10.1111/j.1467-8721.2007.00529.x
   Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064
   Lotrich F E, 2001, Am J Pharmacogenomics, V1, P153, DOI 10.2165/00129785-200101030-00001
   Lotrich Francis E, 2003, Am J Pharmacogenomics, V3, P145, DOI 10.2165/00129785-200303020-00007
   Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016
   Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8
   Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698
   Neuner F, 2008, J CONSULT CLIN PSYCH, V76, P686, DOI 10.1037/0022-006X.76.4.686
   Neuner F, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-34
   Odenwald Michael, 2007, Confl Health, V1, P10, DOI 10.1186/1752-1505-1-10
   ONYUT LP, 2004, INTERVENTION, V2, P90
   R Core Team, 2017, R LANG ENV STAT COMP
   Rausch JL, 2002, BIOL PSYCHIAT, V51, P723, DOI 10.1016/S0006-3223(01)01283-5
   Rhodes RA, 2007, J NEUROSCI, V27, P9233, DOI 10.1523/JNEUROSCI.1175-07.2007
   Segman RH, 2003, CNS SPECTRUMS, V8, P693, DOI 10.1017/S1092852900008889
   Spitzer R.L., 1990, STRUCTURED CLIN INTE
   Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675
   TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002
   Wilhelm K, 2006, BRIT J PSYCHIAT, V188, P210, DOI 10.1192/bjp.bp.105.009522
NR 40
TC 92
Z9 96
U1 0
U2 19
PU PHYSICIANS POSTGRADUATE PRESS
PI MEMPHIS
PA P O BOX 752870, MEMPHIS, TN 38175-2870 USA
SN 0160-6689
EI 1555-2101
J9 J CLIN PSYCHIAT
JI J. Clin. Psychiatry
PD MAY
PY 2010
VL 71
IS 5
BP 543
EP 547
DI 10.4088/JCP.08m04787blu
PG 5
WC Psychology, Clinical; Psychiatry
SC Psychology; Psychiatry
GA 599XC
UT WOS:000277946400005
PM 20441718
OA Green Published
DA 2021-01-25
ER

PT J
AU Peter, JC
   Lecourt, AC
   Weckering, M
   Zipfel, G
   Niehoff, ML
   Banks, WA
   Hofbauer, KG
AF Peter, Jean-Christophe
   Lecourt, Anne-Catherine
   Weckering, Marjorie
   Zipfel, Geraldine
   Niehoff, Michael L.
   Banks, William A.
   Hofbauer, Karl G.
TI A Pharmacologically Active Monoclonal Antibody against the Human
   Melanocortin-4 Receptor: Effectiveness After Peripheral and Central
   Administration
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article
ID BLOOD-BRAIN-BARRIER; BETA-PROTEIN ANTIBODY; CHRONIC DISEASE; ENERGY
   HOMEOSTASIS; ALZHEIMERS-DISEASE; INVERSE AGONIST; HIGH-AFFINITY; MOUSE
   MODEL; GENE; PASSAGE
AB The hypothalamic melanocortin-4 receptor (MC4R) is a constituent of an important pathway regulating food intake and energy expenditure. We produced a monoclonal antibody (mAb) directed against the N-terminal domain of the MC4R and evaluated its potential as a possible therapeutic agent. This mAb (1E8a) showed specific binding to the MC4R in human embryonic kidney 293 cells expressing the human MC4R and blocked the activity of the MC4R under basal conditions and after stimulation with alpha-melanocyte-stimulating hormone (alpha-MSH). The inverse agonist action of Agouti-related protein was significantly enhanced in the presence of mAb 1E8a. After a single intracerebroventricular injection into the third ventricle, mAb 1E8a (1 mu g) increased 24-h food intake in rats. After 7 days of continuous intracerebroventricular administration, mAb 1E8a increased food intake, body weight, and fat pad weight and induced hyperglycemia. Because the complete mAb was ineffective after intravenous injection, we produced single-chain variable fragments (scFvs) derived from mAb 1E8a. In pharmacokinetic studies it was demonstrated that these scFvs crossed the blood-brain barrier and reached the hypothalamus. Consequently, the scFv 1E8a increased significantly food intake and body weight in rats after intravenous administration (300 mu g/kg). The pharmacological profile of mAb 1E8a and the fact that its scFv was active after peripheral administration suggest that derivatives of anti-MC4R mAbs may be useful in the treatment of patients with anorexia or cachexia.
C1 [Hofbauer, Karl G.] Univ Basel, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Niehoff, Michael L.; Banks, William A.] St Louis Univ, Sch Med, Dept Internal Med, Div Geriatr, St Louis, MO USA.
   [Niehoff, Michael L.; Banks, William A.] St Louis Univ, Sch Med, Geriatr Res Educ & Clin Ctr, Vet Affairs Med Ctr St Louis, St Louis, MO USA.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, 50-70 Klingelbergstr, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
RI Banks, William A/K-1330-2017
OI Banks, William A/0000-0002-0496-3619
FU NIA NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [R01 AG029839] Funding Source: Medline; NATIONAL INSTITUTE ON
   AGINGUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [R01AG029839, R01AG029839, R01AG029839, R01AG029839, R01AG029839,
   R01AG029839] Funding Source: NIH RePORTER
CR Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929
   BALLARD DW, 1983, P NATL ACAD SCI-BIOL, V80, P5071, DOI 10.1073/pnas.80.16.5071
   BANKS WA, 1993, J PHARMACOL EXP THER, V267, P690
   Banks WA, 2005, PEPTIDES, V26, P287, DOI 10.1016/j.peptides.2004.09.016
   Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3
   Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9
   BANKS WA, 1991, J PHARMACOL EXP THER, V259, P988
   Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005
   BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2
   Bohen SP, 2003, P NATL ACAD SCI USA, V100, P1926, DOI 10.1073/pnas.0437875100
   BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059
   Cao CH, 2004, DNA CELL BIOL, V23, P836, DOI 10.1089/dna.2004.23.836
   CARROLL WL, 1988, MOL IMMUNOL, V25, P991, DOI 10.1016/0161-5890(88)90005-3
   Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087
   DeBoer MD, 2006, NAT CLIN PRACT ENDOC, V2, P459, DOI 10.1038/ncpendmet0221
   Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395
   Fan T, 2000, ENDOCRINOLOGY, V141, P3072
   Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050
   GANTZ I, 1993, J BIOL CHEM, V268, P15174
   GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V
   Hofbauer KG, 2008, NUTRITION, V24, P791, DOI 10.1016/j.nut.2008.06.001
   Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864
   Kornbluth A, 1998, Inflamm Bowel Dis, V4, P328, DOI 10.1002/ibd.3780040415
   LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987
   Lu XY, 2002, ENDOCRINOLOGY, V143, P3905, DOI 10.1210/en.2002-220150
   Marks DL, 2001, RECENT PROG HORM RES, V56, P359, DOI 10.1210/rp.56.1.359
   Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+
   Nicholson JR, 2006, J PHARMACOL EXP THER, V317, P771, DOI 10.1124/jpet.105.097725
   Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI12954
   OI VT, 1980, J EXP MED, V151, P1260, DOI 10.1084/jem.151.5.1260
   PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1
   Peter JC, 2005, FASEB J, V19, P943, DOI 10.1096/fj.04-3042com
   Peter JC, 2004, J BIOL CHEM, V279, P55697, DOI 10.1074/jbc.M407213200
   Peter JC, 2003, J BIOL CHEM, V278, P36740, DOI 10.1074/jbc.M306877200
   Peter JC, 2007, AM J PHYSIOL-REG I, V292, pR2151, DOI 10.1152/ajpregu.00878.2006
   Scarlett JM, 2005, EXPERT OPIN INV DRUG, V14, P1233, DOI 10.1517/13543784.14.10.1233
   Schuna AA, 2000, AM J HEALTH-SYST PH, V57, P225, DOI 10.1093/ajhp/57.3.225
   Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927
   Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497
   SUENAGA R, 1992, LUPUS, V1, P363, DOI 10.1177/096120339200100605
   TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x
NR 41
TC 14
Z9 15
U1 0
U2 0
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD MAY
PY 2010
VL 333
IS 2
BP 478
EP 490
DI 10.1124/jpet.109.163279
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 584UE
UT WOS:000276777900014
PM 20118207
OA Green Published
DA 2021-01-25
ER

PT J
AU Nicolet, S
   Herrmann, H
   Aebi, U
   Strelkov, SV
AF Nicolet, Stefan
   Herrmann, Harald
   Aebi, Ueli
   Strelkov, Sergei V.
TI Atomic structure of vimentin coil 2
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Intermediate filaments; Vimentin; Crystal structure; Hendecad repeat;
   Coiled coil
ID INTERMEDIATE-FILAMENTS; CRYSTAL-STRUCTURE; MOLECULAR ARCHITECTURE; CELL
   ARCHITECTURE; MECHANISM; SEGMENTS; SEQUENCE; STUTTER; PROGRAM; DOMAINS
AB Intermediate filaments (IFS) are essential cytoskeletal components in metazoan cells. They assemble from elementary dimers that are built around the central alpha-helical coiled-coil rod domain representing the IF 'signature'. The rod consists of two similarly-sized parts, coil 1 and coil 2, connected by a non-alpha-helical linker L12. Coil 2 is absolutely conserved in length across all IF types and was initially predicted to consist of a short coiled-coil segment 2A based on a heptad pattern of hydrophobic residues, another linker L2 and a coiled-coil segment 2B. Here we present the crystal structure of human vimentin fragment including residues 261-335 i.e. approximately the first half of coil 2. The N-terminal part of this fragment reveals a parallel alpha-helical bundle characterized by 3.5 consecutive hendecad repeats. It is immediately followed by a regular left-handed coiled coil. The distinct non-helical linker L2 is therefore not observed. Together with the previously determined crystal structure of the major part of segment 2B (Strelkov et al., 2002), we can now build a complete atomic model of the 21 nm long vimentin coil 2 dimer being a relatively rigid rod. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Nicolet, Stefan; Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut Sci, Louvain, Belgium.
   [Nicolet, Stefan; Aebi, Ueli] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4003 Basel, Switzerland.
   [Herrmann, Harald] German Canc Res Ctr, Grp Funct Architecture Cell, D-6900 Heidelberg, Germany.
RP Strelkov, SV (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut Sci, Louvain, Belgium.
EM sergei.strelkov@pharm.kuleuven.be
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
FU Swiss Society for Research on Muscular Diseases; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); K.U. LeuvenKU Leuven
FX The authors are most grateful to Dr. Norbert Mficke (Heidelberg) for
   help with analytical ultracentrifugation and to Steven Beelen (Leuven)
   for technical assistance. Skillful support of Dr. Meitian Wang during
   measurements at the SLS synchrotron is also acknowledged. This work was
   supported by a grant from the Swiss Society for Research on Muscular
   Diseases (to U.A. and S.V.S.), the Swiss National Science Foundation (to
   U.A.), and by the OT grant from the K.U. Leuven (to S.V.S.).
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Agniswamy J, 2008, ACTA CRYSTALLOGR D, V64, P354, DOI 10.1107/S0907444907068849
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013
   Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4
   Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   DeLano WL, 2002, PYMOL USERS MANUAL
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Garman E, 2003, ACTA CRYSTALLOGR D, V59, P1903, DOI 10.1107/S0907444903012794
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517
   HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214
   Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200
   Hess JF, 2002, J BIOL CHEM, V277, P35516, DOI 10.1074/jbc.M206500200
   Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101
   Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067
   MILAM L, 1982, J CELL BIOL, V94, P592, DOI 10.1083/jcb.94.3.592
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   NORTH ACT, 1994, PROTEINS, V20, P174, DOI 10.1002/prot.340200207
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009
   Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016
   Parry DAD, 2006, J STRUCT BIOL, V155, P370, DOI 10.1016/j.jsb.2006.03.017
   Peters J, 1996, J MOL BIOL, V257, P1031, DOI 10.1006/jmbi.1996.0221
   Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776
   Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103
   Sugahara M, 2005, ACTA CRYSTALLOGR D, V61, P1302, DOI 10.1107/S0907444905019670
   Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215
   Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545
NR 44
TC 66
Z9 67
U1 1
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAY
PY 2010
VL 170
IS 2
SI SI
BP 369
EP 376
DI 10.1016/j.jsb.2010.02.012
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 589XZ
UT WOS:000277188800024
PM 20176112
DA 2021-01-25
ER

PT J
AU Macdonald, PR
   Lustig, A
   Steinmetz, MO
   Kammerer, RA
AF Macdonald, Philip R.
   Lustig, Ariel
   Steinmetz, Michel O.
   Kammerer, Richard A.
TI Laminin chain assembly is regulated by specific coiled-coil interactions
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE AUC; CD spectroscopy; Coiled coil; EM; Laminin; Non-denaturing PAGE
ID LONG ARM; INITIATION; EXPRESSION
AB Laminins are large heterotrimeric, multidomain proteins that play a central role in organising and establishing all basement membranes. Despite a total of 45 potential heterotrimeric chain combinations formed through the coiled-coil domain of the 11 identified laminin chains (alpha 1-5, beta 1-3, gamma 1-3), to date only 15 different laminin isoforms have been reported. This observation raises the question whether laminin assembly is regulated by differential gene expression or specific chain recognition. To address this issue, we here perform a complete analysis of laminin chain assembly and specificity. Using biochemical and biophysical techniques, all possible heterotrimeric combinations from recombinant C-terminal coiled-coil fragments of all chains were analysed. Apart from laminin 323 (alpha 3, beta 2, gamma 3), for which no biochemical evidence of its existence in vivo is available, these experiments confirmed all other known laminin isoforms and identified two novel potential chain combinations, laminins 312 (alpha 3, beta 1, gamma 2) and 422 (alpha 4, beta 2, gamma 4). Our findings contribute to the understanding of basement membrane structure, function and diversity. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Macdonald, Philip R.; Kammerer, Richard A.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.
   [Lustig, Ariel] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
RP Kammerer, RA (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM richard.kammerer@manchester.ac.uk
OI Steinmetz, Michel/0000-0001-6157-3687; Kammerer,
   Richard/0000-0003-4570-5197
FU Wellcome TrustWellcome Trust Funding Source: Medline
CR Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602
   Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000
   Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685
   Mizushima H, 1998, HORM RES, V50, P7, DOI 10.1159/000053118
   Nomizu M, 1996, BIOCHEMISTRY-US, V35, P2885, DOI 10.1021/bi951555n
   NOMIZU M, 1994, J BIOL CHEM, V269, P30386
   NOMIZU M, 1992, INT J PEPT PROT RES, V40, P72
   PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x
   Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037
   Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883
   TIMPL R, 1979, J BIOL CHEM, V254, P9933
   UTANI A, 1995, J BIOL CHEM, V270, P3292, DOI 10.1074/jbc.270.7.3292
   UTANI A, 1994, J BIOL CHEM, V269, P19167
   Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766
NR 16
TC 32
Z9 35
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAY
PY 2010
VL 170
IS 2
SI SI
BP 398
EP 405
DI 10.1016/j.jsb.2010.02.004
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 589XZ
UT WOS:000277188800027
PM 20156561
OA Green Published, Other Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Escher, C
   Lochmuller, H
   Fischer, D
   Frank, S
   Reimann, J
   Walter, MC
   Ehrat, M
   Ruegg, MA
   Gygax, D
AF Escher, Claudia
   Lochmueller, Hanns
   Fischer, Dirk
   Frank, Stephan
   Reimann, Jens
   Walter, Maggie C.
   Ehrat, Markus
   Ruegg, Markus A.
   Gygax, Daniel
TI Reverse protein arrays as novel approach in muscular dystrophies
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Muscular dystrophy; Diagnosis; Reverse protein arrays
ID DMD GENE; DUCHENNE; DIAGNOSIS; DELETIONS; STRATEGY
AB The definite molecular diagnosis in patients with muscular dystrophies often requires the assessment of muscular expression of multiple proteins in small amounts of muscle tissue. The sample material obtained in muscle biopsies is limited and the measurement of multiple proteins is often restricted to conventional, non-quantitative assays, i.e. immunohistochemistry and immunoblotting. Here, we demonstrate that reverse protein arrays are a novel and excellent material-saving method for the measurement and quantification of changes in protein expression between healthy and diseased muscle tissue as well as cultured primary myotubes. We evaluated a set of antibodies and found reproducible differences between Duchenne muscular dystrophy/limb-girdle muscular dystrophy patients and control samples for dystrophin, the sarcoglycans and the dystroglycans. As little as 10 mg of tissue is sufficient for the analysis of all diagnostically relevant proteins. The average coefficient of variation calculated for the sample signals confirmed that the method is highly reproducible. Thus, our experiments provide strong evidence that quantitative protein detection from very small amounts of muscle tissue is possible using reverse protein arrays. This technology may not only be of interest for diagnostic purposes, but also for protein quantification of multiple, follow-up biopsies during clinical trials when protein expression in muscle is considered an important outcome measure or biomarker. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Escher, Claudia; Ruegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Escher, Claudia; Gygax, Daniel] Univ Appl Sci NW Switzerland, Sch Life Sci, CH-4132 Muttenz, Switzerland.
   [Lochmueller, Hanns] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England.
   [Fischer, Dirk] Univ Basel Hosp, Dept Neurol, Basel, Switzerland.
   [Fischer, Dirk] Univ Childrens Hosp Basel, Dept Neuropaediat, Basel, Switzerland.
   [Frank, Stephan] Univ Basel Hosp, Dept Neuropathol, Inst Pathol, Basel, Switzerland.
   [Reimann, Jens] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany.
   [Walter, Maggie C.] Univ Munich, Friedrich Baur Inst, Munich, Germany.
   [Walter, Maggie C.] Univ Munich, Dept Neurol, Munich, Germany.
   [Ehrat, Markus] Zeptosens, CH-4108 Witterswil, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Lochmuller, Hanns/0000-0003-2324-8001
FU German Ministry of Education and Research (BMBF, Bonn, Germany)Federal
   Ministry of Education & Research (BMBF) [01GM0601]; ECEuropean
   CommissionEuropean Commission Joint Research CentreEuropean Community
   (EC) [036825]; Canton of Basel-Stadt and Basel land; Swiss Foundation
   for Research on Muscle Diseases; Euro-BioBank; Medical Research
   CouncilMedical Research Council UK (MRC) [G0601943B, G0601943] Funding
   Source: researchfish
FX The excellent technical assistance of Maria Schmuck
   (Friedrich-Baur-Institute and Dept of Neurology,
   Ludwig-Maximilians-University, Germany) is gratefully acknowledged. The
   Muscle Tissue Culture Collection is part of the German network on
   muscular dystrophies (MD-NET, service structure Si, 01GM0601) funded by
   the German Ministry of Education and Research (BMBF, Bonn, Germany). The
   Muscle Tissue Culture Collection is a partner of Euro-BioBank
   (www.eurobiobank.org) and TREAT-NMD (EC, 6th FP, proposal # 036825).
   Markus A. Ruegg acknowledges the financial support by the Canton of
   Basel-Stadt and Basel land, and the Swiss Foundation for Research on
   Muscle Diseases. We thank Dr. Jens Trankle (Zeptosens - A division of
   Bayer (Schweiz) AG, Switzerland) for the excellent introduction to
   reverse protein array technologies and methods.
CR Anderson LVB, 2000, NEUROMUSCULAR DISORD, V10, P553, DOI 10.1016/S0960-8966(00)00143-7
   Carrie A, 1997, J MED GENET, V34, P470, DOI 10.1136/jmg.34.6.470
   Charlton R, 2009, NEUROMUSCULAR DISORD, V19, P449, DOI 10.1016/j.nmd.2009.05.005
   Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7
   Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941
   Flanigan KM, 2003, AM J HUM GENET, V72, P931, DOI 10.1086/374176
   Griggs RC, 2005, NEUROLOGY, V64, P1498, DOI 10.1212/01.WNL.0000163758.84916.87
   Guglieri M, 2008, NEUROL INDIA, V56, P271
   Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2
   HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4
   Klinge L, 2008, NEUROMUSCULAR DISORD, V18, P934, DOI 10.1016/j.nmd.2008.08.003
   Lai KKS, 2006, CLIN BIOCHEM, V39, P367, DOI 10.1016/j.clinbiochem.2005.11.019
   Manzur AY, 2009, J NEUROL NEUROSUR PS, V80, P706, DOI 10.1136/jnnp.2008.158329
   MATSUMURA K, 1993, NEUROMUSCULAR DISORD, V3, P109, DOI 10.1016/0960-8966(93)90002-2
   Mendell JR, 2001, NEUROLOGY, V57, P645, DOI 10.1212/WNL.57.4.645
   Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9
   Muntoni F, 2001, NEUROLOGY, V57, P574, DOI 10.1212/WNL.57.4.574
   Pandey GS, 2003, NEUROL INDIA, V51, P367
   Pawlak M, 2002, PROTEOMICS, V2, P383, DOI 10.1002/1615-9861(200204)2:4<383::AID-PROT383>3.0.CO;2-E
   Pogue R, 2001, NEUROMUSCULAR DISORD, V11, P80, DOI 10.1016/S0960-8966(00)00154-1
   Prior TW, 2005, J MOL DIAGN, V7, P317, DOI 10.1016/S1525-1578(10)60560-0
   R Development Core Team, 2009, R LANG ENV STAT COMP
   Schara U, 2004, NERVENARZT, V75, P1231, DOI 10.1007/s00115-004-1846-0
   SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909
   van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108
   Weilbach FX, 1999, NERVENARZT, V70, P89, DOI 10.1007/s001150050408
   White SJ, 2006, CYTOGENET GENOME RES, V115, P240, DOI 10.1159/000095920
NR 27
TC 6
Z9 6
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAY
PY 2010
VL 20
IS 5
BP 302
EP 309
DI 10.1016/j.nmd.2010.02.017
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 610WY
UT WOS:000278771300002
PM 20304647
DA 2021-01-25
ER

PT J
AU Brummer, A
   Salazar, C
   Zinzalla, V
   Alberghina, L
   Hofer, T
AF Bruemmer, Anneke
   Salazar, Carlos
   Zinzalla, Vittoria
   Alberghina, Lilia
   Hoefer, Thomas
TI Mathematical Modelling of DNA Replication Reveals a Trade-off between
   Coherence of Origin Activation and Robustness against Rereplication
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE CHROMOSOME; CYCLIN-DEPENDENT KINASES; MULTISITE
   PROTEIN-PHOSPHORYLATION; B-TYPE CYCLINS; S-PHASE; GENOMIC INSTABILITY;
   RE-REPLICATION; INHIBITOR SIC1; CDK; COMPLEX
AB Eukaryotic genomes are duplicated from multiple replication origins exactly once per cell cycle. In Saccharomyces cerevisiae, a complex molecular network has been identified that governs the assembly of the replication machinery. Here we develop a mathematical model that links the dynamics of this network to its performance in terms of rate and coherence of origin activation events, number of activated origins, the resulting distribution of replicon sizes and robustness against DNA rereplication. To parameterize the model, we use measured protein expression data and systematically generate kinetic parameter sets by optimizing the coherence of origin firing. While randomly parameterized networks yield unrealistically slow kinetics of replication initiation, networks with optimized parameters account for the experimentally observed distribution of origin firing times. Efficient inhibition of DNA rereplication emerges as a constraint that limits the rate at which replication can be initiated. In addition to the separation between origin licensing and firing, a time delay between the activation of S phase cyclin-dependent kinase (S-Cdk) and the initiation of DNA replication is required for preventing rereplication. Our analysis suggests that distributive multisite phosphorylation of the S-Cdk targets Sld2 and Sld3 can generate both a robust time delay and contribute to switch-like, coherent activation of replication origins. The proposed catalytic function of the complex formed by Dpb11, Sld3 and Sld2 strongly enhances coherence and robustness of origin firing. The model rationalizes how experimentally observed inefficient replication from fewer origins is caused by premature activation of S-Cdk, while premature activity of the S-Cdk targets Sld2 and Sld3 results in DNA rereplication. Thus the model demonstrates how kinetic deregulation of the molecular network governing DNA replication may result in genomic instability.
C1 [Bruemmer, Anneke; Salazar, Carlos; Hoefer, Thomas] German Canc Res Ctr, Res Grp Modelling Biol Syst B086, D-6900 Heidelberg, Germany.
   [Alberghina, Lilia] Univ Studi Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.
   [Bruemmer, Anneke; Salazar, Carlos; Hoefer, Thomas] BioQuant Ctr, Heidelberg, Germany.
   [Zinzalla, Vittoria] Univ Basel, Biozentrum, Basel, Switzerland.
RP Brummer, A (corresponding author), German Canc Res Ctr, Res Grp Modelling Biol Syst B086, D-6900 Heidelberg, Germany.
EM lilia.alberghina@unimib.it; t.hoefer@dkfz-heidelberg.de
RI Hofer, Thomas/G-5665-2013
OI Hofer, Thomas/0000-0003-3560-8780; Brummer, Anneke/0000-0002-3576-0750;
   Alberghina, Lilia/0000-0003-1694-931X
FU German Federal Ministry for Education and Research (BMBF)Federal
   Ministry of Education & Research (BMBF); Helmholtz AssociationHelmholtz
   Association; MUR-FIRB Italbionet
FX This work was funded by grants in the HepatoSys Programme of the German
   Federal Ministry for Education and Research (BMBF) and the Initiative
   and Networking Fund of the Helmholtz Association within the Helmholtz
   Alliance on Systems Biology/SBCancer (TH), as well as MUR-FIRB
   Italbionet ( LA) is gratefully acknowledged. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ALBERGHINA L, 2009, BIOTECHNOL ADV  0522
   Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064
   Bloom J, 2007, MOL CELL BIOL, V27, P842, DOI 10.1128/MCB.01069-06
   Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663
   Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794
   Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807
   Coccetti P, 2008, CELL CYCLE, V7, P1391, DOI 10.4161/cc.7.10.5825
   Cross FR, 2007, GENETICS, V176, P1541, DOI 10.1534/genetics.107.073494
   Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019
   Dinant C, 2009, J CELL BIOL, V185, P21, DOI 10.1083/jcb.200811080
   Donaldson AD, 2005, TRENDS GENET, V21, P444, DOI 10.1016/j.tig.2005.05.012
   Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491
   Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9
   FANGMAN WL, 1991, ANNU REV CELL BIOL, V7, P375, DOI 10.1146/annurev.cb.07.110191.002111
   Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x
   Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1
   Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Goldar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002919
   Green BM, 2006, MOL BIOL CELL, V17, P2401, DOI 10.1091/mbc.E05-11-1043
   Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022
   Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390
   Heinrich R, 1997, EUR J BIOCHEM, V243, P191
   Ikui AE, 2007, GENETICS, V175, P1011, DOI 10.1534/genetics.106.068213
   Jackson LP, 2006, MOL CELL BIOL, V26, P2456, DOI 10.1128/MCB.26.6.2456-2466.2006
   Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097
   Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063
   Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471
   Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277
   Labib K, 1999, NAT CELL BIOL, V1, P415
   Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0
   Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433
   Lygeros J, 2008, P NATL ACAD SCI USA, V105, P12295, DOI 10.1073/pnas.0805549105
   Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713
   McCune HJ, 2008, GENETICS, V180, P1833, DOI 10.1534/genetics.108.094359
   Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410
   Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009
   NEWLON CS, 1991, GENETICS, V129, P343
   Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7
   Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600
   Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000
   NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320
   Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030
   Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657
   Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317
   Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115
   Randich Alan, 2006, BMC Urol, V6, P2, DOI 10.1186/1471-2490-6-2
   Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313
   Rossi RL, 2005, CELL CYCLE, V4, P1798, DOI 10.4161/cc.4.12.2189
   Salazar C, 2007, FEBS J, V274, P1046, DOI 10.1111/j.1742-4658.2007.05653.x
   Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x
   Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162
   Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308
   Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033
   Sidorova JM, 2003, MUTAT RES-FUND MOL M, V532, P5, DOI 10.1016/j.mrfmmm.2003.08.006
   Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118
   Spiesser TW, 2009, MOL GENET GENOMICS, V282, P25, DOI 10.1007/s00438-009-0443-9
   Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075
   Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002
   Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757
   Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16
   Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465
   TYSON J, 2003, NAT REV MOL CELL BIO, V2, P908
   VANONI M, 1983, J BACTERIOL, V156, P1282, DOI 10.1128/JB.156.3.1282-1291.1983
   Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455
   Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304
   Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017
   Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x
   Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x
   Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432
   Zegerman P, 2009, DNA REPAIR, V8, P1077, DOI 10.1016/j.dnarep.2009.04.023
   Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000
NR 72
TC 27
Z9 28
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD MAY
PY 2010
VL 6
IS 5
AR e1000783
DI 10.1371/journal.pcbi.1000783
PG 13
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA 610TJ
UT WOS:000278759700015
PM 20485558
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

EF